PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Morandini, V; Ferrer, M				Morandini, Virginia; Ferrer, Miguel			How to plan reintroductions of long-lived birds	PLOS ONE			English	Article							DENSITY-DEPENDENT FECUNDITY; LESSER KESTREL; POPULATION; SUCCESS; CONSERVATION; CRITERIA; EAGLE	Reintroductions have been increasingly used for species restoration and it seems that this conservation tool is going to be more used in the future. Nevertheless, there is not a clear consensus about the better procedure for that, consequently a better knowledge of how to optimize this kind of management is needed. Here we examined the dynamics of released long-lived bird populations (lesser kestrel, Falco naumanni, Bonelli's eagle Aquila fasciata, and bearded vulture Gypaetus barbatus) in object-oriented simulated reintroduction programs. To do that, number of young per year and number of years of released necessary to achieve a successful reintroduced population were calculated. We define a successful reintroduction as one in which when the probability of extinction during two times the maximum live-span period for the species (20, 50, and 64 years respectively) was less than 0.001 (P<0.001) and they showed a positive trend in population size (r>0.00). Results showed that a similar total number of young (mean 98.33 +/- 5.26) must be released in all the species in all the scenarios in order to get a successful reintroduction. Consequently, as more young per year are released the new population is going to be larger at the end of the simulations, the lesser the negative effects in the donor population and the lowest the total budget needed will be.	[Morandini, Virginia; Ferrer, Miguel] CSIC, Appl Ecol Grp, Estn Biol Donana, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Morandini, V (corresponding author), CSIC, Appl Ecol Grp, Estn Biol Donana, Seville, Spain.	morandini@ebd.csic.es	Ferrer, Miguel/AFU-8286-2022; Ferrer Baena, Miguel/G-3519-2015; Morandini, Virginia/E-8986-2016	Ferrer Baena, Miguel/0000-0003-0092-8450; Morandini, Virginia/0000-0003-0665-5713				Alcaide M, 2010, CONSERV GENET, V11, P331, DOI 10.1007/s10592-009-9810-7; [Anonymous], [No title captured]; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Balbontin J, 2003, BIOL CONSERV, V109, P417, DOI 10.1016/S0006-3207(02)00168-4; Beck B. B., 1994, P265; DONAZAR JA, 1993, J APPL ECOL, V30, P504, DOI 10.2307/2404190; Ferguson-Lees J., 2003, RAPTORS WORLD; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2014, J APPL ECOL, V51, P1255, DOI 10.1111/1365-2664.12308; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Hiraldo F, 1996, J APPL ECOL, V33, P1085, DOI 10.2307/2404688; IUCN/SSC, 2013, GUID REINTR OTH CONS; Lack D., 1954, P343; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Mora C, 2013, SCIENCE, V341, DOI 10.1126/science.1237254; Muriel R, 2011, ARDEOLA, V58, P323, DOI 10.13157/arla.58.2.2011.323; Muriel R, 2010, ARDEOLA, V57, P175; Newton I., 1998, POPULATION LIMITATIO; O'Rourke E, 2014, LAND USE POLICY, V38, P129, DOI 10.1016/j.landusepol.2013.10.020; Parker K. A., 2013, NOTORNIS, V29, P4470; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Robert A, 2015, ANIM CONSERV, V18, P413, DOI 10.1111/acv.12244; Robert A, 2015, ANIM CONSERV, V18, P397, DOI 10.1111/acv.12188; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Seddon PJ, 2015, ANIM CONSERV, V18, P407, DOI 10.1111/acv.12239; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Seddon PJ, 1999, TRENDS ECOL EVOL, V14, P503, DOI 10.1016/S0169-5347(99)01720-6; Shier DM, 2015, ANIM CONSERV, V18, P411, DOI 10.1111/acv.12242; Soorae PS, 2016, GLOBAL REINTRODUCTIO; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; Sutherland WJ, 2010, CONSERV LETT, V3, P229, DOI 10.1111/j.1755-263X.2010.00113.x; Sutton AE, 2015, PEERJ, V3, DOI 10.7717/peerj.1012	33	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174186	10.1371/journal.pone.0174186	http://dx.doi.org/10.1371/journal.pone.0174186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445473	gold, Green Submitted, Green Published			2022-12-27	WOS:000400309200004
J	Wang, YF; Wu, LD; Luo, L; Zhang, YF; Dong, GH				Wang, Yifan; Wu, Lingdan; Luo, Liang; Zhang, Yifen; Dong, Guangheng			Short-term Internet search using makes people rely on search engines when facing unknown issues	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INTEGRATIVE THEORY; BRAIN; ACTIVATION; INSULA	The Internet search engines, which have powerful search/sort functions and ease of use features, have become an indispensable tool for many individuals. The current study is to test whether the short-term Internet search training can make people more dependent on it. Thirty-one subjects out of forty subjects completed the search training study which included a pre-test, a six-day's training of Internet search, and a post-test. During the pre- and post-tests, subjects were asked to search online the answers to 40 unusual questions, remember the answers and recall them in the scanner. Un-learned questions were randomly presented at the recalling stage in order to elicited search impulse. Comparing to the pre- test, subjects in the post-test reported higher impulse to use search engines to answer un-learned questions. Consistently, subjects showed higher brain activations in dorsolateral prefrontal cortex and anterior cingulate cortex in the post-test than in the pre-test. In addition, there were significant positive correlations self-reported search impulse and brain responses in the frontal areas. The results suggest that a simple six-day's Internet search training can make people dependent on the search tools when facing unknown issues. People are easily dependent on the Internet search engines.	[Wang, Yifan; Zhang, Yifen; Dong, Guangheng] Zhejiang Normal Univ, Inst Psychol & Brain Sci, Dept Psychol, Jinhua, Peoples R China; [Wu, Lingdan] Univ Konstanz, Dept Psychol, Constance, Germany; [Luo, Liang] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Luo, Liang] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Dong, Guangheng] Zhejiang Normal Univ, Inst Psychol & Brain Sci, Jinhua, Peoples R China	Zhejiang Normal University; University of Konstanz; Beijing Normal University; Beijing Normal University; Zhejiang Normal University	Dong, GH (corresponding author), Zhejiang Normal Univ, Inst Psychol & Brain Sci, Dept Psychol, Jinhua, Peoples R China.; Dong, GH (corresponding author), Zhejiang Normal Univ, Inst Psychol & Brain Sci, Jinhua, Peoples R China.	dongguangheng@zjnu.edu.cn	Wu, Lingdan/Q-8561-2017	Wu, Lingdan/0000-0003-3573-1455; Dong, Guang-Heng/0000-0001-8813-8730	National Science foundation of China [31371023]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB 1207]	National Science foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning	Dr. Dong was supported by National Science foundation of China (31371023), and funded by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLYB 1207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2014, COGNITIVE SCI, V38, P1249, DOI 10.1111/cogs.12126; Carr N, 2010, TIMES SATURDAY REV, V14, P1; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dong G, 2015, EUROPEAN J NEUROSCIE; Dong G, BIOL PSYCHIAT; Dong GH, 2016, HUM BRAIN MAPP, V37, P3999, DOI 10.1002/hbm.23290; Dong GH, 2016, NEUROSCIENCE, V335, P82, DOI 10.1016/j.neuroscience.2016.08.028; Dong GH, 2015, EUR J NEUROSCI, V42, P2546, DOI 10.1111/ejn.13039; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Fisher M, 2015, J EXP PSYCHOL GEN, V144, P674, DOI 10.1037/xge0000070; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Heining M, 2003, ANN NY ACAD SCI, V1000, P380, DOI 10.1196/annals.1280.035; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kishinevsky FI, 2012, APPETITE, V58, P582, DOI 10.1016/j.appet.2011.11.029; Kober H, 2015, NEUROPSYCHOPHARMACOL; Loh KK, 2015, NEUROSCIENTIST; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nicholas D, 2011, ASLIB PROC, V63, P28, DOI 10.1108/00012531111103768; Potenza MN, 2012, AM J PSYCHIAT, V169, P406, DOI 10.1176/appi.ajp.2011.11020289; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Sparrow B, 2011, SCIENCE, V333, P776, DOI 10.1126/science.1207745; Spence C, 2015, EATING OUR EYES VISU; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Wang Y, 2016, FRONT PUBLIC HLTH, V274; Wang YF, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00274; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	34	9	9	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176325	10.1371/journal.pone.0176325	http://dx.doi.org/10.1371/journal.pone.0176325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441408	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800044
J	Marcombe, S; Bobichon, J; Somphong, B; Phommavan, N; Maithaviphet, S; Nambanya, S; Corbel, V; Brey, PT				Marcombe, Sebastien; Bobichon, Julie; Somphong, Boutsady; Phommavan, Nothasin; Maithaviphet, Santi; Nambanya, Simone; Corbel, Vincent; Brey, Paul T.			Insecticide resistance status of malaria vectors in Lao PDR	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; KNOCKDOWN RESISTANCE; PYRETHROID RESISTANCE; ANOPHELES-MINIMUS; IDENTIFICATION; MUTATION; DDT; KDR; POPULATIONS; MECHANISMS	Knowledge on insecticide resistance in Anopheles species is a basic requirement to guide malaria vector control programs. In Lao PDR, vector control relies on insecticide residual spraying (IRS) and impregnated bed-nets (ITNs) with the use of pyrethroids. Here, the susceptibility of Anopheles species, including several malaria vectors (An. maculatus and An. minimus), to various insecticides was investigated in ten provinces of Lao PDR through a north-south transect. Bioassays were performed on field caught female mosquitoes using the standard WHO susceptibility tests with DDT (4%), deltamethrin (0.05%) and permethrin (0.75%). In addition, the DIIS6 region of the para-type sodium channel gene was amplified and sequenced to identify knockdown resistance mutations (kdr). Resistance to DDT and permethrin was detected in suspected malaria vectors, such as An. nivipes and An. philippinensis in Lao PDR. Resistance to the formerly used DDT was found in a population of An. maculatus s.l. from Luang Prabang province. No resistance to pyrethroids was found in primary vectors, indicating that these insecticides are still adequate for malaria vector control. However, high resistance levels to pyrethroids was found in-vector species and reduced susceptibility to permethrin in An. minimus and An. maculatus was reported in specific localities which raises concerns for pyrethroid-based control in the future. No kdr mutation was found in any of the resistant populations tested hence suggesting a probable role detoxification enzymes in resistance. This study highlights the necessity to continue the monitoring of insecticide susceptibility to early detect potential occurrence and/or migration of insecticide resistance in malaria vectors in Lao PDR.	[Marcombe, Sebastien; Bobichon, Julie; Somphong, Boutsady; Phommavan, Nothasin; Brey, Paul T.] Minist Hlth, Inst Pasteur Laos, Viangchan, Laos; [Maithaviphet, Santi; Nambanya, Simone] Minist Hlth, Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Corbel, Vincent] UM1CNRS 5290 IRD 224, Inst Rech Dev, MIVEGEC, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Marcombe, S (corresponding author), Minist Hlth, Inst Pasteur Laos, Viangchan, Laos.	s.marcombe@pasteur.la		corbel, vincent/0000-0003-0995-3257	French Ministry of Foreign Affairs and International Development [12INI212]	French Ministry of Foreign Affairs and International Development	This work was supported by contract no 12INI212 with Initiative 5%, http://www.initiative5pour100.fr/er/, French Ministry of Foreign Affairs and International Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chareonviriyaphap T, 2003, J VECTOR ECOL, V28, P108; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dimond JB, 1996, ENVIRON POLLUT, V92, P227, DOI 10.1016/0269-7491(95)00059-3; Dykes CL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0946-7; FINNEY D J, 1971, P333; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Kobayashi J, 2004, ACTA TROP, V89, P299, DOI 10.1016/j.actatropica.2003.10.009; Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P1, DOI 10.5772/3392; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Minisrtry of Health LP, 2010, NAT STRAT MAL CO PRE; MNREPCD, 2016, LAO PEOPL DEM REP NA; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Overgaard HJ, 2006, MALARIA MOSQUITO RES; Perera MDB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-168; Pongvongsa T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-262; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; Rongnoparut P, 2003, J VECTOR ECOL, V28, P150; Syafruddin D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-315; Tran T., 2013, PERSISTENT ORGANIC P, P157; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2016, 2016 WHO; WHO, 2014, WHO GUID COUNT COMB; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; World Health Organization, 2016, TEST PROC INREMO, V2nd, DOI DOI 10.1007/978-3-642-10565-4; World Health Organization, 2016, WHO MAL TERM; World Health Organization, 2015, WORLD MALARIA REPORT; Yang C, 2016, CHINA MALAR J, P15	38	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175984	10.1371/journal.pone.0175984	http://dx.doi.org/10.1371/journal.pone.0175984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437449	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600026
J	Warfield, BM; Anderson, PC				Warfield, Becka M.; Anderson, Peter C.			Molecular simulations and Markov state modeling reveal the structural diversity and dynamics of a theophylline-binding RNA aptamer in its unbound state	PLOS ONE			English	Article							PROTEIN RECOGNITION; SOFTWARE PACKAGE; FOLDING KINETICS; SINGLE-MOLECULE; INDUCED FIT; IN-VITRO; SELECTION; DISCRIMINATION; IMPLEMENTATION; VISUALIZATION	RNA aptamers are oligonucleotides that bind with high specificity and affinity to target ligands. In the absence of bound ligand, secondary structures of RNA aptamers are generally stable, but single-stranded and loop regions, including ligand binding sites, lack defined structures and exist as ensembles of conformations. For example, the well-characterized theophylline-binding aptamer forms a highly stable binding site when bound to theophylline, but the binding site is unstable and disordered when theophylline is absent. Experimental methods have not revealed at atomic resolution the conformations that the theophylline aptamer explores in its unbound state. Consequently, in the present study we applied 21 microseconds of molecular dynamics simulations to structurally characterize the ensemble of conformations that the aptamer adopts in the absence of theophylline. Moreover, we apply Markov state modeling to predict the kinetics of transitions between unbound conformational states. Our simulation results agree with experimental observations that the theophylline binding site is found in many distinct binding-incompetent states and show that these states lack a binding pocket that can accommodate theophylline. The binding-incompetent states interconvert with binding-competent states through structural rearrangement of the binding site on the nanosecond to microsecond timescale. Moreover, we have simulated the complete theophylline binding pathway. Our binding simulations supplement prior experimental observations of slow theophylline binding kinetics by showing that the binding site must undergo a large conformational rearrangement after the aptamer and theophylline form an initial complex, most notably, a major rearrangement of the C27 base from a buried to solvent-exposed orientation. Theophylline appears to bind by a combination of conformational selection and induced fit mechanisms. Finally, our modeling indicates that when Mg2+ ions are present the population of binding-competent aptamer states increases more than twofold. This population change, rather than direct interactions between Mg2+ and theophylline, accounts for altered theophylline binding kinetics.	[Warfield, Becka M.; Anderson, Peter C.] Univ Washington, Dept Phys Sci, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Anderson, PC (corresponding author), Univ Washington, Dept Phys Sci, Bothell, WA 98011 USA.	pca4@uw.edu						Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Antczak M, 2014, NUCLEIC ACIDS RES, V42, pW368, DOI 10.1093/nar/gku330; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bastian AA, 2012, NAT CHEM, V4, P789, DOI [10.1038/NCHEM.1402, 10.1038/nchem.1402]; Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman GR, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755751; Bowman GR, 2009, METHODS, V49, P197, DOI 10.1016/j.ymeth.2009.04.013; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; Chodera JD, 2014, CURR OPIN STRUC BIOL, V25, P135, DOI 10.1016/j.sbi.2014.04.002; Cordero P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004473; Creighton T. E., 1993, PROTEINS STRUCTURES; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DASILVA AWS, 2012, BMC RES NOTES, V5, DOI DOI 10.1186/1756-0500-5-367; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Draper DE, 1996, TRENDS BIOCHEM SCI, V21, P145; ELLINGTON AD, 1994, CURR BIOL, V4, P427, DOI 10.1016/S0960-9822(00)00093-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Famulok M, 2011, ACCOUNTS CHEM RES, V44, P1349, DOI 10.1021/ar2000293; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Han K, 2010, SENSORS-BASEL, V10, P4541, DOI 10.3390/s100504541; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang XH, 2010, BIOCOMPUT-PAC SYM, P228; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jucker FM, 2003, BIOCHEMISTRY-US, V42, P2560, DOI 10.1021/bi027103+; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Keller BG, 2014, J AM CHEM SOC, V136, P4534, DOI 10.1021/ja4098719; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lin PH, 2010, BIOTECHNOL J, V5, P1069, DOI 10.1002/biot.201000212; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Noe F, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2916718; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prinz JH, 2011, PHYS CHEM CHEM PHYS, V13, P16912, DOI 10.1039/c1cp21258c; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Radom F, 2013, BIOTECHNOL ADV, V31, P1260, DOI 10.1016/j.biotechadv.2013.04.007; Salvalaglio M, 2014, J CHEM THEORY COMPUT, V10, P1420, DOI 10.1021/ct500040r; Senne M, 2012, J CHEM THEORY COMPUT, V8, P2223, DOI 10.1021/ct300274u; Singhal N, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2116947; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Swope WC, 2004, J PHYS CHEM B, V108, P6582, DOI 10.1021/jp037422q; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tiwary P, 2015, P NATL ACAD SCI USA, V112, pE386, DOI 10.1073/pnas.1424461112; Tiwary P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230602; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; UHLENBECK OC, 1995, RNA, V1, P4; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Wedekind JE, 1999, NAT STRUCT BIOL, V6, P261, DOI 10.1038/6700; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Woodson SA, 2000, NAT STRUCT BIOL, V7, P349, DOI 10.1038/75106; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zimmerman MI, 2015, J CHEM THEORY COMPUT, V11, P5747, DOI 10.1021/acs.jctc.5b00737; Zimmermann GR, 1997, NAT STRUCT BIOL, V4, P644, DOI 10.1038/nsb0897-644; Zimmermann GR, 1997, THESIS	91	22	22	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176229	10.1371/journal.pone.0176229	http://dx.doi.org/10.1371/journal.pone.0176229			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437473	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600037
J	Zhao, DY; Cao, XY; Huang, R; Zeng, J; Wu, QLL				Zhao, Dayong; Cao, Xinyi; Huang, Rui; Zeng, Jin; Wu, Qinglong L.			Variation of bacterial communities in water and sediments during the decomposition of Microcystis biomass	PLOS ONE			English	Article							LAKE TAIHU; CELLULOSE DEGRADATION; ENCLOSURE EXPERIMENT; SP NOV.; CLOSTRIDIUM; CHINA; DIVERSITY; BLOOMS; IDENTIFICATION; RELEASE	The bacterial community composition in water and sediment samples during the decomposition of Microcystis biomass were analyzed using the 454 pyrosequencing technique. We found dramatic shifts in the bacterial community composition of water and sediments after the addition of Microcystis biomass. Among all the detected phyla, only Firmicutes was found to be dominant in both water and sediment samples. The genus Clostridium sensu stricto was the absolutely dominant group in Firmicutes and showed drastic variations with incubation time during the decomposition process. Peak values in relative abundance of Clostridium sensu stricto appeared in the first few days for water and sediment samples. Environmental factors such as pH, dissolved oxygen (DO), and dissolved organic carbon (DOC) in water samples showed drastic variations during the decomposing process, which might be the prominent forces driving the variation of bacterial communities. The abundant genus, Clostridium sensu stricto, were thought to be well adapted to higher DOC and turbidity and lower pH and DO conditions. Compared with the sediment samples, the decomposition of Microcystis biomass had greater influence on the bacterial community composition in water and Clostridium sensu stricto might play important roles in the process of Microcystis biomass decomposition.	[Zhao, Dayong; Cao, Xinyi; Huang, Rui] Hohai Univ, Coll Hydrol & Water Resources, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Cao, Xinyi; Huang, Rui; Zeng, Jin; Wu, Qinglong L.] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China	Hohai University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Zeng, J (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	jzeng@niglas.ac.cn	Zeng, Jin/AAQ-7810-2020	Zeng, Jin/0000-0002-3298-4820	National Natural Science Foundation of China [41571108, U1202231]; Natural Science Foundation of Jiangsu Province, China [BK20151614]; National Key Technology RD Program [2015BAD13601]; Youth Innovation Promotion Association of Chinese Academy of Sciences [2013203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Key Technology RD Program(National Key Technology R&D Program); Youth Innovation Promotion Association of Chinese Academy of Sciences	JZ received funding from the National Natural Science Foundation of China (41571108) (http://www.nsfc.gov.cn/). JZ received funding from the Natural Science Foundation of Jiangsu Province, China (BK20151614) (http://www.jstd.gov.in/). QW received funding from the National Natural Science Foundation of China (U1202231) (http://www.nsfc.gov.cn/). QW received funding from the National Key Technology R&D Program (2015BAD13601) (http://www.most.gov.cn/). JZ received funding from the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013203) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Burrell PC, 2004, APPL ENVIRON MICROB, V70, P2414, DOI 10.1128/AEM.70.4.2414-2419.2004; Chen MJ, 2010, FEMS MICROBIOL ECOL, V74, P19, DOI 10.1111/j.1574-6941.2010.00923.x; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; Dickinson C. H., 2012, BIOL PLANT LITTER DE; Dilly O, 2004, APPL ENVIRON MICROB, V70, P468, DOI 10.1128/AEM.70.1.468-474.2004; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Grossart HP, 2006, ENVIRON MICROBIOL, V8, P1074, DOI 10.1111/j.1462-2920.2006.00999.x; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Herring CD, 2016, APPL MICROBIOL BIOT, V100, P2907, DOI 10.1007/s00253-016-7294-1; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Jin X. C., 1990, SURVEY SPECIFICATION; Kato S, 2004, FEMS MICROBIOL ECOL, V51, P133, DOI 10.1016/j.femsec.2004.07.015; Landa M, 2016, ISME J, V10, P39, DOI 10.1038/ismej.2015.105; Leff JW, 2012, ECOSYSTEMS, V15, P284, DOI 10.1007/s10021-011-9510-2; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Liu LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081232; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Shao KQ, 2014, SCI TOTAL ENVIRON, V488, P236, DOI [10.1016/j.scitotenv2014.04.101, 10.1016/j.scitotenv.2014.04.101]; Shao KQ, 2013, J BASIC MICROB, V53, P549, DOI 10.1002/jobm.201100532; Shi XL, 2007, MAR FRESHWATER RES, V58, P634, DOI 10.1071/MF06212; Shiratori H, 2009, INT J SYST EVOL MICR, V59, P1764, DOI 10.1099/ijs.0.003483-0; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Wang SG, 2015, ENVIRON SCI POLLUT R, V22, P14269, DOI 10.1007/s11356-015-4652-y; Wu YF, 2014, INT J SYST EVOL MICR, V64, P3844, DOI 10.1099/ijs.0.064345-0; Xie LQ, 2003, ENVIRON POLLUT, V122, P391, DOI 10.1016/S0269-7491(02)00305-6; Xing P, 2011, ISME J, V5, P792, DOI 10.1038/ismej.2010.176; Zeng J, 2016, ENVIRON MICROBIOL, V18, P5175, DOI 10.1111/1462-2920.13526; Zeng J, 2012, APPL ENVIRON MICROB, V78, P177, DOI 10.1128/AEM.05117-11; Zhang ZY, 2016, J HAZARD MATER, V315, P126, DOI 10.1016/j.jhazmat.2016.05.011; Zhao DY, 2014, APPL MICROBIOL BIOT, V98, P9119, DOI 10.1007/s00253-014-5920-3; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhu MY, 2013, ENVIRON SCI POLLUT R, V20, P1803, DOI 10.1007/s11356-012-1084-9	39	28	29	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176397	10.1371/journal.pone.0176397	http://dx.doi.org/10.1371/journal.pone.0176397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437480	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600047
J	Rios-Solis, YA; Saucedo-Espinosa, MA; Caballero-Robledo, GA				Agueda Rios-Solis, Yasmin; Alberto Saucedo-Espinosa, Mario; Arturo Caballero-Robledo, Gabriel			Repayment policy for multiple loans	PLOS ONE			English	Article							OPTIMIZATION; MANAGEMENT; DEBT	The Repayment Policy for Multiple Loans is about a given set of loans and a monthly incoming cash flow: what is the best way to allocate the monthly income to repay such loans? In this article, we close the almost 20-year-old open question about how to model the repayment policy for multiple loans problem together with its computational complexity. Thus, we propose a mixed integer linear programming model that establishes an optimal repayment schedule by minimizing the total amount of cash required to repay the loans. We prove that the most employed repayment strategies, such as the highest interest debt and the debt snowball methods, are not optimal. Experimental results on simulated cases based on real data show that our methodology obtains on average more than 4% of savings, that is, the debtor pays approximately 4% less to the bank or loaner, which is a considerable amount in finances. In certain cases, the debtor can save up to 40%.	[Agueda Rios-Solis, Yasmin] Univ Autonoma Nuevo Leon, Syst Engn, Monterrey, Nuevo Leon, Mexico; [Alberto Saucedo-Espinosa, Mario] Rochester Inst Technol, Microsyst Engn Dept, Rochester, NY USA; [Arturo Caballero-Robledo, Gabriel] CINVESTAV Monterrey, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Rochester Institute of Technology; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Rios-Solis, YA (corresponding author), Univ Autonoma Nuevo Leon, Syst Engn, Monterrey, Nuevo Leon, Mexico.	yasmin.riossis@uanl.edu.mx	Saucedo-Espinosa, Mario A./AAH-8752-2020; Rios solis, yasmin/GLU-5226-2022	Rios solis, yasmin/0000-0003-3785-4440; Caballero-Robledo, Gabriel/0000-0002-0659-2516				Amar M, 2011, J MARKETING RES, V48, pS38, DOI 10.1509/jmkr.48.SPL.S38; [Anonymous], 2015, MUTUAL N 7 TIPS MANA; Banxico, 2013, IND SIC TARJ CRED DA; Chandra Prasanna., 2011, FINANC MANAGE; Glashoff K, 2012, LINEAR OPTIMIZATION, V45; GUPTA SK, 1987, OMEGA-INT J MANAGE S, V15, P323, DOI 10.1016/0305-0483(87)90020-X; GUROBI OPTIMIZATION I., 2015, GUR OPT REF MAN; Ha SH, 2012, COMPUT OPER RES, V39, P765, DOI 10.1016/j.cor.2010.10.032; Hartmann S, 2010, EUR J OPER RES, V207, P1, DOI 10.1016/j.ejor.2009.11.005; Johnson D. S, 1979, COMPUTERS INTRACTABI; Kellerer H., 2004, KNAPSACK PROBLEMS, P235; Martello S., 1990, KNAPSACK PROBLEMS; Natarajan K, 2010, MATH FINANC, V20, P695, DOI 10.1111/j.1467-9965.2010.00417.x; Nemhauser G.L., 1988, COAL B, V20; Ng CT, 2012, ANN OPER RES, V192, P141, DOI 10.1007/s10479-011-0872-9; Papadimitriou C.H., 1982, COMBINATORIAL OPTIMI; Papadimitriou C, 2014, P NATL ACAD SCI USA, V111, P15881, DOI 10.1073/pnas.1416954111; Pimentel, 2001, CONSTR MANAGE EC ROU, V19, P469, DOI DOI 10.1080/01446193.2001.9709623; Serrano-Cinca C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139427; Sohn SY, 2014, COMPUT OPER RES, V48, P81, DOI 10.1016/j.cor.2014.03.013; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117844; Weglarz J, 2011, EUR J OPER RES, V208, P177, DOI 10.1016/j.ejor.2010.03.037	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175782	10.1371/journal.pone.0175782	http://dx.doi.org/10.1371/journal.pone.0175782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430786	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100018
J	Irfan, M; Alam, S; Manzoor, N; Abid, M				Irfan, Mohammad; Alam, Shadab; Manzoor, Nikhat; Abid, Mohammad			Effect of quinoline based 1,2,3-triazole and its structural analogues on growth and virulence attributes of Candida albicans	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; IN-VITRO; ANTIFUNGAL AGENTS; DESIGN; PROTEINASES; DERIVATIVES; ACTIVATION; DIMORPHISM; GLUCOSE; HYBRIDS	Candida albicans, along with some other non-albicans Candida species, is a group of yeast, which causes serious infections in humans that can be both systemic and superficial. Despite the fact that extensive efforts have been put into the discovery of novel antifungal agents, the frequency of these fungal infections has increased drastically worldwide. In our quest for the discovery of novel antifungal compounds, we had previously synthesized and screened quinoline containing 1,2,3-triazole (3a) as a potent Candida spp inhibitor. In the present study, two structural analogues of 3a (3b and 3c) have been synthesized to determine the role of quinoline and their anti-Candida activities have been evaluated. Preliminary results helped us to determine 3a and 3b as lead inhibitors. The IC50 values of compound 3a for C. albicans ATCC 90028 (standard) and C. albicans (fluconazole resistant) strains were 0.044 and 2.3 mu g/ml, respectively while compound 3b gave 25.4 and 32.8 mu g/ml values for the same strains. Disk diffusion, growth and time kill curve assays showed significant inhibition of C. albicans in the presence of compounds 3a and 3b. Moreover, 3a showed fungicidal nature while 3b was fungistatic. Both the test compounds significantly lower the secretion of proteinases and phospholipases. While, 3a inhibited proteinase secretion in C. albicans (resistant strain) by 45%, 3b reduced phospholipase secretion by 68% in C. albicans ATCC90028 at their respective MIC values. Proton extrusion and intracellular pH measurement studies suggested that both compounds potentially inhibit the activity of H+ ATPase, a membrane protein that is crucial for various cell functions. Similarly, 95-97% reduction in ergosterol content was measured in the presence of the test compounds at MIC and MIC/2. The study led to identification of two quinoline based potent inhibitors of C. albicans for further structural optimization and pharmacological investigation.	[Irfan, Mohammad; Alam, Shadab; Abid, Mohammad] Jamia Millia Islamia, Dept Biosci, Med Chem Lab, New Delhi, India; [Irfan, Mohammad; Manzoor, Nikhat] Jamia Millia Islamia, Dept Biosci, Med Mycol Lab, New Delhi, India; [Manzoor, Nikhat] Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, Saudi Arabia; [Abid, Mohammad] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68182 USA	Jamia Millia Islamia; Jamia Millia Islamia; Taibah University; University of Nebraska System; University of Nebraska Medical Center	Abid, M (corresponding author), Jamia Millia Islamia, Dept Biosci, Med Chem Lab, New Delhi, India.; Manzoor, N (corresponding author), Jamia Millia Islamia, Dept Biosci, Med Mycol Lab, New Delhi, India.; Manzoor, N (corresponding author), Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, Saudi Arabia.; Abid, M (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68182 USA.	nikhatmanzoor@yahoo.co.in; mabid@jmi.ac.in		Manzoor, Nikhat/0000-0002-6850-6142; ABID, MOHAMMAD/0000-0002-0507-8451	UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA [5-123/2016 (IC)]; UGC, India	UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA; UGC, India(University Grants Commission, India)	Mohammad Abid gratefully acknowledges UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA (F. No. 5-123/2016 (IC)). MI acknowledges Non-NET fellowship support from UGC, India.; Mohammad Abid gratefully acknowledges UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA (F. No. 5-123/2016 (IC)). MI acknowledges Non-NET fellowship support from UGC, India. The authors are thankful to Dr. Shabana I. Khan, Principal Scientist, National Center for Natural Products Research (NCNPR), School of Pharmacy, University of Mississippi, MS 38677, USA for doing cell-proliferation assay on Vero cells (monkey kidney fibroblasts). We are also thankful to Prof. Luqman A. Khan, JMI for providing the clinical strains of C. albicans and Ms. Babita Aneja for helping in spectral characterization.	Ahmad A, 2010, FITOTERAPIA, V81, P1157, DOI 10.1016/j.fitote.2010.07.020; Aneja B, 2016, ORG BIOMOL CHEM, V14, P10599, DOI [10.1039/C6OB01718E, 10.1039/c6ob01718e]; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calderone Richard A., 2002, P15; Campetelli AN, 2005, FEBS J, V272, P5742, DOI 10.1111/j.1742-4658.2005.04959.x; Cao XF, 2014, J MED CHEM, V57, P3687, DOI 10.1021/jm4016284; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Di Santo R, 2005, J MED CHEM, V48, P5140, DOI 10.1021/jm048997u; Gacser A, 2007, INFECT IMMUN, V75, P4710, DOI 10.1128/IAI.00372-07; Groll Andreas H, 2012, Future Microbiol, V7, P179, DOI 10.2217/fmb.11.154; Irfan M, 2015, EUR J MED CHEM, V93, P246, DOI 10.1016/j.ejmech.2015.02.007; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583; KAUR S, 1988, BIOCHIM BIOPHYS ACTA, V972, P277, DOI 10.1016/0167-4889(88)90202-9; Khan A, 2014, RES MICROBIOL, V165, P411, DOI 10.1016/j.resmic.2014.05.031; Kumar D. A., 2015, British Microbiology Research Journal, V5, P68; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Manohar S, 2012, ACS MED CHEM LETT, V3, P555, DOI 10.1021/ml3000808; Manzoor Nikhat, 2002, Indian Journal of Experimental Biology, V40, P785; Martins N, 2014, MYCOPATHOLOGIA, V177, P223, DOI 10.1007/s11046-014-9749-1; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117; Perlin DS, 1997, ANN NY ACAD SCI, V834, P609, DOI 10.1111/j.1749-6632.1997.tb52330.x; PRICE MF, 1982, SABOURAUDIA, V20, P7; RUCHEL R, 1982, SABOURAUDIA, V20, P233; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schiaffella F, 2005, J MED CHEM, V48, P7658, DOI 10.1021/jm050685j; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SetoYoung D, 1997, BBA-BIOMEMBRANES, V1326, P249, DOI 10.1016/S0005-2736(97)00028-X; Sheng CQ, 2006, J MED CHEM, V49, P2512, DOI 10.1021/jm051211n; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Tobudic S, 2012, MYCOSES, V55, P24, DOI 10.1111/j.1439-0507.2011.02146.x; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952; Wang SZ, 2014, ACS MED CHEM LETT, V5, P506, DOI 10.1021/ml400492t; Wayne, 2002, PERFORMANCE STANDARD, V12, P1; Yao B, 2007, J MED CHEM, V50, P5293, DOI 10.1021/jm0701167	37	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175710	10.1371/journal.pone.0175710	http://dx.doi.org/10.1371/journal.pone.0175710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430797	gold, Green Submitted, Green Published			2022-12-27	WOS:000399876100016
J	dos Santos, TOC; Oliveira, MAD; Monte, JCM; Batista, MC; Pereira, VG; dos Santos, BFC; Santos, OFP; Durao, MD				Claizoni dos Santos, Thais Oliveira; de Souza Oliveira, Marisa Aparecida; Martins Monte, Julio Cesar; Batista, Marcelo Costa; Pereira Junior, Virgilio Goncalves; Cardoso dos Santos, Bento Fortunato; Pavao Santos, Oscar Fernando; Durao Junior, Marcelino de Souza			Outcomes from a cohort of patients with acute kidney injury subjected to continuous venovenous hemodiafiltration: The role of negative fluid balance	PLOS ONE			English	Article							RENAL-REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; MORTALITY; INITIATION; FAILURE; VOLUME; PREDICTORS; MANAGEMENT; INTENSITY; OVERLOAD	Background Several factors influence the outcomes in acute kidney injury (AKI), especially in intensive care unit (ICU) patients. In this scenario, continuous renal replacement therapies (CRRT) are used to control metabolic derangements and blood volume. Knowing this fact, it may be possible to change the course of the disease and decrease the high mortality rate observed. Thus, we aimed to evaluate the main risk factors for death in AKI patients needing CRRT. Results This was a prospective, observational cohort study of ICU patients (N = 183) with AKI who underwent continuous venovenous hemodiafiltration (CVVHDF) as their initial dialysis modality choice. The patients were predominantly male (62.8%) and their median age was 65 (55-76) years. The most frequent comorbidities were cardiovascular disease (39.3%), hypertension (32.8%), diabetes (24%), and cirrhosis (20.7%). The main cause of AKI was sepsis (52.5%). At beginning of CVVHDF, 152 patients (83%) were using vasopressors. The median SAPS 3 and SOFA score at ICU admission was 61 (50-74) and 10 (7-12), respectively. The dialysis dose delivered was 33.2 (28.9-38.7) ml/kg/h. The median time between ICU admission and CVVHDF initiation was 2 (1-4) days. The median cumulative fluid balance during the CVVHDF period was -1838 (-5735 +2993) ml. The mortality rate up to90 days was 58%. The independent mortality risk factors in propensity score model were: chronic obstructive pulmonary disease (OR = 3.44[1.14-10.4; p = 0.028]), hematologic malignancy (OR = 5.14[1.66-15.95; p = 0.005]), oliguria (OR = 2.36[1.15-4.9; p = 0.02]), positive daily fluid balance during CVVHDF (OR = 4.55[2.75-13.1; p < 0.001]), and total SOFA score on first dialysis day (OR = 1.27[1.12-1.45; p < 0.001]). Conclusions Dialysis-related factors may influence the outcomes. In our cohort, positive daily fluid balance during CRRT was associated with lower survival. Multicenter, randomized studies are needed to assess fluid balance as a primary outcome to define the best strategy in this patient population.	[Claizoni dos Santos, Thais Oliveira; de Souza Oliveira, Marisa Aparecida; Batista, Marcelo Costa; Pavao Santos, Oscar Fernando; Durao Junior, Marcelino de Souza] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, SP, Brazil; [de Souza Oliveira, Marisa Aparecida; Martins Monte, Julio Cesar; Batista, Marcelo Costa; Pereira Junior, Virgilio Goncalves; Cardoso dos Santos, Bento Fortunato; Pavao Santos, Oscar Fernando; Durao Junior, Marcelino de Souza] Hosp Israelite Albert Einstein, Nephrol Div, Sao Paulo, SP, Brazil; [Claizoni dos Santos, Thais Oliveira] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Durao, MD (corresponding author), Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, SP, Brazil.; Durao, MD (corresponding author), Hosp Israelite Albert Einstein, Nephrol Div, Sao Paulo, SP, Brazil.	marcelino@einstein.br			Fundacao de Ampan a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19020-9]	Fundacao de Ampan a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors received specific funding from Fundacao de Ampan a Pesquisa do Estado de Sao Paulo (FAPESP-www.fapesp.br) at number 2012/19020-9. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegretti AS, 2013, CRIT CARE, V17, DOI 10.1186/cc12780; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Barbar SD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-270; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Dalfino L, 2008, INTENS CARE MED, V34, P707, DOI 10.1007/s00134-007-0969-4; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kellum JA, 2008, INT J ARTIF ORGANS, V31, P96, DOI 10.1177/039139880803100204; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kim IY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172137; Lobo SM, 2011, CRIT CARE, V15, DOI 10.1186/cc10466; Macedo E, 2015, CRIT CARE CLIN, V31, P773, DOI 10.1016/j.ccc.2015.06.011; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Neyra JA, 2016, CRIT CARE MED, V44, P1891, DOI 10.1097/CCM.0000000000001835; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Oh HJ, 2013, J CRIT CARE, V28, P379, DOI 10.1016/j.jcrc.2012.11.019; Oh HJ, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.08.001; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Park JY, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1437-8; Prowle JR, 2014, NAT REV NEPHROL, V10, P37, DOI 10.1038/nrneph.2013.232; Prowle JR, 2012, CRIT CARE, V16, DOI 10.1186/cc11345; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; Salahuddin N, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0460-6; Schneider AG, 2013, INTENS CARE MED, V39, P987, DOI 10.1007/s00134-013-2864-5; Silversides JA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0624-8; Smith OM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-320; Stein A, 2012, CRIT CARE, V16, DOI 10.1186/cc11368; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; de Oliveira FSV, 2015, J CRIT CARE, V30, P97, DOI 10.1016/j.jcrc.2014.09.002; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Wauters J, 2009, J TRAUMA, V66, P713, DOI 10.1097/TA.0b013e31817c5594; Yilmaz R, 2010, INT UROL NEPHROL, V42, P259, DOI 10.1007/s11255-009-9629-7; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828; Zhang L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.03.025	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175897	10.1371/journal.pone.0175897	http://dx.doi.org/10.1371/journal.pone.0175897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426835	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900066
J	Karml, SH; Holt, SH; Song, LH; Tamir, S; Luo, YT; Bai, F; Adenwalla, A; Darash-Yahana, M; Sohn, YS; Jennings, PA; Azad, RK; Onuchic, JN; Morcos, F; Nechushtail, R; Mittler, R				Karml, Sarah H.; Holt, Sarah H.; Song, Luhua; Tamir, Sagi; Luo, Yuting; Bai, Fang; Adenwalla, Ammar; Darash-Yahana, Merav; Sohn, Yang-Sung; Jennings, Patricia A.; Azad, Rajeev K.; Onuchic, Jose' N.; Morcos, Faruck; Nechushtail, Rachel; Mittler, Ron			Interactions between mitoNEET and NAF-1 in cells	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; FE-S CLUSTER; DRUG TARGET MITONEET; BREAST-CANCER; 2FE-2S CLUSTER; SIGNALING PATHWAY; WOLFRAM-SYNDROME; NEET PROTEINS; TUMOR-GROWTH; IRON	The NEET proteins mitoNEET (mNT) and nutrient-deprivation autophagy factor-1 (NAF-1) are required for cancer cell proliferation and resistance to oxidative stress. NAF-1 and mNT are also implicated in a number of other human pathologies including diabetes, neurodegeneration and cardiovascular disease, as well as in development, differentiation and aging. Previous studies suggested that mNT and NAF-1 could function in the same pathway in mammalian cells, preventing the over-accumulation of iron and reactive oxygen species (ROS) in mitochondria. Nevertheless, it is unknown whether these two proteins directly interact in cells, and how they mediate their function. Here we demonstrate, using yeast two-hybrid, in vivo bimolecular fluorescence complementation (BiFC), direct coupling analysis (DCA), RNA-sequencing, ROS and iron imaging, and single and double shRNA lines with suppressed mNT, NAF-1 and mNT/NAF-1 expression, that mNT and NAF-1 directly interact in mammalian cells and could function in the same cellular pathway. We further show using an in vitro cluster transfer assay that mNT can transfer its clusters to NAF-1. Our study highlights the possibility that mNT and NAF-1 function as part of an iron-sulfur (2Fe-2S) cluster relay to maintain the levels of iron and Fe-S clusters under control in the mitochondria of mammalian cells, thereby preventing the activation of apoptosis and/or autophagy and supporting cellular proliferation.	[Karml, Sarah H.; Tamir, Sagi; Darash-Yahana, Merav; Sohn, Yang-Sung; Nechushtail, Rachel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Edmond J Safra Campus Givat Ram, Jerusalem, Israel; [Holt, Sarah H.; Song, Luhua; Luo, Yuting; Azad, Rajeev K.; Mittler, Ron] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Holt, Sarah H.; Song, Luhua; Luo, Yuting; Azad, Rajeev K.; Mittler, Ron] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Chem, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Biosci, Houston, TX USA; [Adenwalla, Ammar; Morcos, Faruck] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Adenwalla, Ammar; Morcos, Faruck] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Azad, Rajeev K.] Univ North Texas, Dept Math, Denton, TX 76203 USA; [Nechushtail, Rachel] Hebrew Univ Jerusalem, Wolfson Inst Appl Struct Biol, Edmond J Safra Campus Givat Ram, Jerusalem, Israel	Hebrew University of Jerusalem; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Rice University; Rice University; Rice University; Rice University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton; Hebrew University of Jerusalem	Nechushtail, R (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Edmond J Safra Campus Givat Ram, Jerusalem, Israel.; Mittler, R (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Mittler, R (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.; Nechushtail, R (corresponding author), Hebrew Univ Jerusalem, Wolfson Inst Appl Struct Biol, Edmond J Safra Campus Givat Ram, Jerusalem, Israel.	rachel@mail.huji.ac.il; ron.mittler@unt.edu	Mittler, Ron/ABE-6496-2020	Morcos, Faruck/0000-0001-6208-1561; Adenwalla, Ammar/0000-0001-9447-1441	Israel Science Foundation [ISF-865/13]; National Science Foundation [IOS-1353886, IOS-0639964, IOS-0743954, IOS-1557787, MCB-1613462]; National Institutes of Health [DK54441]; Center for Theoretical Biological Physics - National Science Foundation [PHY-1427654, NSF-MCB-1214457]; Cancer and Prevention Institute of Texas (CPRIT) [R1110]; University of North Texas, College of Arts and Sciences; Direct For Biological Sciences [1214457] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1427654] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1613462] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Theoretical Biological Physics - National Science Foundation(National Science Foundation (NSF)); Cancer and Prevention Institute of Texas (CPRIT); University of North Texas, College of Arts and Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the Israel Science Foundation (ISF-865/13) awarded to RN, funding from the National Science Foundation (IOS-1353886, IOS-0639964, IOS-0743954, IOS-1557787, MCB-1613462), and the University of North Texas, College of Arts and Sciences, awarded to RM,and funding from the National Institutes of Health DK54441 awarded to PAJ. JNO is supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (grants PHY-1427654 and NSF-MCB-1214457) and by the Cancer and Prevention Institute of Texas (CPRIT - grant R1110).The funders had no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript.	Acheson JF, 2015, BIOCHEMISTRY-US, V54, P5980, DOI 10.1021/acs.biochem.5b00692; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Banci L, 2014, P NATL ACAD SCI USA, V111, P6203, DOI 10.1073/pnas.1400102111; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Benson SK, 2016, INORG CHEM COMMUN, V63, P86, DOI 10.1016/j.inoche.2015.11.022; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; Bystrom LM, 2015, FREE RADICAL BIO MED, V79, P337, DOI 10.1016/j.freeradbiomed.2014.04.035; Bystrom LM, 2014, ANTIOXID REDOX SIGN, V20, P1917, DOI 10.1089/ars.2012.5014; Cabantchik ZI, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00045; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen B, 2015, INT J CLIN EXP PATHO, V8, P13725; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Danielpur L, 2016, J CLIN ENDOCR METAB, V101, P3592, DOI 10.1210/jc.2016-2240; Darash-Yahana M, 2016, P NATL ACAD SCI USA, V113, P10890, DOI 10.1073/pnas.1612736113; dos Santos RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13652; Du XH, 2015, CELL BIOL INT, V39, P816, DOI 10.1002/cbin.10453; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Habener A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156054; Holt SH, 2016, J CELL SCI, V129, P155, DOI 10.1242/jcs.178293; Kim JY, 2016, J BIOCHEM, V160, P101, DOI 10.1093/jb/mvw016; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Roberts ME, 2013, BIOCHEMISTRY-US, V52, P8969, DOI 10.1021/bi401038w; Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tamir S, 2014, ACTA CRYSTALLOGR D, V70, P1572, DOI 10.1107/S1399004714005458; Tamir S, 2014, P NATL ACAD SCI USA, V111, P5177, DOI 10.1073/pnas.1403770111; Tamir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061202; Tan GQ, 2016, BIOCHEM BIOPH RES CO, V470, P226, DOI 10.1016/j.bbrc.2016.01.040; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wang L, 2016, ONCOTARGET, V7, P3791, DOI 10.18632/oncotarget.6302; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Yang L, 2016, ONCOTARGET, V7, P22720, DOI 10.18632/oncotarget.8150; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P838, DOI 10.1016/j.bbrc.2016.08.034; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	56	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175796	10.1371/journal.pone.0175796	http://dx.doi.org/10.1371/journal.pone.0175796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426722	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900048
J	Kastien-Hilka, T; Rosenkranz, B; Sinanovic, E; Bennett, B; Schwenkglenks, M				Kastien-Hilka, Tanja; Rosenkranz, Bernd; Sinanovic, Edina; Bennett, Bryan; Schwenkglenks, Matthias			Health-related quality of life in South African patients with pulmonary tuberculosis	PLOS ONE			English	Article							IMPORTANT DIFFERENCE; DEPRESSION; IMPACT; QUESTIONNAIRE; ANXIETY; FEASIBILITY; RELIABILITY; LATENT; ADULTS; TB	Background The evaluation of patient-reported health-related quality of life (HRQOL) in pulmonary tuberculosis (TB) contributes to a comprehensive understanding of the burden associated with this disease. The aim of this study was to assess the overall impact of TB on the health status and on single health domains identified in the WHO definition of health, including physical, mental and social health aspects. Methods Four instruments for HRQOL evaluation were applied in a longitudinal multicentre study during six-month standard TB treatment in South Africa. These included the generic SF-12 and EQ-5D-5L, the disease-specific St. George's Respiratory Questionnaire (SGRQ) and the condition-specific Hospital Anxiety and Depression Scale (HADS). Statistical analysis included significance testing, univariable and multivariable analysis, and repeated measures ANOVA. Change over time in the physical component score (PCS) of SF-12 was defined as primary endpoint. A target sample size of 96 patients was estimated. Results HRQOL of the study participants was impaired in all physical, mental and psycho-social health domains at treatment start. HRQOL improved significantly and in a clinically meaningful manner during the course of standard TB treatment, over the period of the study. The greatest improvement (95%) was observed in mental health. Younger patients with higher education and who were employed had a better HRQOL. Discussion This study demonstrates the need for an integrative understanding of TB with HRQOL as core element to inform gaps in current TB management. Improvements in the management of TB following an integrative patient-centred approach will contribute towards meeting the United Nations Sustainable Development Goal 3 (SDG3) target and will support the End TB strategy of the WHO.	[Kastien-Hilka, Tanja] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Kastien-Hilka, Tanja; Schwenkglenks, Matthias] Univ Basel, Basel, Switzerland; [Kastien-Hilka, Tanja; Sinanovic, Edina] Univ Cape Town, Hlth Econ Unit, Fac Hlth Sci, Cape Town, South Africa; [Rosenkranz, Bernd] Stellenbosch Univ, Div Clin Pharmacol, Fac Med & Hlth Sci, Cape Town, South Africa; [Rosenkranz, Bernd] Fundisa African Acad Med Dev, Cape Town, South Africa; [Bennett, Bryan] Adelphi Values, Patient Ctr Outcomes, Bollington, England; [Schwenkglenks, Matthias] Univ Basel, Inst Pharmaceut Med, Basel, Switzerland; [Schwenkglenks, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Cape Town; Stellenbosch University; Adelphi Group Ltd; University of Basel; University of Zurich	Schwenkglenks, M (corresponding author), Univ Basel, Basel, Switzerland.; Schwenkglenks, M (corresponding author), Univ Basel, Inst Pharmaceut Med, Basel, Switzerland.; Schwenkglenks, M (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.	m.schwenkglenks@unibas.ch	Sinanovic, Edina/AAR-2590-2020	Schwenkglenks, Matthias/0000-0001-7217-1173	University of Cape Town (Cape Town/SouthAfrica); Swiss Tropical and Public Health Institute (Basel, Switzerland)	University of Cape Town (Cape Town/SouthAfrica); Swiss Tropical and Public Health Institute (Basel, Switzerland)	Expenses to conduct the field work were borne by Swiss Tropical and Public Health Institute, the employment institution of the first author. No funding from a third party was received. This study was part of a Ph D research project and was also supported through the University of Cape Town (Cape Town/SouthAfrica).; This study is part of the Swiss South African bilateral cooperation and was mainly financed by the Swiss Tropical and Public Health Institute (Basel, Switzerland) and supported by the University of Cape Town (Cape Town, South Africa).	Aamir S, 2010, JCPSP-J COLL PHYSICI, V20, P703, DOI 10.2010/JCPSP.703704; Adeyeye OO, 2014, J PUBLIC HEALTH AFR, V5, P88, DOI [10.4081/jbhia.2014.366, 10.4081/jphia.2014.366]; Aggarwal AN, 2013, INT J TUBERC LUNG D, V17, P947, DOI 10.5588/ijtld.12.0299; Aggarwal AN, 2010, LUNG INDIA, V27, P1, DOI 10.4103/0970-2113.59259; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Awaisu A, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-2; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Balgude Abhishek, 2012, Indian J Med Sci, V66, P71; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Bauer M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0250-4; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Chang B, 2004, QUAL LIFE RES, V13, P1633, DOI 10.1007/s11136-004-0374-1; Chung WS, 2013, INT J TUBERC LUNG D, V17, P425, DOI 10.5588/ijtld.12.0701; Chung WS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-630; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Dhuria M, 2009, ASIA-PAC J PUBLIC HE, V21, P312, DOI 10.1177/1010539509336242; Dion MJ, 2004, QUAL LIFE RES, V13, P653, DOI 10.1023/B:QURE.0000021320.89524.64; Doward LC, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-89; Duko B, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0598-3; El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020; Forde Y., 2009, ST GEORGES RESP QUES; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Guo N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-6; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hansel NN, 2004, QUAL LIFE RES, V13, P639, DOI 10.1023/B:QURE.0000021317.12945.f0; Husain Mohammed O, 2008, Clin Pract Epidemiol Ment Health, V4, P4, DOI 10.1186/1745-0179-4-4; Issa Baba A, 2009, Ment Health Fam Med, V6, P133; Jaber AAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156258; Jelsma Jennifer, 2003, Popul Health Metr, V1, P11, DOI 10.1186/1478-7954-1-11; Jones Paul W, 2005, COPD, V2, P75; Kakhki AD, 2015, TUBERC RESPIR DIS, V78, P309, DOI 10.4046/trd.2015.78.4.309; Kastien-Hilka T, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2016.00125; Kastien-Hilka T, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0442-6; Kittikraisak W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029775; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Louw Julia, 2012, Health Qual Life Outcomes, V10, P77, DOI 10.1186/1477-7525-10-77; Louw JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151892; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Marra Carlo A, 2004, Health Qual Life Outcomes, V2, P58, DOI 10.1186/1477-7525-2-58; Maruish ME, 2009, GUIDE DEV CERTIFIED; Masumoto S, 2014, QUAL LIFE RES, V23, P1523, DOI 10.1007/s11136-013-0571-x; Naidoo P, 2010, SOC BEHAV PERSONAL, V38, P1323, DOI 10.2224/sbp.2010.38.10.1323; Othman GQ, 2011, AFR J PHARM PHARMACO, V5, P547; Ottermann B., PREVALENCE DIABETES; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Peltzer K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-89; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302; Snaith RP., 1994, HOSP ANXIETY DEPRESS; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; Westaway M S, 2001, Curationis, V24, P74; WESTAWAY MS, 1992, SOC SCI MED, V35, P1311, DOI 10.1016/0277-9536(92)90184-R; *WHO, 2015, THE END TB STRAT; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization (WHO), 2015, HTLH 2015 MDGS MILL; World Health Organization (WHO), 2015, MDGS SDGS WHO LAUNCH	62	26	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174605	10.1371/journal.pone.0174605	http://dx.doi.org/10.1371/journal.pone.0174605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426759	Green Published, gold			2022-12-27	WOS:000399875900010
J	Maia, CM; Volpato, GL				Maia, Caroline Marques; Volpato, Gilson Luiz			Preference index supported by motivation tests in Nile tilapia	PLOS ONE			English	Article							ENVIRONMENTAL COLOR; STRESS-RESPONSE; LIGHT SPECTRUM; GROWTH; FISH	The identification of animal preferences is assumed to provide better rearing environments for the animals in question. Preference tests focus on the frequency of approaches or the time an animal spends in proximity to each item of the investigated resource during a multiple- choice trial. Recently, a preference index (PI) was proposed to differentiate animal preferences from momentary responses (Sci Rep, 2016, 6: 28328, DOI: 10.1038/srep28328). This index also quantifies the degree of preference for each item. Each choice response is also weighted, with the most recent responses weighted more heavily, but the index includes the entire bank of tests, and thus represents a history-based approach. In this study, we compared this PI to motivation tests, which consider how much effort is expended to access a resource. We performed choice tests over 7 consecutive days for 34 Nile tilapia fish that presented with different colored compartments in each test. We first detected the preferred and non-preferred colors of each fish using the PI and then tested their motivation to reach these compartments. We found that fish preferences varied individually, but the results were consistent with the motivation profiles, as individual fish were more motivated (the number of touches made on transparent, hinged doors that prevented access to the resource) to access their preferred items. On average, most of the 34 fish avoided the color yellow and showed less motivation to reach yellow and red colors. The fish also exhibited greater motivation to access blue and green colors (the most preferred colors). These results corroborate the PI as a reliable tool for the identification of animal preferences. We recommend this index to animal keepers and researchers to identify an animal's preferred conditions.	[Maia, Caroline Marques; Volpato, Gilson Luiz] UNESP, IB, Lab Anim Physiol & Behav, Botucatu, SP, Brazil	Universidade Estadual Paulista	Maia, CM (corresponding author), UNESP, IB, Lab Anim Physiol & Behav, Botucatu, SP, Brazil.	carolmm_luzi@hotmail.com	Maia, Caroline Marques/H-7646-2016	Maia, Caroline Marques/0000-0002-5549-1017	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2012/06104-0]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/06104-0]	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) through grant 2012/06104-0 to CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose Maia Filho for his assistance with the construction of the experimental apparatus, Patricia Tatemoto for assistance with data collection and Elisabeth Aparecida Marques Maia for assistance with extracting behavioral data from the video records. We also thank Dr. Victoria Anne Braithwaite for suggestions on the editing the English language in a first version of the manuscript. This project was founded by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; process # 2012/06104-0).	Asher L, 2009, APPL ANIM BEHAV SCI, V118, P152, DOI 10.1016/j.applanim.2009.02.029; Browne WJ, 2010, BEHAV PROCESS, V83, P72, DOI 10.1016/j.beproc.2009.10.004; Dawkins MS, 2006, APPL ANIM BEHAV SCI, V100, P4, DOI 10.1016/j.applanim.2006.04.010; Duncan IJH, 2006, APPL ANIM BEHAV SCI, V100, P11, DOI 10.1016/j.applanim.2006.04.011; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Freitas RHA, 2013, J APPL ICHTHYOL, V29, P239, DOI 10.1111/jai.12026; Freitas RHA, 2014, ZOOLOGY, V117, P179, DOI 10.1016/j.zool.2013.09.005; Galhardo L, 2011, APPL ANIM BEHAV SCI, V130, P60, DOI 10.1016/j.applanim.2010.12.008; Barcellos LJG, 2009, AQUACULTURE, V288, P51, DOI 10.1016/j.aquaculture.2008.11.002; Girguis PR, 2006, SCIENCE, V312, P231, DOI 10.1126/science.1125286; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; GOODMAN LA, 1964, ANN MATH STAT, V35, P716, DOI 10.1214/aoms/1177703569; Graber RE, 2015, ETHOLOGY, V121, P17, DOI 10.1111/eth.12313; Head AB, 2000, J WORLD AQUACULT SOC, V31, P73, DOI 10.1111/j.1749-7345.2000.tb00700.x; Houpt KA, 2012, ANIM WELFARE, V21, P1; Johnsson JI, 2000, BEHAV ECOL SOCIOBIOL, V48, P373, DOI 10.1007/s002650000244; Karakatsouli N, 2008, AQUACULT ENG, V38, P36, DOI 10.1016/j.aquaeng.2007.10.006; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Liste G, 2014, ETHOLOGY, V120, P1199, DOI 10.1111/eth.12294; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Luchiari AC, 2007, J ETHOL, V25, P169, DOI 10.1007/s10164-006-0013-0; Maia CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28328; Maia CM, 2013, ZOOLOGY, V116, P64, DOI 10.1016/j.zool.2012.08.001; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; MATTHEWS LR, 1994, ANIM BEHAV, V47, P713, DOI 10.1006/anbe.1994.1096; Mendonca FZ, 2010, J FISH BIOL, V77, P1439, DOI 10.1111/j.1095-8649.2010.02754.x; O'Rourke CF, 2010, BEHAV PROCESS, V85, P157, DOI 10.1016/j.beproc.2010.07.005; Ruchin AB, 2004, FISH PHYSIOL BIOCHEM, V30, P175, DOI 10.1007/s10695-005-1263-4; Sekiya Y, 2004, ZOOL SCI, V21, P859, DOI 10.2108/zsj.21.859; Sherwin CM, 2004, ANIM BEHAV, V67, P711, DOI 10.1016/j.anbehav.2003.08.018; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Suter HC, 2002, J FISH BIOL, V61, P606, DOI 10.1006/jfbi.2002.2084; Volpato GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059134; Volpato GL, 2009, ILAR J, V50, P329, DOI 10.1093/ilar.50.4.329; Volpato GL, 2007, DIS AQUAT ORGAN, V75, P165, DOI 10.3354/dao075165; Volpato Gilson Luiz, 2009, Oecologia Brasiliensis, V13, P5; Volpato GL, 2004, BRAZ J MED BIOL RES, V37, P479, DOI 10.1590/S0100-879X2004000400004; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011	39	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175821	10.1371/journal.pone.0175821	http://dx.doi.org/10.1371/journal.pone.0175821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426689	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900053
J	Pan, KM; Ma, LY; Xiang, Q; Li, XY; Li, HX; Zhou, Y; Yang, L; Cui, YM				Pan, Kunming; Ma, Lingyun; Xiang, Qian; Li, Xueying; Li, Haixia; Zhou, Ying; Yang, Li; Cui, Yimin			Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China	PLOS ONE			English	Article							WORSENING RENAL-FUNCTION; TROUGH CONCENTRATIONS; NEPHROTOXICITY	Objective The objective of this study was to investigate the current situation of vancomycin (VAN)associated acute kidney injury (VA-AKI) in China and identify the risk factors for VA-AKI, as well as to comprehensively examine the risk related to concurrent drug use. Further, we assessed the outcomes of patients who developed VA-AKI and the risk factors for these outcomes. Finally, we aimed to provide suggestions for improving the prevention and treatment of VA-AKI in China. Methods We conducted a retrospective observational study of inpatients who had been treated with VAN between January 2013 and December 2013 at Peking University First Hospital. AKI was defined as an increase in SCr of >= 0.3 mg/dl (>= 26.5 mu mol/l) within 48 hours or an increase to >= 1.5 times the baseline certainly or presumably within the past 7 days. VA-AKI was defined as the development of AKI during VAN therapy or within 7 days following the termination of VAN therapy. In addition, we compared patients with NO-AKI, who did not develop AKI during their hospitalization, with those with VA-AKI. Results Of the 934 patients treated with VAN during their hospital stay, 740 were included in this study. Among those excluded, 38.1% (74/194) were excluded because of a lack of data on serum creatinine (SCr). Among the included patients, 120 had confirmed VA-AKI, with an incidence of 16.2% (120/740). Multiple logistic regression analysis revealed that an elevated baseline estimated glomerular filtration rate (eGFR) (odds ratio [ OR] = 1.009; p = 0.017) and concomitant vasopressor therapy (OR = 2.942; p = 0.009), nitrate use (OR = 2.869; p = 0.007), imipenem-cilastatin treatment (OR = 4.708; p = 0.000), and contrast medium administration (OR = 6.609 p = 0.005) were independent risk factors for VA-AKI; in addition, the receipt of orthopedic/trauma/burn surgery (OR = 0.3575; p = 0.011) and concomitant compound glycyrrhizin use (OR = 0.290; p = 0.017) were independent protective factors for VA-AKI. Multiple logistic regression analysis also demonstrated that among the patients who developed VA-AKI, coronary heart disease (CHD) (OR = 12.6; p = 0.006) and concomitant vasopressor therapy (OR = 15.4; p = 0.001) were independent risk factors for death. We also evaluated the factors influencing improvement of renal function. Multiple logistic regression analysis demonstrated that CHD (OR = 8.858, p = 0.019) and concomitant contrast medium administration (OR = 9.779, p = 0.005) were independent risk factors and that simultaneous beta-blocker treatment (OR = 0.124, p = 0.001) was an independent protective factor for improvement of renal function. Conclusion Patients treated with VAN received insufficient monitoring of SCr and inadequate therapeutic drug monitoring. We recommend that hospitals increase their investment in clinical pharmacists. An elevated baseline eGFR and concomitant vasopressor therapy, nitrate use, imipenem-cilastatin treatment, and contrast medium administration were independent risk factors for VA-AKI; in addition, orthopedic/trauma/burn surgery and concomitant compound glycyrrhizin use were independent protective factors for VA-AKI.	[Pan, Kunming; Ma, Lingyun; Xiang, Qian; Zhou, Ying; Cui, Yimin] Peking Univ, Hosp 1, Dept Pharm, Beijing, Peoples R China; [Pan, Kunming; Ma, Lingyun; Zhou, Ying; Cui, Yimin] Peking Univ, Hlth Sci Ctr, Coll Pharm, Beijing, Peoples R China; [Li, Xueying] Peking Univ, Hosp 1, Dept Biostat, Beijing, Peoples R China; [Li, Haixia] Peking Univ, Hosp 1, Dept Clin Lab, Beijing, Peoples R China; [Yang, Li] Peking Univ, Hosp 1, Dept Nephrol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Zhou, Y (corresponding author), Peking Univ, Hosp 1, Dept Pharm, Beijing, Peoples R China.; Zhou, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Coll Pharm, Beijing, Peoples R China.; Yang, L (corresponding author), Peking Univ, Hosp 1, Dept Nephrol, Beijing, Peoples R China.	zhouying0321@l26.com; li.yang@bjmu.edu.cn		PAN, KUN-MING/0000-0002-9213-123X; Lv, Qianzhou/0000-0002-0866-1546	Peking University First Hospital Department of Pharmacy scientific research funds	Peking University First Hospital Department of Pharmacy scientific research funds	Funded by Peking University First Hospital Department of Pharmacy scientific research funds 4-31 Yimin Cui.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bosso JA, 2011, ANTIMICROB AGENTS CH, V55, P5475, DOI 10.1128/AAC.00168-11; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Silva VTCE, 2014, CRIT CARE MED, V42, P2635, DOI 10.1097/CCM.0000000000000635; Davies SW, 2015, SURG INFECT, V16, P684, DOI 10.1089/sur.2014.198; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elyasi S, 2012, EUR J CLIN PHARMACOL, V68, P1243, DOI 10.1007/s00228-012-1259-9; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Hanrahan TP, 2015, ANAESTH INTENS CARE, V43, P594, DOI 10.1177/0310057X1504300507; Hazlewood KA, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.031; Humanes B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/704382; Li KL, 2004, J CELLULAR MOL IMMUN, V01, P31; Marquis KA, 2015, ANN PHARMACOTHER, V49, P1009, DOI 10.1177/1060028015587900; Masuda N, 2015, INT J CLIN PHARM TH, V53, P284, DOI 10.5414/CP202274; Moffett BS, 2015, CONGENIT HEART DIS, V10, pE6, DOI 10.1111/chd.12187; Pritchard L, 2010, AM J MED, V123, P1143, DOI 10.1016/j.amjmed.2010.07.025; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2009, CLIN INFECT DIS, V49, P325, DOI 10.1086/600877; Seixas GTF, 2016, J PEDIAT HEMATOL ONC, V38, pE56, DOI 10.1097/MPH.0000000000000470; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; Song MA, 2009, J MED FORUM, V01, P82; Wong-Beringer A, 2011, INT J ANTIMICROB AG, V37, P95, DOI 10.1016/j.ijantimicag.2010.10.013; Xiao G, 2008, MODERN MEDICINE HEAL, V14, P2169; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X; Yang WJ, 1989, J TRADITIONAL CHINES, V04, P49; Zhang Y, 2012, CHINESE J CLIN RATIO, V17, P160	26	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175688	10.1371/journal.pone.0175688	http://dx.doi.org/10.1371/journal.pone.0175688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426688	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900040
J	Ribeiro, SP; Milush, JM; Cunha-Neto, E; Kailas, EG; Kalil, J; Passero, LFD; Hunt, PW; Deeks, SG; Nixon, DF; SenGupta, D				Ribeiro, Susan Pereira; Milush, Jeffrey M.; Cunha-Neto, Edecio; Kailas, Esper G.; Kalil, Jorge; Passero, Luiz Felipe D.; Hunt, Peter W.; Deeks, Steven G.; Nixon, Douglas F.; SenGupta, Devi			p16(INK4a) Expression and Immunologic Aging in Chronic HIV Infection (vol 11, e0166759, 2016)	PLOS ONE			English	Correction													Cunha-Neto, Edecio/B-4157-2009; Nixon, Douglas/AAU-5734-2020; KALIL, JORGE/C-8029-2012; Hunt, Peter W./P-2976-2017	Cunha-Neto, Edecio/0000-0002-3699-3345; Nixon, Douglas/0000-0002-2801-1786; KALIL, JORGE/0000-0001-8415-4274; Hunt, Peter W./0000-0002-4571-4870; Kallas, Esper/0000-0003-2026-6925	NIAID NIH HHS [P30 AI027763] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		PEREIRARIBEIRO S, 2016, PLOS ONE, V11; Ribeiro SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166759	2	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176509	10.1371/journal.pone.0176509	http://dx.doi.org/10.1371/journal.pone.0176509			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426830	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900134
J	Tkachenko, N; Weissmann, JD; Petersen, WP; Lake, G; Zollikofer, CPE; Callegari, S				Tkachenko, Natalie; Weissmann, John D.; Petersen, Wesley P.; Lake, George; Zollikofer, Christoph P. E.; Callegari, Simone			Individual-based modelling of population growth and diffusion in discrete time	PLOS ONE			English	Article							STOCHASTIC-MODELS; HUNTER-GATHERERS; ECOLOGY; HUMANS; FRONT	Individual-based models (IBMs) of human populations capture spatio-temporal dynamics using rules that govern the birth, behavior, and death of individuals. We explore a stochastic IBM of logistic growth-diffusion with constant time steps and independent, simultaneous actions of birth, death, and movement that approaches the Fisher-Kolmogorov model in the continuum limit. This model is well-suited to parallelization on high-performance computers. We explore its emergent properties with analytical approximations and numerical simulations in parameter ranges relevant to human population dynamics and ecology, and reproduce continuous-time results in the limit of small transition probabilities. Our model prediction indicates that the population density and dispersal speed are affected by fluctuations in the number of individuals. The discrete-time model displays novel properties owing to the binomial character of the fluctuations: in certain regimes of the growth model, a decrease in time step size drives the system away from the continuum limit. These effects are especially important at local population sizes of <50 individuals, which largely correspond to group sizes of hunter-gatherers. As an application scenario, we model the late Pleistocene dispersal of Homo sapiens into the Americas, and discuss the agreement of model-based estimates of first-arrival dates with archaeological dates in dependence of IBM model parameter settings.	[Tkachenko, Natalie; Lake, George] Univ Zurich, Inst Computat Sci, Zurich, Switzerland; [Tkachenko, Natalie; Weissmann, John D.; Petersen, Wesley P.; Zollikofer, Christoph P. E.; Callegari, Simone] Univ Zurich, Dept Anthropol, Zurich, Switzerland; [Petersen, Wesley P.] Swiss Fed Inst Technol, Seminar Appl Math, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tkachenko, N (corresponding author), Univ Zurich, Inst Computat Sci, Zurich, Switzerland.; Tkachenko, N (corresponding author), Univ Zurich, Dept Anthropol, Zurich, Switzerland.	nataliet@physik.uzh.ch			Swiss Platform for Advanced Scientific Computing (PASC) [F-74105-03-01]; Swiss Platform for Advanced Scientific Computing	Swiss Platform for Advanced Scientific Computing (PASC); Swiss Platform for Advanced Scientific Computing	The authors acknowledge financial support from the Swiss Platform for Advanced Scientific Computing (PASC), grant number: F-74105-03-01.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Model simulations were performed with the QHG code [ 31]. N.T., J.D.W., and S.C. would like to acknowledge financial support from the Swiss Platform for Advanced Scientific Computing.	Ackleh AS, 2007, THEOR POPUL BIOL, V71, P290, DOI 10.1016/j.tpb.2006.12.006; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Binford L.R., 2001, CONSTRUCTING FRAMES; Black AJ, 2010, J THEOR BIOL, V267, P85, DOI 10.1016/j.jtbi.2010.08.014; BREUER HP, 1995, EUROPHYS LETT, V30, P69, DOI 10.1209/0295-5075/30/2/002; BRIEGER LM, 1991, J COMPUT PHYS, V94, P467, DOI 10.1016/0021-9991(91)90231-9; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Brunet E, 1997, PHYS REV E, V56, P2597, DOI 10.1103/PhysRevE.56.2597; Brunet E, 2001, J STAT PHYS, V103, P269, DOI 10.1023/A:1004875804376; Callegari S, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500239; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1007/BF02127704; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; DeAngelis DL, 2013, F1000PRIME REPORTS, V6, P39; Dilla T, 2015, PATIENT PREFER ADHER, V10, DOI 10.2147/PPA.S93760; Doering CR, 2003, PHYSICA A, V325, P243, DOI 10.1016/S0378-4371(03)00203-6; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Enberg R, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.074021; Erban R., 2007, ARXIV07041908; Eriksson A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3127; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; FOLEY P, 1994, CONSERV BIOL, V8, P124, DOI 10.1046/j.1523-1739.1994.08010124.x; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Goldberg A, 2016, NATURE, V532, P232, DOI 10.1038/nature17176; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hallatschek O, 2011, P NATL ACAD SCI USA, V108, P1783, DOI 10.1073/pnas.1013529108; Hallatschek O, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108103; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Kolmogorov A N, 1937, B MGU A, V1, P1; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Murray J, 1989, MATH BIOL, V18; Otto S.P., 2007, BIOL GUIDE MATH MODE, V13; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Renshaw E, 1993, MODELLING BIOL POPUL, V11; Rossetti V, 2011, J R SOC INTERFACE, V8, P1772, DOI 10.1098/rsif.2011.0102; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; SMITH RH, 1980, J THEOR BIOL, V86, P607, DOI 10.1016/0022-5193(80)90302-1; Steele J, 2009, HUM BIOL, V81, P121, DOI 10.3378/027.081.0302; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Stuart A., 1998, DYNAMICAL SYSTEMS NU, V2; WINTERHALDER B, 1988, J ANTHROPOL ARCHAEOL, V7, P289, DOI 10.1016/0278-4165(88)90001-3; Wood KA, 2015, J APPL ECOL, V52, P810, DOI 10.1111/1365-2664.12419; Young DA, 2002, AM ANTHROPOL, V104, P138, DOI 10.1525/aa.2002.104.1.138	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176101	10.1371/journal.pone.0176101	http://dx.doi.org/10.1371/journal.pone.0176101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426763	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875900103
J	Barley, SC; Meekan, MG; Meeuwig, JJ				Barley, Shanta C.; Meekan, Mark G.; Meeuwig, Jessica J.			Diet and condition of mesopredators on coral reefs in relation to shark abundance	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; BODY-SIZE; FORAGING BEHAVIOR; HAWAIIAN-ISLANDS; TROPHIC CASCADES; APEX PREDATORS; HABITAT USE; RISK; FISH; GROWTH	Reef sharks may influence the foraging behaviour of mesopredatory teleosts on coral reefs via both risk effects and competitive exclusion. We used a "natural experiment" to test the hypothesis that the loss of sharks on coral reefs can influence the diet and body condition of mesopredatory fishes by comparing two remote, atoll-like reef systems, the Rowley Shoals and the Scott Reefs, in northwestern Australia. The Rowley Shoals are a marine reserve where sharks are abundant, whereas at the Scott Reefs numbers of sharks have been reduced by centuries of targeted fishing. On reefs where sharks were rare, the gut contents of five species of mesopredatory teleosts largely contained fish while on reefs with abundant sharks, the same mesopredatory species consumed a larger proportion of benthic invertebrates. These measures of diet were correlated with changes in body condition, such that the condition of mesopredatory teleosts was significantly poorer on reefs with higher shark abundance. Condition was defined as body weight, height and width for a given length and also estimated via several indices of condition. Due to the nature of natural experiments, alternative explanations cannot be discounted. However, the results were consistent with the hypothesis that loss of sharks may influence the diet and condition of mesopredators and by association, their fecundity and trophic role. Regardless of the mechanism (risk effects, competitive release, or other), our findings suggest that overfishing of sharks has the potential to trigger trophic cascades on coral reefs and that further declines in shark populations globally should be prevented to protect ecosystem health.	[Barley, Shanta C.; Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Perth, WA, Australia; [Barley, Shanta C.; Meeuwig, Jessica J.] Univ Western Australia, Oceans Inst, Perth, WA, Australia; [Barley, Shanta C.; Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Perth, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Barley, SC (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA, Australia.; Barley, SC (corresponding author), Univ Western Australia, Oceans Inst, Perth, WA, Australia.; Barley, SC (corresponding author), Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Perth, WA, Australia.	shanta.barley@gmail.com		Meeuwig, Jessica/0000-0003-1169-8785; Meekan, Mark/0000-0002-3067-9427	University of Western Australia, an IPRS scholarship; Australian Institute of Marine Science; International Postgraduate Research Scholarship; University of Western Australia, Perth; Australian Institute of Marine Science (AIMS); Woodside Energy Ltd	University of Western Australia, an IPRS scholarship; Australian Institute of Marine Science; International Postgraduate Research Scholarship(Australian Government); University of Western Australia, Perth; Australian Institute of Marine Science (AIMS); Woodside Energy Ltd	All funding came from the University of Western Australia, an IPRS scholarship and the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part by an International Postgraduate Research Scholarship, the University of Western Australia, Perth and the Australian Institute of Marine Science (AIMS). We would like to thank AIMS for providing UVC-based fish abundance data via the AIMS Long Term Monitoring Program and temperature data, the collection of which was funded by Woodside Energy Ltd. We also thank the Department of Fisheries, the Department of Parks and Wildlife (DPaW), the Department of Sustainability, Environment, Water, Population and Communities for arranging permits to conduct research at the Scott Reefs and the Rowley Shoals and the crew on board the RV Solander.	AbitiaCardenas LA, 1997, FISH B-NOAA, V95, P360; Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; [Anonymous], 2014, CONDITION HLTH INDIC; Barley SC, 2017, MAR ECOL PROG SER; Barley SC, 2016, ECOSYSTEMS; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bechet A, 2004, J APPL ECOL, V41, P689, DOI 10.1111/j.0021-8901.2004.00928.x; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Brown JS, 1999, EVOL ECOL RES, V1, P49; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Carrascal LM, 1999, ANIM BEHAV, V58, P281, DOI 10.1006/anbe.1999.1142; Catano LB, 2016, J ANIM ECOL, V85, P146, DOI 10.1111/1365-2656.12440; Clark TD, 2008, P ROY SOC B-BIOL SCI, V275, P2841, DOI 10.1098/rspb.2008.0743; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; del Mar Palacios M, 2015, OIKOS; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Farrell ED, 2012, ICES J MAR SCI, V69, P498, DOI 10.1093/icesjms/fss037; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Fox J, 2009, INDONESIA WATERS EDG, P0; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisch AJ, 2016, CORAL REEFS; FUIMAN LA, 1983, J FISH BIOL, V23, P117, DOI 10.1111/j.1095-8649.1983.tb02886.x; Gagliano M, 2007, J ANIM ECOL, V76, P174, DOI 10.1111/j.1365-2656.2006.01187.x; Galarowicz TL, 2005, CAN J FISH AQUAT SCI, V62, P2330, DOI 10.1139/F05-148; Gillibrand C. J., 2007, Western Indian Ocean Journal of Marine Science, V6, P183; HARPER DG, 1988, J THEOR BIOL, V134, P59, DOI 10.1016/S0022-5193(88)80302-3; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2006, OIKOS, V114, P257; Heupel MR, 2014, MARINE ECOLOGY PROGR, P291; Hixon M.A., 1991, P475; Houtman R, 1998, EVOL ECOL, V12, P251, DOI 10.1023/A:1006544031697; IBRAHIM AA, 1989, BEHAVIOUR, V109, P46, DOI 10.1163/156853989X00150; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Jennings S, 1997, IMPACTS PREDATOR DEP, P71; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kulbicki M, 2005, AQUAT LIVING RESOUR, P231; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; LaPoint SD, 2014, ANIM CONSERV; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Ma Y, 1998, CAN J FISH AQUAT SCI, V55, P900, DOI 10.1139/cjfas-55-4-900; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; Meekan M, 2004, NONDESTRUCTIVE TECHN; Meekan M. M., 2006, SURVEYS SHARK FIN FI; METCALFE NB, 1987, ANIM BEHAV, V35, P931, DOI 10.1016/S0003-3472(87)80134-3; Miao SL, 2006, FRONT ECOL ENVIRON, V4, P227, DOI 10.1890/1540-9295(2006)004[0227:ANDFLE]2.0.CO;2; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; Mourier J, 2016, CURR BIOL, V26, P2011, DOI 10.1016/j.cub.2016.05.058; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Nagelkerken I, 2000, MAR ECOL PROG SER, V194, P55, DOI 10.3354/meps194055; Nanami A, 2013, ENVIRON BIOL FISH, V96, P591, DOI 10.1007/s10641-012-0049-7; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; Nowara G. B., 2001, HIST FOREIGN FISHING; Okey TA, 2007, FISH FISH, P359; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pinkas Leo, 1971, FISH B; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rizzari JR, 2015, CONSERV BIOL, V29, P418, DOI 10.1111/cobi.12385; Rizzari JR, 2014, OIKOS, V123, P829, DOI 10.1111/oik.01318; Robbins WD, 2016, CORAL REEFS, V35, P253, DOI 10.1007/s00338-015-1366-z; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Trippel EA, 2004, CAN J FISH AQUAT SCI, V61, P2097, DOI [10.1139/f04-125, 10.1139/F04-125]; Underwood JN, 2012, ECOL EVOL, V2, P666, DOI 10.1002/ece3.80; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Vail L. L., 1988, REPORT TRADITIONAL I; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; Walsh SM, 2012, J FISH BIOL, V80, P519, DOI 10.1111/j.1095-8649.2011.03209.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; WINGFIELD JC, 1986, HORM BEHAV, V20, P405, DOI 10.1016/0018-506X(86)90003-6; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	98	16	16	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0165113	10.1371/journal.pone.0165113	http://dx.doi.org/10.1371/journal.pone.0165113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422965	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600001
J	Behrens, JW; van Deurs, M; Christensen, EAF				Behrens, Jane W.; van Deurs, Mikael; Christensen, Emil A. F.			Evaluating dispersal potential of an invasive fish by the use of aerobic scope and osmoregulation capacity	PLOS ONE			English	Article							GOBY NEOGOBIUS-MELANOSTOMUS; ROUND GOBY; METABOLIC-RATE; SWIMMING PERFORMANCE; CLIMATE-CHANGE; PHYSIOLOGICAL-MECHANISMS; COMPETITIVE INTERACTIONS; THERMAL-ACCLIMATION; OXYGEN-CONSUMPTION; SALINITY TOLERANCE	Non-indigenous species (NIS) can impact marine biodiversity and ecosystem structure and function. Once introduced into a new region, secondary dispersal is limited by the physiology of the organism in relation to the ambient environment and by complex interactions between a suite of ecological factors such as presence of predators, competitors, and parasites. Early prediction of dispersal potential and future 'area of impact' is challenging, but also a great asset in taking appropriate management actions. Aerobic scope (AS) in fish has been linked to various fitness-related parameters, and may be valuable in determining dispersal potential of aquatic invasive species in novel environments. Round goby, Neogobius melanostomus, one of the most wide-ranging invasive fish species in Europe and North America, currently thrives in brackish and fresh water, but its ability to survive in high salinity waters is unknown to date. We show that AS in round goby is reduced by 30% and blood plasma osmolality increased (indicating reduced capacity for osmoregulation) at salinities approaching oceanic conditions, following slow ramping (5 PSU per week) and subsequent long-term acclimation to salinities ranging between 0 and 30 PSU (8 days at final treatment salinities before blood plasma osmolality measurements, 12-20 additional days before respirometry). Survival was also reduced at the highest salinities yet a significant proportion (61%) of the fish survived at 30 PSU. Reduced physiological performance at the highest salinities may affect growth and competitive ability under oceanic conditions, but to what extent reduced AS and osmoregulatory capacity will slow the current 30 km year(-1) rate of advance of the species through the steep salinity gradient from the brackish Baltic Sea and into the oceanic North Sea remains speculative. An unintended natural experiment is in progress to test whether the rate of advance slows down. At the current rate of advance the species will reach the oceanic North Sea by 2018/2019, therefore time for taking preventative action is short.	[Behrens, Jane W.; van Deurs, Mikael; Christensen, Emil A. F.] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Christensen, Emil A. F.] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark	Technical University of Denmark; University of Copenhagen	Behrens, JW (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	jabeh@aqua.dtu.dk		Behrens, Jane Windfeldt/0000-0002-0136-9681; van Deurs, Mikael/0000-0003-2368-2502	BONUS; Baltic Sea research and development programme [Art185]; European Union's Seventh Framework Programme for Research, Technological Development and Demonstration and Innovation Fund Denmark; Danish Council of Independent research [DFF-4002-00114]	BONUS; Baltic Sea research and development programme; European Union's Seventh Framework Programme for Research, Technological Development and Demonstration and Innovation Fund Denmark; Danish Council of Independent research(Det Frie Forskningsrad (DFF))	The research leading to these results has received funding from BONUS (BIO-C3project), the joint Baltic Sea research and development programme (Art185), funded jointly by the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration and Innovation Fund Denmark, and from the Danish Council of Independent research DFF-4002-00114.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Auer SK, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0793; Auer SK, 2015, FUNCT ECOL, V29, P479, DOI 10.1111/1365-2435.12396; Azour F, 2015, AQUAT BIOL, V24, P41, DOI 10.3354/ab00634; Balshine S, 2005, J GREAT LAKES RES, V31, P68, DOI 10.1016/S0380-1330(05)70238-0; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Beauchamp David A., 2009, V70, P53; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Behrens JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046227; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Borcherding J, 2011, J APPL ICHTHYOL, V27, P153, DOI 10.1111/j.1439-0426.2010.01662.x; Bronnenhuber JE, 2011, MOL ECOL, V20, P1845, DOI 10.1111/j.1365-294X.2011.05030.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Chabot D, 2016, J FISH BIOL, V88, P81, DOI 10.1111/jfb.12845; Child T, 2008, J EXP ZOOL PART A, V309A, P215, DOI 10.1002/jez.450; Claireaux G, 2007, PHILOS T R SOC B, V362, P2031, DOI 10.1098/rstb.2007.2099; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Crooks Jeffrey A., 2009, V204, P173; DePasquale C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2564; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Eliason Ej, 2015, J FISH BIOL; Ellis S, 2009, FRESHWATER BIOL, V54, P77, DOI 10.1111/j.1365-2427.2008.02098.x; Evans TG, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov056; Farrell AP, 2016, SCIENCE, V351, P132, DOI 10.1126/science.351.6269.132-b; Fitzsimons J, 2006, J GREAT LAKES RES, V32, P227, DOI 10.3394/0380-1330(2006)32[227:LEOSEP]2.0.CO;2; Flink H, 2015, THESIS; Franklin CE, 2007, J EXP BIOL, V210, P3068, DOI 10.1242/jeb.003137; Fry F.E.J., 1971, P1; Fry F. E. J., 1947, University of Toronto Studies Biological Series, VNo. 55, P1; Galil BS, 2014, ETHOL ECOL EVOL, V26, P152, DOI 10.1080/03949370.2014.897651; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Grans A, 2014, J EXP BIOL, V217, P711, DOI 10.1242/jeb.096743; Gutowsky LFG, 2011, FISH RES, V108, P228, DOI 10.1016/j.fishres.2010.12.014; Hammill E, 2004, J THERM BIOL, V29, P251, DOI 10.1016/j.jtherbio.2004.04.002; HETTLER WF, 1976, J FISH BIOL, V8, P55, DOI 10.1111/j.1095-8649.1976.tb03907.x; Houston AH, 2002, METHODS FISH BIOL, P273; HWANG PP, 1989, MAR BIOL, V100, P295, DOI 10.1007/BF00391142; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Karlson AML, 2007, ICES J MAR SCI, V64, P479, DOI 10.1093/icesjms/fsl049; Karsiotis SI, 2012, J GREAT LAKES RES, V38, P121, DOI 10.1016/j.jglr.2011.12.010; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Katsanevakis S, 2014, AQUAT INVASIONS, V9, P391, DOI 10.3391/ai.2014.9.4.01; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Killen SS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0603; Killen SS, 2014, FUNCT ECOL, V28, P1367, DOI 10.1111/1365-2435.12296; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kornis MS, 2010, CAN J FISH AQUAT SCI, V67, P553, DOI 10.1139/F10-002; Kotta J, 2015, ESTUAR COAST SHELF S, V169, P15; Kultz D, 2015, J EXP BIOL, V218, P1907, DOI 10.1242/jeb.118695; LaRue EA, 2011, HYDROBIOLOGIA, V663, P71, DOI 10.1007/s10750-010-0555-6; Lauer TE, 2004, T AM FISH SOC, V133, P185, DOI 10.1577/T02-123; Lederer AM, 2008, J GREAT LAKES RES, V34, P690, DOI 10.3394/0380-1330-34.4.690; Lehtiniemi M, 2015, MAR POLICY, V54, P26, DOI 10.1016/j.marpol.2014.12.015; Lennox R, 2015, BIOL INVASIONS, V17, P2213, DOI 10.1007/s10530-015-0884-5; Lom J, 1995, FISH DIS DISORDERS, V1; LUTZ PL, 1972, COMP BIOCHEM PHYSIOL, V42, P711, DOI 10.1016/0300-9629(72)90449-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marras S, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cou059; McKenzie DJ, 1999, J APPL ICHTHYOL, V15, P61, DOI 10.1111/j.1439-0426.1999.tb00208.x; McKenzie DJ, 2001, CAN J FISH AQUAT SCI, V58, P1104, DOI 10.1139/cjfas-58-6-1104; MILLERO FJ, 1980, DEEP-SEA RES, V27, P265, DOI 10.1016/0198-0149(80)90017-5; Morgan JD, 1998, J FISH BIOL, V53, P1110, DOI 10.1006/jfbi.1998.0780; Munday PL, 2015, NAT CLIM CHANGE, V5, P102, DOI 10.1038/nclimate2496; Nestler EJ, 2016, PLOS BIOL; Nilsson S, 1986, FISH PHYSL RECENT AD, P86; Norin T, 2016, J FISH BIOL, V88, P122, DOI 10.1111/jfb.12796; Norin T, 2014, J EXP BIOL, V217, P244, DOI 10.1242/jeb.089755; Ojaveer H, 2015, MANAG BIOL INVASION, V6, P329, DOI 10.3391/mbi.2015.6.4.02; Ojaveer H, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002130; Ojaveer H, 2015, HYDROBIOLOGIA, V750, P171, DOI 10.1007/s10750-014-2080-5; Ojaveer H, 2014, MAR POLICY, V44, P160, DOI 10.1016/j.marpol.2013.08.019; Olenin S, 2014, BIOL CONSERV, V173, P98, DOI 10.1016/j.biocon.2013.07.040; Olsen J., 2002, THESIS; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Randall DJ, COMP BIOCHEMPHYSIO A, V41, P629; Reidy SP, 2000, J EXP BIOL, V203, P347; REIDY SP, 1995, J FISH BIOL, V47, P377, DOI 10.1111/j.1095-8649.1995.tb01907.x; SALONIUS K, 1993, CAN J FISH AQUAT SCI, V50, P759, DOI 10.1139/f93-087; Sapota MR, 2005, BIOL INVASIONS, V7, P157, DOI 10.1007/s10530-004-9035-0; Sapota MR, 2004, HYDROBIOLOGIA, V514, P219, DOI 10.1023/B:hydr.0000018221.28439.ae; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Seebacher F, 2011, J EXP BIOL, V214, P1437, DOI 10.1242/jeb.053124; Shama LNS, 2014, FUNCT ECOL, V28, P1482, DOI 10.1111/1365-2435.12280; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Smith SA, 1992, FISH MED; SOIVIO A, 1975, J EXP BIOL, V63, P207; SOIVIO A, 1977, J FISH BIOL, V10, P91, DOI 10.1111/j.1095-8649.1977.tb04045.x; St-Pierre J, 1998, J EXP BIOL, V201, P2961; STEFFENSEN JF, 1984, COMP BIOCHEM PHYS A, V79, P437, DOI 10.1016/0300-9629(84)90541-3; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Svendsen MBS, 2016, J FISH BIOL, V88, P26, DOI 10.1111/jfb.12797; Tirsgaard B, 2015, COMP BIOCHEM PHYS A, V179, P89, DOI 10.1016/j.cbpa.2014.09.033; Van der Linden A, 1999, COMP BIOCHEM PHYS A, V124, P343, DOI 10.1016/S1095-6433(99)00124-5; VANWAVERSVELD J, 1989, COMP BIOCHEM PHYS A, V92, P159, DOI 10.1016/0300-9629(89)90146-1; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Williamson M., 1997, BIOL INVASIONS; Winwood-Smith HS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov010; Young JAM, 2010, J GREAT LAKES RES, V36, P115, DOI 10.1016/j.jglr.2009.11.001	106	37	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176038	10.1371/journal.pone.0176038	http://dx.doi.org/10.1371/journal.pone.0176038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423029	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600079
J	Azevedo, APD; Mezencio, B; Amadio, AC; Serrao, JC				da Silva Azevedo, Ana Paula; Mezencio, Bruno; Amadio, Alberto Carlos; Serrao, Julio Cerca			16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners (vol 11, e0167234, 2016)	PLOS ONE			English	Correction													Mezêncio, Bruno/W-4273-2019; SERRÃO, JULIO CERCA/G-8499-2015; Mezêncio, Bruno/AAX-3450-2020	Mezêncio, Bruno/0000-0001-6293-5571; SERRÃO, JULIO CERCA/0000-0002-3646-3387; Mezêncio, Bruno/0000-0001-6293-5571	University of Sao Paulo (USP); Coordination of Improvement of People from Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES)	University of Sao Paulo (USP); Coordination of Improvement of People from Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES)	The University of Sao Paulo (USP) provided support for this research through the "USP in 2016 Olympic Games Program." The authors also thank the Coordination of Improvement of People from Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES) for financial support to publish this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Silva Azevedo A.P., 2016, PLOS ONE, V11, P12, DOI [10.1371/journal.pone.0167234, DOI 10.1371/journalpone.0167234]	1	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176426	10.1371/journal.pone.0176426	http://dx.doi.org/10.1371/journal.pone.0176426			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423015	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600103
J	Huang, QY; Rong, MH; Lan, AH; Lin, XM; Lin, XG; He, RQ; Chen, G; Li, MJ				Huang, Qian-Yi; Rong, Min-Hua; Lan, Ai-Hua; Lin, Xiao-Miao; Lin, Xing-Gu; He, Rong-Quan; Chen, Gang; Li, Mu-Jun			The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis	PLOS ONE			English	Article							REPEATED IMPLANTATION FAILURE; OXYTOCIN ANTAGONIST; INFERTILITY; IVF	Background Atosiban is administered to women undergoing in vitro fertilization-embryo transfer (IVF-ET) to improve pregnancy outcomes. However, the results of this treatment were controversial. We conducted this meta-analysis to investigate whether atosiban improves pregnancy outcomes in the women undergoing in vitro fertilization (IVF). Methods Databases of PubMed, EMBASE, Web of Science, China BioMedicine, and Google Scholar were systematically searched. Meta-analyses were performed to investigate whether atosiban improves pregnancy outcomes in the women undergoing IVF. Results Our results showed that atosiban was associated with higher implantation (OR = 1.63, 95% CI: 1.17-2.27; P = 0.004) and clinical pregnancy (OR = 1.84, 95% CI: 1.31-2.57; P < 0.001) rates. However, atosiban showed no significant association with the miscarriage, live birth, multiple pregnancy or ectopic pregnancy rates. When a further subgroup analysis was performed in the women undergoing repeated implantation failure (RIF), implantation (OR = 1.93, 95% CI: 1.45-2.57; P < 0.001), clinical pregnancy (OR = 2.48, 95% CI: 1.70-3.64; P <0.001) and the live birth (OR = 2.89, 95% CI: 1.78-4.67; P < 0.001) rates were significantly higher in the case group. Nevertheless, no significant difference was detected in the miscarriage and multiple pregnancy rates between the case and control groups. Conclusion Atosiban may be more appropriate for women undergoing RIF and play only a limited role in improving pregnancy outcomes in the general population of women undergoing IVF. These conclusions should be verified in large and well-designed studies.	[Huang, Qian-Yi; Lan, Ai-Hua; Li, Mu-Jun] Guangxi Med Univ, Affiliated Hosp 1, Dept Reprod, Med Res Ctr, Nanning, Peoples R China; [Rong, Min-Hua] Guangxi Med Univ, Affiliated Canc Hosp, Res Dept, Nanning, Peoples R China; [Lin, Xiao-Miao] Guangxi Maternal & Child Hlth Hosp, Dept Children Rehabil Med, Nanning, Peoples R China; [Lin, Xing-Gu; He, Rong-Quan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, MJ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Reprod, Med Res Ctr, Nanning, Peoples R China.	limujun1699@126.com	lan, A/HHZ-6588-2022					Chen CYLL, 2014, REPROD CONTRACEPTION, V08, P633; Chou PY, 2011, TAIWAN J OBSTET GYNE, V50, P136, DOI 10.1016/j.tjog.2011.04.003; Dessolle L, 2009, HUM REPROD, V24, P3082, DOI 10.1093/humrep/dep303; Fanchin R, 1998, CONTRACEPT FERTIL S, V26, P498; Ferraretti AP, 2013, HUM REPROD, V28, P2318, DOI 10.1093/humrep/det278; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kushnir VA, 2013, FERTIL STERIL, V100, P736, DOI 10.1016/j.fertnstert.2013.05.012; Li J, 2013, AM J REPROD IMMUNOL, V70, P434, DOI 10.1111/aji.12170; Liang YL, 2009, TAIWAN J OBSTET GYNE, V48, P314, DOI 10.1016/S1028-4559(09)60314-4; Luo YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003337; Matorras R, 2004, HUM REPROD, V19, P2027, DOI 10.1093/humrep/deh366; Moraloglu O, 2010, REPROD BIOMED ONLINE, V21, P338, DOI 10.1016/j.rbmo.2010.04.009; Ng EHY, 2014, HUM REPROD, V29, P2687, DOI 10.1093/humrep/deu263; Pierzynski P, 2007, FERTIL STERIL, V87, P1147, DOI 10.1016/j.fertnstert.2006.08.089; Pierzynski P, 2011, REPROD BIOMED ONLINE, V22, P9, DOI 10.1016/j.rbmo.2010.09.015; Pierzynski P, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2006.09.017; Simon A, 2012, J ASSIST REPROD GEN, V29, P1227, DOI 10.1007/s10815-012-9861-4; Singh Neeta, 2015, J Hum Reprod Sci, V8, P218, DOI 10.4103/0974-1208.170401; Sloman S. A., 2014, MEM COGNITION, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100819; Song Xue-Ru, 2013, Zhonghua Fu Chan Ke Za Zhi, V48, P667; Spandorfer SD, 2003, FERTIL STERIL, V79, P654, DOI 10.1016/S0015-0282(02)04703-9; Vogel JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006169.pub2; Vuong TNL, 2012, REPROD BIOMED ONLINE, V25, P254, DOI 10.1016/j.rbmo.2012.05.014; Zhang YN, 2015, GENE, V571, P9, DOI 10.1016/j.gene.2015.07.083; Zhang YZY, 2014, CHIN J FAM PLANN, V05, P325	25	16	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175501	10.1371/journal.pone.0175501	http://dx.doi.org/10.1371/journal.pone.0175501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422984	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600034
J	Lancee, J; Yasiney, SL; Brendel, RS; Boffo, M; Clarke, PJF; Salemink, E				Lancee, Jaap; Yasiney, Samya L.; Brendel, Ruben S.; Boffo, Marilisa; Clarke, Patrick J. F.; Salemink, Elske			Attentional bias modification training for insomnia: A double-blind placebo controlled randomized trial	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SLEEP PHASE SYNDROME; PSYCHOPHYSIOLOGICAL INSOMNIA; MODIFICATION PROGRAM; SEVERITY INDEX; ANXIETY; VALIDATION; VULNERABILITY; MANIPULATION; DEPRESSION	Background Attentional bias toward sleep-related information is believed to play a key role in insomnia. If attentional bias is indeed of importance, changing this bias should then in turn have effects on insomnia complaints. In this double-blind placebo controlled randomized trial we investigated the efficacy of attentional bias modification training in the treatment of insomnia. Method We administered baseline, post-test, and one-week follow-up measurements of insomnia severity, sleep-related worry, depression, and anxiety. Participants meeting DSM-5 criteria for insomnia were randomized into an attentional bias training group (n = 67) or a placebo training group (n = 70). Both groups received eight training sessions over the course of two weeks. All participants kept a sleep diary for four consecutive weeks (one week before until one week after the training sessions). Results There was no additional benefit for the attentional bias training over the placebo training on sleep-related indices/outcome measures. Conclusions The absence of the effect may be explained by the fact that there was neither attentional bias at baseline nor any reduction in the bias after the training. Either way, this study gives no support for attentional bias modification training as a stand-alone intervention for ameliorating insomnia complaints.	[Lancee, Jaap; Yasiney, Samya L.; Brendel, Ruben S.] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Boffo, Marilisa; Salemink, Elske] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Clarke, Patrick J. F.] Univ Western Australia, Sch Psychol, Perth, WA, Australia; [Clarke, Patrick J. F.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA, Australia	University of Amsterdam; University of Amsterdam; University of Western Australia; Curtin University	Lancee, J (corresponding author), Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	j.lancee@uva.nl		Boffo, Marilisa/0000-0003-4730-7838; Clarke, Patrick/0000-0003-0303-4479; Salemink, Elske/0000-0002-6885-2598				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bar-Haim Y, 2010, J CHILD PSYCHOL PSYC, V51, P859, DOI 10.1111/j.1469-7610.2010.02251.x; Barclay NL, 2013, J SLEEP RES, V22, P414, DOI 10.1111/jsr.12035; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Boettcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071760; Bouma JR., 1995, METEN SYMPTOMEN DEPR; Buysse D J, 1989, Psychiatry Res, V28, P193; Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Clarke PJF, 2016, PSYCHOTHER PSYCHOSOM, V85, P187, DOI 10.1159/000442025; Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Emmelkamp PMG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-63; Espie CA, 2006, SLEEP MED REV, V10, P215, DOI 10.1016/j.smrv.2006.03.002; Espie CA, 2009, SLEEP, V32, P1549, DOI 10.1093/sleep/32.12.1549; Espie Colin A, 2012, J Clin Psychiatry, V73, pe1478, DOI 10.4088/JCP.12m07954; Geiger-Brown JM, 2015, SLEEP MED REV, V23, P54, DOI 10.1016/j.smrv.2014.11.007; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Harris K, 2015, CLIN PSYCHOL REV, V42, P16, DOI 10.1016/j.cpr.2015.08.001; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Jansson-Frojmark Markus, 2011, Cognitive Behaviour Therapy, V40, P65, DOI 10.1080/16506073.2010.538432; Jones BT, 2005, J ABNORM PSYCHOL, V114, P249, DOI 10.1037/0021-843X.114.2.249; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003; Lancee J, 2012, BEHAV RES THER, V50, P22, DOI 10.1016/j.brat.2011.09.012; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Linetzky M, 2015, DEPRESS ANXIETY, V32, P383, DOI 10.1002/da.22344; Lundh L., 1997, COGNITIVE BEHAV THER, V26, P27, DOI DOI 10.1080/16506079708412033; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2007, BEHAV RES METHODS, V39, P533, DOI 10.3758/BF03193023; MacLeod C, 2015, CLIN PSYCHOL SCI, V3, P58, DOI 10.1177/2167702614560749; MacMahon KMA, 2006, SLEEP, V29, P1420, DOI 10.1093/sleep/29.11.1420; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Marchetti LM, 2006, J SLEEP RES, V15, P212, DOI 10.1111/j.1365-2869.2006.00510.x; Milkins B, 2016, CLIN PSYCHOL SCI, V4, P1015, DOI 10.1177/2167702615626898; Mobini S, 2013, COGNITIVE THER RES, V37, P173, DOI 10.1007/s10608-012-9445-8; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; See J, 2009, J ABNORM PSYCHOL, V118, P65, DOI 10.1037/a0014377; Semler CN, 2004, PSYCHOSOM MED, V66, P242, DOI 10.1097/01.PSY.0000114870.50968.90; Spiegelhalder K, 2008, J SLEEP RES, V17, P191, DOI 10.1111/j.1365-2869.2008.00641.x; Spiegelhalder K, 2010, SLEEP, V33, P107, DOI 10.1093/sleep/33.1.107; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Spoormaker Victor I, 2005, Behav Sleep Med, V3, P227, DOI 10.1207/s15402010bsm0304_4; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tang NKY, 2004, BEHAV RES THER, V42, P27, DOI 10.1016/S0005-7967(03)00068-8; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Van Bockstaele B, 2017, COGNITION EMOTION, V31, P369, DOI 10.1080/02699931.2015.1092418; Waechter S, 2014, COGNITIVE THER RES, V38, P313, DOI 10.1007/s10608-013-9588-2; Wicklow A, 2000, BEHAV RES THER, V38, P679, DOI 10.1016/S0005-7967(99)00136-9; Woods HC, 2013, SLEEP, V36, P1491, DOI 10.5665/sleep.3042; Zachariae R, 2016, SLEEP MED REV, V30, P1, DOI 10.1016/j.smrv.2015.10.004; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	66	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174531	10.1371/journal.pone.0174531	http://dx.doi.org/10.1371/journal.pone.0174531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423038	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600018
J	Romkina, AY; Kiriukhin, MY				Romkina, Anastasia Y.; Kiriukhin, Michael Y.			Biochemical and molecular characterization of the isocitrate dehydrogenase with dual coenzyme specificity from the obligate methylotroph Methylobacillus Flagellatus	PLOS ONE			English	Article							PSYCHROPHILIC BACTERIUM; ENZYMATIC CHARACTERIZATION; LYSINE SUCCINYLATION; CRYSTAL-STRUCTURE; NAD; ISOZYMES; REVEALS; IDENTIFICATION; EXPRESSION; STATE	The isocitrate dehydrogenase (MfIDH) with unique double coenzyme specificity from Methylobacillus flagellatus was purified and characterized, and its gene was cloned and overexpressed in E. coli as a fused protein. This enzyme is homodimeric,-with a subunit molecular mass of 45 kDa and a specific activity of 182 U mg(-1) with NAD(+) and 63 U mg(-1) with NADP(+). The MfIDH activity was dependent on divalent cations and Mn2+ enhanced the activity the most effectively. MfIDH exhibited a cofactor-dependent pH-activity profile. The optimum pH values were 8.5 (NAD(+)) and 6.0 (NADP(+)). The Km values for NAD(+) and NADP(+) were 113 mu M and 184 mu M respectively, while the K-m values for DL-isocitrate were 9.0 mu M(NAD(+)), 8.0 mu M(NADP(+)). The MfIDH specificity (k(cat)/K-m) was only 5-times higher for NAD(+) than for NADP(+). The purified MfIDH displayed maximal activity at 60 degrees C. Heat-inactivation studies showed that the MfIDH was remarkably thermostable, retaining full activity at 50 degrees C and losting ca. 50% of its activity after one hour of incubation at 75 degrees C. The enzyme was insensitive to the presence of intermediate metabolites, with the exception of 2mM ATP, which caused 50% inhibition of NADP(+)-linked activity. The indispensability of the N-6 amino group of NAD(P)(+) in its binding to MfIDH was demonstrated. MfIDH showed high sequence similarity with bacterial NAD(P)(+) -dependent type I isocitrate dehydrogenases (IDHs) rather than with eukaryotic NAD(+) -dependent IDHs. The unique double coenzyme specificity of MfIDH potentially resulted from the Lys340, Ile341 and Ala347 residues in the coenzyme-binding site of the enzyme. The discovery of a type I IDH with double coenzyme specificity elucidates the evolution of this subfamily IDHs and may provide fundamental information for engineering enzymes with desired properties.	[Romkina, Anastasia Y.; Kiriukhin, Michael Y.] Ajinomoto Genetika Res Inst, Moscow, Russia	Ajinomoto Co Inc	Kiriukhin, MY (corresponding author), Ajinomoto Genetika Res Inst, Moscow, Russia.	mikhail_kiriukhin@agri.ru			Ajinomoto Co., Inc; Ajinomoto-Genetika Research Institute, Moscow	Ajinomoto Co., Inc; Ajinomoto-Genetika Research Institute, Moscow	Ajinomoto-Genetika Research Institute, Moscow, Russia is a research center of Ajinomoto Co., Inc. Ajinomoto Co., Inc provided support in the form of salaries for authors AYRMYK and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony C, 1983, BIOCH METHYLOTROPHS; Aoshima M, 2004, MOL MICROBIOL, V51, P791, DOI 10.1046/j.1365-2958.2003.03863.x; Baev MV, 1997, ANTON LEEUW INT J G, V71, P353; Banerjee Sharmistha, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-20; Chen RD, 2000, ARCH BIOCHEM BIOPHYS, V383, P238, DOI 10.1006/abbi.2000.2082; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; El-Mansi EMT, 1998, FEMS MICROBIOL LETT, V166, P333, DOI 10.1016/S0378-1097(98)00351-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOFMANN KH, 1980, Z ALLG MIKROBIOL, V20, P399, DOI 10.1002/jobm.3630200606; Huang DS, 2009, PROTEIN J, V28, P443, DOI 10.1007/s10930-009-9212-1; Huang SP, 2016, INT J MOL SCI, V17, P1; Imada K, 2008, PROTEINS, V70, P63, DOI 10.1002/prot.21486; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; ISHII A, 1993, J BACTERIOL, V175, P6873, DOI 10.1128/jb.175.21.6873-6880.1993; Jin MM, 2013, MOL BIOL REP, V40, P2995, DOI 10.1007/s11033-012-2371-8; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; Karlstrom M, 2006, FEBS J, V273, P2851, DOI 10.1111/j.1742-4658.2006.05298.x; KIRIUKHIN MY, 1993, FEMS MICROBIOL LETT, V113, P101; KIRIUKHIN MY, 1992, FEMS MICROBIOL LETT, V93, P155; Lapidus A, 2011, J BACTERIOL, V193, P3757, DOI 10.1128/JB.00404-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LLOYD AJ, 1988, BIOCHEM SOC T, V16, P871, DOI 10.1042/bst0160871; Lv CQ, 2016, J BASIC MICROB, V56, P975, DOI 10.1002/jobm.201500648; Maki S, 2006, EXTREMOPHILES, V10, P237, DOI 10.1007/s00792-005-0493-9; Matsuo S, 2010, ARCH MICROBIOL, V192, P639, DOI 10.1007/s00203-010-0595-3; MEIXNERMONORI B, 1986, BIOCHEM J, V236, P549, DOI 10.1042/bj2360549; Prasad UV, 2013, APPL BIOCHEM BIOTECH, V169, P862, DOI 10.1007/s12010-012-0027-8; Rodriguez-Arnedo A, 2005, PROTEIN J, V24, P259, DOI 10.1007/s10930-005-6746-8; Shimizu T, 2016, BIOCHEM J, P105; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Steen IH, 2002, ARCH MICROBIOL, V178, P297, DOI 10.1007/s00203-002-0439-x; Steen IH, 2001, J BIOL CHEM, V276, P43924, DOI 10.1074/jbc.M105999200; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Stokke R, 2007, EXTREMOPHILES, V11, P481, DOI 10.1007/s00792-006-0060-z; Suzuki K, 2016, BIOSCI BIOTECH BIOCH, V80, P1492, DOI 10.1080/09168451.2016.1165602; Wang A, 2011, MOL BIOL REP, V38, P3717, DOI 10.1007/s11033-010-0486-3; Wang P, 2015, NAT SCI REPORTS, V5, P1, DOI DOI 10.1039/C4RA10590G; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wang P, 2011, BIOCHIMIE, V93, P1470, DOI 10.1016/j.biochi.2011.04.021; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wu MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125229; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang BB, 2013, MOL BIOL REP, V40, P1615, DOI 10.1007/s11033-012-2210-y; Zhang G., 2016, EURASIP J WIREL COMM, V2016, P1, DOI DOI 10.1016/J.CELLIMM.2016.01.007; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao XY, 2014, APPL BIOCHEM BIOTECH, V172, P487, DOI 10.1007/s12010-013-0521-7; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	51	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176056	10.1371/journal.pone.0176056	http://dx.doi.org/10.1371/journal.pone.0176056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423051	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600082
J	Bongiorno, C; Micciche, S; Mantegna, RN				Bongiorno, Christian; Micciche, Salvatore; Mantegna, Rosario N.			An empirically grounded agent based model for modeling directs, conflict detection and resolution operations in air traffic management	PLOS ONE			English	Article								We present an agent based model of the Air Traffic Management socio-technical complex system aiming at modeling the interactions between aircraft and air traffic controllers at a tactical level. The core of the model is given by the conflict detection and resolution module and by the directs module. Directs are flight shortcuts that are given by air controllers to speed up the passage of an aircraft within a certain airspace and therefore to facilitate airline operations. Conflicts between flight trajectories can occur for two main reasons: either the planning of the flight trajectory was not sufficiently detailed to rule out all potential conflicts or unforeseen events during the flight require modifications of the flight plan that can conflict with other flight trajectories. Our model performs a local conflict detection and resolution procedure. Once a flight trajectory has been made conflict-free, the model searches for possible improvements of the system efficiency by issuing directs. We give an example of model calibration based on real data. We then provide an illustration of the capability of our model in generating scenario simulations able to give insights about the air traffic management system. We show that the calibrated model is able to reproduce the existence of a geographical localization of air traffic controllers' operations. Finally, we use the model to investigate the relationship between directs and conflict resolutions (i) in the presence of perfect forecast ability of controllers, and (ii) in the presence of some degree of uncertainty in flight trajectory forecast.	[Bongiorno, Christian; Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Chim, Viale Sci,Ed 18, I-90128 Palermo, Italy; [Mantegna, Rosario N.] Cent European Univ, Ctr Network Sci, Nador 9, H-1051 Budapest, Hungary; [Mantegna, Rosario N.] Cent European Univ, Dept Econ, Nador 9, H-1051 Budapest, Hungary	University of Palermo; Central European University; Central European University	Micciche, S (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Viale Sci,Ed 18, I-90128 Palermo, Italy.	salvatore.micciche@unipa.it	Mantegna, Rosario N/H-3652-2014; Miccichè, Salvatore/B-6575-2008	Mantegna, Rosario N/0000-0003-4177-171X; Miccichè, Salvatore/0000-0003-3779-592X	SESAR-JU (Single European Sky ATM Research joint undertaking) through the research project ELSA "Empirically grounded agent based models for the future ATM scenario" [10-220719-C18]; EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E-ELSA research project	SESAR-JU (Single European Sky ATM Research joint undertaking) through the research project ELSA "Empirically grounded agent based models for the future ATM scenario"; EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E-ELSA research project	The research was funded by SESAR-JU (Single European Sky ATM Research joint undertaking) (http://www.sesarp.eu) through the research project ELSA "Empirically grounded agent based models for the future ATM scenario", Contract Number 10-220719-C18. SESAR-JU is a legal entity founded by the European Union and EUROCONTROL (European Organisation for the Safety of Air Navigation), to coordinate and concentrate all relevant research in the technological and operational dimension of the Single European Sky (SES). Data collection was performed by EUROCONTROL. Data were obtained as part of the SESAR Joint Undertaking WP-E research project ELSA "Empirically grounded agent based model for the future ATM scenario" after competing in a 2011 public call issued by SESAR Joint Undertaking. Anyone interested in the data can request it directly from EUROCONTROL by the following email: ddr2_support@eurocontrol.int.r This work was co-financed by EUROCONTROL on behalf of the SESAR Joint Undertaking in the context of SESAR Work Package E-ELSA research project. We thank the Deep Blue Srl team for providing us useful insights about the ATM system. We also thank all past participants to the ELSA project for interesting discussions.	Agogino AK, 2012, AUTON AGENT MULTI-AG, V24, P1, DOI 10.1007/s10458-010-9142-5; [Anonymous], 2017, 4444 ICAO, P1; Bilimoria KD., 2000, P AIAA GUID NAV CONT, P1; Bongiorno C, 2017, J AIR TRANSP MANAG, V58, P152, DOI 10.1016/j.jairtraman.2016.10.009; Bongiorno C., 2015, P 5 SESAR INN DAYS E; Bongiorno C., 2013, PROCEEDINGS OF THE T; Cook A., 2016, COMPLEXITY SCI AIR T; Durand N., 1997, P 1 US EUR SEM; Eby M. S., 1999, 1999 IEEE Aerospace Conference. Proceedings (Cat. No.99TH8403), P429, DOI 10.1109/AERO.1999.793186; ELSA project, E 02 18 ELSA D1 3 ST; EUROCONTROL, 2012, FREE ROUT DEV EUR; EUROCONTROL, 2005, FIN REP EUR COMM MAN; Gurtner G, 2017, J AIR TRANSP MANAG, V59, P26, DOI 10.1016/j.jairtraman.2016.11.004; Gurtner G, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05028; Heath B, 2009, JASSS-J ARTIF SOC S, V12, pA143; Kernighan BW., 1988, C PROGRAMMING LANGUA; Kuchar J. K., 2000, IEEE Transactions on Intelligent Transportation Systems, V1, P179, DOI 10.1109/6979.898217; Lillo F., 2011, P SESAR INN DAYS EUR; Monechi B., 2014, P 4 SESAR INN DAYS E; Monechi B., 2015, PLOS ONE, V10; SESAR, 2007, SESAR CONC OP; Shah A. P., 2005, PROCEEDINGS OF THE 6; Smart W. M., 1960, TXB SPHERICAL ASTRON; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Windrum P, 2007, JASSS-J ARTIF SOC S, V10	25	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175036	10.1371/journal.pone.0175036	http://dx.doi.org/10.1371/journal.pone.0175036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419160	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200007
J	Dillen, M; Smit, C; Buyse, M; Hofte, M; De Clercq, P; Verheyen, K				Dillen, Mathias; Smit, Christian; Buyse, Martijn; Hofte, Monica; De Clercq, Patrick; Verheyen, Kris			Stronger diversity effects with increased environmental stress: A study of multitrophic interactions between oak, powdery mildew and ladybirds	PLOS ONE			English	Article							BIODIVERSITY; COLEOPTERA; COCCINELLIDAE; PRODUCTIVITY; TEMPERATE; IDENTITY; FORESTS	Recent research has suggested that increasing neighbourhood tree species diversity may mitigate the impact of pests or pathogens by supporting the activities of their natural enemies and/or reducing the density of available hosts. In this study, we attempted to assess these mechanisms in a multitrophic study system of young oak (Quercus), oak powdery mildew (PM, caused by Erysiphe spp.) and a mycophagous ladybird (Psyllobora vigintiduo-punctata). We assessed ladybird mycophagy on oak PM in function of different neighbourhood tree species compositions. We also evaluated whether these species interactions were modulated by environmental conditions as suggested by the Stress Gradient Hypothesis. We adopted a complementary approach of a field experiment where we monitored oak saplings subjected to a reduced rainfall gradient in a young planted forest consisting of different tree species mixtures, as well as a lab experiment where we independently evaluated the effect of different watering treatments on PM infections and ladybird mycophagy. In the field experiment, we found effects of neighbourhood tree species richness on ladybird mycophagy becoming more positive as the target trees received less water. This effect was only found as weather conditions grew drier. In the lab experiment, we found a preference of ladybirds to graze on infected leaves from trees that received less water. We discuss potential mechanisms that might explain this preference, such as emissions of volatile leaf chemicals. Our results are in line with the expectations of the Natural Enemies Hypothesis and support the hypothesis that biodiversity effects become stronger with increased environmental stress.	[Dillen, Mathias; Smit, Christian] Univ Groningen, Groningen Inst Evolutionary Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands; [Dillen, Mathias; Buyse, Martijn; Verheyen, Kris] Univ Ghent, Dept Forest & Water Management, Forest & Nat Lab, Gontrode, Belgium; [Hofte, Monica] Univ Ghent, Dept Crop Protect, Lab Phytopathol, Ghent, Belgium; [De Clercq, Patrick] Univ Ghent, Dept Crop Protect, Lab Agrozool, Ghent, Belgium	University of Groningen; Ghent University; Ghent University; Ghent University	Dillen, M (corresponding author), Univ Groningen, Groningen Inst Evolutionary Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands.; Dillen, M (corresponding author), Univ Ghent, Dept Forest & Water Management, Forest & Nat Lab, Gontrode, Belgium.	M.dillen@rug.nl	Hofte, Monica MR/A-6154-2008; De Clercq, Patrick/B-5721-2015; Buyse, Marc/J-4658-2013; smit, christian/B-9817-2008	De Clercq, Patrick/0000-0003-0664-1602; Dillen, Mathias/0000-0002-3973-1252; Hofte, Monica/0000-0002-0850-3249; Verheyen, Kris/0000-0002-2067-9108; smit, christian/0000-0002-4044-9473	FWO-project (Research Foundation Flanders) [G046413N]; University of Groningen	FWO-project (Research Foundation Flanders); University of Groningen	MD was supported by FWO-project G046413N (Research Foundation Flanders, http://www.fwo.be) and Ubbo Emmius funds from the University of Groningen (http://www.rug.nl/alumni steun-de-rug/ubbo-emmius-fonds/ue-fonds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimar D, 2011, PLANTS ENV, V272; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bert D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155344; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Copolovici L, 2015, SCI PAP E, VIV, P2010; Copolovici L, 2014, TREE PHYSIOL, V34, P1399, DOI 10.1093/treephys/tpu091; de Almeida LM, 1998, J NEW YORK ENTOMOL S, V106, P170; Dieu Hien Truong, 2014, Journal of Environment and Ecology, V5, P276; Dillen M, 2016, FOREST ECOL MANAG, V380, P274, DOI 10.1016/j.foreco.2016.09.004; Feau N, 2012, FUNGAL ECOL, V5, P154, DOI 10.1016/j.funeco.2011.12.003; Giorgi JA, 2009, BIOL CONTROL, V51, P215, DOI 10.1016/j.biocontrol.2009.05.019; Haase J., 2015, OIKOS, P1; Hajji M, 2009, EUR J PLANT PATHOL, V125, P63, DOI 10.1007/s10658-009-9458-7; Hamelin FM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1517; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jactel H., 2005, FOR DIVERS FUNCT TEM, P411; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jucker T, 2016, J ECOL, V104, P388, DOI 10.1111/1365-2745.12522; Kigathi RN, 2009, J CHEM ECOL, V35, P1335, DOI 10.1007/s10886-009-9716-3; Kumar Rajesh, 2010, Munis Entomology & Zoology, V5, P652; Kuznetsova A., 2015, LMERTEST TESTS LINEA; LETOURNEAU DK, 1987, ECOLOGY, V68, P1616, DOI 10.2307/1939853; Liang JJ, 2016, SCIENCE, V354, DOI 10.1126/science.aaf8957; Marcais B, 2014, ANN FOREST SCI, V71, P633, DOI 10.1007/s13595-012-0252-x; Melidossian HS, 2005, PLANT DIS, V89, P1331, DOI 10.1094/PD-89-1331; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Mougou A, 2008, FOREST PATHOL, V38, P275, DOI 10.1111/j.1439-0329.2008.00544.x; Nguyen D, 2016, ECOL EVOL, V6, P2426, DOI 10.1002/ece3.2056; Niinemets U, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00262; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rackham O, 2003, ANCIENT WOODLAND ITS; Rocha S, 1996, J AGR FOOD CHEM, V44, P865, DOI 10.1021/jf9500400; Rockstrom J, 2009, ECOL SOC, V14; S. Effect of temperature, 2013, ARCH BIOL SCI, V65, P1069; Satti A. A., 2015, Journal of the Saudi Society of Agricultural Sciences, V14, P48, DOI 10.1016/j.jssas.2013.06.003; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmidtke A, 2010, OECOLOGIA, V164, P665, DOI 10.1007/s00442-010-1688-z; Significance S., 2012, PERIOD BIOL, V114, P91; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Sutherland AM, 2009, BIOL CONTROL, V51, P284, DOI 10.1016/j.biocontrol.2009.05.012; Tabata J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023799; Thompson I, 2009, TECHNICAL SERIES, V43; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Toigo M, 2015, J ECOL, V103, P502, DOI 10.1111/1365-2745.12353; Verheyen K, 2013, PLANT ECOL EVOL, V146, P26, DOI 10.5091/plecevo.2013.803; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013; Younes Ghydaa Hasan, 2015, Jordan Journal of Agricultural Sciences, V11, P483	49	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176104	10.1371/journal.pone.0176104	http://dx.doi.org/10.1371/journal.pone.0176104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419174	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200073
J	Yamakawa, RH; Saito, PK; Gelmini, GF; da Silva, JS; Bicalho, MD; Borelli, SD				Yamakawa, Roger Haruki; Saito, Patricia Keiko; Gelmini, Georgia Fernanda; da Silva, Jose Samuel; Bicalho, Maria da Graca; Borelli, Sueli Donizete			MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil	PLOS ONE			English	Article							CLASS-I; HAPLOTYPIC VARIATION; POPULATION-GENETICS; CHRONIC REJECTION; BEHCETS-DISEASE; POLYMORPHISM; ANTIBODIES; GENES; FAMILY; ASSOCIATIONS	The major histocompatibility complex (MHC) class I chain-related gene A (MICA) is located centromerically to the human leukocyte antigen (HLA)-B. The short distance between these loci in the MHC indicates the presence of linkage disequilibrium (LD). Similarly to the HLA, the MICA is highly polymorphic, and this polymorphism has not been well documented in different populations. In this study, we estimated the allelic frequencies of MICA and the linkage disequilibrium with HLA-B alleles in 346 renal-transplant candidates in southern Brazil. MICA and HLA were typed using the polymerase chain reactionsequence-specific primer method (PCR-SSO), combined with the Luminex technology. A total of 19 MICA allele groups were identified. The most frequent allele groups were MICA* 008 (21.6%), MICA* 002 (17.0%) and MICA* 004 (14.8%). The most common haplotypes were MICA* 009-B* 51 (7.8%), MICA* 004-B* 44 (6.06%) and MICA* 002-B* 35 (5.63%). As expected from the proximity of the MICA and HLA-B loci, most haplotypes showed strong LD. Renal patients and healthy subjects in the same region of Brazil showed statistically significant differences in their MICA polymorphisms. The MICA* 027 allele group was more frequent in renal patients (Pc = 0.018, OR: 3.421, 95% CI: 1.516-7.722), while the MICA* 019 allele group was more frequent in healthy subjects (Pc = 0.001, OR: 0.027, 95% CI: 0.002-0.469). This study provided information on the distribution of MICA polymorphisms and linkage disequilibrium with HLA-B alleles in Brazilian renal-transplant candidates. This information should help to determine the mechanisms of susceptibility to different diseases in patients with chronic kidney disease, and to elucidate the mechanisms involved in allograft rejection associated with MICA polymorphisms in a Brazilian population.	[Yamakawa, Roger Haruki; Saito, Patricia Keiko; Borelli, Sueli Donizete] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil; [Gelmini, Georgia Fernanda; da Silva, Jose Samuel; Bicalho, Maria da Graca] Univ Fed Parana, Dept Genet, Lab Imunogenet & Histocompatibilidade, Curitiba, Parana, Brazil	Universidade Estadual de Maringa; Universidade Federal do Parana	Borelli, SD (corresponding author), Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.	sueliborelli@gmail.com	Georgia Fernanda, Gelmini/J-8619-2014	Georgia Fernanda, Gelmini/0000-0003-3979-519X				Bahram S, 1996, RES IMMUNOL, V147, P328, DOI 10.1016/0923-2494(96)89646-5; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bolognesi E, 2001, EUR J IMMUNOGENET, V28, P523, DOI 10.1046/j.0960-7420.2001.00250.x; Cambra A, 2009, HUM IMMUNOL, V70, P513, DOI 10.1016/j.humimm.2009.04.005; Clatworthy MR, 2010, CURR OPIN IMMUNOL, V22, P669, DOI 10.1016/j.coi.2010.08.018; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; CROW JF, 1988, GENETICS, V119, P473; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gao XJ, 2006, HUM IMMUNOL, V67, P152, DOI 10.1016/j.humimm.2006.02.009; Gonzalez S, 2001, HUM IMMUNOL, V62, P632, DOI 10.1016/S0198-8859(01)00242-7; Hughes EH, 2005, TISSUE ANTIGENS, V66, P195, DOI 10.1111/j.1399-0039.2005.00465.x; Kafetzi ML, 2013, HUM IMMUNOL, V74, P1425, DOI 10.1016/j.humimm.2013.06.003; Kaimen-Maciel DR, 2009, MOL MED REP, V2, P993, DOI 10.3892/mmr_00000204; Katsuyama Y, 1999, TISSUE ANTIGENS, V54, P178, DOI 10.1034/j.1399-0039.1999.540209.x; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; Lee PC, 2002, TRANSPLANTATION, V74, P1192, DOI 10.1097/00007890-200210270-00025; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Lucas D, 2008, HUM IMMUNOL, V69, P655, DOI 10.1016/j.humimm.2008.07.011; Marin MLC, 2004, EUR J IMMUNOGENET, V31, P63, DOI 10.1111/j.1365-2370.2004.00446.x; Munoz-Saa I, 2006, SCAND J IMMUNOL, V64, P77, DOI 10.1111/j.1365-3083.2006.01780.x; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Petersdorf EW, 1999, IMMUNOGENETICS, V49, P605, DOI 10.1007/s002510050655; Piancatelli D, 2005, HUM IMMUNOL, V66, P931, DOI 10.1016/j.humimm.2005.06.008; Probst CM, 2000, HUM BIOL, V72, P597; Reinders J, 2007, ORAL ONCOL, V43, P232, DOI 10.1016/j.oraloncology.2006.03.003; Ribas F, 2008, TISSUE ANTIGENS, V72, P532, DOI 10.1111/j.1399-0039.2008.01142.x; Sohn YH, 2010, TISSUE ANTIGENS, V75, P48, DOI 10.1111/j.1399-0039.2009.01396.x; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Terasaki PI, 2005, TRANSPLANTATION, V80, P1194, DOI 10.1097/01.tp.0000174338.97313.5a; Tian W, 2003, GENES IMMUN, V4, P500, DOI 10.1038/sj.gene.6364017; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhang YZ, 2006, HUM IMMUNOL, V67, P215, DOI 10.1016/j.humimm.2006.02.014; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160	34	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176072	10.1371/journal.pone.0176072	http://dx.doi.org/10.1371/journal.pone.0176072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419176	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200068
J	Yamburenko, MV; Kieber, JJ; Schaller, GE				Yamburenko, Maria V.; Kieber, Joseph J.; Schaller, G. Eric			Dynamic patterns of expression for genes regulating cytokinin metabolism and signaling during rice inflorescence development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RESPONSE REGULATORS; ORYZA-SATIVA; GRAIN PRODUCTION; ABIOTIC STRESS; FRIZZY-PANICLE; ARABIDOPSIS; ARCHITECTURE; YIELD; TRANSLOCATION	Inflorescence development in cereals, including such important crops as rice, maize, and wheat, directly affects grain number and size and is a key determinant of yield. Cytokinin regulates meristem size and activity and, as a result, has profound effects on inflorescence development and architecture. To clarify the role of cytokinin action in inflorescence development, we used the NanoString nCounter system to analyze gene expression in the early stages of rice panicle development, focusing on 67 genes involved in cytokinin biosynthesis, degradation, and signaling. Results point toward key members of these gene families involved in panicle development and indicate that the expression of many genes involved in cytokinin action differs between the panicle and vegetative tissues. Dynamic patterns of gene expression suggest that subnetworks mediate cytokinin action during different stages of panicle development. The variation of expression during panicle development is greater among genes encoding proteins involved in cytokinin metabolism and negative regulators of the pathway than for the genes in the primary response pathway. These results provide insight into the expression patterns of genes involved in cytokinin action during inflorescence development in a crop of agricultural importance, with relevance to similar processes in other monocots. The identification of subnetworks of genes expressed at different stages of early panicle development suggests that manipulation of their expression could have substantial effects on inflorescence architecture.	[Yamburenko, Maria V.; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill	Schaller, GE (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	george.e.schaller@dartmouth.edu	Kieber, Joseph/GLN-6328-2022	Kieber, Joseph/0000-0002-5766-812X; Yamburenko, Maria/0000-0001-6208-4228; Schaller, Eric/0000-0003-4032-2437	National Science Foundation Plant Genome Research [IOS-1238051]; Direct For Biological Sciences [1238051] Funding Source: National Science Foundation	National Science Foundation Plant Genome Research(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Plant Genome Research Program award number IOS-1238051 to GES and JJK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Azizi P, 2015, MECH DEVELOP, V135, P1, DOI 10.1016/j.mod.2014.11.001; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Du LM, 2007, GENOMICS, V89, P697, DOI 10.1016/j.ygeno.2007.02.001; Furutani I, 2006, PLANT J, V46, P503, DOI 10.1111/j.1365-313X.2006.02703.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gu BG, 2015, MOL PLANT, V8, P1635, DOI 10.1016/j.molp.2015.08.001; Han Qiu-Min, 2004, J Zhejiang Univ Sci, V5, P629, DOI 10.1631/jzus.2004.0629; Han YY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00669; Harrop TWR, 2016, PLANT J, V86, P75, DOI 10.1111/tpj.13147; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P175, DOI 10.1007/s10142-007-0063-6; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-1; Jameson PE, 2016, J EXP BOT, V67, P593, DOI 10.1093/jxb/erv461; Kellogg EA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00250; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Komatsu M, 2001, DEV BIOL, V231, P364, DOI 10.1006/dbio.2000.9988; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Kyozuka J, 2000, PLANT CELL PHYSIOL, V41, P710, DOI 10.1093/pcp/41.6.710; Li M, 2011, PLANT BIOTECHNOL J; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Pareek A, 2006, PLANT PHYSIOL, V142, P380, DOI 10.1104/pp.106.086371; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Schaller GE, 2007, PLANT PHYSIOL, V143, P555, DOI 10.1104/pp.106.093666; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sun LJ, 2014, PLANT PHYSIOL, V165, P335, DOI 10.1104/pp.113.232629; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tsai YC, 2012, PLANT PHYSIOL, V158, P1666, DOI 10.1104/pp.111.192765; Wang J, 2015, RICE, V8, DOI 10.1186/s12284-015-0071-4; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Yeh SY, 2015, RICE, V8, DOI 10.1186/s12284-015-0070-5	45	29	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176060	10.1371/journal.pone.0176060	http://dx.doi.org/10.1371/journal.pone.0176060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419168	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200067
J	Di Capua, I; Maffucci, F; Pannone, R; Mazzocchi, MG; Biffali, E; Amato, A				Di Capua, Iole; Maffucci, Fulvio; Pannone, Raimondo; Mazzocchi, Maria Grazia; Biffali, Elio; Amato, Alberto			Molecular phylogeny of Oncaeidae (Copepoda) using nuclear ribosomal internal transcribed spacer (ITS rDNA)	PLOS ONE			English	Article							SPECIES IDENTIFICATION; BIOLOGICAL IDENTIFICATIONS; REPRODUCTIVE ISOLATION; DNA BARCODES; RED-SEA; MITOCHONDRIAL; CRUSTACEA; ITS2; CALANOIDA; EVOLUTION	Copepods belonging to the Oncaeidae family are commonly and abundantly found in marine zooplankton. In the Mediterranean Sea, forty-seven oncaeid species occur, of which eleven in the Gulf of Naples. In this Gulf, several Oncaea species were morphologically analysed and described at the end of the XIX century by W. Giesbrecht. In the same area, oncaeids are being investigated over seasonal and inter-annual scales at the long-term coastal station LTER-MC. In the present work, we identified six oncaeid species using the nuclear ribosomal internal transcribed spacers (ITS rDNA) and the mitochondrial cytochrome c oxidase subunit I (mtCOI). Phylogenetic analyses based on these two genomic regions validated the sisterhood of the genera Triconia and the Oncaea sensu stricto. ITS1 and ITS2 phylogenies produced incongruent results about the position of Oncaea curta, calling for further investigations on this species. We also characterised the ITS2 region by secondary structure predictions and found that all the sequences analysed presented the distinct eukaryotic hallmarks. A Compensatory Base Change search corroborated the close relationship between O. venusta and O. curta and between O. media and O. venusta already identified by ITS phylogenies. The present results, which stem from the integration of molecular and morphological taxonomy, represent an encouraging step towards an improved knowledge of copepod biodiversity: The two complementary approaches, when applied to long-term copepod monitoring, will also help to better understanding their genetic variations and ecological niches of co-occurring species.	[Di Capua, Iole; Mazzocchi, Maria Grazia; Amato, Alberto] Villa Comunale Naples, Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy; [Maffucci, Fulvio] Villa Comunale Naples, Aquarium Unit, Stn Zool Anton Dohrn, Dept Res Infrastruct Marine Biol Resources, Naples, Italy; [Pannone, Raimondo; Biffali, Elio] Villa Comunale Naples, Stn Zool Anton Dohrn, Mol Biol & Bioinformat Unit, Dept Res Infrastruct Marine Biol Resources, Naples, Italy; [Amato, Alberto] Univ Grenoble Alpes, Inst Rech Sci & Technol Vivant, Lab Physiol Cellulaire & Vegetale, UMR5168,CNRS,CEA,INRA,CEA Grenoble, 17 Rue Martyrs, Grenoble, France	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Amato, A (corresponding author), Villa Comunale Naples, Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy.; Amato, A (corresponding author), Univ Grenoble Alpes, Inst Rech Sci & Technol Vivant, Lab Physiol Cellulaire & Vegetale, UMR5168,CNRS,CEA,INRA,CEA Grenoble, 17 Rue Martyrs, Grenoble, France.	amato@szn.it	Amato, Alberto/AAI-3215-2020; Amato, Alberto/AGX-4882-2022	Di Capua, Iole/0000-0003-2959-8977; Amato, Alberto/0000-0002-9126-5535	Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea); European Union under FP7-People [600407]	Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea); European Union under FP7-People	IDC and AA were partially supported by the Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea). AA was funded by the European Union under FP7-People, GA n. 600407.r Ferdinando Tramontano and Gianluca Zazo are acknowledged for sampling at station LTER-MC, Elvira Mauriello for techinal assistance and Lorenzo Longobardi for producing Fig 5. We thank Marco Uttieri for discussions that helped improving the manuscript and Suzanne Rose for language check. IDC and AA were partially supported by the Flagship project RITMARE (Ricerca ITaliana per il MARE, Italian Research for the Sea). AA was funded by the European Union under FP7-People, GA n. 600407. The present results contributed to the ICES-WGIMT and were presented at the ICES/PICES 6ZPS 2016/S4.	Adamowicz SJ, 2007, BIOL J LINN SOC, V90, P279, DOI 10.1111/j.1095-8312.2007.00723.x; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Baek SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157307; Bersano JGF, 1996, NAUPLIUS, V2, P29; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Boettger-Schnack Ruth, 2009, Marine Biodiversity, V39, P131; Bottger-Schnack R., 1994, Hydrobiologia, V292-293, P271, DOI 10.1007/BF00229951; Bottger-Schnack R., 2001, B BR MUS LONDON NAT, V67, P25; Bottger-Schnack Ruth, 1999, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V96, P37; BOTTGERSCHNACK R, 1992, MAR ECOL PROG SER, V80, P301, DOI 10.3354/meps080301; BOTTGERSCHNACK R, 1995, MAR ECOL PROG SER, V118, P81, DOI 10.3354/meps118081; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Braga E, 1999, MAR BIOL, V133, P79, DOI 10.1007/s002270050445; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bucklin A, 2007, J PLANKTON RES, V29, P483, DOI 10.1093/plankt/fbm031; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P40, DOI 10.1016/j.dsr2.2009.08.005; Bucklin A, 2009, J CRUSTACEAN BIOL, V29, P111, DOI 10.1651/07-2879.1; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Cornils A, 2013, MOL PHYLOGENET EVOL, V69, P861, DOI 10.1016/j.ympev.2013.06.018; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; D'Alcala MR, 2004, SCI MAR, V68, P65; Di Capuai I, 2008, J MAR BIOL ASSOC UK, V88, P1407, DOI 10.1017/S002531540800194X; Dvoretsky VG, 2009, MAR ECOL PROG SER, V385, P165, DOI 10.3354/meps07984; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Elvers D, 2006, MAR BIOL, V149, P503, DOI 10.1007/s00227-005-0234-8; Eyun S, 2002, ZOOLOG SCI, V4, P265; Figueroa DF, 2011, J CRUSTACEAN BIOL, V31, P153, DOI 10.1651/10-3341.1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giesbrecht W., 1893, SYSTEMATIK FAUNISTIK; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heron GA, 2000, P BIOL SOC WASH, V113, P1015; Holynska M, 2006, ZOOL J LINN SOC-LOND, V147, P1; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Marszalek MA, 2009, HYDROBIOLOGIA, V624, P61, DOI 10.1007/s10750-008-9666-8; MAZZOCCHI MG, 1995, ICES J MAR SCI, V52, P679, DOI 10.1016/1054-3139(95)80081-6; Mazzocchi MG, 2016, PROGR OCEANOGR; Nei M, 2000, MOL EVOLUTION PHYLOG; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raupach MJ, 2015, PLOS ONE; Razouls C, DIVERSITY GEOGRAPHIC; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sabia L, 2017, EUR ZOOL J, V84, P104, DOI 10.1080/11250003.2016.1276639; Sars GO, 1916, B I OCEANOGR MONACO, V323, P1; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Shmeleva A., 1969, Bulletin de l'Institut Oceanographique Monaco, V68, P1; SHMELEVA A. A., 1966, ZOOL ZH, V45, P932; SHMELEVA A A, 1968, Zoologicheskii Zhurnal, V47, P1784; SHMELEVA AA, 1979, ZOOL ZH, V58, P491; Shoemaker KM, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv064; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; van de Velde I., 1984, Crustaceana Supplement (Leiden), P404; VANDEVELDE I, 1984, HYDROBIOLOGIA, V109, P3, DOI 10.1007/BF00006297; Walter TC, 2017, WORLD COPEPODS DATAB; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wyngaard GA, 2010, MOL PHYLOGENET EVOL, V55, P753, DOI 10.1016/j.ympev.2010.02.029; Yebra L, 2016, CHARACTERIZATION PLA; Zagoskin MV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926342; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175662	10.1371/journal.pone.0175662	http://dx.doi.org/10.1371/journal.pone.0175662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441395	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800009
J	Nambiar, AM; Anzueto, AR; Peters, JI				Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.			Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; AZATHIOPRINE; ACETYLCYSTEINE; PROLIFERATION; MAINTENANCE; EXPRESSION; AUTOIMMUNE; TRIAL	Background Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses important antiproliferative and antifibrotic effects. The safety and effectiveness of MMF in IPF is unknown. Methods We performed a retrospective multicohort analysis of IPF patients treated with MMF compared to those treated with either ineffective/harmful treatments or no treatment. Longitudinal change in forced vital capacity (FVC) between the groups was analyzed using a mixed model with random intercept and slope allowing for repeated measures within subjects. Categorical change in FVC, median overall survival, and adverse events were also assessed. Results Forty-one IPF patients were included: 11 treated with MMF, 20 treated with ineffective/harmful agents (such as prednisone, azathioprine, and/or NAC), and 10 did not receive any specific treatment for their IPF. After one year, there was a trend towards reduced FVC decline in the MMF-treated group (-76.3 mL, -2.4% of predicted) compared to the non-MMF-treated (-165 mL, -8.9% of predicted) and the no-treatment (-239 mL, -11.5% of predicted) groups, respectively. By categorical change, there was a trend towards greater FVC stability in the MMF-treated group (87.5%) compared to the non-MMF-treated (57%) and the no-treatment groups (50%), respectively. MMF-treated IPF patients had a trend towards improved median overall survival (40.3 months) compared to the non-MMF-treated (25.5 months) and the no-treatment (29.3 months) groups, respectively. Treatment-related adverse events were not different between groups; however, very few adverse events were reported overall. Conclusions MMF treatment was associated with potentially clinically important trends toward reduced annual FVC decline (similar to approved antifibrotics), greater FVC stability and improved overall survival in IPF patients. MMF was generally safe, well tolerated, and relatively inexpensive. Future prospective studies of MMF in combination with antifibrotic therapy in IPF are needed.	[Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA; [Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.] South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Nambiar, AM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA.; Nambiar, AM (corresponding author), South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, Dept Med, San Antonio, TX 78229 USA.	Nambiar@uthscsa.edu	Nambiar, Anoop M./P-5319-2017	Nambiar, Anoop M./0000-0003-2778-0433	National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1 TR001120]	National Center for Advancing Translational Sciences, National Institutes of Health (NIH)	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through Grant UL1 TR001120. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Altschuler EL, 2001, MED HYPOTHESES, V57, P701, DOI 10.1054/mehy.2001.1437; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Appel GB, 2005, TRANSPLANTATION, V80, pS265, DOI 10.1097/01.tp.0000186389.19911.9c; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Chartrand S, 2016, RESP MED, V119, P150, DOI 10.1016/j.rmed.2016.09.002; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Ferreira LM., 2014, PULMONARY FIBRO 1023; Fischer A, 2005, ARTHRITIS RHEUM-US, V52, pS712; Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; GOLDBLUM R, 1993, CLIN EXP RHEUMATOL, V11, pS117; Groetzner J, 2006, TRANSPLANTATION, V81, P355, DOI 10.1097/01.tp.0000195781.02268.5e; Grotz W, 1998, LANCET, V352, P1195, DOI 10.1016/S0140-6736(05)60533-8; Guo H, 2005, LUPUS, V14, P583, DOI 10.1191/0961203305lu2170oa; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kouba DJ, 2003, BRIT J DERMATOL, V148, P147, DOI 10.1046/j.1365-2133.2003.05042.x; Koutroumpas A, 2010, CLIN RHEUMATOL, V29, P1167, DOI 10.1007/s10067-010-1498-z; Langford CA, 2004, ARTHRIT RHEUM-ARTHR, V51, P278, DOI 10.1002/art.20240; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Morisset J, 2016, CHEST; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Omair MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124205; Palmer SM, 2001, TRANSPLANTATION, V71, P1772, DOI 10.1097/00007890-200106270-00012; Petrova DT, 2010, THER DRUG MONIT, V32, P405, DOI 10.1097/FTD.0b013e3181e44260; Simeon-Aznar CP, 2011, CLIN RHEUMATOL, V30, P1393, DOI 10.1007/s10067-011-1823-1; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Samad AS, 2003, SOUTH MED J, V96, P705, DOI 10.1097/01.SMJ.0000054424.20202.7D; Shimizu H, 2004, TRANSPLANTATION, V77, P1661, DOI 10.1097/01.TP.0000127592.13707.B6; Swigris JJ, 2006, CHEST, V130, P30, DOI 10.1016/S0012-3692(15)50949-5; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; Tzouvelekis A, 2011, PULM MED, V2011, DOI 10.1155/2011/849035; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Waller JR, 2005, TRANSPL P, V37, P164, DOI 10.1016/j.transproceed.2005.01.049; Zamora AC, 2008, RESP MED, V102, P150, DOI 10.1016/j.rmed.2007.07.021	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176312	10.1371/journal.pone.0176312	http://dx.doi.org/10.1371/journal.pone.0176312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441449	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800043
J	Salehe, BR; Jones, CI; Di Fatta, G; McGuffin, LJ				Salehe, Bajuna Rashid; Jones, Chris Ian; Di Fatta, Giuseppe; McGuffin, Liam James			RAPIDSNPs: A new computational pipeline for rapidly identifying key genetic variants reveals previously unidentified SNPs that are significantly associated with individual platelet responses	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; MISSING HERITABILITY; VARIABLE IMPORTANCE; RIDGE-REGRESSION; COMMON DISEASES; CANDIDATE GENE; WIDE; SELECTION; AGGREGATION; CLASSIFICATION	Advances in omics technologies have led to the discovery of genetic markers, or single nucleotide polymorphisms (SNPs), that are associated with particular diseases or complex traits. Although there have been significant improvements in the approaches used to analyse associations of SNPs with disease, further optimised and rapid techniques are needed to keep up with the rate of SNP discovery, which has exacerbated the 'missing heritability' problem. Here, we have devised a novel, integrated, heuristic-based, hybrid analytical computational pipeline, for rapidly detecting novel or key genetic variants that are associated with diseases or complex traits. Our pipeline is particularly useful in genetic association studies where the genotyped SNP data are highly dimensional, and the complex trait phenotype involved is continuous. In particular, the pipeline is more efficient for investigating small sets of genotyped SNPs defined in high dimensional spaces that may be associated with continuous phenotypes, rather than for the investigation of whole genome variants. The pipeline, which employs a consensus approach based on the random forest, was able to rapidly identify previously unseen key SNPs, that are significantly associated with the platelet response phenotype, which was used as our complex trait case study. Several of these SNPs, such as rs6141803 of COMMD7 and rs41316468 in PKT2B, have independently confirmed associations with cardiovascular diseases (CVDs) according to other unrelated studies, suggesting that our pipeline is robust in identifying key genetic variants. Our new pipeline provides an important step towards addressing the problem of ` missing heritability' through enhanced detection of key genetic variants (SNPs) that are associated with continuous complex traits/ disease phenotypes.	[Salehe, Bajuna Rashid; Jones, Chris Ian; McGuffin, Liam James] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Di Fatta, Giuseppe] Univ Reading, Dept Comp Sci, Reading, Berks, England	University of Reading; University of Reading	Salehe, BR (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	b.r.salehe@pgr.reading.ac.uk	McGuffin, Liam/A-5598-2008; Di+Fatta, Giuseppe/ABG-6652-2020	McGuffin, Liam/0000-0003-4501-4767; Di+Fatta, Giuseppe/0000-0003-3096-2844; Jones, Chris/0000-0001-7537-1509; Salehe, Bajuna/0000-0003-2953-4674	Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government; 6th Framework Program of the European Union [LSHM-CT-2004-503485]	Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government; 6th Framework Program of the European Union(European Commission)	The authors thank the Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government for studentship funding (to BRS) and Bloodomics project supported by the 6th Framework Program of the European Union (LSHM-CT-2004-503485) which provided the data.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Braga-Neto U, 2004, BIOINFORMATICS, V20, P253, DOI 10.1093/bioinformatics/btg399; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cule E., 2015, PACKAGE RIDGE; Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frost S., 2013, CARBONIC ANHYDRASE M; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Harrell FE, 2001, REGRESSION MODELING; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kamide K, 2007, PHARMACOGENET GENOM, V17, P931, DOI 10.1097/FPC.0b013e3282ef640e; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Koch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080754; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kursa MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-8; Lawrence R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-367; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MJ, 2013, NUCLEIC ACIDS RES; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lumley T, 2015, PACKAGE LEAPS; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Motsinger AA, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P1; Motyer Allan J, 2011, BMC Proc, V5 Suppl 9, pS24, DOI 10.1186/1753-6561-5-S9-S24; Nakai M., 2011, INT J MATH ANAL, V5, P1; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Nonyane BA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-71; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Paul J, 2013, ECML WORKSH SOLV COM; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Saar-Tsechansky M, 2007, J MACH LEARN RES, V8, P1625; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Stanner S, 2008, CARDIOVASCULAR DIS D; Strobl C., 2008, P 18 INT C COMP STAP; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Nguyen TT, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Viles-Gonzalez JF, 2004, EUR HEART J, V25, P1197, DOI 10.1016/j.ehj.2004.03.011; Woodman R, 2010, HYPERTENSION, V56, P463, DOI 10.1161/HYPERTENSIONAHA.110.154476; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu QY, 2012, IEEE T NANOBIOSCI, V11, P216, DOI 10.1109/TNB.2012.2214232; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zhu X., 2014, OPEN J STAT, V4, P933, DOI [DOI 10.4236/OJS.2014.411088, 10.4236/ojs.2014.411088]	72	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175957	10.1371/journal.pone.0175957	http://dx.doi.org/10.1371/journal.pone.0175957			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441463	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800015
J	Wong, CS; Lin, YC; Sung, LC; Chen, TT; Ma, HP; Hsu, YH; Tsai, SH; Lin, YF; Wu, MY				Wong, Chung-Shun; Lin, Ying-Chin; Sung, Li-Chin; Chen, Tzu-Ting; Ma, Hon-Ping; Hsu, Yung-Ho; Tsai, Shin-Han; Lin, Yuh-Feng; Wu, Mei-Yi			Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan	PLOS ONE			English	Article							MORTALITY; MODERATE	Background Carbon monoxide (CO) poisoning may cause toxicity to the cardiovascular system. However, the association between CO poisoning and the risk of major adverse cardiovascular events (MACE) remains unestablished. We investigated the incidence of MACE after CO poisoning in Taiwan and evaluated whether CO-poisoned individuals had a higher risk of MACE than did the general population. Methods Using Taiwan's National Health Insurance Research Database (NHIRD) during 2005-2013, a nationwide population-based cohort study was conducted among patients who experienced CO poisoning between 2005 and 2013. CO poisoning was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes. The study cohort comprised patients with CO poisoning between 2005 and 2010 (N = 13,939). Each patient was matched according to age, sex and index date with four randomly selected controls from the comparison cohort (N = 55,756). All patients were followed from the study date until MACE development, death, or the end of 2013. The hazard ratios for MACE were compared between the two cohorts by using Cox proportional hazards regressions analyses. Results Incident cases of MACE were identified from the NHIRD. After adjustment for potential confounders, the study cohort was independently associated with a higher MACE risk (adjusted hazard ratio, 2.00; 95% confidence interval, 1.83-2.18). Conclusion This population-based cohort study indicated that patients with CO poisoning have a higher risk of MACE than do individuals without CO poisoning.	[Wong, Chung-Shun; Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, Taipei, Taiwan; [Wong, Chung-Shun; Lin, Yuh-Feng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wong, Chung-Shun; Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Sch Med, Coll Med, Dept Family Med, Taipei, Taiwan; [Sung, Li-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chen, Tzu-Ting; Wu, Mei-Yi] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Hsu, Yung-Ho; Lin, Yuh-Feng; Wu, Mei-Yi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Hsu, Yung-Ho; Lin, Yuh-Feng; Wu, Mei-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Lin, YF (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Wu, MY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Lin, YF; Wu, MY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.; Lin, YF; Wu, MY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	linyf@s.tmu.edu.tw; e220121@gmail.com		sung, lichin/0000-0001-6292-7117; Wu, Mei-Yi/0000-0002-5777-2752; Wong, Chung-Shun/0000-0003-3347-3843				Chiew AL, 2014, CRIT CARE, V18, DOI 10.1186/cc13846; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; Lee FY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000624; Nikkanen Heikki, 2011, Emerg Med Pract, V13, P1; Ruth-Sahd LA, 2011, DIMENS CRIT CARE NUR, V30, P303, DOI 10.1097/DCC.0b013e31822fb017; Ryoo SM, 2013, HUM EXP TOXICOL, V32, P1193, DOI 10.1177/0960327112472991; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Shie HG, 2007, INHAL TOXICOL, V19, P905, DOI 10.1080/08958370701432173; Szponar Jaroslaw, 2012, Przegl Lek, V69, P528; Teksam O, 2010, EUR J EMERG MED, V17, P192, DOI 10.1097/MEJ.0b013e328320ad48; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf Stephen J, 2008, J Emerg Nurs, V34, pe19, DOI 10.1016/j.jen.2008.02.009; Yanir Y, 2002, ANN EMERG MED, V40, P420, DOI 10.1067/mem.2002.126744	15	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176465	10.1371/journal.pone.0176465	http://dx.doi.org/10.1371/journal.pone.0176465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441428	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800061
J	Schaeffer, C; Merella, S; Pasqualetto, E; Lazarevic, D; Rampoldi, L				Schaeffer, Celine; Merella, Stefania; Pasqualetto, Elena; Lazarevic, Dejan; Rampoldi, Luca			Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; JUVENILE HYPERURICEMIC NEPHROPATHY; GLOMERULOCYSTIC KIDNEY-DISEASE; TRANSCRIPTION FACTOR; SODIUM 4-PHENYLBUTYRATE; GENE-EXPRESSION; STRESS; MUTATIONS; MICE; CELLS	Uromodulin is the most abundant urinary protein in physiological conditions. It is exclusively produced by renal epithelial cells lining the thick ascending limb of Henle's loop (TAL) and it plays key roles in kidney function and disease. Mutations in UMOD, the gene encoding uromodulin, cause autosomal dominant tubulointerstitial kidney disease uromodulin-related (ADTKD-UMOD), characterised by hyperuricemia, gout and progressive loss of renal function. While the primary effect of UMOD mutations, retention in the endoplasmic reticulum (ER), is well established, its downstream effects are still largely unknown. To gain insight into ADTKD-UMOD pathogenesis, we performed transcriptional profiling and biochemical characterisation of cellular models (immortalised mouse TAL cells) of robust expression of wild type or mutant GFP-tagged uromodulin. In this model mutant uromodulin accumulation in the ER does not impact on cell viability and proliferation. Transcriptional profiling identified 109 genes that are differentially expressed in mutant cells relative to wild type ones. Up-regulated genes include several ER resident chaperones and protein disulphide isomerases. Consistently, pathway enrichment analysis indicates that mutant uromodulin expression affects ER function and protein homeostasis. Interestingly, mutant uromodulin expression induces the Unfolded Protein Response (UPR), and specifically the IRE1 branch, as shown by an increased splicing of XBP1. Consistent with UPR induction, we show increased interaction of mutant uromodulin with ER chaperones Bip, calnexin and PDI. Using metabolic labelling, we also demonstrate that while autophagy plays no role, mutant protein is partially degraded by the proteasome through ER-associated degradation. Our work demonstrates that ER stress could play a central role in ADTKD-UMOD pathogenesis. This sets the bases for future work to develop novel therapeutic strategies through modulation of ER homeostasis and associated protein degradation pathways.	[Schaeffer, Celine; Pasqualetto, Elena; Rampoldi, Luca] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Genet Renal Disorders, Milan, Italy; [Merella, Stefania; Lazarevic, Dejan] IRCCS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Rampoldi, L (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Genet Renal Disorders, Milan, Italy.	rampoldi.luca@hsr.it	Pasqualetto, Elena/AAN-2239-2020; Lazarevic, Dejan/AAN-1861-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/AAN-6228-2020; Schaeffer, Celine/AAU-5713-2020; Rampoldi, Luca/L-3639-2018; Pasqualetto, Elena/ABG-4473-2020	Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Pasqualetto, Elena/0000-0003-2130-1577; lazarevic, dejan/0000-0003-4527-290X	Fondazione Telethon [GGP14263]; Italian Ministry of Health [RF-2010-2319394, PE-2011-02352286]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by Fondazione Telethon (http://www.telethon.it), grant no. GGP14263 (LR); Italian Ministry of Health (http://www.salute.gov.it), grants n. RF-2010-2319394 and PE-2011-02352286 (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bingham C, 2003, KIDNEY INT, V63, P1645, DOI 10.1046/j.1523-1755.2003.00903.x; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Brunati M, 2015, ELIFE, V4, DOI 10.7554/eLife.08887; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cantore A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1405; Chen YM, 2013, J AM SOC NEPHROL, V24, P1223, DOI 10.1681/ASN.2012121149; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Darisipudi MN, 2012, J AM SOC NEPHROL, V23, P1783, DOI 10.1681/ASN.2012040338; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fedeles SV, 2015, J CLIN INVEST, V125, P1955, DOI 10.1172/JCI78863; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Garimella PS, 2016, AM J KIDNEY DIS; Garimella PS, 2016, CLIN J AM SOC NEPHRO; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hassan H, 2016, J AM SOC NEPHROL, V27, P1055, DOI 10.1681/ASN.2015020191; Hassler JR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002277; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiang DD, 2015, SEMIN CANCER BIOL, V33, P48, DOI 10.1016/j.semcancer.2015.04.010; Kemter E, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42970; Kemter E, 2014, J BIOL CHEM, V289, P10715, DOI 10.1074/jbc.M113.537035; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kim Y, 2016, J AM SOC NEPHROL, V27, P2974, DOI 10.1681/ASN.2014100986; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lens XM, 2005, AM J KIDNEY DIS, V46, P52, DOI 10.1053/j.ajkd.2005.04.003; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moskowitz JL, 2013, CLIN J AM SOC NEPHRO, V8, P1349, DOI 10.2215/CJN.11151012; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Schaeffer C, 2012, KIDNEY INT, V81, P769, DOI 10.1038/ki.2011.456; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; SERAFINICESSI F, 1979, BIOCHEM J, V183, P381, DOI 10.1042/bj1830381; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Utami SB, 2015, CLIN EXP NEPHROL, V19, P576, DOI 10.1007/s10157-014-1032-8; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Walter F, 2015, CELL DEATH DIFFER, V22, P1502, DOI 10.1038/cdd.2014.241; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang Y, 2000, J BIOL CHEM, V275, P27013; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zivna M, 2009, AM J HUM GENET, V85, P204, DOI 10.1016/j.ajhg.2009.07.010	71	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175970	10.1371/journal.pone.0175970	http://dx.doi.org/10.1371/journal.pone.0175970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437467	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600024
J	Ito, S; Nagoshi, T; Minai, K; Kashiwagi, Y; Sekiyama, H; Yoshii, A; Kimura, H; Inoue, Y; Ogawa, K; Tanaka, TD; Ogawa, T; Kawai, M; Yoshimura, M				Ito, Satoshi; Nagoshi, Tomohisa; Minai, Kosuke; Kashiwagi, Yusuke; Sekiyama, Hiroshi; Yoshii, Akira; Kimura, Haruka; Inoue, Yasunori; Ogawa, Kazuo; Tanaka, Toshikazu D.; Ogawa, Takayuki; Kawai, Makoto; Yoshimura, Michihiro			Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE LEVELS; SERUM POTASSIUM; INTRAVENOUS GLUCOSE; AKT ACTIVATION; HEART; REPERFUSION; ISCHEMIA; FAILURE; IMPACT	Objective Although glucose-insulin-potassium (GIK) therapy ought to be beneficial for ischemic heart disease in general, variable outcomes in many clinical trials of GIK in acute coronary syndrome (ACS) had a controversial impact. This study was designed to examine whether "insulin resistance" is involved in ACS and to clarify other potential intrinsic compensatory mechanisms for GIK tolerance through highly statistical procedure. Methods and results We compared the degree of insulin resistance during ACS attack and remission phase after treatment in individual patients (n = 104). During ACS, homeostasis model assessment of insulin resistance (HOMA-IR) values were significantly increased (P < 0.001), while serum potassium levels were transiently decreased (degree of which was indicated by Delta K) (P < 0.001). This finding provides a renewed paradox, as Delta K, a surrogate marker of intrinsic GIK cascade activation, probably reflects the validated glucose metabolism during ischemic attack. Indeed, multiple regression analysis revealed that plasma glucose level during ACS was positively correlated with Delta K (P = 0.026), whereas HOMA-IR had no impact on Delta K. This positive correlation between Delta K and glucose was confirmed by covariance structure analysis with a strong impact (beta: 0.398, P = 0.015). Intriguingly, a higher incidence of myocardial infarction relative to unstable angina pectoris, as well as a longer hospitalization period were observed in patients with larger Delta K, indicating that Delta K also reflects disease severity of ACS. Conclusions Insulin resistance most likely increases during ACS; however, Delta K was positively correlated with plasma glucose level, which overwhelmed insulin resistance condition. The present study with covariance structure analysis suggests that there are potential endogenous glu-cose-coupled potassium lowering mechanisms, other than insulin, regulating glucose metabolism during ACS.	[Ito, Satoshi; Nagoshi, Tomohisa; Minai, Kosuke; Kashiwagi, Yusuke; Sekiyama, Hiroshi; Yoshii, Akira; Kimura, Haruka; Inoue, Yasunori; Ogawa, Kazuo; Tanaka, Toshikazu D.; Ogawa, Takayuki; Kawai, Makoto; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan	Jikei University	Nagoshi, T (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan.	tnagoshi@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880; Nagoshi, Tomohisa/0000-0002-8980-881X	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Foo K, 2003, HEART, V89, P31, DOI 10.1136/heart.89.1.31; Grossman AN, 2013, CIRCULATION, V127, P1040, DOI 10.1161/CIRCULATIONAHA.112.130625; Iguchi T, 2014, EUR HEART J-CARD IMG, V15, P284, DOI 10.1093/ehjci/jet158; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Kashiwagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130605; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Kloner RA, 2008, CIRCULATION, V117, P2423, DOI 10.1161/CIRCULATIONAHA.107.697979; Komukai K, 2012, CIRC J, V76, P145, DOI 10.1253/circj.CJ-11-0727; Lazzeri C, 2014, ANGIOLOGY, V65, P519, DOI 10.1177/0003319713489018; Madias JE, 2000, CHEST, V118, P904, DOI 10.1378/chest.118.4.904; Matsui T, 2001, CIRCULATION, V104, P330; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Nagoshi T, 2011, CURR PHARM DESIGN, V17, P3846, DOI 10.2174/138161211798357773; Nam MC, 2016, CARDIOVASC DRUGS THE; Ogawa K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005455; Ramachandran A, 2005, DIABETES CARE, V28, P2492, DOI 10.2337/diacare.28.10.2492; Ramratnam M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000899; Riehle C, 2016, CIRC RES, V118, P1151, DOI 10.1161/CIRCRESAHA.116.306206; Sack MN, 2003, J AM COLL CARDIOL, V41, P1404, DOI 10.1016/S0735-1097(03)00164-5; Sekiyama H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-4; Selker HP, 2016, AM HEART J, V178, P168, DOI 10.1016/j.ahj.2016.03.026; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Selker HP, 2014, AM J CARDIOL, V113, P1599, DOI 10.1016/j.amjcard.2014.02.010; Trifunovic D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-73; van der Horst ICC, 2012, NAT REV CARDIOL, V9, P377, DOI 10.1038/nrcardio.2012.75; Yagi H, 2010, J CARDIOL, V55, P345, DOI 10.1016/j.jjcc.2009.12.010; Yee J, 1999, CHEST, V115, p149S, DOI 10.1378/chest.115.suppl_2.149S	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176435	10.1371/journal.pone.0176435	http://dx.doi.org/10.1371/journal.pone.0176435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430816	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100045
J	Bozkurt, OO; Biricik, G; Taysi, ZC				Bozkurt, Omer Ozgur; Biricik, Goksel; Taysi, Ziya Cihan			Artificial neural network and SARIMA based models for power load forecasting in Turkish electricity market	PLOS ONE			English	Article							SHORT-TERM LOAD; TIME-SERIES; HYBRID MODEL; ALGORITHM; PRICE	Load information plays an important role in deregulated electricity markets, since it is the primary factor to make critical decisions on production planning, day-to-day operations, unit commitment and economic dispatch. Being able to predict the load for a short term, which covers one hour to a few days, equips power generation facilities and traders with an advantage. With the deregulation of electricity markets, a variety of short term load forecasting models are developed. Deregulation in Turkish Electricity Market has started in 2001 and liberalization is still in progress with rules being effective in its predefined schedule. However, there is a very limited number of studies for Turkish Market. In this study, we introduce two different models for current Turkish Market using Seasonal Autoregressive Integrated Moving Average (SARIMA) and Artificial Neural Network (ANN) and present their comparative performances. Building models that cope with the dynamic nature of deregulated market and are able to run in real-time is the main contribution of this study. We also use our ANN based model to evaluate the effect of several factors, which are claimed to have effect on electrical load.	[Bozkurt, Omer Ozgur; Biricik, Goksel; Taysi, Ziya Cihan] Yildiz Tech Univ, Comp Engn Dept, Istanbul, Turkey	Yildiz Technical University	Biricik, G (corresponding author), Yildiz Tech Univ, Comp Engn Dept, Istanbul, Turkey.	goksel@ce.yildiz.edu.tr	Biricik, Göksel/AAA-4020-2022; TAYSI, Ziya Cihan/ABA-3292-2020	Biricik, Göksel/0000-0002-4768-7431; TAYSI, Ziya Cihan/0000-0003-3916-7492	Scientific and Technological Research Council Of Turkey (TUBITAK SME-RDI) [7140008]; Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee [7140008]	Scientific and Technological Research Council Of Turkey (TUBITAK SME-RDI); Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee	The research stands on the project funded by the Scientific and Technological Research Council Of Turkey, Research, Development & Innovation Grant Programme (TUBITAK SME-RDI) with number 7140008 and the previous studies of the authors. 0 OB: The Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee. Grant Number: 7140008. URL: hilps.//wwwtubitak.gov.tr/nl/funds/industryinational-supportprogrammes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinia O, 2015, INT T ELECT ENERGY; Agalgaonkar A.P., 2014, IEEE IND APPL SOC AN, P1; Al-Hamadi HM, 2004, ELECTR POW SYST RES, V68, P47, DOI 10.1016/S0378-7796(03)00150-0; Almeshaiei E, 2011, ALEX ENG J, V50, P137, DOI 10.1016/j.aej.2011.01.015; Amjady N, 2001, IEEE T POWER SYST, V16, P498, DOI 10.1109/59.932287; Campbell P. R. J., 2006, INT SYST 2006 3 INT, P800, DOI DOI 10.1109/IS.2006.348523; Catalao JPS, 2007, ELECTR POW SYST RES, V77, P1297, DOI 10.1016/j.epsr.2006.09.022; Cevik Hasan Huseyin, 2014, Proceedings of the 2014 6th International Conference on Electronics, Computers and Artificial Intelligence (ECAI), P29, DOI 10.1109/ECAI.2014.7090206; Che JX, 2014, INT J ELEC POWER, V61, P259, DOI 10.1016/j.ijepes.2014.03.056; Chen H, 2001, 2001 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-3, P411, DOI 10.1109/PESW.2001.916876; Chen JF, 1995, ELECTR POW SYST RES, V34, P187, DOI 10.1016/0378-7796(95)00977-1; Deihimi A, 2013, ENERGY, V57, P382, DOI 10.1016/j.energy.2013.06.007; Fattaheian-Dehkordi S, 2014, INT T ELECTR ENERGY, V24, P1650, DOI 10.1002/etep.1791; Feinberg EA, 2005, POWER ELECTRON POWER, P269, DOI 10.1007/0-387-23471-3_12; Feng CXJ, 2006, J MANUF SYST, V25, P239, DOI 10.1016/S0278-6125(08)00006-X; Filik UB, 2013, ENERJI VERIMLILIGI K, P35; Filik UB, 2011, INT J INNOV COMPUT I, V7, P3545; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Hardle W, 1997, INT STAT REV, V65, P49; Hooshmand RA, 2013, INT J ELEC POWER, V45, P313, DOI 10.1016/j.ijepes.2012.09.002; Hu ZY, 2015, ENG APPL ARTIF INTEL, V40, P17, DOI 10.1016/j.engappai.2014.12.014; Ishik M.Y., 2015, 3 INT SMART GRID C F, P1; Isikli Esener I, 2015, TURK J ELECTR ENG CO, V23, P370, DOI 10.3906/elk-1209-28; Jaramillo-Moran MA, 2013, INT J ELEC POWER, V49, P253, DOI 10.1016/j.ijepes.2013.01.019; Kalaitzakis K, 2002, ELECTR POW SYST RES, V63, P185, DOI 10.1016/S0378-7796(02)00123-2; Karsaz A, 2010, INT J ELEC POWER, V32, P408, DOI 10.1016/j.ijepes.2009.11.001; Kavousi-Fard A, 2014, EXPERT SYST APPL, V41, P6047, DOI 10.1016/j.eswa.2014.03.053; Kennedy P., 2003, GUIDE ECONOMETRICS; Khatoon S, 2014, 2014 INNOVATIVE APPLICATIONS OF COMPUTATIONAL INTELLIGENCE ON POWER, ENERGY AND CONTROLS WITH THEIR IMPACT ON HUMANITY (CIPECH), P243, DOI 10.1109/CIPECH.2014.7019112; Kolmek MA, 2015, TURK J ELECTR ENG CO, V23, P841, DOI 10.3906/elk-1212-136; Lahouar A, 2015, ENERG CONVERS MANAGE, V103, P1040, DOI 10.1016/j.enconman.2015.07.041; Lange K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130834; Lee CM, 2011, EXPERT SYST APPL, V38, P5902, DOI 10.1016/j.eswa.2010.11.033; Li PH, 2014, INT J ELEC POWER, V55, P749, DOI 10.1016/j.ijepes.2013.10.020; Liu N, 2014, APPL ENERG, V129, P336, DOI 10.1016/j.apenergy.2014.05.023; Manda P, 2006, INT J ELEC POWER, V28, P367, DOI 10.1016/j.ijepes.2005.12.007; Monterio C., 2012, ELECTR POW SYST RES, P1; Mori H, 1996, IEEE T POWER SYST, V11, P390, DOI 10.1109/59.486123; Pagan A., 1999, NONPARAMETRIC ECONOM; Pandey AS, 2010, IEEE T POWER SYST, V25, P1266, DOI 10.1109/TPWRS.2010.2042471; Quan H, 2013, IEEE SYMP COMPUT, P66, DOI 10.1109/CIASG.2013.6611500; Quan H, 2014, IEEE T NEUR NET LEAR, V25, P303, DOI 10.1109/TNNLS.2013.2276053; Rothe JP, 2009, SHORT TERM LOAD FORE; Scott DW, 2009, MULTIVARIATE DENSITY; Shang HL, 2011, MATH COMPUT SIMULAT, V81, P1310, DOI 10.1016/j.matcom.2010.04.027; Shayeghi H, 2015, ENERG CONVERS MANAGE, V95, P371, DOI 10.1016/j.enconman.2015.02.023; Smith BL, 2002, TRANSPORT RES C-EMER, V10, P303, DOI 10.1016/S0968-090X(02)00009-8; Song YH, 2003, OPERATION MARKET ORI; Sudheer G, 2015, ENERGY SCI ENG, V3, P51, DOI 10.1002/ese3.48; Taylor JW, 2007, IEEE T POWER SYST, V22, P2213, DOI 10.1109/TPWRS.2007.907583; Topalli AK, 2003, NEUROCOMPUTING, V51, P495, DOI 10.1016/S0925-2312(02)00870-6; Topalli AK, 2006, INT J ELEC POWER, V28, P437, DOI 10.1016/j.ijepes.2006.02.004; Vilar-Fernandez JM, 2007, COMMUN STAT-SIMUL C, V36, P311, DOI 10.1080/03610910601158377; Wang Y, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND NATURAL COMPUTING, VOL I, P58, DOI 10.1109/CINC.2009.107; Weron R, 2005, P EUR EL MARK EEM 05, P133; Weron R, 2014, INT J FORECASTING, V30, P1030, DOI 10.1016/j.ijforecast.2014.08.008; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Xiao LY, 2015, INT J ELEC POWER, V64, P311, DOI 10.1016/j.ijepes.2014.07.029; Xiao Z, 2009, EXPERT SYST APPL, V36, P273, DOI 10.1016/j.eswa.2007.09.031; Yang Y, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/208964; Zheng TX, 2000, ELECTR POW SYST RES, V54, P11, DOI 10.1016/S0378-7796(99)00063-2	61	34	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175915	10.1371/journal.pone.0175915	http://dx.doi.org/10.1371/journal.pone.0175915			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426739	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900069
J	Lee, HL; Cheng, HL; Liu, YF; Chou, MC; Yang, SF; Chou, YE				Lee, Hsiang-Lin; Cheng, Hsin-Lin; Liu, Yu-Fan; Chou, Ming-Chih; Yang, Shun-Fa; Chou, Ying-Erh			Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; FRAGILE GENES; CELL-DEATH; EXPRESSION; CANCER; OVARIAN; PROTEIN; BREAST; APOPTOSIS; LUNG	Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Human WW domain-containing oxidoreductase (WWOX) gene has been identified as a tumor suppressor gene in multiple cancers. We hypothesize that genetic variations in WWOX are associated with HCC risk. Methodology/Principal findings Five single-nucleotide polymorphisms (SNPs) of the WWOX gene were evaluated from 708 normal controls and 354 patients with HCC. We identified a significant association between a WWOX single nucleotide polymorphism (SNP), rs73569323, and decreased risk of HCC. After adjustment for potential confounders, patients with at least one T allele at rs11545028 of WWOX may have a significantly smaller tumor size, reduced levels of alpha-fetoprotein and alanine aminotransferase (ALT). Moreover, the A allele at SNP rs12918952 in WWOX conferred higher risk of vascular invasion. Additional in silico analysis also suggests that WWOX rs12918952 polymorphism tends to affect WWOX expression, which in turn contributes to tumor vascular invasion. Conclusions In conclusion, genetic variations in WWOX may be a significant predictor of early HCC occurrence and a reliable biomarker for disease progression.	[Lee, Hsiang-Lin; Cheng, Hsin-Lin; Chou, Ming-Chih; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Hsiang-Lin; Chou, Ming-Chih; Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Hsiang-Lin; Chou, Ming-Chih] Chung Shan Med Univ Hosp, Deptartment Surg, Taichung, Taiwan; [Liu, Yu-Fan; Yang, Shun-Fa] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chou, YE (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chou, YE (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	intointo814@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital, Taiwan [CSH-2016-C-016, CSH-2016-E-002-Y2]	Chung Shan Medical University Hospital, Taiwan	This study was supported by agrant (CSH-2016-C-016, CSH-2016-E-002-Y2) from Chung Shan Medical University Hospital, Taiwan. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Ambade A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21340; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CLIN CANCER RES, V10, P3053, DOI 10.1158/1078-0432.CCR-03-0594; Bednarek AK, 2001, CANCER RES, V61, P8068; Cancemi L, 2011, INT J CANCER, V129, P2816, DOI 10.1002/ijc.25937; Chang NS, 2016, EXP BIOL MED, V241, P1306, DOI 10.1177/1535370216644531; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 2003, BIOCHEM PHARMACOL, V66, P1347, DOI 10.1016/S0006-2952(03)00484-2; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Cheng H. L., 2016, ONCOTARGET; Del Mare S, 2009, J CELL BIOCHEM, V108, P737, DOI 10.1002/jcb.22298; Ekizoglu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115353; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fu J, 2011, BLOOD, V117, P1652, DOI 10.1182/blood-2010-08-303073; Garg R, 2006, GYNECOL ONCOL, V103, P793, DOI 10.1016/j.ygyno.2006.08.043; Gourley C, 2005, INT J ONCOL, V26, P1681; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Guler G, 2004, CANCER, V100, P1605, DOI 10.1002/cncr.20137; Guo W, 2013, MOL CARCINOGEN, V52, P265, DOI 10.1002/mc.21853; Guo W, 2013, ENVIRON MOL MUTAGEN, V54, P112, DOI 10.1002/em.21748; He D, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0525-y; Hsu LJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00141; Huang DS, 2013, MOL CARCINOGEN, V52, P19, DOI 10.1002/mc.21934; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kamiyama T, 2009, ANN SURG ONCOL, V16, P1560, DOI 10.1245/s10434-009-0407-7; Lan YY, 2013, BIOCHEM BIOPH RES CO, V436, P672, DOI 10.1016/j.bbrc.2013.06.014; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Li G, 2015, CELL BIOCHEM BIOPHYS, V73, P417, DOI 10.1007/s12013-015-0654-0; Li YP, 2013, APMIS, V121, P120, DOI 10.1111/j.1600-0463.2012.02947.x; Lin Jie, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P357, DOI 10.3760/cma.j.issn.1007-3418.2010.05.011; Liu YR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-145; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo JY, 2015, EXP BIOL MED, V240, P383, DOI 10.1177/1535370214566747; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Nunez MI, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-64; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Park SW, 2004, BRIT J CANCER, V91, P753, DOI 10.1038/sj.bjc.6602023; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pazin Michael J, 2015, Cold Spring Harb Protoc, V2015, P522, DOI 10.1101/pdb.top084988; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pimenta FJ, 2006, INT J CANCER, V118, P1154, DOI 10.1002/ijc.21446; Potz BA, 2016, J SURG RES, V203, P154, DOI 10.1016/j.jss.2016.03.009; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramos D, 2008, HISTOPATHOLOGY, V52, P831, DOI 10.1111/j.1365-2559.2008.03033.x; Schirmer MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv387; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Urata Y, 2016, HEPATOL RES, V46, P434, DOI 10.1111/hepr.12572; Wen CP, 2012, J NATL CANCER I, V104, P1599, DOI 10.1093/jnci/djs372; Yan HC, 2015, MOL MED REP, V12, P1783, DOI 10.3892/mmr.2015.3640; Yarden RI, 2008, BREAST CANCER RES TR, V111, P497, DOI 10.1007/s10549-007-9797-z; Yendamuri S, 2003, CANCER RES, V63, P878; Zhang NN, 2016, ONCOTARGETS THER, V9, P807, DOI 10.2147/OTT.S99106; Zhou Yulong, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P162	63	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176141	10.1371/journal.pone.0176141	http://dx.doi.org/10.1371/journal.pone.0176141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426730	Green Published, gold			2022-12-27	WOS:000399875900105
J	Ligasova, A; Konecny, P; Frydrych, I; Koberna, K				Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel			Cell cycle profiling by image and flow cytometry: The optimised protocol for the detection of replicational activity using 5-Bromo-2 '-deoxyuridine, low concentration of hydrochloric acid and exonuclease III	PLOS ONE			English	Article							DNA-REPLICATION; S-PHASE; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; CLICK CHEMISTRY; PROLIFERATION; DYNAMICS; PROGRESSION; ANTIBODIES; CLUSTERS	The approach for the detection of replicational activity in cells using 5-bromo-2 '-deoxyuridine, a low concentration of hydrochloric acid and exonuclease III is presented in the study. The described method was optimised with the aim to provide a fast and robust tool for the detection of DNA synthesis with minimal impact on the cellular structures using image and flow cytometry. The approach is based on the introduction of breaks into the DNA by the low concentration of hydrochloric acid followed by the subsequent enzymatic extension of these breaks using exonuclease III. Our data showed that the method has only a minimal effect on the tested protein localisations and is applicable both for formaldehyde-and ethanol-fixed cells. The approach partially also preserves the fluorescence of the fluorescent proteins in the HeLa cells expressing Fluorescent Ubiquitin Cell Cycle Indicator. In the case of the short labelling pulses that disabled the use of 5-ethynyl-2 '-deoxyuridine because of the low specific signal, the described method provided a bright signal enabling reliable recognition of replicating cells. The optimized protocol was also successfully tested for the detection of trifluridine, the nucleoside used as an antiviral drug and in combination with tipiracil also for the treatment of some types of cancer.	[Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel] Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Konecny, Petr] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Immunol, Cape Town, South Africa	Palacky University Olomouc; University of Cape Town	Ligasova, A; Koberna, K (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.	anna.ligasova@upol.cz; karel.koberna@upol.cz	KOBERNA, Karel/G-5551-2019; Ligasová, Anna/P-5460-2015	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768	Technology Agency of the Czech Republic [TA03010719, TE02000058]; Ministry of Health of the Czech Republic [AZV15-31604A]; Ministry of Education, Youth and Sports [LO1304, LM2015064]	Technology Agency of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010719 and TE02000058]; the Ministry of Health of the Czech Republic [AZV15-31604A] and the Ministry of Education, Youth and Sports [LO1304 and LM2015064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chou TY, 2014, THER CLIN RISK MANAG, V10, P665, DOI 10.2147/TCRM.S58242; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Frum Rebecca A, 2013, Methods Mol Biol, V962, P147, DOI 10.1007/978-1-62703-236-0_12; Hua H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr063; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kitao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25286; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Kopper F, 2013, P NATL ACAD SCI USA, V110, P16856, DOI 10.1073/pnas.1304355110; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Li X, 1995, CELL PROLIFERAT, V28, P571, DOI 10.1111/j.1365-2184.1995.tb00045.x; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132393; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Loschberger A, 2014, BIOTECHNOL J, V9, P693, DOI 10.1002/biot.201400026; MANDERS EMM, 1992, J CELL SCI, V103, P857; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Tkatchenko AV, 2006, BIOTECHNIQUES, V40, P29, DOI 10.2144/000112094; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175880	10.1371/journal.pone.0175880	http://dx.doi.org/10.1371/journal.pone.0175880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426799	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900063
J	Previte, DM; O'Connor, EC; Novak, EA; Martins, CP; Mollen, KP; Piganelli, JD				Previte, Dana M.; O'Connor, Erin C.; Novak, Elizabeth A.; Martins, Christina P.; Mollen, Kevin P.; Piganelli, Jon D.			Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4(+) T cell activation	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION; EFFECTOR FUNCTION; NADPH OXIDASE; RECEPTOR STIMULATION; LINEAGE COMMITMENT; HYDROGEN-PEROXIDE; IMMUNE-RESPONSES; OXIDATIVE STRESS; AMPK ACTIVATION; INNATE IMMUNITY	The immune system is necessary for protecting against various pathogens. However, under certain circumstances, self-reactive immune cells can drive autoimmunity, like that exhibited in type 1 diabetes (T1D). CD4(+) T cells are major contributors to the immunopathology in T1D, and in order to drive optimal T cell activation, third signal reactive oxygen species (ROS) must be present. However, the role ROS play in mediating this process remains to be further understood. Recently, cellular metabolic programs have been shown to dictate the function and fate of immune cells, including CD4(+) T cells. During activation, CD4(+) T cells must transition metabolically from oxidative phosphorylation to aerobic glycolysis to support proliferation and effector function. As ROS are capable of modulating cellular metabolism in other models, we sought to understand if blocking ROS also regulates CD4(+) T cell activation and effector function by modulating T cell metabolism. To do so, we utilized an ROS scavenging and potent antioxidant manganese metalloporphyrin (MnP). Our results demonstrate that redox modulation during activation regulates the mTOR/AMPK axis by maintaining AMPK activation, resulting in diminished mTOR activation and reduced transition to aerobic glycolysis in diabetogenic splenocytes. These results correlated with decreased Myc and Glut1 upregulation, reduced glucose uptake, and diminished lactate production. In an adoptive transfer model of T1D, animals treated with MnP demonstrated delayed diabetes progression, concurrent with reduced CD4(+) T cell activation. Our results demonstrate that ROS are required for driving and sustaining T cell activation-induced metabolic reprogramming, and further support ROS as a target to minimize aberrant immune responses in autoimmunity.	[Previte, Dana M.; O'Connor, Erin C.; Novak, Elizabeth A.; Martins, Christina P.; Mollen, Kevin P.; Piganelli, Jon D.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA 15213 USA; [Previte, Dana M.; Piganelli, Jon D.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Piganelli, JD (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA 15213 USA.; Piganelli, JD (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.	jdp51@pitt.edu		Piganelli, Jon/0000-0003-2699-9011; Previte, Dana/0000-0003-1525-9843; Mollen, Kevin/0000-0001-7629-2722	American Diabetes Association [1-12-BS-1 61]; National Institutes of Health Training Grant [T32 AI089443-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101753] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association (Grant #1-12-BS-1 61; awarded to JDP) and the National Institutes of Health Training Grant (T32 AI089443-05; awarded to DMP).	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521; Batinic-Haberle I, 2015, REDOX BIOL, V5, P43, DOI 10.1016/j.redox.2015.01.017; Batinic-Haberle I, 2012, AMINO ACIDS, V42, P95, DOI 10.1007/s00726-010-0603-6; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dang CV, 1999, MOL CELL BIOL, V19, P1; Day BJ, 1999, FREE RADICAL BIO MED, V26, P730, DOI 10.1016/S0891-5849(98)00261-5; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Delmastro MM, 2012, DIABETES, V61, P1760, DOI 10.2337/db11-1591; Delmastro MM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/593863; Delmastro-Greenwood MM, 2013, ANTIOXIDANTS REDOX S; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dong F, 1998, MOL BIOL CELL, V9, P2081, DOI 10.1091/mbc.9.8.2081; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fracchia KM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00324; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Haskins K, 2003, ANN NY ACAD SCI, V1005, P43, DOI 10.1196/annals.1288.006; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Kesarwani P, 2013, ANTIOXID REDOX SIGN, V18, P1497, DOI 10.1089/ars.2011.4073; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kuystermans D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-76; Kwon J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000976; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Nakajima EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102452; Nazarewicz RR, 2013, J BIOMOL SCREEN, V18, P498, DOI 10.1177/1087057112468765; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Palmer CS, 2016, EBIOMEDICINE, V6, P31, DOI 10.1016/j.ebiom.2016.02.012; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Piganelli JD, 2002, DIABETES, V51, P347, DOI 10.2337/diabetes.51.2.347; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Pollizzi KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121710; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Sklavos MM, 2008, FREE RADICAL BIO MED, V45, P1477, DOI 10.1016/j.freeradbiomed.2008.08.023; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Triebel F, 2006, CANCER LETT, V235, P147, DOI 10.1016/j.canlet.2005.04.015; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; Tse HM, 2007, J IMMUNOL, V178, P908, DOI 10.4049/jimmunol.178.2.908; Tse HM, 2010, J IMMUNOL, V185, P5247, DOI 10.4049/jimmunol.1001472; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yang Z, 2014, AUTOPHAGY, V10, P382, DOI 10.4161/auto.27345; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Yin YM, 2016, J IMMUNOL, V196, P80, DOI 10.4049/jimmunol.1501537; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yoshida K, 2002, INT IMMUNOL, V14, P1439, DOI 10.1093/intimm/dxf106; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	77	50	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175549	10.1371/journal.pone.0175549	http://dx.doi.org/10.1371/journal.pone.0175549			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426686	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900032
J	Barrel, MS; Etichetti, CB; Di Benedetto, C; Rosano, GL; Margarit, E; Del Sal, G; Mione, M; Girardini, J				Solange Barrel, Maria; Borini Etichetti, Carla; Di Benedetto, Carolina; Rosano, German L.; Margarit, Ezequiel; Del Sal, Giannino; Mione, Marina; Girardini, Javier			Dynamic regulation of Pin1 expression and function during zebrafish development	PLOS ONE			English	Article							PROLYL-ISOMERASE PIN1; ALZHEIMERS-DISEASE; PHOSPHORYLATED-TAU; PROTEIN STABILITY; CELL CARCINOMA; STEM-CELLS; BETA-TRCP; WILD-TYPE; CANCER; P53	The prolyl isomerase Pin1 plays a key role in the modulation of proline-directed phosphorylation signaling by inducing local conformational changes in phosphorylated protein substrates. Extensive studies showed different roles for Pin1 in physiological processes and pathological conditions such as cancer and neurodegenerative diseases. However, there are still several unanswered questions regarding its biological role. Notably, despite evidences from cultured cells showing that Pin1 expression and activity may be regulated by different mechanisms, little is known on their relevance in vivo. Using Danio rerio (zebrafish) as a vertebrate model organism we showed that pin1 expression is regulated during embryogenesis to achieve specific mRNA and protein distribution patterns. Moreover, we found different subcellular distribution in particular stages and cell types and we extended the study of Pin1 expression to the adult zebrafish brain. The analysis of Pin1 overexpression showed alterations on zebrafish development and the presence of p53-dependent apoptosis. Collectively, our results suggest that specific mechanisms are operated in different cell types to regulate Pin1 function.	[Solange Barrel, Maria; Borini Etichetti, Carla; Di Benedetto, Carolina; Rosano, German L.; Girardini, Javier] Inst Biol Mol & Celular Rosario IBR, CONICET, Rosario, Argentina; [Margarit, Ezequiel] CEFOBI, CONICET, Rosario, Argentina; [Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk Padriciano, Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Mione, Marina] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Trieste; University of Trento	Girardini, J (corresponding author), Inst Biol Mol & Celular Rosario IBR, CONICET, Rosario, Argentina.	girardini@ibr-conicet.gov.ar	Mione, Maria Caterina/ABG-9926-2021; Rosano, Germán/I-6429-2019	Rosano, Germán/0000-0002-8313-6813; Mione, Maria Caterina/0000-0002-9040-3705; Margarit, Ezequiel/0000-0003-0031-2779	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 1221]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11420100100141]; Institute Nacional del Cancer, Ministerio de Salud; Institute Nacional del Cancer, Ministerio de Salud, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute Nacional del Cancer, Ministerio de Salud; Institute Nacional del Cancer, Ministerio de Salud, Argentina	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT http://www.agencia.mincyt.gob.ar/, PICT 1221), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET http://www.conicet.gov.ar/, PIP 11420100100141) and Institute Nacional del Cancer, Ministerio de Salud (http://inc.msal.gov.ar/), to JG. MSI was awarded with a fellowship from Institute Nacional del Cancer, Ministerio de Salud, Argentina, and is a doctoral fellow from CONICET. CBE is a doctoral fellow from CONICET. CD is a doctoral fellow from ANPCyT. JG is a staff member from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, NEUROBIOL AGING, V34, P757, DOI 10.1016/j.neurobiolaging.2012.08.004; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Ayala G, 2003, CANCER RES, V63, P6244; Baik SH, 2015, ANN NEUROL, V77, P504, DOI 10.1002/ana.24347; Balastik M, 2015, CELL REP, V13, P812, DOI 10.1016/j.celrep.2015.09.026; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bitomsky N, 2013, P NATL ACAD SCI USA, V110, pE4203, DOI 10.1073/pnas.1310001110; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Driver JA, 2015, BBA-GEN SUBJECTS, V1850, P2069, DOI 10.1016/j.bbagen.2014.12.025; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Fanghanel J, 2006, FEBS LETT, V580, P3237, DOI 10.1016/j.febslet.2006.04.087; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grison A, 2011, P NATL ACAD SCI USA, V108, P17979, DOI 10.1073/pnas.1106198108; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozlowski LP., 2016, BIORXIV; Krishnan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085427; Kumar R, 2009, J CLIN INVEST, V119, P2887, DOI 10.1172/JCI40784; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee YC, 2013, J CELL SCI, V126, P4862, DOI 10.1242/jcs.121368; Leung KW, 2009, ONCOL REP, V21, P1097, DOI 10.3892/or_00000329; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Litchfield DW, 2015, BBA-GEN SUBJECTS, V1850, P2077, DOI 10.1016/j.bbagen.2015.02.018; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Mantovani F, 2015, BBA-GEN SUBJECTS, V1850, P2048, DOI 10.1016/j.bbagen.2015.01.013; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; Ramakrishnan P, 2003, NEUROBIOL DIS, V14, P251, DOI 10.1016/S0969-9961(03)00109-8; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Restelli M, 2014, HUM MOL GENET, V23, P3830, DOI 10.1093/hmg/ddu096; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Teng BL, 2011, MOL ONCOL, V5, P465, DOI 10.1016/j.molonc.2011.06.002; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorpe JR, 2004, NEUROBIOL DIS, V17, P237, DOI 10.1016/j.nbd.2004.07.008; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	71	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175939	10.1371/journal.pone.0175939	http://dx.doi.org/10.1371/journal.pone.0175939			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426725	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900071
J	van Rijn, R; Hoogland, PER; Lehner, F; van Heurn, ELW; Porte, RJ				van Rijn, Rianne; Hoogland, Pieter E. R.; Lehner, Frank; van Heurn, Ernest L. W.; Porte, Robert J.			Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; HEART-BEATING DONORS; CARDIAC DEATH; BILIARY STRICTURES; ORGAN DONATION; CHILDREN; COMPLICATIONS; INCREASE; FAILURE; INJURY	Background Liver grafts from donation after circulatory death (DCD) donors are increasingly accepted as an extension of the organ pool for transplantation. There is little data on the outcome of liver transplantation with DCD grafts from a pediatric donor. The objective of this study was to assess the outcome of liver transplantation with pediatric DCD grafts and to compare this with the outcome after transplantation of livers from pediatric donation after brain death (DBD) donors. Method All transplantations performed with a liver from a pediatric donor (<= 16 years) in the Netherlands between 2002 and 2015 were included. Patient survival, graft survival, and complication rates were compared between DCD and DBD liver transplantation. Results In total, 74 liver transplantations with pediatric grafts were performed; twenty (27%) DCD and 54 (73%) DBD. The median donor warm ischemia time (DWIT) was 24 min (range 15-43 min). Patient survival rate at 10 years was 78% for recipients of DCD grafts and 89% for DBD grafts (p = 0.32). Graft survival rate at 10 years was 65% in recipients of DCD versus 76% in DBD grafts (p = 0.20). If donor livers in this study would have been rejected for transplantation when the DWIT >= 30 min (n = 4), the 10-year graft survival rate would have been 81% after DCD transplantation. The rate of non-anastomotic biliary strictures was 5% in DCD and 4% in DBD grafts (p = 1.00). Other complication rates were also similar between both groups. Conclusions Transplantation of livers from pediatric DCD donors results in good long-term outcome especially when the DWIT is kept <= 30 min. Patient and graft survival rates are not significantly different between recipients of a pediatric DCD or DBD liver. Moreover, the incidence of non-anastomotic biliary strictures after transplantation of pediatric DCD livers is remarkably low.	[van Rijn, Rianne; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Sect Hepatobiliary Surg & Liver Transplantat, Dept Surg, Groningen, Netherlands; [Hoogland, Pieter E. R.] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands; [Lehner, Frank] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [van Heurn, Ernest L. W.] Acad Med Ctr, Dept Pediat Surg, Amsterdam, Netherlands	University of Groningen; Maastricht University; Hannover Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Porte, RJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Hepatobiliary Surg & Liver Transplantat, Dept Surg, Groningen, Netherlands.	r.j.porte@umcg.nl						Abt P, 2006, TRANSPLANTATION, V82, P1708, DOI 10.1097/01.tp.0000254762.95625.d0; Bartlett A, 2010, PEDIATR TRANSPLANT, V14, P388, DOI 10.1111/j.1399-3046.2009.01206.x; Blok JJ, 2016, LIVER TRANSPLANTATIO; den Dulk AC, 2015, TRANSPL INT, V28, P492, DOI 10.1111/tri.12524; DeOliveira ML, 2011, ANN SURG, V254, P716, DOI 10.1097/SLA.0b013e318235c572; Detry O, 2010, TRANSPL INT, V23, P611, DOI 10.1111/j.1432-2277.2009.01029.x; Detry O, 2009, TRANSPL P, V41, P565, DOI 10.1016/j.transproceed.2009.02.040; Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Foley DP, 2005, ANN SURG, V242, P724, DOI 10.1097/01.sla.0000186178.07110.92; Gozzini S, 2010, PEDIATR TRANSPLANT, V14, P554, DOI 10.1111/j.1399-3046.2009.01280.x; Grewal HP, 2009, LIVER TRANSPLANT, V15, P1028, DOI 10.1002/lt.21811; Hong JC, 2014, JAMA SURG, V149, P77, DOI 10.1001/jamasurg.2013.3195; Hu LS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002834; Karimian N, 2013, J HEPATOL, V58, P1065, DOI 10.1016/j.jhep.2013.02.023; Lue A, 2016, WORLD J GASTROENTERO, V22, P4966, DOI 10.3748/wjg.v22.i21.4966; Merion RM, 2006, ANN SURG, V244, P555, DOI 10.1097/01.sla.0000239006.33633.39; Moore P, 2008, J PAEDIATR CHILD H, V44, P404, DOI 10.1111/j.1440-1754.2008.01353.x; Muiesan P, 2006, AM J TRANSPLANT, V6, P1012, DOI 10.1111/j.1600-6143.2006.01293.x; Netherlands Transplant Foundation (Dutch: Nederlandse Transplantatie Stichting), 2001, MOD POSTM ORG WEEFS; Netherlands Transplant Foundation (Dutch: Nederlandse Transplantatie Stichting), 2006, MOD POSTM ORG WEEFS; ONeill S, 2014, TRANSPL INT; Op den Dries S, 2014, J HEPATOL, V60, P1172, DOI 10.1016/j.jhep.2014.02.010; Perera MTPR, 2009, TRANSPL INT, V22, P757, DOI 10.1111/j.1432-2277.2009.00886.x; Pine JK, 2009, LIVER TRANSPLANT, V15, P1072, DOI 10.1002/lt.21853; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x; Shore PM, 2011, PEDIATRICS, V128, pE631, DOI 10.1542/peds.2010-3319; Sieber-Rasch M, 2003, JAARVERSLAG 2002; Taner CB, 2012, TRANSPL INT, V25, P838, DOI 10.1111/j.1432-2277.2012.01508.x; Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992; van der Hilst CS, 2013, TRANSPL INT, V26, P411, DOI 10.1111/tri.12059	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175097	10.1371/journal.pone.0175097	http://dx.doi.org/10.1371/journal.pone.0175097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426684	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900018
J	Hageri, C; Biernot, S; Buettner, M; Glage, S; Keubler, LM; Held, N; Bleich, EM; Otto, K; Muller, CW; Decker, S; Talbot, SR; Bleich, A				Haegeri, C.; Biernot, S.; Buettner, M.; Glage, S.; Keubler, L. M.; Held, N.; Bleich, E. M.; Otto, K.; Muller, C. W.; Decker, S.; Talbot, S. R.; Bleich, A.			The Sheep Grimace Scale as an indicator of post-operative distress and pain in laboratory sheep	PLOS ONE			English	Article							FACIAL EXPRESSION; CASTRATION; ANIMALS; LAMBS; BUPRENORPHINE; CORTISOL; WELFARE	The EU Directive 2010/63/EU changed the requirements regarding the use of laboratory animals and raised important issues related to assessing the severity of all procedures undertaken on laboratory animals. However, quantifiable parameters to assess severity are rare, and improved assessment strategies need to be developed. Hence, a Sheep Grimace Scale (SGS) was herein established by observing and interpreting sheep facial expressions as a consequence of pain and distress following unilateral tibia osteotomy. The animals were clinically investigated and scored five days before surgery and at 1, 3, 7, 10, 14 and 17 days afterwards. Additionally, cortisol levels in the saliva of the sheep were determined at the respective time points. For the SGS, video recording was performed, and pictures of the sheep were randomized and scored by blinded observers. Osteotomy in sheep resulted in an increased clinical severity score from days 1 to 17 post-surgery and elevated salivary cortisol levels one day post-surgery. An analysis of facial expressions revealed a significantly increased SGS on the day of surgery until day 3 post-surgery; this elevated level was sustained until day 17. Clinical severity and SGS scores correlated positively with a Pearson's correlation coefficient of 0.47. Further investigations regarding the applicability of the SGS revealed a high inter-observer reliability with an intraclass correlation coefficient of 0.92 and an accuracy of 68.2%. In conclusion, the SGS represents a valuable approach for severity assessment that may help support and refine a widely used welfare assessment for sheep during experimental procedures, thereby meeting legislation requirements and minimizing the occurrence of unrecognized distress in animal experimentation.	[Haegeri, C.; Biernot, S.; Buettner, M.; Glage, S.; Keubler, L. M.; Held, N.; Bleich, E. M.; Otto, K.; Talbot, S. R.; Bleich, A.] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Haegeri, C.; Biernot, S.; Buettner, M.; Glage, S.; Keubler, L. M.; Held, N.; Bleich, E. M.; Otto, K.; Talbot, S. R.; Bleich, A.] Hannover Med Sch, Cent Anim Facil, Hannover, Germany; [Muller, C. W.; Decker, S.] Hannover Med Sch, Trauma Dept, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Bleich, A (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.; Bleich, A (corresponding author), Hannover Med Sch, Cent Anim Facil, Hannover, Germany.	bleich.andre@mh-hannover.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Authors are part of a Research Group funded by Deutsche Forschungsgemeinschaft. The authors received no specific funding for this work.	[Anonymous], 2009, EXPERT WORKING GROUP; [Anonymous], 2013, 7 REP STAT NUMB AN E; Chambers CT, 2015, PAIN, V156, P798, DOI 10.1097/j.pain.0000000000000133; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Decker S, 2015, TECHNOL HEALTH CARE, V23, P463, DOI 10.3233/THC-150912; Decker S, 2014, ORTHOP REV, V6, P168, DOI 10.4081/or.2014.5575; Deyo KS, 2004, PAIN, V107, P16, DOI 10.1016/S0304-3959(03)00263-X; Drobromylskyj PF P.A., 2000, PAIN MANAGEMENT ANIM, P81; Fitzpatrick J, 2006, SMALL RUMINANT RES, V62, P55, DOI 10.1016/j.smallrumres.2005.07.028; Guesgen MJ, 2016, BEHAV PROCESS, V132, P49, DOI 10.1016/j.beproc.2016.09.010; Hawkins P, 2011, LAB ANIM-UK, V45, P1, DOI 10.1258/la.2010.010031; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Holden E, 2014, J SMALL ANIM PRACT, V55, P615, DOI 10.1111/jsap.12283; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; McLennan KM, 2016, APPL ANIM BEHAV SCI, V176, P19, DOI 10.1016/j.applanim.2016.01.007; Molony V, 1997, J ANIM SCI, V75, P266; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Otto KA, 2000, J EXP ANIM SCI, V41, P133, DOI 10.1016/S0939-8600(00)80005-X; Pascual-Alonso M, 2016, J ANIM PHYSL ANIM NU; Paull DR, 2009, AUST VET J, V87, P230, DOI 10.1111/j.1751-0813.2009.00429.x; Paull DR, 2012, VET ANAESTH ANALG, V39, P539, DOI 10.1111/j.1467-2995.2012.00716.x; Reifenrath J, 2013, J BIOMED MAT RES A; Russell WMS., 1959, MED J AUSTRALIA; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stafford KJ, 2002, RES VET SCI, V73, P61, DOI 10.1016/S0034-5288(02)00045-0; Walkowiak KJ, 2015, J AM ASSOC LAB ANIM, V54, P763	27	64	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175839	10.1371/journal.pone.0175839	http://dx.doi.org/10.1371/journal.pone.0175839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422994	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600056
J	Lu, Y; Figler, B; Huang, H; Tu, YC; Wang, J; Cheng, F				Lu, Yin; Figler, Bryan; Huang, Hong; Tu, Yi-Cheng; Wang, Ju; Cheng, Feng			Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms	PLOS ONE			English	Article							P-GLYCOPROTEIN; THEOPHYLLINE; METABOLISM; INHIBITION; QUINIDINE	Identifying drug-drug interaction (DDI) is an important topic for the development of safe pharmaceutical drugs and for the optimization of multidrug regimens for complex diseases such as cancer and HIV. There have been about 150,000 publications on DDIs in PubMed, which is a great resource for DDI studies. In this paper, we introduced an automatic computational method for the systematic analysis of the mechanism of DDIs using MeSH (Medical Subject Headings) terms from PubMed literature. MeSH term is a controlled vocabulary thesaurus developed by the National Library of Medicine for indexing and annotating articles. Our method can effectively identify DDI-relevant MeSH terms such as drugs, proteins and phenomena with high accuracy. The connections among these MeSH terms were investigated by using co-occurrence heatmaps and social network analysis. Our approach can be used to visualize relationships of DDI terms, which has the potential to help users better understand DDIs. As the volume of PubMed records increases, our method for automatic analysis of DDIs from the PubMed database will become more accurate.	[Lu, Yin; Figler, Bryan; Cheng, Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL 33620 USA; [Tu, Yi-Cheng] Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA; [Wang, Ju] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Cheng, Feng] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Tianjin Medical University; State University System of Florida; University of South Florida	Cheng, F (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.; Cheng, F (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA.	fcheng1@health.usf.edu	Cheng, Feng/A-9760-2009; Huang, Hong/G-5957-2016	Cheng, Feng/0000-0003-3619-8090; Huang, Hong/0000-0002-8957-4881	National Natural Science Foundation of China [31271411]; Ed and Ethel Moore Alzheimer's Disease Research Program of Florida Department of Health [7AZ23]; National Institutes of Health (NIH) [RO1GM086707]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ed and Ethel Moore Alzheimer's Disease Research Program of Florida Department of Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by a grant from National Natural Science Foundation of China (Grant No: 31271411) to Ju Wang, the Ed and Ethel Moore Alzheimer's Disease Research Program of Florida Department of Health (Award No: 7AZ23) to Feng Cheng, and in part, supported by a grant (Grant No: RO1GM086707) from National Institutes of Health (NIH), USA, to Yi-Cheng Tu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker ML, 2007, PHARMACOEPIDEM DR S, V16, P641, DOI 10.1002/pds.1351; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Dai Y, 2004, BIOCHEM PHARMACOL, V68, P1889, DOI 10.1016/j.bcp.2004.07.012; Damkier P, 1999, PHARMACOL TOXICOL, V85, P257, DOI 10.1111/j.1600-0773.1999.tb02019.x; DuBuske LM, 2005, DRUG SAFETY, V28, P789, DOI 10.2165/00002018-200528090-00004; Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614; FARRAR KT, 1985, LANCET, V1, P983; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Huang JL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002998; Huang SM, 2007, CLIN PHARMACOL THER, V81, P298, DOI 10.1038/sj.clpt.6100054; Hutzler JM, 2011, PHARMACOKINETICS IN DRUG DEVELOPMENT, VOL 3: ADVANCES AND APPLICATIONS, P21, DOI 10.1007/978-1-4419-7937-7_2; Isoherranen N, 2004, DRUG METAB DISPOS, V32, P1121, DOI 10.1124/dmd.104.000315; Kostoff RN, 2004, INT J MED INFORM, V73, P515, DOI 10.1016/j.ijmedinf.2004.02.008; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lill J, 2000, AM J HEALTH-SYST PH, V57, P1579, DOI 10.1093/ajhp/57.17.1579; List AF, 2002, BLOOD, V100, P1910, DOI 10.1182/blood.V100.5.1910.h81702001910_1910_1912; Lu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17357; Luo H, 2014, NUCLEIC ACIDS RES, V42, pW46, DOI 10.1093/nar/gku433; Miyazawa Y, 2002, J INT MED RES, V30, P34, DOI 10.1177/147323000203000106; Obach RS, 2003, DRUG TODAY, V39, P301, DOI 10.1358/dot.2003.39.5.799456; Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Psarra TA, 2007, J VET PHARMACOL THER, V30, P541, DOI 10.1111/j.1365-2885.2007.00904.x; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Strandell J, 2008, BRIT J CLIN PHARMACO, V65, P144, DOI 10.1111/j.1365-2125.2007.02981.x; Takarabe M, 2011, J CHEM INF MODEL, V51, P2977, DOI 10.1021/ci200367w; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Thakrar BT, 2007, BRIT J CLIN PHARMACO, V64, P489, DOI 10.1111/j.1365-2125.2007.02900.x; TWUMBARIMA Y, 1981, NEW ENGL J MED, V304, P1466, DOI 10.1056/NEJM198106113042405; Vilar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058321; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Wang ZP, 2009, J BIOMED INFORM, V42, P726, DOI 10.1016/j.jbi.2009.03.010; Wanwimolruk S, 2014, EXCLI J, V13, P347; Yan Su, 2013, Proceedings (IEEE Int Conf Bioinformatics Biomed), P349, DOI 10.1109/BIBM.2013.6732517	36	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173548	10.1371/journal.pone.0173548	http://dx.doi.org/10.1371/journal.pone.0173548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422961	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600010
J	Siddiqi, MZ; Cui, CH; Park, SK; Han, NS; Kim, SC; Im, WT				Siddiqi, Muhammad Zubair; Cui, Chang-Hao; Park, Seul-Ki; Han, Nam Soo; Kim, Sun-Chang; Im, Wan-Taek			Comparative analysis of the expression level of recombinant ginsenoside-transforming beta-glucosidase in GRAS hosts and mass production of the ginsenoside Rh-2-Mix	PLOS ONE			English	Article							OSTEOBLASTIC MC3T3-E1 CELLS; HUMAN INTESTINAL MICROFLORA; SACCHAROMYCES-CEREVISIAE; CANCER CELLS; ENZYMATIC BIOTRANSFORMATION; RH2; MODEL; RG(1); PHARMACOKINETICS; DIFFERENTIATION	The ginsenoside Rh-2, a pharmaceutically active component of ginseng, is known to have anticancer and antitumor effects. However, white ginseng and red ginseng have extremely low concentrations of Rh-2 or Rh-2-Mix [20(S)-Rh-2, 20(R)-Rh-2, Rk(2), and Rh-3]. To enhance the production of food-grade ginsenoside Rh-2, an edible enzymatic bioconversion technique was developed adopting GRAS host strains. A beta-glucosidase (BglPm), which has ginsenoside conversion ability, was expressed in three GRAS host strains (Corynebacterium glutamicum, Saccharomyces cerevisiae and Lactococus lactis) by using a different vector system. Enzyme activity in these three GRAS hosts were 75.4%, 11.5%, and 9.3%, respectively, compared to that in the E. coli pGEX 4T-1 expression system. The highly expressed BglPm_C in C. glutamicum can effectively transform the ginsenoside Rg(3)-Mix [20(S)-Rg(3), 20(R)-Rg(3), Rk(1), Rg(5)] to Rh-2-Mix [20(S)-Rh-2, 20(R)-Rh-2, Rk(2), Rh-3] using a scaled-up biotransformation reaction, which was performed in a 10-L jar fermenter at pH 6.5/7.0 and 37 degrees C for 24 h. To our knowledge, this is the first report in which 50 g of PPD-Mix (Rb-1, Rb-2, Rb-3, R-c, and Rd) as a starting substrate was converted to ginsenoside Rg(3)-Mix by acid heat treatment and then 24.5-g Rh-2-Mix was obtained by enzymatic transformation of Rg(3)-Mix through by BglPm_C. Utilization of this enzymatic method adopting a GRAS host could be usefully exploited in the preparation of ginsenoside Rh-2-Mix in cosmetics, functional food, and pharmaceutical industries, thereby replacing the E. coli expression system.	[Siddiqi, Muhammad Zubair; Im, Wan-Taek] Hankyoung Natl Univ, Dept Biotechnol, Kyonggi Do, South Korea; [Siddiqi, Muhammad Zubair; Im, Wan-Taek] Hankyoung Natl Univ, Grad Sch Bio & Informat Technol, Ctr Genet Informat, Kyonggi Do, South Korea; [Cui, Chang-Hao; Park, Seul-Ki; Kim, Sun-Chang] Intelligent Synthet Biol Ctr, Daejeon, South Korea; [Han, Nam Soo] Chungbuk Natl Univ, Div Anim Hort & Food Sci, Brain Korea Ctr Bioresource Dev 21, Cheongju, South Korea	Chungbuk National University	Im, WT (corresponding author), Hankyoung Natl Univ, Dept Biotechnol, Kyonggi Do, South Korea.; Im, WT (corresponding author), Hankyoung Natl Univ, Grad Sch Bio & Informat Technol, Ctr Genet Informat, Kyonggi Do, South Korea.	wandra@hknu.ac.kr	Cui, Changhao/ABC-8055-2021		Intelligent Synthetic Biology Center of Global Frontier Project-Ministry of Education, Science and Technology [2014M3A6A8066437]; Basic Science Research Program through the National Research Foundation of Korea (NRF)-Ministry of Education [2015R1D1A1A01060255]	Intelligent Synthetic Biology Center of Global Frontier Project-Ministry of Education, Science and Technology; Basic Science Research Program through the National Research Foundation of Korea (NRF)-Ministry of Education	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2014M3A6A8066437) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01060255).	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bae EA, 2005, BIOL PHARM BULL, V28, P1903, DOI 10.1248/bpb.28.1903; Bae EA, 2004, ARCH PHARM RES, V27, P61, DOI 10.1007/BF02980048; Choi JR, 2011, J GINSENG RES, V35, P301, DOI 10.5142/jgr.2011.35.3.301; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Cui CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085727; Cui CH, 2013, APPL ENVIRON MICROB, V79, P5788, DOI 10.1128/AEM.01150-13; Cui CH, 2013, APPL MICROBIOL BIOT, V97, P649, DOI 10.1007/s00253-012-4324-5; Deng X, 2014, FEBS OPEN BIO, V4, P200, DOI 10.1016/j.fob.2014.02.004; Du J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096914; He L, 2012, BONE, V50, P1207, DOI 10.1016/j.bone.2012.03.022; Hong H, 2012, J GINSENG RES, V36, P418, DOI 10.5142/jgr.2012.36.4.418; Hou J, 2013, J MED FOOD, V16, P772, DOI 10.1089/jmf.2012.2564; Hwang JT, 2007, BIOCHEM BIOPH RES CO, V364, P1002, DOI 10.1016/j.bbrc.2007.10.125; Jia L, 2009, CURR MED CHEM, V16, P2475, DOI 10.2174/092986709788682146; Jong-Uk P, 2008, J MICROBIOL BIOTECHN, V18, P639; Kim DY, 2011, BMB REP, V44, P659, DOI 10.5483/BMBRep.2011.44.10.659; Kim JK, 2012, J BIOTECHNOL, V161, P294, DOI 10.1016/j.jbiotec.2012.06.021; Ko SR, 2003, CHEM PHARM BULL, V51, P404, DOI 10.1248/cpb.51.404; Lee CH, 2014, J GINSENG RES, V38, P161, DOI 10.1016/j.jgr.2014.03.001; Lee WK, 2006, CLIN EXP PHARMACOL P, V33, P27, DOI 10.1111/j.1440-1681.2006.04319.x; Li BH, 2011, CANCER LETT, V301, P185, DOI 10.1016/j.canlet.2010.11.015; Li L, 2016, J AGR FOOD CHEM, V64, P2506, DOI 10.1021/acs.jafc.5b04098; Li SY, 2014, TUMOR BIOL, V35, P5593, DOI 10.1007/s13277-014-1739-x; Liu SL, 2015, CELL PHYSIOL BIOCHEM, V36, P499, DOI 10.1159/000430115; Musende AG, 2009, CANCER CHEMOTH PHARM, V64, P1085, DOI 10.1007/s00280-009-0965-1; Nijkamp JF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-36; Oh M, 1999, INT J ONCOL, V14, P869; Popovich DG, 2004, CAN J PHYSIOL PHARM, V82, P183, DOI 10.1139/Y04-001; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Sengupta S, 2004, CIRCULATION, V110, P1219, DOI 10.1161/01.CIR.0000140676.88412.CF; Siddiqi MH, 2014, PHYTOTHER RES, V28, P1447, DOI 10.1002/ptr.5146; Siddiqi MZ, 2015, J MED FOOD, V18, P542, DOI 10.1089/jmf.2014.3251; Tang XP, 2013, WORLD J GASTROENTERO, V19, P1582, DOI 10.3748/wjg.v19.i10.1582; Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wang CZ, 2009, ONCOL REP, V21, P577, DOI 10.3892/or_00000259; Xu QF, 2003, J ETHNOPHARMACOL, V84, P187, DOI 10.1016/S0378-8741(02)00317-3; Yang JH, 2009, BIOL PHARM BULL, V32, P1710, DOI 10.1248/bpb.32.1710; Yuan CS, 2002, AM J CLIN NUTR, V75, P600, DOI 10.1093/ajcn/75.3.600; Zhou J, 2015, CELL PHYSIOL BIOCHEM, V36, P980, DOI 10.1159/000430272	41	18	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176098	10.1371/journal.pone.0176098	http://dx.doi.org/10.1371/journal.pone.0176098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423055	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600086
J	Twerd, L; Krzyzynski, M; Waldon-Rudzionek, B; Olszewski, P				Twerd, Lucyna; Krzyzynski, Maciej; Waldon-Rudzionek, Barbara; Olszewski, Piotr			Can soda ash dumping grounds provide replacement habitats for digger wasps (Hymenoptera, Apoidea, Spheciformes)?	PLOS ONE			English	Article							LIMESTONE QUARRIES; COMMUNITIES; CRABRONIDAE; BIODIVERSITY; LANDSCAPE; RECORDS; NUMBER; BEES	Background Published sources document a loss of biodiversity at an extreme rate, mainly because natural and semi-natural ecosystems are becoming fragmented and isolated, thus losing their biological functions. These changes significantly influence biological diversity, which is a complex phenomenon that changes over time. Contemporary ecologists must therefore draw attention to anthropogenic replacement habitats and increase their conservation status. In our studies we show the positive role of soda ash dumping grounds as an alternative habitat for digger wasps, especially the thermophilic species. Methodology/Principal findings In the years 2007-2010 we carried out investigations in postindustrial soda ash dumping grounds located in Central Poland. We demonstrated that these areas serve as replacement habitats for thermophilic species of Spheciformes and, indirectly, for their potential prey. The studies were conducted in three microhabitat types, varying in soil moisture, salinity and alkalinity, that were changing in the course of ecological succession. We trapped 2571 specimens belonging to 64 species of digger wasps. Species typical of open sunny spaces comprised 73% of the whole inventory. The obtained results suggest that the stage of succession determines the richness, abundance and diversity of Spheciformes. The most favorable conditions for digger wasps were observed in habitats at late successional stages. Conclusions/Significance Our results clearly showed that these habitats were replacement habitats for thermophilous Spheciformes, including rare taxa that require genetic, species and ecosystem protection, according to the Biodiversity Convention. We showed that some types of industry might play a positive role in the preservation of taxa in the landscape, and that even degraded industrial wasteland can replace habitats under anthropopressure, serving as refugia of biological diversity, especially for disturbance-dependent species.	[Twerd, Lucyna] Kazimierz Wielki Univ, Inst Environm Biol, Dept Ecol, Bydgoszcz, Poland; [Krzyzynski, Maciej; Olszewski, Piotr] Nicolaus Copernicus Univ Torun, Fac Biol & Environm Protect, Chair Ecol & Biogeog, Torun, Poland; [Waldon-Rudzionek, Barbara] Kazimierz Wielki Univ, Inst Environm Biol, Dept Bot, Bydgoszcz, Poland	Kazimierz Wielki University; Nicolaus Copernicus University; Kazimierz Wielki University	Krzyzynski, M (corresponding author), Nicolaus Copernicus Univ Torun, Fac Biol & Environm Protect, Chair Ecol & Biogeog, Torun, Poland.	m_krzy@doktorant.umk.pl	Olszewski, Piotr/AAM-1999-2020; Waldon-Rudzionek, Barbara/AAD-3094-2020; Krzyżyński, Maciej/C-4883-2016	Waldon-Rudzionek, Barbara/0000-0002-0132-992X; Olszewski, Piotr/0000-0002-8538-4183; Twerd, Lucyna/0000-0002-8333-1635				Abramski K., 1977, GOSPOD WODNA, V4, P107; Babin-Fenske J, 2011, ENVIRON POLLUT, V159, P3036, DOI 10.1016/j.envpol.2011.04.011; Banaszak J., 1991, Wiadomosci Entomologiczne, V10, P113; Banaszak Jozef, 2010, Polish Journal of Entomology, V79, P291; Benes J, 2003, CONSERV BIOL, V17, P1058, DOI 10.1046/j.1523-1739.2003.02092.x; Blosch M., 2000, GRABWESPEN DEUTSCHLA; Bogdanowicz W, 2004, FAUNA POLAND CHARACT; CHAO A, 1984, SCAND J STAT, V11, P265; Chapman VJ, 1960, SALT MARSHES SALT DE; Christie F, 2009, J INSECT CONSERV, V13, P213, DOI 10.1007/s10841-008-9146-5; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cruz-Sanchez MA, 2011, J INSECT CONSERV, V15, P487, DOI 10.1007/s10841-010-9322-2; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Davis B.N.K., 1979, Minerals and the Environment, V1, P48, DOI 10.1007/BF02010717; Dygus KH, 2014, INZ EKOLOG, V36, P65; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P258; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Harabis F, 2012, J INSECT CONSERV, V16, P121, DOI 10.1007/s10841-011-9400-0; Heneberg P, 2016, ECOL ENG, V93, P187, DOI 10.1016/j.ecoleng.2016.05.026; Heneberg P, 2014, J INSECT CONSERV, V18, P1123, DOI 10.1007/s10841-014-9723-8; JACOBS H-J, 1990, Beitraege zur Entomologie, V40, P121; Lomholdt O., 1984, SPHECIDAE HYMENOPTER, V2nd, P452; Molenda T., 2013, J ECOLOGY HLTH, V17, P76; Moron D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101297; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; Niklewska A., 2000, Biuletyn Naukowy, P195; O'Neill K., 2001, CORNELL S ARTHR BIOL, pXIV + 406; Olszewski P, 2016, ZOOTAXA, V4061, P164, DOI 10.11646/zootaxa.4061.2.6; Olszewski Piotr, 2013, Wiadomosci Entomologiczne, V32, P266; Olszewski Piotr, 2013, Wiadomosci Entomologiczne, V32, P202; Olszewski Piotr, 2014, Polish Journal of Entomology, V83, P189, DOI 10.2478/pjen-2014-0014; Olszewski Piotr, 2013, Fragmenta Faunistica (Warsaw), V56, P39, DOI 10.3161/00159301FF2013.56.1.039; Olszewski Piotr, 2013, Fragmenta Faunistica (Warsaw), V56, P43, DOI 10.3161/00159301FF2013.56.1.043; Pawlikowski T, 1996, WIAD ENTOMOL, V16, P165; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Saure C., 2015, MAERK ENTOMOL NACHR, V17, P1; Schmid-Egger C, 1995, FAUNA FLORA RHEINLAN; Siuta J, 2001, INZ EKOLOG, V3, P43; Siuta J., 2014, INZ EKOLOG, V36, P98; Srba M, 2012, J INSECT CONSERV, V16, P557, DOI 10.1007/s10841-011-9441-4; Szadziewski R., 1983, Polskie Pismo Entomologiczne, V53, P31; Szczepko K., 2013, EKOLOGIA GRZEBACZOWA; ter Braak CJ, 1998, MICROCOMPUTER POWER; Tropek R, 2008, LAND DEGRAD DEV, V19, P104, DOI 10.1002/ldr.817; Tropek R, 2014, ECOL ENG, V73, P45, DOI 10.1016/j.ecoleng.2014.09.011; Tropek R, 2013, ECOL ENG, V57, P252, DOI 10.1016/j.ecoleng.2013.04.024; Tropek R, 2013, BIOL CONSERV, V162, P60, DOI 10.1016/j.biocon.2013.03.027; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Twerd L., 2013, J INSECT CONSERV, V17, P473; Twerd L., 2012, NATURAL HUMAN ENV DA, P275; Urbanska J, 2012, GEOMAT ENV ENG, V6, P83; Vieira LC, 2011, BIODIVERS CONSERV, V20, P519, DOI 10.1007/s10531-010-9962-2; Vojar J., 2006, Scientia Agriculturae Bohemica, V37, P35; Wisniowski B., 2008, J LAND STUD, V1, P169; Zarzycki K., 2002, ECOLOGICAL INDICATOR	55	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175664	10.1371/journal.pone.0175664	http://dx.doi.org/10.1371/journal.pone.0175664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423033	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600040
J	Donini, S; Garavaglia, S; Ferraris, DM; Miggiano, R; Mori, S; Shibayama, K; Rizzi, M				Donini, Stefano; Garavaglia, Silvia; Ferraris, Davide M.; Miggiano, Riccardo; Mori, Shigetarou; Shibayama, Keigo; Rizzi, Menico			Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis	PLOS ONE			English	Article							PYROPHOSPHATE SYNTHETASE; ESCHERICHIA-COLI; TUBERCULOSIS; PURIFICATION; ENZYME; REFINEMENT; FEATURES; PATHWAY; BINDING; PURINE	Mycobacterium smegmatis represents one model for studying the biology of its pathogenic relative Mycobacterium tuberculosis. The structural characterization of a M. tuberculosis ortholog protein can serve as a valid tool for the development of molecules active against the M. tuberculosis target. In this context, we report the biochemical and structural characterization of M. smegmatis phosphoribosylpyrophosphate synthetase (PrsA), the ortholog of M. tuberculosis PrsA, the unique enzyme responsible for the synthesis of phosphoribosylpyrophosphate (PRPP). PRPP is a key metabolite involved in several biosynthetic pathways including those for histidine, tryptophan, nucleotides and decaprenylphosphoryl-arabinose, an essential precursor for the mycobacterial cell wall biosynthesis. Since M. tuberculosis PrsA has been validated as a drug target for the development of antitubercular agents, the data presented here will add to the knowledge of the mycobacterial enzyme and could contribute to the development of M. tuberculosis PrsA inhibitors of potential pharmacological interest.	[Donini, Stefano; Garavaglia, Silvia; Ferraris, Davide M.; Miggiano, Riccardo; Rizzi, Menico] Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, Novara, Italy; [Mori, Shigetarou; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Gakuen 4-7-1, Musashimurayama, Tokyo, Japan	University of Eastern Piedmont Amedeo Avogadro; National Institute of Infectious Diseases (NIID)	Rizzi, M (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, Novara, Italy.	menico.rizzi@uniupo.it	garavaglia, silvia/AIA-1816-2022; Ferraris, Davide Maria/AAO-9743-2020; Ferraris, Davide Maria/AAP-7110-2020; Miggiano, Riccardo/AAO-7887-2020	Ferraris, Davide Maria/0000-0001-5112-9910; garavaglia, silvia/0000-0001-8494-1729; MIGGIANO, Riccardo/0000-0002-2159-3314	European Community's Seventh Framework Program [260872]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED	European Community's Seventh Framework Program; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was funded by the European Community's Seventh Framework Program (Grant 260872; MM4TB) and the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the European Community's Seventh Framework Program (Grant 260872; MM4TB) and the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED. We would like to thank Michela Ferrari (University of Piemonte Orientale) for technical support and the ESRF (Grenoble, France) personnel for assistance during data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], THE PYMOL MOLECULAR; Barry CE, 2001, TRENDS MICROBIOL, V9, P473, DOI 10.1016/S0966-842X(01)02169-2; BECKER MA, 1973, P NATL ACAD SCI USA, V70, P2749, DOI 10.1073/pnas.70.10.2749; Breda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039245; Cherney MM, 2011, J MOL BIOL, V413, P844, DOI 10.1016/j.jmb.2011.09.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksen TA, 2002, PROTEIN SCI, V11, P271, DOI 10.1110/ps.28502; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; FOX IH, 1971, J BIOL CHEM, V246, P5739; GIBSON KJ, 1982, J BIOL CHEM, V257, P2391; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; ISHIJIMA S, 1991, J BIOL CHEM, V266, P15693; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; Kolly GS, 2014, MOL MICROBIOL, V92, P194, DOI 10.1111/mmi.12546; Krath BN, 2001, PROTEIN SCI, V10, P2317, DOI 10.1110/ps.11801; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Lucarelli AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015494; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Payne T, 1997, J MED VET MYCOL, V35, P305; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Riccardi G, 2013, APPL MICROBIOL BIOT, V97, P8841, DOI 10.1007/s00253-013-5218-x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROTH DG, 1974, J BIOL CHEM, V249, P291; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; SCHUBERT KR, 1975, J BIOL CHEM, V250, P7492; Shiloh MU, 2010, CURR OPIN MICROBIOL, V13, P86, DOI 10.1016/j.mib.2009.11.006; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tyagi JS, 2002, TRENDS MICROBIOL, V10, P68, DOI 10.1016/S0966-842X(01)02296-X; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; World Health Organization, GLOB TUB REP 2016; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	47	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175815	10.1371/journal.pone.0175815	http://dx.doi.org/10.1371/journal.pone.0175815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419153	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875200048
J	Kilonzo, KG; Jones, ESW; Okpechi, IG; Wearne, N; Barday, Z; Swanepoel, CR; Yeates, K; Rayner, BL				Kilonzo, Kajiru G.; Jones, Erika S. W.; Okpechi, Ikechi G.; Wearne, Nicola; Barday, Zunaid; Swanepoel, Charles R.; Yeates, Karen; Rayner, Brian L.			Disparities in dialysis allocation: An audit from the new South Africa	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; CHRONIC KIDNEY-DISEASE	End Stage Kidney Disease (ESKD) is a public health problem with an enormous economic burden. In resource limited settings management of ESKD is often rationed. Racial and socio-economic inequalities in selecting candidates have been previously documented in South Africa. New guidelines for dialysis developed in the Western Cape have focused on prioritizing treatment. With this in mind we aimed at exploring whether the new guidelines would improve inequalities previously documented. A retrospective study of patients presented to the selection committee was conducted at Groote Schuur Hospital. A total of 564 ESKD patients presented between 1 January 2008 and 31 December 2012 were assessed. Half of the patients came from low socioeconomic areas, and presentation was late with either overt uremia (n = 181, 44 .4%) or fluid overload (n = 179, 43 .9%). More than half (53 . 9%) of the patients were not selected for the program. Predictors of non-acceptance onto the program included age above 50 years (OR 0.3, p = 0.001), unemployment (OR 0.3, p < 0.001), substance abuse (OR 0.2, p < 0.001), diabetes (OR 0.4, p = 0.016) and a poor psychosocial assessment (OR 0.13, p < 0.001). Race, gender and marital status were not predictors. The use of new guidelines has not led to an increase in inequalities. In view of the advanced nature of presentation greater efforts need to be made to prevent early kidney disease, to allocate more resources to renal replacement therapy in view of the loss of young and potentially productive life.	[Kilonzo, Kajiru G.; Jones, Erika S. W.; Okpechi, Ikechi G.; Wearne, Nicola; Barday, Zunaid; Swanepoel, Charles R.; Rayner, Brian L.] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Nephrol & Hypertens, Cape Town, Western Cape, South Africa; [Kilonzo, Kajiru G.] Kilimanjaro Christian Med Univ Coll, Internal Med Dept, Kilimanjaro, Moshi, Tanzania; [Yeates, Karen] Queens Univ, Dept Nephrol, Kingston, ON, Canada	University of Cape Town; Queens University - Canada	Kilonzo, KG (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Div Nephrol & Hypertens, Cape Town, Western Cape, South Africa.; Kilonzo, KG (corresponding author), Kilimanjaro Christian Med Univ Coll, Internal Med Dept, Kilimanjaro, Moshi, Tanzania.	kajiru@yahoo.com	Rayner, Brian/AAA-3174-2021		ISN award to train in Nephrology at Groote Schuur Hospital/University of Cape Town; ISN Fellowship	ISN award to train in Nephrology at Groote Schuur Hospital/University of Cape Town; ISN Fellowship	The First Author received an ISN award to train in Nephrology at Groote Schuur Hospital/University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been made possible through an ISN Fellowship.	Alebiosu C Olutayo, 2006, Afr Health Sci, V6, P132; Arogundade FA, 2011, AFR HEALTH SCI, V11, P594; Davids MR., 2014, S AFRICAN RENAL REGI; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Junod V, 2010, SWISS MED WEEKLY EUR, P1; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Moosa M, 2010, GUIDELINE PRIORITY S, P1; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Naicker S, 2003, KIDNEY INT, V63, P119, DOI 10.1046/j.1523-1755.63.s83.25.x; Okpechi IG, 2012, J NEPHROL, V25, P551, DOI 10.5301/jn.5000032; Okpechi IG, 2010, J NATL MED ASSOC, V102, P1193, DOI 10.1016/S0027-9684(15)30774-4; Pozo ME, 2012, TRANSPL INT, V25, P652, DOI 10.1111/j.1432-2277.2012.01468.x; Rayner B, 2003, SAMJ S AFR MED J, V93, P673; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Tamura MK, 2014, KIDNEY INT, V85, P686, DOI 10.1038/ki.2013.369; Van Zyl-smit R, 1997, S AFR MED J, V87, P3; Wauters JP, 2005, NEPHROL DIAL TRANSPL, V20, P490, DOI 10.1093/ndt/gfh709; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715	19	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176041	10.1371/journal.pone.0176041	http://dx.doi.org/10.1371/journal.pone.0176041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419150	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200063
J	Marty, MJ; Vicente, J; Oyler, BL; Place, A; Hill, RT				Marty, Micah Jaarsma; Vicente, Jan; Oyler, Benjamin L.; Place, Allen; Hill, Russell T.			Sponge symbioses between Xestospongia deweerdtae and Plakortis spp. are not motivated by shared chemical defense against predators	PLOS ONE			English	Article							CORAL-REEF SPONGES; RESOURCE TRADE-OFF; CARIBBEAN SPONGES; MARINE SPONGE; INVERTEBRATE PREDATORS; SECONDARY METABOLITES; 2-SPONGE ASSOCIATION; GROWTH; ACIDS; ANGULOSPICULATUS	However, X. deweerdtae effectively deters predators with its own defensive chemistry. Multiple lines of evidence provide no support for the shared chemical defense hypothesis. Given the diversity of other potential food resources available to predators on coral reefs, it is improbable that the evolution of these specialized sponge-sponge symbioses has been driven by predation pressure.The recently described epizoic sponge-sponge symbioses between Xestospongia deweerdtae and two species of Plakortis present an unusual series of sponge interactions. Sponges from the genus Plakortis are fierce allelopathic competitors, rich in cytotoxic secondary metabolites, and yet X. deweerdtae flourishes as an epizoic encrustation on Plakortis deweerdtaephila and Plakortis symbiotica. Our objective in this study was to evaluate the hypothesis that X. deweerdtae grows epizoic to these two species of Plakortis due to a shared chemical defense against predators. We collected free-living individuals of X. deweerdtae and symbiotic pairs from a wide geographical range to generate crude organic extracts and a series of polarity fractions from sponge extract. We tested the deterrency of these extracts against three common coral reef predators: the bluehead wrasse, Thalassoma bifasciatum, the Caribbean sharpnose puffer, Canthigaster rostrata, and the white spotwrist hermit crab, Pagurus criniticornis. While the chemical defenses of P. deweerdtaephila and P. symbiotica are more potent than those of X. deweerdtae, all of the sponge species we tested significantly deterred feeding in all three generalist predators. The free-living form of X. deweerdtae is mostly defended across the region, with a few exceptions. The associated form of X. deweerdtae is always defended, and both species of Plakortis are very strongly defended, with puffers refusing to consume extract-treated pellets until the extract was diluted to 1/256x concentration. Using diode-array high performance liquid chromatography ( HPLC) coupled with high-resolution mass spectrometry (LC-MS/IT-TOF), we found two secondary metabolites from P. deweerdtaephila, probably the cyclic endoperoxides plakinic acid I and plakinic acid K, in low concentrations in the associated D but not the free-living D form of X. deweerdtae, suggesting a possible translocation of defensive chemicals from the basibiont to the epibiont. Comparing the immense deterrency of Plakortis spp. extracts to the extracts of X. deweerdtae gives the impression that there may be some sharing of chemical defenses: one partner in the symbiosis is clearly more defended than the other and a small amount of its defensive chemistry may translocate to the partner. However, X. deweerdtae effectively deters predators with its own defensive chemistry. Multiple lines of evidence provide no support for the shared chemical defense hypothesis. Given the diversity of other potential food resources available to predators on coral reefs, it is improbable that the evolution of these specialized sponge-sponge symbioses has been driven by predation pressure.	[Marty, Micah Jaarsma] Univ North Carolina Wilmington, Ctr Marine Sci, Dept Biol & Marine Biol, Wilmington, NC USA; [Vicente, Jan; Oyler, Benjamin L.; Place, Allen; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA	University of North Carolina; University of North Carolina Wilmington; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Place, Allen R/F-9267-2013; Hill, Russell/AAF-4190-2019; Marty, Micah/AAH-5515-2019; Marty, Micah/F-8102-2016	Hill, Russell/0000-0002-9832-1851; Oyler, Benjamin/0000-0003-3436-9175; Marty, Micah/0000-0003-0778-0452	NOAA Nancy Foster Scholarship award [NA1 2N054290142]; STRI-short term fellowship award; NOAA LMRCSC award [NA11SEC4810002]; NSF award [OCE- 1029515]	NOAA Nancy Foster Scholarship award; STRI-short term fellowship award; NOAA LMRCSC award; NSF award(National Science Foundation (NSF))	Project funding awarded to J.V. was provided by the NOAA Nancy Foster Scholarship award NA1 2N054290142, STRI-short term fellowship award and the NOAA LMRCSC award NA11SEC4810002. UNOLS research cruises were supported by NSF award OCE- 1029515 to Joseph R. Pawlik.	Avila Enrique, 2007, V28, P147; Cardenas P, 2016, J CHEM ECOL, V42, P339, DOI 10.1007/s10886-016-0693-z; Chanas B., 1997, P1363; Dalisay DS, 2010, ORG LETT, V12, P1524, DOI 10.1021/ol100249v; Dalisay DS, 2009, ANGEW CHEM INT EDIT, V48, P4367, DOI 10.1002/anie.200900888; Engel S, 2000, MAR ECOL PROG SER, V207, P273, DOI 10.3354/meps207273; Hoye TR, 2015, ARKIVOC, P164, DOI 10.3998/ark.5550190.p008.948; Jimenez MD, 2003, J NAT PROD, V66, P655, DOI 10.1021/np030021h; Jung JH, 1995, J NAT PROD, V58, P1722, DOI 10.1021/np50125a012; Kossuga MH, 2008, J NAT PROD, V71, P334, DOI 10.1021/np0705256; Lehnert H., 1999, BEAUFORTIA, V49, P141; Lehnert Helmut, 1999, Beaufortia, V49, P141; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Loh TL, 2015, PEERJ, V3, DOI 10.7717/peerj.901; Loh TL, 2014, P NATL ACAD SCI USA, V111, P4151, DOI 10.1073/pnas.1321626111; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Marty MJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52429; Marty MJ, 2016, J EXP MAR BIOL ECOL, V485, P57, DOI 10.1016/j.jembe.2016.08.014; MARTY MJ, 2015, J VISUALIZED EXPT, V95; Pawlik JR, 2015, CORAL REEFS, V34, P663, DOI 10.1007/s00338-015-1279-x; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; PAWLIK JR, 2012, HDB MARINE NATURAL P, V677, P710; Pawlik JR, 2012, HDB MARINE NATURAL P, P677, DOI DOI 10.1007/978-90-481-3834-0_12; PAWLIK JR, 2007, LIMNOLOGY OCEANOGRAP, V907, P11, DOI DOI 10.7717/PEERJ.901; PENNINGS SC, 1994, J EXP MAR BIOL ECOL, V180, P137, DOI 10.1016/0022-0981(94)90083-3; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Puyana M, 2003, MAR ECOL PROG SER, V246, P127, DOI 10.3354/meps246127; PUYANA M, 2003, MARINE ECOLOGY PROGR, V127, P35; Ramsby B, 2012, HYDROBIOLOGIA, V687, P331, DOI 10.1007/s10750-011-0878-y; RUTZLER K, 1970, OECOLOGIA, V5, P85, DOI 10.1007/BF00347624; Santos EA, 2015, J NAT PROD, V78, P996, DOI 10.1021/np5008944; Sara M., 1970, Symp. zool. Soc. Lond., VNo. 25, P273; Schupp P, 1999, MAR BIOL, V135, P573, DOI 10.1007/s002270050658; Swearingen DC, 1998, MAR BIOL, V131, P619, DOI 10.1007/s002270050354; Vicente J, 2016, ZOOTAXA, V4178, P209, DOI 10.11646/zootaxa.4178.2.3; Waddell B, 2000, MAR ECOL PROG SER, V195, P125, DOI 10.3354/meps195125; Waddell B, 2000, MAR ECOL PROG SER, V195, P133, DOI 10.3354/meps195133; WADDELL B, 2000, MARINE ECOLOGY PROGR, V125, P32, DOI DOI 10.1073/PNAS.1321626111; Walters KD, 2005, INTEGR COMP BIOL, V45, P352, DOI 10.1093/icb/45.2.352; Wilcox TP, 2002, CORAL REEFS, V21, P198, DOI 10.1007/s00228-002-0221-1; Wooster MK, 2016, MARINE ECOLOGY; Wulff JL, 2008, MAR ECOL-EVOL PERSP, V29, P193, DOI 10.1111/j.1439-0485.2008.00224.x; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 1997, ECOLOGY, V78, P146; Zhang JR, 2013, J NAT PROD, V76, P600, DOI 10.1021/np300771p	48	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0174816	10.1371/journal.pone.0174816	http://dx.doi.org/10.1371/journal.pone.0174816			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419173	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200004
J	Wang, YS; Zou, YJ; Henrickson, K; Wang, YH; Tang, JJ; Park, BJ				Wang, Yinsong; Zou, Yajie; Henrickson, Kristian; Wang, Yinhai; Tang, Jinjun; Park, Byung-Jung			Google Earth elevation data extraction and accuracy assessment for transportation applications	PLOS ONE			English	Article							POSITIONAL ACCURACY; TOOL	Roadway elevation data is critical for a variety of transportation analyses. However, it has been challenging to obtain such data and most roadway GIS databases do not have them. This paper intends to address this need by proposing a method to extract roadway elevation data from Google Earth (GE) for transportation applications. A comprehensive accuracy assessment of the GE-extracted elevation data is conducted for the area of conterminous USA. The GE elevation data was compared with the ground truth data from nationwide GPS benchmarks and roadway monuments from six states in the conterminous USA. This study also compares the GE elevation data with the elevation raster data from the U.S. Geological Survey National Elevation Dataset (USGS NED), which is a widely used data source for extracting roadway elevation. Mean absolute error (MAE) and root mean squared error (RMSE) are used to assess the accuracy and the test results show MAE, RMSE and standard deviation of GE roadway elevation error are 1.32 meters, 2.27 meters and 2.27 meters, respectively. Finally, the proposed extraction method was implemented and validated for the following three scenarios: (1) extracting roadway elevation differentiating by directions, (2) multi-layered roadway recognition in freeway segment and (3) slope segmentation and grade calculation in freeway segment. The methodology validation results indicate that the proposed extraction method can locate the extracting route accurately, recognize multi-layered roadway section, and segment the extracted route by grade automatically. Overall, it is found that the high accuracy elevation data available from GE provide a reliable data source for various transportation applications.	[Wang, Yinsong] Shanghai Int Automobile City Grp Co Ltd, Shanghai, Peoples R China; [Zou, Yajie] Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China; [Henrickson, Kristian; Wang, Yinhai] Univ Washington, Dept Civil Engn, Seattle, WA 98195 USA; [Tang, Jinjun] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Park, Byung-Jung] Myongji Univ, Dept Transportat Engn, Seoul, South Korea	Tongji University; University of Washington; University of Washington Seattle; Central South University; Myongji University	Zou, YJ (corresponding author), Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China.; Wang, YH (corresponding author), Univ Washington, Dept Civil Engn, Seattle, WA 98195 USA.	zonyajie@gmail.com; yinhai@uw.edu	Wang, Yinhai/B-5396-2012	Wang, Yinhai/0000-0002-4180-5628	Federal Highway Administration (FHWA); Pacific Northwest Transportation Consortium (PacTrans); USDOT University Transportation Center for Federal Region 10; National Natural Science Foundation of China [51608386]; Shanghai Sailing Program [16YF1411900]; Shanghai International Automobile City (Group) Co., Ltd	Federal Highway Administration (FHWA); Pacific Northwest Transportation Consortium (PacTrans); USDOT University Transportation Center for Federal Region 10; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Shanghai International Automobile City (Group) Co., Ltd	The authors appreciate the funding support from the Federal Highway Administration (FHWA), the Pacific Northwest Transportation Consortium (PacTrans), USDOT University Transportation Center for Federal Region 10, the National Natural Science Foundation of China (grant no. 51608386), and Shanghai Sailing Program (grant no. 16YF1411900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder [Shanghai International Automobile City (Group) Co., Ltd] provided support in the form of salaries for author Yinsong Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; The authors appreciate the funding support from the Federal Highway Administration (FHWA), the Pacific Northwest Transportation Consortium (PacTrans), USDOT University Transportation Center for Federal Region 10, the National Natural Science Foundation of China (grant no. 51608386), and Shanghai Sailing Program (grant no. 16YF1411900). This study would not have been possible without their financial supports.	Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Benker SC, 2011, GEOCARTO INT, V26, P291, DOI 10.1080/10106049.2011.568125; Boriboonsomsin K, 2009, TRANSPORT RES REC, P21, DOI 10.3141/2139-03; Butler D, 2006, NATURE, V439, P776, DOI 10.1038/439776a; Chen Z, 2014, TRANSPORT RES REC, P54, DOI 10.3141/2427-06; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Geiger P, 2013, ENG ADV LOCATION BAS; Gesch DB, 2014, US GEOLOGICAL SURVEY, P2331; Kim JK, 2007, J TRANSP ENG, V133, P11, DOI 10.1061/(ASCE)0733-947X(2007)133:1(11); Kockelman KK, 2010, FREEWAY SPEEDS SPEED; Ma XL, 2014, J TRANSP ENG, V140, DOI 10.1061/(ASCE)TE.1943-5436.0000714; Ma XL, 2011, TRANSPORT RES REC, P37, DOI 10.3141/2215-04; Meyer DJ, 2012, INT ARCH PHOTOGRAMM, V39-B4, P291; Potere D, 2008, SENSORS-BASEL, V8, P7973, DOI 10.3390/s8127973; Reutebuch SE, 2005, J FOREST, V103, P286; Sheppard SRJ, 2009, J ENVIRON MANAGE, V90, P2102, DOI 10.1016/j.jenvman.2007.09.012; SHUMAKER BP, 1984, SKY TELESCOPE, V68, P158; Tachikawa T, 2011, INT GEOSCI REMOTE SE, P3657, DOI 10.1109/IGARSS.2011.6050017; Tang J, 2017, INORGANIC AND ORGANOMETALLIC TRANSITION METAL COMPLEXES WITH BIOLOGICAL MOLECULES AND LIVING CELLS, P1, DOI 10.1016/B978-0-12-803814-7.00001-0; Yu L, 2012, INT J REMOTE SENS, V33, P3966, DOI 10.1080/01431161.2011.636081; Zou Y, P I CIVIL ENG TRANSP, P1; Zou YJ, 2013, ACCIDENT ANAL PREV, V50, P1042, DOI 10.1016/j.aap.2012.08.004	22	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175756	10.1371/journal.pone.0175756	http://dx.doi.org/10.1371/journal.pone.0175756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445480	gold, Green Published, Green Submitted			2022-12-27	WOS:000400309200026
J	Fallath, T; Kidd, BN; Stiller, J; Davoine, C; Bjorklund, S; Manners, JM; Kazan, K; Schenk, PM				Fallath, Thorya; Kidd, Brendan N.; Stiller, Jiri; Davoine, Celine; Bjorklund, Stefan; Manners, John M.; Kazan, Kemal; Schenk, Peer M.			MEDIATOR18 and MEDIATOR20 confer susceptibility to Fusarium oxysporum in Arabidopsis thaliana	PLOS ONE			English	Article							SIGNALING PATHWAYS; SALICYLIC-ACID; ABSCISIC-ACID; DISEASE RESISTANCE; GENE-EXPRESSION; CROSS-TALK; JASMONATE; DEFENSE; RESPONSES; COMPLEX	The conserved protein complex known as Mediator conveys transcriptional signals by acting as an intermediary between transcription factors and RNA polymerase II. As a result, Mediator subunits play multiple roles in regulating developmental as well as abiotic and biotic stress pathways. In this report we identify the head domain subunits MEDIATOR18 and MEDIATOR20 as important susceptibility factors for Fusarium oxysporum infection in Arabidopsis thaliana. Mutants of MED18 and MED20 display down-regulation of genes associated with jasmonate signaling and biosynthesis while up-regulation of salicylic acid associated pathogenesis related genes and reactive oxygen producing and scavenging genes. We propose that MED18 and MED20 form a sub-domain within Mediator that controls the balance of salicylic acid and jasmonate associated defense pathways.	[Fallath, Thorya; Kidd, Brendan N.; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, St Lucia, Qld, Australia; [Kidd, Brendan N.; Stiller, Jiri; Kazan, Kemal] CSIRO Agr & Food, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Davoine, Celine; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea Plant Sci Ctr, Umea, Sweden; [Manners, John M.] CSIRO Agr & Food, Canberra, ACT, Australia; [Kazan, Kemal; Schenk, Peer M.] Univ Queensland, QAAFI, St Lucia, Qld, Australia; [Kidd, Brendan N.] CSIRO Agr & Food, Ctr Environm & Life Sci, Floreat, WA 6913, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Umea University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schenk, PM (corresponding author), Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, St Lucia, Qld, Australia.; Schenk, PM (corresponding author), Univ Queensland, QAAFI, St Lucia, Qld, Australia.	p.schenk@uq.edu.au	Kidd, Brendan N/D-9801-2017; Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Manners, John M/A-4922-2008; Schenk, Peer/B-7879-2016; Kidd, Brendan/J-9672-2014	Kazan, Kemal/0000-0002-5169-8934; Schenk, Peer/0000-0003-4878-3799; Kidd, Brendan/0000-0003-1770-1404	Australian Research Council [DP110104354]; Swedish Cancer Society [15 0537]; Swedish Research Council [621-2010-4969]; Swedish Governmental Agency for Innovation Systems; Knut and Alice Wallenberg Foundation [2015-0056]; Kempe Foundation	Australian Research Council(Australian Research Council); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe Foundation	This work was supported by the Australian Research Council [htpp://www.arc.gov.au] grant no. DP110104354 to PMS, JMM, and KK. CD and SB were supported by grants from the Swedish Cancer Society (15 0537); the Swedish Research Council (621-2010-4969); the Swedish Governmental Agency for Innovation Systems, the Knut and Alice Wallenberg Foundation (2015-0056) and the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen T, 2015, NUCLEIC ACIDS RES, V43, P8283, DOI 10.1093/nar/gkv751; Cole SJ, 2014, MOL PLANT PATHOL, V15, P589, DOI 10.1111/mpp.12117; Cui FH, 2013, PLANT PHYSIOL, V162, P1018, DOI 10.1104/pp.113.219659; Cui P, 2016, PLANT CELL, V28, P770, DOI 10.1105/tpc.15.00771; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Diener A, 2012, MOL PLANT MICROBE IN, V25, P1531, DOI 10.1094/MPMI-02-12-0042-TA; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Havko NE, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010007; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; JEFFERSON RA, 1987, EMBO J, V6, P3901; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kidd BN, 2011, SEMIN CELL DEV BIOL, V22, P741, DOI 10.1016/j.semcdb.2011.07.012; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laloi C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00039; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liao CJ, 2016, PLANT CELL, V28, P1662, DOI 10.1105/tpc.16.00105; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121902; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; Misas-Villamil JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003281; Pantelides IS, 2013, PLANT PATHOL, V62, P1302, DOI 10.1111/ppa.12042; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Samanta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00757; Schumann Ulrike, 2013, Silence, V4, P3, DOI 10.1186/1758-907X-4-3; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Shaikhibrahim Z, 2009, P NATL ACAD SCI USA, V106, P20728, DOI 10.1073/pnas.0907645106; Shumbe L, 2016, PLANT PHYSIOL, V170, P1757, DOI 10.1104/pp.15.01546; Smakowska E, 2016, CURR OPIN PLANT BIOL, V29, P129, DOI 10.1016/j.pbi.2015.12.005; Thatcher LF, 2016, J EXP BOT, V67, P2367, DOI 10.1093/jxb/erw040; Thatcher LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126978; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Windram O, 2014, ANNU REV PHYTOPATHOL, V52, P93, DOI 10.1146/annurev-phyto-102313-050103; Yang Y, 2014, PLANT J, V77, P838, DOI 10.1111/tpj.12440; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924	64	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176022	10.1371/journal.pone.0176022	http://dx.doi.org/10.1371/journal.pone.0176022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441405	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800020
J	Hayat, T; Qayyum, S; Alsaedi, A; Asghar, S				Hayat, Tasawar; Qayyum, Sajid; Alsaedi, Ahmed; Asghar, Saleem			Radiation effects on the mixed convection flow induced by an inclined stretching cylinder with non-uniform heat source/sink	PLOS ONE			English	Article							STAGNATION-POINT FLOW; NONLINEAR THERMAL-RADIATION; CHEMICAL-REACTION; VISCOELASTIC FLUID; MAXWELL NANOFLUID; MICROPOLAR FLUID; COMPLEX NETWORK; MAGNETIC-FIELD; JEFFREY FLUID; TIME-SERIES	This study investigates the mixed convection flow of Jeffrey liquid by an impermeable inclined stretching cylinder. Thermal radiation and non-uniform heat source/sink are considered. The convective boundary conditions at surface are imposed. Nonlinear expressions of momentum, energy and concentration are transformed into dimensionless systems. Convergent homotopic solutions of the governing systems are worked out by employing homotopic procedure. Impact of physical variables on the velocity, temperature and concentration distributions are sketched and discussed. Numerical computations for skin friction coefficient, local Nusselt and Sherwood numbers are carried out. It is concluded that velocity field enhances for Deborah number while reverse situation is observed regarding ratio of relaxation to retardation times. Temperature and heat transfer rate are enhanced via larger thermal Biot number. Effect of Schmidt number on the concentration and local Sherwood number is quite reverse.	[Hayat, Tasawar; Qayyum, Sajid] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah, Saudi Arabia; [Asghar, Saleem] COMSATS Inst Informat Technol, Dept Math Sci, Islamabad, Pakistan	Quaid I Azam University; King Abdulaziz University; COMSATS University Islamabad (CUI)	Qayyum, S (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	sajidqayyum94@gmail.com	Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922				Abbasi FM, 2016, J MAGN MAGN MATER, V404, P159, DOI 10.1016/j.jmmm.2015.11.090; Abbasi FM, 2015, AIP ADV, V5, DOI 10.1063/1.4914549; Ashraf MB, 2015, AIP ADV, V5, DOI 10.1063/1.4913719; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Farooq U, 2015, COMPUT FLUIDS, V111, P69, DOI 10.1016/j.compfluid.2015.01.005; Fetecau C, 2014, Z NATURFORSCH A, V69, P232, DOI 10.5560/ZNA.2014-0022; Fetecau C, 2010, Z ANGEW MATH PHYS, V61, P959, DOI 10.1007/s00033-009-0038-7; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Ghanbari M, 2013, APPL COMPUT MATH-BAK, V12, P355; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2015, COMPUT FLUIDS, V108, P179, DOI 10.1016/j.compfluid.2014.11.016; Hayat T, 2014, APPL MATH MECH-ENGL, V35, P717, DOI 10.1007/s10483-014-1824-6; Hayat T., 2015, THERMAL SCI; Hayat T., 2017, RESULTS PHYS; Hayat T, 2017, J MOL LIQ, V230, P641, DOI 10.1016/j.molliq.2017.01.045; Hayat T, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16422-x; Hayat T, 2016, J MOL LIQ, V224, P801, DOI 10.1016/j.molliq.2016.10.055; Hayat T, 2016, J MOL LIQ, V223, P969, DOI 10.1016/j.molliq.2016.08.102; Hayat T, 2016, INT J HEAT MASS TRAN, V103, P99, DOI 10.1016/j.ijheatmasstransfer.2016.06.055; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2015, INT J HEAT MASS TRAN, V84, P903, DOI 10.1016/j.ijheatmasstransfer.2015.01.099; Malik R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107989; Narayana PVS, 2016, J TAIWAN INST CHEM E, V59, P18, DOI 10.1016/j.jtice.2015.07.014; Pal D., 2012, INT J NONLINEAR SCI, V14, P115; Ramesh GK, 2012, INT J HEAT MASS TRAN, V55, P4900, DOI 10.1016/j.ijheatmasstransfer.2012.05.003; Rashad AM, 2014, J TAIWAN INST CHEM E, V45, P2163, DOI 10.1016/j.jtice.2014.07.002; Shehzad SA, 2016, J MAGN MAGN MATER, V397, P108, DOI 10.1016/j.jmmm.2015.07.057; Shehzad SA, 2015, B POL ACAD SCI-TECH, V63, P465, DOI 10.1515/bpasts-2015-0053; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, J MAGN MAGN MAT, V2105, P36; Singh G, 2015, THERM SCI, V19, P119, DOI 10.2298/TSCI120718110S; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022	40	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175584	10.1371/journal.pone.0175584	http://dx.doi.org/10.1371/journal.pone.0175584			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441392	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800008
J	Shi, CF; Li, M; Dushoff, J				Shi, Chyun-Fung; Li, Michael; Dushoff, Jonathan			Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized Sub-Saharan countries	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; POSTTRIAL FOLLOW-UP; HIV-INFECTION RISK; UNCIRCUMCISED MEN; PREVENTION; BEHAVIOR; RAKAI; TRIAL; PARTICIPANTS; PEOPLE	Background WHO and UNAIDS prioritized 14 eastern and southern African countries with high HIV and low male circumcision prevalence for a voluntary medical male circumcision (VMMC) scale-up in 2007. Because circumcision provides only partial protection against HIV infection to men, the issue of possible risk compensation in response to VMMC campaigns is of particular concern. In this study, we looked at population-level survey data from the countries prioritized by WHO for a VMMC scale-up. We compared the difference in sexual risk behaviours (SRB) between circumcised and uncircumcised men before and after the WHO's official VMMC promotion. Materials and methods Ten countries (Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe) participating in the WHO's VMMC scale-up had available data from the Demographic and Health Surveys (DHS). We used cumulative-link mixed models to investigate interactions between survey period and circumcision status in predicting SRB, in order to evaluate whether the difference between the behavior of the two groups changed before and after the scale-up, while controlling for socio-demographic and knowledge-related covariates.The main responses were condom use at last sex and number of non-cohabiting sexual partners, both in the last 12 months. Results There was little change in condom use by circumcised men relative to uncircumcised men from before the VMMC scale up to after the scale up. The relative odds ratio is 1.06 (95% CI, 0.95 -1.18; interaction P = 0.310). Similarly, there was little change in the number of noncohabiting partners in circumcised men (relative to uncircumcised men): the relative odds ratio of increasing the number of partners is 0.95 (95% CI, 0.86-1.05; interaction P = 0.319). Age, religion, education, job, marital status, media use and HIV knowledge also showed statistically significant association with the studied risk behaviours. We also found significant differences among countries, while controlling for covariates. Conclusions Overall, we find no evidence of sexual risk compensation in response to VMMC campaigns in countries prioritized by WHO. Changes in relative partner behaviour and the relative odds of condom use were small (and of uncertain sign). In fact, our estimates, though not significant, both suggest slightly less risky behavior. We conclude that sexual risk compensation in response to VMMC campaigns has not been a serious problem to date, but urge continued attention to local context, and to promulgating accurate messages about circumcision within and beyond the VMMC context.	[Shi, Chyun-Fung; Li, Michael; Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Dushoff, Jonathan] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Dushoff, Jonathan] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Shi, CF (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	shicf@mcmaster.ca		Li, Michael/0000-0001-5150-8662; shi, chyunfung/0000-0003-3661-594X	James S. McDonnell foundation	James S. McDonnell foundation	This study was funded by a grant from the James S. McDonnell foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions of this article are those of the authors and do not necessarily represent the views of the funding agency.; We thank Ben Bolker, Fiona Kouyoumdjian, Marta Wayne, Audrey Patocs and David Champredon for their helpful comments, and Bolker again for statistical assistance. Support for this paper was provided by the James S. McDonnell Foundation.	ALCENA V, 1986, NEW YORK STATE J MED, V86, P446; Andersson N, 2012, AIDS CARE, V24, P301, DOI 10.1080/09540121.2011.608793; [Anonymous], 2008, SCALPEL SCALE UP SHA; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Ayala G, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21098; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2006, WHO TECH REP SER, V938, P205; CAMERON DW, 1989, LANCET, V2, P403; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Dushoff J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028608; Eaton LA, 2011, INT J STD AIDS, V22, P674, DOI 10.1258/ijsa.2011.011006; Gelman Andrew, 2006, AM STAT, V60, P112; Gilliam FD, 2010, AIDS BEHAV, V14, P1207, DOI 10.1007/s10461-009-9656-5; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grund JM, 2012, AIDS CARE, V24, P245, DOI 10.1080/09540121.2011.596516; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kibira SPS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-25; Kibira SPS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2668-3; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; L'Engle K, 2014, HEALTH EDUC RES, V29, P122, DOI 10.1093/her/cyt103; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Limburgh CM, 2013, AIDS CARE, V25, P1278, DOI 10.1080/09540121.2013.764392; Matovu JKB, 2007, REPROD HEALTH MATTER, V15, P68, DOI 10.1016/S0968-8080(07)29306-1; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Maughan-Brown B, 2015, AIDS BEHAV, V19, P1170, DOI 10.1007/s10461-014-0882-0; Mukama T, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.354.7125; Muzyka CN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-465; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; UNAIDS/ WHO/ SACEMA expert group on modelling the impact and cost of male circumcision for HIV prevention, 2009, PLOS MED, V6; Wang AL, 2009, B WORLD HEALTH ORGAN, V87, P595, DOI 10.2471/BLT.09.066704; Westercamp M, 2016, J ACQUIR IMMUNE DEFI; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; World Health Organization, 2015, WHO PROGR BRIEF 2015; World Health Organization, 2011, PROGR SCAL VOL MED M; World Health Organization, 2007, MAL CIRC GLOB TRENDS	42	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175928	10.1371/journal.pone.0175928	http://dx.doi.org/10.1371/journal.pone.0175928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441458	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800013
J	Kang, HW; Kang, HB				Kang, Hyeon-Woo; Kang, Hang-Bong			Prediction of crime occurrence from multi-modal data using deep learning	PLOS ONE			English	Article							VIOLENT CRIME; UNEMPLOYMENT; PREVENTION; INEQUALITY; HOMICIDE; PATTERNS	In recent years, various studies have been conducted on the prediction of crime occurrences. This predictive capability is intended to assist in crime prevention by facilitating effective implementation of police patrols. Previous studies have used data from multiple domains such as demographics, economics, and education. Their prediction models treat data from different domains equally. These methods have problems in crime occurrence prediction, such as difficulty in discovering highly nonlinear relationships, redundancies, and dependencies between multiple datasets. In order to enhance crime prediction models, we consider environmental context information, such as broken windows theory and crime prevention through environmental design. In this paper, we propose a feature-level data fusion method with environmental context based on a deep neural network (DNN). Our dataset consists of data collected from various online databases of crime statistics, demographic and meteorological data, and images in Chicago, Illinois. Prior to generating training data, we select crime-related data by conducting statistical analyses. Finally, we train our DNN, which consists of the following four kinds of layers: spatial, temporal, environmental context, and joint feature representation layers. Coupled with crucial data extracted from various domains, our fusion DNN is a product of an efficient decision-making process that statistically analyzes data redundancy. Experimental performance results show that our DNN model is more accurate in predicting crime occurrence than other prediction models.	[Kang, Hyeon-Woo; Kang, Hang-Bong] Catholic Univ Korea, Dept Digital Media, Bucheon, Gyonggi Do, South Korea	Catholic University of Korea	Kang, HB (corresponding author), Catholic Univ Korea, Dept Digital Media, Bucheon, Gyonggi Do, South Korea.	hbkang@catholic.ac.kr		Kang, Hang-Bong/0000-0002-7064-478X	Basin Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2015R1A2A1A10056304]	Basin Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by Basin Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (No. 2015R1A2A1A10056304).	Akers TA, 2009, AM J PUBLIC HEALTH, V99, P397, DOI 10.2105/AJPH.2008.139808; Alves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077066; ANDERSON CA, 1984, J PERS SOC PSYCHOL, V46, P91, DOI 10.1037/0022-3514.46.1.91; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Casteel C, 2000, AM J PREV MED, V18, P99, DOI 10.1016/S0749-3797(00)00146-X; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chen P, 2008, FIFTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 5, PROCEEDINGS, P627, DOI 10.1109/FSKD.2008.222; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Poveda AC, 2012, J INT DEV, V24, P809, DOI 10.1002/jid.2819; Cozens PM, 2005, PROP MANAG, V23, P328, DOI 10.1108/02637470510631483; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003; Gorr W, 2003, INT J FORECASTING, V19, P579, DOI 10.1016/S0169-2070(03)00092-X; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hipp JR, 2004, SOC FORCES, V82, P1333, DOI 10.1353/sof.2004.0074; Hojman D., 2002, B LAT AM RES, V21, P121; Hojman DE, 2004, CRIME LAW SOCIAL CH, V41, P33, DOI 10.1023/B:CRIS.0000015327.30140.8d; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kelly M, 2000, REV ECON STAT, V82, P530, DOI 10.1162/003465300559028; Kianmehr K, 2006, I C COMP SYST APPLIC, P951; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lauritsen JL, 2014, J CONTEMP CRIM JUST, V30, P7, DOI 10.1177/1043986213509024; Levitt SD, 2001, J QUANT CRIMINOL, V17, P377, DOI 10.1023/A:1012541821386; Liu W, 2015, PROC CVPR IEEE, P3013, DOI 10.1109/CVPR.2015.7298920; Lu X, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P457, DOI 10.1145/2647868.2654927; McDowall D, 2012, J QUANT CRIMINOL, V28, P389, DOI 10.1007/s10940-011-9145-7; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Nelson AL, 2001, APPL GEOGR, V21, P249, DOI 10.1016/S0143-6228(01)00008-X; Ngiam J., 2011, P 28 INT C MACH LEAR, P689, DOI DOI 10.5555/3104482.3104569; Pereira DVS, 2016, J ENVIRON PSYCHOL, V46, P116, DOI 10.1016/j.jenvp.2016.04.006; Renjie Liao, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P1757, DOI 10.1109/ICMLC.2010.5580971; Rock DJ, 2008, INJURY, V39, P1047, DOI 10.1016/j.injury.2008.03.025; Salesses P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068400; Shingleton JS, 2012, CRIME TREND PREDICTI; Srivastava N, 2014, J MACH LEARN RES, V15, P2949; Wang P., 2010, INT C MANAGEMENT SER, P1, DOI DOI 10.1109/PES.2010.5588163; Wilson JQ, 1982, BROKEN WINDOWS CRITI, P395; Xinyu Chen, 2015, 2015 Systems and Information Engineering Design Symposium. proceedings, P63, DOI 10.1109/SIEDS.2015.7117012; Yan YY, 2000, PERCEPT MOTOR SKILL, V90, P451; Yu Zheng, 2015, IEEE Transactions on Big Data, V1, P16, DOI 10.1109/TBDATA.2015.2465959	41	90	91	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176244	10.1371/journal.pone.0176244	http://dx.doi.org/10.1371/journal.pone.0176244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437486	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600039
J	Ichinose, N; Yada, T; Wada, H				Ichinose, Natsuhiro; Yada, Tetsushi; Wada, Hiroshi			Estimating optimal sparseness of developmental gene networks using a semi-quantitative model	PLOS ONE			English	Article							SPECIFICATION; STABILITY	To estimate gene regulatory networks, it is important that we know the number of connections, or sparseness of the networks. It can be expected that the robustness to perturbations is one of the factors determining the sparseness. We reconstruct a semi-quantitative model of gene networks from gene expression data in embryonic development and detect the optimal sparseness against perturbations. The dense networks are robust to connection-removal perturbation, whereas the sparse networks are robust to misexpression perturbation. We show that there is an optimal sparseness that serves as a trade-off between these perturbations, in agreement with the optimal result of validation for testing data. These results suggest that the robustness to the two types of perturbations determines the sparseness of gene networks.	[Ichinose, Natsuhiro] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan; [Yada, Tetsushi] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Iizuka, Fukuoka, Japan; [Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Kyoto University; Kyushu Institute of Technology; University of Tsukuba	Ichinose, N (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan.	ichinose@i.kyoto-u.ac.jp			JSPS KAKENHI Grant [15KT0074]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15KT0074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hoyle NP, 2013, P NATL ACAD SCI USA, V110, pE4316, DOI 10.1073/pnas.1308811110; Ichinose N, 2008, J THEOR BIOL, V255, P378, DOI 10.1016/j.jtbi.2008.09.006; Ikemoto Y, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042705; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Oliveri P, 2003, DEV BIOL, V258, P32, DOI 10.1016/S0012-1606(03)00108-8; Osborne MR, 2000, J COMPUT GRAPH STAT, V9, P319, DOI 10.2307/1390657; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Peter IS, 2012, P NATL ACAD SCI USA, V109, P16434, DOI 10.1073/pnas.1207852109; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	17	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176492	10.1371/journal.pone.0176492	http://dx.doi.org/10.1371/journal.pone.0176492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430819	Green Published, gold			2022-12-27	WOS:000399876100046
J	Lee, SW; Liu, CW; Hu, JY; Chiang, LM; Chuu, CP; Wu, LSH; Kao, YH				Lee, Shih-Wei; Liu, Chi-Wei; Hu, Jia-Ying; Chiang, Li-Mei; Chuu, Chih-Pin; Wu, Lawrence Shih-Hsin; Kao, Yung-Hsi			Suppressors of cytokine signaling in tuberculosis	PLOS ONE			English	Article							GENE-EXPRESSION; CANDIDATE BIOMARKERS; DENDRITIC CELL; SOCS PROTEINS; ACTIVATION; INFLAMMATION; INFECTION	Tuberculosis (TB), a global disease mainly infected by Mycobacterium tuberculosis, remains leading public health problem worldwide. Suppressors of cytokine signaling (SOCSs) play important roles in the protection against microbial infection. However, the relationship between members of the SOCS family and tuberculosis infection remains unclear. Using peripheral blood mononuclear cells, we investigated the mRNA expression profiles of SOCS subfamilies among active TB, latent tuberculosis infection (LTBI), and healthy individuals. Our results showed that active tuberculosis subjects had higher levels of SOCS-3 mRNA, lower expressions of SOCS-2, -4, -5, -6, -7, and cytokine-inducible SH2-containing protein-1 (CIS-1) mRNAs, but not SOCS-1 mRNA than healthy and LTBI subjects. In men, LTBI patients had lower SOCS-3 than healthy subjects, and active TB patients had lower levels of SOCS-4, -5, and CIS-1 mRNAs but higher levels of SOCS-3 mRNA than healthy subjects. In women, LTBI patients had lower SOCS-3 mRNA level than healthy subjects, and active TB patients had lower CIS-1 mRNA level than healthy subjects. In non-aged adults (< 65 years old), TB patients had higher SOCS-3 mRNA and lower levels of SOCS-2, -4, -5, -6, -7, and CIS-1 mRNAs; whereas, aged TB patients (>= 65 years old) had lower levels of SOCS-5 and CIS-1 mRNAs. These data suggest that particular SOCS members and their correlative relationships allow discrimination of active TB from healthy and LTBI subjects.	[Lee, Shih-Wei; Chiang, Li-Mei; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Lee, Shih-Wei; Liu, Chi-Wei; Hu, Jia-Ying] Minist Hlth & Welf, Taoyuan Gen Hosp, Taoyuan, Taiwan; [Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Wu, Lawrence Shih-Hsin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	National Central University; National Health Research Institutes - Taiwan; Tzu Chi University	Kao, YH (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.; Wu, LSH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	lshwu@hotmail.com; ykao@cc.ncu.edu.tw	Chuu, Chih-Pin/N-6697-2019		Taoyuan General Hospital, Taiwan [PTH10227, PTH10310, PTH10327, PTH10419]; Ministry of Sciences and Technologies, Taiwan [MOST105-2311-B008-003]	Taoyuan General Hospital, Taiwan; Ministry of Sciences and Technologies, Taiwan	This study was supported in part by the Taoyuan General Hospital, Taiwan, Grants PTH10227, PTH10310, PTH10327 and PTH10419 to S.-W. Lee and by the Ministry of Sciences and Technologies, Taiwan, Grant MOST105-2311-B008-003 to Y.-H. Kao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboa L, 2016, INT J MED MICROBIOL, V306, P541, DOI 10.1016/j.ijmm.2016.06.004; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bibova I, 2012, DIAGN MICR INFEC DIS, V72, P68, DOI 10.1016/j.diagmicrobio.2011.09.024; Chang HH, 2012, GEN COMP ENDOCR, V178, P450, DOI 10.1016/j.ygcen.2012.06.024; Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; da Silva MV, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/639107; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Haan S., 2016, FRONT BIOSCI-LANDMRK, V8, P189, DOI DOI 10.2741/E760; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Bini EI, 2015, TUBERCULOSIS, V95, P701, DOI 10.1016/j.tube.2015.06.002; Bini EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093831; Jacobsen M, 2011, CLIN MICROBIOL INFEC, V17, P1323, DOI 10.1111/j.1469-0691.2010.03326.x; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kedzierski L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004134; Lee SW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0848-x; Linke A, 2010, J INVEST DERMATOL, V130, P866, DOI 10.1038/jid.2009.345; Masood KI, 2012, SCAND J IMMUNOL, V76, P398, DOI 10.1111/j.1365-3083.2012.02731.x; Masood KI, 2016, J MICROBIOL IMMUNOL, V49, P984, DOI 10.1016/j.jmii.2015.08.018; Masood KI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-13; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matthews J, 2005, BIOCHEM BIOPH RES CO, V335, P168, DOI 10.1016/j.bbrc.2005.07.057; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; Neuwirt H, 2007, ENDOCR-RELAT CANCER, V14, P1007, DOI 10.1677/ERC-07-0172; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092020; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Wu LSH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/895179; Yang CH, 2014, TAIWAN TUBERCULOSIS; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020	35	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176377	10.1371/journal.pone.0176377	http://dx.doi.org/10.1371/journal.pone.0176377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430824	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100041
J	Aitken, D; Hodgson, P; Cook, G; Lawson, A				Aitken, Dominic; Hodgson, Philip; Cook, Glenda; Lawson, Allison			Facework and trust in facilitating health-focused housing interventions	PLOS ONE			English	Article							PSYCHOSOCIAL BENEFITS; DATA SATURATION; HOME; COLD; WEST	The link between housing and health is of increasing importance in the UK policy and practice context, in which poor housing is often accepted as a social determinant of poor health. Service users' experiences of, and outcomes from, a British information, advice, support and guidance service focused on the relationship between housing problems and health issues were explored. This service facilitates home improvements for privately housed residents with housing issues exacerbating or causing health problems. In-depth interviews with occupants of 15 households which received the service were completed. The findings highlighted three key themes: the need for participants' person-home fit to reflect and adapt to any degeneration in health conditions; the facilitation of knowledge and access to housing and other support available to them; and perceived positive health and wellbeing outcomes from the receipt of personalised advice and support. The delivery of these outcomes by a named officer of the service team, and the relationship this developed with the service user, are considered within the context of facework, whereby they became a trusted source of guidance in navigating a complex system of assistance. These findings add to the growing knowledge base on housing and health, and also highlight the critical importance of a facework approach in allowing service users to navigate complex systems in order to achieve beneficial outcomes.	[Aitken, Dominic] Newcastle Univ, Sch Architecture Planning & Landscape, Newcastle Upon Tyne, Tyne & Wear, England; [Hodgson, Philip; Cook, Glenda; Lawson, Allison] Northumbria Univ, Dept Nursing Midwifery & Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Northumbria University	Hodgson, P (corresponding author), Northumbria Univ, Dept Nursing Midwifery & Hlth, Newcastle Upon Tyne, Tyne & Wear, England.	philip2.hodgson@northumbria.ac.uk		Hodgson, Philip/0000-0002-4364-6712	North Tyneside Council	North Tyneside Council	We would like to thank all of the participants of this study for giving up their time, as well as Robert Peach, Wendy Burke, Christine Jordan, Roy Marston and Eleanor Binks at North Tyneside Council for their support in completing this study.	ADASS [Association of Directors of Adult Social Services] ADPH [Association of Directors of Public Health] Care & Repair England CIEH [Chartered Institute of Environmental Health] CIH [Chartered Institute of Housing] DCLG [Department for Communities and Local Government] DH [Department of Health] FTN [Foundation Trust Network] Sitra, 2014, MEM UND MOU SUPP JOI; [Anonymous], 2006, ESSENTIALS NURSING R; Barnes M., 2013, DYNAMICS BAD HOUSING; Basham M., 2004, CENTRAL HEATING UNCO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Clark J, 2012, HOUSING STUD, V27, P915, DOI 10.1080/02673037.2012.725829; Cotter N, 2012, QUAL AGEING OLDER AD, V13, P38, DOI 10.1108/14717791211213607; Creswell JW, 2013, RES DESIGN QUALITATI; Curl A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2524-5; Dahlgren G, 2007, EUROPEAN STRATEGIES; Doran KM, 2013, NEW ENGL J MED, V369, P2374, DOI 10.1056/NEJMp1310121; Fitzpatrick-Lewis D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-638; Gibson M, 2011, HEALTH PLACE, V17, P175, DOI 10.1016/j.healthplace.2010.09.011; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Gilbertson J, 2006, SOC SCI MED, V63, P946, DOI 10.1016/j.socscimed.2006.02.021; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Harrington B, 2005, HLTH SOCIAL CARE COM, V13, P59; Howden-Chapman P, 2012, ENERG POLICY, V49, P134, DOI 10.1016/j.enpol.2011.09.044; Kearns A, 2000, HOUSING STUD, V15, P387, DOI 10.1080/02673030050009249; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Leng G, 2015, REPRESENTATION, V51, P485; Liddell C, 2010, ENERG POLICY, V38, P2987, DOI 10.1016/j.enpol.2010.01.037; Low LL, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00109; LUHMANN Niklas, 1979, TRUST POWER; Macintyre S, 2003, HEALTH PLACE, V9, P207, DOI 10.1016/S1353-8292(02)00040-0; Mallin CA, 2011, HANDBOOK ON INTERNATIONAL CORPORATE GOVERNANCE, P3; Marmot M, 2010, FAIR SOC HLTH LIVES; Maxwell J, 1997, HDB APPL SOCIAL RES; Nicol S., 2015, COST POOR HOUSING NH; Spurr H, 2016, INSIDE HOUSING; Thomson H., 2009, AM J PUBLIC HLTH S3, V99, pS681, DOI [DOI 10.2105/AJPH.2008.143909, 10.2105/AJPH.2008.143909]; Thomson H, 2015, SOC SCI MED, V124, P205, DOI 10.1016/j.socscimed.2014.11.043; Thomson H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008657.pub2	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176074	10.1371/journal.pone.0176074	http://dx.doi.org/10.1371/journal.pone.0176074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426836	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875900098
J	Cai, GS; Xiao, FF; Cheng, C; Li, YF; Amos, CI; Whitfield, ML				Cai, Guoshuai; Xiao, Feifei; Cheng, Chao; Li, Yafang; Amos, Christopher I.; Whitfield, Michael L.			Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients	PLOS ONE			English	Article							RNA-SEQ; CANCER CELLS; OVEREXPRESSION; SMOKING; PROFILE; RISK	Background We analyzed and integrated transcriptome data from two large studies of lung adenocarcinomas on distinct populations. Our goal was to investigate the variable gene expression alterations between paired tumor-normal tissues and prospectively identify those alterations that can reliably predict lung disease related outcomes across populations. Methods We developed a mixed model that combined the paired tumor-normal RNA-seq from two populations. Alterations in gene expression common to both populations were detected and validated in two independent DNA microarray datasets. A 10-gene prognosis signature was developed through a /1 penalized regression approach and its prognostic value was evaluated in a third independent microarray cohort. Results Deregulation of apoptosis pathways and increased expression of cell cycle pathways were identified in tumors of both Caucasian and Asian lung adenocarcinoma patients. We demonstrate that a 10-gene biomarker panel can predict prognosis of lung adenocarcinoma in both Caucasians and Asians. Compared to low risk groups, high risk groups showed significantly shorter overall survival time (Caucasian patients data: HR = 3.63, p-value = 0.007; Asian patients data: HR = 3.25, p-value = 0.001). Conclusions This study uses a statistical framework to detect DEGs between paired tumor and normal tissues that considers variances among patients and ethnicities, which will aid in understanding the common genes and signalling pathways with the largest effect sizes in ethnically diverse cohorts. We propose multifunctional markers for distinguishing tumor from normal tissue and prognosis for both populations studied.	[Cai, Guoshuai; Cheng, Chao; Whitfield, Michael L.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA; [Xiao, Feifei] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Cheng, Chao; Li, Yafang; Amos, Christopher I.] Dartmouth Coll, Dept Biomed Data Sci, Hanover, NH 03755 USA	Dartmouth College; University of South Carolina System; University of South Carolina Columbia; Dartmouth College	Whitfield, ML (corresponding author), Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA.; Amos, CI (corresponding author), Dartmouth Coll, Dept Biomed Data Sci, Hanover, NH 03755 USA.	Christopher.I.Amos@dartmouth.edu; Michael.L.Whitfield@dartmouth.edu	Xiao, Feifei/AAD-9539-2021; Whitfield, Michael/AAC-5010-2020; Cai, Guoshuai/AAD-9620-2021		NIH [P30B02101, U19CA148127, P30CA023108]; Dr. Ralph and Marian Falk Medical Research Trust Award [P01304]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant (P30B02101 to M L. Whitfield, U19CA148127 and P30CA023108 to C I. Amos) and the Dr. Ralph and Marian Falk Medical Research Trust Award (P01304 to M L. Whitfield).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arinaga M, 2003, ONCOL REP, V10, P1381; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Chanvorachote P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057466; Chen L, 2013, MOL MED REP, V7, P1477, DOI 10.3892/mmr.2013.1351; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Glorieux C, 2011, BIOCHEM PHARMACOL, V82, P1384, DOI 10.1016/j.bcp.2011.06.007; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jing LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097522; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee SY, 2012, J CLIN INVEST, V122, P3211, DOI 10.1172/JCI60498; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Luo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020971; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Peters S, 2013, J CLIN ONCOL, V31, pE341, DOI 10.1200/JCO.2012.47.6143; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wood K, 2016, JAMA ONCOL, V2, P805, DOI 10.1001/jamaoncol.2016.0405; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012; Zhou XS, 2015, ONCOTARGET, V6, P9271, DOI 10.18632/oncotarget.3375	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175850	10.1371/journal.pone.0175850	http://dx.doi.org/10.1371/journal.pone.0175850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426704	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900057
J	Dai, CS; Zhao, TT; Yang, X; Xiao, XL; Velkov, T; Tang, SS				Dai, Chongshan; Zhao, Tingting; Yang, Xing; Xiao, Xilong; Velkov, Tony; Tang, Shusheng			Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PENICILLIN-RESISTANT; ESCHERICHIA-COLI; RESIDUES; ANIMALS; SYNERGY; PIGLETS; DISEASE; TRACT; FEED	A new compound granular premix of amoxicillin (20% w/w dry mass)/apramycin (5% w/w dry mass) was developed, and its pharmacokinetics and relative bioavailability were determined in pigs following oral administration following a cross-over study design. The pharmacokinetic parameters of amoxicillin (t(1/2 lambda) = 6.43 +/- 4.85h, C-max = 3.2 +/- 1.35 mu g.mL(-1), T-max = 1.92 +/- 0.58, AUC(INF) = 8.98 +/- 2.11 h.mu g.mL(-1)) and apramycin (t(1/2 lambda) = 8.67 +/- 4.4h, C-max = 0.23 +/- 0.12 mu g.mL(-1), T-max = 2.25 +/- 0.82 h, AUC(INF) = 12.37 +/- 8.64h.mu g.mL(-1)) when administered as the amoxicillin-apramycin granular premix did not significantly differ from those for the single-ingredient powder form of each component. The relative bioavailability of amoxicillin following oral administration of the amoxicillin-apramycin granular premix was 22.62% when compared to the intramuscular administration of commercial amoxicillin sodium-powder. This is the first report of a new amoxicillin-apramycin combination which has a potential veterinary application the for prevention and treatment digestive tract infections in pigs.	[Dai, Chongshan; Zhao, Tingting; Yang, Xing; Xiao, Xilong; Tang, Shusheng] China Agr Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Beijing, Peoples R China; [Velkov, Tony] Monash Univ, Monash Inst Pharmaceut Sci, Dept Drug Delivery Disposit & Dynam, Clayton, Vic, Australia	China Agricultural University; Monash University	Tang, SS (corresponding author), China Agr Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Beijing, Peoples R China.; Velkov, T (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Drug Delivery Disposit & Dynam, Clayton, Vic, Australia.	Tony.velkov@monash.edu; tssfj@cau.edu.cn	Dai, Chongshan/AAH-6185-2020	Dai, Chongshan/0000-0002-4677-0524; velkov, tony/0000-0002-0017-7952; Tang, Shusheng/0000-0003-1860-3582	Key Projects in the National Science and Technology Pillar Program [2015BAD11B03]	Key Projects in the National Science and Technology Pillar Program	This study was supported by Key Projects in the National Science and Technology Pillar Program during the 12th Five-year Plan Period (2015BAD11B03). TV is a National Health and Medical Research Council of Australia (NHMRC) CDA2 Industry Fellow.	Afifi NA, 1997, RES VET SCI, V62, P249, DOI 10.1016/S0034-5288(97)90199-5; Agerso H, 1998, J VET PHARMACOL THER, V21, P41, DOI 10.1046/j.1365-2885.1998.00107.x; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Anfossi P, 2002, J VET PHARMACOL THER, V25, P329, DOI 10.1046/j.1365-2885.2002.00428.x; Bergamaschi CDC, 2006, INT J ANTIMICROB AG, V27, P417, DOI 10.1016/j.ijantimicag.2006.02.005; (CCVP) CoCVP, 2010, APP CHIN VET PHARM; DarrasJoly C, 1996, ANTIMICROB AGENTS CH, V40, P2147, DOI 10.1128/AAC.40.9.2147; Desbiolles N, 2001, ANTIMICROB AGENTS CH, V45, P3328, DOI 10.1128/AAC.45.12.3328-3333.2001; Godoy C, 2011, J VET PHARMACOL THER, V34, P265, DOI 10.1111/j.1365-2885.2010.01220.x; He J, 2011, J VET PHARMACOL THER, V34, P42, DOI 10.1111/j.1365-2885.2010.01191.x; Hernandez E, 2005, VET J, V170, P237, DOI 10.1016/j.tvjl.2004.06.003; Jacobson M, 2003, RES VET SCI, V74, P163, DOI 10.1016/S0034-5288(02)00187-X; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Lees P, 2002, INT J ANTIMICROB AG, V19, P269, DOI 10.1016/S0924-8579(02)00025-0; Leitner G, 2001, VET QUART, V23, P62, DOI 10.1080/01652176.2001.9695083; Lennernas H, 2002, EUR J PHARM SCI, V15, P271, DOI 10.1016/S0928-0987(02)00005-2; Lombo LH, 2004, J NANJING MED U, V18, P105; Martinez-Larranaga MR, 2004, VET REC, V154, P627, DOI 10.1136/vr.154.20.627; Mathew AG, 2005, FOODBORNE PATHOG DIS, V2, P212, DOI 10.1089/fpd.2005.2.212; Meyer M, 2014, ANTIMICROB AGENTS CH, V58, P6938, DOI 10.1128/AAC.03239-14; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Papich MG, 2014, AM J VET RES, V75, P316, DOI 10.2460/ajvr.75.4.316; Schwarz S, 2008, VET MICROBIOL, V126, P178, DOI 10.1016/j.vetmic.2007.06.023; Shang RuoFeng, 2004, Chinese Journal of Veterinary Medicine, V40, P3; Soliman AM, 2013, J VET SCI, V14, P395, DOI 10.4142/jvs.2013.14.4.395; Wang X, 2010, CHINA ANIMAL HUSBAND, V37, P186; Zemanova M, 2008, ACTA VET BRNO, V77, P341, DOI 10.2754/avb200877030341; Zhanel GG, 2006, ANTIMICROB AGENTS CH, V50, P2228, DOI 10.1128/AAC.01620-05; 姚浪群, 2003, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V34, P250	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176149	10.1371/journal.pone.0176149	http://dx.doi.org/10.1371/journal.pone.0176149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426744	gold, Green Published			2022-12-27	WOS:000399875900108
J	Davidson, J; McDonald, T; Sutherland, C; Mostazirm, M; VanAalten, L; Wilkint, T				Davidson, Jane; McDonald, Timothy; Sutherland, Calum; Mostazirm, Mohammod; VanAalten, Lidy; Wilkint, Terence			Proinsulin is stable at room temperature for 24 hours in EDTA: A clinical laboratory analysis (adAPT 3)	PLOS ONE			English	Article								Aims Reference laboratories advise immediate separation and freezing of samples for the assay of proinsulin, which limit its practicability for smaller centres. Following the demonstration that insulin and C-peptide are stable in EDTA at room temperature for at least 24hours, we undertook simple stability studies to establish whether the same might apply to proinsulin. Methods Venous blood samples were drawn from six adult women, some fasting, some not, aliquoted and assayed immediately and after storage at either 4 degrees C or ambient temperature for periods from 2h to 24h. Results There was no significant variation or difference with storage time or storage condition in either individual or group analysis. Conclusion Proinsulin appears to be stable at room temperature in EDTA for at least 24h. Immediate separation and storage on ice of samples for proinsulin assay is not necessary, which will simplify sample transport, particularly for multicentre trials.	[Davidson, Jane; Sutherland, Calum; VanAalten, Lidy] Univ Dundee, Cardiovasc & Diabet Med, Dundee, Scotland; [McDonald, Timothy] Royal Devon & Exeter NHS Fdn Trust, NIHR Clin Res Facil, Blood Sci, Exeter, Devon, England; [Mostazirm, Mohammod; Wilkint, Terence] Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon, England; [Mostazirm, Mohammod] Univ Exeter, CLES, Exeter, Devon, England	University of Dundee; University of Exeter; University of Exeter; University of Exeter	McDonald, T (corresponding author), Royal Devon & Exeter NHS Fdn Trust, NIHR Clin Res Facil, Blood Sci, Exeter, Devon, England.	timothy.mcdonald@nhs.net		Sutherland, Calum/0000-0003-4398-7434; Mostazir, Mohammod/0000-0002-8657-515X; McDonald, Timothy James/0000-0003-3559-6660	Juvenile Diabetes Research Foundation [1-SRA-2014-54-M-A]; Tayside Clinical Trials Unit (TCTU)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Tayside Clinical Trials Unit (TCTU)	This work was supported by Juvenile Diabetes Research Foundation grant #1-SRA-2014-54-M-A, https://jdrf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our thanks to the members of the Tayside Clinical Trials Unit (TCTU), who supported this study, and to the volunteers whose blood samples were used. Terence Wilkin passed away before the submission of the final version of this manuscript. Timothy McDonald accepts responsibility for the integrity and validity of the data collected and analysed.	KITABCHI AE, 1977, METABOLISM, V26, P547, DOI 10.1016/0026-0495(77)90099-3; McDonald TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042084; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682	4	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0171716	10.1371/journal.pone.0171716	http://dx.doi.org/10.1371/journal.pone.0171716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426711	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900001
J	Kadota, Y; Toriuchi, Y; Aki, Y; Mizuno, Y; Kawakami, T; Nakaya, T; Sato, M; Suzuki, S				Kadota, Yoshito; Toriuchi, Yuriko; Aki, Yuka; Mizuno, Yuto; Kawakami, Takashige; Nakaya, Tomoko; Sato, Masao; Suzuki, Shinya			Metallothioneins regulate the adipogenic differentiation of 3T3-L1 cells via the insulin signaling pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXYGEN-FREE-RADICALS; ADIPOCYTE DIFFERENTIATION; MOLECULAR REGULATION; CLONAL EXPANSION; NULL MICE; OBESITY; GENES; EXPRESSION; PREADIPOCYTES	Knockout of metallothionein (MT) genes contributes to a heavier body weight in early life and the potential to become obese through the intake of a high fat diet (HFD) in mice. It has thus been suggested that MT genes regulate the formation of adipose tissue, which would become the base for later HFD-induced obesity. We evaluated the fat pads of mice during the lactation stage. The fat mass and adipocyte size of MT1 and MT2 knockout mice were greater than those of wild type mice. Next, we assayed the ability of small interfering RNA (siRNA) to silence MT genes in the 3T3-L1 cell line. The expressions of MT1 and MT2 genes were transiently upregulated during adipocyte differentiation, and the siRNA pretreatment led to the suppression of the expression of both MT mRNAs and proteins. The MT siRNA promoted lipid accumulation in adipocytes and caused proliferation of post-confluent preadipocytes; these effects were suppressed by an inhibitor of phosphatidylinositol 3-kinase (LY294002). In addition, MT siRNA promoted insulin-stimulated phosphorylation of Akt, a downstream kinase of the insulin signaling pathway. Enhanced lipid accumulation in 3T3-L1 cells resulting from MT-gene silencing was inhibited by pretreatment with an antioxidant, N-acetylcysteine, used as a substitute for antioxidant protein MTs. These results suggest that interference in MT expression enhanced the activation of the insulin signaling pathway, resulting in higher lipid accumulation in 3T3-L1 adipocytes.	[Kadota, Yoshito; Toriuchi, Yuriko; Aki, Yuka; Mizuno, Yuto; Kawakami, Takashige; Nakaya, Tomoko; Sato, Masao; Suzuki, Shinya] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan	Tokushima Bunri University	Kadota, Y (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan.	ykadota@ph.bunri-u.ac.jp		Kadota, Yoshito/0000-0002-2721-4100	Japan Society for the Promotion of Science (JSPS) KAKENHI [24790133]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 24790133 awarded to Yoshito Kadota. URL: https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Barraco GM, 2014, INT J MOL SCI, V15, P19760, DOI 10.3390/ijms151119760; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Byun HR, 2011, NEUROBIOL DIS, V44, P125, DOI 10.1016/j.nbd.2011.06.012; Cappellini A, 2003, LEUKEMIA, V17, P2157, DOI 10.1038/sj.leu.2403111; Chen SQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137583; Cousins R J, 1987, Experientia Suppl, V52, P545; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fu J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-462; Giacconi R, 2005, BIOGERONTOLOGY, V6, P407, DOI 10.1007/s10522-005-4907-y; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Haynes V, 2013, MOL GENET METAB, V108, P90, DOI 10.1016/j.ymgme.2012.10.012; Kadota Y, 2015, EXP GERONTOL, V66, P21, DOI 10.1016/j.exger.2015.04.007; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lindeque JZ, 2015, OMICS, V19, P92, DOI 10.1089/omi.2014.0087; Luo KQ, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0044-3; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Mitterberger MC, 2013, J GERONTOL A-BIOL, V68, P1356, DOI 10.1093/gerona/glt019; Mocchegiani E, 2013, CURR PHARM DESIGN, V19, P1753; Nakanishi A, 2014, AGING DIS, V5, P203, DOI 10.14336/AD.2014.0500203; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Raudenska M, 2014, METALLOMICS, V6, P55, DOI 10.1039/c3mt00132f; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Sato M, 2013, CURR PHARM BIOTECHNO, V14, P9; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Schmidt C, 1999, ARCH BIOCHEM BIOPHYS, V364, P91, DOI 10.1006/abbi.1999.1107; STENNARD FA, 1994, BBA-GENE STRUCT EXPR, V1218, P357, DOI 10.1016/0167-4781(94)90189-9; Summermatter S, 2016, MOL CELL BIOL; Swindell WR, 2011, AGEING RES REV, V10, P132, DOI 10.1016/j.arr.2010.09.007; Szrok S, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0533-3; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; Trayhurn P, HORM METAB RES HORM, V32, P542; Wu H, 2015, TOXICOL LETT, V232, P340, DOI 10.1016/j.toxlet.2014.11.015; Yang L, 2015, FREE RADICAL RES, V49, P1187, DOI 10.3109/10715762.2015.1013952; Yang L, 2008, AM J PHYSIOL-ENDOC M, V294, pE987, DOI 10.1152/ajpendo.90234.2008; Zhang T, 2016, ENDOCRINE; Zhou SS, 2014, TOXICOL LETT, V227, P113, DOI 10.1016/j.toxlet.2014.03.011	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176070	10.1371/journal.pone.0176070	http://dx.doi.org/10.1371/journal.pone.0176070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426713	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900096
J	Svensson, T; Kitlinski, M; Engstrom, G; Melander, O				Svensson, Thomas; Kitlinski, Mariusz; Engstrom, Gunnar; Melander, Olle			A genetic risk score for CAD, psychological stress, and their interaction as predictors of CAD, fatal MI, non-fatal MI and cardiovascular death	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MENTAL STRESS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL FACTORS; PERCEIVED STRESS; JOB STRAIN; ASSOCIATION; VARIANTS; CHOLESTEROL; MORTALITY	Background Psychological stress is an independent risk factor for cardiovascular disease (CVD), but the mechanism by which stress is associated with CVD is not entirely understood. Although genetic factors are implied in both stress responsivity and cardiovascular reactivity, no studies to date have investigated their interactions with stress for cardiovascular end points. The objective was to elucidate the association and interactions between a genetic risk score (GRS), individual genetic variants and stress for three cardiovascular end points: coronary artery disease (CAD), fatal myocardial infarction (MI), non-fatal MI, and cardiovascular death. Methods and findings 18,559 participants from the Malmo Diet Cancer Study, a population-based prospective study, were included in the analyses. Cox proportional hazards regression models were used and adjusted for a large number of known predictors of cardiovascular end points. Mean follow-up time in years was 14.6 (CAD; n = 1938), 14.8 (fatal MI; n = 436), 14.8 (non-fatal MI; n = 1108), and 15.1 (cardiovascular death; n = 1071) respectively. GRS was significantly associated with increased risks of CAD (top quartile hazard ratio [HR], 1.72; 95% confidence interval [CI], 1.51-1.96), fatal MI (top quartile HR, 1.62; 95% CI, 1.23-2.15), non-fatal MI (top quartile HR, 1.55; 95% CI, 1.31-1.84), and cardiovascular death (top quartile HR, 1.29; 95% CI, 1.08-1.53). Stress was not independently associated with any end point and did not interact with GRS. Four individual genetic variants interacted unfavorably with stress for end points with mortality outcomes. Conclusion A GRS composed of 50 SNPs and predictive of CAD was found for the first time to also strongly predict fatal MI, non-fatal MI and cardiovascular death. A stress-sensitive component of the GRS was isolated on the basis of individual genetic variants that interacted unfavorably with stress.	[Svensson, Thomas; Kitlinski, Mariusz; Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Svensson, Thomas] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Svensson, Thomas] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Keio, Japan; [Kitlinski, Mariusz] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; University of Tokyo; Keio University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Svensson, T (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.; Svensson, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.; Svensson, T (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Keio, Japan.	thomas.svensson@med.lu.se	Svensson, Thomas/AAJ-4578-2020	Svensson, Thomas/0000-0003-1283-358X; Melander, Olle/0000-0002-2581-484X	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Novo Nordisk Foundation; Skane University Hospital; Medical Faculty; Lund University; clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustav V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden [NNF14OC0009819, NNF13OC0005339, NNF17OC0026936] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Skane University Hospital; Medical Faculty; Lund University; clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustav V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the European Research Council (StG-282255), the Swedish Heart and Lung Foundation, Swedish Research Council; the Novo Nordisk Foundation, the Skane University Hospital donation funds; the Medical Faculty, Lund University; the Governmental funding of clinical research within the national health services, the Albert Pahlsson Research Foundation, Region Skane, the King Gustav V and Queen Victoria Foundation and the Marianne and Marcus Wallenberg Foundation. Genotyping of the GRS SNPs in the MDC study was performed at the Quest Diagnostics Science and Innovation genotyping facility in Alameda, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; De Geus EJC, 2007, PSYCHOSOM MED, V69, P356, DOI 10.1097/PSY.0b013e318049cc2d; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Fujimaki T, 2015, BIOMED REP, V3, P118, DOI 10.3892/br.2014.371; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Jain S, 2007, PSYCHOPHYSIOLOGY, V44, P154, DOI 10.1111/j.1469-8986.2006.00480.x; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kashani M, 2012, STRESS, V15, P45, DOI 10.3109/10253890.2011.578266; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; MOBERG E, 1994, DIABETOLOGIA, V37, P247; Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005; National Board of Health and Welfare, 2000, EV DIAGN QUAL AC MYO; Ollila HM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.20; Ozaki K, 2016, J HUM GENET, V61, P71, DOI 10.1038/jhg.2015.70; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosvall M, 2002, INT J EPIDEMIOL, V31, P1169, DOI 10.1093/ije/31.6.1169; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Statistics sweden, 2007, 19824 MIS STAT SWED; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Strike PC, 2006, P NATL ACAD SCI USA, V103, P4322, DOI 10.1073/pnas.0507097103; Svensson T, 2016, EUR HEART J, V37, P890, DOI 10.1093/eurheartj/ehv724; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932; World Health Organization, 2010, GLOBAL STATUS REPORT; Wu T, 2010, NEUROSCI BIOBEHAV R, V35, P58, DOI 10.1016/j.neubiorev.2009.12.001; Zgraggen L, 2005, THROMB RES, V115, P175, DOI 10.1016/j.thromres.2004.08.022	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176029	10.1371/journal.pone.0176029	http://dx.doi.org/10.1371/journal.pone.0176029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426714	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900089
J	Huang, SH; Zhu, ZD; Zhang, W; Chen, Y; Zhen, SJ				Huang, Shihua; Zhu, Zude; Zhang, Wei; Chen, Yu; Zhen, Shuangju			Trait impulsivity components correlate differently with proactive and reactive control	PLOS ONE			English	Article							INFERIOR FRONTAL-CORTEX; COGNITIVE-CONTROL; RESPONSE-INHIBITION; PREFRONTAL CORTEX; WORKING-MEMORY; INTERFERENCE RESOLUTION; NEURAL MECHANISMS; TASK; FMRI; PERFORMANCE	The relationship between impulsivity and cognitive control is still unknown. We hypothesized that trait impulsivity would differentially correlate with specific cognitive control processes. Trait impulsivity was measured by the Barratt Impulsiveness Scale, which assesses motor, attention, and non-planning impulsiveness components. Cognitive control was measured by a hybrid-designed Stroop task, which distinguishes proactive and reactive control. Thirtythree participants performed the Stroop task while they were scanned by functional magnetic resonance imaging. Proactive and reactive control involved increased activity in the fronto-parietal network, and brain activity was associated with impulsivity scores. Specifically, higher motor impulsiveness was associated with a larger proactive control effect in the inferior parietal lobule and a smaller reactive control effect in the right dorsolateral prefrontal cortex (DLPFC) and anterior cingulate contex. Higher attention impulsivity was associated with a smaller proactive control effect in the right DLPFC. Such a correlation pattern suggests that impulsivity trait components are attributable to different cognitive control subsystems.	[Huang, Shihua; Zhang, Wei; Chen, Yu; Zhen, Shuangju] South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Huang, Shihua; Zhang, Wei; Chen, Yu; Zhen, Shuangju] South China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China; [Huang, Shihua] Guangzhou Univ Chinese Med, Sch Econ & Management, Guangzhou, Guangdong, Peoples R China; [Zhu, Zude] Jiangsu Normal Univ, Sch Linguist & Arts, Xuzhou, Peoples R China; [Zhu, Zude] Jiangsu Normal Univ, Collaborat Innovat Ctr Language Competence, Xuzhou, Peoples R China	South China Normal University; South China Normal University; Guangzhou University of Chinese Medicine; Jiangsu Normal University; Jiangsu Normal University	Zhang, W (corresponding author), South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.; Zhang, W (corresponding author), South China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.; Zhu, ZD (corresponding author), Jiangsu Normal Univ, Sch Linguist & Arts, Xuzhou, Peoples R China.; Zhu, ZD (corresponding author), Jiangsu Normal Univ, Collaborat Innovat Ctr Language Competence, Xuzhou, Peoples R China.	zhuzude@163.com; zhangwei@scnu.edu.cn	Chen, Yu/AAV-6158-2021	Chen, Yu/0000-0003-4946-4693	Natural Science Foundation of China [NSF 81671154, NSF 31571156]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [14YJC190007, 12YJC190040]; Scientific Research Foundation of Graduate School of South China Normal University [2012kyjj107]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [2012WYM_0041]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE (Ministry of Education in China) Project of Humanities and Social Sciences; Scientific Research Foundation of Graduate School of South China Normal University; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China	This work was supported by grants from the the Natural Science Foundation of China (NSF 81671154), Natural Science Foundation of China (NSF 31571156), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (14YJC190007), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (12YJC190040), the Scientific Research Foundation of Graduate School of South China Normal University (2012kyjj107), and Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (2012WYM_0041).	Andrews-Hanna JR, 2011, PLOS ONE, V6, P672; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Dalley J, 2001, NEURON, V69, P680; Ding WN, 2003, BEHAV BRAIN FUNCT, V10, P1; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Fassbender C, 2014, COGN AFFECT BEHAV NE, V14, P175, DOI 10.3758/s13415-014-0252-4; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gorlyn M, 2005, PERS INDIV DIFFER, V38, P1549, DOI 10.1016/j.paid.2004.09.014; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Huang S, 2013, NEUROIMAGE, V83, P1098, DOI 10.1016/j.neuroimage.2013.07.074; Hughes ME, 2014, EUR J NEUROSCI, V39, P1363, DOI 10.1111/ejn.12497; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kam JWY, 2012, INT J PSYCHOPHYSIOL, V85, P174, DOI 10.1016/j.ijpsycho.2012.05.006; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Karabanov A, 2010, NEUROSCI RES, V72, P59; Keilp JG, 2005, PSYCHIAT RES, V135, P191, DOI 10.1016/j.psychres.2005.03.006; Lawrence AJ, 2009, PSYCHOPHARMACOLOGY, V207, P163, DOI 10.1007/s00213-009-1645-x; Lesh TA, 2013, NEUROIMAGE-CLIN, V2, P590, DOI 10.1016/j.nicl.2013.04.010; Leshem R, 2016, COGN PROCESS, V17, P89, DOI 10.1007/s10339-015-0733-6; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Li CSR, 2005, J PSYCHIATR RES, V39, P197, DOI 10.1016/j.jpsychires.2004.06.003; [李献云 LI XianYun], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P610; Luijten M, 2015, PSYCHIAT RES-NEUROIM, V231, P262, DOI 10.1016/j.pscychresns.2015.01.004; Morein-Zamir S, 2014, HUM BRAIN MAPP, V35, P5141, DOI 10.1002/hbm.22539; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pietrzak RH, 2008, J RES PERS, V42, P1347, DOI 10.1016/j.jrp.2008.03.004; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Reise SP, 2013, PSYCHOL ASSESSMENT, V25, P631, DOI 10.1037/a0032161; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067391; Schmidt A, 2013, NEUROPSYCHOPHARMACOL, V38, P2231, DOI 10.1038/npp.2013.123; Sebastian A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00698; Shen ZH, 2016, ZHEJIANG PREVENTIVE, V28, P368; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Spinella M, 2004, INT J NEUROSCI, V114, P95, DOI 10.1080/00207450490249347; van der Laan LN, 2016, BEHAV BRAIN RES, V296, P442, DOI 10.1016/j.bbr.2015.09.026; Wilbertz T, 2014, NEUROIMAGE, V103, P241, DOI 10.1016/j.neuroimage.2014.09.021; [徐雷 Xu Lei], 2012, [心理科学进展, Advances in Psychological Science], V20, P1012; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Yi YJ, 2011, BRAIN RES, V1411, P41, DOI 10.1016/j.brainres.2011.07.004; Yi YJ, 2009, COGN AFFECT BEHAV NE, V9, P249, DOI 10.3758/CABN.9.3.249; Zhang JX, 2010, NEUROPSYCHOLOGIA, V48, P2167, DOI 10.1016/j.neuropsychologia.2010.04.008; [周亮 ZHOU Liang], 2006, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V14, P343	51	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176102	10.1371/journal.pone.0176102	http://dx.doi.org/10.1371/journal.pone.0176102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423021	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600087
J	Lytle, KA; Wong, CP; Jump, DB				Lytle, Kelli A.; Wong, Carmen P.; Jump, Donald B.			Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr(-/-) mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TOLL-LIKE RECEPTORS; AMERICAN ASSOCIATION; HEPATIC INFLAMMATION; PRACTICE GUIDELINE; METABOLIC SYNDROME; NATURAL-HISTORY; GENE-EXPRESSION; WEIGHT-LOSS; N-3	Background Nonalcoholic fatty liver disease (NAFLD) is a major public health concern in western societies. Nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, is characterized by hepatic steatosis, inflammation, oxidative stress and fibrosis. NASH is a risk factor for cirrhosis and hepatocellular carcinoma. NASH is predicted to be the leading cause of liver transplants by 2020. Despite this growing public health concern, there remain no Food and Drug Administration (FDA) approved NASH treatments. Using Ldlr(-/-) mice as a preclinical model of western diet (WD)-induced NASH, we previously established that dietary supplementation with docosahexaenoic acid (DHA, 22:6,omega 3) attenuated WD-induced NASH in a prevention study. Herein, we evaluated the capacity of DHA supplementation of the WD and a low fat diet to fully reverse NASH in mice with pre-existing disease. Methods Ldlr(-/-) mice fed the WD for 22 wks developed metabolic syndrome (MetS) and a severe NASH phenotype, including obesity, dyslipidemia, hyperglycemia, hepatic steatosis, inflammation, fibrosis and low hepatic polyunsaturated fatty acid (PUFA) content. These mice were randomized to 5 groups: a baseline group (WDB, sacrificed at 22 wks) and 4 treatments: 1) WD + olive oil (WDO); 2) WD + DHA (WDD); 3) returned to chow + olive oil (WDChO); or 4) returned to chow + DHA (WDChD). The four treatment groups were maintained on their respective diets for 8 wks. An additional group was maintained on standard laboratory chow (Reference Diet, RD) for the 30-wk duration of the study. Results When compared to the WDB group, the WDO group displayed increased hepatic expression of genes linked to inflammation (Opn, Il1rn, Gdf15), hepatic fibrosis (collagen staining, Col1A1, Thbs2, Lox) reflecting disease progression. Mice in the WDD group, in contrast, had increased hepatic C20-22 omega 3 PUFA and no evidence of NASH progression. MetS and NASH markers in the WDChO or WDChD groups were significantly attenuated and marginally different from the RD group, reflecting disease remission. Conclusion While these studies establish that DHA supplementation of the WD blocks WD-induced NASH progression, DHA alone does not promote full remission of diet-induced MetS or NASH.	[Lytle, Kelli A.; Wong, Carmen P.; Jump, Donald B.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA; [Lytle, Kelli A.; Wong, Carmen P.; Jump, Donald B.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Lytle, Kelli A.] Mayo Clin, Endocrine Res Unit, Rochester, MN USA	Oregon State University; Oregon State University; Mayo Clinic	Jump, DB (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR 97331 USA.; Jump, DB (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.	Donald.Jump@oregonstate.edu			USDA; National Institute of Food and Agriculture Grant [2009-65200-05846]; National Institutes of Health [DK 094600]	USDA(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the USDA, National Institute of Food and Agriculture Grant (2009-65200-05846) and the National Institutes of Health (DK 094600). The funders had no role in the study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Arendt BM, 2015, HEPATOLOGY, V61, P1565, DOI 10.1002/hep.27695; Arendt BM, 2009, J NUTR, V139, P691, DOI 10.3945/jn.108.101782; Argo CK, 2015, J HEPATOL, V62, P190, DOI 10.1016/j.jhep.2014.08.036; Arrizazu E, 2016, GUT; Barter P, 2008, AM J CARDIOL, V102, P1040, DOI 10.1016/j.amjcard.2008.05.056; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Bulchandani DG, 2010, EUR J GASTROEN HEPAT, V22, P1245, DOI 10.1097/MEG.0b013e32833b257a; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chan HLY, 2007, J GASTROEN HEPATOL, V22, P801, DOI 10.1111/j.1440-1746.2007.04977.x; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Da Silva HE, 2014, J ACAD NUTR DIET, V114, P1181, DOI 10.1016/j.jand.2014.01.009; Depner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083756; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Di Minno MND, 2012, WORLD J GASTROENTERO, V18, P5839, DOI 10.3748/wjg.v18.i41.5839; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Duarte-Salles T, 2016, CANC PREV R IN PRESS; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ferolla SM, 2015, WORLD J HEPATOL, V7, P2522, DOI 10.4254/wjh.v7.i24.2522; Glass LM, 2015, DIGEST DIS SCI, V60, P1024, DOI 10.1007/s10620-014-3380-3; Herrera B, 2014, INT J MOL SCI, V15, P5199, DOI 10.3390/ijms15045199; Ishikawa Y, 2010, CIRC J, V74, P1451, DOI 10.1253/circj.CJ-09-0520; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99, DOI 10.5551/jat.5876; Itoh N, 2016, FRONT CELL DEV BIOL, V4, P1, DOI DOI 10.3389/FCELL.2016.00110; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Jump DB, 2016, P NUTR SOC, V75, P1, DOI 10.1017/S002966511500244X; Jump DB, 2015, ADV NUTR, V6, P694, DOI 10.3945/an.115.009423; Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kappler R., 2015, LIFE SCI VC; Kishino T, 2011, CLIN CHEM LAB MED, V49, P159, DOI 10.1515/CCLM.2011.020; Kwon H, 2016, HEPATOLOGY, V63, P1155, DOI 10.1002/hep.28289; Lee JY, 2010, NUTR REV, V68, P38, DOI 10.1111/j.1753-4887.2009.00259.x; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Leslie M, 2015, SCIENCE, V349, P18, DOI 10.1126/science.347.6217.18; LIBBY P, 1986, AM J PATHOL, V124, P179; Liu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127518; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Lytle KA, 2015, J LIPID RES, V56, P1936, DOI 10.1194/jlr.M061275; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Malhotra N, 2015, WORLD J HEPATOL, V7, P2962, DOI 10.4254/wjh.v7.i30.2962; Marchesini G, 2015, J HEPATOL, V62, P15, DOI 10.1016/j.jhep.2014.10.023; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Nagoshi S, 2014, HEPATOL RES, V44, P22, DOI 10.1111/hepr.12166; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Pagliassotti MJ, 1996, AM J PHYSIOL-REG I, V271, pR1319, DOI 10.1152/ajpregu.1996.271.5.R1319; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Petit JM, 2012, CLIN NUTR, V31, P520, DOI 10.1016/j.clnu.2011.12.007; Phillips RJ, 2012, WORLD J GASTROENTERO, V18, P3389, DOI 10.3748/wjg.v18.i26.3389; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Prashanth M, 2009, J Assoc Physicians India, V57, P205; Pratt CM, 2009, AM HEART J, V158, P163, DOI 10.1016/j.ahj.2009.05.024; Rao G, 2013, ONCOIMMUNOLOGY, V25; Roh YS, 2013, J GASTROEN HEPATOL, V28, P38, DOI 10.1111/jgh.12019; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Saxena NK, 2015, TRENDS ENDOCRIN MET, V26, P153, DOI 10.1016/j.tem.2015.01.002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sofi F, 2014, WORLD J GASTROENTERO, V20, P7339, DOI 10.3748/wjg.v20.i23.7339; Sofi F, 2010, INT J FOOD SCI NUTR, V61, P792, DOI 10.3109/09637486.2010.487480; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Strazzabosco M, 2014, GUT, V63, P1693, DOI 10.1136/gutjnl-2014-307712; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Tripathy S, 2013, J LIPID RES, V54, P71, DOI 10.1194/jlr.M028787; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Tsutsui H, 2000, IMMUNOL REV, V174, P192, DOI 10.1034/j.1600-0528.2002.017418.x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Vosshenrich CAJ, 2002, CURR BIOL, V12, pR760, DOI 10.1016/S0960-9822(02)01286-1; Weiskirchen R, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00303; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zheng JS, 2012, LIPIDS, V47, P549, DOI 10.1007/s11745-012-3671-4	99	33	35	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173376	10.1371/journal.pone.0173376	http://dx.doi.org/10.1371/journal.pone.0173376			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422962	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600008
J	Tessum, CW; Hill, JD; Marshall, JD				Tessum, Christopher W.; Hill, Jason D.; Marshall, Julian D.			InMAP: A model for air pollution interventions	PLOS ONE			English	Article							CHEMICAL-TRANSPORT MODEL; GASEOUS DRY DEPOSITION; PUBLIC-HEALTH IMPACTS; SURFACE RESISTANCES; QUALITY MODELS; BOUNDARY-LAYER; UNITED-STATES; GLOBAL-SCALE; PART I; PM2.5	Mechanistic air pollution modeling is essential in air quality management, yet the extensive expertise and computational resources required to run most models prevent their use in many situations where their results would be useful. Here, we present InMAP (Intervention Model for Air Pollution), which offers an alternative to comprehensive air quality models for estimating the air pollution health impacts of emission reductions and other potential interventions. InMAP estimates annual-average changes in primary and secondary fine particle (PM2.5) concentrations-the air pollution outcome generally causing the largest monetized health damages-attributable to annual changes in precursor emissions. InMAP leverages pre-processed physical and chemical information from the output of a state-of-the-science chemical transport model and a variable spatial resolution computational grid to perform simulations that are several orders of magnitude less computationally intensive than comprehensive model simulations. In comparisons run here, InMAP recreates comprehensive model predictions of changes in total PM2.5 concentrations with population-weighted mean fractional bias (MFB) of -17% and population-weighted R-2 = 0.90. Although InMAP is not specifically designed to reproduce total observed concentrations, it is able to do so within published air quality model performance criteria for total PM2.5. Potential uses of InMAP include studying exposure, health, and environmental justice impacts of potential shifts in emissions for annual-average PM2.5. InMAP can be trained to run for any spatial and temporal domain given the availability of appropriate simulation output from a comprehensive model. The InMAP model source code and input data are freely available online under an open-source license.	[Tessum, Christopher W.; Marshall, Julian D.] Univ Washington, Seattle, WA 98195 USA; [Hill, Jason D.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Tessum, CW (corresponding author), Univ Washington, Seattle, WA 98195 USA.	ctessum@uw.edu	Hill, Jason/A-8919-2008; Marshall, Julian/AAC-1376-2020	Hill, Jason/0000-0001-7609-6713; Marshall, Julian/0000-0003-4087-1209; Tessum, Christopher/0000-0002-8864-7436	University of Minnesota Institute on the Environment Initiative [R1-0026-09]; US Department of Energy [DE-EE0004397]; US Department of Agriculture NIFA/AFRI Grant [2011-68005-30411]; U.S. Environmental Protection Agency [R835873]; US Environmental Protection Agency [R835873]	University of Minnesota Institute on the Environment Initiative; US Department of Energy(United States Department of Energy (DOE)); US Department of Agriculture NIFA/AFRI Grant; U.S. Environmental Protection Agency(United States Environmental Protection Agency); US Environmental Protection Agency(United States Environmental Protection Agency)	The authors thank Andrew Goodkind, Dylan Millet, Dev Millstein, David Paolella, Arvind Singh, and Vaughan Voller for feedback and input into model development, and John Michalakes for assistance with WRF-Chem performance tuning. We also thank the anonymous reviewers whose comments on previous versions of this manuscript have greatly improved its quality. We additionally acknowledge the University of Minnesota Institute on the Environment Initiative for Renewable Energy and the Environment Grants No. R1-0026-09 and RO-0002-11, the US Department of Energy Award No. DE-EE0004397, and the US Department of Agriculture NIFA/AFRI Grant No. 2011-68005-30411 for funding; and the Minnesota Super computing Institute and the Department of Energy National Center for Computational Sciences Award No. DD-ATM007 for computational resources.; This article was developed under Assistance Agreement No. R835873 awarded by the U.S. Environmental Protection Agency. It has not been formally reviewed by EPA. The views expressed in this document are solely those of authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.; We received funding from the University of Minnesota Institute on the Environment Initiative for Renewable Energy and the Environment Grants No. RI-0026-09 (JDM) and RO-0002-11 (JDH), the US Department of Energy Award No. DE-EE0004397 (JDH), the US Department of Agriculture NIFA/AFRI Grant No. 2011-68005 30411 (JDH), and the US Environmental Protection Agency Award No. R835873 (JDM, JDH) for funding; and the Minnesota Supercomputing Institute (JDM) and the Department of Energy National Center for Computational Sciences Award No. DD-ATM007 (JDH) for computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadov R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016831; American Society of Mechanical Engineers (ASME), 1973, REC GUID PRED DISP A; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; [Anonymous], 2003, TRANSBOUNDARY ACID 1; [Anonymous], 2006, TECHN SUPP DOC PROP; Boylan JW, 2006, ATMOS ENVIRON, V40, P4946, DOI 10.1016/j.atmosenv.2005.09.087; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Buonocore JJ, 2014, ENVIRON INT, V68, P200, DOI 10.1016/j.envint.2014.03.031; Byun D. W., 1999, SCI ALGORITHMS EPA M; Carnevale C, 2009, ATMOS ENVIRON, V43, P4811, DOI 10.1016/j.atmosenv.2008.07.064; Cimorelli AJ, 2005, J APPL METEOROL, V44, P682, DOI 10.1175/JAM2227.1; Cohon J.L., 2010, HIDD COSTS EN UNPR C; Courant R, 1928, MATH ANN, V100, P32, DOI 10.1007/BF01448839; Dedoussi IC, 2014, ATMOS ENVIRON, V99, P610, DOI 10.1016/j.atmosenv.2014.10.033; Delucchi MA, 2000, J TRANSP ECON POLICY, V34, P135; Draxler R.R., 2004, ARL224 ERL NOAA; ENVIRON, 2011, US GUID COMPR AIR QU; Environmental Systems Research Institute, 1998, ESRI SHAP TECHN DESC; Foley KM, 2014, ATMOS ENVIRON, V98, P283, DOI 10.1016/j.atmosenv.2014.08.046; Fountoukis C, 2013, ATMOS ENVIRON, V68, P24, DOI 10.1016/j.atmosenv.2012.11.008; Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027; Guttikunda S.K., 2009, SIM AIR MODELING TOO; Hakami A, 2007, ENVIRON SCI TECHNOL, V41, P7807, DOI 10.1021/es070944p; Heo J, 2016, ATMOS ENVIRON, V137, P80, DOI 10.1016/j.atmosenv.2016.04.026; Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5385, DOI 10.1029/2000JD900560; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Li Y, 2016, AIR QUAL ATMOS HLTH, V9, P51, DOI 10.1007/s11869-015-0321-z; Liang M, 2015, EARTH SURF DYNAM, V3, P67, DOI 10.5194/esurf-3-67-2015; Liang M. Y., 2013, THESIS; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Logue JM, 2011, ATMOS ENVIRON, V45, P476, DOI 10.1016/j.atmosenv.2010.09.053; Muller Nicholas Z., 2006, AIR POLLUTION EMISSI; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Pleim JE, 2007, J APPL METEOROL CLIM, V46, P1383, DOI 10.1175/JAM2539.1; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Scire J.S., 2000, USERS GUIDE CALPUFF; Tessum CW, 2015, GEOSCI MODEL DEV, V8, P957, DOI 10.5194/gmd-8-957-2015; Tessum CW, 2014, P NATL ACAD SCI USA, V111, P18490, DOI 10.1073/pnas.1406853111; Tessum CW, 2012, ENVIRON SCI TECHNOL, V46, P11408, DOI 10.1021/es3010514; Thunis P, 2012, ATMOS ENVIRON, V59, P476, DOI 10.1016/j.atmosenv.2012.05.043; United States Environmental Protect ion Agency (EPA), 2012, US MAN COB RISK ASS; US EPA, 2004, EPA452R04011; US EPA, 2005, AIRDATA; Wagstrom KM, 2008, ATMOS ENVIRON, V42, P5650, DOI 10.1016/j.atmosenv.2008.03.012; Walmsley JL, 1996, ATMOS ENVIRON, V30, P1181, DOI 10.1016/1352-2310(95)00403-3; WESELY ML, 1989, ATMOS ENVIRON, V23, P1293, DOI 10.1016/0004-6981(89)90153-4; Wilson R, 2004, ANN GEOPHYS-GERMANY, V22, P3869, DOI 10.5194/angeo-22-3869-2004; Zhang W, 2012, GEOSCI MODEL DEV, V5, P355, DOI 10.5194/gmd-5-355-2012	49	67	68	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176131	10.1371/journal.pone.0176131	http://dx.doi.org/10.1371/journal.pone.0176131			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423049	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600092
J	Navarro, G; Martinez-Pinilla, E; Sanchez-Melgar, A; Ortiz, R; Noe, V; Martins, M; Ciudad, C; Franco, R				Navarro, Gemma; Martinez-Pinilla, Eva; Sanchez-Melgar, Alejandro; Ortiz, Raquel; Noe, Veronique; Martins, Mairena; Ciudad, Carlos; Franco, Rafael			A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression	PLOS ONE			English	Article							INTERACTION NETWORKS; ALZHEIMERS-DISEASE; A-BETA; CELLS; MODEL; TOCOPHEROL; RECEPTORS; ADENOSINE; INCREASES; PROTEINS	The mode of action of trans-resveratrol, a promising lead compound for the development of neuroprotective drugs, is unknown. Data from a functional genomics study were retrieved with the aim to find differentially expressed genes that may be involved in the benefits provided by trans-resveratrol. Genes that showed a significantly different expression (p< 0.05, cut-off of a two-fold change) in mice fed with a control diet or a control diet containing transresveratrol were different in cortex, heart and skeletal muscle. In neocortex, we identified 4 up-regulated (Strap, Pkp4, Rab2a, Cpne3) and 22 down-regulated (Actn1, Arf3, Atp6v01, Atp1a3, Atp1b2, Cacng7, Crtc1, Dbn1, Dnm1, Epn1, Gfap, Hap, Mark41, Rab5b, Nrxn2, Ogt, Palm, Ptprn2, Ptprs, Syn2, Timp2, Vamp2) genes upon trans-resveratrol consumption. Network analysis of gene products provided evidence of plakophilin 4 up-regulation as a triggering factor for down-regulation of events related to synaptic vesicle transport and neurotransmitter release via underexpression of dynamin1 and Vamp2 (synaptobrevin 2) as node-gene drivers. Analysis by RT-qPCR of some of the selected genes in a glioma cell line showed that dynamin 1 mRNA was down-regulated even in acute trans-resveratrol treatments. Taken all together, these results give insight on the glial-neuronal networks involved in the neuroprotective role of trans-resveratrol.	[Navarro, Gemma; Franco, Rafael] Inst Salud Carlos III, CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Navarro, Gemma; Franco, Rafael] Univ Barcelona IBUB, Inst Biomed, Barcelona, Spain; [Navarro, Gemma; Ortiz, Raquel; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain; [Martinez-Pinilla, Eva] Univ Oviedo, Inst Neurociencias Principado Asturias INEUROPA, Dept Morfol & Biol Celular, Fac Med, Asturias, Spain; [Sanchez-Melgar, Alejandro; Martins, Mairena] Univ Castilla La Mancha, Fac Ciencias & Tecnol Quim, Dept Quim Inorgan Organ & Bioquim, CRIB, Ciudad Real, Spain; [Sanchez-Melgar, Alejandro; Martins, Mairena] Univ Castilla La Mancha, Fac Med, Dept Quim Inorgan Organ & Bioquim, CRIB, Ciudad Real, Spain; [Noe, Veronique; Ciudad, Carlos] Univ Barcelona, Dept Biochem & Physiol, Sch Pharm, Barcelona, Spain; [Noe, Veronique; Ciudad, Carlos] Univ Barcelona IN2UB, Inst Nanotechnol, Barcelona, Spain	CIBERNED; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona; University of Oviedo; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Barcelona; University of Barcelona	Martinez-Pinilla, E (corresponding author), Univ Oviedo, Inst Neurociencias Principado Asturias INEUROPA, Dept Morfol & Biol Celular, Fac Med, Asturias, Spain.	martinezpinillaeva@gmail.com	Martínez-Pinilla, Eva/C-7907-2013; López, Mairena Martín/H-9788-2015; Ciudad, Carlos J./D-7917-2014; Melgar, Alejandro/AAD-2980-2021; Navarro, Gemma/AAO-7866-2021; Sanchez-Melgar, Alejandro/L-1088-2018; Noe, Veronica/K-3615-2014	Martínez-Pinilla, Eva/0000-0002-0572-0926; López, Mairena Martín/0000-0002-6843-3449; Ciudad, Carlos J./0000-0002-7855-392X; Navarro, Gemma/0000-0003-4654-0873; Sanchez-Melgar, Alejandro/0000-0002-9348-3608; Noe, Veronica/0000-0001-7937-8038	Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") [SAF2014-51825-R]; Junta de Comunidades de Castilla-La Mancha, Spain [PEII-2014-030-P, PRE-8002/2014]	Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion"); Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This work was partially supported by SAF2014-51825-R from Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") and by grant PEII-2014-030-P from Junta de Comunidades de Castilla-La Mancha, Spain. ASM was awarded a fellowship (PRE-8002/2014) from Junta de Comunidades de Castilla-La Mancha, Spain.r In Memoriam: Prof. Adela Mazo, she was a brilliant Chemistry student and, later, a stunning colleague. This work was partially supported by SAF2014-51825-R from Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") and by grant PEII-2014-030-P from Junta de Comunidades de Castilla-La Mancha, Spain. ASM was awarded a fellowship (PRE-8002/2014) from Junta de Comunidades de Castilla-La Mancha, Spain.	Castillo CA, 2007, NEUROCHEM RES, V32, P1056, DOI 10.1007/s11064-006-9273-x; Arendt T, 2000, NEUROBIOL AGING, V21, P783, DOI 10.1016/S0197-4580(00)00216-5; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Borroto-Escuela DO, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0183; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Cuzzola VF, 2011, CNS NEUROL DISORD-DR, V10, P849, DOI 10.2174/187152711798072310; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Dresen I. M. Gana, 2003, Current Pharmaceutical Biotechnology, V4, P417, DOI 10.2174/1389201033377436; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Ferretta A, 2014, BBA-MOL BASIS DIS, V1842, P902, DOI 10.1016/j.bbadis.2014.02.010; Franco R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00146; Giust D, 2014, J BIOMED NANOTECHNOL, V10, P1610, DOI 10.1166/jbn.2014.1845; Hebbar S, 2004, J NEUROBIOL, V60, P499, DOI 10.1002/neu.20031; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Karagiannis TC, 2012, PATHOBIOL AGING AGE, P2; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Keil R, 2013, BIOL CHEM, V394, P1005, DOI 10.1515/hsz-2013-0114; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kontush A, 1996, J LIPID RES, V37, P1436; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Levitan IB, 2015, NEURON CELL MOL BIOL; Liu DX, 2014, PROG NEURO-PSYCHOPH, V49, P21, DOI 10.1016/j.pnpbp.2013.10.017; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Michels G, 2006, TOXICOLOGY, V225, P173, DOI 10.1016/j.tox.2006.05.014; Nolze A, 2013, RNA, V19, P1483, DOI 10.1261/rna.037945.112; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prince M, 2015, ALZHEIMERS DIS INT, V2015, P84, DOI DOI 10.1111/J.0963-7214.2004.00293.X; Quincozes-Santos A, 2014, TOXICOL IN VITRO, V28, P544, DOI 10.1016/j.tiv.2013.12.021; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Romeu Antoni, 2014, BMC Res Notes, V7, P188, DOI 10.1186/1756-0500-7-188; Sakai H, 2013, J PHYSIOL-LONDON, V591, P5851, DOI 10.1113/jphysiol.2013.263558; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; Savaskan E, 2003, GERONTOLOGY, V49, P380, DOI 10.1159/000073766; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takaoka M., 1939, NIPPON KAGAKU KAISHI, V60, P1090, DOI [10.1246/nikkashi1921.60.1090, DOI 10.1246/NIKKASHI1921.60.1090]; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Verkhratsky A., 2007, GLIAL NEUROBIOLOGY T; Villaflores OB, 2012, TAIWAN J OBSTET GYNE, V51, P515, DOI 10.1016/j.tjog.2012.09.005; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Winkle CC, 2016, JOVE-J VIS EXP, DOI 10.3791/53743; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	60	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176067	10.1371/journal.pone.0176067	http://dx.doi.org/10.1371/journal.pone.0176067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441400	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800023
J	Can, MT; Kurkcuoglu, Z; Ezeroglu, G; Uyar, A; Kurkcuoglu, O; Doruker, P				Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Kurkcuoglu, Ozge; Doruker, Pemra			Conformational dynamics of bacterial trigger factor in apo and ribosome-bound states	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; NASCENT CHAIN; FORCE-FIELD; PROTEIN; SIMULATION; COMPLEX; AMBER; CHAPERONES; MECHANICS; ALGORITHM	The chaperone trigger factor (TF) binds to the ribosome exit tunnel and helps cotranslational folding of nascent chains (NC) in bacterial cells and chloroplasts. In this study, we aim to investigate the functional dynamics of fully-atomistic apo TF and its complex with 50S. As TF accomodates a high percentage of charged residues on its surface, the effect of ionic strength on TF dynamics is assessed here by performing five independent molecular dynamics (MD) simulations (total of 1.3 micro-second duration) at 29 mM and 150 mM ionic strengths. At both concentrations, TF exhibits high inter-and intra-domain flexibility related to its binding (BD), core (CD), and head (HD) domains. Even though large oscillations in gyration radius exist during each run, we do not detect the so-called 'fully collapsed' state with both HD and BD collapsed upon the core. In fact, the extended conformers with relatively open HD and BD are highly populated at the physiological concentration of 150 mM. More importantly, extended TF snapshots stand out in terms of favorable docking onto the 50S subunit. Elastic network modeling (ENM) indicates significant changes in TF's functional dynamics and domain decomposition depending on its conformation and positioning on the 50S. The most dominant slow motions are the lateral sweeping and vertical opening/ closing of HD relative to 50S. Finally, our ENM-based efficient technique -ClustENM-is used to sample atomistic conformers starting with an extended TF-50S complex. Specifically, BD and CD motions are restricted near the tunnel exit, while HD is highly mobile. The atomistic conformers generated without an NC are in agreement with the cryo-EM maps available for TF-ribosome-NC complex.	[Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Doruker, Pemra] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey; [Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Doruker, Pemra] Bogazici Univ, Polymer Res Ctr, Istanbul, Turkey; [Kurkcuoglu, Ozge] Istanbul Tech Univ, Dept Chem Engn, Istanbul, Turkey; [Kurkcuoglu, Zeynep] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Uyar, Arzu] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Bogazici University; Bogazici University; Istanbul Technical University; Utrecht University; Michigan State University	Doruker, P (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.; Doruker, P (corresponding author), Bogazici Univ, Polymer Res Ctr, Istanbul, Turkey.	doruker@boun.edu.tr	Kurkcuoglu, Zeynep/AAG-2591-2019; Kurkcuoglu, Ozge/ABF-1400-2020	Kurkcuoglu, Ozge/0000-0003-0228-3211; Doruker, Pemra/0000-0002-4824-2223				ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Barbet-Massin E, 2015, ANGEW CHEM INT EDIT, V54, P4367, DOI 10.1002/anie.201409393; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Can MT, 2012, THESIS; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deeng J, 2016, J MOL BIOL, V428, P3588, DOI 10.1016/j.jmb.2016.06.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ezeroglu G., 2014, THESIS; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gamerdinger M, 2014, SCIENCE, V344, P590, DOI 10.1126/science.1254064; GRIMES RG, 1994, SIAM J MATRIX ANAL A, V15, P228, DOI 10.1137/S0895479888151111; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Hoffmann A, 2009, NAT STRUCT MOL BIOL, V16, P1006, DOI 10.1038/nsmb1009-1006; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kurkcuoglu O, 2009, BIOPHYS J, V97, P1178, DOI 10.1016/j.bpj.2009.06.009; Kurkcuoglu Z, 2016, PLOS ONE, V11, P1; Kurkcuoglu Z, 2016, J CHEM THEORY COMPUT; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Singhal K, 2013, PLOS ONE, P8; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Thomas AS, 2013, BIOPHYS J, V105, P732, DOI 10.1016/j.bpj.2013.06.028; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005	52	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176262	10.1371/journal.pone.0176262	http://dx.doi.org/10.1371/journal.pone.0176262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437479	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600040
J	Renner, SW; Walker, LM; Forsberg, LJ; Sexton, JZ; Brenman, JE				Renner, Sarah W.; Walker, Lauren M.; Forsberg, Lawrence J.; Sexton, Jonathan Z.; Brenman, Jay E.			Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice	PLOS ONE			English	Article							HEPATIC CD36 EXPRESSION; CYTOSOLIC ISOZYME-III; ACTIVE-SITE; PROTEOMIC ANALYSIS; RODENT MODELS; S-THIOLATION; IN-VIVO; LIVER; MOUSE; INSULIN	Carbonic anhydrases are a family of enzymes that catalyze the reversible condensation of water and carbon dioxide to carbonic acid, which spontaneously dissociates to bicarbonate. Carbonic anhydrase III (Car3) is nutritionally regulated at both the mRNA and protein level. It is highly enriched in tissues that synthesize and/or store fat: liver, white adipose tissue, brown adipose tissue, and skeletal muscle. Previous characterization of Car3 knockout mice focused on mice fed standard diets, not high-fat diets that significantly alter the tissues that highly express Car3. We observed lower protein levels of Car3 in high-fat diet fed mice treated with niclosamide, a drug published to improve fatty liver symptoms in mice. However, it is unknown if Car3 is simply a biomarker reflecting lipid accumulation or whether it has a functional role in regulating lipid metabolism. We focused our in vitro studies toward metabolic pathways that require bicarbonate. To further determine the role of Car3 in metabolism, we measured de novo fatty acid synthesis with in vitro radiolabeled experiments and examined metabolic biomarkers in Car3 knockout and wild type mice fed high-fat diet. Specifically, we analyzed body weight, body composition, metabolic rate, insulin resistance, serum and tissue triglycerides. Our results indicate that Car3 is not required for de novo lipogenesis, and Car3 knockout mice fed high-fat diet do not have significant differences in responses to various diets to wild type mice.	[Renner, Sarah W.; Brenman, Jay E.] Univ North Carolina Chapel Hill, Genet & Mol Biol Curriculum, Chapel Hill, NC 27599 USA; [Walker, Lauren M.; Forsberg, Lawrence J.; Brenman, Jay E.] Univ North Carolina Chapel Hill, UNC Neurosci Ctr, Chapel Hill, NC USA; [Sexton, Jonathan Z.] North Carolina Cent Univ, Biomfg Res Inst & Technol Enterprise, Durham, NC USA; [Brenman, Jay E.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina Central University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Renner, SW (corresponding author), Univ North Carolina Chapel Hill, Genet & Mol Biol Curriculum, Chapel Hill, NC 27599 USA.	srenner@email.unc.edu		Walker, Lauren/0000-0003-2122-6271	UNC startup funds; NRSA T32 grant [GM 007092-39]; NIDDK grant [P30DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	UNC startup funds; NRSA T32 grant; NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by UNC startup funds to JB (http://research.unc.edu/), and NRSA T32 grant GM 007092-39 to SR (https.//www.nigms.nih.gov/). Additionally, this publication was supported by NIDDK grant P30DK056350 to the UNC Nutrition Obesity Research Center (https://www.niddk.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Alver A, 2004, J ENZYM INHIB MED CH, V19, P279, DOI 10.1080/14756360410001720445; An HQ, 2002, BBA-PROTEINS PROTEOM, V1599, P21, DOI 10.1016/S0167-4838(02)00374-6; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Aroor AR, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-29; Aspatwar A, 2014, SUBCELL BIOCHEM, V75, P135, DOI 10.1007/978-94-007-7359-2_8; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bondia-Pons I, 2011, J NUTRIGENET NUTRIGE, V4, P344, DOI 10.1159/000336075; Caballero VJ, 2011, J PHYSIOL BIOCHEM, V67, P43, DOI 10.1007/s13105-010-0047-1; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; Carter WG, 2015, BIOCHEM BIOPH RES CO, V458, P626, DOI 10.1016/j.bbrc.2015.01.158; CHAI YC, 1991, ARCH BIOCHEM BIOPHYS, V284, P270, DOI 10.1016/0003-9861(91)90295-T; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chegwidden WR, 2000, EXS, V90, P13; Chowdhury MKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40159; Cooper DE, 2015, J BIOL CHEM, V290, P15112, DOI 10.1074/jbc.M115.649970; Deol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132672; DODGSON SJ, 1991, BIOCHEM CELL BIOL, V69, P761, DOI 10.1139/o91-116; DODGSON SJ, 1993, J APPL PHYSIOL, V75, P1186, DOI 10.1152/jappl.1993.75.3.1186; DODGSON SJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P410, DOI 10.1016/0003-9861(90)90597-R; DUBUC PU, 1985, ANN NUTR METAB, V29, P358, DOI 10.1159/000176992; Duda DM, 2005, BIOCHEMISTRY-US, V44, P10046, DOI 10.1021/bi050610h; Eisinger K, 2014, INT J MOL SCI, V15, P2991, DOI 10.3390/ijms15022991; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Elder I, 2007, PROTEINS, V68, P337, DOI 10.1002/prot.21403; Feng HZ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00597; GIBSON DM, 1958, BIOCHIM BIOPHYS ACTA, V30, P376, DOI 10.1016/0006-3002(58)90063-5; Grimes A, 1997, BIOCHEM J, V321, P341, DOI 10.1042/bj3210341; Hazen SA, 1996, FASEB J, V10, P481, DOI 10.1096/fasebj.10.4.8647347; HERBERT JD, 1984, ANN NY ACAD SCI, V429, P525, DOI 10.1111/j.1749-6632.1984.tb12381.x; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kim G, 2004, MOL CELL BIOL, V24, P9942, DOI 10.1128/MCB.24.22.9942-9947.2004; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lehenkari P, 1998, EXP CELL RES, V242, P128, DOI 10.1006/excr.1998.4071; LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033; Lindskog S, 2000, EXS, V90, P175; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; LOGRASSO PV, 1993, BIOCHEMISTRY-US, V32, P5786, DOI 10.1021/bi00073a010; LYNCH CJ, 1993, AM J PHYSIOL, V264, pE621, DOI 10.1152/ajpendo.1993.264.4.E621; LYNCH CJ, 1995, BIOCHEM J, V310, P197, DOI 10.1042/bj3100197; Lynch J, 1992, PYRUVATE CARBOXYLASE; MABROUK GM, 1990, J BIOL CHEM, V265, P6330; Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6; MELDRUM N. IT., 1933, JOUR PHYSIOL, V80, P113; Mendez L, 2017, J NUTR BIOCHEM, V41, P84, DOI 10.1016/j.jnutbio.2016.12.005; Mitterberger MC, 2012, EXP CELL RES, V318, P877, DOI 10.1016/j.yexcr.2012.02.011; Monti DM, 2017, J ENZYM INHIB MED CH, V32, P5, DOI 10.1080/14756366.2016.1225046; Nishimori I, 2007, BIOORGAN MED CHEM, V15, P7229, DOI 10.1016/j.bmc.2007.08.037; Nishimori I, 2009, J ENZYM INHIB MED CH, V24, P70, DOI [10.1080/14756360801907143, 10.1080/14756360801907143 ]; NISHITA T, 1995, INT J BIOCHEM CELL B, V27, P359, DOI 10.1016/1357-2725(94)00090-X; Nixon JP, 2010, OBESITY, V18, P1652, DOI 10.1038/oby.2009.471; Onyenwoke RU, 2012, MOL BIOL CELL, V23, P381, DOI 10.1091/mbc.E11-08-0699; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; Patrikainen M, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0082-2; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Raisanen SR, 1999, FASEB J, V13, P513, DOI 10.1096/fasebj.13.3.513; Ronchi VP, 2004, INT J BIOCHEM CELL B, V36, P1993, DOI 10.1016/j.biocel.2004.02.019; Shah GN, 2013, P NATL ACAD SCI USA, V110, P7423, DOI 10.1073/pnas.1305805110; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; STANTON LW, 1991, MOL ENDOCRINOL, V5, P860, DOI 10.1210/mend-5-6-860; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Tao H, 2014, NATURE MED; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; TU CK, 1994, J BIOL CHEM, V269, P23002; Van Schothorst EM, 2005, OBES RES, V13, P1031, DOI 10.1038/oby.2005.121; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamada M, 2013, ALCOHOL CLIN EXP RES, V37, pE79, DOI 10.1111/j.1530-0277.2012.01883.x; Zagani R, 2015, ONCOTARGET, V6, P28282, DOI 10.18632/oncotarget.5061; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553; Zimmerman UJP, 2004, IUBMB LIFE, V56, P343, DOI 10.1080/1521-6540400000850	80	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176502	10.1371/journal.pone.0176502	http://dx.doi.org/10.1371/journal.pone.0176502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437447	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600049
J	Celiberto, LS; Bedani, R; Dejani, NN; de Medeiros, AI; Zuanon, JAS; Spolidorio, LC; Adorno, MAT; Varesche, MBA; Galvao, FC; Valentini, SR; de Valdez, GF; Rossi, EA; Cavallinil, DCU				Sbaglia Celiberto, Larissa; Bedani, Raquel; Dejani, Naiara Naiana; de Medeiros, Alexandra Ivo; Sampaio Zuanon, Jose Antonio; Spolidorio, Luis Carlos; Tallarico Adorno, Maria Angela; Amancio Varesche, Maria Bernadete; Galvao, Fabio Carrilho; Valentini, Sandro Roberto; Font de Valdez, Graciela; Rossi, Elizeu Antonio; Umbelino Cavallinil, Daniela Cardoso			Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; DEXTRAN SODIUM-SULFATE; DSS-INDUCED COLITIS; ULCERATIVE-COLITIS; FECAL MICROBIOTA; NITRIC-OXIDE; LACTOBACILLUS-FERMENTUM; 5-AMINOSALICYLIC ACID; INTESTINAL MICROBIOTA	Background Some probiotic strains have the potential to assist in relieving the symptoms of inflammatory bowel disease. The impact of daily ingestion of a soy-based product fermented by Enterococcus faecium CRL 183 and Lactobacillus helveticus 416 with the addition of Bifidobacterium longum ATCC 15707 on chemically induced colitis has been investigated thereof within a period of 30 days. Methods Colitis was induced by dextran sulfate sodium. The animals were randomly assigned into five groups: Group C: negative control; Group CL: positive control; Group CLF: DSS with the fermented product; Group CLP: DSS with the non-fermented product (placebo); Group CLS: DSS with sulfasalazine. The following parameters were monitored: disease activity index, fecal microbial analyses, gastrointestinal survival of probiotic microorganisms and short-chain fatty acids concentration in the feces. At the end of the protocol the animals' colons were removed so as to conduct a macroscopical and histopathological analysis, cytokines and nitrite quantification. Results Animals belonging to the CLF group showed fewer symptoms of colitis during the induction period and a lower degree of inflammation and ulceration in their colon compared to the CL, CLS and CLP groups (p<0.05). The colon of the animals in groups CL and CLS presented severe crypt damage, which was absent in CLF and CLP groups. A significant increase in the population of Lactobacillus spp. and Bifidobacterium spp. at the end of the protocol was verified only in the CLF animals (p<0.05). This group also showed an increase in short-chain fatty acids (propionate and acetate). Furthermore, the intestinal survival of E. faecium CRL 183 and B. longum ATCC 15707 in the CLF group has been confirmed by biochemical and molecular analyzes. Conclusions The obtained results suggest that a regular intake of the probiotic product, and placebo to a lesser extent, can reduce the severity of DSS-induced colitis on rats.	[Sbaglia Celiberto, Larissa; Rossi, Elizeu Antonio; Umbelino Cavallinil, Daniela Cardoso] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil; [Bedani, Raquel] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, SP, Brazil; [Dejani, Naiara Naiana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Dejani, Naiara Naiana; de Medeiros, Alexandra Ivo; Galvao, Fabio Carrilho; Valentini, Sandro Roberto] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Araraquara, SP, Brazil; [Sampaio Zuanon, Jose Antonio; Spolidorio, Luis Carlos] Univ Estadual Paulista, UNESP, Fac Odontol, Dept Fisiol & Patol, Araraquara, SP, Brazil; [Tallarico Adorno, Maria Angela; Amancio Varesche, Maria Bernadete] Univ Sao Paulo, Fac Engn, Dept Hidraul & Saneamento, Sao Carlos, SP, Brazil; [Font de Valdez, Graciela] CERELA, Ctr Referencia Lactobacilos, San Miguel De Tucuman, Argentina	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Cavallinil, DCU (corresponding author), Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil.	cavallinidc@fcfar.unesp.br	Varesche, Maria Bernadete Amancio/K-6127-2012; Spolidorio, Luís Carlos/G-1857-2012; dejani, naiara naiana/AAQ-1395-2020; Valentini, Sandro R/C-4353-2012; Cavallini, Daniela Cardoso Umbelino/B-6447-2012; Bedani, Raquel/C-6463-2012	Varesche, Maria Bernadete Amancio/0000-0003-3124-7471; Spolidorio, Luís Carlos/0000-0002-0592-542X; dejani, naiara naiana/0000-0001-9818-1572; Bedani, Raquel/0000-0001-6806-085X; Celiberto, Larissa/0000-0001-9057-9041; Cavallini, Daniela/0000-0003-2146-662X; Valentini, Sandro Roberto/0000-0003-4453-5413	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC [2012/07785-0]; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC [PROPe 10/12]; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC (2012/07785-0), http://www.fapesp.br/; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC (PROPe 10/12), http://unesp.br/portal#!/prope; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP. DCUC (PADC), http://www2.fcfar.unesp.br/ #!/pesquisa/padc/historico/; and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - LSC (2012/07706-3), http://www.fapesp.br/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M., 2014, AM J ANAL CHEM, V5, P406, DOI [10.4236/ajac.2014.57049, DOI 10.4236/AJAC.2014.57049]; Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; AIKO S, 1995, GASTROENTEROLOGY, V109, P142, DOI 10.1016/0016-5085(95)90279-1; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Arab HH, 2014, FOOD CHEM TOXICOL, V69, P294, DOI 10.1016/j.fct.2014.04.032; Basavanna Girishkumar, 2012, Annals Food Science and Technology, V13, P231; Bedani R., 2008, THESIS, P140; Bedani R, 2013, FOOD MICROBIOL, V34, P382, DOI 10.1016/j.fm.2013.01.012; Bedani R, 2011, BRAZ J MICROBIOL, V42, P1238, DOI [10.1590/S1517-83822011000300050, 10.1590/S1517-838220110003000050]; Bedani R, 2010, J SCI FOOD AGR, V90, P233, DOI 10.1002/jsfa.3800; BELL CJ, 1995, AM J PHYSIOL-GASTR L, V268, pG622, DOI 10.1152/ajpgi.1995.268.4.G622; Bento AF, 2012, BIOCHEM PHARMACOL, V84, P1459, DOI 10.1016/j.bcp.2012.09.007; Bertazzoni E, 2013, J CHEMOTHERAPY, V25, P193, DOI 10.1179/1973947813Y.0000000078; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; boyd d., 2008, THESIS; Brigidi P, 2001, RES MICROBIOL, V152, P735, DOI 10.1016/S0923-2508(01)01254-2; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Bullock Natalie R, 2004, Curr Issues Intest Microbiol, V5, P59; Camuesco D, 2005, INFLAMM BOWEL DIS, V11, P265, DOI 10.1097/01.MIB.0000160808.30988.d9; Cano VPS, 2007, LAIT, V87, P59, DOI 10.1051/lait:2007002; Cavallini DCU, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-126; Celiberto LS, 2015, CRIT REV FOOD SCI NU; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Cui HH, 2004, WORLD J GASTROENTERO, V10, P1521; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Edlund C, 2000, SCAND J INFECT DIS, V32, P81, DOI 10.1080/00365540050164272; Ettreiki C, 2012, WORLD J GASTROENTERO, V18, P2619, DOI 10.3748/wjg.v18.i21.2619; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Feagins LA, 2010, INFLAMM BOWEL DIS, V16, P1963, DOI 10.1002/ibd.21281; Fedorak RN, 2004, INFLAMM BOWEL DIS, V10, P286, DOI 10.1097/00054725-200405000-00018; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Gisbert JP, 2002, DIGEST DIS SCI, V47, P471, DOI 10.1023/A:1017987229718; Griffiths Keith, 2016, Diseases, V4, DOI 10.3390/diseases4030028; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Herllinger KR, 2006, AM J GASTROENTEROL, V101, P793, DOI 10.1111/j.1572-0241.2005.00356.x; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Howarth GS, 2008, J GASTROEN HEPATOL, V23, P1777, DOI 10.1111/j.1440-1746.2008.05685.x; Jiang HY, 2011, J NUTR, V141, P1239, DOI 10.3945/jn.110.137414; Jo SG, 2016, J MICROBIOL, V54, P503, DOI 10.1007/s12275-016-6160-2; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kaur IP, 2002, EUR J PHARM SCI, V15, P1, DOI 10.1016/S0928-0987(01)00209-3; Kinouchi FL, 2012, FOOD CHEM TOXICOL, V50, P4144, DOI 10.1016/j.fct.2012.08.038; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kringston DGI, 1990, CHEM RES TOXICOL, V3, P39; Krzyzanowsky F, 2003, REV INST MED TROP SA; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lane TE, 1996, INFECT IMMUN, V61, P1468; Langa S, 2003, INT J FOOD MICROBIOL, V88, P197, DOI 10.1016/S0168-1605(03)00180-6; LIVINGSTON SJ, 1978, J CLIN MICROBIOL, V7, P448; MAHIDA YR, 1991, GUT, V32, P50, DOI 10.1136/gut.32.1.50; Malago JJ, 2008, J ZHEJIANG UNIV-SC B, V9, P341, DOI 10.1631/jzus.B0720198; Marzotto M, 2006, RES MICROBIOL, V157, P857, DOI 10.1016/j.resmic.2006.06.007; Mater DDG, 2005, FEMS MICROBIOL LETT, V250, P185, DOI 10.1016/j.femsle.2005.07.006; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4512; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Montesi A, 2005, INT J FOOD MICROBIOL, V98, P281, DOI 10.1016/j.ijfoodmicro.2004.06.005; Morampudi V, 2016, MUCOSAL IMMUNOL, V9, P1218, DOI 10.1038/mi.2015.140; Moussa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049547; MUNOA FJ, 1988, APPL ENVIRON MICROB, V54, P1715; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Musch E, 2005, CLIN GASTROENTEROL H, V3, P581, DOI 10.1016/S1542-3565(05)00208-9; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Nassri Carlos Guilherme Giazzi, 2008, Rev bras. colo-proctol., V28, P306, DOI 10.1590/S0101-98802008000300006; Nemoto H, 2012, DIGEST DIS SCI, V57, P2955, DOI 10.1007/s10620-012-2236-y; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; O'Hara AM, 2007, THESCIENTIFICWORLDJO, V7, P31, DOI 10.1100/tsw.2007.26; Ocon B, 2013, EUR J NUTR, V52, P457, DOI 10.1007/s00394-012-0347-z; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Osman N, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-31; Ozaki K, 2012, CURR GENE THER, V12, P484, DOI 10.2174/156652312803519814; Panneerselvam S, 2016, BIOCH ANAL BIOCH, V5, P2, DOI DOI 10.4172/2161-1009.1000266; Peran L, 2006, INT J COLORECTAL DIS, V21, P737, DOI 10.1007/s00384-005-0773-y; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Ramiah K, 2008, RES MICROBIOL, V159, P470, DOI 10.1016/j.resmic.2008.06.002; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; ROSSI EA, 1984, ARQ BIOL TECNOL, V27, P387; Sakata S, 2002, INT J SYST EVOL MICR, V52, P1945, DOI [10.1099/ijs.0.02221-0, 10.1099/00207713-52-6-1945]; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Shiguemoto GE, 2007, MATURITAS, V57, P261, DOI 10.1016/j.maturitas.2007.01.011; Sivieri K, 2008, EUR FOOD RES TECHNOL, V228, P231, DOI 10.1007/s00217-008-0927-6; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Toure R, 2003, J APPL MICROBIOL, V95, P1058, DOI 10.1046/j.1365-2672.2003.02085.x; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Van de Wiele T, 2004, FEMS MICROBIOL ECOL, V51, P143, DOI 10.1016/j.femsec.2004.07.014; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Vinolo MAR, 2010, THESIS; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Weber TE, 2006, VET IMMUNOL IMMUNOP, V113, P139, DOI 10.1016/j.vetimm.2006.04.006; Wine E, 2009, FEMS MICROBIOL LETT, V300, P146, DOI 10.1111/j.1574-6968.2009.01781.x; Wolever TMS, 2002, AM J CLIN NUTR, V75, P1023, DOI 10.1093/ajcn/75.6.1023; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Yu J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060361; Zhou FX, 2012, WORLD J GASTROENTERO, V18, P2344, DOI 10.3748/wjg.v18.i19.2344	121	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175935	10.1371/journal.pone.0175935	http://dx.doi.org/10.1371/journal.pone.0175935			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437455	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600023
J	Lin, LY; Peng, CC; Chen, Y; Huang, BC; Chang, CC; Peng, RY				Lin, Li-Yun; Peng, Chiung-Chi; Chen, Yeh; Huang, Boa-Chan; Chang, Chun Chao; Peng, Robert Y.			Aminoazo dye-protein-adduct enhances inhibitory effect on digestibility and damages to Gastro-Duodenal-Hepatic axis	PLOS ONE			English	Article							LIVER; RATS; CARCINOGENESIS	4-Dimethylaminoazobenzene (DAB, methyl yellow, or butter yellow), a human carcinogen, has been banned for use in foods since 1988. In 2014, DAB adulteration in Tofu occurred in Taiwan. We hypothesize that DAB can form [DAB center dot SBP](adduct) adduct with soybean protein (SBP) which could damage Gastro-Duodenal-Hepatic axis. Sprague-Dawley rats gavage fed [DAB center dot SBP](adduct) adduct revealed severely reduced body weight and damaged duodenum, liver, hepatic mitochondria, and spleen. Hepatic levels of glutathione and ATP were severely reduced. Serum GOT and GPT were substantially elevated. Analysis by the adsorption isotherm clearly revealed DAB formed very stable [DAB center dot SBP](adduct) adduct at 1:1 molar ration (Phase A). The equilibrium constant of this colloidal adduct [DAB center dot SBP](adduct) was K-eqA = proportional to, behaving as the most stable and toxic species. At higher protein concentration (Phase C) it formed conjugate [DABxSBP(gross)](conjugate), with K-eqC = 3.23x10(-2) mg/mL, implicating a moderately strong adsorption. The in vitro pepsin digestibility test showed apparently reduced digestibility by 27% (by Ninhydrin assay) or 8% (by Bradford assay). Conclusively, this is the first report indicating that [DAB center dot SBP](adduct) potentially is capable to damage the Gastro-Duodenal-Hepatic axis.	[Lin, Li-Yun; Huang, Boa-Chan] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Shalu County, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, Yeh; Peng, Robert Y.] Hungkuang Univ, Res Inst Biotechnol, Sch Med & Nursing, Sec 6,Taiwan Blvd, Taichung, Taiwan; [Chang, Chun Chao] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Chang, Chun Chao] Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	Hungkuang University; Taipei Medical University; Hungkuang University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Peng, RY (corresponding author), Hungkuang Univ, Res Inst Biotechnol, Sch Med & Nursing, Sec 6,Taiwan Blvd, Taichung, Taiwan.; Chang, CC (corresponding author), Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Chang, CC (corresponding author), Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan.; Peng, RY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	chunchao@tmu.edu.tw; ypeng@seed.net.tw			Ministry of Agriculture and Food Stuff (Taiwan, ROC); Ministry of Science and Technology (Taiwan, ROC) [MOST 105-2320-B-038-034-MY3, MOST 103-2313-B-038-002-MY3]; Taipei Medical University Shuang Ho Hospital [105TMU-SHH-16]; Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC) [HK101-171]; Chi Mei Medical Center [106CM-TMU-05]	Ministry of Agriculture and Food Stuff (Taiwan, ROC); Ministry of Science and Technology (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); Taipei Medical University Shuang Ho Hospital; Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC); Chi Mei Medical Center	The 103-Agriculture-3.1.3.-Food-Stuffs-Z1(5) funding support from the Ministry of Agriculture and Food Stuff (Taiwan, ROC), MOST 105-2320-B-038-034-MY3 from the Ministry of Science and Technology (Taiwan, ROC), and the funding support of 105TMU-SHH-16 from Taipei Medical University Shuang Ho Hospital are gratefully acknowledged.; Financial support of Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC) (HK101-171) and MOST 105-2320-B-038-034-MY3; MOST 103-2313-B-038-002-MY3 from the Ministry of Science and Technology (Taiwan, ROC), the funding support of 105TMU-SHH-16 from Taipei Medical University Shuang Ho Hospital, and 106CM-TMU-05 from the Chi Mei Medical Center are gratefully acknowledged.	[Anonymous], 2012, SEG MED DICT; [Anonymous], 2012, 2 SPRINGER SCI BUSIN; ARCOS JC, 1958, BIOCHIM BIOPHYS ACTA, V28, P9, DOI 10.1016/0006-3002(58)90421-9; Bryant S, 1997, BR J CAN, V36, P678; DAOUD AH, 1976, CANCER RES, V36, P2885; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Eigenmann PA, 2004, LANCET, V364, P823, DOI 10.1016/S0140-6736(04)16996-1; FLEXNEWS, 2009, FLEXNEWS        0411; Ghanbari-Niaki A, 1999, ARCH PHYSIOL BIOCHEM, V107, P393, DOI 10.1076/1381-3455(199912)107:05;1-5;FT393; LIN JK, 1975, CANCER RES, V35, P844; Malinauskyte E, 2014, FOOD CHEM, V165, P104, DOI 10.1016/j.foodchem.2014.05.078; MILLER EC, 1947, CANCER RES, V7, P468; Ni Q, 2015, ANAL CELL PATHOL, V2015, P5; Opie EL, 1944, J EXP MED, V80, P231, DOI 10.1084/jem.80.3.231; Orr JW, 1940, J PATHOL BACTERIOL, V50, P393, DOI 10.1002/path.1700500302; PORTER KR, 1959, CANCER RES, V19, P997; Saeed S. M. G., 2011, Journal of Pharmacy and Nutrition Sciences, V1, P34; SANCHEZCHIANG L, 1987, COMP BIOCHEM PHYS B, V87, P793, DOI 10.1016/0305-0491(87)90390-7; Sarkar A, 2009, FOOD HYDROCOLLOID, V23, P1563, DOI 10.1016/j.foodhyd.2008.10.014; Sasaki T. YT, 1935, VIRCHOWS ARCH PATH A, V295; Schmahl S, 1975, Z KREBSFORSCHUNG KLI; Suthanthiran A, 1990, P NATL ACAD SCI USA, V87; SWEENEY EA, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.2307/3432164; Tacal O, 2004, J BIOCHEM MOL TOXIC, V18, P253, DOI 10.1002/jbt.20034; Thomas, 2013, ELSEVIER, V7, P147; Toyo'oka T, 2001, BIOMEDICAL CHROMATOG, V15; U.S. Department of Health and Human Services. Public Health Service CfDaH Division of Standards Development and Technology Transfer, 1988, OCC SAF HLTH GUID 4	27	53	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0170555	10.1371/journal.pone.0170555	http://dx.doi.org/10.1371/journal.pone.0170555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430776	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100001
J	Peeters, C; Cooper, VS; Hatcher, PJ; Verheyde, B; Carlier, A; Vandamme, P				Peeters, Charlotte; Cooper, Vaughn S.; Hatcher, Philip J.; Verheyde, Bart; Carlier, Aurelien; Vandamme, Peter			Comparative genomics of Burkholderia multivorans, a ubiquitous pathogen with a highly conserved genomic structure	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; RIBOSOMAL-RNA GENE; CEPACIA COMPLEX; SPECIES DISTRIBUTION; SEQUENCE; EPIDEMIOLOGY; TOOL; DIFFERENTIATION; COLONIZATION; TRANSMISSION	The natural environment serves as a reservoir of opportunistic pathogens. A well-established method for studying the epidemiology of such opportunists is multilocus sequence typing, which in many cases has defined strains predisposed to causing infection. Burkholderia multivorans is an important pathogen in people with cystic fibrosis (CF) and its epidemiology suggests that strains are acquired from non-human sources such as the natural environment. This raises the central question of whether the isolation source (CF or environment) or the multilocus sequence type (ST) of B. multivorans better predicts their genomic content and functionality. We identified four pairs of B. multivorans isolates, representing distinct STs and consisting of one CF and one environmental isolate each. All genomes were sequenced using the PacBio SMRT sequencing technology, which resulted in eight high-quality B. multivorans genome assemblies. The present study demonstrated that the genomic structure of the examined B. multivorans STs is highly conserved and that the B. multivorans genomic lineages are defined by their ST. Orthologous protein families were not uniformly distributed among chromosomes, with core orthologs being enriched on the primary chromosome and ST-specific orthologs being enriched on the second and third chromosome. The ST-specific orthologs were enriched in genes involved in defense mechanisms and secondary metabolism, corroborating the strain-specificity of these virulence characteristics. Finally, the same B. multivorans genomic lineages occur in both CF and environmental samples and on different continents, demonstrating their ubiquity and evolutionary persistence.	[Peeters, Charlotte; Verheyde, Bart; Carlier, Aurelien; Vandamme, Peter] Univ Ghent, Lab Microbiol, Ghent, Belgium; [Cooper, Vaughn S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Hatcher, Philip J.] Univ New Hampshire, Dept Comp Sci, Durham, NH 03824 USA	Ghent University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System Of New Hampshire; University of New Hampshire	Vandamme, P (corresponding author), Univ Ghent, Lab Microbiol, Ghent, Belgium.	peter.vandamme@ugent.be	Carlier, Aurelien/M-9671-2016; Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021	Carlier, Aurelien/0000-0001-7565-1586; Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; Cooper, Vaughn/0000-0001-7726-0765; Peeters, Charlotte/0000-0002-1891-4869	NIGMS NIH HHS [R01 GM110444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110444] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Agresti A., 2002, CATEGORICAL DATA ANA, P70, DOI DOI 10.1002/0471249688.CH3; Aris RM, 2001, AM J RESP CRIT CARE, V164, P2102, DOI 10.1164/ajrccm.164.11.2107022; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Baldwin A, 2008, J CLIN MICROBIOL, V46, P290, DOI 10.1128/JCM.01818-07; Baldwin A, 2007, EMERG INFECT DIS, V13, P458, DOI 10.3201/eid1303.060403; Bartell JA, 2014, J BACTERIOL, V196, P210, DOI 10.1128/JB.00997-13; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Brisse S, 2004, J CLIN MICROBIOL, V42, P4824, DOI 10.1128/JCM.42.10.4824-4827.2004; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlier A, 2016, ENVIRON MICROBIOL, V18, P2507, DOI 10.1111/1462-2920.13184; Carlier AL, 2012, ENVIRON MICROBIOL, V14, P2757, DOI 10.1111/j.1462-2920.2012.02763.x; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Cooper VS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000732; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Boeck K, 2004, EUR RESPIR J, V23, P851, DOI 10.1183/09031936.04.00118804; De Smet B, 2015, J CLIN MICROBIOL, V53, P323, DOI 10.1128/JCM.02574-14; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McAdam PR, 2014, CURR OPIN MICROBIOL, V19, P106, DOI 10.1016/j.mib.2014.06.002; Medina-Pascual MJ, 2012, EUR J CLIN MICROBIOL, V31, P3385, DOI 10.1007/s10096-012-1707-6; Morrow JD, 2012, GENOME BIOL EVOL, V4, P1256, DOI 10.1093/gbe/evs099; Nazir R, 2012, J BACTERIOL, V194, P4480, DOI 10.1128/JB.00725-12; Norskov-Lauritsen N, 2010, J CLIN MICROBIOL, V48, P2981, DOI 10.1128/JCM.00383-10; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pinto-Carbo M, 2016, ISME J, V10, P2092, DOI 10.1038/ismej.2016.27; Pope CE, 2010, J CYST FIBROS, V9, P442, DOI 10.1016/j.jcf.2010.08.011; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Schwab U, 2014, INFECT IMMUN, V82, P4729, DOI 10.1128/IAI.01876-14; Scott D, 2015, CURR MICROBIOL, V70, P338, DOI 10.1007/s00284-014-0721-6; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segonds C, 1999, J CLIN MICROBIOL, V37, P2201, DOI 10.1128/JCM.37.7.2201-2208.1999; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Spilker T, 2009, J CLIN MICROBIOL, V47, P2607, DOI 10.1128/JCM.00770-09; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Ussery DW, 2009, GENOME DYNAM, V6, P140, DOI 10.1159/000235768; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176191	10.1371/journal.pone.0176191	http://dx.doi.org/10.1371/journal.pone.0176191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430818	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100032
J	Masia, M; Padilla, S; de la Tabla, VO; Gonzalez, M; Bas, C; Gutierrez, F				Masia, Mar; Padilla, Sergio; Ortiz de la Tabla, Victoria; Gonzalez, Matilde; Bas, Cristina; Gutierrez, Felix			Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; INVASIVE PNEUMOCOCCAL DISEASE; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; ATYPICAL PATHOGENS; ETIOLOGY; BACTEREMIA; GUIDELINES; MANAGEMENT; SOCIETY	Objective We aimed to assess the role of procalcitonin (PCT) to guide the initial selection of the antibiotic regimen for low-risk community-acquired pneumonia (CAP). Methods A single-arm clinical trial was conducted including outpatients with CAP and Pneumonia Severity Index risk classes I-II. Antimicrobial selection was based on the results of PCT measured with a rapid point-of-care testing. According to serum PCT levels, patients were assigned to two treatment strategies: oral azithromycin if PCT was < 0.5 ng/ml, or levofloxacin if levels were >= 0.5 ng/ml. Primary outcome was clinical cure rate. Short-term and long-term outcomes were assessed. Results were compared with those of a historical standard-of-care control-group treated in our centre. Results Of 253 subjects included, 216 (85.4%) were assigned to azithromycin. Pneumococcal infection was diagnosed in 26 (12%) and 21 (56.8%) patients allocated to azithromycin and levofloxacin groups, respectively. No patients in the azithromycin group developed bacteraemia. Atypical organisms were more common in patients given azithromycin (18.5% vs 8.1%, respectively). The majority (93%) of patients with atypical pneumonia had low PCT levels. Clinical cure rates were 95.8% in the azithromycin group, 94.6% in the levofloxacin group, and 94.4% in the historical control group. No 30-day mortality or recurrences were observed, and the 3-year rates of recurrence and mortality were very low in both groups. Adverse events occurrence was also infrequent. Conclusion A PCT-guided strategy with a rapid point-of-care testing safely allowed selecting empirical narrow-spectrum antibiotics in outpatients with CAP.	[Masia, Mar; Padilla, Sergio; Bas, Cristina; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain; [Ortiz de la Tabla, Victoria] Hosp Univ San Juan, Microbiol Serv, Alicante, Spain; [Gonzalez, Matilde] Hosp Gen Univ Elche, Emergency Dept, Elche, Spain	Universidad Miguel Hernandez de Elche	Masia, M; Gutierrez, F (corresponding author), Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain.	marmasiac@gmali.com; gutierrez_fel@gva.es	Rodero, Félix Gutiérrez/Q-7880-2018; Padilla, Sergio/U-7682-2017; Masia, Mar/U-7510-2017	Rodero, Félix Gutiérrez/0000-0002-9485-6867; Masia, Mar/0000-0001-9878-2458; Padilla, Sergio/0000-0002-8420-7310	Conselleria de Sanidad, Generalitat Valenciana [Pi QA-2004-35, DOGV 4.781 de 23 de Junio]	Conselleria de Sanidad, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This study was supported by a grant from Conselleria de Sanidad, Generalitat Valenciana (Pi QA-2004-35 to MM and DOGV 4.781 de 23 de Junio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2007, RESP MED, V101, P2168, DOI 10.1016/j.rmed.2007.05.007; Artiles F, 2009, ENFERM INFEC MICR CL, V27, P14, DOI 10.1016/j.eimc.2008.03.001; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Blasi F, 2004, EUR RESPIR J, V24, P171, DOI 10.1183/09031936.04.00135703; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borg MA, 2009, CLIN MICROBIOL INFEC, V15, P232, DOI 10.1111/j.1469-0691.2008.02651.x; Branche AR, 2015, J INFECT DIS, V212, P1692, DOI 10.1093/infdis/jiv252; Capelastegui A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-134; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Doern GV, 2005, CLIN INFECT DIS, V41, P139, DOI 10.1086/430906; File TM, 2013, INFECT DIS CLIN N AM, V27, P99, DOI 10.1016/j.idc.2012.11.005; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gant CM, 2012, ANTIMICROB AGENTS CH, V56, P4988, DOI 10.1128/AAC.01201-12; Gutierrez F, 2005, CLIN MICROBIOL INFEC, V11, P788, DOI 10.1111/j.1469-0691.2005.01226.x; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Gutierrez F, 2008, DRUG AGING, V25, P585, DOI 10.2165/00002512-200825070-00005; Kelley MA, 2000, CLIN INFECT DIS, V31, P1008, DOI 10.1086/318157; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kristoffersen KB, 2009, CLIN MICROBIOL INFEC, V15, P481, DOI 10.1111/j.1469-0691.2009.02709.x; Kruger S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-65; Lim WS, 2011, THORAX, V66, P548, DOI 10.1136/thoraxjnl-2011-200081; Long W, 2011, RESPIROLOGY, V16, P819, DOI 10.1111/j.1440-1843.2011.01978.x; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Masia M, 2007, CLIN MICROBIOL INFEC, V13, P153, DOI 10.1111/j.1469-0691.2006.01629.x; Masia M, 2005, CHEST, V128, P2223, DOI 10.1378/chest.128.4.2223; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Prat C, 2006, J INFECTION, V52, P169, DOI 10.1016/j.jinf.2005.05.019; Rozenbaum MH, 2013, EUR J CLIN MICROBIOL, V32, P305, DOI 10.1007/s10096-012-1778-4; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Spindler C, 2012, SCAND J INFECT DIS, V44, P885, DOI 10.3109/00365548.2012.700120; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	33	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175634	10.1371/journal.pone.0175634	http://dx.doi.org/10.1371/journal.pone.0175634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426811	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900035
J	Sun, CL; Zhang, HL; Liu, M; Wang, W; Crowder, CM				Sun, Chun-Ling; Zhang, Huiliang; Liu, Meng; Wang, Wang; Crowder, C. Michael			A screen for protective drugs against delayed hypoxic injury	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; C-ELEGANS; ISCHEMIA/REPERFUSION INJURY; CEREBRAL-ISCHEMIA; HYDROGEN-PEROXIDE; INHIBITION; RATS; PHENAZOPYRIDINE; CYPERMETHRIN	Despite longstanding efforts to develop cytoprotective drugs against ischemia/reperfusion (IR) injuries, there remains no effective therapeutics to treat hypoxic injury. The failure of traditional strategies at solving this problem suggests the need for novel and unbiased approaches that can lead to previously unsuspected targets and lead compounds. Towards this end, we report here a unique small molecule screen in the nematode C. elegans for compounds that improve recovery when applied after the hypoxic insult, using a C. elegans strain engineered to have delayed cell non-autonomous death. In a screen of 2000 compounds, six were found to produce significant protection of C. elegans from delayed death. Four of the compounds were tested in an ex vivo mouse heart ischemia/reperfusion model and two, meclocycline and 3-amino-1,2,4-triazole, significantly reduced infarction size. Our work demonstrates the feasibility of this novel C. elegans screen to discover hypoxia protective drugs that are also protective in a mammalian model of hypoxic injury.	[Sun, Chun-Ling; Zhang, Huiliang; Liu, Meng; Wang, Wang; Crowder, C. Michael] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Liu, Meng] Second Mil Med Univ, Dept Anesthesiol, Shanghai, Peoples R China; [Crowder, C. Michael] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Liu, Meng] Dept Anesthesiol, Qingdao, Shandong, Peoples R China	University of Washington; University of Washington Seattle; Naval Medical University; University of Washington; University of Washington Seattle	Crowder, CM (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA.; Crowder, CM (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA.	cmc53@uw.edu	Zhang, Huiliang/AAW-7729-2020; wang, wang/GWQ-7272-2022; Zhang, Huiliang/AAP-1243-2020	Zhang, Huiliang/0000-0002-8967-1219; Wang, Wang/0000-0001-9093-412X	NIH Office of Research Infrastructure Programs [P40 OD010440]; National Institute of Neurological Disorders and Stroke [R01NS045905, R21NS084360]; International Anesthesia Research Society Frontiers in Anesthesia Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Anesthesia Research Society Frontiers in Anesthesia Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Barbara Scott for her technical contributions to the work. We also grateful to Timothy J Martins and James Annis (Quellos High Throughput Screening Core, UW) for the assistance of high-throughput screen. Strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).; The work was supported by National Institute of Neurological Disorders and Stroke [Grants R01NS045905, R21NS084360] and by the International Anesthesia Research Society Frontiers in Anesthesia Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMER SM, 1985, MUTAT RES, V155, P135, DOI 10.1016/0165-1218(85)90132-6; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; AUYEUNG YY, 1995, CIRCULATION, V92, P3318, DOI 10.1161/01.CIR.92.11.3318; BRENNER S, 1974, GENETICS, V77, P71; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Gong GH, 2013, JOVE-J VIS EXP, DOI 10.3791/50818; Guo S, 2012, CIRC RES, V110, P948, DOI 10.1161/CIRCRESAHA.111.263715; Hu JX, 2013, J APPL TOXICOL, V33, P576, DOI 10.1002/jat.1769; Kagawa N, 2005, FRONT BIOSCI-LANDMRK, V10, P608, DOI 10.2741/1557; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kingma JG, 1996, AM J PHYSIOL-HEART C, V270, pH1165, DOI 10.1152/ajpheart.1996.270.4.H1165; Kosma CI, 2016, SCI TOTAL ENVIRON, V569, P732, DOI 10.1016/j.scitotenv.2016.06.160; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; MARGOLIASH E, 1958, BIOCHEM J, V68, P468, DOI 10.1042/bj0680468; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; MUNDAY R, 1994, FREE RADICAL RES, V21, P67, DOI 10.3109/10715769409056558; Munday R, 1998, J APPL TOXICOL, V18, P161, DOI 10.1002/(SICI)1099-1263(199803/04)18:2<161::AID-JAT491>3.3.CO;2-V; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Rauthan Manish, 2015, Worm, V4, pe1096490, DOI 10.1080/21624054.2015.1096490; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schwartz J, 2013, TOXICOL APPL PHARM, V273, P172, DOI 10.1016/j.taap.2013.08.027; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Singh AK, 2012, CURR NEUROPHARMACOL, V10, P64, DOI 10.2174/157015912799362779; Singh AK, 2012, NEUROBIOL AGING, V33, P404, DOI 10.1016/j.neurobiolaging.2010.02.018; Sun CL, 2014, CELL DEATH DIFFER, V21, P557, DOI 10.1038/cdd.2013.176; TATENO C, 1993, CELL BIOL TOXICOL, V9, P215, DOI 10.1007/BF00755600; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; THOMAS BH, 1990, J PHARM SCI, V79, P321, DOI 10.1002/jps.2600790410; Wojtovich AP, 2012, FEBS LETT, V586, P428, DOI 10.1016/j.febslet.2012.01.021; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu QJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000555	44	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176061	10.1371/journal.pone.0176061	http://dx.doi.org/10.1371/journal.pone.0176061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426808	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900095
J	Vogeler, S; Galloway, TS; Isupov, M; Bean, TP				Vogeler, Susanne; Galloway, Tamara S.; Isupov, Michail; Bean, Tim P.			Cloning retinoid and peroxisome proliferator-activated nuclear receptors of the Pacific oyster and in silico binding to environmental chemicals	PLOS ONE			English	Article							HIGH-AFFINITY LIGAND; X-RECEPTOR; ENDOCRINE DISRUPTION; ORGANOTIN COMPOUNDS; CRASSOSTREA-GIGAS; GENE-EXPRESSION; ROCK SHELL; ACID; RXR; RAR	Disruption of nuclear receptors, a transcription factor superfamily regulating gene expression in animals, is one proposed mechanism through which pollution causes effects in aquatic invertebrates. Environmental pollutants have the ability to interfere with the receptor's functions through direct binding and inducing incorrect signals. Limited knowledge of invertebrate endocrinology and molecular regulatory mechanisms, however, impede the understanding of endocrine disruptive effects in many aquatic invertebrate species. Here, we isolated three nuclear receptors of the Pacific oyster, Crassostrea gigas: two isoforms of the retinoid X receptor, CgRXR-1 and CgRXR-2, a retinoic acid receptor ortholog CgRAR, and a peroxisome proliferator-activated receptor ortholog CgPPAR. Computer modelling of the receptors based on 3D crystal structures of human proteins was used to predict each receptor's ability to bind to different ligands in silico. CgRXR showed high potential to bind and be activated by 9-cis retinoic acid and the organotin tributyltin (TBT). Computer modelling of CgRAR revealed six residues in the ligand binding domain, which prevent the successful interaction with natural and synthetic retinoid ligands. This supports an existing theory of loss of retinoid binding in molluscan RARs. Modelling of CgPPAR was less reliable due to high discrepancies in sequence to its human ortholog. Yet, there are suggestions of binding to TBT, but not to rosiglitazone. The effect of potential receptor ligands on early oyster development was assessed after 24h of chemical exposure. TBT oxide (0.2 mu g/l), all-trans retinoic acid (ATRA) (0.06 mg/L) and perfluorooctanoic acid (20 mg/L) showed high effects on development (> 74% abnormal developed D-shelled larvae), while rosiglitazone (40 mg/L) showed no effect. The results are discussed in relation to a putative direct (TBT) disruption effect on nuclear receptors. The inability of direct binding of ATRA to CgRAR suggests either a disruptive effect through a pathway excluding nuclear receptors or an indirect interaction. Our findings provide valuable information on potential mechanisms of molluscan nuclear receptors and the effects of environmental pollution on aquatic invertebrates.	[Vogeler, Susanne; Galloway, Tamara S.; Isupov, Michail] Univ Exeter, Coll Life & Environm Sci, Sch Biosci, Exeter, Devon, England; [Vogeler, Susanne; Bean, Tim P.] Ctr Environm Fisheries & Aquaculture Sci, Cefas Weymouth Lab, Weymouth, England	University of Exeter; Centre for Environment Fisheries & Aquaculture Science	Bean, TP (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Cefas Weymouth Lab, Weymouth, England.	tim.bean@cefas.co.uk	Isupov, Mikhail/AAA-8280-2019; Bean, Tim/H-6792-2014	Vogeler, Susanne/0000-0003-3571-5121; Bean, Tim/0000-0002-2544-9918; Isupov, Michail/0000-0001-6842-4289	Centre for Environment, Fisheries and Aquaculture Science (Cefas); University of Exeter	Centre for Environment, Fisheries and Aquaculture Science (Cefas); University of Exeter	The study was funded by the Centre for Environment, Fisheries and Aquaculture Science (Cefas; https://www.cefas.co.uk) and by the University of Exeter (http://www.exeter.ac.uk).	Abbott BD, 2007, TOXICOL SCI, V98, P571, DOI 10.1093/toxsci/kfm110; Authority EFS, 2012, EFSA J, V10, P10; Bergman A, 2012, TOXICOL LETT, V211, pS3, DOI 10.1016/j.toxlet.2012.03.020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M., 2014, NUCL ACIDS RES; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Carter CJ, 2015, J EXP ZOOL PART B, V324, P51, DOI 10.1002/jez.b.22604; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Cheng XG, 2008, TOXICOL SCI, V106, P37, DOI 10.1093/toxsci/kfn161; CRETON R, 1993, DEV GROWTH DIFFER, V35, P357; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Gesto M, 2013, AQUAT TOXICOL, V142, P96, DOI 10.1016/j.aquatox.2013.08.001; Giesy JP, 2010, AQUATIC TOXICOLOGY P, P1; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez-Mazariegos J, 2014, ENDOCRINOLOGY, V155, P4275, DOI 10.1210/en.2014-1181; Harada S, 2015, SCI REPORTS, P5; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Heral M., 1989, AQUACULTURE BIOTECHN, P1081; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Higuera-Ruiz R, 2011, ENVIRON TECHNOL, V32, P583, DOI 10.1080/09593330.2010.506201; Horiguchi T, 2007, AQUAT TOXICOL, V84, P379, DOI 10.1016/j.aquatox.2007.06.019; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Inoue D, 2010, J HEALTH SCI, V56, P221, DOI 10.1248/jhs.56.221; IPCS IPoCS, 1990, TRIB COMP ENV HLTH C; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kamata R, 2008, TOXICOL IN VITRO, V22, P1050, DOI 10.1016/j.tiv.2008.01.002; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kaur S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121259; Klaholz BP, 1998, NAT STRUCT BIOL, V5, P199, DOI 10.1038/nsb0398-199; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LAUGHLIN RB, 1986, ENVIRON SCI TECHNOL, V20, P201, DOI 10.1021/es00144a016; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Leverett D, 2013, OYSTER EMBRYO LARVAL; Levin AA, 1992, 9 CIS RETINOIC ACID; Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mhadhbi L, 2012, J ENVIRON MONITOR, V14, P1375, DOI 10.1039/c2em30037k; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascoal S, 2013, MOL ECOL, V22, P1589, DOI 10.1111/mec.12137; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RUIZ JM, 1995, MAR ENVIRON RES, V40, P363, DOI 10.1016/0141-1136(94)00154-H; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shmarakov IO, 2015, HEPATOL SURG NUTR, V4, P243, DOI 10.3978/j.issn.2304-3881.2015.05.05; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; THAIN JE, 1986, WATER SCI TECHNOL, V18, P193, DOI 10.2166/wst.1986.0195; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsunemasa N, 2011, ARCH ENVIRON CON TOX, V61, P128, DOI 10.1007/s00244-010-9598-y; Urushitani H, 2013, AQUAT TOXICOL, V142, P403, DOI 10.1016/j.aquatox.2013.09.008; Urushitani H, 2011, AQUAT TOXICOL, V103, P101, DOI 10.1016/j.aquatox.2011.02.012; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Vierke Lena, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-16; Vogeler S, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0129-6; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; WALDOCK MJ, 1983, MAR POLLUT BULL, V14, P411, DOI 10.1016/0025-326X(83)90445-9; WAN YJY, 1994, EXP CELL RES, V210, P56, DOI 10.1006/excr.1994.1009; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wu WJ, 2008, EXP PARASITOL, V120, P208, DOI 10.1016/j.exppara.2008.07.005; Yamashita N, 2005, MAR POLLUT BULL, V51, P658, DOI 10.1016/j.marpolbul.2005.04.026; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang X-k, 1992, HOMODIMER FORMATION	84	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176024	10.1371/journal.pone.0176024	http://dx.doi.org/10.1371/journal.pone.0176024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426724	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900087
J	Ronowicz, M; Boissin, E; Postaire, B; Bourmaud, CAF; Gravier-Bonnet, N; Schuchert, P				Ronowicz, Marta; Boissin, Emilie; Postaire, Bautisse; Bourmaud, Chloe Annie-France; Gravier-Bonnet, Nicole; Schuchert, Peter			Modern alongside traditional taxonomy-Integrative systematics of the genera Gymnangium Hincks, 1874 and Taxella Allman, 1874 (Hydrozoa, Aglaopheniidae)	PLOS ONE			English	Article							HYDROIDS CNIDARIA HYDROZOA; FAMILY HYDRACTINIIDAE; INDIAN-OCEAN; DIVERSITY; CONSERVATION; MALDIVES	We studied the diversity within the former genus Gymnangium in the South West Indian Ocean by using an integrative approach of both traditional (morphology-based) and modern molecular taxonomy. Nine species were recorded in the material collected. A total of 97 16S mitochondrial DNA sequences and 54 Calmodulin nuclear sequences from eight Gymnangium/Taxella species were analyzed. We found both morphological and molecular differences in the studied Gymnangium species that make it necessary to split the genus. It is proposed to revalidate the genus Taxella which is currently regarded as a synonym of Gymnangium. Two species of the genus Taxella (T. eximia and T. gracilicaulis), until now regarded as distinct species based on morphological characteristics, cluster together in one phylogenetic clade. Possible explanations are discussed. Two species from Madagascar new to science are herein described and rare species from the Indian Ocean islands are redescribed.	[Ronowicz, Marta] Polish Acad Sci, Dept Marine Ecol, Inst Oceanol, Sopot, Poland; [Boissin, Emilie] Univ Perpignan, Ctr Rech Insulaire & Observ Environm USR3278, Perpignan, France; [Postaire, Bautisse] Avignon Univ, Aix Marseille Univ, CNRS, IRD,IMBE UMR 7263, Marseille, France; [Postaire, Bautisse; Bourmaud, Chloe Annie-France; Gravier-Bonnet, Nicole] Univ La Reunion, Fac Sci & Technol, UMR ENTROPIE, St Denis, France; [Postaire, Bautisse; Bourmaud, Chloe Annie-France; Gravier-Bonnet, Nicole] Lab Excellence Corail, Perpignan, France; [Schuchert, Peter] Nat Hist Museum Geneva, Geneva, Switzerland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Universite Perpignan Via Domitia; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); University of La Reunion	Ronowicz, M (corresponding author), Polish Acad Sci, Dept Marine Ecol, Inst Oceanol, Sopot, Poland.	martar@iopan.gda.pl	Boissin, Emilie/F-2750-2011; Postaire, Bautisse Didier/AAW-5096-2021	Boissin, Emilie/0000-0002-4110-790X; Postaire, Bautisse Didier/0000-0001-8566-1040; Bourmaud, Chloe/0000-0003-1653-7550; Ronowicz, Marta/0000-0001-8703-9132	Polish National Science Center grant [UMO-2012/04/M/NZ8/00670]; budget of the statutory activity of the Institute of Oceanology Polish Academy of Sciences; Polish National Science grant [UMO-2014/15/B/NZ8/00237]	Polish National Science Center grant; budget of the statutory activity of the Institute of Oceanology Polish Academy of Sciences; Polish National Science grant	The research was funded by the Polish National Science Center grant (UMO-2012/04/M/NZ8/00670) to MR. The publication has been financed by the budget of the statutory activity of the Institute of Oceanology Polish Academy of Sciences and partly by the Polish National Science grant (UMO-2014/15/B/NZ8/00237).	ALLMAN GJ, 1874, NATURE, V11, P179; Allman GJ., 1883, ZOOLOGY, V7, P1; ALLMAN GJ, 1876, J LINN SOC LOND, V12, P251; [Anonymous], 1995, HYDROIDS SAGAMI BA 2; Armstrong SJ., 1879, J ASIA SOC BENG, V48, P98; Bale W.M., 1884, CATALOGUE AUSTR HYDR; Bedot M., 1921, Revue Suisse de Zoologie, V28, P311; Billard A., 1918, Arch Zool Exp Notes et Rev Paris, V57; Billard A., 1905, B MUSEUM HIST NATURE, V11, P331; Billard A., 1907, ZOOLOGIE BIOL ANIM 9, V9, P319; Billard A, 1913, RES EXPLOR SIBOGA 19, V7, P1; Billard A., 1907, ARCH ZOOLOGIE EXPT G, VVII, P385; Billard A., 1901, B MUSEUM HIST NATURE, V7, P117; BILLARD ARMAND, 1933, MEM INST EGYPTE, V21, P1; Bogle M.A., 1975, THESIS; Bouillon J., 1985, Indo-Malayan Zoology, V2, P29; Bouillon J., 2006, INTRO HYDROZOA; Briggs E. A., 1918, Records of the Australian Museum, V12; Briggs E. A., 1915, P LINN SOC N S W, V40, P196, DOI [DOI 10.5962/BHL.PART.18870, 10.5962/bhl.part.18870]; Briggs EA, 1931, GREAT BARRIER REEF E, V4, P181; Busk G, 1852, NARRATIVE VOYAGE HMS, V1, P343, DOI DOI 10.5962/BHL.TITLE.4847; Calder DR, 2013, ZOOTAXA, V3648, P1; Calder Dale R., 1997, Royal Ontario Museum Life Sciences Contributions, V161, P1; Campenhausen BV, 1897, ZOOL I U JENA, P297; Coleman CO, 2006, ZOOTAXA, P61, DOI 10.11646/zootaxa.1360.1.4; Cornelius P.F.S., 1995, SYNOPSES BRIT FAUNA, V50; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; de Ruijter WPM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013714; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dollfus RP, 1933, B I EGYPTE, V15, P125; El Beshbeeshy M., 1995, Bulletin of the National Institute of Oceanography and Fisheries, V21, P319; Fraser CM, 1936, P T ROYAL SOC CANADA, V30, P49; Galea HR, 2013, ZOOTAXA, V3686, P1; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gorley C.K., 2006, GETTING STARTED PRIM; Gravier-Bonnet N, 2004, P 10 INT COR REEF S, P188; Gravier-Bonnet N., 1979, ZOOL VERHANDEL, V169, P76; Gravier-Bonnet Nicole, 2006, Western Indian Ocean Journal of Marine Science, V5, P123; Gravier-Bonnet Nicole, 2012, Atoll Research Bulletin, P85; Hincks XVIII T., 1874, ANN MAG NAT HIST, V4, P125; Hirohito, 1983, PUBLICATIONS BIOL LA, V6, P1; Hoareau TB, 2013, J BIOGEOGR, V40, P2167, DOI 10.1111/jbi.12155; Hodgson MM, 1950, P ROYAL SOC TASMANIA, P1; Hughes R. G., 1992, Scientia Marina, V56, P269; Jaderholm E., 1903, ARK ZOOL, V1, P259; JADERHOLM E, 1916, KUNGLIGA SVENSKA VET, V52, P1; Jaderholm E., 1919, ARK ZOOL, V12, P1, DOI DOI 10.5962/BHL.PART.789; JADERHOLM E, 1920, ARK ZOOL, V13, P1; Jarvis F. E., 1922, Transactions of the Linnean Society of London Zool, V18, P331; Jimenez H, 2012, J SEA RES, V72, P77, DOI 10.1016/j.seares.2012.04.011; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirchenpauer G. H., 1876, ABHANDLUNGEN GEBIETE, V6, P1; Kirkendale Lisa, 2003, Micronesica, V35-36, P159; Kirkpatrick R., 1890, REPORTS ZOOLOGICAL C, P603; Leciere L, 2009, SYST BIOL, V58, P509; LELOUP E., 1932, BULL MUS ROY HIST NAT BELGIQUE, V8, P1; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; MAMMEN TA, 1967, J MAR BIOL ASSOC IND, V7, P291; Marktanner-Turneretscher G., 1890, ANN KK NATURHISTORIS, V5, P195; McClanahan TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093385; Medel M.D., 1995, ZOOLOGISCHE VERHANDE, V300, P1; Mergner H., 1977, Meteor Forschungsergebnisse Reihe D - Biologie, V24D, P1; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; MILLARD N A H, 1978, Annals of the South African Museum, V74, P159; Millard N. A. H., 1968, Vidensk. Meddr dansk. naturh. Foren, V131, P251; MILLARD N. A. H., 1962, ANN S AFRICAN MUS, V46, P261; MILLARD N. A. H., 1958, AMU S AFRICAN MUS, V44, P165; Millard N.A.H., 1973, SCI ZOOLOGIQUES, V206, P1; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Millard NAH, 1974, ANN S AFR MUS, P1; Millard NAH, 1967, ANN S AFR MUS, V50, P168; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2012, ZOOL J LINN SOC-LOND, V164, P717, DOI 10.1111/j.1096-3642.2011.00784.x; Nutting C. C., 1927, Bulletin United States National Museum, V100, P195; Nutting C.C., 1906, B US FISH COMM, V23, p[931, 1]; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; OOISHI SHIGEKO, 1964, REP FAC FISH PREFECT UNIV MIE, V5, P189; Pennycuik PR, 1959, MARINE BRACKISH WA 5, V1, P141; Postaire B, 2015, ZOOL SCR, V12; Postaire B, 2016, MOL PHYLOGENET EVOL, V105, P36, DOI 10.1016/j.ympev.2016.08.013; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; REES W J, 1965, Proceedings of the Royal Society of Edinburgh Section B (Biology), V69, P34; Rees W. J., 1987, ZOOLOGISCHE VERHANDE, V237, P1; Rho B. J., 1977, ILLUSTRATED FLORA FA, V20, P1; Rho B.J., 1967, KOREAN CULTURE RES I, V10, P341; Rho BJ, 1974, I HYDROIDS J KOREAN, V12, P133; Ritchie J, 1910, P ZOOL SOC LOND, V1910, P826; Ritchie James, 1911, Memoirs of the Australian Museum, V4; Ritchie James, 1910, Records of the Indian Museum, V5; Ritchie James, 1909, Annals & Magazine of Natural History Series 8, V3; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rossi S, 2000, SCI MAR, V64, P135, DOI 10.3989/scimar.2000.64s1135; RYLAND J S, 1991, Memoirs of the Queensland Museum, V30, P525; Schmidt H.-E., 1973, P283; Schmidt H.-E., 1972, Journal of the Marine Biological Association of India, V13, P27; Schneider KC., 1897, ZOOLOGISCHE JB SGBT, V10, P472; Schuchert P., 1874, WORLD HYDROZOA DATA; Schuchert Peter, 2003, Steenstrupia, V27, P137; Schuchert P, 2015, REV SUISSE ZOOL, V122, P325, DOI 10.5281/zenodo.30004; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; Siedler G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027399; Smaldon G, 1976, NAT HIST, V4, P1; Stechow E., 1919, Zoologische Jahrbuecher (Systematik), V42; Stechow E., 1924, Zoologischer Anzeiger Leipzig, V59, P57; Stechow E., 1912, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V32; Stechow E., 1925, Zoologische Jahrbuecher Abteilungen f Systematik, V50, P191; Stechow E., 1921, Zoologischer Anzeiger Leipzig, V53, P223; Stechow E., 1907, Zoologischer Anzeiger Leipzig, V32; Stechow E, 1909, ABHANDLUNGEN MATH PH, V1, P1; Stechow E., 1923, ZOOL JB SYST, V47, P29; Stechow E., 1913, ABHANDLUNGEN KONI MP, V3, P1, DOI DOI 10.5962/BHL.TITLE.11621; Stechow E, 1923, GESELLSCHAFT, V35, P459; Stechow E., 1923, J COLL SCI IMP U TOK, V44, P1; THORNELY LA, 1904, REPORT GOVT CEYLON S, V2, P107; Thornely LR, 1908, J LINN SOC LOND, V31, P80; THORPE RS, 1980, BIOL J LINN SOC, V13, P7, DOI 10.1111/j.1095-8312.1980.tb00067.x; van Praet M., 1980, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V1, P871; van Soest R.W.M., 1976, Beaufortia, V25, P79; VANGEMERDENHOOG.GC, 1965, STUD FAUNA CURACAO, V22, P1; Ver voort W., 1966, Galathea Report, V8, P97; Vervoort V., 1993, ISRAEL ZOOL MED LEID, V67, P537; Vervoort W., 1941, TEMMINCKIA, V6, P186; Vervoort W., 1987, P83; Vervoort W, 1967, HYDROGRAPHIC NEWSLET, V5, P61; VERVOORT W, 1968, ZOOL VERH-LEIDEN, V92, P1; VERVOORT W., 1977, ZOOLOGISCHE VERHANDE, V159, P3; Vervoort Willem, 2003, NIWA Biodiversity Memoir, V119, P1; Von Schenck D. A., 1965, Revue Suisse de Zoologie, V72, P885; Watson J.E., 2001, Zoologische Verhandelingen (Leiden), V334, P151; WATSON J E, 1973, Transactions of the Royal Society of South Australia, V97, P153; Watson J.E., 2005, MARINE FLORA FAUNA E, P495; Watson Jeanette E., 2000, Beagle, V16, P1; Yamada M., 1959, PUBLICATIONS AKKESHI, V9, P1101; YAMADA MAYUMI, 1958, JOUR FAC SCI HOKKAIDO UNIV SER VI ZOOL, V14, P51	136	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174244	10.1371/journal.pone.0174244	http://dx.doi.org/10.1371/journal.pone.0174244			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422958	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600016
J	Katiraei, S; Hoving, LR; van Beek, L; Mohamedhoesein, S; Carlotti, F; van Diepen, JA; Rensen, PCN; Netea, MG; van Dijk, KW; Berbee, JFP; van Harmelen, V				Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; Carlotti, Francoise; van Diepen, Janna A.; Rensen, Patrick C. N.; Netea, Mihai G.; van Dijk, Ko Willems; Berbee, Jimmy F. P.; van Harmelen, Vanessa			BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion	PLOS ONE			English	Article							ADIPOSE; ADIPOCYTES; CAPACITY; DEPOT; CELLS	Experimental bone marrow transplantation (BMT) in mice is commonly used to assess the role of immune cell-specific genes in various pathophysiological settings. The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to characterize metabolic tissues that may be affected by the BMT procedure and impair the HFD-induced response. Male C57BL/6 mice underwent syngeneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-fat diet (LFD) or HFD for 16 weeks. HFD-induced obesity was reduced in mice after BMT as compared to HFD-fed control mice, characterized by both a reduced fat (-33%; p<0.01) and lean (-11%; p<0.01) mass, while food intake and energy expenditure were unaffected. As compared to control mice, BMT-treated mice had a reduced mature adipocyte volume (approx. -45%; p<0.05) and reduced numbers of preadipocytes (-38%; p<0.05) and macrophages (-62%; p<0.05) in subcutaneous, gonadal and visceral white adipose tissue. In BMT-treated mice, pancreas weight (-46%; p<0.01) was disproportionally decreased. This was associated with reduced plasma insulin (-68%; p<0.05) and C-peptide (-37%; p<0.01) levels and a delayed glucose clearance in BMT-treated mice on HFD as compared to control mice. In conclusion, the reduction in HFD-induced obesity after BMT in mice is at least partly due to alterations in the adipose tissue cell pool composition as well as to a decreased pancreatic secretion of the anabolic hormone insulin. These effects should be considered when interpreting results of experimental BMT in metabolic studies.	[Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; Carlotti, Francoise; Rensen, Patrick C. N.; van Dijk, Ko Willems; Berbee, Jimmy F. P.; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Carlotti, Francoise] Leiden Univ, Med Ctr, Div Nephrol, Dept Med, Leiden, Netherlands; [van Diepen, Janna A.; Netea, Mihai G.] Radboud UMC, Dept Internal Med, Nijmegen, Netherlands; [Rensen, Patrick C. N.; van Dijk, Ko Willems; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Div Endocrinol, Dept Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Katiraei, S (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.; Katiraei, S (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	s.katiraei@lumc.ni	Netea, Mihai/N-5155-2014; Carlotti, Françoise/AAN-5018-2021; van Dijk, Ko Willems/AAT-4681-2021; Hoving, Lisa/S-4167-2018; Rensen, Patrick C.N./D-7176-2018; van Diepen, Janna/E-9485-2010; Carlotti, Françoise/H-1060-2014; van Dijk, Ko Willems/A-1798-2008	Carlotti, Françoise/0000-0001-7929-8468; van Dijk, Ko Willems/0000-0002-2172-7394; Hoving, Lisa/0000-0002-3096-7533; Rensen, Patrick C.N./0000-0002-8455-4988; van Diepen, Janna/0000-0001-9091-1075; Carlotti, Françoise/0000-0001-7929-8468; van Dijk, Ko Willems/0000-0002-2172-7394; van Harmelen, Vanessa/0000-0003-0111-9858	Rembrandt Institute of Cardiovascular Sciences (RICS); Cardiovascular Research Netherlands (CVON IN CONTROL); ERC Consolidator Grant [310372]; Veni Grant of the Netherlands Organization for the Scientific Research [91616083]	Rembrandt Institute of Cardiovascular Sciences (RICS); Cardiovascular Research Netherlands (CVON IN CONTROL); ERC Consolidator Grant; Veni Grant of the Netherlands Organization for the Scientific Research	Funded by Rembrandt Institute of Cardiovascular Sciences (RICS) and Cardiovascular Research Netherlands (CVON IN CONTROL). M.G.N was supported by an ERC Consolidator Grant (#310372). J.A.v.D. was supported by a Veni Grant of the Netherlands Organization for the Scientific Research (#91616083).	Ablamunits V, 2007, OBESITY, V15, P1419, DOI 10.1038/oby.2007.170; Aparicio-Vergara M, 2010, ATHEROSCLEROSIS, V213, P335, DOI 10.1016/j.atherosclerosis.2010.05.030; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Ellenbroek JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056922; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Kathryn E., 2003, J CLIN INVEST, V112, P1785; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nylander V, 2016, DIABETES; Poglio S, 2009, AM J PATHOL, V174, P44, DOI 10.2353/ajpath.2009.080505; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; van Beek L, 2015, OBESITY, V23, P2435, DOI 10.1002/oby.21309; van Beek L, 2015, DIABETOLOGIA, V58, P1601, DOI 10.1007/s00125-015-3594-8; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Waas MV, 2010, J HEMATOL ONCOL, V32, P171; Wei C, 2015, CLIN ENDOCRINOL, V82, P59, DOI 10.1111/cen.12575	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175524	10.1371/journal.pone.0175524	http://dx.doi.org/10.1371/journal.pone.0175524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445487	Green Published, gold, Green Submitted			2022-12-27	WOS:000400309200023
J	Zheng, Z; Wang, DD; He, H; Wei, C				Zheng, Zhou; Wang, Dandan; He, Hong; Wei, Cong			Bacterial diversity of bacteriomes and organs of reproductive, digestive and excretory systems in two cicada species (Hemiptera: Cicadidae)	PLOS ONE			English	Article							TRANSOVARIAL TRANSMISSION; INTRACELLULAR SYMBIONTS; XYLEM FLUID; ENDOSYMBIONTS; LEAFHOPPER; GENOMICS; INSECTS; IDENTIFICATION; MEIOTHERMUS; EVOLUTION	Cicadas form intimate symbioses with bacteria to obtain nutrients that are scarce in the xylem fluid they feed on. The obligate symbionts in cicadas are purportedly confined to specialized bacteriomes, but knowledge of bacterial communities associated with cicadas is limited. Bacterial communities in the bacteriomes and organs of reproductive, digestive and excretory systems of two cicada species (Platypleura kaempferi and Meimuna mongolica) were investigated using different methods, and the bacterial diversity and distribution patterns of dominant bacteria in different tissues were compared. Within each species, the bacterial communities of testes are significantly different from those of bacteriomes and ovaries. The dominant endosymbiont Candidatus Sulcia muelleri is found not only in the bacteriomes and reproductive organs, but also in the "filter chamber + conical segment" of both species. The transmission mode of this endosymbiont in the alimentary canal and its effect on physiological processes merits further study. A novel bacterium of Rhizobiales, showing similar to 80% similarity to Candidatus Hodgkinia cicadicola, is dominant in the bacteriomes and ovaries of P. kaempferi. Given that the genome of H. cicadicola exhibits rapid sequence evolution, it is possible that this novel bacterium is a related endosymbiont with beneficial trophic functions similar to that of H. cicadicola in some other cicadas. Failure to detect H. cicadicola in M. mongolica suggests that it has been subsequently replaced by another bacterium, a yeast or gut microbiota which compensates for the loss of H. cicadicola. The distribution of this novel Rhizobiales species in other cicadas and its identification require further investigation to help establish the definition of the bacterial genus Candidatus Hodgkinia and to provide more information on sequence divergence of related endosymbionts of cicadas. Our results highlight the complex bacterial communities of cicadas, and are informative for further studies of the interactions and co- evolution of insect- microbial symbioses in Cicadoidea.	[Wang, Dandan; Wei, Cong] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China; [Zheng, Zhou; He, Hong] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wei, C (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.; He, H (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	hehong@nwsuaf.edu.cn; congwei@nwsuaf.edu.cn		Wei, Cong/0000-0002-1492-7240	National Natural Science Foundation of China [31572302, 31493021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially funded by the National Natural Science Foundation of China (Grant No. 31572302, No. 31493021) to C.W. (http://www.nsfc.gov.cn/). There was no additional external funding received for this study.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Ammar ED, 2011, ARCH MICROBIOL, V193, P35, DOI 10.1007/s00203-010-0637-x; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bressan A, 2013, ENV MICROBIOL REP, V5, P499, DOI 10.1111/1758-2229.12051; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chou I, 1997, CICADIDAE CHINA HOMO, P1; CLARK TB, 1982, SCIENCE, V217, P57, DOI 10.1126/science.217.4554.57; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gonella E, 2011, APPL ENVIRON MICROB, V77, P1423, DOI 10.1128/AEM.02121-10; Gosalbes MJ, 2010, INT J MED MICROBIOL, V300, P271, DOI 10.1016/j.ijmm.2009.12.001; Gupta R, 2012, MOL BIOL REP, V39, P5607, DOI 10.1007/s11033-011-1365-2; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hou Z, 2014, J INSECT SCI, V15, P42; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Ishii Y, 2013, APPL ENVIRON MICROB, V79, P5013, DOI 10.1128/AEM.01527-13; Jurkevitch E, 2011, BENEFICIAL MICROORGA, P27; Koga R, 2013, ENVIRON MICROBIOL, V15, P2073, DOI 10.1111/1462-2920.12121; Koga R, 2012, P NATL ACAD SCI USA, V109, pE1230, DOI 10.1073/pnas.1119212109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masurat P, 2005, J APPL MICROBIOL, V98, P727, DOI 10.1111/j.1365-2672.2004.02519.x; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Michalik A, 2014, ARTHROPOD STRUCT DEV, V43, P579, DOI 10.1016/j.asd.2014.07.005; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Muller H. J., 1962, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V51, P190, DOI 10.1007/BF00409635; Noda H, 2012, APPL ENTOMOL ZOOL, V47, P217, DOI 10.1007/s13355-012-0110-1; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pachebat JA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00329-3; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sacchi L, 2008, TISSUE CELL, V40, P231, DOI 10.1016/j.tice.2007.12.005; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Urban JM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-87; Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047; Van Leuven JT, 2012, GENOME BIOL EVOL, V4, P24, DOI 10.1093/gbe/evr125; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch EW, 2015, SYMBIOSIS, V66, P1, DOI 10.1007/s13199-015-0332-4; Yassin AF, 2005, INT J SYST EVOL MICR, V55, P1575, DOI 10.1099/ijs.0.63571-0; YOUNG D, 1995, J EXP BIOL, V198, P1001; [Zhang Ying 张瑛], 2015, [微生物学通报, Microbiology China], V42, P516; Zhong HY, 2015, ENTOMOL SCI, V18, P340, DOI 10.1111/ens.12115; Zhou WT, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev113	69	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175903	10.1371/journal.pone.0175903	http://dx.doi.org/10.1371/journal.pone.0175903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437427	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600020
J	Rees, SJ; Tay, AK; Savio, E; Da Costa, ZM; Silove, D				Rees, Susan J.; Tay, Alvin Kuowei; Savio, Elise; Da Costa, Zelia Maria; Silove, Derrick			Identifying a combined construct of grief and explosive anger as a response to injustice amongst survivors of mass conflict: A latent class analysis of data from Timor-Leste	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HUMAN-RIGHTS VIOLATIONS; MENTAL-HEALTH; PREVALENCE; TRAUMA; DISTRESS; VIOLENCE; TORTURE	Previous studies have identified high rates of explosive anger amongst post-conflict populations including Timor-Leste. We sought to test whether explosive anger was integrally associated with symptoms of grief amongst the Timorese, a society that has experienced extensive conflict-related losses. In 2010 and 2011 we recruited adults (n = 2964), 18-years and older, living in an urban and a rural village in Timor-Leste. We applied latent class analysis to identify subpopulations based on symptoms of explosive anger and grief. The best fitting model comprised three classes: grief (24%), grief-anger (25%), and a low symptom group (51%). There were more women and urban dwellers in the grief and grief-anger classes compared to the reference class. Persons in the grief and grief-anger classes experienced higher rates of witnessing murder and atrocities and traumatic losses, ongoing poverty, and preoccupations with injustice for the two historical periods of conflict (the Indonesian occupation and the later internal conflict). Compared to the reference class, only the grief-anger class reported greater exposure to extreme deprivations during the conflict, ongoing family conflict, and preoccupations with injustice for contemporary times; and compared to the grief class, greater exposure to traumatic losses, poverty, family conflict and preoccupations with injustice for both the internal conflict and contemporary times. A substantial number of adults in this postconflict country experienced a combined constellation of grief and explosive anger associated with extensive traumatic losses, deprivations, and preoccupations with injustice. Importantly, grief-anger may be linked to family conflict in this post-conflict environment.	[Rees, Susan J.; Tay, Alvin Kuowei; Savio, Elise; Da Costa, Zelia Maria; Silove, Derrick] Univ New South Wales, Level Mental Hlth Ctr 2, Acad Mental Hlth Unit, Psychiat Res & Teaching Unit, Sydney, NSW, Australia; [Savio, Elise; Da Costa, Zelia Maria] Alola Fdn, Dili, Timor-Leste	University of New South Wales Sydney	Rees, SJ (corresponding author), Univ New South Wales, Level Mental Hlth Ctr 2, Acad Mental Hlth Unit, Psychiat Res & Teaching Unit, Sydney, NSW, Australia.	j.rees@unsw.edu.au	Tay, Alvin Kuowei/AAW-3508-2021	Tay, Alvin Kuowei/0000-0002-9330-3929	National Health and Medical Research Council, Australia [08333]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council, Australia (Grant No 08333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamzawi A, 2012, ACTA PSYCHIAT SCAND, V126, P219, DOI 10.1111/j.1600-0447.2012.01855.x; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Berkowitz L, 2004, EMOTION, V4, P107, DOI 10.1037/1528-3542.4.2.107; Bonanno GA, 2001, CLIN PSYCHOL REV, V20, P1; Brooks R, 2011, J AFFECT DISORDERS, V131, P268, DOI 10.1016/j.jad.2010.12.020; Bryant RA, 2013, CURR OPIN PSYCHIATR, V26, P41, DOI 10.1097/YCO.0b013e32835b2ca2; Bryant RA, 2012, BRIT J PSYCHIAT, V201, P9, DOI 10.1192/bjp.bp.111.102889; Burstein M, 2012, J CONSULT CLIN PSYCH, V80, P102, DOI 10.1037/a0026069; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; Collins L.M., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Eckhardt C, 2004, AGGRESS VIOLENT BEH, V9, P17, DOI 10.1016/S1359-1789(02)00116-7; Fava M, 1999, J CLIN PSYCHIAT, V60, P21; Fincham D, 2009, PSYCHOPATHOLOGY, V42, P92, DOI 10.1159/000203341; Hinton D, 2003, BEHAV RES THER, V41, P647, DOI 10.1016/S0005-7967(02)00035-9; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Liddell BJ, 2013, J AFFECT DISORDERS, V150, P1242, DOI 10.1016/j.jad.2013.06.006; Maercker A, 2013, WORLD PSYCHIATRY, V12, P198, DOI 10.1002/wps.20057; McGCutcheon A.C., 1987, LATENT CLASS ANAL; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Momartin S, 2004, COMPR PSYCHIAT, V45, P475, DOI 10.1016/j.comppsych.2004.07.013; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Parkes Collin Murray, 1972, BEREAVEMENT STUDIES; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Rees S, 2015, SOC SCI MED, V130, P284, DOI 10.1016/j.socscimed.2015.02.013; Rees S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069207; ROGLER LH, 1994, J NERV MENT DIS, V182, P327, DOI 10.1097/00005053-199406000-00003; Shear K, 2005, DEV PSYCHOBIOL, V47, P253, DOI 10.1002/dev.20091; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Silove D, 2010, J TRAUMA STRESS, V23, P151, DOI 10.1002/jts.20499; Silove D, 2013, ADAPT MODEL CONCEPTU, V11; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; Silove D, 2014, PSYCHIAT RES, V219, P341, DOI 10.1016/j.psychres.2014.05.043; Silove D, 2014, LANCET GLOB HEALTH, V2, pE293, DOI 10.1016/S2214-109X(14)70196-2; Silove D, 2009, SOC SCI MED, V69, P670, DOI 10.1016/j.socscimed.2009.06.030; Simon NM, 2011, DEPRESS ANXIETY, V28, P118, DOI 10.1002/da.20775; Tay AK, 2015, SOC PSYCHIAT PSYCHIA; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; Yoshimasu K, 2011, PSYCHIAT RES, V186, P384, DOI 10.1016/j.psychres.2010.07.018	39	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175019	10.1371/journal.pone.0175019	http://dx.doi.org/10.1371/journal.pone.0175019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430793	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100011
J	Saputra, S; Jordan, D; Worthing, KA; Norris, JM; Wong, HS; Abraham, R; Trott, DJ; Abraham, S				Saputra, Sugiyono; Jordan, David; Worthing, Kate A.; Norris, Jacqueline M.; Wong, Hui S.; Abraham, Rebecca; Trott, Darren J.; Abraham, Sam			Antimicrobial resistance in coagulase-positive staphylococci isolated from companion animals in Australia: A one year study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; RISK-FACTORS; AUREUS; PSEUDINTERMEDIUS; PREVALENCE; CATS; ENVIRONMENT; INFECTION; CARRIAGE; PETS	Methicillin-resistant coagulase-positive staphylococci (CoPS) have become increasingly recognised as opportunistic pathogens that limit therapeutic options in companion animals. The frequency of methicillin resistance amongst clinical isolates on an Australia-wide level is unknown. This study determined antimicrobial susceptibility patterns for CoPS isolated from clinical infections in companion animals (dogs, cats and horses) as part of the first nation-wide survey on antimicrobial resistance in animal pathogens in Australia for a one-year period (January 2013 to January 2014). Clinical Staphylococcus spp. isolates (n = 888) obtained from 22 veterinary diagnostic laboratories were identified by MALDI-TOF mass spectrometry and subjected to antimicrobial susceptibility testing for 16 antimicrobials, representing 12 antimicrobial classes. Potential risk factors associated with methicillin resistance in Staphylococcus pseudintermedius isolates from dogs were analysed based on demographic factors and clinical history, including gender, age, previous antimicrobial treatment, chronic and/or recurrent diseases and site of infections. The most commonly identified CoPS were S. pseudintermedius (70.8%; dogs n = 616, cats n = 13) and S. aureus (13.2%, horses n = 53, dogs n = 47 and cats n = 17). Overall, the frequency of methicillin resistance among S. pseudintermedius (MRSP) and S. aureus (MRSA) was 11.8% and 12.8%, respectively. MRSP isolates were strongly associated with resistance to fluoroquinolones (OR 287; 95% CI 91.2-1144.8) and clindamycin (OR 105.2, 95% CI 48.5-231.9). MRSA isolates from dogs and cats were also more likely to be resistant to fluoroquinolones (OR 5.4, 95% CI 0.6-252.1), whereas MRSA from horses were more likely to be resistant to rifampicin. In multivariate analysis, MRSP-positive status was significantly associated with particular infection sites, including surgical (OR 8.8; 95% CI 3.74-20.7), and skin and soft tissue (OR 3.9; 95% CI 1.97-7.51). S. pseudintermedius isolated from dogs with surgical site infections were three times more likely to be methicillin-resistant if cases had received prior antimicrobial treatment. Whilst the survey results indicate the proportion of CoPS obtained from Australian companion animals that are methicillin-resistant is currently moderate, the identified risk factors suggest that it could rapidly increase without adequate biosecurity and infection control procedures in veterinary practice.	[Saputra, Sugiyono; Wong, Hui S.; Abraham, Rebecca; Trott, Darren J.; Abraham, Sam] Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Saputra, Sugiyono] Indonesian Inst Sci, Res Ctr Biol, Cibinong, West Java, Indonesia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Worthing, Kate A.; Norris, Jacqueline M.] Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia; [Abraham, Rebecca; Abraham, Sam] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Adelaide; Indonesian Institute of Sciences; NSW Department of Primary Industries; University of Sydney; Murdoch University	Trott, DJ; Abraham, S (corresponding author), Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia.; Abraham, S (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	darren.trott@adelaide.edu.au; s.abraham@murdoch.edu.au	Jordan, David/P-7281-2019; Worthing, Kate/AAG-4907-2019; Saputra, Sugiyono/AAT-9363-2020	Worthing, Kate/0000-0001-8713-7189; Norris, Jacqueline/0000-0002-0003-6930; Saputra, Sugiyono/0000-0002-5449-3387; Abraham, Sam/0000-0003-0950-2317	Australian Research Council-Linkage Grant [LP130100736]; Australia Awards Scholarship - Australian Department Foreign Affairs and Trade; Zoetis	Australian Research Council-Linkage Grant(Australian Research Council); Australia Awards Scholarship - Australian Department Foreign Affairs and Trade; Zoetis	This work was supported by Zoetis and Australian Research Council-Linkage Grant (grant number LP130100736). SS was supported by an Australia Awards Scholarship sponsored by Australian Department Foreign Affairs and Trade. The funders had no role in study design, data collection and analysis, decision to publish, or identified risk factors suggest that it could rapidly increase without adequate biosecurity and preparation of the manuscript.	Abraham S, 2015, J GLOB ANTIMICROB RE, V3, P273, DOI 10.1016/j.jgar.2015.08.002; [Anonymous], 2014, DEV NAT ANT RES STRA; Axon JE, 2011, AUST VET J, V89, P221, DOI 10.1111/j.1751-0813.2011.00711.x; Ballhausen B, 2014, ANTIMICROB AGENTS CH, V58, P3791, DOI 10.1128/AAC.02731-13; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; CLSI, 2016, ECOFFINDER; CLSI, 2021, PERFORMANCE STANDARD, V5th; Crowley J, 2013, EQUINE VET J, V45, P20, DOI 10.1111/evj.12166; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST, 2016, ANT WILD TYP DISTR M; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; Feng YY, 2012, VET MICROBIOL, V160, P517, DOI 10.1016/j.vetmic.2012.06.015; Gandolfi-Decristophoris P, 2013, J VET SCI, V14, P449, DOI 10.4142/jvs.2013.14.4.449; Gingrich EN, 2011, J VET DIAGN INVEST, V23, P947, DOI 10.1177/1040638711407301; Gold RM, 2014, J CLIN MICROBIOL, V52, P3641, DOI 10.1128/JCM.01253-14; Groves MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146034; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Lehner G, 2014, VET MICROBIOL, V168, P154, DOI 10.1016/j.vetmic.2013.10.023; Magalhaes RJS, 2010, VET RES, V41, DOI 10.1051/vetres/2010028; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Malik S, 2006, J CLIN MICROBIOL, V44, P413, DOI 10.1128/JCM.44.2.413-416.2006; Malik S, 2006, J ANTIMICROB CHEMOTH, V58, P428, DOI 10.1093/jac/dkl253; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; NORM/NORM- VET, 2013, US ANT AG OCC ANT RE; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Savini V, 2013, RES MICROBIOL, V164, P371, DOI 10.1016/j.resmic.2013.02.004; Shaban R.Z., 2014, SURVEILLANCE REPORTI; Siak M, 2014, J MED MICROBIOL, V63, P1228, DOI 10.1099/jmm.0.076117-0; Smith TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004564; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; SWEDRES/SVARM, 2015, USE OF ANTIMICROBIAL; Trott D, 2013, MICROBIOL AUST, V34, P25, DOI 10.1071/MA13008; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Worthing KA, 2016, J ANTIMICROB CHEMOTH; Youn JH, 2014, COMP IMMUNOL MICROB, V37, P123, DOI 10.1016/j.cimid.2014.01.003; Youn JH, 2011, J VET DIAGN INVEST, V23, P268, DOI 10.1177/104063871102300211	43	57	59	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176379	10.1371/journal.pone.0176379	http://dx.doi.org/10.1371/journal.pone.0176379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430811	Green Published, gold			2022-12-27	WOS:000399876100042
J	Yin, CC; Yau, SST				Yin, Changchuan; Yau, Stephen S. -T.			A coevolution analysis for identifying protein-protein interactions by Fourier transform	PLOS ONE			English	Article							EBOLA-VIRUS; INFLUENZA-VIRUS; HEMAGGLUTININ MUTATIONS; GENETIC INTERACTIONS; INTERACTION NETWORKS; MARBURG-VIRUS; NS2 PROTEIN; HOST-RANGE; TRANSCRIPTION; REPLICATION	Protein-protein interactions (PPIs) play key roles in life processes, such as signal transduction, transcription regulations, and immune response, etc. Identification of PPIs enables better understanding of the functional networks within a cell. Common experimental methods for identifying PPIs are time consuming and expensive. However, recent developments in computational approaches for inferring PPIs from protein sequences based on coevolution theory avoid these problems. In the coevolution theory model, interacted proteins may show coevolutionary mutations and have similar phylogenetic trees. The existing coevolution methods depend on multiple sequence alignments (MSA); however, the MSA-based coevolution methods often produce high false positive interactions. In this paper, we present a computational method using an alignment-free approach to accurately detect PPIs and reduce false positives. In the method, protein sequences are numerically represented by biochemical properties of amino acids, which reflect the structural and functional differences of proteins. Fourier transform is applied to the numerical representation of protein sequences to capture the dissimilarities of protein sequences in biophysical context. The method is assessed for predicting PPIs in Ebola virus. The results indicate strong coevolution between the protein pairs (NP-VP24, NP-VP30, NP-VP40, VP24-VP30, VP24-VP40, and VP30-VP40). The method is also validated for PPIs in influenza and E.coli genomes. Since our method can reduce false positive and increase the specificity of PPI prediction, it offers an effective tool to understand mechanisms of disease pathogens and find potential targets for drug design.	[Yin, Changchuan] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60607 USA; [Yau, Stephen S. -T.] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tsinghua University	Yau, SST (corresponding author), Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China.	yau@uic.edu		Yin, Changchuan/0000-0002-4147-4195	National Natural Sciences Foundation of China [31271408]; Tsinghua University startup fund; Tsinghua University Independent Research Project grant	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University startup fund; Tsinghua University Independent Research Project grant	This work was supported by National Natural Sciences Foundation of China (31271408 to S.S.-T. Yau), Tsinghua University startup fund and Tsinghua University Independent Research Project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.; The corresponding author gratefully acknowledges the support from the National Natural Sciences Foundation of China (Grant No. 31271408), Tsinghua University startup fund and Tsinghua University Independent Research Project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Anastassiou D, 2001, IEEE SIGNAL PROC MAG, V18, P8, DOI 10.1109/79.939833; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Biedenkopf N, 2013, J BIOL CHEM, V288, P11165, DOI 10.1074/jbc.M113.461285; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; Bullido R, 2001, J VIROL, V75, P4912, DOI 10.1128/JVI.75.10.4912-4917.2001; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; ELS MC, 1989, VIROLOGY, V170, P346, DOI 10.1016/0042-6822(89)90394-2; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao H., 2009, SCI REP, V2015, P5; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Han ZY, 2003, J VIROL, V77, P1793, DOI 10.1128/JVI.77.3.1793-1800.2003; Hoang T, 2015, J THEOR BIOL, V372, P135, DOI 10.1016/j.jtbi.2015.02.026; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Hu L, 2016, IEEE ACM T COMPUTATI; Huang Y, 2002, MOL CELL, V10, P307, DOI 10.1016/S1097-2765(02)00588-9; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; KYTE J, 1982, NATURE, V299, P23; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin CC, 2009, J PROTEOME RES, V8, P1925, DOI 10.1021/pr8008786; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Muhlberger E, 1998, J VIROL, V72, P8756; Muhlberger E, 1999, J VIROL, V73, P2333; Ochoa D, 2010, BIOINFORMATICS, V26, P1370, DOI 10.1093/bioinformatics/btq137; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Rajagopala SV, 2008, BIOINFORMATICS, V24, P2622, DOI 10.1093/bioinformatics/btn481; Ren XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-409; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Su C, 2008, NUCLEIC ACIDS RES, V36, pD632, DOI 10.1093/nar/gkm807; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang H, 2013, J COMPUT BIOL, V20, P344, DOI 10.1089/cmb.2012.0273; Wang Y, 2009, IEEE ACM T COMPUT BI, V6, P583, DOI 10.1109/TCBB.2007.70250; Watanabe S, 2007, J INFECT DIS, V196, pS284, DOI 10.1086/520582; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wuchty S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07187; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; Yewdell JW, 2012, SCIENCE, V337, P164, DOI 10.1126/science.1225539; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Yin CC, 2014, J THEOR BIOL, V359, P18, DOI 10.1016/j.jtbi.2014.05.043; Zahiri J, 2013, CURR GENOMICS, V14, P397, DOI 10.2174/1389202911314060004	68	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174862	10.1371/journal.pone.0174862	http://dx.doi.org/10.1371/journal.pone.0174862			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430779	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100007
J	Imboden, MT; Swartz, AM; Finch, HW; Herber, MP; Kaminsky, LA				Imboden, Mary T.; Swartz, Ann M.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.			Reference standards for lean mass measures using GE dual energy x-ray absorptiometry in Caucasian adults	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; BODY-COMPOSITION; FUNCTIONAL IMPAIRMENT; PHYSICAL-DISABILITY; REFERENCE RANGES; OLDER MEN; SARCOPENIA; WOMEN; DXA; FAT	Body composition assessments commonly focus predominantly on fat mass, however lean mass (LM) measurements also provide useful information regarding clinical and nutritional status. LM measurements help predict health outcomes and diagnose sarcopenia, which has been associated with frailty. Dual energy x-ray absorptiometry (DXA) is an established technique used in clinical and research settings to assess body composition including total and regional LM. Currently, there are no reference values available that were derived from GE-Healthcare DXA systems directly for US adults for LM, LM index (LMI), percent LM (% LM), and appendicular lean mass index (ALMI) and it is known that whole-body and regional LM measures differ by DXA manufacturer.	[Imboden, Mary T.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.] Ball State Univ, Muncie, IN 47306 USA; [Swartz, Ann M.] Univ Wisconsin Milwaukee, Milwaukee, WI USA	Ball State University; University of Wisconsin System; University of Wisconsin Milwaukee	Imboden, MT (corresponding author), Ball State Univ, Muncie, IN 47306 USA.	Mstuttle2@bsu.edu						Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bijlsma AY, 2013, AGE, V35, P871, DOI 10.1007/s11357-012-9384-z; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Clark P, 2016, CALCIF TISSUE INT; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fuller NJ, 1999, INT J OBESITY, V23, P1295, DOI 10.1038/sj.ijo.0801070; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Gould H, 2014, CALCIFIED TISSUE INT, V94, P363, DOI 10.1007/s00223-013-9830-7; Guo S., 1997, AGE NUTR, V8, P12; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hong S, 2011, J KOREAN MED SCI, V26, P1599, DOI 10.3346/jkms.2011.26.12.1599; Hull H, 2009, J CLIN DENSITOM, V12, P95, DOI 10.1016/j.jocd.2008.09.004; Imboden MT, 2017, PLOS ONE; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kirschner MM, 2011, MED SCI SPORTS EXERC, V43; Lustgarten MS, 2011, J NUTR HEALTH AGING, V15, P368, DOI 10.1007/s12603-011-0049-x; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Morrison SA, 2016, J CLIN DENSITOM, V19, P290, DOI 10.1016/j.jocd.2015.06.003; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Stults-Kolehmainen MA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.5; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wells JCK, 2010, INT J OBESITY, V34, P649, DOI 10.1038/ijo.2009.249	31	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176161	10.1371/journal.pone.0176161	http://dx.doi.org/10.1371/journal.pone.0176161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426779	Green Published, gold			2022-12-27	WOS:000399875900112
J	Jelinska, A; Zagozdzon, A; Gorecki, M; Wisniewska, A; Frelek, J; Holyst, R				Jelinska, Aldona; Zagozdzon, Anna; Gorecki, Marcin; Wisniewska, Agnieszka; Frelek, Jadwiga; Holyst, Robert			Denaturation of proteins by surfactants studied by the Taylor dispersion analysis	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; SODIUM DODECYL-SULFATE; FLUORESCENCE CORRELATION SPECTROSCOPY; DYNAMIC LIGHT-SCATTERING; CIRCULAR-DICHROISM SPECTROSCOPY; X-RAY-SCATTERING; BETA-LACTOGLOBULIN; IONIC SURFACTANTS; AGGREGATION; COMPLEXES	We showed that the Taylor Dispersion Analysis (TDA) is a fast and easy to use method for the study of denaturation proteins. We applied TDA to study denaturation of beta-lactoglobulin, transferrin, and human insulin by anionic surfactant sodium dodecyl sulfate (SDS). A series of measurements at constant protein concentration (for transferrin was 1.9 x 10(-5) M, for beta-lactoglobulin was 7.6 x 10(-5) M, and for insulin was 1.2 x 10(-4) M) and varying SDS concentrations were carried out in the phosphate-buffered saline (PBS). The structural changes were analyzed based on the diffusion coefficients of the complexes formed at various surfactant concentrations. The concentration of surfactant was varied in the range from 1.2 x 10(-4) M to 8.7 x 10(-2) M. We determined the minimum concentration of the surfactant necessary to change the native conformation of the proteins. The minimal concentration of SDS for beta-lactoglobulin and transferrin was 4.3 x 10(-4) M and for insulin 2.3 x 10(-4) M. To evaluate the TDA as a novel method for studying denaturation of proteins we also applied other methods i.e. electronic circular dichroism (ECD) and dynamic light scattering (DLS) to study the same phenomenon. The results obtained using these methods were in agreement with the results from TDA.	[Jelinska, Aldona; Zagozdzon, Anna; Wisniewska, Agnieszka; Holyst, Robert] Polish Acad Sci, Inst Phys Chem, Warsaw, Poland; [Gorecki, Marcin; Frelek, Jadwiga] Polish Acad Sci, Inst Organ Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Warsaw, Poland.	rholyst@ichf.edu.pl	Górecki, Marcin/W-9352-2019; Wiśniewska, Agnieszka/HCI-1785-2022	Górecki, Marcin/0000-0001-7472-3875; Wiśniewska, Agnieszka/0000-0001-5317-757X; Holyst, Robert/0000-0002-3211-4286	National Science Centre [UMO-2012/07/B/ST4/01400]	National Science Centre(National Science Centre, Poland)	This research was supported by the National Science Centre Grant Opus4 (UMO-2012/07/B/ST4/01400).; This research was supported by the National Science Centre Grant Opus 4 (UMO-2012/07/B/ST4/01400).	Anand U, 2010, J PHYS CHEM B, V114, P15839, DOI 10.1021/jp106703h; Andersen KK, 2008, LANGMUIR, V24, P399, DOI 10.1021/la702890y; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; Borysik AJ, 2015, ANAL CHEM, V87, P8970, DOI 10.1021/acs.analchem.5b02172; Chalton DA, 2010, ANAL CHEM, V82, P3073, DOI 10.1021/ac902932c; Chamieh J, 2015, BIOMACROMOLECULES, V16, P3945, DOI 10.1021/acs.biomac.5b01260; Cottet H, 2007, BIOMACROMOLECULES, V8, P3235, DOI 10.1021/bm070268j; Cottet H, 2014, ANALYST, V139, P3552, DOI 10.1039/c4an00192c; Fiedler S, 2013, ANAL CHEM, V85, P1868, DOI 10.1021/ac303244g; Geissler E., 1993, DYNAMIC LIGHT SCATTE; Gelamo EL, 2000, SPECTROCHIM ACTA A, V56, P2255, DOI 10.1016/S1386-1425(00)00313-9; Gelamo EL, 2004, J COLLOID INTERF SCI, V277, P471, DOI 10.1016/j.jcis.2004.04.065; Ghosh S, 2008, COLLOID SURFACE B, V66, P178, DOI 10.1016/j.colsurfb.2008.06.011; Gull N, 2009, COLLOID SURFACE B, V69, P122, DOI 10.1016/j.colsurfb.2008.11.009; GUO XH, 1990, BIOPOLYMERS, V29, P335, DOI 10.1002/bip.360290206; Hansted JG, 2011, BBA-PROTEINS PROTEOM, V1814, P713, DOI 10.1016/j.bbapap.2011.03.011; Joshi V, 2014, ANAL CHEM, V86, P11606, DOI 10.1021/ac503140j; Kronberg B, 2014, SURFACE CHEMISTRY OF SURFACTANTS AND POLYMERS, P1, DOI 10.1002/9781118695968; Lad MD, 2003, LANGMUIR, V19, P5098, DOI 10.1021/la0269560; Leclercq L, 2015, MACROMOLECULES, V48, P7216, DOI 10.1021/acs.macromol.5b01824; Lewandrowska A, 2013, ANAL CHEM, V85, P4051, DOI 10.1021/ac4007792; Majcher A, 2015, ANAL CHIM ACTA, V855, P51, DOI 10.1016/j.aca.2014.12.008; Navea S, 2002, ANAL CHEM, V74, P6031, DOI 10.1021/ac025914d; Oshima T, 2012, ANAL CHIM ACTA, V710, P102, DOI 10.1016/j.aca.2011.10.034; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Sahihi M, 2012, J CHEM THERMODYN, V52, P16, DOI 10.1016/j.jct.2011.12.017; Santos SF, 2003, J COLLOID INTERF SCI, V262, P400, DOI 10.1016/S0021-9797(03)00109-7; Schneider GF, 2008, J AM CHEM SOC, V130, P17384, DOI 10.1021/ja804736t; TAKEDA K, 1992, J COLLOID INTERF SCI, V154, P385, DOI 10.1016/0021-9797(92)90153-D; TANNER RE, 1982, J CHEM PHYS, V76, P3866, DOI 10.1063/1.443528; Thyparambil AA, 2015, LANGMUIR, V31, P11814, DOI 10.1021/acs.langmuir.5b02741; Valstar A, 2000, LANGMUIR, V16, P922, DOI 10.1021/la990423i; Wahlgren M, 1997, J DISPER SCI TECHNOL, V18, P449, DOI 10.1080/01932699708943747; Zhang D, 2008, BIOPHYS J, V95, P3439, DOI 10.1529/biophysj.108.133215; Zhang XZ, 2016, SOFT MATTER, V12, P8186, DOI 10.1039/c6sm01791f; Zhang XZ, 2015, SOFT MATTER, V11, P2512, DOI 10.1039/c5sm00101c	36	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175838	10.1371/journal.pone.0175838	http://dx.doi.org/10.1371/journal.pone.0175838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426809	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900056
J	Neffatti, H; Lebraud, P; Hottelet, C; Gharbi, J; Challouf, T; Roque-Afonso, AM				Neffatti, Houcine; Lebraud, Patricia; Hottelet, Corinne; Gharbi, Jawher; Challouf, Taieb; Roque-Afonso, Anne-Marie			Southern Tunisia: A still high endemicity area for hepatitis A	PLOS ONE			English	Article							E VIRUS; SEROPREVALENCE; INFECTION; EPIDEMIOLOGY; CHILDREN; AFRICA; AGE	Background Hepatitis A (HAV) and E (HEV) viruses are responsible for enterically transmitted hepatitis. Tunisia is reported to be of intermediate endemicity for HAV and of low seroprevalence for HEV; however, data from rural areas of South Tunisia are lacking. Methods Sera from 216 asymptomatic pregnant women and from 92 patients with acute hepatitis were collected between October 2014 and November 2015. Total and IgM-anti-HAV immunoglobulins and anti-HEV IgG and IgM were investigated. Anti-HAV IgM-positive samples were subjected to RTPCR targeting the VP1/2A region and sequenced. HEV IgM positive samples and all samples from acute hepatitis patients were assessed for HEV RNA. Results Among pregnant women (mean age 32+/-8), HAV seroprevalence was 98.6%, none presented anti-HAV IgM; HEV seroprevalence was 5.1% and three presented weakly reactive anti-HEV IgM without detectable RNA. Among acute hepatitis patients (mean age 18.5 +/-14), HEV seroprevalence was 19,5%, none presented anti-HEV IgM, nor HEV RNA. HAV seroprevalence exceeded 90% by age 5 and acute HAV infection was detected in 20 patients (21,7%), younger than patients with other hepatitis causes (9,8 years vs. 20,4 years, p = 0,004); 65% were male. Most acute HAV infections were observed in a coastal area where HAV infections represented 52% of hepatitis etiology. Phylogenetic analysis identified genotype IA strains, clustering close to previously published Tunisian sequences. Conclusion The present study confirmed a low HEV endemicity and evidenced a still high level of HAV circulation in Southern Tunisia, suggesting distinct dissemination patterns for these viruses.	[Neffatti, Houcine; Lebraud, Patricia; Hottelet, Corinne; Roque-Afonso, Anne-Marie] Hop Paul Brousse, AP HP, Virol, Villejuif, France; [Neffatti, Houcine; Gharbi, Jawher] Univ Monastir, Inst Super Biotechnol, Monastir, Tunisia; [Challouf, Taieb] Hop Medenine, Med Interne, Medenine, Tunisia; [Roque-Afonso, Anne-Marie] INSERM, U1193, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Universite de Monastir; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Roque-Afonso, AM (corresponding author), Hop Paul Brousse, AP HP, Virol, Villejuif, France.; Roque-Afonso, AM (corresponding author), INSERM, U1193, Villejuif, France.	anne-marie.roque@aphp.fr	GHARBI, Jawhar/AHD-9205-2022; Roque-Afonso, Anne-Marie/AAF-9706-2021; Roque-Afonso, Anne-Marie/D-5737-2014	GHARBI, Jawhar/0000-0001-9170-3403; Roque-Afonso, Anne-Marie/0000-0002-6612-2030				[Anonymous], 2012, Wkly Epidemiol Rec, V87; Beji-Hamza A, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0249-9; Ben-Ayed Y, 2015, J MED VIROL, V87, P441, DOI 10.1002/jmv.24082; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Desbois D, 2005, GASTROEN CLIN BIOL, V29, P573, DOI 10.1016/S0399-8320(05)82132-3; Gharbi-Khelifi H, 2006, J VIROL METHODS, V138, P109, DOI 10.1016/j.jviromet.2006.08.001; Gharbi-Khelifi H, 2012, INDIAN J VIROL, V23, P29, DOI 10.1007/s13337-012-0063-6; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Hannachi N, 2011, Pathol Biol (Paris), V59, pe115, DOI 10.1016/j.patbio.2009.06.004; Hasan G, 2016, J INT MED RES, V44, P1115, DOI 10.1177/0300060516659575; Hellara Olfa, 2014, Tunis Med, V92, P201; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Letaief A, 2005, AM J TROP MED HYG, V73, P40, DOI 10.4269/ajtmh.2005.73.40; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; Neffati H, 2012, CLIN MICROBIOL INFEC, V18, pE119, DOI 10.1111/j.1469-0691.2012.03793.x; Ouardani I, 2016, APPL ENVIRON MICROB, V82, P3834, DOI 10.1128/AEM.00619-16; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Schwarz NG, 2008, EURO SURVEILL, V13	20	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175887	10.1371/journal.pone.0175887	http://dx.doi.org/10.1371/journal.pone.0175887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426700	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900064
J	Nehme, R; Carpenter, B; Singhal, A; Strege, A; Edwards, PC; White, CF; Du, HJ; Grisshammer, R; Tate, CG				Nehme, Rony; Carpenter, Byron; Singhal, Ankita; Strege, Annette; Edwards, Patricia C.; White, Courtney F.; Du, Haijuan; Grisshammer, Reinhard; Tate, Christopher G.			Mini-G proteins: Novel tools for studying GPCRs in their active conformation	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTOR; BETA-ADRENERGIC-RECEPTORS; COUPLED RECEPTOR; STRUCTURAL BASIS; NEUROTENSIN RECEPTOR; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; ACTIVATION; AGONIST; CRYSTALLIZATION	Mini-G proteins are the engineered GTPase domains of G alpha subunits. They couple to GPCRs and recapitulate the increase in agonist affinity observed upon coupling of a native heterotrimeric G protein. Given the small size and stability of mini-G proteins, and their ease of expression and purification, they are ideal for biophysical studies of GPCRs in their fully active state. The first mini-G protein developed was mini-G(s). Here we extend the family of mini-G proteins to include mini-G(olf), mini-G(i1), mini-G(o1) and the chimeras mini-G(s/q) and mini-G(s/i). The mini-G proteins were shown to couple to relevant GPCRs and to form stable complexes with purified receptors that could be purified by size exclusion chromatography. Agonist-bound GPCRs coupled to a mini-G protein showed higher thermal stability compared to the agonist-bound receptor alone. Fusion of GFP at the N-terminus of mini-G proteins allowed receptor coupling to be monitored by fluorescence-detection size exclusion chromatography (FSEC) and, in a separate assay, the affinity of mini-G protein binding to detergent-solubilised receptors was determined. This work provides the foundation for the development of any mini-G protein and, ultimately, for the structure determination of GPCRs in a fully active state.	[Nehme, Rony; Carpenter, Byron; Singhal, Ankita; Strege, Annette; Edwards, Patricia C.; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge, England; [White, Courtney F.; Du, Haijuan; Grisshammer, Reinhard] NINDS, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD USA; [Carpenter, Byron] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Sch Life Sci, Gibbet Hill Campus, Warwick, England	MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Warwick	Tate, CG (corresponding author), MRC Lab Mol Biol, Cambridge, England.	cgt@mrc-lmb.cam.ac.uk	Carpenter, Byron/S-5206-2019	Carpenter, Byron/0000-0003-1712-3528; Tate, Christopher/0000-0002-2008-9183	European Research Council [EMPSI 339995]; Heptares Therapeutics; Medical Research Council [MC_U105197215]; Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke [ZIA NS003016-11]; Medical Research Council [1570806] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003016] Funding Source: NIH RePORTER; MRC [MC_U105197215] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Heptares Therapeutics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the European Research Council (EMPSI 339995; R.N., A.S., C.G.T.), Heptares Therapeutics (B.C., C.G.T.), the Medical Research Council (MC_U105197215; A.S., P.E., C.G.T.) and the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke (ZIA NS003016-11; C.F.W., H.D., R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter B, 2017, BIOPROTOCOL IN PRESS; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chan P, 2013, P NATL ACAD SCI USA, V110, P3794, DOI 10.1073/pnas.1220943110; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Clawges HM, 1997, BIOCHEMISTRY-US, V36, P12930, DOI 10.1021/bi970112b; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; GREEN SA, 1992, MOL PHARMACOL, V41, P889; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Lebon G, 2012, CURR OPIN STRUCT BIO; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Magnani F, 2016, NAT PROTOC, V11, P1554, DOI 10.1038/nprot.2016.088; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Semack A, 2016, J BIOL CHEM, V291, P17929, DOI 10.1074/jbc.M116.735720; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thomas JA, 2014, J MOL BIOL, V426, P4139, DOI 10.1016/j.jmb.2014.10.012; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang XJ, 2015, TRENDS BIOCHEM SCI, V40, P79, DOI 10.1016/j.tibs.2014.12.005	51	100	101	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175642	10.1371/journal.pone.0175642	http://dx.doi.org/10.1371/journal.pone.0175642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426733	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900036
J	Qiao, YC; Chen, YL; Pan, YH; Tian, F; Xu, Y; Zhang, XX; Zhao, HL				Qiao, Yong-chao; Chen, Yin-ling; Pan, Yan-hong; Tian, Fang; Xu, Yan; Zhang, Xiao-xi; Zhao, Hai-lu			The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis	PLOS ONE			English	Review							BLOOD MONONUCLEAR-CELLS; C-REACTIVE PROTEIN; GLYCEMIC CONTROL; TNF-ALPHA; INSULIN-RESISTANCE; T-CELLS; ASSOCIATION; CHILDREN; EXPRESSION; CYTOKINES	Objective The aim of this study was used meta-analysis to investigate changes of serum tumor necrosis factor-alpha (TNF-alpha) in patients with type 1 diabetes mellitus (T1DM). Methods Relevant literatures were identified from PubMed, Cochrane Library, CNKI, WanFang and Chinese-Cqvip databases (published from January 1, 1999 to September 30, 2016). Eligible reports were included for pooled analysis of serum TNF-alpha level and subgroup analysis was performed in relation with age, disease duration and ethnicity. Results A total of 23 articles (1631 T1DM cases, 1429 healthy controls) were included for this meta-analysis. Compared with the controls, the patients had significantly increased serum TNF-alpha level (P < 0.001). Similar results were also found among all subgroup analysis of different age, disease duration and ethnicity (with the exception of Asian) (all P < 0.05). Regression analysis indicated that age (P = 0.680), disease duration (P = 0.957), and ethnicity (P = 0.526) of patients were not significant impact factors for the high heterogeneity. The results were stable according to the sensitivity analysis and no publication bias existed in this meta-analysis. Conclusions Serum TNF-alpha level in T1DM patients has significantly elevated among all age, disease duration and ethnicity groups.	[Qiao, Yong-chao; Chen, Yin-ling; Pan, Yan-hong; Zhang, Xiao-xi; Zhao, Hai-lu] Guilin Med Univ, Ctr Diabet Syst Med, Guangxi Key Lab Excellence, Guilin, Peoples R China; [Qiao, Yong-chao; Tian, Fang; Xu, Yan; Zhao, Hai-lu] Cent South Univ, Dept Immunol, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Chen, Yin-ling; Pan, Yan-hong; Zhang, Xiao-xi; Zhao, Hai-lu] Guilin Med Univ, Fac Basic Med, Dept Immunol, Guilin, Peoples R China	Guilin Medical University; Central South University; Guilin Medical University	Zhao, HL (corresponding author), Guilin Med Univ, Ctr Diabet Syst Med, Guangxi Key Lab Excellence, Guilin, Peoples R China.; Zhao, HL (corresponding author), Cent South Univ, Dept Immunol, Xiangya Sch Med, Changsha, Hunan, Peoples R China.; Zhao, HL (corresponding author), Guilin Med Univ, Fac Basic Med, Dept Immunol, Guilin, Peoples R China.	zhaohailu9@126.com			National Natural Science Foundation of China [81471054]; Innovation Project of Guangxi Graduate Education [JGY2015128]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Guangxi Graduate Education	This study was supported by the National Natural Science Foundation of China (81471054) and the Innovation Project of Guangxi Graduate Education (JGY2015128). (http://www.medsci.cn/sci/nsfc.do?action=q).	Abdel Aziz M T, 2001, East Mediterr Health J, V7, P679; Aguilera E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0287-z; Alexandraki KI, 2008, J CLIN IMMUNOL, V28, P314, DOI 10.1007/s10875-007-9164-1; Gabbay MAL, 2012, CLIN EXP IMMUNOL, V168, P60, DOI 10.1111/j.1365-2249.2011.04538.x; Araya AV, 2003, EUR CYTOKINE NETW, V14, P128; Balic I, 2009, HUM IMMUNOL, V70, P116, DOI 10.1016/j.humimm.2008.12.007; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; De Mattia G, 1999, DIABETOLOGIA, V42, P1235, DOI 10.1007/s001250051297; Borges APD, 2011, ARQ BRAS ENDOCRINOL, V55, P686, DOI 10.1590/S0004-27302011000900003; Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia, 2006, DEF DIAGN DIAB MELL, P21; DEISHER TA, 1993, FEBS LETT, V331, P285, DOI 10.1016/0014-5793(93)80354-W; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duarte PM, 2012, J PERIODONTOL, V83, P426, DOI 10.1902/jop.2011.110324; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Samahy MH, 2015, J DIABETES COMPLICAT, V29, P120, DOI 10.1016/j.jdiacomp.2014.07.004; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Flores L, 2004, DIABETIC MED, V21, P818, DOI 10.1111/j.1464-5491.2004.01242.x; Foss-Freitas MC, 2007, BRAZ J MED BIOL RES, V40, P671, DOI 10.1590/S0100-879X2007000500010; Foss-Freitas MC, 2008, DIABETES RES CLIN PR, V82, P329, DOI 10.1016/j.diabres.2008.09.003; Foss-Freitas MC, 2006, ANN NY ACAD SCI, V1079, P177, DOI 10.1196/annals.1375.027; Gahring LC, 1996, NEUROIMMUNOMODULAT, V3, P289, DOI 10.1159/000097283; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hegazy Sahar K, 2013, Rev Diabet Stud, V10, P58, DOI 10.1900/RDS.2013.10.58; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Iacopino A M, 2001, Ann Periodontol, V6, P125, DOI 10.1902/annals.2001.6.1.125; Karavanaki K, 2012, CLIN BIOCHEM, V45, P1383, DOI 10.1016/j.clinbiochem.2012.05.003; Lampropoulou IT, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/394206; Lechleitner M, 2000, J INTERN MED, V248, P67, DOI 10.1046/j.1365-2796.2000.00705.x; Lo HC, 2004, CLIN BIOCHEM, V37, P666, DOI 10.1016/j.clinbiochem.2004.02.002; Lv L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/507103; Machnica L, 2014, ATHEROSCLEROSIS, V237, P129, DOI 10.1016/j.atherosclerosis.2014.09.006; Martos-Moreno GA, 2006, EUR J ENDOCRINOL, V155, P757, DOI 10.1530/eje.1.02273; Mitrovic M, 2011, VOJNOSANIT PREGL, V68, P756, DOI 10.2298/VSP1109756M; Mohamed-Ali V, 2001, J INTERN MED, V250, P415, DOI 10.1046/j.1365-2796.2001.00900.x; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Oghagbon E K, 2014, West Afr J Med, V33, P130; Hara CDP, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7154524; Pertynska-Marczewska M, 2010, AM J REPROD IMMUNOL, V63, P150, DOI 10.1111/j.1600-0897.2009.00775.x; Pham MN, 2011, DIABETOLOGIA, V54, P1630, DOI 10.1007/s00125-011-2088-6; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Poplawska-Kita A, 2014, ADV MED SCI-POLAND, V59, P126, DOI 10.1016/j.advms.2014.01.002; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Romano M, 2001, DIABETES CARE, V24, P1674, DOI 10.2337/diacare.24.9.1674; Saxena M, 2013, MOL BIOL REP, V40, P6271, DOI 10.1007/s11033-013-2739-4; Su PF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S11; Talaat IM, 2016, J ENDOCRINOLOGICAL I; Targher G, 2001, DIABETES CARE, V24, P956, DOI 10.2337/diacare.24.5.956; VANLINT J, 1992, J BIOL CHEM, V267, P25916; Wells G.A., NEWCASTLE OTTAWA SCA; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yuan T, 2010, CHINESE MED J-PEKING, V123, P2018, DOI 10.3760/cma.j.issn.0366-6999.2010.15.012	60	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176157	10.1371/journal.pone.0176157	http://dx.doi.org/10.1371/journal.pone.0176157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426801	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900110
J	Simon, O; Erlandson, MA; Frayssinet, M; Williams, T; Theilmann, DA; Volkoff, AN; Caballero, P				Simon, Oihane; Erlandson, Martin A.; Frayssinet, Marie; Williams, Trevor; Theilmann, David A.; Volkoff, Anne-Nathalie; Caballero, Primitivo			Lacanobia oleracea nucleopolyhedrovirus (LaolNPV): A new European species of alphabaculovirus with a narrow host range	PLOS ONE			English	Article							CHRYSODEIXIS-CHALCITES NUCLEOPOLYHEDROVIRUS; MAMESTRA-CONFIGURATA LEPIDOPTERA; SPODOPTERA-EXIGUA; GENOME SEQUENCE; MOLECULAR-IDENTIFICATION; GENETIC-VARIATION; BERTHA ARMYWORM; RACHIPLUSIA-OU; BACULOVIRUSES; NOCTUIDAE	During an insect sampling program in alfalfa crops near Montpellier, France in 2011, Lacanobia oleracea larvae were collected that died due to nucleopolyhedrovirus infection (LaolNPV). This virus was subjected to molecular and biological characterization. The virus was a multiple nucleocapsid NPV that showed similar restriction profiles to Mamestra configurata NPV-A (MacoNPV-A) but with significant differences. Polypeptide analysis demonstrated similar proteins in occlusion bodies and occlusion derived virions, to those observed in NPVs from Mamestra spp. Terminal sequencing revealed that the genome organization shared similarity with that of MacoNPV-A. The most homologous virus was MacoNPV-A 90/2 isolate (95.63% identity and 96.47% similarity), followed by MacoNPV-A 90/4 strain (95.37% and 96.26%), MacoNPV-B (89.21% and 93.53%) and M. brassicae MNPV (89.42% and 93.74%). Phylogenetic analysis performed with lef-8, lef-9, polh and a concatenated set of genes showed that LaolNPV and the Mamestra spp. NPVs clustered together with HaMNPV, but with a closer genetic distance to MacoNPV-A strains. The Kimura 2-parameter (K-2-P) distances of the complete genes were greater than 0.05 between LaolNPV and the MbMNPV/MacoNPV-B/HaMNPV complex, which indicates that LaolNPV is a distinct species. K-2-P distances were in the range 0.015-0.050 for comparisons of LaolNPV with MacoNPV-A strains, such that additional biological characteristics should be evaluated to determine species status. While MacoNPV-A was pathogenic to seven lepidopteran species tested, LaolNPV was only pathogenic to Chrysodeixis chalcites. Given these findings, Lacanobia oleracea nucleopolyhedrovirus should be considered as a new species in the Alphabaculovirus genus.	[Simon, Oihane; Caballero, Primitivo] Gobierno Navarra, CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Mutilva Baja, Navarra, Spain; [Erlandson, Martin A.] Agr & Agri Food Canada, Sakatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Frayssinet, Marie; Volkoff, Anne-Nathalie] UMR 1333 INRA Univ Montpellier 2, DGIMI, Montpellier, France; [Williams, Trevor; Volkoff, Anne-Nathalie] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Theilmann, David A.] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Caballero, Primitivo] Univ Publica Navarra, Dept Prod Agraria, Campus Arrosadia S-N, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Agriculture & Agri Food Canada; INRAE; Universite de Montpellier; Instituto de Ecologia - Mexico; Agriculture & Agri Food Canada; Universidad Publica de Navarra	Simon, O (corresponding author), Gobierno Navarra, CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Mutilva Baja, Navarra, Spain.	oihane.simon@unavarra.es	Williams, Trevor/F-1447-2011; Caballero, Primitivo/D-5063-2009; Theilmann, David A/N-6024-2017; Williams, Trevor/ABG-3961-2020; Simon, Oihane/G-5703-2014	Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625; Theilmann, David A/0000-0002-4910-3057; Simon, Oihane/0000-0003-1239-1486; Volkoff, Anne-Nathalie/0000-0002-7211-1370	National Institute of Agricultural Research from the Spanish Ministry [RTA2013-00114-C02-02]; Department of Industry of the Government of Navarre [IIQ1406-RII]; Agriculture and Agri-Food Canada Research [J000197]	National Institute of Agricultural Research from the Spanish Ministry; Department of Industry of the Government of Navarre; Agriculture and Agri-Food Canada Research(Agriculture & Agri Food Canada)	We thank Noelia Gorria and Itxaso Ibanez for insect rearing and Leire Bardaji and Eduardo Aguirre for technical assistance. We thank Doug Baldwin for assistance with bioassays in M. configurata and T. ni. TW received logistical support from Gabriel Mercado (INECOL). This study received financial support from the National Institute of Agricultural Research from the Spanish Ministry project RTA2013-00114-C02-02 (Dr. Oihane Simon) and from the Department of Industry of the Government of Navarre project IIQ1406-RII (Dr. Primitivo Caballero). This study was supported in part by funding from Agriculture and Agri-Food Canada Research Project J000197 (Dr. Martin A. Erlandson).; This study received financial support from the National Institute of Agricultural Research from the Spanish Ministry project RTA2013-00114-C02-02 (Dr. Oihane Simon) and from the Department of Industry of the Government of Navarre project II01406-RI1 (Dr. Primitivo Caballero). This study was supported in part by funding from Agriculture and Agri-Food Canada Research Project J000197 (Dr. Martin A. Erlandson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrizubieta M, 2014, PEST MANAG SCI, V70, P967, DOI 10.1002/ps.3637; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Barrera G, 2011, BIOL CONTROL, V58, P113, DOI 10.1016/j.biocontrol.2011.04.009; Bernal A, 2013, BIOL CONTROL, V67, P101, DOI 10.1016/j.biocontrol.2013.08.006; BUCHER GE, 1976, CAN ENTOMOL, V108, P1327, DOI 10.4039/Ent1081327-12; Chen XW, 2002, J GEN VIROL, V83, P673, DOI 10.1099/0022-1317-83-3-673; Choi JB, 2013, VIRUS GENES, V47, P133, DOI 10.1007/s11262-013-0922-2; Cory JS, 2005, J INVERTEBR PATHOL, V89, P101, DOI 10.1016/j.jip.2005.03.008; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Eberle KE, 2009, J GEN VIROL, V90, P662, DOI 10.1099/vir.0.006999-0; ERLANDSON MA, 1990, J INVERTEBR PATHOL, V56, P47, DOI 10.1016/0022-2011(90)90143-T; Erlandson MA, 2013, BIOL CONTROL PROGRAM, P228; Erlandson Martin A., 2009, Virologica Sinica, V24, P458, DOI 10.1007/s12250-009-3052-1; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Harrison RL, 1999, J GEN VIROL, V80, P2793, DOI 10.1099/0022-1317-80-10-2793; Harrison RL, 2014, J INVERTEBR PATHOL, V116, P27, DOI 10.1016/j.jip.2013.12.005; Harrison RL, 2009, VIRUS GENES, V38, P155, DOI 10.1007/s11262-008-0297-y; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2012, 9 INT COMM TAX VIR, P167; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Jakubowska AK, 2006, J GEN VIROL, V87, P537, DOI 10.1099/vir.0.81461-0; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King A.M., 2012, 9 REP INT COMM TAXON, P486, DOI DOI 10.1016/B978-0-12-384684-6.00034-3; KISLEV N, 1982, VIROLOGY, V119, P219, DOI 10.1016/0042-6822(82)90081-2; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2004, VIROLOGY, V325, P36, DOI 10.1016/j.virol.2004.04.023; Li LL, 2005, J GEN VIROL, V86, P91, DOI 10.1099/vir.0.80488-0; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Mason PG, 1998, CAN ENTOMOL, V130, P321, DOI 10.4039/Ent130321-3; Mukawa S, 2006, J GEN VIROL, V87, P1491, DOI 10.1099/vir.0.81853-0; Munoz D, 1999, VIRUS RES, V59, P61, DOI 10.1016/S0168-1702(98)00125-7; Murillo R, 2001, J APPL ENTOMOL, V125, P267, DOI 10.1046/j.1439-0418.2001.00533.x; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Redman EM, 2016, J ANIM ECOL, V85, P1200, DOI 10.1111/1365-2656.12547; Redman EM, 2010, J INVERTEBR PATHOL, V105, P190, DOI 10.1016/j.jip.2010.06.008; Rovesti L, 2000, J INVERTEBR PATHOL, V75, P2, DOI 10.1006/jipa.1999.4903; Shapiro M, 2000, J ECON ENTOMOL, V93, P572, DOI 10.1603/0022-0493-93.3.572; SHAPIRO M, 1995, J ECON ENTOMOL, V88, P265, DOI 10.1093/jee/88.2.265; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-168; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; Willis LG, 2005, VIROLOGY, V338, P209, DOI 10.1016/j.virol.2005.04.041; Zhang CX, 2005, VIROLOGY, V333, P190, DOI 10.1016/j.virol.2004.12.028	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176171	10.1371/journal.pone.0176171	http://dx.doi.org/10.1371/journal.pone.0176171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426736	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900115
J	Bennett, EA; Champlot, S; Peters, J; Arbuckle, BS; Guimaraes, S; Pruvost, M; Bar-David, S; Davis, SJM; Gautier, M; Kaczensky, P; Kuehn, R; Mashkour, M; Morales-Muniz, A; Pucher, E; Tournepiche, JF; Uerpmann, HP; Balasescu, A; Germonpre, M; Gundem, CY; Hemami, MR; Moulle, PE; Otzan, A; Uerpmann, M; Walzer, C; Grange, T; Geigl, EM				Bennett, E. Andrew; Champlot, Sophie; Peters, Joris; Arbuckle, Benjamin S.; Guimaraes, Silvia; Pruvost, Melanie; Bar-David, Shirli; Davis, Simon J. M.; Gautier, Mathieu; Kaczensky, Petra; Kuehn, Ralph; Mashkour, Marjan; Morales-Muniz, Arturo; Pucher, Erich; Tournepiche, Jean-Francois; Uerpmann, Hans-Peter; Balasescu, Adrian; Germonpre, Mietje; Guendem, Can Y.; Hemami, Mahmoud-Reza; Moulle, Pierre-Elie; Otzan, Aliye; Uerpmann, Margarete; Walzer, Chris; Grange, Thierry; Geigl, Eva-Maria			Taming the late Quaternary phylogeography of the Eurasiatic wild ass through ancient and modern DNA	PLOS ONE			English	Article							EQUUS-HYDRUNTINUS; PHYLOGENETIC ANALYSIS; EVOLUTIONARY HISTORY; LATE PLEISTOCENE; HIGH-RESOLUTION; CONTROL REGION; HORSE EQUUS; EQUIDS; CLIMATE; MAMMALIA	Taxonomic over-splitting of extinct or endangered taxa, due to an incomplete knowledge of both skeletal morphological variability and the geographical ranges of past populations, continues to confuse the link between isolated extant populations and their ancestors. This is particularly problematic with the genus Equus. To more reliably determine the evolution and phylogeographic history of the endangered Asiatic wild ass, we studied the genetic diversity and inter-relationships of both extinct and extant populations over the last 100,000 years, including samples throughout its previous range from Western Europe to Southwest and East Asia. Using 229 bp of the mitochondrial hypervariable region, an approach which allowed the inclusion of information from extremely poorly preserved ancient samples, we classify all non-African wild asses into eleven clades that show a clear phylogeographic structure revealing their phylogenetic history. This study places the extinct European wild ass, E. hydruntinus, the phylogeny of which has been debated since the end of the 19th century, into its phylogenetic context within the Asiatic wild asses and reveals recent mitochondrial introgression between populations currently regarded as separate species. The phylogeographic organization of clades resulting from these efforts can be used not only to improve future taxonomic determination of a poorly characterized group of equids, but also to identify historic ranges, interbreeding events between various populations, and the impact of ancient climatic changes. In addition, appropriately placing extant relict populations into a broader phylogeographic and genetic context can better inform ongoing conservation strategies for this highly-endangered species.	[Bennett, E. Andrew; Champlot, Sophie; Guimaraes, Silvia; Grange, Thierry; Geigl, Eva-Maria] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France; [Peters, Joris; Pruvost, Melanie] Ludwig Maximilians Univ Munchen, Inst Palaeoanat Domesticat Res & Hist Vet Med, Munich, Germany; [Peters, Joris] SNSB, Bavarian State Collect Anthropol & Palaeoanat, Munich, Germany; [Arbuckle, Benjamin S.] Univ North Carolina Chapel Hill, Dept Anthropol, Chapel Hill, NC USA; [Bar-David, Shirli] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Jacob Blaustein Inst Desert Res, Sede Boger Campus, Midreshet Ben Gurion, Israel; [Davis, Simon J. M.] DGPC, La Arqueociencias, Lisbon, Portugal; [Gautier, Mathieu] Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Kaczensky, Petra] Univ Vet Med, Res Inst Wildlife Ecol, A-8 RES INS Vienna, Austria; [Kuehn, Ralph] Tech Univ Munich, AG Mol Zool, Lehrstuhl Zool, Freising Weihenstephan, Germany; [Mashkour, Marjan] CNRS, Paris, France; [Mashkour, Marjan] Museum Natl Hist Nat, UMR 7209, Archeozool Archeobot Soc Prat & Environm, Dept Ecol & Gest Biodivers, Paris, France; [Morales-Muniz, Arturo] Univ Autonoma Madrid, Dept Biol, Lab Archaeozool, Madrid, Spain; [Pucher, Erich] Nat Hist Museum, Vienna, Austria; [Tournepiche, Jean-Francois] Musee Angoulerne, Angouleme, France; [Uerpmann, Hans-Peter; Guendem, Can Y.; Uerpmann, Margarete] Eberhard Karls Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Altere Urgeschichte & Quartarokol, Zentrum Nat Wissensch Archaol, Tubingen, Germany; [Balasescu, Adrian] Natl Hist Museum Romania, Natl Ctr Pluridisciplinary Res, Bucharest, Romania; [Germonpre, Mietje] Royal Belgian Inst Nat Sci, Earth & Hist Life, Brussels, Belgium; [Hemami, Mahmoud-Reza] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran; [Moulle, Pierre-Elie] Musee Prehist Reg, Menton, France; [Otzan, Aliye] Ankara Univ, Dil & Tarih Cografya Fak, Ankara, Turkey; [Pruvost, Melanie] Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France; [Guendem, Can Y.] Batman Univ, Fen Edebiyat Fak, Batman, Turkey	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Munich; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Ben Gurion University; Institut de Recherche pour le Developpement (IRD); Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Autonomous University of Madrid; Eberhard Karls University of Tubingen; Royal Belgian Institute of Natural Sciences; Isfahan University of Technology; Ankara University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Batman University	Grange, T; Geigl, EM (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France.	Thierry.grange@ijm.fr; eva-maria.geigl@ijm.fr	BAR-DAVID, SHIRLI/F-1512-2012; gautier, mathieu/AAU-8789-2020; gautier, mathieu/F-7429-2010; Germonpré, Mietje/O-5952-2014; Mashkour, Marjan/AFV-2652-2022; Hemami, Mahmoud-Reza/AAH-2553-2022; Muñiz, Arturo Morales/ABG-7980-2020; Hemami, Mahmoud-Reza/AFM-0224-2022; Balasescu, Adrian/L-6149-2013; Mashkour, Marjan/B-5724-2018	BAR-DAVID, SHIRLI/0000-0001-8103-041X; gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; Germonpré, Mietje/0000-0001-8865-0937; Muñiz, Arturo Morales/0000-0002-9933-6836; Balasescu, Adrian/0000-0001-7834-5111; Geigl, Eva-Maria/0000-0001-6376-2094; Kuehn, Ralph/0000-0001-9518-0590; Peters, Joris/0000-0003-0894-2628; Walzer, Chris/0000-0002-0437-5147; Mashkour, Marjan/0000-0003-3630-9459; Guimaraes, Silvia/0000-0002-3778-3315; Pruvost, Melanie/0000-0001-7824-2155; davis, simon/0000-0002-3124-1638; Kaczensky, Petra/0000-0001-5428-1176	Centre National de la Recherche Scientifique CNRS, France; University Paris Diderot; Labex "Whom am I''; French ministry of research; "The Origins of Equid Domestication" of the National Science Foundation NSF [BCS-1311551]; Deutsche Forschungsgemeinschaft [DFG-PE 424/9-1, DFG-PE 424/9-2]; Division Of Behavioral and Cognitive Sci [1311551] Funding Source: National Science Foundation	Centre National de la Recherche Scientifique CNRS, France(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot; Labex "Whom am I''; French ministry of research(Ministry of Research, FranceEuropean Commission); "The Origins of Equid Domestication" of the National Science Foundation NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The Centre National de la Recherche Scientifique CNRS, France, provided the financial support for the project to the Epigenome and Paleogenome group of the Jacques Monod Institute. University Paris Diderot financed the infrastructure including the high containment laboratory of the Jacques Monod Institute. The Labex "Whom am I'' supported E. Andrew Bennett. The French ministry of research supported Sophie Champlot during her PhD research. The project BCS-1311551 "The Origins of Equid Domestication" of the National Science Foundation NSF granted to Benjamin S. Arbuckle supported Silvia Guimaraes and contributed to the project. The project DFG-PE 424/9-1,2 "Ungulate domestication and early animal husbandry in the Upper Euphratess basin" funded by the Deutsche Forschungsgemeinschaft to Joris Peters supported Melanie Pruvost.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; [Anonymous], 2014, TRACER V1 6; Antonius O., 1929, ZOOL GART NF, V1, P19; Aujoulat N, 2009, LASCAUX VISIT CAVE A; Aujoulat N, 2013, LASCAUX LE GESTE ESP; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Bennett EA, 2014, BIOTECHNIQUES, V56, P289, DOI 10.2144/000114176; Bernor Raymond L., 2010, P685; BOKONYI S., 1983, ORIGINI, VXII, P581; Bonifay M.F., 1991, EQUIDS ANCIENT WORLD, VII, P178; Boulbes N, 2009, QUATERNAIRE, V20, P449; Burke A., 2002, EQUIDS TIME SPACE, P62; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chessel D., 2004, R NEWS, V4, P5; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Crees JJ, 2014, QUATERNARY SCI REV, V91, P16, DOI 10.1016/j.quascirev.2014.03.003; DAVIS SJ, 1980, ZOOL J LINN SOC-LOND, V70, P289, DOI 10.1111/j.1096-3642.1980.tb00854.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eisenmann V, 2000, ZOOL SCR, V29, P89, DOI 10.1046/j.1463-6409.2000.00034.x; Eisenmann V., 2000, FICHE OSTEOLOGIE A B; Eisenmann V., 1986, EQUIDS ANCIENT WORLD, V19, P117; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FORSTEN A, 1988, PALAEOGEOGR PALAEOCL, V65, P23, DOI 10.1016/0031-0182(88)90109-5; FORSTEN A, 1991, ANN ZOOL FENN, V28, P301; Geigl EM, 2012, ANN ANAT, V194, P88, DOI 10.1016/j.aanat.2011.06.002; Groves C, 2011, UNGULATE TAXONOMY; Gueta T, 2014, CONSERV GENET, V15, P1231, DOI 10.1007/s10592-014-0614-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemami M-R, 2012, INT WILD EQ C VIENN; International Union for Conservation of Nature (IUCN), 2013, GUID REINTR OTH CONS; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jonsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111; Kaczensky P., 2015, IUCN RED LIST THREAT; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Khaire D., 2016, MITOCHONDRIAL DNA A, VA12, P1; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kruger K, 2005, J ANIM BREED GENET, V122, P78, DOI 10.1111/j.1439-0388.2005.00505.x; Kuhle M, 2011, ENCY SNOW ICE GLACIE, P924; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINDSAY EH, 1980, NATURE, V287, P135, DOI 10.1038/287135a0; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; Massilani D, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0317-7; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers PG, 2003, MAR GEOL, V201, P253, DOI 10.1016/S0025-3227(03)00225-1; Oakenfull EA, 1998, ANIM GENET, V29, P456, DOI 10.1046/j.1365-2052.1998.296380.x; Oakenfull EA, 2000, CONSERV GENET, V1, P345; Orlando L, 2003, J MOL EVOL, V57, pS29, DOI 10.1007/s00239-003-0005-4; Orlando L, 2006, MOL ECOL, V15, P2083, DOI 10.1111/j.1365-294X.2006.02922.x; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Ozdogan M., 2011, OXFORD HDB ANCIENT A, P657; Pfeiffer I, 2004, FORENSIC SCI INT, V141, P149, DOI 10.1016/j.forsciint.2004.01.016; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruvost M, 2005, BIOTECHNIQUES, V38, P569, DOI 10.2144/05384ST03; Renan S, 2015, MOL ECOL, V24, P1433, DOI 10.1111/mec.13131; Roberts N, 1997, EVOLUTION ENV ANATOL; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rosenbom S, 2015, MOL PHYLOGENET EVOL, V85, P88, DOI 10.1016/j.ympev.2015.01.005; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111; Schreiber A., 2000, EEP ASIATIC EQUIDS H; Shah N, 2015, IUCN RED LIST THREAT, V2015; Sharifi A, 2015, QUATERNARY SCI REV, V123, P215, DOI 10.1016/j.quascirev.2015.07.006; Siracusano G, 2004, 2001 EXCAVATION CAMP, P49; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Uerpmann M, 2005, EARLY DILMUN SETTLEM; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Verpmann H.-P., 1986, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P246; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Zohary M, 1973, GEOBOTANICAL FDN MID	82	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174216	10.1371/journal.pone.0174216	http://dx.doi.org/10.1371/journal.pone.0174216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422966	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600015
J	Pires, APF; Leal, JD; Peeters, ETHM				Flauzino Pires, Aliny Patricia; Leal, Juliana da Silva; Peeters, Edwin T. H. M.			Rainfall changes affect the algae dominance in tank bromeliad ecosystems	PLOS ONE			English	Article							REGIME SHIFTS; EPIPHYTIC BROMELIADS; ALTERNATIVE STATES; AQUATIC ECOSYSTEM; HABITAT SIZE; BIODIVERSITY; DIVERSITY; WATER; LAKES; DECOMPOSITION	Climate change and biodiversity loss have been reported as major disturbances in the biosphere which can trigger changes in the structure and functioning of natural ecosystems. Nonetheless, empirical studies demonstrating how both factors interact to affect shifts in aquatic ecosystems are still unexplored. Here, we experimentally test how changes in rainfall distribution and litter diversity affect the occurrence of the algae-dominated condition in tank bromeliad ecosystems. Tank bromeliads are miniature aquatic ecosystems shaped by the rainwater and allochthonous detritus accumulated in the bases of their leaves. Here, we demonstrated that changes in the rainfall distribution were able to reduce the chlorophyll-a concentration in the water of bromeliad tanks affecting significantly the occurrence of algae dominated conditions. On the other hand, litter diversity did not affect the algae dominance irrespective to the rainfall scenario. We suggest that rainfall changes may compromise important self-reinforcing mechanisms responsible for maintaining high levels of algae on tank bromeliads ecosystems. We summarized these results into a theoretical model which suggests that tank bromeliads may show two different regimes, determined by the bromeliad ability in taking up nutrients from the water and by the total amount of light entering the tank. We concluded that predicted climate changes might promote regime shifts in tropical aquatic ecosystems by shaping their structure and the relative importance of other regulating factors.	[Flauzino Pires, Aliny Patricia; Leal, Juliana da Silva] Univ Fed Rio de Janeiro, Inst Biol, Dept Ecol, Rio De Janeiro, Brazil; [Flauzino Pires, Aliny Patricia] Fundacao Brasileira Desenvolvimento Sustentavel, Rio De Janeiro, Brazil; [Flauzino Pires, Aliny Patricia] Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil; [Peeters, Edwin T. H. M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, Dept Environm Sci, Wageningen, Netherlands	Universidade Federal do Rio de Janeiro; Instituto Nacional de Pesquisas Espaciais (INPE); Wageningen University & Research	Pires, APF (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Ecol, Rio De Janeiro, Brazil.; Pires, APF (corresponding author), Fundacao Brasileira Desenvolvimento Sustentavel, Rio De Janeiro, Brazil.; Pires, APF (corresponding author), Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil.	alinypfpires@gmail.com	Pires, Aliny/Z-2023-2019	Pires, Aliny/0000-0003-1531-8831; Peeters, Edwin T.H.M./0000-0003-2541-1829	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [476926/2012-2]; FAPERJ (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro) [E-26/103316/2011]; CENPES/PETROBRAS (Project "Impact of Global Climate Changes on Tropical Continental Aquatic Ecosystems"); CNPq; CAPES; Brazilian Research Network on Global Climate Change; FINEP/ Rede CLIMA [01.13.0353-00]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CENPES/PETROBRAS (Project "Impact of Global Climate Changes on Tropical Continental Aquatic Ecosystems"); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Network on Global Climate Change; FINEP/ Rede CLIMA	Financial support was provided by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Project 476926/2012-2), FAPERJ (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro, Project E-26/103316/2011) and CENPES/PETROBRAS (Project "Impact of Global Climate Changes on Tropical Continental Aquatic Ecosystems"). APFP and JSL are grateful to CNPq and CAPES for graduate scholarships. This paper is a contribution of the Brazilian Research Network on Global Climate Change, FINEP/ Rede CLIMA Grant Number 01.13.0353-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to V. Dib for field assistance and V. F. Farjalla and two anonymous reviewers for comments on the manuscript. Financial support was provided by CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico, Project 476926/2012-2), FAPERJ (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro, Project E-26/103316/2011) and CENPES/PETROBRAS (Project "Impact of Global Climate Changes on Tropical Continental Aquatic Ecosystems"). APFP and JSL are grateful to CNPq and CAPES for graduate scholarships. This paper is a contribution of the Brazilian Research Network on Global Climate Change, FINEP/ Rede CLIMA Grant Number 01.13.0353-00.	[Anonymous], 1978, SIL P, DOI DOI 10.1080/03680770.1977.11896681; Auguie B, 2017, GRIDEXTRA MISCELLANE; BENZING DH, 2000, BROMELIACEAE PROFILE; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carrias JF, 2014, PLANT BIOLOGY, V16, P997, DOI 10.1111/plb.12139; Farjalla VF, 2016, ECOLOGY, V97, P2147, DOI 10.1002/ecy.1432; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gessner MO, 2004, OIKOS, V104, P419, DOI 10.1111/j.0030-1299.1999.13252.x; Goncalves AZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152113; Goncalves AZ, 2014, BIOTROPICA, V46, P170, DOI 10.1111/btp.12086; Goncalves AZ, 2011, ANN BOT-LONDON, V107, P1047, DOI 10.1093/aob/mcr047; Green A. J., 2017, FRONTIERS ECOLOGY EN, V15, P1; Haubrich CS, 2009, HYDROBIOLOGIA, V632, P347, DOI 10.1007/s10750-009-9841-6; Inselsbacher E, 2007, NEW PHYTOL, V175, P311, DOI 10.1111/j.1469-8137.2007.02098.x; IPCC, 2001, ECOSYSTEMS, V4, P151; Jeppesen E, 1999, HYDROBIOLOGIA, V408, P217, DOI 10.1023/A:1017071600486; Kominoski JS, 2009, OIKOS, V118, P457, DOI 10.1111/j.1600-0706.2008.17222.x; Kosten S, 2012, FRESHWATER BIOL, V57, P1191, DOI 10.1111/j.1365-2427.2012.02785.x; Lehours AC, 2016, ENV MICROBIOL REP, V8, P689, DOI 10.1111/1758-2229.12426; Leroy C, 2016, J PLANT ECOL, V9, P241, DOI 10.1093/jpe/rtv052; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Mackereth F.J.H., 1978, WATER ANAL SOME REVI; Marengo JA, 2010, CLIM DYNAM, V35, P1089, DOI 10.1007/s00382-009-0721-6; Marino NAC, 2017, GLOBAL CHANGE BIOL, V23, P673, DOI 10.1111/gcb.13399; Marino NAC, 2013, INSECT CONSERV DIVER, V6, P372, DOI 10.1111/j.1752-4598.2012.00224.x; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Nobre C. A., 2016, Journal of Water Resource and Protection, V8, P252, DOI 10.4236/jwarp.2016.82022; Norlin JI, 2005, FRESHWATER BIOL, V50, P868, DOI 10.1111/j.1365-2427.2005.01366.x; Nusch E., 1975, GAS WASSERFACH WASSE, V116; Petermann JS, 2015, ECOLOGY, V96, P428, DOI 10.1890/14-0304.1; Pires APF, 2016, ECOLOGY, V97, P2750, DOI 10.1002/ecy.1501; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Sanpera-Calbet I, 2009, FRESHWATER BIOL, V54, P1671, DOI 10.1111/j.1365-2427.2009.02216.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Lopez LCS, 2009, HYDROBIOLOGIA, V625, P151, DOI 10.1007/s10750-009-9704-1; Sirota J, 2013, P NATL ACAD SCI USA, V110, P7742, DOI 10.1073/pnas.1221037110; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Van De Koppel J, 2001, ECOLOGY, V82, P3449, DOI 10.1890/0012-9658(2001)082[3449:DASSOI]2.0.CO;2; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zotz G, 1999, ANN BOT-LONDON, V83, P183, DOI 10.1006/anbo.1998.0809	53	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175436	10.1371/journal.pone.0175436	http://dx.doi.org/10.1371/journal.pone.0175436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422988	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600032
J	Grondahl, ML; Christiansen, SL; Kesmodel, US; Agerholm, IE; Lemmen, JG; Lundstrom, P; Bogstad, J; Raaschou-Jensen, M; Ladelund, S				Grondahl, Marie Louise; Christiansen, Sofie Lindgren; Kesmodel, Ulrik Schioler; Agerholm, Inge Errebo; Lemmen, Josephine Gabriela; Lundstrom, Peter; Bogstad, Jeanette; Raaschou-Jensen, Morten; Ladelund, Steen			Effect of women's age on embryo morphology, cleavage rate and competence-A multicenter cohort study	PLOS ONE			English	Article							ENDOMETRIAL GENE-EXPRESSION; IN-VITRO FERTILIZATION; MATERNAL AGE; HUMAN OOCYTES; IVF; ANEUPLOIDY; QUALITY; PROFILES; OUTCOMES; ORIGIN	This multicenter cohort study on embryo assessment and outcome data from 11,744 IVF/ICSI cycles with 104,830 oocytes and 42,074 embryos, presents the effect of women's age on oocyte, zygote, embryo morphology and cleavage parameters, as well as cycle outcome measures corrected for confounding factors as center, partner's age and referral diagnosis. Cycle outcome data confirmed the well-known effect of women's age. Oocyte nuclear maturation and proportion of 2 pro-nuclear (2PN) zygotes were not affected by age, while a significant increase in 3PN zygotes was observed in both IVF and ICSI (p<0.0001) with increasing age. Maternal age had no effect on cleavage parameters or on the morphology of the embryo day 2 post insemination. Interestingly, initial hCG value after single embryo transfer followed by ongoing pregnancy was increased with age in both IVF (p = 0.007) and ICSI (p = 0.001) cycles. For the first time, we show that a woman's age does impose a significant footprint on early embryo morphological development (3PN). In addition, the developmentally competent embryos were associated with increased initial hCG values as the age of the women increased. Further studies are needed to elucidate, if this increase in initial hCG value with advancing maternal age is connected to the embryo or the uterus.	[Grondahl, Marie Louise; Christiansen, Sofie Lindgren; Kesmodel, Ulrik Schioler] Copenhagen Univ Hosp, Herlev Hosp, Fertil Clin, Herlev, Denmark; [Kesmodel, Ulrik Schioler] Aarhus Univ Hosp, Fertil Clin, Aarhus, Denmark; [Agerholm, Inge Errebo] Brmdstrup Fertil Clin, Horsens, Denmark; [Lemmen, Josephine Gabriela] Rigshosp, Copenhagen Univ Hosp, Fertil Clin, Copenhagen, Denmark; [Lundstrom, Peter] Ballerup IVF, Copenhagen, Denmark; [Bogstad, Jeanette] Hvidovre Univ Hosp, Copenhagen Univ Hosp, Fertil Clin, Hvidovre, Denmark; [Raaschou-Jensen, Morten] CellCura Solut A S, Copenhagen, Denmark; [Ladelund, Steen] Hvidovre Univ Hosp, Copenhagen Univ Hosp, Clin Res Ctr, Stat, Hvidovre, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Grondahl, ML (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Fertil Clin, Herlev, Denmark.	marie.louise.groendahl@regionh.dk	; Ladelund, Steen/I-7205-2012	Christiansen, Sofie Lindgren/0000-0003-3810-4123; Ladelund, Steen/0000-0001-5695-8419	MSD, Denmark; Cell Cura Solutions; Balleup IVF	MSD, Denmark; Cell Cura Solutions; Balleup IVF	The study was supported with an unrestricted grant from MSD, Denmark. Cell Cura Solutions and Balleup IVF provided support in the form of salaries for authors MRJ (Cell Cura Solutions) and PL (Balleup IVF), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agerholm IE, 2008, FERTIL STERIL, V90, P1649, DOI 10.1016/j.fertnstert.2007.08.015; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; [Anonymous], 2014, R LANG ENV STAT COMP; Armstrong DT, 2001, THERIOGENOLOGY, V55, P1303, DOI 10.1016/S0093-691X(01)00484-8; Campbell A, 2013, REPROD BIOMED ONLINE, V27, P140, DOI 10.1016/j.rbmo.2013.04.013; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Davies S, 2012, HUM REPROD, V27; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Franasiak JM, 2014, FERTIL STERIL, V101, P656, DOI 10.1016/j.fertnstert.2013.11.004; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Handyside AH, 2012, BBA-MOL BASIS DIS, V1822, P1913, DOI 10.1016/j.bbadis.2012.07.007; Hardarson T, 2002, Reprod Biomed Online, V5, P36; Horcajadas JA, 2005, MOL HUM REPROD, V11, P195, DOI 10.1093/molehr/gah150; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Humaidan P, 2012, HUM REPROD, V27, P3259, DOI 10.1093/humrep/des279; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lee HJ, 2012, YONSEI MED J, V53, P181, DOI 10.3349/ymj.2012.53.1.181; Lemmen JG, 2008, REPROD BIOMED ONLINE, V17, P385, DOI 10.1016/S1472-6483(10)60222-2; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Liu YH, 2014, REPROD BIOL, V14, P249, DOI 10.1016/j.repbio.2014.08.003; Lundin K, 2001, HUM REPROD, V16, P2652, DOI 10.1093/humrep/16.12.2652; Luzhna Lidiya, 2013, Frontiers in Genetics, V4, P131, DOI 10.3389/fgene.2013.00131; McCallie BR, 2014, J ASSIST REPROD GEN, V31, P913, DOI 10.1007/s10815-014-0235-y; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Nazemian Z, 2011, J ASSIST REPROD GEN, V28, P101, DOI 10.1007/s10815-010-9499-z; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Stensen MH, 2010, REPROD BIOMED ONLINE, V21, P118, DOI 10.1016/j.rbmo.2010.03.018; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Yan JH, 2012, SCI CHINA LIFE SCI, V55, P694, DOI 10.1007/s11427-012-4357-0; Ziebe S, 2003, HUM REPROD, V18, P2575, DOI 10.1093/humrep/deg489	31	32	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0172456	10.1371/journal.pone.0172456	http://dx.doi.org/10.1371/journal.pone.0172456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422964	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600006
J	Mujal, E; Fortuny, J; Bolet, A; Oms, O; Lopez, JA				Mujal, Eudald; Fortuny, Josep; Bolet, Arnau; Oms, Oriol; Angel Lopez, Jose			An archosauromorph dominated ichnoassemblage in fluvial settings from the late Early Triassic of the Catalan Pyrenees (NE Iberian Peninsula)	PLOS ONE			English	Article							HOLY-CROSS MOUNTAINS; MASS EXTINCTION; TETRAPOD FOOTPRINTS; SOUTHERN PYRENEES; NORTHERN HESSE; HIGH ATLAS; TRACKS; BASIN; EVOLUTION; RECOVERY	The vertebrate recovery after the end-Permian mass extinction can be approached through the ichnological record, which is much more abundant than body fossils. The late Olenekian (Early Triassic) tetrapod ichnoassemblage of the Catalan Pyrenean Basin is the most complete and diverse of this age from Western Tethys. This extensional basin, composed of several depocenters, was formed in the latest phases of the Variscan orogeny (Pangea breakup) and was infilled by braided and meandering fluvial systems of the red-beds Bunt-sandstein facies. Abundant and diverse tetrapod ichnites are recorded in these facies, including Prorotodactylus mesaxonichnus isp. nov. (tracks possibly produced by euparkeriids), cf. Rotodactylus, at least two large chirotheriid morphotypes (archosauriform trackmakers), Rhynchosauroides cf. schochardti, two other undetermined Rhynchosauroides forms, an undetermined Morphotype A (archosauromorph trackmakers) and two types of Characichnos isp. (swimming traces, here associated to archosauromorph trackmakers). The Pyrenean ichnoassemblage suggests a relatively homogeneous ichnofaunal composition through the late Early Triassic of Central Pangea, characterized by the presence of Prorotodactylus and Rotodactylus. Small archosauromorph tracks dominate and present a wide distribution through the different fluviatile facies of the Triassic Pyrenean Basin, with large archosaurian footprints being present in a lesser degree. Archosauromorphs radiated and diversified through the Triassic vertebrate recovery, which ultimately lead to the archosaur and dinosaur dominance of the Mesozoic.	[Mujal, Eudald; Oms, Oriol; Angel Lopez, Jose] Univ Autonoma Barcelona, Dept Geol, Bellaterra, Spain; [Fortuny, Josep] Museum Natl Hist Nat, Ctr Rech Paleobiodivers & Paleoenvironm, Batiment Paleonol, Paris, France; [Fortuny, Josep; Bolet, Arnau] Inst Catala Paleontol Miquel Crusafont, ICTA ICP Bldg, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut Catala de Paleontologia Miquel Crusafont (ICP)	Mujal, E (corresponding author), Univ Autonoma Barcelona, Dept Geol, Bellaterra, Spain.	eudald.mujal@gmail.com	Fortuny, Josep/L-2523-2014; Bolet, Arnau/N-1059-2016; Mujal, Eudald/AAG-7531-2021; Oms, Oriol/AAZ-6312-2020	Fortuny, Josep/0000-0003-4282-1619; Bolet, Arnau/0000-0003-4416-4560; Mujal, Eudald/0000-0002-6310-323X; 	Universitat Autonoma de Barcelona; Centre de Recherche sur la Paleobiodiversite et les Paleoenvironnements (CR2P, MNHN); Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [BP-A 00048]; Generalitat de Catalunya [2014/100606, 57 641992013 03]; CERCA programme	Universitat Autonoma de Barcelona; Centre de Recherche sur la Paleobiodiversite et les Paleoenvironnements (CR2P, MNHN); Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya(Generalitat de Catalunya); CERCA programme	This work was supported by the Universitat Autonoma de Barcelona (www.uab.cat), PhD grant (PIF Geologia) to EM, the Centre de Recherche sur la Paleobiodiversite et les Paleoenvironnements (CR2P, MNHN), the Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (http://agaur.gencat.cat/) through grant 2014 - BP-A 00048 to JF, the Generalitat de Catalunya (http://web.gencat.cat/) through fieldwork projects 2014/100606 and 57 641992013 03 to JF, and by the CERCA programme to JF and AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzini M, 2011, EARTH AND ENVIRONMENTAL SCIENCES, P591; Benton MJ, 2014, GONDWANA RES, V25, P1308, DOI 10.1016/j.gr.2012.12.010; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bernardi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128449; Borruel-Abadia V, 2015, PALAEOGEOGR PALAEOCL, V440, P671, DOI 10.1016/j.palaeo.2015.09.043; Bourquin S, 2011, PALAEOGEOGR PALAEOCL, V299, P265, DOI 10.1016/j.palaeo.2010.11.007; Brusatte SL, 2012, N M MUS NAT HIST SCI, V59, P1; Brusatte SL, 2011, P ROY SOC B-BIOL SCI, V278, P1107, DOI 10.1098/rspb.2010.1746; Calvet F., 1993, Acta Geologica Hispanica, V28, P33; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; DEMATHIEU G R, 1984, Annales de Paleontologie, V70, P247; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2016, PEERJ, V4, DOI 10.7717/peerj.1778; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Fichter J., 2013, Comunicacoes Geologicas, V100, P81; Fichter J, 2015, Z DTSCH GES GEOWISS, V166, P253, DOI 10.1127/1860-1804/2015/0036; Fortuny J, 2011, J IBER GEOL, V37, P65, DOI 10.5209/rev_JIGE.2011.v37.n1.5; Gretter N, 2015, EARTH-SCI REV, V150, P679, DOI 10.1016/j.earscirev.2015.09.001; Haubold H, 1998, TRIASSIC ZENTRALBL 1, P783; Haubold H., 1971, PALAONTOLOGISCHE A A, V4, P395; Haubold H., 1971, ENCY PALEOHERPETOLOG, V18; Haubold Hartmut, 2002, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V24, P1; Irmis RB, 2012, P ROY SOC B-BIOL SCI, V279, P1310, DOI 10.1098/rspb.2011.1895; Klein H, 2007, N M MUS NAT HIST SCI, V641, P120; Klein H., 2010, NEW MEXICO MUSEUM NA, V50, P1; Klein H, 2013, ICHNOS, V20, P24, DOI 10.1080/10420940.2012.757699; Klein H, 2010, GEOL SOC SPEC PUBL, V334, P419, DOI 10.1144/SP334.14; Klein H, 2010, ICHNOS, V17, P215, DOI 10.1080/10420940.2010.510030; Krainer Karl, 2012, Jahrbuch der Geologischen Bundesanstalt, V152, P205; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P157, DOI 10.1144/SP379.9; Leonardi G., 1987, GLOSSARY MANUAL TETR; Lovelace DM, 2012, PALAIOS, V27, P637, DOI 10.2110/palo.2012.p12-011r; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Mey PHW, 1968, LEIDSE GEOLOGISCHE M, V41, P153; Miall A D, 1992, FACIES MODELS RESPON, P119; MIALL AD, 1985, EARTH-SCI REV, V22, P261, DOI 10.1016/0012-8252(85)90001-7; Montenat C., 2007, PALAEOVERTEBRATA, V1-4, P1; Mujal E, 2016, PALAEOGEOGR PALAEOCL, V445, P18, DOI 10.1016/j.palaeo.2015.12.008; Mujal E, 2016, GEOL MAG, V153, P578, DOI 10.1017/S0016756815000576; Nagtegaal P.J.C., 1969, LEIDSE GEOL MEDED, V42, P143; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Niedzwiedzki G, 2007, ACTA GEOL POL, V57, P325; Niedzwiedzki G, 2013, GEOL SOC SPEC PUBL, V379, P319, DOI 10.1144/SP379.12; Padian K, 2013, EARTH ENV SCI T R SO, V103, P1; Peabody FE., 1948, B DEP GEOLOGICAL SCI, V27, P295; Petti Fabio M., 2013, Bulletin of the New Mexico Museum of Natural History and Science, P458; Pinheiro FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22817; Ptaszynski T, 2000, ACTA PALAEONTOL POL, V45, P151; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Saura E., 2004, THESIS U AUTONOMA BA, P355; Saura E, 2006, J STRUCT GEOL, V28, P1909, DOI 10.1016/j.jsg.2006.06.005; Seguret M., 1972, THESIS MONTPELLIER U, V2, P1; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002; Sookias RB, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150674; Sookias RB, 2013, GEOL SOC SPEC PUBL, V379, P35, DOI 10.1144/SP379.6; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; SPEKSNIJDER A, 1985, SEDIMENT GEOL, V44, P179, DOI 10.1016/0037-0738(85)90014-4; Thomson TJ, 2015, GEOLOGY, V43, P215, DOI 10.1130/G36332.1; Torsvik TH, 2013, GONDWANA RES, V24, P999, DOI 10.1016/j.gr.2013.06.012; Tourani A, 2010, CR PALEVOL, V9, P201, DOI 10.1016/j.crpv.2010.05.001; Whyte M.A., 2001, Ichnos, V8, P223; Zwart H.J., 1979, LEIDSE GEOL MEDED, V50, P1	63	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174693	10.1371/journal.pone.0174693	http://dx.doi.org/10.1371/journal.pone.0174693			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423005	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600020
J	Yao, L; Chen, WN; Song, K; Han, C; Gandhi, CR; Lim, K; Wu, T				Yao, Lu; Chen, Weina; Song, Kyoungsub; Han, Chang; Gandhi, Chandrashekhar R.; Lim, Kyu; Wu, Tong			15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INFLAMMATORY RESPONSE; NUCLEAR RECEPTORS; TNF-ALPHA; MECHANISMS; GROWTH	The NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) catalyzes the oxidation of the 15(S)-hydroxyl group of prostaglandin E-2 (PGE(2)), converting the pro-inflammatory PGE(2) to the anti-inflammatory 15-keto-PGE(2) (an endogenous ligand for peroxisome proliferator-activated receptor-gamma [PPAR-gamma]). To evaluate the significance of 15-PGDH/15-keto-PGE(2) cascade in liver inflammation and tissue injury, we generated transgenic mice with targeted expression of 15-PGDH in the liver (15-PGDH Tg) and the animals were subjected to lipopolysaccharide (LPS)/Galactosamine (GalN)-induced acute liver inflammation and injury. Compared to the wild type mice, the 15-PGDH Tg mice showed lower levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), less liver tissue damage, less hepatic apoptosis/necrosis, less macrophage activation, and lower inflammatory cytokine production. In cultured Kupffer cells, treatment with 15-keto-PGE(2) or the conditioned medium (CM) from 15-PGDH Tg hepatocyes inhibited LPS-induced cytokine production, in vitro. Both 15-keto-PGE(2) and the CM from15-PGDH Tg hepatocyes also up-regulated the expression of PPAR-gamma downstream genes in Kupffer cells. In cultured hepatocytes, 15-keto-PGE(2) treatment or 15PGDH overexpression did not influence TNF-alpha-induced hepatocyte apoptosis. These findings suggest that 15-PGDH protects against LPS/GalN-induced liver injury and the effect is mediated via 15-keto-PGE(2), which activates PPAR-gamma in Kupffer cells and thus inhibits their ability to produce inflammatory cytokines. Accordingly, we observed that the PPAR-gamma antagonist, GW9662, reversed the effect of 15-keto-PGE(2) in Kupffer cell in vitro and restored the susceptibility of 15-PGDH Tg mice to LPS/GalN-induced acute liver injury in vivo. Collectively, our findings suggest that 15-PGDH-derived 15-keto-PGE(2) from hepatocytes is able to activate PPAR-gamma and inhibit inflammatory cytokine production in Kupffer cells and that this paracrine mechanism negatively regulates LPS-induced necro-inflammatory response in the liver. Therefore, induction of 15-PGDH expression or utilization of 15-keto-PGE(2) analogue may have therapeutic benefits for the treatment of endotoxin-associated liver inflammation/injury.	[Yao, Lu; Chen, Weina; Song, Kyoungsub; Han, Chang; Wu, Tong] Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Lim, Kyu] Chungnam Natl Univ, Canc Res Inst, Coll Med, Dept Biochem, Daejeon, South Korea; [Lim, Kyu] Chungnam Natl Univ, Infect Signaling Network Res Ctr, Daejeon, South Korea	Tulane University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Chungnam National University; Chungnam National University	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	twu@tulane.edu	yao, lu/AAC-4304-2022		NIH [CA102325, DK077776]; NATIONAL CANCER INSTITUTE [R01CA102325] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The work in the author's laboratory is supported by the NIH grants (CA102325 and DK077776). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; CHEN K, 2014, PPAR RES, V2014, DOI DOI 10.1155/2014/215631; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Han C, 2010, HEPATOLOGY, V52, P644, DOI 10.1002/hep.23703; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Kondo Y, 2013, PPAR RES, V2013, DOI 10.1155/2013/896412; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu XJ, 2011, CHEM RES TOXICOL, V24, P2227, DOI 10.1021/tx200336f; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; OGAWA Y, 2012, PPAR RES, DOI DOI 10.1155/2012/940384; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Tai HH, 2006, CURR PHARM DESIGN, V12, P955, DOI 10.2174/138161206776055958; Yu YH, 2013, J LIPID RES, V54, P2391, DOI 10.1194/jlr.M037556; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	26	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176106	10.1371/journal.pone.0176106	http://dx.doi.org/10.1371/journal.pone.0176106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423012	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600088
J	Andruszkiewicz, EA; Starks, HA; Chavez, FP; Sassoubre, LM; Block, BA; Boehm, AB				Andruszkiewicz, Elizabeth A.; Starks, Hilary A.; Chavez, Francisco P.; Sassoubre, Lauren M.; Block, Barbara A.; Boehm, Alexandria B.			Biomonitoring of marine vertebrates in Monterey Bay using eDNA metabarcoding	PLOS ONE			English	Article							ENVIRONMENTAL DNA; DETECTION PROBABILITIES; OCCUPANCY; DIVERSITY	Molecular analysis of environmental DNA (eDNA) can be used to assess vertebrate biodiversity in aquatic systems, but limited work has applied eDNA technologies to marine waters. Further, there is limited understanding of the spatial distribution of vertebrate eDNA in marine waters. Here, we use an eDNA metabarcoding approach to target and amplify a hypervariable region of the mitochondrial 12S rRNA gene to characterize vertebrate communities at 10 oceanographic stations spanning 45 km within the Monterey Bay National Marine Sanctuary (MBNMS). In this study, we collected three biological replicates of small volume water samples (1 L) at 2 depths at each of the 10 stations. We amplified fish mitochondrial DNA using a universal primer set. We obtained 5,644,299 high quality Illumina sequence reads from the environmental samples. The sequence reads were annotated to the lowest taxonomic assignment using a bioinformatics pipeline. The eDNA survey identified, to the lowest taxonomic rank, 7 families, 3 subfamilies, 10 genera, and 72 species of vertebrates at the study sites. These 92 distinct taxa come from 33 unique marine vertebrate families. We observed significantly different vertebrate community composition between sampling depths (0 m and 20/40 m deep) across all stations and significantly different communities at stations located on the continental shelf (<200 m bottom depth) versus in the deeper waters of the canyons of Monterey Bay (>200 m bottom depth). All but 1 family identified using eDNA metabarcoding is known to occur in MBNMS. The study informs the implementation of eDNA metabarcoding for vertebrate biomonitoring.	[Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Starks, Hilary A.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Sassoubre, Lauren M.] Univ Buffalo State Univ New York, Dept Civil Struct & Environm Engn, Buffalo, NY USA	Stanford University; Stanford University; Monterey Bay Aquarium Research Institute; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	aboehm@stanford.edu	Allan, Elizabeth Andruszkiewicz/AAD-2255-2021	Allan, Elizabeth Andruszkiewicz/0000-0002-9675-0003; Boehm, Alexandria/0000-0002-8162-5090	Seaver Institute to Woods Institute for the Environment at Stanford University; NASA [NNX14AP62A, NOPP RFP NOAA-NOS-IOOS-2014-2003803]; NOAA [NOPP RFP NOAA-NOS-IOOS-2014-2003803]; BOEM [NOPP RFP NOAA-NOS-IOOS-2014-2003803]; U.S. Integrated Ocean Observing System (IOOS) Program Office; U.S. Environmental Protection Agency (EPA) [F15E211913419]; David and Lucile Packard Foundation	Seaver Institute to Woods Institute for the Environment at Stanford University; NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); BOEM; U.S. Integrated Ocean Observing System (IOOS) Program Office; U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by a gift from the Seaver Institute to Woods Institute for the Environment at Stanford University and was partially supported by NASA grant NNX14AP62A 'National Marine Sanctuaries as Sentinel Sites for a Demonstration Marine Biodiversity Observation Network (MBON)' funded under the National Ocean Partnership Program (NOPP RFP NOAA-NOS-IOOS-2014-2003803 in partnership between NOAA, BOEM, and NASA), and the U.S. Integrated Ocean Observing System (IOOS) Program Office. This publication was developed under STAR Fellowship Assistance Agreement no. F15E211913419 awarded by the U.S. Environmental Protection Agency (EPA). It has not been formally reviewed by EPA. The views expressed in this publication are solely those of Elizabeth Andruszkiewicz and co-authors, and EPA does not endorse any products or commercial services mentioned in this publication. The CANON cruise was supported by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Burton EJ, 2013, CHECKLIST FISHES KNO, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Clarke K. R., 2001, CHANGES MARINE COMMU; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guerrero J, 2014, MONTEREY BAY NATL MA; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kelly RP, GENETIC MANUAL SURVE; Kelly RP, 2016, PEERJ, V4, DOI 10.7717/peerj.2444; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Oksanen J, 2016, VEGAN INTRO ORDINATI, P1; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Radulovici Adriana E., 2010, Diversity, V2, P450; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Schnell IB, 2015, MOL ECOL RESOUR, V15, P1289, DOI 10.1111/1755-0998.12402; Schratzberger M, 2002, MAR BIOL, V140, P83, DOI 10.1007/s002270100688; Shelton AO, 2016, ECOL APPL, V26, P1645, DOI 10.1890/15-1733.1; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Spaink HP, 2014, BRIEF FUNCT GENOMICS, V13, P144, DOI 10.1093/bfgp/elt046; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Xiong W, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2911-1; Yamashiro S, 2016, ENV DNA METABARCODIN, P1; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	60	88	95	7	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176343	10.1371/journal.pone.0176343	http://dx.doi.org/10.1371/journal.pone.0176343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441466	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800048
J	Companioni, O; Sanz-Anquela, JM; Pardo, ML; Puigdecanet, E; Nonell, L; Garcia, N; Blanco, VP; Lopez, C; Andreu, V; Cuatrecasas, M; Garmendia, M; Gisbert, JP; Gonzalez, CA; Sala, N				Companioni, Osmel; Miguel Sanz-Anquela, Jose; Luisa Pardo, Maria; Puigdecanet, Eulalia; Nonell, Lara; Garcia, Nadia; Parra Blanco, Veronica; Lopez, Consuelo; Andreu, Victoria; Cuatrecasas, Miriam; Garmendia, Maddi; Gisbert, Javier P.; Gonzalez, Carlos A.; Sala, Nuria			Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PRENEOPLASTIC LESIONS; IDENTIFICATION; PROTEINS; PROLIFERATION; BIOLOGY; ANTIGEN; MARKER; RISK	Background Intestinal metaplasia (IM) is a precursor lesion that precedes gastric cancer (GC). There are two IM histological subtypes, complete (CIM) and incomplete (IIM), the latter having higher progression rates to GC. This study was aimed at analysing gene expression and molecular processes involved in the progression from normal mucosa to IM, and also from IM subtypes to GC. Methodology We used expression data to compare the transcriptome of healthy gastric mucosa to that of IM not progressing to GC, and the transcriptome of IM subtypes that had progressed to GC to those that did not progress. Some deregulated genes were validated and pathway analyses were performed. Results Comparison of IM subtypes that had progressed to GC with those that did not progress showed smaller differences in the expression profiles than the comparison of IM that did not progress with healthy mucosa. New transcripts identified in IM not progressing to GC included TRIM, TMEM, homeobox and transporter genes and SNORD116. Comparison to normal mucosa identified non tumoral Warburg effect and melatonin degradation as previously unreported processes involved in IM. Overexpressed antigen processing is common to both IM-subtypes progressing to GC, but IIM showed more over-expressed oncogenic genes and molecular processes than CIM. Conclusions There are greater differences in gene expression and molecular processes involved in the progression from normal healthy mucosa to IM than from IM to gastric cancer. While antigen processing is common in both IM-subtypes progressing to GC, more oncogenic processes are observed in the progression of IIM.	[Companioni, Osmel; Garcia, Nadia; Gonzalez, Carlos A.; Sala, Nuria] Inst Catala Oncol, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Canc Registry, Hosp Univ Principe Asturias, Madrid, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Dept Pathol, Hosp Univ Principe Asturias, Madrid, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Fac Med, Dept Med & Med Specialties, Madrid, Spain; [Luisa Pardo, Maria] Complejo Hosp Soria, Dept Pathol, Madrid, Spain; [Puigdecanet, Eulalia; Nonell, Lara] Hosp del Mar Med Res Inst IMIM, Microarray Anal Serv, Barcelona, Spain; [Parra Blanco, Veronica] Hosp Univ Gregorio Maranon, Dept Histopathol, Madrid, Spain; [Lopez, Consuelo] Hosp Univ Princesa, Dept Pathol, Madrid, Spain; [Andreu, Victoria] Hosp Viladecans, Dept Gastroenterol, Barcelona, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Hosp Clin Barcelona, Dept Pathol, Biobanc Clin IDIBAPS, Barcelona, Spain; [Garmendia, Maddi] Univ Pais Vasco UPV EHU, Dept Pathol, Hosp Donostia, Inst Biodonostia,CIBEREHD, San Sebastian, Spain; [Garmendia, Maddi] Univ Pais Vasco UPV EHU, Dept Gastroenterol, Hosp Donostia, Inst Biodonostia,CIBEREHD, San Sebastian, Spain; [Gisbert, Javier P.] Hosp Univ La Princesa, Gastroenterol Unit, Madrid, Spain; [Gisbert, Javier P.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Sanitaria Princesa IIS IP, Madrid, Spain	Catalan Institute of Oncology; Prince of Asturias University Hospital; Universidad de Alcala; Prince of Asturias University Hospital; Universidad de Alcala; Universidad de Alcala; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Gregorio Maranon Hospital; Hospital de La Princesa; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Valdecans; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; Hospital de La Princesa; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Companioni, O; Sala, N (corresponding author), Inst Catala Oncol, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain.	osmel.companioni@yahoo.es; nsala@iconcologia.net	Napoles, Osmel Companioni/AAH-7636-2021; Gisbert, Javier P/ABB-7531-2021; Gisbert, Javier P/GRY-2719-2022; Cuatrecasas, Miriam/C-9156-2019; Puigdecanet, Eulàlia/U-7568-2019; parra-blanco, veronica/ABC-7069-2020; Sala, Nuria/G-8471-2015	Gisbert, Javier P/0000-0003-2090-3445; Cuatrecasas, Miriam/0000-0003-3063-0110; parra-blanco, veronica/0000-0002-7916-5478; Companioni Napoles, Osmel/0000-0001-6605-945X; Sanz-Anquela, Jose Miguel/0000-0001-9723-6615; Sala, Nuria/0000-0003-3585-7613	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER) "A way to build Europe" [PI03/0077, PI10/01089, PI10/01031, PI10/01203, RETICC RD12/0036/0018]; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain [exp. 2014 SGR 726]; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER) "A way to build Europe"; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health. Cofounded by European Regional Development Funds (ERDF/FEDER) "A way to build Europe". http://www.isciii.es/. Grant numbers: PI03/0077 (CAG) PI10/01089 (CAG), PI10/01031 (JG), PI10/01203 (JMS) RETICC RD12/0036/0018 (CAG, NS, OC, NG). Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain. http://agaur.gencat.cat/en/inici/index.html. Grant number: exp. 2014 SGR 726 (CAG, OC, NG, NS). Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), http://www.idibell.cat/en, PhD scholarship to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PRISM VERS 5 01 WIND; Aquino PF, 2012, J PROTEOME RES, V11, P5836, DOI 10.1021/pr300612x; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Boussioutas A, 2006, CANCER RES, V63, P2569; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Curt MJC, 2015, GLYCOBIOLOGY, V25, P617, DOI 10.1093/glycob/cwv004; Dinis-Ribeiro M, 2012, VIRCHOWS ARCH, V460, P19, DOI 10.1007/s00428-011-1177-8; Garay J, 2016, CANCER LETT, V371, P90, DOI 10.1016/j.canlet.2015.10.037; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomes LI, 2005, CANCER RES, V65, P7127, DOI 10.1158/0008-5472.CAN-05-1035; Gonzalez CA, 2016, J GASTROEN HEPATOL, V31, P953, DOI 10.1111/jgh.13249; Gonzalez CA, 2013, INT J CANCER, V133, P1023, DOI 10.1002/ijc.28003; Gonzalez CA, 2010, INT J CANCER, V127, P2654, DOI 10.1002/ijc.25273; Hamamoto T, 1997, J CLIN PATHOL, V50, P841, DOI 10.1136/jcp.50.10.841; Han Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0564-1; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu CY, 2013, INT J ONCOL, V43, P1487, DOI 10.3892/ijo.2013.2078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishigami S, 2012, CANCER IMMUNOL IMMUN, V61, P1663, DOI 10.1007/s00262-012-1225-5; Jang BG, 2015, VIRCHOWS ARCH, V467, P285, DOI 10.1007/s00428-015-1793-9; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kameshima H, 2000, WORLD J SURG, V24, P1243, DOI 10.1007/s002680010246; Kim Kyong Rae, 2007, Korean J Gastroenterol, V49, P209; Kim MS, 2012, PATHOLOGY, V44, P576, DOI 10.1097/PAT.0b013e3283583bf6; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee HJ, 2010, GASTROENTEROLOGY, V139, P358; Lee K, 2014, GUT LIVER, V8, P131, DOI 10.5009/gnl.2014.8.2.131; Liu Q, 2007, MODERN PATHOL, V20, P1286, DOI 10.1038/modpathol.3800968; Liu R, 2009, MOL CELL PROTEOMICS, V8, P70, DOI 10.1074/mcp.M800195-MCP200; Magnusson PKE, 2001, CANCER RES, V61, P2684; Mesquita Patricia, 2006, Critical Reviews in Oncogenesis, V12, P3; Mimura K, 2013, J IMMUNOL, V191, P6261, DOI 10.4049/jimmunol.1301597; Nam KH, 2013, PATHOBIOLOGY, V80, P87, DOI 10.1159/000341685; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Shiotani A, 2005, AM J GASTROENTEROL, V100, P581, DOI 10.1111/j.1572-0241.2005.41001.x; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sonachalam Madhankumar, 2012, Frontiers in Genetics, V3, P80, DOI 10.3389/fgene.2012.00080; Sousa JF, 2012, AM J PATHOL, V181, P1560, DOI 10.1016/j.ajpath.2012.07.027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; WEE A, 1992, J CLIN PATHOL, V45, P30, DOI 10.1136/jcp.45.1.30; Wu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114746; Xie Y, 2015, ONCOTARGETS THER, V8, P567, DOI 10.2147/OTT.S79150; Zang Shizhu, 2014, Genomics Proteomics & Bioinformatics, V12, P276, DOI 10.1016/j.gpb.2014.09.004; Zhang SW, 2015, AM J CANCER RES, V5, P928	54	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176043	10.1371/journal.pone.0176043	http://dx.doi.org/10.1371/journal.pone.0176043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441455	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800021
J	Li, XY; Xu, W; Hu, N; Liang, X; Huang, W; Jiang, DM; Chen, H				Li, Xinyu; Xu, Wei; Hu, Ning; Liang, Xi; Huang, Wei; Jiang, Dianming; Chen, Hong			Relationship between acromial morphological variation and subacromial impingement: A three-dimensional analysis	PLOS ONE			English	Article							ROTATOR CUFF TEARS; CORACOACROMIAL LIGAMENT; ACROMIOPLASTY; DECOMPRESSION; ASSOCIATION; REPAIR; ANATOMY; SPACE	Purpose: To evaluate the association of acromial morphology and subacromial impingement. Methods: Bilateral shoulder computed tomography was performed in 138 patients who received shoulder arthroscopy. Measured parameters included: acromial tilt (AT), modified acromial tilt (mAT), acromial slope (AS), acromiohumeral interval (AHI), lateral acromial angle (LAA), acromial index (AI), critical shoulder angle (CSA), acromial anterior protrusion (AAP), and acromial inferior protrusion (AIP). Acromial morphological characteristics were compared between groups. Side-to-side differences were assessed between affected and non-affected shoulders. Intra-and inter-observer agreements for each parameter were calculated. Results: AT (25.90 vs. 29.41 degrees E), mAT (18.88 vs. 22.64 degrees E), and AHI (5.46 vs. 6.47 mm) were significantly smaller in impinged patients. The impingement group demonstrated significantly larger AI (63.50 vs. 59.84%), CSA (31.78 vs. 28.74 degrees E), AAP (7.13 vs. 5.32 mm), and AIP (5.51 vs. 4.04 mm). Regarding side-to-side comparison, the acromial morphology was significantly different between the affected and non-affected shoulders in impinged patients, while the difference was slight and insignificant in control patients. All, except AS and LAA, measured parameters demonstrated good intra-and inter-observer agreements. Conclusions: Three-dimensional reconstructed CT scan is a reliable method to measure shoulder morphology. The acromial morphological variation is related with sub acromial impingement, however, the causal relationship of them should be further explored.	[Li, Xinyu] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, Chongqing, Peoples R China; [Xu, Wei; Hu, Ning; Liang, Xi; Huang, Wei; Jiang, Dianming; Chen, Hong] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, H (corresponding author), Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China.	chhong113@126.com	CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X				Balke M, 2016, KNEE SURG SPORT TR A, V24, P2200, DOI 10.1007/s00167-014-3499-y; Balke M, 2013, ACTA ORTHOP, V84, P178, DOI 10.3109/17453674.2013.773413; Banas M P, 1995, J Shoulder Elbow Surg, V4, P454, DOI 10.1016/S1058-2746(05)80038-2; Budoff JE, 2005, ARTHROSCOPY, V21, P1081, DOI 10.1016/j.arthro.2005.05.019; Chahal J, 2012, ARTHROSCOPY, V28, P720, DOI 10.1016/j.arthro.2011.11.022; Codman EA, 1934, SHOULDER RUPTURE SUP, P468; Fujisawa Y, 2014, AM J SPORT MED, V42, P2621, DOI 10.1177/0363546514544683; Gill TJ, 2002, J SHOULDER ELB SURG, V11, P327, DOI 10.1067/mse.2002.124425; Goldberg BA, 2001, CLIN ORTHOP RELAT R, P142, DOI 10.1097/00003086-200109000-00017; Hamid N, 2012, J SHOULDER ELB SURG, V21, P1289, DOI 10.1016/j.jse.2011.09.028; Henkus HE, 2009, J BONE JOINT SURG BR, V91B, P504, DOI 10.1302/0301-620X.91B4.21442; Khan Yousaf, 2013, Open Orthop J, V7, P347, DOI 10.2174/1874325001307010347; Kitay G S, 1995, J Shoulder Elbow Surg, V4, P441, DOI 10.1016/S1058-2746(05)80036-9; Lee TQ, 2001, J SHOULDER ELB SURG, V10, P68, DOI 10.1067/mse.2001.111138; Mackenzie TA, 2015, CLIN BIOMECH, V30, P641, DOI 10.1016/j.clinbiomech.2015.06.001; McCallister WV, 2005, J BONE JOINT SURG AM, V87A, P1278, DOI 10.2106/JBJS.D.02432; Michener LA, 2015, KNEE SURG SPORT TR A, V23, P363, DOI 10.1007/s00167-013-2542-8; Moor BK, 2013, BONE JOINT J, V95B, P935, DOI 10.1302/0301-620X.95B7.31028; Moor BK, 2014, J SHOULDER ELB SURG, V23, P536, DOI 10.1016/j.jse.2013.11.008; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Nyffeler RW, 2006, J BONE JOINT SURG AM, V88A, P800, DOI 10.2106/JBJS.D.03042; Oh JH, 2010, CLIN ORTHOP RELAT R, V468, P1542, DOI 10.1007/s11999-009-1058-5; Saupe N, 2006, AM J ROENTGENOL, V187, P376, DOI 10.2214/AJR.05.0435; Scheibel M, 2004, J SHOULDER ELB SURG, V13, P272, DOI 10.1016/j.jse.2004.01.007; Shi LL, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/467571; Su WR, 2009, ARTHROSCOPY, V25, P13, DOI 10.1016/j.arthro.2008.10.004	26	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176193	10.1371/journal.pone.0176193	http://dx.doi.org/10.1371/journal.pone.0176193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441418	Green Submitted, gold, Green Published			2022-12-27	WOS:000400308800031
J	Wang, YT; Wang, LB; Qiao, PG; Sheng, FG; Han, C; Ye, EM; Lei, Y; Yan, F; Chen, SS; Zhu, YY; Mi, GY; Li, GJ; Yang, Z				Wang, Yituo; Wang, Lubin; Qiao, Penggang; Sheng, Fugeng; Han, Cong; Ye, Enmao; Lei, Yu; Yan, Feng; Chen, Shanshan; Zhu, Yuyang; Mi, Guiyun; Li, Gongjie; Yang, Zheng			Impact of aberrant cerebral perfusion on resting-state functional MRI: A preliminary investigation of Moyamoya disease	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; EMISSION COMPUTED-TOMOGRAPHY; CAROTID-ARTERY OCCLUSION; LEVEL-DEPENDENT MRI; CEREBROVASCULAR REACTIVITY; BRAIN-FUNCTION; DEFAULT MODE; BLOOD-FLOW; QUANTITATIVE-EVALUATION; FMRI	The impact of chronic cerebral hypoperfusion on resting-state blood oxygen level-dependent signal fluctuations remains unknown. We aimed to determine whether chronic ischemia induces changes in amplitude of low-frequency fluctuations (ALFF) and to investigate the correlation between ALFF and perfusion-weighted magnetic resonance imaging (PWI) parameters in patients with moyamoya disease (MMD). Thirty patients with pre- and postoperative resting-state functional magnetic resonance imaging and PWI were included, and thirty normal controls underwent resting-state functional magnetic resonance imaging. A decrease in preoperative frontal lobe ALFF was observed in patients with MMD. Postoperative frontal lobe ALFF showed moderate improvement but still remained lower than those in normal controls. The values of mean transit time and time-to-peak, but not cerebral blood volume and cerebral blood flow, correlated significantly with frontal lobe ALFF. Moreover, there were significant negative correlations between changes in frontal lobe PWI parameters and changes in frontal lobe ALFF on both operated side and contralateral side after the unilateral revascularization surgery. Our results demonstrate that reduced ALFF are closely related to the abnormal PWI parameters and vary with the alteration of cerebral perfusion in patients with MMD.	[Wang, Yituo; Wang, Lubin; Ye, Enmao; Lei, Yu; Chen, Shanshan; Zhu, Yuyang; Mi, Guiyun; Yang, Zheng] Beijing Inst Basic Med Sci, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Wang, Yituo; Qiao, Penggang; Sheng, Fugeng; Yan, Feng; Li, Gongjie] Acad Mil Med Sci, Affiliated Hosp, Dept Radiol, Beijing, Peoples R China; [Han, Cong] Acad Mil Med Sci, Affiliated Hosp, Dept Neurosurg, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Yang, Z (corresponding author), Beijing Inst Basic Med Sci, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China.; Li, GJ (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Radiol, Beijing, Peoples R China.	ligj307@163.com; yangz236@163.com	Wang, Yi-Tuo/GYR-0385-2022; Chen, Shanshan/ACO-4807-2022	Wang, Yi-Tuo/0000-0002-9295-8894; Chen, Shanshan/0000-0001-9723-2403	Youth Programs of Beijing Natural Science Foundation [7144231]; Capital Characteristic Clinic Project [Z141107002514171]	Youth Programs of Beijing Natural Science Foundation; Capital Characteristic Clinic Project	This work was supported by grant 7144231 from the Youth Programs of Beijing Natural Science Foundation (PQ) and by grant Z141107002514171 from Capital Characteristic Clinic Project (GL).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan F, 2015, NEUROSURGERY, V76, P302, DOI 10.1227/NEU.0000000000000609; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Eicker S, 2011, EUR J MED RES, V16, P484, DOI 10.1186/2047-783X-16-11-484; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Fukunaga M, 2008, J CEREBR BLOOD F MET, V28, P1377, DOI 10.1038/jcbfm.2008.25; Han JS, 2011, STROKE, V42, P3047, DOI 10.1161/STROKEAHA.111.615955; Han JS, 2011, STROKE, V42, P1261, DOI 10.1161/STROKEAHA.110.603225; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Honda M, 2006, SURG NEUROL, V66, P155, DOI 10.1016/j.surneu.2005.08.022; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jahanian H, 2016, J CEREB BLOOD FLOW M; Kawano T, 2016, CEREBROVASC DIS, V42, P131, DOI 10.1159/000445696; Kemna LJ, 2001, NEUROIMAGE, V14, P642, DOI 10.1006/nimg.2001.0859; Kim E, 2009, J COMPUT ASSIST TOMO, V33, P546, DOI 10.1097/RCT.0b013e318188887d; Kim JH, 2000, AM J NEURORADIOL, V21, P1450; Kohno K, 1998, NEUROSURGERY, V42, P752, DOI 10.1097/00006123-199804000-00043; Kuhn FP, 2015, J STROKE CEREBROVASC, V24, P965, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.017; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mark CI, 2015, J MAGN RESON IMAGING, V42, P231, DOI 10.1002/jmri.24786; Mazerolle EL, 2016, CLIN PHYSL FUNCT IMA; Mitra PP, 1997, MAGNET RESON MED, V37, P511, DOI 10.1002/mrm.1910370407; Nariai T, 2005, J NEUROL NEUROSUR PS, V76, P663, DOI 10.1136/jnnp.2003.025049; Noguchi T, 2013, EUR J RADIOL, V82, pE840, DOI 10.1016/j.ejrad.2013.08.040; Park JC, 2010, CEREBROVASC DIS, V30, P547, DOI 10.1159/000319026; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Tanaka Y, 2006, J CEREBR BLOOD F MET, V26, P291, DOI 10.1038/sj.jcbfm.9600187; Thomas B, 2013, CHILD NERV SYST, V29, P457, DOI 10.1007/s00381-012-1952-0; Tong Y., 2016, J CEREB BLOOD FLOW M; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yun TJ, 2009, RADIOLOGY, V251, P216, DOI 10.1148/radiol.2511080654; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176461	10.1371/journal.pone.0176461	http://dx.doi.org/10.1371/journal.pone.0176461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441445	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800060
J	Chanwimalueang, T; Aufegger, L; Adjei, T; Wasley, D; Cruder, C; Mandic, DP; Williamon, A				Chanwimalueang, Theerasak; Aufegger, Lisa; Adjei, Tricia; Wasley, David; Cruder, Cinzia; Mandic, Danilo P.; Williamon, Aaron			Stage call: Cardiovascular reactivity to audition stress in musicians	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TIME-SERIES ANALYSIS; COMPLEXITY; SPECTRA	Auditioning is at the very center of educational and professional life in music and is associated with significant psychophysical demands. Knowledge of how these demands affect cardiovascular responses to psychosocial pressure is essential for developing strategies to both manage stress and understand optimal performance states. To this end, we recorded the electrocardiograms (ECGs) of 16 musicians (11 violinists and 5 flutists) before and during performances in both low-and high-stress conditions: with no audience and in front of an audition panel, respectively. The analysis consisted of the detection of R-peaks in the ECGs to extract heart rate variability (HRV) from the notoriously noisy real-world ECGs. Our data analysis approach spanned both standard (temporal and spectral) and advanced (structural complexity) techniques. The complexity science approaches-namely, multiscale sample entropy and multiscale fuzzy entropy-indicated a statistically significant decrease in structural complexity in HRV from the low-to the high-stress condition and an increase in structural complexity from the pre-performance to performance period, thus confirming the complexity loss theory and a loss in degrees of freedom due to stress. Results from the spectral analyses also suggest that the stress responses in the female participants were more parasympathetically driven than those of the male participants. In conclusion, our findings suggest that interventions to manage stress are best targeted at the sensitive pre-performance period, before an audition begins.	[Chanwimalueang, Theerasak; Adjei, Tricia; Mandic, Danilo P.] Imperial Coll London, Dept Elect & Elect Engn, London, England; [Aufegger, Lisa; Williamon, Aaron] Royal Coll Mus, Ctr Performance Sci, London, England; [Aufegger, Lisa; Williamon, Aaron] Imperial Coll London, Fac Med, London, England; [Wasley, David] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff, S Glam, Wales; [Cruder, Cinzia] Conservatory Southern Switzerland, Dept Res & Dev, Lugano, Switzerland	Imperial College London; Royal College of Music - UK; Imperial College London; Cardiff Metropolitan University	Mandic, DP (corresponding author), Imperial Coll London, Dept Elect & Elect Engn, London, England.; Williamon, A (corresponding author), Royal Coll Mus, Ctr Performance Sci, London, England.; Williamon, A (corresponding author), Imperial Coll London, Fac Med, London, England.	d.mandic@imperial.ac.uk; aaron.williamon@rcm.ac.uk	; Williamon, Aaron/C-5796-2013	Wasley, David/0000-0002-6730-4127; Williamon, Aaron/0000-0002-1713-6161	UK's Arts and Humanities Research Council [AH/K002287/1]; Peter Sowerby Foundation; EPSRC grant [EP/K025643/1]; EPSRC Pathways to Impact Grant [PSA256]; EPSRC Multidisciplinary University Research Initiative [EP/P008461]; Engineering and Physical Sciences Research Council [EP/K025643/1]; Engineering and Physical Sciences Research Council (Multidisciplinary University Research Initiative) [EP/P008461]; Engineering and Physical Sciences Research Council (Pathways to Impact Grant) [PSA256]; Arts and Humanities Research Council [AH/K002287/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K503733/1] Funding Source: researchfish; AHRC [AH/K002287/1] Funding Source: UKRI; EPSRC [EP/K025643/1] Funding Source: UKRI	UK's Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Peter Sowerby Foundation; EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Pathways to Impact Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Multidisciplinary University Research Initiative(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (Multidisciplinary University Research Initiative)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (Pathways to Impact Grant)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We wish to thank the musicians and the adjudicators who took part in this study. The research reported in this article was supported by grants from the UK's Arts and Humanities Research Council (grant ref. AH/K002287/1), the Peter Sowerby Foundation, EPSRC grant EP/K025643/1, EPSRC Pathways to Impact Grant PSA256, and EPSRC.; The research reported in this article was supported by grants from the UK's Arts and Humanities Research Council (grant ref. AH/K002287/1), the Peter Sowerby Foundation, and the Engineering and Physical Sciences Research Council (grant ref. EP/K025643/1, Multidisciplinary University Research Initiative EP/P008461, and Pathways to Impact Grant PSA256).	Abel J.L., 1990, PSYCHOL MUSIC, V18, P171, DOI [10.1177/0305735690182006, DOI 10.1177/0305735690182006]; AHMED AK, 1982, EUR J APPL PHYSIOL O, V50, P95, DOI 10.1007/BF00952248; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P599, DOI 10.1111/j.1469-8986.1994.tb02352.x; Berntson GG, 2007, HEART RATE VARIABILI, P57; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BROTONS M, 1994, J MUSIC THER, V31, P63, DOI 10.1093/jmt/31.1.63; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Camm AJ, 1996, CIRCULATION, V93, P1043; Chanwimalueang T, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING (DSP), P134, DOI 10.1109/ICDSP.2015.7251845; Chanwimalueang T, 2016, INT CONF ACOUST SPEE, P814, DOI 10.1109/ICASSP.2016.7471788; Chen WT, 2007, IEEE T NEUR SYS REH, V15, P266, DOI 10.1109/TNSRE.2007.897025; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; CRASKE MG, 1984, BEHAV RES THER, V22, P267, DOI 10.1016/0005-7967(84)90007-X; Delaney JPA, 2000, PERCEPT MOTOR SKILL, V91, P515, DOI 10.2466/PMS.91.6.515-524; Domitrovich PP, 2002, COMPUT CARDIOL, V29, P665, DOI 10.1109/CIC.2002.1166860; Friedman BH, 1996, CLIN AUTON RES, V6, P147, DOI 10.1007/BF02281901; Johnstone JA, 2012, J SPORT SCI MED, V11, P400; Johnstone JA, 2012, J SPORT SCI MED, V11, P409; Kattimani YR, 2015, INT J SCI STUDY, V3, P48, DOI 10.17354/ijss/2015/154; Kukielka M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00003; Kuusela T, 2013, HEART RATE VARIABILITY (HRV) SIGNAL ANALYSIS: CLINICAL APPLICATIONS, P9; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lucini D, 2002, HYPERTENSION, V39, P184, DOI 10.1161/hy0102.100784; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Milicevic G, 2005, COLLEGIUM ANTROPOL, V29, P295; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Peltola MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00148; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Saleh TM, 2007, CLIN EXP PHARMACOL P, V34, P827, DOI 10.1111/j.1440-1681.2007.04663.x; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Singh D., 2004, Journal of Medical Engineering & Technology, V28, P263, DOI 10.1080/03091900410001662350; SLOAN RP, 1994, BIOL PSYCHOL, V37, P89, DOI 10.1016/0301-0511(94)90024-8; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Tiller W A, 1996, Altern Ther Health Med, V2, P52; Tuzcu V, 2006, EUROPACE, V8, P398, DOI 10.1093/europace/eul031; Visnovcova Z, 2014, PHYSIOL MEAS, V35, P1319, DOI 10.1088/0967-3334/35/7/1319; Williamon A., 2004, MUSICAL EXCELLENCE S; Williamon A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0719; Xiong GL, 2010, J ZHEJIANG UNIV-SC A, V11, P270, DOI 10.1631/jzus.A0900360; Yoshie M, 2009, EXP BRAIN RES, V199, P117, DOI 10.1007/s00221-009-1979-y	43	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176023	10.1371/journal.pone.0176023	http://dx.doi.org/10.1371/journal.pone.0176023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437466	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600028
J	Gandy, LM; Gumm, J; Fertig, B; Thessen, A; Kennish, MJ; Chavan, S; Marchionni, L; Xia, XX; Shankrit, S; Fertig, EJ				Gandy, Lisa M.; Gumm, Jordan; Fertig, Benjamin; Thessen, Anne; Kennish, Michael J.; Chavan, Sameer; Marchionni, Luigi; Xia, Xiaoxin; Shankrit, Shambhavi; Fertig, Elana J.			Synthesizer: Expediting synthesis studies from context-free data with information retrieval techniques	PLOS ONE			English	Article								Scientists have unprecedented access to a wide variety of high-quality datasets. These datasets, which are often independently curated, commonly use unstructured spreadsheets to store their data. Standardized annotations are essential to perform synthesis studies across investigators, but are often not used in practice. Therefore, accurately combining records in spreadsheets from differing studies requires tedious and error-prone human curation. These efforts result in a significant time and cost barrier to synthesis research. We propose an information retrieval inspired algorithm, Synthesize, that merges unstructured data automatically based on both column labels and values. Application of the Synthesize algorithm to cancer and ecological datasets had high accuracy (on the order of 85-100%). We further implement Synthesize in an open source web application, Synthesizer (https:// github.com/lisagandy/synthesizer). The software accepts input as spreadsheets in comma separated value (CSV) format, visualizes the merged data, and outputs the results as a new spreadsheet. Synthesizer includes an easy to use graphical user interface, which enables the user to finish combining data and obtain perfect accuracy. Future work will allow detection of units to automatically merge continuous data and application of the algorithm to other data formats, including databases.	[Gandy, Lisa M.; Gumm, Jordan] Cent Michigan Univ, Dept Comp Sci, Mt Pleasant, MI 48859 USA; [Fertig, Benjamin; Thessen, Anne] Ronin Inst Independent Scholarship, Montclair, NJ USA; [Kennish, Michael J.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ USA; [Chavan, Sameer] Univ Colorado Denver, Colorado Ctr Personal Med, Denver, CO USA; [Marchionni, Luigi; Xia, Xiaoxin; Shankrit, Shambhavi; Fertig, Elana J.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA	Central Michigan University; Rutgers State University New Brunswick; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University	Gandy, LM (corresponding author), Cent Michigan Univ, Dept Comp Sci, Mt Pleasant, MI 48859 USA.; Fertig, EJ (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.	gandy1l@cmich.edu; ejfertig@jhmi.edu	Chavan, Sameer/AAU-2285-2021; Marchionni, Luigi/S-6774-2017	Chavan, Sameer/0000-0002-0220-0845; Marchionni, Luigi/0000-0002-7336-8071; Fertig, Elana/0000-0003-3204-342X; Gandy, Lisa/0000-0001-6487-8064; Thessen, Anne/0000-0002-2908-3327; Gumm, Jordan/0000-0002-6326-7621	National Institutes of Health (NIH) National Cancer Institute (NCI) [P30CA006973, R01CA200859, K25 K25CA141053]; Cleveland Foundation's Helen Masenhimer Fellowship Award; Pilot Project through the Johns Hopkins University Head and Neck SPORE from the NIH National Institute of Dental and Craniofacial Research (NIDCR) [P50DE019032]; New Jersey Sea Grant Consortium (NJSGC); National Oceanic and Atmospheric Administration (NOAA) Office of Sea Grant, U.S. Department of Commerce, under NOM grant [NA100AR4170075]; NJSGC; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA200859] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cleveland Foundation's Helen Masenhimer Fellowship Award; Pilot Project through the Johns Hopkins University Head and Neck SPORE from the NIH National Institute of Dental and Craniofacial Research (NIDCR); New Jersey Sea Grant Consortium (NJSGC); National Oceanic and Atmospheric Administration (NOAA) Office of Sea Grant, U.S. Department of Commerce, under NOM grant; NJSGC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EJF and LM were supported by the National Institutes of Health (NIH) National Cancer Institute (NCI) (P30CA006973, R01CA200859 for LM and EJF and K25 K25CA141053 for EJF) and by the Cleveland Foundation's Helen Masenhimer Fellowship Award. EJF was also supported by a Pilot Project through the Johns Hopkins University Head and Neck SPORE from the NIH National Institute of Dental and Craniofacial Research (NIDCR, P50DE019032). Seagrass data from the Barnegat Bay-Little Egg Harbor Estuary are the result of research sponsored by the New Jersey Sea Grant Consortium (NJSGC) with funds from the National Oceanic and Atmospheric Administration (NOAA) Office of Sea Grant, U.S. Department of Commerce, under NOM grant number (NA100AR4170075) and the NJSGC to MK.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bing L, 2013, SYNTHESIS LECT HUMAN, V5, P1; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Cerami E., 2012, CBIO CANC GENOMICS P; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Dai M., 2008, AMIA SUMMIT TRANSLAT, P21; Davies M., 2008, CORPUS CONT AM ENGLI; Fellbaume C., 1998, WORDNET ELECT LEXICA; Gandy L, 2013, AAAI; Ganzfried BF, 2013, CURATEDOVERIANDATA; Kannan L, 2015, BRIEF BIOINFORM; Madhavan S, 2011, NEOPLASIA, V13, P771, DOI 10.1593/neo.11806; Parker HS, 2014, BIOINFORMATICS, V30, P2757, DOI 10.1093/bioinformatics/btu375; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Shah NH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S1; Short FT, 2004, SEAGRASSNET MANUAL S; Verborgh R., 2013, USING OPENREFINE; Xu M, 2009, P NATL ACAD SCI USA, V106, P12323, DOI 10.1073/pnas.0900883106	19	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175860	10.1371/journal.pone.0175860	http://dx.doi.org/10.1371/journal.pone.0175860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437440	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600018
J	Pene, V; Lemasson, M; Harper, F; Pierron, G; Rosenberg, AR				Pene, Veronique; Lemasson, Matthieu; Harper, Francis; Pierron, Gerard; Rosenberg, Arielle R.			Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; LIPID DROPLET; PROTEIN; PARTICLES; MEMBRANE; DENSITY; GLYCOPROTEINS; ASSOCIATION; DEGRADATION; MATURATION	In hepatitis C virus (HCV) polyprotein sequence, core protein terminates with E1 envelope signal peptide. Cleavage by signal peptidase (SP) separates E1 from the complete form of core protein, anchored in the endoplasmic reticulum (ER) membrane by the signal peptide. Subsequent cleavage of the signal peptide by signal-peptide peptidase (SPP) releases the mature form of core protein, which preferentially relocates to lipid droplets. Both of these cleavages are required for the HCV infectious cycle, supporting the idea that HCV assembly begins at the surface of lipid droplets, yet SPP-catalyzed cleavage is dispensable for initiation of budding in the ER. Here we have addressed at what step(s) of the HCV infectious cycle SP-catalyzed cleavage at the core-E1 junction is required. Taking advantage of the sole system that has allowed visualization of HCV budding events in the ER lumen of mammalian cells, we showed that, unexpectedly, mutations abolishing this cleavage did not prevent but instead tended to promote the initiation of viral budding. Moreover, even though no viral particles were released from Huh-7 cells transfected with a full-length HCV genome bearing these mutations, intracellular viral particles containing core protein protected by a membrane envelope were formed. These were visualized by electron microscopy as capsid-containing particles with a diameter of about 70 nm and 40 nm before and after delipidation, respectively, comparable to intracellular wild-type particle precursors except that they were non-infectious. Thus, our results show that SP-catalyzed cleavage is dispensable for HCV budding per se, but is required for the viral particles to acquire their infectivity and secretion. These data support the idea that HCV assembly occurs in concert with budding at the ER membrane. Furthermore, capsid- containing particles did not accumulate in the absence of SP-catalyzed cleavage, suggesting the quality of newly formed viral particles is controlled before secretion.	[Pene, Veronique; Lemasson, Matthieu; Rosenberg, Arielle R.] Univ Paris 05, EA 4474, Virol Hepatite C, Paris, France; [Harper, Francis; Pierron, Gerard] CNRS, Inst Gustave Roussy, UMR 9196, Villejuif, France; [Rosenberg, Arielle R.] AP HP, Hop Cochin, Serv Virol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Pene, V; Rosenberg, AR (corresponding author), Univ Paris 05, EA 4474, Virol Hepatite C, Paris, France.; Rosenberg, AR (corresponding author), AP HP, Hop Cochin, Serv Virol, Paris, France.	veronique.pene@parisdescartes.fr; arielle.rosenberg@parisdescartes.fr		Rosenberg, Arielle/0000-0003-2085-8146	"AVENIR" grant from the INSERM; Fondation Bettencourt-Schueller; Region Ile-de-France; Fondation pour la Recherche Medicale; INSERM	"AVENIR" grant from the INSERM; Fondation Bettencourt-Schueller; Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by an "AVENIR" grant from the INSERM, and by the Fondation Bettencourt-Schueller. V.P. received a fellowship co financed by the INSERM and the Region Ile-de-France, followed by a fellowship from the Fondation pour la Recherche Medicale.; This work was supported by an "AVENIR" grant from the INSERM, and by the Fondation Bettencourt-Schueller. V.P. received a fellowship co-financed by the INSERM and the Region Ile-de-France, followed by a fellowship from the Fondation pour la Recherche Medicale.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Klein KC, 2004, J VIROL, V78, P9257, DOI 10.1128/JVI.78.17.9257-9269.2004; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oehler V, 2012, J VIROL, V86, P7818, DOI 10.1128/JVI.00457-12; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pesne V, 2015, J VIROL, V89, P5462, DOI 10.1128/JVI.03197-14; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Piver E, 2016, GUT; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Popescu CI, 2011, VIRUSES-BASEL, V3, P2238, DOI 10.3390/v3112238; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Scholtes C, 2012, HEPATOLOGY, V56, P39, DOI 10.1002/hep.25628; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Vieyres G, 2014, VIRUSES-BASEL, V6, P1149, DOI 10.3390/v6031149; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Zaidi S, 2010, GASTROENTEROLOGY, V139, P1355; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9739	62	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175810	10.1371/journal.pone.0175810	http://dx.doi.org/10.1371/journal.pone.0175810			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437468	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600014
J	Jin, M; Monroig, O; Lu, Y; Yuan, Y; Li, Y; Ding, LY; Tocher, DR; Zhou, QC				Jin, Min; Monroig, Oscar; Lu, You; Yuan, Ye; Li, Yi; Ding, Liyun; Tocher, Douglas R.; Zhou, Qicun			Dietary DHA/EPA ratio affected tissue fatty acid profiles, antioxidant capacity, hematological characteristics and expression of lipid-related genes but not growth in juvenile black seabream (Acanthopagrus schlegelii)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SALMON SALMO-SALAR; CATFISH PELTEOBAGRUS-FULVIDRACO; BREAM SPARUS-MACROCEPHALUS; SEA BREAM; FISH-OIL; OXIDATIVE STRESS; YELLOW CATFISH; LIPOPROTEIN METABOLISM; DOCOSAHEXAENOIC ACIDS	An 8-week feeding trial was conducted to investigate the effects of dietary docosahexaenoic to eicosapentaenoic acid ratio (DHA/EPA) on growth performance, fatty acid profiles, antioxidant capacity, hematological characteristics and expression of some lipid metabolism related genes of juvenile black seabream (Acanthopagrus schlegelii) of initial weight 9.47 +/- 0.03 g. Five isonitrogenous and isolipidic diets (45% crude protein and 14% crude lipid) were formulated to contain graded DHA/EPA ratios of 0.65, 1.16, 1.60, 2.03 and 2.67. There were no differences in growth performance and feed utilization among treatments. Fish fed higher DHA/EPA ratios had higher malondialdehyde (MDA) contents in serum than lower ratios. Serum triacylglycerol (TAG) content was significantly higher in fish fed the lowest DHA/EPA ratio. Tissue fatty acid profiles reflected the diets despite down-regulation of LCP-UFA biosynthesis genes, fatty acyl desaturase 2 (fads2) and elongase of very long-chain fatty acids 5 (elovl5), by high DHA/EPA ratios. Expression of acetyl-CoA carboxylase alpha (acc alpha) and carnitine palmitoyl transferase 1A (cpt1a) were up-regulated by high DHA/EPA ratio, whereas sterol regulatory element-binding protein-1 (srebp-1) and hormone-sensitive lipase (hsl) were down-regulated. Fatty acid synthase (fas), 6-phosphogluconate dehydrogenase (6pgd) and peroxisome proliferator-activated receptor alpha (ppar alpha) showed highest expression in fish fed intermediate (1.16) DHA/EPA ratio. Overall, this study indicated that dietary DHA/EPA ratio affected fatty acid profiles and significantly influenced lipid metabolism including LC-PUFA biosynthesis and other anabolic and catabolic pathways, and also had impacts on antioxidant capacity and hematological characteristics.	[Jin, Min; Lu, You; Yuan, Ye; Li, Yi; Ding, Liyun; Zhou, Qicun] Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China; [Jin, Min; Zhou, Qicun] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China; [Monroig, Oscar; Tocher, Douglas R.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling, Scotland	Ningbo University; Ningbo University; University of Stirling	Zhou, QC (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China.; Zhou, QC (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	zhouqicun@nbu.edu.cn	Monroig, Oscar/K-9117-2014; Tocher, Douglas R/C-5652-2011	Monroig, Oscar/0000-0001-8712-0440; Tocher, Douglas R/0000-0002-8603-9410	National Natural Science Foundation of China [31272670, 41476125]; Major Spark Plan Project of the National Ministry of Science and Technology [2014GA701001]; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Spark Plan Project of the National Ministry of Science and Technology; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	This research was supported by the National Natural Science Foundation of China (Grant Nos. 31272670 and 41476125), Major Spark Plan Project of the National Ministry of Science and Technology (2014GA701001), the Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University, K. C. Wong Magna Fund and K. C. Wong Education Foundation at Ningbo University.	A. O. A. C, 2006, OFFICIAL METHODS OF; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Brufau G, 2008, NUTR RES, V28, P217, DOI 10.1016/j.nutres.2008.02.003; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Canaud B, 1999, BLOOD PURIFICAT, V17, P99, DOI 10.1159/000014381; Castro C, 2016, BRIT J NUTR, V116, P19, DOI 10.1017/S000711451600163X; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Chen QL, 2013, ARCH ENVIRON CON TOX, V64, P301, DOI 10.1007/s00244-012-9835-7; Collier T. K., 2012, ECOLOGICAL BIOMARKER, P385; Cowey C.B., 1989, FISH NUTR, V2, P259; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gamboa-Gomez C, 2014, FOOD FUNCT, V5, P927, DOI 10.1039/c3fo60604j; Gao J, 2014, AQUACULTURE, V422, P84, DOI 10.1016/j.aquaculture.2013.11.031; Gilman CI, 2003, GEN COMP ENDOCR, V130, P172, DOI 10.1016/S0016-6480(02)00590-7; Gonzalez EB, 2008, AQUAC RES, V39, P1307, DOI 10.1111/j.1365-2109.2008.01996.x; Gregory MK, 2016, BRIT J NUTR, V115, P1721, DOI 10.1017/S0007114516000830; Gueraud F, 2015, FREE RADICAL BIO MED, V83, P192, DOI 10.1016/j.freeradbiomed.2015.02.023; Jiao BW, 2006, J MOL ENDOCRINOL, V36, P23, DOI 10.1677/jme.1.01945; Jordal AEO, 2005, J NUTR, V135, P2355, DOI 10.1093/jn/135.10.2355; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; KOVEN WM, 1993, AQUACULTURE, V116, P71, DOI 10.1016/0044-8486(93)90223-L; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Li M, 2014, FISH SHELLFISH IMMUN, V38, P158, DOI 10.1016/j.fsi.2014.03.015; Liang XF, 2002, COMP BIOCHEM PHYS A, V132, P913, DOI 10.1016/S1095-6433(02)00118-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Ma JJ, 2008, AQUACULT NUTR, V14, P464, DOI 10.1111/j.1365-2095.2007.00551.x; Ma JJ, 2013, J WORLD AQUACULT SOC, V44, P311, DOI 10.1111/jwas.12032; MacKay DS, 2011, EUR J LIPID SCI TECH, V113, P1427, DOI 10.1002/ejlt.201100100; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; McNamara Robert K., 2013, PharmaNutrition, V1, P41, DOI 10.1016/j.phanu.2012.10.004; Menoyo D, 2004, BRIT J NUTR, V92, P41, DOI 10.1079/BJN20041165; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Monroig O, 2011, AVANCES NUTR ACUICOL, V11, P257; Morais S, 2012, BMC GENOMICS, V13, P1; Morais S, 2011, BRIT J NUTR, V106, P1457, DOI 10.1017/S0007114511001954; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; National Research Council (NRC), 2011, NUTR REQ FISH, P102; NILSSONEHLE P, 1980, ANNU REV BIOCHEM, V49, P667, DOI 10.1146/annurev.bi.49.070180.003315; Nip THM, 2003, ENVIRON BIOL FISH, V66, P197, DOI 10.1023/A:1023611207492; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Peng M, 2014, AQUACULTURE, V433, P442, DOI 10.1016/j.aquaculture.2014.07.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Qian Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119518; Reitan Kjell Inge, 1994, Aquaculture International, V2, P33, DOI 10.1007/BF00118531; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Richard N, 2006, AQUACULTURE, V261, P1077, DOI 10.1016/j.aquaculture.2006.07.021; Rodriguez C, 1998, FISH PHYSIOL BIOCHEM, V18, P177, DOI 10.1023/A:1007750218840; Rodriguez C., 1994, Aquaculture and Fisheries Management, V25, P295, DOI 10.1111/j.1365-2109.1994.tb00692.x; Rodriguez C, 1998, AQUACULTURE, V169, P9, DOI 10.1016/S0044-8486(98)00328-7; Rodriguez C, 1997, AQUACULTURE, V150, P77, DOI 10.1016/S0044-8486(96)01472-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Shao QJ, 2008, AQUACULTURE, V277, P92, DOI 10.1016/j.aquaculture.2008.01.029; Stubhaug I, 2005, LIPIDS, V40, P39, DOI 10.1007/s11745-005-1358-4; TAKAI T, 1988, ARCH BIOCHEM BIOPHYS, V266, P313, DOI 10.1016/0003-9861(88)90263-9; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Turchini GM, 2003, AQUACULTURE, V225, P251, DOI 10.1016/S0044-8486(03)00294-1; van der Leij FR, 2007, GENOMICS, V90, P680, DOI 10.1016/j.ygeno.2007.08.004; Visioli F, 1997, NUTR METAB CARDIOVAS, V7, P459; Visioli Francesco, 2013, PharmaNutrition, V1, P9, DOI 10.1016/j.phanu.2012.10.002; WAKIL SJ, 1961, J LIPID RES, V2, P1; Wang XX, 2015, AQUAC RES, V46, P272, DOI 10.1111/are.12176; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; WATANABE T, 1989, NIPPON SUISAN GAKK, V55, P1635; Watanabe Takeshi, 1993, Journal of the World Aquaculture Society, V24, P152, DOI 10.1111/j.1749-7345.1993.tb00004.x; Weber RE, 1989, LUNG BIOLOGY IN HEAL; Yan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129937; Yang JH, 2010, CHEMOSPHERE, V81, P548, DOI 10.1016/j.chemosphere.2010.06.028; Zheng JL, 2014, BRIT J NUTR, V112, P698, DOI 10.1017/S0007114514001378; Zheng JL, 2013, GENE, V531, P53, DOI 10.1016/j.gene.2013.08.028; Zhou F, 2011, AQUACULT NUTR, V17, P469, DOI 10.1111/j.1365-2095.2010.00823.x; Zhou F, 2010, AQUACULT NUTR, V16, P194, DOI 10.1111/j.1365-2095.2009.00651.x; Zhou F, 2010, AQUAC RES, V41, pe418, DOI 10.1111/j.1365-2109.2009.02474.x; Zhou QC, 2015, AQUACULTURE, V437, P84, DOI 10.1016/j.aquaculture.2014.11.030; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378; Zuo RT, 2012, AQUACULTURE, V334, P101, DOI 10.1016/j.aquaculture.2011.12.045; Zuo RT, 2014, AQUACULT RES	88	43	45	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176216	10.1371/journal.pone.0176216	http://dx.doi.org/10.1371/journal.pone.0176216			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430821	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100034
J	Baazizi, R; Mahapatra, M; Clarke, BD; Ait-Oudhia, K; Khelef, D; Parida, S				Baazizi, Ratiba; Mahapatra, Mana; Clarke, Brian Donald; Ait-Oudhia, Khatima; Khelef, Djamel; Parida, Satya			Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; ASIAN LINEAGE; CATTLE; PHYLOGENETICS; INFECTION; DISTRICT; RECEPTOR; MOROCCO; SPREAD	Background Peste des petits ruminants (PPR) is a contagious disease listed by the World Organisation for Animal health (OIE) as being a specific hazard. It affects sheep, goats, and wild ungulates, and is prevalent throughout the developing world particularly Asia, the Middle East, and Africa. PPR has been targeted for eradication by 2030 by the Food and Agriculture Organization of the United Nations (FAO) and the OIE, after the successful eradication of the related disease, rinderpest in cattle. PPR was first reported in 1942 in the Ivory Coast in Western Africa and has since extended its range in Asia, the Middle East, and Africa posing an immediate threat of incursion into Europe, South East Asia and South Africa. Although robust vaccines are available, the use of these vaccines in a systematic and rational manner is not widespread, resulting in this devastating disease becoming an important neglected tropical disease in the developing world. Methodology We isolated and characterized the PPR virus from an outbreak in Cheraga, northern Algeria, during October 2015 by analyzing the partial N-gene sequence in comparison with other viruses from the Maghreb region. As well as sequencing the full length viral genome and performing real-time RT-PCR on clinical samples. Maximum-likelihood and Bayesian temporal and phylogeographic analyses were performed to assess the persistence and spread of PPRV circulation from Eastern Africa in the Maghreb region of North Africa. Conclusions Recent PPR outbreaks in Cheraga, in the northern part of Algiers (October 2015) and North-West Morocco (June, 2015) highlight that PPRV has spread to the northern border of North Africa and may pose a threat of introduction to Europe. Phylogeographic analysis suggests that lineage IV PPRV has spread from Eastern Africa, most likely from the Sudan 2000 outbreak, into Northern Africa resulting in the 2008 Moroccan outbreak. Maximum-likelihood and Bayesian analysis shows that these North African viruses cluster closely together suggesting the existence of continual regional circulation. Considering the same virus is circulating in Algeria, Morocco and Tunisia, implementation of a common Maghreb PPR eradication strategy would be beneficial for the region.	[Baazizi, Ratiba; Ait-Oudhia, Khatima; Khelef, Djamel] Natl Vet Higher Sch, Algiers, Algeria; [Mahapatra, Mana; Clarke, Brian Donald; Parida, Satya] Pirbright Inst, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Parida, S (corresponding author), Pirbright Inst, Woking, Surrey, England.	satya.parida@pirbright.ac.uk	koulate, liliane/O-6716-2017; Parida, Satya/E-5463-2015	Parida, Satya/0000-0001-8253-9461; Ait-Oudhia, Khatima/0000-0002-2514-5615; Mahapatra, Mana/0000-0002-3977-1465; Clarke, Brian/0000-0001-8447-0381	Biotechnology and Biological Sciences Research Council; European Commission ANIHWA ERA [BB/L004801/1, BB/L013657/1]; Biotechnology and Biological Sciences Research Council [BB/L004801/1, BBS/E/I/00007037, BBS/E/I/00007031, BBS/E/I/00001703] Funding Source: researchfish; BBSRC [BB/L004801/1, BBS/E/I/00007037, BBS/E/I/00001703, BBS/E/I/00007031] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission ANIHWA ERA; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biotechnology and Biological Sciences Research Council and the European Commission ANIHWA ERA fund for providing support for PPR epidemiological research under the FADH and IUEPPR projects led by the Pirbright Institute (SP) (BB/L004801/1 and BB/L013657/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rahim IHAA, 2010, REV SCI TECH OIE, V29, P655, DOI 10.20506/rst.29.3.2004; Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Ane C, 2007, MOL BIOL EVOL, V24, P412; Ayari-Fakhfakh E, 2011, VET J, V187, P402, DOI 10.1016/j.tvjl.2010.01.007; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Balamurugan V, 2012, J VET SCI, V13, P203, DOI 10.4142/jvs.2012.13.2.203; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Batten C, 2011, TRANSBOUNDARY AND EM; Battena CA, 2011, J VIROL METHODS, V171, P401, DOI 10.1016/j.jviromet.2010.11.022; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Birch J, 2013, J VIROL; Bouguedour R, 2016, 12TH JPC REMESA; Bouslikhare M., 2015, CROSS BORDER MOVEMEN; Couacy-Hymann E, 2009, RES VET SCI, V87, P332, DOI 10.1016/j.rvsc.2009.03.002; De Nardi M, 2012, TRANSBOUND EMERG DIS, V59, P214, DOI 10.1111/j.1865-1682.2011.01260.x; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dufour L, 2009, REV EPID SAN ANIM, P243; Fakri F, 2016, VET MICROBIOL, V197, P137, DOI 10.1016/j.vetmic.2016.11.006; Fakri FE, 2016, MICROBIOLOGY FORTHCO; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Kardjadj M, 2015, TROP ANIM HEALTH PRO, V47, P1279, DOI 10.1007/s11250-015-0860-1; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kwiatek O, 2011, EMERG INFECT DIS, V17, P1223, DOI 10.3201/eid1707.101216; Lembo T, 2013, EMERG INFECT DIS, V19, P2037, DOI 10.3201/eid1912.130973; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Libeau G., 2014, Animal Frontiers, V4, P14, DOI 10.2527/af.2014-0003; Mahapatra M, 2015, EMERG INFECT DIS, V21, P2230, DOI 10.3201/eid2112.150223; Mariner JC, 2016, J IMMUNOL, V196, P3499, DOI 10.4049/jimmunol.1502625; Molla B, 2015, TROP ANIM HEALTH PRO, V47, P45, DOI 10.1007/s11250-014-0681-7; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Muniraju M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01023-14; Muniraju M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00096-13; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Ouagal M, 2010, ACTA TROP, V116, P147, DOI 10.1016/j.actatropica.2010.07.004; Ozkul A, 2002, EMERGING INFECTIOUS, V8; Parida S, 2015, VET MICROBIOL, V181, P90, DOI 10.1016/j.vetmic.2015.08.009; Parida S, 2016, SMALL RUMINANT RESEA; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; Ratta B, 2016, CURRENT MICROBIOLOGY, P1; Sghaier S, 2014, EMERG INFECT DIS, V20, P2184, DOI 10.3201/eid2012.141116; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Waret-Szkuta A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-34; Xia J, SEQUENCE ANALYSIS OF	53	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175461	10.1371/journal.pone.0175461	http://dx.doi.org/10.1371/journal.pone.0175461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426782	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900030
J	Bellworthy, J; Gledhill, M; Esposito, M; Achterberg, EP				Bellworthy, Jessica; Gledhill, Martha; Esposito, Mario; Achterberg, Eric P.			Abundance of the iron containing biomolecule, heme b, during the progression of a spring phytoplankton bloom in a mesocosm experiment	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INCREASED PCO(2); CO2; SPECIATION; SEAWATER; TEMPERATURE; NITRATE; AVAILABILITY; LIMITATION; PHOSPHATE	Concentrations of heme b were determined in a mesocosm experiment situated in Gullmar Fjord off Sweden. The mesocosm experiment lasted for ca. one hundred days and was characterised by the growth of a primary nutrient replete and a secondary nutrient deplete phytoplankton bloom. Heme b varied between 40 +/- 10 pmol L-1 in the prebloom period up to a maximum of 700 +/- 400 pmol L-1 just prior to the time of the primary chlorophyll a maximum. Thereafter, heme b concentrations decreased again to an average of 120 +/- 60 pmol L-1. When normalised to total particulate carbon, heme b was most abundant during the initiation of the nutrient replete spring bloom, when ratios reached 52 +/- 24 mu mol mol(-1); ten times higher than values observed both pre and post the primary bloom. Concentrations of heme b correlated with those of chlorophyll a. Nevertheless, differences were observed in the relative concentrations of the two parameters, with heme b concentrations increasing relative to chlorophyll a during the growth of the primary bloom, decreasing over the period of the secondary bloom and increasing again through the latter period of the experiment. Heme b abundance was therefore influenced by nutrient concentrations and also likely by changing community composition. In half of the mesocosms, pCO(2) was elevated and maintained at ca. 1000 mu atm, however we observed no significant differences between heme b in plus or ambient pCO(2) mesocosms, either in absolute terms, or relative to total particulate carbon and chlorophyll a. The results obtained in this study contribute to our understanding of the distribution of this significant component of the biogenic iron pool, and provide an iron replete coastal water end member that aids the interpretation of the distributions of heme b in more iron deplete open ocean waters.	[Bellworthy, Jessica; Gledhill, Martha; Esposito, Mario; Achterberg, Eric P.] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Gledhill, Martha; Achterberg, Eric P.] Geomar Helmholtz Inst Ocean Res, Kiel, Germany	University of Southampton; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Gledhill, M (corresponding author), Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England.; Gledhill, M (corresponding author), Geomar Helmholtz Inst Ocean Res, Kiel, Germany.	mgledhill@geomar.de	Gledhill, Martha/AAG-6062-2021; Achterberg, Eric P/C-5820-2009; Gledhill, Martha/D-2819-2009; Bellworthy, Jessica/ABG-6390-2020	Gledhill, Martha/0000-0003-3859-2112; Achterberg, Eric P/0000-0002-3061-2767; Gledhill, Martha/0000-0003-3859-2112; 	German Federal Ministry of Science and Education (BMBF) [FKZ 03F06550]; UK Natural Environmental Research Council [NE/E013546/1, NE/H017348/1]	German Federal Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). Additional support for MG, JB and EPA was provided by the UK Natural Environmental Research Council (grant numbers NE/E013546/1 and NE/H017348/1).; The authors would like to thank chief scientist Ulf Riebesell and Andrea Ludwig (GEOMAR) for organising and facilitating our participation in the KOSMOS 2013, Gullmar Fjord experiment and the Sven Loven Centre for Marine Sciences, Kristineberg for giving us access to their facilities. Our thanks are extended to Saskia Audritz and Matthias Fischer for POC/N and chlorophyll analysis respectively. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). Additional support for MG, JB and EPA was provided by the UK Natural Environmental Research Council (grant numbers NE/E013546/1 and NE/H017348/1). The authors would like to thank the anonymous reviewers for their comments on the manuscript.	Avendano L, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00058; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1065, DOI 10.5194/bg-7-1065-2010; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; Carotenuto Y., 2007, BIOGEOSCIENCES DISCU, V4, P3913, DOI DOI 10.5194/BGD-4-3913-2007; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Espinas NA, 2012, PLANT CELL PHYSIOL, V53, P1344, DOI 10.1093/pcp/pcs067; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; Gledhill M, 2007, MAR CHEM, V103, P393, DOI 10.1016/j.marchem.2006.10.008; Gledhill M, 2015, MAR CHEM, V177, P421, DOI 10.1016/j.marchem.2015.03.016; Gledhill M, 2015, MAR ECOL PROG SER, V532, P29, DOI 10.3354/meps11345; Gledhill M, 2014, ANAL CHIM ACTA, V841, P33, DOI 10.1016/j.aca.2014.06.045; Gledhill M, 2013, GLOBAL BIOGEOCHEM CY, V27, P1072, DOI 10.1002/2013GB004639; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Hartnett A, 2012, METALLOMICS, V4, P1160, DOI 10.1039/c2mt20144e; Hogle SL, 2014, METALLOMICS, V6, P1107, DOI 10.1039/c4mt00031e; Hogle SL, 2016, APPL ENV MICROBIOL; Honey DJ, 2013, MAR ECOL PROG SER, V483, P1, DOI 10.3354/meps10367; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Nielsdottir MC, 2012, MAR CHEM, V130, P62, DOI 10.1016/j.marchem.2011.12.004; Nielsdottir MC, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003410; Orr JC., 2011, OCEAN ACIDIFICATION, P326; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Patey MD, 2010, ANAL CHIM ACTA, V673, P109, DOI 10.1016/j.aca.2010.05.029; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U, 2011, OCEAN ACIDIFICATION, P326; Rijkenberg MJA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004264; Roe KL, 2013, APPL ENVIRON MICROB, V79, P5753, DOI 10.1128/AEM.01562-13; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Scripps, 2014, KEEP CURV; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Stolpe B, 2010, LIMNOL OCEANOGR, V55, P187, DOI 10.4319/lo.2010.55.1.0187; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; TIMMERMANS KR, 1994, MAR BIOL, V121, P389, DOI 10.1007/BF00346749; Ussher SJ, 2007, LIMNOL OCEANOGR, V52, P2530, DOI 10.4319/lo.2007.52.6.2530	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176268	10.1371/journal.pone.0176268	http://dx.doi.org/10.1371/journal.pone.0176268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426768	Green Accepted, Green Published, gold			2022-12-27	WOS:000399875900124
J	Marko, MD; Kyle, JP; Wang, YS; Terrell, EJ				Marko, Matthew David; Kyle, Jonathan P.; Wang, Yuanyuan Sabrina; Terrell, Elon J.			Tribological investigations of the load, temperature, and time dependence of wear in sliding contact	PLOS ONE			English	Article							ELASTOHYDRODYNAMIC FILM THICKNESS; SURFACE-TOPOGRAPHY; ROUGH SURFACES; LUBRICATION; EVOLUTION; STEEL; MODEL	An effort was made to study and characterize the evolution of transient tribological wear in the presence of sliding contact. Sliding contact is often characterized experimentally via the standard ASTM D4172 four-ball test, and these tests were conducted for varying times ranging from 10 seconds to 1 hour, as well as at varying temperatures and loads. A numerical model was developed to simulate the evolution of wear in the elastohydrodynamic regime. This model uses the results of a Monte Carlo study to develop novel empirical equations for wear rate as a function of asperity height and lubricant thickness; these equations closely represented the experimental data and successfully modeled the sliding contact.	[Marko, Matthew David; Kyle, Jonathan P.; Wang, Yuanyuan Sabrina; Terrell, Elon J.] Columbia Univ, Dept Mech Engn, 500 W 120 St, New York, NY 10027 USA; [Marko, Matthew David] US Navy, Warfare Ctr Aircraft Div, Joint Base McGuire Dix Lakehurst, Lakehurst, NJ 08733 USA; [Kyle, Jonathan P.] Blue Origin, Kent, WA USA; [Wang, Yuanyuan Sabrina] Foxconn, New Taipei, Peoples R China; [Terrell, Elon J.] Sentient Sci Corp, 672 Delaware Ave, Buffalo, NY 14209 USA	Columbia University; Hon Hai Precision Industry	Marko, MD (corresponding author), Columbia Univ, Dept Mech Engn, 500 W 120 St, New York, NY 10027 USA.; Marko, MD (corresponding author), US Navy, Warfare Ctr Aircraft Div, Joint Base McGuire Dix Lakehurst, Lakehurst, NJ 08733 USA.	matthew.marko@navy.mil	Abdelbary, A./K-7643-2013	Abdelbary, A./0000-0001-5581-9839; Marko, Matthew/0000-0002-6775-7636	Science Mathematics And Research for Transformation (SMART); Navy Air Systems Command Chief Technology Officer Organization as an Independent Laboratory In-House Research (ILIR) [(NAVAIR)-4.0T]	Science Mathematics And Research for Transformation (SMART); Navy Air Systems Command Chief Technology Officer Organization as an Independent Laboratory In-House Research (ILIR)	Sources of funding for this effort to pay the tuition and salary of MDM include both the Navy Air Systems Command (NAVAIR)-4.0T Chief Technology Officer Organization as an Independent Laboratory In-House Research (ILIR) Basic Research Project (Smooth Particle Applied Mechanics); and the Science Mathematics And Research for Transformation (SMART) fellowship. The Department of Mechanical Engineering at Columbia University in the City of NY provided the laboratory space and salaries for JPK, YSW, and EJT. Blue Origin, Foxconn, and Sentient Science Corporation had no involvement in or contribution to this project. Blue Origin, Foxconn, and Sentient Science Corporation provided salaries to JPK, YSW, and EJT, respectively. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2011, WEAR, V271, P2947, DOI 10.1016/j.wear.2011.06.018; [Anonymous], 2010, D417294 ASTM INT; [Anonymous], 2009, D34109 ASTM INT; ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448; Archard JF, 1958, WEAR, V2, P438, DOI DOI 10.1016/0043-1648(59)90159-0; da Silva CRA, 2008, TRIBOL INT, V41, P473, DOI 10.1016/j.triboint.2007.10.007; Barus C., 1893, AM J SCI, V45, P87, DOI [10.2475/ajs.s3-45.266.87, DOI 10.2475/AJS.S3-45.266.87]; BAYER RG, 1975, WEAR, V35, P251, DOI 10.1016/0043-1648(75)90074-5; Blau PJ, 2005, TRIBOL INT, V38, P1007, DOI 10.1016/j.triboint.2005.07.020; Blok H., 1937, PROC GEN DISCUSS LUB, V2, P222; BUSH AW, 1976, MECH RES COMMUN, V3, P169, DOI 10.1016/0093-6413(76)90006-9; BUSH AW, 1975, WEAR, V35, P87, DOI 10.1016/0043-1648(75)90145-3; CAMERON A, 1966, PROC R SOC LON SER-A, V291, P520, DOI 10.1098/rspa.1966.0112; Carbone G, 2009, J MECH PHYS SOLIDS, V57, P1093, DOI 10.1016/j.jmps.2009.03.004; Cengel Y. A., 2004, HEAT TRANSFER PRACTI; Conway H. D., 1974, Transactions of the ASME. Series F, Journal of Lubrication Technology, V96, P300, DOI 10.1115/1.3451946; CROOK AW, 1958, PHILOS TR R SOC S-A, V250, P387, DOI 10.1098/rsta.1958.0001; Dowson D, 1995, WEAR, V190, P125, DOI 10.1016/0043-1648(95)06660-8; Einstein A, 1906, ANN PHYS-BERLIN, V19, P289, DOI 10.1002/andp.19063240204; Elcoate CD, 2001, P I MECH ENG J-J ENG, V215, P319, DOI 10.1243/1350650011543574; ENDO K, 1973, WEAR, V26, P239, DOI 10.1016/0043-1648(73)90138-5; Evans HP, 2010, TRIBOL T, V53, P179, DOI 10.1080/10402000903097452; FINKIN EF, 1970, WEAR, V15, P291, DOI 10.1016/0043-1648(70)90019-0; Garcia A, 1999, NUMERICAL METHODS PH; Gohar R., 2002, ELASTOHYDRODYNAMICS; GOLDEN JM, 1976, WEAR, V39, P25, DOI 10.1016/0043-1648(76)90220-9; Goodyer CE, 2006, SIAM J SCI COMPUT, V28, P626, DOI 10.1137/050622092; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Hamrock B., 1976, D8317 NASA; Hamrock B., 1976, D8318 NASA; Hamrock BJ, 1975, D804 NASA; HU YZ, 1991, J TRIBOL-T ASME, V113, P499, DOI 10.1115/1.2920651; Jaeger J.C., 1942, PROC R SOC N S, V76, P203, DOI DOI 10.1109/TCST.2018.2852743; JAHANMIR S, 1977, WEAR, V44, P87, DOI 10.1016/0043-1648(77)90087-4; Jamali HU, 2015, TRIBOL T, V58, P119, DOI 10.1080/10402004.2014.936990; Jiang P, 2009, TRIBOL LETT, V33, P161, DOI 10.1007/s11249-008-9399-x; Johnson KL., 1985, CONTACT MECH, DOI [10.1017/CBO9781139171731, DOI 10.1201/B17588-12]; Klapperich C, 1999, J TRIBOL-T ASME, V121, P394, DOI 10.1115/1.2833952; Pabst W, 2004, CERAM-SILIKATY, V48, P6; PEIRAN Y, 1990, TRIBOL INT, V23, P17, DOI 10.1016/0301-679X(90)90067-Y; Persson BNJ, 2006, SURF SCI REP, V61, P201, DOI 10.1016/j.surfrep.2006.04.001; RANGER AP, 1975, P ROY SOC LOND A MAT, V346, P227, DOI 10.1098/rspa.1975.0174; Roelands CJA, 1963, J BASIC ENG-T ASME, V85, P601, DOI [10.1115/1.3656919, DOI 10.1115/1.3656919]; SHAFIA MA, 1980, WEAR, V61, P87, DOI 10.1016/0043-1648(80)90114-3; Sharif KJ, 2006, P I MECH ENG J-J ENG, V220, P295, DOI 10.1243/13506501JET122; Sharif KJ, 2012, P I MECH ENG J-J ENG, V226, P1039, DOI 10.1177/1350650112458220; Smeeth M, 1997, J TRIBOL-T ASME, V119, P291, DOI 10.1115/1.2833204; SO BYC, 1980, ASLE TRANS, V23, P409, DOI 10.1080/05698198008982986; Spanu C., 2008, ANN U DUNAREA JOS GA, V8, P186; Stachowiak GW, 2005, ENGINEERING TRIBOLOGY, 3RD EDITION; SUZUKI M, 1987, J TRIBOL-T ASME, V109, P587, DOI 10.1115/1.3261511; TERRILL RM, 1983, WEAR, V92, P67, DOI 10.1016/0043-1648(83)90008-X; White FM., 1994, FLUID MECH-SOV RES, V3; ZHANG PS, 1989, WEAR, V130, P357, DOI 10.1016/0043-1648(89)90189-0	54	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175198	10.1371/journal.pone.0175198	http://dx.doi.org/10.1371/journal.pone.0175198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426674	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900021
J	Zuzarte, I; Indic, P; Barton, B; Paydarfar, D; Bednarek, F; Bloch-Salisbury, E				Zuzarte, Ian; Indic, Premananda; Barton, Bruce; Paydarfar, David; Bednarek, Francis; Bloch-Salisbury, Elisabeth			Vibrotactile stimulation: A non-pharmacological intervention for opioid-exposed newborns	PLOS ONE			English	Article							NEONATAL ABSTINENCE SYNDROME; STOCHASTIC RESONANCE; SLEEP-DEPRIVATION; OPIATE WITHDRAWAL; INFANTS; MORPHINE; MECHANISMS; TOLERANCE; METHADONE; CHILDREN	Objective To examine the therapeutic potential of stochastic vibrotactile stimulation (SVS) as a complementary non-pharmacological intervention for withdrawal in opioid-exposed newborns. Study design A prospective, within-subjects single-center study was conducted in 26 opioid-exposed newborns (>37 weeks; 16 male) hospitalized since birth and treated pharmacologically for Neonatal Abstinence Syndrome. A specially-constructed mattress delivered low-level SVS (30-60Hz, 10-12 mu m RMS), alternated in 30-min intervals between continuous vibration (ON) and no vibration (OFF) over a 6-8 hr session. Movement activity, heart rate, respiratory rate, axillary temperature and blood-oxygen saturation were calculated separately for ON and OFF. Results There was a 35% reduction in movement activity with SVS (p<0.001), with significantly fewer movement periods >30 sec duration for ON than OFF (p = 0.003). Incidents of tachypneic breaths and tachycardic heart beats were each significantly reduced with SVS, whereas incidents of eupneic breaths and eucardic heart beats each significantly increased with SVS (p<0.03). Infants maintained body temperature and arterial-blood oxygen level independent of stimulation condition. Conclusions SVS reduced hyperirritability and pathophysiological instabilities commonly observed in pharmacologically-managed opioid-exposed newborns. SVS may provide an effective complementary therapeutic intervention for improving autonomic function in newborns with Neonatal Abstinence Syndrome.	[Zuzarte, Ian; Indic, Premananda; Paydarfar, David] Univ Massachusetts, Med Sch, Dept Neurol, Worcester, MA 01605 USA; [Barton, Bruce] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Paydarfar, David] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Bednarek, Francis; Bloch-Salisbury, Elisabeth] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01605 USA; [Zuzarte, Ian] Northeastern Univ, Dept Biomed Engn, Boston, MA 02115 USA; [Indic, Premananda] Univ Texas Tyler, Dept Elect Engn, Tyler, TX 75799 USA; [Paydarfar, David] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; University of Texas System; University of Texas at Tyler; University of Texas System; University of Texas Austin	Bloch-Salisbury, E (corresponding author), Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01605 USA.	Elisabeth.Salisbury@umassmed.edu		Salisbury, Elisabeth/0000-0002-7708-3428; Zuzarte, Ian/0000-0002-1428-6922	Neonatology Associates of Worcester (EBS); National Institute on Drug Abuse [R01 DA042074-01]; Wyss Institute at Harvard University; National Institutes of Health [NIDA R21 DA035355 EBS]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042074, R21DA035355] Funding Source: NIH RePORTER	Neonatology Associates of Worcester (EBS); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Wyss Institute at Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Neonatology Associates of Worcester (EBS), the National Institute on Drug Abuse R01 DA042074-01(EBS), Wyss Institute at Harvard University (DP), and National Institutes of Health (NIDA R21 DA035355 EBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand KJS, 2010, PEDIATRICS, V125, pE1208, DOI 10.1542/peds.2009-0489; Anders T, 1971, MANUAL STANDARDIZED; Ardiel EL, 2010, PAED CHILD HEALT-CAN, V15, P153, DOI 10.1093/pch/15.3.153; Attarian S, 2014, BRAIN SCI, V4, P321, DOI 10.3390/brainsci4020321; Bagley SM, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-19; Barr GA, 2011, ILAR J, V52, P329, DOI 10.1093/ilar.52.3.329; Beckwith AM, 2015, CLIN PEDIATR, V54, P328, DOI 10.1177/0009922814549545; Bloch-Salisbury E, 2009, J APPL PHYSIOL, V107, P1017, DOI 10.1152/japplphysiol.00058.2009; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; de Graaf J, 2011, PAIN, V152, P1391, DOI 10.1016/j.pain.2011.02.017; Dieckmann R, 2000, PEDIATRIC ED PREHOSP, P43; Ednick M, 2009, SLEEP, V32, P1449, DOI 10.1093/sleep/32.11.1449; Finnegan LP, 1990, CURRENT THERAPY NEON, V2, P262; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Franco P, 2004, PEDIATRICS, V114, P192, DOI 10.1542/peds.114.2.e192; Franco P, 2003, SLEEP, V26, P845, DOI 10.1093/sleep/26.7.845; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; HAGAN R, 1977, J APPL PHYSIOL, V42, P362, DOI 10.1152/jappl.1977.42.3.362; HANDELMANN GE, 1985, PEPTIDES, V6, P29, DOI 10.1016/0196-9781(85)90131-7; Holmes AV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2929; Howard Mary Beth, 2017, Hosp Pediatr, V7, P63, DOI 10.1542/hpeds.2016-0147; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Hunt RW, 2008, EARLY HUM DEV, V84, P29, DOI 10.1016/j.earlhumdev.2007.01.013; Jansson LM, 2012, CURR OPIN PEDIATR, V24, P252, DOI 10.1097/MOP.0b013e32834fdc3a; Jansson LM, 2010, DRUG ALCOHOL DEPEN, V109, P198, DOI 10.1016/j.drugalcdep.2010.01.004; Kocek M, 2016, EARLY HUM DEV, V92, P29, DOI 10.1016/j.earlhumdev.2015.11.001; Kocherlakota P, 2014, PEDIATRICS, V134, pE547, DOI 10.1542/peds.2013-3524; Kuschel C, 2007, SEMIN FETAL NEONAT M, V12, P127, DOI 10.1016/j.siny.2007.01.004; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lester BM, 2010, J ADDICT DIS, V29, P259, DOI 10.1080/10550881003684921; MacMullen Nancy J, 2014, Pediatr Nurs, V40, P165; Marx J., 2013, ROSENS EMERGENCY MED; McGlone L, 2015, EARLY HUM DEV, V91, P19, DOI 10.1016/j.earlhumdev.2014.10.006; Mirmiran M, 2003, PEDIATR RES, V53, P933, DOI 10.1203/01.PDR.0000061541.94620.12; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Muhammad A, 2011, BRAIN RES, V1400, P53, DOI 10.1016/j.brainres.2011.05.038; O'Brien C, 2004, ARCH DIS CHILD-FETAL, V89, pF305, DOI 10.1136/adc.2002.025270; O'Brien CM, 2002, J PAEDIATR CHILD H, V38, P66, DOI 10.1046/j.1440-1754.2002.00724.x; Patrick SW, 2015, J PERINATOL, V35, P667, DOI 10.1038/jp.2015.63; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Peirano P, 2003, J PEDIATR-US, V143, pS70, DOI 10.1067/S0022-3476(03)00404-9; Smith VC, 2015, PEDIATRICS, V136, pE1561, DOI 10.1542/peds.2015-1334; STRAUSS ME, 1976, AM J DRUG ALCOHOL AB, V3, P339, DOI 10.3109/00952997609077202; Sublett J, 2013, MCN-AM J MATERN-CHIL, V38, P102, DOI 10.1097/NMC.0b013e31826e978e; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER, V38A; Suresh S, 1998, SEMIN PERINATOL, V22, P425, DOI 10.1016/S0146-0005(98)80058-X; Taddio A, 2009, CLIN J PAIN, V25, P418, DOI 10.1097/AJP.0b013e31819b7a3b; Tarullo AR, 2011, INFANT CHILD DEV, V20, P35, DOI 10.1002/icd.685; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Velez M, 2008, J ADDICT MED, V2, P113, DOI 10.1097/ADM.0b013e31817e6105; White-Traut Rosemary, 2002, J Perinatol, V22, P291, DOI 10.1038/sj.jp.7210695; Zuzarte I, 2014, IEEE ENG MED BIO, P5466, DOI 10.1109/EMBC.2014.6944863	53	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175981	10.1371/journal.pone.0175981	http://dx.doi.org/10.1371/journal.pone.0175981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426726	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900081
J	Chang, JW				Chang, Ji Woong			Refractive error change and vision improvement in moderate to severe hyperopic amblyopia after spectacle correction: Restarting the emmetropization process?	PLOS ONE			English	Article							MYOPIA PROGRESSION; EYE GROWTH; 12-YEAR-OLD CHILDREN; FULL CORRECTION; VISUAL-ACUITY; INFANTS; UNDERCORRECTION; AGE; EMMETROPISATION; ACCOMMODATION	Purpose The aims of the study were to develop guidelines for prescribing spectacles for patients with moderate to severe hyperopic amblyopia and to demonstrate how emmetropization progresses. Methods Children with hyperopic amblyopia who had a spherical equivalent of >= +4.0 diopters (D) or more were included, while those who had astigmatism of > 2.0 D or anisometropia of > 2.0 D were excluded. The patients were divided into a full correction group and an under-correction group according to the amount of hyperopia correction applied. The under-correction group was further subdivided into a fixed under-correction group and a post-cycloplegic refraction (PCR) under-correction group. The duration of amblyopia treatment and changes in initial hyperopia were compared between the groups. Results In total, 76 eyes of 38 patients were analyzed in this study. The full correction group and under-correction group were subjected to 5.5 months and 5.9 months of amblyopia treatment, respectively (P = 0.570). However, the PCR under-correction group showed more rapid improvement (2.9 months; P = 0.001). In the under-correction group, initial hyperopia was decreased by -0.28 D and -0.49 D at 6 months and 12 months, respectively, after initial cycloplegic refraction. Moreover, the amount of hyperopia under-correction was correlated with the amount of hyperopia reduction (P = 0.010). Conclusion The under-correction of moderate to severe hyperopic amblyopia has beneficial effects for treating amblyopia and activating emmetropization. PCR under-correction can more rapidly improve visual acuity, while both fixed under-correction and PCR under-correction can induce emmetropization and effectively reduce initial hyperopia.	[Chang, Ji Woong] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Ophthalmol, Goyang, South Korea; [Chang, Ji Woong] Yonsei Univ, Grad Program Cognit Sci, Seoul, South Korea	Inje University; Yonsei University	Chang, JW (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Ophthalmol, Goyang, South Korea.; Chang, JW (corresponding author), Yonsei Univ, Grad Program Cognit Sci, Seoul, South Korea.	jiwoong_chang@paik.ac.kr			Inje University research grant	Inje University research grant	This work was supported by the 2016 Inje University research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2006, CLIN EXP OPTOM, V89, P315, DOI 10.1111/j.1444-0938.2006.00055.x; Ai LK, 2009, INVEST OPHTH VIS SCI, V50, P295, DOI 10.1167/iovs.08-1972; Atkinson J, 1996, EYE, V10, P189, DOI 10.1038/eye.1996.46; Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Babinsky E, 2013, INVEST OPHTH VIS SCI, V54, P4941, DOI 10.1167/iovs.12-10670; Chung K, 2002, VISION RES, V42, P2555, DOI 10.1016/S0042-6989(02)00258-4; Donahue SP, 2007, OPTOMETRY VISION SCI, V84, P110, DOI 10.1097/OPX.0b013e318031b09b; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Ehrlich DL, 1997, OPTOMETRY VISION SCI, V74, P822, DOI 10.1097/00006324-199710000-00022; Glaser SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P268; GLICKSTEIN M, 1970, SCIENCE, V168, P605, DOI 10.1126/science.168.3931.605; GROSVENOR T, 1987, AM J OPTOM PHYS OPT, V64, P657; HEATH G G, 1956, Am J Optom Arch Am Acad Optom, V33, P569; INGRAM RM, 1991, BRIT J OPHTHALMOL, V75, P414, DOI 10.1136/bjo.75.7.414; INGRAM RM, 1990, BRIT J OPHTHALMOL, V74, P158, DOI 10.1136/bjo.74.3.158; Ingram RM, 2000, BRIT J OPHTHALMOL, V84, P324, DOI 10.1136/bjo.84.3.324; KUTSCHKE PJ, 1991, OPHTHALMOLOGY, V98, P258; Li SM, 2013, CLIN EXP OPHTHALMOL, V41, P329, DOI 10.1111/j.1442-9071.2012.02884.x; Li SY, 2015, GRAEF ARCH CLIN EXP, V253, P1363, DOI 10.1007/s00417-015-3053-8; Lyons SA, 2004, OPTOMETRY VISION SCI, V81, P233, DOI 10.1097/00006324-200404000-00008; MacEwen CJ, 2008, BRIT J OPHTHALMOL, V92, P1329, DOI 10.1136/bjo.2007.126417; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; McBrien NA, 1999, OPTOMETRY VISION SCI, V76, P419, DOI 10.1097/00006324-199906000-00022; MEDINA A, 1987, ACTA OPHTHALMOL, V65, P565; Miller JM, 1998, J PEDIAT OPHTH STRAB, V35, P51; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Mutti DO, 2004, OPTOMETRY VISION SCI, V81, P753, DOI 10.1097/00006324-200410000-00007; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P666, DOI 10.1097/OPX.0b013e3181a6174f; OOJ CS, 1995, OPTOMETRY VISION SCI, V72, P60, DOI 10.1097/00006324-199502000-00004; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Robaei D, 2005, OPHTHALMOLOGY, V112, P1275, DOI 10.1016/j.ophtha.2005.01.052; SCHAEFFEL F, 1988, VISION RES, V28, P639, DOI 10.1016/0042-6989(88)90113-7; Smith EL, 2013, OPTOMETRY VISION SCI, V90, P1176, DOI 10.1097/OPX.0000000000000038; SORSBY A, 1961, Memo Med Res Counc, V301(Special), P1; Sun YY, 2017, GRAEF ARCH CLIN EXP, V255, P189, DOI 10.1007/s00417-016-3529-1; Thorn F, 2005, OPTOMETRY VISION SCI, V82, P286, DOI 10.1097/01.OPX.0000159370.66540.34; TROILO D, 1992, EYE, V6, P154, DOI 10.1038/eye.1992.31; TROILO D, 1991, VISION RES, V31, P1237, DOI 10.1016/0042-6989(91)90048-A; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1936	42	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175780	10.1371/journal.pone.0175780	http://dx.doi.org/10.1371/journal.pone.0175780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423020	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600052
J	de Carvalho, WJ; Fujimura, PT; Bonetti, AM; Goulart, LR; Cloonan, K; da Silva, NM; Araujo, ECB; Ueira-Vieira, C; Leal, WS				de Carvalho, Washington Joao; Fujimura, Patricia Tieme; Bonetti, Ana Maria; Goulart, Luiz Ricardo; Cloonan, Kevin; da Silva, Neide Maria; Borges Araujo, Ester Cristina; Ueira-Vieira, Carlos; Leal, Walter S.			Characterization of antennal sensilla, larvae morphology and olfactory genes of Melipona scutellaris stingless bee	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; HONEY-BEE; CHEMOSENSORY PROTEINS; FUNCTIONAL-MORPHOLOGY; FLAGELLAR SENSILLA; HYMENOPTERA; APIDAE; WORKERS; PHEROMONE; QUEENS	There is growing evidence in the literature suggesting that caste differentiation in the stingless bee, Melipona scutellaris, and other bees in the genus Melipona, is triggered by environmental signals, particularly a primer pheromone. With the proper amount of food and a chemical stimulus, 25% of females emerge as queens, in agreement with a long-standing "two loci/two alleles model" proposed in the 1950s. We surmised that these larvae must be equipped with an olfactory system for reception of these chemical signals. Here we describe for the first time the diversity of antennal sensilla in adults and the morphology of larvae of M. scutellaris. Having found evidence for putative olfactory sensilla in larvae, we next asked whether olfactory proteins were expressed in larvae. Since the molecular basis of M. scutellaris is still unknown, we cloned olfactory genes encoding chemosensory proteins (CSP) and odorant-binding proteins (OBPs) using M. scutellaris cDNA template and primers designed on the basis CSPs and OBPs previously reported from the European honeybee, Apis mellifera. We cloned two CSP and two OBP genes and then attempted to express the proteins encoded by these genes. With a recombinant OBP, MscuOBP8, and a combinatorial single-chain variable fragment antibody library, we generated anti-MscuOBP8 monoclonal antibody. By immunohistochemistry we demonstrated that the anti-MscuOBP8 binds specifically to the MscuOBP8. Next, we found evidence that MscuOBP8 is expressed in M. scutellaris larvae and it is located in the mandibular region, thus further supporting the hypothesis of olfactory function in immature stages. Lastly, molecular modeling suggests that MscuOBP8 may function as a carrier of primer pheromones or other ligands.	[de Carvalho, Washington Joao; Cloonan, Kevin; Ueira-Vieira, Carlos; Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [de Carvalho, Washington Joao; Fujimura, Patricia Tieme; Bonetti, Ana Maria; Ueira-Vieira, Carlos] Univ Fed Uberlandia, Inst Genet & Bioquim, Lab Genet, Uberlandia, MG, Brazil; [de Carvalho, Washington Joao; Fujimura, Patricia Tieme; Goulart, Luiz Ricardo] Univ Fed Uberlandia, Inst Genet & Bioquim, Lab Nanobiotecnol, Uberlandia, MG, Brazil; [Goulart, Luiz Ricardo] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [da Silva, Neide Maria; Borges Araujo, Ester Cristina] Univ Fed Uberlandia, Inst Ciencias Biomed, Lab Immunopatol, Uberlandia, MG, Brazil; [Cloonan, Kevin] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of California System; University of California Davis; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Federal de Uberlandia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Ueira-Vieira, Carlos/J-8998-2014; Leal, Walter/ACX-9082-2022; Bonetti, Ana/V-3811-2019; Leal, Walter/AAU-6997-2021; Silva, Neide/C-7813-2013; Goulart, Luiz R/G-7357-2012	Ueira-Vieira, Carlos/0000-0002-8369-9069; Leal, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-1241-5225; Silva, Neide/0000-0002-3615-1340; Goulart, Luiz R/0000-0002-1803-4861; Borges Araujo, Ester Cristina/0000-0001-7053-6757	Brazil's Coordination for the Improvement of Higher Education Personnel (CAPES); Brazilian National Council for Scientific and Technological Development (CNPq) through scholarships under the Brazil's Science Mobility Program for WJC; CU-V at UC Davis; Bedoukian Research Inc.,; KC at UC Davis; State Funding Agency of Minas Gerais; Fuji Flavor Co., Ltd. (Japan); NIGMS [P41-GM103311]	Brazil's Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development (CNPq) through scholarships under the Brazil's Science Mobility Program for WJC; CU-V at UC Davis; Bedoukian Research Inc.,; KC at UC Davis; State Funding Agency of Minas Gerais; Fuji Flavor Co., Ltd. (Japan); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported in part by Brazil's Coordination for the Improvement of Higher Education Personnel (CAPES) and The Brazilian National Council for Scientific and Technological Development (CNPq) through scholarships under the Brazil's Science Mobility Program for WJC and CU-V at UC Davis, Bedoukian Research Inc., through a Research Agreement that supported KC at UC Davis, the State Funding Agency of Minas Gerais and gifts from various donors, including Bedoukian Research, Inc., and Fuji Flavor Co., Ltd. (Japan), made to UC Davis to support WSL's research program. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by NIGMS P41-GM103311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren L, 1996, APIDOLOGIE, V27, P433, DOI 10.1051/apido:19960601; Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Al Ghamdi Ahmad A., 2006, Bulletin of the Entomological Society of Egypt (A.R.E.), V83, P1; Azevedo DD, 2008, MICROSC RES TECHNIQ, V71, P196, DOI 10.1002/jemt.20539; Barbas III CF, 2000, PHAGE DISPLAY LAB MA; Bartlet E, 1999, INT J INSECT MORPHOL, V28, P291, DOI 10.1016/S0020-7322(99)00032-X; Bonetti Ana Maria, 1995, Revista Brasileira de Biologia, V55, P113; Borges AA, 2012, INSECT SOC, V59, P479, DOI 10.1007/s00040-012-0242-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo J M F, 2013, CATALOGUE BEES HYMEN; Carneiro AP, 2014, BRIT J CANCER, V111, P551, DOI 10.1038/bjc.2014.331; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; Eilers EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041357; Fang Y, 2012, J PROTEOMICS, V75, P756, DOI 10.1016/j.jprot.2011.09.012; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Frasnelli E, 2010, BEHAV BRAIN RES, V209, P221, DOI 10.1016/j.bbr.2010.01.046; Galvani GL, 2012, MICRON, V43, P673, DOI 10.1016/j.micron.2011.12.003; GETZ WM, 1993, APIDOLOGIE, V24, P195, DOI 10.1051/apido:19930303; GUPTA M, 1992, APIDOLOGIE, V23, P47, DOI 10.1051/apido:19920105; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hartfelder K, 2006, APIDOLOGIE, V37, P144, DOI 10.1051/apido:2006013; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Jarau S, 2010, J CHEM ECOL, V36, P565, DOI 10.1007/s10886-010-9793-3; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Keil TA, 1997, INT J INSECT MORPHOL, V26, P151, DOI 10.1016/S0020-7322(97)00017-2; KERR WE, 1950, GENETICS, V35, P143; Kerr WE, 2004, APIDOLOGIE, V35, P611, DOI 10.1051/apido:2004052; KERR WE, 1950, EVOLUTION, V4, P7, DOI 10.2307/2405530; Krenn HW, 1998, ZOOMORPHOLOGY, V118, P23, DOI 10.1007/s004350050053; Kropf J, 2014, CELL TISSUE RES, V357, P583, DOI 10.1007/s00441-014-1892-y; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Landim C. C., 2009, ABELHAS MORFOLOGIA F; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Levenhagen MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10447; Li DZ, 2015, INT J BIOL SCI, V11, P1281, DOI 10.7150/ijbs.12528; Missbach C, 2011, ARTHROPOD STRUCT DEV, V40, P317, DOI 10.1016/j.asd.2011.03.004; Nakanishi A, 2009, CELL TISSUE RES, V338, P79, DOI 10.1007/s00441-009-0863-1; Nascimento Marcilia Aparecida, 2013, EntomoBrasilis, V6, P64, DOI 10.12741/ebrasilis.v6i1.252; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poivet E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2050; Fialho MDQ, 2014, J APICULT RES, V53, P392, DOI 10.3896/IBRA.1.53.3.07; Ravaiano SV, 2014, NATURWISSENSCHAFTEN, V101, P603, DOI 10.1007/s00114-014-1184-0; Rozen JG, 2011, ZOOKEYS, P279, DOI [10.3897/zookeys.138.1839, 10.3897/zookeys.148.1839]; Sakagami S. F., 1982, Social insects. Vol. III, P361; Sakagami S. F., 1963, Journal of the Faculty of Science Hokkaido University Zoology (6), V15, P300; Shang LN, 2010, ANN ENTOMOL SOC AM, V103, P654, DOI 10.1603/AN10017; Silva-Zacarin E.C.M., 2012, CURRENT MICROSCOPY C, P696; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Stort A. C., 1999, Revista Brasileira de Biologia, V59, P161, DOI 10.1590/S0034-71081999000100020; STORT AC, 1981, J KANSAS ENTOMOL SOC, V54, P751; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Trhlin M, 2011, VET MED-CZECH, V56, P265, DOI 10.17221/1543-VETMED; van Veen JW, 2000, APIDOLOGIE, V31, P411, DOI 10.1051/apido:2000131; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt R.G., 2005, P753; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; YOKOHARI F, 1982, CELL TISSUE RES, V226, P63, DOI 10.1007/BF00217082; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302; Zakaria M. E., 2007, Journal of Applied Sciences Research, P653	70	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174857	10.1371/journal.pone.0174857	http://dx.doi.org/10.1371/journal.pone.0174857			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423045	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600022
J	Shepherd, JA; Ng', BK; Fan, B; Schwartz, AV; Cawthon, P; Cummings, SR; Kritchevsky, S; Nevitt, M; Santanasto, A; Cootes, TF				Shepherd, John A.; Ng', Bennett K.; Fan, Bo; Schwartz, Ann V.; Cawthon, Peggy; Cummings, Steven R.; Kritchevsky, Stephen; Nevitt, Michael; Santanasto, Adam; Cootes, Timothy F.			Modeling the shape and composition of the human body using dual energy X-ray absorptiometry images	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MUSCLE MASS; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; OLDER PERSONS; HIP RATIO; ALL-CAUSE; MORTALITY; OBESITY; WEIGHT	There is growing evidence that body shape and regional body composition are strong indicators of metabolic health. The purpose of this study was to develop statistical models that accurately describe holistic body shape, thickness, and leanness. We hypothesized that there are unique body shape features that are predictive of mortality beyond standard clinical measures. We developed algorithms to process whole-body dual-energy X-ray absorptiometry (DXA) scans into body thickness and leanness images. We performed statistical appearance modeling (SAM) and principal component analysis (PCA) to efficiently encode the variance of body shape, leanness, and thickness across sample of 400 older Americans from the Health ABC study. The sample included 200 cases and 200 controls based on 6-year mortality status, matched on sex, race and BMI. The final model contained 52 points outlining the torso, upper arms, thighs, and bony landmarks. Correlation analyses were performed on the PCA parameters to identify body shape features that vary across groups and with metabolic risk. Stepwise logistic regression was performed to identify sex and race, and predict mortality risk as a function of body shape parameters. These parameters are novel body composition features that uniquely identify body phenotypes of different groups and predict mortality risk. Three parameters from a SAM of body leanness and thickness accurately identified sex (training AUC = 0.99) and six accurately identified race (training AUC = 0.91) in the sample dataset. Three parameters from a SAM of only body thickness predicted mortality (training AUC = 0.66, validation AUC = 0.62). Further study is warranted to identify specific shape/composition features that predict other health outcomes.	[Shepherd, John A.; Ng', Bennett K.; Fan, Bo] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Shepherd, John A.; Ng', Bennett K.] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Shepherd, John A.; Ng', Bennett K.] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Schwartz, Ann V.; Nevitt, Michael] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Cawthon, Peggy; Cummings, Steven R.; Kritchevsky, Stephen] Calif Pacific Med Ctr, San Francisco Coordinating Ctr, Res Inst, San Francisco, CA USA; [Santanasto, Adam] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Cootes, Timothy F.] Univ Manchester, Ctr Imaging Sci, Manchester, Lancs, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Manchester	Shepherd, JA (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Shepherd, JA (corresponding author), Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA.; Shepherd, JA (corresponding author), Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA.	john.shepherd@ucst.edu	Santanasto, Adam/AFU-4175-2022; Shepherd, John/S-3146-2018	Santanasto, Adam/0000-0002-6912-2909; Shepherd, John/0000-0003-2280-2541; Ng, Bennett/0000-0003-4625-3161; Cootes, Timothy/0000-0002-2695-9063	National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK109008]; National Institute of Nursing Research (NINR) [R01-NR012459]	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Institute on Aging (NIA) [https://www.nia.nih.gov/]: N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [https://www.niddk.nih.gov/]: R01-DK109008; and National Institute of Nursing Research (NINR) [https://www.ninr.nih.gov/]: R01-NR012459.	Alissa R, 2010, EUR J ORAL IMPLANTOL, V3, P121; Baker-Lepain JC, 2010, RHEUMATOLOGY OXFORD; Beymer D, 2008, ENG MED BIOL SOC 200; Blake GM, 1999, EVALUATION OSTEOPORO; Cootes T. F., 2012, LECT NOTES COMPUT SC, P278, DOI DOI 10.1007/978-3-642-33786-4; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Cristinacce D, 2008, PATTERN RECOGN, V41, P3054, DOI 10.1016/j.patcog.2008.01.024; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Edwards G. J., 1998, Computer Vision - ECCV'98. 5th European Conference on Computer Vision. Proceedings, P581, DOI 10.1007/BFb0054766; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; GARRISON RJ, 1985, ANN INTERN MED, V103, P1006, DOI 10.7326/0003-4819-103-6-1006; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Goodyear SR, 2013, BONE, V53, P188, DOI 10.1016/j.bone.2012.11.042; Humbert L, 2017, IEEE T MED IMAGING, V36, P27, DOI 10.1109/TMI.2016.2593346; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Price GM, 2006, AM J CLIN NUTR, V84, P449; RABKIN SW, 1977, AM J CARDIOL, V39, P452, DOI 10.1016/S0002-9149(77)80104-5; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Shi D, 2003, IEEE T PATTERN ANAL, V25, P277, DOI 10.1109/TPAMI.2003.1177158; Solloway S, 1997, MAGNET RESON MED, V37, P943, DOI 10.1002/mrm.1910370620; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Whitmarsh T, 2011, LECT NOTES COMPUT SC, V6892, P393, DOI 10.1007/978-3-642-23629-7_48; Wilson JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068716; Wilson JP, 2012, AM J CLIN NUTR, V95, P25, DOI 10.3945/ajcn.111.019273; Wilson JP, 2013, J CLIN DENSITOM; Wilson JP, 2013, SEARCH ADV IMAGING D; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175857	10.1371/journal.pone.0175857	http://dx.doi.org/10.1371/journal.pone.0175857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423041	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600057
J	Zwicker, S; Hettinger, E; Bureik, D; Batycka-Baran, A; Schmidt, A; Gerber, PA; Rothenfusser, S; Gilliet, M; Ruzicka, T; Wolf, R				Zwicker, Stephanie; Hettinger, Eva; Bureik, Daniela; Batycka-Baran, Aleksandra; Schmidt, Andreas; Gerber, Peter-Arne; Rothenfusser, Simon; Gilliet, Michel; Ruzicka, Thomas; Wolf, Ronald			Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VITAMIN-D; T-CELLS; 1,25-DIHYDROXYVITAMIN D-3; INFLAMMATORY CASPASES; MOLECULAR-CLONING; PSORIASIN S100A7; INTERFERON-GAMMA; EXPRESSION; KERATINOCYTES	IL-1 beta is a potent player in cutaneous inflammation and central for the development of a Th17 micro-milieu in autoinflammatory diseases including psoriasis. Its production is controlled at the transcriptional level and by subsequent posttranslational processing via inflammatory caspases. In this study, we detected inflammatory caspase-5 active in epidermal keratinocytes and in psoriatic skin lesions. Further, interferon-gamma and interleukin-17A synergistically induced caspase-5 expression in cultured keratinocytes, which was dependent on the antimicrobial peptide psoriasin (S100A7). However, diseases-relevant triggers for caspase-5 activity and IL-1 beta production remain unknown. Recently, extranuclear DNA has been identified as danger-signals abundant in the psoriatic epidermis. Here, we could demonstrate that cytosolic double-stranded (ds) DNA transfected into keratinocytes triggered the activation of caspase-5 and the release of IL-1 beta. Further, interleukin-17A promoted caspase- 5 function via facilitation of the NLRP1-inflammasome. Anti-inflammatory vitamin D interfered with the IL-1 beta release and suppressed caspase-5 in keratinocytes and in psoriatic skin lesions. Our data link the disease-intrinsic danger signals psoriasin (S100A7) and dsDNA for NLPR1-dependent caspase-5 activity in psoriasis providing potential therapeutic targets in Th17-mediated skin autoinflammation.	[Zwicker, Stephanie; Hettinger, Eva; Bureik, Daniela; Batycka-Baran, Aleksandra; Ruzicka, Thomas; Wolf, Ronald] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergol, Frauenlobstr 9-11, Munich, Germany; [Zwicker, Stephanie] Karolinska Inst, Dept Dent Med, Alfred Nobels Alle 8, Huddinge, Sweden; [Batycka-Baran, Aleksandra] Wroclaw Med Univ, Dept Dermatol Venereol & Allergy, Chalubinskiego 1, Wroclaw, Poland; [Schmidt, Andreas; Rothenfusser, Simon] Ludwig Maximilian Univ Munich, Med Klin 4, Div Clin Pharmacol, Ziemssenstr 1, Munich, Germany; [Gerber, Peter-Arne] Univ Hosp Dusseldorf, Dept Dermatol, Moorenstr 5, Dusseldorf, Germany; [Gilliet, Michel] Univ Hosp Lausanne, CHUV Univ Hosp, Dept Dermatol, Rue Bugnon 46, Lausanne, Switzerland; [Wolf, Ronald] Philipps Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany	University of Munich; Karolinska Institutet; Wroclaw Medical University; University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Philipps University Marburg	Wolf, R (corresponding author), Ludwig Maximilian Univ Munich, Dept Dermatol & Allergol, Frauenlobstr 9-11, Munich, Germany.; Wolf, R (corresponding author), Philipps Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany.	ronald.wolf@med.uni-marburg.de		Batycka-Baran, Aleksandra/0000-0003-1935-1380	Else Kroner-Fresenius-Foundation [2012_A294]; German Research Foundation [GRK1202, SCHM 2670/1-1]; Otto Braun -Falco Scholarship	Else Kroner-Fresenius-Foundation; German Research Foundation(German Research Foundation (DFG)); Otto Braun -Falco Scholarship	This work was supported by grants from the Else Kroner-Fresenius-Foundation (R.W., 2012_A294), the German Research Foundation (S.R., GRK1202; A.S., SCHM 2670/1-1), and the Otto Braun -Falco Scholarship (A.B.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balato A, 2013, ARCH DERMATOL RES, V305, P255, DOI 10.1007/s00403-013-1327-8; Buchau AS, 2007, J INVEST DERMATOL, V127, pS130; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Dyring-Andersen B, 2015, SCAND J IMMUNOL, V82, P84, DOI 10.1111/sji.12304; Ekman AK, 2014, BRIT J DERMATOL, V171, P1517, DOI 10.1111/bjd.13178; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fogh K, 1997, CLIN DERMATOL, V15, P705, DOI 10.1016/S0738-081X(97)00021-7; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gregersen PK, 2007, NEW ENGL J MED, V356, P1263, DOI 10.1056/NEJMe078017; Hattinger E, 2016, PHOTODERMATOL PHOTO, V32, P165, DOI 10.1111/phpp.12234; Hegyi Z, 2012, J INVEST DERMATOL, V132, P1416, DOI 10.1038/jid.2011.486; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Kong J, 2006, J IMMUNOL, V176, P3780, DOI 10.4049/jimmunol.176.6.3780; Krishnan AV, 2010, ENDOCR-RELAT CANCER, V17, pR19, DOI 10.1677/ERC-09-0139; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Maleki M, 2016, J CUTAN MED SURG, V20, P207, DOI 10.1177/1203475415622207; Mansouri B, 2014, BRIT J DERMATOL; Marie J, 2014, BRIT J DERMATOL, V170, P816, DOI 10.1111/bjd.12691; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; MILLS KHG, 2009, NAT MED, V15, P1363, DOI DOI 10.1038/NM1209-1363; Muhr P, 2010, EXP DERMATOL, V19, P1105, DOI 10.1111/j.1600-0625.2010.01134.x; Napier BA, 2016, J EXP MED, V213, P2365, DOI 10.1084/jem.20160027; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Peehl DM, 2004, J STEROID BIOCHEM, V92, P131, DOI 10.1016/j.jsbmb.2004.07.003; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Raymond AA, 2007, BRIT J DERMATOL, V156, P420, DOI 10.1111/j.1365-2133.2006.07656.x; Relja B, 2015, J MOL MED, V93, P1391, DOI 10.1007/s00109-015-1320-0; Salskov-Iversen ML, 2011, J INVEST DERMATOL, V131, P670, DOI 10.1038/jid.2010.370; Sanders MG, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.186; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Shamsabadi RM, 2015, INFLAMMATION, V38, P205, DOI 10.1007/s10753-014-0023-y; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolf R, 2003, FASEB J, V17, P1969, DOI 10.1096/fj.03-0148fje; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolf R, 2011, AMINO ACIDS, V41, P789, DOI 10.1007/s00726-010-0666-4; Wolf R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001108; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Yang CA, 2015, J AUTOIMMUNITY	52	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175153	10.1371/journal.pone.0175153	http://dx.doi.org/10.1371/journal.pone.0175153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422993	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600027
J	Mei, L; Shen, BJ; Ling, PX; Liu, SY; Xue, JJ; Liu, FY; Shao, HR; Chen, JY; Ma, AB; Liu, X				Mei, Li; Shen, Bojiang; Ling, Peixue; Liu, Shaoying; Xue, Jiajun; Liu, Fuyan; Shao, Huarong; Chen, Jianying; Ma, Aibin; Liu, Xia			Culture-expanded allogenic adipose tissue-derived stem cells attenuate cartilage degeneration in an experimental rat osteoarthritis model	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; STROMAL CELLS; DIFFERENTIATION; PROGRESSION; ACTIVATION	Mesenchymal stem cell (MSC)-based cell therapy is a promising avenue for osteoarthritis (OA) treatment. In the present study, we evaluated the efficacy of intra-articular injections of culture-expanded allogenic adipose tissue-derived stem cells (ADSCs) for the treatment of anterior cruciate ligament transection (ACLT) induced rat OA model. The paracrine effects of major histocompatibility complex (MHC)-unmatched ADSCs on chondrocytes were investigated in vitro. Rats were divided into an OA group that underwent ACLT surgery and a sham-operated group that did not undergo ACLT surgery. Four weeks after surgery mild OA was induced in the OA group. Subsequently, the OA rats were randomly divided into ADSC and control groups. A single dose of 1 x 10(6) ADSCs suspended in 60 mu L phosphate-buffered saline (PBS) was intra-articularly injected into the rats of the ADSC group. The control group received only 60 mu L PBS. OA progression was evaluated macroscopically and histologically at 8 and 12 weeks after surgery. ADSC treatment did not cause any adverse local or systemic reactions. The degeneration of articular cartilage was significantly weaker in the ADSC group compared to that in the control group at both 8 and 12 weeks. Chondrocytes were co-cultured with MHC-unmatched ADSCs in trans-wells to assess the paracrine effects of ADSCs on chondrocytes. Co-culture with ADSCs counteracted the IL-1 beta-induced mRNA upregulation of the extracellular matrix-degrading enzymes MMP-3 and MMP-13 and the pro-inflammatory cytokines TNF-alpha and IL-6 in chondrocytes. Importantly, ADSCs increased the expression of the anti-inflammatory cytokine IL-10 in chondrocytes. The results of this study indicated that the intra-articular injection of culture-expanded allogenic ADSCs attenuated cartilage degeneration in an experimental rat OA model without inducing any adverse reactions. MHC-unmatched ADSCs protected chondrocytes from inflammatory factor-induced damage. The paracrine effects of ADSCs on OA chondrocytes are at least part of the mechanism by which ADSCs exert their therapeutic activity.	[Mei, Li; Ling, Peixue; Liu, Fuyan; Ma, Aibin] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China; [Mei, Li; Ling, Peixue; Liu, Shaoying; Xue, Jiajun; Liu, Fuyan; Shao, Huarong; Chen, Jianying; Ma, Aibin; Liu, Xia] Shandong Acad Pharmaceut Sci, Postdoctoral Sci Res Workstn, Jinan, Shandong, Peoples R China; [Shen, Bojiang] Univ New South Wales, St George Hosp, Orthoped Res Inst, Dept Orthoped Res, Sydney, NSW, Australia	Shandong University; St George Hospital; University of New South Wales Sydney	Ling, PX (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China.; Ling, PX (corresponding author), Shandong Acad Pharmaceut Sci, Postdoctoral Sci Res Workstn, Jinan, Shandong, Peoples R China.	lpx@sdfmg.com		Ling, Peixue/0000-0002-2783-7463; Liu, fuyan/0000-0002-9905-7052				Aida Y, 2005, LIFE SCI, V77, P3210, DOI 10.1016/j.lfs.2005.05.052; Altman Roy Davis, 2009, Am J Manag Care, V15, pS236; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Buschmann J, 2013, CYTOTHERAPY, V15, P1098, DOI 10.1016/j.jcyt.2013.04.009; Cawston TE, 2010, CELL TISSUE RES, V339, P221, DOI 10.1007/s00441-009-0887-6; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Cheng K.-H., 2011, GENOMIC MED BIOMARKE, V3, P53, DOI [10.1016/j.gmbhs.2011.08.003, DOI 10.1016/J.GMBHS.2011.08.003]; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Desando G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4156; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Han GY, 2012, CARBOHYD POLYM, V89, P870, DOI 10.1016/j.carbpol.2012.04.023; Kim JE, 2014, INT J NANOMED, V9, P141, DOI 10.2147/IJN.S54114; Koh YG, 2015, KNEE SURG SPORT TR A, V23, P1308, DOI 10.1007/s00167-013-2807-2; Kuroda K, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0701-4; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Liu SH, 2016, AM J MED, V129, P497, DOI 10.1016/j.amjmed.2015.12.029; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; McAlindon TE, 2010, OSTEOARTHR CARTILAGE, V18, P473, DOI 10.1016/j.joca.2010.02.011; Mehrabani D, 2013, WORLD J PLAST SURG, V2, P65; Pak J, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-337; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pickarski M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-197; Platas J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/357014; Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z; Ren Y, 2012, RES VET SCI, V93, P404, DOI 10.1016/j.rvsc.2011.08.014; Richards MM, 2016, PHYSICIAN SPORTSMED, V44, P101, DOI 10.1080/00913847.2016.1168272; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; Toghraie F, 2012, ARCH IRAN MED, V15, P495, DOI 012158/AIM.0011; Van Pham P, 2013, J MED ENG, V2013; Wu L, 2012, TISSUE ENG PT A, V18, P1542, DOI [10.1089/ten.tea.2011.0715, 10.1089/ten.TEA.2011.0715]; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	35	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176107	10.1371/journal.pone.0176107	http://dx.doi.org/10.1371/journal.pone.0176107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419155	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200074
J	Song, Y; Yu, M; Jiang, GY; Shao, F; Peng, ZJ				Song, Yang; Yu, Mei; Jiang, Gangyi; Shao, Feng; Peng, Zongju			Video quality assessment using motion-compensated temporal filtering and manifold feature similarity	PLOS ONE			English	Article								Well-performed Video quality assessment (VQA) method should be consistent with human visual systems for better prediction accuracy. In this paper, we propose a VQA method using motion-compensated temporal filtering (MCTF) and manifold feature similarity. To be more specific, a group of frames (GoF) is first decomposed into a temporal high-pass component (HPC) and a temporal low-pass component (LPC) by MCTF. Following this, manifold feature learning (MFL) and phase congruency (PC) are used to predict the quality of temporal LPC and temporal HPC respectively. The quality measures of the LPC and the HPC are then combined as GoF quality. A temporal pooling strategy is subsequently used to integrate GoF qualities into an overall video quality. The proposed VQA method appropriately processes temporal information in video by MCTF and temporal pooling strategy, and simulate human visual perception by MFL. Experiments on publicly available video quality database showed that in comparison with several state-of-the-art VQA methods, the proposed VQA method achieves better consistency with subjective video quality and can predict video quality more accurately.	[Song, Yang; Yu, Mei; Jiang, Gangyi; Shao, Feng; Peng, Zongju] Ningbo Univ, Fac Elect Engn & Comp Sci, Ningbo, Zhejiang, Peoples R China	Ningbo University	Song, Y; Jiang, GY (corresponding author), Ningbo Univ, Fac Elect Engn & Comp Sci, Ningbo, Zhejiang, Peoples R China.	songyang_ac@126.com; jianggangyi@126.com	Peng, Zongju/AAA-2914-2020	Peng, Zongju/0000-0001-8286-538X	Natural Science Foundation of China [61271270, 61271021, 61311140262, U1301257]; National High-tech R&D Program of China [2015AA015901]; Zhejiang Provincial Natural Science Foundation of China [LY15F010005, Y16F010010]; K. C. Wong Magna Fund at Ningbo University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund at Ningbo University	This study was supported by the Natural Science Foundation of China under grants 61271270, 61271021, 61311140262 and U1301257, the National High-tech R&D Program of China (2015AA015901), Zhejiang Provincial Natural Science Foundation of China (LY15F010005, Y16F010010) and the K. C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Natural Science Foundation of China under Grants 61271270, 61271021, 61311140262 and U1301257, the National High-tech R&D Program of China (2015AA015901), Zhejiang Provincial Natural Science Foundation of China (LY15F010005, Y16F010010) and the K. C. Wong Magna Fund at Ningbo University.	Amirshahi SA, 2011, INT WORK QUAL MULTIM, P84, DOI 10.1109/QoMEX.2011.6065718; [Anonymous], 2002, SCIENCE; Cai D, 2006, IEEE T IMAGE PROCESS, V15, P3608, DOI 10.1109/TIP.2006.881945; Chang HW, 2013, IEEE T IMAGE PROCESS, V22, P4007, DOI 10.1109/TIP.2013.2266579; Choi SJ, 1999, IEEE T IMAGE PROCESS, V8, P155, DOI 10.1109/83.743851; Han YH, 2013, SIGNAL PROCESS, V93, P2169, DOI 10.1016/j.sigpro.2012.05.036; He X., 2005, ADV NEURAL INFORM PR, V45, P186; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; LI RX, 1994, IEEE T CIRC SYST VID, V4, P438, DOI 10.1109/76.313138; Li SN, 2012, IEEE T CIRC SYST VID, V22, P1100, DOI 10.1109/TCSVT.2012.2190473; Masry M, 2006, IEEE T CIRC SYST VID, V16, P260, DOI 10.1109/TCSVT.2005.861946; Omar H, 2015, J VISION, V15, P9; Park MC, 2015, J DISP TECHNOL, V11, P877, DOI 10.1109/JDT.2015.2389212; Pinson MH, 2004, IEEE T BROADCAST, V50, P312, DOI 10.1109/TBC.2004.834028; Seshadrinathan K, 2010, IEEE T IMAGE PROCESS, V19, P335, DOI 10.1109/TIP.2009.2034992; Seung HS, 2000, SCIENCE, V290, P2268, DOI 10.1126/science.290.5500.2268; Shao F, 2015, IEEE SIGNAL PROC LET, V22, P1548, DOI 10.1109/LSP.2015.2413946; Sheikh HR, 2005, LIVE IMAGE QUALITY D; Silva VD, 2003, ADV NEURAL INFORM PR, V15, P1959; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Song L, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P37, DOI 10.1109/VCIP.2014.7051498; Torkamani-Azar F, 2015, J VIS COMMUN IMAGE R, V27, P1, DOI 10.1016/j.jvcir.2014.12.004; You JY, 2010, INT CONF ACOUST SPEE, P1002, DOI 10.1109/ICASSP.2010.5495313; Zhang F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1329-3; Zhang L, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2426416; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730	26	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175798	10.1371/journal.pone.0175798	http://dx.doi.org/10.1371/journal.pone.0175798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445489	Green Submitted, Green Published, gold			2022-12-27	WOS:000400309200027
J	Chen, J; Huang, CL; Wang, JJ; Zhou, H; Lu, YY; Lou, LH; Zheng, JY; Tian, L; Wang, XP; Cao, ZW; Zeng, Y				Chen, Jing; Huang, Chunlan; Wang, Jingjing; Zhou, Hui; Lu, Yingying; Lou, Lihong; Zheng, Junyuan; Tian, Ling; Wang, Xingpeng; Cao, Zhongwei; Zeng, Yue			Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; TIME-COURSE; INJURY; INFLAMMATION; DYSFUNCTION; HOMEOSTASIS; MECHANISM; NECROSIS; LIVER; MODEL	Objectives Intestinal barrier dysfunction plays an important role in acute necrotizing pancreatitis (ANP) and intestinal microbiota dysbiosis was involved in intestinal barrier failure. Paneth cells protect intestinal barrier and are associated with intestinal microbiota. Here, we investigated changes in intestinal microbiota and antimicrobial peptides of Paneth cells in ileum during ANP. Methods Rats with ANP were established by retrograde injection of 3.5% sodium taurocholate into biliopancreatic duct and sacrificed at 24h and 48h, respectively. Injuries of pancreas and distal ileum were evaluated by histopathological score. Intestinal barrier function was assessed by plasma diamine oxidase activity (DAO) and D-lactate. Systemic and intestinal inflammation was evaluated by TNF alpha, IL-1 beta and IL-17A concentration by ELISA, respectively. 16S rRNA high throughput sequencing on fecal samples was used to investigate the changes in intestinal microbiota in the ANP group at 48h. Lysozyme and alpha-defensin5 were measured by real-time PCR, western blot and immunofluoresence. Results ANP rats had more severe histopathological injuries in pancreas and distal ileum, injured intestinal barrier and increased expression of TNFa, IL-1 beta and IL-17A in plasma and distal ileum compared with those of the sham-operated (SO) group. Principal component analysis (PCA) showed structural segregation between the SO and ANP groups. Operational taxonomic unit (OTU) number and ACE index revealed decreased microbiota diversity in the ANP group. Taxonomic analysis showed dysbiosis of intestinal microbiota structure. At phyla level, Saccharibacteria and Tenericutes decreased significantly. At genus level, Escherichia-Shigella and Phascolarctobacterium increased significantly, while Candidatus_Saccharimonas, Prevotellaceae_UCG-001, Lachnospiraceae_UCG-001, Ruminiclostridium_ 5 and Ruminococcaceae_UCG-008 decreased significantly. Lysozyme and alpha-defensin5 mRNA expression levels decreased significantly in ANP group at 48h. Protein expression of lysozyme decreased in ANP groups at 24h and 48h. Meanwhile, the relative abundance of Escherichia-Shigella correlated inversely with the decrease in lysozyme. Conclusion The disorder in intestinal microbiota and decreases of Paneth cell antimicrobial peptides might participate in the pathogenesis of intestinal barrier dysfunction during ANP.	[Chen, Jing; Huang, Chunlan; Zhou, Hui; Lu, Yingying; Zheng, Junyuan; Wang, Xingpeng; Cao, Zhongwei; Zeng, Yue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Wang, Jingjing; Tian, Ling; Zeng, Yue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Lou, Lihong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Int Med Care Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cao, ZW; Zeng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai, Peoples R China.; Zeng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China.	caozhongwei@medmail.com.cn; zengyue1610@163.com	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022		medical-engineering cross project of Shanghai Jiao Tong university [YG2015MS29, YG2014ZD10]; Natural Science Foundation for Young Scholars of China [81600500]	medical-engineering cross project of Shanghai Jiao Tong university; Natural Science Foundation for Young Scholars of China	This study was supported by funds from the medical-engineering cross project of Shanghai Jiao Tong university (YG2015MS29, YG2014ZD10) (URL: http//kejichu.sjtu.edu.cn/) and Natural Science Foundation for Young Scholars of China (81600500) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bashashati M, 2015, CURR DRUG TARGETS, V16, P199, DOI 10.2174/1389450116666150120104012; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P484; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Dowds CM, 2015, CLIN IMMUNOL, V159, P128, DOI 10.1016/j.clim.2015.05.008; Fernandez MI, 2008, J IMMUNOL, V180, P4924, DOI 10.4049/jimmunol.180.7.4924; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Grootjans J, 2011, GASTROENTEROLOGY, V140, P529, DOI 10.1053/j.gastro.2010.10.040; Hodin CM, 2011, AM J PATHOL, V179, P2885, DOI 10.1016/j.ajpath.2011.08.030; Liang HY, 2014, J DIGEST DIS, V15, P386, DOI 10.1111/1751-2980.12148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26337; Mooney JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14603; Oto J, 2013, CRIT CARE, V17, DOI 10.1186/cc13169; Park SW, 2012, J IMMUNOL, V189, P5421, DOI 10.4049/jimmunol.1200581; Park SW, 2011, LAB INVEST, V91, P63, DOI 10.1038/labinvest.2010.151; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu ZY, 2016, INFLAMM RES, V65, P647, DOI 10.1007/s00011-016-0947-9; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Schwarz M, 2000, SURGERY, V127, P427, DOI 10.1067/msy.2000.104116; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen YF, 2012, INFLAMM RES, V61, P743, DOI 10.1007/s00011-012-0467-1; Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49; Surbatovic M, 2013, J CLIN GASTROENTEROL, V47, P637, DOI 10.1097/MCG.0b013e31828a6cfc; Tan CC, 2015, PANCREAS, V44, P868, DOI 10.1097/MPA.0000000000000355; Teltschik Z, 2012, HEPATOLOGY, V55, P1154, DOI 10.1002/hep.24789; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wang YL, 2009, J DIGEST DIS, V10, P30, DOI 10.1111/j.1751-2980.2008.00360.x; Wang YL, 2015, CELL BIOCHEM BIOPHYS, V71, P765, DOI 10.1007/s12013-014-0261-5; Xu GD, 2014, J APPL MATH, DOI 10.1155/2014/568697; Zhang XP, 2007, WORLD J GASTROENTERO, V13, P4566, DOI 10.3748/wjg.v13.i34.4566; Zhang Xi-ping, 2007, Journal of Zhejiang University-Science B, V8, P888, DOI 10.1631/jzus.2007.B0888; Zhang Z, 2016, SCI CHINA LIFE SCI, V59, P463, DOI 10.1007/s11427-016-5018-5	34	66	76	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176583	10.1371/journal.pone.0176583	http://dx.doi.org/10.1371/journal.pone.0176583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441432	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800068
J	Wang, J; Zhou, X; Liu, Y; Li, Z; Li, X				Wang, Jin; Zhou, Xu; Liu, Yu; Li, Zheng; Li, Xiang			Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PRETREATMENT NEUTROPHIL; STATISTICAL-METHODS; MONOCYTE RATIO; LUNG-CANCER; INFLAMMATION; PERFORMANCE; RITUXIMAB; PD-1	Background Neutrophil-to-lymphocyte ratio (NLR) has been investigated as a prognostic marker in patients with diffuse large B-cell lymphoma (DLBCL); however, the results remain controversial. This study aimed to explore the association between NLR and survival outcomes and clinicopathological factors in DLBCL. Methods Relevant studies were retrieved by searching PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI) databases. The last search was updated on February 17, 2017. Hazard ratios (HRs) and odds ratios (ORs) and their 95% confidence intervals (CIs) were used as effective measures in the meta-analysis. Random-effects models and fixed-effects models were used for analyses. Meta-regression was performed. Publication bias was assessed using Begg's test. Stata version 12.0 was used for all analyses. Results A total of 9 studies with 2297 patients were included in the meta-analysis. The pooled results showed that NLR was a significant indicator for poor overall survival (OS) (HR = 1.84, 95% CI = 1.52-2.22, p<0.001) and poor progression-free survival (PFS) (HR = 1.64, 95% CI = 1.36-1.98, p<0.001). NLR remained a significant biomarker for OS and PFS regardless of location, sample size or cut-off value. In addition, high NLR was also associated with Ann Arbor stage (OR = 2.09, 95% CI = 1.14-3.81, p = 0.017), lactate dehydrogenase level (OR = 2.74, 95% CI = 1.16-6.46, p = 0.021), extranodal disease (OR = 1.63, 95% CI = 1.06-2.52, p = 0.027), and International Prognostic Index score (OR = 2.44, 95% CI = 1.03-5.08, p = 0.043). However, NLR was found to have no significant association with sex (OR = 0.89, 95% CI = 0.71-1.11, p = 0.29), age (OR = 1.18, 95% CI = 0.94-1.48, p = 0.152), European Cooperative Oncology Group performance status score (OR = 1.78, 95% CI = 0.71-4.46, p = 0.217), or presence of B symptoms (OR = 1.56, 95% CI = 0.7-3.48, p = 0.278). Conclusion In conclusion, our meta-analysis demonstrated that NLR has a strong association with worse OS and PFS in patients with DLBCL. NLR could be recommended as an inexpensive prognostic biomarker in DLBCL.	[Wang, Jin; Zhou, Xu; Liu, Yu; Li, Zheng; Li, Xiang] Third Mil Med Univ, Daping Hosp, Dept Hematol, Inst Surg Res, Chongqing, Peoples R China	Army Medical University	Wang, J (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Hematol, Inst Surg Res, Chongqing, Peoples R China.	bdu811@163.com						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Asano Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153459; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Chen J, 2015, FEBS OPEN BIO, V5, P502, DOI 10.1016/j.fob.2015.05.003; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dong YW, 2016, ONCOTARGETS THER, V9, P3127, DOI 10.2147/OTT.S103031; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Feng JH, 2012, INT J HEMATOL, V95, P143, DOI 10.1007/s12185-011-0993-6; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep12493; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho CL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000993; Hong JY, 2016, HEMATOLOGICAL ONCOLO; Hu KM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006404; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Keam B, 2015, LEUKEMIA LYMPHOMA, V56, P2032, DOI 10.3109/10428194.2014.982642; Koh YW, 2012, AM J CLIN PATHOL, V138, P846, DOI 10.1309/AJCPO46GFKGNXCBR; Kong SY, 2014, BLOOD, V124; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Lin BC, 2015, LEUKEMIA LYMPHOMA, V56, P2563, DOI 10.3109/10428194.2015.1014367; Luo Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001670; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Melchardt T, 2015, J NATL COMPR CANC NE, V13, P1501, DOI 10.6004/jnccn.2015.0178; Ming Z, 2015, J LEUKEMIA LYMPHOMA, V24, P460; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Ni Jing, 2016, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V24, P427, DOI 10.7534/j.issn.1009-2137.2016.02.022; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Porrata LF, 2010, AM J HEMATOL, V85, P896, DOI 10.1002/ajh.21849; Salazar-Onfray F, 2007, CYTOKINE GROWTH F R, V18, P171, DOI 10.1016/j.cytogfr.2007.01.015; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sehn LH, 2009, LEUKEMIA LYMPHOMA, V50, P1744, DOI 10.3109/10428190903308064; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Spassov B, 2015, HAEMATOLOGICA, V100, P664; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sun HL, 2016, ONCOTARGETS THER, V9, P3017, DOI 10.2147/OTT.S96910; Sun JX, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/7862469; Sun XD, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/4743808; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Wang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004893; Wang JX, 2017, ONCOTARGET, V8, P5414, DOI 10.18632/oncotarget.14289; Xiao WK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-117; Yin YM, 2015, CLINICS, V70, P524, DOI 10.6061/clinics/2015(07)10; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111906; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	50	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176008	10.1371/journal.pone.0176008	http://dx.doi.org/10.1371/journal.pone.0176008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441396	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800017
J	Claydon, J; Sur, A; Callejas, A; Ladd, M; Kwan, E; Taylor, R; Turvey, SE; Solimano, A; Lavoie, PM; Marr, N				Claydon, Jennifer; Sur, Amitava; Callejas, Allison; Ladd, Mihoko; Kwan, Eddie; Taylor, Richard; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.; Marr, Nico			Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; PHARMACOKINETICS; INFECTION; CHILDREN; HEART	Background Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in atrisk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing serum antibodies (NAb) against RSV in at-risk infants who had received an abbreviated course of palivizumab prophylaxis. Methods Serum samples were collected from infants enrolled in the RSV Immunoprophylaxis Program in British Columbia, Canada over 2 consecutive RSV seasons (2013 to 2015). Infants in this program had received an abbreviated course of palivizumab in accordance with the provincial guidelines. Data were compared to adults and infants less than 12 months of age who did not receive palivizumab. Anti-RSV NAb titers were measured using an RSV microneutralization assay. Findings Infants who received palivizumab had anti-RSV NAb titers at the end of the RSV season that persisted beyond what is expected from the pharmacokinetics of palivizumab alone. Moreover, 54% of the control infants who did not receive palivizumab and all tested adults had protective anti-RSV NAb titers. Conclusions Based on our observations, we hypothesize that naturally acquired NAb provide additive protection, which may significantly reduce the need for additional doses of palivizumab in infants at risk of severe RSV infections.	[Claydon, Jennifer; Ladd, Mihoko; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.; Marr, Nico] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Claydon, Jennifer; Ladd, Mihoko; Turvey, Stuart E.; Lavoie, Pascal M.; Marr, Nico] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Sur, Amitava; Callejas, Allison; Kwan, Eddie; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Taylor, Richard] Univ Victoria, Dept Pediat, Victoria, BC, Canada; [Marr, Nico] Canadian Ctr Vaccinol, Halifax, NS, Canada; [Marr, Nico] Sidra Med & Res Ctr, Doha, Qatar	University of British Columbia; BC Women's Hospital & Health Centre; University of Victoria; Sidra Medical & Research Center	Marr, N (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.; Marr, N (corresponding author), BC Childrens Hosp Res Inst, Vancouver, BC, Canada.; Marr, N (corresponding author), Canadian Ctr Vaccinol, Halifax, NS, Canada.; Marr, N (corresponding author), Sidra Med & Res Ctr, Doha, Qatar.	nmarr@sidra.org	Marr, Nico/T-7741-2019; Turvey, Stuart/HGV-1191-2022	Marr, Nico/0000-0002-1927-7072; Lavoie, Pascal/0000-0002-2205-0362; Turvey, Stuart/0000-0003-1599-1065; Callejas, Allison/0000-0001-9590-2880	British Columbia Lung Association; Sandra Schmirier Foundation; Canadian Institutes of Health Research	British Columbia Lung Association; Sandra Schmirier Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the British Columbia Lung Association (to NM), the Sandra Schmirier Foundation (to A. Sur, AC and NM), and the Canadian Institutes of Health Research (to PML and SET). SET holds the Aubrey J. Tingle Professorship in Pediatric Immunology and both SET and PML are clinical scholars of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; DESIERRA TM, 1993, J PEDIATR-US, V122, P787, DOI 10.1016/S0022-3476(06)80027-2; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Gutfraind A, 2015, JAMA PEDIATR, V169, P341, DOI 10.1001/jamapediatrics.2014.3804; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Krajden M, 2009, CLIN VACCINE IMMUNOL, V16, P1840, DOI 10.1128/CVI.00238-09; Kwilas AR, 2010, J VIROL, V84, P7770, DOI 10.1128/JVI.00346-10; La Via WV, 2013, PULM PHARMACOL THER, V26, P666, DOI 10.1016/j.pupt.2013.03.007; Lavoie PM, 2016, JAMA PEDIATR, V170, P174, DOI 10.1001/jamapediatrics.2015.3235; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Meissner HC, 2016, NEW ENGL J MED, V374, P1793, DOI 10.1056/NEJMc1601509; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Robbie GJ, 2012, ANTIMICROB AGENTS CH, V56, P4927, DOI 10.1128/AAC.06446-11; Saez-Llorens X, 1998, PEDIATR INFECT DIS J, V17, P787, DOI 10.1097/00006454-199809000-00007; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; Wang EEL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e9	18	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176152	10.1371/journal.pone.0176152	http://dx.doi.org/10.1371/journal.pone.0176152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437470	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600031
J	Jun, JE; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Lee, MK; Kim, JH				Jun, Ji Eun; Lee, Seung-Eun; Lee, You-Bin; Jee, Jae Hwan; Bae, Ji Cheol; Jin, Sang-Man; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon			Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BETA-CELL FUNCTION; OXIDATIVE STRESS; INSULIN-RESISTANCE; ANTIOXIDANT PROPERTIES; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; POPULATION; PREDICTION	Aim Serum albumin concentration is associated with both type 2 diabetes and metabolic syndrome (MetS). We sought to investigate whether baseline serum albumin and change in serum albumin could be independent risk factors for prediabetes in subjects without MetS. We further examined the effect of serum albumin on progression to overt diabetes in subjects who developed prediabetes. Methods Among 10,792 participants without diabetes and MetS who consecutively underwent yearly health check-ups over six years, 9,807 subjects without incident MetS were enrolled in this longitudinal retrospective study. The risk of developing prediabetes (impared fasting glucose or hemoglobin A1c) was analyzed according to baseline and percent change in serum albumin concentration using Cox regression analysis. Serial changes in serum albumin concentration were measured from baseline to one year before prediabetes diagnosis, and then from the time of prediabetes diagnosis to progression to overt diabetes or final follow-up. Results A total of 4,398 incident cases of prediabetes developed during 35,807 person-years (median 3.8 years). The hazard ratio for incident prediabetes decreased as percent change in serum albumin concentration (quartiles and per 1%) increased in a crude and fully adjusted model. However, baseline serum albumin concentration itself was not associated with prediabetic risk. Serum albumin levels kept increasing until the end of follow-up in prediabetic subjects who returned to normal glycemic status, whereas these measures did not change in prediabetic subjects who developed type 2 diabetes. Serum albumin concentration measured at the end of follow-up was the highest in the regression group, compared to the stationary (p = 0.014) or progression groups (p = 0.009). Conclusions Increase in serum albumin concentration might protect against early glycemic deterioration and progression to type 2 diabetes even in subjects without MetS.	[Jun, Ji Eun; Lee, Seung-Eun; Lee, You-Bin; Jin, Sang-Man; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Med,Div Endocrinol & Metab, Chang Won, South Korea; [Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea.; Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea.	jaehyeon@skku.edu	Jin, Sang-Man/AFO-5933-2022	Lee, You-Bin/0000-0003-4058-1738				Abbasi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051496; Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Bossard M, 2014, INT J CARDIOL, V171, pE24, DOI 10.1016/j.ijcard.2013.11.125; Busher JT, 1990, SERUM ALBUMIN GLOBUL, V3rd; Candiano G, 2009, J PROTEOMICS, V73, P188, DOI 10.1016/j.jprot.2009.06.006; Cho Hye Min, 2012, J Prev Med Public Health, V45, P98, DOI 10.3961/jpmph.2012.45.2.98; Dohi Y, 2007, INT J CARDIOL, V115, P63, DOI 10.1016/j.ijcard.2006.04.006; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244; GUTTERIDGE JMC, 1986, BIOCHIM BIOPHYS ACTA, V869, P119, DOI 10.1016/0167-4838(86)90286-4; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Ishizaka N, 2007, ATHEROSCLEROSIS, V193, P373, DOI 10.1016/j.atherosclerosis.2006.06.031; Jin SM, 2016, METABOLISM, V65, P1629, DOI 10.1016/j.metabol.2016.08.006; Kunutsor SK, 2015, DIABETOLOGIA, V58, P961, DOI 10.1007/s00125-015-3520-0; Maschirow L, 2015, CLIN BIOCHEM, V48, P581, DOI 10.1016/j.clinbiochem.2015.02.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Nwose EU, 2006, REDOX REP, V11, P99, DOI 10.1179/135100006X116583; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Park S, 2013, CLIN ENDOCRINOL, V79, P65, DOI 10.1111/j.1365-2265.2012.04512.x; Rao MS, 2012, NITTE UNIV J HEALTH, V2, P18; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Sitar ME, 2013, CLIN LAB, V59, P945, DOI 10.7754/Clin.Lab.2012.121115; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59	28	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176209	10.1371/journal.pone.0176209	http://dx.doi.org/10.1371/journal.pone.0176209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430803	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100033
J	Lefevre, EM; Medley, GA; Reeks, T; Alexander, S; Burne, THJ; Eyles, DW				Lefevre, Emilia M.; Medley, Gregory A.; Reeks, Timothy; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.			Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation	PLOS ONE			English	Article							INDUCED CORTICOSTERONE SECRETION; COCAINE-INDUCED SENSITIZATION; STRESS-INDUCED SENSITIZATION; TYROSINE-HYDROXYLASE GENE; MESSENGER-RNA; NEUROENDOCRINE RESPONSES; PLASMA-CORTICOSTERONE; ENVIRONMENTAL CONTEXT; NUCLEUS-ACCUMBENS; RAT-BRAIN	Stress is known to modulate sensitisation to repeated psychostimulant exposure. However, there is no direct evidence linking glucocorticoids and sensitisation achieved by repeated administration of the NMDA receptor antagonist MK-801. We tested the hypothesis that co-administration of RU486, a glucocorticoid receptor (GR) antagonist, prior to repeated daily MK-801 injections would block the expression of locomotor sensitisation due to its dual effects on corticosterone and dopamine. We employed a repeated MK-801 administration locomotor sensitisation paradigm in male Sprague Dawley rats. RU486 or a dimethyl sulfoxide (DMSO) vehicle was co-administered with MK-801 or saline during the induction phase. Subsequent to withdrawal, rats were challenged with MK-801 alone to test for the expression of sensitisation. In a separate cohort of rats, plasma corticosterone levels were quantified from blood samples taken on the 1(st), 4(th) and 7(th) day of induction and at expression. One day after challenge, nucleus accumbens tissue levels of dopamine and its metabolites DOPAC and HVA were measured. During the induction phase, RU486 progressively enhanced locomotor sensitisation to MK-801. RU486 and MK-801 both showed stimulatory effects on corticosterone levels and this was further augmented when given in combination. Contrary to our hypothesis, RU486 did not block the expression of locomotor sensitisation to MK-801 and actually increased levels of dopamine, DOPAC and HVA in nucleus accumbens tissue. Our results showed that RU486 has augmentative rather than inhibitory effects on MK-801-induced sensitisation. This study indicates a divergent role for glucocorticoids in sensitisation to MK-801 compared to sensitisation with other psychostimulants.	[Lefevre, Emilia M.; Medley, Gregory A.; Reeks, Timothy; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Medley, Gregory A.; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research	Eyles, DW (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.; Eyles, DW (corresponding author), Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia.	eyles@uq.edu.au	Eyles, Darryl W/X-3386-2018; Burne, Thomas H/C-5656-2009	Eyles, Darryl W/0000-0002-5023-7095; Burne, Thomas H/0000-0003-3502-9789; Lefevre, Emilia/0000-0002-6116-4549; Medley, Gregory/0000-0002-7462-9536	National Health and Medical Research Council [1024239]; NHMRC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Health and Medical Research Council [https://www.nhmrc.gov.au/] Grant # 1024239 to Darryl Eyles & Thomas Burne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NHMRC project grant 1024239.	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Barrot M, 2000, EUR J NEUROSCI, V12, P973, DOI 10.1046/j.1460-9568.2000.00996.x; Baulieu E-E, 1985, ANTIPROGESTIN STEROI, pix; Baumann MH, 2000, DRUG ALCOHOL DEPEN, V59, P143, DOI 10.1016/S0376-8716(99)00113-1; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BOROWSKY B, 1991, BRAIN RES, V543, P301, DOI 10.1016/0006-8993(91)90041-S; CARLSSON A, 1973, J PHARM PHARMACOL, V25, P437, DOI 10.1111/j.2042-7158.1973.tb09129.x; CRISWELL HE, 1993, J PHARMACOL EXP THER, V265, P1001; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; DAYANITHI G, 1989, ENDOCRINOLOGY, V125, P308, DOI 10.1210/endo-125-1-308; de Jong IEM, 2007, BEHAV BRAIN RES, V177, P329, DOI 10.1016/j.bbr.2006.11.015; de Jong IEM, 2009, PSYCHOPHARMACOLOGY, V204, P693, DOI 10.1007/s00213-009-1498-3; de Jong IEM, 2009, EUR J PHARMACOL, V604, P66, DOI 10.1016/j.ejphar.2008.12.026; DeBattista C, 2006, TRENDS ENDOCRIN MET, V17, P117, DOI 10.1016/j.tem.2006.02.006; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Donoghue K, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0757-1; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; FOSSOM LH, 1992, MOL PHARMACOL, V42, P898; Gallagher P, 2005, BIOL PSYCHIAT, V57, P155, DOI 10.1016/j.biopsych.2004.10.017; Gallagher Peter, 2006, Neuropsychiatr Dis Treat, V2, P33; Garcia-Keller C, 2013, EUR J NEUROSCI, V37, P982, DOI 10.1111/ejn.12121; Hagerty T, 2001, J NEUROCHEM, V76, P825, DOI 10.1046/j.1471-4159.2001.00072.x; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; HOWLAND RH, 2013, J PSYCHOSOC NURS MEN, V51, P13; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; KAKIHANA R, 1968, NATURE, V218, P360, DOI 10.1038/218360a0; KALIVAS PW, 1993, BEHAV PHARMACOL, V4, P315; KNYCH ET, 1979, NEUROENDOCRINOLOGY, V29, P110, DOI 10.1159/000122912; LEE S, 1994, MOL BRAIN RES, V24, P192, DOI 10.1016/0169-328X(94)90132-5; Lefevre EM, 2016, BEHAV BRAIN RES, V298, P241, DOI 10.1016/j.bbr.2015.11.014; LEVY AD, 1992, LIFE SCI, V51, P887, DOI 10.1016/0024-3205(92)90396-7; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; McCullers DL, 2001, J NEUROSCI RES, V64, P277; Mihic SJ, 1999, NEUROCHEM INT, V35, P115, DOI 10.1016/S0197-0186(99)00053-4; MILANES MV, 1993, NEUROPEPTIDES, V24, P279, DOI 10.1016/0143-4179(93)90016-4; Moldow RL, 2005, NEUROSCI LETT, V374, P25, DOI 10.1016/j.neulet.2004.10.016; Nelson AM, 2010, NEUROSCI LETT, V476, P9, DOI 10.1016/j.neulet.2010.03.032; PECHNICK RN, 1990, J PHARMACOL EXP THER, V254, P344; PECHNICK RN, 1989, EUR J PHARMACOL, V164, P257, DOI 10.1016/0014-2999(89)90466-4; Prasad BM, 1996, PSYCHOPHARMACOLOGY, V125, P265, DOI 10.1007/BF02247338; Przegalinski E, 2000, J PHYSIOL PHARMACOL, V51, P193; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; van der Veen R, 2013, PSYCHOPHARMACOLOGY, V230, P547, DOI 10.1007/s00213-013-3176-8; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZZANI A, 1989, J PHARMACOL EXP THER, V249, P278; WEDZONY K, 1994, BRAIN RES, V657, P351, DOI 10.1016/0006-8993(94)90991-1; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; WOLF ME, 1993, BEHAV PHARMACOL, V4, P429	53	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176156	10.1371/journal.pone.0176156	http://dx.doi.org/10.1371/journal.pone.0176156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430805	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100028
J	Agrawal, V; Coroller, TP; Hou, Y; Lee, SW; Romano, JL; Baldini, EH; Chen, AB; Kozono, D; Swanson, SJ; Wee, JO; Aerts, HJWL; Mak, RH				Agrawal, Vishesh; Coroller, Thibaud P.; Hou, Ying; Lee, Stephanie W.; Romano, John L.; Baldini, Elizabeth H.; Chen, Aileen B.; Kozono, David; Swanson, Scott J.; Wee, Jon O.; Aerts, Hugo J. W. L.; Mak, Raymond H.			Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; INDUCTION CHEMOTHERAPY; TUMOR VOLUME; SURGICAL RESECTION; PROGNOSTIC-FACTORS; RADIATION-THERAPY; RADIOTHERAPY; TRIAL; NUMBER; CHEMORADIATION	Background Locally advanced non-small cell lung cancer (LA-NSCLC) patients have poorer survival and local control with mediastinal node (N2) tumor involvement at resection. Earlier assessment of nodal burden could inform clinical decision-making prior to surgery. This study evaluated the association between clinical outcomes and lymph node volume before and after neoadjuvant therapy. Materials and methods CT imaging of patients with operable LA-NSCLC treated with chemoradiation and surgical resection was assessed. Clinically involved lymph node stations were identified by FDG-PET or mediastinoscopy. Locoregional recurrence (LRR), distant metastasis (DM), progression free survival (PFS) and overall survival (OS) were analyzed by the Kaplan Meier method, concordance index and Cox regression. Results 73 patients with Stage IIIA-IIIB NSCLC treated with neoadjuvant chemoradiation and surgical resection were identified. The median RT dose was 54 Gy and all patients received concurrent chemotherapy. Involved lymph node volume was significantly associated with LRR and OS but not DM on univariate analysis. Additionally, lymph node volume greater than 10.6 cm 3 after the completion of preoperative chemoradiation was associated with increased LRR (p<0.001) and decreased OS (p = 0.04). There was no association between nodal volumes and nodal clearance. Conclusion For patients with LA-NSCLC, large volume nodal disease post-chemoradiation is associated with increased risk of locoregional recurrence and decreased survival. Nodal volume can thus be used to further stratify patients within the heterogeneous Stage IIIA-IIIB population and potentially guide clinical decision-making.	[Agrawal, Vishesh; Coroller, Thibaud P.; Hou, Ying; Lee, Stephanie W.; Romano, John L.; Baldini, Elizabeth H.; Chen, Aileen B.; Kozono, David; Aerts, Hugo J. W. L.; Mak, Raymond H.] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Agrawal, Vishesh; Coroller, Thibaud P.; Baldini, Elizabeth H.; Chen, Aileen B.; Kozono, David; Swanson, Scott J.; Wee, Jon O.; Aerts, Hugo J. W. L.; Mak, Raymond H.] Harvard Med Sch, Boston, MA 02115 USA; [Swanson, Scott J.; Wee, Jon O.] Brigham & Womens Hosp, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Mak, RH (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA.; Mak, RH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	rmak@partners.org	Aerts, Hugo/ABF-2821-2020	Aerts, Hugo/0000-0002-2122-2003; Mak, Raymond/0000-0002-8754-0565; Coroller, Thibaud/0000-0001-7662-8724	National Institutes of Health [NIH-USA U24CA194354, NIH-USA U01CA190234]; Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; NATIONAL CANCER INSTITUTE [U24CA194354, U01CA190234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234). This project was partially funded by the Kaye Scholar Award and the Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant.; This work was supported by the National Institutes of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234). This project was partially funded by the Kaye Scholar Award and the Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant.	Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880, DOI 10.1200/JCO.1995.13.8.1880; Alexander BM, 2011, INT J RADIAT ONCOL, V79, P1381, DOI 10.1016/j.ijrobp.2009.12.060; Amini A, 2013, ANN SURG ONCOL, V20, P1934, DOI 10.1245/s10434-012-2800-x; Andre F, 2000, J CLIN ONCOL, V18, P2981, DOI 10.1200/JCO.2000.18.16.2981; Arslan D, 2015, J BUON, V20, P573; Asamura H, 2015, J THORAC ONCOL, V10, P1675, DOI 10.1097/JTO.0000000000000678; Basaki K, 2006, INT J RADIAT ONCOL, V64, P449, DOI 10.1016/j.ijrobp.2005.07.967; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berghmans Thierry, 2011, Ther Adv Med Oncol, V3, P127, DOI 10.1177/1758834011401951; Betticher DC, 2003, J CLIN ONCOL, V21, P1752, DOI 10.1200/JCO.2003.11.040; Bezjak A, 2015, J CLIN ONCOL, V33, P2100, DOI 10.1200/JCO.2014.59.2360; Bueno R, 2000, ANN THORAC SURG, V70, P1826, DOI 10.1016/S0003-4975(00)01585-X; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Friedel G, 2010, J CLIN ONCOL, V28, P942, DOI 10.1200/JCO.2008.21.7810; Fukui T, 2006, J THORAC ONCOL, V1, P120, DOI 10.1097/01243894-200602000-00004; Jaklitsch MT, 2006, J SURG ONCOL, V94, P599, DOI 10.1002/jso.20644; Lee JG, 2008, ANN THORAC SURG, V85, P211, DOI 10.1016/j.athoracsur.2007.08.020; Ohri N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv004; Sawabata N, 2003, LUNG CANCER-J IASLC, V42, P69, DOI 10.1016/S0169-5002(03)00245-9; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Speicher PJ, 2015, EUR J CARDIO-THORAC, V47, P636, DOI 10.1093/ejcts/ezu270; Stinchcombe TE, 2006, LUNG CANCER, V52, P67, DOI 10.1016/j.lungcan.2005.11.008; Suntharalingam M, 2012, INT J RADIAT ONCOL, V84, P456, DOI 10.1016/j.ijrobp.2011.11.069; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; van Meerbeeck JP, 2007, JNCI-J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093	28	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174268	10.1371/journal.pone.0174268	http://dx.doi.org/10.1371/journal.pone.0174268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426673	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900008
J	Lukies, MW; Watanabe, Y; Tanaka, H; Takahashi, H; Ogata, S; Omura, K; Yorifuji, S; Tomiyama, N				Lukies, Matthew W.; Watanabe, Yoshiyuki; Tanaka, Hisashi; Takahashi, Hiroto; Ogata, Soshiro; Omura, Kayoko; Yorifuji, Shiro; Tomiyama, Noriyuki		Osaka Univ Twin Res Grp	Heritability of brain volume on MRI in middle to advanced age: A twin study of Japanese adults	PLOS ONE			English	Article							CORTICAL SURFACE-AREA; ENVIRONMENTAL CONTRIBUTIONS; GENETIC-ANALYSIS	Brain atrophy is part of the aging process and accelerated by neurodegenerative diseases, so an understanding of the background heritability of brain volume is essential. The purpose of this study was to determine the heritability of brain volume in middle to advanced age East Asian adults, an age group less studied and an ethnicity not previously studied. 3T magnetic resonance images were obtained and volumetric analyses conducted for a total of 74 individuals, 20 monozygotic twin pairs (mean age 61y min 41y max 75y) and 17 dizygotic twin pairs (mean age 64y min 41y max 85y). Total brain volume and a further seven regions were assessed, including lobar volumes, lateral divisions, and separated grey and white matter. Additive genetics and unique environment (AE) models for global brain volumes including total brain (90%), grey matter (91%) and white matter (84%) and many lobar volumes demonstrated high heritability in our study population. Our results present the heritability of brain volume in middle to advanced age as possibly higher in East Asian adults.	[Lukies, Matthew W.; Watanabe, Yoshiyuki; Tanaka, Hisashi; Takahashi, Hiroto; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka, Japan; [Ogata, Soshiro] Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, Suita, Osaka, Japan; [Ogata, Soshiro; Osaka Univ Twin Res Grp] Osaka Univ, Grad Sch Med, Twin Res Grp, Suita, Osaka, Japan; [Omura, Kayoko] Mie Prefectural Nursing Coll, Dept Publ Hlth & Community Nursing, Tsu, Mie, Japan; [Yorifuji, Shiro] Osaka Univ, Med Sch, Div Funct Diagnost Sci, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Watanabe, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka, Japan.	watanabe@radiol.osaka-u.ac.jp		Tanaka, Hisashi/0000-0002-6148-0672; Lukies, Matthew/0000-0001-6746-1184	Ministry of Education, Science, Sports and Culture of Japan; Japanese Society for the Promotion of Science KAKENHI [15J03698]; Japan Society for the Promotion of Science [15K12701]; JSPS KAKENHI [15J03698, 15K12701]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Osaka University Center for Twin Research is supported as part of a Management Expenses Grant from the Ministry of Education, Science, Sports and Culture of Japan. This study was supported by the Japanese Society for the Promotion of Science KAKENHI grant number 15J03698 (author Soshiro Ogata only); Japan Society for the Promotion of Science grant number 15K12701 (author ShiroYorifuji); Osaka University Center for Twin Research is supported as part of a Management Expenses Grant from the Ministry of Education, Science, Sports and Culture of Japan.; Osaka University Center for Twin Research is supported as part of a Management Expenses Grant from the Ministry of Education, Science, Sports and Culture of Japan.; This study was supported by JSPS KAKENHI, Grant Number 15K12701 and 15J03698.	Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Batouli SAH, 2014, AGEING RES REV, V13, P1, DOI 10.1016/j.arr.2013.10.003; Batouli SAH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.10.079; Bohlken MM, 2014, HUM BRAIN MAPP, V35, P5295, DOI 10.1002/hbm.22550; Brouwer RM, 2014, NEUROIMAGE, V100, P676, DOI 10.1016/j.neuroimage.2014.04.072; Chee MWL, 2009, NEUROIMAGE, V46, P257, DOI 10.1016/j.neuroimage.2009.01.036; Chen CH, 2013, P NATL ACAD SCI USA, V110, P17089, DOI 10.1073/pnas.1308091110; Creavin ST, 2016, COCHRANE DB SYST REV, V1; DeStefano AL, 2009, ALZ DIS ASSOC DIS, V23, P218, DOI 10.1097/WAD.0b013e31819cadd8; Eyler LT, 2011, CEREB CORTEX, V21, P2313, DOI 10.1093/cercor/bhr013; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Gilmore JH, 2010, HUM BRAIN MAPP, V31, P1174, DOI 10.1002/hbm.20926; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Hulshoff-Pol HE, 2006, J NEUROSCI, V26, P10235, DOI 10.1523/JNEUROSCI.1312-06.2006; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Jansen AG, 2015, NEUROPSYCHOL REV, V25, P27, DOI 10.1007/s11065-015-9278-9; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kuusisto H, 2012, MED LITH, V48, P437; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lessov-Schlaggar CN, 2012, NEUROBIOL AGING, V33, P636, DOI 10.1016/j.neurobiolaging.2010.06.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miyahira Yoshinao, 2004, Seishin Shinkeigaku Zasshi, V106, P138; Mohr A, 2004, COGNITIVE BRAIN RES, V20, P106, DOI 10.1016/j.cogbrainres.2004.02.001; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Posthuma D, 2000, BEHAV GENET, V30, P311, DOI 10.1023/A:1026501501434; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Takao H, 2012, EUR J RADIOL, V81, P2801, DOI 10.1016/j.ejrad.2011.10.011; Tang Y, 2001, J NEUROIMAGING, V11, P393, DOI 10.1111/j.1552-6569.2001.tb00068.x; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wallace GL, 2006, J CHILD PSYCHOL PSYC, V47, P987, DOI 10.1111/j.1469-7610.2006.01676.x; Wright IC, 2002, NEUROIMAGE, V17, P256, DOI 10.1006/nimg.2002.1163; Yoon U, 2011, NEUROSCI LETT, V493, P8, DOI 10.1016/j.neulet.2011.01.070	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175800	10.1371/journal.pone.0175800	http://dx.doi.org/10.1371/journal.pone.0175800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426696	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900049
J	Saghafipour, A; Vatandoost, H; Zahraei-Ramazani, AR; Yaghoobi-Ershadi, MR; Rassi, Y; Jooshin, MK; Shirzadi, MR; Akhavan, AA				Saghafipour, Abedin; Vatandoost, Hassan; Zahraei-Ramazani, Ali Reza; Yaghoobi-Ershadi, Mohammad Reza; Rassi, Yavar; Jooshin, Moharram Karami; Shirzadi, Mohammad Reza; Akhavan, Amir Ahmad			Control of zoonotic cutaneous leishmaniasis vector, Phlebotomus papatasi, using attractive toxic sugar baits (ATSB)	PLOS ONE			English	Article							NONTARGET ORGANISMS; MALARIA VECTORS; SAND FLIES; FOCUS; ENVIRONMENTS; PSYCHODIDAE; VEGETATION; DIPTERA; FLORIDA; IRAN	Introduction Attractive Toxic Sugar Baits (ATSB) is a new vector control method that meets Integrated Vector Management (IVM) goals. In an experimental design, this study aimed to determine effects of ATSB on control of Phlebotomus papatasi, as a main vector of Zoonotic Cutaneous Leishmaniasis (ZCL), in Qom Province, center of Iran. Methods In a cross-sectional design, boric acid was mixed with brown sugar solution and tested as toxic baits for P. papatasi. Two methods were utilized to use the baits: (a) spraying ATSB on vegetation, bushes, and shrubs; and (b) setting ATSB-treated barrier fences in front of colonies at 500 m distance from the houses in outskirts of villages. In order to examine the residual efficacy rate of ATSB-treated barrier fences, the bioassay test was used. Density of P. papatasi sandflies was measured using sticky and light traps biweekly. For data analysis, Mann-Whitney U Test and Kruskal-Wallis were used. Results ATSB-treated barrier fences led to 3 times reduction in P. papatasi population. Besides that, ATSB spraying on plants led to more than 5 times reduction in P. papatasi population. Conclusions Comparing the incidence of leishmaniasis in treated villages before and after the study showed that the incidence was statistically reduced. Therefore, ATSB is an effective method to control vectors and prevent leishmaniasis.	[Saghafipour, Abedin] Univ Tehran Med Sci, Dept Med Entomol & Vector Control, Sch Publ Hlth, Int Campus IC TUMS, Tehran, Iran; [Vatandoost, Hassan; Zahraei-Ramazani, Ali Reza; Yaghoobi-Ershadi, Mohammad Reza; Rassi, Yavar; Akhavan, Amir Ahmad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran; [Jooshin, Moharram Karami] Qom Univ Med Sci, Qom Prov Hlth Ctr, Qom, Iran; [Shirzadi, Mohammad Reza] Minist Hlth & Med Educ, Communicable Dis Management Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME)	Vatandoost, H (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.	hvatandoost1@yahoo.com	Saghafipour, Abedin/T-5150-2017; Zahraei-Ramazani, Alireza/Q-9766-2019; Vatandoost, Hassan/AAY-2459-2021	Vatandoost, Hassan/0000-0002-5983-9420; shirzadi, mohammad reza/0000-0002-7993-8362	Tehran University of Medial Sciences [29826]	Tehran University of Medial Sciences	This research was funded by Tehran University of Medial Sciences (Project NO.: 29826). We would like to thank the healthcare staff at Qom Health Center for providing support in the field work.; This research is a part of Ph.D thesis which is supported by Tehran University of Medical Sciences as research project with number 29826. The regulation of University is supporting all the projects which have been approved by expert committee of University. They provide all the expenses which declared in the research proposal.	Aslanabadi A, 2015, LANCET INFECT DIS, V15, P1480, DOI 10.1016/S1473-3099(15)00292-3; Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31; David MC, 2010, J GLOB INFECT DIS, V2, P127; Hazratian T, 2011, ASIAN PAC J TROP MED, V4, P604, DOI 10.1016/S1995-7645(11)60156-9; Molyneux DH, 1983, THE BIOLOGY OF TRYPA; MOORE JS, 1987, MED VET ENTOMOL, V1, P427, DOI 10.1111/j.1365-2915.1987.tb00373.x; Mozafari M, 2013, IRAN J MICROBIOL, V5, P366; Muller GC, 2010, MED VET ENTOMOL, V24, P346, DOI 10.1111/j.1365-2915.2010.00876.x; Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108; Muller GC, 2011, J VECTOR ECOL, V36, pS64, DOI 10.1111/j.1948-7134.2011.00113.x; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; Muller G, 2004, J VECTOR ECOL, V29, P154; Muller GC, 2008, T ROY SOC TROP MED H, V102, P480, DOI 10.1016/j.trstmh.2008.01.008; Qualls WA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0671-2; Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004; Qureshi S. A., 2007, 125 IWMI; Rostami MN, 2013, INT J INFECT DIS, V17, pE1198, DOI 10.1016/j.ijid.2013.07.003; Schlein Y, 1999, MED VET ENTOMOL, V13, P65, DOI 10.1046/j.1365-2915.1999.00138.x; SCHLEIN Y, 1986, J MED ENTOMOL, V23, P11, DOI 10.1093/jmedent/23.1.11; Schlein Y, 2010, T ROY SOC TROP MED H, V104, P766, DOI 10.1016/j.trstmh.2010.08.014; Smart J, 1965, INSECTS MED IMPORTAN, P286; Wang C, 2010, ACS SYM SER, V1015, P125; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; WHO, 2014, MAL ENT VECT CONTR D; Xue RD, 2006, J AM MOSQUITO CONTR, V22, P497, DOI 10.2987/8756-971X(2006)22[497:AOBABT]2.0.CO;2; Yaghoobi-Ershadi MR, 2012, J ARTHROPOD-BORNE DI, V6, P1	26	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0173558	10.1371/journal.pone.0173558	http://dx.doi.org/10.1371/journal.pone.0173558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426679	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900005
J	Srut, M; Drechsel, V; Hockner, M				Srut, Maja; Drechsel, Victoria; Hoeckner, Martina			Low levels of Cd induce persisting epigenetic modifications and acclimation mechanisms in the earthworm Lumbricus terrestris	PLOS ONE			English	Article							METALLOTHIONEIN GENE-EXPRESSION; EISENIA-FOETIDA ANNELIDA; GENOMIC DNA METHYLATION; LIFE-CYCLE PARAMETERS; CADMIUM EXPOSURE; ENVIRONMENTAL EPIGENETICS; PHYTOCHELATIN SYNTHASE; HEAVY-METALS; BIOMARKER; RESPONSES	Toxic effects of cadmium (Cd), a common soil pollutant, are still not very well understood, particularly in regard to its epigenetic impact. Therefore, the aim of this study was to assess DNA methylation changes and their persistence in the earthworm Lumbricus terrestris upon chronic low dose Cd exposure using methylation sensitive amplification polymorphism (MSAP). Moreover, the biomarker response and fitness of the earthworms, as well as the expression of detoxification-related genes (metallothionein (MT) and phytochelatin synthase (PCS)) was evaluated. Low levels of Cd caused an increase in genome-wide DNA methylation, which remained partly modified, even after several months of recovery in unpolluted soil. Increased cellular stress seemed to decrease after two weeks of exposure whereas fitness parameters remained unaffected by Cd, probably as a result from the activation of detoxification mechanisms like the expression of MTs. Interestingly, even though the level of Cd exposure was very low, MT expression levels indicate the development of acclimation mechanisms. Taken together, this study demonstrates that acclimation, as well as epigenetic modifications can occur already in moderately polluted environments. In addition, these effects can have long-lasting impacts on key species of soil invertebrates and might persist long after the actual heavy metal challenge has passed.	[Srut, Maja] Univ Zagreb, Fac Sci, Dept Zool, Rooseveltov Trg 6, Zagreb, Croatia; [Drechsel, Victoria; Hoeckner, Martina] Univ Innsbruck, Inst Zool, Dept Ecophysiol, Ctr Mol Biosci, Technikerstr 25, A-6020 Innsbruck, Austria	University of Zagreb; University of Innsbruck	Srut, M (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Rooseveltov Trg 6, Zagreb, Croatia.; Hockner, M (corresponding author), Univ Innsbruck, Inst Zool, Dept Ecophysiol, Ctr Mol Biosci, Technikerstr 25, A-6020 Innsbruck, Austria.	msrut@biol.pmf.hr; martina.hoeckner@uibk.ac.at	Šrut, Maja/AAZ-7267-2021	Hockner, Martina/0000-0001-8093-3756	University of Innsbruck [194584]; Tyrolean science foundation (TWF) [GZ:UNI-0404/1417, GZ:UNI-0404/1807]; Austrian Agency for International Cooperation in Education and Research (OeAD GmbH) [ICM-2014-07081]; Centre for International Cooperation Mobility (ICM) [HR 08/2016]	University of Innsbruck; Tyrolean science foundation (TWF); Austrian Agency for International Cooperation in Education and Research (OeAD GmbH); Centre for International Cooperation Mobility (ICM)	The study was funded by the University of Innsbruck (Nachwuchsforderprogramm 2014 No. 194584), the Tyrolean science foundation (TWF) (Projects GZ:UNI-0404/1417 and GZ:UNI-0404/1807), an Ernst Mach grant (Austrian Agency for International Cooperation in Education and Research (OeAD GmbH; ICM-2014-07081) awarded to Maja Srut, and a Scientific and Technological Cooperation grant by the Centre for International Cooperation & Mobility (ICM; HR 08/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alonso C, 2016, MOL ECOL RESOUR, V16, P80, DOI 10.1111/1755-0998.12426; Anderson RS, 1999, DEV COMP IMMUNOL, V23, P443, DOI 10.1016/S0145-305X(99)00029-4; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Beaumelle L, 2014, ENVIRON POLLUT, V191, P182, DOI 10.1016/j.envpol.2014.04.021; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Brulle F, 2011, SCI TOTAL ENVIRON, V409, P5470, DOI 10.1016/j.scitotenv.2011.08.040; Bundy JG, 2014, ENVIRON SCI TECHNOL, V48, P885, DOI 10.1021/es4054779; Chen YY, 2014, AQUAT TOXICOL, V157, P196, DOI 10.1016/j.aquatox.2014.10.018; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Doi T, 2011, TOXICOL SCI, V120, P475, DOI 10.1093/toxsci/kfr022; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fisker KV, 2013, COMP BIOCHEM PHYS C, V157, P220, DOI 10.1016/j.cbpc.2012.11.007; Fuller-Espie SL, 2011, PEDOBIOLOGIA, V54, pS31, DOI 10.1016/j.pedobi.2011.09.009; Greco M, 2012, J EXP BOT, V63, P695, DOI 10.1093/jxb/err313; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hockner M, 2015, BIOCHEM BIOPH RES CO, V460, P537, DOI 10.1016/j.bbrc.2015.03.065; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; Homa J, 2015, ENVIRON TOXICOL CHEM, V34, P1397, DOI 10.1002/etc.2944; Hossain MB, 2012, ENVIRON HEALTH PERSP, V120, P879, DOI 10.1289/ehp.1104600; Huang DJ, 2008, TOXICOL LETT, V179, P43, DOI 10.1016/j.toxlet.2008.03.018; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Jimenez-Chillaron JC, 2015, EPIGENETICS-US, V10, P259, DOI 10.1080/15592294.2015.1020267; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Klobucar GIV, 2011, ENVIRON POLLUT, V159, P841, DOI 10.1016/j.envpol.2011.01.009; Langdon CJ, 2003, ENVIRON TOXICOL CHEM, V22, P2344, DOI 10.1897/02-554; Legeay A, 2005, AQUAT TOXICOL, V74, P242, DOI 10.1016/j.aquatox.2005.05.015; Lei YX, 2015, GENET MOL RES, V14, P515, DOI 10.4238/2015.January.26.5; Li M, 2009, CHEMOSPHERE, V74, P621, DOI 10.1016/j.chemosphere.2008.10.048; Li Y SH, 2007, RAPID KINETIC MICROA, V18, P162; Li ZL, 2015, ENVIRON TOXICOL CHEM, V34, P2095, DOI 10.1002/etc.3033; Liebeke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081271; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Lukkari T, 2004, ENVIRON POLLUT, V129, P377, DOI 10.1016/j.envpol.2003.12.008; Santoyo MM, 2011, ENVIRON POLLUT, V159, P2387, DOI 10.1016/j.envpol.2011.06.041; Martinez-Zamudio R, 2011, EPIGENETICS-US, V6, P820, DOI 10.4161/epi.6.7.16250; Mielke H.W., 2005, INT J ENV RES PUB HE, V2, P308; Mirbahai L, 2014, MUTAT RES-GEN TOX EN, V764, P10, DOI 10.1016/j.mrgentox.2013.10.003; Mustonen M, 2014, ECOTOXICOLOGY, V23, P1732, DOI 10.1007/s10646-014-1338-z; Nahmani J, 2007, ENVIRON POLLUT, V149, P44, DOI 10.1016/j.envpol.2006.12.018; Novo M, 2014, TOXICOL LETT, V229, pS18, DOI 10.1016/j.toxlet.2014.06.095; Otomo PV, 2014, B ENVIRON CONTAM TOX, V92, P285, DOI 10.1007/s00128-013-1157-6; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Panzarino O, 2016, CHEMOSPHERE, V145, P480, DOI 10.1016/j.chemosphere.2015.11.077; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Pierron F, 2014, ENVIRON SCI TECHNOL, V48, P797, DOI 10.1021/es4048347; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Rieswijk L, 2016, TOXICOLOGY, V350, P31, DOI 10.1016/j.tox.2016.05.002; Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x; Saez G, 2015, ENVIRON TOXICOL, V30, P918, DOI 10.1002/tox.21966; Sandbichler AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010139; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Suarez-Ulloa V, 2015, MAR POLLUT BULL, V98, P5, DOI 10.1016/j.marpolbul.2015.06.020; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Tang S, 2015, CHEMOSPHERE, V120, P92, DOI 10.1016/j.chemosphere.2014.06.011; van Gestel CAM, 2009, ENVIRON POLLUT, V157, P895, DOI 10.1016/j.envpol.2008.11.002; Vandegehuchte MB, 2009, ENVIRON INT, V35, P700, DOI 10.1016/j.envint.2009.01.002; Vasseur P, 2014, CURR ZOOL, V60, P255, DOI 10.1093/czoolo/60.2.255; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang JH, 2012, ENVIRON TOXICOL CHEM, V31, P2035, DOI 10.1002/etc.1907; Wang XT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1119; Wu B, 2012, ECOTOX ENVIRON SAFE, V81, P122, DOI 10.1016/j.ecoenv.2012.05.003; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Ye S, 2014, MUTAT RES-GEN TOX EN, V773, P34, DOI 10.1016/j.mrgentox.2014.08.004; Yoshida M, 2005, TOXICOLOGY, V213, P74, DOI 10.1016/j.tox.2005.05.008; Zaltauskaite J, 2014, ECOTOX ENVIRON SAFE, V103, P9, DOI 10.1016/j.ecoenv.2014.01.036; Zhang JL, 2009, ENVIRON TOXICOL PHAR, V27, P345, DOI 10.1016/j.etap.2008.11.012; Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015; Zhu J., 2006, J ENVIRON SCI, P1210	77	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176047	10.1371/journal.pone.0176047	http://dx.doi.org/10.1371/journal.pone.0176047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426746	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900092
J	Sun, L; Moritake, T; Ito, K; Matsumoto, Y; Yasui, H; Nakagawa, H; Hirayame, A; Inanami, O; Tsuboi, K				Sun, Lue; Moritake, Takashi; Ito, Kazuya; Matsumoto, Yoshitaka; Yasui, Hironobu; Nakagawa, Hidehiko; Hirayame, Aki; Inanami, Osamu; Tsuboi, Koji			Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; NF-KAPPA-B; CANCER-CELLS; IONIZING-RADIATION; IN-VITRO; MITOCHONDRIAL FISSION; DICHLOROACETATE DCA; AEROBIC GLYCOLYSIS; HYDROGEN-PEROXIDE; DNA-REPAIR	Medulloblastoma is a fatal brain tumor in children, primarily due to the presence of treatment-resistant medulloblastoma stem cells. The energy metabolic pathway is a potential target of cancer therapy because it is often different between cancer cells and normal cells. However, the metabolic properties of medulloblastoma stem cells, and whether specific metabolic pathways are essential for sustaining their stem cell-like phenotype and radioresistance, remain unclear. We have established radioresistant medulloblastoma stem-like clones (rMSLCs) by irradiation of the human medulloblastoma cell line ONS-76. Here, we assessed reactive oxygen species (ROS) production, mitochondria function, oxygen consumption rate (OCR), energy state, and metabolites of glycolysis and tricarboxylic acid cycle in rMSLCs and parental cells. rMSLCs showed higher lactate production and lower oxygen consumption rate than parental cells. Additionally, rMSLCs had low mitochondria mass, low endogenous ROS production, and existed in a low-energy state. Treatment with the metabolic modifier dichloroacetate (DCA) resulted in mitochondria dysfunction, glycolysis inhibition, elongated mitochondria morphology, and increased ROS production. DCA also increased radiosensitivity by suppression of the DNA repair capacity through nuclear oxidization and accelerated the generation of acetyl CoA to compensate for the lack of ATP. Moreover, treatment with DCA decreased cancer stem cell-like characters (e.g., CD133 positivity and sphere-forming ability) in rMSLCs. Together, our findings provide insights into the specific metabolism of rMSLCs and illuminate potential metabolic targets that might be exploited for therapeutic benefit in medulloblastoma.	[Sun, Lue; Moritake, Takashi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Radiol Hlth Sci, Kitakyushu, Fukuoka, Japan; [Ito, Kazuya] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Radiobiol, Tsukuba, Ibaraki, Japan; [Matsumoto, Yoshitaka; Tsuboi, Koji] Univ Tsukuba, Fac Med, Proton Med Res Ctr, Tsukuba, Ibaraki, Japan; [Yasui, Hironobu] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan; [Nakagawa, Hidehiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Lab Organ & Med Chem, Nagoya, Aichi, Japan; [Hirayame, Aki] Tsukuba Univ Technol, Ctr Integrat Med, Tsukuba, Ibaraki, Japan; [Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido, Japan	University of Occupational & Environmental Health - Japan; University of Tsukuba; University of Tsukuba; Hokkaido University; Nagoya City University; Tsukuba University of Technology; Hokkaido University	Moritake, T (corresponding author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Radiol Hlth Sci, Kitakyushu, Fukuoka, Japan.	moritake@med.uoeh-u.ac.jp	Hirayama, Aki/G-7842-2017; Yasui, Hironobu/E-3794-2010; Sun, Lue/H-2479-2019; Inanami, Osamu/A-5197-2012	Hirayama, Aki/0000-0001-5777-4208; Yasui, Hironobu/0000-0002-6757-1110; Sun, Lue/0000-0001-8485-6380; Inanami, Osamu/0000-0001-7895-3918	University of Tsukuba; Japan Society for the Promotion of Science (JSPS) [JP25670616]; JSPS [JP15H06804]; Grants-in-Aid for Scientific Research [17K16668] Funding Source: KAKEN	University of Tsukuba; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by University of Tsukuba Basic Research Support Program Type A (to L.S. and K.T.), http://kiyo.sec.tsukuba.ac.jp/docs/rpg/gaiyo.html; Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Challenging Exploratory Research Number JP25670616 (to T.M.), https://kaken.nil.ac.jp/en/grant/KAKENHI-PROJECT-25670616; and JSPS Grant-in-Aid for Research Activity start-up Number JP15H06804 (to L.S.), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15H06804/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEUROLOGIA MED CHI S, V49, pS1; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duan Y, 2013, ONCOTARGETS THER, V6, P189, DOI 10.2147/OTT.S40992; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fujii H, 2008, RADIOTHER ONCOL, V86, P354, DOI 10.1016/j.radonc.2007.11.020; Gerelchuluun A, 2011, INT J RADIAT BIOL, V87, P57, DOI 10.3109/09553002.2010.518201; GIRBAL L, 1994, J BACTERIOL, V176, P6433, DOI 10.1128/JB.176.21.6433-6438.1994; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Horner MJ, 2009, SEER CANC STAT REV 1; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; HU JJ, 1995, MUTAT RES-DNA REPAIR, V336, P193, DOI 10.1016/0921-8777(94)00054-A; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ikeda M, 2012, BIOORG MED CHEM LETT, V22, P1949, DOI 10.1016/j.bmcl.2012.01.042; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kobashigawa S, 2011, BIOCHEM BIOPH RES CO, V414, P795, DOI 10.1016/j.bbrc.2011.10.006; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lin G, 2014, BRIT J CANCER, V111, P375, DOI 10.1038/bjc.2014.281; Lu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121046; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Matsuhashi T, 2015, J MOL CELL CARDIOL, V82, P116, DOI 10.1016/j.yjmcc.2015.02.021; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Morfouace M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.561; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Packer RJ, 2005, J NEURO-ONCOL, V75, P239, DOI 10.1007/s11060-005-6745-9; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shyh-Chang N, 2015, CELL METAB, V21, P349, DOI 10.1016/j.cmet.2015.02.011; Singh SK, 2003, CANCER RES, V63, P5821; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tamura K, 2010, J NEUROSURG, V113, P310, DOI 10.3171/2010.2.JNS091607; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	79	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176162	10.1371/journal.pone.0176162	http://dx.doi.org/10.1371/journal.pone.0176162			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426747	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900113
J	Wu, LY; Wang, Z				Wu, Leying; Wang, Zheng			Examining drivers of the emissions embodied in trade	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; GROWING CO2 EMISSIONS; STRUCTURAL DECOMPOSITION; CHINESE EXPORTS; CARBON; CONSUMPTION; PERSPECTIVE; MITIGATION; CHAINS; INDEX	Emissions embodied in provincial trade (EEPT) have important effects on provinces' responsibilities for carbon emission reductions. Based on a multi-regional input-output model, we calculated EEPT for China's 30 provinces in 2002, 2007 and 2010, and we attempted to determine the drivers of EEPT. The results showed that, during this period, the ratio of EEPT to production-based emissions increased over time, reaching 40.24% in 2010. In consideration of its important role in carbon emissions, we analyzed the factors attributable to EEPT through structure decomposition analysis. The decomposition results showed that final demand and carbon emission intensity were two major factors in EEPT, while the final demand in other provinces and the carbon emission intensity in the local province were major factors for Emissions embodied in provincial exports and the final demand in the local province and the carbon emission intensity in other provinces were major factors for Emissions embodied in provincial imports. Regarding the differences among the EEPT of different provinces, changes in the structure of trade were the primary reason.	[Wu, Leying; Wang, Zheng] East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China; [Wang, Zheng] Chinese Acad Sci, Inst Policy & Management, Beijing, Peoples R China	East China Normal University; Chinese Academy of Sciences; CAS Institutes of Science & Development	Wang, Z (corresponding author), East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China.; Wang, Z (corresponding author), Chinese Acad Sci, Inst Policy & Management, Beijing, Peoples R China.	wangzheng@casipm.ac.cn			National Key RAMP;D Program of China [2016YFA0602702]; National Natural Science Foundation of China [41501130]; National Basic Research Program of China [2012CB955800]	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Key R&D Program of China (2016YFA0602702), http:// www.most.gov.cn/, National Natural Science Foundation of China (41501130), http://www.nsfc. gov.cn/, National Basic Research Program of China (2012CB955800), http://www.973.gov.cn.	Ang BW, 2009, ENERG POLICY, V37, P4624, DOI 10.1016/j.enpol.2009.06.017; Chen ZM, 2010, COMMUN NONLINEAR SCI, V15, P1942, DOI 10.1016/j.cnsns.2009.08.001; De Boer P, 2008, ECON SYST RES, V20, P97, DOI 10.1080/09535310801892066; de Haan M., 2001, ECON SYST RES, V13, P181, DOI DOI 10.1080/09537320120052452; Dietzenbacher E., 1998, ECON SYST RES, V10, P307, DOI [10.1080/09535319800000023, DOI 10.1080/09535319800000023, 10.1080/]; Dong HJ, 2015, APPL ENERG, V144, P165, DOI 10.1016/j.apenergy.2015.02.020; Dong YL, 2010, ENERG POLICY, V38, P6784, DOI 10.1016/j.enpol.2010.06.050; Du HB, 2011, ENERG POLICY, V39, P5980, DOI 10.1016/j.enpol.2011.06.060; Feng KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8714; Feng KS, 2014, ECOL INDIC, V47, P26, DOI 10.1016/j.ecolind.2014.04.045; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Feng KS, 2012, J IND ECOL, V16, P600, DOI 10.1111/j.1530-9290.2012.00494.x; Gregg JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032887; Guan D, 2012, NATURE CLIMATE CHANG, V8, P631; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; Guo JE, 2012, ENERG POLICY, V42, P486, DOI 10.1016/j.enpol.2011.12.015; Li Y, 2008, ENERG POLICY, V36, P1907, DOI 10.1016/j.enpol.2008.02.005; Liang S, 2014, ENVIRON SCI TECHNOL, V48, P1103, DOI 10.1021/es4042429; Liu HG, 2015, ENERG ECON, V50, P294, DOI 10.1016/j.eneco.2015.06.006; Liu HG, 2015, J CLEAN PROD, V103, P362, DOI 10.1016/j.jclepro.2014.09.077; Liu W., 2012, THEORY PRACTICE BUIL; Liu W., 2014, THEORY PRACTICE BUIL; Liu XB, 2010, ENERG POLICY, V38, P1510, DOI 10.1016/j.enpol.2009.11.034; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; Liu Z, 2012, ENERG POLICY, V49, P751, DOI 10.1016/j.enpol.2012.07.016; Minx JC, 2011, ENVIRON SCI TECHNOL, V45, P9144, DOI 10.1021/es201497m; Peters GP, 2008, ENVIRON SCI TECHNOL, V42, P1401, DOI 10.1021/es072023k; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Serrano M, 2010, ECOL ECON, V69, P2224, DOI 10.1016/j.ecolecon.2010.06.008; Shui B, 2006, ENERG POLICY, V34, P4063, DOI 10.1016/j.enpol.2005.09.010; Su B, 2014, ENERGY, V69, P778, DOI 10.1016/j.energy.2014.03.074; Su B, 2014, APPL ENERG, V114, P377, DOI 10.1016/j.apenergy.2013.09.036; Su B, 2011, ECOL ECON, V71, P42, DOI 10.1016/j.ecolecon.2011.08.024; Su B, 2010, ECOL ECON, V70, P10, DOI 10.1016/j.ecolecon.2010.08.016; Su B, 2010, ENERG ECON, V32, P166, DOI 10.1016/j.eneco.2009.07.010; Tian X, 2014, APPL ENERG, V123, P19, DOI 10.1016/j.apenergy.2014.02.016; Wang T., 2007, WHO OWNS CHINAS CARB; [王铮 Wang Zheng], 2013, [地理科学, Scientia Geographica Sinica], V33, P641; Weber CL, 2008, ENERG POLICY, V36, P3572, DOI 10.1016/j.enpol.2008.06.009; Weitzel M, 2014, ENERG ECON, V45, P45, DOI 10.1016/j.eneco.2014.06.012; Wu R, 2016, J CLEAN PROD, V112, P4151, DOI 10.1016/j.jclepro.2015.07.017; Xia Y, 2015, APPL ENERG, V150, P296, DOI 10.1016/j.apenergy.2015.04.028; Xie X, 2015, SUSTAINABILITY-BASEL, V7, P10098, DOI 10.3390/su70810098; Xu Y, 2014, ECOL ECON, V101, P10, DOI 10.1016/j.ecolecon.2014.02.015; Zhang Q, 2015, SUSTAINABILITY-BASEL, V7, P8223, DOI 10.3390/su7078223	47	3	3	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176159	10.1371/journal.pone.0176159	http://dx.doi.org/10.1371/journal.pone.0176159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426769	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900111
J	Yang, X; Beres, ZT; Jin, L; Parrish, JT; Zhao, WY; Mackey, D; Snow, AA				Yang, Xiao; Beres, Zachery T.; Jin, Lin; Parrish, Jason T.; Zhao, Wanying; Mackey, David; Snow, Allison A.			Effects of over-expressing a native gene encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) on glyphosate resistance in Arabidopsis thaliana	PLOS ONE			English	Article							HERBICIDE RESISTANCE; AMARANTHUS-PALMERI; SHIKIMATE PATHWAY; FITNESS COST; AMPLIFICATION; PLANTS; MECHANISM; EVOLUTION; CELLS; PCR	Widespread overuse of the herbicide glyphosate, the active ingredient in RoundUp((R)), has led to the evolution of glyphosate-resistant weed biotypes, some of which persist by overproducing the herbicide's target enzyme, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). EPSPS is a key enzyme in the shikimic acid pathway for biosynthesis of aromatic amino acids, lignin, and defensive compounds, but little is known about how overproducing EPSPS affects downstream metabolites, growth, or lifetime fitness in the absence of glyphosate. We are using Arabidopsis as a model system for investigating phenotypic effects of overproducing EPSPS, thereby avoiding confounding effects of genetic background or other mechanisms of herbicide resistance in agricultural weeds. Here, we report results from the first stage of this project. We designed a binary vector expressing a native EPSPS gene from Arabidopsis under control of the CaMV35S promoter (labelled OX, for overexpression). For both OX and the empty vector (labelled EV), we obtained nine independent T3 lines. Subsets of these lines were used to characterize glyphosate resistance in greenhouse experiments. Seven of the nine OX lines exhibited enhanced glyphosate resistance when compared to EV and wild-type control lines, and one of these was discarded due to severe deformities. The remaining six OX lines exhibited enhanced EPSPS gene expression and glyphosate resistance compared to controls. Glyphosate resistance was correlated with the degree of EPSPS over-expression for both vegetative and flowering plants, indicating that glyphosate resistance can be used as a surrogate for EPSPS expression levels in this system. These findings set the stage for examination of the effects of EPSPS overexpression on fitness-related traits in the absence of glyphosate. We invite other investigators to contact us if they wish to study gene expression, downstream metabolic effects, and other questions with these particular lines.	[Yang, Xiao; Beres, Zachery T.; Snow, Allison A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Jin, Lin; Parrish, Jason T.; Zhao, Wanying; Mackey, David] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yang, X (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	yangxiao@fudan.edu.cn		Yang, Xiao/0000-0002-2351-4827; Beres, Zachery/0000-0001-6513-6142	Weedy and Invasive Plants Grant Program [2016-67013-24804]; USDA National Institute of Food and Agriculture; International Postdoctoral Exchange Fellowship Program, Office of China	Weedy and Invasive Plants Grant Program; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); International Postdoctoral Exchange Fellowship Program, Office of China	This project was supported by the Weedy and Invasive Plants Grant Program, Grant No. 2016-67013-24804, from the USDA National Institute of Food and Agriculture (recipient: Ohio State University, AA Snow and DL Mackey). X Yang was partly funded by the International Postdoctoral Exchange Fellowship Program, Office of China	Baerson SR, 2002, WEED SCI, V50, P721, DOI 10.1614/0043-1745(2002)050[0721:ITMOGR]2.0.CO;2; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; Brotherton JE, 2007, J PLANT PHYSIOL, V164, P1337, DOI 10.1016/j.jplph.2006.08.008; Chen JC, 2015, PLANTA, V242, P859, DOI 10.1007/s00425-015-2324-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dinelli G, 2006, PESTIC BIOCHEM PHYS, V86, P30, DOI 10.1016/j.pestbp.2006.01.004; Franz J. E., 1997, GLYPHOSATE UNIQUE GL; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Gaines TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065819; Gaines TA, 2011, J AGR FOOD CHEM, V59, P5886, DOI 10.1021/jf104719k; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Heap I., 2017, INT SURVEY HERBICIDE; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Jones JD, 1996, PLANT CELL REP, V15, P431, DOI 10.1007/BF00232070; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; KLEE HJ, 1987, MOL GEN GENET, V210, P437, DOI 10.1007/BF00327194; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Lee RM, 2006, THESIS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu BR, 2014, NEW PHYTOL, V202, P363, DOI 10.1111/nph.12684; Lu BR, 2014, NEW PHYTOL, V202, P370, DOI 10.1111/nph.12748; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Malone JM, 2016, PEST MANAG SCI, V72, P81, DOI 10.1002/ps.4019; Mohseni-Moghadam M, 2013, WEED SCI, V61, P517, DOI 10.1614/WS-D-13-00028.1; Muller A, 1998, PLANTA, V206, P362, DOI 10.1007/s004250050411; Neve P, 2008, PEST MANAG SCI, V64, P392, DOI 10.1002/ps.1495; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powles SB, 2010, P NATL ACAD SCI USA, V107, P955, DOI 10.1073/pnas.0913433107; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Roux F, 2005, EVOLUTION, V59, P2264, DOI 10.1111/j.0014-3820.2005.tb00934.x; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; SUH H, 1993, PLANT MOL BIOL, V22, P195, DOI 10.1007/BF00014928; Tani E, 2015, PLANT MOL BIOL REP; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2014, PLANTA; Wang W, 2014, NEW PHYTOL, V202, P679, DOI 10.1111/nph.12428; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yanniccari M, 2016, WEED SCI, V64, P71, DOI 10.1614/WS-D-15-00065.1	43	10	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175820	10.1371/journal.pone.0175820	http://dx.doi.org/10.1371/journal.pone.0175820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426703	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900052
J	Baranova, IN; Souza, ACP; Bocharov, AV; Vishnyakova, TG; Hue, XZ; Vaisman, BL; Amar, MJ; Chen, Z; Remaley, AT; Patterson, AP; Yuen, PST; Star, RA; Eggerman, TL				Baranova, Irina N.; Souza, Ana C. P.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Hue, Xuzhen; Vaisman, Boris L.; Amar, Marcelo J.; Chen, Zhigang; Remaley, Alan T.; Patterson, Amy P.; Yuen, Peter S. T.; Star, Robert A.; Eggerman, Thomas L.			Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo	PLOS ONE			English	Article							SERUM-AMYLOID-A; B TYPE-I; HIGH-DENSITY-LIPOPROTEIN; PROTEIN-COUPLED RECEPTOR; CORONARY-ARTERY-DISEASE; ACUTE-PHASE REACTANT; C-REACTIVE PROTEIN; SCAVENGER RECEPTOR; RHEUMATOID-ARTHRITIS; POLYMORPHONUCLEAR LEUKOCYTES	Serum amyloid A (SAA) is an acute phase protein with cytokine-like and chemotactic properties, that is markedly up-regulated during various inflammatory conditions. Several receptors, including FPRL-1, TLR2, TLR4, RAGE, class B scavenger receptors, SR-BI and CD36, have been identified as SAA receptors. This study provides new evidence that SR-BII, splice variant of SR-BI, could function as an SAA receptor mediating its uptake and pro-inflammatory signaling. The uptake of Alexa Fluor488 SAA was markedly (similar to 3 fold) increased in hSR-BII-expressing HeLa cells when compared with mock-transfected cells. The levels of SAA-induced interleukin-8 secretion by hSR-BII-expressing HEK293 cells were also significantly (similar to 3-3.5 fold) higher than those detected in control cells. Moderately enhanced levels of phosphorylation of all three mitogen-activated protein kinases, ERK1/2, and p38 and JNK, were observed in hSR-BII-expressing cells following SAA stimulation when compared with control wild type cells. Transgenic mice with pLiv-11-directed liver/kidney overexpression of hSR-BI or hSR-BII were used to assess the in vivo role of each receptor in SAA-induced pro-inflammatory response in these organs. Six hours after intraperitoneal SAA injection both groups of transgenic mice demonstrated markedly higher (similar to 2- fold) expression levels of inflammatory mediators in the liver and kidney compared to wild type mice. Histological examinations of hepatic and renal tissue from SAA-treated mice revealed moderate level of damage in the liver of both transgenic but not in the wild type mice. Activities of plasma transaminases, biomarkers of liver injury, were also moderately higher in hSR-B transgenic mice when compared to wild type mice. Our findings identify hSR-BII as a functional SAA receptor that mediates SAA uptake and contributes to its pro-inflammatory signaling via the MAPKs-mediated signaling pathways.	[Baranova, Irina N.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Chen, Zhigang; Patterson, Amy P.; Eggerman, Thomas L.] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Souza, Ana C. P.; Hue, Xuzhen; Yuen, Peter S. T.; Star, Robert A.] NIDDK, Renal Diagnost & Therapeut Unit, NIH, Bethesda, MD 20892 USA; [Vaisman, Boris L.; Amar, Marcelo J.; Remaley, Alan T.; Patterson, Amy P.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Baranova, IN (corresponding author), NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	ibaranova@mail.nih.gov	Amar, Marcelo/AAD-5599-2019; Vaisman, Boris L/B-3453-2008; ST Yuen, Peter/B-1954-2008	ST Yuen, Peter/0000-0001-9557-3909	NIH Intramural Research Programs at the Clinical Center; NIDDK; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043403] Funding Source: NIH RePORTER	NIH Intramural Research Programs at the Clinical Center; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the NIH Intramural Research Programs at the Clinical Center, NIDDK, and NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Baranova IN, 2016, J IMMUNOL, V196, P3135, DOI 10.4049/jimmunol.1501709; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Cai SF, 2001, J LIPID RES, V42, P902; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; CHAMBERS RE, 1987, EUR J CLIN INVEST, V17, P460, DOI 10.1111/j.1365-2362.1987.tb01143.x; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; Connolly M, 2016, ANN RHEUM DIS, V75, P1392, DOI 10.1136/annrheumdis-2015-207655; Ebeling P, 1999, DIABETOLOGIA, V42, P1433, DOI 10.1007/s001250051315; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Haffner SM, 2000, AM J CARDIOL, V85, P1395, DOI 10.1016/S0002-9149(00)00784-0; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hong CC, 2015, MOL IMMUNOL, V66, P340, DOI 10.1016/j.molimm.2015.03.254; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Ishida M, 1998, CIRC RES, V82, P7; Jousilahti P, 2001, ATHEROSCLEROSIS, V156, P451, DOI 10.1016/S0021-9150(00)00681-X; LAVIE G, 1978, J EXP MED, V148, P1020, DOI 10.1084/jem.148.4.1020; Lavin-Gomez Bernardo A, 2011, Adv Perit Dial, V27, P33; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Leelahavanichkul A, 2012, J IMMUNOL, V188, P2749, DOI 10.4049/jimmunol.1003445; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Li W, 2015, MOL MED, V21, P515, DOI 10.2119/molmed.2015.00109; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Migita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096703; Mulcahy JV, 2004, BIOCHEM J, V377, P741, DOI 10.1042/bj20030307; Mullan RH, 2010, AM J PATHOL, V176, P1999, DOI 10.2353/ajpath.2010.090014; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAITO N, 1991, AM J PATHOL, V139, P1053; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SILVERMAN SL, 1982, IMMUNOLOGY, V46, P737; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; XU LL, 1995, J IMMUNOL, V155, P1184; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	68	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175824	10.1371/journal.pone.0175824	http://dx.doi.org/10.1371/journal.pone.0175824			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423002	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600055
J	Son, M; Jung, J; Park, W				Son, Minseok; Jung, Jaemoon; Park, Woojin			Evaluating the utility of two gestural discomfort evaluation methods	PLOS ONE			English	Article							MUSCULOSKELETAL SYMPTOMS; MUSCLE FATIGUE; POSTURE; WORK; JOINT; DISORDERS; RULA; INTERPRETERS; ERGONOMICS; PREVENTION	Evaluating physical discomfort of designed gestures is important for creating safe and usable gesture-based interaction systems; yet, gestural discomfort evaluation has not been extensively studied in HCI, and few evaluation methods seem currently available whose utility has been experimentally confirmed. To address this, this study empirically demonstrated the utility of the subjective rating method after a small number of gesture repetitions (a maximum of four repetitions) in evaluating designed gestures in terms of physical discomfort resulting from prolonged, repetitive gesture use. The subjective rating method has been widely used in previous gesture studies but without empirical evidence on its utility. This study also proposed a gesture discomfort evaluation method based on an existing ergonomics posture evaluation tool (Rapid Upper Limb Assessment) and demonstrated its utility in evaluating designed gestures in terms of physical discomfort resulting from prolonged, repetitive gesture use. Rapid Upper Limb Assessment is an ergonomics postural analysis tool that quantifies the work-related musculoskeletal disorders risks for manual tasks, and has been hypothesized to be capable of correctly determining discomfort resulting from prolonged, repetitive gesture use. The two methods were evaluated through comparisons against a baseline method involving discomfort rating after actual prolonged, repetitive gesture use. Correlation analyses indicated that both methods were in good agreement with the baseline. The methods proposed in this study seem useful for predicting discomfort resulting from prolonged, repetitive gesture use, and are expected to help interaction designers create safe and usable gesture-based interaction systems.	[Son, Minseok; Jung, Jaemoon; Park, Woojin] Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea	Seoul National University (SNU)	Park, W (corresponding author), Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea.	woojinpark@snu.ac.kr			Global Frontier R&D Program on <Human-centered Interaction for Coexistence> - National Research Foundation of Korea grant - Korean Government (MEST) [NRF-M1AXA003-2011-0031425]	Global Frontier R&D Program on <Human-centered Interaction for Coexistence> - National Research Foundation of Korea grant - Korean Government (MEST)	This work was supported by the Global Frontier R&D Program on <Human-centered Interaction for Coexistence> funded by the National Research Foundation of Korea grant funded by the Korean Government (MEST) (NRF-M1AXA003-2011-0031425). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACGIH Worldwide, 2001, HAND ACT LEV TLV; Alvarez-Santos V, 2014, J VIS COMMUN IMAGE R, V25, P499, DOI 10.1016/j.jvcir.2013.03.017; Anita A.R., 2014, MALAYSIAN J MED HLTH, V10, P23; ARMSTRONG TJ, 1978, J BIOMECH, V11, P119, DOI 10.1016/0021-9290(78)90004-0; Bai H., 2014, P SIGGRAPH AS 2014 M; Bernard B., 1997, MUSCULOSKELETAL DISO; Bleiweiss A., 2010, ACM SIGGRAPH ASIA 20, P34; Breen R, 2007, ERGONOMICS, V50, P1582, DOI 10.1080/00140130701584944; Brown R, 2003, CONT ERGON; Burgess PR, 1995, SOMATOSENS MOT RES, V12, P343, DOI 10.3109/08990229509093667; Cesar M, 2014, LEAP MOTION WIMP BAS; Chae J, 2012, KOR HCI C, P653; Chaffin D., 1973, J OCCUP ENV MED; Choobineh A, 2012, J ISLAM DENT ASS IRA, V24, P310; Choobineh A, 2007, APPL ERGON, V38, P617, DOI 10.1016/j.apergo.2006.06.005; 최은정, 2012, [Journal of the Korean Institute of Industrial Engineers, 대한산업공학회지], V38, P182; Chung MK, 2005, ERGONOMICS, V48, P492, DOI 10.1080/00140130400029217; Chung MK, 2002, HUM FACTOR ERGON MAN, V12, P267, DOI 10.1002/hfm.10017; CORLETT EN, 1976, ERGONOMICS, V19, P175, DOI 10.1080/00140137608931530; DECARO JJ, 1992, AM ANN DEAF, V137, P288, DOI 10.1353/aad.2012.0483; Dennerlein JT, 1996, FINGER FLEXOR TENDON; DUL J, 1994, ERGONOMICS, V37, P807, DOI 10.1080/00140139408963690; Feuerstein M, 1997, J OCCUP REHABIL, V7, P187, DOI 10.1023/B:JOOR.0000010855.47587.0a; Fikkert W, 2010, ADV PATTERN RECOGNIT, P215, DOI 10.1007/978-1-84996-507-1_9; Gandavadi A, 2007, BRIT DENT J, V203, P601, DOI 10.1038/bdj.2007.1047; GANDEVIA SC, 1990, BRAIN, V113, P1563, DOI 10.1093/brain/113.5.1563; GENAIDY AM, 1993, ERGONOMICS, V36, P785, DOI 10.1080/00140139308967942; Gerling K., 2012, P 2012 ACM ANN C HUM, P1873, DOI [10.1145/2207676.2208324, DOI 10.1145/2207676.2208324]; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Gunnar B, 1998, HUMAN KINETICS; HEDGE A, 1995, HUM FAC ERG SOC P, P630; Henze Niels, 2010, P 9 INT C MOBILE UBI, DOI [DOI 10.1145/1899475.1899491, 10.1145/1899475.1899491]; Hignett S, 2000, APPL ERGON, V31, P201, DOI 10.1016/S0003-6870(99)00039-3; Kam Lai, 2012, Proceedings of the 2012 IEEE Southwest Symposium on Image Analysis & Interpretation (SSIAI 2012), P185, DOI 10.1109/SSIAI.2012.6202484; Karnan J, 2014, INT J REV ELECT COMM, V2, P42; Kee D, 2001, APPL ERGON, V32, P357, DOI 10.1016/S0003-6870(01)00006-0; Kee D, 2012, APPL ERGON, V43, P277, DOI 10.1016/j.apergo.2011.06.002; Kendon A., 1994, RES LANG SOC INTERAC, V27, P175, DOI [10.1207/s15327973rlsi2703_2, DOI 10.1207/S15327973RLSI2703_2]; Kilroy N, 2000, BRIT J BIOMED SCI, V57, P199; Kuhnel C, 2011, INT J HUM-COMPUT ST, V69, P693, DOI 10.1016/j.ijhcs.2011.04.005; Lawson EH, 2007, J ROBOT SURG, V1, P61, DOI 10.1007/s11701-007-0016-z; Leap Motion App Store, 2014, SHORTC; Lee EC, 2005, SURG ENDOSC, V19, P1064, DOI 10.1007/s00464-004-8213-6; Lee I, 2014, J ERGON SOC KOREA; Lee I, 2004, P HUM FACTORS ERG SO, V48, P1397; Liu Y, 2014, RES J APPL SCI ENG T, V7, P374; Lu ZY, 2014, IEEE T HUM-MACH SYST, V44, P293, DOI 10.1109/THMS.2014.2302794; Marshall M., 2004, INT S GEST INT MULT; Massaccesi M, 2003, APPL ERGON, V34, P303, DOI 10.1016/S0003-6870(03)00052-8; Mauser Stanislas, 2014, Stud Health Technol Inform, V196, P265; MCATAMNEY L, 1993, APPL ERGON, V24, P91, DOI 10.1016/0003-6870(93)90080-S; McCloskey D I, 1983, Adv Neurol, V39, P151; McNeill, 1992, HAND MIND WHAT GESTU, P75; MEALS RA, 1988, J HAND SURG-AM, V13A, P686, DOI 10.1016/S0363-5023(88)80124-2; Miedema MC, 1997, INT J IND ERGONOM, V19, P9, DOI 10.1016/0169-8141(95)00037-2; MILNER N, 1986, CLIN BIOMECH, V1, P29, DOI 10.1016/0268-0033(86)90034-3; Moon C., 2005, J KOREAN I IND ENG, V31, P289; MOORE JS, 1995, AM IND HYG ASSOC J, V56, P443; Morreau M, 2010, CURR RES SEMANT PRAG, V21, P261; Na S., 2006, JAPANESE J ERGONOMIC, V42, P590, DOI [10.5100//jje.42.Supplement_590, DOI 10.5100//JJE.42.SUPPLEMENT_590]; NAG PK, 1991, APPL ERGON, V22, P185, DOI 10.1016/0003-6870(91)90158-E; Nielsen M, 2003, LECT NOTES ARTIF INT, V2915, P409; Occhipinti E, 1998, ERGONOMICS, V41, P1290, DOI 10.1080/001401398186315; Ogutu J, 2015, WORK, V52, P123, DOI 10.3233/WOR-141944; Olendorf MR, 2001, ERGONOMICS, V44, P1341, DOI 10.1080/00140130110085358; Ozturk N, 2011, INT J IND ERGONOM, V41, P585, DOI 10.1016/j.ergon.2011.07.001; Pereira A, 2015, HUM FACTORS, V57, P607, DOI 10.1177/0018720814559307; Person JG, 2001, SURG ENDOSC-ULTRAS, V15, P997, DOI 10.1007/s004640080155; Piumsomboon T, 2013, LECT NOTES COMPUT SC, V8118, P282; Posti Maaret, 2014, P INT S PERV DISPL P, P200, DOI [10.1145/2611009.2614392, DOI 10.1145/2611009.2614392]; Putz-Anderson V., 1993, INT J IND ERGONOM, V11, P19, DOI 10.1016/0169-8141(93)90051-E; Qian K., 2013, INT J SMART HOME, V7, P203; Reenen HHHV, 2008, ERGONOMICS, V51, P637, DOI 10.1080/00140130701743433; Rempel D, 2014, INT J HUM-COMPUT ST, V72, P728, DOI 10.1016/j.ijhcs.2014.05.003; Sanders M. S., 1993, HUMAN FACTORS ENG DE; SCHOENMARKLIN RW, 1989, HUM FACTORS, V31, P413, DOI 10.1177/001872088903100405; Sharan D, 2012, WORK, V41, P512, DOI 10.3233/WOR-2012-0205-512; Soltani F., 2012, 2012 Sixth International Conference on Complex, Intelligent, and Software Intensive Systems (CISIS), P491, DOI 10.1109/CISIS.2012.55; Son M., 2014, EVALUATING USABILITY; Stern HI, 2008, INT J SEMANT COMPUT, V2, P137, DOI 10.1142/S1793351X08000385; Stern HI, 2006, IEEE SYS MAN CYBERN, P4052, DOI 10.1109/ICSMC.2006.384767; Svendsen SW, 2004, ARTHRITIS RHEUM-US, V50, P3314, DOI 10.1002/art.20495; Tirgar A, 2015, J BACK MUSCULOSKELET, V28, P755, DOI 10.3233/BMR-140579; Wachs J, 2008, 2 ANN VIS IC LANG C, P24; Weerakkody NS, 2003, SOMATOSENS MOT RES, V20, P27, DOI 10.1080/0899022031000083816; Widmer Antoine, 2014, P INT C MULTIMEDIA R, P503, DOI [10.1145/2578726.2578804, DOI 10.1145/2578726.2578804]; Wiker S.F., 1990, INT J IND ERGONOM, V5, P133, DOI [https://doi.org/10.1016/0169-8141(90)90004-L, DOI 10.1016/0169-8141(90)90004-L]; WIKER SF, 1989, ERGONOMICS, V32, P211, DOI 10.1080/00140138908966080; Wobbrock JO, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1083	89	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176123	10.1371/journal.pone.0176123	http://dx.doi.org/10.1371/journal.pone.0176123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423016	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600090
J	Ussher, JM; Perz, J				Ussher, Jane M.; Perz, Janette			Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial	PLOS ONE			English	Article							PSYCHOLOGICAL INTERVENTION; WOMENS EXPERIENCE; PMS; DEPRESSION; SYMPTOMS; CONSTRUCTION; NEGOTIATION; MANAGEMENT; IMPACT; SCALE	Design A randomised control trial (RCT) was conducted to examine the efficacy of couple-based cognitive behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait-list control. Methods Triangulation of quantitative and qualitative outcome measures evaluated changes pre-post intervention. Eighty three women were randomly allocated across three conditions, with 63 completing post-intervention measures, a retention rate of 76%. Results Repeated measures analysis of variance found a significant time by group interaction identifying that women in the two CBT conditions reported lower total premenstrual symptoms, emotional reactivity/mood, and premenstrual distress, in comparison to the wait list control. Significantly higher active behavioural coping post-intervention was found in the couple condition than in the one-to-one and wait list control groups. Qualitative analysis provided insight into the subjective experience of PMDs and participation in the intervention study. Across groups, women reported increased awareness and understanding of premenstrual change post-intervention. A larger proportion of women in the CBT conditions reported reduction in intensity and frequency of negative premenstrual emotional reactivity, increased communication and help-seeking, increased understanding and acceptance of embodied change, and the development of coping skills, post-intervention. Increased partner understanding and improved relationship post-intervention was reported by a greater proportion of participants in the CBT conditions, most markedly in the couple condition. Conclusion These findings suggest that one-to-one and couple CBT interventions can significantly reduce women's premenstrual symptomatology and distress, and improve premenstrual coping. Couple based CBT interventions may have a greater positive impact upon behavioural coping and perceptions of relationship context and support. This suggests that CBT should be available for women reporting moderate-severe PMDs, with couple-based CBT offering additional benefits to a one-to-one modality.	[Ussher, Jane M.; Perz, Janette] Western Sydney Univ, Sch Med, Translat Hlth Res Inst, Sydney, NSW, Australia	Western Sydney University	Ussher, JM (corresponding author), Western Sydney Univ, Sch Med, Translat Hlth Res Inst, Sydney, NSW, Australia.	j.ussher@westernsydney.edu.au		Ussher, Jane/0000-0002-2128-0019	Australian Research Council [DP0984913]	Australian Research Council(Australian Research Council)	This study was funded by an Australian Research Council Discovery Grant DP0984913 awarded to JU and JP, http://www.arc.gov.au/.	Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blake F, 1998, J PSYCHOSOM RES, V45, P307, DOI 10.1016/S0022-3999(98)00042-7; BLAKE F, 1995, COGN BEHAV PRACT, V2, P167, DOI 10.1016/S1077-7229(05)80009-4; Bordo Susan., 2003, UNBEARABLE WEIGHT FE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown M A, 1986, J Obstet Gynecol Neonatal Nurs, V15, P31, DOI 10.1111/j.1552-6909.1986.tb01364.x; Busse JW, 2009, PSYCHOTHER PSYCHOSOM, V78, P6, DOI 10.1159/000162296; CHOI PYL, 1995, BRIT J CLIN PSYCHOL, V34, P139, DOI 10.1111/j.2044-8260.1995.tb01446.x; Chrisler JC, 2002, ANN REV SEX RES, V13, P274; Chrisler JC, 2008, PSYCHOL WOMEN QUART, V32, P1, DOI 10.1111/j.1471-6402.2007.00402.x; CHRISTENSEN AP, 1995, J AFFECT DISORDERS, V33, P57, DOI 10.1016/0165-0327(94)00073-I; Cortese J, 1989, J Obstet Gynecol Neonatal Nurs, V18, P405, DOI 10.1111/j.1552-6909.1989.tb00494.x; Cosgrove L, 2003, WOMEN HEALTH, V38, P37, DOI 10.1300/J013v38n03_04; COUGHLIN PC, 1990, SOC WORK, V35, P351; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Dimmock PW, 2000, LANCET, V356, P1131, DOI 10.1016/S0140-6736(00)02754-9; Endicott J, 1990, DAILY RATING SEVERIT; Fikkan JL, 2012, SEX ROLES, V66, P575, DOI 10.1007/s11199-011-0022-5; FONTANA AM, 1994, J PSYCHOSOM RES, V38, P557, DOI 10.1016/0022-3999(94)90053-1; FRANK B, 1993, J COUNS PSYCHOL, V40, P109, DOI 10.1037/0022-0167.40.1.109; Frank CE, 1995, DISS ABSTR INT A, V55; Gupta M, 2003, J FAM THER, V25, P317, DOI 10.1111/1467-6427.00253; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(03)00098-2; Hammond DC, 1988, PREMENSTRUAL SYNDROM, P128; Hartlage SA, 2012, ARCH GEN PSYCHIAT, V69, P300, DOI 10.1001/archgenpsychiatry.2011.1368; Hendrix H., 1990, GETTING LOVE YOU WAN; Hildebrandt BA, 2015, INT J EAT DISORDER, V48, P477, DOI 10.1002/eat.22326; Hunter M, 2003, J REPROD INFANT PSYC, V21, P183, DOI 10.1080/0264683031000155006; Hunter MS, 2002, J PSYCHOSOM OBST GYN, V23, P193, DOI 10.3109/01674820209074672; Hunter MS, 1995, SEXUAL MARITAL THERA, V10, P253; Hunter MS, 2002, J PSYCHOSOMATIC RES, V53; Jack DC, 1999, INTERACTIONAL NATURE OF DEPRESSION, P221, DOI 10.1037/10311-008; JACK DC, 1992, PSYCHOL WOMEN QUART, V16, P97, DOI 10.1111/j.1471-6402.1992.tb00242.x; Jones A, 2000, PSYCHOL COUPLES ILLN, P217; King M., 2014, WOMENS REPROD HLTH, V1, P3, DOI [DOI 10.1080/23293691.2014.901796, 10.1080/23293691.2014, DOI 10.1080/23293691.2014]; KIRKBY RJ, 1994, J CONSULT CLIN PSYCH, V62, P1026, DOI 10.1037/0022-006X.62.5.1026; Kleinstauber M, 2016, INT J BEHAV MED, V23, P752, DOI 10.1007/s12529-016-9564-9; Kleinstauber M, 2012, J CLIN PSYCHOL MED S, V19, P308, DOI 10.1007/s10880-012-9299-y; KUCZMIERCZYK AR, 1992, J PSYCHOSOM RES, V36, P787, DOI 10.1016/0022-3999(92)90137-Q; Lewis CM, 1995, THESIS, V56; Lustyk MKB, 2009, ARCH WOMEN MENT HLTH, V12, P85, DOI 10.1007/s00737-009-0052-y; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Miller WL., 2005, SAGE HDB QUALITATIVE, P605; Miyaoka Y, 2009, J JPN SOC PSYCHOSOM, V14, P194; Morse C, 1989, J RATION-EMOT COGN-B, V7, P98; MORSE CA, 1991, J BEHAV MED, V14, P469, DOI 10.1007/BF00845105; Nevatte T, 2013, ARCH WOMEN MENT HLTH, V16, P279, DOI 10.1007/s00737-013-0346-y; O'Brien S, 2011, BRIT MED J, P342; Parry B., 1994, PREMENSTRUAL DYSPHOR, P47; Pearlstein T, 1992, J Psychother Pract Res, V1, P49; Perz J, 2006, J REPROD INFANT PSYC, V24, P289, DOI 10.1080/02646830600973883; Rapkin AJ, 2013, WOMENS HEALTH, V9, P537, DOI [10.2217/WHE.13.62, 10.2217/whe.13.62]; REISSMAN C, 1993, NARRATIVE ANAL QUALI; ROBINSON GE, 1990, CAN J PSYCHIAT, V35, P199, DOI 10.1177/070674379003500301; Robinson RL, 2000, J WOMEN HEALTH GEN-B, V9, P757, DOI 10.1089/15246090050147736; Rundle R, 2005, DISS ABSTR INT B, V66, P1185; RYSER R, 1992, AM J FAM THER, V20, P179, DOI 10.1080/01926189208250887; SLADE P, 1989, BEHAV PSYCHOTHER, V17, P135, DOI 10.1017/S0141347300016116; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4; Steiner M, 2000, INT CLIN PSYCHOPHARM, V15, pS5; STOUT AL, 1985, J PSYCHOSOM RES, V29, P621, DOI 10.1016/0022-3999(85)90071-6; Sveinsdottir H, 2002, SCAND J CARING SCI, V16, P414, DOI 10.1046/j.1471-6712.2002.00077.x; Ussher J.M., 2006, MANAGING MONSTROUS F; Ussher JM, 2008, FEM PSYCHOL, V18, P87, DOI 10.1177/0959353507084954; Ussher JM, 2006, J REPROD INFANT PSYC, V24, P347, DOI 10.1080/02646830600974147; Ussher JM, 2014, FEM PSYCHOL, V24, P332, DOI 10.1177/0959353514539650; Ussher JM, 2013, PSYCHOL HEALTH, V28, P909, DOI 10.1080/08870446.2013.765004; Ussher JM, 2013, SEX ROLES, V68, P132, DOI 10.1007/s11199-011-9977-5; Ussher JM, 2003, J FAM THER, V25, P388, DOI 10.1111/1467-6427.00257; Ussher JM, 2002, CLIN PSYCHOL PSYCHOT, V9, P319, DOI 10.1002/cpp.340; Ussher JM, 2010, DEPRESSION EPIDEMIC, P435, DOI DOI 10.1093/ACPROF:OSO/9780195398090.003.0022.; Ussher JM, 2008, QUALITATIVE RES PSYC, V5, P33; Ussher JM., 2003, J MED HUMANIT, V24, P131, DOI [10.1023/A:1021366001305, DOI 10.1023/A:1021366001305]; Ussher JM, 2007, INT J CRITICAL PSYCH, V21, P145; Winter E., 1991, NURSE PRACTITIONER, V16, P37; Wright SE, 1986, DISS ABSTR INT 1, V46, P3879; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	79	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175068	10.1371/journal.pone.0175068	http://dx.doi.org/10.1371/journal.pone.0175068			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419170	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200009
J	Hodgskiss, T; Wadley, L				Hodgskiss, Tammy; Wadley, Lyn			How people used ochre at Rose Cottage Cave, South Africa: Sixty thousand years of evidence from the Middle Stone Age	PLOS ONE			English	Article							HOWIESONS POORT; WESTERN-CAPE; BLOMBOS CAVE; RITUALIZED DISPLAY; ENGRAVED OCHRE; HUMAN-BEHAVIOR; SHELL BEADS; RED OCHRE; SIBUDU; ADHESIVES	We describe colour, hardness, grain size, geological type and surface modifications of ochre pieces excavated, first by Malan and later by Harper, from the Middle Stone Age (MSA) of Rose Cottage Cave, 96, 000 to 30, 000 years ago. Soft, bright-red shales are abundant, and most ochre has clayey or silty grain sizes. The post-Howiesons Poort layers contain the most ochre pieces, but the Howiesons Poort layers have the highest frequency of ochre per sediment volume. The pre-Howiesons Poort layers have the highest utilization rate. Use-traces include rubbing, grinding, combined grinding and rubbing, and rare instances of scoring. The processing techniques are proxies for ochre use. Rubbing transfers red ochre powder directly onto soft surfaces, such as human skin, or animal hide. This is appropriate when skin colouring and marking or skin protection (for example from sun, insects or bacteria) is the purpose. Grinding produces ochre powder that can be used for a variety of tasks. It can be mixed with water or other products to create paint, cosmetics or adhesives. Multiple uses of ochre powder and ochre pieces are therefore implied at Rose Cottage and changes through time are apparent.	[Hodgskiss, Tammy; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	University of Witwatersrand	Hodgskiss, T (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	tammyhodgie@gmail.com	Wadley, Lyn/AAC-6577-2022	Hodgskiss, Tammy/0000-0003-4184-8406	Centre of Excellence in Palaeosciences; National Research Foundation, South Africa [91595]	Centre of Excellence in Palaeosciences; National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was supported by the Centre of Excellence in Palaeosciences, post-doctoral fellowship (www.ancient-earth.co.za) (TH); National Research Foundation, South Africa (African Origins Platform grant 91595 (www.nrf.ac.za) (LW).	Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; Backwell LR, 2014, QUATERNARY SCI REV, V99, P42, DOI 10.1016/j.quascirev.2014.06.017; Barham LS, 2002, CURR ANTHROPOL, V43, P181, DOI 10.1086/338292; Beaumont PB, 1978, THESIS; Butzer KW, 1984, SO AFRICAN PREHISTOR; Butzer KW, 1979, WORKSH BETT UN UNPUB; Clark JD, 2001, J ARCHAEOL SCI, V28, P305, DOI 10.1006/jasc.2000.0563; Cooke CK, 1971, S AFR ARCHAEOL B, V26, P104, DOI [10.2307/3887799, DOI 10.2307/3887799]; COVENTRY RJ, 1981, AUST J SOIL RES, V19, P103, DOI 10.1071/SR9810103; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2015, ARCHAEOMETRY, V57, P51, DOI 10.1111/arcm.12072; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2016, J HUM EVOL, V93, P91, DOI 10.1016/j.jhevol.2016.01.002; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; Dayer L, 2014, J ARCHAEOL SCI, V44, P180, DOI 10.1016/j.jas.2014.01.032; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; Deacon H.J., 1995, S AFR ARCHAEOL B, V50, P121, DOI [10.2307/3889061, DOI 10.2307/3889061]; dErrico F., 2008, CURRENT THEMES MIDDL, V10, P168; Dubiel SM, 2011, APPL CLAY SCI, V51, P54, DOI 10.1016/j.clay.2010.11.001; Evans U., 1994, S AFR FIELD ARCHAEOL, V3, P63; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Harper PT, 1994, THESIS; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Hodgskiss T, 2014, CAMB ARCHAEOL J, V24, P405, DOI 10.1017/S0959774314000663; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Hodgskiss T, 2010, J ARCHAEOL SCI, V37, P3344, DOI 10.1016/j.jas.2010.08.003; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Hughes J.C., 2000, NATAL MUSEUM J HUMAN, V12, P15; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Kozowyk PRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150436; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Malan BD, 1947, P PAN AFR C PREH 194; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marshall Lorna., 1976, KUNG NYAE NYAE; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Moyo S, 2016, QUATERN INT, V404, P20, DOI 10.1016/j.quaint.2015.09.041; Parkington J, 2003, S AFR J SCI, V99, P243; Pienaar M, 2008, S AFR J SCI, V104, P65; Plisson H., 1982, CAHIERS CTR RECHERCH, V8, P33; Rifkin RE, 2015, S AFR ARCHAEOL BULL, V70, P64; Rifkin RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136090; Rifkin RF, 2015, S AFR J SCI, V111, P65; Rifkin RF, 2012, J ANTHROPOL ARCHAEOL, V31, P174, DOI 10.1016/j.jaa.2011.11.004; Rifkin RF, 2011, J AFR ARCHAEOL, V9, P131, DOI 10.3213/2191-5784-10199; Rigaud JP, 2006, CR PALEVOL, V5, P839, DOI 10.1016/j.crpv.2006.02.003; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Rosso DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164793; Schwertmann U, 1991, IRON OXIDES LAB PREP; Shaham D, 2010, J ARCHAEOL SCI, V37, P2010, DOI 10.1016/j.jas.2010.03.006; Singer R., 1982, MIDDLE STONE AGE KLA; Soressi M, 2007, NEANDERTALIENS BIOL; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Thackeray AI, 2000, J HUM EVOL, V38, P147, DOI 10.1006/jhev.1999.0354; Tomlinson N, 1998, THESIS; Tucker M.E., 1982, FIELD DESCRIPTION SE; Valladas H, 2005, S AFR J SCI, V101, P169; Van Peer P., 2004, FARMING, V2004, P1, DOI [DOI 10.3828/BFARM.2004.3.1, 10.3828/bfarm.2004.3.1]; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Visser OJL, 1955, S AFR GEOL SURV MEM, V47, P1; Vogelsang R.., 1998, MIDDLE STONE AGE FUN; Volman T, SO AFRICAN PREHISTOR, V2984; Wadley L, 1997, S AFR J SCI, V93, P439; Wadley L, 2001, CAMB ARCHAEOL J, V11, P201, DOI 10.1017/S0959774301000117; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L., 1991, S AFR ARCHAEOL BULL, V46, P125; Wadley L, 2014, S AFR ARCHAEOL BULL, V69, P19; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102; Watts I, 1999, EVOLUTION CULTURE, P113; Watts I, 1998, THESIS U LONDON; Watts I, 2009, CRADLE LANGUAGE, P62; Watts I, 2016, CURR ANTHROPOL, V57, P287, DOI 10.1086/686484; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Wendt W. E., 1976, S AFR ARCHAEOL BULL, V31, P5, DOI DOI 10.2307/3888265; Wendt WE, 1972, CIMBEBASIA B, V2, P1; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Will M, 2013, J HUM EVOL, V64, P518, DOI 10.1016/j.jhevol.2013.02.012; Williamson BS, 2000, THESIS; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	90	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176317	10.1371/journal.pone.0176317	http://dx.doi.org/10.1371/journal.pone.0176317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET5FI	28445491	Green Submitted, gold, Green Published			2022-12-27	WOS:000400309200046
J	Langer, JAF; Sharma, R; Schmidt, SI; Bahrdt, S; Horn, HG; Alguero-Muniz, M; Nam, B; Achterberg, EP; Riebesell, U; Boersma, M; Thines, M; Schwenk, K				Langer, Julia A. F.; Sharma, Rahul; Schmidt, Susanne I.; Bahrdt, Sebastian; Horn, Henriette G.; Alguero-Muniz, Maria; Nam, Bora; Achterberg, Eric P.; Riebesell, Ulf; Boersma, Maarten; Thines, Marco; Schwenk, Klaus			Community barcoding reveals little effect of ocean acidification on the composition of coastal plankton communities: Evidence from a long-term mesocosm study in the Gullmar Fjord, Skagerrak	PLOS ONE			English	Article							CO2 CONCENTRATION; ELEVATED CO2; MARINE; PHOSPHATE; SEAWATER; IMPACTS; NITRATE; SEARCH	The acidification of the oceans could potentially alter marine plankton communities with consequences for ecosystem functioning. While several studies have investigated effects of ocean acidification on communities using traditional methods, few have used genetic analyses. Here, we use community barcoding to assess the impact of ocean acidification on the composition of a coastal plankton community in a large scale, in situ, long-term mesocosm experiment. High-throughput sequencing resulted in the identification of a wide range of planktonic taxa (Alveolata, Cryptophyta, Haptophyceae, Fungi, Metazoa, Hydrozoa, Rhizaria, Straminipila, Chlorophyta). Analyses based on predicted operational taxonomical units as well as taxonomical compositions revealed no differences between communities in high CO2 mesocosms (similar to 760 mu atm) and those exposed to present-day CO2 conditions. Observed shifts in the planktonic community composition were mainly related to seasonal changes in temperature and nutrients. Furthermore, based on our investigations, the elevated CO2 did not affect the intraspecific diversity of the most common mesozooplankter, the calanoid copepod Pseudocalanus acuspes. Nevertheless, accompanying studies found temporary effects attributed to a raise in CO2. Differences in taxa composition between the CO2 treatments could, however, only be observed in a specific period of the experiment. Based on our genetic investigations, no compositional long-term shifts of the plankton communities exposed to elevated CO2 conditions were observed. Thus, we conclude that the compositions of planktonic communities, especially those in coastal areas, remain rather unaffected by increased CO2.	[Langer, Julia A. F.; Horn, Henriette G.; Alguero-Muniz, Maria; Boersma, Maarten] Biol Anstalt Helgoland, Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany; [Sharma, Rahul; Nam, Bora; Thines, Marco] Senckenberg Gesell Nat Kunde, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Sharma, Rahul; Nam, Bora; Thines, Marco] Fac Biol Sci, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Schmidt, Susanne I.; Bahrdt, Sebastian; Schwenk, Klaus] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Achterberg, Eric P.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Boersma, Maarten] Univ Bremen, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Koblenz & Landau; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bremen	Langer, JAF (corresponding author), Biol Anstalt Helgoland, Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany.	julia.lange@awi.de	Schwenk, Klaus/G-9603-2015; Schmidt, Susanne/Q-1657-2015; Achterberg, Eric P/C-5820-2009; Riebesell, Ulf/AAC-9717-2020; Boersma, Maarten/A-5475-2013; Schmidt, Susanne/ABH-1143-2020; Algueró-Muñiz, María/AAA-9748-2020; Horn, Henriette G./R-7667-2016	Schmidt, Susanne/0000-0003-0051-6480; Achterberg, Eric P/0000-0002-3061-2767; Boersma, Maarten/0000-0003-1010-026X; Schmidt, Susanne/0000-0003-0051-6480; Algueró-Muñiz, María/0000-0001-8064-6212; Horn, Henriette G./0000-0002-4020-5559	German Federal Ministry of Education and Science (BMBF); Swedish Academy of Science [WP 1.14 (FKZ 03F06556)]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Swedish Academy of Science	This study is part of the German Federal Ministry of Education and Science (BMBF) funded "Verbundprojekt" BIOACID Phase II (Biological Impacts of Ocean ACIDification), consortium 1, WP 1.14 (FKZ 03F06556) and received funding from the Swedish Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hansen H.P., 1999, METHODS SEAWATER ANA, P399; Hofmann LC, 2015, OECOLOGIA, V177, P1157, DOI 10.1007/s00442-015-3242-5; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Horn HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165800; Horn HG, 2015, ICES J MAR SCI; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huys R, 2006, BIOL J LINN SOC, V87, P403, DOI 10.1111/j.1095-8312.2005.00579.x; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Lejzerowicz F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13932; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051590; Lischka S., 2015, BIOGEOSCIENCES DISCU, V12, P20025, DOI [10.5194/bgd-12-20025-2015, DOI 10.5194/BGD-12-20025-2015]; Loder MGJ, 2011, MAR BIOL, V158, P1551, DOI 10.1007/s00227-011-1670-2; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Niehoff B, 2013, BIOGEOSCIENCES, V10, P1391, DOI 10.5194/bg-10-1391-2013; Oksanen J, 2016, COMMUNITY ECOLOGY PA; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Peck LS, 2015, GLOBAL CHANGE BIOL, V21, P1907, DOI 10.1111/gcb.12841; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Rao R, 1995, QUESTIIO, V17, P23; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Riebesell U, 2008, BIOGEOSCIENCES, V5, P1157, DOI 10.5194/bg-5-1157-2008; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Rouco M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00155; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Sambrook J., 1989, MOLECULAR CLONING A; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R.K., 2015, GREEN CHEM, V1, P1, DOI DOI 10.1109/ICRIT0.2015.7359296; Silyakova A, 2013, BIOGEOSCIENCES, V10, P4847, DOI 10.5194/bg-10-4847-2013; Sperling M, 2013, BIOGEOSCIENCES, V10, P181, DOI 10.5194/bg-10-181-2013; Stein ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051273; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885; Zaiko A, 2015, MAR POLLUT BULL, V100, P53, DOI 10.1016/j.marpolbul.2015.09.030	57	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175808	10.1371/journal.pone.0175808	http://dx.doi.org/10.1371/journal.pone.0175808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445483	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200029
J	Voss, C; Dean, PH; Gardner, RF; Duncombe, SL; Harris, KC				Voss, Christine; Dean, Paige H.; Gardner, Ross F.; Duncombe, Stephanie L.; Harris, Kevin C.			Validity and reliability of the Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) in individuals with congenital heart disease	PLOS ONE			English	Article							OLDER CHILDREN; SELF-REPORT; TASK-FORCE; ASSOCIATION; CALIBRATION; POPULATION; PREVALENCE; VALIDATION; PREVENTION; WORLDWIDE	Objective To assess the criterion validity, internal consistency, reliability and cut-point for the Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) in children and adolescents with congenital heart disease-a special population at high cardiovascular risk in whom physical activity has not been extensively evaluated. Methods We included 84 participants (13.6 +/- 2.9 yrs, 50% female) with simple (37%), moderate (31%), or severe congenital heart disease (27%), as well as cardiac transplant recipients (6%), from BC Children's Hospital, Canada. They completed the PAQ-C (<= 11yrs, n = 28) or-A (>= 12yrs, n = 56), and also wore a triaxial accelerometer (GT3X+ or GT9X) over the right hip for 7 days (n = 59 met valid wear time criteria). Results Median daily moderate-to-vigorous physical activity was 46.9 minutes per day (IQR 31.6-61.8) and 25% met physical activity guidelines defined as >= 60 minutes of moderate-to-vigorous physical activity per day. Median PAQ-score was 2.6 (IQR 1.9-3.0). PAQ-Scores were significantly related to accelerometry-derived metrics of physical activity (rho = 0.44-0.55, all p<0.01) and sedentary behaviour (rho = -0.53, p<0.001). Internal consistency was high (alpha = 0.837), as was reliability (stability) of PAQ-Scores over a 4-months period (ICC = 0.73, 95% CI 0.55-0.84; p<0.001). We identified that a PAQ-Score cut-point of 2.87 discriminates between those meeting physical guidelines and those that do not in the combined PAQ-C and-A samples (area under the curve = 0.80 (95% CI 0.67-0.92). Conclusion Validity and reliability of the PAQ in children and adolescents with CHD was comparable to or stronger than previous studies in healthy children. Therefore, the PAQ may be used to estimate general levels of physical activity in children and adolescents with CHD.	[Voss, Christine; Dean, Paige H.; Gardner, Ross F.; Duncombe, Stephanie L.; Harris, Kevin C.] BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada; [Voss, Christine; Harris, Kevin C.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia	Harris, KC (corresponding author), BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada.; Harris, KC (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.	kharris2@cw.bc.ca	Voss, Christine/E-7425-2010; Duncombe, Stephanie/ABA-4330-2021	Voss, Christine/0000-0003-3811-2465; Duncombe, Stephanie/0000-0003-0673-6409	Heart and Stroke Foundation of Canada, BC; Yukon division [F1504]	Heart and Stroke Foundation of Canada, BC; Yukon division	We received funding form the Heart and Stroke Foundation of Canada, BC & Yukon division (F1504; PI Harris) to support the ongoing research project from which the current data were drawn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio D, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0115-2; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Benitez-Porres J, 2016, NUTR HOSP, V33, P1036, DOI 10.20960/nh.564; Benitez-Porres J, 2016, J SCHOOL HEALTH, V86, P677, DOI 10.1111/josh.12418; Bervoets L, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-47; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Boneva RS, 2001, CIRCULATION, V103, P2376; Canadian Society for Exercise Physiology, 2016, 24 HOUR MOVEMENT GUI; Carson Valerie, 2011, BMC Public Health, V11, P274, DOI 10.1186/1471-2458-11-274; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Gabel L, 2015, MED SCI SPORT EXER, V47, P363, DOI 10.1249/MSS.0000000000000418; Gobbi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156354; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396; Martinez-Gomez D, 2009, REV ESP SALUD PUBLIC, V83, P427, DOI 10.1590/s1135-57272009000300008; Saint-Maurice PF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-461; Thomas EL, 2014, PSYCHOL SPORT EXERC, V15, P280, DOI 10.1016/j.psychsport.2014.02.002; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Voss C, 2013, PEDIATR INT, V55, P498, DOI 10.1111/ped.12092; Wang JJ, 2016, BIOMED ENVIRON SCI, V29, P177, DOI 10.3967/bes2016.022; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	38	42	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175806	10.1371/journal.pone.0175806	http://dx.doi.org/10.1371/journal.pone.0175806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445485	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200028
J	Cisneros, L; Bussey, KJ; Orr, AJ; Miocevic, M; Lineweaver, CH; Davies, P				Cisneros, Luis; Bussey, Kimberly J.; Orr, Adam J.; Miocevic, Milica; Lineweaver, Charles H.; Davies, Paul			Ancient genes establish stress-induced mutation as a hallmark of cancer	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; DNA-POLYMERASE-ZETA; TRANSLESION POLYMERASES; CATALYTIC SUBUNIT; ADAPTIVE MUTATION; RESISTANCE; EVOLUTION; GENOME; MULTICELLULARITY; RESPONSES	Cancer is sometimes depicted as a reversion to single cell behavior in cells adapted to live in a multicellular assembly. If this is the case, one would expect that mutation in cancer disrupts functional mechanisms that suppress cell-level traits detrimental to multicellularity. Such mechanisms should have evolved with or after the emergence of multicellularity. This leads to two related, but distinct hypotheses: 1) Somatic mutations in cancer will occur in genes that are younger than the emergence of multicellularity (1000 million years [ MY]); and 2) genes that are frequently mutated in cancer and whose mutations are functionally important for the emergence of the cancer phenotype evolved within the past 1000 million years, and thus would exhibit an age distribution that is skewed to younger genes. In order to investigate these hypotheses we estimated the evolutionary ages of all human genes and then studied the probability of mutation and their biological function in relation to their age and genomic location for both normal germline and cancer contexts. We observed that under a model of uniform random mutation across the genome, controlled for gene size, genes less than 500 MY were more frequently mutated in both cases. Paradoxically, causal genes, defined in the COSMIC Cancer Gene Census, were depleted in this age group. When we used functional enrichment analysis to explain this unexpected result we discovered that COSMIC genes with recessive disease phenotypes were enriched for DNA repair and cell cycle control. The non-mutated genes in these pathways are orthologous to those underlying stress-induced mutation in bacteria, which results in the clustering of single nucleotide variations. COSMIC genes were less common in regions where the probability of observing mutational clusters is high, although they are approximately 2-fold more likely to harbor mutational clusters compared to other human genes. Our results suggest this ancient mutational response to stress that evolved among prokaryotes was co-opted to maintain diversity in the germline and immune system, while the original phenotype is restored in cancer. Reversion to a stress-induced mutational response is a hallmark of cancer that allows for effectively searching ''protected'' genome space where genes causally implicated in cancer are located and underlies the high adaptive potential and concomitant therapeutic resistance that is characteristic of cancer.	[Cisneros, Luis; Bussey, Kimberly J.] NantOmics, Tempe, AZ 85283 USA; [Cisneros, Luis; Davies, Paul] Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ USA; [Bussey, Kimberly J.] Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA; [Orr, Adam J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Miocevic, Milica] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Lineweaver, Charles H.] Australian Natl Univ, Planetary Sci Inst, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Lineweaver, Charles H.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Australian National University; Australian National University	Bussey, KJ (corresponding author), NantOmics, Tempe, AZ 85283 USA.; Bussey, KJ (corresponding author), Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA.	kim.bussey@nantomics.com	Bussey, Kimberly J./D-2567-2011	Bussey, Kimberly/0000-0003-1001-8207; Orr, Adam/0000-0001-9074-4799; Lineweaver, Charles/0000-0003-2047-1558; Cisneros, Luis/0000-0002-7890-1269	Institut National de la Sante A et de la Recherche Medicale (Inserm) of the ICGC program; Barretos Cancer Hospital; Ministry of Education, University, and Research University of Verona; NIH grant [U54CA143862]; NantOmics, LLC; NantOmics; Institut National de la Sante et de la Recherche Medicale (Inserm) within ICGC; Federal Ministry of Education and Research (BMBF); National Health and Medical Research Council (NHMRC); Queensland State Government; University of Queensland; Institute for Molecular Bioscience; Cancer Council NSW; Garvan Institute of Medical Research; Cancer Institute NSW; Italian Ministry of Education, University, and Research; University of Verona; German Cancer Aid (DKH); Ontario Institute for Cancer Research; Prostate Cancer Canada; Pio XII Foundation - Barretos Cancer Hospital; Rene Rachou Research Center [FI0CRUZ]; International Genome Sample Resource (IGSR) - Wellcome Trust [WT104947/Z/14/Z]	Institut National de la Sante A et de la Recherche Medicale (Inserm) of the ICGC program; Barretos Cancer Hospital; Ministry of Education, University, and Research University of Verona; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NantOmics, LLC; NantOmics; Institut National de la Sante et de la Recherche Medicale (Inserm) within ICGC(Institut National de la Sante et de la Recherche Medicale (Inserm)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government; University of Queensland(University of Queensland); Institute for Molecular Bioscience; Cancer Council NSW(Cancer Council New South Wales); Garvan Institute of Medical Research; Cancer Institute NSW; Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); University of Verona; German Cancer Aid (DKH)(Deutsche Krebshilfe); Ontario Institute for Cancer Research; Prostate Cancer Canada; Pio XII Foundation - Barretos Cancer Hospital; Rene Rachou Research Center; International Genome Sample Resource (IGSR) - Wellcome Trust	We thank Susan Rosenberg and Bob Austin for insightful discussions into the role of genomic instability in cancer within an evolutionary context. We also acknowledge the work of the clinical collaborators, data analysis teams, and funders in generating the WGS data in the ICGC database, release 19. In particular, data from Ewing sarcoma sequencing project was supported by grants from the Institut National de la Sante A et de la Recherche Medicale (Inserm) in the frame of the ICGC program. The ICGC/SKCA-BR project was supported by Barretos Cancer Hospital. The ICGC/PACA-IT project was supported by Italian Ministry of Education, University, and Research University of Verona.; This work was supported by NIH grant U54CA143862 (https.//projectreporter.nih.gov) and NantOmics, LLC. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NantOmics provided support in the form of salaries for authors KJB and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Data used in this study from the International Cancer Genomics Consortium (ICGC) was generated with the support of the following: Institut National de la Sante et de la Recherche Medicale (Inserm) within the framework of the ICGC, Federal Ministry of Education and Research (BMBF), National Health and Medical Research Council (NHMRC), Queensland State Government, University of Queensland, Institute for Molecular Bioscience, The Cancer Council NSW, Garvan Institute of Medical Research, Cancer Institute NSW, Italian Ministry of Education, University, and Research, University of Verona, German Cancer Aid (DKH), Ontario Institute for Cancer Research, Prostate Cancer Canada, Pio XII Foundation - Barretos Cancer Hospital, and Rene Rachou Research Center (FI0CRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data from the 1000 Genomes Project is maintained and supported by the International Genome Sample Resource (IGSR), funded by the Wellcome Trust grant number WT104947/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON ED, 1987, DEVELOPMENT, V99, P449; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almassalha LM, 2016, CANCER RES, V76, P5605, DOI 10.1158/0008-5472.CAN-16-0585; Alvarado AS, 2012, CURR BIOL, V22, pR772, DOI 10.1016/j.cub.2012.08.008; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CAIRNS J, 1991, GENETICS, V128, P695; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chen H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7367; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies PCW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015001; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Foster PL, 2004, J BACTERIOL, V186, P4846, DOI 10.1128/JB.186.15.4846-4852.2004; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; HALL BG, 1988, GENETICS, V120, P887; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara T, 2005, PROSTATE, V65, P268, DOI 10.1002/pros.20282; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Lineweaver CH, 2014, BIOESSAYS, V36, P827, DOI 10.1002/bies.201400070; Massey RC, 2002, TRENDS MICROBIOL, V10, P580, DOI 10.1016/S0966-842X(02)02475-7; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moore SW, 2009, PEDIATR BLOOD CANCER, V52, P755, DOI 10.1002/pbc.21831; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Paguirigan AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0763; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Peng CH, 2016, CANCER RES, V76, P2340, DOI 10.1158/0008-5472.CAN-15-1884; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Rainey PB, 1993, ADV MICROB ECOL, P263; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sakofsky CJ, 2015, MOL CELL, V60, P860, DOI 10.1016/j.molcel.2015.10.041; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shi TY, 2013, MED ONCOL, V30, DOI [10.1007/s12032-013-0500-4, 10.1007/s12032-013-0697-2]; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Tomicic MT, 2014, CANCER RES, V74, P5585, DOI 10.1158/0008-5472.CAN-14-0953; Troussellier M, 1998, OCEANOL ACTA, V21, P965, DOI 10.1016/S0399-1784(99)80019-X; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wenger Y, 2013, GENOME BIOL EVOL, V5, P1949, DOI 10.1093/gbe/evt142; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Xu XY, 2013, P NATL ACAD SCI USA, V110, P18638, DOI 10.1073/pnas.1303958110; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhou WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083978; Zhu XZ, 2016, ONCOL REP, V35, P1664, DOI 10.3892/or.2016.4549	73	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176258	10.1371/journal.pone.0176258	http://dx.doi.org/10.1371/journal.pone.0176258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441401	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800039
J	Odili, JB; Kahar, MNM; Noraziah, A				Odili, Julius Beneoluchi; Kahar, Mohd Nizam Mohmad; Noraziah, A.			Parameters-tuning of PID controller for automatic voltage regulators using the African buffalo optimization	PLOS ONE			English	Article								In this paper, an attempt is made to apply the African Buffalo Optimization (ABO) to tune the parameters of a PID controller for an effective Automatic Voltage Regulator (AVR). Existing metaheuristic tuning methods have been proven to be quite successful but there were observable areas that need improvements especially in terms of the system's gain overshoot and steady steady state errors. Using the ABO algorithm where each buffalo location in the herd is a candidate solution to the Proportional-Integral-Derivative parameters was very helpful in addressing these two areas of concern. The encouraging results obtained from the simulation of the PID Controller parameters-tuning using the ABO when compared with the performance of Genetic Algorithm PID (GA-PID), Particle-Swarm Optimization PID (PSO-PID), Ant Colony Optimization PID (ACO-PID), PID, Bacteria-Foraging Optimization PID (BFO-PID) etc makes ABO-PID a good addition to solving PID Controller tuning problems using metaheuristics.	[Odili, Julius Beneoluchi; Kahar, Mohd Nizam Mohmad; Noraziah, A.] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Malaysia; [Noraziah, A.] Univ Malaysia Pahang, IBM Ctr Excellence, Kuantan, Malaysia	Universiti Malaysia Pahang; Universiti Malaysia Pahang	Odili, JB (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Malaysia.	odili_julest@yahoo.com	Odili, Julius/D-4037-2015; Mohmad Kahar, Mohd Nizam/M-5102-2016	Odili, Julius/0000-0002-1195-397X; Mohmad Kahar, Mohd Nizam/0000-0003-0811-0856	Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang [GRS 1403118]; Ministry of Higher Education, Malaysia under Fundamental Research Grant Scheme [RDU 140101]	Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang; Ministry of Higher Education, Malaysia under Fundamental Research Grant Scheme	The authors are grateful to the Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang, for funding this study under Grant GRS 1403118. Also the Ministry of Higher Education, Malaysia for additional funding under Fundamental Research Grant Scheme RDU 140101.; The author is grateful to the Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang, Kuantan, Malaysia, for funding this study under Grant GRS 1403118. Also, our gratitude to the Ministry of Higher Education, Malaysia, for additional funding under Fundamental Research Grant Scheme RDU 140101	Aravind P., 2013, INT J ADV RES ELECT, V2, P842; Bayram MB, 2013, POW ENG EN EL DRIV P; Bhatt V.K., 2013, INT J ENG RES APPL I, V3, P1480; Chang WD, 2007, APPL MATH MODEL, V31, P541, DOI 10.1016/j.apm.2005.11.024; Giwa A., 2012, INT J ENG RES TECHNO, V1, P1924; Korkmaz M, 2012, INN INT SYST APPL IN; Kushwah M., 2014, ADV ELECT ELECT ENG, V4, P141; Lees F., 2012, LEESLOSS PREVENTION; Li X, 2011, CONTR AUT ICCA 2011; Liptak B., 2013, PROCESS CONTROL INST; Manuaba IB, 2015, CONTROL INTELLIGENT, V43; Nagaraj B, 2010, COMM CONTR COMP TECH; Neath MJ, 2014, IEEE T POWER ELECTR, V29, P1523, DOI 10.1109/TPEL.2013.2262953; Odili JB, 2013, SCI J ELECT ELECT EN, V2013, P175; Odili JB, 2015, AFRICAN BUFFALO OPTI; Odili JB, 2016, COMPUTATIONAL INTELL, V2016, P12; Odili JB, 2015, SOFTW ENG COMP SYST; Odili JB, 2015, COMPUTATIONAL INTELL, V501; Odili JB, AFRICAN BUFFALO OPTI; Odili JB., 2015, BRIT J MATH COMPUTER, V10, P1, DOI DOI 10.9734/BJMCS/2015/17145; Ramakrishnan V, 2015, P INT C INF ENG MAN; S/rensen K., 2013, ENCY OPERATIONS RES, P960, DOI [10.1007/978-1-4419-1153-7_1167, DOI 10.1007/978-1-4419-1153-7_1167, 10.1007/978-1-4419-1153-7]; Shahrokhi M, 2013, COMP PID CONTROLLER, P1; Sorensen K, 2015, INT T OPER RES, V22, P3, DOI 10.1111/itor.12001; Solihin M.I., 2011, INT J ADV SCI ENG IN, V1, P458, DOI [10.18517/ijaseit.1.4.93, DOI 10.18517/IJASEIT.1.4.93]; Tenne Y., 2010, COMPUTATIONAL INTELL; Unal M, 2012, COMP PID CONTROLLER; Xu H, 2012, IEEE T PATTERN ANAL, V34, P187, DOI 10.1109/TPAMI.2011.177; Zou CF, 2016, IEEE T CONTR SYST T, V24, P1594, DOI 10.1109/TCST.2015.2502899	29	17	17	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175901	10.1371/journal.pone.0175901	http://dx.doi.org/10.1371/journal.pone.0175901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441390	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800012
J	Telenczuk, M; Fontaine, B; Brette, R				Telenczuk, Maria; Fontaine, Bertrand; Brette, Romain			The basis of sharp spike onset in standard biophysical models	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CHANNELS RYANODINE RECEPTORS; PYRAMIDAL NEURONS; SODIUM-CHANNEL; AXON; SEGMENT; BACKPROPAGATION; INACTIVATION; FEATURES; REVEALS	In most vertebrate neurons, spikes initiate in the axonal initial segment (AIS). When recorded in the soma, they have a surprisingly sharp onset, as if sodium (Na) channels opened abruptly. The main view stipulates that spikes initiate in a conventional manner at the distal end of the AIS, then progressively sharpen as they backpropagate to the soma. We examined the biophysical models used to substantiate this view, and we found that spikes do not initiate through a local axonal current loop that propagates along the axon, but through a global current loop encompassing the AIS and soma, which forms an electrical dipole. Therefore, the phenomenon is not adequately modeled as the backpropagation of an electrical wave along the axon, since the wavelength would be as large as the entire system. Instead, in these models, we found that spike initiation rather follows the critical resistive coupling model proposed recently, where the Na current entering the AIS is matched by the axial resistive current flowing to the soma. Besides demonstrating it by examining the balance of currents at spike initiation, we show that the observed increase in spike sharpness along the axon is artifactual and disappears when an appropriate measure of rapidness is used; instead, somatic onset rapidness can be predicted from spike shape at initiation site. Finally, we reproduce the phenomenon in a two-compartment model, showing that it does not rely on propagation. In these models, the sharp onset of somatic spikes is therefore not an artifact of observing spikes at the incorrect location, but rather the signature that spikes are initiated through a global soma-AIS current loop forming an electrical dipole.	[Telenczuk, Maria; Brette, Romain] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, Paris, France; [Fontaine, Bertrand] Univ Leuven, Lab Auditory Neurophysiol, Leuven, Belgium	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; KU Leuven	Brette, R (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, Paris, France.	romain.brette@inserm.fr	Brette, Romain/I-7120-2016	Brette, Romain/0000-0003-0110-1623	Agence Nationale de la Recherche [ANR-14-CE13-0003]; European Research Council [240132]; Ecole des Neurosciences de Paris (ENP); DIM Cerveau et Pensee; European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship [AUDICON-655137]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Ecole des Neurosciences de Paris (ENP); DIM Cerveau et Pensee; European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship	RB was supported by Agence Nationale de la Recherche (ANR-14-CE13-0003, http://www.agence-nationale-recherche.fr/) and the European Research Council (StG 240132, https://erc.europa.eu/). MT was supported by Ecole des Neurosciences de Paris (ENP, http://www.paris-neuroscience.fr/) and DIM Cerveau et Pensee (http://dimcerveaupensee.fr/). BF was supported by the European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship (AUDICON-655137, https://ec.europa.eu/programmes/horizon2020/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsiero M, 2007, J NEUROSCI, V27, P3274, DOI 10.1523/JNEUROSCI.4937-06.2007; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Baranauskas G, 2013, P NATL ACAD SCI USA, V110, P4051, DOI 10.1073/pnas.1215125110; BARRETT JN, 1980, J PHYSIOL-LONDON, V304, P231, DOI 10.1113/jphysiol.1980.sp013322; Bekkers JM, 2007, P NATL ACAD SCI USA, V104, P11447, DOI 10.1073/pnas.0701586104; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brette R., 2015, WHAT IS MOST REALIST; Brette R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003338; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Eyal G, 2014, J NEUROSCI, V34, P8063, DOI 10.1523/JNEUROSCI.5431-13.2014; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hay E, 2013, J NEUROPHYSIOL, V109, P2972, DOI 10.1152/jn.00048.2013; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, P9; Hodgkin AL, 1939, J PHYSIOL-LONDON, V94, P560, DOI 10.1113/jphysiol.1939.sp003702; Holt GR, 1997, CRITICAL REEXAMINATI; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037629; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; KOCH C, 1995, J COMPUT NEUROSCI, V2, P63, DOI 10.1007/BF00962708; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kuba H, 2012, J PHYSIOL-LONDON, V590, P5571, DOI 10.1113/jphysiol.2012.237305; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Milescu LS, 2010, J NEUROSCI, V30, P7740, DOI 10.1523/JNEUROSCI.6136-09.2010; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; Oz P, 2015, J COMPUT NEUROSCI, V39, P63, DOI 10.1007/s10827-015-0561-9; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Stimberg M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00006; Telenczuk B, 2016, ZENODO; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Wyatt KD, 2005, EUR J NEUROSCI, V21, P2285, DOI 10.1111/j.1460-9568.2005.04053.x; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	46	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175362	10.1371/journal.pone.0175362	http://dx.doi.org/10.1371/journal.pone.0175362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441389	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800004
J	Estiu, MC; Frailuna, MA; Otero, C; Dericco, M; Williamson, C; Marin, JJG; Macias, RIR				Estiu, Maria C.; Frailuna, Maria A.; Otero, Carla; Dericco, Marcela; Williamson, Catherine; Marin, Jose J. G.; Macias, Rocio I. R.			Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID; MATERNAL CHOLESTASIS; BILE-ACIDS; OXIDATIVE STRESS; AMNIOTIC-FLUID; PROGESTERONE; IMPAIRMENT; APOPTOSIS; PRURITUS	Background Intrahepatic cholestasis of pregnancy (ICP) is the commonest gestational liver disease. The risk of adverse fetal outcome has been associated with the severity of maternal hypercholanemia after diagnosis. Objective To investigate whether there is a relationship between the severity and timing of onset of hypercholanemia and the risk of meconium-stained amniotic fluid (MSAF) and adverse neonatal events. Study design The study included 382 pregnancies complicated by ICP managed at a referral hospital in Buenos Aires (Argentina) between June 2009 and December 2013. The patients were classified into three groups according to the severity of hypercholanemia at diagnosis; mild (10-19.9 mu mol/L), moderate (20-39.9 mu mol/L) and severe (>= 40 mu mol/L). Their clinical characteristics and pregnancy outcomes were investigated in a prospective observational study. Results Higher risk of MSAF was observed when ICP appeared early in gestation or when hypercholanemia was more severe. Taking both parameters into account an MSAF risk factor (MRF) was defined. Based on a model of positive/negative predictive values, a cut-off point of MRF = 3 was selected, which prioritized sensitivity versus specificity. In ICP patients with MRF>3, the probability of MSAF was enhanced 4-fold. An increase in the frequency of MSAF was also associated with higher serum levels at diagnosis of alanine transaminase, alkaline phosphatase and direct bilirubin. Conclusions The risk of MSAF is associated not only with the magnitude of hypercholanemia at diagnosis but also with the early gestational onset of raised maternal serum bile acids.	[Estiu, Maria C.; Frailuna, Maria A.; Otero, Carla; Dericco, Marcela] Ramon Sarda Mothers & Childrens Hosp, Buenos Aires, DF, Argentina; [Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Marin, Jose J. G.; Macias, Rocio I. R.] Univ Salamanca, Expt Hepatol & Drug Targeting HEVEFARM, IBSAL, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Salamanca, Spain	University of London; King's College London; University of Salamanca	Macias, RIR (corresponding author), Univ Salamanca, Expt Hepatol & Drug Targeting HEVEFARM, IBSAL, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Salamanca, Spain.	rociorm@usal.es	Macias, Rocio/ABG-8938-2020; Marin, Jose/D-5017-2011	Macias, Rocio/0000-0002-4748-0326; Williamson, Catherine/0000-0002-6226-7611; Marin, Jose/0000-0003-1186-6849	Spanish Ministerio de Ciencia e Innovacion, "Junta de Castilla y Leon" [SAF2013-40620-R, SA015U13]	Spanish Ministerio de Ciencia e Innovacion, "Junta de Castilla y Leon"	This study was supported by the Spanish Ministerio de Ciencia e Innovacion (SAF2013-40620-R), "Junta de Castilla y Leon" (SA015U13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2016, HEPATOLOGY, V63, P1287, DOI 10.1002/hep.28265; Arrese Marco, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000628; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Dargaville PA, 2006, PEDIATRICS, V117, P1712, DOI 10.1542/peds.2005-2215; Estiu MC, 2015, BRIT J CLIN PHARMACO, V79, P316, DOI 10.1111/bcp.12480; Friberg AK, 2016, ARCH GYNECOL OBSTET, V294, P709, DOI 10.1007/s00404-016-4019-8; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; HEIKKINEN J, 1980, OBSTET GYNECOL, V56, P60; Herraez E, 2014, J MOL MED, V92, P359, DOI 10.1007/s00109-013-1106-1; Hutton EK, 2014, EARLY HUM DEV, V90, P333, DOI 10.1016/j.earlhumdev.2014.04.005; Kawakita T, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.021; KIRWAN WO, 1975, GUT, V16, P894, DOI 10.1136/gut.16.11.894; L Brouwers, 2015, PLOS MED, V212, pe1, DOI DOI 10.1016/J.AJ0G.2014.07.026.25046809; Lammert Frank, 2003, Curr Treat Options Gastroenterol, V6, P123, DOI 10.1007/s11938-003-0013-x; Leslie KK, 2000, OBSTET GYNECOL, V95, P372, DOI 10.1016/S0029-7844(99)00533-5; Lo JO, 2015, J MATERN-FETAL NEO M, V28, P2254, DOI 10.3109/14767058.2014.984605; Luca D, 2009, INTENS CARE MED, V35, P321, DOI 10.1007/s00134-008-1321-3; Macias RIR, 2000, HEPATOLOGY, V31, P975, DOI 10.1053/he.2000.5921; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; Martineau M, 2014, EUR J OBSTET GYN R B, V176, P80, DOI 10.1016/j.ejogrb.2013.12.037; Monte MJ, 1996, HEPATOLOGY, V23, P1208; Naritaka N, 2015, CLIN CHIM ACTA, V446, P76, DOI 10.1016/j.cca.2015.04.008; Oruc AS, 2014, J OBSTET GYNAECOL RE, V40, P1883, DOI 10.1111/jog.12444; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Pascual MJ, 2002, CLIN SCI, V102, P587, DOI 10.1042/CS20010258; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028; Puljic A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.012; REYES H, 1979, J CHRON DIS, V32, P499, DOI 10.1016/0021-9681(79)90111-5; Reyes H, 1997, J GASTROEN HEPATOL, V12, P211, DOI 10.1111/j.1440-1746.1997.tb00410.x; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Rodrigues CMP, 1999, GUT, V45, P446, DOI 10.1136/gut.45.3.446; Sentilhes L, 2008, J GYNECOL OBST BIO R, V37, P118, DOI 10.1016/j.jgyn.2006.09.007; Serrano MA, 2003, J PHARMACOL EXP THER, V305, P515, DOI 10.1124/jpet.102.047977; Shemer EAW, 2015, J HEPATOL, V63, P456, DOI 10.1016/j.jhep.2015.03.010; Wensink MJ, 2016, AM J OBSTET GYNECOL, V215, P807, DOI 10.1016/j.ajog.2016.07.033; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x	41	23	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176504	10.1371/journal.pone.0176504	http://dx.doi.org/10.1371/journal.pone.0176504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437442	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600050
J	Jacob, J; Rajendran, RU; Priya, SH; Purushothaman, J; Amma, DKBNS				Jacob, Jubi; Rajendran, Reshma Uma; Priya, Syama Hari; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy			Enhanced antibacterial metabolite production through the application of statistical methodologies by a Streptomyces nogalater NIIST A30 isolated from Western Ghats forest soil	PLOS ONE			English	Article							ANTIFUNGAL PRODUCTION; ANTIBIOTIC-ACTIVITY; OPTIMIZATION; ACTINOMYCETE; IMPROVEMENT	Streptomyces strains isolated from Nelliyampathy forest soil of Western Ghats, Kerala, India were evaluated for their antibacterial efficacy against two indicator pathogenic bacteria (Escherichia coli and Staphylococcus aureus). Among 140 strains tested, sixteen recorded potent antibacterial properties and were further screened against eleven bacterial pathogens. A strain identified as Streptomyces nogalater and designated as NIIST A30 exhibited maximum inhibition against all the test pathogens. Among the eight fermentation media tested, inorganic salts starch broth recorded the best for antibacterial production. The ethyl acetate crude extract exhibited antioxidant properties with IC50 value of 30 mu g/ mL and had no cytotoxicity towards L6, H9c2 and RAW 264.7 cell lines up to a concentration of 50 mu g/ mL. Maximum metabolite production was achieved in pH 7.0 at 35 degrees C after 7 days incubation. The significant media components for maximum metabolite production were optimized through response surface methodology employing Plackett-Burman and Box-Behnken designs. The composition of the final optimized medium was soluble starch, 14.97g; (NH4)(2)SO4, 2.89g; K2HPO4, 2.07g; MgSO4 center dot 7H(2)O, 1g; NaCl, 1g, CaCO3, 2g; FeSO4 center dot 7H(2)O, 1mg; MnCl2.7H(2)O, 1mg; and ZnSO4.7H(2)O, 1mg per litre of distilled water. The optimization resulted an antibacterial activity of 28 +/- 1.5mm against S. epidermidis which was in close accordance with the predicted value of 30 mm. It is also evident from the result that an increase of 86.66% antibacterial production was recorded in optimized media. The chosen method was economical, efficient and useful for future antibacterial drug discovery from a broad spectrum metabolite producer like Streptomyces nogalater NIIST A30.	[Jacob, Jubi; Rajendran, Reshma Uma; Priya, Syama Hari; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy] CSIR, NIIST, Agroproc & Technol Div, Thiruvananthapuram, Kerala, India; [Jacob, Jubi; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy] CSIR, NIIST, Acad Sci & Innovat Res AcSIR, Thiruvananthapuram, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Amma, DKBNS (corresponding author), CSIR, NIIST, Agroproc & Technol Div, Thiruvananthapuram, Kerala, India.; Amma, DKBNS (corresponding author), CSIR, NIIST, Acad Sci & Innovat Res AcSIR, Thiruvananthapuram, Kerala, India.	kumardileep@niist.res.in	HP, Syama/GOV-6372-2022		Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram; Department of Science and Technology, New Delhi [IF 130648]	Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram; Department of Science and Technology, New Delhi(Department of Science & Technology (India))	Financial support from Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram and the Department of Science and Technology, New Delhi for Inspire Fellowship (IF 130648) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was received from Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram and the Department of Science and Technology, New Delhi for Inspire Fellowship (IF 130648) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Shadi M.A., 2010, J AM SCI, V6, P915; Al-Duais M, 2009, EUR FOOD RES TECHNOL, V228, P813, DOI 10.1007/s00217-008-0994-8; Anvari M, 2014, J DAIRY RES, V81, P59, DOI 10.1017/S0022029913000733; Arul Jose Polpass, 2013, Int J Microbiol, V2013, P526260, DOI 10.1155/2013/526260; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; Bizuye A, 2013, ASIAN PAC J TROP DIS, V3, P375, DOI DOI 10.1016/S2222-1808(13)60087-0; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Che Q, 2012, ORG LETT, V14, P3438, DOI 10.1021/ol301396h; Chun J, 2000, INT J SYST EVOL MICR, V50, P1909, DOI 10.1099/00207713-50-5-1909; CLSI, 2012, M02A1 CLSI, V7th; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Dehnad A, 2010, AFR J MICROBIOL RES, V4, P1542; Drummond A. J., 2012, GENEIOUS V5 6; Feng JT, 2011, AFR J AGR RES, V6, P4424; Fukuda T, 2005, J ANTIBIOT, V58, P252, DOI 10.1038/ja.2005.29; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54, DOI 10.1099/00207713-24-1-54; Grahovac J, 2014, CROP PROT, V65, P143, DOI 10.1016/j.cropro.2014.07.020; IWAI Y, 1982, J ANTIBIOT, V35, P123, DOI 10.7164/antibiotics.35.123; Jose PA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906097; Larpent JP, 1990, MEMENTO TECHNIQUE MI; Li TL, 2015, APPL BIOCHEM BIOTECH, V175, P2845, DOI 10.1007/s12010-014-1445-6; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014; Messis A, 2014, MED CHEM RES, V23, P310, DOI 10.1007/s00044-013-0627-z; Moraes-De-Souza RA, 2008, CIENC TECNOL ALIMENT, V6, P41, DOI 10.1080/11358120809487626; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nampoothiri KM, 2013, J SCI IND RES INDIA, V72, P617; Nishanth Kumar, 2013, Archives of Phytopathology and Plant Protection, V46, P721, DOI 10.1080/03235408.2012.750815; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Ripa F. A., 2009, Mycobiology, V37, P211, DOI 10.4489/MYCO.2009.37.3.211; Sevilla-Perea A, 2015, INT J ENVIRON SCI TE, V12, P125, DOI 10.1007/s13762-013-0443-5; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Singh LS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0278-3; Souagui Y, 2015, J MYCOL MED, V25, P108, DOI 10.1016/j.mycmed.2014.12.004; Suganthi V, 2015, J FOOD SCI TECH MYS, V52, P3773, DOI 10.1007/s13197-014-1440-5; Tarkka Mika, 2008, V14, P107; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Wang YH, 2011, MICROB CELL FACT, V10, DOI [10.1155/2011/672369, 10.1186/1475-2859-10-98]; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Xiong ZQ, 2008, J IND MICROBIOL BIOT, V35, P729, DOI 10.1007/s10295-008-0339-4; Zhu CH, 2007, APPL MICROBIOL BIOT, V73, P1031, DOI 10.1007/s00253-006-0572-6	41	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175919	10.1371/journal.pone.0175919	http://dx.doi.org/10.1371/journal.pone.0175919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437452	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600022
J	Montenegro, CF; Casali, BC; Lino, RLB; Pachane, BC; Santos, PK; Horwitz, AR; Selistre-de-Araujo, HS; Lamers, ML				Montenegro, Cyntia F.; Casali, Bruna C.; Lino, Rafael L. B.; Pachane, Bianca C.; Santos, Patty K.; Horwitz, Alan R.; Selistre-de-Araujo, Heloisa S.; Lamers, Marcelo L.			Inhibition of alpha(v)beta(3) integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)	PLOS ONE			English	Article							SNAKE-VENOM DISINTEGRIN; ALPHA-ACTININ; MYOSIN-II; MIGRATION; ADHESION; MATRIX; MICROENVIRONMENT; ALPHA(5)BETA(1); ANGIOGENESIS; GLIOBLASTOMA	The connective tissue formed by extracellular matrix (ECM) rich in fibronectin and collagen consists a barrier that cancer cells have to overpass to reach blood vessels and then a metastatic site. Cell adhesion to fibronectin is mediated by alpha(v)beta(3) and alpha(5)beta(1) integrins through an RGD motif present in this ECM protein, thus making these receptors key targets for cell migration studies. Here we investigated the effect of an RGD disintegrin, DisBa-01, on the migration of human fibroblasts (BJ) and oral squamous cancer cells (OSCC, SCC25) on a fibronectin-rich environment. Time-lapse images were acquired on fibronectin-coated glassbottomed dishes. Migration speed and directionality analysis indicated that OSCC cells, but not fibroblasts, showed significant decrease in both parameters in the presence of DisBa-01 (1 mu M and 2 mu M). Integrin expression levels of the alpha(5), alpha(v) and beta(3) subunits were similar in both cell lines, while beta(1) subunit is present in lower levels on the cancer cells. Next, we examined whether the effects of DisBa-01 were related to changes in adhesion properties by using paxillin immunostaining and total internal reflection fluorescence TIRF microscopy. OSCCs in the presence of DisBa-01 showed increased adhesion sizes and number of maturing adhesion. The same parameters were analyzed using beta 3-gfp overexpressing cells and showed that beta(3) overexpression restored cell migration velocity and the number of maturing adhesion that were altered by DisBa-01. Surface plasmon resonance analysis showed that DisBa-01 has 100x higher affinity for a v beta(3) integrin than alpha(v)beta(3) integrin. In conclusion, our results suggest that the alpha(v)beta(3) integrin is the main receptor involved in cell directionality and its blockage may be an interesting alternative against metastasis.	[Montenegro, Cyntia F.; Casali, Bruna C.; Lino, Rafael L. B.; Pachane, Bianca C.; Santos, Patty K.; Selistre-de-Araujo, Heloisa S.] Univ Fed Sao Carlos, Ctr Biol & Hlth Sci, Dept Physiol Sci, Rod Washington Luis, Sao Carlos, SP, Brazil; [Horwitz, Alan R.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Lamers, Marcelo L.] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Rua Sarmento Leite, Porto Alegre, RS, Brazil	Universidade Federal de Sao Carlos; University of Virginia; Universidade Federal do Rio Grande do Sul	Selistre-de-Araujo, HS (corresponding author), Univ Fed Sao Carlos, Ctr Biol & Hlth Sci, Dept Physiol Sci, Rod Washington Luis, Sao Carlos, SP, Brazil.	hsaraujo@ufscar.br	dos Santos, Patty Karina/Y-1305-2019; LAMERS, MARCELO/A-5291-2013; Pachane, Bianca C/N-7512-2018; Selistre-de-Araujo, Heloisa/A-3792-2016; Bressani Lino, Rafael Luis/P-2512-2016	dos Santos, Patty Karina/0000-0002-4704-2799; LAMERS, MARCELO/0000-0001-5296-5662; Pachane, Bianca C/0000-0002-7302-4498; Selistre-de-Araujo, Heloisa/0000-0002-2372-7814; Bressani Lino, Rafael Luis/0000-0002-5683-7040; Casali, Bruna/0000-0002-1056-8236	National Institute of Health [NIH] [GM23244]; FAPESP [2013/00798-2]; CNPq [140130/2012-8, 308096/2013-4]	National Institute of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institute of Health [NIH, GM23244], Alan R. Horwitz, https://www.nih.gov; FAPESP 2013/00798-2, HSS Araujo, www.fapesp.br; CNPq 140130/2012-8, CF Montenegro, 308096/2013-4 HSS Araujo, www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AM, 2014, TUMOR BIOL, V35, P8483, DOI 10.1007/s13277-014-2421-z; Anderson HJ, 2016, CELL ONCOL, V39, P229, DOI 10.1007/s13402-016-0267-7; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Calvete JJ, 2013, TOXICON, V62, P40, DOI 10.1016/j.toxicon.2012.09.005; Cassini-Vieira P, 2014, TOXICON, V92, P81, DOI 10.1016/j.toxicon.2014.10.007; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Christmann M., 2016, ONCOTARGET; Coelho ALJ, 1999, EXP CELL RES, V251, P379, DOI 10.1006/excr.1999.4583; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Desgrosellier J, 2015, NAT REV, V10, P9, DOI DOI 10.1038/NRC2748.INTEGRINS; Di Cio S, 2016, ACTA BIOMATER, V30, P26, DOI 10.1016/j.actbio.2015.11.027; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gleber-Netto FO, 2015, ORAL ONCOL, V51, P738, DOI 10.1016/j.oraloncology.2015.04.016; HARADA T, 1994, VIRCHOWS ARCH, V424, P257; Huang TF, 1998, CELL MOL LIFE SCI, V54, P527, DOI 10.1007/s000180050181; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Lucena S, 2015, TOXICON, V93, P136, DOI 10.1016/j.toxicon.2014.11.228; Marcinkiewicz C, 2013, INT J BIOCHEM CELL B, V45, P1974, DOI 10.1016/j.biocel.2013.06.009; Missirlis D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23258; Montenegro CF, 2012, BIOCHIMIE, V94, P1812, DOI 10.1016/j.biochi.2012.04.020; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; Muntion S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146722; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Olfa KZ, 2005, LAB INVEST, V85, P1507, DOI 10.1038/labinvest.3700350; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parvani JG, 2015, CANCER RES, V75, P2316, DOI 10.1158/0008-5472.CAN-14-3485; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Selistre-de-Araujo HS, 2010, TOXINS, V2, P2606, DOI 10.3390/toxins2112606; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Tian J, 2007, TOXICON, V49, P899, DOI 10.1016/j.toxicon.2006.12.013; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653	47	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176226	10.1371/journal.pone.0176226	http://dx.doi.org/10.1371/journal.pone.0176226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437464	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600035
J	Wang, RL; Lin, SR; Wang, Y; Qian, WP; Zhou, L				Wang, Ruolin; Lin, Shouren; Wang, Yong; Qian, Weiping; Zhou, Liang			Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; HYPERSTIMULATION SYNDROME; INVITRO FERTILIZATION; LEUPROLIDE ACETATE; EMBRYO TRANSFER; CETRORELIX; WOMEN; IVF	Objective To evaluate the effectiveness and safety of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol and gonadotropin-releasing hormone agonist (GnRH-a) long protocol in patients with normal ovarian reserve. Methods We searched the PubMed (1992-2016), Cochrane Library (1999-2016), Web of Science (1950-2016), Chinese Biomedical Database (CBM, 1979-2016), and China National Knowledge Infrastructure (CNKI, 1994-2016). Any randomized controlled trials (RCTs) that compared GnRH-ant protocol and GnRH-a long protocol in patients with normal ovarian reserve were included, and data were extracted independently by two reviewers. The meta-analysis was performed by Revman 5.3 software. Results Twenty-nine RCTs (6399 patients) were included in this meta-analysis. Stimulation days (mean difference (MD) [95% confidence interval (CI)] = -0.8 [-1.36, -0.23], P = 0.006), gonadotrophin (Gn) dosage (MD [95% CI] = -3.52 [-5.56, -1.48], P = 0.0007), estradiol (E2) level on the day of human chorionic gonadotrophin (HCG) administration (MD [95% CI] = -365.49 [-532.93, -198.05], P<0.0001), the number of oocytes retrieved (MD [95% CI] = -1.41 [-1.84, -0.99], P<0.00001), the embryos obtained (MD [95% CI] = -0.99 [-1.38, -0.59], P<0.00001), incidence of ovarian hyperstimulation syndrome (OHSS) (OR [95% CI] = 0.69 [0.57, 0.83], P<0.0001) were statistically significantly lower in GnRH-ant protocol than GnRH-a long protocol. However, the clinical pregnancy rate (OR [95% CI] = 0.90 [0.80, 1.01], P = 0.08), ongoing pregnancy rate (OR [95% CI] = 0.88 [0.77, 1.00], P = 0.05), live birth rate (OR [95% CI] = 0.95 [0.74, 1.09], P = 0.27), miscarriage rate (OR [95% CI] = 0.98 [0.69, 1.40], P = 0.93), and cycle cancellation rate (OR [95% CI] = 0.86 [0.52, 1.44], P = 0.57) showed no significant differences between the two groups. Conclusion GnRH-ant protocol substantially decreased the incidence of OHSS without influencing the pregnancy rate and live birth rate compared to GnRH-a long protocol among patients with normal ovarian reserve.	[Wang, Ruolin; Lin, Shouren; Wang, Yong; Qian, Weiping; Zhou, Liang] Peking Univ, Shenzhen Hosp, Reprod Med Ctr, Shenzhen, Peoples R China; [Wang, Ruolin] Shantou Univ, Med Coll, Shantou, Peoples R China	Peking University; Shantou University	Qian, WP; Zhou, L (corresponding author), Peking Univ, Shenzhen Hosp, Reprod Med Ctr, Shenzhen, Peoples R China.	qianwp2014@163.com; zhouliang1002@163.com			National Natural Science Foundation of China [30900817]; Guangdong Medical Research Foundation [A2015397]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Medical Research Foundation	LZ received the National Natural Science Foundation of China (30900817); Guangdong Medical Research Foundation (A2015397). LZ as the correspondence author of this article, conceived and designed the study, revised the paper and finally approved the version.	Al-Inany HG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub2; Al-Inany HG, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub4; Al-Inany HG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub3; Albano C, 2000, HUM REPROD, V15, P526, DOI 10.1093/humrep/15.3.526; Baart EB, 2007, HUM REPROD, V22, P980, DOI 10.1093/humrep/del484; Badrawi A, 2005, MID E FERTIL SOC J, V10, P49; Barmat LI, 2005, FERTIL STERIL, V83, P321, DOI 10.1016/j.fertnstert.2004.06.076; Bodri D, 2011, FERTIL STERIL, V95, P164, DOI 10.1016/j.fertnstert.2010.06.068; Borm G, 2000, HUM REPROD, V15, P1490; Check JH, 2011, CLIN EXP OBSTET GYN, V38, P313; Check M L, 2004, Clin Exp Obstet Gynecol, V31, P257; Coccia ME, 2004, EUR J OBSTET GYN R B, V115, pS44, DOI 10.1016/j.ejogrb.2004.01.033; Depalo R, 2009, GYNECOL ENDOCRINOL, V25, P328, DOI 10.1080/09513590802617762; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Ferrari B, 2006, EUR J OBSTET GYN R B, V124, P70, DOI 10.1016/j.ejogrb.2005.08.017; Firouzabadi RD, 2010, ARCH GYNECOL OBSTET, V281, P81, DOI 10.1007/s00404-009-1073-5; FLEMING R, 1982, BRIT J OBSTET GYNAEC, V89, P80, DOI 10.1111/j.1471-0528.1982.tb04642.x; Fluker M, 2001, FERTIL STERIL, V75, P38, DOI 10.1016/S0015-0282(00)01638-1; FORMAN RG, 1990, FERTIL STERIL, V53, P502; Friedler S, 2006, REPROD BIOMED ONLINE, V12, P27, DOI 10.1016/S1472-6483(10)60976-5; Griesinger G, 2005, HUM REPROD, V20, P2373, DOI 10.1093/humrep/dei086; Griesinger G, 2008, FERTIL STERIL, V90, P1055, DOI 10.1016/j.fertnstert.2007.07.1354; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; Hohmann FP, 2003, J CLIN ENDOCR METAB, V88, P166, DOI 10.1210/jc.2002-020788; Hsieh YY, 2008, TAIWAN J OBSTET GYNE, V47, P66, DOI 10.1016/S1028-4559(08)60057-1; HUGHES EG, 1992, FERTIL STERIL, V58, P888; Klement AH, 2015, EUR J OBSTET GYN R B, V185, P170, DOI 10.1016/j.ejogrb.2014.12.021; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Lee TH, 2005, FERTIL STERIL, V83, P1700, DOI 10.1016/j.fertnstert.2004.12.037; Loutradis D, 2004, FERTIL STERIL, V82, P1446, DOI 10.1016/j.fertnstert.2004.04.051; Moraloglu O, 2008, ADV THER, V25, P266, DOI 10.1007/s12325-008-0028-8; Olivennes F, 2000, FERTIL STERIL, V73, P314, DOI 10.1016/S0015-0282(99)00524-5; Papanikolaou EG, 2012, HUM REPROD, V27, P1822, DOI 10.1093/humrep/des066; PORTER RN, 1984, LANCET, V2, P1284, DOI 10.1016/S0140-6736(84)92840-X; Qiao J, 2012, GYNECOL ENDOCRINOL, V28, P800, DOI 10.3109/09513590.2012.665103; Rabati BK, 2012, J RES MED SCI, V17, P1063; Rombauts L, 2006, HUM REPROD, V21, P95, DOI 10.1093/humrep/dei302; Sauer MV, 2004, REPROD BIOMED ONLINE, V9, P487, DOI 10.1016/S1472-6483(10)61631-8; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Serafini P, 2006, FERTIL STERIL, V86, P830, DOI 10.1016/j.fertnstert.2006.02.110; Toftager M, 2016, HUM REPROD, V31, P1253, DOI 10.1093/humrep/dew051; Xavier P, 2005, EUR J OBSTET GYN R B, V120, P185, DOI 10.1016/j.ejogrb.2004.11.005; Xiao JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095214, 10.1371/journal.pone.0090396]; Ye H, 2009, J ASSIST REPROD GEN, V26, P105, DOI 10.1007/s10815-009-9300-3; 2001, HUMAN REPROD OXFORD, V16, P644	45	39	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175985	10.1371/journal.pone.0175985	http://dx.doi.org/10.1371/journal.pone.0175985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437434	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600027
J	Kou, HX; Zhao, YQ; Ren, K; Chen, XL; Lu, YQ; Wang, D				Kou, HongXiang; Zhao, YiQiang; Ren, Kang; Chen, XiaoLi; Lu, YongQiang; Wang, Dong			Automated measurement of cattle surface temperature and its correlation with rectal temperature	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; DAIRY-COWS; ESTRUS DETECTION; INFRARED THERMOGRAPHY; BODY-TEMPERATURE; RETICULORUMEN TEMPERATURE; VAGINAL TEMPERATURE; RADIOTELEMETRY; MICROSYSTEM; PREDICTION	The body temperature of cattle varies regularly with both the reproductive cycle and disease status. Establishing an automatic method for monitoring body temperature may facilitate better management of reproduction and disease control in cattle. Here, we developed an Automatic Measurement System for Cattle's Surface Temperature (AMSCST) to measure the temperature of metatarsus by attaching a special shell designed to fit the anatomy of cattle's hind leg. Using AMSCST, the surface temperature (ST) on the metatarsus of the hind leg was successively measured during 24 hours a day with an interval of one hour in three tested seasons. Based on ST and rectal temperature (RT) detected by AMSCST and mercury thermometer, respectively, a linear mixed model was established, regarding both the time point and seasonal factors as the fixed effects. Unary linear correlation and Bland-Alt-man analysis results indicated that the temperatures measured by AMSCST were closely correlated to those measured by mercury thermometer (R-2 = 0.998), suggesting that the AMSCST is an accurate and reliable way to detect cattle's body temperature. Statistical analysis showed that the differences of STs among the three seasons, or among the different time points were significant (P < 0.05), and the differences of RTs among the different time points were similarly significant (P < 0.05). The prediction accuracy of the mixed model was verified by 10-fold cross validation. The average difference between measured RT and predicted RT was about 0.10 +/- 0.10 degrees C with the association coefficient of 0.644, indicating the feasibility of this model in measuring cattle body temperature. Therefore, an automated technology for accurately measuring cattle body temperature was accomplished by inventing an optimal device and establishing the AMSCST system.	[Kou, HongXiang; Chen, XiaoLi; Wang, Dong] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing, Peoples R China; [Kou, HongXiang] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Peoples R China; [Zhao, YiQiang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Ren, Kang; Lu, YongQiang] Anim Husb Stn Beijing, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Agricultural University; China Agricultural University	Wang, D (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing, Peoples R China.; Lu, YQ (corresponding author), Anim Husb Stn Beijing, Beijing, Peoples R China.	luyongqiang@163.com; dwangcn2002@vip.sina.com			Beijing Innovation Team of Technology System in Dairy Industry [BAIC06-2016]; National Natural Science Foundation of China [31372296]; Agricultural Science and Technology Innovation Program (ASTIP) [cxgc-ias-06]	Beijing Innovation Team of Technology System in Dairy Industry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program (ASTIP)	This work was supported by grants from the Beijing Innovation Team of Technology System in Dairy Industry (BAIC06-2016), National Natural Science Foundation of China (No. 31372296) and the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06).; This work was supported by grants from the Beijing Innovation Team of Technology System in Dairy Industry (BAIC06-2016), National Natural Science Foundation of China (No. 31372296) and the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06).	Aalseth E., 2005, 7 W DAIR MAN C REN N, P1; Bland MJ, 1986, LANCET, V327, P307; BLIGH J, 1974, P NUTR SOC, V33, P173, DOI 10.1079/PNS19740031; Church JS, 2014, RES VET SCI, V96, P220, DOI 10.1016/j.rvsc.2013.11.006; Firk R, 2002, LIVEST PROD SCI, V75, P219, DOI 10.1016/S0301-6226(01)00323-2; GALLO LM, 1985, BIOMED TECH, V30, P284, DOI 10.1515/bmte.1985.30.11.284; GAUTHERIE M, 1980, CANCER, V45, P51, DOI 10.1002/1097-0142(19800101)45:1<51::AID-CNCR2820450110>3.0.CO;2-L; Gil Z, 2001, THERIOGENOLOGY, V56, P685, DOI 10.1016/S0093-691X(01)00600-8; HAHN GL, 1990, J ANIM SCI, V68, P2658; Hicks L.C., 2001, LIVESTOCK ENV 6 P 6, P432, DOI [10.13031/2013.7101, DOI 10.13031/2013.7101]; Hoffmann G, 2013, VET RES COMMUN, V37, P91, DOI 10.1007/s11259-012-9549-3; Hu L, 2004, J BIOMECH ENG-T ASME, V126, P204, DOI 10.1115/1.1688779; Jiang L. J., 2005, Journal of Medical Engineering & Technology, V29, P257, DOI 10.1080/03091900512331333158; KOHAVI R, 1995, INT JOINT C ART INT, P1137; Kyle BL, 1998, THERIOGENOLOGY, V49, P1437, DOI 10.1016/S0093-691X(98)00090-9; LEWIS GS, 1984, J DAIRY SCI, V67, P146, DOI 10.3168/jds.S0022-0302(84)81278-3; Liang D, 2013, J DAIRY SCI, V96, P5072, DOI 10.3168/jds.2012-6537; Metzner M, 2014, VET J, V199, P57, DOI 10.1016/j.tvjl.2013.10.030; Miranda N, 2009, PROCEDIA CHEM, V1, P505, DOI 10.1016/j.proche.2009.07.126; Morais R, 2006, SENSOR ACTUAT A-PHYS, V132, P354, DOI 10.1016/j.sna.2006.04.011; Paulrud C. O., 2002, Journal of Dairy Science, V85, P84; Pezeshki A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-15; Prendiville D, 2002, BEEF PROD NO SER, P57; Schaefer AL, 2012, RES VET SCI, V93, P928, DOI 10.1016/j.rvsc.2011.09.021; Suthar V, 2013, J DAIRY RES, V80, P240, DOI 10.1017/S0022029913000071; Talukder S, 2014, THERIOGENOLOGY, V81, P925, DOI 10.1016/j.theriogenology.2014.01.009; Timsit E, 2011, VET J, V190, P136, DOI 10.1016/j.tvjl.2010.09.012; WRENN TR, 1958, J DAIRY SCI, V41, P1071, DOI 10.3168/jds.S0022-0302(58)91053-1	28	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175377	10.1371/journal.pone.0175377	http://dx.doi.org/10.1371/journal.pone.0175377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426682	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900026
J	Salvador, R; Radua, J; Canales-Rodriguez, EJ; Solanes, A; Sarro, S; Goikolea, JM; Valiente, A; Monte, GC; Natividad, MD; Guerrero-Pedraza, A; Moro, N; Fernandez-Corcuera, P; Amann, BL; Maristany, T; Vieta, E; McKenna, PJ; Pomarol-Clotet, E				Salvador, Raymond; Radua, Joaquim; Canales-Rodriguez, Erick J.; Solanes, Aleix; Sarro, Salvador; Goikolea, Jose M.; Valiente, Alicia; Monte, Gemma C.; del Carmen Natividad, Maria; Guerrero-Pedraza, Amalia; Moro, Noemi; Fernandez-Corcuera, Paloma; Amann, Benedikt L.; Maristany, Teresa; Vieta, Eduard; McKenna, Peter J.; Pomarol-Clotet, Edith			Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BIPOLAR DISORDER; CLASSIFICATION; BRAIN; REGULARIZATION; SCHIZOPHRENIA; SELECTION	A relatively large number of studies have investigated the power of structural magnetic resonance imaging (sMRI) data to discriminate patients with schizophrenia from healthy controls. However, very few of them have also included patients with bipolar disorder, allowing the clinically relevant discrimination between both psychotic diagnostics. To assess the efficacy of sMRI data for diagnostic prediction in psychosis we objectively evaluated the discriminative power of a wide range of commonly used machine learning algorithms (ridge, lasso, elastic net and L0 norm regularized logistic regressions, a support vector classifier, regularized discriminant analysis, random forests and a Gaussian process classifier) on main sMRI features including grey and white matter voxel-based morphometry (VBM), vertex-based cortical thickness and volume, region of interest volumetric measures and wavelet-based morphometry (WBM) maps. All possible combinations of algorithms and data features were considered in pairwise classifications of matched samples of healthy controls (N = 127), patients with schizophrenia (N = 128) and patients with bipolar disorder (N = 128). Results show that the selection of feature type is important, with grey matter VBM (without data reduction) delivering the best diagnostic prediction rates (averaging over classifiers: schizophrenia vs. healthy 75%, bipolar disorder vs. healthy 63% and schizophrenia vs. bipolar disorder 62%) whereas algorithms usually yielded very similar results. Indeed, those grey matter VBM accuracy rates were not even improved by combining all feature types in a single prediction model. Further multi-class classifications considering the three groups simultaneously made evident a lack of predictive power for the bipolar group, probably due to its intermediate anatomical features, located between those observed in healthy controls and those found in patients with schizophrenia. Finally, we provide MRIPredict (https://www. nitrc.org/projects/mripredict/), a free tool for SPM, FSL and R, to easily carry out voxelwise predictions based on VBM images.	[Salvador, Raymond; Radua, Joaquim; Canales-Rodriguez, Erick J.; Solanes, Aleix; Sarro, Salvador; Monte, Gemma C.; McKenna, Peter J.; Pomarol-Clotet, Edith] FIDMAG Germanes Hosp, Barcelona, Spain; [Salvador, Raymond; Radua, Joaquim; Canales-Rodriguez, Erick J.; Sarro, Salvador; Goikolea, Jose M.; Monte, Gemma C.; Amann, Benedikt L.; Vieta, Eduard; McKenna, Peter J.; Pomarol-Clotet, Edith] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain; [Radua, Joaquim] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Radua, Joaquim] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Solanes, Aleix] Univ Barcelona, Barcelona, Spain; [Goikolea, Jose M.; Monte, Gemma C.; Vieta, Eduard] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona, Spain; [Valiente, Alicia; Guerrero-Pedraza, Amalia; Moro, Noemi; Fernandez-Corcuera, Paloma] Hosp Benito Menni CASM, St Boi De Llobregat, Spain; [del Carmen Natividad, Maria] Hosp Mare de Deu de la Merce, Barcelona, Spain; [Amann, Benedikt L.] Ctr Forum Res Unit, Inst Neuropsiquiatria & Addicc, Parc Salut Mar, Barcelona, Spain; [Amann, Benedikt L.] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Amann, Benedikt L.] Autonomous Univ Barcelona, Dept Psychiat, Barcelona, Spain; [Maristany, Teresa] Hosp St Joan de Deu, Esplugas de Llobregat, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of London; King's College London; Karolinska Institutet; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Salvador, R (corresponding author), FIDMAG Germanes Hosp, Barcelona, Spain.; Salvador, R (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain.	rsalvador@fidmag.com	Canales-Rodríguez, Erick Jorge/F-7278-2010; Font, Aleix Solanes/AAC-5146-2020; Monté-Rubio, Gemma C./Z-5188-2019; Guerrero-Pedraza, Amalia/AFN-6434-2022; Solanes, Aleix/HGB-1640-2022; Radua, Joaquim/H-6424-2019; Vieta, Eduard/Y-2919-2019	Canales-Rodríguez, Erick Jorge/0000-0001-6421-2633; Font, Aleix Solanes/0000-0002-2491-200X; Monté-Rubio, Gemma C./0000-0002-3532-2224; Solanes, Aleix/0000-0002-2491-200X; Radua, Joaquim/0000-0003-1240-5438; Vieta, Eduard/0000-0002-0548-0053; Moro, Noemi/0000-0002-8115-732X; Pomarol-Clotet, Edith/0000-0002-8159-8563; Salvador, Raymond/0000-0001-5557-1562; Amann, Benedikt L/0000-0002-4407-1519; Valiente-Gomez, Alicia/0000-0003-0220-2397	Catalonian Government [2014-SGR-1573, 2014-SGR-398]; Plan Nacional de I+D+i; Instituto de Salud Carlos III; European Union (ERDF/ESF) [CPII13/00018, MS14/00041, CES12/02, MS10/00596 4];  [PI14/01151];  [PI14/01148];  [PI14/00292];  [CP14/00041];  [PI14/01691];  [PI15/00277]	Catalonian Government; Plan Nacional de I+D+i; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (ERDF/ESF); ; ; ; ; ; 	This work was supported by the Catalonian Government (2014-SGR-1573 to FIDMAG and 2014-SGR-398 to the Bipolar Disorders Group) and several grants from the Plan Nacional de I+D+i 2008-2011 and 2013-2016, and the Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future"): Miguel Servet Research Contracts (CPII13/00018 to RS, MS14/00041 to JR, CES12/024 to BA and MS10/00596 to EP-C,) and Research Project Grants (PI14/01151 to RS, PI14/01148 to EP-C, PI14/00292 and CP14/00041 to JR, PI14/01691 to P.M. and PI15/00277 to EC-R)	Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Bansal R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050698; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Buhlmann P, 2014, ANN STAT, V42, P469, DOI 10.1214/13-AOS1175A; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; DelSer T, 1997, BRAIN COGNITION, V33, P343, DOI 10.1006/brcg.1997.0877; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Falahati F, 2014, J ALZHEIMERS DIS, V41, P685, DOI 10.3233/JAD-131928; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guo Y, 2006, BIOSTATISTICS, V7, P100, DOI 10.1093/biostatistics/kxi043; Hastie T., 2009, UNSUPERVISED LEARNIN; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Canales-Rodriguez EJ, 2013, NEUROIMAGE, V72, P214, DOI 10.1016/j.neuroimage.2013.01.058; Khondoker M., 2013, STAT METHODS MED RES; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; Patel MJ, 2016, NEUROIMAGE-CLIN, V10, P115, DOI 10.1016/j.nicl.2015.11.003; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Robinson ME, 2015, J PAIN, V16, P472, DOI 10.1016/j.jpain.2015.02.002; Rocha-Rego V, 2014, PSYCHOL MED, V44, P519, DOI 10.1017/S0033291713001013; Schnack HG, 2014, NEUROIMAGE, V84, P299, DOI 10.1016/j.neuroimage.2013.08.053; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Serpa MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/706157; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sweeney EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095753; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Wolfers T, 2015, NEUROSCI BIOBEHAV R, V57, P328, DOI 10.1016/j.neubiorev.2015.08.001; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	51	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175683	10.1371/journal.pone.0175683	http://dx.doi.org/10.1371/journal.pone.0175683			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426817	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900038
J	Xie, GL; Zhu, L; Zhang, YM; Zhang, QN; Yu, Q				Xie, Guang-liang; Zhu, Lin; Zhang, Yan-min; Zhang, Qian-nan; Yu, Qing			Change in iron metabolism in rats after renal ischemia/reperfusion injury	PLOS ONE			English	Article							HEPCIDIN GENE-EXPRESSION; OXIDATIVE STRESS; REPERFUSION INJURY; PEPTIDE HEPCIDIN; KIDNEY; FERROPORTIN; TRANSPORTER; THERAPY; CELLS; INFLAMMATION	Previous studies have indicated that hepcidin, which can regulate iron efflux by binding to ferroportin-1 (FPN1) and inducing its internalization and degradation, acts as the critical factor in the regulation of iron metabolism. However, it is unknown whether hepcidin is involved in acute renal ischemia/reperfusion injury (IRI). In this study, an IRI rat model was established via right renal excision and blood interruption for 45 min in the left kidney, and iron metabolism indexes were examined to investigate the change in iron metabolism and to analyze the role of hepcidin during IRI. From 1 to 24 h after renal reperfusion, serum creatinine and blood urea nitrogen were found to be time-dependently increased with different degrees of kidney injury. Regular variations in iron metabolism indexes in the blood and kidneys were observed in renal IRI. Renal iron content, serum iron and serum ferritin increased early after reperfusion and then declined. Hepcidin expression in the liver significantly increased early after reperfusion, and its serum concentration increased beginning at 8 h after reperfusion. The splenic iron content decreased significantly in the early stage after reperfusion and then increased time-dependently with increasing reperfusion time, and the hepatic iron content showed a decrease in the early stage after reperfusion. The early decrease of the splenic iron content and hepatic iron content might indicate their contribution to the increase in serum iron in renal IRI. In addition, the duodenal iron content showed time-dependently decreased since 12 h after reperfusion in the IRI groups compared to the control group. Along with the spleen, the duodenum might contribute to the decrease in serum iron in the later stage after reperfusion. The changes in iron metabolism indexes observed in our study demonstrate an iron metabolism disorder in renal IRI, and hepcidin might be involved in maintaining iron homeostasis in renal IRI. These findings might suggest a self-protection mechanism regulating iron homeostasis in IRI and provide a new perspective on iron metabolism in attenuating renal IRI.	[Xie, Guang-liang; Zhu, Lin; Zhang, Yan-min; Zhang, Qian-nan; Yu, Qing] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yu, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China.	yuqingsh2014@sina.com			Shanghai Committee of Science and Technology Foundation [14411963300]	Shanghai Committee of Science and Technology Foundation	This research is funded by the Shanghai Committee of Science and Technology Foundation (http://www.stcsm.gov.cn/); the funding number is 14411963300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Al-Ismaili Z, 2011, PEDIATR NEPHROL, V26, P1781, DOI 10.1007/s00467-010-1727-3; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Costa E, 2008, AM J NEPHROL, V28, P677, DOI 10.1159/000121478; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ferguson CJ, 2003, KIDNEY INT, V64, P1755, DOI 10.1046/j.1523-1755.2003.00274.x; Fernandes JC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/421304; Ganz T, 2016, SEMIN NEPHROL, V36, P87, DOI 10.1016/j.semnephrol.2016.02.001; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Garrido P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124048; Garrido P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010028; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Gu D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2093940; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Javedan G, 2016, MOL NUTR FOOD RES, V60, P2665, DOI 10.1002/mnfr.201600112; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kyriazis I, 2013, WORLD J UROL, V31, P597, DOI 10.1007/s00345-012-0980-4; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; Lim CS, 2004, AM J NEPHROL, V24, P569, DOI 10.1159/000082201; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mena NP, 2006, BIOL RES, V39, P191, DOI 10.4067/S0716-97602006000100022; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Ribeiro S, 2016, BIOFACTORS, V42, P296, DOI 10.1002/biof.1275; Ribeiro S, 2016, BLOOD CELL MOL DIS, V59, P63, DOI 10.1016/j.bcmd.2016.04.008; Ribeiro S, 2016, BIOCHIMIE, V125, P150, DOI 10.1016/j.biochi.2016.03.012; Ribeiro S, 2016, BLOOD REV, V30, P65, DOI 10.1016/j.blre.2015.07.006; Scindia Y, 2015, J AM SOC NEPHROL, V26, P2800, DOI 10.1681/ASN.2014101037; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; van Eijk LT, 2014, HAEMATOLOGICA, V99, P579, DOI 10.3324/haematol.2013.088047; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Walker VJ, 2016, SEMIN NEPHROL, V36, P62, DOI 10.1016/j.semnephrol.2016.01.003; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; ZAGER RA, 1993, J CLIN INVEST, V91, P702, DOI 10.1172/JCI116251	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175945	10.1371/journal.pone.0175945	http://dx.doi.org/10.1371/journal.pone.0175945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426710	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900073
J	Yoon, CW; Choi, Y; Jeon, S; Lee, DH; Yoon, BN; Park, HK; Rha, JH				Yoon, Cindy W.; Choi, Yoonjae; Jeon, Seun; Lee, Dae Hyung; Yoon, Byung-Nam; Park, Hee-Kwon; Rha, Joung-Ho			Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?	PLOS ONE			English	Editorial Material							ELDERLY-PEOPLE; ROTTERDAM SCAN; LESIONS; STROKE; LEUKOARAIOSIS; POPULATION; PREDICTOR; DECLINE; RISK	Objective We performed this study to assess the effect of an antiplatelet agent on the progression of white matter hyperintensities (WMH). Methods From August 2003 to May 2005, we consecutively enrolled patients who underwent brain magnetic resonance imaging (MRI) for health check-up purposes and showed no significant findings other than WMH of any degree. Patients were divided into two groups based on whether or not they received antiplatelet therapy. All patients had a follow-up brain MRI after 5 years and WMH volume change was measured using imaging analysis software. To minimize selection bias potentially arising from antiplatelet treatment assignment, analyses were inverse probability weighted. Results Among the 93 patients who met the inclusion criteria, 54 patients (58.1%) were grouped as the antiplatelet group (AG), and the remaining 39 patients (41.9%) as the non-antiplatelet group (NAG). After inverse propensity weighting, all baseline characteristics were similar between the two groups, and antiplatelet treatment did not show any significant effect on the total WMH volume change (p = 0.957). Conclusion Antiplatelet medication may not alter the progression of WMH.	[Yoon, Cindy W.; Choi, Yoonjae; Yoon, Byung-Nam; Park, Hee-Kwon; Rha, Joung-Ho] Inha Univ, Dept Neurol, Sch Med, Incheon, South Korea; [Jeon, Seun] McGill Univ, Montreal Neurol Inst, McGill Ctr Integrat Neurosci, Montreal, PQ, Canada; [Lee, Dae Hyung] Inha Univ, Clin Res Ctr, Sch Med, Incheon, South Korea	Inha University; McGill University; Inha University	Rha, JH (corresponding author), Inha Univ, Dept Neurol, Sch Med, Incheon, South Korea.	jhrha@inha.ac.kr	Jeon, Seun/AAK-3204-2020; Yoon, Cindy/HCJ-0079-2022	Jeon, Seun/0000-0003-2817-3352; Yoon, Cindy/0000-0002-4697-6610	NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan CL, 2015, BRIT J PSYCHIAT, V206, P308, DOI 10.1192/bjp.bp.114.153536; Choi JC, 2015, J STROKE, V17, P7, DOI 10.5853/jos.2015.17.1.7; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Enzinger C, 2007, J NEUROL SCI, V257, P5, DOI 10.1016/j.jns.2007.01.018; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Gardener H, 2012, ARCH NEUROL-CHICAGO, V69, P251, DOI 10.1001/archneurol.2011.548; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; Jeon S, 2011, INT J IMAG SYST TECH, V21, P193, DOI 10.1002/ima.20277; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Launer Lenore J, 2004, Top Magn Reson Imaging, V15, P365, DOI 10.1097/01.rmr.0000168216.98338.8d; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Tran T, 2016, J NEUROL NEUROSUR PS, V87, P260, DOI 10.1136/jnnp-2014-309685; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176300	10.1371/journal.pone.0176300	http://dx.doi.org/10.1371/journal.pone.0176300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426738	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900128
J	Kruse, CPS; Basu, P; Luesse, DR; Wyatt, SE				Kruse, Colin P. S.; Basu, Proma; Luesse, Darron R.; Wyatt, Sarah E.			Transcriptome and proteome responses in RNAlater preserved tissue of Arabidopsis thaliana	PLOS ONE			English	Article								Tissue preservation is a minimal requirement for the success of plant RNA and protein expression studies. The standard of snap-freezing in liquid nitrogen is not always practical or possible. RNAlater,a concentrated solution of ammonium and cesium sulfates, has become a standard preservative in the absence of liquid nitrogen. Here, we demonstrate the effectiveness of RNAlater in preserving both RNA and proteins in Arabidopsis thaliana tissues for use in RNAseq and LC-MS/MS analysis of proteins. While successful in preserving plant material, a transcriptomic and proteomic response is evident. Specifically, 5770 gene transcripts, 84 soluble proteins, and 120 membrane-bound proteins were found to be differentially expressed at a log-fold change of +/- 1 (P <= 0.05). This response is mirrored in the abundance of post-translational modifications, with 23 of the 108 (21.3%) phosphorylated proteins showing altered abundance at a log-fold change of +/- 1 (P <= 0.05). While RNAlater is effective in preserving biological information, our findings warrant caution in its use for transcriptomic and proteomic experiments.	[Kruse, Colin P. S.; Basu, Proma; Wyatt, Sarah E.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Luesse, Darron R.] Southern Illinois Univ Edwardsville, Dept Biol Sci, Edwardsville, IL USA	University System of Ohio; Ohio University; Southern Illinois University System; Southern Illinois University Edwardsville	Wyatt, SE (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA.	wyatts@ohio.edu		Basu, Proma/0000-0002-2723-9981; Kruse, Colin/0000-0001-7070-8889	National Science Foundation [DBI-0922879]; NCI Cancer Center Support Grant [P30 CA91842]; ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 TR000448]; NIH Roadmap for Medical Research; NASA [NNX13AM48G]; NASA GeneLab; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NASA GeneLab; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Dr. Sophie Alvarez, Dr. Mike Naldrett and the Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science Center for protein sample preparation, iTRAQ labeling and LC-MS/MS analysis of the samples. Their work was supported by Grant No. DBI-0922879 from the National Science Foundation for acquisition of the LTQ-Velos Pro Orbitrap LC-MS/MS. We also thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1 TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. And finally, this research was partially funded by NASA (# NNX13AM48G to SEW and DRL) with supplemental funding provided by NASA GeneLab.; This research was partially funded by NASA (#NNX13AM48G to SEW and DRL) with supplemental funding provided by NASA GeneLab. SEW spent a portion of her faculty fellowship at NASA Genelab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu P, 2015, METHODS MOL BIOL, V1309, P119, DOI 10.1007/978-1-4939-2697-8_10; Bennike Tue Bjerg, 2016, EuPA Open Proteom, V10, P9, DOI 10.1016/j.euprot.2015.10.001; Bennike TB, 2016, DATA BRIEF, V6, P942, DOI 10.1016/j.dib.2016.01.061; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Drakulovski P, 2013, EXP PARASITOL, V135, P257, DOI 10.1016/j.exppara.2013.07.002; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Kwon T, 2015, AM J BOT, V102, P21, DOI 10.3732/ajb.1400458; Levine H G, 1999, Life Support Biosph Sci, V6, P221; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Paul AL, 2005, ACTA ASTRONAUT, V56, P623, DOI 10.1016/j.actaastro.2004.10.001; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Ryba-White M, 2001, PLANT CELL PHYSIOL, V42, P657, DOI 10.1093/pcp/pce082; Saito MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00215; Schultz ER, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300034; Nguyen PT, 2015, J EXP BOT, V66, P6399, DOI 10.1093/jxb/erv348; Yang F, 2012, EXPERT REV PROTEOMIC, V9, P129, DOI [10.1586/EPR.12.15, 10.1586/epr.12.15]	17	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175943	10.1371/journal.pone.0175943	http://dx.doi.org/10.1371/journal.pone.0175943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423006	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600065
J	Mathew, B; Nagaraj, R				Mathew, Basil; Nagaraj, Ramakrishnan			Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing	PLOS ONE			English	Article							POTENT ANTIMICROBIAL ACTIVITY; HUMAN ALPHA-DEFENSINS; HUMAN BETA-DEFENSINS; ANTIBACTERIAL ACTIVITY; HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; INDUCIBLE PEPTIDE; ANALOGS INSIGHTS; HOST-DEFENSE; PANETH CELLS	Human a and beta-defensins are cationic antimicrobial peptides characterized by three disulfide bonds with a triple stranded beta-sheet motif. It is presumed that interaction with the bacterial cell surface and membrane permeabilization by defensins is an important step in the killing process. In this study, we have compared interactions of three human alpha-defensins HNP3, HNP4, HD5 and human beta-defensins HBD1-4 that are active against Escherichia coli, with its cell surface and inner membrane as well as negatively charged model membranes. We have also included the inactive alpha-defensin HD6 in the study. Among the alpha-defensins, HNP4, HD5 and HD6 were more effective in increasing the zeta potential as compared to HNP3. Among the beta-defensins, HBD1 was the least effective in increasing the zeta potential. The zeta potential modulation data indicate variations in the surface charge neutralizing ability of alpha- and beta-defensins. Comparison of E. coli inner membrane and model membrane permeabilizing abilities indicated that HD5, HD6 and HBD1 do not permeabilize membranes. Although HBD4 does not permeabilize model membranes, considerable damage to the inner membrane of E. coli is observed. Our data indicate that mammalian defensins do not kill E. coli by a simple mechanism involving membrane permeabilization though their antibacterial potencies are very similar.	[Mathew, Basil; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	nraj@ccmb.res.in	Mathew, Basil/AAA-6931-2021	Mathew, Basil/0000-0002-8230-8089	JC Bose fellowship from the Department of Science and Technology, India; National Academy of Science, India; Senior Research Fellowship from CSIR	JC Bose fellowship from the Department of Science and Technology, India(Department of Science & Technology (India)); National Academy of Science, India; Senior Research Fellowship from CSIR	RN is a recipient of the JC Bose fellowship from the Department of Science and Technology, India. RN is grateful to the National Academy of Science, India for NASI-Senior Scientist Platinum Jubilee Fellowship. BM was a recipient of Senior Research Fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Nandini Rangaraj, CCMB for her assistance in the use of confocal microscope and A. Harikrishna for recording the electron microscopy images. RN is a recipient of the JC Bose fellowship from the Department of Science and Technology, India. RN is grateful to the National Academy of Science, India for NASI-Senior Scientist Platinum Jubilee Fellowship. BM was a recipient of Senior Research Fellowship from CSIR.	Ageitos JM, 2017, BIOCHEM PHARMACOL, V133, P117, DOI 10.1016/j.bcp.2016.09.018; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chairatana P, 2014, J AM CHEM SOC, V136, P13267, DOI 10.1021/ja5057906; Chileveru HR, 2015, BIOCHEMISTRY-US, V54, P1767, DOI 10.1021/bi501483q; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Das S, 2010, MOL BIOL EVOL, V27, P2333, DOI 10.1093/molbev/msq118; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Krishnakumari V, 2013, FEMS MICROBIOL LETT, V348, P52, DOI 10.1111/1574-6968.12242; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; LINZMEIER R, 1993, FEBS LETT, V321, P267, DOI 10.1016/0014-5793(93)80122-B; Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mathew B, 2015, J PEPT SCI, V21, P811, DOI 10.1002/psc.2821; Mathew B, 2015, PEPTIDES, V71, P128, DOI 10.1016/j.peptides.2015.07.009; MATSUZAKI K, 1989, BIOCHIM BIOPHYS ACTA, V981, P130, DOI 10.1016/0005-2736(89)90090-4; Matsuzaki K, 1997, BBA-BIOMEMBRANES, V1327, P119, DOI 10.1016/S0005-2736(97)00051-5; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Nigro E, 2015, SCI REP, V5, P18450; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Radhakrishnan Y, 2005, GENES IMMUN, V6, P203, DOI 10.1038/sj.gene.6364184; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Scudiero O, 2015, INT J NANOMED, V10, P6523, DOI 10.2147/IJN.S89610; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Sharma H, 2015, J PEPT SCI, V21, P501, DOI 10.1002/psc.2770; Sharma H, 2012, PEPTIDES, V38, P255, DOI 10.1016/j.peptides.2012.08.024; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; VILJANEN P, 1988, INFECT IMMUN, V56, P2324, DOI 10.1128/IAI.56.9.2324-2329.1988; Wang C, 2015, J MED CHEM, V58, P3083, DOI 10.1021/jm501824a; Wang W, 1998, J BIOL CHEM, V273, P27438, DOI 10.1074/jbc.273.42.27438; Wang W, 1999, BBA-GEN SUBJECTS, V1473, P418, DOI 10.1016/S0304-4165(99)00200-7; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wommack AJ, 2012, BIOCHEMISTRY-US, V51, P9624, DOI 10.1021/bi301255u; Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	65	18	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175858	10.1371/journal.pone.0175858	http://dx.doi.org/10.1371/journal.pone.0175858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423004	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600058
J	O'Connor, KM; Nathan, LR; Liberati, MR; Tingley, MW; Vokoun, JC; Rittenhouse, TAG				O'Connor, Kelly M.; Nathan, Lucas R.; Liberati, Marjorie R.; Tingley, Morgan W.; Vokoun, Jason C.; Rittenhouse, Tracy A. G.			Camera trap arrays improve detection probability of wildlife: Investigating study design considerations using an empirical dataset	PLOS ONE			English	Article							AUTOMATICALLY TRIGGERED CAMERAS; ESTIMATING SITE OCCUPANCY; WHITE-TAILED DEER; IMPERFECT DETECTION; PHOTOGRAPHIC RATES; ESTIMATE DENSITIES; SAMPLING DESIGN; CRYPTIC MAMMALS; HABITAT; TIGERS	Camera trapping is a standard tool in ecological research and wildlife conservation. Study designs, particularly for small-bodied or cryptic wildlife species often attempt to boost low detection probabilities by using non-random camera placement or baited cameras, which may bias data, or incorrectly estimate detection and occupancy. We investigated the ability of non-baited, multi-camera arrays to increase detection probabilities of wildlife. Study design components were evaluated for their influence on wildlife detectability by iteratively parsing an empirical dataset (1) by different sizes of camera arrays deployed (1-10 cameras), and (2) by total season length (1-365 days). Four species from our dataset that represented a range of body sizes and differing degrees of presumed detectability based on life history traits were investigated: white-tailed deer (Odocoileus virginianus), bobcat (Lynx rufus), raccoon (Procyon lotor), and Virginia opossum (Didelphis virginiana). For all species, increasing from a single camera to a multi-camera array significantly improved detection probability across the range of season lengths and number of study sites evaluated. The use of a two camera array increased survey detection an average of 80% (range 40-128%) from the detection probability of a single camera across the four species. Species that were detected infrequently benefited most from a multiple-camera array, where the addition of up to eight cameras produced significant increases in detectability. However, for species detected at high frequencies, single cameras produced a season-long (i.e, the length of time over which cameras are deployed and actively monitored) detectability greater than 0.75. These results highlight the need for researchers to be critical about camera trap study designs based on their intended target species, as detectability for each focal species responded differently to array size and season length. We suggest that researchers a priori identify target species for which inference will be made, and then design camera trapping studies around the most difficult to detect of those species.	[O'Connor, Kelly M.; Nathan, Lucas R.; Liberati, Marjorie R.; Vokoun, Jason C.; Rittenhouse, Tracy A. G.] Univ Connecticut, Wildlife & Fisheries Conservat Ctr, Dept Nat Resources & Environm, Storrs, CT 06269 USA; [Tingley, Morgan W.] Univ Connecticut, Ecol & Evolutionary Biol, Storrs, CT USA; [O'Connor, Kelly M.] Archbold Biol Stn, Venus, FL 33960 USA	University of Connecticut; University of Connecticut	O'Connor, KM (corresponding author), Univ Connecticut, Wildlife & Fisheries Conservat Ctr, Dept Nat Resources & Environm, Storrs, CT 06269 USA.; O'Connor, KM (corresponding author), Archbold Biol Stn, Venus, FL 33960 USA.	kelly.oconnor8@gmail.com	Tingley, Morgan W/F-8519-2011	Tingley, Morgan W/0000-0002-1477-2218; Liberati, Marjorie/0000-0002-8434-1659	Federal Aid in Wildlife Restoration Act [W-49-R]; USDA National Institute of Food and Agricultural Hatch [C0NS00920]; Connecticut Department of Energy and Environmental Protection [2014-38420-21802]	Federal Aid in Wildlife Restoration Act; USDA National Institute of Food and Agricultural Hatch; Connecticut Department of Energy and Environmental Protection	Funding provided by Federal Aid in Wildlife Restoration Act under Project W-49-R "Wildlife Investigations" administered by the Connecticut Department of Energy and Environmental Protection, Wildlife Division. USDA National Institute of Food and Agricultural Hatch Project C0NS00920 to TR. Connecticut Department of Energy and Environmental Protection 2014-38420-21802 to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073707; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Curtis PD, 2009, 25 HUM WILDL INT; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; ESRI (Environmental Systems Resource Institute), 2015, ARCMAP 10 1; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Heilbrun RD, 2003, WILDLIFE SOC B, V31, P748; Heilbrun RD, 2006, WILDLIFE SOC B, V34, P69, DOI 10.2193/0091-7648(2006)34[69:EBAUAT]2.0.CO;2; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kelly MJ, 2003, CARIBB GEOGR, V13, P19; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Meek PD, 2015, AUST MAMMAL, V37, P13, DOI 10.1071/AM14023; Newey S, 2015, AMBIO, V44, pS624, DOI 10.1007/s13280-015-0713-1; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; O'Connor KM, 2017, AM MIDL NAT, V177, P15, DOI 10.1674/0003-0031-177.1.15; R Development Core Team, 2012, R LANG ENV STAT COMP; Roberts CW, 2006, J WILDLIFE MANAGE, V70, P263, DOI 10.2193/0022-541X(2006)70[263:COCARS]2.0.CO;2; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Ruell EW, 2009, J MAMMAL, V90, P129, DOI 10.1644/07-MAMM-A-249.1; Sargeant G.A., 2003, SWIFT FOX ECOLOGY CO, P99; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Williams SC, 2013, WILDLIFE SOC B, V37, P137, DOI 10.1002/wsb.236	40	36	37	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175684	10.1371/journal.pone.0175684	http://dx.doi.org/10.1371/journal.pone.0175684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422973	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600041
J	Ravensbergen, SJ; Berends, M; Stienstra, Y; Ott, A				Ravensbergen, Sofanne J.; Berends, Matthijs; Stienstra, Ymkje; Ott, Alewijn			High prevalence of MRSA and ESBL among asylum seekers in the Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS	Migration is one of the risk factors for the spread of multidrug-resistant organisms (MDRO). The increasing influx of migrants challenges local health care systems. To provide evidence for both hospital hygiene measure and empirical antibiotic therapy, we analysed all cultures performed in asylum seekers between January 1 st 2014 and December 31 st 2015 for methicillin resistant Staphylococcus aureus (MRSA) and for multidrugresistant Enterobacteriaceae (MDRE). We compared these with cultures from the Dutch patient population with risk factors for carriage of MDRO. A total of 7181 patients were screened for MRSA. 7357 S. aureus were isolated in clinical cultures. Of 898 screened asylum seekers, almost 10% were MRSA positive. Of 118 asylum seekers with S. aureus in clinical cultures almost 19% were MRSA positive. The general patient population had a 1.3% rate of MRSA in S. aureus isolates. A higher rate of Panton-Valentine leukocidin (PVL) positive strains (RR: 2.4; 95% CI: 1.6-3.4) was found in asylum seekers compared to the general patient population. In 33475 patients one or more Enterobacteriaceae were obtained. More than 21% of the asylum seekers were carrier of MDRE, most of them producing extended spectrum beta-lactamases (20.3%). 5.1% of the general patient population was MDRE carrier. It can be concluded that asylum seekers present with higher rate of MDRO compared to the general patient population. These results justify continued screening of asylum seekers to anticipate multidrug-resistant organisms during hospital care of patients.	[Ravensbergen, Sofanne J.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands; [Berends, Matthijs; Ott, Alewijn] Certe, Dept Med Microbiol, Groningen, Netherlands; [Ott, Alewijn] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen; University of Groningen	Ravensbergen, SJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.	s.j.ravensbergen@umcg.nl	Berends, Matthijs/AFJ-9786-2022; Berends, Matthijs/GYQ-6019-2022; Berends, Matthijs/AAF-6852-2022	Berends, Matthijs/0000-0001-7620-1800; Berends, Matthijs/0000-0001-7620-1800				Angeletti S, 2016, TRAVEL MED INFECT DI, V14, P115, DOI 10.1016/j.tmaid.2016.03.005; Balkhair A, 2014, SCI WORLD J, DOI 10.1155/2014/157102; Dudareva S, 2011, EUROSURVEILLANCE, V16, P2; Hassing RJ, 2015, EURO SURVEILL, V20; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Jain A, 2008, J MED MICROBIOL, V57, P957, DOI 10.1099/jmm.0.47152-0; Jaton L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.026; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Ravensbergen SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154791; Reinheimer C, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.2.30110; Souverein D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148175; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Teicher CL, 2014, EMERG INFECT DIS, V20, P1949, DOI 10.3201/eid2011.140835; Tenenbaum T, 2016, INFECT CONT HOSP EP, V37, P1310; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	16	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176481	10.1371/journal.pone.0176481	http://dx.doi.org/10.1371/journal.pone.0176481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441421	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800064
J	Rohaut, B; Porcher, R; Hissem, T; Heming, N; Chillet, P; Djedaini, K; Moneger, G; Kandelman, S; Allary, J; Cariou, A; Sonneville, R; Polito, A; Antona, M; Azabou, E; Annane, D; Siami, S; Chretien, F; Mantz, J; Sharshar, T				Rohaut, Benjamin; Porcher, Raphael; Hissem, Tarik; Heming, Nicholas; Chillet, Patrick; Djedaini, Kamel; Moneger, Guy; Kandelman, Stanislas; Allary, Jeremy; Cariou, Alain; Sonneville, Romain; Polito, Andrea; Antona, Marion; Azabou, Eric; Annane, Djillali; Siami, Shidasp; Chretien, Fabrice; Mantz, Jean; Sharshar, Tarek		Grp Exploration Neurologique	Brainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; INTENSIVE-CARE SEDATION; LONG-TERM MORTALITY; POINT-PREVALENCE; ICU PATIENTS; COMA SCALE; DELIRIUM; MULTICENTER; RELIABILITY; VALIDATION	Background and purpose Deep sedation is associated with acute brain dysfunction and increased mortality. We had previously shown that early-assessed brainstem reflexes may predict outcome in deeply sedated patients. The primary objective was to determine whether patterns of brainstem reflexes might predict mortality in deeply sedated patients. The secondary objective was to generate a score predicting mortality in these patients. Methods Observational prospective multicenter cohort study of 148 non-brain injured deeply sedated patients, defined by a Richmond Assessment sedation Scale ( RASS) <-3. Brainstem reflexes and Glasgow Coma Scale were assessed within 24 hours of sedation and categorized using latent class analysis. The Full Outline Of Unresponsiveness score ( FOUR) was also assessed. Primary outcome measure was 28-day mortality. A "Brainstem Responses Assessment Sedation Score " (BRASS) was generated. Results Two distinct sub-phenotypes referred as homogeneous and heterogeneous brainstem reactivity were identified (accounting for respectively 54.6% and 45.4% of patients). Homogeneous brainstem reactivity was characterized by preserved reactivity to nociceptive stimuli and a partial and topographically homogenous depression of brainstem reflexes. Heterogeneous brainstem reactivity was characterized by a loss of reactivity to nociceptive stimuli associated with heterogeneous brainstem reflexes depression. Heterogeneous sub-phenotype was a predictor of increased risk of 28-day mortality after adjustment to Simplified Acute Physiology Score-II (SAPS-II) and RASS (Odds Ratio [95% confidence interval] = 6.44 [2.63-15.8]; p< 0.0001) or Sequential Organ Failure Assessment (SOFA) and RASS (OR [95% CI] = 5.02 [2.01-12.5]; p = 0.0005). The BRASS (and marginally the FOUR) predicted 28-day mortality (c-index [95% CI] = 0.69 [0.54-0.84] and 0.65 [0.49- 0.80] respectively). Conclusion In this prospective cohort study, around half of all deeply sedated critically ill patients displayed an early particular neurological sub-phenotype predicting 28-day mortality, which may reflect a dysfunction of the brainstem.	[Rohaut, Benjamin] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Intens Care Unit, Paris, France; [Rohaut, Benjamin] UPMC Univ Paris 06, Sorbonne Univ, Fac Med Pitie Salpetriere, Paris, France; [Rohaut, Benjamin] Inst Cerveau & Moelle Epiniere, ICM, PICNIC Lab, Paris, France; [Rohaut, Benjamin] INSERM, U1127, Paris, France; [Porcher, Raphael] Descartes Univ, Hotel Dieu Hosp, AP HP, Ctr Clin Epidemiol, Paris, France; [Hissem, Tarik; Siami, Shidasp] Sud Essonne Hosp, Gen Intens Care Unit, Etampes, France; [Heming, Nicholas; Moneger, Guy; Polito, Andrea; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin Yvelines, Raymond Poincare Hosp, AP HP, Gen Intens Care Unit, Garches, France; [Chillet, Patrick] Chalons En Champagne Hosp, Gen Intens Care Unit, Chalons Sur Marne, France; [Djedaini, Kamel] Geoffroy St Hilaire Hosp, Gen Intens Care Unit, Paris, France; [Kandelman, Stanislas; Allary, Jeremy] Diderot Univ, Beaujon Claude Bernard Hosp, AP HP, Dept Anesthesiol, Paris, France; [Kandelman, Stanislas; Allary, Jeremy] Diderot Univ, Beaujon Claude Bernard Hosp, AP HP, Intens Care Unit, Paris, France; [Cariou, Alain] Descartes Univ, Cochin Hosp, AP HP, Intens Care Unit, Paris, France; [Sonneville, Romain] Diderot Univ, Bichat Claude Bernard Hosp, AP HP, Med Intens Care Unit, Paris, France; [Antona, Marion] Descartes Univ, Cochin Hosp, AP HP, Surg Intens Care Unit, Paris, France; [Azabou, Eric] Univ Versailles St Quentin Yvelines, Raymond Poincare Hosp, AP HP, Dept Physiol, Garches, France; [Chretien, Fabrice; Mantz, Jean; Sharshar, Tarek] Pasteur Inst, Lab Human Histopathol & Anim Models, Paris, France; [Chretien, Fabrice] Descartes Univ, St Anne Hosp, Dept Neuropathol, Paris, France; [Mantz, Jean] Descartes Univ, Georges Pompidou European Hosp, AP HP, Dept Anesthesiol, Paris, France; [Mantz, Jean] Descartes Univ, Georges Pompidou European Hosp, AP HP, Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Sharshar, T (corresponding author), Univ Versailles St Quentin Yvelines, Raymond Poincare Hosp, AP HP, Gen Intens Care Unit, Garches, France.; Sharshar, T (corresponding author), Pasteur Inst, Lab Human Histopathol & Anim Models, Paris, France.	tsharshar@gmail.com	Sonneville, Romain/AAE-7039-2020; Annane, Djillali/R-7947-2019; Rohaut, Benjamin/O-9250-2017; Chretien, fabrice B/D-4035-2018; Sharshar, Tarek/ABF-4117-2021	Sonneville, Romain/0000-0003-0245-309X; Rohaut, Benjamin/0000-0001-6752-8756; Chretien, fabrice B/0000-0002-2794-1383; Porcher, Raphael/0000-0002-5277-4679				Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Balzer F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0929-2; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Boisseau N, 2002, BRIT J ANAESTH, V88, P785, DOI 10.1093/bja/88.6.785; Collins L. M., 2013, LATENT CLASS LATENT, V718; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Elliott D, 2013, CRIT CARE RESUSC, V15, P213; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Grap MJ, 2012, AM J CRIT CARE, V21, pE53, DOI 10.4037/ajcc2012301; Grp ST, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-24; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Le Gall JR, 2005, CRIT CARE, V9, pR645, DOI 10.1186/cc3821; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Liu EHC, 2005, BRIT J ANAESTH, V94, P193, DOI 10.1093/bja/aei003; Nydahl P, 2014, CRIT CARE MED, V42, P1178, DOI 10.1097/CCM.0000000000000149; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; R Development Core Team, 2012, R LANG ENV STAT COMP; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Rotheray KR, 2012, RESUSCITATION, V83, P86, DOI 10.1016/j.resuscitation.2011.07.017; Sauder P, 2008, ANN FR ANESTH, V27, P541, DOI 10.1016/j.annfar.2008.04.021; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sharshar T, 2002, CRIT CARE MED, V30, P2371, DOI 10.1097/00003246-200210000-00031; Sharshar T, 2011, CRIT CARE MED, V39, P1960, DOI 10.1097/CCM.0b013e31821b843b; Shehabi Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12679; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; van den Boogaard M, 2014, INTENS CARE MED, V40, P361, DOI 10.1007/s00134-013-3202-7; van den Boogaard M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e420; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wurpts IC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00920	39	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176012	10.1371/journal.pone.0176012	http://dx.doi.org/10.1371/journal.pone.0176012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441453	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800018
J	Lamberti, M; Napolitano, F; Napolitano, P; Arnese, A; Crispino, V; Panariello, G; Di Giuseppe, G				Lamberti, Monica; Napolitano, Francesco; Napolitano, Paola; Arnese, Antonio; Crispino, Vincenzo; Panariello, Gianclaudio; Di Giuseppe, Gabriella			Prevalence of alcohol use disorders among under-and post-graduate healthcare students in Italy	PLOS ONE			English	Article							MEDICAL-STUDENTS; AUDIT-C; IDENTIFICATION TEST; DRUG-USE; RISKY DRINKING; GLOBAL BURDEN; SUBSTANCE USE; UNIVERSITY; CONSUMPTION; MORBIDITY	cross-sectional study was carried out on 641 medical students, 359 students attending a degree course in the healthcare professions, and 500 resident physicians, all undergoing health surveillance at the ambulatory of the Division of Occupational Medicine, Second University of Naples, Italy. 76.1% of the participants drank alcohol, with 85.5% of medical students, 77.4% of resident physicians, and 63% of healthcare-professions students reporting regular alcohol use. In the whole sample, the mean Audit-C score was 1.6 for men and 1.1 for women; only 5.5% of men and 7.1% of women had a hazardous alcohol consumption with an Audit-C score of respectively >= 4 and >= 3. Multivariate regression modeling revealed that regular alcohol use was more likely in individuals who were men, were younger, had a lower body-mass index, were active smokers, were habitual coffee drinkers, and who were resident physicians or medical students rather than healthcare-professions students. This finding identifies a need to assess alcohol use in medical-profession workers in order to identify risky behavior early on and to carry out rapidly effective preventive and curative interventions.	[Lamberti, Monica; Crispino, Vincenzo; Panariello, Gianclaudio] Univ Naples 2, Sch Med, Dept Expt Med, Sect Occupat Med, Naples, Italy; [Napolitano, Francesco; Napolitano, Paola; Arnese, Antonio; Di Giuseppe, Gabriella] Univ Naples 2, Sch Med, Dept Expt Med, Sect Hyg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Lamberti, M (corresponding author), Univ Naples 2, Sch Med, Dept Expt Med, Sect Occupat Med, Naples, Italy.	monica.lamberti@unina2.it		DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418				Andersson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-229; Ball S, 2002, ACAD MED, V77, P911, DOI 10.1097/00001888-200209000-00023; Beard E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173458; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley KA, 2016, ADDICTION, V111, P1975, DOI 10.1111/add.13505; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Connor J, 2013, ALCOHOL CLIN EXP RES, V37, P1971, DOI 10.1111/acer.12175; Cousins K, 2014, DRUG ALCOHOL DEPEN, V143, P120, DOI 10.1016/j.drugalcdep.2014.07.015; Croen LG, 1997, ACAD MED, V72, P376, DOI 10.1097/00001888-199705000-00017; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Frank E, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2155; Fujii H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3053-6; Gerstenkorn Andrzej, 2003, Wiad Lek, V56, P402; Guthrie EA, 1995, MED EDUC, V29, P337, DOI 10.1111/j.1365-2923.1995.tb00022.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nash LM, 2010, MED J AUSTRALIA, V193, P161, DOI 10.5694/j.1326-5377.2010.tb03837.x; Newbury-Birch D, 2002, BRIT DENT J, V192, P646, DOI 10.1038/sj.bdj.4801448a; Newbury-Birch D, 2001, DRUG ALCOHOL DEPEN, V64, P265, DOI 10.1016/S0376-8716(01)00128-4; Osaki Y, 2014, ASIAN PAC J CANCER P, V15, P6571, DOI 10.7314/APJCP.2014.15.16.6571; Pickard M, 2000, MED EDUC, V34, P148, DOI 10.1046/j.1365-2923.2000.00491.x; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Sarikaya O, 2006, INT J CLIN PRACT, V60, P1414, DOI 10.1111/j.1742-1241.2006.00869.x; Shield KD, 2013, WHO REGIONAL OFFICE, P3; Stata Corporation, 2007, STAT REF MAN REL 10; Stewart SM, 1999, MED EDUC, V33, P243; Voigt K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-219; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Webb E, 1996, LANCET, V348, P922, DOI 10.1016/S0140-6736(96)03410-1; Wurst FM, 2013, GEN HOSP PSYCHIAT, V35, P561, DOI 10.1016/j.genhosppsych.2013.04.018	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175719	10.1371/journal.pone.0175719	http://dx.doi.org/10.1371/journal.pone.0175719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437428	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600011
J	Jaakkola, S; Nuotio, I; Kiviniemi, TO; Virtanen, R; Issakoff, M; Airaksinen, KEJ				Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Issakoff, Melina; Airaksinen, K. E. Juhani			Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; CHRONIC KIDNEY-DISEASE; ORAL ANTICOAGULATION; RISK-FACTORS; COMPLICATIONS; MORTALITY; OVERANTICOAGULATION; CARDIOVERSION; EPIDEMIOLOGY; HEMODIALYSIS	Vitamin K antagonist warfarin is widely used in clinical practice and excessive anticoagulation is a well-known complication of this therapy. Little is known about permanent and temporary predictors for severe overanticoagulation. The aim of this study was to investigate the occurrence and predicting factors for episodes with very high (>= 9) international normalized ratio (INR) values in warfarin treated patients with atrial fibrillation (AF). Excessive Warfarin Anticoagulation (EWA) study screened all patients (n = 13618) in the Turku University Hospital region with an INR >= 2 between years 2003-2015. Patients using warfarin anticoagulation for AF with very high (>= 9) INR values (EWA Group) were identified (n = 412 patients) and their characteristics were compared to a control group (n = 405) of AF patients with stable INR during long-term follow-up. Over 20% (n = 92) of the EWA patients had more than one event of very high INR and in 105 (25.5%) patients EWA led to a bleeding event. Of the several temporary and permanent EWA risk factors observed, strongest were excessive alcohol consumption in 9.6% of patients (OR 24.4, 95% CI 9.9-50.4, p<0.0001) and reduced renal function (OR 15.2, 95% CI 5.67-40.7, p<0.0001). Recent antibiotic or antifungal medication, recent hospitalization or outpatient clinic visit and the first 6 months of warfarin use were the most significant temporary risk factors for EWA. Excessive warfarin anticoagulation can be predicted with several permanent and temporary clinical risk factors, many of which are modifiable.	[Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku, Finland; [Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Issakoff, Melina; Airaksinen, K. E. Juhani] Univ Turku, Turku, Finland; [Nuotio, Ilpo] Turku Univ Hosp, Dept Acute Internal Med, Turku, Finland; [Virtanen, Raine] Turku City Hosp, Dept Cardiol, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, Turku, Finland.; Airaksinen, KEJ (corresponding author), Univ Turku, Turku, Finland.	juhani.airaksinen@tyks.fi	Kiviniemi, Tuomas/A-1107-2016; Airaksinen, Juhani/AAC-7857-2021	Kiviniemi, Tuomas/0000-0002-0908-3741; Airaksinen, Juhani/0000-0002-0193-568X; Jaakkola, Samuli/0000-0001-5944-6814	Finnish Foundation for Cardiovascular Research, Helsinki, Finland: State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland [140027, 13016]	Finnish Foundation for Cardiovascular Research, Helsinki, Finland: State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland	This study was funded by The Finnish Foundation for Cardiovascular Research, Helsinki, Finland, (140027): State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland (13016).	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Bergman M, 2014, AM J MED SCI, V348, P71, DOI 10.1097/MAJ.0000000000000209; Boriani G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30271; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Dodson JA, 2016, JAMA CARDIOL, V1, P65, DOI 10.1001/jamacardio.2015.0345; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Garg L, 2016, INT J CARDIOL, V222, P47, DOI 10.1016/j.ijcard.2016.07.118; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Grzymala-Lubanski B, 2017, HEART, V103, P198, DOI 10.1136/heartjnl-2016-309585; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Hylek EM, 2001, ANN INTERN MED, V135, P393, DOI 10.7326/0003-4819-135-6-200109180-00008; Koo S, 2004, ARCH INTERN MED, V164, P1557, DOI 10.1001/archinte.164.14.1557; Levin A.S., 2013, KIDNEY INT SUPPL, V3, P19, DOI [10.1038/kisup.2012.64, DOI 10.1038/KISUP.2012.64]; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Luzny Jan, 2014, Acta Medica (Hradec Kralove), V57, P73, DOI 10.14712/18059694.2014.43; Marie I, 2012, QJM-INT J MED, V105, P53, DOI 10.1093/qjmed/hcr136; Oden A, 2002, BMJ-BRIT MED J, V325, P1073, DOI 10.1136/bmj.325.7372.1073; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palomaki A, 2016, INT J CARDIOL, V203, P269, DOI 10.1016/j.ijcard.2015.10.168; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; Pottegard A, 2013, EUR J CLIN PHARMACOL, V69, P641, DOI 10.1007/s00228-012-1363-x; Reddy U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1282; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; van Walraven C, 2007, CHEST, V131, P1508, DOI 10.1378/chest.06-2628; Visser LE, 2004, BRIT J HAEMATOL, V127, P85, DOI 10.1111/j.1365-2141.2004.05162.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wittkowsky AK, 2004, PHARMACOTHERAPY, V24, P1311, DOI 10.1592/phco.24.14.1311.43144; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175975	10.1371/journal.pone.0175975	http://dx.doi.org/10.1371/journal.pone.0175975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426737	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900079
J	Ma, JJ; Baker, AR; Calabro, A; Derwin, KA				Ma, Jinjin; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.			Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; LOSS INJURY; BIOLOGIC SCAFFOLD; DEFECT MODEL; MURINE MODEL; TISSUE; TRANSPLANTATION; CELLS; MEDICINE	Wounds causing extensive injury loss of muscle, also known as volumetric muscle loss (VML), are frequently associated with high-energy civilian trauma and combat-related extremity injuries. Currently, no effective clinical therapy is available for promoting de novo muscle tissue regeneration to restore muscle function following VML. Recent studies have shown evidence that osteoactivin (OA), a transmembrane glycoprotein, has the ability to prevent skeletal muscle atrophy in response to denervation. Therefore the objective of this study is to investigate the potential regenerative effect of OA embedded and delivered via a cross-linked gelatin hydrogel within a volumetric tibialis anterior muscle defect in a rat model. After 4 weeks, however, no evidence for muscle formation was found in defects treated with either low (5 mu g/ml) or high (50 mu g/ml) OA. It is possible that a different delivery scaffold, delivery kinetics, or OA concentration may have yielded an alternate outcome, or it is also possible that the spaciostructural environment of VML, or the local (versus systemic) delivery of OA, simply does not support any potential regenerative activity of OA in VML. Together with prior work, this study demonstrates that an efficacious and scalable therapy for regenerating muscle volume and function in VML remains a veritable clinical challenge worthy of continued future research efforts.	[Ma, Jinjin; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ma, JJ (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	maj3@ccf.org		Ma, Jinjin/0000-0002-5446-2214	Cleveland Clinic LRI Chair's Innovative Research Fund	Cleveland Clinic LRI Chair's Innovative Research Fund	This work was supported by Cleveland Clinic LRI Chair's Innovative Research Fund.; Authors have nothing to disclose. This work was supported by Cleveland Clinic LRI Chair's Innovative Research Fund.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Arosarena OA, 2011, J CELL PHYSIOL, V226, P2943, DOI 10.1002/jcp.22639; Aurora A, 2015, BIOMATERIALS, V67, P393, DOI 10.1016/j.biomaterials.2015.07.040; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; Gentile NE, 2014, AM J PHYS MED REHAB, V93, pS79, DOI 10.1097/PHM.0000000000000145; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Ma JJ, 2015, J BIOMED MATER RES B, V103, P355, DOI 10.1002/jbm.b.33166; Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]; MacKenzie EJ, 2007, J BONE JOINT SURG AM, V89A, P1685, DOI 10.2106/JBJS.F.01350; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.tea.2012.0475, 10.1089/ten.TEA.2012.0475]; Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014; Tonogai I, 2015, J PEDIATR ORTHOP B, V24, P162, DOI 10.1097/BPB.0000000000000117; Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]; Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029; Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039; Ward CL, 2015, BIORESEARCH OPEN ACC, V4, P198, DOI 10.1089/biores.2015.0009; Wu XW, 2012, BIORESEARCH OPEN ACC, V1, P280, DOI 10.1089/biores.2012.0271	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175853	10.1371/journal.pone.0175853	http://dx.doi.org/10.1371/journal.pone.0175853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426701	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900058
J	Zeng, F; Chen, EQ; Du, LY; Yan, LB; Li, H; Bai, L; Feng, P; Tang, H				Zeng Fan; Chen EnQiang; Du Ling Yao; Yan LiBo; Li Hong; Bai Lang; Feng Ping; Tang Hong			Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system	PLOS ONE			English	Article							INJURY	Aim Hepatitis B virus-related acute-on-chronic liver failure has high short-term mortality. Artificial liver support systems (ALSS) may improve outcome and avoid liver transplantation, but predicting short-term prognosis in such patients is difficult. This study aimed to determine whether the neutrophil-lymphocyte ratio (NLR), an inflammation marker, predicted mortality in patients treated with ALSS. Methods A total of 560 patients with hepatitis B virus-related acute-on-chronic liver failure were enrolled, 338 were treated with ALSS and the others treated with standard of care(SOC). Clinical variables and the NLR were evaluated for prognostic value. Results Thirty-day mortality was 28.4% in ALSS and 55.4% in SOC patients. The NLR was lower in survivors than in ALSS or SOC patients who died. Univariate and multivariate analysis found that NLR and the chronic liver failure sequential organ failure assessment scores (CLIF-SOFA) were independently associated with 30-day mortality. Among patients with NLRs <= 3, 3-6, and > 6, 30-day mortality was 7.7%, 23.1%, and 69.2% in ALSS and 25.5%, 50.0%, and 75.0% in SOC patients. Among patients with NLRs <= 3 or 3-6, mortality was lower in ALSS than in SOC patients (P < 0.01). Mortality rates of ALSS and SOC patients with NLRs > 6 did not different (P > 0.05). The area under curve of NLR and CLIF-SOFA was 0.82 and 0.88 in ALSS group, 0.78 and 0.86 in SOC group. The results suggest that liver function in most patients with NLRs <= 3 recovered with ALSS treatment, and patients with NLRs > 6 needed emergency liver transplantation. Conclusion NLR was an independent predictor of mortality in ALSS patients and may assist physicians in determining treatment options.	[Zeng Fan; Chen EnQiang; Du Ling Yao; Yan LiBo; Li Hong; Bai Lang; Feng Ping; Tang Hong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China; [Zeng Fan] Hosp Univ Elect Sci, Sichuan Prov Peoples Hosp, Dept Intens Care Unit, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital	Tang, H (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China.	htang6198@hotmail.com	Chen, En-Qiang/S-7967-2019		National Natural Science Foundation of China [81300319, 30972622]; National Twelve-Five Project of China [2012ZX10002007-001-003]; Science and Technology Support Program of Sichuan China [No. 2015SZ0049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelve-Five Project of China; Science and Technology Support Program of Sichuan China	Dr HongTang received this three founder: National Natural Science Foundation of China (No.81300319) and National Twelve-Five Project of China (2012ZX10002007-001-003) http//www.nsfc.gov.cnThe funders; Science and Technology Support Program of Sichuan China (No. 2015SZ0049)http//www.scst.gov.cn.Dr EnqiangChen received one funding: National Natural Science Foundation of China (No. 30972622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab B, 2011, PANCREATOLOGY, V11, P445, DOI 10.1159/000331494; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bhatia V, 2008, HEPATOL INT, V2, P465, DOI 10.1007/s12072-008-9098-6; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Cisneros-Garza LE, 2014, ANN HEPATOL, V13, P240, DOI 10.1016/S1665-2681(19)30887-7; Du WB, 2005, TRANSPL P, V37, P4359, DOI 10.1016/j.transproceed.2005.11.044; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI DOI 10.1053/JHEP.2002.31250; Laleman W, 2011, EXPERT REV GASTROENT, V5, P523, DOI [10.1586/egh.11.47, 10.1586/EGH.11.47]; Liu H, 2014, J VIRAL HEPATITIS, V21, P499, DOI 10.1111/jvh.12160; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Pan HC, 2014, ALIMENT PHARM THER, V40, P1056, DOI 10.1111/apt.12953; Runyon BA, 2004, HEPATOLOGY, V39, P841, DOI 10.1002/hep.20066; Saliba F, 2013, ANN INTERN MED, V159, P522, DOI 10.7326/0003-4819-159-8-201310150-00005; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seto WK, 2012, J GASTROEN HEPATOL, V27, P662, DOI 10.1111/j.1440-1746.2011.06971.x; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.006; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Twu YC, 2011, EUR J IMMUNOL, V41, P335, DOI 10.1002/eji.201040639; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Zou ZS, 2009, J CLIN GASTROENTEROL, V43, P182, DOI 10.1097/MCG.0b013e3181624464	21	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175332	10.1371/journal.pone.0175332	http://dx.doi.org/10.1371/journal.pone.0175332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426800	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900024
J	Carr, SB; Beal, J; Densmore, DM				Carr, Swati B.; Beal, Jacob; Densmore, Douglas M.			Reducing DNA context dependence in bacterial promoters	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; TRANSCRIPTION; TRANSLATION; DESIGN	Variation in the DNA sequence upstream of bacterial promoters is known to affect the expression levels of the products they regulate, sometimes dramatically. While neutral synthetic insulator sequences have been found to buffer promoters from upstream DNA context, there are no established methods for designing effective insulator sequences with predictable effects on expression levels. We address this problem with Degenerate Insulation Screening (DIS), a novel method based on a randomized 36-nucleotide insulator library and a simple, high-throughput, flow-cytometry-based screen that randomly samples from a library of 4(36) potential insulated promoters. The results of this screen can then be compared against a reference uninsulated device to select a set of insulated promoters providing a precise level of expression. We verify this method by insulating the constitutive, inducible, and repressible promotors of a four transcriptional-unit inverter (NOT-gate) circuit, finding both that order dependence is largely eliminated by insulation and that circuit performance is also significantly improved, with a 5.8-fold mean improvement in on/off ratio.	[Carr, Swati B.] Boston Univ, Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Beal, Jacob] Raytheon BBN Technol, Cambridge, MA 02138 USA; [Densmore, Douglas M.] Boston Univ, Elect & Comp Engn, Boston, MA 02215 USA	Boston University; Raytheon Technologies; Raytheon BBN Technologies; Boston University	Beal, J (corresponding author), Raytheon BBN Technol, Cambridge, MA 02138 USA.	jakebeal@ieee.org	Densmore, Douglas/AAC-7059-2020	Beal, Jacob/0000-0002-1663-5102	National Science Foundation (NSF) [1522074, 1253856]; Office of Naval Research (ONR) [N000141110725]; Raytheon BBN Technologies; Division of Computing and Communication Foundations [1522074] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Raytheon BBN Technologies; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Funding for this work comes from the National Science Foundation (NSF; nsf.gov) Expeditions in Computing Program Award #1522074 as part of the Living Computing Project (JB, DMD), as well as from National Science Foundation (NSF; nsf.gov) Award #1253856 (SBC, DMD) and from the Office of Naval Research (ONR; www.onr.navy.mil) under award N000141110725 (SBC, DMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raytheon BBN Technologies provided support in the form of salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions"section.; Funding for this work comes from the National Science Foundation (nsf. gov) Expeditions in Computing Program Award #1522074 as part of the Living Computing Project (JSB, DMD), as well as from National Science Foundation (nsf. gov) Award #253856 (SBC, DMD) and from the Office of Naval Research (www.onr.navy.mil) under award N000141110725 (SBC, DMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raytheon BBN Technologies provided support in the form of salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section. This document does not contain technology or technical data controlled under either the U.S. International Traffic in Arms Regulations or the U.S. Export Administration Regulations. The authors would also like to acknowledge help and assistance in the wet lab from Traci Haddock-Angelli and Rahul Veetakat.	Beal J., 2015, FRONTIERS BIOENGINEE, V2; Beal J., 2012, MITCSAILTR2012008; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Davidsohn N, 2015, ACS SYNTH BIOL, V4, P673, DOI 10.1021/sb500263b; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Haddock TL, 2015, 94 BBF RFC; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; iGEM Foundation, REG STAND BIOL PARTS; Iverson SV, 2016, ACS SYNTH BIOL, V5, P99, DOI 10.1021/acssynbio.5b00124; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Madsen C., 2015, 7 INT WORKSH BIOD AU; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Mitchison G, 2005, TRENDS GENET, V21, P440, DOI 10.1016/j.tig.2005.06.002; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yeung E, 2014, IEEE DECIS CONTR P, P5405, DOI 10.1109/CDC.2014.7040234	23	44	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176013	10.1371/journal.pone.0176013	http://dx.doi.org/10.1371/journal.pone.0176013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422998	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600076
J	Rauschert, I; Aldunate, F; Preussner, J; Arocena-Sutz, M; Peraza, V; Looso, M; Benech, JC; Agrelo, R				Rauschert, Ines; Aldunate, Fabian; Preussner, Jens; Arocena-Sutz, Miguel; Peraza, Vanina; Looso, Mario; Benech, Juan C.; Agrelo, Ruben			Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells	PLOS ONE			English	Article							A-TYPE LAMINS; ADULT STEM-CELLS; NUCLEAR LAMINA; DNA METHYLATION; DIFFERENTIAL EXPRESSION; RETINOBLASTOMA PROTEIN; CANCER-THERAPY; GENE; PROGERIA; INACTIVATION	Nuclear lamins support the nuclear envelope and provide anchorage sites for chromatin. They are involved in DNA synthesis, transcription, and replication. It has previously been reported that the lack of Lamin A/C expression in lymphoma and leukaemia is due to CpG island promoter hypermethylation. Here, we provide evidence that Lamin A/C is silenced via this mechanism in a subset of neuroblastoma cells. Moreover, Lamin A/C expression can be restored with a demethylating agent. Importantly, Lamin A/C reintroduction reduced cell growth kinetics and impaired migration, invasion, and anchorage-independent cell growth. Cytoskeletal restructuring was also induced. In addition, the introduction of lamin Delta 50, known as Progerin, caused senescence in these neuroblastoma cells. These cells were stiffer and developed a cytoskeletal structure that differed from that observed upon Lamin A/C introduction. Of relevance, short hairpin RNA Lamin A/C depletion in unmethylated neuroblastoma cells enhanced the aforementioned tumour properties. A cytoskeletal structure similar to that observed in methylated cells was induced. Furthermore, atomic force microscopy revealed that Lamin A/C knockdown decreased cellular stiffness in the lamellar region. Finally, the bioinformatic analysis of a set of methylation arrays of neuroblastoma primary tumours showed that a group of patients (around 3%) gives a methylation signal in some of the CpG sites located within the Lamin A/C promoter region analysed by bisulphite sequencing PCR. These findings highlight the importance of Lamin A/C epigenetic inactivation for a subset of neuroblastomas, leading to enhanced tumour properties and cytoskeletal changes. Additionally, these findings may have treatment implications because tumour cells lacking Lamin A/C exhibit more aggressive behaviour.	[Rauschert, Ines; Benech, Juan C.] Inst Invest Biol Clemente Estable, Lab Cellular Signaling & Nanobiol, Montevideo, Uruguay; [Aldunate, Fabian; Arocena-Sutz, Miguel; Peraza, Vanina; Agrelo, Ruben] Inst Pasteur Montevideo, Epigenet Canc & Aging Lab, Montevideo, Uruguay; [Preussner, Jens; Looso, Mario] Max Planck Inst Heart & Lung Res, Bioinformat Core Unit, Bad Nauheim, Germany	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Max Planck Society	Benech, JC (corresponding author), Inst Invest Biol Clemente Estable, Lab Cellular Signaling & Nanobiol, Montevideo, Uruguay.; Agrelo, R (corresponding author), Inst Pasteur Montevideo, Epigenet Canc & Aging Lab, Montevideo, Uruguay.	jbenech@iibce.edu.uy; agrelo@pasteur.edu.uy		Preussner, Jens/0000-0003-1927-3458; Looso, Mario/0000-0003-1495-9530	Agencia Nacional de Investigacion e Inovacion [URUGUAY-DCI-ALA/2007/19.040 URU-UE]; Programa de Desarrollo de Ciencias Basicas (PEDECIBA) Uruguay	Agencia Nacional de Investigacion e Inovacion; Programa de Desarrollo de Ciencias Basicas (PEDECIBA) Uruguay	This research was supported by the Agencia Nacional de Investigacion e Inovacion (Programa INNOVA URUGUAY-DCI-ALA/2007/19.040 URU-UE) and Programa de Desarrollo de Ciencias Basicas (PEDECIBA) Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2005, J CLIN ONCOL, V23, P3940, DOI 10.1200/JCO.2005.11.650; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Ballestar E, 2011, ADV EXP MED BIOL, V711, P1; Bell ES, 2016, EUR J CELL BIOL; Benech JC, 2014, AM J PHYSIOL-CELL PH, V307, pC910, DOI 10.1152/ajpcell.00192.2013; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; BRIDGER JM, 1993, J CELL SCI, V104, P297; Broers JLV, 2004, J PATHOL, V204, P478, DOI 10.1002/path.1655; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Broers JLV, 2014, ADV EXP MED BIOL, V773, P27, DOI 10.1007/978-1-4899-8032-8_2; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x; Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711; Christensen RM, 1982, THEORY VISCOELSATICI; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahl KN, 2010, J BIOMECH, V43, P2, DOI 10.1016/j.jbiomech.2009.09.002; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Decock A, 2011, EPIGENETICS-US, V6, P962, DOI 10.4161/epi.6.8.16516; Denais C, 2014, ADV EXP MED BIOL, V773, P435, DOI 10.1007/978-1-4899-8032-8_20; Dittmer TA, 2014, MOL BIOL CELL, V25, P1493, DOI 10.1091/mbc.E14-02-0733; Domingo-Fernandez R, 2013, PEDIATR SURG INT, V29, P101, DOI 10.1007/s00383-012-3239-7; Eckersley-Maslin MA, 2013, NUCLEUS-PHILA, V4, P53, DOI 10.4161/nucl.23384; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Esteller M, 2005, CURR OPIN ONCOL, V17, P55, DOI 10.1097/01.cco.0000147383.04709.10; Etus V, 2002, TOHOKU J EXP MED, V197, P55, DOI 10.1620/tjem.197.55; Fraldi M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0656; Geltmeier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134999; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gomez S, 2015, GENOM DATA, V5, P360, DOI 10.1016/j.gdata.2015.07.016; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Henrich KO, 2016, CANCER RES, V76, P5523, DOI 10.1158/0008-5472.CAN-15-2507; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; HOZAK P, 1995, J CELL SCI, V108, P635; Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Ikai A, 2008, WORLD OF NANO-BIOMECHANICS: MECHANICAL IMAGING AND MEASUREMENT BY ATOMIC FORCE MICROSCOPY, P1; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kaufmann A, 2011, NUCLEUS-AUSTIN, V2, P310, DOI 10.4161/nucl.2.4.16119; Kennedy BK, 2014, ADV EXP MED BIOL, V773, P127, DOI 10.1007/978-1-4899-8032-8_6; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18; Lammerding J, 2011, COMPR PHYSIOL, V1, P783, DOI 10.1002/cphy.c100038; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lanzicher T, 2015, NUCLEUS-PHILA, V6, P394, DOI 10.1080/19491034.2015.1084453; Lanzicher T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13388; Lee J., 2008, FORCE BIOL UNDERSTAN; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lombardi ML, 2010, METHOD CELL BIOL, V98, P121, DOI 10.1016/S0091-679X(10)98006-0; Lozoya OA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23047; Maresca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045513; Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Marques S. P. C., 2012, COMPUTATIONAL VISCOE; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Milner JS, 2012, J FUNCT BIOMATER, V3, P209, DOI 10.3390/jfb3010209; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naetar N, 2009, CELL CYCLE, V8, P1488, DOI 10.4161/cc.8.10.8499; Nardella M, 2015, ONCOTARGET, V6, P32821, DOI 10.18632/oncotarget.5104; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Oh JE, 2006, AMINO ACIDS, V31, P289, DOI 10.1007/s00726-005-0256-z; Olsson M, 2016, EPIGENETICS-US, V11, P74, DOI 10.1080/15592294.2016.1138195; Or M, 2009, ULTRASOUND MED BIOL, V35, P1015, DOI 10.1016/j.ultrasmedbio.2008.11.011; Pacheco LM, 2014, AGING-US, V6, P1049, DOI 10.18632/aging.100709; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Perovanovic J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4991; Phipps SMO, 2009, MOL BIOTECHNOL, V41, P201, DOI 10.1007/s12033-008-9118-8; Preussner J, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0045-1; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Ribeiro AJS, 2014, CELL MOL BIOENG, V7, P544, DOI 10.1007/s12195-014-0358-3; Sabatino G, 2009, ACTA NEUROCHIR, V151, P495, DOI 10.1007/s00701-009-0227-3; Sartore-Bianchi A, 2015, J NATL CANC I; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Schulte Johannes H., 2015, Critical Reviews in Oncogenesis, V20, P245, DOI 10.1615/CritRevOncog.2015014033; Sehgal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057891; Sharma P, 2016, SENP1 MODULATED SUMO; Shimi T, 2015, MOL BIOL CELL, V26, P4075, DOI 10.1091/mbc.E15-07-0461; Sirghi L, 2008, EUR BIOPHYS J BIOPHY, V37, P935, DOI 10.1007/s00249-008-0311-2; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Takamori Y, 2007, EUR J NEUROSCI, V25, P1653, DOI 10.1111/j.1460-9568.2007.05450.x; Takeshi S, 2016, METHODS MOL BIOL, V1411, P99, DOI 10.1007/978-1-4939-3530-7_5; Tang J, 2015, TECHNOL CANCER RES T, V14, P221, DOI 10.7785/tcrt.2012.500407; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Uslu GH, 2015, ONCOL LETT, V10, P3651, DOI 10.3892/ol.2015.3821; Wang AS, 2015, DIFFERENTIATION, V89, P11, DOI 10.1016/j.diff.2014.12.002; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Wenzel V, 2012, BIOL OPEN, V1, P516, DOI 10.1242/bio.20121149; Wilche G., 1998, J CELL SCI, V111, P2477; Williams A. R, 1983, ULTRASOUND BIOL EFFE; Willis ND, 2008, BIOCHEM SOC T, V36, P1350, DOI 10.1042/BST0361350; Wong V, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv307; Worman HJ, 2015, CURR OPIN CELL BIOL, V34, P101, DOI 10.1016/j.ceb.2015.06.003; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zuo BF, 2012, BIOL OPEN, V1, P1118, DOI 10.1242/bio.20121586	118	13	14	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175953	10.1371/journal.pone.0175953	http://dx.doi.org/10.1371/journal.pone.0175953			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422997	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600068
J	Wait, LF; Fox, S; Peck, S; Power, ML				Wait, Liana F.; Fox, Samantha; Peck, Sarah; Power, Michelle L.			Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii)	PLOS ONE			English	Article							QUENDA ISOODON-OBESULUS; NEW-YORK-STATE; AUSTRALIAN WILDLIFE; PETROGALE-PENICILLATA; WESTERN-AUSTRALIA; PREVALENCE; IDENTIFICATION; DUODENALIS; LOCUS; DIVERSITY	The Tasmanian devil (Sarcophilus harrisii) is a carnivorous marsupial found only in the wild in Tasmania, Australia. Tasmanian devils are classified as endangered and are currently threatened by devil facial tumour disease, a lethal transmissible cancer that has decimated the wild population in Tasmania. To prevent extinction of Tasmanian devils, conservation management was implemented in 2003 under the Save the Tasmanian Devil Program. This study aimed to assess if conservation management was altering the interactions between Tasmanian devils and their parasites. Molecular tools were used to investigate the prevalence and diversity of two protozoan parasites, Cryptosporidium and Giardia, in Tasmanian devils. A comparison of parasite prevalence between wild and captive Tasmanian devils showed that both Cryptosporidium and Giardia were significantly more prevalent in wild devils (p < 0.05); Cryptosporidium was identified in 37.9% of wild devils but only 10.7% of captive devils, while Giardia was identified in 24.1% of wild devils but only 0.82% of captive devils. Molecular analysis identified the presence of novel genotypes of both Cryptosporidium and Giardia. The novel Cryptosporidium genotype was 98.1% similar at the 18S rDNA to Cryptosporidium varanii (syn. C. saurophilum) with additional samples identified as C. fayeri, C. muris, and C. galli. Two novel Giardia genotypes, TD genotype 1 and TD genotype 2, were similar to G. duodenalis from dogs (94.4%) and a Giardia assemblage A isolate from humans (86.9%). Giardia duodenalis BIV, a zoonotic genotype of Giardia, was also identified in a single captive Tasmanian devil. These findings suggest that conservation management may be altering host-parasite interactions in the Tasmanian devil, and the presence of G. duodenalis BIV in a captive devil points to possible human-devil parasite transmission.	[Wait, Liana F.; Power, Michelle L.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Fox, Samantha; Peck, Sarah] Dept Primary Ind Pk Water & Environm, Save Tasmanian Devil Program, Hobart, Tas, Australia	Macquarie University	Wait, LF (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	liana.f.wait@gmail.com		Fox, Samantha/0000-0002-0371-3458; Power, Michelle/0000-0003-3160-4301	Macquarie University	Macquarie University	Funding was provided by Macquarie University as part of a Master of Research degree.	Adams PJ, 2004, INFECT GENET EVOL, V4, P365, DOI 10.1016/j.meegid.2004.05.003; Appelbee AJ, 2005, TRENDS PARASITOL, V21, P370, DOI 10.1016/j.pt.2005.06.004; Bender HS, 2014, ANNU REV ANIM BIOSCI, V2, P165, DOI 10.1146/annurev-animal-022513-114204; Bettiol SS, 1997, J WILDLIFE DIS, V33, P352, DOI 10.7589/0090-3558-33.2.352; Beveridge I., 2003, P383; Brown O. J. F., 2006, ALCHERINGA AUST J PA, V30, P49, DOI DOI 10.1080/03115510609506855; Burton AJ, 2010, VET PARASITOL, V174, P139, DOI 10.1016/j.vetpar.2010.08.019; Delport Tiffany C., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P269, DOI 10.1016/j.ijppaw.2014.09.001; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Feng YY, 2011, EXP PARASITOL, V127, P238, DOI 10.1016/j.exppara.2010.08.002; Hikosaka K, 2005, PARASITOL RES, V97, P373, DOI 10.1007/s00436-005-1459-7; Hill NJ, 2008, APPL ENVIRON MICROB, V74, P5549, DOI 10.1128/AEM.00809-08; Hill NJ, 2012, PARASITOL INT, V61, P461, DOI 10.1016/j.parint.2012.03.003; Hillman A, 2016, INT J PARASITOL-PAR, V5, P110, DOI 10.1016/j.ijppaw.2016.01.002; Hollings Tracey, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P110, DOI 10.1016/j.ijppaw.2013.02.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kettlewell JS, 1998, J TRAVEL MED, V5, P127, DOI 10.1111/j.1708-8305.1998.tb00485.x; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees C., 2012, TASMANIAN DEVIL INSU; Li N, 2014, EMERG INFECT DIS, V20, P217, DOI 10.3201/eid2002.121797; McCarthy S, 2008, EXP PARASITOL, V118, P596, DOI 10.1016/j.exppara.2007.10.014; McGlade TR, 2003, VET PARASITOL, V110, P197, DOI 10.1016/S0304-4017(02)00322-9; Morgan UM, 1998, J CLIN MICROBIOL, V36, P995, DOI 10.1128/JCM.36.4.995-998.1998; MUNDAY BL, 1978, J WILDLIFE DIS, V14, P417, DOI 10.7589/0090-3558-14.4.417; Power ML, 2008, J PARASITOL, V94, P1114, DOI 10.1645/GE-1508.1; Power ML, 2010, EXP PARASITOL, V124, P40, DOI 10.1016/j.exppara.2009.07.014; Power ML, 2009, EXP PARASITOL, V121, P219, DOI 10.1016/j.exppara.2008.10.016; Power ML, 2005, APPL ENVIRON MICROB, V71, P6159, DOI 10.1128/AEM.71.10.6159-6164.2005; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Ryan UM, 2003, J PARASITOL, V89, P809, DOI 10.1645/GE-74RI; Ryan U, 2012, PARASITOLOGY, V139, P1673, DOI 10.1017/S0031182012001151; Team RC, 2014, R LANG ENV STAT COMP; Thompson J, 2008, EXP PARASITOL, V120, P88, DOI 10.1016/j.exppara.2008.05.002; Thompson RCA, 2010, VET PARASITOL, V170, P207, DOI 10.1016/j.vetpar.2010.02.012; Vermeulen ET, 2015, INFECT GENET EVOL, V33, P277, DOI 10.1016/j.meegid.2015.05.015; Vermeulen ET, 2015, INT J PARASITOL-PAR, V4, P190, DOI 10.1016/j.ijppaw.2015.02.005; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Wang RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043782; Warren KS, 2003, AUST VET J, V81, P739, DOI 10.1111/j.1751-0813.2003.tb14602.x; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Ziegler PE, 2007, VET PARASITOL, V147, P176, DOI 10.1016/j.vetpar.2007.03.024	46	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174994	10.1371/journal.pone.0174994	http://dx.doi.org/10.1371/journal.pone.0174994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423030	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600025
J	Zhu, GR; Xie, ZL; Li, TY; Ma, ZW; Xu, XG				Zhu, Gaoru; Xie, Zhenglei; Li, Tuoyu; Ma, Zongwen; Xu, Xuegong			Assessment ecological risk of heavy metal caused by high-intensity land reclamation in Bohai Bay, China	PLOS ONE			English	Article							YELLOW-RIVER DELTA; COASTAL RECLAMATION; FRESH-WATER; WETLAND SOILS; SEDIMENTS; ESTUARY; CONTAMINATION; POLLUTION; CHRONOSEQUENCE; MANAGEMENT	The article examines the detailed spatial and temporal distributions of coastal reclamation in the northwest coast of Bohai Bay experiencing rapid coastal reclamation in China from 1974 to 2010 in annual intervals. Moreover, soil elements properties and spatial distribution in reclaimed area and inform the future coastal ecosystems management was also analyzed. The results shows that 910.7 km(2) of coastal wetlands have been reclaimed and conversed to industrial land during the past 36 years. It covers intertidal beach, shallow sea and island with a percentage of 76.0%, 23.5% and 0.5%, respectively. The average concentration of Mn is 686.91mg/kg and the order of concentration of heavy metal are Cr > Zn > As > Ni >-Cu > Pb > Cd > Hg. We used the "space for time substitution" method to test the soil properties changes after reclamation. The potential ecological risk of heavy metal is in low level and the risk of Cd and As is relatively higher. The ecosystem-based coastal protection and management are urgent to support sustainable coastal ecosystems in Bohai bay in the future.	[Zhu, Gaoru] Minist Transport Peoples Republ China, Transport Planning & Res Inst, Beijing, Peoples R China; [Zhu, Gaoru; Xu, Xuegong] Peking Univ, Coll Urban & Environm Sci, Minist Educ, Key Lab Earth Surface Proc, Beijing, Peoples R China; [Xie, Zhenglei] Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China; [Li, Tuoyu] Capital Normal Univ, Editorial Dept Journal, Beijing, Peoples R China; [Ma, Zongwen] Minist Sci & Technol, China Sci & Technol Exchange Ctr, Beijing, Peoples R China	Ministry of Transport of the People's Republic of China; Peking University; Jiangxi Normal University; Capital Normal University	Xu, XG (corresponding author), Peking Univ, Coll Urban & Environm Sci, Minist Educ, Key Lab Earth Surface Proc, Beijing, Peoples R China.; Xie, ZL (corresponding author), Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China.	xzl2121@163.com; xxg@urban.pku.edu.cn			National Natural Science Foundation of China [41601105, 40830746, 41361018, 41271102, 41601191]; Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation [JXS-EW-00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation	This study was co-supported by the National Natural Science Foundation of China (No. 41601105, 40830746, 41361018, 41271102, 41601191), and the Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation (No. JXS-EW-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah H, 2016, MAR POLLUT BULL, V107, P383, DOI 10.1016/j.marpolbul.2016.03.042; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Bai JH, 2014, PLOS ONE, V9; Bai JH, 2015, J HYDROL, V520, P186, DOI 10.1016/j.jhydrol.2014.11.007; Bai JH, 2012, J HYDROL, V450, P244, DOI 10.1016/j.jhydrol.2012.05.006; Chen JY, 2000, CHINA RECLAMATION OC; Cho DO, 2007, OCEAN COAST MANAGE, V50, P930, DOI 10.1016/j.ocecoaman.2007.02.005; Cui BS, 2016, WETLANDS, V36, pS1, DOI 10.1007/s13157-016-0737-8; Feng L, 2015, MAR POLLUT BULL, V100, P182, DOI 10.1016/j.marpolbul.2015.08.051; Feng L, 2014, MAR POLLUT BULL, V89, P102, DOI 10.1016/j.marpolbul.2014.10.029; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Han Q., 2013, WORLD ACAD SCI ENG T, V7, P669; He Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep05995; Jiang TT, 2015, ESTUAR COAST SHELF S, V164, P265, DOI 10.1016/j.ecss.2015.07.046; Li M, 2016, MAR POLLUT BULL, V103, P227, DOI 10.1016/j.marpolbul.2015.12.014; Li QS, 2007, ENVIRON POLLUT, V149, P158, DOI 10.1016/j.envpol.2007.01.006; Liu SS, 2015, MAR POLLUT BULL, V100, P483, DOI 10.1016/j.marpolbul.2015.09.028; Liu W., 2008, GUANGZHOU ENV SCI, V2, P26; Liu Ya-nan, 2011, Huanjing Kexue, V32, P2087; Lu QQ, 2016, WETLANDS, V36, pS125, DOI 10.1007/s13157-014-0598-y; Pan K, 2012, SCI TOTAL ENVIRON, V421, P3, DOI 10.1016/j.scitotenv.2011.03.013; Perkins MJ, 2015, ESTUAR COAST SHELF S, V167, P504, DOI 10.1016/j.ecss.2015.10.033; SFA (State Forestry Administration), 2014, REP 2 INV WETL RES C; Shen CC, 2016, MAR POLLUT BULL, V103, P144, DOI 10.1016/j.marpolbul.2015.12.028; Sun ZG, 2015, ENVIRON INT, V79, P25, DOI 10.1016/j.envint.2015.02.017; Suzuki T, 2003, MAR POLLUT BULL, V47, P226, DOI 10.1016/S0025-326X(02)00405-8; Tian B, 2016, ESTUAR COAST SHELF S, V170, P83, DOI 10.1016/j.ecss.2016.01.006; Tim CJ, 2013, ESTUAR COAST SHELF S, V130, P1; Wang W, 2014, OCEAN COAST MANAGE, V102, P415, DOI 10.1016/j.ocecoaman.2014.03.009; Wang ZH, 2015, ESTUAR COAST SHELF S, V164, P493, DOI 10.1016/j.ecss.2015.08.002; [沃飞 WO Fei], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P11; Xiao R, 2016, J SOIL SEDIMENT, V16, P821, DOI 10.1007/s11368-015-1274-4; Xiao R, 2015, SCI TOTAL ENVIRON, V517, P66, DOI 10.1016/j.scitotenv.2015.02.052; Xie ZL, 2014, ENVIRON MONIT ASSESS, V186, P7211, DOI 10.1007/s10661-014-3922-3; Xie ZL, 2010, ESTUAR COAST SHELF S, V86, P379, DOI 10.1016/j.ecss.2009.03.040; Zhang GL, 2016, ECOL INDIC, V69, P331, DOI 10.1016/j.ecolind.2016.04.042; Zhou X., 2010, THESIS; Zhu G.R., 2012, THESIS; Zhu MS, 2016, WETLANDS, V36, pS11, DOI 10.1007/s13157-014-0610-6; Zhuang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094145	40	11	11	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175627	10.1371/journal.pone.0175627	http://dx.doi.org/10.1371/journal.pone.0175627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422982	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600037
J	Grandahl, M; Larsson, M; Tyden, T; Stenhammar, C				Grandahl, Maria; Larsson, Margareta; Tyden, Tanja; Stenhammar, Christina			School nurses' attitudes towards and experiences of the Swedish school-based HPV vaccination programme - A repeated cross sectional study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; PROVIDER COMMUNICATION; PROFESSIONAL PRACTICE; HESITANCY; KNOWLEDGE; PARENTS; TRUST	The aim was to investigate school nurses' attitudes towards, and experiences of vaccination against human papillomavirus (HPV), and compare the results with a similar study three years earlier. School nurses (n = 736) from all counties in Sweden completed a questionnaire in spring 2016, four years after the implementation of the national HPV vaccination programme, and three years after the previous survey. Overall, the school nurses had more favourable attitudes towards the HPV vaccination programme compared to the study in 2013 (p = 0.015). More than half of the nurses (n = 415, 56%) strongly agreed that boys should also be offered the vaccine (p<0.001). There were no differences in school nurses' perceived knowledge about HPV in order to inform and to answer questions about the vaccine from the girls or from the parents. More than half of the nurses (n = 409, 56%) reported that they needed more education about HPV. Almost all nurses (n = 659, 90%) had been contacted by parents with questions about the vaccine, and most questions were related to vaccine safety. School nurses have a more favourable attitude towards the vaccination programme against HPV compared to three years earlier, although almost all nurses had been contacted by parents with diverse questions and concerns. The nurses believed that they needed more education about HPV. Thus, it is essential to provide ongoing education and training for school nurses who are key healthcare professionals for providing information about HPV and HPV vaccination to parents and to pupils.	[Grandahl, Maria; Larsson, Margareta; Tyden, Tanja; Stenhammar, Christina] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Grandahl, Maria] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Grandahl, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Grandahl, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	maria.grandahl@pubcare.uu.se		Grandahl, Maria/0000-0002-4553-6656	Swedish Cancer Society [130744]; Uppsala Orebro Regional Research Council [RFR-387561/476021]	Swedish Cancer Society(Swedish Cancer Society); Uppsala Orebro Regional Research Council	This work was supported by the Swedish Cancer Society grant number 130744 (https://www.cancerfonden.se/forskning), and Uppsala Orebro Regional Research Council grant number RFR-387561/476021 (http://www.fou.nu/is/rfr/ansokan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CODEX RUL GUID RES U; Boyce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043416; Brabin L, 2011, VACCINE, V29, P3192, DOI 10.1016/j.vaccine.2011.02.038; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Butler R, 2015, VACCINE, V33, P4176, DOI 10.1016/j.vaccine.2015.04.038; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Editors TPM, 2014, PLOS MED, V11; Ferrer HB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-700; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gilkey MB, 2016, VACCINE, V34, P1187, DOI 10.1016/j.vaccine.2016.01.023; Gilkey MB, 2015, PREV MED, V77, P181, DOI 10.1016/j.ypmed.2015.05.024; Goldstein S, 2015, VACCINE, V33, P4212, DOI 10.1016/j.vaccine.2015.04.042; Gottvall M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014255; Gottvall M, 2013, UPSALA J MED SCI, V118, P263, DOI 10.3109/03009734.2013.809039; Grandahl M, 2017, J SCHOOL HEALTH, V87, P62, DOI 10.1111/josh.12470; Hanley SJB, 2015, LANCET, V385, P2571, DOI 10.1016/S0140-6736(15)61152-7; Hilton S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-226; Hudson SM, 2016, VACCINE, V34, P3515, DOI 10.1016/j.vaccine.2016.02.066; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; Marlow LAV, 2007, HUM VACCINES, V3, P171, DOI 10.4161/hv.3.5.4310; McRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003; Moss JL, 2016, HUM VACC IMMUNOTHER, V12, P1476, DOI 10.1080/21645515.2015.1128601; Perkins RB, 2016, HUM VACC IMMUNOTHER, V12, P1327, DOI 10.1080/21645515.2016.1177680; Polit D. F., 2012, NURSING RES GENERATI; Public Health Agency of Sweden, 2016, INF VACC; Public Health Agency of Sweden, STAT HPV VACC 2015; Rose SB, 2011, J SCHOOL HEALTH, V81, P680, DOI 10.1111/j.1746-1561.2011.00644.x; Rosen BL, 2016, PSYCHOL HEALTH MED, P1; Rosen BL, 2016, J SCH NURS, V32, P138, DOI 10.1177/1059840515583312; Rosen BL, 2015, J SCHOOL HEALTH, V85, P73, DOI 10.1111/josh.12229; Tafuri S, 2010, VACCINE, V28, P5609, DOI 10.1016/j.vaccine.2010.06.028; Zimet GD, 2013, PREV MED, V57, P414, DOI 10.1016/j.ypmed.2013.05.013	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175883	10.1371/journal.pone.0175883	http://dx.doi.org/10.1371/journal.pone.0175883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419156	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200050
J	Miller, B; Hamilton, K; Boushel, R; Williamson, K; Laner, V; Gnaiger, E; Davis, M				Miller, Benjamin; Hamilton, Karyn; Boushel, Robert; Williamson, Katherine; Laner, Verena; Gnaiger, Erich; Davis, Michael			Mitochondrial respiration in highly aerobic canines in the non-raced state and after a 1600-km sled dog race	PLOS ONE			English	Article							SUBSTRATE PATHWAYS; EXERCISE; CARBOHYDRATE; RECOVERY; DESIGN; OXYGEN; WELL	At the annual Iditarod Race, Alaskan Huskies repeatedly run for up to 8 hours at 16 km/h to complete 1600 km. We previously demonstrated high rates of mitochondrial protein synthesis in Alaskan Huskies, which we suspected allowed rapid remodeling of mitochondrial proteins in response to energetic stress. The purpose of this study was to examine mitochondrial respiration in permeabilized skeletal muscle fibers of Alaskan Huskies in the offseason (Non-raced) and following the 1600 km Iditarod Sled Dog Race (Raced). We hypothesized that compared to Non-raced Huskies, raced Huskies that completed a 1600 km race would have greater mitochondrial respiratory capacities, and improvements in capacities of oxidative phosphorylation (OXPHOS) based on NADH-generating substrates as compared to fatty acids. Using high-resolution respirometry (HRR) we investigated the respiration of permeabilized muscle fibers from Alaskan Huskies. Maximum capacities were 254 +/- 26 pmol. s(-1).mg(-1) for OXPHOS (coupled, P) and 254 +/- 37 pmol. s(-1).mg(-1) for the electron transfer system (ETS; non-coupled, E). After racing respiratory capacities from NADHlinked substrates, but not fat-derived substrates increased. Finally, the OXPHOS to ETS capacity ratio (P/E) increased after racing from 0.90 +/- 0.03 to 0.97 +/- 0.02. From our previous studies and the current study, we conclude that Alaskan Huskies maintain high mitochondrial protein turnover to facilitate rapid adaptation to environmental extremes and energetic challenges.	[Miller, Benjamin; Hamilton, Karyn] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Boushel, Robert] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Williamson, Katherine] Waypoint Vet Educ, Edmond, OK USA; [Laner, Verena] Oroboros Instruments, Innsbruck, Austria; [Gnaiger, Erich] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, D Swarvoski Res Lab, Innsbruck, Austria; [Davis, Michael] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Colorado State University; University of British Columbia; Medical University of Innsbruck; Oklahoma State University System; Oklahoma State University - Stillwater	Davis, M (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	Michael.davis@okstate.edu	Boushel, Robert/ABD-7840-2021	Gnaiger, Erich/0000-0003-3647-5895	K-Regio project MitoFit; Oroboros Instruments	K-Regio project MitoFit; Oroboros Instruments	EG and VL were supported by the K-Regio project MitoFit. EG is the CEO and author VL an employee of Oroboros Instruments, a commercial entity based in Austria that designed and manufactures the high resolution respirometry instruments used in this study. Through the involvement of these authors, Oroboros Instruments provided salary and travel funds for these authors, as well as several "loaner" instruments that were used in addition to instruments owned by other authors for sample analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We acknowledge the continuing enthusiasm and participation of Martin Buser and Happy Trails Kennels. In addition, we acknowledge the assistance of Pierre-Louis Heus and Shannon Massie in performing these studies. EG and VL were supported by the K-Regio project MitoFit.	Banse HE, 2007, EQUINE COMP EXER PHY, V4; Baskin CR, 2000, AM J VET RES, V61, P886, DOI 10.2460/ajvr.2000.61.886; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Brooks GA, 2004, EXERCISE PHYSL; Conley KE, 2013, EXP PHYSIOL, V98, P768, DOI 10.1113/expphysiol.2012.067314; Davis MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103087; Gerth N, 2010, J COMP PHYSIOL B, V180, P577, DOI 10.1007/s00360-009-0432-7; Gnaiger E, 2015, SCAND J MED SCI SPOR, V25, P126, DOI 10.1111/sms.12612; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Laner V, 2014, MITOCHONDRIAL PHYSL, V19; LINDSTEDT SL, 1991, NATURE, V353, P748, DOI 10.1038/353748a0; McKenzie E, 2005, MED SCI SPORT EXER, V37, P1307, DOI 10.1249/01.mss.0000175086.41080.01; Miller BF, 2015, J APPL PHYSIOL, V118, P1502, DOI 10.1152/japplphysiol.00588.2014; Miller BF, 2015, J APPL PHYSIOL, V118, P811, DOI 10.1152/japplphysiol.00982.2014; Miller BF, 2012, AM J PHYSIOL-ENDOC M, V302, pE496, DOI 10.1152/ajpendo.00578.2011; Miller BF, 2014, J APPL PHYSL, V118; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Poole DC, 2011, COMPR PHYSIOL, V1, P1, DOI 10.1002/cphy.c091001; REYNOLDS AJ, 1995, J APPL PHYSIOL, V79, P1601, DOI 10.1152/jappl.1995.79.5.1601; Roberts TJ, 1996, J EXP BIOL, V199, P1651; Schlagowski AI, 2014, J APPL PHYSIOL, V116, P364, DOI 10.1152/japplphysiol.01177.2013; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Vock R, 1996, J EXP BIOL, V199, P1689; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089	29	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174874	10.1371/journal.pone.0174874	http://dx.doi.org/10.1371/journal.pone.0174874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445477	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200013
J	Lee, MK; Shaffer, JR; Leslie, EJ; Orlova, E; Carlson, JC; Feingold, E; Marazita, ML; Weinberg, SM				Lee, Myoung Keun; Shaffer, John R.; Leslie, Elizabeth J.; Orlova, Ekaterina; Carlson, Jenna C.; Feingold, Eleanor; Marazita, Mary L.; Weinberg, Seth M.			Genome-wide association study of facial morphology reveals novel associations with FREM1 and PARK2	PLOS ONE			English	Article							MUTATIONS; BRAIN; FACE	Several studies have now shown evidence of association between common genetic variants and quantitative facial traits in humans. The reported associations generally involve simple univariate measures and likely represent only a small fraction of the genetic loci influencing facial morphology. In this study, we applied factor analysis to a set of 276 facial linear distances derived from 3D facial surface images of 2187 unrelated individuals of European ancestry. We retained 23 facial factors, which we then tested for genetic associations using a genome-wide panel of 10,677,593 single nucleotide polymorphisms (SNPs). In total, we identified genome-wide significant (p < 5 x 10(-8)) associations in three regions, including two that are novel: one involving measures of midface height at 6q26 within an intron of PARK2 (lead SNP rs9456748; p = 4.99 x 10(-8)) and another involving measures of central upper lip height at 9p22 within FREM1 (lead SNP rs72713618; p = 2.02 x 10(-8)). In both cases, the genetic association was stronger with the composite facial factor phenotype than with any of the individual linear distances that comprise those factors. While the biological role of PARK2 in the craniofacial complex is currently unclear, there is evidence from both mouse models and Mendelian syndromes that FREM1 may influence facial variation. These results highlight the potential value of data-driven multivariate phenotyping for genetic studies of human facial morphology.	[Lee, Myoung Keun; Leslie, Elizabeth J.; Marazita, Mary L.; Weinberg, Seth M.] Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; [Shaffer, John R.; Orlova, Ekaterina; Feingold, Eleanor; Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Carlson, Jenna C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA.; Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA.	smwst46@pitt.edu	Leslie, Elizabeth/AAP-8941-2021	Leslie, Elizabeth/0000-0002-5735-1712; Carlson, Jenna/0000-0001-5483-0833; Shaffer, John/0000-0003-1897-1131; Weinberg, Seth/0000-0001-9467-4556	National Institute for Dental and Craniofacial Research [U01-DE020078, U01-DE020057, R01-DE016148, K99-DE02560]; National Human Genome Research Institute [X01-HG007821]; University of Washington from the National Institute for Dental and Craniofacial Research [HHSN268201200008I]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE025060, R01DE016148] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Washington from the National Institute for Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The National Institute for Dental and Craniofacial Research (http://www.nider.nih.gov/) provided funding through the following grants: U01-DE020078; U01-DE020057; R01-DE016148; K99-DE02560. Funding for genotyping was provided by the National Human Genome Research Institute (https://www.genome.gov/): X01-HG007821. Funding for initial genomic data cleaning by the University of Washington was provided by contract #HHSN268201200008I from the National Institute for Dental and Craniofacial Research (http://wm.nidcr.nih.gov/) awarded to the Center for Inherited Disease Research (CIDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11616; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Changeux JPN, 2000, NAT GENET, V25, P431; Claes P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004224; Cole JB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006174; COLE T, 2003, WINEDMA SOFTWARE EUC; Coussens AK, 2005, GENOMICS, V85, P563, DOI 10.1016/j.ygeno.2005.02.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Heike CL, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-18; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Lu WS, 2015, HUM MOL GENET, V24, P2390, DOI 10.1093/hmg/ddu731; Nguyen VT A, 2004, NATURE, V427, P636; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shaffer JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006149; Slavotinek AM, 2011, J MED GENET, V48, P375, DOI 10.1136/jmg.2011.089631; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Weinberg S. M., 2016, CLEFT PALAT IN PRESS; Williams FMK, 2013, ANN RHEUM DIS, V72, P1141, DOI 10.1136/annrheumdis-2012-201551	34	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176566	10.1371/journal.pone.0176566	http://dx.doi.org/10.1371/journal.pone.0176566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441456	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800066
J	Marshall, EA; Oates, JC; Shoaibi, A; Obeid, JS; Habrat, ML; Warrens, RW; Brady, KT; Lenert, LA				Marshall, Elizabeth A.; Oates, Jim C.; Shoaibi, Azza; Obeid, Jihad S.; Habrat, Melissa L.; Warrens, Robert W.; Brady, Kathleen T.; Lenert, Leslie A.			A population-based approach for implementing change from opt-out to opt-in research permissions	PLOS ONE			English	Article							CLINICAL-RESEARCH; RANDOMIZED-TRIAL; MEDICAL-RESEARCH; RECRUITMENT; CONSENT; CANCER; PARTICIPANTS; EFFICIENCY; REGISTRY; BIOBANK	Due to recently proposed changes in the Common Rule regarding the collection of research preferences, there is an increased need for efficient methods to document opt-in research preferences at a population level. Previously, our institution developed an opt-out paper-based workflow that could not be utilized for research in a scalable fashion. This project was designed to demonstrate the feasibility of implementing an electronic health record (EHR)-based active opt-in research preferences program. The first phase of implementation required creating and disseminating a patient questionnaire through the EHR portal to populate discreet fields within the EHR indicating patients' preferences for future research study contact (contact) and their willingness to allow anonymised use of excess tissue and fluid specimens (biobank). In the second phase, the questionnaire was presented within a clinic nurse intake workflow in an obstetrical clinic. These permissions were tabulated in registries for use by investigators for feasibility studies and recruitment. The registry was also used for research patient contact management using a new EHR encounter type to differentiate research from clinical encounters. The research permissions questionnaire was sent to 59,670 patients via the EHR portal. Within four months, 21,814 responses (75% willing to participate in biobanking, and 72% willing to be contacted for future research) were received. Each response was recorded within a patient portal encounter to enable longitudinal analysis of responses. We obtained a significantly lower positive response from the 264 females who completed the questionnaire in the obstetrical clinic (55% volunteers for biobank and 52% for contact). We demonstrate that it is possible to establish a research permissions registry using the EHR portal and clinic-based workflows. This patient-centric, population-based, opt-in approach documents preferences in the EHR, allowing linkage of these preferences to health record information.	[Marshall, Elizabeth A.; Shoaibi, Azza; Habrat, Melissa L.; Lenert, Leslie A.] Med Univ South Carolina, Biomed Informat Ctr, Charleston, SC 29425 USA; [Marshall, Elizabeth A.; Shoaibi, Azza; Obeid, Jihad S.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Oates, Jim C.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Oates, Jim C.] Ralph H Johnson VA Med Ctr, Rheumatol Sect, Med Serv, Charleston, SC USA; [Warrens, Robert W.] Med Univ South Carolina, Div Pediat Rheumatol & Immunol, Dept Pediat, Charleston, SC 29425 USA; [Brady, Kathleen T.] Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA; [Lenert, Leslie A.] Med Univ South Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Marshall, EA (corresponding author), Med Univ South Carolina, Biomed Informat Ctr, Charleston, SC 29425 USA.; Marshall, EA (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	marshae@musc.edu	Obeid, Jihad S/P-9793-2016	Obeid, Jihad S/0000-0002-7193-7779; Brady, Kathleen/0000-0002-3944-8051; Oates, Jim/0000-0002-5426-1359	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [1UL1TR001450-01]; NIH - NCATS [1UL1TR001450-01]; South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH - NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Administrating institute: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES Funded: KTB Project Number: 1UL1TR001450-01 https://projectreporter.nih.gov/project_info_description.ctm?aid=90858646&icde=28875368 Dr. Kathleen Brady was the principal investigator of the grant and was instrumental in study design and project implementation. KTB is the principal investigator for the NIH - NCATS Grant Number 1UL1TR001450-01 which allowed for partial salary operational funding for this project design and implementation for KTB and for co-Authors JCO, JSO, and LAL.; This project was supported by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina. Editorial assistance was provided by MUSC Writing Center. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH/NCATS. This material is the result of work supported with resources and the use of facilities at the Ralph H. Johnson VA Medical Center.	Alshaikh Fahdah, 2014, J Med Internet Res, V16, pe171, DOI 10.2196/jmir.3050; Altekruse SF, 2014, CANCER EPIDEM BIOMAR, V23, P2681, DOI 10.1158/1055-9965.EPI-14-0490; Baucom R B, 2014, Appl Clin Inform, V5, P1005, DOI 10.4338/ACI-2014-07-CR-0059; Berry JG, 2013, CLIN TRIALS, V10, P483, DOI 10.1177/1740774513480568; Bryant J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1416-5; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Cote ML, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0054-x; De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244; Emanuel EJ, 2015, N ENGL J MED; Gul RB, 2010, J CLIN NURS, V19, P227, DOI 10.1111/j.1365-2702.2009.03041.x; Harris PA, 2012, ACAD MED, V87, P66, DOI 10.1097/ACM.0b013e31823ab7d2; Hewison J, 2006, BMJ-BRIT MED J, V333, P300, DOI 10.1136/bmj.333.7562.300; Johnson T, 2015, USING MYCHART RES RE; Junghans C, 2005, BMJ-BRIT MED J, V331, P940, DOI 10.1136/bmj.38583.625613.AE; Kaiser J, 2016, SCIENCE, V352, P878, DOI 10.1126/science.352.6288.878; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; LeBlanc J, 2013, BIOPRESERV BIOBANK, V11, P144, DOI 10.1089/bio.2013.0004; Lenert L A, 1993, Proc Annu Symp Comput Appl Med Care, P274; Madathil KC, 2013, INT J MED INFORM, V82, P854, DOI 10.1016/j.ijmedinf.2013.04.008; Obeid Jihad S, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P189; OHRP, 2011, ANPRM REV COMM RUL; Overby CL, 2015, J PERS MED, V5, P264, DOI 10.3390/jpm5030264; Rahm AK, 2013, J COMMUN GENET, V4, P445, DOI 10.1007/s12687-013-0146-0; Sanderson IC, 2013, CLIN TRIALS, V10, P604, DOI 10.1177/1740774513491338; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Sinclair M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-132; Smith SG, 2015, J AM MED INFORM ASSN, V22, P888, DOI 10.1093/jamia/ocv025; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P24, DOI 10.1093/jncimonographs/lgr009; Willison DJ, 2003, BRIT MED J, V326, P373, DOI 10.1136/bmj.326.7385.373	29	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0168223	10.1371/journal.pone.0168223	http://dx.doi.org/10.1371/journal.pone.0168223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441388	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800001
J	Rovner, GS; Sunnerhagen, KS; Bjorkdahl, A; Gerdle, B; Borsbo, B; Johansson, F; Gillanders, D				Rovner, Graciela S.; Sunnerhagen, Katharina S.; Bjorkdahl, Ann; Gerdle, Bjorn; Borsbo, Bjorn; Johansson, Fredrik; Gillanders, David			Chronic pain and sex-differences; women accept and move, while men feel blue	PLOS ONE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; QUALITY-OF-LIFE; LOW-BACK-PAIN; HOSPITAL ANXIETY; GENDER-DIFFERENCES; HEALTH SURVEY; TAMPA SCALE; SWEDISH; FEAR; KINESIOPHOBIA	Purpose The aim of this study is to explore differences between male and female patients entering a rehabilitation program at a pain clinic in order to gain a greater understanding of different approaches to be used in rehabilitation. Method 1371 patients referred to a specialty pain rehabilitation clinic, completed sociodemographic and pain related questionnaires. They rated their pain acceptance (CPAQ-8), their kinesiophobia (TSK), the impact of pain in their life (MPI), anxiety and depression levels (HAD) and quality of life scales: the SF-36, LiSat-11, and the EQ-5D. Because of the large sample size of the study, the significance level was set at the p <= .01. Results Analysis by t-test showed that when both sexes experience the same pain severity, women report significantly higher activity level, pain acceptance and social support while men report higher kinesiophobia, mood disturbances and lower activity level. Conclusion Pain acceptance (CPAQ-8) and kinesiophobia (TSK) showed the clearest differences between men and women. Pain acceptance and kinesiophobia are behaviorally defined and have the potential to be changed.	[Rovner, Graciela S.; Sunnerhagen, Katharina S.; Bjorkdahl, Ann] Univ Gothenburg, Sahlgrenska Acad, Rehabil Med, Inst Neurosci & Physiol, Gothenburg, Sweden; [Rovner, Graciela S.] Danderyd Hosp, Div Rehabil Med, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden; [Rovner, Graciela S.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Bjorkdahl, Ann] Ersta Skondal Univ Coll, Campus Bracke, Gothenburg, Sweden; [Gerdle, Bjorn] Linkoping Univ, Pain & Rehabilitat Ctr, SE-58185 Linkoping, Sweden; [Gerdle, Bjorn] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Borsbo, Bjorn] Linkoping Univ, Div Community Med, Dept Med & Hlth Sci, Linkoping, Sweden; [Borsbo, Bjorn] Cty Hosp Ryhov, Clin Dept Rehabil Med, Jonkoping, Sweden; [Johansson, Fredrik] Danderyd Hosp, Med Library, Stockholm, Sweden; [Gillanders, David] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland	University of Gothenburg; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; Linkoping University; Linkoping University; Danderyds Hospital; University of Edinburgh	Sunnerhagen, KS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Rehabil Med, Inst Neurosci & Physiol, Gothenburg, Sweden.	ks.sunnerhagen@neuro.gu.se	Björkdahl, Ann/ABD-6197-2021; Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Rovner, Graciela/ABF-4482-2020	Björkdahl, Ann/0000-0002-2194-6773; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Rovner, Graciela/0000-0002-6738-1624	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation; RehSAM; AFA insurance, Sweden; Swedish Association for Survivors of Accident and Injury (RTP); Renee Eanders Foundation	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation; RehSAM; AFA insurance, Sweden; Swedish Association for Survivors of Accident and Injury (RTP); Renee Eanders Foundation	The first author was part-time founded by The Swedish Association for Survivors of Accident and Injury (RTP) and from Renee Eanders Foundation related to the Swedish Association of Physiotherapists. The rest of her time was unfunded. Professor Bjorn Gerdle was funded by the Swedish Association of Local Authorities and Regions (SALAR), the Vardal Foundation, (RehSAM) and AFA insurance, Sweden.; The present study was supported by grants from The Swedish Association for Survivors of Accident and Injury (RTP), Renee Eanders Foundation, the Swedish Association of Local Authorities and Regions (SALAR), the Vardal Foundation, (RehSAM) and AFA insurance, Sweden.	Ahlgren C, 2016, DISABIL REHABIL, V38, P2255, DOI 10.3109/09638288.2015.1127435; American Psychological Association APA, 2010, PUBL MAN AM PSYCH AS, Vxviii; Baranoff J, 2012, INT J BEHAV MED; Bergstrom G, 1998, PAIN, V75, P101, DOI 10.1016/S0304-3959(97)00210-8; Bergstrom KG, 1999, EUR J PAIN-LONDON, V3, P261, DOI 10.1016/S1090-3801(99)90053-8; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; BIEDERMAN JJ, 1994, BEHAV MODIF, V18, P89; Branstrom H, 2008, J REHABIL MED, V40, P375, DOI 10.2340/16501977-0186; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; BROOKS RG, 1991, HEALTH POLICY, V18, P37, DOI 10.1016/0168-8510(91)90142-K; BUCKELEW SP, 1990, PAIN, V42, P287, DOI 10.1016/0304-3959(90)91141-5; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dawson A, 2009, J ORAL REHABIL, V36, P271, DOI 10.1111/j.1365-2842.2009.01943.x; Edwards RR, 2003, PAIN, V106, P419, DOI 10.1016/j.pain.2003.09.004; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fillingim RB, 1998, PAIN, V75, P121, DOI 10.1016/S0304-3959(97)00214-5; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fish RA, 2013, J PAIN, V14, P233, DOI 10.1016/j.jpain.2012.11.004; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; FUGELMEYER AR, 1988, SCAND J REHABIL MED, P51; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Fugl-Meyer AR, 1987, SCANDINAVIAN J REH S, V17, P51; Gatchel RJ., 1999, PSYCHOSOCIAL FACTORS; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Green CR, 2010, J PAIN, V11, P746, DOI 10.1016/j.jpain.2009.11.003; Grotle M, 2010, PAIN, V151, P790, DOI 10.1016/j.pain.2010.09.014; Haukenes I, 2015, EUR J PAIN, V19, P826, DOI 10.1002/ejp.609; Keogh E, 2006, EUR J PAIN, V10, P413, DOI 10.1016/j.ejpain.2005.05.007; King BM, 2010, AM J PHYSIOL-REG I, V298, pR1700, DOI 10.1152/ajpregu.00694.2009; Laursen BS, 2005, EUR J PAIN, V9, P267, DOI 10.1016/j.ejpain.2004.07.003; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; Lofgren M, 2006, DISABIL REHABIL, V28, P447, DOI 10.1080/09638280500197891; Lundberg Mari K. E., 2004, Physiotherapy Theory and Practice, V20, P121, DOI 10.1080/09593980490453002; Manson JE, 2010, METABOLISM, V59, pS16, DOI 10.1016/j.metabol.2010.07.013; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; Miller RP., 1991, CLIN J PAIN, V7, P51, DOI [10.1097/00002508-199103000-00053, DOI 10.1097/00002508-199103000-00053]; Monticone M, 2015, EUROPEAN J PAIN; Monticone M, 2014, EUR SPINE J, V23, P2105, DOI 10.1007/s00586-014-3478-5; Munce SEP, 2007, PSYCHOSOMATICS, V48, P394, DOI 10.1176/appi.psy.48.5.394; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nyberg V, 2011, J REHABIL MED, V43, P50, DOI 10.2340/16501977-0631; Pells J, 2007, CLIN J PAIN, V23, P707, DOI 10.1097/AJP.0b013e31814da3eb; Peolsson M, 2004, J REHABIL MED, V36, P28, DOI 10.1080/11026480310015530; Pieh C, 2012, PAIN, V153, P197, DOI 10.1016/j.pain.2011.10.016; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Riley JL, 2001, J PAIN, V2, P354, DOI 10.1054/jpai.2001.27000; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Rovner GS, 2014, J REHABIL MED, V46, P73, DOI 10.2340/16501977-1227; Rustoen Tone, 2004, Pain Manag Nurs, V5, P105, DOI 10.1016/j.pmn.2004.01.004; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Sullivan M., 2002, SF 36 HALSOENKAT SVE; Sullivan M, 2002, SF 36 H LSOENK T SVE; Swinkels-Meewisse IEJ, 2003, PAIN, V105, P371, DOI 10.1016/S0304-3959(03)00255-0; Symonds TL, 1995, SPINE, V20, P2738, DOI 10.1097/00007632-199512150-00016; TURK DC, 1987, BEHAV RES THER, V25, P237, DOI 10.1016/0005-7967(87)90002-7; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Vlaeyen JWS, 2002, CLIN J PAIN, V18, P251, DOI 10.1097/00002508-200207000-00006; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Wallin MKM, 2008, EUR J PAIN, V12, P842, DOI 10.1016/j.ejpain.2007.12.008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003; Wijnhoven HAH, 2006, PAIN, V124, P158, DOI 10.1016/j.pain.2006.04.012; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams ACdC, 2012, PSYCHOL THERAPIES MA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	57	59	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175737	10.1371/journal.pone.0175737	http://dx.doi.org/10.1371/journal.pone.0175737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441403	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800010
J	Yuan, X; Li, Z; Baines, AC; Gavriilaki, E; Ye, ZH; Wen, ZX; Braunstein, EM; Biesecker, LG; Cheng, LZ; Dong, XZ; Brodsky, RA				Yuan, Xuan; Li, Zhe; Baines, Andrea C.; Gavriilaki, Eleni; Ye, Zhaohui; Wen, Zhexing; Braunstein, Evan M.; Biesecker, Leslie G.; Cheng, Linzhao; Dong, Xinzhong; Brodsky, Robert A.			A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MENTAL-RETARDATION SYNDROME; ANCHOR-SYNTHESIS PATHWAY; PLURIPOTENT STEM-CELLS; GERMLINE MUTATION; CAUSE HYPERPHOSPHATASIA; SOMATIC MUTATION; CD59 DEFICIENCY; A GENE; MICE	Mutations in genes involved in glycosylphosphatidylinositol (GPI) anchor biosynthesis underlie a group of congenital syndromes characterized by severe neurodevelopmental defects. GPI anchored proteins have diverse roles in cell adhesion, signaling, metabolism and complement regulation. Over 30 enzymes are required for GPI anchor biosynthesis and PIGA is involved in the first step of this process. A hypomorphic mutation in the X-linked PIGA gene (c.1234C>T) causes multiple congenital anomalies hypotonia seizure syndrome 2 (MCAHS2), indicating that even partial reduction of GPI anchored proteins dramatically impairs central nervous system development, but the mechanism is unclear. Here, we established a human induced pluripotent stem cell (hiPSC) model containing the PIGAc.1234C>T mutation to study the effects of a hypomorphic allele of PIGA on neuronal development. Neuronal differentiation from neural progenitor cells generated by EB formation in PIGAc.1234C>T is significantly impaired with decreased proliferation, aberrant synapse formation and abnormal membrane depolarization. The results provide direct evidence for a critical role of GPI anchor proteins in early neurodevelopment. Furthermore, neural progenitors derived from PIGAc.1234C>T hiPSCs demonstrate increased susceptibility to complement-mediated cytotoxicity, suggesting that defective complement regulation may contribute to neurodevelopmental disorders.	[Yuan, Xuan; Baines, Andrea C.; Gavriilaki, Eleni; Ye, Zhaohui; Braunstein, Evan M.; Cheng, Linzhao; Brodsky, Robert A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Li, Zhe; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ye, Zhaohui; Wen, Zhexing; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brodsky, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	brodsro@jhmi.edu	Wen, Zhexing/L-1228-2018	Wen, Zhexing/0000-0002-1518-3845; Ye, Zhaohui/0000-0001-5272-9168; Gavriilaki, Eleni/0000-0002-8883-8208	Maryland Stem Cell Research Fund (MSCRF) [2013-MSCRFII-0082];  [R01 HC133113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133113] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	1. Maryland Stem Cell Research Fund (MSCRF) (Grants 2013-MSCRFII-0082) 2. R01 HC133113	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Belet S, 2014, HUM MUTAT, V35, P350, DOI 10.1002/humu.22498; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brodsky RA, 2007, BLOOD; Brodsky RA, 2015, BLOOD, V126, P2459, DOI 10.1182/blood-2015-06-640995; Brodsky RA, 2014, BLOOD, V124, P2804, DOI 10.1182/blood-2014-02-522128; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; CColakoglu G, 2014, P NATL ACAD SCI USA, V111, pE394, DOI 10.1073/pnas.1313769110; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Fauth C, 2016, AM J MED GENET A, V170, P392, DOI 10.1002/ajmg.a.37452; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Gavriilaki E, 2015, BLOOD, V125, P3637, DOI 10.1182/blood-2015-02-629683; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hochsmann B, 2014, NEW ENGL J MED, V370, P90, DOI 10.1056/NEJMc1308104; Hu WT, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0277-8; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Kim YO, 2016, BRAIN DEV; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Krawitz PM, 2013, BLOOD, V122, P1312, DOI 10.1182/blood-2013-01-481499; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a; Leyton Lisette, 2014, Adv Neurobiol, V8, P3; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Narisawa S, 2001, J PATHOL, V193, P125, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH722&gt;3.0.CO;2-Y; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; Trump N, 2016, J MED GENET; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Yuan X, 2013, STEM CELL TRANSL MED, V2, P819, DOI 10.5966/sctm.2013-0069	50	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0174074	10.1371/journal.pone.0174074	http://dx.doi.org/10.1371/journal.pone.0174074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441409	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800003
J	Zhan, ZP; Yang, Y; Zhan, YF; Chen, DY; Liang, LQ; Yang, XY				Zhan, Zhongping; Yang, Ying; Zhan, Yanfeng; Chen, Dongying; Liang, Liuqin; Yang, Xiuyan			Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus	PLOS ONE			English	Article							PREDICTORS; IMPACT; HYDROXYCHLOROQUINE; RECOMMENDATIONS; NEPHRITIS	This study aims to investigate the fetal outcomes and associated factors of adverse pregnancy outcomes (APOs) in pregnant women with systemic lupus erythematosus (SLE). Clinical data from 251 SLE patients with 263 pregnancies from 2001 to 2015 were analyzed retrospectively. APOs occurred in 70.0% of pregnancies, in which pregnancy loss occurred in 28.5%; preterm delivery occurred in 21.3%; intrauterine growth retardation occurred in 12.2%; and fetal distress occurred in 8.0%. Over time, the rate of APOs decreased from 82.8% during 2001 similar to 2005 to 59.6% during 2011 similar to 2015. In multivariate analysis, predictors of APOs included positive antiphospholipid antibodies (OR 8.4, 95% CI 1.7 similar to 40.8, P = 0.008), lower complement (OR 3.6, 95% CI 1.3 similar to 9.9, P = 0.01), hypoalbuminemia (OR 3.2, 95% CI 1.2 similar to 8.3, P = 0.02), and hypertension (OR 14.6, 95% CI 1.5 similar to 141.6, P = 0.02). The use of antimalarial medications was associated with lower risk for APOs (OR 0.3, 95% CI 0.1 similar to 0.7, P = 0.01). In total, 109 patients underwent fetal umbilical artery Doppler in the third trimester. The The adjusted systole/diastole (S/D) ratio, pulsatility index (PI) and resistance index (RI) of SLE patients with APOs were higher than that of patients without APOs (2.9 +/- 0.9 vs. 2.4 +/- 0.5, P = 0.001). Lupus pregnancy was still at high risk of APOs in terms of pregnancy loss and preterm delivery. Umbilical artery Doppler was a good monitor method for APOs in the third trimester.	[Zhan, Zhongping; Yang, Ying; Chen, Dongying; Liang, Liuqin; Yang, Xiuyan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Zhan, Yanfeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, DY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.	cdongying@163.com			grants of Guangdong Technology Project [2014A020221009, 2016A020215043]; National Natural Science Foundation of China [81603435]	grants of Guangdong Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants of Guangdong Technology Project (No.2014A020221009, No.2016A020215043) and a grant of National Natural Science Foundation of China (81603435).	Al Arfaj AS, 2010, LUPUS, V19, P1665, DOI 10.1177/0961203310378669; Bertsias G, 2008, ANN RHEUM DIS, V67, P195, DOI 10.1136/ard.2007.070367; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Buyon JP, 1999, LUPUS, V8, P677, DOI 10.1191/096120399680411272; Carmona F, 2001, AM J REPROD IMMUNOL, V46, P274, DOI 10.1034/j.1600-0897.2001.d01-13.x; Clark CA, 2003, J RHEUMATOL, V30, P2127; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002/art.22159; Clowse MEB, 2013, ANN RHEUM DIS, V72, P1536, DOI 10.1136/annrheumdis-2012-202449; Clowse MEB, 2011, J RHEUMATOL, V38, P1012, DOI 10.3899/jrheum.100746; Cortes-Hernandez J, 2002, RHEUMATOLOGY, V41, P643, DOI 10.1093/rheumatology/41.6.643; Georgiou PE, 2000, RHEUMATOLOGY, V39, P1014, DOI 10.1093/rheumatology/39.9.1014; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huong DLT, 2006, RHEUMATOLOGY, V45, P332, DOI 10.1093/rheumatology/kei159; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Kim MY, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.066; Kwok LW, 2011, LUPUS, V20, P829, DOI 10.1177/0961203310397967; Lateef A, 2013, BEST PRACT RES CL RH, V27, P435, DOI 10.1016/j.berh.2013.07.005; Leroux M, 2015, LUPUS, V24, P1384, DOI 10.1177/0961203315591027; Madazli R, 2014, ARCH GYNECOL OBSTET, V289, P49, DOI 10.1007/s00404-013-2935-4; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; Moroni G, 2016, J AUTOIMMUN, V74, P6, DOI 10.1016/j.jaut.2016.07.010; Piccoli GB, 2016, NEPHROL DIAL TRANSPL, V31, P1915, DOI 10.1093/ndt/gfv395; de Jesus GR, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/943490; Ruperto N, 2011, LUPUS, V20, P453, DOI 10.1177/0961203310388445; Saavedra MA, 2012, CLIN RHEUMATOL, V31, P813, DOI 10.1007/s10067-012-1941-4; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110	29	36	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176457	10.1371/journal.pone.0176457	http://dx.doi.org/10.1371/journal.pone.0176457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441446	gold, Green Submitted, Green Published			2022-12-27	WOS:000400308800057
J	Bo, QJ; Mao, Z; Li, XB; Wang, ZM; Wang, CY; Ma, X				Bo, Qijing; Mao, Zhen; Li, Xianbin; Wang, Zhimin; Wang, Chuanyue; Ma, Xin			Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis	PLOS ONE			English	Article							SOCIAL COGNITION; EUTHYMIC PATIENTS; SCHIZOPHRENIA; NEUROCOGNITION; IMPAIRMENT	Background The Measurement and Treatment Research to Improve Cognition Schizophrenia Consensus Cognitive Battery (MCCB) has also been proposed for use in clinical trials to assess cognitive deficits in patients with bipolar disorder (BD). The aim of this study was to evaluate cognitive function assessed by the MCCB in BD. Methods A literature search of the PubMed, Embase, PsycINFO, SCI, Cochrane Library databases and the Cochrane Controlled Trials Register was conducted. Case reports, reviews and meta-analyses were excluded and a systematic review of the remaining studies of cognitive function in BD was carried out. The cognitive outcome measure was the MCCB, including 7 domains and overall cognition. A random-effects model was applied. Results Eighty eight studies were initially identified. Seven clinical studies comprising a total of 487 patients and 570 healthy controls (HC) were included in the meta-analysis. Patients with BD performed worse than HC in overall cognition and processing speed with a large effect size of > 0.8; with a medium effect size (0.5 -0.8) in attention, working memory, verbal learning and visual learning; and with a small effect size (0.2 -0.5) in reasoning and problem solving and social cognition. Conclusion Patients with BD performed worse than HC in overall cognition and all cognitive domains of the MCCB. Cognitive deficits in domains of processing speed and working memory are prominent in patients with BD. Our findings suggest that MCCB can be usefully applied in BD.	[Bo, Qijing; Mao, Zhen; Li, Xianbin; Wang, Zhimin; Wang, Chuanyue; Ma, Xin] Capital Med Univ, Beijing Anding Hosp, Dept Psychiat, Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Bo, Qijing; Mao, Zhen; Li, Xianbin; Wang, Zhimin; Wang, Chuanyue] Capital Med Univ, Ctr Schizophrenia, Beijing Inst Brain Disorders, Lab Brain Disorders,Minist Sci & Technol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ma, X (corresponding author), Capital Med Univ, Beijing Anding Hosp, Dept Psychiat, Beijing Key Lab Mental Disorders, Beijing, Peoples R China.	mxmanu@163.com	Wang, Chuan-Yue/C-9369-2015; Bo, Qijing/AHC-4122-2022	Wang, Chuan-Yue/0000-0001-6549-3713; Bo, Qijing/0000-0002-3275-7978	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201403]; Beijing Science and Technology Commission [D121100005012002]	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Science and Technology Commission	Supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201403) and the Beijing Science and Technology Commission (D121100005012002).	Bakkour N, 2014, PSYCHIAT RES, V216, P291, DOI 10.1016/j.psychres.2014.02.014; Barbero JD, 2015, SCHIZOPHR RES, V166, P37, DOI 10.1016/j.schres.2015.04.030; Bora E, 2005, ACTA PSYCHIAT SCAND, V112, P110, DOI 10.1111/j.1600-0447.2005.00570.x; Bora E, 2016, SCHIZOPHR RES, V175, P72, DOI 10.1016/j.schres.2016.04.018; Bora E, 2015, SCHIZOPHRENIA BULL, V41, P1095, DOI 10.1093/schbul/sbu198; Bortolato B, 2015, NEUROPSYCH DIS TREAT, V11, P3111, DOI 10.2147/NDT.S76700; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Burdick KE, 2014, PSYCHOL MED, V44, P3083, DOI 10.1017/S0033291714000439; Burdick KE, 2011, NEUROPSYCHOPHARMACOL, V36, P1587, DOI 10.1038/npp.2011.36; Cardenas SA, 2016, NEUROSCI BIOBEHAV R, V69, P193, DOI 10.1016/j.neubiorev.2016.08.002; Cassidy C, 2014, J PSYCHIATR NEUROSCI, V39, P31, DOI 10.1503/jpn.120242; Colom F, 2012, ACTA PSYCHIAT SCAND, V125, P264, DOI 10.1111/j.1600-0447.2012.01833.x; Cusi AM, 2012, J PSYCHIATR NEUROSCI, V37, P154, DOI 10.1503/jpn.100179; Daglas R, 2015, INT J BIPOLAR DISORD, V3, DOI 10.1186/s40345-015-0024-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garcia M, 2016, COMPR PSYCHIAT, V68, P86, DOI 10.1016/j.comppsych.2016.04.004; Goldberg T, SCHIZOPHRENIA, P168; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Harvey PD, 2010, BIPOLAR DISORD, V12, P364, DOI 10.1111/j.1399-5618.2010.00831.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kenney J, 2015, SCHIZOPHR RES, V169, P101, DOI 10.1016/j.schres.2015.09.007; Kessler U, 2014, J CLIN PSYCHIAT, V75, pE1306, DOI 10.4088/JCP.13m08960; Kessler U, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-105; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Lewandowski KE, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00100; [李志营 Li Zhiying], 2014, [中国心理卫生杂志, Chinese Mental Health Journal], V28, P332; Martinez-Aran A, 2015, EUR NEUROPSYCHOPHARM, V25, P151, DOI 10.1016/j.euroneuro.2015.01.007; Martino DJ, 2015, PSYCHIAT RES, V226, P23, DOI 10.1016/j.psychres.2014.12.044; MILLER WR, 1975, PSYCHOL BULL, V82, P238, DOI 10.1037/h0076367; Minor KS, 2015, AUST NZ J PSYCHIAT, V49, P444, DOI 10.1177/0004867414565473; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montag C, 2010, J AFFECT DISORDERS, V123, P264, DOI 10.1016/j.jad.2009.08.017; Murphy FC, 2001, BRIT J PSYCHIAT, V178, pS120, DOI 10.1192/bjp.178.41.s120; Nitzburg GC, 2016, J AFFECT DISORDERS, V198, P185, DOI 10.1016/j.jad.2016.03.028; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Russo M, 2015, J AFFECT DISORDERS, V187, P156, DOI 10.1016/j.jad.2015.08.009; Russo M, 2014, J AFFECT DISORDERS, V169, P51, DOI 10.1016/j.jad.2014.07.038; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Samame C, 2014, J AFFECT DISORDERS, V164, P130, DOI 10.1016/j.jad.2014.04.028; Samame C, 2013, BIPOLAR DISORD, V15, P633, DOI 10.1111/bdi.12077; Sanchez-Morla EM, 2016, ACTA PSYCHIAT SCANDI; Sperry SH, 2015, J INT NEUROPSYCH SOC, V21, P468, DOI 10.1017/S1355617715000442; Torres IJ BV, 2007, ACTA PSYCHIAT SCAN S; Van Rheenen TE, 2014, BIPOLAR DISORD, V16, P318, DOI 10.1111/bdi.12134; Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x	48	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176212	10.1371/journal.pone.0176212	http://dx.doi.org/10.1371/journal.pone.0176212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437438	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600033
J	Kim, YG; Shin, D; Park, MY; Lee, S; Jeon, MS; Yoon, D; Park, RW				Kim, Young-Gun; Shin, Dahye; Park, Man Young; Lee, Sukhoon; Jeon, Min Seok; Yoon, Dukyong; Park, Rae Woong			ECG-ViEW II, a freely accessible electrocardiogram database	PLOS ONE			English	Article							WAVE AXIS DEVIATION; QT PROLONGATION; RISK; INTERVAL; WOMEN; MEN	The Electrocardiogram Vigilance with Electronic data Warehouse II (ECG-ViEW II) is a large, single-center database comprising numeric parameter data of the surface electrocardiograms of all patients who underwent testing from 1 June 1994 to 31 July 2013. The electrocardiographic data include the test date, clinical department, RR interval, PR interval, QRS duration, QT interval, QTc interval, P axis, QRS axis, and T axis. These data are connected with patient age, sex, ethnicity, comorbidities, age-adjusted Charlson comorbidity index, prescribed drugs, and electrolyte levels. This longitudinal observational database contains 979,273 electrocardiograms from 461,178 patients over a 19-year study period. This database can provide an opportunity to study electrocardiographic changes caused by medications, disease, or other demographic variables. ECG-ViEW II is freely available at http://www. ecgview. org.	[Kim, Young-Gun; Shin, Dahye; Lee, Sukhoon; Jeon, Min Seok; Yoon, Dukyong; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea; [Park, Man Young] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea; [Jeon, Min Seok; Park, Rae Woong] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, South Korea; [Lee, Sukhoon] Kunsan Natl Univ, Dept Software Convergence Engn, Gunsan, South Korea	Ajou University; Korea Institute of Oriental Medicine (KIOM); Ajou University; Kunsan National University	Yoon, D; Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea.; Park, RW (corresponding author), Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, South Korea.	d.yoon.ajou@gmail.com; veritas@ajou.ac.kr		Kim, Young-Gun/0000-0002-8982-5230	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992, HI16C0982]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992 and HI16C0982). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar RD, 2015, J CARDIOVASC THORAC, V7, P154, DOI 10.15171/jcvtr.2015.33; Assanelli D, 2013, J ELECTROCARDIOL, V46, P487, DOI 10.1016/j.jelectrocard.2013.08.002; Bonaccio M, 2015, THROMB HAEMOSTASIS, V114, P1199, DOI 10.1160/TH15-02-0177; Brid SV, 2014, J CLIN DIAGNOSTIC RE, V8; Gupta A, 2007, AM HEART J, V153, P891, DOI 10.1016/j.ahj.2007.01.040; Hagiwara T, 2001, JPN J PHARMACOL, V87, P231, DOI 10.1254/jjp.87.231; Kligfield P, 2012, J ELECTROCARDIOL, V45, P690, DOI 10.1016/j.jelectrocard.2012.07.012; Kligfield P, 2010, AM HEART J, V160, P1023, DOI 10.1016/j.ahj.2010.09.002; Kwok CS, 2016, HEART, V102, P672, DOI 10.1136/heartjnl-2015-308956; Laguna P, 2014, J ELECTROCARDIOL, V47, P408, DOI 10.1016/j.jelectrocard.2014.04.018; Li YB, 2014, AM J CARDIOL, V113, P372, DOI 10.1016/j.amjcard.2013.08.050; Moody GB, 2000, COMPUT CARDIOL, V27, P179, DOI 10.1109/CIC.2000.898485; Moody GB, 2011, IEEE ENG MED BIO, P8327, DOI 10.1109/IEMBS.2011.6092053; Park MY, 2012, CLIN PHARMACOL THER, V92, P393, DOI 10.1038/clpt.2012.93; Park SI, 2016, EXPERT OPINION DRUG; Rago L, 2013, ATHEROSCLEROSIS, V226, P412, DOI 10.1016/j.atherosclerosis.2012.11.010; Rangel MO, 2016, AM J CARDIOL, V117, P100, DOI 10.1016/j.amjcard.2015.10.013; Rautaharju PM, 2001, AM J CARDIOL, V88, P118, DOI 10.1016/S0002-9149(01)01604-6; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; Yun J, 2015, CARDIOVASC TOXICOL, V15, P197, DOI 10.1007/s12012-014-9285-8	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176222	10.1371/journal.pone.0176222	http://dx.doi.org/10.1371/journal.pone.0176222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437484	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600034
J	El Guerrab, A; Cayre, A; Kwiatkowski, F; Privat, M; Rossignol, JM; Rossignol, F; Penault-Llorca, F; Bignon, YJ				El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Rossignol, Jean-Marc; Rossignol, Fabrice; Penault-Llorca, Frederique; Bignon, Yves-Jean			Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROGNOSTIC-SIGNIFICANCE; SIGNAL-TRANSDUCTION; ERYTHROPOIETIN; FACTOR-1-ALPHA; ACTIVATION; PROTEIN; IDENTIFICATION; SIGNATURES; INVASION	Breast cancers are solid tumors frequently characterized by regions with low oxygen concentrations. Cellular adaptations to hypoxia are mainly determined by "hypoxia inducible factors" that mediate transcriptional modifications involved in drug resistance and tumor progression leading to metastasis and relapse occurrence. In this study, we investigated the prognostic value of hypoxia-related gene expression in breast cancer. A systematic review was conducted to select a set of 45 genes involved in hypoxia signaling pathways and breast tumor progression. Gene expression was quantified by RT-qPCR in a retrospective series of 32 patients with invasive ductal carcinoma. Data were analyzed in relation to classical clinicopathological criteria and relapse occurrence. Coordinated overexpression of selected genes was observed in high-grade and HER2+ tumors. Hierarchical cluster analysis of gene expression significantly segregated relapsed patients (p = 0.008, Chi(2) test). All genes (except one) were up-regulated and six markers were significantly expressed in tumors from recurrent patients. The expression of this 6-gene set was used to develop a basic algorithm for identifying recurrent patients according to a risk score of relapse. Analysis of Kaplan-Meier relapse-free survival curves allowed the definition of a threshold score of 2 (p = 0.021, Mantel-Haenszel test). The risk of recurrence was increased by 40% in patients with a high score. In addition to classical prognostic factors, we showed that hypoxic markers have potential prognostic value for outcome and late recurrence prediction, leading to improved treatment decision-making for patients with early-stage invasive breast cancer. It will be necessary to validate the clinical relevance of this prognostic approach through independent studies including larger prospective patient cohorts.	[El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Penault-Llorca, Frederique; Bignon, Yves-Jean] Ctr Jean Perrin, 58 Rue Montalembert, Clermont Ferrand, France; [El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Penault-Llorca, Frederique; Bignon, Yves-Jean] Univ Auvergne, Fac Med, ERTICa EA4677, 28 Pl Henri Dunant, Clermont Ferrand, France; [Rossignol, Jean-Marc; Rossignol, Fabrice] Adelbio, 13 Rue Pariou, Aubiere, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA)	Bignon, YJ (corresponding author), Ctr Jean Perrin, 58 Rue Montalembert, Clermont Ferrand, France.; Bignon, YJ (corresponding author), Univ Auvergne, Fac Med, ERTICa EA4677, 28 Pl Henri Dunant, Clermont Ferrand, France.	yves-jean.bignon@clermont.unicancer.fr	, Maud/ABB-9090-2021; , bignon/Y-3243-2019	, Maud/0000-0002-9373-3902; CAYRE, Anne/0000-0002-2578-8557	Conseil Regional d'Auvergn; Centre Jean Perrin (Clermont-Ferrand, France)	Conseil Regional d'Auvergn; Centre Jean Perrin (Clermont-Ferrand, France)	This work was supported in part by grant from the Conseil Regional d'Auvergne (http://www. auvergne.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The internal funding was provided by the Centre Jean Perrin (Clermont-Ferrand, France) where the majority of the authors of this article are employed.	Acs G, 2004, CANCER LETT, V214, P243, DOI 10.1016/j.canlet.2004.04.027; Ahn SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063510; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Binley K, 2003, GENE THER, V10, P540, DOI 10.1038/sj.gt.3301944; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Chitneni SK, 2011, J NUCL MED, V52, P165, DOI 10.2967/jnumed.110.075663; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ebert BL, 1999, BLOOD, V94, P1864; El Guerrab A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025080; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Farr Alex, 2013, Rev Obstet Gynecol, V6, P165; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Gassmann M, 1997, KIDNEY INT, V51, P567, DOI 10.1038/ki.1997.81; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Kwiatkowski F, 2000, B CANCER, V87, P715; LEDOUSSAL V, 1989, CANCER, V64, P1914, DOI 10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G; Li XF, 2014, TRANSL ONCOL, V7, P240, DOI 10.1016/j.tranon.2014.02.010; Liang K, 2014, CANCER BIOL THER, V15, P89, DOI 10.4161/cbt.26717; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnon C, 2007, J CLIN INVEST, V117, P1844, DOI 10.1172/JCI30269; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Rundqvist H, 2013, J INTERN MED, V274, P105, DOI 10.1111/joim.12091; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Sestak I, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0516-0; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Z., 2011, INFORM RES, V2011, P1, DOI DOI 10.1111/J.1365-313X.2011.04659.X; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Wong C, 2003, GYNECOL ONCOL, V91, P513, DOI 10.1016/j.ygyno.2003.08.022; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200; Zundel W, 2000, GENE DEV, V14, P391	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175960	10.1371/journal.pone.0175960	http://dx.doi.org/10.1371/journal.pone.0175960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430808	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100025
J	Di Cavalcanti, D; Alves, LV; Furtado, GJ; Santos, CC; Feitosa, FG; Ribeiro, MC; Menge, P; Lira, IM; Alves, JG				Di Cavalcanti, Danielle; Alves, Lucas V.; Furtado, Geraldo J.; Santos, Cleusa C.; Feitosa, Fabiana G.; Ribeiro, Maria C.; Menge, Paulo; Lira, Izabelle M.; Alves, Joao G.			Echocardiographic findings in infants with presumed congenital Zika syndrome: Retrospective case series study	PLOS ONE			English	Article							ATRIAL SEPTAL-DEFECT; HEART-DISEASE; CHILDREN	Objective To report the echocardiographic evaluation of 103 infants with presumed congenital Zika syndrome. Methods An observational retrospective study was performed at Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil. 103 infants with presumed congenital Zika syndrome. All infants had microcephaly and head computed tomography findings compatible with congenital Zika syndrome. Zika IgM antibody was detected in cerebrospinal fluid samples of 23 infants. In 80 infants, the test was not performed because it was not available at that time. All infants had negative serology for HIV, syphilis, rubella, cytomegalovirus and toxoplasmosis. A complete transthoracic two-dimensional, M-mode, continuous wave and pulsed wave Doppler and color Doppler echocardiographic (PHILIPS HD11XE or HD15) examination was performed on all infants. Results 14/103 (13.5%) echocardiograms were compatible with congenital heart disease: 5 with an ostium secundum atrial septal defect, 8 had a hemodynamically insignificant small apical muscular ventricular septal defect and one infant with dyspnea had a large membranous ventricular septal defect. The echocardiograms considered normal included 45 infants with a persistent foramen ovale and 16 with a minimum patent ductus arteriosus. Conclusions Preliminarily this study suggests that congenital Zika syndrome may be associated with an increase prevalence of congenital heart disease. However the types of defects noted were septal defects, a proportion of which would not be hemodynamically significant.	[Di Cavalcanti, Danielle; Alves, Lucas V.; Furtado, Geraldo J.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil; [Santos, Cleusa C.; Feitosa, Fabiana G.; Ribeiro, Maria C.; Menge, Paulo; Lira, Izabelle M.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil	Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil.	joaoguilherme@imip.org.br	Feitosa, Fabiana/GXH-5221-2022; Alves, João G/J-6483-2013	Alves, João G/0000-0002-9170-0808				Brassard M, 1999, AM J CARDIOL, V83, P1552, DOI 10.1016/S0002-9149(99)00146-0; Brazilian Ministry of Health, 2015, MICR EP B; Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Hanslik A, 2006, PEDIATRICS, V118, P1560, DOI 10.1542/peds.2005-3037; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Ishikawa T, 2011, ACTA PAEDIATR, V100, pE55, DOI 10.1111/j.1651-2227.2011.02248.x; Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293; Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147; Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; MITCHELL SC, 1957, J PEDIATR-US, V51, P12, DOI 10.1016/S0022-3476(57)80275-3; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Ramussen AS, 2016, NEW ENGL J MED, V374, P1981; Smith BG, 2012, J PAEDIATR CHILD H, V48, P1082, DOI 10.1111/j.1440-1754.2012.02467.x; Zhang Jun, 2015, Proc (Bayl Univ Med Cent), V28, P516	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175065	10.1371/journal.pone.0175065	http://dx.doi.org/10.1371/journal.pone.0175065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426680	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900017
J	Diana, A; Mallard, SR; Haszard, JJ; Purnamasari, DM; Nurulazmi, I; Herliani, PD; Nugraha, GI; Gibson, RS; Houghton, L				Diana, Aly; Mallard, Simonette R.; Haszard, Jillian J.; Purnamasari, Dwi Monik; Nurulazmi, Ikrimah; Herliani, Pratami D.; Nugraha, Gaga I.; Gibson, Rosalind S.; Houghton, Lisa			Consumption of fortified infant foods reduces dietary diversity but has a positive effect on subsequent growth in infants from Sumedang district, Indonesia	PLOS ONE			English	Article							YOUNG-CHILD NUTRITION; FEEDING PRACTICES; LINEAR GROWTH; MILK; ZINC; SCHOOL; IRON; UNDERNUTRITION; INTERVENTIONS; BANGLADESH	Stunting and underweight among under-five children in Indonesia are common, raising public health concerns. Whether inappropriate complementary feeding (CF) practices compromise optimal growth during late infancy in Indonesia is uncertain. Therefore we characterized and evaluated CF practices in Indonesian infants and investigated their relationship with subsequent growth. We enrolled breastfed infants at 6 months of age (n = 230); and followed them at 9 (n = 202) and 12 months of age (n = 190). We collected socio-demographic and anthropometric data and two-day in-home weighed food records. Relations between WHO CF indicators, sentinel foods, and energy and micronutrient intakes at 9 months and growth at 12 months were explored using multiple linear regression. Stunting and underweight increased from 15.8% and 4.4% at 6 months to 22.6% and 10.5% at 12 months, respectively. Median intakes of calcium, iron, zinc, and riboflavin were below WHO recommendations. Infants consuming fortified infant foods (FIFs) at 9 months had diets with a lower dietary diversity (DD) score (2.3 vs. 3.0), energy density, median energy (250 vs. 310 kcal/d) and protein (6.5 vs. 9.1 g/d) intake than non-consumers (p<0.01), despite higher intakes of calcium, iron, and vitamins A and C (p<0.001). Positive relations existed for 9-month consumption of iron-rich/iron fortified infant foods with length-for-age Z-score (LAZ) at 12 months (beta = 0.22; 95% CI: 0.01, 0.44; P = 0.04), and for fortified infant foods alone with both LAZ (beta = 0.29; 95% CI: 0.09, 0.48; P = 0.04) and weight-for-age Z-score (beta = 0.14; 95% CI: 0.02, 0.26; P = 0.02) at 12 months. The positive association of FIFs with subsequent growth may be attributed to their content of both powdered cow's milk and multi-micronutrient fortificants. Nonetheless, mothers should not be encouraged to over-rely on FIFs as they reduce DD.	[Diana, Aly; Purnamasari, Dwi Monik; Nurulazmi, Ikrimah; Herliani, Pratami D.; Nugraha, Gaga I.] Padjadjaran State Univ, Fac Med, Java, Indonesia; [Diana, Aly; Mallard, Simonette R.; Haszard, Jillian J.; Gibson, Rosalind S.; Houghton, Lisa] Univ Otago, Dept Human Nutr, Otago, New Zealand	Universitas Padjadjaran; University of Otago	Diana, A (corresponding author), Padjadjaran State Univ, Fac Med, Java, Indonesia.; Diana, A (corresponding author), Univ Otago, Dept Human Nutr, Otago, New Zealand.	diana.aly@gmail.com	Mallard, Simonette R/AAT-3266-2021		Meat and Livestock Australia; University of Otago Research Grant	Meat and Livestock Australia(Meat and Livestock Australia); University of Otago Research Grant	This work was supported by the Meat and Livestock Australia: (https://www.mia.com.au/) and the University of Otago Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; [Anonymous], 2015, NAT NUTR DAT STAND R; Badan Perencanaan Pembangunan Daerah Kabupaten Sumedang, 2014, PROF DAER KAB SUM 20; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Birch LL, 2014, AM J CLIN NUTR, V99, p723S, DOI 10.3945/ajcn.113.069047; Bognar A., 2002, TABLES WEIGHT YIELD; BPS & BKKBN, 2013, IND DEM HLTH SURV 20; Bunch S, 1997, USERS GUIDE OPERATIO; Chan SSL, 2007, J FOOD COMPOS ANAL, V20, P609, DOI 10.1016/j.jfca.2007.03.003; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2016, MATERN CHILD NUTR, V12, P27, DOI 10.1111/mcn.12282; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Dewey KG, 2001, PEDIATR CLIN N AM, V48, P87, DOI 10.1016/S0031-3955(05)70287-X; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; EFSA, 2013, EFSA J, V11; Faber M, 2005, AM J CLIN NUTR, V82, P1032, DOI 10.1093/ajcn/82.5.1032; FAO/WHO/UNU, 2001, HUM EN REQ REP JOINT; FERGUSON EL, 1993, J NUTR, V123, P1487, DOI 10.1093/jn/123.9.1487; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson SR, 2008, INTERACTIVE 24 HOUR; Grillenberger M, 2006, BRIT J NUTR, V95, P379, DOI 10.1079/BJN20051641; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Huffman SL, 2014, MATERN CHILD NUTR, V10, P562, DOI 10.1111/mcn.12126; Institute of Medicine, 2010, DIETARY REFERENCE IN; Isabelle M, 2011, ASIA PAC J CLIN NUTR, V20, P141; Jack SJ, 2012, ARCH PEDIAT ADOL MED, V166, P842, DOI 10.1001/archpediatrics.2012.1003; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Kimmons JE, 2005, J NUTR, V135, P444, DOI 10.1093/jn/135.3.444; Kolsteren PW, 1997, TROP MED INT HEALTH, V2, P291, DOI 10.1046/j.1365-3156.1997.d01-262.x; KUSIN JA, 1991, EUR J CLIN NUTR, V45, P77; Lind T, 2004, AM J CLIN NUTR, V80, P729; MADDEN JP, 1976, J AM DIET ASSOC, V68, P143; MALCOLM LA, 1970, BRIT J NUTR, V24, P297, DOI 10.1079/BJN19700029; Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547; Mallard SR, 2016, J NUTR; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Maulen-Radovan I, 1999, SALUD PUBLICA MEXICO, V41, P389; Menon P, 2015, MATERN CHILD NUTR, V11, P73, DOI 10.1111/mcn.12036; Michaelsen KF, 2013, FOOD NUTR BULL, V34, P268, DOI 10.1177/156482651303400224; National Institute of Health Research and Development, 2010, IND BAS HLTH RES 201; National Institute of Health Research and Development, 2013, IND BAS HLTH RES 201; Ng CS, 2012, PUBLIC HEALTH NUTR, V15, P827, DOI 10.1017/S1368980011002485; Nordic Council of Ministers, 2012, NORD NUTR REC INT NU; *PAHO WHO, 2003, GUID PRINC COMPL FEE; Pries AM, 2016, MATERN CHILD NUTR, V12, P22, DOI 10.1111/mcn.12267; ProPAN D Process for the Promotion of Child Feeding, 2015, PROPAN PROC PROM CHI; Rutstein S.O., 2004, DHS COMP REPORTS; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Senarath U, 2012, MATERN CHILD NUTR, V8, P5, DOI 10.1111/j.1740-8709.2011.00371.x; The Chilenje Infant Growth Nutrition and Infection Study Team, 2010, PLOS ONE, V5; WHO, 2004, ANTHR TRAIN VID WHO; WHO, 2006, WHO CHILD GROWTH STA; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Working Group on Infant and Young Child Feeding Indicators, 2006, DEV VAL SIMPL IND DI; Working Group on Infant and Young Child Feeding Indicators, 2007, DEV VAL SIMPL IND DI; World Health Organization, 1998, COMPL FEED YOUNG CHI; World Health Organization, 1995, PHYS STATA US INT AN; World Health Organization, 2008, IND ASS INF YOUNG CH; Zongrone A, 2012, PUBLIC HEALTH NUTR, V15, P1697, DOI 10.1017/S1368980012001073	68	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175952	10.1371/journal.pone.0175952	http://dx.doi.org/10.1371/journal.pone.0175952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426828	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900075
J	Kuchenbecker, J; Reinbott, A; Mtimuni, B; Krawinkel, MB; Jordan, I				Kuchenbecker, Judith; Reinbott, Anika; Mtimuni, Beatrice; Krawinkel, Michael B.; Jordan, Irmgard			Nutrition education improves dietary diversity of children 6-23 months at community-level: Results from a cluster randomized controlled trial in Malawi	PLOS ONE			English	Article							AFLATOXIN CONTAMINATION; YOUNG-CHILDREN; GROWTH; AGE; UNDERNUTRITION; INTERVENTIONS; EXPOSURE	Background: Low dietary quality and quantity and inappropriate feeding practices can cause undernutrition. Poor nutritional status in early childhood is associated with growth faltering. The objective of the study was to assess the potential of community-based nutrition education to improve height-for-age z-scores in children 6-23 months of age. Methods and Findings: We carried out a cluster-randomized-controlled trial to assess the effectiveness of nutrition education. A total of 24 Extension Planning Area Sections served as clusters. The selection criteria were: the position of the extension officer was staffed and the sections had been selected by the project for activities in its first project year. The sections were randomized into intervention and control restricted on mean height for age Z-score using baseline information. In the intervention area, food security activities and community-based nutrition education was implemented. The control area received food security activities only. At baseline (2011) and endline (2014), caregivers with a child below two years of age were enrolled. Data assessment included anthropometric measurements, interviews on socio-economic status, dietary intake and feeding practices. A difference-indifferences estimator was used to calculate intervention effects. A positive impact on child dietary diversity was observed (B (SE) = 0.39 (0.15), p = 0.01; 95%CI 0.09-0.68). There was a non-significant positive intervention effect on mean height-for-age z-scores (B (SE) = 0.17 (0.12), p = 0.15; 95%CI -0.06-0.41). Limitations: The 24h dietary recalls used to measure dietary diversity did not consider quantities of consumed foods. Unrecorded poor quality of consumed foods might have masked a potential benefit of increased child dietary diversity on growth. Conclusions: Participatory community-based nutrition education for caregivers improved child dietary diversity even in a food insecure area. Nutrition education should be part of programs in food insecure settings aiming at ameliorating food insecurity among communities.	[Kuchenbecker, Judith; Reinbott, Anika; Krawinkel, Michael B.; Jordan, Irmgard] Justus Liebig Univ Giessen, Inst Nutrit Sci, Giessen, Germany; [Mtimuni, Beatrice] Lilongwe Univ Agr & Nat Resources, Bunda Campus, Lilongwe, Malawi	Justus Liebig University Giessen; Lilongwe University of Agriculture & Natural Resources	Jordan, I (corresponding author), Justus Liebig Univ Giessen, Inst Nutrit Sci, Giessen, Germany.	Irmgard.Jordan@ernaehrung.uni-giessen.de	Krawinkel, Michael/J-7916-2019; Jordan, Irmgard/AFN-6697-2022	Jordan, Irmgard/0000-0002-8822-1021	FAO; Bilateral Trust Fund Project [GCP/INT/108/GER]; Federal Ministry of Food and Agriculture of Germany	FAO; Bilateral Trust Fund Project; Federal Ministry of Food and Agriculture of Germany	The research was funded by FAO through a Letter of Agreement, through a Bilateral Trust Fund Project (GCP/INT/108/GER) with support of the Federal Ministry of Food and Agriculture of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; [Anonymous], 2011, HOUSEHOLD HUNGER SCA; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Ayad M, 1997, DHS COMP STUDIES, V26, P36; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; BROWN KH, 1998, COMPLEMENTARY FEEDIN; Castelino JM, 2015, MOL NUTR FOOD RES, V59, P574, DOI 10.1002/mnfr.201300619; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Contento IR., 2016, NUTR ED LINKING RES; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Derlagen C., 2012, ANAL INCENTIVES DISI; ENA for SMART, 2011, SOFTW EM NUTR ASS IN; EpiData Association, 2008, EP SOFTW EP ENTR; FAO, 2014, NUTR ED CONS AW; Free Software Foundation, 2014, GNU OP SYST; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Graham J.W, 2012, STAT SOCIAL BEHAV SC; Hayes RJ, 2009, INTERD STAT, P3; Iannotti LL, 2014, NUTR REV, V72, P355, DOI 10.1111/nure.12107; IBM Corp. Released, 2011, IBM SPSS STAT WINDOW; Kuchenbecker J, 2015, PAEDIATR INT CHILD H, V35, P14, DOI 10.1179/2046905514Y.0000000134; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547; Marquis GS, 2015, J NUTR, V145, P335, DOI 10.3945/jn.114.194498; Matumba L, 2014, FOOD CONTROL, V39, P87, DOI 10.1016/j.foodcont.2013.09.068; Monyo ES, 2012, CROP PROT, V42, P149, DOI 10.1016/j.cropro.2012.07.004; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; National Statistical Office (NSO) [Malawi] and ORC Macro, 2005, MAL DEM HLTH SURV 20; National Statistical Office - NSO/Malawi and ICF Macro, 2011, MAL DEM HLTH SURV 20; Negash C, 2014, FOOD NUTR BULL, V35, P480, DOI 10.1177/156482651403500409; NSO Zomba Malawi, 2014, MAL MDG ENDL SURV 20; Reinbott A, 2015, PAEDIATR INT CHILD H, V35, P124, DOI 10.1179/2046905514Y.0000000155; Rutstein S. O., 2004, DHS WEALTH INDEX; Shirima CP, 2014, ENV HLTH PERSPECT; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; The R Foundation, 2011, R R PROJ STAT COMP; UNICEF, 2010, COMMUNITY BASED INFA; Waswa LM, 2015, PUBLIC HEALTH NUTR, V18, P3406, DOI 10.1017/S1368980015000920; WHO/UNICEF, 2010, INDICATORS FOR ASSES; WHO (World Health Organization), 2011, WHO ANTHR VERS 3 2 2; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	42	55	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175216	10.1371/journal.pone.0175216	http://dx.doi.org/10.1371/journal.pone.0175216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426678	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900022
J	Monzo, C; Stansly, PA				Monzo, Cesar; Stansly, Philip A.			Economic injury levels for Asian citrus psyllid control in process oranges from mature trees with high incidence of huanglongbing	PLOS ONE			English	Article							RADIATA HYMENOPTERA EULOPHIDAE; HEMIPTERA PSYLLIDAE; THRESHOLDS; MANAGEMENT; DISEASE; APHIDIDAE; VECTOR; SPREAD	The Asian citrus psyllid (ACP), Diaphorina citri Kuwayama, is the key pest of citrus wherever it occurs due to its role as vector of huanglongbing (HLB) also known as citrus greening disease. Insecticidal vector control is considered to be the primary strategy for HLB management and is typically intense owing to the severity of this disease. While this approach slows spread and also decreases severity of HLB once the disease is established, economic viability of increasingly frequent sprays is uncertain. Lacking until now were studies evaluating the optimum frequency of insecticide applications to mature trees during the growing season under conditions of high HLB incidence. We related different degrees of insecticide control with ACP abundance and ultimately, with HLB-associated yield losses in two four-year replicated experiments conducted in commercial groves of mature orange trees under high HLB incidence. Decisions on insecticide applications directed at ACP were made by project managers and confined to designated plots according to experimental design. All operational costs as well as production benefits were taken into account for economic analysis. The relationship between management costs, ACP abundance and HLB-associated economic losses based on current prices for process oranges was used to determine the optimum frequency and timing for insecticide applications during the growing season. Trees under the most intensive insecticidal control harbored fewest ACP resulting in greatest yields. The relationship between vector densities and yield loss was significant but differed between the two test orchards, possibly due to varying initial HLB infection levels, ACP populations or cultivar response. Based on these relationships, treatment thresholds during the growing season were obtained as a function of application costs, juice market prices and ACP densities. A conservative threshold for mature trees with high incidence of HLB would help maintain economic viability by reducing excessive insecticide sprays, thereby leaving more room for non-aggressive management tools such as biological control.	[Monzo, Cesar; Stansly, Philip A.] Univ Florida, IFAS, Southwest Florida Res & Educ Ctr, Entomol & Hematol Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Monzo, C (corresponding author), Univ Florida, IFAS, Southwest Florida Res & Educ Ctr, Entomol & Hematol Dept, Gainesville, FL 32611 USA.	cmonzo@ufl.edu	Monzo, Cesar/L-7055-2014; Monzo, C./O-5248-2019	Monzo, Cesar/0000-0003-3247-7412; Monzo, C./0000-0003-3247-7412	Citrus Research and Development Foundation [CRDF/7803]	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation, Grant: CRDF/7803 (URL:citrusrdf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Citrus Research and Development Foundation for funding this project, grove owners Mr. Gene Paul and Mr. Oscar Moreno and their respective managers, Di Ragoonanan and Ralph Jordan for splendid cooperation, Bayer Cropscience, Dow AgroSciences, Gowan Company, FMC Corporation, Makehteshim Agan of North America Inc., Syngenta and Valent for product donations, and the University of Florida, SWREC team: Cameron Brennan, Matthew Conley, Scott Croxton, Katherine Hendricks, Barry Kostyk, Zachary Lahey, Joel Mendez, Benny Pena, Katiria Perez, Miriam Ortez, Miguel Rua, Robert Riefer, Shea Teams and Ted Stansly for outstanding technical assistance.	Baldwin E, 2017, HORTECHNOLOGY UNPUB; Baldwin E, 2010, J AGR FOOD CHEM, V58, P1247, DOI 10.1021/jf9031958; Belasque J, 2010, J PLANT PATHOL, V92, P285; Bouffard K., 2014, THE LEDGER; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brodersen C, 2014, HORTSCIENCE, V49, P59, DOI 10.21273/HORTSCI.49.1.59; CDFA, 2015, PLANT HLTH PEST PRES; COUSENS R, 1985, ANN APPL BIOL, V107, P239, DOI 10.1111/j.1744-7348.1985.tb01567.x; Croxton SD, 2014, PEST MANAG SCI, V70, P318, DOI 10.1002/ps.3566; De Mendoza AH, 2001, J ECON ENTOMOL, V94, P439, DOI 10.1603/0022-0493-94.2.439; Farnsworth D, 2014, CHOICES, V29, P3; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Graham JH, 2013, PLANT DIS, V97, P1195, DOI 10.1094/PDIS-01-13-0024-RE; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2009, J ECON ENTOMOL, V102, P446, DOI 10.1603/029.102.0158; De Mendoza AH, 2006, J ECON ENTOMOL, V99, P1273, DOI 10.1603/0022-0493-99.4.1273; Hoddle MS, 2014, J ECON ENTOMOL, V107, P125, DOI 10.1603/EC13318; Hodges A. W., 2006, EC IMPACTS CITRUS GR; Jackson L.K., 1999, CITRUS GROWING FLORI; Jones MM, 2013, ANN M FLA STAT HORT, V126; Lee JA, 2015, P NATL ACAD SCI USA, V112, P7605, DOI 10.1073/pnas.1508253112; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lopes S. A., 2008, MANAGEMENT CITRUS HU; Monzo C, 2015, ENVIRON ENTOMOL, V44, P780, DOI 10.1093/ee/nvv032; Monzo C, 2014, B ENTOMOL RES, V104, P576, DOI 10.1017/S0007485314000315; Monzo C, 2015, ACTA HORTIC, V1065, P1137; NASS. United States Department of Agriculture. Agricultural Marketing Service. National Agricultural Statistics Service, 2016, FLOR CITR STAT 2015; Pedigo, 1996, EC THRESHOLDS INTEGR; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Rogers ME, 2012, 2012 FLORIDA CITRUS; Roistacher C. N., 1996, INT ORG CITRUS VIROL, V13, P279, DOI [10.5070/C53KG8M6JR, DOI 10.5070/C53KG8M6JR]; Roka FM, 2015, SUMMARY 2013 14 PROD, pFE968; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Tansey JA, 2015, CROP PROT, V76, P59, DOI 10.1016/j.cropro.2015.06.011; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Turechek WW, 2012, P 10 INT EP WKSHP 2, V2, P158; Udell J, ANN APPL BIOL; Wardowski W., 1995, QUALITY TESTS FLORID	44	37	39	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175333	10.1371/journal.pone.0175333	http://dx.doi.org/10.1371/journal.pone.0175333			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426676	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900025
J	Patel, H; Lissoos, T; Rubin, DT				Patel, Haridarshan; Lissoos, Trevor; Rubin, David T.			Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB DOSE INTENSIFICATION; ANTI-TNF THERAPY; MANAGEMENT; CARE; ADULTS	This study assessed the occurrence of indicators for suboptimal biologic therapy among ulcerative colitis (UC) and Crohn's disease (CD) patients over time in the United States (US). Data from a large US claims database (2005-2013) were used to retrospectively identify patients with diagnosed with either UC or CD who were new biologic users. Indicators of suboptimal biologic therapy included: dose escalation during the maintenance phase, discontinuation of the initial biologic, switch to another biologic within 90 days following the last day of supply of the initial biologic, augmentation with a non-biologic systemic therapy, UC-or CD-related surgery, UC-or CD-related urgent care, and development of fistula (for CD only). Kaplan-Meier analyses were used. A total of 1,699 UC and 4,569 CD patients were included. Among UC patients, 51.1% and 90.9% experienced >= 1 indicator of suboptimal biologic therapy within 6 months and 36 months of biologic therapy initiation, respectively. Among CD patients, 54.3% and 91.4% experienced >= 1 indicator of suboptimal biologic therapy within 6 and 36 months of biologic therapy initiation, respectively. For both UC and CD patients, the most frequent indicators of suboptimal biologic therapy were discontinuation, dose escalation and augmentation. In conclusion, this study found that the occurrence of suboptimal biologic therapy is common among patients with UC and CD, with approximately 90% of patients experiencing at least one indicator of suboptimal biologic therapy within 36 months of biologic treatment initiation.	[Patel, Haridarshan] Immens Consulting Inc, Chicago, IL USA; [Lissoos, Trevor] Takeda Pharmaceut USA Inc, Chicago, IL USA; [Rubin, David T.] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA)	Rubin, DT (corresponding author), Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA.	drubin@medicine.bsd.uchicago.edu		Rubin, David/0000-0001-5647-1723	Takeda Pharmaceuticals International, Inc.	Takeda Pharmaceuticals International, Inc.(Takeda Pharmaceutical Company Ltd)	This study was funded in full by Takeda Pharmaceuticals International, Inc. The funder provided support in the form of salary for Trevor Lissoos, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The design, analysis, reporting of findings, and intent to publish represent the views and opinions of the authors and do not represent the views and opinions of their respective organizations/companies. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Baran B, 2013, ISRN GASTROENTEROLOG, V2013, P12; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Colletti RB, 2009, J PEDIATR GASTR NUTR, V49, P297, DOI 10.1097/MPG.0b013e3181919695; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Ding NS, 2016, ALIMENT PHARM THER, V43, P30, DOI 10.1111/apt.13445; Esrailian E, 2007, ALIMENT PHARM THER, V26, P1005, DOI 10.1111/j.1365-2036.2007.03445.x; Ghosh Subrata, 2010, Therap Adv Gastroenterol, V3, P239, DOI 10.1177/1756283X10373176; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hilsden R, 2002, CAN J GASTROENTEROL, V16, P865, DOI 10.1155/2002/463015; Jung SA, 2012, CLIN ENDOSC, V45, P254, DOI 10.5946/ce.2012.45.3.254; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2005, GASTROENTEROLOGY, V128, P862, DOI 10.1053/j.gastro.2005.01.048; Lin KK, 2012, DIGEST DIS SCI, V57, P1013, DOI 10.1007/s10620-011-1969-3; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Nguyen DL, 2015, THER ADV CHRONIC DIS, V6, P147, DOI 10.1177/2040622315579621; Panaccione Remo, 2010, Therap Adv Gastroenterol, V3, P179, DOI 10.1177/1756283X09357579; Park SC, 2015, GUT LIVER, V9, P18, DOI 10.5009/gnl14226; Reddy SI, 2005, AM J GASTROENTEROL, V100, P1357, DOI 10.1111/j.1572-0241.2005.40849.x; Regueiro M, 2007, INFLAMM BOWEL DIS, V13, P1093, DOI 10.1002/ibd.20177; Rubin DT, 2014, ALIMENT PHARM THER, V39, P1143, DOI 10.1111/apt.12727; Rubin DT, 2017, INFLAMM BOWEL DIS, V23, P224, DOI 10.1097/MIB.0000000000000994; Sales-Campos H, 2015, BRAZ J MED BIOL RES, V48, P96, DOI [10.1590/1414-431X20143774, 10.1590/1414-431x20143774]; Sandborn WJ, 2014, GASTROENTEROLOGY, V147, P702, DOI 10.1053/j.gastro.2014.07.022; Schreiber Stefan, 2011, Therap Adv Gastroenterol, V4, P375, DOI 10.1177/1756283X11413315; Steenholdt C, 2016, INFLAMM BOWEL DIS, V22, P1999, DOI 10.1097/MIB.0000000000000772; Strik AS, 2016, EXPERT REV CLIN PHAR, V9, P429, DOI 10.1586/17512433.2016.1133288; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Zampeli Evanthia, 2014, World J Gastrointest Pathophysiol, V5, P293, DOI 10.4291/wjgp.v5.i3.293	33	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175099	10.1371/journal.pone.0175099	http://dx.doi.org/10.1371/journal.pone.0175099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426675	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900019
J	Schmiedl, A; Roolfs, T; Tutdibi, E; Gortner, L; Monz, D				Schmiedl, Andreas; Roolfs, Torge; Tutdibi, Erol; Gortner, Ludwig; Monz, Dominik			Influence of prenatal hypoxia and postnatal hyperoxia on morphologic lung maturation in mice	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; ENDOTHELIAL GROWTH-FACTOR; BRONCHOPULMONARY DYSPLASIA; NEONATAL HYPEROXIA; MOUSE MODEL; STEREOLOGICAL ESTIMATION; PERINATAL INFLAMMATION; ANIMAL-MODELS; FETAL LUNG; PATHOGENESIS	Background Oxygen supply as a lifesaving intervention is frequently used to treat preterm infants suffering additionally from possible prenatal or perinatal pathogen features. The impact of oxygen and/or physical lung injury may influence the morphological lung development, leading to a chronic postnatal lung disease called bronchopulmonary dysplasia (BPD). At present different experimental BPD models are used. However, there are no systematic comparative studies regarding different influences of oxygen on morphological lung maturation. Objective We investigated the influence of prenatal hypoxia and/or postnatal hyperoxia on morphological lung maturation based on stereological parameters, to find out which model best reflects morphological changes in lung development comparable with alterations found in BPD. Methods Pregnant mice were exposed to normoxia, the offspring to normoxia (No/No) or to hyperoxia (No/Hyper). Furthermore, pregnant mice were exposed to hypoxia and the offspring to normoxia (Hypo/No) or to hyperoxia (Hypo/Hyper). Stereological investigations were performed on all pups at 14 days after birth. Results Compared to controls (No/No) 1) the lung volume was significantly reduced in the No/Hyper and Hypo/Hyper groups, 2) the volume weighted mean volume of the parenchymal air-spaces was significantly higher in the Hypo/Hyper group, 3) the total air space volume was significantly lower in the No/Hyper and Hypo/Hyper groups, 4) the total septal surface showed significantly lower values in the No/Hyper and Hypo/Hyper groups, 5) the wall thickness of septa showed the highest values in the Hypo/Hyper group without reaching significance, 6) the volume density and the volume weighted mean volume of lamellar bodies in alveolar epithelial cells type II (AEII) were significantly lower in the Hypo/Hyper group. Conclusion Prenatal hypoxia and postnatal hyperoxia differentially influence the maturation of lung parenchyma. In 14 day old mice a significant retardation of morphological lung development leading to BPD-like alterations indicated by different parameters was only seen after hypoxia and hyperoxia.	[Schmiedl, Andreas; Roolfs, Torge] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Schmiedl, Andreas] Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Schmiedl, Andreas] Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany; [Tutdibi, Erol; Gortner, Ludwig; Monz, Dominik] Saarland Univ, Dept Pediat & Neonatol, Homburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Universitatsklinikum des Saarlandes	Schmiedl, A (corresponding author), Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany.; Schmiedl, A (corresponding author), Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.; Schmiedl, A (corresponding author), Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany.	Schmiedl.Andreas@mh-hannover.de			Sino-German Center for Research Promotion; Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL); German Research Federation (DFG) via the Cluster of Excellence REBIRTH	Sino-German Center for Research Promotion; Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL)(Federal Ministry of Education & Research (BMBF)); German Research Federation (DFG) via the Cluster of Excellence REBIRTH(German Research Foundation (DFG))	This work was in part supported by the Sino-German Center for Research Promotion, by the Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL) as well as by the German Research Federation (DFG) via the Cluster of Excellence REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Abman SH, 2008, PEDIATRICS, V122, P658, DOI 10.1542/peds.2008-1599; Albertine KH, 2013, SEMIN PERINATOL, V37, P60, DOI 10.1053/j.semperi.2013.01.001; AMY RWM, 1977, J ANAT, V124, P131; Baker GJ, 1985, ACTA STEREOL, V4, P103; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; BLANCO LN, 1991, AM J PHYSIOL, V261, pL370, DOI 10.1152/ajplung.1991.261.6.L370; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brasch F, 2004, AM J RESP CELL MOL, V30, P449, DOI 10.1165/rcmb.2003-0262OC; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Cerny L, 2008, LUNG, V186, P75, DOI 10.1007/s00408-007-9069-z; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao CM, 2017, J PATHOL, V241, P91, DOI 10.1002/path.4834; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Chou HC, 2016, AM J TRANSL RES, V8, P342; CLEMENTS JA, 1970, AM REV RESPIR DIS, V101, P984; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Deakins KM, 2009, RESP CARE, V54, P1252; Deng FT, 2015, J HUAZHONG U SCI-MED, V35, P122, DOI 10.1007/s11596-015-1400-y; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fehrenbach A, 1999, J ANAT, V194, P127, DOI 10.1046/j.1469-7580.1999.19410127.x; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Gortner L, 2005, BIOL NEONATE, V88, P129, DOI 10.1159/000085895; Gortner L, 2013, ANN ANAT, V195, P351, DOI 10.1016/j.aanat.2013.02.010; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Grisaru-Granovsky S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.025; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Hayes D, 2010, RESPIRATION, V79, P425, DOI 10.1159/000242497; Herring MJ, 2014, AM J PHYSIOL-LUNG C, V307, pL338, DOI 10.1152/ajplung.00094.2014; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hyde DM, 2007, AM J PHYSIOL-LUNG C, V293, pL570, DOI 10.1152/ajplung.00467.2006; Jones CV, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0110-5; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; LARSON JE, 1988, PEDIATR RES, V24, P156, DOI 10.1203/00006450-198808000-00003; Lee HJ, 2010, J PERINAT MED, V38, P675, DOI 10.1515/jpm.2010.091; Mammoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041596; Manzano RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095844; MASSARO GD, 1973, J CLIN INVEST, V52, P566, DOI 10.1172/JCI107217; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; MINCHENKO A, 1994, LAB INVEST, V71, P374; Mizikova I, 2015, AM J PHYSIOL-LUNG C, V308, pL1145, DOI 10.1152/ajplung.00039.2015; Monz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074740; Muhlfeld C, 2015, AM J PHYSIOL-LUNG C, V309, pL526, DOI 10.1152/ajplung.00047.2015; Muhlfeld C, 2013, AM J PHYSIOL-LUNG C, V305, P1205, DOI 10.1152/ajplung.00427.2012; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Nold MF, 2013, P NATL ACAD SCI USA, V110, P14384, DOI 10.1073/pnas.1306859110; Ochs M, 2014, ANN ANAT, V196, P26, DOI 10.1016/j.aanat.2013.10.004; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Orgeig S, 2011, RESP PHYSIOL NEUROBI, V178, P129, DOI 10.1016/j.resp.2011.05.015; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Ratner V, 2009, NEONATOLOGY, V95, P299, DOI 10.1159/000178798; Roth-Kleiner M, 2014, HISTOCHEM CELL BIOL, V141, P75, DOI 10.1007/s00418-013-1132-7; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SCHERLE W, 1970, Mikroskopie, V26, P57; SCHITTNY JC, 2008, FISHMANS PULMONARY D, P91; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Schwartz JE, 1998, BIOL NEONATE, V73, P313, DOI 10.1159/000013990; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Tibboel J, 2013, EUR RESPIR J, V42, P776, DOI 10.1183/09031936.00092212; Tsao PN, 2013, NEONATOLOGY, V103, P300, DOI 10.1159/000347103; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Tschanz SA, 2014, J APPL PHYSIOL, V117, P89, DOI 10.1152/japplphysiol.01355.2013; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; VELDHUIZEN RAW, 1993, BIOCHEM J, V295, P141, DOI 10.1042/bj2950141; Velten M, 2010, J APPL PHYSIOL, V108, P1347, DOI 10.1152/japplphysiol.01392.2009; Vogel ER, 2015, CAN J PHYSIOL PHARM, V93, P119, DOI 10.1139/cjpp-2014-0387; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Willfuhr A, 2015, AM J PHYSIOL-LUNG C, V309, pL1286, DOI 10.1152/ajplung.00410.2014; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yee M, 2011, AM J PATHOL, V178, P2601, DOI 10.1016/j.ajpath.2011.02.010; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032	84	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175804	10.1371/journal.pone.0175804	http://dx.doi.org/10.1371/journal.pone.0175804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426693	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900051
J	Bravo, F; Cross, I; Stamatakis, EA; Rohrmeier, M				Bravo, Fernando; Cross, Ian; Stamatakis, Emmanuel Andreas; Rohrmeier, Martin			Sensory cortical response to uncertainty and low salience during recognition of affective cues in musical intervals	PLOS ONE			English	Article							INTERMODAL SELECTIVE ATTENTION; VISUAL-SPATIAL ATTENTION; AUDITORY-CORTEX; EMOTIONAL RESPONSES; FUNCTIONAL-ANATOMY; PITCH PERCEPTION; COMPLEX TONES; MENTAL STATES; HUMAN BRAIN; CONSONANCE	Previous neuroimaging studies have shown an increased sensory cortical response (i.e., heightened weight on sensory evidence) under higher levels of predictive uncertainty. The signal enhancement theory proposes that attention improves the quality of the stimulus representation, and therefore reduces uncertainty by increasing the gain of the sensory signal. The present study employed functional magnetic resonance imaging (fMRI) to investigate the neural correlates for ambiguous valence inferences signaled by auditory information within an emotion recognition paradigm. Participants categorized sound stimuli of three distinct levels of consonance/dissonance controlled by interval content. Separate behavioural and neuroscientific experiments were conducted. Behavioural results revealed that, compared with the consonance condition (perfect fourths, fifths and octaves) and the strong dissonance condition (minor/major seconds and tritones), the intermediate dissonance condition (minor thirds) was the most ambiguous, least salient and more cognitively demanding category (slowest reaction times). The neuroscientific findings were consistent with a heightened weight on sensory evidence whilst participants were evaluating intermediate dissonances, which was reflected in an increased neural response of the right Heschl's gyrus. The results support previous studies that have observed enhanced precision of sensory evidence whilst participants attempted to represent and respond to higher degrees of uncertainty, and converge with evidence showing preferential processing of complex spectral information in the right primary auditory cortex. These findings are discussed with respect to music-theoretical concepts and recent Bayesian models of perception, which have proposed that attention may heighten the weight of information coming from sensory channels to stimulate learning about unknown predictive relationships.	[Bravo, Fernando; Cross, Ian] Univ Cambridge, Ctr Mus & Sci, Cambridge, England; [Bravo, Fernando; Rohrmeier, Martin] Tech Univ Dresden, Inst Kunst & Mus Wissensch, Dresden, Germany; [Stamatakis, Emmanuel Andreas] Univ Cambridge, Div Anaesthesia, Cambridge, England	University of Cambridge; Technische Universitat Dresden; University of Cambridge	Bravo, F (corresponding author), Univ Cambridge, Ctr Mus & Sci, Cambridge, England.; Bravo, F (corresponding author), Tech Univ Dresden, Inst Kunst & Mus Wissensch, Dresden, Germany.	nanobravo@fulbrightmail.org		Rohrmeier, Martin Alois/0000-0002-4323-7257; Cross, Ian Ralph McKenzie/0000-0002-2404-7765; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Queens' College Cambridge Walker Studentship; Zukunftskonzept at TU Dresden (Exzellenzinitiative of the Deutsche Forschungsgemeinschaft); SEMPRE (Arnold Bentley New Initiatives Fund); Cambridge Society for the Application of Research through a CSAR	Queens' College Cambridge Walker Studentship; Zukunftskonzept at TU Dresden (Exzellenzinitiative of the Deutsche Forschungsgemeinschaft); SEMPRE (Arnold Bentley New Initiatives Fund); Cambridge Society for the Application of Research through a CSAR	This project was made possible through the support of a Queens' College Cambridge Walker Studentship to F. Bravo. Financial support has also been provided by: Zukunftskonzept at TU Dresden (Exzellenzinitiative of the Deutsche Forschungsgemeinschaft), SEMPRE (Arnold Bentley New Initiatives Fund), and Cambridge Society for the Application of Research through a CSAR Student Award to F. Bravo	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Ayres T, 1980, J Aud Res, V20, P31; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bamiou DE, 2007, BRAIN RES REV, V56, P170, DOI 10.1016/j.brainresrev.2007.07.003; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beck AT, 1991, COGNITIVE THERAPY AN; Berna C, 2011, PERS INDIV DIFFER, V51, P349, DOI 10.1016/j.paid.2011.04.005; BHARUCHA JJ, 1986, PERCEPT PSYCHOPHYS, V40, P137, DOI 10.3758/BF03203008; Bidelman GM, 2011, NEUROREPORT, V22, P212, DOI 10.1097/WNR.0b013e328344a689; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Bravo F, 2012, FROM SOUNDS TO MUSIC, P366; Bravo F, 2014, LECT NOTES COMPUT SC, V8905, P494, DOI 10.1007/978-3-319-12976-1_29; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burns EM, 1999, THE PSYCHOLOGY OF MU, P215; BUTLER G, 1983, ADV BEHAV RES THER, V5, P51, DOI 10.1016/0146-6402(83)90015-2; BUTLER JW, 1968, J GEN PSYCHOL, V79, P129, DOI 10.1080/00221309.1968.9710460; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M., 2014, OXFORD HDB ATTENTION, P183, DOI [DOI 10.1093/OXFORDHB/9780199675111.013.004, 10.1093/oxfordhb/9780199675111.013.004]; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chiandetti C, 2011, PSYCHOL SCI, V22, P1270, DOI 10.1177/0956797611418244; Clark JJ, 1990, DATA FUSION FOR SENS; Cohn Richard., 2012, AUDACIOUS EUPHONY CH; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; Dayan P, 2003, IETE J RES, V49, P171, DOI 10.1080/03772063.2003.11416335; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DEWITT LA, 1987, PERCEPT PSYCHOPHYS, V41, P73, DOI 10.3758/BF03208216; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; Dumoulin SO, 2007, VISION RES, V47, P1608, DOI 10.1016/j.visres.2007.01.031; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fang F, 2008, J VISION, V8, DOI 10.1167/8.7.2; FANNIN HA, 1971, PERCEPT MOTOR SKILL, V32, P191, DOI 10.2466/pms.1971.32.1.191; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fletcher H, 1940, REV MOD PHYS, V12, P0047, DOI 10.1103/RevModPhys.12.47; Foss AH, 2007, NEUROREPORT, V18, P1521, DOI 10.1097/WNR.0b013e3282ef6b51; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fritz TH, 2013, EUR J NEUROSCI; Fujisawa TX, 2011, BRAIN IMAGING BEHAV, V5, P109, DOI 10.1007/s11682-011-9116-5; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Hansen KA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00163; Helmholtz H von, 1895, ON THE SENSATIONS OF; Huron D, 2008, SWEET ANTICIPATION M; Itoh K, 2003, NEUROREPORT, V14, P2303, DOI 10.1097/00001756-200312190-00003; Itoh K, 2010, J ACOUST SOC AM, V128, P3781, DOI 10.1121/1.3500685; Izumi A, 2000, J ACOUST SOC AM, V108, P3073, DOI 10.1121/1.1323461; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; Knill DC, 1996, PERCEPTION AS BAYESI; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2013, NEUROIMAGE, V81, P49, DOI 10.1016/j.neuroimage.2013.05.008; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; Krumhansl CL, 2001, COGNITIVE FOUNDATION; Lawson C, 2002, J ABNORM PSYCHOL, V111, P321, DOI 10.1037//0021-843X.111.2.321; Lawson RP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00302; Liegeois-Chauvel C, 2001, ANN NY ACAD SCI, V930, P117, DOI 10.1111/j.1749-6632.2001.tb05728.x; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; McDermott J, 2004, COGNITION, V94, pB11, DOI 10.1016/j.cognition.2004.04.004; McDermott JH, 2016, NATURE; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; MCKINNEY MF, 2001, PHYSL PSYCHOPHYSICAL, P83; Menon V, 2002, NEUROIMAGE, V17, P1742, DOI 10.1006/nimg.2002.1295; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer, 1956, EMOTION AND MEANING, P76; Minati L, 2009, NEUROREPORT, V20, P87, DOI 10.1097/WNR.0b013e32831af235; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Parncutt R., 1989, HARMONY A PSYCHOACOU; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Peretz I, 2001, BRAIN, V124, P928, DOI 10.1093/brain/124.5.928; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Piston Walter., 1987, HARMONY; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; SCHELLENBERG EG, 1994, PERCEPT PSYCHOPHYS, V56, P472, DOI 10.3758/BF03206738; Schellenberg EG, 1996, J ACOUST SOC AM, V100, P3321, DOI 10.1121/1.417355; Schoenberg Arnold, 1983, THEORY HARMONY; Schonberg A., 1966, HARMONIELEHRE; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Soveri A, 2013, EXP PSYCHOL, V60, P44, DOI 10.1027/1618-3169/a000172; Sugimoto T, 2010, PRIMATES, V51, P7, DOI 10.1007/s10329-009-0160-3; Temperley D, 2010, MUSIC AND PROBABILIT; TERHARDT E, 1984, MUSIC PERCEPT, V1, P276; TERHARDT E, 1978, PERCEPT PSYCHOPHYS, V23, P483, DOI 10.3758/BF03199523; Turnbull WW, 1944, J EXP PSYCHOL, V34, P302, DOI 10.1037/h0063434; Tymoczko D, 2011, A GEOMETRY OF MUSIC; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Van Overwalle F, 2009, SOC COGN AFFECT NEUR, V4, P177, DOI 10.1093/scan/nsp003; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; VOS J, 1985, PERCEPT PSYCHOPHYS, V37, P507, DOI 10.3758/BF03204914; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; ZWICKER E, 1957, J ACOUST SOC AM, V29, P548, DOI 10.1121/1.1908963	133	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175991	10.1371/journal.pone.0175991	http://dx.doi.org/10.1371/journal.pone.0175991			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422990	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600073
J	Castle, J; Morris, K; Pritchard, S; Kirwan, CC				Castle, John; Morris, Karen; Pritchard, Susan; Kirwan, Cliona C.			Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; RECEPTOR STATUS; STEM-CELL; SIZE; DIFFERENTIATION; METASTASIS; BIOMARKERS; MARKER; ISET	Introduction Given the current postulated plasticity between epithelial and mesenchymal states of migratory cancer cells the detection of non-epithelial CTCs is an important scientific and clinical goal. Methods We used the filtration-based ISET technology to enrich circulating tumour cells (CTCs) in early breast cancer blood samples and identify them using a morphology-based immunocytochemistry (ICC) approach. Results We found greater numbers of putative CTCs by this approach than by the cytokeratin-based CellSearch technology, but a high number of CTC false positives were identified in healthy volunteer samples which were not reduced in successive blood draws. Preliminary work using an oestrogen receptor (ER)-based multiplex ICC method in metastatic breast cancer ISET samples indicated a low number of ER+ CTCs even at this advanced stage. Conclusions This work highlights the challenges in enumerating CTCs without conventional epithelial markers.	[Castle, John; Morris, Karen] Canc Res UK Manchester Inst, Clin & Expt Pharmacol, Manchester, Lancs, England; [Pritchard, Susan] Univ Hosp South Manchester, Dept Histopathol, Manchester, Lancs, England; [Kirwan, Cliona C.] Univ Manchester, Div Mol & Clin Canc Sci, Manchester, Lancs, England; [Kirwan, Cliona C.] Univ Hosp South Manchester, Dept Acad Surg, Manchester, Lancs, England	Cancer Research UK; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Kirwan, CC (corresponding author), Univ Manchester, Div Mol & Clin Canc Sci, Manchester, Lancs, England.; Kirwan, CC (corresponding author), Univ Hosp South Manchester, Dept Acad Surg, Manchester, Lancs, England.	cliona.kirwan@manchester.ac.uk	Kirwan, Cliona/HHZ-8872-2022	Kirwan, Cliona/0000-0002-1725-4790; Castle, John/0000-0001-8213-9775	National Institute for Health and Research [NIHR-CS-011014]; Academy of Medical Sciences; NIHR Clinician Scientist Award [NIHR-CS-011014]; National Institute for Health Research [NIHR-CS-011-014] Funding Source: researchfish	National Institute for Health and Research; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); NIHR Clinician Scientist Award; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health and Research (NIHR-CS-011014) and the Academy of Medical Sciences. C. C. Kirwan is supported by a NIHR Clinician Scientist Award (NIHR-CS-011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah EA, 2015, INT J CANCER, V137, P1397, DOI 10.1002/ijc.29495; Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Aktas B, 2011, GYNECOL ONCOL, V122, P356, DOI 10.1016/j.ygyno.2011.04.039; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038; Bain B., 2006, BLOOD CELLS PRACTICA, VFourth, P416; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Biggers B, 2009, ANN SURG ONCOL, V16, P969, DOI 10.1245/s10434-009-0314-y; Boos CJ, 2006, J THROMB THROMBOLYS, V22, P125, DOI 10.1007/s11239-006-8422-z; Castle J, 2014, BREAST, V23, P552, DOI 10.1016/j.breast.2014.07.002; Chen JF, 2015, CANCER-AM CANCER SOC, V121, P3240, DOI 10.1002/cncr.29455; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Giorgi V, 2010, ARCH DERMATOL, V146, P1120, DOI 10.1001/archdermatol.2010.264; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; El-Heliebi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-214; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Frithiof H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0493-1; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Hong B, 2013, THERANOSTICS, V3, P377, DOI 10.7150/thno.5195; Kalinsky K, 2015, CLIN TRANSL ONCOL, V17, P539, DOI 10.1007/s12094-015-1275-1; Khoja L, 2012, BRIT J CANCER, V106, P508, DOI 10.1038/bjc.2011.545; Khoja L, 2014, MELANOMA RES, V24, P40, DOI 10.1097/CMR.0000000000000025; Krawczyk N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.352; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Lau AHY, 2012, PROSTAG LEUKOTR ESS, V86, P119, DOI 10.1016/j.plefa.2011.12.002; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Li H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001565; Mao SZ, 2015, ARTERIOSCL THROM VAS, V35, P1635, DOI 10.1161/ATVBAHA.115.305519; Massard C, 2016, ONCOTARGET; McDaniel AS, 2016, BJU INT; Morris KL, 2014, CANCER CHEMOTH PHARM, V74, P323, DOI 10.1007/s00280-014-2508-7; Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066; Strijbos MH, 2009, THROMB HAEMOSTASIS, V102, P347, DOI 10.1160/TH08-11-0762; Tomer A, 2004, BLOOD, V104, P2722, DOI 10.1182/blood-2004-02-0769; Vona G, 2004, HEPATOLOGY, V39, P792, DOI 10.1002/hep.20091; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175647	10.1371/journal.pone.0175647	http://dx.doi.org/10.1371/journal.pone.0175647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422972	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600039
J	Soler, M; de Neve, L; Roldan, M; Perez-Contreras, T; Soler, JJ				Soler, Manuel; de Neve, Liesbeth; Roldan, Maria; Perez-Contreras, Tomas; Jose Soler, Juan			Great spotted cuckoo nestlings have no antipredatory effect on magpie or carrion crow host nests in southern Spain	PLOS ONE			English	Article							BROOD PARASITISM; CLAMATOR-GLANDARIUS; GIANT COWBIRDS; PRODUCTIVITY; POPULATION; DYNAMICS; BEHAVIOR; DEFENSE; RISK	Host defences against cuckoo parasitism and cuckoo trickeries to overcome them are a classic example of antagonistic coevolution. Recently it has been reported that this relationship may turn to be mutualistic in the case of the carrion crow (Corvus corone) and its brood parasite, the great spotted cuckoo (Clamator glandarius), given that experimentally and naturally parasitized nests were depredated at a lower rate than non-parasitized nests. This result was interpreted as a consequence of the antipredatory properties of a fetid cloacal secretion produced by cuckoo nestlings, which presumably deters predators from parasitized host nests. This potential defensive mechanism would therefore explain the detected higher fledgling success of parasitized nests during breeding seasons with high predation risk. Here, in a different study population, we explored the expected benefits in terms of reduced nest predation in naturally and experimentally parasitized nests of two different host species, carrion crows and magpies (Pica pica). During the incubation phase non-parasitized nests were depredated more frequently than parasitized nests. However, during the nestling phase, parasitized nests were not depredated at a lower rate than non-parasitized nests, neither in magpie nor in carrion crow nests, and experimental translocation of great spotted cuckoo hatchlings did not reveal causal effects between parasitism state and predation rate of host nests. Therefore, our results do not fit expectations and, thus, do not support the fascinating possibility that great spotted cuckoo nestlings could have an antipredatory effect for host nestlings, at least in our study area. We also discuss different possibilities that may conciliate these with previous results, but also several alternative explanations, including the lack of generalizability of the previously documented mutualistic association.	[Soler, Manuel; Roldan, Maria; Perez-Contreras, Tomas] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [de Neve, Liesbeth] Univ Ghent, Dept Biol, Terr Ecol Unit, Ghent, Belgium; [Jose Soler, Juan] Estn Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Almeria, Spain	University of Granada; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Pérez-Contreras, Tomás/N-2523-2019; De Neve, Liesbeth/F-7896-2011; Soler, J. J./H-2363-2011	Pérez-Contreras, Tomás/0000-0002-2271-1706; De Neve, Liesbeth/0000-0003-0041-9824; Soler, J. J./0000-0003-2990-1489	Junta de Andalucia [CVI-6653]; Spanish Ministerio de Economia y Competitividad/FEDER [CGL2011-25634/BOS]	Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Economia y Competitividad/FEDER	This work was partially supported by the Junta de Andalucia (research project CVI-6653) and the Spanish Ministerio de Economia y Competitividad/FEDER (research project CGL2011-25634/BOS to MS). There was no additional funding received for this study.	Altman D.G., 1991, PRACTICAL STATISTIC; Baglione V, 2016, BEHAV ECOL; Boncoraglio G, 2012, BEHAV ECOL SOCIOBIOL, V66, P539, DOI 10.1007/s00265-011-1302-3; Canestrari D, 2014, SCIENCE, V343, P1350, DOI 10.1126/science.1249008; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cramp S, 1994, BIRDS W PALEARTIC, VVIII; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Ibanez-Alamo JD, 2012, J ORNITHOL, V153, P801, DOI 10.1007/s10336-011-0797-8; Ibanez-Alamo JD, 2012, HORM BEHAV, V61, P590, DOI 10.1016/j.yhbeh.2012.02.008; Fraga RM, 2011, WILSON J ORNITHOL, V123, P277, DOI 10.1676/10-103.1; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Hannon SJ, 2009, OIKOS, V118, P1035, DOI 10.1111/j.1600-0706.2008.17383.x; Kosciuch KL, 2008, ECOL APPL, V18, P537, DOI 10.1890/07-0984.1; Kristin A, 2001, HDB BIRDS WORLD, P396; Martin-Galvez D, 2007, EVOLUTION, V61, P2340, DOI 10.1111/j.1558-5646.2007.00194.x; Payne R. B., 1997, HDB BIRDS WORLD, V4, P508; ROBINSON SK, 1988, WILSON BULL, V100, P224; Roldan M, 2013, ACTA ORNITHOL, V48, P221, DOI 10.3161/000164513X678865; SMITH NG, 1968, NATURE, V219, P690, DOI 10.1038/219690a0; Soler JJ, 1999, BEHAV ECOL, V10, P275, DOI 10.1093/beheco/10.3.275; Soler JJ, 2014, OECOLOGIA, V175, P105, DOI 10.1007/s00442-014-2901-2; Soler JJ, 2013, ECOLOGY, V94, P1338, DOI 10.1890/12-1350.1; SOLER M, 1995, CONDOR, V97, P804, DOI 10.2307/1369188; SOLER M, 1991, CONDOR, V93, P49, DOI 10.2307/1368605; Soler M, 1999, J ORNITHOL, V140, P199, DOI 10.1007/BF01653599; Soler M, 1998, OX ORN SER, V9, P113; SOLER M, 1995, EVOLUTION, V49, P770, DOI 10.1111/j.1558-5646.1995.tb02312.x; Soler M, 1998, OECOLOGIA, V117, P381, DOI 10.1007/s004420050671; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M, 1999, CAN J ZOOL, V77, P1794, DOI 10.1139/cjz-77-11-1794; Soler Manuel, 1999, Animal Cognition, V2, P97, DOI 10.1007/s100710050029; Soler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107412; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2014, BEHAV ECOL SOCIOBIOL, V68, P333, DOI 10.1007/s00265-013-1648-9; Soler M, 2013, BEHAV ECOL SOCIOBIOL, V67, P601, DOI 10.1007/s00265-013-1479-8; Soler M, 2012, ETHOLOGY, V118, P1036, DOI 10.1111/eth.12004; Soler M, 2012, ANIM BEHAV, V83, P163, DOI 10.1016/j.anbehav.2011.10.022; Soler Manuel, 2002, Avian Science, V2, P25; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Tilgar V, 2009, ANIM BEHAV, V77, P43, DOI 10.1016/j.anbehav.2008.08.027; Trnka A, 2016, J AVIAN BIOL, V47, P288, DOI 10.1111/jav.00785; WEBSTER MS, 1994, CONDOR, V96, P794, DOI 10.2307/1369483; Weidinger K, 2010, OIKOS, V119, P138, DOI 10.1111/j.1600-0706.2009.17649.x; Wyllie I., 1981, CUCKOO; YOMTOV Y, 1976, BEHAVIOUR, V59, P247, DOI 10.1163/156853976X00389	46	6	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173080	10.1371/journal.pone.0173080	http://dx.doi.org/10.1371/journal.pone.0173080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422953	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600007
J	Tiran, V; Stanzer, S; Heitzer, E; Meilinger, M; Rossmann, C; Lax, S; Tsybrovskyy, O; Dandachi, N; Balic, M				Tiran, Verena; Stanzer, Stefanie; Heitzer, Ellen; Meilinger, Michael; Rossmann, Christopher; Lax, Sigurd; Tsybrovskyy, Oleksiy; Dandachi, Nadia; Balic, Marija			Genetic profiling of putative breast cancer stem cells from malignant pleural effusions	PLOS ONE			English	Article							HETEROGENEITY; EVOLUTION; SURVIVAL	A common symptom during late stage breast cancer disease is pleural effusion, which is related to poor prognosis. Malignant cells can be detected in pleural effusions indicating metastatic spread from the primary tumor site. Pleural effusions have been shown to be a useful source for studying metastasis and for isolating cells with putative cancer stem cell (CSC) properties. For the present study, pleural effusion aspirates from 17 metastatic breast cancer patients were processed to propagate CSCs in vitro. Patient-derived aspirates were cultured under sphere forming conditions and isolated primary cultures were further sorted for cancer stem cell subpopulations ALDH1(+) and CD44(+) CD24 (-/low). Additionally, sphere forming efficiency of CSC and non-CSC subpopulations was determined. In order to genetically characterize the different tumor subpopulations, DNA was isolated from pleural effusions before and after cell sorting, and compared with corresponding DNA copy number profiles from primary tumors or bone metastasis using low-coverage whole genome sequencing (SCNA-seq). In general, unsorted cells had a higher potential to form spheres when compared to CSC subpopulations. In most cases, cell sorting did not yield sufficient cells for copy number analysis. A total of five from nine analyzed unsorted pleura samples (55%) showed aberrant copy number profiles similar to the respective primary tumor. However, most sorted subpopulations showed a balanced profile indicating an insufficient amount of tumor cells and low sensitivity of the sequencing method. Finally, we were able to establish a long term cell culture from one pleural effusion sample, which was characterized in detail. In conclusion, we confirm that pleural effusions are a suitable source for enrichment of putative CSC. However, sequencing based molecular characterization is impeded due to insufficient sensitivity along with a high number of normal contaminating cells, which are masking genetic alterations of rare cancer (stem) cells.	[Tiran, Verena; Stanzer, Stefanie; Rossmann, Christopher; Dandachi, Nadia; Balic, Marija] Med Univ Graz, Dept Internal Med, Div Oncol, Graz, Austria; [Heitzer, Ellen] Med Univ Graz, Inst Human Genet, Graz, Austria; [Meilinger, Michael] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Meilinger, Michael] Otto Wagner Spital, Internal Div Pulmonol 2, Vienna, Austria; [Lax, Sigurd] LKH Graz West, Inst Pathol, Graz, Austria; [Tsybrovskyy, Oleksiy] Med Univ Graz, Inst Pathol, Graz, Austria; [Dandachi, Nadia] Med Univ Graz, Res Unit Epigenet & Genet Canc Biomarkers, Graz, Austria; [Balic, Marija] Med Univ Graz, Res Unit Circulating Tumor Cells & Canc Stem Cell, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Dandachi, N; Balic, M (corresponding author), Med Univ Graz, Dept Internal Med, Div Oncol, Graz, Austria.; Dandachi, N (corresponding author), Med Univ Graz, Res Unit Epigenet & Genet Canc Biomarkers, Graz, Austria.; Balic, M (corresponding author), Med Univ Graz, Res Unit Circulating Tumor Cells & Canc Stem Cell, Graz, Austria.	nadia.dandachi@medunigraz.at; Marija.balic@medunigraz.at	Tsybrovskyy, Oleksiy/AAE-2127-2020; Lax, Sigurd F./AAE-8500-2020	Tsybrovskyy, Oleksiy/0000-0002-3998-1649; 	Oesterreichische Nationalbank, Anniversary Fund [14001]	Oesterreichische Nationalbank, Anniversary Fund	Funded by Oesterreichische Nationalbank, Anniversary Fund, project number 14001; www.oenb.at/Ueber-Uns/ Forschungsfoerderung/Jubilaeumsfonds.html StSt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Balic M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-358; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Camillo ND, 2014, ACTA CYTOL, V58, P446, DOI 10.1159/000367919; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Cheah HM, 2016, RESPIROLOGY; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Collina F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/158682; Deng T, 2009, CLIN CANCER RES, V15, P119, DOI 10.1158/1078-0432.CCR-08-1708; Donnenberg VS, 2010, CYTOM PART B-CLIN CY, V78B, P287, DOI 10.1002/cyto.b.20530; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; dos Santos GT, 2012, J BRAS PNEUMOL, V38, P487, DOI 10.1590/S1806-37132012000400011; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giarnieri E, 2015, J CELL PHYSIOL, V230, P272, DOI 10.1002/jcp.24806; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V306, P385, DOI 10.1001/jama.2011.1034; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P149, DOI 10.1006/exmp.1999.2251; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Kaczmarek M, 2012, WSPOLCZESNA ONKOL, V16, P279, DOI 10.5114/wo.2012.30054; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lin CY, 2016, HISTOPATHOLOGY, V68, P119, DOI 10.1111/his.12868; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Qiu Y, 2014, J BREAST CANCER, V17, P54, DOI 10.4048/jbc.2014.17.1.54; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shao J, 2016, MOL MED REP, V14, P4991, DOI 10.3892/mmr.2016.5899; Shiozawa Y, 2013, PHARMACOL THERAPEUT, V138, P285, DOI 10.1016/j.pharmthera.2013.01.014; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Ulz P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12008; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yang F, 2017, CELL MOL LIFE SCI, V74, P951, DOI 10.1007/s00018-016-2334-7; Young MJ, 2015, CARCINOGENESIS, V36, P498, DOI 10.1093/carcin/bgv018	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175223	10.1371/journal.pone.0175223	http://dx.doi.org/10.1371/journal.pone.0175223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423035	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600028
J	Hou, JQ; Lie, MX; Mao, XH; Hao, Y; Ding, J; Liu, DM; Xi, BD; Liu, HL				Hou, Jiaqi; Lie, Mingxiao; Mao, Xuhui; Hao, Yan; Ding, Jie; Liu, Dongming; Xi, Beidou; Liu, Hongliang			Response of microbial community of organic-matter-impoverished arable soil to long-term application of soil conditioner derived from dynamic rapid fermentation of food waste	PLOS ONE			English	Article							NITROGEN MINERALIZATION; FERTILIZER APPLICATION; BACTERIAL COMMUNITIES; TUNDRA SOIL; FRESH-WATER; DIVERSITY; MANAGEMENT; SYSTEMS; CARBON; COMPOST	Rapid fermentation of food waste can be used to prepare soil conditioner. This process consumes less time and is more cost-effective than traditional preparation technology. However, the succession of the soil microbial community structure after long-term application of rapid fermentation-derived soil conditioners remains unclear. Herein, dynamic rapid fermentation (DRF) of food waste was performed to develop a soil conditioner and the successions and diversity of bacterial communities in an organic-matter-impoverished arable soil after six years of application of DRF-derived soil conditioner were investigated. Results showed that the treatment increased soil organic matter (SOM) accumulation and strawberry yield by 5.3 g/ kg and 555.91 kg/ha, respectively. Proteobacteria, Actinobacteria, Acidobacteria, and Firmicutes became the dominant phyla, occupying 65.95% -77.52% of the bacterial sequences. Principal component analysis (PCA) results showed that the soil bacterial communities were largely influenced by the treatment. Redundancy analysis (RDA) results showed that the relative abundances of Gemmatimonadetes, Chloroflexi, Verrucomicrobia, Nitrospirae, and Firmicutes were significantly correlated with soil TC, TN, TP, NH4+-N, NO3--N, OM, and moisture. These communities were all distributed in the soil samples collected in the sixth year of application. Long-term treatment did not enhance the diversity of bacterial species but significantly altered the distribution of major functional bacterial communities in the soils. Application of DRF-derived soil conditioner could improve the soil quality and optimize the microbial community, ultimately enhancing fruit yields.	[Hou, Jiaqi; Xi, Beidou; Liu, Hongliang] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing, Peoples R China; [Hou, Jiaqi; Lie, Mingxiao; Hao, Yan; Ding, Jie; Liu, Dongming; Xi, Beidou; Liu, Hongliang] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Mao, Xuhui] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences; Wuhan University	Xi, BD (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing, Peoples R China.; Lie, MX; Xi, BD (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	limingxiao81220@163.com; xibeidou0@163.com			National Natural Science Foundation of China [51408572]; China National Funds for Distinguished Young Scientists [51325804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	The authors would like to acknowledge the financial support by the National Natural Science Foundation of China (Grant No. 51408572) and China National Funds for Distinguished Young Scientists (No.51325804).	Bending GD, 2000, BIOL FERT SOILS, V31, P78, DOI 10.1007/s003740050627; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Chang JI, 2008, BIORESOURCE TECHNOL, V99, P8068, DOI 10.1016/j.biortech.2008.03.043; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Crecchio C, 2007, SOIL BIOL BIOCHEM, V39, P1391, DOI 10.1016/j.soilbio.2006.12.016; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dong WL, 2015, J INTEGR AGR, V14, P1092, DOI 10.1016/S2095-3119(14)60992-8; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; FAO, 2003, DIG SOIL MAP WORLD; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; HOSSAIN AKMA, 1995, BIOL FERT SOILS, V19, P246, DOI 10.1007/BF00336167; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jiang Y, 2015, BIORESOURCE TECHNOL, V197, P7, DOI 10.1016/j.biortech.2015.08.053; Jolanun B, 2010, BIORESOURCE TECHNOL, V101, P4484, DOI 10.1016/j.biortech.2010.01.116; Kell S, 2015, AGR ECOSYST ENVIRON, V209, P138, DOI 10.1016/j.agee.2015.02.012; Kumar P., 2012, NEW YORK SCI J, V5, P90; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lenk S, 2011, ENVIRON MICROBIOL, V13, P758, DOI 10.1111/j.1462-2920.2010.02380.x; Li ZJ, 2006, CHEMOSPHERE, V62, P1374, DOI 10.1016/j.chemosphere.2005.07.050; Lu YJ, 2009, WASTE MANAGE, V29, P1152, DOI 10.1016/j.wasman.2008.06.030; Lv MR, 2011, BIOL FERT SOILS, V47, P777, DOI 10.1007/s00374-011-0584-y; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marshall B, 1998, NEMATOLOGICA, V44, P303, DOI 10.1163/005425998X00062; Mulvaney RL, 1996, METHODS SOIL ANAL, P1123, DOI DOI 10.2136/SSSAB00KSER5.3.C38; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nosengo N, 2003, NATURE, V425, P894, DOI 10.1038/425894a; Nyberg K, 2006, BIOL FERT SOILS, V42, P315, DOI 10.1007/s00374-005-0029-6; Pokhrel B, 2015, J AGR FOOD CHEM, V63, P5578, DOI 10.1021/acs.jafc.5b01366; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Schrempf H, 2001, ANTON LEEUW INT J G, V79, P285, DOI 10.1023/A:1012058205158; Shu WX, 2016, AGR ECOSYST ENVIRON, V219, P111, DOI 10.1016/j.agee.2015.12.009; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Stamatiadis S, 1999, APPL SOIL ECOL, V12, P217, DOI 10.1016/S0929-1393(99)00013-X; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; Vandermeersch T, 2014, RESOUR CONSERV RECY, V87, P57, DOI 10.1016/j.resconrec.2014.03.008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Yan N, 2015, INT SOIL WATER CONSE, V3, P316, DOI 10.1016/j.iswer.2015.11.003; Yavari S, 2009, J PLANT NUTR, V32, P1498, DOI 10.1080/01904160903092697; Yi J, 2012, APPL MICROBIOL BIOT, V93, P411, DOI 10.1007/s00253-011-3425-x; Zaman M, 1999, BIOL FERT SOILS, V29, P178, DOI 10.1007/s003740050542; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2; Zhang W, 2016, J HAZARD MATER, V301, P1, DOI 10.1016/j.jhazmat.2015.08.037; Zhou J, 2015, SOIL BIOL BIOCHEM, V90, P42, DOI 10.1016/j.soilbio.2015.07.005	54	28	33	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175715	10.1371/journal.pone.0175715	http://dx.doi.org/10.1371/journal.pone.0175715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419163	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200035
J	Boussida, S; Traore, AS; Durif, F				Boussida, Salem; Traore, Amidou S.; Durif, Franck			Mapping of the brain hemodynamic responses to sensorimotor stimulation in a rodent model: A BOLD fMRI study	PLOS ONE			English	Article							FUNCTIONAL MRI; SOMATOSENSORY STIMULATION; RAT-BRAIN; ISOFLURANE; ACTIVATION; FOREPAW; SIGNAL; REPRESENTATION; HALOTHANE; HINDPAW	Blood Oxygenation Level Dependent functional MRI (BOLD fMRI) during electrical paw stimulation has been widely used in studies aimed at the understanding of the somatosensory network in rats. However, despite the well-established anatomical connections between cortical and subcortical structures of the sensorimotor system, most of these functional studies have been concentrated on the cortical effects of sensory electrical stimulation. BOLD fMRI study of the integration of a sensorimotor input across the sensorimotor network requires an appropriate methodology to elicit functional activation in cortical and subcortical areas owing to the regional differences in both neuronal and vascular architectures between these brain regions. Here, using a combination of low level anesthesia, long pulse duration of the electrical stimulation along with improved spatial and temporal signal to noise ratios, we provide a functional description of the main cortical and subcortical structures of the sensorimotor rat brain. With this calibrated fMRI protocol, unilateral non-noxious sensorimotor electrical hind-paw stimulation resulted in robust positive activations in the contralateral sensorimotor cortex and bilaterally in the sensorimotor thalamus nuclei, whereas negative activations were observed bilaterally in the dorsolateral caudate-putamen. These results demonstrate that, once the experimental setup allowing necessary spatial and temporal signal to noise ratios is reached, hemodynamic changes related to neuronal activity, as preserved by the combination of a soft anesthesia with a soft muscle relaxation, can be measured within the sensorimotor network. Moreover, the observed responses suggest that increasing pulse duration of the electrical stimulus adds a proprioceptive component to the sensory input that activates sensorimotor network in the brain, and that these activation patterns are similar to those induced by digits paw's movements. These findings may find application in fMRI studies of sensorimotor disorders within cortico-basal network in rodents.	[Boussida, Salem; Traore, Amidou S.] INRA, UR370, QuaPA, St Genes Champanelle, France; [Durif, Franck] CHU, Neurol A, Clermont Ferrand, France	INRAE; CHU Clermont Ferrand	Traore, AS (corresponding author), INRA, UR370, QuaPA, St Genes Champanelle, France.	amidou.traore@inra.fr	Durif, Franck/CAA-1077-2022; TRAORE, Amidou/D-9387-2019	TRAORE, Amidou/0000-0002-3574-3475				ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; [Anonymous], 1990, SCIENCE, V250, P1457; Baudewig J, 2003, MAGN RESON IMAGING, V21, P1121, DOI 10.1016/j.mri.2003.08.013; Bock C, 1998, NMR BIOMED, V11, P115, DOI 10.1002/(SICI)1099-1492(199805)11:3<115::AID-NBM526>3.0.CO;2-K; Bourgeon S, 2004, BEHAV BRAIN RES, V153, P217, DOI 10.1016/j.bbr.2003.12.002; Brinker G, 1999, MAGNET RESON MED, V41, P469, DOI 10.1002/(SICI)1522-2594(199903)41:3<469::AID-MRM7>3.0.CO;2-9; Burke M, 2000, MAGNET RESON MED, V44, P317, DOI 10.1002/1522-2594(200008)44:2<317::AID-MRM20>3.0.CO;2-R; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Cho YR, 2007, MAGN RESON MED, V58, P901, DOI 10.1002/mrm.21408; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Devonshire IM, 2012, NEUROIMAGE, V59, P1997, DOI 10.1016/j.neuroimage.2011.09.050; Ebner F. F., 2015, RAT NERVOUS SYSTEM, P675; Erro ME, 2002, NEUROSCI RES, V42, P45, DOI 10.1016/S0168-0102(01)00302-9; Erro ME, 2001, HISTOCHEM CELL BIOL, V115, P447; FORSTER A, 1982, ANESTHESIOLOGY, V56, P453, DOI 10.1097/00000542-198206000-00009; Francis JT, 2008, J NEUROPHYSIOL, V99, P2291, DOI 10.1152/jn.01206.2007; Grill WM, 1996, IEEE T BIO-MED ENG, V43, P161, DOI 10.1109/10.481985; Grune M, 1999, MAGNET RESON MED, V42, P118, DOI 10.1002/(SICI)1522-2594(199907)42:1<118::AID-MRM16>3.0.CO;2-T; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hayes DJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00027; Imas OA, 2005, ANESTHESIOLOGY, V102, P937, DOI 10.1097/00000542-200505000-00012; Keilholz SD, 2004, MAGN RESON MED, V52, P89, DOI 10.1002/mrm.20114; LEE JG, 1994, ANESTH ANALG, V79, P58; Li CX, 2014, BRAIN CONNECT, V4, P760, DOI 10.1089/brain.2014.0326; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; LOW JST, 1986, J COMP NEUROL, V243, P510, DOI 10.1002/cne.902430406; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; O'Herron P, 2016, NATURE, V534, P378, DOI 10.1038/nature17965; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Orth M, 2006, ANESTH ANALG, V102, P1709, DOI 10.1213/01.ane.0000205752.00303.94; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Paxinos G., 2015, RAT NERVOUS SYSTEM, V4th; Peeters RR, 1999, EUR J NEUROSCI, V11, P2720, DOI 10.1046/j.1460-9568.1999.00687.x; Raspopovic S, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-17; Schlegel F, 2015, NEUROIMAGE, V116, P40, DOI 10.1016/j.neuroimage.2015.05.013; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Silva AC, 2002, P NATL ACAD SCI USA, V99, P15182, DOI 10.1073/pnas.222561899; Sloan HL, 2010, NEUROIMAGE, V53, P399, DOI 10.1016/j.neuroimage.2010.07.014; Spenger C, 2000, EXP NEUROL, V166, P246, DOI 10.1006/exnr.2000.7524; Triantafyllou C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024519; Van Camp N, 2006, NMR BIOMED, V19, P10, DOI [10.1002/nbm0986, 10.1002/nbm.986]; van Meer MPA, 2011, J CEREBR BLOOD F MET, V31, P1583, DOI 10.1038/jcbfm.2011.61; Vertes RP, 2015, RAT NERVOUS SYSTEM, P335; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604; Younce JR, 2014, JOVE-J VIS EXP, DOI 10.3791/51271	56	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176512	10.1371/journal.pone.0176512	http://dx.doi.org/10.1371/journal.pone.0176512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441420	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800065
J	Chen, Z; Sun, Y; Yang, XJ; Wu, ZF; Guo, KF; Niu, XR; Wang, QS; Ruan, JS; Bu, WJ; Gao, S				Chen, Ze; Sun, Yu; Yang, Xiaojun; Wu, Zhenfeng; Guo, Kaifei; Niu, Xiaoran; Wang, Qingsong; Ruan, Jishou; Bu, Wenjun; Gao, Shan			Two featured series of rRNA-derived RNA fragments (rRFs) constitute a novel class of small RNAs	PLOS ONE			English	Article							SIRNAS	In this study, we reported two featured series of rRNA-derived RNA fragments (rRFs) from the small RNA sequencing (sRNA-seq) data of Amblyomma testudinarium using the Illunima platform. Two series of rRFs (rRF5 and rRF3) were precisely aligned to the 5' and 3' ends of the 5.8S and 28S rRNA gene. The rRF5 and rRF3 series were significantly more highly expressed than the rRFs located in the body of the rRNA genes. These series contained perfectly aligned reads, the lengths of which varied progressively with 1-bp differences. The rRF5 and rRF3 series in the same expression pattern exist ubiquitously from ticks to human. The cellular experiments showed the RNAi knockdown of one 20-nt rRF3 induced the cell apoptosis and inhibited the cell proliferation. In addition, the RNAi knockdown resulted in a significant decrease of H1299 cells in the G2 phase of the cell cycle. These results indicated the rRF5 and rRF3 series were not random intermediates or products during rRNA degradation, but could constitute a new class of small RNAs that deserves further investigation.	[Chen, Ze] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Sun, Yu; Niu, Xiaoran; Bu, Wenjun; Gao, Shan] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Yang, Xiaojun] Southwest Forestry Univ, Fac Ecotourism, Kunming, Yunnan, Peoples R China; [Wu, Zhenfeng] Nankai Univ, Sch Math Sci, Tianjin, Peoples R China; [Wang, Qingsong] Tianjin Med Univ, Tianjin Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Gao, Shan] Nankai Univ, Inst Stat, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Nankai University; Southwest Forestry University - China; Nankai University; Tianjin Medical University; Nankai University	Bu, WJ; Gao, S (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.; Gao, S (corresponding author), Nankai Univ, Inst Stat, Tianjin, Peoples R China.	wenjunbu@nankai.edu.cn; gao_shan@mail.nankai.edu.cn	Guo, Kai-Fei/ABG-2655-2021	Guo, Kai-Fei/0000-0001-8118-0012; Sun, Yu/0000-0003-4269-7187; , Ze/0000-0001-8236-5764; Gao, Shan/0000-0002-8919-1338	Fundamental Research Funds for the Central Universities (for Nankai University); National Natural Science Foundation of China [31471967, 31260106]; Natural Science Foundation of China [81472052]	Fundamental Research Funds for the Central Universities (for Nankai University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Fundamental Research Funds for the Central Universities (for Nankai University) to Shan Gao, National Natural Science Foundation of China (31471967) to Ze Chen, National Natural Science Foundation of China (31260106) to Xiaojun Yang, and Natural Science Foundation of China (81472052) to Qingsong Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cao QH, 2016, TROP PLANT BIOL, V9, P63, DOI 10.1007/s12042-016-9162-7; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Gao S., 2014, P INT WINTER WORKSHO, P1, DOI DOI 10.3780/J.ISSN.1000-758X.2014.01.009; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lodish H, 2000, MOL CELL BIOL, V4, P120; Mi Zhang, 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P44, DOI 10.1109/BIBM.2014.6999309; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; REDDY R, 1981, J BIOL CHEM, V256, P8452; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wang F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2596782; Wang YZ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7020007; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2	18	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176458	10.1371/journal.pone.0176458	http://dx.doi.org/10.1371/journal.pone.0176458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441451	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800058
J	Shimozuru, M; Yamanaka, M; Nakanishi, M; Moriwaki, J; Mori, F; Tsujino, M; Shirane, Y; Ishinazaka, T; Kasai, S; Nose, T; Masuda, Y; Tsubota, T				Shimozuru, Michito; Yamanaka, Masami; Nakanishi, Masanao; Moriwaki, Jun; Mori, Fumihiko; Tsujino, Masakatsu; Shirane, Yuri; Ishinazaka, Tsuyoshi; Kasai, Shinsuke; Nose, Takane; Masuda, Yasushi; Tsubota, Toshio			Reproductive parameters and cub survival of brown bears in the Rusha area of the Shiretoko Peninsula, Hokkaido, Japan	PLOS ONE			English	Article							GRIZZLY BEARS; BLACK BEAR; EASTERN HOKKAIDO; NATIONAL-PARK; URSUS-ARCTOS; POPULATION; INFANTICIDE; IDENTIFICATION; CONSERVATION; DEMOGRAPHICS	servation and management of wildlife. In this study, we investigated the demographic parameters, including age of primiparity, litter size, inter-birth interval, reproductive rate, and cub survival rate, of Hokkaido brown bears (Ursus arctos yesoensis) in the Rusha area on the Shiretoko Peninsula, Hokkaido, Japan, based on a long-term, individual-based monitoring survey. A total of 15 philopatric females were observed nearly every year from 2006 to 2016, and these observations were used to estimate reproductive parameters. The mean age of primiparity was 5.3 +/- 0.2 (SE) years (n = 7, 95% CI = 5.0-5.6). We observed 81 cubs in 46 litters from 15 bears. Litter size ranged from one to three cubs, and averaged 1.76 +/- 0.08 (SE) cubs/litter (95% CI = 1.61-1.91). Inter-birth intervals ranged from 1 to 4 years, and the mean value was estimated as 2.43 (95% CI = 2.16-2.76) and 2.53 (95% CI = 2.26-2.85) years in all litters and in litters that survived at least their first year, respectively. The reproductive rate was estimated from 0.70 to 0.76 young born/year/reproductive adult female, depending on the method of calculation. The cub survival rate between 0.5 and 1.5 years ranged from 60 to 73%. Most cub disappearances occurred in July and August, suggesting that cub mortality is mainly due to poor nutrition in the summer. All reproductive parameters observed in the Rusha area on the Shiretoko Peninsula fell within the range reported in Europe and North America, and were among the lowest or shortest age of primiparity, litter size, and inter-birth intervals, and ranked at a high level for reproductive rate.	[Shimozuru, Michito; Moriwaki, Jun; Mori, Fumihiko; Tsujino, Masakatsu; Shirane, Yuri; Tsubota, Toshio] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan; [Yamanaka, Masami] Shiretoko Museum, Shari, Japan; [Nakanishi, Masanao; Ishinazaka, Tsuyoshi; Kasai, Shinsuke; Nose, Takane; Masuda, Yasushi] Shiretoko Nat Fdn, Shari, Japan	Hokkaido University	Shimozuru, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan.	shimozuru@vetmed.hokudai.ac.jp			Mitsui & Co., Ltd. Environment Fund [R14-0026]; Daikin Industries, Ltd.	Mitsui & Co., Ltd. Environment Fund; Daikin Industries, Ltd.	This study was funded by The Mitsui & Co., Ltd. Environment Fund (MS received the funding, grant No. R14-0026, https://www.mitsui.com/jp/en/csr/contribution/environment/fund/index.html) and Daikin Industries, Ltd. (http://www.daikin.co.jp/csr/shiretoko/). The funders had no role in study design, data collection and analysis,	Bunnell FL, 1981, DYNAMICS LARGE MAMMA, P78; Clapham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035404; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; CRAIGHEAD JJ, 1976, INT C BEAR RES MAN, V3, P337; Dahle B, 2003, J MAMMAL, V84, P536, DOI 10.1644/1545-1542(2003)084<0536:FBIBBA>2.0.CO;2; EILER JH, 1989, J WILDLIFE MANAGE, V53, P353, DOI 10.2307/3801137; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Gardner CL, 2014, URSUS, V25, P121, DOI 10.2192/URSUS-D-14-00015.1; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Garshelis DL, 1998, URSUS-SERIES, V10, P437; Higashide D, 2012, J ZOOL, V288, P199, DOI 10.1111/j.1469-7998.2012.00942.x; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hokkaido Government, 2017, BROWN BEAR MAN PLAN; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Itoh T, 2013, ACTA THERIOL, V58, P127, DOI 10.1007/s13364-012-0095-8; Itoh T, 2009, J FOREST RES-JPN, V14, P117, DOI 10.1007/s10310-009-0110-3; King TR, 1944, J AGRIC RES, V69, P0033; Kohira M., 2006, WILDLIFE SHIRETOKO Y, P238; Kohira M, 2010, URSUS, V21, P192, DOI 10.2192/09SC030.1; Kohira M, 2009, URSUS, V20, P12, DOI 10.2192/1537-6176-20.1.12; Lopez-Alfaro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128088; Mano T, 2002, J MAMMAL, V83, P1026, DOI 10.1644/1545-1542(2002)083<1026:RCOBBO>2.0.CO;2; MCLELLAN B, 1994, INT BEAR MS, P15; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1865, DOI 10.1139/z89-266; McLellan BN, 2015, J WILDLIFE MANAGE, V79, P749, DOI 10.1002/jwmg.896; Miller SD, 1988, IMPACTS INCREASED HU; Miller Sterling D., 2003, Ursus (Knoxville), V14, P130; Moriwaki J, 2016, URSUS, V27, P99, DOI 10.2192/URSUS-D-16-00005.1; Nawaz MA, 2008, BIOL CONSERV, V141, P2230, DOI 10.1016/j.biocon.2008.06.012; Odden M, 2014, OECOLOGIA, V175, P1, DOI 10.1007/s00442-014-2892-z; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rogers L., 1976, 41 N AM WILDL NAT RE; Saether BE, 1998, OIKOS, V83, P403, DOI 10.2307/3546856; Sato Yoshikazu, 2004, Mammal Study, V29, P47, DOI 10.3106/mammalstudy.29.47; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Sellers R.A., 1994, INT C BEAR RES MANAG, V9, P283, DOI [10.2307/3872712, DOI 10.2307/3872712]; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Steyaert SMJG, 2012, MAMMAL REV, V42, P12, DOI 10.1111/j.1365-2907.2011.00184.x; Stringham S. F., 1980, INT C BEAR RES MANAG, V4, P337; Stringham SF, 1990, BEARS THEIR BIOL MAN, V8, P433, DOI DOI 10.2307/3872948; Swenson JE, 2001, URSUS-SERIES, V12, P69; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; TSUBOTA T, 1990, INT C BEAR, V8, P125; Tsubota T, 1991, WILDLIFE CONSERVATIO, P214; Tsubota Toshio, 1993, Journal of Reproduction and Development, V39, P325, DOI 10.1262/jrd.39.325; Yamamoto K, 2002, J VET MED SCI, V64, P505, DOI 10.1292/jvms.64.505; Yokoyama Y, 2010, NIPPON SUISAN GAKK, V76, P383, DOI 10.2331/suisan.76.383; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005; Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8	53	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176251	10.1371/journal.pone.0176251	http://dx.doi.org/10.1371/journal.pone.0176251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441423	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800037
J	Dhiman, SS; Zhao, X; Li, JL; Kim, D; Kalia, VC; Kim, IW; Kim, JY; Lee, JK				Dhiman, Saurabh Sudha; Zhao, Xin; Li, Jinglin; Kim, Dongwook; Kalia, Vipin C.; Kim, In-Won; Kim, Jae Young; Lee, Jung-Kul			Metal accumulation by sunflower (Helianthus annuus L.) and the efficacy of its biomass in enzymatic saccharification	PLOS ONE			English	Article							ETHANOL-PRODUCTION; SUGAR YIELDS; HYDROLYSIS; PHYTOREMEDIATION; LIGNOCELLULASES; DETOXIFICATION; PRETREATMENT; STALKS; ACID; PHYTOEXTRACTION	Accumulation of metal contaminants in soil as a result of various industrial and anthropogenic activities has reduced soil fertility significantly. Phytoextraction of metal contaminants can improve soil fertility and provide inexpensive feedstock for biorefineries. We investigated the hyperaccumulation capacity of sunflower (Helianthus annuus) biomass by cultivating these plants in various concentrations of metal contaminants. Sunflowers were grown in soils contaminated with various levels of heavy metals (10-2,000 mg/kg dry soil). The degree of metal uptake by different parts of the biomass and the residual concentration in the soil were estimated through inductively coupled plasma mass spectrometry. An almost 2.5-fold hyperaccumulation of Zn2+ was observed in the leaf and flower biomass compared with the concentration in the soil. For the subsequent saccharification of biomass with hyperaccumulated contaminants, a fungal lignocellulosic consortium was used. The fungal consortium cocktail retained more than 95% filter paper activity with 100 mM Ni2+ ions even after 36 h. The highest saccharification yield (SY, 87.4%) was observed with Ni2+ as the contaminant (10 mg/kg dry wt), whereas Pb2+ (251.9 mg/kg dry wt) was the strongest inhibitor of biomass hydrolysis, resulting in only a 30% SY. Importantly, the enzyme cocktail produced by the fungal consortium resulted in almost the same SY (%) as that obtained from a combination of commercial cellulase and beta-glucosidase. Significant sugar conversion (61.7%) from H. annuus biomass hydrolysate occurred, resulting in the production of 11.4 g/L of bioethanol. This is the first study to assess the suitability of phytoremediated sunflower biomass for bioethanol production.	[Dhiman, Saurabh Sudha; Li, Jinglin; Kim, In-Won; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul, South Korea; [Zhao, Xin; Kim, Jae Young] Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea; [Kim, Dongwook] Phygen, Daejeon, South Korea; [Kalia, Vipin C.] Delhi Univ Campus, CSIR, IGIB, Mall Rd, Delhi, India	Konkuk University; Seoul National University (SNU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kim, IW; Lee, JK (corresponding author), Konkuk Univ, Dept Chem Engn, Seoul, South Korea.; Kim, JY (corresponding author), Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea.	inwon@konkuk.ac.kr; jaeykim@snu.ac.kr; jkrhee@konkuk.ac.kr	Lee, Jungkukl/D-9104-2011	Zhao, Xin/0000-0002-9580-5092; Dhiman, Saurabh/0000-0001-8727-2946	Korea Ministry of Environment as GAIA Project [G112-00055-0023-0]; Energy Efficiency & Resources Core Technology Program of the KETEP [20153010092130, 20153030091450]	Korea Ministry of Environment as GAIA Project(Ministry of Environment (ME), Republic of Korea); Energy Efficiency & Resources Core Technology Program of the KETEP	This research was supported by Korea Ministry of Environment as GAIA Project (G112-00055-0023-0). This study was also supported by the Energy Efficiency & Resources Core Technology Program of the KETEP (20153010092130 and 20153030091450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesodun JK, 2010, WATER AIR SOIL POLL, V207, P195, DOI 10.1007/s11270-009-0128-3; Alkorta I., 2004, Reviews in Environmental Science and Bio/Technology, V3, P71, DOI 10.1023/B:RESB.0000040059.70899.3d; Amna, 2015, INT J PHYTOREMEDIAT, V17, P981, DOI 10.1080/15226514.2014.989311; An J, 2012, J HAZARD MATER, V203, P69, DOI 10.1016/j.jhazmat.2011.11.085; [Anonymous], 1992, J AM OIL CHEM SOC, V69, P890; Camargo D, 2014, BIOPROC BIOSYST ENG, V37, P2235, DOI 10.1007/s00449-014-1201-x; Cantarella M, 2004, PROCESS BIOCHEM, V39, P1533, DOI 10.1016/S0032-9592(03)00285-1; Chandel AK, 2007, BIORESOURCE TECHNOL, V98, P1947, DOI 10.1016/j.biortech.2006.07.047; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Dhiman SS, 2016, FUEL, V183, P107, DOI 10.1016/j.fuel.2016.06.025; Dhiman SS, 2015, BIORESOURCE TECHNOL, V179, P50, DOI 10.1016/j.biortech.2014.11.059; Dhiman SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102581; Dhiman SS, 2013, APPL MICROBIOL BIOT, V97, P1081, DOI 10.1007/s00253-012-4381-9; Gaur R, 2015, INT J POLYM SCI, V2015, DOI 10.1155/2015/986324; Guo B, 2007, ENVIRON POLLUT, V147, P743, DOI 10.1016/j.envpol.2006.09.007; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Jagtap SS, 2013, BIORESOURCE TECHNOL, V133, P307, DOI 10.1016/j.biortech.2013.01.118; Jagtap SS, 2012, BIORESOURCE TECHNOL, V120, P264, DOI 10.1016/j.biortech.2012.06.002; Jeya M, 2012, BIORESOURCE TECHNOL, V117, P310, DOI 10.1016/j.biortech.2012.03.047; Jung CD, 2013, BIORESOURCE TECHNOL, V138, P1, DOI 10.1016/j.biortech.2013.03.033; Jurado M, 2009, BIORESOURCE TECHNOL, V100, P6378, DOI 10.1016/j.biortech.2009.07.049; Krgovic R, 2015, ENVIRON SCI POLLUT R, V22, P10506, DOI 10.1007/s11356-015-4192-5; Lin CC, 2009, ENVIRON EXP BOT, V65, P410, DOI 10.1016/j.envexpbot.2008.12.003; Liu DZ, 2007, J ANTIBIOT, V60, P332, DOI 10.1038/ja.2007.44; Lopes CA, 2015, ECOTOX ENVIRON SAFE, V119, P170, DOI 10.1016/j.ecoenv.2015.05.016; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Pilanee Vaithanomsat SC, 2009, ENG TECHNOLOGY, V3, P4; Ramachandran P, 2015, BIOPROC BIOSYST ENG, V38, P1645, DOI 10.1007/s00449-015-1406-7; Ruiz E, 2008, ENZYME MICROB TECH, V42, P160, DOI 10.1016/j.enzmictec.2007.09.002; Ruiz E, 2006, APPL BIOCHEM BIOTECH, V130, P631, DOI 10.1385/ABAB:130:1:631; Sharma SK, 2004, BIOMASS BIOENERG, V27, P399, DOI 10.1016/j.biombioe.2004.03.005; Sharma SK, 2002, BIOMASS BIOENERG, V23, P237, DOI 10.1016/S0961-9534(02)00050-8; Singleton V L, 1969, Adv Food Res Suppl, V1, P1; Sluiter A, 2008, DETERMINATION STRUCT, DOI DOI 10.3390/POLYM2040728; Tandjung AS, 2005, BIOMACROMOLECULES, V6, P1654, DOI 10.1021/bm049220l; Taniguchi M, 2005, J BIOSCI BIOENG, V100, P637, DOI 10.1263/jbb.100.637; Tejirian A, 2010, APPL ENVIRON MICROB, V76, P7673, DOI 10.1128/AEM.01376-10; Turgut C, 2004, ENVIRON POLLUT, V131, P147, DOI 10.1016/j.envpol.2004.01.017; Ullah R, 2011, AFR J BIOTECHNOL, V10, P17192, DOI 10.5897/AJB11.1832; Valls C, 2010, J HAZARD MATER, V177, P586, DOI 10.1016/j.jhazmat.2009.12.073; van der Ent A, 2015, J CHEM ECOL, V41, P396, DOI 10.1007/s10886-015-0573-y; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Vintila T, 2016, J CHEM TECHNOL BIOT, V91, P1607, DOI 10.1002/jctb.4902; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Zeng Rong, 2016, Bioengineering-Basel, V3, P13, DOI 10.3390/bioengineering3020013	45	25	26	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175845	10.1371/journal.pone.0175845	http://dx.doi.org/10.1371/journal.pone.0175845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437478	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600015
J	Cho, SY; Na, W; Lee, SW; Cho, MC; Oh, JJ; Lee, S; Park, J; Ahn, S; Jeong, CW				Cho, Sung Yong; Na, Woong; Lee, Sang Wook; Cho, Min Chul; Oh, Jong Jin; Lee, Sangchul; Park, Juhyun; Ahn, Soyeon; Jeong, Chang Wook			Medical expulsive therapy for ureter stone using naftopidil: A multicenter, randomized, double-blind, and placebo-controlled trial	PLOS ONE			English	Article							ALPHA-BLOCKERS; FACILITATE; METAANALYSIS; TAMSULOSIN; PASSAGE; CALCULI	Objectives A prospective, multicenter, randomized, double-blind, placebo-controlled trial evaluated the effects of naftopidil 75 mg for medical expulsive therapy for a single ureter stone. Materials and methods Patients diagnosed with a ureter stone were prescribed aceclofenac 100 mg or a combined medication of tramadol 37.5 mg and acetaminophen 325 mg. Patients then randomly received either naftopidil 75 mg or placebo. Primary endpoint was the stone passage rate at 14 days after medication. Results The 150 patients enrolled in 6 institutions randomly received either naftopidil (n = 75) or placebo (n = 75). The percentages of ureter stone passed spontaneously 14 days after medication was 60.9% in the naftopidil group and 53.3% in the placebo group. Stone-free rates and the total use of analgesics showed no significant differences between the two groups. Stone-free rates at 14 days after medication were decreased when maximal stone size was increased: 39.4% (>= 5 mm), 15.5% (>= 6 mm), and 7.0% (>= 7 mm). Conclusions The use of naftopidil 75 mg once daily was not effective in increasing spontaneous stone passage rates or reducing analgesic use. The maximal stone size < 6 mm and the follow-up for two weeks would be appropriate for applying medical expulsive therapy to patients with a single ureter stone.	[Cho, Sung Yong; Cho, Min Chul; Park, Juhyun] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Urol, Boramae Med Ctr, Seoul, South Korea; [Na, Woong] Natl Med Ctr, Dept Urol, Seoul, South Korea; [Lee, Sang Wook] Kangwon Natl Univ, Sch Med, Dept Urol, Clin Res Inst,Kangwon Natl Univ Hosp, Chunchon, South Korea; [Oh, Jong Jin; Lee, Sangchul] Seoul Natl Univ, Dept Urol, Bundang Hosp, Seongnam, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Med Res Collaborat Ctr, Bundang Hosp, Seongnam, South Korea; [Jeong, Chang Wook] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jeong, CW (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	drboss@gmail.com	CHO, MIN CHUL/R-7835-2019; 나, 웅/GQA-7496-2022	Cho, Sung Yong/0000-0001-9271-6951				Bos D, 2014, CUAJ-CAN UROL ASSOC, V8, P442, DOI 10.5489/cuaj.2472; Fan B, 2013, INT J UROL, V20, P818, DOI 10.1111/iju.12048; Kohjimoto Y, 2015, WORLD J UROL, V33, P2125, DOI 10.1007/s00345-015-1556-x; Lee SW, 2014, INT J CLIN PRACT, V68, P216, DOI 10.1111/ijcp.12271; Lee SR, 2012, UROLOGY, V80, P784, DOI 10.1016/j.urology.2012.06.032; Liu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134589; MORITA T, 1994, NEUROUROL URODYNAM, V13, P315, DOI 10.1002/1520-6777(1994)13:3<315::AID-NAU1930130313>3.0.CO;2-G; Ramello A, 2000, J NEPHROL, V13, pS45; Sahin C, 2015, UROLITHIASIS, V43, P271, DOI 10.1007/s00240-015-0762-8; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Singh A, 2007, ANN EMERG MED, V50, P552, DOI 10.1016/j.annemergmed.2007.05.015; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Turk C, 2016, EAU GUIDELINES UROLI; Zhu YF, 2010, BJU INT, V106, P256, DOI 10.1111/j.1464-410X.2009.09014.x	14	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174962	10.1371/journal.pone.0174962	http://dx.doi.org/10.1371/journal.pone.0174962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430785	Green Submitted, gold, Green Published			2022-12-27	WOS:000399876100010
J	Oke, TA; Hager, HA				Oke, Tobi A.; Hager, Heather A.			Assessing environmental attributes and effects of climate change on Sphagnum peatland distributions in North America using single- and multi-species models	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; DOMINATED PEATLANDS; WATER-BALANCE; CARBON ACCUMULATION; DECOMPOSITION; PHOTOSYNTHESIS; DYNAMICS; PATTERNS; MAXIMUM; GROWTH	The fate of Northern peatlands under climate change is important because of their contribution to global carbon (C) storage. Peatlands are maintained via greater plant productivity (especially of Sphagnum species) than decomposition, and the processes involved are strongly mediated by climate. Although some studies predict that warming will relax constraints on decomposition, leading to decreased C sequestration, others predict increases in productivity and thus increases in C sequestration. We explored the lack of congruence between these predictions using single-species and integrated species distribution models as proxies for understanding the environmental correlates of North American Sphagnum peatland occurrence and how projected changes to the environment might influence these peatlands under climate change. Using Maximum entropy and BIOMOD modelling platforms, we generated single and integrated species distribution models for four common Sphagnum species in North America under current climate and a 2050 climate scenario projected by three general circulation models. We evaluated the environmental correlates of the models and explored the disparities in niche breadth, niche overlap, and climate suitability among current and future models. The models consistently show that Sphagnum peatland distribution is influenced by the balance between soil moisture deficit and temperature of the driest quarter-year. The models identify the east and west coasts of North America as the core climate space for Sphagnum peatland distribution. The models show that, at least in the immediate future, the area of suitable climate for Sphagnum peatland could expand. This result suggests that projected warming would be balanced effectively by the anticipated increase in precipitation, which would increase Sphagnum productivity.	[Oke, Tobi A.; Hager, Heather A.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada	University of Guelph	Oke, TA (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.	ooke@uoguelph.ca	Hager, Heather/A-2984-2014	Hager, Heather/0000-0002-0066-6844				Aerts R, 1999, ECOLOGY, V80, P2170, DOI 10.1890/0012-9658(1999)080[2170:PMCONC]2.0.CO;2; ANDRUS RE, 1986, CAN J BOT, V64, P416, DOI 10.1139/b86-057; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; Charman D., 2002, Peatlands and environmental change; Charman DJ, 2013, BIOGEOSCIENCES, V10, P929, DOI 10.5194/bg-10-929-2013; Charman DJ, 2007, HOLOCENE, V17, P217, DOI 10.1177/0959683607075836; Charman DJ, 2015, QUATERNARY SCI REV, V121, P110, DOI 10.1016/j.quascirev.2015.05.012; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elumeeva TG, 2011, J VEG SCI, V22, P152, DOI 10.1111/j.1654-1103.2010.01237.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Freeman C, 2004, SOIL BIOL BIOCHEM, V36, P1663, DOI 10.1016/j.soilbio.2004.07.012; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Frolking S, 2010, EARTH SYST DYNAM, V1, P1, DOI 10.5194/esd-1-1-2010; Gajewski K, 2001, GLOBAL BIOGEOCHEM CY, V15, P297, DOI 10.1029/2000GB001286; Gignac L, 1993, ADV BRYOLOGY, V5, P187; Gignac LD, 2000, J BIOGEOGR, V27, P1139, DOI 10.1046/j.1365-2699.2000.00458.x; GLIME JM, 1982, AM MIDL NAT, V108, P209, DOI 10.2307/2425482; Gorham E, 2007, QUATERNARY SCI REV, V26, P300, DOI 10.1016/j.quascirev.2006.08.008; Gunnarsson U, 2005, J BRYOL, V27, P269, DOI 10.1179/174328205X70029; Hager HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100032; Hajek T, 2008, ANN BOT-LONDON, V101, P165, DOI 10.1093/aob/mcm287; Hajkova P, 2007, J BRYOL, V29, P18, DOI 10.1179/174328207X160577; Halsey L, 1997, WETLANDS, V17, P243, DOI 10.1007/BF03161413; Halsey LA, 2000, BRYOLOGIST, V103, P334, DOI 10.1639/0007-2745(2000)103[0334:SDPINA]2.0.CO;2; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hayward, 1982, BRYOPHYTE ECOLOGY, P229, DOI DOI 10.1007/978-94-009-5891-3_8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ise T, 2008, NAT GEOSCI, V1, P763, DOI 10.1038/ngeo331; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lang SI, 2009, J ECOL, V97, P299, DOI 10.1111/j.1365-2745.2008.01472.x; Lavoie M, 2004, ENVIRON REV, V13, P21; LI YH, 1991, CAN J BOT, V69, P2643, DOI 10.1139/b91-331; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Loisel J, 2012, BIOGEOSCIENCES, V9, P2737, DOI 10.5194/bg-9-2737-2012; Loisel J., 2012, Biogeosciences, V9, P2737, DOI 10.5194/bg-9-2737-2012; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Oke OA, 2014, ECOGRAPHY, V37, P614, DOI 10.1111/j.1600-0587.2013.00459.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Platts PJ, 2013, ECOGRAPHY, V36, P518, DOI 10.1111/j.1600-0587.2012.07805.x; Rasmussen S., 1994, ACTA HORTIC, P243; ROCHEFORT L, 1990, ECOLOGY, V71, P1986, DOI 10.2307/1937607; Rydin H, 2006; Rydin Hakan, 2006, V188, P47; Schipperges B, 1998, NEW PHYTOL, V140, P677, DOI 10.1046/j.1469-8137.1998.00311.x; Skrzypek G, 2008, GEOCHEM J, V42, P481, DOI 10.2343/geochemj.42.481; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W., 2014, PACKAGE BIOMOD2 ENSE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; TITUS JE, 1984, ECOLOGY, V65, P1765, DOI 10.2307/1937772; TITUS JE, 1983, ECOLOGY, V64, P1109, DOI 10.2307/1937821; Trabucco A, 2008, AGR ECOSYST ENVIRON, V126, P81, DOI 10.1016/j.agee.2008.01.015; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Vitt DH, 2000, CAN J EARTH SCI, V37, P683, DOI 10.1139/e99-097; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Yu ZC, 2009, GEOPHYS MONOGR SER, V184, P55, DOI 10.1029/2008GM000822; Zoltai SC, 1996, NATO ASI SER SER I, V40, P47	67	17	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175978	10.1371/journal.pone.0175978	http://dx.doi.org/10.1371/journal.pone.0175978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426754	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900080
J	Sterbenc, A; Hosnjak, L; Chouhy, D; Bolatti, EM; Ostrbenk, A; Seme, K; Kocjan, BJ; Luzar, B; Giri, AA; Poljak, M				Sterbenc, Anja; Hosnjak, Lea; Chouhy, Diego; Bolatti, Elisa M.; Ostrbenk, Anja; Seme, Katja; Kocjan, Bostjan J.; Luzar, Bostjan; Giri, Adriana A.; Poljak, Mario			Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; GAMMAPAPILLOMAVIRUS GENERA; VIRAL REPLICATION; CUTANEOUS WARTS; CELL CARCINOMA; NORMAL SKIN; DNA; PROTEIN; INFECTION; E1	HPV204 is the only newly identified Mupapillomavirus (Mu-PV) type in more than a decade. To comprehensively characterize HPV204, we performed a detailed molecular analysis of the viral genome and evaluated its clinical relevance in comparison to the other Mu-PVs, HPV1 and HPV63. The 7,227-bp long genome of HPV204 exhibits typical genomic organization of Mu-PVs with eight open reading frames (ORFs) (E6, E7, E1, E2, E8, E4, L2, and L1). We developed three type-specific quantitative real-time PCRs and used them to test a representative collection (n = 1,006) of various HPV-associated benign and malignant neoplasms, as well as samples of clinically normal cutaneous, mucosal, and mucocutaneous origins. HPV204, HPV1, and HPV63 were detected in 1.1%, 2.7%, and 1.9% of samples tested, respectively, and were present in skin and mucosa, suggesting dual tissue tropism of all Mu-PVs. To evaluate the etiological role of Mu-PVs in the development of HPV-associated neoplasms, Mu-PV viral loads per single cell were estimated. HPV1 and HPV63 were present in high viral copy numbers in 3/43 and 1/43 cutaneous warts, respectively, and were identified as the most likely causative agents of these warts. HPV204 viral load was extremely low in a single HPV204-positive cutaneous wart (7.4 x 10(-7) viral copies/cell). Hence, etiological association between HPV204 and the development of cutaneous warts could not be established. To the best of our knowledge, this is the first study to evaluate the genetic variability of Mu-PVs by sequencing complete LCR genomic regions of HPV204, HPV1, and HPV63. We detected several nucleotide substitutions and deletions within the LCR genomic regions of Mu-PVs and identified two genetic variants of HPV204 and HPV63 and five genetic variants of HPV1.	[Sterbenc, Anja; Hosnjak, Lea; Ostrbenk, Anja; Seme, Katja; Kocjan, Bostjan J.; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Chouhy, Diego; Bolatti, Elisa M.; Giri, Adriana A.] Rosario Natl Univ, Sch Biochem & Pharmaceut Sci, Virol Area, Rosario, Santa Fe, Argentina; [Luzar, Bostjan] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia	University of Ljubljana; National University of Rosario; University of Ljubljana	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si	Luzar, Bostjan/ACR-4860-2022; Bolatti, Elisa/AAH-7486-2021; Giri, Adriana/GLU-6290-2022; luzar, bostjan/AGY-8991-2022	luzar, bostjan/0000-0003-2534-8671; Bolatti, Elisa/0000-0001-6467-0650	Slovenian Research Agency (ARRS); Slovenian-Argentinian Bilateral Project [BI-AR-15-17-005]; CoheaHr Project (European Commission FP7 Program) [603019]; Young Researcher Training Program	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian-Argentinian Bilateral Project; CoheaHr Project (European Commission FP7 Program); Young Researcher Training Program	This study is a result of doctoral research and is financially supported by the Slovenian Research Agency (ARRS), which funded AS through the Young Researcher Training Program, and in part by the Slovenian-Argentinian Bilateral Project BI-AR-15-17-005. In addition, LH, AO, and MP obtained funding through the CoheaHr Project (European Commission FP7 Program, grant number: 603019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2005, J CLIN VIROL, V32, pS1, DOI 10.1016/j.jcv.2004.10.021; Bolatti EM, 2016, INFECT GENET EVOL, V42, P20, DOI 10.1016/j.meegid.2016.04.018; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Bruggink SC, 2012, J CLIN VIROL, V55, P250, DOI 10.1016/j.jcv.2012.07.014; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; Chen G, 2002, MOL CELL BIOL, V22, P7712, DOI 10.1128/MCB.22.21.7712-7720.2002; Chouhy D, 2010, VIROLOGY, V397, P205, DOI 10.1016/j.virol.2009.11.020; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; DANOS O, 1980, EUR J BIOCHEM, V109, P457, DOI 10.1111/j.1432-1033.1980.tb04815.x; DANOS O, 1982, EMBO J, V1, P231, DOI 10.1002/j.1460-2075.1982.tb01152.x; Daugaard I, 2015, EXP MOL PATHOL, V99, P632, DOI 10.1016/j.yexmp.2015.11.007; de Koning MNC, 2015, BRIT J DERMATOL, V172, P196, DOI 10.1111/bjd.13216; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Deng WT, 2004, J VIROL, V78, P13954, DOI 10.1128/JVI.78.24.13954-13965.2004; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Dreer M, 2017, VIRUS RES, V231, P96, DOI 10.1016/j.virusres.2016.11.005; Dreer M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005556; EGAWA K, 1993, VIROLOGY, V194, P789, DOI 10.1006/viro.1993.1320; Egawa K, 2005, BRIT J DERMATOL, V152, P993, DOI 10.1111/j.1365-2133.2005.06390.x; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Favre M, 1998, J INVEST DERMATOL, V110, P311, DOI 10.1046/j.1523-1747.1998.00164.x; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Fradet-Turcotte A, 2010, J VIROL, V84, P11747, DOI 10.1128/JVI.01445-10; Hawkins MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-137; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; HEILMAN CA, 1980, J VIROL, V36, P395, DOI 10.1128/JVI.36.2.395-407.1980; Hosnjak L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119154; Iannacone MR, 2013, J INVEST DERMATOL, V133, P1512, DOI 10.1038/jid.2012.478; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kalantari M, 2009, VIROLOGY, V390, P261, DOI 10.1016/j.virol.2009.05.006; Kocjan BJ, 2015, CLIN MICROBIOL INFEC, V21, P808, DOI 10.1016/j.cmi.2015.05.011; Kocjan BJ, 2015, ACTA DERMATOVEN ALP, V24, P21, DOI 10.15570/actaapa.2015.7; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Lacey CJN, 2005, J CLIN VIROL, V32, pS82, DOI 10.1016/j.jcv.2004.10.020; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lipari F, 2001, BIOCHEMISTRY-US, V40, P1196, DOI 10.1021/bi001837+; Liu ZJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0583-6; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mischo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062584; Mlakar J, 2015, BRIT J OPHTHALMOL, V99, P431, DOI 10.1136/bjophthalmol-2014-306087; Neale RE, 2013, CANCER EPIDEM BIOMAR, V22, P719, DOI 10.1158/1055-9965.EPI-12-0917-T; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; Ostrbenk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138628; Prescott EL, 2014, J VIROL, V88, P12599, DOI 10.1128/JVI.02029-14; Schneider I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-186; Straub E, 2014, J VIROL, V88, P937, DOI 10.1128/JVI.02296-13; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017	63	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175892	10.1371/journal.pone.0175892	http://dx.doi.org/10.1371/journal.pone.0175892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426749	Green Published, gold			2022-12-27	WOS:000399875900065
J	Alkemade, A; de Hollander, G; Keuken, MC; Schafer, A; Ott, DVM; Schwarz, J; Weise, D; Kotz, SA; Forstmann, BU				Alkemade, Anneke; de Hollander, Gilles; Keuken, Max C.; Schaefer, Andreas; Ott, Derek V. M.; Schwarz, Johannes; Weise, David; Kotz, Sonja A.; Forstmann, Birte U.			Comparison of T-2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; BRAIN IRON; LATERALIZATION; STIMULATION; IMAGES; ACCURACY; AGE	The subthalamic nucleus (STN) plays a crucial role in the surgical treatment of Parkinson's disease (PD). Studies investigating optimal protocols for STN visualization using state of the art magnetic resonance imaging (MRI) techniques have shown that susceptibility weighted images, which display the magnetic susceptibility distribution, yield better results than T-1-weighted, T-2-weighted, and T-2*-weighted contrasts. However, these findings are based on young healthy individuals, and require validation in elderly individuals and persons suffering from PD. Using 7T MRI, the present study set out to investigate which MRI contrasts yielded the best results for STN visualization in 12 PD patients and age-matched healthy controls (HC). We found that STNs were more difficult to delineate in PD as reflected by a lower inter-rater agreement when compared to HCs. No STN size differences were observed between the groups. Analyses of quantitative susceptibility mapping (QSM) images showed a higher inter-rater agreement reflected by increased Dice-coefficients. The location of the center of mass of the STN was not affected by contrast. Overall, contrast-to-noise ratios (CNR) were higher in QSM than in T-2*-weighted images. This can at least partially, explain the higher inter-rater agreement in QSM. The current results indicate that the calculation of QSM contrasts contributes to an improved visualization of the entire STN. We conclude that QSM contrast is the preferred choice for the visualization of the STN in persons with PD as well as in aging HC.	[Alkemade, Anneke; de Hollander, Gilles; Keuken, Max C.; Forstmann, Birte U.] Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands; [Keuken, Max C.; Schaefer, Andreas; Ott, Derek V. M.; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Ott, Derek V. M.] Epilepsy Ctr Berlin Brandenburg, Berlin, Germany; [Schwarz, Johannes] Tech Univ Munich, Klin Haag, Oberbayern, Munich, Germany; [Weise, David] Univ Klin Leipzig, Klin & Poliklin Neurol, Leipzig, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [Forstmann, Birte U.] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Max Planck Society; Technical University of Munich; Leipzig University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Alkemade, A (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands.	jmalkemade@gmail.com	Forstmann, Birte/AAS-8515-2020	Alkemade, Anneke/0000-0002-3234-353X; Keuken, Max/0000-0002-9703-9125	Deutsche Forschungs-Gemeinschaft (DFG) [KO2268/6-1]; Brain Foundation of the Netherlands; Vidi grant from the Netherlands Organisation for Scientific Research (NWO); Starter Grant from the European Research Council	Deutsche Forschungs-Gemeinschaft (DFG)(German Research Foundation (DFG)); Brain Foundation of the Netherlands; Vidi grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starter Grant from the European Research Council	The authors would like to thank Domenica Wilfing and Elizabeth Wladimirow (MTAs 7T Leipzig) for excellent technical assistance and Jana Kynast for support in recruitment. This work was supported financially by Deutsche Forschungs-Gemeinschaft (DFG KO2268/6-1) (SAK), The Brain Foundation of the Netherlands (BUF and AA), a Starter Grant from the European Research Council (BUF), Vidi grant from the Netherlands Organisation for Scientific Research (NWO) (BUF).; This work was supported financially by Deutsche Forschungs-Gemeinschaft (DFG KO2268/6-1) (SAK), The Brain Foundation of the Netherlands (BUF and AA), a Starter Grant from the European Research Council (BUF), Vidi grant from the Netherlands Organisation for Scientific Research (NWO) (BUF).	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Boviatsis EJ, 2010, ACTA NEUROCHIR, V152, P2053, DOI 10.1007/s00701-010-0749-8; Castrioto A, 2014, LANCET NEUROL, V13, P287, DOI 10.1016/S1474-4422(13)70294-1; Chandran AS, AM ASS NEUROLOGICAL, V124, P96; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Dammann P, 2011, ACAD RADIOL, V18, P910, DOI 10.1016/j.acra.2011.02.011; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dormont D, 2004, AM J NEURORADIOL, V25, P1516; Dormont D, 2010, AM J NEURORADIOL, V31, P15, DOI 10.3174/ajnr.A1644; Duchin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037328; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eitan R, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00069; Elolf E, 2007, AM J NEURORADIOL, V28, P1093, DOI 10.3174/ajnr.A0527; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Greenhouse I, 2013, NEUROPSYCHOLOGIA, V51, P1302, DOI 10.1016/j.neuropsychologia.2013.03.008; Haase A, 2011, J Magn Reson, V213, P533, DOI 10.1016/j.jmr.2011.09.021; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Letranc M, 2014, NEUROSURGERY, V74, P615; Liu T, 2013, RADIOLOGY, V269, P216, DOI 10.1148/radiol.13121991; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Massey LA, 2012, NEUROIMAGE, V59, P2035, DOI 10.1016/j.neuroimage.2011.10.016; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Mulder MJ, 2014, BRAIN STRUCT FUNCT, V219, P1239, DOI 10.1007/s00429-013-0561-3; Munhoz RP, 2013, PARKINSONISM RELAT D, V19, P77, DOI 10.1016/j.parkreldis.2012.07.008; Ogg RJ, 1999, MAGN RESON IMAGING, V17, P1141, DOI 10.1016/S0730-725X(99)00017-X; Pereira JLB, 2016, BASAL GANGLIA, V6, P83, DOI 10.1016/j.baga.2016.01.003; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Planting BR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00876; Poletti M, 2013, J CLIN EXP NEUROPSYC, V35, P124, DOI 10.1080/13803395.2012.751966; Rauscher A, 2005, AM J NEURORADIOL, V26, P736; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Ropele S, 2016, NMR BIOMED; Schafer A, 2012, HUM BRAIN MAPP, V33, P2831, DOI 10.1002/hbm.21404; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schweser F, 2016, NMR BIOMED; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Team RC, 2015, J COMPUT GRAPH STAT, V5, P299; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Vertinsky AT, 2009, AM J NEURORADIOL, V30, P1717, DOI 10.3174/ajnr.A1669; Volz S, 2009, NEUROIMAGE, V45, P1135, DOI 10.1016/j.neuroimage.2009.01.018; Waskom M., 2015, SEABORN V0 6 0; Xiao YM, 2012, MAGN RESON IMAGING, V30, P627, DOI 10.1016/j.mri.2012.02.006	49	37	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176130	10.1371/journal.pone.0176130	http://dx.doi.org/10.1371/journal.pone.0176130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423027	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600091
J	Asfaw, H; Laqua, K; Walkowska, AM; Cunningham, F; Martinez-Martinez, MS; Cuevas-Zurita, JC; Ballell-Pages, L; Imming, P				Asfaw, Henok; Laqua, Katja; Walkowska, Anna Maria; Cunningham, Fraser; Santos Martinez-Martinez, Maria; Carlos Cuevas-Zurita, Juan; Ballell-Pages, Lluis; Imming, Peter			Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ANTIMYCOBACTERIAL ACTIVITY; HOST-DEFENSE; TRYPTOPHAN-RICH; ARGININE-RICH; AMINO-ACID; HEXAPEPTIDES; MACROPHAGES; MECHANISMS; GROWTH	Wollamide B is a cationic antimycobacterial cyclohexapeptide that exhibits activity against Mycobacterium bovis (M. bovis) (IC50 of 3.1 mu M). Aiming to define its structural activity relationship (SAR), optimizing potency and pharmacokinetic properties, libraries of analogues were synthesized following a standard Fmoc-based solid phase peptide synthesis approach. The antimycobacterial activities of wollamide B and all the synthesized analogues were tested against Mycobacterium tuberculosis (Mtb) H37Rv. Parallely, in vitro drug metabolism and pharmacokinetic (ADME) profiling was done for the synthesized compounds to evaluate their drug likeness. Among the 25 synthesized wollamides five of them showed potent activities with MICs <= 3.1 mu M and found to be nontoxic against human HepG2 cells up to 100 mu M. The results of the in vitro ADME profiling revealed the remarkable plasma stability and very good aqueous solubility of the class in general while the metabolic stability was found to be moderate to low. Of particular note, compounds 7c (MIC = 1.1 mu M) and 13c (0.6 mu M) that exhibited good balance of antimycobacterial activity vs. optimal pharmacokinetic properties could be used as a new lead for further development.	[Asfaw, Henok; Laqua, Katja; Walkowska, Anna Maria; Imming, Peter] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Salle, Germany; [Cunningham, Fraser; Santos Martinez-Martinez, Maria; Carlos Cuevas-Zurita, Juan; Ballell-Pages, Lluis] GlaxoSmithKline, Dis Developing World, Med Dev Campus, Madrid, Spain; [Cunningham, Fraser] GlaxoSmithKline, GSK Med Res Ctr, Cytokine Chemokine & Complement DPU Immunoinflamm, Stevenage, Herts, England	Martin Luther University Halle Wittenberg; GlaxoSmithKline; GlaxoSmithKline	Imming, P (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Salle, Germany.	peter.immng@pharmazie.uni-halle.de		Ballell, Lluis/0000-0002-3029-1860; Cunningham, Fraser/0000-0001-6436-7555	Tres Cantos Open Lab Foundation, Milton Keynes, Buckinghamshire, United Kingdom. [MK9 1BP]; Deutscher Akademischer Austauschdienst (DAAD), Bonn, Germany [53175];  [TC152]	Tres Cantos Open Lab Foundation, Milton Keynes, Buckinghamshire, United Kingdom.; Deutscher Akademischer Austauschdienst (DAAD), Bonn, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); 	This work was supported by the Tres Cantos Open Lab Foundation, Milton Keynes, Buckinghamshire, MK9 1BP, United Kingdom. Award Number TC152 to PI and the Deutscher Akademischer Austauschdienst (DAAD), 53175 Bonn, Germany, Personal Reference Number: 91540938 to HA. The funders provided support in the form of salaries for authors KL and HA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abedinzadeh M, 2015, J ANTIMICROB CHEMOTH, V70, P1285, DOI 10.1093/jac/dku570; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Biron E, 2008, ANGEW CHEM INT EDIT, V47, P2595, DOI 10.1002/anie.200705797; Cai GP, 2013, J NAT PROD, V76, P2009, DOI 10.1021/np400145u; Carroll James, 2011, Bioeng Bugs, V2, P241, DOI 10.4161/bbug.2.5.16229; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chatterjee J, 2012, NAT PROTOC, V7, P432, DOI 10.1038/nprot.2011.450; Danial M, 2015, ORG BIOMOL CHEM, V13, P2464, DOI 10.1039/c4ob02041c; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Di L, 2003, CURR OPIN CHEM BIOL, V7, P402, DOI 10.1016/S1367-5931(03)00055-3; Donaghy John, 2010, Bioeng Bugs, V1, P437, DOI 10.4161/bbug.1.6.13855; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Garcia A, 2012, EUR J MED CHEM, V49, P1, DOI 10.1016/j.ejmech.2011.12.029; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Gutsmann T, 2016, BBA-BIOMEMBRANES, V1858, P1034, DOI 10.1016/j.bbamem.2016.01.031; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; Jena P, 2011, PEPTIDES, V32, P881, DOI 10.1016/j.peptides.2011.03.002; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; Khalil ZG, 2014, ORG LETT, V16, P5120, DOI 10.1021/ol502472c; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kling A, 2015, SCIENCE, V348, P1106, DOI 10.1126/science.aaa4690; Mamolo MG, 2001, FARMACO, V56, P593; Montaser R, 2011, PHYTOCHEMISTRY, V72, P2068, DOI 10.1016/j.phytochem.2011.07.014; Muller D, 2006, J MED CHEM, V49, P4871, DOI 10.1021/jm060327w; Nagai K, 2012, BIOORG MED CHEM LETT, V22, P7739, DOI 10.1016/j.bmcl.2012.09.069; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okunade AL, 2004, PHYTOCHEMISTRY, V65, P1017, DOI 10.1016/j.phytochem.2004.02.013; Ovadia O, 2011, MOL PHARMACEUT, V8, P479, DOI 10.1021/mp1003306; Padhi A, 2014, TUBERCULOSIS, V94, P363, DOI 10.1016/j.tube.2014.03.011; Pulido D, 2013, ANTIMICROB AGENTS CH, V57, P3797, DOI 10.1128/AAC.00428-13; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sosunov V, 2007, J ANTIMICROB CHEMOTH, V59, P919, DOI 10.1093/jac/dkm053; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; Taira J, 2010, J PEPT SCI, V16, P607, DOI 10.1002/psc.1270; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Teng TS, 2015, CELL PHYSIOL BIOCHEM, V35, P452, DOI 10.1159/000369711; Valko K, 2003, J PHARM SCI-US, V92, P2236, DOI 10.1002/jps.10494; Vongvanich N, 2002, J NAT PROD, V65, P1346, DOI 10.1021/np020055+; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Waring MJ, 2009, BIOORG MED CHEM LETT, V19, P2844, DOI 10.1016/j.bmcl.2009.03.109; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; World Health Organization, 2015, GLOB TUB REP 2015; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zelezetsky I, 2005, BIOCHEM J, V390, P177, DOI 10.1042/BJ20042138	53	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176088	10.1371/journal.pone.0176088	http://dx.doi.org/10.1371/journal.pone.0176088			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423019	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600085
J	Carvajal-Rodriguez, A				Carvajal-Rodriguez, Antonio			HacDivSel: Two new methods (haplotype-based and outlier-based) for the detection of divergent selection in pairs of populations	PLOS ONE			English	Article							POSITIVE SELECTION; LITTORINA-SAXATILIS; LINKAGE DISEQUILIBRIUM; ADAPTIVE PHENOTYPES; LOCAL ADAPTATION; GENOMIC SCANS; GENE FLOW; ASSOCIATION; SWEEPS; MODEL	The detection of genomic regions involved in local adaptation is an important topic in current population genetics. There are several detection strategies available depending on the kind of genetic and demographic information at hand. A common drawback is the high risk of false positives. In this study we introduce two complementary methods for the detection of divergent selection from populations connected by migration. Both methods have been developed with the aim of being robust to false positives. The first method combines haplotype information with inter-population differentiation (F-ST). Evidence of divergent selection is concluded only when both the haplotype pattern and the F-ST value support it. The second method is developed for independently segregating markers i.e. there is no haplotype information. In this case, the power to detect selection is attained by developing a new outlier test based on detecting a bimodal distribution. The test computes the F-ST outliers and then assumes that those of interest would have a different mode. We demonstrate the utility of the two methods through simulations and the analysis of real data. The simulation results showed power ranging from 60-95% in several of the scenarios whilst the false positive rate was controlled below the nominal level. The analysis of real samples consisted of phased data from the HapMap project and unphased data from intertidal marine snail ecotypes. The results illustrate that the proposed methods could be useful for detecting locally adapted polymorphisms. The software HacDivSel implements the methods explained in this manuscript.	[Carvajal-Rodriguez, Antonio] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo, Spain	Universidade de Vigo	Carvajal-Rodriguez, A (corresponding author), Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo, Spain.	acraaj@uvigo.es	, ACR/A-7676-2012	, ACR/0000-0002-6242-3581	Xunta de Galicia (Grupo de Referencia Competitiva) [ED431C2016-037]; Fondos FEDER ("Unha maneira de facer Europa"); Ministerio de Economia y Competitividad [BFU2013-44635-P, CGL2012-3 9861-C02-01, CGL2016-75482-P]	Xunta de Galicia (Grupo de Referencia Competitiva)(Xunta de Galicia); Fondos FEDER ("Unha maneira de facer Europa"); Ministerio de Economia y Competitividad(Spanish Government)	Support was provided by: 1) Xunta de Galicia (Grupo de Referencia Competitiva, ED431C2016-037. Fondos FEDER ("Unha maneira de facer Europa")); 2) Ministerio de Economia y Competitividad (BFU2013-44635-P, CGL2012-3 9861-C02-01 and CGL2016-75482-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Carvajal-Rodriguez A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-223; Carvajal-Rodriguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024700; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Crisci JL, 2013, FRONT GENET, P4; Crisci JL, 2012, J HEREDITY; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; Debarre F, 2015, THE AMERICAN NATURAL; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; DHARMADHIKARI SW, 1989, COMMUN STAT-THEOR M, V18, P3235, DOI 10.1080/03610928908830089; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hollander J, 2015, J EVOLUTION BIOL, V28, P328, DOI 10.1111/jeb.12564; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hussin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-65; Jensen JD, 2016, MOL ECOL, V25, P1, DOI 10.1111/mec.13493; Johannesson K, 2015, EVOLUTIONARY APPL; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1973, GENETICS, V74, P175; Lin K, 2011, GENETICS, V187, P229, DOI 10.1534/genetics.110.122614; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Maksimova N, 2010, J MED GENETICS; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravinet M, 2016, MOL ECOL, V25, P287, DOI 10.1111/mec.13332; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Rivas MJ, 2015, CURR GENOMICS, V16, P203, DOI 10.2174/1389202916666150313230943; Rolan-Alvarez E, 2007, J MOLLUS STUD, V73, P1, DOI 10.1093/mollus/eyl023; Rolan-Alvarez E, 2015, OCEANOGR MAR BIOL, V53, P157; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schubert E, 2014, DATA MIN KNOWL DISC, V28, P190, DOI 10.1007/s10618-012-0300-z; Segarra NG, 2015, AM J MED GENET A, V167, P2902, DOI 10.1002/ajmg.a.37338; Shibata H, 2013, PSYCHIAT GENET, V23, P117, DOI 10.1097/YPG.0b013e32835fe4f1; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sousa VC, 2013, GENETICS, V194, P211, DOI 10.1534/genetics.113.149211; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Thibert-Plante X, 2013, ECOL LETT; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tukey JW, 1977, EXPLORATORY DATA ANA; Vatsiou AI, 2016, MOL ECOL, V25, P89, DOI 10.1111/mec.13360; Vattani A, 2011, DISCRETE COMPUT GEOM, V45, P596, DOI 10.1007/s00454-011-9340-1; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Whitlock MC, 2015, AM NAT, V186, pS1, DOI 10.1086/682933; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Yeaman S, 2015, AM NAT, V186, pS74, DOI 10.1086/682405; Yeaman S, 2011, EVOLUTION, V65, P2123, DOI 10.1111/j.1558-5646.2011.01277.x; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119	64	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175944	10.1371/journal.pone.0175944	http://dx.doi.org/10.1371/journal.pone.0175944			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423003	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600066
J	Gourrier, A; Chadefaux, C; Lemaitre, E; Bellot-Gurlet, L; Reynolds, M; Burghammer, M; Plazanet, M; Boivin, G; Farlay, D; Bunk, O; Reiche, I				Gourrier, Aurelien; Chadefaux, Celine; Lemaitre, Estelle; Bellot-Gurlet, Ludovic; Reynolds, Michael; Burghammer, Manfred; Plazanet, Marie; Boivin, Georges; Farlay, Delphine; Bunk, Oliver; Reiche, Ina			Nanoscale modifications in the early heating stages of bone are heterogeneous at the microstructural scale	PLOS ONE			English	Article							X-RAY-SCATTERING; BURNED BONE; THERMAL-DENATURATION; ARCHAEOLOGICAL BONE; ELECTRON-MICROSCOPY; MINERAL CRYSTALS; ALTERED BONE; COLLAGEN; TEMPERATURE; DIFFRACTION	Nanoscale studies of bone provide key indicators to evidence subtle structural changes that may occur in the biomedical, forensic and archaeological contexts. One specific problem encountered in all those disciplines, for which the identification of nanostructural cues could prove useful, is to properly monitor the effect of heating on bone tissue. In particular, the mechanisms at work at the onset of heating are still relatively unclear. Using a multiscale approach combining Raman microspectroscopy, transmission electron microscopy (TEM), synchrotron quantitative scanning small-angle X-ray scattering imaging (qsSAXSI) and polarized light (PL) microscopy, we investigate the ultrastructure of cortical bovine bone heated at temperatures <300 degrees C, from the molecular to the macroscopic scale. We show that, despite limited changes in crystal structure, the mineral nanoparticles increase in thickness and become strongly disorganized upon heating. Furthermore, while the nanostructure in distinct anatomical quadrants appears to be statistically different, our results demonstrate this stems from the tissue histology, i.e. from the high degree of heterogeneity of the microstructure induced by the complex cellular processes involved in bone tissue formation. From this study, we conclude that the analysis of bone samples based on the structure and organization of the mineral nanocrystals requires performing measurements at the histological level, which is an advantageous feature of qsSAXSI. This is a critical aspect that extends to a much broader range of questions relating to nanoscale investigations of bone, which could also be extended to other classes of nanostructured heterogeneous materials.	[Gourrier, Aurelien; Lemaitre, Estelle; Plazanet, Marie] Univ Grenoble Alpes, Lab Interdisciplinaire Phys LIPHY, Grenoble, France; [Gourrier, Aurelien; Lemaitre, Estelle; Plazanet, Marie] CNRS, LIPHY, Grenoble, France; [Gourrier, Aurelien; Reynolds, Michael; Burghammer, Manfred] European Synchrotron Radiat Facil, Grenoble, France; [Chadefaux, Celine; Reiche, Ina] Univ Paris 06, Sorbonne Univ, Lab Archeol Mol & Struct, UMR CNRS 8220, Paris, France; [Bellot-Gurlet, Ludovic] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, MONARIS Mol Nanoobjets React Interact & Spectrosc, UMR UPMC CNRS 8233, Paris, France; [Boivin, Georges; Farlay, Delphine] INSERM U1033, LYOS, Lyon, France; [Bunk, Oliver] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland; [Reiche, Ina] Staatl Museen Berlin Stiftung Preuss Kulturbes, Rathgen Forschungslabor, Berlin, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Gourrier, A (corresponding author), Univ Grenoble Alpes, Lab Interdisciplinaire Phys LIPHY, Grenoble, France.; Gourrier, A (corresponding author), CNRS, LIPHY, Grenoble, France.	aurelien.gourrier@univ-grenoble-alpes.fr	FARLAY, Delphine/AGF-1234-2022; Reiche, Ina/AAQ-3897-2020; Bunk, Oliver/B-7602-2013; Bellot-Gurlet, Ludovic/G-7132-2012	FARLAY, Delphine/0000-0001-6487-0337; Bunk, Oliver/0000-0001-6563-4053; Bellot-Gurlet, Ludovic/0000-0002-7995-6261; Gourrier, Aurelien/0000-0001-9526-5746	Agence Nationale de la Recherche [ANR-07-JCJC-0149, ANR-13-BS09-0006-03]; Ministere de la Culture et de la Communication; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la Culture et de la Communication; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was financially supported by the Agence Nationale de la Recherche ANR-07-JCJC-0149, 'ArBoCo' (IR) and ANR-13-BS09-0006-03' MULTIPS' (AG). IR, AG and LBG acknowledge financial support from the Ministere de la Culture et de la Communication (Fr) through the Programme National de Recherche sur la Connaissance et la Conservation des materiaux du patrimoine Culturel PNRCC 2010-2011 'OsIRIs'. AG, MP, DF and GB would also like to acknowledge the CNRS for financial support in developing the qsSAXSI method: Defi Instrumentation aux Limites 'qsSAXSI Biomat'.	Asmussen B, 2009, J ARCHAEOL SCI, V36, P528, DOI 10.1016/j.jas.2008.10.005; Bala Y, 2010, BONE, V46, P1204, DOI 10.1016/j.bone.2009.11.032; BOIVIN G, 1990, ACTA ORTHOP SCAND, V61, P170, DOI 10.3109/17453679009006514; BONAR LC, 1970, J ULTRA MOL STRUCT R, V32, P545, DOI 10.1016/S0022-5320(70)80027-2; Bozec L, 2011, BIOPHYS J, V101, P228, DOI 10.1016/j.bpj.2011.04.033; Bunk O, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123016; Chadefaux C, 2009, J NANO RES-SW, V8, P157, DOI 10.4028/www.scientific.net/JNanoR.8.157; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Currey J.D., 2002, BONES STRUCTURE MECH; Duer M, 2013, NAT MATER, V12, P1081, DOI 10.1038/nmat3822; Ellingham STD, 2016, J FORENSIC SCI, V61, P153, DOI 10.1111/1556-4029.12855; Ellingham STD, 2015, SCI JUSTICE, V55, P181, DOI 10.1016/j.scijus.2014.12.002; Enzo S, 2007, J ARCHAEOL SCI, V34, P1731, DOI 10.1016/j.jas.2006.12.011; Etok SE, 2007, J MATER SCI, V42, P9807, DOI 10.1007/s10853-007-1993-z; FRATZL P, 1992, J BONE MINER RES, V7, P329; FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454; Fratzl P, 1996, Connect Tissue Res, V34, P247, DOI 10.3109/03008209609005268; Fratzl P, 1997, J APPL CRYSTALLOGR, V30, P765, DOI 10.1107/S0021889897001775; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Fratzl P, 2005, PROG COLLOID POLYM S, V130, P273; Gadaleta SJ, 1996, CONNECT TISSUE RES, V34, P203, DOI 10.3109/03008209609000699; Goncalves D, 2011, J ARCHAEOL SCI, V38, P1308, DOI 10.1016/j.jas.2011.01.006; Gourrier A, 2007, J APPL CRYSTALLOGR, V40, pS78, DOI 10.1107/S0021889807006693; Gourrier A, 2010, J APPL CRYSTALLOGR, V43, P1385, DOI 10.1107/S0021889810035090; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; HAYASHI T, 1979, BIOCHEMISTRY-US, V18, P4182, DOI 10.1021/bi00586a022; Hiller JC, 2006, J ARCHAEOL SCI, V33, P560, DOI 10.1016/j.jas.2005.09.012; Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; HOLDEN JL, 1995, FORENSIC SCI INT, V74, P29, DOI 10.1016/0379-0738(95)01735-2; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalsbeek N, 2006, STUD CONSERV, V51, P123, DOI 10.1179/sic.2006.51.2.123; Karampas IA, 2013, J BIOPHOTONICS, V6, P573, DOI 10.1002/jbio.201200053; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Koon HEC, 2010, J ARCHAEOL SCI, V37, P62, DOI 10.1016/j.jas.2009.08.015; Koon HEC, 2003, J ARCHAEOL SCI, V30, P1393, DOI 10.1016/S0305-4403(03)00034-7; Kubisz L, 2005, J NON-CRYST SOLIDS, V351, P2935, DOI 10.1016/j.jnoncrysol.2005.05.041; Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066; LANDIS WJ, 1977, J ULTRA MOL STRUCT R, V59, P185, DOI 10.1016/S0022-5320(77)80079-8; Mayne Correia P., 1997, FORENSIC TAPHONOMY P, P275, DOI DOI 10.1201/9781439821923.CH18; Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2; Paris O, 2008, BIOINTERPHASES, V3, pFB16, DOI 10.1116/1.2955443; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Piga G, 2008, J ARCHAEOL SCI, V35, P2171, DOI 10.1016/j.jas.2008.02.003; Putnis A., 1992, INTRO MINERAL SCI; R Core Team, 2013, R LANG ENV STAT COMP; Ramos PM, 2005, J RAMAN SPECTROSC, V36, P848, DOI 10.1002/jrs.1370; ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013; Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7; Rogers K, 2010, PALAEOGEOGR PALAEOCL, V296, P125, DOI 10.1016/j.palaeo.2010.06.021; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Ruppel ME, 2008, OSTEOPOROSIS INT, V19, P1251, DOI 10.1007/s00198-008-0579-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stout S, 2012, BONE HISTOLOGY: AN ANTHROPOLOGICAL PERSPECTIVE, P1; Sui T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0928; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Tarnowski CP, 2004, J BONE MINER RES, V19, P64, DOI 10.1359/JBMR.0301201; Thompson TJU, 2004, FORENSIC SCI INT, V146, pS203, DOI 10.1016/j.forsciint.2004.09.063; Ubelaker DH, 2009, FORENSIC SCI INT, V183, P1, DOI 10.1016/j.forsciint.2008.09.019; Wagermaier W, 2013, RSC SMART MATER, P46, DOI 10.1039/9781849737555-00046; Wang Y, 2013, NAT MATER, V12, P1144, DOI [10.1038/NMAT3787, 10.1038/nmat3787]; Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/NMAT3362, 10.1038/nmat3362]; WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0; Wess T, 2002, CALCIFIED TISSUE INT, V70, P103, DOI 10.1007/s002230020045; Wess T. J., 2008, P49, DOI 10.1007/978-0-387-73906-9_3; Ye J, 2004, J FORENSIC SCI, V49, P754; Zazzo A, 2013, RADIOCARBON, V55, P1409, DOI 10.1017/S0033822200048347; ZIV V, 1994, CONNECT TISSUE RES, V30, P165, DOI 10.3109/03008209409061969	68	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176179	10.1371/journal.pone.0176179	http://dx.doi.org/10.1371/journal.pone.0176179			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423023	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600096
J	Zarmi, Y				Zarmi, Yair			Zooming in: From spatially extended traveling waves to localized structures: The case of the Sine-Gordon equation in (1+3) dimensions	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; EVOLUTION-EQUATIONS; EXCITATIONS; EXCHANGE; ENERGY	The Sine-Gordon equation in (1+3) dimensions has N-traveling front ("kink", "domain wall")-solutions for all N >= 1. A nonlinear functional of the solution, which vanishes on a single-front, maps multi-front solutions onto sets of infinitely long, but laterally bounded, rods, which move in space. Each rod is localized in the vicinity of the intersection of two Sine-Gordon fronts. The rod systems are solutions of the linear wave equation, driven by a term that is constructed out of Sine-Gordon fronts. An additional linear operation maps multi-rod systems onto sets of blobs. Each blob is localized in the vicinity of rod intersection, and moves in space. The blob systems are solutions of the linear wave equation, driven by a term that is also constructed out of Sine-Gordon fronts. The temporal evolution of multi-blob solutions mimics elastic collisions of systems of spatially extended particles.	[Zarmi, Yair] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel	Ben Gurion University	Zarmi, Y (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel.	zarmi@bgu.ac.il		Zarmi, Yair/0000-0001-8830-9667				Ablowitz MJ, 1991, NONLINEAR EVOLUTION; Alagesan T, 2004, CHAOS SOLITON FRACT, V21, P879, DOI 10.1016/j.chaos.2003.12.052; CLARKSON PA, 1985, LETT MATH PHYS, V10, P297, DOI 10.1007/BF00420570; Derks G, 2011, PHYSICA D, V240, P1805, DOI 10.1016/j.physd.2011.08.005; ENGLANDER SW, 1980, P NATL ACAD SCI-BIOL, V77, P7222, DOI 10.1073/pnas.77.12.7222; Golobin E, 2000, PHYS LETT A, V266, P67; Griffiths SD, 2003, THEOR MATH PHYS+, V137, P1448, DOI 10.1023/A:1026008907682; HIROTA R, 1972, J PHYS SOC JPN, V33, P1459, DOI 10.1143/JPSJ.33.1459; HIROTA R, 1973, J PHYS SOC JPN, V35, P1566, DOI 10.1143/JPSJ.35.1566; Khusnutdinova KR, 2003, WAVE MOTION, V38, P1, DOI 10.1016/S0165-2125(03)00022-2; KOBAYASHI KK, 1976, J PHYS SOC JPN, V41, P1091, DOI 10.1143/JPSJ.41.1091; Nakagiri S, 2001, TAIWAN J MATH, V5, P297, DOI 10.11650/twjm/1500407338; Salas AH, 2010, NONLINEAR ANAL-REAL, V11, P3930, DOI 10.1016/j.nonrwa.2010.02.020; Shang DS, 2010, APPL MATH COMPUT, V217, P1577, DOI 10.1016/j.amc.2009.06.072; Vasumathi V, 2008, PHYS LETT A, V373, P76, DOI 10.1016/j.physleta.2008.10.058; WEISS J, 1984, J MATH PHYS, V25, P2226, DOI 10.1063/1.526415; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; Zarmi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148993; Zarmi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124306; Zhang J, 2003, MATH METHOD APPL SCI, V26, P11, DOI 10.1002/mma.340; Zhao YM, 2011, J APPL MATH SCI, V5, P1621; Zhao YM, 2014, J APPL MATH, DOI 10.1155/2014/534346	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175783	10.1371/journal.pone.0175783	http://dx.doi.org/10.1371/journal.pone.0175783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422999	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600053
J	Ghorbani, A; Saeedi, Y; de Boer, HJ				Ghorbani, Abdolbaset; Saeedi, Yousef; de Boer, Hugo J.			Unidentifiable by morphology: DNA barcoding of plant material in local markets in Iran	PLOS ONE			English	Article							BOTANICAL NOMENCLATURE; MEDICINAL-PLANTS; ANCIENT DNA; IDENTIFICATION; TAXONOMY; PHARMACOVIGILANCE; AUTHENTICATION; DISCRIMINATION; CONTAMINATION; COMPLEMENTS	Local markets provide a rapid insight into the medicinal plants growing in a region as well as local traditional health concerns. Identification of market plant material can be challenging as plants are often sold in dried or processed forms. In this study, three approaches of DNA barcoding-based molecular identification of market samples are evaluated, two objective sequence matching approaches and an integrative approach that coalesces sequence matching with a priori and a posteriori data from other markers, morphology, ethnoclassification and species distribution. Plant samples from markets and herbal shops were identified using morphology, descriptions of local use, and vernacular names with relevant floras and pharmacopoeias. DNA barcoding was used for identification of samples that could not be identified to species level using morphology. Two methods based on BLAST similaritybased identification, were compared with an integrative identification approach. Integrative identification combining the optimized similarity-based approach with a priori and a posteriori information resulted in a 1.67, 1.95 and 2.00 fold increase for ITS, trnL-F spacer, and both combined, respectively. DNA barcoding of traded plant material requires objective strategies to include data from multiple markers, morphology, and traditional knowledge to optimize species level identification success.	[Ghorbani, Abdolbaset; de Boer, Hugo J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden; [Ghorbani, Abdolbaset; Saeedi, Yousef] Shahid Beheshti Univ Med Sci, Tradit Med & Mat Med Res Ctr, Tehran, Iran; [de Boer, Hugo J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [de Boer, Hugo J.] Univ Oslo, Nat Hist Museum, Oslo, Norway	Shahid Beheshti University Medical Sciences; Naturalis Biodiversity Center; University of Oslo	de Boer, HJ (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden.; de Boer, HJ (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.; de Boer, HJ (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	Hugo.DeBoer@ebc.uu.se	de Boer, Hugo Joris/AAS-7585-2020	de Boer, Hugo Joris/0000-0003-1985-7859	International Foundation for Science, Sweden; Carl Tryggers Foundation, Sweden	International Foundation for Science, Sweden(International Foundation for Science); Carl Tryggers Foundation, Sweden	The research was supported by a grant to AG from the International Foundation for Science, Sweden (http://www.ifs.se/) and a grant to HdB from Carl Tryggers Foundation, Sweden (http://www.carltryggersstiftelse.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin GR, 1991, POPULAR MED PLANTS I, V1; Amiri MS, 2013, AVICENNA J PHYTOMEDI, V3, P254; [Anonymous], 2002, IR HERB PHARM; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Aynehchi Y., 1986, PHARMACOGNOSY AND ME; Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; Baker DA, 2012, J AOAC INT, V95, P1023, DOI 10.5740/jaoacint.11-261; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bellstedt DU, 2001, AM J BOT, V88, P2088, DOI 10.2307/3558434; Bennett BC, 2014, J ETHNOPHARMACOL, V152, P387, DOI 10.1016/j.jep.2013.11.042; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Bussmann Rainer W, 2007, J Ethnobiol Ethnomed, V3, P37; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Cunningham AB, 2001, APPLIED ETHNOBOTANY; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; de Boer HJ, 2015, DRUG SAFETY, V38, P611, DOI 10.1007/s40264-015-0306-8; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Farah MH, 2006, DRUG SAFETY, V29, P1023, DOI 10.2165/00002018-200629110-00002; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060799; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Joharchi MR, 2012, AVICENNA J PHYTOMEDI, V2, P105; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; LINARES E, 1987, J ETHNOPHARMACOL, V19, P153, DOI 10.1016/0378-8741(87)90039-0; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Liu J, 2015, DIVERS DISTRIB, V21, P188, DOI 10.1111/ddi.12276; Mahadani P., 2013, DNA BARCODES, V1, P35, DOI [10.2478/dna-2013-0002, DOI 10.2478/DNA-2013-0002]; Mati E, 2011, J ETHNOPHARMACOL, V133, P490, DOI 10.1016/j.jep.2010.10.023; MEYRICK B, 1979, AM J PATHOL, V94, P37; Moradi-Lake M, 2009, Q J PAYESH, V7, P321; Mozafarian V., 1996, DICT IRANIAN PLANT N; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Naghibi F., 2005, IRAN J PHARM RES, V2, P63, DOI DOI 10.22037/IJPR.2010.619; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Otieno J, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-10; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Posadzki P, 2013, EUR J CLIN PHARMACOL, V69, P295, DOI 10.1007/s00228-012-1353-z; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rechinger KH, 1963, FLORA IRANICA; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Rivera D, 2014, J ETHNOPHARMACOL, V152, P393, DOI 10.1016/j.jep.2013.12.022; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SMITH LW, 1981, J NAT PROD, V44, P129, DOI 10.1021/np50014a001; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Suwanchaikasem P., 2012, Journal of Medicinal Plants Research, V6, P2955; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; The Plant List, 2013, VERS 1 1; Thompson KA, 2014, BIODIVERS CONSERV, V23, P1411, DOI 10.1007/s10531-014-0672-z; Towns AM, 2014, J ETHNOPHARMACOL, V155, P1184, DOI 10.1016/j.jep.2014.06.052; van Geel B, 2008, QUATERNARY RES, V69, P361, DOI 10.1016/j.yqres.2008.02.004; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williams VL, 2000, ECON BOT, V54, P310, DOI 10.1007/BF02864784; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168	76	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175722	10.1371/journal.pone.0175722	http://dx.doi.org/10.1371/journal.pone.0175722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419161	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200038
J	Bruce-Keller, AJ; Fernandez-Kim, SO; Townsend, RL; Kruger, C; Carmouche, R; Newman, S; Salbaum, JM; Berthoud, HR				Bruce-Keller, Annadora J.; Fernandez-Kim, Sun-Ok; Townsend, R. Leigh; Kruger, Claudia; Carmouche, Richard; Newman, Susan; Salbaum, J. Michael; Berthoud, Hans-Rudolf			Maternal obese-type gut microbiota differentially impact cognition, anxiety and compulsive behavior in male and female offspring in mice	PLOS ONE			English	Article							DIETARY-FAT INTAKE; INTESTINAL MICROBIOTA; GENE-EXPRESSION; MENTAL-HEALTH; MOUSE MODELS; PREGNANCY; CHILDREN; INFLAMMATION; BUTYRATE; STRESS	Maternal obesity is known to predispose offspring to metabolic and neurodevelopmental abnormalities. While the mechanisms underlying these phenomena are unclear, high fat diets dramatically alter intestinal microbiota, and gut microbiota can impact physiological function. To determine if maternal diet-induced gut dysbiosis can disrupt offspring neurobehavioral function, we transplanted high fat diet-(HFD) or control low fat diet-associated (CD) gut microbiota to conventionally-housed female mice. Recipient mice were then bred and the behavioral phenotype of male and female offspring was tracked. While maternal behavior was unaffected, neonatal offspring from HFD dams vocalized less upon maternal separation than pups from CD dams. Furthermore, weaned male offspring from HFD dams had significant and selective disruptions in exploratory, cognitive, and stereotypical/compulsive behavior compared to male offspring from CD dams; while female offspring from HFD dams had increases in body weight and adiposity. 16S metagenomic analyses confirmed establishment of divergent microbiota in CD and HFD dams, with alterations in diversity and taxonomic distribution throughout pregnancy and lactation. Likewise, significant alterations in gut microbial diversity and distribution were noted in offspring from HFD dams compared to CD dams, and in males compared to females. Regression analyses of behavioral performance against differentially represented taxa suggest that decreased representation of specific members of the Firmicutes phylum predict behavioral decline in male offspring. Collectively, these data establish that high fat diet-induced maternal dysbiosis is sufficient to disrupt behavioral function in murine offspring in a sex-specific manner. Thus these data reinforce the essential link between maternal diet and neurologic programming in offspring and suggest that intestinal dysbiosis could link unhealthy modern diets to the increased prevalence of neurodevelopmental and childhood disorders.	[Bruce-Keller, Annadora J.; Fernandez-Kim, Sun-Ok; Townsend, R. Leigh; Kruger, Claudia; Carmouche, Richard; Newman, Susan; Salbaum, J. Michael; Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bruce-Keller, AJ (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	annadora.bruce-keller@pbrc.edu	Bruce-Keller, Annadora/N-1954-2017; Berthoud, Hans-Rudolf/N-1950-2017		National Institutes of Health (NIH) [1U54-GM-104940, 3P30-GM118430, 2P30 DK072476, P50AT002776-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047348, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health (NIH) grant 1U54-GM-104940, which funds the Louisiana Clinical and Translational Science Center. This work also utilized Genomics and Animal Behavior/Phenotyping core facilities supported by NIH 3P30-GM118430, NIH 2P30 DK072476, and NIH P50AT002776-11.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Angoa-Perez Mariana, 2013, J Vis Exp, P50978, DOI 10.3791/50978; [Anonymous], 2009, NCHS DATA BRIEF; Avila C, 2015, CURR OBES REP, V4, P303, DOI 10.1007/s13679-015-0164-9; Aziz Q, 2013, NEUROGASTROENT MOTIL, V25, P4, DOI 10.1111/nmo.12046; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bested AC, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-4; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chu DM, 2016, GUT MICROBES, V7, P459, DOI 10.1080/19490976.2016.1241357; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Dinan TG, 2011, AUST NZ J PSYCHIAT, V45, P1023, DOI 10.3109/00048674.2011.613766; Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; El Aidy S, 2016, ADV EXP MED BIOL, V874, P301, DOI 10.1007/978-3-319-20215-0_15; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Friedman JE, 2015, DIABETES CARE, V38, P1402, DOI 10.2337/dc15-0628; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Kang SS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0156-9; Kim DW, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117259; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lerch S, 2016, LAB ANIM-UK, V50, P167, DOI 10.1177/0023677215603260; Li YM, 2015, J AUTISM DEV DISORD; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luckey T D, 1965, Adv Appl Microbiol, V7, P169, DOI 10.1016/S0065-2164(08)70387-3; Lyall K, 2013, AM J EPIDEMIOL, V178, P209, DOI 10.1093/aje/kws433; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Maftei O, 2015, DIABETIC MED, V32, P174, DOI 10.1111/dme.12637; Mahony SMO, 2015, BIRTH DEFECTS RES C, V105, P296, DOI 10.1002/bdrc.21118; Majidi-Zolbanin J, 2015, NEUROSCIENCE, V294, P69, DOI 10.1016/j.neuroscience.2015.03.016; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ogden CL, 2013, NCHS DATA BRIEF, V131, P1; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Olfson M, 2014, JAMA PSYCHIAT, V71, P81, DOI 10.1001/jamapsychiatry.2013.3074; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pinto RQ, 2015, PSYCHIAT GENET, V25, P223, DOI 10.1097/YPG.0000000000000106; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012; Rosenfeld CS, 2015, DRUG METAB DISPOS, V43, P1557, DOI 10.1124/dmd.115.063826; Sacks KN, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.030; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Selkrig J, 2014, GUT MICROBES, V5, P369, DOI 10.4161/gmic.28681; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Sweeney TE, 2013, JAMA SURG, V148, P563, DOI 10.1001/jamasurg.2013.5; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Veena SR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1011-z; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wilcoxon JS, 2003, AM J PHYSIOL-ENDOC M, V285, pE31, DOI 10.1152/ajpendo.00552.2002; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Yi P, 2012, VET MICROBIOL, V157, P1, DOI 10.1016/j.vetmic.2011.10.024; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	88	41	41	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175577	10.1371/journal.pone.0175577	http://dx.doi.org/10.1371/journal.pone.0175577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441394	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800007
J	Fonceca, AM; Chopra, A; Levy, A; Noakes, PS; Poh, MWP; Bear, NL; Prescott, S; Everard, ML				Fonceca, Angela Mary; Chopra, Abha; Levy, Avram; Noakes, Paul Stanton; Poh, Matthew Wee-Peng; Bear, Natasha Leanne; Prescott, Susan; Everard, Mark Lloyd			Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN DENDRITIC CELLS; HIGH-RISK; PERSISTENCE; ASTHMA; ADULTS; PREGNANCY; IMMUNITY; INFANTS; MODEL	Background Human respiratory syncytial virus (RSV) remains the most common cause of severe lower respiratory tract disease amongst infants, and continues to cause annual epidemics of respiratory disease every winter worldwide. Demonstrating placental transmission of viable RSV in human samples is a major paradigm shift in respiratory routes considered likely for RSV transmission. Methods Droplet digital PCR (ddPCR) was used to identify RSV present in cord blood mononucleocytes (CBM). CBMs testing positive for RSV were treated with phytohemagglutinin (PHA), PHA and nitric oxide (NO) or PHA, NO and palivizumab, and co-cultured with HeLa cell monolayers. Subsequent immuno-staining for RSV was used to visualize infective viral plaques. Results RSV was detected in 26 of 45 samples (57.7%) by ddPCR. CBM's collected in winter were more likely to test positive for RSV (17/21 samples, risk = 80%, OR = 7.08; 95% CI 1.80 - 27.80; p = 0.005) compared to non-winter months (9/24 samples, 37.5%). RSV plaques were observed in non-treated and treated co-cultured HeLa monolayers. Conclusions Demonstrating active RSV in CBMs suggests in utero transmission of infective virus to the fetus without causing overt disease. This is likely to have an important impact on immune development as well as future virus-host interactions, thereby warranting further investigation.	[Fonceca, Angela Mary; Poh, Matthew Wee-Peng; Prescott, Susan; Everard, Mark Lloyd] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia; [Chopra, Abha] Murdoch Univ, Inst Immun & Infect Dis, Murdoch, WA, Australia; [Levy, Avram] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Nedlands, WA, Australia; [Levy, Avram] Univ Western Australia, Queen Elizabeth II Med Ctr, Sch Pathol & Lab Med, Nedlands, WA, Australia; [Noakes, Paul Stanton; Prescott, Susan] Telethon Kids Inst, Subiaco, WA, Australia; [Bear, Natasha Leanne; Prescott, Susan; Everard, Mark Lloyd] CAHS, Dept Hlth, Subiaco, WA, Australia; [Noakes, Paul Stanton] Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Notre Dame Australia	Fonceca, AM (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia.	angela.fonceca@uwa.edu.au		Poh, Wee Peng/0000-0002-0973-5914; Levy, Avram/0000-0002-0934-2387; Noakes, Paul/0000-0002-2678-1971; Everard, Mark/0000-0003-1571-261X; Chopra, Abha/0000-0001-5008-9080	McCusker Medical Research Foundation; Princess Margaret Hospital for Children Foundation; Wesfarmers Centre for Vaccines and Infectious Diseases	McCusker Medical Research Foundation; Princess Margaret Hospital for Children Foundation; Wesfarmers Centre for Vaccines and Infectious Diseases	This work was supported by McCusker Medical Research Foundation, Princess Margaret Hospital for Children Foundation and Wesfarmers Centre for Vaccines and Infectious Diseases.	Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Bhatt Jayesh M, 2004, Paediatr Respir Rev, V5, P333, DOI 10.1016/j.prrv.2004.07.003; Brownlie J, 1998, CLIN DIAGNOSTIC VIRO, V10; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Calvani M, 2004, ALLERGY, V59, P99, DOI 10.1046/j.1398-9995.2003.00338.x; Commission ALR, 2003, ESS YOURS PROT HUM G, P96; Cubie HA, 1997, PEDIATR PATHOL LAB M, V17, P927, DOI 10.1080/107710497174372; DOMURAT F, 1985, J INFECT DIS, V152, P895, DOI 10.1093/infdis/152.5.895; Dunstan JA, 2003, CLIN EXP ALLERGY, V33, P442, DOI 10.1046/j.1365-2222.2003.01590.x; Everard ML, 2008, RESP SYNCYTIAL VIRUS, P491; Falsey AR, 2006, J MED VIROL, V78, P1493, DOI 10.1002/jmv.20724; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fonceca AM, 2015, ERS INT C 2015, V2015; Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; HEGELE RG, 1994, CHEST, V105, P1848, DOI 10.1378/chest.105.6.1848; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Hughes CH, 1999, CLIN EXP ALLERGY, V29, P1378; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Khan TK, 2015, CURR OPIN ALLERGY CL, V15, P402, DOI 10.1097/ACI.0000000000000209; Mejias A, 2008, PEDIATR INFECT DIS J, V27, pS60, DOI 10.1097/INF.0b013e3181684d52; Murphy VE, 2014, PEDIAT ALLERG IMM-UK, V25, P151, DOI 10.1111/pai.12156; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Piedimonte G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061309; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Stapleton Jack T, 2014, Trans Am Clin Climatol Assoc, V125, P14; Ugonna K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091855; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0173738	10.1371/journal.pone.0173738	http://dx.doi.org/10.1371/journal.pone.0173738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437435	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600001
J	Casal, S; DellaValle, N; Mittone, L; Soraperra, I				Casal, Sandro; DellaValle, Nives; Mittone, Luigi; Soraperra, Ivan			Feedback and efficient behavior	PLOS ONE			English	Article							ENERGY-CONSERVATION; SAVINGS BEHAVIOR; BUYING BEHAVIOR; RETIREMENT PLAN; SOCIAL NORMS; INFORMATION; PARTICIPATION; DECISIONS; FREQUENCY; FIELD	Feedback is an effective tool for promoting efficient behavior: it enhances individuals' awareness of choice consequences in complex settings. Our study aims to isolate the mechanisms underlying the effects of feedback on achieving efficient behavior in a controlled environment. We design a laboratory experiment in which individuals are not aware of the consequences of different alternatives and, thus, cannot easily identify the efficient ones. We introduce feedback as a mechanism to enhance the awareness of consequences and to stimulate exploration and search for efficient alternatives. We assess the efficacy of three different types of intervention: provision of social information, manipulation of the frequency, and framing of feedback. We find that feedback is most effective when it is framed in terms of losses, that it reduces efficiency when it includes information about inefficient peers' behavior, and that a lower frequency of feedback does not disrupt efficiency. By quantifying the effect of different types of feedback, our study suggests useful insights for policymakers.	[Casal, Sandro] Univ Milan, Dept Econ Management & Quantitat Methods, Milan, Italy; [DellaValle, Nives] Univ Trento, Sch Social Sci, Trento, Italy; [Mittone, Luigi] Univ Trento, Dept Econ, Trento, Italy; [Soraperra, Ivan] Univ Amsterdam, Dept Econ, Amsterdam, Netherlands	University of Milan; University of Trento; University of Trento; University of Amsterdam; Vrije Universiteit Amsterdam	DellaValle, N (corresponding author), Univ Trento, Sch Social Sci, Trento, Italy.	nives.dellavalle@unitn.it	Casal, Sandro/ABE-6081-2020; Della Valle, Nives/AAG-2479-2020	Della Valle, Nives/0000-0001-8241-4677; Mittone, Luigi/0000-0001-6521-7698; Soraperra, Ivan/0000-0002-4596-3885	Autorita per l'Energia Elettrica, il Gas e il Sistema Idrico	Autorita per l'Energia Elettrica, il Gas e il Sistema Idrico	This work was supported by Autorita per l'Energia Elettrica, il Gas e il Sistema Idrico, http://www.autorita.energia.it/it/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the financial support of the Autorita per l'Energia Elettrica, il Gas e il Sistema Idrico and the technical assistance of Marco Tecilla. We are grateful to the academic editor Eldad Yechiam and to three anonymous referees for their encouragement and constructive advice. We also thank Dominique Cappelletti, Matteo Ploner, and participants of the DEMM seminar at the University of Milan for useful comments.	Abeler J, 2011, AM ECON REV, V101, P470, DOI 10.1257/aer.101.2.470; Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Alos-Ferrer C, 2009, HDB RATIONAL SOCIAL, P246; Annett J., 1969, FEEDBACK HUMAN BEHAV; [Anonymous], 1988, BRIT J PSYCHIAT, DOI DOI 10.1192/S0007125000223416; Asensio OI, 2015, P NATL ACAD SCI USA, V112, pE510, DOI 10.1073/pnas.1401880112; Ayres I., 2012, J LAW ECON ORGAN; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Barron G, 2003, J BEHAV DECIS MAKING, V16, P215, DOI 10.1002/bdm.443; Benartzi S, 2007, J ECON PERSPECT, V21, P81, DOI 10.1257/jep.21.3.81; Beshears J, 2015, J FINANC, V70, P1161, DOI 10.1111/jofi.12258; BILODEAU EA, 1958, J EXP PSYCHOL, V55, P379, DOI 10.1037/h0043214; Cherry TL, 2002, AM ECON REV, V92, P1218, DOI 10.1257/00028280260344740; CHHOKAR JS, 1984, J APPL PSYCHOL, V69, P524, DOI 10.1037/0021-9010.69.3.524; CIALDINI RB, 1976, J PERS SOC PSYCHOL, V34, P366, DOI 10.1037//0022-3514.34.3.366; COOK SW, 1981, J SOC ISSUES, V37, P73, DOI 10.1111/j.1540-4560.1981.tb02627.x; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Duflo E, 2003, Q J ECON, V118, P815, DOI 10.1162/00335530360698432; Duflo E, 2002, J PUBLIC ECON, V85, P121, DOI 10.1016/S0047-2727(01)00098-6; Erev I, 2005, PSYCHOL REV, V112, P912, DOI 10.1037/0033-295X.112.4.912; Erev I, 2013, THE HANDBOOK OF EXPE, V2; Erev I, 2014, P NATL ACAD SCI USA, V111, P10818, DOI 10.1073/pnas.1402846111; Faruqui A, 2010, ENERGY, V35, P1598, DOI 10.1016/j.energy.2009.07.042; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischer C, 2008, ENERG EFFIC, V1, P79, DOI 10.1007/s12053-008-9009-7; Ganzach Y, 1997, J BUS RES, V40, P91, DOI 10.1016/S0148-2963(96)00208-1; GANZACH Y, 1995, J BUS RES, V32, P11, DOI 10.1016/0148-2963(93)00038-3; Grosskopf B, 2006, INT J GAME THEORY, V34, P285, DOI 10.1007/s00182-006-0015-8; Hochman G, 2013, PSYCHON B REV, V20, P1336, DOI 10.3758/s13423-013-0432-1; HUTTON RB, 1986, J CONSUM RES, V13, P327, DOI 10.1086/209072; Jones GM, 1910, PSYCHOL REV, V17, P269, DOI 10.1037/h0074504; Judd CH, 1905, PSYCHOL REV MONOGR S; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lam CF, 2011, ORGAN BEHAV HUM DEC, V116, P217, DOI 10.1016/j.obhdp.2011.05.002; Lynham J, 2016, ENERG ECON, V54, P173, DOI 10.1016/j.eneco.2015.11.007; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Martin NG, 2016, ENERGY PERFORMANCE B, P107; McCalley LT, 2002, J ECON PSYCHOL, V23, P589, DOI 10.1016/S0167-4870(02)00119-8; Merlo A, 2003, GAME ECON BEHAV, V42, P116, DOI 10.1016/S0899-8256(02)00537-7; MEYER RJ, 1987, J CONSUM RES, V14, P155, DOI 10.1086/209103; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Ramalho EA, 2011, J ECON SURV, V25, P19, DOI 10.1111/j.1467-6419.2009.00602.x; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Simonsohn U, 2008, GAME ECON BEHAV, V62, P263, DOI 10.1016/j.geb.2007.03.010; SMITH VL, 1976, AM ECON REV, V66, P274; TELLIS GJ, 1990, J MARKETING, V54, P34, DOI 10.2307/1251868; Wood G, 2007, ENERG BUILDINGS, V39, P495, DOI 10.1016/j.enbuild.2006.06.009; Wright WR, 1906, PSYCHOL REV, V13, P23, DOI 10.1037/h0076041; Yechiam E, 2007, J MATH PSYCHOL, V51, P75, DOI 10.1016/j.jmp.2006.11.002; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	54	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175738	10.1371/journal.pone.0175738	http://dx.doi.org/10.1371/journal.pone.0175738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430787	Green Submitted, gold, Green Published			2022-12-27	WOS:000399876100017
J	Koeppen, D; Piepenbrock, C; Kroppenstedt, S; Cabraja, M				Koeppen, Daniel; Piepenbrock, Claudia; Kroppenstedt, Stefan; Cabraja, Mario			The influence of sagittal profile alteration and final lordosis on the clinical outcome of cervical spondylotic myelopathy. A Delta-Omega-analysis	PLOS ONE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; AOSPINE NORTH-AMERICA; 2-YEAR FOLLOW-UP; RECONSTRUCTIVE TECHNIQUES; SURGICAL-MANAGEMENT; ASYMPTOMATIC ADULTS; SPINAL ALIGNMENT; FUSION SURGERY; T1 SLOPE; ANTERIOR	Purpose Decompression and maintaining or restoring a cervical lordosis are major goals in the surgical treatment of cervical spondylotic myelopathy (CSM). Numerous studies support the assumption that cervical lordosis is a key factor for neurological recovery and pain reduction. However, even kyphotic patients can be asymptomatic. The balance of the spine is subject of an increasing number of publications. The main purpose of the study was to evaluate the validity of lordotic alignment on the course of CSM and to set this parameter in context with well-validated tools, namely the modified Japanese Orthopaedic Association scoring system (mJOAS) and the visual analogue scale (VAS), to predict and measure the clinical outcome after surgery. Methods This is a retrospective study with prospectively collected data of a heterogeneous cohort. The authors analyzed the records of 102 patients suffering from CSM that underwent decompressive surgery and instrumentation. Clinical outcome was assessed by using the mJOAS, VAS and Odom's criteria. The radiological analysis involved comparison of pre- and postoperative radiographs. The patients were divided into subgroups to be able to compare the influence of various amounts of correction (3 Delta-groups: <0 degrees, 1-7 degrees and >= 8 degrees) and final lordosis (4 Omega-groups: 0-7 degrees, 8-14 degrees, 15-21 degrees, >= 22 degrees). Results 219 levels were fused in 102 patients. Surgery improved the clinical outcome of all groups significantly. A lordotic profile was achieved in all analyzed groups. Patients that showed small lordosis after surgery (<8 degrees) did not have an inferior clinical outcome compared to patients with larger cervical lordosis (>4 degrees). The comparison of Odom's criteria showed that preoperatively kyphotic patients benefitted more from surgery than lordotic patients (p = 0.029), but no differences could be seen comparing neck pain and neurological improvement. The improvement of pain and neurological impairment measured by VAS and mJOAS supports the statistical impact and validity of the data despite comparatively small numbers of patients. The lack of postoperative kyphosis is a major limitation of the study to encompass the impact of sagittal alignment on clinical outcome. Conclusions Decompression and stabilization appear to be key elements of surgical treatment of CSM. While the achievement of cervical lordosis remains a major goal of surgery, clinical improvement is not hindered in patients who show small lordosis. However, kyphosis should be eliminated in symptomatic patients. The terms "balance" and "physiologic lordosis" remain complex entities without clear definition. To check the results of our study controlled randomized trials to validate and determine the exact role of cervical balance on the course of CSM would be helpful.	[Koeppen, Daniel] Bundeswehrkrankenhaus Berlin, Dept Orthoped Surg & Traumatol, Berlin, Germany; [Piepenbrock, Claudia; Cabraja, Mario] Vivantes Auguste Viktoria Klinikum, Joint Spine Ctr, Berlin, Germany; [Kroppenstedt, Stefan] Sana Kliniken Sommerfeld, Dept Orthoped Surg, Kremmen, Germany		Cabraja, M (corresponding author), Vivantes Auguste Viktoria Klinikum, Joint Spine Ctr, Berlin, Germany.	mario.cabraja@vivantes.de						Ahn JS, 2010, CLIN ORTHOP SURG, V2, P98, DOI 10.4055/cios.2010.2.2.98; Albert TJ, 1998, SPINE, V23, P1596, DOI 10.1097/00007632-199807150-00017; Ames CP, 2013, SPINE, V38, pS149, DOI 10.1097/BRS.0b013e3182a7f449; Andaluz N, 2012, J NEUROSURG-SPINE, V16, P2, DOI 10.3171/2011.9.SPINE10430; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Cabraja M, 2010, CENT EUR NEUROSURG, V71, P59, DOI 10.1055/s-0029-1246135; Cabraja M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-172; Cabraja M, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09253; Cho JH, 2014, SPINE, P39; CONNELL MD, 1992, ORTHOP CLIN N AM, V23, P369; DiAngelo DJ, 2000, SPINE, V25, P783, DOI 10.1097/00007632-200004010-00005; Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007; Emery SE, 1997, SPINE, V22, P2622, DOI 10.1097/00007632-199711150-00008; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Geisler FH, 1998, SPINE, V23, P911, DOI 10.1097/00007632-199804150-00013; Gu JA, 2015, CLIN NEUROL NEUROSUR, V139, P319, DOI 10.1016/j.clineuro.2015.10.031; Gum JL, 2012, AM J ORTHOP, V41, P81; Hamburger C, 1997, SPINE, V22, P1990, DOI 10.1097/00007632-199709010-00009; Hann S, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1429; Hyun SJ, 2016, SPINE, V41, pE396, DOI 10.1097/BRS.0000000000001264; Iyer S, 2016, SPINE, V41, P1826, DOI 10.1097/BRS.0000000000001642; JOHNSTON FG, 1995, J NEUROSURG, V82, P234, DOI 10.3171/jns.1995.82.2.0234; Kaye ID, 2015, EUR SPINE J, V24, P2910, DOI 10.1007/s00586-015-4010-2; Kuntz C, 2008, NEUROSURGERY, V63, pA25, DOI 10.1227/01.NEU.0000313120.81565.D7; Kuntz C, 2007, J NEUROSURG-SPINE, V6, P104, DOI 10.3171/spi.2007.6.2.104; Kurakawa T, 2016, EUR SPINE J, V25, P2060, DOI 10.1007/s00586-016-4548-7; Lawrence BD, 2013, SPINE, V38, pS171, DOI 10.1097/BRS.0b013e3182a7f4ff; Lee CK, 2016, J NEUROSURG-SPINE, V24, P100, DOI 10.3171/2015.4.SPINE141004; Lee JY, 2013, YONSEI MED J, V54, P726, DOI 10.3349/ymj.2013.54.3.726; Lee SH, 2012, J SPINAL DISORD TECH, V25, pE41, DOI 10.1097/BSD.0b013e3182396301; Li XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140031; Liu Y, 2012, EUR SPINE J, V21, P2428, DOI 10.1007/s00586-012-2323-y; Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4; Maeno T, 2015, GLOB SPINE J, V5, P118, DOI 10.1055/s-0034-1396759; Manzano GR, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182305669; Mummaneni PV, 2007, NEUROSURGERY, V60, P82, DOI 10.1227/01.NEU.0000215355.64127.76; ODOM GL, 1958, JAMA-J AM MED ASSOC, V166, P23, DOI 10.1001/jama.1958.02990010025006; Oe S, 2016, SPINE, V41, pE1168, DOI 10.1097/BRS.0000000000001578; Protopsaltis TS, 2015, J NEUROSURG-SPINE, V23, P153, DOI 10.3171/2014.11.SPINE1441; Scheer JK, 2013, J NEUROSURG-SPINE, V19, P141, DOI 10.3171/2013.4.SPINE12838; Shamji MF, 2016, WORLD NEUROSURG, V86, P112, DOI 10.1016/j.wneu.2015.09.044; Shimizu K, 2005, SPINE, V30, P2388, DOI 10.1097/01.brs.0000184378.67465.5c; Smith JS, 2015, J NEUROSURG-SPINE, V23, P349, DOI 10.3171/2014.12.SPINE14777; Smith JS, 2013, SPINE, V38, pS161, DOI 10.1097/BRS.0b013e3182a7eb9e; Suchomel P, 2014, EUR SPINE J, V23, P1124, DOI 10.1007/s00586-014-3223-0; Suda K, 2003, SPINE, V28, P1258, DOI 10.1097/00007632-200306150-00008; Tang JA, 2012, NEUROSURGERY, V71, P662, DOI 10.1227/NEU.0b013e31826100c9; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Traynelis VC, 2013, SPINE, V38, pS210, DOI 10.1097/BRS.0000000000000009; Wang MY, 2004, SURG NEUROL, V62, P487, DOI 10.1016/j.surneu.2004.02.040; Wu WJ, 2012, EUR SPINE J, V21, P1374, DOI 10.1007/s00586-011-2131-9; Yukawa Y, 2016, EUR SPINE J	53	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174527	10.1371/journal.pone.0174527	http://dx.doi.org/10.1371/journal.pone.0174527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430792	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100005
J	Ransome, E; Geller, JB; Timmers, M; Leray, M; Mahardini, A; Sembiring, A; Collins, AG; Meyer, CP				Ransome, Emma; Geller, Jonathan B.; Timmers, Molly; Leray, Matthieu; Mahardini, Angka; Sembiring, Andrianus; Collins, Allen G.; Meyer, Christopher P.			The importance of standardization for biodiversity comparisons: A case study using autonomous reef monitoring structures (ARMS) and metabarcoding to measure cryptic diversity on Mo'orea coral reefs, French Polynesia	PLOS ONE			English	Article							MARINE BIODIVERSITY; CLIMATE-CHANGE; SAMPLES; PATTERNS; NETWORK	The advancement of metabarcoding techniques, declining costs of high-throughput sequencing and development of systematic sampling devices, such as autonomous reef monitoring structures (ARMS), have provided the means to gather a vast amount of diversity data from cryptic marine communities. However, such increased capability could also lead to analytical challenges if the methods used to examine these communities across local and global scales are not standardized. Here we compare and assess the underlying biases of four ARMS field processing methods, preservation media, and current bioinformatic pipelines in evaluating diversity from cytochrome c oxidase I metabarcoding data. Illustrating the ability of ARMS-based metabarcoding to capture a wide spectrum of biodiversity, 3,372 OTUs and twenty-eight phyla, including 17 of 33 marine metazoan phyla, were detected from 3 ARMS (2.607 m(2) area) collected on coral reefs in Mo'orea, French Polynesia. Significant differences were found between processing and preservation methods, demonstrating the need to standardize methods for biodiversity comparisons. We recommend the use of a standardized protocol (NOAA method) combined with DMSO preservation of tissues for sessile macroorganisms because it gave a more accurate representation of the underlying communities, is cost effective and removes chemical restrictions associated with sample transportation. We found that sequences identified at >= 97% similarity increased more than 7-fold (5.1% to 38.6%) using a geographically local barcode inventory, highlighting the importance of local species inventories. Phylogenetic approaches that assign higher taxonomic ranks accrued phylum identification errors (9.7%) due to sparse taxonomic coverage of the understudied cryptic coral reef community in public databases. However, a >= 85% sequence identity cut-off provided more accurate results (0.7% errors) and enabled phylum level identifications of 86.3% of the sequence reads. With over 1600 ARMS deployed, standardizing methods and improving databases are imperative to provide unprecedented global baseline assessments of understudied cryptic marine species in a rapidly changing world.	[Ransome, Emma; Meyer, Christopher P.] Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA; [Geller, Jonathan B.] Moss Landing Marine Labs, Moss Landing, CA USA; [Timmers, Molly] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI USA; [Timmers, Molly] Natl Ocean & Atmospher Adm, Pacif Islands Fisheries Sci Ctr, Ecosyst Sci Div, Honolulu, HI USA; [Leray, Matthieu] Smithsonian Trop Res Inst, Panama City, Panama; [Mahardini, Angka; Sembiring, Andrianus] Indonesian Biodivers Res Ctr, Denpasar, Indonesia; [Sembiring, Andrianus] Udayana Univ, Dept Environm Sci, Denpasar, Indonesia; [Collins, Allen G.] Natl Marine Fisheries Serv, Natl Systemat Lab, Washington, DC USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Moss Landing Marine Laboratories; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian Tropical Research Institute; Universitas Udayana; National Oceanic Atmospheric Admin (NOAA) - USA	Ransome, E (corresponding author), Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA.	RansomeE@si.edu	Collins, Allen G/A-7944-2008	Collins, Allen G/0000-0002-3664-9691; Meyer, Christopher/0000-0003-2501-7952; Ransome, Emma/0000-0002-5720-1570; Mahardini, Angka/0000-0001-7812-6015; Leray, Matthieu/0000-0002-7327-1878	National Science Foundation [OISE-1243541]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation with a "Partnerships for International Research and Education" grant, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505038 (OISE-1243541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rshaidat MMD, 2016, GENOME, V59, P724, DOI 10.1139/gen-2015-0208; Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Davies N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-2; Davies N, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-5; Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gaither MR, 2011, CORAL REEFS, V30, P329, DOI 10.1007/s00338-010-0687-1; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Glynn PW, 2011, B MAR SCI, V87, P767, DOI 10.5343/bms.2010.1025; Gorley C.K., 2006, GETTING STARTED PRIM; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; Hirai J, 2015, J EXP MAR BIOL ECOL, V469, P36, DOI 10.1016/j.jembe.2015.04.011; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hurley KKC, 2016, CORAL REEFS, V35, P103, DOI 10.1007/s00338-015-1382-z; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kopf A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0066-5; Leray M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0331; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Meyer C., 2016, MERRITT COLLECTION M; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Pearman JK, 2016, MAR ENVIRON RES, V118, P20, DOI 10.1016/j.marenvres.2016.04.011; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Reaka-Kudla Marjorie L., 1997, P83; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06986; Rogers CS, 2013, ISRN OCEANOGRAPHY, V213, P18; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; SUTTLE CA, 1991, APPL ENVIRON MICROB, V57, P721, DOI 10.1128/AEM.57.3.721-726.1991; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Williams ST, 2007, J MOLLUS STUD, V73, P416, DOI 10.1093/mollus/eym039; Zimmerman Todd L., 2004, Gulf and Caribbean Research, V16, P59	47	45	50	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175066	10.1371/journal.pone.0175066	http://dx.doi.org/10.1371/journal.pone.0175066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430780	gold, Green Submitted, Green Published			2022-12-27	WOS:000399876100012
J	Wu, SQ; Xu, JJ				Wu, Suqian; Xu, Jianjiang			Incidence and risk factors for post-penetrating keratoplasty glaucoma: A systematic review and meta-analysis	PLOS ONE			English	Review							INCREASED INTRAOCULAR-PRESSURE; CORNEAL TRANSPLANTATION; STATISTICAL-METHODS; MANAGEMENT; PHACOEMULSIFICATION; PUBLICATION; PREVALENCE; GOLDMANN; IMPACT; BIAS	Objectives To establish the incidence and risk factors for post penetrating keratoplasty glaucoma (PKKG). Methods Studies published between 1947 and 2016 regarding penetrating keratoplasty (PK) were identified using an electronic search and reviewed. For search purpose, PKKG was defined as ocular hypertension (> 21mmHg) after PK. The incidence and risk factors of PKKG were extracted for all studies. Pooled incidence, odd ratios (ORs) and 95% confidence intervals (CIs) were calculated. Results Thirty studies reporting on 27146 patients were included in the analysis of the incidence and risk factors for PKKG. Exact PKKG definitions used in the literature could be classified in to three subgroups: I, ocular hypertension (> 21mmHg) after PK; II, I plus > 4 weeks medical treatment required; III, II plus treatment escalation among patients with preexisting glaucoma. Overall (Definition I) pooled incidence in all studies was 21.5% (95% CI 17.8%, 25.7%). The incidence varied according to different definitions. The highest incidence value was found when only studies using Goldmann tonometer were included (22.5%), while the lowest incidence was found when a strict definition was used and steroid-induced PPKG was excluded (12.1%). The incidence was higher in patients with preexisting glaucoma, bullous keratopathy (BK), aphakia, pseudophakia, failed graft, and surgical indication of trauma. A triple procedure (combined PK with extra capsular cataract extraction and intraocular lens implantation) was not identified as being associated with the increased risk for PKKG. Conclusions The overall pooled incidence of PKKG was 21.5%, but it varied according to the criteria used to define the presence of PPKG. Strong risk factors for PKKG included preexisting glaucoma and aphakia, while modest predictors included pseudophakia, regrafting, and pre-operative diagnosis like BK and trauma. There may not be sufficient evidence to identify a significant association between a triple procedure and PKKG.	[Wu, Suqian; Xu, Jianjiang] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China	Fudan University	Xu, JJ (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.	jianjiangxu@126.com			Key Clinic Medicine Research Program, the Ministry of Health, China [201302015]; National Science and Technology Research Program, the Ministry of Science and Technology, China [2012BA108B01]; National Natural Science Foundation of China [81170817, 81200658, 81300735, 81270978, U1205025, 81330022]; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai [13441900900, 13430720400]; New Technology Joint Research Project in Shanghai Hospitals [SHDC12014114]	Key Clinic Medicine Research Program, the Ministry of Health, China; National Science and Technology Research Program, the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); New Technology Joint Research Project in Shanghai Hospitals	This study was supported by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (201302015); the National Science and Technology Research Program, the Ministry of Science and Technology, China (2012BA108B01); the National Natural Science Foundation of China (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); the Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai (13441900900, 13430720400); and the New Technology Joint Research Project in Shanghai Hospitals (SHDC12014114). The sponsors or funding organizations had no role in the design or conduct of this research.	Al-Mohaimeed M, 2007, OPHTHALMOLOGY, V114, P2281, DOI 10.1016/j.ophtha.2007.08.043; Bachmann B, 2010, OPHTHALMOLOGY, V117, P1300, DOI 10.1016/j.ophtha.2010.01.039; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; CHIEN AM, 1993, AM J OPHTHALMOL, V115, P711, DOI 10.1016/S0002-9394(14)73636-0; Dandona Lalit, 1998, Indian Journal of Ophthalmology, V46, P149; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; FOULKS GN, 1987, OPHTHALMOLOGY, V94, P871; Franca ET, 2002, CORNEA, V21, P284, DOI 10.1097/00003226-200204000-00009; GOLDBERG DB, 1981, AM J OPHTHALMOL, V92, P372, DOI 10.1016/0002-9394(81)90527-4; Haddadin RI, 2014, SEMIN OPHTHALMOL, V29, P380, DOI 10.3109/08820538.2014.959201; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huber KK, 2013, GRAEF ARCH CLIN EXP, V251, P105, DOI 10.1007/s00417-012-2065-x; Ing JJ, 1998, OPHTHALMOLOGY, V105, P1855, DOI 10.1016/S0161-6420(98)91030-2; Karadag O, 2010, CORNEA, V29, P278, DOI 10.1097/ICO.0b013e3181b6eb9e; KARESH JW, 1983, AM J OPHTHALMOL, V96, P160, DOI 10.1016/S0002-9394(14)77783-9; KIRKNESS CM, 1992, CORNEA, V11, P427, DOI 10.1097/00003226-199209000-00012; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Kornmann HL, 2016, CURR OPIN OPHTHALMOL, V27, P132, DOI 10.1097/ICU.0000000000000237; Kushwaha D C, 1981, Indian J Ophthalmol, V29, P167; MCMILLAN F, 1975, ARCH OPHTHALMOL-CHIC, V93, P420; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neuburger M, 2013, J GLAUCOMA, V22, P584, DOI 10.1097/IJG.0b013e31824cef11; OLSON RJ, 1977, INVEST OPHTH VIS SCI, V16, P1085; Orucoglu F, 2014, J GLAUCOMA, V23, P599, DOI 10.1097/IJG.0b013e31828700f5; Pershing S, 2011, CURR OPIN OPHTHALMOL, V22, P37, DOI 10.1097/ICU.0b013e3283414fb3; Rahman I, 2009, EYE, V23, P1288, DOI 10.1038/eye.2008.305; Rao SK, 1999, OPHTHALMIC SURG LAS, V30, P488; Reinhard T, 1997, GRAEF ARCH CLIN EXP, V235, P553, DOI 10.1007/BF00947083; Sharma RA, 2016, CAN J OPHTHALMOL, V51, P19, DOI 10.1016/j.jcjo.2015.09.014; Sihota R, 1998, AUST NZ J OPHTHALMOL, V26, P305, DOI 10.1111/j.1442-9071.1998.tb01334.x; Simmons R B, 1989, Trans Am Ophthalmol Soc, V87, P79; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wagoner MD, 2009, CORNEA, V28, P385, DOI 10.1097/ICO.0b013e31818d3aef; WILLIAMS KA, 1995, EYE, V9, P219, DOI 10.1038/eye.1995.43; WILLIAMS KA, 1993, AUST NZ J OPHTHALMOL, V21, P1; Williams KA., 2007, AUSTR CORNEAL GRAFT; Xie L, 2000, Zhonghua Yan Ke Za Zhi, V36, P116; Yildirim N, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/951294	40	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176261	10.1371/journal.pone.0176261	http://dx.doi.org/10.1371/journal.pone.0176261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430806	gold, Green Submitted, Green Published			2022-12-27	WOS:000399876100036
J	Barnas, E; Ksiazek, M; Ras, R; Skret, A; Skret-Magierlo, J; Dmoch-Gajzlerska, E				Barnas, Edyta; Ksiazek, Mariusz; Ras, Renata; Skret, Andrzej; Skret-Magierlo, Joanna; Dmoch-Gajzlerska, Ewa			Benign metastasizing leiomyoma: A review of current literature in respect to the time and type of previous gynecological surgery	PLOS ONE			English	Review							PULMONARY BENIGN; LUNG; UTERUS	Introduction Benign metastasizing leiomyoma (BML) is a rare disorder that affects women with a history of uterine leiomyoma, which is found to metastasise within extrauterine sites. The aetiology of BML remains unexplained. Because BML is rare, and most publications contain descriptions of single cases, no statistically determined time relations were found between the primary and secondary surgeries, which may have aetiological implications. Objectives To determine age before BML surgery, age during diagnosis of BML, type of prior surgery, and location of metastasis based on the literature. Methods A systematic review of four databases (Medline/PubMed, Embase, Web of Science, and Cochrane) covering articles published from 1 January 1965 to 10 April 2016. The inclusion criteria were full-text articles in English and articles containing case reports. Articles in languages other than English (39), articles containing incomplete data (14), i.e. no information regarding the time of surgery and/or the site of metastasis, articles bereft of case studies (25), and articles with access only to summaries, without access to the complete text (10) were excluded. Of 321 titles identified, only 126 articles met the aforementioned criteria. Results and conclusions The mean age during primary surgery and BML diagnosis was 38.5 years and 47.3 years, respectively. The most common surgery was total hysterectomy. The most frequent site of metastasis was the lungs; other organs were affected less frequently. The site of metastases and their number were not related to the longer time span between the patient's initial surgery and occurrence of metastasis. The analysed data, such as the age during primary surgery, age during BML diagnosis, site and type of metastasis, do not provide us a clear answer. Thus, BML pathogenesis is most probably complex in nature and requires further multidirectional research.	[Barnas, Edyta] Univ Rzeszow, Med Fac, Inst Obstet & Emergency Med, Rzeszow, Poland; [Ksiazek, Mariusz] Frederick Chopin Clin Prov Hosp 1, Clin Dept Pathol, Rzeszow, Poland; [Ras, Renata; Skret, Andrzej; Skret-Magierlo, Joanna] Univ Rzeszow, Frederick Chopin Clin Prov Hosp Rzeszow 1, Obstet & Gynecol Clin, Rzeszow, Poland; [Dmoch-Gajzlerska, Ewa] Med Univ Warsaw, Fac Hlth Sci, Gynaecol & Obstet Dept, Warsaw, Poland	University of Rzeszow; University of Rzeszow; Medical University of Warsaw	Barnas, E (corresponding author), Univ Rzeszow, Med Fac, Inst Obstet & Emergency Med, Rzeszow, Poland.	ebarnas@interia.eu	Dmoch-Gajzlerska, Ewa/V-4439-2018	Dmoch-Gajzlerska, Ewa/0000-0002-1244-6531; Barnas, Edyta/0000-0002-7567-3782; Skret-Magierlo, Joanna Ewa/0000-0003-1679-264X				Aboualfa K, 2011, HISTOPATHOLOGY, V59, P796, DOI 10.1111/j.1365-2559.2011.03952.x; Ahmad SZ, 2011, EUR J OBSTET GYN R B, V159, P240, DOI 10.1016/j.ejogrb.2011.07.017; AKackiran Y, 2014, TURK PATOLOJI DERG; Baboci A, 2014, HEART LUNG CIRC, V23, P174, DOI 10.1016/j.hlc.2013.10.058; Bodner K, 2011, ARCH GYNECOL OBSTET, V283, P525, DOI 10.1007/s00404-010-1368-6; Bowen JM, 2012, CANCER GENET-NY, V205, P249, DOI 10.1016/j.cancergen.2012.04.005; Cai A, 2014, HERZ, V39, P867, DOI 10.1007/s00059-013-3904-1; Chen S, 2014, J THORAC DIS, V6, pE92, DOI 10.3978/j.issn.2072-1439.2014.04.37; Chen SF, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-163; CLARK DH, 1977, AM J OBSTET GYNECOL, V127, P672, DOI 10.1016/0002-9378(77)90373-8; Cobellis L, 2014, EUR J GYNAECOL ONCOL, V35, P195; Consamus Erin N, 2014, Methodist Debakey Cardiovasc J, V10, P251, DOI 10.14797/mdcj-10-4-251; de Ruiter GCW, 2006, CLIN NEUROPATHOL, V25, P282; DREVELENGAS A, 1995, EUR J RADIOL, V19, P121, DOI 10.1016/0720-048X(94)00591-Y; Fatima S, 2010, INDIAN J PATHOL MICR, V53, P802, DOI 10.4103/0377-4929.72099; Fu YL, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-268; Goto T, 2012, ANN THORAC CARDIOVAS, V18, P121, DOI 10.5761/atcs.cr.11.01688; Goyle KK, 2003, AM J CLIN ONCOL-CANC, V26, P473, DOI 10.1097/01.coc.0000037737.78080.E3; Hayashi S, 1996, CANCER GENET CYTOGEN, V89, P98, DOI 10.1016/0165-4608(95)00354-1; Hur JW, 2015, EUR SPINE J, V24, pS600, DOI 10.1007/s00586-015-3774-8; del Real-Romo ZJ, 2014, CASE REP SURG, V2014, DOI 10.1155/2014/439061; Jayakody S, 2011, J CLIN NEUROSCI, V18, P1135, DOI 10.1016/j.jocn.2011.01.004; Jeon HW, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-281; Jiang GQ, 2010, CHINESE MED J-PEKING, V123, P3367, DOI 10.3760/cma.j.issn.0366-6999.2010.22.039; Jo Ji Hoon, 2006, Korean Journal of Internal Medicine, V21, P199; Joo HJ, 2013, CLIN NEUROL NEUROSUR, V115, P1180, DOI 10.1016/j.clineuro.2012.10.028; Joseph V, 2003, SURG NEUROL, V60, P575, DOI 10.1016/S0090-3019(03)00268-4; Kang MW, 2011, ANN THORAC SURG, V91, P924, DOI 10.1016/j.athoracsur.2010.08.030; Kayser K, 2000, VIRCHOWS ARCH, V437, P284, DOI 10.1007/s004280000207; Ki EY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-279; Kolaczyk K, 2015, POL J RADIOL, V80, P107, DOI 10.12659/PJR.892733; Kwon Young-Il, 2006, Korean Journal of Internal Medicine, V21, P173; Lee HJ, 2008, INT J GYNECOL PATHOL, V27, P340, DOI 10.1097/PGP.0b013e3181656dab; Loukeri AA, 2014, RESP CARE, V59, pE94, DOI 10.4187/respcare.02775; Ma H, 2015, ONCOL LETT, V9, P1347, DOI 10.3892/ol.2015.2878; MARK J, 1991, ANTICANCER RES, V11, P33; MARK J, 1990, CANCER GENET CYTOGEN, V44, P1, DOI 10.1016/0165-4608(90)90192-D; Miller J, 2016, ANN THORAC SURG, V101, P253, DOI 10.1016/j.athoracsur.2015.05.107; Miyamoto H, 2009, PATHOLOGY, V41, P234, DOI 10.1080/00313020902756238; Mizuno M, 2011, INT J CLIN ONCOL, V16, P587, DOI 10.1007/s10147-010-0156-4; Mlika M, 2009, PATHOLOGICA, V101, P9; Nakajo M., 2012, ACTA RADIOLOGICA SHO, V23, P1; Ni Y, 2012, CLIN EXP OBSTET GYN, V39, P249; Nucci MR, 2007, AM J SURG PATHOL, V31, P737, DOI 10.1097/01.pas.0000213414.15633.4e; Orejola WC, 2014, ANN THORAC SURG, V98, pE113, DOI 10.1016/j.athoracsur.2014.07.057; PARENTI DJ, 1992, RESPIRATION, V59, P347; Patton KT, 2006, MODERN PATHOL, V19, P130, DOI 10.1038/modpathol.3800504; Poujade O, 2010, EUR J GYNAECOL ONCOL, V31, P329; Radzikowska Elzbieta, 2012, Pneumonol Alergol Pol, V80, P560; Ras R, 2016, MENOPAUSE REV, V15, P117, DOI 10.5114/pm.2016.61195; Rege AS, 2012, ANN THORAC SURG, V93, pE149, DOI 10.1016/j.athoracsur.2011.12.047; Simon P, 2010, ACTA CHIR BELG, V110, P611, DOI 10.1080/00015458.2010.11680689; Taftaf R, 2014, CASE REP ONCOL MED, V2014, DOI 10.1155/2014/842801; Taveira-DaSilva AM, 2012, OBSTET GYNECOL, V119, P438, DOI 10.1097/AOG.0b013e318240090e; Tori M, 2008, SURG TODAY, V38, P432, DOI 10.1007/s00595-007-3609-2; Usman Y, 2015, CHEST, V148, DOI 10.1378/chest.2264285; Wang LX, 2012, SPINE, V37, pE259, DOI 10.1097/BRS.0b013e31822e9578; Wei WT, 2015, ONCOL LETT, V10, P307, DOI 10.3892/ol.2015.3224; Wentling GK, 2005, INT J GYNECOL CANCER, V15, P1213, DOI 10.1111/j.1525-1438.2005.00190.x; Yu R, 2015, CASE REP EMERG MED, V2015; Zyla MM, 2015, ACTA OBSTET GYN SCAN, V94, P220, DOI 10.1111/aogs.12549	61	43	51	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175875	10.1371/journal.pone.0175875	http://dx.doi.org/10.1371/journal.pone.0175875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426767	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900061
J	Bartho, JD; Bellini, D; Wuerges, J; Demitri, N; Toccafondi, M; Schmitt, AO; Zhao, YF; Walsh, MA; Benini, S				Bartho, Joseph D.; Bellini, Dom; Wuerges, Jochen; Demitri, Nicola; Toccafondi, Mirco; Schmitt, Armin O.; Zhao, Youfu; Walsh, Martin A.; Benini, Stefano			The crystal structure of Erwinia amylovora AmyR, a member of the YbjN protein family, shows similarity to type III secretion chaperones but suggests different cellular functions	PLOS ONE			English	Article							RCS PHOSPHORELAY SYSTEM; X-RAY ANALYSIS; SHIGELLA-FLEXNERI; VIRULENCE FACTORS; BIOFILM FORMATION; GENOME SEQUENCE; ANTI-ACTIVATOR; LEVANSUCRASE; EXPRESSION; PATHOGEN	AmyR is a stress and virulence associated protein from the plant pathogenic Enterobacteriaceae species Erwinia amylovora, and is a functionally conserved ortholog of YbjN from Escherichia coli. The crystal structure of E. amylovora AmyR reveals a class I type III secretion chaperone-like fold, despite the lack of sequence similarity between these two classes of protein and lacking any evidence of a secretion-associated role. The results indicate that AmyR, and YbjN proteins in general, function through protein-protein interactions without any enzymatic action. The YbjN proteins of Enterobacteriaceae show remarkably low sequence similarity with other members of the YbjN protein family in Eubacteria, yet a high level of structural conservation is observed. Across the YbjN protein family sequence conservation is limited to residues stabilising the protein core and dimerization interface, while interacting regions are only conserved between closely related species. This study presents the first structure of a YbjN protein from Enterobacteriaceae, the most highly divergent and well-studied subgroup of YbjN proteins, and an in-depth sequence and structural analysis of this important but poorly understood protein family.	[Bartho, Joseph D.; Wuerges, Jochen; Toccafondi, Mirco; Schmitt, Armin O.; Benini, Stefano] Free Univ Bolzano, Fac Sci & Technol, Bioorgan Chem & Biocrystallog Lab B2CI, Piazza Univ 5, Bolzano, Italy; [Bellini, Dom; Walsh, Martin A.] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Bellini, Dom; Walsh, Martin A.] Res Complex Harwell, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Demitri, Nicola] Elettra Sincrotrone Trieste, SS 14 Km 163-5 Area Sci Pk, Trieste, Italy; [Schmitt, Armin O.] Georg August Univ Gottingen, Dept Nutztierwissensch, Breeding Informat, Margarethe von Wrangell Weg 7, Gottingen, Germany; [Zhao, Youfu] Univ Illinois, Dept Crop Sci, 1201 W Gregory Dr, Urbana, IL 61801 USA	Free University of Bozen-Bolzano; Diamond Light Source; Elettra Sincrotrone Trieste; University of Gottingen; University of Illinois System; University of Illinois Urbana-Champaign	Benini, S (corresponding author), Free Univ Bolzano, Fac Sci & Technol, Bioorgan Chem & Biocrystallog Lab B2CI, Piazza Univ 5, Bolzano, Italy.	stefano.benini@unibz.it	Demitri, Nicola/O-7469-2015; Benini, Stefano/C-2598-2009; Walsh, Martin A/I-1566-2013	Demitri, Nicola/0000-0003-0288-3233; Benini, Stefano/0000-0001-6299-888X; Walsh, Martin A/0000-0001-5683-1151; Bartho, Joseph Dale/0000-0003-3853-2347; Schmitt, Armin/0000-0002-4910-9467	Free University of Bolzano; Fondazione Libera Universita di Bolzano; Autonomous Province of Bolzano; Faculty of Science and Technology, Free University of Bolzano	Free University of Bolzano; Fondazione Libera Universita di Bolzano; Autonomous Province of Bolzano(Pronvincia Autonoma di Bolzano); Faculty of Science and Technology, Free University of Bolzano	JDB was supported by a predoctoral fellowship from the Free University of Bolzano MT was supported by a postdoctoral fellowship by the Fondazione Libera Universita di Bolzano. The work was supported by the grant: "A structural genomics approach for the study of the virulence and pathogenesis of Erwinia amylovora" from the Autonomous Province of Bolzano and the grant: "GenSelEa" from the Faculty of Science and Technology, Free University of Bolzano. The above mentioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." The funder Diamond Light Source Ltd. provided beamtime at the beamlines 104 and 104-1 for data collection, and support in the form of salaries for the authors DB and MAW but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; BELLEMANN P, 1992, J GEN MICROBIOL, V138, P931, DOI 10.1099/00221287-138-5-931; BERNHARD F, 1993, MOL GEN GENET, V239, P158, DOI 10.1007/BF00281614; BERNHARD F, 1990, MOL PLANT MICROBE IN, V3, P429, DOI 10.1094/MPMI-3-429; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Caputi L, 2013, J AGR FOOD CHEM, V61, P12265, DOI 10.1021/jf4023178; Caputi L, 2013, ACTA CRYSTALLOGR F, V69, P570, DOI 10.1107/S1744309113010750; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fattori J, 2011, PROTEIN PEPTIDE LETT, V18, P158, DOI 10.2174/092986611794475048; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; GROSS M, 1992, PHYSIOL MOL PLANT P, V40, P371, DOI 10.1016/0885-5765(92)90029-U; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Janjusevic R, 2013, J BACTERIOL, V195, P658, DOI 10.1128/JB.01621-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koczan JM, 2011, APPL ENVIRON MICROB, V77, P7031, DOI 10.1128/AEM.05138-11; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lohou D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00435; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Nissinen RM, 2007, MOL PLANT PATHOL, V8, P55, DOI 10.1111/j.1364-3703.2006.00370.x; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Pique N, 2015, INT J MOL SCI, V16, P12836, DOI 10.3390/ijms160612836; Rao XC, 2009, GENE DEV, V23, P1818, DOI 10.1101/gad.1784009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen L, 2015, J BIOL CHEM, V290, P28141, DOI 10.1074/jbc.M115.670232; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Toccafondi M, 2014, ACTA CRYSTALLOGR F, V70, P1249, DOI 10.1107/S2053230X14016458; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vanneste J.L., 2000, FIRE BLIGHT DIS ITS; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Vrancken K, 2013, MICROBIOL-SGM, V159, P823, DOI 10.1099/mic.0.064881-0; WANG D, 2012, PLOS ONE, V7; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025011; Wang DP, 2012, MOL PLANT MICROBE IN, V25, P6, DOI 10.1094/MPMI-08-11-0207; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x; Wei CF, 2005, MOL MICROBIOL, V57, P520, DOI 10.1111/j.1365-2958.2005.04704.x; Wei ZM, 2000, MOL PLANT MICROBE IN, V13, P1251, DOI 10.1094/MPMI.2000.13.11.1251; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; Zhao YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-245	83	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176049	10.1371/journal.pone.0176049	http://dx.doi.org/10.1371/journal.pone.0176049			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426806	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900094
J	Chen, J; Shi, H; Chen, YL; Fan, SJ; Liu, DY; Li, CH				Chen, Ji; Shi, Hua; Chen, Yonglong; Fan, Shijie; Liu, Dingyi; Li, Chenghua			DNA damage induces expression of WWP1 to target triangle Np63 alpha to degradation	PLOS ONE			English	Article							PROTEIN STABILITY; P53 HOMOLOG; CELL-DIFFERENTIATION; P63 GENE; DELTA-NP63-ALPHA; TRANSCRIPTION; CANCER; PROLIFERATION; APOPTOSIS; SURVIVAL	triangle Np63 alpha plays key roles in cell survival and proliferation. So its expression is always tightly controlled in cells. We previously reported that DNA damage down-regulates transcription of triangle Np63 alpha in FaDu and HaCat cells, which contributes to cell apoptosis. In the present study, we found that DNA damage induces down-regulation of triangle Np63 alpha via facilitating its proteasomal degradation in cell lines such as MDA-MB-231 and MCF10A. Further investigation revealed that transcription of WWP1 is stimulated by DNA damage in these cells. Knockdown of WWP1 abrogates DNA damage-induced down-regulation of triangle Np63 alpha and partially rescues cell apoptosis. Interestingly, DNA damage may stimulate WWP1 through different mechanisms in different cell types: it up-regulates transcription of WWP1 in a p53-dependent manner in MCF10A and HEK293 cells, while miR-452 may be involved in DNA damage-induced up-regulation of WWP1 in MDA-MB-231 cells. Our study demonstrates a novel pathway which regulates triangle Np63 alpha upon cellular response to chemotherapeutic agents.	[Chen, Ji; Chen, Yonglong; Fan, Shijie; Li, Chenghua] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Key Lab Biol Resources & Ecol Environm,Minist Edu, Chengdu, Peoples R China; [Chen, Ji; Liu, Dingyi] Seventh Peoples Hosp Chengdu, Dept Med Oncol, Chengdu, Peoples R China; [Shi, Hua] Sichuan Univ, West China Univ Hosp 2, Dept Lab Med, Chengdu, Peoples R China	Sichuan University; Sichuan University	Li, CH (corresponding author), Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Key Lab Biol Resources & Ecol Environm,Minist Edu, Chengdu, Peoples R China.	lichenghua@scu.edu.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	National Natural Science Foundation of China [31671423]; Science and Technology Department of Sichuan Province [2016JY0152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province	This work was supported by National Natural Science Foundation of China (#31671423) and and Science and Technology Department of Sichuan Province (#2016JY0152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (#31671423) and and Science and Technology Department of Sichuan Province (#2016JY0152).	Bakkers J, 2005, CELL CYCLE, V4, P790, DOI 10.4161/cc.4.6.1694; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Deutsch GB, 2011, CELL CYCLE, V10, P1884, DOI 10.4161/cc.10.12.15590; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Goto Y, 2016, BRIT J CANCER, V114, P1135, DOI 10.1038/bjc.2016.95; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Li XR, 2012, BIOCHEM BIOPH RES CO, V423, P338, DOI 10.1016/j.bbrc.2012.05.126; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Maisse C, 2003, BIOCHEM PHARMACOL, V66, P1555, DOI 10.1016/S0006-2952(03)00511-2; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Wu GJ, 2003, CANCER RES, V63, P2351; Wu GJ, 2005, CANCER RES, V65, P758; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	28	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176142	10.1371/journal.pone.0176142	http://dx.doi.org/10.1371/journal.pone.0176142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426804	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900106
J	Saulton, A; Bulthoff, HH; de la Rosa, S; Dodds, TJ				Saulton, Aurelie; Buelthoff, Heinrich H.; de la Rosa, Stephan; Dodds, Trevor J.			Cultural differences in room size perception	PLOS ONE			English	Article							CONTEXT; ENVIRONMENT; DIMENSIONS; ATTENTION; COGNITION; IMPACT; AREA	Cultural differences in spatial perception have been little investigated, which gives rise to the impression that spatial cognitive processes might be universal. Contrary to this idea, we demonstrate cultural differences in spatial volume perception of computer generated rooms between Germans and South Koreans. We used a psychophysical task in which participants had to judge whether a rectangular room was larger or smaller than a square room of reference. We systematically varied the room rectangularity (depth to width aspect ratio) and the viewpoint (middle of the short wall vs. long wall) from which the room was viewed. South Koreans were significantly less biased by room rectangularity and viewpoint than their German counterparts. These results are in line with previous notions of general cognitive processing strategies being more context dependent in East Asian societies than Western ones. We point to the necessity of considering culturally-specific cognitive processing strategies in visual spatial cognition research.	[Saulton, Aurelie; Buelthoff, Heinrich H.; de la Rosa, Stephan; Dodds, Trevor J.] Max Planck Inst Biol Cybernet, Human Percept, Cognit & Act, Tubingen, Germany	Max Planck Society	Saulton, A; Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Human Percept, Cognit & Act, Tubingen, Germany.	aurelie.saulton@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; 	Max Planck Society	Max Planck Society(Max Planck Society)	This research was supported by the Max Planck Society.	Anastasi A, 1936, J GEN PSYCHOL, V14, P201, DOI 10.1080/00221309.1936.9713146; [Anonymous], 2021, LANG ENV STAT COMP; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Boduroglu A, 2009, J CROSS CULT PSYCHOL, V40, P349, DOI 10.1177/0022022108331005; Choi I, 2007, PERS SOC PSYCHOL B, V33, P691, DOI 10.1177/0146167206298568; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Durak A, 2007, BUILD ENVIRON, V42, P3476, DOI 10.1016/j.buildenv.2006.10.048; Goeke C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11426; Hameed S., 2004, AUD ENG SOC CONV 116; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Holmberg L., 1969, PSYCHOL RES B, V9; Holmberg L., 1975, PSYCHOL RES B, V15, P1; Inui M., 1973, LIGHTING RES TECHNOL, V5, P103, DOI [https://doi.org/10.1177/096032717300500205, DOI 10.1177/096032717300500205]; Ishii K, 2003, PSYCHOL SCI, V14, P39, DOI 10.1111/1467-9280.01416; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Krider RE, 2001, MARKET SCI, V20, P405, DOI 10.1287/mksc.20.4.405.9756; Krishna A, 2008, J CONSUM RES, V35, P337, DOI 10.1086/588686; Kwallek N, 1996, PERCEPT MOTOR SKILL, V83, P49, DOI 10.2466/pms.1996.83.1.49; Larsson P., 2002, P FOR AC 3 EAA EUR C; Levinson S. C., 2003, SPACE LANGUAGE COGNI; Levinson SC, 2002, COGNITION, V84, P155, DOI 10.1016/S0010-0277(02)00045-8; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; McCullagh P, 1989, GEN LINEAR MODELS; MERSHON DH, 1989, PERCEPTION, V18, P403, DOI 10.1068/p180403; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Morey RD, 2015, PACKAGE BAYESFACTOR; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Oberfeld D, 2011, HUM FACTORS, V53, P284, DOI 10.1177/0018720811407331; Padilla L. M, 2016, PSYCHONOMIC B REV, P1; Piaget J., 1969, PSYCHOL CHILD; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SADALLA EK, 1984, ENVIRON BEHAV, V16, P394, DOI 10.1177/0013916584163005; Saulton A, 2016, J VISION, V16, DOI 10.1167/16.6.2; Ulrich R, 2009, ATTEN PERCEPT PSYCHO, V71, P1219, DOI 10.3758/APP.71.6.1219; Vashro L, 2015, EVOL HUM BEHAV, V36, P123, DOI 10.1016/j.evolhumbehav.2014.09.009; VERGE CG, 1978, J EXP CHILD PSYCHOL, V25, P337, DOI 10.1016/0022-0965(78)90087-5; von Castell C, 2017, Q J EXP PSYCHOL, V70, P516, DOI 10.1080/17470218.2015.1136658; von Castell C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113267; Witkin H. A, 1975, J CROSS CULTURAL PSY	46	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176115	10.1371/journal.pone.0176115	http://dx.doi.org/10.1371/journal.pone.0176115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426729	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900104
J	Yu, Q; Tong, C; Luo, MD; Xue, XY; Mei, QY; Ma, LX; Yu, XL; Mao, WX; Kong, LB; Yu, XL; Li, SS				Yu, Qi; Tong, Chong; Luo, Mingdan; Xue, Xiangyan; Mei, Qianyun; Ma, Lixin; Yu, Xiaolan; Mao, Wuxiang; Kong, Lingbao; Yu, Xilan; Li, Shanshan			Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites	PLOS ONE			English	Article							PYRUVATE-KINASE; CANCER METABOLISM; HISTONE H3; GENE; SERINE; YEAST; PKM2	Cancer cells prefer aerobic glycolysis, but little is known about the underlying mechanism. Recent studies showed that the rate-limiting glycolytic enzymes, pyruvate kinase M2 (PKM2) directly phosphorylates H3 at threonine 11 (H3T11) to regulate gene expression and cell proliferation, revealing its non-metabolic functions in connecting glycolysis and histone modifications. We have reported that the yeast homolog of PKM2, Pyk1 phosphorylates H3T11 to regulate gene expression and oxidative stress resistance. But how glycolysis regulates H3T11 phosphorylation remains unclear. Here, using a series of glycolytic enzyme mutants and commercial available metabolites, we investigated the role of glycolytic enzymes and metabolites on H3T11 phosphorylation. Mutation of glycolytic genes including phosphoglucose isomerase (PGI1), enolase (ENO2), triosephosphate isomerase (TPI1), or folate biosynthesis enzyme (FOL3) significantly reduced H3T11 phosphorylation. Further study demonstrated that glycolysis regulates H3T11 phosphorylation by fueling the substrate, phosphoenonylpyruvate and the coactivator, FBP to Pyk1. Thus, our results provide a comprehensive view of how glycolysis modulates H3T11 phosphorylation.	[Yu, Qi; Tong, Chong; Luo, Mingdan; Xue, Xiangyan; Mei, Qianyun; Ma, Lixin; Yu, Xiaolan; Mao, Wuxiang; Yu, Xilan; Li, Shanshan] Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan, Hunan, Peoples R China; [Kong, Lingbao] Nanchang Univ, Human Aging Res Inst, Dept HumanPopulat Genet, Nanchang, Jiangxi, Peoples R China; [Kong, Lingbao] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China	Hubei University; Nanchang University; Nanchang University	Yu, XL; Li, SS (corresponding author), Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan, Hunan, Peoples R China.	Yuxilan@hubu.edu.cn; shl@hubu.edu.cn	Li, Shanshan/AAF-4758-2020	Li, Shanshan/0000-0002-0359-2369; qi, yu/0000-0001-5704-1792; Li, Shanshan/0000-0002-6424-2792	Hubei Collaborative Innovation Center for Green Transformation of Bio-resources; Hubei University start grant [080-170035]; National Natural Science Foundation of China [31671335, 31600046]; Natural Science Foundation of Hubei Province [2016CFB103]	Hubei Collaborative Innovation Center for Green Transformation of Bio-resources; Hubei University start grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This project was supported by funding from Hubei Collaborative Innovation Center for Green Transformation of Bio-resources (S.Li), Hubei University start grant (080-170035 to Xilan Yu), National Natural Science Foundation of China (no. 31671335 to S.Li; no. 31600046 to Xilan Yu), and the Natural Science Foundation of Hubei Province (2016CFB103 to Xilan Yu).The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Professor Markus Ralser (Max Planck Institute for Molecular Genetics, Germany) for providing strains (TEF1pr-PYK1, CYC1pr-PYK1). We thank Professor Zhang Lab in Hubei University for technique support. This project was supported by funding from Hubei Collaborative Innovation Center for Green Transformation of Bio-resources (Shanshan Li), Hubei University start grant (080-170035 to Xilan Yu), Natural Science Foundation of Hubei Province (2016CFB103 to Xilan Yu), National Natural Science Foundation of China (No. 31671335 to Shanshan Li; No. 31600046 to Xilan Yu).	Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang L, 2012, NATURE, V489, P511, DOI 10.1038/489511a; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Liu XS, 2015, ONCOTARGET, V6, P4214, DOI 10.18632/oncotarget.2929; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; MCALISTER L, 1982, J BIOL CHEM, V257, P7181; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Sadhu MJ, 2013, GENETICS, V195, P831, DOI 10.1534/genetics.113.153981; Xu WY, 2016, GENET EPIGENETICS, V8, P43, DOI 10.4137/GEG.S32160; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yu X, 2017, ONCOGENE, V36, P2629, DOI 10.1038/onc.2016.410; Yu XL, 2017, ONCOTARGET, V8, P5619, DOI 10.18632/oncotarget.13639	27	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175576	10.1371/journal.pone.0175576	http://dx.doi.org/10.1371/journal.pone.0175576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426732	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900033
J	Cavaliere, FM; Prezzo, A; Bilotta, C; Iacobini, M; Quinti, I				Cavaliere, Filomena Monica; Prezzo, Alessandro; Bilotta, Caterina; Iacobini, Metello; Quinti, Isabella			The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; MEDIATED PHAGOCYTOSIS OCCURS; RHEUMATOID-ARTHRITIS; RESPIRATORY BURST; OXIDATIVE BURST; CROSS-LINKING; ACTIVATION; PROTEIN; MACROPHAGES; RECEPTORS	The lack of BTK in X-linked agammaglobulinemia (XLA) patients does not affect monocytes and polymorphonuclear cells (PMN) phenotype and functions. In this study, we show that XLA patients had an increased frequency of the intermediate monocytes subset and that BTK-deficient monocytes and PMN had a normal expression of receptors involved in the activation and cellular responses. We demonstrate that BTK is not required for migration, phagocytosis and the production of reactive oxygen species (ROS) following engagement of FC gamma receptors (Fc gamma R). XLA monocytes and PMN showed an efficient calcium (Ca2+)-independent activation of oxidative burst, suggesting that oxidative burst is less dependent by Ca2+ mobilization. The phagocytosis was functional and it remained unaltered also after Ca2+ chelation, confirming the independence of phagocytosis on Ca2+ mobilization. Intravenous immunoglobulin (IVIg) infusion exerted an anti-inflammatory effect by reducing the frequency of pro-inflammatory monocytes. In monocytes, the IVIg reduce the oxidative burst and phagocytosis even if these functions remained efficient.	[Cavaliere, Filomena Monica; Prezzo, Alessandro; Bilotta, Caterina; Quinti, Isabella] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Iacobini, Metello] Sapienza Univ Rome, Dept Pediat, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Quinti, I (corresponding author), Sapienza Univ Rome, Dept Mol Med, Rome, Italy.	isabella.quinti@uniroma1.it		Quinti, Isabella/0000-0002-3328-7584				Abolhassani H, 2015, ALLERGOL IMMUNOPATH, V43, P62, DOI 10.1016/j.aller.2013.09.013; Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Alinari L, 2015, CLIN PHARMACOL THER, V97, P469, DOI 10.1002/cpt.65; Amoras ALB, 2003, J INVEST ALLERG CLIN, V13, P181; Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; AUKRUST P, 1994, BLOOD, V84, P2136; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; CAMPANA D, 1990, J IMMUNOL, V145, P1675; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Casulli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026469; Cavaliere FM, 2015, INT IMMUNOPHARMACOL, V28, P596, DOI 10.1016/j.intimp.2015.07.017; Chear CT, 2015, GENE, V560, P245, DOI 10.1016/j.gene.2015.02.019; Choi OH, 1996, NATURE, V380, P634; CONLEY ME, 1985, J IMMUNOL, V134, P3070; Conley ME, 2002, J PEDIATR-US, V141, P566, DOI 10.1067/mpd.2002.127711; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Davids MS, 2014, FUTURE ONCOL, V10, P957, DOI 10.2217/fon.14.51; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Farrar JE, 1996, CLIN IMMUNOL IMMUNOP, V81, P271, DOI 10.1006/clin.1996.0188; Fiedler K, 2011, BLOOD, V117, P1329, DOI 10.1182/blood-2010-04-281170; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; KARIMI K, 1995, J IMMUNOL, V155, P5786; Kerr J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00629; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Krystufkova O, 2014, ANN RHEUM DIS, V73, pA20, DOI 10.1136/annrheumdis-2013-205124.47; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; KUIJPERS TW, 1993, J IMMUNOL, V151, P4934; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lehmann AK, 1998, CYTOMETRY, V33, P406, DOI 10.1002/(SICI)1097-0320(19981201)33:4<406::AID-CYTO3>3.0.CO;2-L; LENNARTZ MR, 1993, J LEUKOCYTE BIOL, V54, P389, DOI 10.1002/jlb.54.5.389; Lopez-Herrera G, 2014, J LEUKOCYTE BIOL, V95, P243, DOI 10.1189/jlb.0513307; Lougaris V, 2014, J ALLERGY CLIN IMMUN, V133, P1644, DOI 10.1016/j.jaci.2013.12.1085; Marron TU, 2010, CLIN IMMUNOL, V137, P74, DOI 10.1016/j.clim.2010.06.011; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Nair KS, 2001, CELL IMMUNOL, V208, P96, DOI 10.1006/cimm.2001.1772; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Norman P, 2016, EXPERT OPIN INV DRUG, V25, P891, DOI 10.1080/13543784.2016.1182499; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Paquin-Proulx D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00637; Plebani A, 2002, CLIN IMMUNOL, V104, P221, DOI 10.1006/clim.2002.5241; Prezzo A, 2016, CELL IMMUNOL, V306, P25, DOI 10.1016/j.cellimm.2016.05.006; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ren L, 2016, J BIOL CHEM, V291, P3043, DOI 10.1074/jbc.M115.687251; ROSALES C, 1994, P NATL ACAD SCI USA, V91, P3534, DOI 10.1073/pnas.91.9.3534; ROSALES C, 1992, J BIOL CHEM, V267, P5265; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Schroder AK, 2006, HUM IMMUNOL, V67, P676, DOI 10.1016/j.humimm.2006.05.004; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Smith SL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0868-y; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Suri D, 2016, INDIAN J PEDIATR, V83, P331, DOI 10.1007/s12098-015-2024-8; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Varma G, 2016, CLIN ADV HEMATOL ONC, V14, P543; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wu JJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0313-y; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	69	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175961	10.1371/journal.pone.0175961	http://dx.doi.org/10.1371/journal.pone.0175961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422989	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600071
J	Gasparinho, C; Piedade, J; Mirante, MC; Mendes, C; Mayer, C; Nery, SV; Brito, M; Istrate, C				Gasparinho, Carolina; Piedade, Joao; Mirante, Maria Clara; Mendes, Cristina; Mayer, Carlos; Nery, Susana Vaz; Brito, Miguel; Istrate, Claudia			Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MATERNAL EDUCATION; SURVEILLANCE NETWORK; STRAIN DIVERSITY; HIGH PREVALENCE; BURKINA-FASO; DIARRHEA; EPIDEMIOLOGY; MORTALITY; GENOTYPE	Background Rotavirus group A (RVA) is considered the leading cause of pediatric diarrhea, responsible for the high burden of diarrheal diseases in sub-Saharan Africa. Despite recent studies, the existent data are scarce for some African countries like Angola, a country with one of the highest RVA-related death estimates. The aim of this study was to determine the RVA detection rate and circulating genotypes in children less than five years of age with acute gastroenteritis attended at the Bengo General Hospital in Caxito, Bengo province, Angola, before vaccine introduction. Methods Between September 2012 and December 2013, 342 fecal specimens were collected from children enrolled. Positive samples for RVA by immunochromatographic rapid test were G and P-typed by hemi-nested type-specific multiplex PCR, and subgrouped for the VP6 gene. VP4 and VP7 genes from a subset of samples were sequenced for phylogenetic analysis. Results During the study period, a high RVA detection rate was registered (25.1%, 86/342). The age group most affected by RVA infection includes children under 6 months of age (p < 0.01). Vomiting was highly associated with RVA infection (72.1%; p < 0.001). From the 86 RVA-positive samples, 72 (83.7%) were genotyped. The most prevalent genotype was G1P[8] (34/72; 47.2%), followed by the uncommon G1P[6] (21/72; 29.2%), and G2P[4] (9/72; 12.5%). Only two G-types were found: G1 (60/72; 83.3%) and G2 (11/72; 15.3%). Among the P-genotypes, P[8] was the most prevalent (34/72; 47.2%), followed by P[6] (22/72; 30.6%) and P[4] (9/72; 12.5%). In the phylogenetic trees, the identified G and P-types clustered tightly together and with reference sequences in specific monophyletic groups, with highly significant bootstrap values (>= 92%). Conclusion This pre-vaccination study revealed, for the first time for Bengo province (Angola), the RVA genotype profile, including phylogenetic relationships, and a high RVA detection rate, supporting the immediate introduction of a RVA vaccine in the national immunization programme.	[Gasparinho, Carolina; Mirante, Maria Clara; Nery, Susana Vaz; Brito, Miguel] CISA, Caxito, Provincia Do Be, Angola; [Piedade, Joao; Mendes, Cristina; Istrate, Claudia] Univ Nova Lisboa, IHMT, Unidade Microbiol Med, GHTM, Lisbon, Portugal; [Mayer, Carlos] Hosp Geral Bengo, Caxito, Provincia Do Be, Angola; [Nery, Susana Vaz] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Brito, Miguel] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Australian National University; Universidade de Lisboa	Istrate, C (corresponding author), Univ Nova Lisboa, IHMT, Unidade Microbiol Med, GHTM, Lisbon, Portugal.	claudia.istrate@ihmt.unl.pt	Istrate, Claudia/H-3781-2011; Piedade, Joao/A-2132-2009; Brito, Miguel/A-7970-2016	Istrate, Claudia/0000-0003-4706-7598; Piedade, Joao/0000-0001-6384-1737; Brito, Miguel/0000-0001-6394-658X; Gasparinho, Carolina/0000-0002-0095-6155	Camoes Institute for Cooperation and Language; Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government; Ministry of Health of Angola	Camoes Institute for Cooperation and Language; Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government; Ministry of Health of Angola	This work was supported by Camoes Institute for Cooperation and Language, Calouste Gulbenkian Foundation, Angolan Ministry of Health, Bengo Provincial Government and the Ministry of Health of Angola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the children who participated and all caregivers who collaborated in this study. We would also like to thank all the CISA staff and the Bengo General Hospital, especially the clinical staff for their support and collaboration. We acknowledge Ines Cunha Portinha for participation in RVA genotyping and Aida Esteves for all the support in RVA studies throughout the years. We acknowledge the CISA project promoters: Camoes-Institute for Cooperation and Language, Calouste Gulbenkian Foundation, Angolan Ministry of Health, Bengo Provincial Government and the Ministry of Health of Angola, for their contribution in developing this study.	Angel J, 2014, HUM VACC IMMUNOTHER, V10, P3659, DOI 10.4161/hv.34361; [Anonymous], 2009, WHO CHILD GROWTH STA; Atherly D, 2009, J INFECT DIS, V200, pS28, DOI 10.1086/605033; Baker KK, 2013, AM J TROP MED HYG, V89, P214, DOI 10.4269/ajtmh.12-0256; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Breiman RF, 2012, VACCINE, V30, pA24, DOI 10.1016/j.vaccine.2011.08.124; Chilengi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150100; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; DARGENTMOLINA P, 1994, SOC SCI MED, V38, P343, DOI 10.1016/0277-9536(94)90404-9; Das S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146243; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Doro R, 2014, INFECT GENET EVOL, V28, P446, DOI 10.1016/j.meegid.2014.08.017; Esteves A, 2016, J MED VIROLOGY; Gasparinho C, 2016, PEDIATR INFECT DIS J, V35, pE28, DOI 10.1097/INF.0000000000000957; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Grepin KA, 2015, J HEALTH ECON, V44, P97, DOI 10.1016/j.jhealeco.2015.08.003; Hall TA, BIOEDIT USER FRIENDL; INE GdA, 2014, RES PREL REC GER POP; Instituto Nacional de Estatistica L Angola, 2016, RES DEF REC GER POP, V2014; Istrate C, 2015, ARCH VIROL, V160, P423, DOI 10.1007/s00705-014-2244-7; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Japhet MO, 2012, J MED VIROL, V84, P1489, DOI 10.1002/jmv.23343; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720; Mason J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059663; Mayindou G, 2015, J MED VIROL; Moon SS, 2016, CLIN INFECT DIS, V62, P157, DOI 10.1093/cid/civ828; Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1; Mukaratirwa A, 2014, PEDIATR INFECT DIS J, V33, pS45, DOI 10.1097/INF.0000000000000050; Mwenda JM, 2014, PEDIATR INFECT DIS J, V33, pS6, DOI 10.1097/INF.0000000000000174; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Neuzil KM, 2015, LANCET GLOB HEALTH, V3, pE510, DOI 10.1016/S2214-109X(15)00052-2; Ngabo F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149805; Nhampossa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119824; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Nordgren J, 2014, CLIN INFECT DIS, V59, P1567, DOI 10.1093/cid/ciu633; Nordgren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069557; Nordgren J, 2012, INFECT GENET EVOL, V12, P1892, DOI 10.1016/j.meegid.2012.08.014; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Plenge-Bonig A, 2010, EUR J PEDIATR, V169, P1471, DOI 10.1007/s00431-010-1245-0; Rudd C, 2015, VACCINE, V33, P3263, DOI 10.1016/j.vaccine.2015.04.002; Sanderson C, 2011, GLOBAL REV ROTAVIRUS; Steele AD, 2016, HUMAN VACCINES IMMUN, P1; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Thongprachum A, 2010, J VIROL METHODS, V168, P191, DOI 10.1016/j.jviromet.2010.05.013; Velasquez DE, 2014, INFECT GENET EVOL, V28, P561, DOI 10.1016/j.meegid.2014.10.008; Verkerke H, 2016, J CLIN MICROBIOL; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Welch H, 2013, PEDIATR INFECT DIS J, V32, P570, DOI 10.1097/INF.0b013e3182847295; Whittier CA, 2004, J VIROL METHODS, V116, P11, DOI 10.1016/j.jviromet.2003.10.003; WHO, 2009, WKLY EPIDEMIOL REC, V32, P325; World Health Organization, 2011, WHO ANTHR PERS COMP; Yang H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-19	58	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176046	10.1371/journal.pone.0176046	http://dx.doi.org/10.1371/journal.pone.0176046			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422995	Green Published, gold			2022-12-27	WOS:000399875600080
J	Kim, SY; Lee, E; Nam, SJ; Kim, EK; Moon, HJ; Yoon, JH; Han, KH; Kwak, JY				Kim, Soo-Yeon; Lee, Eunjung; Nam, Se Jin; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Han, Kyung Hwa; Kwak, Jin Young			Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma	PLOS ONE			English	Article							NODULES; RECURRENCE; FEATURES; US; PATTERN; BENIGN	This retrospective study aimed to evaluate whether ultrasound texture analysis is useful to predict lymph node metastasis in patients with papillary thyroid microcarcinoma (PTMC). This study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. Between May and July 2013, 361 patients (mean age, 43.8 +/- 11.3 years; range, 16-72 years) who underwent staging ultrasound (US) and subsequent thyroidectomy for conventional PTMC <= 10 mm between May and July 2013 were included. Each PTMC was manually segmented and its histogram parameters (Mean, Standard deviation, Skewness, Kurtosis, and Entropy) were extracted with Matlab software. The mean values of histogram parameters and clinical and US features were compared according to lymph node metastasis using the independent t-test and Chi-square test. Multivariate logistic regression analysis was performed to identify the independent factors associated with lymph node metastasis. Tumors with lymph node metastasis (n = 117) had significantly higher entropy compared to those without lymph node metastasis (n = 244) (mean +/- standard deviation, 6.268 +/- 0.407 vs. 6.171 +/-.0.405; P = .035). No additional histogram parameters showed differences in mean values according to lymph node metastasis. Entropy was not independently associated with lymph node metastasis on multivariate logistic regression analysis (Odds ratio, 0.977 [95% confidence interval (CI), 0.482-1.980]; P = .949). Younger age (Odds ratio, 0.962 [95% CI, 0.940-0.984]; P = .001) and lymph node metastasis on US (Odds ratio, 7.325 [95% CI, 3.573-15.020]; P < .001) were independently associated with lymph node metastasis. Texture analysis was not useful in predicting lymph node metastasis in patients with PTMC.	[Kim, Soo-Yeon; Nam, Se Jin; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Han, Kyung Hwa; Kwak, Jin Young] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea; [Lee, Eunjung] Yonsei Univ, Dept Computat Sci & Engn, Seoul, South Korea; [Kim, Soo-Yeon] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Seoul National University (SNU); Seoul National University Hospital	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea.	docjin@yuhs.ac	Lee, Eunjung/F-6671-2013; Kim, Eun-Kyung/E-5211-2017	Lee, Eunjung/0000-0001-9989-3555; Moon, Hee Jung/0000-0002-5643-5885; Han, Kyunghwa/0000-0002-5687-7237; Kwak, Jin Young/0000-0002-6212-1495; Kim, Eun-Kyung/0000-0002-3368-5013; Yoon, Jung Hyun/0000-0002-2100-3513	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03930375]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Choi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Haugen BM, 2015, THYROID, V2015; Hay Ian D, 2007, Endocr Pract, V13, P521; Huang Y, 2016, RADIOLOGY; Ito Y, 2005, WORLD J SURG, V29, P1007, DOI 10.1007/s00268-005-7834-9; Ito Y, 2014, ENDOCR J, V61, P205, DOI 10.1507/endocrj.EJ13-0403; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim J-H, 2016, RADIOLOGY; Kim KE, 2013, WORLD J SURG, V37, P385, DOI 10.1007/s00268-012-1826-3; Kim SY, 2015, RADIOLOGY, V277, P574, DOI 10.1148/radiol.2015142470; Kim SY, 2015, AM J ROENTGENOL, V205, pW343, DOI 10.2214/AJR.14.13825; Kim YM, 2012, ANN AM ACAD POLIT SS, V644, P147, DOI 10.1177/0002716212456008; Kwak JY, 2009, ANN SURG ONCOL, V16, P1348, DOI 10.1245/s10434-009-0384-x; Lim YC, 2009, BRIT J SURG, V96, P253, DOI 10.1002/bjs.6484; Mazzaferri Ernest L, 2007, Endocr Pract, V13, P498; Moon HJ, 2012, ANN SURG ONCOL, V19, P2279, DOI 10.1245/s10434-011-2212-3; Moon HJ, 2012, ULTRASOUND MED BIOL, V38, P568, DOI 10.1016/j.ultrasmedbio.2012.01.002; Nam SY, 2013, J CLIN ENDOCR METAB, V98, P1476, DOI 10.1210/jc.2012-4072; Nam SJ, 2016, J ULTRAS MED, V35, P775, DOI 10.7863/ultra.15.05055; Park VY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004292; Pazaitou-Panayiotou K, 2007, THYROID, V17, P1085, DOI 10.1089/thy.2007.0005; Roh JL, 2008, ANN SURG ONCOL, V15, P2482, DOI 10.1245/s10434-008-0044-6; Roti E, 2008, EUR J ENDOCRINOL, V159, P659, DOI 10.1530/EJE-07-0896; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siddiqui S, 2016, THYROID, V26, P807, DOI 10.1089/thy.2015.0429; So YK, 2010, SURGERY, V148, P526, DOI 10.1016/j.surg.2010.01.003; Son JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104066; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Zeng RC, 2012, CLIN TRANSL ONCOL, V14, P842, DOI 10.1007/s12094-012-0875-2; Zhou YL, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-67	36	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176103	10.1371/journal.pone.0176103	http://dx.doi.org/10.1371/journal.pone.0176103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419171	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200072
J	Poorolajal, J; Zeraati, F; Soltanian, AR; Sheikh, V; Hooshmand, E; Maleki, A				Poorolajal, Jalal; Zeraati, Fatemeh; Soltanian, Ali Reza; Sheikh, Vida; Hooshmand, Elham; Maleki, Akram			Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; BLOOD-PRESSURE; SYSTEMATIC REVIEWS; DIETARY POTASSIUM; DOUBLE-BLIND; SODIUM; MAGNESIUM; REDUCTION; BIAS; KCL	Importance Increased dietary potassium intake is thought to be associated with low blood pressure (BP). Whether potassium supplementation may be used as an antihypertensive agent is a question that should be answered. Objective To assess the effect of oral potassium supplementation on blood pressure in patients with primary hypertension. Search methods We searched Medline, Web of Science, Scopus, Cochrane Central Register of Controlled Trials until October 2016. We also screened reference lists of articles and previous reviews. We applied no language restrictions. Selection criteria We included randomized placebo-controlled clinical trials addressing the effect of potassium supplementation on primary hypertension for a minimum of 4 weeks. Data collection and analysis We extracted data on systolic and diastolic BP (SBP and DBP) at the final follow-up. We explored the heterogeneity across studies using Cochran's test and I-2 statistic and assessed the probability of publication bias using Begg's and Egger's tests. We reported the mean difference (MD) of SBP and DBP in a random-effects model. Results We found a total of 9059 articles and included 23 trials with 1213 participants. Compared to placebo, potassium supplementation resulted in modest but significant reductions in both SBP (MD -4.25 mmHg; 95% CI: -5.96 to -2.53; I-2 = 41%) and DBP (MD -2.53 mmHg; 95% CI: -4.05 to -1.02; I-2 = 65%). According to the change-score analysis, based on 8 out of 23 trials, compared to baseline, the mean changes in SBP (MD -8.89 mmHg; 95% CI: -13.67 to -4.11) and DBP (MD -6.42 mmHg; 95% CI: -10.99 to -1.84) was significantly higher in the intervention group than the control group. Conclusions Our findings indicated that potassium supplementation is a safe medication with no important adverse effects that has a modest but significant impact BP and may be recommended as an adjuvant antihypertensive agent for patients with essential hypertension.	[Poorolajal, Jalal; Maleki, Akram] Hamadan Univ Med Sci, Dept Epidemiol, Sch Publ Hlth, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Res Ctr Hlth Sci, Hamadan, Iran; [Poorolajal, Jalal; Soltanian, Ali Reza] Hamadan Univ Med Sci, Noncommunicable Dis Res Ctr, Hamadan, Iran; [Zeraati, Fatemeh] Hamadan Univ Med Sci, Med Plants & Nat Prod Res Ctr, Hamadan, Iran; [Soltanian, Ali Reza] Hamadan Univ Med Sci, Dept Biostat, Sch Publ Hlth, Hamadan, Iran; [Sheikh, Vida] Hamadan Univ Med Sci, Sch Med, Dept Internal Med, Hamadan, Iran; [Hooshmand, Elham] Neyshabur Univ Med Sci, Dept Publ Hlth, Neyshabur, Iran		Maleki, A (corresponding author), Hamadan Univ Med Sci, Dept Epidemiol, Sch Publ Hlth, Hamadan, Iran.	arak.maleki@gmail.com	hooshmand, elham/F-6030-2018; Soltanian, Ali Reza/AAV-9146-2020; Poorolajal, Jalal/D-3506-2013; Soltanian, Ali Reza/L-2231-2017; Sheikh, Vida/F-6815-2017	hooshmand, elham/0000-0003-1801-493X; Soltanian, Ali Reza/0000-0002-7483-3502; Soltanian, Ali Reza/0000-0002-7483-3502; Zeraati, fatemeh/0000-0002-1678-954X; Sheikh, Vida/0000-0001-6545-2954	Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	The Vice-Chancellor for Research and Technology, the Hamadan University of Medical Sciences.; This was part of the MSc thesis in Epidemiology. We would like to appreciate the Vice-Chancellor for Research and Technology of the Hamadan University of Medical Sciences for supporting this work.	Aburto Nancy J, 2013, BMJ, V346, pf1378, DOI 10.1136/bmj.f1378; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Binia A, 2015, J HYPERTENS, V33, P1509, DOI 10.1097/HJH.0000000000000611; Buemi M, 2002, MED RES REV, V22, P419, DOI 10.1002/med.10013; Burgess E, 1999, CAN MED ASSOC J, V160, pS35; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickinson HO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004641.pub2; Dietary Guidelines Advisory Committee, 2005, REP DIET GUID ADV CO; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FORRESTER TE, 1988, W INDIAN MED J, V37, P92; FOTHERBY MD, 1992, J HYPERTENS, V10, P1403, DOI 10.1097/00004872-199211000-00013; Franzoni F, 2005, BIOMED PHARMACOTHER, V59, P25, DOI 10.1016/j.biopha.2004.11.002; Gijsbers L, 2015, J HUM HYPERTENS, V29, P592, DOI 10.1038/jhh.2015.3; GRIMM RH, 1988, J HYPERTENS, V6, pS591, DOI 10.1097/00004872-198812040-00185; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; He FJ, 2010, HYPERTENSION, V55, P681, DOI 10.1161/HYPERTENSIONAHA.109.147488; HESELTINE D, 1990, AGE AGEING, V19, P409, DOI 10.1093/ageing/19.6.409; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KAPLAN NM, 1985, NEW ENGL J MED, V312, P746, DOI 10.1056/NEJM198503213121203; Kawano Y, 1998, AM J HYPERTENS, V11, P1141, DOI 10.1016/S0895-7061(98)00037-5; KHAW KT, 1988, CIRCULATION, V77, P53, DOI 10.1161/01.CIR.77.1.53; LAWTON WJ, 1990, CIRCULATION, V81, P173, DOI 10.1161/01.CIR.81.1.173; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MACGREGOR GA, 1982, LANCET, V2, P567; MACGREGOR GA, 1984, J CARDIOVASC PHARM, V6, pS244, DOI 10.1097/00005344-198400061-00038; Maleki Akram, 2016, Clin Hypertens, V22, P18, DOI 10.1186/s40885-016-0054-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; OBEL AO, 1989, J CARDIOVASC PHARM, V14, P294, DOI 10.1097/00005344-198908000-00016; PATKI PS, 1990, BRIT MED J, V301, P521, DOI 10.1136/bmj.301.6751.521; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Rahimi ARO, 2007, PAK J MED SCI, V23, P589; RICHARDS AM, 1984, LANCET, V1, P757, DOI 10.1016/S0140-6736(84)91276-5; Sawka MN, 2000, AM J CLIN NUTR, V72, p564S, DOI 10.1093/ajcn/72.2.564S; SIANI A, 1991, ANN INTERN MED, V115, P753, DOI 10.7326/0003-4819-115-10-753; SIANI A, 1987, BMJ-BRIT MED J, V294, P1453, DOI 10.1136/bmj.294.6585.1453; SMITH SJ, 1985, BMJ-BRIT MED J, V290, P110, DOI 10.1136/bmj.290.6462.110; SVETKEY LP, 1987, HYPERTENSION, V9, P444, DOI 10.1161/01.HYP.9.5.444; VALDES G, 1991, J HUM HYPERTENS, V5, P91; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organization, 2014, GUID POT INT AD CHIL; Wu GR, 2006, CLIN EXP HYPERTENS, V28, P489, DOI 10.1080/10641960600798705	45	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0174967	10.1371/journal.pone.0174967	http://dx.doi.org/10.1371/journal.pone.0174967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419159	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200006
J	Zhang, X; Liu, WZ; Wang, X				Zhang, Xin; Liu, Wenzhe; Wang, Xin			How the ovules get enclosed in magnoliaceous carpels	PLOS ONE			English	Article							VASCULAR ANATOMY; ANGIOSPERM; FLOWER; MORPHOLOGY; EVOLUTION	Angiosperms distinguish themselves from gymnosperms by their ovules that are enclosed before pollination. However, how the ovules get enclosed in angiosperms remains a mystery, especially for Magnoliaceae. The only key to this mystery is finding a series of carpels transitional from fully closed with enclosed ovules to open with naked ovules. We use routine paraffin section technology, LM, SEM to document the morphology and anatomy of carpel variation in Michelia figo (Magnoliaceae). A series of carpel variations within a single flower of Michelia figo (Magnoliaceae) are documented, in which the ovules are exposed in atypical carpels. These atypical and typical carpels for the first time demonstrate clearly how the naked ovule get enclosed. Each atypical carpel, with naked ovules, clearly comprises two parts, namely, subtending foliar part and branches bearing ovules, suggesting that a typical carpel is actually an end-product of the fusion between the ovuliferous branches and subtending foliar parts. The only difference among these carpels is the extent of fusion between these two parts. This generalization is in full agreement with the molecular genetic studies on angiosperm flowers.	[Zhang, Xin] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China; [Liu, Wenzhe] Northwest Univ Xian, Coll Life Sci, Xian, Peoples R China; [Wang, Xin] Chinese Acad Sci, State Key Lab Palaeobiol & Stratig, Nanjing Inst Geol & Palaeontol, Nanjing, Jiangsu, Peoples R China	Northwest A&F University - China; Northwest University Xi'an; Chinese Academy of Sciences	Wang, X (corresponding author), Chinese Acad Sci, State Key Lab Palaeobiol & Stratig, Nanjing Inst Geol & Palaeontol, Nanjing, Jiangsu, Peoples R China.	xinwang@nigpas.ac.cn	Zhang, Xin/AAF-3053-2019	Zhang, Xin/0000-0003-0669-8342	National Basic Research Program of China (973 Program) [2012CB821901]; Research Fund for the Doctoral Program of Higher Education of China [Z109021501]; Fundamental Research Funds for the Central Universities [Z109021614]; National Forestry Industry Research Special Funds for Public Welfare Projects (China) [201404302]; National Natural Science Foundation of China [41688103]; Strategic Priority Research Program (B) of Chinese Academy of Sciences [XDB18000000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Forestry Industry Research Special Funds for Public Welfare Projects (China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of Chinese Academy of Sciences	This research is supported by the National Basic Research Program of China (973 Program 2012CB821901), Research Fund for the Doctoral Program of Higher Education of China (Z109021501), the Fundamental Research Funds for the Central Universities (Z109021614), National Forestry Industry Research Special Funds for Public Welfare Projects (China) (201404302), National Natural Science Foundation of China (41688103), Strategic Priority Research Program (B) of Chinese Academy of Sciences (Grant No. XDB18000000).; We appreciate the generous support from the Botanical Garden of the Ruhr University Bochum allowing us to collect the material for the present study. This research is supported by the National Basic Research Program of China (973 Program 2012CB821901), Research Fund for the Doctoral Program of Higher Education of China (Z109021501), the Fundamental Research Funds for the Central Universities (Z109021614), National Forestry Industry Research Special Funds for Public Welfare Projects (China) (201404302), National Natural Science Foundation of China (41688103), Strategic Priority Research Program (B) of Chinese Academy of Sciences (Grant No. XDB18000000).	[Anonymous], 1907, J LINN SOC LOND BOT, DOI DOI 10.1111/J.1095-8339.1907.TB01074.X; APG III, 2009, BOT J LINN SOC, V161, P105, DOI DOI 10.1111/J.1095-8339.2009.00996.X; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; CANRIGHT JE, 1960, AM J BOT, V47, P145, DOI 10.2307/2439049; Cronquist A., 1988, EVOLUTION CLASSIFICA; Eames AJ, 1961, MORPHOLOGY ANGIOSPER; Eckardt T, 1954, BERICHTE DTSCH BOT G, V67, P113; Endress PK, 2009, AM J BOT, V96, P22, DOI 10.3732/ajb.0800047; Florin R., 1949, ACTA HORTI BERGIANI, V15, P79; Gerstberger P, 1993, B JARDIN BOT NATL BE, V62, P69; Guo XM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00391; Liu WZ, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-28; Mathews S, 2012, NEW PHYTOL, V194, P910, DOI 10.1111/j.1469-8137.2012.04091.x; MEEUSE A.D.J., 1963, ACTA BIOTHEOR, V16, P127, DOI 10.1007/BF01556603; OMORI Y, 1993, J PLANT RES, V106, P249, DOI 10.1007/BF02344593; Roe JL, 1997, PLANT CELL, V9, P335, DOI 10.1105/tpc.9.3.335; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Taylor D.W., 1996, FLOWERING PLANT ORIG; Tomlinson PB, 2002, CAN J BOT, V80, P1250, DOI [10.1139/B02-112, 10.1139/b02-112]; Wang X., 2010, THE DAWN ANGIOSPERMS; Wang Xin, 2012, Palaeoworld, V21, P193, DOI 10.1016/j.palwor.2012.10.002; Zhou ZY, 2003, NATURE, V423, P821, DOI 10.1038/423821a	24	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174955	10.1371/journal.pone.0174955	http://dx.doi.org/10.1371/journal.pone.0174955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430814	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100009
J	Chen, YW; Li, CH; Yang, CD; Liu, CH; Chen, CH; Sheu, JJ; Lin, SK; Chen, AC; Chen, PK; Chen, PL; Yeh, CH; Chen, JR; Hsiao, YJ; Lin, CH; Hsu, SP; Chen, TS; Sung, SF; Yu, SC; Muo, CH; Wen, CP; Sung, FC; Jeng, JS; Hsu, CY				Chen, Yu-Wei; Li, Chen-Hua; Yang, Chih-Dong; Liu, Chung-Hsiang; Chen, Chih-Hung; Sheu, Jau-Jiuan; Lin, Shinn-Kuang; Chen, An-Chih; Chen, Ping-Kun; Chen, Po-Lin; Yeh, Chung-Hsin; Chen, Jiunn-Rong; Hsiao, Yu-Jen; Lin, Ching-Huang; Hsu, Shih-Pin; Chen, Tsang-Shan; Sung, Sheng-Feng; Yu, Shih-Chieh; Muo, Chih-Hsin; Wen, Chi Pang; Sung, Fung-Chang; Jeng, Jiann-Shing; Hsu, Chung Y.		Taiwan Stroke Registry Investigato	Low cholesterol level associated with severity and outcome of spontaneous intracerebral hemorrhage: Results from Taiwan Stroke Registry	PLOS ONE			English	Article							BODY-MASS INDEX; COA REDUCTASE INHIBITORS; CORONARY-HEART-DISEASE; RISK-FACTORS; STATIN USE; CEREBRAL-HEMORRHAGE; LDL CHOLESTEROL; LIPID-LEVELS; METAANALYSIS; MORTALITY	The relationship between cholesterol level and hemorrhagic stroke is inconclusive. We hypothesized that low cholesterol levels may have association with intracerebral hemorrhage (ICH) severity at admission and 3-month outcomes. This study used data obtained from a multi-center stroke registry program in Taiwan. We categorized acute spontaneous ICH patients, based on their baseline levels of total cholesterol (TC) measured at admission, into 3 groups with <160, 160-200 and >200 mg/dL of TC. We evaluated risk of having initial stroke severity, with National Institutes of Health Stroke Scale (NIHSS) >15 and unfavorable outcomes (modified Rankin Scale [mRS] score >2, 3-month mortality) after ICH by the TC group. A total of 2444 ICH patients (mean age 62.5 +/- 14.2 years; 64.2% men) were included in this study and 854 (34.9%) of them had baseline TC <160 mg/dL. Patients with TC <160 mg/dL presented more often severe neurological deficit (NIHSS >15), with an adjusted odds ratio [aOR] of 1.80; 95% confidence interval [CI], 1.41-2.30), and 3-month mRS >2 (aOR, 1.41; 95% CI, 1.11-1.78) using patients with TC >200 mg/dL as reference. Those with TC >160 mg/dL and body mass index (BMI) <22 kg/m(2) had higher risk of 3-month mortality (aOR 3.94, 95% CI 1.76-8.80). Prior use of lipid-lowering drugs (2.8% of the ICH population) was not associated with initial severity and 3-month outcomes. A total cholesterol level lower than 160 mg/dL was common in patients with acute ICH and was associated with greater neurological severity on presentation and poor 3-month outcomes, especially with lower BMI.	[Chen, Yu-Wei; Li, Chen-Hua; Jeng, Jiann-Shing] Taiwan Landseed Hosp, Dept Neurol, Taoyuan, Taiwan; [Chen, Yu-Wei; Li, Chen-Hua] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Yang, Chih-Dong] Taiwan Landseed Hosp, Dept Neurosurg, Taoyuan, Taiwan; [Liu, Chung-Hsiang] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Chen, Chih-Hung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Shinn-Kuang] Tzu Chi Univ, Taipei Tzu Chi Hosp, Dept Neurol, Hualien, Taiwan; [Lin, Shinn-Kuang] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, An-Chih] Chung Shan Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Chen, Ping-Kun] Lin Shin Hosp, Dept Neurol, Taichung, Taiwan; [Chen, Po-Lin] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yeh, Chung-Hsin] Yuan Rung Hosp, Dept Neurol, Changhua, Taiwan; [Yeh, Chung-Hsin] Dayeh Univ, Dept Sport & Hlth Management, Changhua, Taiwan; [Yeh, Chung-Hsin] Hung Kuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Chen, Jiunn-Rong] Yunlin Christian Hosp, Dept Neurol, Xiluo, Yunlin, Taiwan; [Hsiao, Yu-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Yunlin Branch, Xiluo, Yunlin, Taiwan; [Lin, Ching-Huang] Kaohsiung Vet Gen Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Shih-Pin] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chen, Tsang-Shan] Sin Lau Hosp, Dept Neurol, Tainan, Taiwan; [Sung, Sheng-Feng] ChiaYi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Yu, Shih-Chieh] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wen, Chi Pang] Natl Hlth Res Inst, Miaoli, Taiwan; [Wen, Chi Pang; Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; Taipei Medical University Hospital; Tzu Chi University; Tzu Chi University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Da Yeh University; Hungkuang University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital; E-Da Hospital; Chia-Yi Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Jeng, JS (corresponding author), Taiwan Landseed Hosp, Dept Neurol, Taoyuan, Taiwan.; Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Jeng, JS (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	fcsung1008@yahoo.com.tw; jsjeng@ntu.edu.tw		JENG, JIANN-SHING/0000-0002-1456-3686; Hsu, Chung Y./0000-0002-5632-2733	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; China Medical University Hospital; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank Stroke Biosignature Project; China Medical University Hospital; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bazzano LA, 2010, ANN NEUROL, V67, P11, DOI 10.1002/ana.21950; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; Biffi A, 2011, NEUROLOGY, V76, P1581, DOI 10.1212/WNL.0b013e3182194be9; Biffi A, 2011, STROKE, V42, P2526, DOI 10.1161/STROKEAHA.111.617225; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Dowlatshahi D, 2012, STROKE; Eichel R, 2010, EUR J NEUROL, V17, P78, DOI 10.1111/j.1468-1331.2009.02747.x; FitzMaurice E, 2008, STROKE, V39, P2151, DOI 10.1161/STROKEAHA.107.508861; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Hackam DG, 2011, CIRCULATION, V124, P2233, DOI 10.1161/CIRCULATIONAHA.111.055269; Hanger HC, 2007, J NEUROL NEUROSUR PS, V78, P836, DOI 10.1136/jnnp.2006.106500; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kita Y, 2009, INT J STROKE, V4, P241, DOI 10.1111/j.1747-4949.2009.00293.x; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Lei C, 2014, EUR J NEUROL, V21, P192, DOI 10.1111/ene.12273; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Ramirez-Moreno JM, 2009, STROKE, V40, P1917, DOI 10.1161/STROKEAHA.108.536698; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mustanoja S, 2013, STROKE, V44, P2330, DOI 10.1161/STROKEAHA.113.001829; Noda H, 2009, CIRCULATION, V119, P2136, DOI 10.1161/CIRCULATIONAHA.108.795666; Pezzini A, 2016, J NEUROL NEUROSUR PS, V87, P924, DOI 10.1136/jnnp-2015-312736; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rodriguez-Luna D, 2011, STROKE, V42, P2447, DOI 10.1161/STROKEAHA.110.609461; Roquer J, 2005, NEUROLOGY, V65, P1198, DOI 10.1212/01.wnl.0000180968.26242.4a; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092388; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woo D, 2004, STROKE, V35, P1360, DOI 10.1161/01.STR.0000127786.16612.A4; Woo D, 2013, STROKE, V44, P3013, DOI 10.1161/STROKEAHA.113.001304; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; Yeh SJ, 2014, STROKE, V45, P2636, DOI 10.1161/STROKEAHA.114.005598; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	49	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0171379	10.1371/journal.pone.0171379	http://dx.doi.org/10.1371/journal.pone.0171379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422955	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600004
J	Sponchiado, M; Gomes, NS; Fontes, PK; Martins, T; del Collado, M; Pastore, AD; Pugliesi, G; Nogueira, MFG; Binelli, M				Sponchiado, Mariana; Gomes, Nathalia Souza; Fontes, Patricia Kubo; Martins, Thiago; del Collado, Maite; Pastore, Athos de Assumpcao; Pugliesi, Guilherme; Gouveia Nogueira, Marcelo Fabio; Binelli, Mario			Pre-hatching embryo-dependent and -independent programming of endometrial function in cattle	PLOS ONE			English	Article							GENE-EXPRESSION; BOVINE ENDOMETRIUM; MESSENGER-RNA; EXTRACELLULAR-MATRIX; ESTROUS-CYCLE; BEEF HEIFERS; INTERFERON; PREGNANCY; PROGESTERONE; TROPHOBLAST	The bovine pre-implantation embryo secretes bioactive molecules from early development stages, but effects on endometrial function are reported to start only after elongation. Here, we interrogated spatially defined regions of the endometrium transcriptome for responses to a day 7 embryo in vivo. We hypothesize that exposure to an embryo changes the abundance of specific transcripts in the cranial region of the pregnant uterine horn. Endometrium was collected from the uterotubal junction (UTJ), anterior (IA), medial (IM) and posterior (IP) regions of the uterine horn ipsilateral to the CL 7 days after estrus from sham-inseminated (Con) or artificially inseminated, confirmed pregnant (Preg) cows. Abundance of 86 transcripts was evaluated by qPCR using a microfluidic platform. Abundance of 12 transcripts was modulated in the Preg endometrium, including classical interferon-stimulated genes (ISG15, MX1, MX2 and OAS1Y), prostaglandin biosynthesis genes (PTGES, HPGD and AKR1C4), water channel (AQP4) and a solute transporter (SLC1A4) and this was in the UTJ and IA mainly. Additionally, for 71 transcripts, abundance varied according to region of the reproductive tract. Regulation included downregulation of genes associated with proliferation (IGF1, IGF2, IGF1R and IGF2R) and extracellular matrix remodeling (MMP14, MMP19 and MMP2) and upregulation of anti-adhesive genes (MUC1) in the cranial regions of uterine horn. Physical proximity to the embryo provides paracrine regulation of endometrial function. Embryo-independent regulation of the endometrial transcriptome may support subsequent stages of embryo development, such as elongation and implantation. We speculate that successful early embryo-dependent and -independent programming fine-tune endometrial functions that are important for maintenance of pregnancy in cattle.	[Sponchiado, Mariana; Gomes, Nathalia Souza; Martins, Thiago; Binelli, Mario] Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, SP, Brazil; [Fontes, Patricia Kubo] Sao Paulo State Univ, Dept Pharmacol, Botucatu, SP, Brazil; [del Collado, Maite] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Pastore, Athos de Assumpcao] Androvet, Sertaozinho, SP, Brazil; [Pugliesi, Guilherme] Minas Gerais Fed Univ, Sch Vet, Dept Clin & Surg Vet, Belo Horizonte, MG, Brazil; [Gouveia Nogueira, Marcelo Fabio] Sao Paulo State Univ, Dept Biol Sci, Assis, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Binelli, M (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, SP, Brazil.	binelli@usp.br	Pugliesi, Guilherme/AAK-9557-2020; del Collado, Maite/M-4870-2015; Nogueira, Marcelo Fábio Gouveia/D-9801-2012; pugliesi, Guilherme/A-9149-2013; Fontes, Patricia Kubo/R-8362-2017; Binelli, Mario/I-5991-2013	Pugliesi, Guilherme/0000-0001-5739-0677; del Collado, Maite/0000-0002-4098-4855; Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; Fontes, Patricia Kubo/0000-0002-4280-9575; Binelli, Mario/0000-0002-5995-3944	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03226-4]; NSG [2015/21831-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSG	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): MS; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): MB (grant number 2011/03226-4) and NSG (grant number 2015/21831-3).	Araujo ER, 2015, REPROD FERTILITY DEV; Arosh JA, 2004, ENDOCRINOLOGY, V145, P5280, DOI 10.1210/en.2004-0587; Arosh JA, 2016, J DAIRY SCI; Austin KJ, 1996, BIOL REPROD, V54, P600, DOI 10.1095/biolreprod54.3.600; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bazer FW, 2011, BIOL REPROD, V85, P1094, DOI 10.1095/biolreprod.111.094722; Beal WE, 1998, THERIOGENOLOGY, V49, P241, DOI 10.1016/S0093-691X(98)90594-5; Beltman ME, 2010, REPROD FERT DEVELOP, V22, P987, DOI 10.1071/RD09302; Bowen JA, 1997, BIOL REPROD, V56, P409, DOI 10.1095/biolreprod56.2.409; CAMERON IT, 1993, J REPROD FERTIL, V98, P251; CAMERON IT, 1995, J STEROID BIOCHEM, V53, P209, DOI 10.1016/0960-0760(95)00048-5; Correia-Alvarez E, 2015, J REPROD IMMUNOL, V110, P1, DOI 10.1016/j.jri.2015.03.006; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dyce KM, 2004, TRATADO DE ANATOMIA; Emond V, 1998, BIOL REPROD, V58, P143, DOI 10.1095/biolreprod58.1.143; FARIN CE, 1989, MOL ENDOCRINOL, V3, P1099, DOI 10.1210/mend-3-7-1099; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Guillomot M, 1999, PLACENTA, V20, P339, DOI 10.1053/plac.1998.0385; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; Guillomot M., 1994, J REPROD FERTILITY S, V49, P39; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; HEALD PJ, 1979, BIOL REPROD, V20, P1195, DOI 10.1095/biolreprod20.5.1195; HOOK SJ, 1968, J MORPHOL, V125, P159, DOI 10.1002/jmor.1051250204; Kane MT, 1997, HUM REPROD UPDATE, V3, P137, DOI 10.1093/humupd/3.2.137; Kubisch HM, 1998, MOL REPROD DEV, V49, P254, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;254::AID-MRD5&gt;3.0.CO;2-N; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; MAGNESS RR, 1981, PROSTAG LEUKOTR ESS, V6, P389, DOI 10.1016/0161-4630(81)90071-9; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Mesquita FS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129031; Michael DD, 2006, ENDOCRINOLOGY, V147, P3571, DOI 10.1210/en.2006-0234; NEWCOMB R, 1980, J REPROD FERTIL, V59, P31, DOI 10.1530/jrf.0.0590031; Parent M, 2006, REPRODUCTION, V131, P573, DOI 10.1530/rep.1.00804; Pfarrer C, 2003, PLACENTA, V24, P588, DOI 10.1016/S0143-4004(03)00059-6; POPE WF, 1982, ANAT RECORD, V203, P245, DOI 10.1002/ar.1092030206; Pugliesi G, 2016, THERIOGENOLOGY, V85, P1239, DOI [10.1016/j.theriogenology.2015.12.006, 10.1016/j.theriogenology.20]; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; Robinson RS, 2006, MOL REPROD DEV, V73, P470, DOI 10.1002/mrd.20431; Salamonsen LA, 2013, FERTILITY STERILITY; Scenna FN, 2004, PROSTAG OTH LIPID M, V73, P215, DOI 10.1016/j.prostaglandins.2004.02.001; Scolari SC, DYNAMIC REMODELING E; Seals RC, 1998, PROSTAG OTH LIPID M, V56, P377, DOI 10.1016/S0090-6980(98)00063-X; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer TE, 2015, ADV ANAT EMBRYOL CEL, V216, P105, DOI 10.1007/978-3-319-15856-3_7; Spencer TE, 2013, REPRODUCTION, V146, P377, DOI 10.1530/REP-13-0165; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639; Thatcher WW, 2001, THERIOGENOLOGY, V56, P1435, DOI 10.1016/S0093-691X(01)00645-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; WROBEL KH, 1993, CELL TISSUE RES, V271, P227, DOI 10.1007/BF00318609; Wydooghe E, 2015, BIOL REV; Zhu C, 2015, FRONT BIOSCI-LANDMRK, V20, P838, DOI 10.2741/4341	54	70	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175954	10.1371/journal.pone.0175954	http://dx.doi.org/10.1371/journal.pone.0175954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423001	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600069
J	Takamochi, K; Mogushi, K; Kawaji, H; Imashimizu, K; Fukui, M; Oh, S; Itoh, M; Hayashizaki, Y; Ko, W; Akeboshi, M; Suzuki, K				Takamochi, Kazuya; Mogushi, Kaoru; Kawaji, Hideya; Imashimizu, Kota; Fukui, Mariko; Oh, Shiaki; Itoh, Masayoshi; Hayashizaki, Yoshihide; Ko, Weijey; Akeboshi, Masao; Suzuki, Kenji			Correlation of EGFR or KRAS mutation status with F-18-FDG uptake on PET-CT scan in lung adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; DIFFERENTIAL EXPRESSION ANALYSIS; LARGE GENE LISTS; GLUCOSE-TRANSPORTER; SENSITIVE DETECTION; FDG-PET; CANCER; BIOINFORMATICS; GLUT-1	Background F-18-fluoro-2-deoxy-glucose (F-18-FDG) positron emission tomography (PET) is a functional imaging modality based on glucose metabolism. The correlation between EGFR or KRAS mutation status and the standardized uptake value (SUV) of F-18-FDG PET scanning has not been fully elucidated. Methods Correlations between EGFR or KRAS mutation status and clinicopathological factors including SUVmax were statistically analyzed in 734 surgically resected lung adenocarcinoma patients. Molecular causal relationships between EGFR or KRAS mutation status and glucose metabolism were then elucidated in 62 lung adenocarcinomas using cap analysis of gene expression (CAGE), a method to determine and quantify the transcription initiation activities of mRNA across the genome. Results EGFR and KRAS mutations were detected in 334 (46%) and 83 (11%) of the 734 lung adenocarcinomas, respectively. The remaining 317 (43%) patients had wild-type tumors for both genes. EGFR mutations were more frequent in tumors with lower SUVmax. In contrast, no relationship was noted between KRAS mutation status and SUVmax. CAGE revealed that 4 genes associated with glucose metabolism (GPI, G6PD, PKM2, and GAPDH) and 5 associated with the cell cycle (ANLN, PTTG1, CIT, KPNA2, and CDC25A) were positively correlated with SUVmax, although expression levels were lower in EGFR-mutated than in wildtype tumors. No similar relationships were noted with KRAS mutations. Conclusions EGFR-mutated adenocarcinomas are biologically indolent with potentially lower levels of glucose metabolism than wild-type tumors. Several genes associated with glucose metabolism and the cell cycle were specifically down-regulated in EGFR-mutated adenocarcinomas.	[Takamochi, Kazuya; Imashimizu, Kota; Fukui, Mariko; Oh, Shiaki; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan; [Mogushi, Kaoru] Juntendo Univ, Sch Med, Ctr Genom & Regenerat Med, Tokyo, Japan; [Kawaji, Hideya; Itoh, Masayoshi; Hayashizaki, Yoshihide] RIKEN Adv Ctr Comp & Commun, Prevent Med & Appl Genom Unit, Yokohama, Kanagawa, Japan; [Kawaji, Hideya] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Ko, Weijey; Akeboshi, Masao] Yotsuya Med Cube, Diagnost Imaging Ctr, Tokyo, Japan	Juntendo University; Juntendo University; RIKEN; RIKEN	Takamochi, K (corresponding author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan.	ktakamo@juntendo.ac.jp	Kawaji, Hideya/N-5116-2015; Itoh, Masayoshi/N-5363-2015	Kawaji, Hideya/0000-0002-0575-0308; Itoh, Masayoshi/0000-0002-1772-318X; Mogushi, Kaoru/0000-0002-2618-8684	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by a Grant-in-Aid for Scientific Research (C) to Kazuya Takamochi, a Smoking Research Foundation to Kazuya Takamochi, a Research Grant for the RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki, and a Research Grant to the RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT to Yoshihide Hayashizaki.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Baselga J, 2002, ONCOLOGIST, V7, P2; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hattori A, 2014, INTERACT CARDIOV TH, V18, P329, DOI 10.1093/icvts/ivt500; Higashi K, 2000, EUR J NUCL MED, V27, P1778, DOI 10.1007/s002590000367; Higashi K, 2000, J NUCL MED, V41, P85; Higashi K, 2005, J NUCL MED, V46, P267; Huang CT, 2010, MED ONCOL, V27, P9, DOI 10.1007/s12032-008-9160-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Ko KH, 2014, EUR J NUCL MED MOL I, V41, P1889, DOI 10.1007/s00259-014-2802-y; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mak RH, 2011, ONCOLOGIST, V16, P319, DOI 10.1634/theoncologist.2010-0300; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Murata M, 2014, METHODS MOL BIOL, V1164, P67, DOI 10.1007/978-1-4939-0805-9_7; Na II, 2010, LUNG CANCER, V67, P76, DOI 10.1016/j.lungcan.2009.03.010; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sasaki H, 2012, MOL MED REP, V5, P599, DOI 10.3892/mmr.2011.736; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stroobants S, 2003, EUR J RADIOL, V45, P49, DOI 10.1016/S0720-048X(02)00282-6; Suganuma N, 2007, BJU INT, V99, P1143, DOI 10.1111/j.1464-410X.2007.06765.x; Takamochi K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2792-1; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Tsao AS, 2006, J THORAC ONCOL, V1, P231, DOI 10.1016/S1556-0864(15)31573-2; van Baardwijk A, 2007, EUR J CANCER, V43, P1392, DOI 10.1016/j.ejca.2007.03.027; Vesselle H, 2000, CLIN CANCER RES, V6, P3837	37	18	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175622	10.1371/journal.pone.0175622	http://dx.doi.org/10.1371/journal.pone.0175622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422979	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600036
J	Zhu, B; Wu, XM; Wu, B; Pei, D; Zhang, L; Wei, LX				Zhu, Bo; Wu, Xiaomei; Wu, Bo; Pei, Dan; Zhang, Lu; Wei, Lixuan			The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies	PLOS ONE			English	Article							POPULATION-BASED ANALYSIS; GROWTH-FACTOR-I; COLON-CANCER; INSULIN-RESISTANCE; CHINESE PATIENTS; RISK-FACTORS; MELLITUS; MORTALITY; SURVIVAL; IMPACT	Introduction Though a meta-analysis reported the effect of diabetes on colorectal prognosis in 2013, a series of large-scale long-term cohort studies has comprehensively reported the outcome effect estimates on the relationship between diabetes and colorectal prognosis, and their results were still consistent. Methods We carried out an extensive search strategy in multiple databases and conducted a metaanalysis on the effect of diabetes on colorectal prognosis, based on the included 36 cohort studies, which contained 2,299,012 subjects. In order to collect more data, besides conventional methods, we used the professional software to extract survival data from the Kaplan-Meier curves, and analyzed both the 5-year survival rate and survival risk in overall survival, cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival, to comprehensively reflect the effect of diabetes on colorectal prognosis. Results The results found that compared to patients without diabetes, patients with diabetes will have a 5-year shorter survival in colorectal, colon and rectal cancer, with a 18%, 19% and 16% decreased in overall survival respectively. We also found similar results in cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival, but not all these results were significant. We performed the subgroup analysis and sensitivity analysis to find the source of heterogeneity. Their results were similar to the overall results. Conclusions Our meta-analysis suggested that diabetes had a negative effect on colorectal cancer in overall survival. More studies are still needed to confirm the relationship between diabetes and colorectal prognosis in cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival.	[Zhu, Bo; Zhang, Lu; Wei, Lixuan] China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Dept Canc Prevent & Treatment, Shenyang, Peoples R China; [Wu, Xiaomei] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Med, Shenyang, Peoples R China; [Wu, Bo] China Med Univ, Hosp 1, Dept Anus & Intestine Surg, Shenyang, Peoples R China; [Pei, Dan] China Natl Petr Corp, Liaohe Petrochem Co, Dept Occupat Hlth, Xinglongtai Dist, Panjin, Peoples R China	China Medical University; China Medical University; China Medical University; China National Petroleum Corporation	Zhu, B (corresponding author), China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Dept Canc Prevent & Treatment, Shenyang, Peoples R China.	15998896991@163.com			General Foundation of scientific research in the Department of Education in Liaoning [L2015592]	General Foundation of scientific research in the Department of Education in Liaoning	This work was supported by General Foundation of scientific research in the Department of Education in Liaoning (L2015592).; This work was supported by General Foundation of scientific research in the Department of Education in Liaoning (L2015592).	Bella F, 2013, J CANCER RES CLIN, V139, P1303, DOI 10.1007/s00432-013-1439-8; Chen CQ, 2010, CHINESE MED J-PEKING, V123, P3084, DOI 10.3760/cma.j.issn.0366-6999.2010.21.024; Chen KH, 2014, ONCOLOGIST, V19, P951, DOI 10.1634/theoncologist.2013-0423; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chiao EY, 2010, J CANCER SURVIV, V4, P381, DOI 10.1007/s11764-010-0141-y; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Cossor FI, 2013, CANCER EPIDEMIOL, V37, P742, DOI 10.1016/j.canep.2013.04.015; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Cui G, 2015, MED SCI MONITOR, V21, P3825, DOI 10.12659/MSM.894783; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Ding J, 2016, PATHOL ONCOL RES, V22, P773, DOI 10.1007/s12253-016-0065-6; Fransgaard T, 2016, COLORECTAL DIS, V18, pO22, DOI 10.1111/codi.13158; Huang CW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-76; Huang YC, 2011, J CANCER RES CLIN, V137, P211, DOI 10.1007/s00432-010-0879-7; Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953; Jeon JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055196; Jullumstro E, 2009, ACTA ONCOL, V48, P361, DOI 10.1080/02841860802637765; Klil-Drori AJ, 2016, NATURE REVIEWS CLINI; Lai CC, 2011, INT J COLORECTAL DIS, V26, P473, DOI 10.1007/s00384-010-1113-4; Lee SJ, 2017, DIABETES RES CLIN PR, V124, P66, DOI 10.1016/j.diabres.2016.12.009; Lemmens VEPP, 2005, BRIT J SURG, V92, P615, DOI 10.1002/bjs.4913; Lieffers JR, 2011, CANCER-AM CANCER SOC, V117, P1957, DOI 10.1002/cncr.25653; Liu D, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-271; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071930; Luo J, 2014, BRIT J CANCER, V110, P1847, DOI 10.1038/bjc.2014.68; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; Morrison DS, 2011, J EPIDEMIOL COMMUN H, V65, P1053, DOI 10.1136/jech.2010.127555; Morrison DS, 2013, ASIAN PAC J CANCER P, V14, P1083, DOI 10.7314/APJCP.2013.14.2.1083; Noh Geum Youb, 2010, J Korean Soc Coloproctol, V26, P424, DOI 10.3393/jksc.2010.26.6.424; Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Paulus JK, 2016, CANCER EPIDEM BIOMAR, V25, P1418, DOI 10.1158/1055-9965.EPI-16-0312; Polednak AP, 2006, CANCER DETECT PREV, V30, P466, DOI 10.1016/j.cdp.2006.07.003; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; Ramjeesingh R, 2016, CURR ONCOL, V23, pE116, DOI 10.3747/co.23.2809; Sarfati D, 2011, NEW ZEAL MED J, V124, P76; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shonka NA, 2006, MED ONCOL, V23, P515, DOI 10.1385/MO:23:4:515; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tong LY, 2014, ANN EPIDEMIOL, V24, P411, DOI 10.1016/j.annepidem.2014.01.005; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van de Poll-Franse LV, 2012, DIABETOLOGIA, V55, P2163, DOI 10.1007/s00125-012-2555-8; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; Waheed S, 2014, J GASTROEN HEPATOL, V29, P1963, DOI 10.1111/jgh.12637; Walker JJ, 2013, DIABETOLOGIA, V56, P1531, DOI 10.1007/s00125-013-2917-x; Winder T, 2010, CLIN CANCER RES, V16, P5591, DOI 10.1158/1078-0432.CCR-10-2092; Yang IP, 2016, ONCOTARGET, V7, P18837, DOI 10.18632/oncotarget.7719; Yeh HC, 2012, DIABETES CARE, V35, P113, DOI 10.2337/dc11-0255; Zhang R, 2013, J INT MED RES, V41, P1228, DOI 10.1177/0300060513487631; Zhu B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41681; Zhu LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154795	55	66	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176068	10.1371/journal.pone.0176068	http://dx.doi.org/10.1371/journal.pone.0176068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423026	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600084
J	Grady, C; Touloumi, G; Walker, AS; Smolskis, M; Sharma, S; Babiker, AG; Pantazis, N; Tavel, J; Florence, E; Sanchez, A; Hudson, F; Papadopoulos, A; Emanuel, E; Clewett, M; Munroe, D; Denning, E				Grady, Christine; Touloumi, Giota; Walker, A. Sarah; Smolskis, Mary; Sharma, Shweta; Babiker, Abdel G.; Pantazis, Nikos; Tavel, Jorge; Florence, Eric; Sanchez, Adriana; Hudson, Fleur; Papadopoulos, Antonios; Emanuel, Ezekiel; Clewett, Megan; Munroe, David; Denning, Eileen		INSIGHT START Informed Consent	A randomized trial comparing concise and standard consent forms in the START trial	PLOS ONE			English	Article							INFORMED-CONSENT; CLINICAL-TRIALS; BIOMEDICAL-RESEARCH; READABILITY; PARTICIPANTS; COMPREHENSION; INFORMATION; LONGER; INTERVENTIONS; DOCUMENTS	Background Improving the effectiveness and efficiency of research informed consent is a high priority. Some express concern about longer, more complex, written consent forms creating barriers to participant understanding. A recent meta-analysis concluded that randomized comparisons were needed. Methods We conducted a cluster-randomized non-inferiority comparison of a standard versus concise consent form within a multinational trial studying the timing of starting antiretroviral therapy in HIV+ adults (START). Interested sites were randomized to standard or concise consent forms for all individuals signing START consent. Participants completed a survey measuring comprehension of study information and satisfaction with the consent process. Site personnel reported usual site consent practices. The primary outcome was comprehension of the purpose of randomization (pre-specified 7.5% non-inferiority margin). Results 77 sites (2429 participants) were randomly allocated to use standard consent and 77 sites (2000 participants) concise consent, for an evaluable cohort of 4229. Site and participant characteristics were similar for the two groups. The concise consent was non-inferior to the standard consent on comprehension of randomization (80.2% versus 82%, site adjusted difference: 0.75% (95% CI -3.8%, +5.2%)); and the two groups did not differ significantly on total comprehension score, satisfaction, or voluntariness (p>0.1). Certain independent factors, such as education, influenced comprehension and satisfaction but not differences between consent groups. Conclusions An easier to read, more concise consent form neither hindered nor improved comprehension of study information nor satisfaction with the consent process among a large number of participants. This supports continued efforts to make consent forms more efficient.	[Grady, Christine] NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Touloumi, Giota; Pantazis, Nikos] Univ Athens, Dept Hyg Epidemiol & Med Stat, Med Sch, Athens, Greece; [Walker, A. Sarah; Babiker, Abdel G.; Hudson, Fleur] UCL, MRC Clin Trials Unit, London, England; [Smolskis, Mary] NIAID, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sharma, Shweta; Denning, Eileen] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Tavel, Jorge] Genentech Res & Early Dev, San Francisco, CA USA; [Florence, Eric] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Sanchez, Adriana] Washington VA Med Ctr, Washington ICC & Terry Beirn CPCRA CTU, Washington, DC USA; [Papadopoulos, Antonios] Univ Athens, Dept Internal Med 4, Med Sch, Athens, Greece; [Emanuel, Ezekiel] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Clewett, Megan] Univ New South Wales, Sydney, NSW, Australia; [Munroe, David] Univ Minnesota, START Community Advisory Board CAB, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National & Kapodistrian University of Athens; Medical Research Council Clinical Trials Unit; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; Institute of Tropical Medicine (ITM); National & Kapodistrian University of Athens; University of Pennsylvania; University of New South Wales Sydney; University of Minnesota System; University of Minnesota Twin Cities	Grady, C (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	cgrady@nih.gov	Walker, Sarah/HDM-8717-2022; PAPADOPOULOS, ANTONIOS/AAD-7808-2019	Florence, Eric/0000-0002-7004-9120; Grady, Christine/0000-0002-9093-4450; Pantazis, Nikos/0000-0002-4196-5066	National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [UM1-A1068641, UM1-A1120197]; NIH intramural program through the Clinical Center; US National Institutes of Health (NIH); MRC [MC_EX_UU_G0800814, MC_UU_12023/24] Funding Source: UKRI; Medical Research Council [MC_UU_12023/24, MC_UU_12023/23, MC_EX_UU_G0800814] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI120197, UM1AI068641] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010531] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH intramural program through the Clinical Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This study was funded through National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID) Grants UM1-A1068641 and UM1-A1120197, as well as the NIH intramural program through the Clinical Center. The funder of this substudy, the US National Institutes of Health (NIH), provided support in the form of salaries for some authors [CG, MS], and grant support for some authors [AB, SS, ASW] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section. Genentech Research and Early Development had no role in this study.	Albala Ilene, 2010, IRB, V32, P7; [Anonymous], 2014, FDA INF CONS INF SHE; BAKER MT, 1983, JAMA-J AM MED ASSOC, V250, P2646, DOI 10.1001/jama.250.19.2646; Coyne CA, 2003, J CLIN ONCOL, V21, P836, DOI 10.1200/JCO.2003.07.022; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Denning E, 2015, HIV MED, V16, P24, DOI 10.1111/hiv.12230; Dresden GM, 2001, ACAD EMERG MED, V8, P246, DOI 10.1111/j.1553-2712.2001.tb01300.x; Emanuel EJ, 2008, HASTINGS CENT REP, V38, P10, DOI 10.1353/hcr.0.0018; Enama ME, 2012, CONTEMP CLIN TRIALS, V33, P895, DOI 10.1016/j.cct.2012.04.005; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Guarino P, 2006, CLIN TRIALS, V3, P19, DOI 10.1191/1740774506cn133oa; Hochhauser M., 2005, APPL CLIN TRIALS; Hochhauser M., 2008, SOCRA SOURCE PUBLICA, V58, P62; Ittenbach RF, 2015, J EMPIR RES HUM RES, V10, P444, DOI 10.1177/1556264615615006; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Kass NE, 2015, CLIN TRIALS, V12, P54, DOI 10.1177/1740774514560831; Kincaid JP, 1975, 875 MEMPH NAV AIR ST; Lorell BH, 2015, CLIN TRIALS, V12, P692, DOI 10.1177/1740774515594362; LOVERDE ME, 1989, J GEN INTERN MED, V4, P410, DOI 10.1007/BF02599693; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Matsui K, 2012, J EPIDEMIOL, V22, P308, DOI 10.2188/jea.JE20110104; Murphy DA, 1999, AIDS EDUC PREV, V11, P389; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Plaut Victoria C., 2011, LAW HUMAN BEHAV, P1, DOI [10.1007/s10979-011- 9288- y, DOI 10.1007/S10979-011-9288-Y, 10.1007/s10979-011-9288-y]; Resnik DB, 2009, CONTEMP CLIN TRIALS, V30, P114, DOI 10.1016/j.cct.2008.10.004; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Stunkel Leanne, 2010, IRB, V32, P1; TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; TAUB HA, 1987, EXP AGING RES, V13, P173	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0172607	10.1371/journal.pone.0172607	http://dx.doi.org/10.1371/journal.pone.0172607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445471	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200001
J	Kim, SJ; Jin, YH; Kim, BS				Kim, Seung Jae; Jin, Young-Hee; Kim, Byung S.			Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease	PLOS ONE			English	Article							MURINE ENCEPHALOMYELITIS VIRUS; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; VIRAL-INFECTION; UP-REGULATION; CYTOKINE PRODUCTION; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; TH17 CELLS	Infection of various cells with Theiler's murine encephalomyelitis virus ( TMEV) activates the TLR- and melanoma differentiation-associated gene 5 (MDA5)-dependent pathways, resulting in the production of IL-1 beta via the activation of caspase-1 upon assembly of the node-like receptor protein 3 (NLRP3) inflammasome. The role of IL-1 beta in the pathogenesis of TMEV-induced demyelinating disease was previously investigated. However, the signaling effects of prostaglandin E2 (PGE(2)) downstream of the NLRP3 inflammasome on the immune responses to viral determinants and the pathogenesis of demyelinating disease are unknown. In this study, we investigated the levels of intermediate molecules leading to PGE(2) signaling and the effects of blocking PGE(2) signaling on the immune response to TMEV infection, viral persistence and the development of demyelinating disease. We demonstrate here that TMEV infection activates the NLRP3 inflammasome and PGE(2) signaling much more vigorously in dendritic cells (DCs) and CD11b(+) cells from susceptible SJL mice than in cells from resistant B6 mice. Inhibition of virus-induced PGE(2) signaling using AH23848 resulted in decreased pathogenesis of demyelinating disease and viral loads in the central nervous system (CNS). In addition, AH23848 treatment caused the elevation of protective early IFN-Y-producing CD4(+) and CD8(+) T cell responses. Because the levels of IFN-beta were lower in AH23848-treated mice but the level of IL-6 was similar, over-production of pathogenic IFN-beta was modulated and the generation of IFN-Y-producing T cell responses was enhanced by the inhibition of PGE(2) signaling. These results strongly suggest that excessive activation of the NLRP3 inflammasome and downstream PGE(2) signaling contribute to the pathogenesis of TMEV-induced demyelinating disease.	[Kim, Seung Jae; Jin, Young-Hee; Kim, Byung S.] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Kim, Seung Jae] Univ Illinois, Div Rheumatol, 835 S Wolcott Ave, Chicago, IL USA; [Jin, Young-Hee] Korea Inst Oriental Med, Korean Med Applicat Ctr, 70 Cheomdan Ro, Daegu, South Korea	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Korea Institute of Oriental Medicine (KIOM)	Kim, BS (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	bskim@northwestern.edu	JIN, YOUNG-HEE/AAW-3506-2020; Kim, Byung/AAU-7450-2020	JIN, YOUNG-HEE/0000-0001-9916-1418; 	United Stated Public Health Service Grants [R01 NS28752, R01 NS33008]; National Multiple Sclerosis society [RG 4001-A6]	United Stated Public Health Service Grants; National Multiple Sclerosis society(National Multiple Sclerosis Society)	This work was supported by the United Stated Public Health Service Grants (R01 NS28752 and R01 NS33008) and by a grant From the National Multiple Sclerosis society (RG 4001-A6).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arosh JA, 2015, P NATL ACAD SCI USA, V112, P9716, DOI 10.1073/pnas.1507931112; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BRITTAIN RT, 1985, CIRCULATION, V72, P1208, DOI 10.1161/01.CIR.72.6.1208; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Carlson NG, 2006, J NEUROIMMUNOL, V174, P21, DOI 10.1016/j.jneuroim.2006.01.008; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Chaudhry U, 2010, EXP NEUROL, V223, P359, DOI 10.1016/j.expneurol.2009.07.027; CRANE MA, 1993, J NEUROIMMUNOL, V45, P67, DOI 10.1016/0165-5728(93)90165-U; Dal Canto Mauro C., 1996, Methods (Orlando), V10, P453, DOI 10.1006/meth.1996.0123; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Fuller AC, 2005, J IMMUNOL, V175, P3955, DOI 10.4049/jimmunol.175.6.3955; Hou WQ, 2007, PLOS PATHOG, V3, P1036, DOI 10.1371/journal.ppat.0030124; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jin DQ, 2014, NAT CELL BIOL, V16, P841, DOI 10.1038/ncb3029; Jin YH, 2015, J VIROL, V89, P1867, DOI 10.1128/JVI.02471-14; Jin YH, 2007, J VIROL, V81, P11690, DOI 10.1128/JVI.01034-07; Jin YH, 2013, J VIROL, V87, P11538, DOI 10.1128/JVI.01967-13; Jin YH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-178; Jin YH, 2012, J VIROL, V86, P1531, DOI 10.1128/JVI.06457-11; Jin YH, 2011, J VIROL, V85, P3033, DOI 10.1128/JVI.02400-10; Jin YH, 2010, J NEUROIMMUNOL, V226, P27, DOI 10.1016/j.jneuroim.2010.05.028; Johnson R T, 1975, Adv Neurol, V13, P1; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Joseph T, 2012, AM J REPROD IMMUNOL, V67, P482, DOI 10.1111/j.1600-0897.2011.01099.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kim BS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-217; Kundu N, 2009, BREAST CANCER RES TR, V117, P235, DOI 10.1007/s10549-008-0180-5; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Martinez A, 2007, HUM IMMUNOL, V68, P685, DOI 10.1016/j.humimm.2007.05.005; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; Mestre L, 2006, BIOCHEM PHARMACOL, V72, P869, DOI 10.1016/j.bcp.2006.06.037; Mohindru M, 2006, EUR J IMMUNOL, V36, P2106, DOI 10.1002/eji.200535785; Mohri I, 2003, GLIA, V42, P263, DOI 10.1002/glia.10183; Molina-Holgado E, 2002, NEUROSCI LETT, V324, P237, DOI 10.1016/S0304-3940(02)00209-4; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Myoung JJ, 2008, J VIROL, V82, P5606, DOI 10.1128/JVI.02442-07; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Palma JP, 2003, J VIROL, V77, P6322, DOI 10.1128/JVI.77.11.6322-6331.2003; Palma JP, 2001, J NEUROIMMUNOL, V117, P166, DOI 10.1016/S0165-5728(01)00326-5; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; PULLEN LC, 1993, EUR J IMMUNOL, V23, P2287, DOI 10.1002/eji.1830230935; Qian XS, 2013, J IMMUNOL, V190, P5894, DOI 10.4049/jimmunol.1203141; Richards MH, 2011, J AUTOIMMUN, V36, P142, DOI 10.1016/j.jaut.2010.12.005; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Schiffmann S, 2014, BIOCHEM PHARMACOL, V87, P625, DOI 10.1016/j.bcp.2013.12.006; SKIAS DD, 1987, J IMMUNOL, V138, P3254; So EY, 2009, GLIA, V57, P1216, DOI 10.1002/glia.20843; So EY, 2006, GLIA, V53, P858, DOI 10.1002/glia.20346; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas DW, 2003, J IMMUNOL, V171, P6389, DOI 10.4049/jimmunol.171.12.6389; Wang HQ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0264-x; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yauch RL, 1998, J VIROL, V72, P6169, DOI 10.1128/JVI.72.7.6169-6174.1998	68	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176406	10.1371/journal.pone.0176406	http://dx.doi.org/10.1371/journal.pone.0176406			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445497	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200057
J	Liu, ZY; Mao, XQ; Song, P				Liu, Zhengyan; Mao, Xianqiang; Song, Peng			GHGs and air pollutants embodied in China's international trade: Temporal and spatial index decomposition analysis	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; CO2 EMISSIONS; CARBON EMISSIONS; US TRADE; DRIVING FORCES; ENERGY; CONSUMPTION; EXPORTS; DRIVERS; IMPACT	Temporal index decomposition analysis and spatial index decomposition analysis were applied to understand the driving forces of the emissions embodied in China's exports and net exports during 2002 - 2011, respectively. The accumulated emissions embodied in exports accounted for approximately 30% of the total emissions in China; although the contribution of the sectoral total emissions intensity (technique effect) declined, the scale effect was largely responsible for the mounting emissions associated with export, and the composition effect played a largely insignificant role. Calculations of the emissions embodied in net exports suggest that China is generally in an environmentally inferior position compared with its major trade partners. The differences in the economy-wide emission intensities between China and its major trade partners were the biggest contribution to this reality, and the trade balance effect played a less important role. However, a lower degree of specialization in pollution intensive products in exports than in imports helped to reduce slightly the emissions embodied in net exports. The temporal index decomposition analysis results suggest that China should take effective measures to optimize export and supply-side structure and reduce the total emissions intensity. According to spatial index decomposition analysis, it is suggested that a more aggressive import policy was useful for curbing domestic and global emissions, and the transfer of advanced production technologies and emission control technologies from developed to developing countries should be a compulsory global environmental policy option to mitigate the possible leakage of pollution emissions caused by international trade.	[Liu, Zhengyan; Mao, Xianqiang] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China; [Song, Peng] Chongqing Univ, Sch Publ Affairs, Chongqing, Peoples R China	Beijing Normal University; Chongqing University	Mao, XQ (corresponding author), Beijing Normal Univ, Sch Environm, Beijing, Peoples R China.	maoxq@hnu.edu.cn			National Social Science Fund project [11BJY065]; Environmental Protection Gongyi Project [201009051]; Fundamental Research Funds for the Central Universities	National Social Science Fund project; Environmental Protection Gongyi Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Social Science Fund project (Re: 11BJY065), Environmental Protection Gongyi Project (Re: 201009051), and Fundamental Research Funds for the Central Universities.; This study is supported by the National Social Science Fund project (Re:11BJY065) and the Environmental Protection Gongyi Project (Re: 201009051) and the Fundamental Research Funds for the Central Universities. We sincerely thank colleagues in the PRCEE of MEP; Mrs. Li Liping, the Director of the International Environmental Policy Program; and, Mr. Yuan Qingdan, the Deputy Director of PRCEE.	Aichele R, 2012, J ENVIRON ECON MANAG, V63, P336, DOI 10.1016/j.jeem.2011.10.005; Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010; Ang BW, 2003, ENERG POLICY, V31, P1561, DOI 10.1016/S0301-4215(02)00206-9; Ang BW, 1998, ENERGY, V23, P489, DOI 10.1016/S0360-5442(98)00016-4; Ang BW, 2000, ENERGY, V25, P1149, DOI 10.1016/S0360-5442(00)00039-6; Arto I, 2014, ECOL ECON, V97, P93, DOI 10.1016/j.ecolecon.2013.11.005; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; BOYD GA, 1988, ENERG ECON, V10, P309, DOI 10.1016/0140-9883(88)90042-4; British Petroleum (BP), 2012, STAT REV WORLD EN 20; Carr JA, 2012, PLOS ONE, V8, P118; COPELAND BR, 1995, AM ECON REV, V85, P716; COPELAND BR, 1994, Q J ECON, V109, P755, DOI 10.2307/2118421; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Deng GY, 2016, J CLEAN PROD, V135, P332, DOI 10.1016/j.jclepro.2016.06.114; Dong YL, 2010, ENERG POLICY, V38, P6784, DOI 10.1016/j.enpol.2010.06.050; Du HB, 2011, ENERG POLICY, V39, P5980, DOI 10.1016/j.enpol.2011.06.060; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Gasim AA, 2015, ENERG POLICY, V86, P186, DOI 10.1016/j.enpol.2015.06.043; Greene WH, 2003, J AM STAT ASSOC, V89, P182; Grossman A.B., 1991, ENV IMPACTS N AM FRE; Hoekstra R, 2003, ENERG ECON, V25, P39, DOI 10.1016/S0140-9883(02)00059-2; Hu Tao, 2011, ENV SUSTAIN DEV, V36, P20; IEA, 2009, CO2 EMISSIONS FUEL C; International Energy Agency (IEA), 2011, CO2 EMISSIONS FUEL C; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jakob M, 2013, NAT CLIM CHANGE, V3, P19, DOI 10.1038/nclimate1630; Kagohashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132133; Kanemoto K, 2014, GLOBAL ENVIRON CHANG, V24, P52, DOI 10.1016/j.gloenvcha.2013.09.008; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Kondo Y, 1998, APPL ENERG, V59, P163, DOI 10.1016/S0306-2619(98)00011-7; LEAMER EE, 1980, J POLIT ECON, V88, P495, DOI 10.1086/260882; Lenzen M., 2004, ECON SYST RES, V16, P391, DOI [DOI 10.1080/0953531042000304272, 10.1080/0953531042000304272]; Lin BQ, 2010, ENERG POLICY, V38, P613, DOI 10.1016/j.enpol.2009.10.014; Liu QL, 2015, ECOL ECON, V113, P39, DOI 10.1016/j.ecolecon.2015.02.026; Liu ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132459; Ma S., 2009, CHINA WORLD ECON, V19, P109; Mao XQ, 2014, ENVIRON SCI TECHNOL, V48, P10036, DOI 10.1021/es501729d; Munksgaard J, 2001, ENERG POLICY, V29, P327, DOI 10.1016/S0301-4215(00)00120-8; NBS MEP, 2012, CHIN STAT YB ENV 201; NBSC, 2013, CHIN STAT YB 2013; NBSC (National Bureau of Statistics of China), 2016, CHIN 2012 INP OUTP T; NBSC (National Bureau of Statistics of China), 2013, CHIN 2010 INP OUTP T; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Qi TY, 2014, ENERG ECON, V42, P204, DOI 10.1016/j.eneco.2013.12.011; REITLER W, 1987, ENERG ECON, V9, P145, DOI 10.1016/0140-9883(87)90019-3; Ren SG, 2014, ENERG POLICY, V69, P624, DOI 10.1016/j.enpol.2014.02.032; Sanchez-Choliz J, 2004, ENERG POLICY, V32, P1999, DOI 10.1016/S0301-4215(03)00199-X; Statistics D.O.I., 2011, XIAM STAT YB; Su B, 2016, ENERG ECON, V59, P414, DOI 10.1016/j.eneco.2016.09.006; Su B, 2014, ENERGY, V69, P778, DOI 10.1016/j.energy.2014.03.074; Su B, 2014, APPL ENERG, V114, P377, DOI 10.1016/j.apenergy.2013.09.036; Su B, 2013, ECOL ECON, V88, P119, DOI 10.1016/j.ecolecon.2013.01.017; Tan H, 2013, ENERG POLICY, V61, P1212, DOI 10.1016/j.enpol.2013.06.048; Tang X, 2012, ENERGY, V48, P464, DOI 10.1016/j.energy.2012.10.010; The World Bank, 2015, WORLD DEV INDICATORS; Tian X, 2011, FRONT ENVIRON SCI EN, V5, P445, DOI 10.1007/s11783-011-0330-6; Timmer, 2012, 10 WIOD; Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178; U. S. Census Bureau, 2012, 2012 STAT ABSTR; Wang C, 2005, ENERGY, V30, P73, DOI 10.1016/j.energy.2004.04.002; Weber CL, 2008, ENERG POLICY, V36, P3572, DOI 10.1016/j.enpol.2008.06.009; Weitzel M, 2014, ENERG ECON, V45, P45, DOI 10.1016/j.eneco.2014.06.012; Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wu R, 2016, J CLEAN PROD, V112, P4151, DOI 10.1016/j.jclepro.2015.07.017; Xu M, 2011, ENERG POLICY, V39, P7381, DOI 10.1016/j.enpol.2011.08.068; Xu M, 2009, ENVIRON SCI TECHNOL, V43, P3378, DOI 10.1021/es803142v; Xu Y, 2014, ECOL ECON, V101, P10, DOI 10.1016/j.ecolecon.2014.02.015; Yan YF, 2010, ENERG POLICY, V38, P350, DOI 10.1016/j.enpol.2009.09.025; Yang RR, 2014, ENERG POLICY, V72, P110, DOI 10.1016/j.enpol.2014.04.024; Zhang YG, 2009, ECOL ECON, V68, P2399, DOI 10.1016/j.ecolecon.2009.03.014; Zhang ZH, 2017, RENEW SUST ENERG REV, V68, P492, DOI 10.1016/j.rser.2016.10.009; Zhao YH, 2016, J CLEAN PROD, V131, P678, DOI 10.1016/j.jclepro.2016.04.114; Zhou J, 2015, CHINA J CLEANER PROD, V112, P1767, DOI DOI 10.1016/j.jclepro.2015.08.015	75	15	16	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176089	10.1371/journal.pone.0176089	http://dx.doi.org/10.1371/journal.pone.0176089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441399	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800024
J	Goncalves, GSR; Cerqueira, PV; Brasil, LS; Santos, MPD				Ribeiro Goncalves, Gabriela Silva; Cerqueira, Pablo Vieira; Brasil, Leandro Schlemmer; Dantas Santos, Marcos Persio			The role of climate and environmental variables in structuring bird assemblages in the Seasonally Dry Tropical Forests (SDTFs)	PLOS ONE			English	Article							BETA-DIVERSITY; COMMUNITY; PATTERNS; NICHE; DISTRIBUTIONS; ABUNDANCE; DYNAMICS; ECOLOGY; AREA	Understanding the processes that influence species diversity is still a challenge in ecological studies. However, there are two main theories to discuss this topic, the niche theory and the neutral theory. Our objective was to understand the importance of environmental and spatial processes in structuring bird communities within the hydrological seasons in dry forest areas in northeastern Brazil. The study was conducted in two National Parks, the Serra da Capivara and Serra das Confusoes National Parks, where 36 areas were sampled in different seasons (dry, dry/rainy transition, rainy, rainy/dry transition), in 2012 and 2013. We found with our results that bird species richness is higher in the rainy season and lower during the dry season, indicating a strong influence of seasonality, a pattern also found for environmental heterogeneity. Richness was explained by local environmental factors, while species composition was explained by environmental and spatial factors. The environmental factors were more important in explaining variations in composition. Climate change predictions have currently pointed out frequent drought events and a rise in global temperature by 2050, which would lead to changes in species behavior and to increasing desertification in some regions, including the Caatinga. In addition, the high deforestation rates and the low level of representativeness of the Caatinga in the conservation units negatively affects bird communities. This scenario has demonstrated how climatic factors affect individuals, and, therefore, should be the starting point for conservation initiatives to be developed in xeric environments.	[Ribeiro Goncalves, Gabriela Silva; Cerqueira, Pablo Vieira; Brasil, Leandro Schlemmer] Univ Fed Para, Curso Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Dantas Santos, Marcos Persio] Univ Fed Para, Inst Ciencias Biol, Lab Ecol & Zool Vertebrados, Belem, Para, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidade Federal do Para	Goncalves, GSR (corresponding author), Univ Fed Para, Curso Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil.	gabrielasrgoncalves@gmail.com	Cerqueira, Pablo Vieira/D-9268-2013; Pérsio, Marcos/B-8653-2016; Brasil, Leandro/T-1628-2019	Pérsio, Marcos/0000-0001-8819-867X; Brasil, Leandro/0000-0002-2725-9181	Capes; CNPQ project "Birds of Caatinga" ("Aves da Caatinga") [CNPQ 552011/2011-8]; Capes Doctoral fellowship	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ project "Birds of Caatinga" ("Aves da Caatinga"); Capes Doctoral fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	G.S.R.G. and M.P.D.S. are thankful to Capes for granting a Doctoral fellowship, to CNPQ for financing the project "Birds of Caatinga" ("Aves da Caatinga", process CNPQ 552011/2011-8) and PROPESP/UFPA by cost aid. Support to P.V.C.'s graduate research was provided by a Capes Doctoral fellowship. L.S.B. is thankful to CNPQ for granting Doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Rodrigo Lima Paz, Andre Santos, Leonardo Moura and Shirliane for helping in data collection. We are also thankful to Andre Pessoa for providing us accommodation in the Serra da Capivara National Park, to Mr. Fernando Tizianel head of the Serra da Capirava National Park for the support in conducting the research in the park, to Mr. Jose Wilmington Ribeiro (Mitinha), head of the Serra das Confusoes National Park for the support in conducting the research in the park. G.S.R.G. and M.P.D.S. is thankful to Capes for granting a Doctoral fellowship, to CNPQ for financing the project "Birds of Caatinga" ("Aves da Caatinga",process CNPQ 552011/2011-8) and PROPESP/UFPA by cost aid. Support to P.V.C.'s graduate research was provided by a Capes Doctoral fellowship. L.S.B. is thankful to CNPQ for granting Doctoral fellowship. Finally, we acknowledge the suggestions of two anonymous reviewers, which improved this manuscript.	Aleixo A, 1999, CONDOR, V101, P537, DOI 10.2307/1370183; Aleixo Alexandre, 1995, Revista Brasileira de Zoologia, V12, P493, DOI 10.1590/S0101-81751995000300004; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrade-Lima D., 1981, REV BRAS BOTA NICA, V4, P149; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Barbosa DCA, 1989, ACTA BOT BRAS, P313; Barbosa MRDV, CAATINGA ESTRUTURA F, P333; de Sousa AEBA, 2012, REV BRAS ORNITOL, V20, P230; Beale CM, 2013, ECOL LETT, V16, P1061, DOI 10.1111/ele.12139; BLONDEL J, 1970, Alauda, V38, P55; Boleli Isabel Cristina, 2012, International Journal of Poultry Science, V11, P517; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; COLWELL RK, 2000, ESTIMATES STAT ESTIM; Conner Richard N., 1997, Texas Journal of Science, V49, P123; Cubina A, 2001, BIOTROPICA, V33, P260, DOI 10.1111/j.1744-7429.2001.tb00177.x; Delfim FR., 2007, OECOLOGIA BRAS, V11, P365, DOI [10.4257/oeco.2007.1103.07, DOI 10.4257/OECO.2007.1103.07]; DeMarco PJ, 2006, OECOLOGIA BRAS, V8; Develey PF, 2000, J TROP ECOL, V16, P33, DOI 10.1017/S0266467400001255; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Driscoll DA, 2009, ECOL MONOGR, V79, P485, DOI 10.1890/08-1114.1; Elphick J., 2007, ATLAS BIRD MIGRATION, P180; Emperaire L., 1989, VEGETATION GESTION R; Feng GL, 2016, PROCEEDINGS 2016 FIRST INTERNATIONAL CONFERENCE ON MULTIMEDIA AND IMAGE PROCESSING (ICMIP 2016), P1, DOI 10.1109/ICMIP.2016.13; Freeman CP, 2015, VEGAN GREEN FOOD A T, P264; FREEMARK KE, 1986, BIOL CONSERV, V36, P115, DOI 10.1016/0006-3207(86)90002-9; FREIRE E.M.X., 2009, RECURSOS NATURAIS CA, P51; Goncalves GR, 2017, J ARID ENVIRON, V140, P6, DOI 10.1016/j.jaridenv.2017.01.004; Goncalves MR, 2003, PLANO MANEJO PARQUE; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; GRUBB J C, 1975, Herpetologica, V31, P219; Haegeman B, 2011, J THEOR BIOL, V269, P150, DOI 10.1016/j.jtbi.2010.10.006; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heavy J., 2014, OECOLOGIA, V174, P1033; Hijmans R.J., **DATA OBJECT**; Hubbell S.P., 2001, UNIFIED NEUTRAL THEO, DOI DOI 10.1111/2041-210X.12067; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Illan JG, 2014, GLOBAL CHANGE BIOL, V20, P3351, DOI 10.1111/gcb.12642; Jacomine PKT, 1986, B PESQUISA, V18; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Juen L, 2011, INSECT CONSERV DIVER, V4, P265, DOI 10.1111/j.1752-4598.2010.00130.x; Kaufman P.B., 1999, NATURAL PRODUCTS PLA; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; LEFEBVRE G, 1994, CAN J ZOOL, V72, P757, DOI 10.1139/z94-102; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Mac Nally R, 2014, OECOLOGIA, V176, P849, DOI 10.1007/s00442-014-3060-1; Machado ICS, 1997, BIOTROPICA, V29, P57, DOI 10.1111/j.1744-7429.1997.tb00006.x; Marsden SJ, 2002, FOREST ECOL MANAG, V165, P117, DOI 10.1016/S0378-1127(01)00653-3; Martinez-Garza C, 2011, L DEGRAD DEV, V24, P287; Martins LA, 2012, AVALIACAO PROCESSOS; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morales MB, COMPROMISSOS ADAPTAT; Nabout JC, 2009, ACTA OECOL, V35, P720, DOI 10.1016/j.actao.2009.07.002; Padial AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111227; Paglia P.A., 1995, BRAS REV BRAS ZOOL, V12, P67, DOI DOI 10.1590/S0101-81751995000100010; Parry M. L., 2007, CLIMATE CHANGE 2007; Peck D.V., 2006, W PILOT STUDY FIELD; Pellerin J., 1991, PLANO MANEJO PARQUE; Pennington RT, 2000, NEOTROPICAL SEASONAL, P261; Perez SEA, 2008, ECOLOGIA ONCA PINTAD; Peter M B, 2002, EVOLUTIONARY ECOLOGY; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; Quirino ZGM, 2006, FENOLOGIA SISTEMA RE; Ricklefs RE, EC NATUREZA; Santos MPD, 2004, COMUNIDADES AVES DUA, V12, P113; Shimano Y, 2013, REV BRAS ENTOMOL, V57, P359, DOI 10.1590/S0085-56262013005000043; Siepielski AM, 2013, FRESHWATER BIOL, V58, P758, DOI 10.1111/fwb.12082; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Tebbich S, 2004, CONDOR, V106, P95, DOI 10.1650/7293; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Trovão Dilma M. de B. M., 2007, Rev. bras. eng. agríc. ambient., V11, P307, DOI 10.1590/S1415-43662007000300010; Tubelis DP, 2000, BIRD CONSERV INT, V10, P331, DOI 10.1017/S0959270900000290; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Vasconcellos A, 2010, REV BRAS ENTOMOL, P54; Vielliard J. M. E., 2010, ORNITOLOGIA CONSERVA, P47; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Wu MX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10001; Wu Y. F., 2016, 2016 IEEE International Workshop on Electromagnetics (iWEM): Applications and Student Innovation Competition, P1, DOI 10.1109/iWEM.2016.7504911; Zaher H., DIVERSIDADE VERTEBRA; Zar JH., 2010, BIOSTAT ANAL, V5th	95	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176066	10.1371/journal.pone.0176066	http://dx.doi.org/10.1371/journal.pone.0176066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441412	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800022
J	Perri, V; Pellegrino, M; Ceccacci, F; Scipioni, A; Petrini, S; Gianchecchi, E; Lo Russo, A; De Santis, S; Mancini, G; Fierabracci, A				Perri, Valentina; Pellegrino, Marsha; Ceccacci, Francesca; Scipioni, Anita; Petrini, Stefania; Gianchecchi, Elena; Lo Russo, Anna; De Santis, Serena; Mancini, Giovanna; Fierabracci, Alessandra			Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; TYPE-1 DIABETES-MELLITUS; OF-FUNCTION VARIANT; AUTOIMMUNE-DISEASES; CARBON NANOTUBES; GEMINI AMPHIPHILES; CLINICAL-TRIALS; MESSENGER-RNA; DOXORUBICIN; ARTHRITIS	Type 1 diseases based on the selective inhibition of variant PTPN22 allele using lipoplexes of siRNA antisense oligomers.Type 1 diabetes and thyroid disease are T cell-dependent autoimmune endocrinopathies. The standard substitutive administration of the deficient hormones does not halt the autoimmune process; therefore, development of immunotherapies aiming to preserve the residual hormonal cells, is of crucial importance. PTPN22 C1858T mutation encoding for the R620W lymphoid tyrosine phosphatase variant, plays a potential pathophysiological role in autoimmunity. The PTPN22 encoded protein Lyp is a negative regulator of T cell antigen receptor signaling; R620W variant, leading to a gain of function with paradoxical reduced T cell activation, may represent a valid therapeutic target. We aimed to develop novel wild type PTPN22 short interfering RNA duplexes (siRNA) and optimize their delivery into Jurkat T cells and PBMC by using liposomal carriers. Conformational stability, size and polydispersion of siRNA in lipoplexes was measured by CD spectroscopy and DLS. Lipoplexes internalization and toxicity evaluation was assessed by confocal microscopy and flow cytometry analysis. Their effect on Lyp expression was evaluated by means of Western Blot and confocal microscopy. Functional assays through engagement of TCR signaling were established to evaluate biological consequences of down-modulation. Both Jurkat T cells and PBMC were efficiently transfected by stable custom lipoplexes. Jurkat T cell morphology and proliferation was not affected. Lipoplexes incorporation was visualized in CD3+ but also in CD3- peripheral blood immunotypes without signs of toxicity, damage or apoptosis. Efficacy in affecting Lyp protein expression was demonstrated in both transfected Jurkat T cells and PBMC. Moreover, impairment of Lyp inhibitory activity was revealed by increase of IL-2 secretion in culture supernatants of PBMC following anti-CD3/CD28 T cell receptor-driven stimulation. The results of our study open the pathway to future trials for the treatment of autoimmune	[Perri, Valentina; Pellegrino, Marsha; Gianchecchi, Elena; Lo Russo, Anna; Fierabracci, Alessandra] Childrens Hosp Bambino Gesu, Type Diabet Ctr 1, Infectivol & Clin Trials Area, Rome, Italy; [Ceccacci, Francesca] Sapienza Univ, CNR IMC SMR, Rome, Italy; [Scipioni, Anita; De Santis, Serena] Sapienza Univ, Dept Chem, Rome, Italy; [Petrini, Stefania] Childrens Hosp Bambino Gesu, Res Labs, Confocal Microscopy Core Facil, Rome, Italy; [Mancini, Giovanna] CNR, Chem Methodol Inst IMC, Rome, Italy; [Gianchecchi, Elena] Vismederi Srl, Siena, Italy	IRCCS Bambino Gesu; Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR)	Fierabracci, A (corresponding author), Childrens Hosp Bambino Gesu, Type Diabet Ctr 1, Infectivol & Clin Trials Area, Rome, Italy.	alessandra.fierabracci@opbg.net	Ceccacci, Francesca/AAE-9125-2022; Pellegrino, Marsha/K-4500-2016; Fierabracci, Alessandra/K-5930-2016; Petrini, Stefania/I-1464-2018; De Santis, Serena/AAI-8820-2020	Pellegrino, Marsha/0000-0002-9002-3622; Fierabracci, Alessandra/0000-0003-3078-9754; Petrini, Stefania/0000-0002-3249-0003; De Santis, Serena/0000-0001-9772-2891; Ceccacci, Francesca/0000-0003-3191-8562	Italian Ministry of Health-Ricerca Corrente [201502P003496]	Italian Ministry of Health-Ricerca Corrente(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health-Ricerca Corrente 201502P003496. AF Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakos E, 2009, ARTHRITIS RHEUM, V60, P994, DOI 10.1002/art.24434; Atkinson MA, 2013, LANCET DIABETES ENDO, V1, P268, DOI 10.1016/S2213-8587(13)70172-4; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bello C, 2006, LANGMUIR, V22, P9333, DOI 10.1021/la061230f; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Boitard C, 2012, PRESSE MED, V41, pE636, DOI 10.1016/j.lpm.2012.10.003; Bombelli C, 2005, LANGMUIR, V21, P10271, DOI 10.1021/la051324+; Bombelli C, 2005, J MED CHEM, V48, P5378, DOI 10.1021/jm050477r; Bombelli C, 2010, MOL PHARMACEUT, V7, P130, DOI 10.1021/mp900173v; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cato MH, 2008, J NANOSCI NANOTECHNO, V8, P2259, DOI 10.1166/jnn.2008.501; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Clemente-Casares X, 2014, IMMUNOL LETT, V158, P167, DOI 10.1016/j.imlet.2013.12.018; Daifotis AG, 2013, CLIN IMMUNOL, V149, P268, DOI 10.1016/j.clim.2013.05.001; Del Fattore A, 2015, CELL TRANSPLANT, V24, P2615, DOI 10.3727/096368915X687543; Delogu LG, 2009, BIOCONJUGATE CHEM, V20, P427, DOI 10.1021/bc800540j; Dittmar M, 2010, THYROID, V20, P737, DOI 10.1089/thy.2010.1639; Dutta C, 2016, MOL THER, V24, P770, DOI 10.1038/mt.2016.4; Effraimidis G, 2014, EUR J ENDOCRINOL, V170, pR241, DOI 10.1530/EJE-14-0047; Fierabracci A, 2011, CURR PHARM DESIGN, V17, P3092, DOI 10.2174/138161211798157577; Garciafigueroa Y, 2015, CLIN IMMUNOL, V160, P36, DOI 10.1016/j.clim.2015.03.016; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P717, DOI 10.1016/j.autrev.2012.12.003; Greenbaum CJ, 2012, DIABETES, V61, P1323, DOI 10.2337/db11-1452; Hope MJ, 1992, REDUCTION LIPOSOMES; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Joly F, 2011, GYNECOL ONCOL, V122, P226, DOI 10.1016/j.ygyno.2011.04.019; Kakleas K, 2015, AUTOIMMUN REV, V14, P781, DOI 10.1016/j.autrev.2015.05.002; Kudoh K, 2011, GYNECOL ONCOL, V122, P233, DOI 10.1016/j.ygyno.2011.04.046; Laron Z, 2015, PEDIATR ENDOCR REV P, V12, P266; Lin XT, 2016, DIABETES, V65, P2134, DOI 10.2337/db16-0061; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Lysik MA, 2003, J PHARM SCI, V92, P1559, DOI 10.1002/jps.10399; Maine CJ, 2012, J IMMUNOL, V188, P5267, DOI 10.4049/jimmunol.1200150; Marshall NB, 2007, J IMMUNOL METHODS, V325, P114, DOI 10.1016/j.jim.2007.06.009; Matteucci E, 2015, DRUG DES DEV THER, V9, P3109, DOI 10.2147/DDDT.S79322; McLachlan SM, 2014, ENDOCR REV, V35, P59, DOI 10.1210/er.2013-1055; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Mitragotri S, 2011, ARCH PHARM RES, V34, P1887, DOI 10.1007/s12272-011-1109-9; Ogawa T, 2012, AURIS NASUS LARYNX, V39, P224, DOI 10.1016/j.anl.2011.03.006; Opanasopit P, 2011, INT J NANOMED, V6, P975, DOI 10.2147/IJN.S18647; Petre CE, 2007, INT J NANOMED, V2, P277; Pranatharthiharan S, 2013, DRUG DELIV TRANSL RE, V3, P446, DOI 10.1007/s13346-012-0116-9; Pujol-Autonell I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127057; Radetti G, 2014, ENDOCR DEV, V26, P158, DOI 10.1159/000363162; Saenger W., 1984, J CLIN INVEST; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; SEEBACH D, 1977, HELV CHIM ACTA, V60, P301, DOI 10.1002/hlca.19770600202; Serra P, 2015, CLIN IMMUNOL, V160, P3, DOI 10.1016/j.clim.2015.02.003; Sharp RC, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00095; Silva AC, 2015, CURR DRUG METAB, V16, P3, DOI 10.2174/1389200216666150401110211; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wagner S, 2008, J NEURO-ONCOL, V86, P175, DOI 10.1007/s11060-007-9444-x; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; WEISS A, 1984, J IMMUNOL, V133, P123; Wiebolt J, 2010, EUR J CLIN INVEST, V40, P1144, DOI 10.1111/j.1365-2362.2010.02366.x; Woittiez NJC, 2015, IMMUNOTHERAPY-UK, V7, P163, DOI 10.2217/imt.14.104; Wu DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086677; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	68	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175784	10.1371/journal.pone.0175784	http://dx.doi.org/10.1371/journal.pone.0175784			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437437	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600013
J	Shen, MX; Smith, GN; Rodger, M; White, RR; Walker, MC; Wen, SW				Shen, Minxue; Smith, Graeme N.; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu			Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MATERNAL MORBIDITY; ANGIOGENIC FACTORS; EARLY-PREGNANCY; COMPLICATIONS; PATERNITY; COHORT	Background It remains an enigma whether gestational hypertension (GH) and pre-eclampsia (PE) are distinct entities or different spectrum of the same disease. We aimed to compare the risk factors and outcomes between GH and PE. Method A total of 7,633 pregnant women recruited between 12 and 20 weeks of gestation in the Ottawa and Kingston Birth Cohort from 2002 to 2009 were included in the analysis. Cox proportional hazards model was used to identify and compare the risk factors for GH and PE by treating gestational age at delivery as the survival time. Logistic regression model was used to compare outcome. Subgroup analysis was performed for early-and late-onset PE. Results GH and PE shared most risk factors including overweight and obesity, nulliparity, PE history, type 1 and 2 diabetes, and twin birth. Effect size of PE history (RR = 14.1 for GH vs. RR = 6.4 for PE) and twin birth (RR = 4.8 for GH vs. RR = 10.3 for PE) showed substantial difference. Risk factors modified gestational age at delivery in patients with GH and PE in similar pattern. Subgroup analysis showed that early-and late-onset PE shared some risk factors with different effect sizes, whereas folic acid supplementation showed protective effect for early-onset PE only. PE was strongly associated with several adverse outcomes including cesarean section, placental abruption, small for gestational age, preterm birth, and 5 min Apgar score < 7, whereas GH was associated with increased risk of preterm birth only. Conclusions GH and PE shared common risk factors. Differences in effect sizes of risk factors and outcomes indicate that the conditions may have different pathophysiology and mechanism.	[Shen, Minxue] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Shen, Minxue; Wen, Shi Wu] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Shen, Minxue; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu] Univ Ottawa, Dept Obstet & Gynecol, OMNI Res Grp, Fac Med, Ottawa, ON, Canada; [Shen, Minxue; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada; [Rodger, Marc; Wen, Shi Wu] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada; [Rodger, Marc] Univ Ottawa, Dept Med, Fac Med, Ottawa, ON, Canada	Central South University; Central South University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; University of Ottawa; University of Ottawa	Wen, SW (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.; Wen, SW (corresponding author), Univ Ottawa, Dept Obstet & Gynecol, OMNI Res Grp, Fac Med, Ottawa, ON, Canada.; Wen, SW (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Wen, SW (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada.	swwen@ohri.ca	Smith, Graeme Neil/ABB-6863-2021; Shen, Minxue/P-5140-2019	Smith, Graeme Neil/0000-0002-3128-4523; Shen, Minxue/0000-0003-0441-9303; Rodger, Marc/0000-0001-8166-3487; Stacey, Dawn/0000-0002-2681-741X	Canadian Institutes of Health Research [M0P53188, M0P 82802, MCT-98030]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research, Grant Nos.: M0P53188, M0P 82802, MCT-98030 to SWW. URL: http://www.cihr-irsc.gc.ca/e/193.html..	Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Boghossian NS, 2014, ANN EPIDEMIOL, V24, P871, DOI 10.1016/j.annepidem.2014.10.003; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Cecil RL, 2012, GOLDMANS CECIL MED; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; GARNER PR, 1990, AM J OBSTET GYNECOL, V163, P505, DOI 10.1016/0002-9378(90)91184-E; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Klatsky PC, 2010, OBSTET GYNECOL, V116, P1387, DOI 10.1097/AOG.0b013e3181fb8e59; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levron Y, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.044; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Li X, 2016, PREGNANCY HYPERTENS, V6, P66, DOI 10.1016/j.preghy.2015.11.004; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Martinez-Varea A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/210241; McDonald SD, 2009, BJOG-INT J OBSTET GY, V116, P1578, DOI 10.1111/j.1471-0528.2009.02317.x; Mustafa R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/105918; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Gorman N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.034; Paternoster DM, 2006, CLIN APPL THROMB-HEM, V12, P330, DOI 10.1177/1076029606291382; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/297397; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Saudan P, 1998, BRIT J OBSTET GYNAEC, V105, P1177, DOI 10.1111/j.1471-0528.1998.tb09971.x; Shiozaki A, 2013, J OBSTET GYNAECOL RE, V39, P492, DOI 10.1111/j.1447-0756.2012.01990.x; Stergiotou I, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.030; Tangeras LH, 2015, ARTERIOSCL THROM VAS, V35, P2478, DOI 10.1161/ATVBAHA.115.305817; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Walker MC, 2011, J OBSTET GYNAECOL CA, V33, P1124, DOI 10.1016/S1701-2163(16)35080-0; Wang Z, 2013, OBES REV, V14, P508, DOI 10.1111/obr.12025; Wen SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149818; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P254, DOI 10.1016/j.ajog.2003.12.003; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018	43	98	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175914	10.1371/journal.pone.0175914	http://dx.doi.org/10.1371/journal.pone.0175914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437461	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600021
J	Tutakhel, OAZ; Moes, AD; Valdez-Flores, MA; Kortenoeven, MLA; von den Vries, M; Jelen, S; Fenton, RA; Zietse, R; Hoenderop, JGJ; Hoorn, EJ; Hilbrands, L; Bindels, RJM				Tutakhel, Omar A. Z.; Moes, Arthur D.; Valdez-Flores, Marco A.; Kortenoeven, Marleen L. A.; v. D. Vries, Mathijs; Jelen, Sabina; Fenton, Robert A.; Zietse, Robert; Hoenderop, Joost G. J.; Hoorn, Ewout J.; Hilbrands, Luuk; Bindels, Rene J. M.			NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity	PLOS ONE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; NA+-CL-COTRANSPORTER; DIURETIC TREATMENT; RENAL-TRANSPLANT; CYCLOSPORINE; TACROLIMUS; HYPERTENSION; HYPERKALEMIA; EXOSOMES; ACTIVATION	Animal studies have shown that the calcineurin inhibitors (CNIs) cyclosporine and tacrolimus can activate the thiazide-sensitive NaCl cotransporter (NCC). A common side effect of CNIs is hypertension. Renal salt transporters such as NCC are excreted in urinary extracellular vesicles (uEVs) after internalization into multivesicular bodies. Human studies indicate that CNIs also increase NCC abundance in uEVs, but results are conflicting and no relationship with NCC function has been shown. Therefore, we investigated the effects of CsA and Tac on the abundance of both total NCC (tNCC) and phosphorylated NCC at Thr60 phosphorylation site (pNCC) in uEVs, and assessed whether NCC abundance in uEVs predicts the blood pressure response to thiazide diuretics. Our results show that in kidney transplant recipients treated with cyclosporine (n = 9) or tacrolimus (n = 23), the abundance of both tNCC and pNCC in uEVs is 4-5 fold higher than in CNI-free kidney transplant recipients (n = 13) or healthy volunteers (n = 6). In hypertensive kidney transplant recipients, higher abundances of tNCC and pNCC prior to treatment with thiazides predicted the blood pressure response to thiazides. During thiazide treatment, the abundance of pNCC in uEVs increased in responders (n = 10), but markedly decreased in non-responders (n = 8). Thus, our results show that CNIs increase the abundance of both tNCC and pNCC in uEVs, and these increases correlate with the blood pressure response to thiazides. This implies that assessment of NCC in uEVs could represent an alternate method to guide anti-hypertensive therapy in kidney transplant recipients.	[Tutakhel, Omar A. Z.; Valdez-Flores, Marco A.; Jelen, Sabina; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [Moes, Arthur D.; Zietse, Robert; Hoorn, Ewout J.] Erasmus MC, Dept Internal Med Nephrol & Transplantat, Rotterdam, Netherlands; [Valdez-Flores, Marco A.] Univ Autonoma Sinaloa, Programa Reg Doctorado Biotecnol, Sinaloa, Mexico; [Kortenoeven, Marleen L. A.; Fenton, Robert A.] Aarhus Univ, Ctr Interact Prot Epithelial Transport, Dept Biomed, Aarhus, Denmark; [v. D. Vries, Mathijs; Hilbrands, Luuk] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Universidad Autonoma de Sinaloa; Aarhus University; Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	Hoorn, Ewout/S-4135-2019; Flores, Marco Antonio Valdez/AAG-8838-2020; Fenton, Robert A/ABD-9824-2021; Tutakhel, Omar/AAW-6591-2021; Tutakhel, Omar A.Z./G-3638-2016; Kortenoeven, Marleen/B-8565-2014; Fenton, Robert/AFR-6983-2022; Hilbrands, Luuk/B-4921-2011; Bindels, René JM/B-9824-2013	Hoorn, Ewout/0000-0002-8738-3571; Tutakhel, Omar A.Z./0000-0002-1872-8409; Fenton, Robert/0000-0003-1623-199X; Hilbrands, Luuk/0000-0002-4935-9765; Bindels, René JM/0000-0003-1167-1339; Kortenoeven, Marleen/0000-0001-9962-8276	Dutch Kidney Foundation [PHD12.14, 160104, KSP-14OK19]; EURenOmics from European Union seventh Framework Program (FP7) [305608]; Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico); "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico; Netherlands Organisation for Scientific Research (NWO) [Veni 916.12.140]; Danish Medical Research Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Lundbeck Foundation [R173-2014-1373, R44-2009-4252] Funding Source: researchfish	Dutch Kidney Foundation; EURenOmics from European Union seventh Framework Program (FP7); Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Danish Medical Research Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This study was supported by Dutch Kidney Foundation (PHD12.14 and 160104) and EURenOmics funding from European Union seventh Framework Program (FP7/2007-2013, agreement no 305608). M.A.V. was funded by Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico) and "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico. E.J.H. was supported by grants from Netherlands Organisation for Scientific Research (NWO, Veni 916.12.140) and Dutch Kidney Foundation (KSP-14OK19). R.A.F. was supported by Danish Medical Research Foundation, Lundbeck Foundation and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Hamed Qaderdan for technical assistance and Drs Sjoerd Verkaart and Luke Shelton for critical reading of the manuscript. This study was supported by Dutch Kidney Foundation (PHD12.14 and 160104) and EURenOmics funding from European Union seventh Framework Program (FP7/2007-2013, agreement no 305608). M.A.V. was funded by Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico) and "Doctores-J6venes" program, Universidad Autonoma de Sinaloa in Mexico. E.J.H. was supported by grants from Netherlands Organisation for Scientific Research (NWO, Veni 916.12.140) and Dutch Kidney Foundation (KSP-14OK19). R.A.F. was supported by Danish Medical Research Foundation, Lundbeck Foundation and Novo Nordisk Foundation. M.L.A.K. was supported by Danish Medical Research Council.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; ARNOLD JE, 1969, AM J MED, V47, P461, DOI 10.1016/0002-9343(69)90230-7; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Canzanello V J, 1997, Liver Transpl Surg, V3, P1; Canzanello VJ, 1998, LIVER TRANSPLANT SUR, V4, P328, DOI 10.1002/lt.500040404; CHEN ZF, 1990, J AM SOC NEPHROL, V1, P91; Corbetta S, 2015, NEPHROL DIAL TRANSPL, V30, P621, DOI 10.1093/ndt/gfu362; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Esteva-Font C, 2014, AM J NEPHROL, V39, P528, DOI 10.1159/000362905; FIRST MR, 1994, J AM SOC NEPHROL, V4, pS30; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; GORDON RD, 1986, CLIN EXP PHARMACOL P, V13, P329, DOI 10.1111/j.1440-1681.1986.tb00358.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Holt S, 2002, TRANSPLANTATION, V73, P673, DOI 10.1097/00007890-200203150-00001; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Isobe K, 2013, AM J PHYSIOL-RENAL, V305, pF1374, DOI 10.1152/ajprenal.00208.2013; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joo KW, 2007, AM J KIDNEY DIS, V50, P765, DOI 10.1053/j.ajkd.2007.07.022; KAMEL KS, 1992, J AM SOC NEPHROL, V2, P1279; Kim GH, 2004, AM J NEPHROL, V24, P595, DOI 10.1159/000082314; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lazelle RA, 2016, J AM SOC NEPHROL, V27, P1456, DOI 10.1681/ASN.2015040466; Ligtenberg G, 2001, J AM SOC NEPHROL, V12, P368, DOI 10.1681/ASN.V122368; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; LYSON T, 1993, CIRC RES, V73, P596, DOI 10.1161/01.RES.73.3.596; Mangray M, 2011, AM J KIDNEY DIS, V57, P331, DOI 10.1053/j.ajkd.2010.10.048; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Mayan H, 2008, NEPHROL DIAL TRANSPL, V23, P492, DOI 10.1093/ndt/gfm641; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Moes AD, AM J KIDNEY IN PRESS; MURRAY BM, 1985, KIDNEY INT, V28, P767, DOI 10.1038/ki.1985.196; Na KY, 2003, AM J PHYSIOL-RENAL, V284, pF133, DOI 10.1152/ajprenal.00227.2002; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pathare G, 2017, AM J PHYSL IN PRESS; PAVER W K, 1964, Med J Aust, V2, P305; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Pessoa BS, 2013, NAT REV NEPHROL, V9, P26, DOI 10.1038/nrneph.2012.249; Pham SM, 1996, J THORAC CARDIOV SUR, V111, P764, DOI 10.1016/S0022-5223(96)70336-7; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rojas-Vega L, 2015, AM J PHYSIOL-RENAL, V309, pE836, DOI 10.1152/ajprenal.00326.2015; Rojas-Vega L, 2015, AM J PHYSIOL-RENAL, V308, pF799, DOI 10.1152/ajprenal.00447.2014; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Salih M, 2016, AM J PHYSIOL-RENAL, V310, pF796, DOI 10.1152/ajprenal.00463.2015; Salih M, 2014, AM J PHYSIOL-RENAL, V306, pF1251, DOI 10.1152/ajprenal.00128.2014; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Schwertfeger E, 2001, J AUTON PHARMACOL, V21, P205, DOI 10.1046/j.1365-2680.2001.00228.x; Shoda W, 2017, KIDNEY INT, V91, P402, DOI 10.1016/j.kint.2016.09.001; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Terker AS, 2016, J AM SOC NEPHROL, V27, P2436, DOI 10.1681/ASN.2015070815; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; van der Lubbe N, 2012, HYPERTENSION, V60, P741, DOI 10.1161/HYPERTENSIONAHA.112.198135; Veiras LC, 2016, HYPERTENSION, V68, P904, DOI 10.1161/HYPERTENSIONAHA.116.07389; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wolley MJ, 2017, J AM SOC NEPHROL, V28, P56, DOI 10.1681/ASN.2015111221; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033	63	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176220	10.1371/journal.pone.0176220	http://dx.doi.org/10.1371/journal.pone.0176220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430812	Green Published, gold			2022-12-27	WOS:000399876100035
J	Besley, JC; McCright, AM; Zahry, NR; Elliott, KC; Kaminski, NE; Martin, JD				Besley, John C.; McCright, Aaron M.; Zahry, Nagwan R.; Elliott, Kevin C.; Kaminski, Norbert E.; Martin, Joseph D.			Perceived conflict of interest in health science partnerships	PLOS ONE			English	Article							GROUP ENGAGEMENT MODEL; PROCEDURAL JUSTICE; INTEREST DISCLOSURE; SOCIAL IDENTITY; INDUSTRY; TRUST; SCIENTISTS; IMPACT; FOOD; UNCERTAINTY	University scientists conducting research on topics of potential health concern often want to partner with a range of actors, including government entities, non-governmental organizations, and private enterprises. Such partnerships can provide access to needed resources, including funding. However, those who observe the results of such partnerships may judge those results based on who is involved. This set of studies seeks to assess how people perceive two hypothetical health science research collaborations. In doing so, it also tests the utility of using procedural justice concepts to assess perceptions of research legitimacy as a theoretical way to investigate conflict of interest perceptions. Findings show that including an industry collaborator has clear negative repercussions for how people see a research partnership and that these perceptions shape people's willingness to see the research as a legitimate source of knowledge. Additional research aimed at further communicating procedures that might mitigate the impact of industry collaboration is suggested.	[Besley, John C.; Zahry, Nagwan R.] Michigan State Univ, Coll Commun Arts & Sci, E Lansing, MI 48824 USA; [McCright, Aaron M.] Michigan State Univ, Lyman Briggs Coll, Dept Sociol, Environm Sci & Policy Program, E Lansing, MI 48824 USA; [Elliott, Kevin C.] Michigan State Univ, Dept Fisheries & Wildlife, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Elliott, Kevin C.] Michigan State Univ, Dept Philosophy, E Lansing, MI 48824 USA; [Kaminski, Norbert E.] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Martin, Joseph D.] Consortium Hist Sci Technol & Med, Philadelphia, PA USA; [Martin, Joseph D.] Univ Leeds, Ctr Hist & Philosophy Sci, Leeds, W Yorkshire, England	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; University of Leeds	Besley, JC (corresponding author), Michigan State Univ, Coll Commun Arts & Sci, E Lansing, MI 48824 USA.	jbesley@msu.edu	Besley, John C/N-7845-2013; McCright, Aaron M./Z-1967-2019	Besley, John/0000-0002-8778-4973; zahry, Nagwan/0000-0003-3454-8763	Science Studies at State (S3) program, Michigan State University	Science Studies at State (S3) program, Michigan State University	A grant from the Science Studies at State (S3) program, Michigan State University, provided funding for this project.	Agoritsas T, 2011, J CLIN EPIDEMIOL, V64, P107, DOI 10.1016/j.jclinepi.2010.02.007; Anderson TS, 2014, JAMA-J AM MED ASSOC, V311, P1353, DOI 10.1001/jama.2013.284925; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Besley J.C., 2014, EFFECTIVE RISK COMMU, P108; Besley JC, 2014, RISK ANAL, V34, P949, DOI 10.1111/risa.12151; Blader SL, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P329; Blader SL, 2009, J APPL PSYCHOL, V94, P445, DOI 10.1037/a0013935; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Brossard D, 2007, THE MEDIA THE PUBLIC, Vxxiv; Brulle RJ, 2014, CLIMATIC CHANGE, V122, P681, DOI 10.1007/s10584-013-1018-7; Cain DM, 2011, J CONSUM RES, V37, P836, DOI 10.1086/656252; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Clements J., 2015, ENVIRON SOCIOL, V1, P27, DOI [10.1080/23251042.2015.1020466, DOI 10.1080/23251042.2015.1020466]; Colquitt JA, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P3; Colquitt JA, 2001, J APPL PSYCHOL, V86, P425, DOI 10.1037//0021-9010.86.3.425; Davies MJ, 2001, CHALLENGES IN ACUTE CORONARY SYNDROMES, P3; Dunlap R., 2015, CLIMATE CHANGE SOC S, P300, DOI DOI 10.1093/ACPROF:OSO/9780199356102.003.0010; Elliott KC, 2011, IS A LITTLE POLLUTIO, Vx; Elliott KC, 2008, ACCOUNT RES, V15, P1, DOI 10.1080/08989620701783725; Faul F, 1992, G POWER VERSION 3 1C; Field MJ, 2009, CONFLICT OF INTEREST; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13593, DOI 10.1073/pnas.1317505111; Frewer LJ, 1996, RISK ANAL, V16, P473, DOI 10.1111/j.1539-6924.1996.tb01094.x; Gangl A, 2003, POLIT BEHAV, V25, P119, DOI 10.1023/A:1023847829172; Goodwin RE, 2009, BRIT FOOD J, V111, P408, DOI 10.1108/00070700910957267; Guest G, 2012, APPLIED THEMATIC ANA, Vxx; Gulbrandsen M, 2011, RES POLICY, V40, P1, DOI 10.1016/j.respol.2010.09.007; Hampson LA, 2006, NEW ENGL J MED, V355, P2330, DOI 10.1056/NEJMsa064160; Hayes AF., 2013, INTRODUCTION TO MEDI, Vxvii; Hibbing JR, 2002, STEALTH DEMOCRACY AM, Vxiv; Horel S, SPECIAL REPORT SCIEN; Huffman W. E., 2004, American Journal of Agricultural Economics, V86, P1222, DOI 10.1111/j.0002-9092.2004.00669.x; Joss S., 1999, SCI PUBL POLICY, V26, P321, DOI DOI 10.3152/147154399781782347; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; Kloor K, 2015, NATURE, V524, P145, DOI 10.1038/nature.2015.18146; Korn D, 2013, JAMA-J AM MED ASSOC, V310, P2397, DOI 10.1001/jama.2013.280889; Leventhal G. S., 1980, SOCIAL EXCHANGE ADVA; Levinsky NG, 2002, NEW ENGL J MED, V347, P759, DOI 10.1056/NEJMsb020853; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; LIND EA, 1980, J PERS SOC PSYCHOL, V39, P643, DOI 10.1037/0022-3514.39.4.643; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; Malina D, 2015, THE NEW ENGLAND JOUR, V372, P1959; McComas KA, 2005, PUBLIC UNDERST SCI, V14, P285, DOI 10.1177/0963662505052891; McComas KA, 2003, SCI COMMUN, V24, P395, DOI 10.1177/1075547003024004001; McComas K, 2007, J APPL SOC PSYCHOL, V37, P905, DOI 10.1111/j.1559-1816.2007.00192.x; McComas KA, 2007, J HEALTH COMMUN, V12, P527, DOI 10.1080/10810730701508245; McComas KA, 2014, APPETITE, V78, P8, DOI 10.1016/j.appet.2014.02.006; McComas KA, 2008, RISK ANAL, V28, P1539, DOI 10.1111/j.1539-6924.2008.01129.x; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; McCright AM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044029; McGarity TO, 2008, BENDING SCIENCE HOW, Vviii; Michaels D, 2005, AM J PUBLIC HEALTH, V95, pS39, DOI 10.2105/AJPH.2004.043059; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; National Science Foundation, 2014, SCI ENG IND 2014, P4; Nestle M, 2016, JAMA INTERN MED, V176, P13, DOI 10.1001/jamainternmed.2015.6667; Oreskes Naomi, 2010, MERCHANTS OF DOUBT H; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Proctor RN, 2012, TOB CONTROL, V21, P87, DOI 10.1136/tobaccocontrol-2011-050338; RASINSKI K, 1985, J PERS SOC PSYCHOL, V49, P386, DOI 10.1037/0022-3514.49.2.386; Rosner D, 2002, DECEIT AND DENIAL TH; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Skitka L. J., 2001, SOC JUSTICE RES, V14, P305, DOI [DOI 10.1023/A:1014372008257, 10.1023/A:1014372008257]; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; Thibaut J. W, 1975, PROCEDURAL JUSTICE A; Thrasher JF, 2010, SOC SCI MED, V70, P787, DOI 10.1016/j.socscimed.2009.10.064; Tyler TR, 2011, EUR J CRIMINOL, V8, P254, DOI 10.1177/1477370811411462; Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07; Tyler TR, 2000, INT J PSYCHOL, V35, P117, DOI 10.1080/002075900399411; van den Bos K, 2001, J PERS SOC PSYCHOL, V80, P931, DOI 10.1037/0022-3514.80.6.931; van den Bos K, 2000, J PERS SOC PSYCHOL, V79, P355, DOI 10.1037/0022-3514.79.3.355; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P95, DOI 10.1037/0022-3514.72.1.95; Webler T., 2013, EFFECTIVE RISK COMMU, P124, DOI 10.4324/9780203109861; Weinberg JD, 2014, SOCIOL SCI, V1, P292, DOI 10.15195/v1.a19; Weinfurt KP, 2008, J GEN INTERN MED, V23, P860, DOI 10.1007/s11606-008-0590-4	81	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175643	10.1371/journal.pone.0175643	http://dx.doi.org/10.1371/journal.pone.0175643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426697	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875900037
J	Cornejo-Romero, A; Vargas-Mendoza, CF; Aguilar-Martinez, GF; Medina-Sanchez, J; Rendon-Aguilar, B; Valverde, PL; Zavala-Hurtado, JA; Serrato, A; Rivas-Arancibia, S; Perez-Hernandez, A; Lopez-Ortega, G; Jimenez-Sierra, C				Cornejo-Romero, Amelia; Fabian Vargas-Mendoza, Carlos; Aguilar-Martinez, Gustavo F.; Medina-Sanchez, Javier; Rendon-Aguilar, Beatriz; Luis Valverde, Pedro; Alejandro Zavala-Hurtado, Jose; Serrato, Alejandra; Rivas-Arancibia, Sombra; Aurelio Perez-Hernandez, Marco; Lopez-Ortega, Gerardo; Jimenez-Sierra, Cecilia			Alternative glacial-interglacial refugia demographic hypotheses tested on Cephalocereus columna-trajani (Cactaceae) in the intertropical Mexican drylands	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; LEPTONYCTERIS-CURASOAE; CLIMATIC OSCILLATIONS; DISJUNCT DISTRIBUTION; NORTH-AMERICA; PHYLOGEOGRAPHY; CHLOROPLAST; HISTORY; SONORAN; CACTUS	Historic demography changes of plant species adapted to New World arid environments could be consistent with either the Glacial Refugium Hypothesis (GRH), which posits that populations contracted to refuges during the cold-dry glacial and expanded in warm-humid interglacial periods, or with the Interglacial Refugium Hypothesis (IRH), which suggests that populations contracted during interglacials and expanded in glacial times. These contrasting hypotheses are developed in the present study for the giant columnar cactus Cephalocereus columna-trajani in the intertropical Mexican drylands where the effects of Late Quaternary climatic changes on phylogeography of cacti remain largely unknown. In order to determine if the historic demography and phylogeographic structure of the species are consistent with either hypothesis, sequences of the chloroplast regions psbA-trnH and trnT-trnL from 110 individuals from 10 populations comprising the full distribution range of this species were analysed. Standard estimators of genetic diversity and structure were calculated. The historic demography was analysed using a Bayesian approach and the palaeodistribution was derived from ecological niche modelling to determine if, in the arid environments of south-central Mexico, glacial-interglacial cycles drove the genetic divergence and diversification of this species. Results reveal low but statistically significant population differentiation (F-ST = 0.124, P < 0.001), although very clear geographic clusters are not formed. Genetic diversity, haplotype network and Approximate Bayesian Computation (ABC) demographic analyses suggest a population expansion estimated to have taken place in the Last Interglacial (123.04 kya, 95% CI 115.3-130.03). The species palaeodistribution is consistent with the ABC analyses and indicates that the potential area of palaedistribution and climatic suitability were larger during the Last Interglacial and Holocene than in the Last Glacial Maximum. Overall, these results suggest that C. columna-trajani experienced an expansion following the warm conditions of interglacials, in accordance with the GRH.	[Cornejo-Romero, Amelia; Fabian Vargas-Mendoza, Carlos; Aguilar-Martinez, Gustavo F.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Mexico City, DF, Mexico; [Medina-Sanchez, Javier] Univ Leicester, Dept Geog, Leicester, Leics, England; [Rendon-Aguilar, Beatriz; Luis Valverde, Pedro; Alejandro Zavala-Hurtado, Jose; Aurelio Perez-Hernandez, Marco; Lopez-Ortega, Gerardo; Jimenez-Sierra, Cecilia] Univ Autonoma Metropolitana lztapalapa, Dept Biol, Mexico City, DF, Mexico; [Serrato, Alejandra] Univ Autonoma Metropolitana lztapalapa, Dept Hidrobiol, Mexico City, DF, Mexico; [Rivas-Arancibia, Sombra] Benemerita Univ Autonoma Puebla, Escuela Biol, Puebla, Mexico	Instituto Politecnico Nacional - Mexico; University of Leicester; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Benemerita Universidad Autonoma de Puebla	Vargas-Mendoza, CF (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Mexico City, DF, Mexico.	carfvargas@yahoo.com		Vargas-Mendoza, Carlos F./0000-0002-3904-9093; Medina-Sanchez, Javier/0000-0002-1929-5238	Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT) [252478]; CONACYT [FOSEMARNAT- 2004-01-26]; SIP-IPN [20150755]	Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SIP-IPN	ACR was supported by the Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT) with a post-doctoral scholarship (no. 252478). CONACYT provided support for this study by financing the project FOSEMARNAT- 2004-01-26, and SIP-IPN financing the project 20150755.	Allal F, 2011, HEREDITY, V107, P174, DOI 10.1038/hdy.2011.5; Arias S, 2012, FLORA VALLE TEHUACAN; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barberi M, 2000, J S AM EARTH SCI, V13, P241, DOI 10.1016/S0895-9811(00)00022-5; Barcenas-Arguello ML, 2011, THESIS; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Butterworth CA, 2004, AM J BOT, V91, P1086, DOI 10.3732/ajb.91.7.1086; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Clark-Tapia R, 2003, HEREDITY, V90, P443, DOI 10.1038/sj.hdy.6800252; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Collevatti RG, 2012, ECOL EVOL, V2, P1024, DOI 10.1002/ece3.236; Collevatti RG, 2009, ANN BOT-LONDON, V104, P655, DOI 10.1093/aob/mcp157; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Davila P, 2002, BIODIVERS CONSERV, V11, P421, DOI 10.1023/A:1014888822920; De la Maza-Elvira RG, 2001, VALLE TEHUACAN CUICA, P23; Drummond AJ, 2002, BAYESIAN EVOLUTIONAR; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Ezcurra RAE (Universidad Nacional Autonoma de Mexico. Instituto de Ecologia), 1990, G003 SNIBCONABIO; Fehlberg SD, 2009, MOL PHYLOGENET EVOL, V50, P326, DOI 10.1016/j.ympev.2008.11.011; Ornelas JF, 2015, J HERED, V106, P196, DOI 10.1093/jhered/esu113; Gamez N, 2014, J BIOGEOGR, V41, P871, DOI 10.1111/jbi.12249; Garcia E., 2004, SERIE LIBROS, V6; Garrick RC, 2009, MOL ECOL, V18, P1916, DOI 10.1111/j.1365-294X.2009.04148.x; Gibson A.C., 1986, CACTUS PRIMER, DOI DOI 10.4159/HARVARD.9780674281714; Godinez-Alvarez H, 2000, BIOTROPICA, V32, P552, DOI 10.1111/j.1744-7429.2000.tb00502.x; Godinez-Alvarez H, 2002, ECOLOGY, V83, P2617, DOI 10.1890/0012-9658(2002)083[2617:TROSDI]2.0.CO;2; Gutierrez-Flores C, 2016, PERSPECT PLANT ECOL, V22, P1, DOI 10.1016/j.ppees.2016.06.003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kerwin MW, 1999, PALEOCEANOGRAPHY, V14, P200, DOI 10.1029/1998PA900011; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Moraes EM, 2005, GENETICA, V125, P311, DOI 10.1007/s10709-005-0716-0; Nason JD, 2002, EVOLUTION, V56, P2214, DOI 10.1111/j.0014-3820.2002.tb00146.x; Nassar JM, 2003, AM J BOT, V90, P1628, DOI 10.3732/ajb.90.11.1628; Nei M., 1987, MOL EVOLUTIONARY GEN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orum TV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160899; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pritchard J.K., DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2003, TRACER V1 5 0 MCMC T; Ramirez-Arriaga E, 2014, PALYNOLOGY, V38, P1, DOI 10.1080/01916122.2013.802750; Rebernig CA, 2010, MOL PHYLOGENET EVOL, V54, P594, DOI 10.1016/j.ympev.2009.10.010; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Rojas-Martinez A, 1999, J BIOGEOGR, V26, P1065, DOI 10.1046/j.1365-2699.1999.00354.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sahley CT, 1993, J MAMMAL; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Serrano Estrada B, 2010, THESIS; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sosa V, 2009, J BIOGEOGR, V36, P18, DOI 10.1111/j.1365-2699.2008.01957.x; Steenbergh W.F., 1983, ECOLOGY SAGUARO; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Valiente-Banuet A., 2009, GUIA VEGETACION VALL; ValienteBanuet A, 1996, J TROP ECOL, V12, P103, DOI 10.1017/S0266467400009330; Valverde PL, 2007, PLANT ECOL, V188, P17, DOI 10.1007/s11258-006-9144-1; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; VANDEVENDER TR, 1994, QUATERNARY RES, V41, P99, DOI 10.1006/qres.1994.1011; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zavala-Hurtado J.A., 1982, BIOTICA, V1, P99	77	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175905	10.1371/journal.pone.0175905	http://dx.doi.org/10.1371/journal.pone.0175905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426818	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900067
J	Hall, SE; Negus, C; Johinke, D; Bathgate, R				Hall, Sally E.; Negus, Cameron; Johinke, Danielle; Bathgate, Roslyn			Adjusting cryodiluent composition for improved post-thaw quality of rabbit spermatozoa	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; EGG-YOLK; FERTILIZING ABILITY; SPERM; CRYOPRESERVATION; CRYOPROTECTANTS; ACETAMIDE; FROZEN; SEMEN; PARAMETERS	Improved fertility following artificial insemination with frozen-thawed spermatozoa would offer rabbit producers faster genetic improvement. Previous work investigating cryoprotectants for rabbit spermatozoa have reported inconsistent results. Semen was collected from three rabbit bucks by artificial vagina and frozen using a standard procedure with varied cryodiluent components. Post-thaw analysis encompassed motility, sperm kinematic parameters and acrosome and membrane integrity. Spermatozoa were evaluated at 0, 2 and 4 h after thawing. Experiment 1 compared diluents with 3.5% dimethyl sulfoxide (DMSO), 1.5% acetamide, 1.75% DMSO + 0.75% acetamide or 3.5% DMSO + 1.5% acetamide. The treatment that resulted in the highest post-thaw motility (P<0.001) and acrosome integrity (P<0.001) was DMSO alone. Experiment 2 compared 3.5, 7 and 10% DMSO in the cryodiluent. The best post-thaw sperm motility (P< 0.001) and linearity (P =.002) was in 3.5% DMSO, while 10% DMSO afforded higher acrosome/membrane integrity at this last time point (P< 0.05). Experiment 3 varied the cryodiluent to contain either 9 or 17% egg yolk or 9 or 17% low density lipoproteins extracted from whole egg yolk. The treatment with the best post-thaw result was 17% egg yolk (motility, P = 0.01; acrosome/membrane integrity, P< 0.001). Experiment 4 compared different carbohydrates in the cryodiluent; 50 mM glucose (TCG), 25 mM glucose with 25 mM sucrose (TCGS low), or 50 mM glucose with 50 mM sucrose (TCGS high). When data were pooled across time points, TCG had significantly higher motility than TCGS high (P = 0.021), but was not different from TCGS low. However, TCG had fewer spermatozoa with intact acrosomes and membranes than both TCGS low and TCGS high (P =.002). Put together, these results indicate that the best cryodiluent for rabbit spermatozoa frozen under the conditions used in this paper is with 7% DMSO and 17% egg yolk in a base medium containing 25 mM glucose and 25 mM sucrose.	[Hall, Sally E.; Negus, Cameron; Johinke, Danielle; Bathgate, Roslyn] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Bathgate, R (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	roslyn.bathgate@sydney.edu.au	Bathgate, Roslyn/AAC-2504-2019	Bathgate, Roslyn/0000-0002-7922-5610	Rural Industries Research and Development Corporation [PRJ00585]	Rural Industries Research and Development Corporation	This work was supported by the Rural Industries Research and Development Corporation (http://www.rirdc.gov.au/) grant PRJ00585. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad E., 2012, ANIMAL HLTH PRODUCTI, V1, P123; Amiridis GS, 2012, ANIM REPROD SCI, V130, P152, DOI 10.1016/j.anireprosci.2012.01.009; Arriola J, 2001, J ANDROL, V22, P458; Bencharif D, 2008, THERIOGENOLOGY, V70, P1478, DOI 10.1016/j.theriogenology.2008.06.095; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P779, DOI 10.2527/jas.2011-4311; Chinsomboon S, 1990, J Med Assoc Thai, V73 Suppl 1, P100; CURRY MR, 1995, CRYOBIOLOGY, V32, P175, DOI 10.1006/cryo.1995.1016; Dalimata AM, 1997, THERIOGENOLOGY, V48, P831, DOI 10.1016/S0093-691X(97)00305-1; DICKERSON GE, 1978, ANIM PROD, V27, P367, DOI 10.1017/S0003356100036278; Farshad A, 2011, ASIAN AUSTRAL J ANIM, V24, P181, DOI 10.5713/ajas.2011.10141; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Gillan L, 2005, THERIOGENOLOGY, V63, P445, DOI 10.1016/j.theriogenology.2004.09.024; Gillan L, 2008, ANIM REPROD SCI, V103, P201, DOI 10.1016/j.anireprosci.2006.12.010; Gomez-Fernandez J, 2012, ANIM REPROD SCI, V133, P109, DOI 10.1016/j.anireprosci.2012.06.010; Hino Toshiaki, 2007, Reproductive Medicine and Biology, V6, P229, DOI 10.1111/j.1447-0578.2007.00190.x; Hu JH, 2006, ASIAN AUSTRAL J ANIM, V19, P486, DOI 10.5713/ajas.2006.486; Iaffaldano N, 2014, ANIM REPROD SCI, V151, P220, DOI 10.1016/j.anireprosci.2014.10.020; Iorio M. di, 2014, Italian Journal of Animal Science, V13, P710; Kashiwazaki N, 2006, J REPROD DEVELOP, V52, P511, DOI 10.1262/jrd.18008; Lavara R, 2005, THERIOGENOLOGY, V64, P1130, DOI 10.1016/j.theriogenology.2005.01.009; Moce E, 2010, REPROD DOMEST ANIM, V45, pE1, DOI 10.1111/j.1439-0531.2009.01507.x; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; Moussa M, 2002, THERIOGENOLOGY, V57, P1695, DOI 10.1016/S0093-691X(02)00682-9; Okuda Y, 2007, EXP ANIM TOKYO, V56, P29, DOI 10.1538/expanim.56.29; Pillet E, 2011, THERIOGENOLOGY, V75, P105, DOI 10.1016/j.theriogenology.2010.07.015; Prayaga K. C., 2000, Asian-Australasian Journal of Animal Sciences, V13, P357; PURSEL VG, 1972, J ANIM SCI, V35, P580; Roca J, 2000, ANIM REPROD SCI, V64, P103, DOI 10.1016/S0378-4320(00)00185-8; Rosato MP, 2013, THERIOGENOLOGY, V79, P508, DOI 10.1016/j.theriogenology.2012.11.008; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Si W, 2006, THERIOGENOLOGY, V65, P788, DOI 10.1016/j.theriogenology.2005.06.010; Vicente JS, 1996, REPROD NUTR DEV, V36, P485, DOI 10.1051/rnd:19960504; ViudesdeCastro MP, 1996, ANIM REPROD SCI, V44, P195, DOI 10.1016/0378-4320(96)01550-3; WATSON PF, 1976, J THERM BIOL, V1, P137, DOI 10.1016/0306-4565(76)90003-6	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175965	10.1371/journal.pone.0175965	http://dx.doi.org/10.1371/journal.pone.0175965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426717	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900076
J	Kaur, P; Shukla, N; Joshi, G; VijayaKumar, C; Jagannath, A; Agarwal, M; Goel, S; Kumar, A				Kaur, Pritam; Shukla, Neha; Joshi, Gopal; VijayaKumar, Cheeni; Jagannath, Arun; Agarwal, Manu; Goel, Shailendra; Kumar, Amar			Genome-wide identification and characterization of miRNAome from tomato (Solanum lycopersicum) roots and root-knot nematode (Meloidogyne incognita) during susceptible interaction	PLOS ONE			English	Article							SMALL RNAS; MICRORNA TARGETS; REGULATORY ROLES; FUNCTIONAL-ROLE; PLANT; ARABIDOPSIS; STRESS; GENES; CYST; CLASSIFICATION	Root-knot nematodes (RKNs, Meloidogyne spp.) are the most damaging plant parasites causing severe losses to crop production. The present study reports genome-wide identification and characterization of both tomato and RKN miRNAs simultaneously from RKN-infected susceptible tomato roots using high-throughput sequencing technique. RNAseq data from 11 small RNA libraries derived from 5 disease development stages identified 281 novel miRNAs of tomato in addition to 52 conserved and 4 variants of conserved miRNAs. Additionally, the same set of RNAseq data identified 38 conserved and 290 novel RKN miRNAs. Both tomato and RKN miRNAs showed differential expression at 5 stages of disease development based on digital expression profiles. In tomato, further validation through qRT-PCR confirmed that majority of miRNAs were significantly upregulated during susceptible response whereas downregulated during resistance response. The predicted targets of 8 conserved and 1 novel miRNAs were validated through 5' RLM-RACE. A negative correlation between expression profiles of a few conserved miRNAs (miR156, miR159, miR164 and miR396) and their targets (SBP, GAMYB-like, NAC and GRF1 transcription factor) was confirmed. A novel Sly_miRNA996 also showed a negative correlation with its target MYB-like transcription factor. These results indicate that the conserved and novel tomato miRNAs are involved in regulating developmental changes in host root during RKN infection. In RKN, the targets of conserved miRNAs were also predicted and a few of their predicted target genes are known to be involved in nematode parasitism. Further, the potential roles of both tomato and RKN miRNAs have been discussed.	[Kaur, Pritam; Shukla, Neha; Joshi, Gopal; VijayaKumar, Cheeni; Jagannath, Arun; Agarwal, Manu; Goel, Shailendra; Kumar, Amar] Univ Delhi, Dept Bot, Delhi, India	University of Delhi	Kumar, A (corresponding author), Univ Delhi, Dept Bot, Delhi, India.	akumar23j@gmail.com	Shukla, Neha/AAF-4425-2021	Shukla, Neha/0000-0002-7175-8308; AGARWAL, MANU/0000-0003-4241-5055; Goel, Shailendra/0000-0002-8731-8892	National Agricultural Science Fund (NASF), Indian Council of Agricultural Research [NFBSFARA/RNA-3022/2012-13]; RAMP;D grant, University of Delhi; Council of Scientific and Industrial Research, India	National Agricultural Science Fund (NASF), Indian Council of Agricultural Research; RAMP;D grant, University of Delhi; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This research work was supported by grants sanctioned to AK by National Agricultural Science Fund (NASF), Indian Council of Agricultural Research, project code (NFBSFARA/RNA-3022/2012-13) and R&D grant, University of Delhi. PK is also thankful to Council of Scientific and Industrial Research, India for providing her junior and senior research fellowships.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BYBD DW, 1983, J NEMATOL, V15, P142; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cabrera J, 2016, NEW PHYTOL, V209, P1625, DOI 10.1111/nph.13735; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Escobar C, 2015, ADV BOT RES, V73, P1, DOI 10.1016/bs.abr.2015.01.001; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154955; Hewezi T, 2008, MOL PLANT MICROBE IN, V21, P1622, DOI 10.1094/MPMI-21-12-1622; Hewezi T, 2015, ADV BOT RES, V73, P221, DOI 10.1016/bs.abr.2014.12.007; Hewezi T, 2013, MOL PLANT MICROBE IN, V26, P9, DOI 10.1094/MPMI-05-12-0106-FI; Hewezi T, 2012, PLANT PHYSIOL, V159, P321, DOI 10.1104/pp.112.193649; Huang Y, 2010, MOL BIOL REP, V37, P3171, DOI 10.1007/s11033-009-9897-4; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kyndt T, 2013, PLANTA, V238, P807, DOI 10.1007/s00425-013-1923-z; Lakhotia N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-6; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Portillo M, 2013, NEW PHYTOL, V197, P1276, DOI 10.1111/nph.12121; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Salinas M, 2012, PLANTA, V235, P1171, DOI 10.1007/s00425-011-1565-y; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shukla N, 2017, MOL PLANT PATHOL; Shukla Neha, 2016, Indian Journal of Plant Physiology, V21, P477, DOI 10.1007/s40502-016-0263-y; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Subasic D, 2015, GENOME RES, V25, P1680, DOI 10.1101/gr.183160.114; Subramanian P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101758; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133491; Williamson VM, 1996, PLANT CELL, V8, P1735, DOI 10.1105/tpc.8.10.1735; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YQ, 2016, FUNCT INTEGR GENOMIC, V16, P127, DOI 10.1007/s10142-015-0472-x; Zhao WC, 2015, J EXP BOT, V66, P4653, DOI 10.1093/jxb/erv238; Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007	63	28	30	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175178	10.1371/journal.pone.0175178	http://dx.doi.org/10.1371/journal.pone.0175178			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426683	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900020
J	Kempinska-Podhorodecka, A; Milkiewicz, M; Jablonski, D; Milkiewicz, P; Wunsch, E				Kempinska-Podhorodecka, Agnieszka; Milkiewicz, Malgorzata; Jablonski, Dariusz; Milkiewicz, Piotr; Wunsch, Ewa			ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; BONE-MINERAL DENSITY; DEPRESSIVE SYMPTOMS; GENETIC ASSOCIATION; INHIBITION; HEPATITIS; FATIGUE; VDR	Background Polymorphisms of vitamin D receptor (VDR) contribute to the pathogenesis of multiple autoimmune conditions. Methods We investigated the incidence of VDR polymorphisms (rs1544410-BsmI; rs7975232-ApaI; rs731236-TaqI) in a group of patients with primary sclerosing cholangitis (PSC, n = 275) and in healthy controls (n = 376). Additionally, correlations of the VDR polymorphisms with clinical and biochemical factors of the disease were analysed. Results The genotype and allele distributions of these polymorphisms in PSC patients were similar to those observed in controls. However, the ApaI polymorphism was associated with an impaired health-related quality of life (HRQoL). The generic SF-36 questionnaire showed that the Role-Physical (p = 0.01), Role-Emotional (p = 0.01), Physical Component Summary (p = 0.01) and Mental Component Summary (p = 0.003) scores were significantly affected. Similarly, the disease-specific questionnaires, PBC-40 and PBC-27, demonstrated that carriers of the C allele suffered from more severe Itch (p = 0.03 assessed by PBC-40 and PBC-27), more Fatigue (p = 0.02 assessed by PBC-40 and PBC-27) and Impaired Cognitive Capacity (p = 0.04 and p = 0.03). Correspondingly, individuals who were AA homozygotes (non-carriers of the C allele of ApaI) had higher summary scores for the Physical (p = 0.01) and Mental Components (p = 0.006) measured with SF-36. Moreover, they experienced less itch (p = 0.03) and less Fatigue (p = 0.03) and had better Cognitive Abilities (p = 0.04) as assessed by the PBC-40 and PBC-27 questionnaires. No associations between other VDR polymorphisms and clinical or laboratory findings were made. Conclusion In summary, this study is the first to show that the ApaI polymorphisms in VDR may exert an effect on disease-related symptoms and quality of life in patients with PSC.	[Kempinska-Podhorodecka, Agnieszka; Milkiewicz, Malgorzata] Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland; [Jablonski, Dariusz] Med Univ Warsaw, Dept Gen & Endocrine Surg, Warsaw, Poland; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland; [Wunsch, Ewa] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland	Pomeranian Medical University; Medical University of Warsaw; Medical University of Warsaw; Pomeranian Medical University	Kempinska-Podhorodecka, A (corresponding author), Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland.	agnieszkakempinska@interia.eu		Milkiewicz, Piotr/0000-0002-1817-0724; Kempinska-Podhorodecka, Agnieszka/0000-0002-7513-8640; Milkiewicz, Malgorzata/0000-0002-2064-0545	Foundation for Polish Science	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Ewa Wunsch was supported by the Foundation for Polish Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Arnson Y, 2011, AUTOIMMUN REV, V10, P490, DOI 10.1016/j.autrev.2011.02.002; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Benito de Valle Maria, 2012, Clin Gastroenterol Hepatol, V10, P769, DOI 10.1016/j.cgh.2012.01.025; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Carlberg C, 2003, RECENT RESULTS CANC, V164, P29; Cheung AC, 2016, DIGEST DIS SCI, V61, P1692, DOI 10.1007/s10620-015-4013-1; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fan LY, 2005, WORLD J GASTROENTERO, V11, P2768, DOI 10.3748/wjg.v11.i18.2768; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Gatto NM, 2016, J NEUROL SCI, V370, P100, DOI 10.1016/j.jns.2016.09.013; Guardiola J, 2000, GASTROENTEROLOGY, V119, P599, DOI 10.1053/gast.2000.16155; Halmos B, 2000, DIGEST DIS SCI, V45, P1091, DOI 10.1023/A:1005581414918; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Hochrath K, 2014, HEPATOL INT, V8, P443, DOI 10.1007/s12072-014-9548-2; Ishikawa L.L., 2016, CLIN REV ALLERGY IMM; Jiang W, 2006, BIOCHEM BIOPH RES CO, V351, P176, DOI 10.1016/j.bbrc.2006.10.027; JORGENSEN RA, 1995, J CLIN GASTROENTEROL, V20, P215, DOI 10.1097/00004836-199504000-00011; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kempinska-Podhorecka A, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/408723; Kempinska-Podhorodecka A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020289; Keyimu K, 2014, INT J CLIN EXP MED, V7, P5282; Kivity S, 2011, CELL MOL IMMUNOL, V8, P243, DOI 10.1038/cmi.2010.73; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Lakatos LP, 2002, EUR J GASTROEN HEPAT, V14, P733, DOI 10.1097/00042737-200207000-00004; Lerner A, 2012, CLIN REV ALLERG IMMU, V42, P322, DOI 10.1007/s12016-010-8237-8; Lim Lei Yuan, 2012, Curr Gastroenterol Rep, V14, P67, DOI 10.1007/s11894-011-0231-7; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Milkiewicz P, 2004, GUT, V53, P475, DOI 10.1136/gut.2003.025155; Milkiewicz P, 2011, RECENT RESULTS CANC, V185, P117, DOI 10.1007/978-3-642-03503-6_7; Montali L, 2010, DIGEST LIVER DIS, V42, P718, DOI 10.1016/j.dld.2010.01.004; Newton JL, 2006, J HEPATOL, V44, P776, DOI 10.1016/j.jhep.2005.12.012; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x; Raszeja-Wyszomirska J, 2015, LIVER INT, V35, P1764, DOI 10.1111/liv.12730; Resnick RH, 2000, GASTROENTEROLOGY, V119, P1805, DOI 10.1016/S0016-5085(00)70039-4; Rosen Y, 2016, SCAND J RHEUMATOL, V45, P439, DOI 10.3109/03009742.2016.1151072; Roy S, 2014, N AM J MED SCI, V6, P396, DOI 10.4103/1947-2714.139291; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Springer JE, 2000, GASTROENTEROLOGY, V118, P145, DOI 10.1016/S0016-5085(00)70423-9; Stokes CS, 2016, CLIN NUTR, V35, P950, DOI 10.1016/j.clnu.2015.07.004; Stokes CS, 2013, LIVER INT, V33, P338, DOI 10.1111/liv.12106; Tanaka A, 2009, J HEPATOL, V50, P1202, DOI 10.1016/j.jhep.2009.01.015; Trepo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wunsch E, 2014, HEPATOLOGY, V60, P931, DOI 10.1002/hep.27074	50	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176264	10.1371/journal.pone.0176264	http://dx.doi.org/10.1371/journal.pone.0176264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426778	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900123
J	Bylenga, CH; Cummings, VJ; Ryan, KG				Bylenga, Christine H.; Cummings, Vonda J.; Ryan, Ken G.			High resolution microscopy reveals significant impacts of ocean acidification and warming on larval shell development in Laternula elliptica	PLOS ONE			English	Article							SEAWATER ACIDIFICATION; TEMPORAL VARIABILITY; MARINE CALCIFIERS; ANTARCTIC BIVALVE; CARBONIC-ACID; GROWTH-RATE; FUTURE; TEMPERATURE; CO2; FERTILIZATION	Environmental stressors impact marine larval growth rates, quality and sizes. Larvae of the Antarctic bivalve, Laternula elliptica, were raised to the D-larvae stage under temperature and pH conditions representing ambient and end of century projections (-1.6 degrees C to +0.4 degrees C and pH 7.98 to 7.65). Previous observations using light microscopy suggested pH had no influence on larval abnormalities in this species. Detailed analysis of the shell using SEM showed that reduced pH is in fact a major stressor during development for this species, producing D-larvae with abnormal shapes, deformed shell edges and irregular hinges, cracked shell surfaces and even uncalcified larvae. Additionally, reduced pH increased pitting and cracking on shell surfaces. Thus, apparently normal larvae may be compromised at the ultrastructural level and these larvae would be in poor condition at settlement, reducing juvenile recruitment and overall survival. Elevated temperatures increased prodissoconch II sizes. However, the overall impacts on larval shell quality and integrity with concurrent ocean acidification would likely overshadow any beneficial results from warmer temperatures, limiting populations of this prevalent Antarctic species.	[Bylenga, Christine H.; Ryan, Ken G.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Cummings, Vonda J.] Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand	Victoria University Wellington; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Bylenga, CH (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	Christine.bylenga@gmail.com		Ryan, Ken/0000-0001-7075-0112; Cummings, Vonda/0000-0003-1076-3995	VUW Grant [100241]; Victoria Doctoral Scholarship Fund; Royal Society of New Zealand Marsden Fund [NIW1101]	VUW Grant; Victoria Doctoral Scholarship Fund; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was funded by VUW Grant 100241 (KGR), the Victoria Doctoral Scholarship Fund (CHB), and the Royal Society of New Zealand Marsden Fund NIW1101 (VJC).	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Andersen S, 2013, BIOGEOSCIENCES DISCU, V10, P3281, DOI [10.5194/bgd-10-3281-2013, DOI 10.5194/BGD-10-3281-2013]; Ansell AD, 1997, J MOLLUS STUD, V63, P109, DOI 10.1093/mollus/63.1.109; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bednarsek N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109183; Bylenga CH, 2015, MAR ECOL PROG SER, V536, P187, DOI 10.3354/meps11436; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carriker Melbourne R., 1996, P75; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Davis AR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064808, 10.1371/journal.pone.0055939]; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorey N, 2013, MAR BIOL, V160, P2007, DOI 10.1007/s00227-012-2059-6; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Edenhofer O., 2014, CONTRIBUTION WORKING; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Guo X, 2015, AQUAT BIOL, V23, P147, DOI 10.3354/ab00615; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Higgins FA, 2012, J THERM BIOL, V37, P83, DOI 10.1016/j.jtherbio.2011.11.004; Kraeuter J.N., 2001, BIOL HARD CLAM; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Martel AL, 2014, J SHELLFISH RES, V33, P443, DOI 10.2983/035.033.0213; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Muller MN, 2015, MAR ECOL PROG SER, V531, P81, DOI 10.3354/meps11309; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Pecorino D, 2014, MAR BIOL, V161, P101, DOI 10.1007/s00227-013-2318-1; Pereira AM, 2016, REG ENVIRON CHANGE, V16, P855, DOI 10.1007/s10113-015-0803-4; Phillips NE, 2002, INVERTEBR REPROD DEV, V41, P171, DOI 10.1080/07924259.2002.9652749; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Tans P., 2015, TRENDS ATMOSPHERIC C; Thomsen J, 2015, BIOGEOSCIENCES DISCU, V12, P1543, DOI DOI 10.5194/BGD-12-1543-2015; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Timmins-Schiffman E, 2013, MAR BIOL, V160, P1973, DOI 10.1007/s00227-012-2055-x; Tunnicliffe V, 2009, NAT GEOSCI, V2, P344, DOI 10.1038/NGEO500; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044655; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; White MM, 2014, MAR ECOL PROG SER, V498, P173, DOI 10.3354/meps10621; Wicks LC, 2012, OCEANOGR MAR BIOL, V50, P127; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	56	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175706	10.1371/journal.pone.0175706	http://dx.doi.org/10.1371/journal.pone.0175706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423059	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600045
J	Kuo, SJ; Yang, WH; Liu, SC; Tsai, CH; Hsu, HC; Tang, CH				Kuo, Shu-Jui; Yang, Wei-Hung; Liu, Shan-Chi; Tsai, Chun-Hao; Hsu, Horng-Chaung; Tang, Chih-Hsin			Transforming growth factor beta 1 enhances heme oxygenase 1 expression in human synovial fibroblasts by inhibiting microRNA 519b synthesis	PLOS ONE			English	Article							PROTEIN-KINASE-C; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; IMMUNE-RESPONSES; PHOSPHOLIPASE-C; UP-REGULATION; TGF-BETA; OSTEOARTHRITIS; ACTIVATION; INDUCTION	Background Osteoarthritis (OA) is manifested by synovial inflammation and cartilage destruction that is directly linked to synovitis, joint swelling and pain. In the light of the role of synovium in the pathogenesis and the symptoms of OA, synovium-targeted therapy is a promising strategy to mitigate the symptoms and progression of OA. Transforming growth factor beta 1 (TGF-beta 1), a secreted homodimeric protein, possesses unique and potent anti-inflammatory and immune-regulatory properties in many cell types. Heme oxygenase 1 (HO-1) is an inducible anti-inflammatory and stress responsive enzyme that has been proven to prevent injuries caused by many diseases. Despite the similar anti-inflammatory profile and their involvement in the pathogenesis of arthritic diseases, no studies have as yet explored the possibility of any association between the expression of TGF-beta 1 and HO-1. Methodology/Principal findings TGF-beta 1-induced HO-1 expression was examined by HO-1 promoter assay, qPCR, and Western blotting. The siRNAs and enzyme inhibitors were utilized to determine the intermediate involved in the signal transduction pathway. We showed that TGF-beta 1 stimulated the synthesis of HO-1 in a concentration-and time-dependent manner, which can be mitigated by blockade of the phospholipase (PLC)gamma/protein kinase C alpha (PKC) alpha pathway. We also showed that the expression of miRNA-519b, which blocks HO-1 transcription, is inhibited by TGF-beta 1, and the suppression of miRNA 519b could be reversed via blockade of the PLC gamma/PKC alpha pathway. Conclusions/Significance TGF-beta 1 stimulated the expression of HO-1 via activating the PLC gamma/PKC alpha pathway and suppressing the downstream expression of miRNA-519b. These results may shed light on the pathogenesis and treatment of OA.	[Kuo, Shu-Jui; Tsai, Chun-Hao; Hsu, Horng-Chaung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kuo, Shu-Jui; Tsai, Chun-Hao; Hsu, Horng-Chaung] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Yang, Wei-Hung] Minist Hlth & Welf, Taichung Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Yang, Wei-Hung] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Yang, Wei-Hung] Natl Taichung Univ Sci & Technol, Dept Nursing, Taichung, Taiwan; [Yang, Wei-Hung] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan; [Liu, Shan-Chi; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Taichung University of Science & Technology; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan.; Tang, CH (corresponding author), Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tsai, Chun-Hao/H-3140-2013	Tsai, Chun-Hao/0000-0002-4428-3132	Ministry of Science and Technology of Taiwan [MOST103-2628-B-039-002-MY3, MOST1052 320-B-039-015-MY3, MOST105-2811-B-0390 14]; China Medical University, Taiwan [CMU103S-06]; Chinese Medicine Research Center; China Medical University (the Ministry of Education, the Aim for the Top University Plan)	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University); Chinese Medicine Research Center; China Medical University (the Ministry of Education, the Aim for the Top University Plan)	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST103-2628-B-039-002-MY3; MOST1052 320-B-039-015-MY3; MOST105-2811-B-0390 14), China Medical University, Taiwan (CMU103S-06) and in part from the grant from Chinese Medicine Research Center, China Medical University (the Ministry of Education, the Aim for the Top University Plan).	Asahara Hiroshi, 2016, J Bone Metab, V23, P121, DOI 10.11005/jbm.2016.23.3.121; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Chiu YC, 2008, MOL IMMUNOL, V45, P1587, DOI 10.1016/j.molimm.2007.10.004; Evans CH, 1999, INTERNAL MED, V38, P233, DOI 10.2169/internalmedicine.38.233; Fang J, 2016, HISTOL HISTOPATHOL, P11779; Fuchs S, 2004, OSTEOARTHR CARTILAGE, V12, P409, DOI 10.1016/j.joca.2004.02.005; Furuhashi I, 2008, J PHARMACOL SCI, V108, P104, DOI 10.1254/jphs.08126FP; Gao Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149032; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; LAFYATIS R, 1989, J IMMUNOL, V143, P1142; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu GT, 2015, CANCER LETT, V357, P476, DOI 10.1016/j.canlet.2014.11.015; Nakasa T, 2011, PHYSIOL GENOMICS, V43, P566, DOI 10.1152/physiolgenomics.00142.2010; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Perillan PR, 2002, J BIOL CHEM, V277, P1974, DOI 10.1074/jbc.M107984200; Remst DFG, 2014, ARTHRITIS RHEUMATOL, V66, P647, DOI 10.1002/art.38266; Remst DFG, 2015, RHEUMATOLOGY, V54, P1954, DOI 10.1093/rheumatology/kev228; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Soares MP, 2007, FRONT BIOSCI, V12, P4932, DOI 10.2741/2439; Sondag GR, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0604-x; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takada T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0792-1; TAKETAZU F, 1994, LAB INVEST, V70, P620; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Yang WH, 2014, INT J MOL SCI, V15, P15778, DOI 10.3390/ijms150915778; Zhang ZJ, 2012, J AGR FOOD CHEM, V60, P8171, DOI 10.1021/jf301511m	34	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176052	10.1371/journal.pone.0176052	http://dx.doi.org/10.1371/journal.pone.0176052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423042	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600081
J	McDuff, D; Kodra, E; el Kaliouby, R; LaFrance, M				McDuff, Daniel; Kodra, Evan; el Kaliouby, Rana; LaFrance, Marianne			A large-scale analysis of sex differences in facial expressions	PLOS ONE			English	Article							GENDER-DIFFERENCES; SMILE; EXPERIENCE; EMOTION; FROWN	There exists a stereotype that women are more expressive than men; however, research has almost exclusively focused on a single facial behavior, smiling. A large-scale study examines whether women are consistently more expressive than men or whether the effects are dependent on the emotion expressed. Studies of gender differences in expressivity have been somewhat restricted to data collected in lab settings or which required labor-intensive manual coding. In the present study, we analyze gender differences in facial behaviors as over 2,000 viewers watch a set of video advertisements in their home environments. The facial responses were recorded using participants' own webcams. Using a new automated facial coding technology we coded facial activity. We find that women are not universally more expressive across all facial actions. Nor are they more expressive in all positive valence actions and less expressive in all negative valence actions. It appears that generally women express actions more frequently than men, and in particular express more positive valence actions. However, expressiveness is not greater in women for all negative valence actions and is dependent on the discrete emotional state.	[McDuff, Daniel] Microsoft Res, Redmond, WA 98052 USA; [Kodra, Evan] RisQ Inc, Cambridge, MA USA; [el Kaliouby, Rana] Affectiva Inc, Waltham, MA USA; [LaFrance, Marianne] Yale Univ, New Haven, CT USA	Microsoft; Yale University	McDuff, D (corresponding author), Microsoft Res, Redmond, WA 98052 USA.	damcduff@microsoft.com						Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; BRITON NJ, 1995, SEX ROLES, V32, P79, DOI 10.1007/BF01544758; BUCK R, 1974, J PERS SOC PSYCHOL, V30, P587, DOI 10.1037/h0037041; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Chaplin TM, 2013, PSYCHOL BULL, V139, P735, DOI 10.1037/a0030737; Darwin C., EXPRESSION EMOTIONS; Diener ML, 2004, J CROSS CULT PSYCHOL, V35, P525, DOI 10.1177/0022022104268387; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; EISENBERG N, 1995, COGNITION EMOTION, V9, P203, DOI 10.1080/02699939508409009; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P., 2002, MANUAL INVESTIGATORS; Evers C, 2011, EMOTION REGULATION AND WELL-BEING, P211, DOI 10.1007/978-1-4419-6953-8_13; FABES RA, 1991, PERS SOC PSYCHOL B, V17, P532, DOI 10.1177/0146167291175008; Fridlund A. J., 2015, BEHAV ECOLOGY VIEW F; Friesen WV, 1983, EMFACS 7 EMOTI UNPUB, V2; Hall JA, NONVERBAL COMMUNICAT, P639; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Hwang H., 2015, UNDERSTANDING FACIAL, P41; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Jack RE, 2012, J EXP PSYCHOL GEN, V141, P19, DOI 10.1037/a0023463; Keltner D., 2015, UNDERSTANDING MULTIM; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Krumhuber E, 2007, J NONVERBAL BEHAV, V31, P39, DOI 10.1007/s10919-006-0019-x; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; McDuff D., 2016, 2016 CHI C EXTENDED, P3723, DOI [DOI 10.1145/2851581.2890247, 10.1145/2851581.2890247]; McDuff D., 2016, J NONVERBAL BEHAV, P1; Pavlova MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157636; Russell J.A., 2015, MOVING BASIC EMOTION; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; Senechal T, 2015, P IEEE INT C COMP VI; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Thunberg M, 2000, J NONVERBAL BEHAV, V24, P45, DOI 10.1023/A:1006662822224; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; WALLBOTT HG, 1988, J NONVERBAL BEHAV, V12, P98, DOI 10.1007/BF00986928	37	50	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173942	10.1371/journal.pone.0173942	http://dx.doi.org/10.1371/journal.pone.0173942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422963	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600012
J	Lal, B; Gautam, P; Panda, BB; Raja, R; Singh, T; Tripathi, R; Shahid, M; Nayak, AK				Lal, B.; Gautam, Priyanka; Panda, B. B.; Raja, R.; Singh, Teekam; Tripathi, R.; Shahid, M.; Nayak, A. K.			Crop and varietal diversification of rainfed rice based cropping systems for higher productivity and profitability in Eastern India	PLOS ONE			English	Article							CLIMATE-CHANGE; MATTER; OPPORTUNITIES; ADAPTATION; STRATEGIES; GROWTH; YIELDS; AREAS; GRAIN	Rice-rice system and rice fallows are no longer productive in Southeast Asia. Crop and varietal diversification of the rice based cropping systems may improve the productivity and profitability of the systems. Diversification is also a viable option to mitigate the risk of climate change. In Eastern India, farmers cultivate rice during rainy season (June-September) and land leftovers fallow after rice harvest in the post-rainy season (November-May) due to lack of sufficient rainfall or irrigation amenities. However, in lowland areas, sufficient residual soil moistures are available in rice fallow in the post-rainy season (November-March), which can be utilized for raising second crops in the region. Implementation of suitable crop/varietal diversification is thus very much vital to achieve this objective. To assess the yield performance of rice varieties under timely and late sown conditions and to evaluate the performance of dry season crops following them, three different duration rice cultivars were transplanted in July and August. In dry season several non-rice crops were sown in rice fallow to constitute a cropping system. The results revealed that tiller occurrence, biomass accumulation, dry matter remobilization, crop growth rate, and ultimately yield were significantly decreased under late transplanting. On an average, around 30% yield reduction obtained under late sowing may be due to low temperature stress and high rainfall at reproductive stages of the crop. Dry season crops following short duration rice cultivars performed better in terms of grain yield. In the dry season, toria was profitable when sown earlier and if sowing was delayed greengram was suitable. Highest system productivity and profitability under timely sown rice may be due to higher dry matter remobilization from source to sink. A significant correlation was observed between biomass production and grain yield. We infer that late transplanting decrease the tiller occurrence and assimilate remobilization efficiency, which may be responsible for the reduced grain yield.	[Lal, B.; Gautam, Priyanka; Panda, B. B.; Raja, R.; Tripathi, R.; Shahid, M.; Nayak, A. K.] ICAR Natl Rice Res Inst, Crop Prod Div, Cuttack, Orissa, India; [Singh, Teekam] RRLRRS, Gerua, Assam, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Lal, B (corresponding author), ICAR Natl Rice Res Inst, Crop Prod Div, Cuttack, Orissa, India.	blalsgnr@gmail.com	Lal, B./ABC-1426-2020; Gautam, Priyanka/AAU-3483-2021; Shahid, Dr Mohammad/F-4359-2015	Nayak, A. K./0000-0002-2257-3243; Shahid, Dr Mohammad/0000-0001-6961-2708				Ahmadi A., 2004, Iranian Journal of Agricultural Sciences, V35, P921; Cassman KG, 1996, PLANT SOIL, V182, P267, DOI 10.1007/BF00029058; Chen CB, 2007, J AGROTECH EC, V1, P48; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Gebrehiwot T, 2013, ENVIRON MANAGE, V52, P1; Ghosh D. C., 1998, Environment and Ecology, V16, P446; Hassan Gul, 2003, Scientific Khyber, V16, P129; Hossain M, 1997, SYST APPR S, V5, P263; Kabisch N, 2016, ECOL SOC, V21, DOI 10.5751/ES-08373-210239; Kar G, 2004, AGR WATER MANAGE, V67, P47, DOI 10.1016/j.agwat.2003.12.005; Kirchhof G, 2000, SOIL TILL RES, V56, P51, DOI 10.1016/S0167-1987(00)00122-7; Kumari BP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031133; Liu Q. H., 2015, PLOS ONE, V10; Magor N.P., 1984, THESIS U SYDNEY SYDN, P3; Masutomi Y, 2009, AGR ECOSYST ENVIRON, V131, P281, DOI 10.1016/j.agee.2009.02.004; Matsushima S., 1966, P CROP SCI SOC JPN, V34, P478; MoA, 2013, REP EXP GROUP PULS, P9; Mujeri MK, 2012, GLOBAL RES CAPACITY, V8, P389; Nahar K, 2009, ACAD J PLANT SCI, V2, P132; Olekar J. N., 2000, Karnataka Journal of Agricultural Sciences, V13, P897; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rashid MH, 2012, INT C ENV AGR FOOD S, P13; Rotter R, 1999, CLIMATIC CHANGE, V43, P651, DOI 10.1023/A:1005541132734; Samant TK, 2015, J AGR FORESTRY ENV S, V1, P13; Singh AK, 2014, RICE SCI, V21, P299, DOI 10.1016/S1672-6308(13)60190-0; Subbarao G.V., 2001, SPATIAL DISTRIBUTION, P316; Sun YF, 1995, CHINA RICE, V5, P38; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Xiong J, 2013, AGRON J, V105, P1142, DOI 10.2134/agronj2012.0297; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; YOSHIDA S, 1981, FUNDAMENTALS RICE CR, P267; Yoshida S, 1978, RES PAPER SERIES, V20; Zentner RP, 2002, AGRON J, V94, P216, DOI 10.2134/agronj2002.0216	34	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e017570	10.1371/journal.pone.0175709	http://dx.doi.org/10.1371/journal.pone.0175709			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437487	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600010
J	Phoompoung, P; Ankasekwinai, N; Pithukpakorn, M; Foongladda, S; Umrod, P; Suktitipat, B; Mahasirimongkol, S; KiertiburanakuI, S; Suputtamongkoll, Y				Phoompoung, Pakpoom; Ankasekwinai, Nasikarn; Pithukpakorn, Manop; Foongladda, Suporn; Umrod, Pinklow; Suktitipat, Bhoom; Mahasirimongkol, Surakameth; Kiertiburanakul, Sasisopin; Suputtamongkol, Yupin			Factors associated with acquired Anti IFN-gamma autoantibody in patients with nontuberculous mycobacterial infection	PLOS ONE			English	Article							ADULT-ONSET IMMUNODEFICIENCY; AVIUM COMPLEX INFECTION; HIV; THAILAND; TAIWAN	Background The clinical syndrome of disseminated nontuberculous mycobacterial (NTM) infection in patients who were previously healthy is now well recognized to be associated with an acquired autoantibody to Interferon gamma (Anti IFN-gamma autoantibody). However, the risk factors of this syndrome remain unknown. Method We performed an unmatched case control study among patients with NTM diseases who were diagnosed and treated at Siriraj Hospital, Bangkok, Thailand. Anti-IFN autoantibody was detected by enzyme-linked immunosorbent assay (ELISA) method. Cases were patients with NTM diseases and detectable anti IFN-gamma autoantibody. Controls were randomly selected from those with undetectable anti IFN-gamma autoantibody. Data from both groups including demographic data, clinical presentation, laboratory results, other risk factors and HLA genotypes were collected. Univariate and multivariate analyses were performed to identify independent risk factors for this syndrome. Results 70 cases (mean age 50 +/- 11 years) and 70 controls (mean age 58 +/- 18 years) were enrolled into the study. Mycobacterial abscessus was the most common NTM pathogen found in both groups (72.9% in cases and 41.4% in controls respectively). However, disseminated NTM disease was significantly more common in cases (92.9%) than in the controls (14.3%, p<0.001). Binary logistic regression analysis showed that previous OIs (adjusted OR14.87, 95% CI 2.36-93.86), birthplace outside Central region (adjusted OR 19.19, 95% CI 3.86-95.35), lack of comorbidities lead to immunosuppression, such as HIV infection or diabetes mellitus (adjusted OR 23.68, 95% CI 4.01-139.94), and presence of HLA DRB1*15/16 (adjusted OR 153.28, 95% CI 16.87-139.88) were independent factors associated with this syndrome. Conclusion Patients with NTM disease associated with anti IFN-gamma autoantibody are almost always previously healthy and HIV negative. Most of these patients presented with disseminated NTM disease with generalized lymphadenitis and often with reactive skin lesions. Factors associated with detectable anti IFN-gamma autoantibody are HLA-DRB1 and DQB1 alleles, and history of previous OIs in patients without comorbidity that leads to immunosuppression. Further studies are needed to better understand these associations and to improve the treatment outcome.	[Phoompoung, Pakpoom; Ankasekwinai, Nasikarn; Pithukpakorn, Manop; Suputtamongkol, Yupin] Mahidol Univ, Siriraj Hosp, Dept Med, Fac Med, Bangkok, Thailand; [Foongladda, Suporn] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand; [Umrod, Pinklow] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med, Bangkok, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Siriraj Hosp, Dept Biochem, Fac Med, Bangkok, Thailand; [Mahasirimongkol, Surakameth] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Dept Med, Fac Med, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Ministry of Public Health - Thailand; Mahidol University	Suputtamongkoll, Y (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Med, Fac Med, Bangkok, Thailand.	yupin.sup@mahidol.ac.th	Pithukpakorn, Manop/K-9825-2013; Suktitipat, Bhoom/H-4239-2019	Pithukpakorn, Manop/0000-0003-3611-5718; Suktitipat, Bhoom/0000-0001-8034-7757	Siriraj Research Development Grant [R015634003]; National Science and Technology Development Agency Grant [P-13-00374]; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	Siriraj Research Development Grant; National Science and Technology Development Agency Grant; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	This work was supported by Siriraj Research Development Grant, Grant No. R015634003 (http://www.si.mahidol.ac.th/th/research-academics/research/en_wijai.asp) and National Science and Technology Development Agency Grant, Grant No. P-13-00374 (http://www.nstda.or.th) to YS; Siriraj Core Research Facility (SiCRF) Grant to MP; and Siriraj Chalermphrakiat Grant to PP, MP, NA, BS, SF and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chan JFW, 2013, DERMATOLOGY, V226, P157, DOI 10.1159/000347112; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Chetchotisakd P, 2014, SE ASIAN J TROP MED, V45, P1125; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Fitness J, 2002, GENES IMMUN, V3, P441, DOI 10.1038/sj.gene.6363926; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Honda JR, 2015, CLIN CHEST MED, V36, P1, DOI 10.1016/j.ccm.2014.10.001; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Ku CL, 2016, J ALLERGY CLIN IMMUN, V137, P945, DOI 10.1016/j.jaci.2015.09.018; Lai CC, 2006, J INFECTION, V53, P77, DOI 10.1016/j.jinf.2005.10.009; LeBlanc SB, 2000, TISSUE ANTIGENS, V55, P17, DOI 10.1034/j.1399-0039.2000.550103.x; Pithukpakorn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128481; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; Rossi M, 2001, SWISS MED WKLY, V131, P471; Smith GS, 2016, J INFECTION, V72, P678, DOI 10.1016/j.jinf.2016.03.008; Wongkulab P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076371	17	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176342	10.1371/journal.pone.0176342	http://dx.doi.org/10.1371/journal.pone.0176342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437431	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600043
J	Yoshioka, M; Iehisa, JCM; Ohno, R; Kimura, T; Enoki, H; Nishimura, S; Nasuda, S; Takumi, S				Yoshioka, Motohiro; Iehisa, Julio C. M.; Ohno, Ryoko; Kimura, Tatsuro; Enoki, Hiroyuki; Nishimura, Satoru; Nasuda, Shuhei; Takumi, Shigeo			Three dominant awnless genes in common wheat: Fine mapping, interaction and contribution to diversity in awn shape and length	PLOS ONE			English	Article							SEED DISPERSAL; BARLEY; MAP; RESISTANCE; GENOME; GRAIN; CHROMOSOME; GENETICS; PROTEIN; SPIKES	The awn is a long needle-like structure formed at the tip of the lemma in the florets of some grass species. It plays a role in seed dispersal and protection against animals, and can contribute to the photosynthetic activity of spikes. Three main dominant inhibitors of awn development (Hd, B1 and B2) are known in hexaploid wheat, but the causal genes have not been cloned yet and a genetic association with awn length diversity has been found only for the B1 allele. To analyze the prevalence of these three awning inhibitors, we attempted to predict the genotypes of 189 hexaploid wheat varieties collected worldwide using markers tightly linked to these loci. Using recombinant inbred lines derived from two common wheat cultivars, Chinese Spring and Mironovskaya 808, both with short awns, and a high-density linkage map, we performed quantitative trait locus analysis to identify tightly linked markers. Because this linkage map was constructed with abundant array-based markers, we converted the linked markers to PCR-based markers and determined the genotypes of 189 hexaploids. A significant genotype-phenotype correlation was observed at the Hd and B1 regions. We also found that interaction among these three awning inhibitors is involved in development of a membranous outgrowth at the base of awn resembling the Hooded mutants of barley. For the hooded awn phenotype, presence of the Hd dominant allele was essential but not sufficient, so B2 and other factors appear to act epistatically to produce the ectopic tissue. On the other hand, the dominant B1 allele acted as a suppressor of the hooded phenotype. These three awning inhibitors largely contribute to the genetic variation in awn length and shape of common wheat.	[Yoshioka, Motohiro; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Iehisa, Julio C. M.] Univ Nacl Asuncion, Fac Ciencias Quim, Dept Biotechnol, San Lorenzo, Paraguay; [Ohno, Ryoko] Kobe Univ, Grad Sch Sci Technol & Innovat, Kobe, Hyogo, Japan; [Kimura, Tatsuro; Enoki, Hiroyuki] Toyota Motor Co Ltd, Biotechnol & Afforestat Lab, New Business Planning Div, Miyoshi, Aichi, Japan; [Nishimura, Satoru] Toyota Motor Co Ltd, Frontier Res Planning Dept, Frontier Res Ctr, Toyota, Aichi, Japan; [Nasuda, Shuhei] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Yoshioka, Motohiro] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto, Japan	Kobe University; Universidad Nacional de Asuncion; Kobe University; Toyota Motor Corporation; Toyota Motor Corporation; Kyoto University; Kyoto University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan.	takumi@kobe-u.ac.jp		Nasuda, Shuhei/0000-0002-9019-8692; Iehisa, Julio/0000-0002-2133-9340	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16H04862]; Special Coordination Funds for Promoting Science and Technology; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe); MEXT, Japan; TOYOTA Motor Corporation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TOYOTA Motor Corporation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant-in-Aid for Scientific Research (B) No. 16H04862), and by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe), MEXT, Japan. TOYOTA Motor Corporation provides support in the form of salaries for authors [TK, HE, SaN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bariana HS, 2006, THEOR APPL GENET, V112, P1143, DOI 10.1007/s00122-006-0216-3; Bessho-Uehara K, 2016, P NATL ACAD SCI USA, V113, P8969, DOI 10.1073/pnas.1604849113; Cao LZ, 2016, BREEDING SCI, V66, P260, DOI 10.1270/jsbbs.66.260; Dahlgren R.M.T., 1985, FAMILIES MONOCOTYLED, P520, DOI [10.1007/978-3-642-61663-1, DOI 10.1007/978-3-642-61663-1]; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; EVANS LT, 1970, AUST J BIOL SCI, V23, P245, DOI 10.1071/BI9700245; EVANS LT, 1972, ANN APPL BIOL, V70, P67, DOI 10.1111/j.1744-7348.1972.tb04689.x; Gervais L, 2003, THEOR APPL GENET, V106, P961, DOI 10.1007/S00122-002-1160-5; Hori K, 2003, THEOR APPL GENET, V107, P806, DOI 10.1007/s00122-003-1342-9; Hua L, 2015, PLANT CELL, V27, P1875, DOI 10.1105/tpc.15.00260; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kato K, 1998, EUPHYTICA, V101, P91, DOI 10.1023/A:1018372231063; Kobayashi F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1803-y; Kobayashi F, 2010, THEOR APPL GENET, V121, P629, DOI 10.1007/s00122-010-1335-4; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kosuge K, 2008, EUPHYTICA, V159, P289, DOI 10.1007/s10681-007-9488-1; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Mackay IJ, 2014, G3-GENES GENOM GENET, V4, P1603, DOI 10.1534/g3.114.012963; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MCDONOUGH WT, 1959, MARYLAND AGR EXP S A, V103, P1; MCINTOSH RA, 1998, P 9 INT WHEAT GEN S, V5, P235; Morimoto R, 2005, PLANT MOL BIOL, V57, P907, DOI 10.1007/s11103-005-3247-2; MULLER KJ, 1995, NATURE, V374, P727, DOI 10.1038/374727a0; Perlitius L, 1903, EINFLUSS BEGRANNUNG; Roig C, 2004, GENETICS, V167, P439, DOI 10.1534/genetics.167.1.439; SEARS ER, 1954, MO AGR EXP STN RES B, P572; SORENSEN AE, 1986, ANNU REV ECOL SYST, V17, P443, DOI 10.1146/annurev.es.17.110186.002303; Sourdille P, 2002, PLANT BREEDING, V121, P320, DOI 10.1046/j.1439-0523.2002.728336.x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; STEBBINS GL, 1966, GENETICS, V54, P727; TAKAHASHI N, 1986, Reports of the Institute for Agricultural Research Tohoku University, V35, P21; TAKAHASHI R., 1953, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V10, P29; Takenaka S, 2014, WHEAT INFORM SERV, V118, P23; Takumi S, 2000, GENE, V249, P171, DOI 10.1016/S0378-1119(00)00164-5; Toriba T, 2014, PLANT J, V77, P616, DOI 10.1111/tpj.12411; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VERVELDE G. J., 1953, Netherlands Journal of Agricultural Science, V1, P2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Watkins AE, 1940, J GENET, V40, P243, DOI 10.1007/BF02982493; Yuo T, 2012, J EXP BOT, V63, P5223, DOI 10.1093/jxb/ers182	43	31	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176148	10.1371/journal.pone.0176148	http://dx.doi.org/10.1371/journal.pone.0176148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437453	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600030
J	Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M				Bezan, Angelika; Posch, Florian; Ploner, Ferdinand; Bauernhofer, Thomas; Pichler, Martin; Szkandera, Joanna; Hutterer, Georg C.; Pummer, Karl; Gary, Thomas; Samonigg, Hellmut; Beyer, Joerg; Winder, Thomas; Hermanns, Thomas; Fankhauser, Christian D.; Gerger, Armin; Stotz, Michael			Risk stratification for venous thromboembolism in patients with testicular germ cell tumors	PLOS ONE			English	Article							CANCER-PATIENTS; EUROPEAN CONSENSUS; AMERICAN SOCIETY; COMPETING RISKS; CHEMOTHERAPY; DIAGNOSIS; RECOMMENDATIONS; PROPHYLAXIS; THROMBOSIS; GUIDELINE	Background Patients with testicular germ cell tumors (TGCT) have an increased risk for venous thromboembolism (VTE). We identified risk factors for VTE in this patient cohort and developed a clinical risk model. Methods In this retrospective cohort study at the Medical University of Graz we included 657 consecutive TGCT patients across all clinical stages. A predictive model for VTE was developed and externally validated in 349 TGCT patients treated at the University Hospital Zurich. Results Venous thromboembolic events occurred in 34 (5.2%) patients in the Graz cohort. In univariable competing risk analysis, higher clinical stage (cS) and a retroperitoneal lymphadenopathy (RPLN) were the strongest predictors of VTE (p<0.0001). As the presence of a RPLN with more than 5cm in greatest dimension without coexisting visceral metastases is classified as cS IIC, we constructed an empirical VTE risk model with the following four categories (12-month-cumulative incidence): cS IA-B 8/463 patients (1.7%), cS IS-IIB 5/86 patients (5.9%), cS IIC 3/21 patients (14.3%) and cS IIIA-C 15/70 patients (21.4%). This risk model was externally validated in the Zurich cohort (12-month-cumulative incidence): cS IA-B (0.5%), cS IS-IIB (6.0%), cS IIC (11.1%) and cS IIIA-C (19.1%). Our model had a significantly higher discriminatory performance than a previously published classifier (RPLN-VTE-risk-classifier) which is based on the size of RPLN alone (AUC-ROC: 0.75 vs. 0.63, p = 0.007). Conclusions According to our risk stratification, TGCT patients with cS IIC and cS III disease have a very high risk of VTE and may benefit from primary thromboprophylaxis for the duration of chemotherapy.	[Bezan, Angelika; Posch, Florian; Ploner, Ferdinand; Bauernhofer, Thomas; Pichler, Martin; Szkandera, Joanna; Samonigg, Hellmut; Gerger, Armin] Med Univ Graz, Dept Internal Med, Div Clin Oncol, Graz, Austria; [Bezan, Angelika; Posch, Florian; Gerger, Armin; Stotz, Michael] Med Univ Graz, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria; [Bauernhofer, Thomas; Gerger, Armin] Ctr Biomarker Res Med CBmed, Graz, Austria; [Pichler, Martin] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Hutterer, Georg C.; Pummer, Karl] Med Univ Graz, Dept Urol, Graz, Austria; [Gary, Thomas] Med Univ Graz, Dept Internal Med, Div Angiol, Graz, Austria; [Beyer, Joerg; Winder, Thomas] Univ Zurich, Univ Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Hermanns, Thomas; Fankhauser, Christian D.] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland	Medical University of Graz; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center; Medical University of Graz; Medical University of Graz; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Gerger, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Clin Oncol, Graz, Austria.; Gerger, A (corresponding author), Med Univ Graz, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria.; Gerger, A (corresponding author), Ctr Biomarker Res Med CBmed, Graz, Austria.; Fankhauser, CD (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland.	christian.fankhauser@usz.ch; armin.gerger@medunigraz.at	Beyer, Joerg/I-9954-2017; Bauernhofer, Thomas/AAF-4905-2020; Fankhauser, Christian Daniel/I-4672-2017	Beyer, Joerg/0000-0003-1755-9700; Fankhauser, Christian Daniel/0000-0002-4073-5488; Pichler, Martin/0000-0002-8701-9462; Posch, Florian/0000-0002-0448-6314; Terbuch, Angelika/0000-0003-2918-1370; Szkandera, Joanna/0000-0002-2217-893X				Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898; Agnelli G, 2009, LANCET ONCOL, V10, P943, DOI 10.1016/S1470-2045(09)70232-3; Beyer J, 2013, ANN ONCOL, V24, P878, DOI 10.1093/annonc/mds579; Bezan A, 2014, ANTICANCER RES, V34, P2709; Cathomas R, 2010, SWISS MED WKLY, V140, P356, DOI smw-12993; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094048; Chew HK, 2006, ARCH INTERN MED, V166, P458; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gary T, 2012, BRIT J CANCER, V107, P1244, DOI 10.1038/bjc.2012.401; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Haugnes HS, 2012, J CLIN ONCOL, V30, P3752, DOI 10.1200/JCO.2012.43.4431; Honecker F, 2013, ONKOLOGIE, V36, P663, DOI 10.1159/000355652; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2009, J CLIN ONCOL, V27, P4839, DOI 10.1200/JCO.2009.22.3271; Kristinsson SY, 2010, HEMATOL-AM SOC HEMAT, P437, DOI 10.1182/asheducation-2010.1.437; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Mead GM, 1997, J CLIN ONCOL, V15, P594; Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669; Ozturk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141244; Posch F, 2016, THROMB HAEMOST; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rustin GJ, 2007, J CLIN ONCOL, V25, P1310, DOI 10.1200/JCO.2006.08.4889; Schmoll HJ, 2004, ANN ONCOL, V15, P1377, DOI 10.1093/annonc/mdh301; Schmoll HJ, 1999, KOMPENDIUM INTERNIST; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Srikanthan A, 2015, J CLIN ONCOL, V33, P582, DOI 10.1200/JCO.2014.58.6537; Wymer KM, 2017, J UROLOGY, V197, P684, DOI 10.1016/j.juro.2016.09.073	31	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176283	10.1371/journal.pone.0176283	http://dx.doi.org/10.1371/journal.pone.0176283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430804	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000399876100038
J	Rahman, MM; Lim, UT				Rahman, M. Mahbubur; Lim, Un Taek			Evaluation of mature soybean pods as a food source for two pod-sucking bugs, Riptortus pedestris (Hemiptera: Alydidae) and Halyomorpha halys (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							GREEN STINK BUG; STYLET PENETRATION; SEASONAL ABUNDANCE; HETEROPTERA; YIELD; PERFORMANCE; JACKKNIFE; DYNAMICS; QUALITY; IMPACT	Riptortus pedestris (Fabricius) and Halyomorpha halys (Stal) cause injury to soybeans by piercing and sucking pods and seeds. Growers believe that new damage decreases near to harvest despite the occurrence of these bugs at that time. As this question has never been assessed, we evaluated two diets: a) mature soybean pods (dried shell + dried soybean seeds) and b) dried soybean seeds for the two bugs by assessing their biological, behavioral, and morphological attributes on each diet in laboratory. While nymphs of both species were able to develop and adults able to reproduce on the tested diets, bugs fed on pods had longer development times and 2.2 to 5.0 times higher mortality rates than bugs fed on seeds. Furthermore, adult longevity of R. pedestris and H. halys fed on pods was 8.4 and 7.5 days shorter, respectively, than that of bugs fed on seeds. However, pod feeding had no effect on adult fecundity or egg viability. In a behavioral choice test, adult R. pedestris preferred seeds over pods and probed seeds longer than pods. On average, adult H. halys also preferred seeds over pods, although 15.6% of H. halys showed the reverse, preferring pods over seeds. The proboscis length and estimated depth of stylet penetration into the host tissue of both nymphs and adults of both species was much greater than the thickness of the pod shell, suggesting that mouthpart structure does not explain the negative effects of pods vs. seeds. In conclusion, mature soybean pods were found to be a suitable food source for both R. pedestris and H. halys despite some negative effects, and thus careful attention should be paid to the population levels of these two bugs approaching harvest to reduce economic damage in soybean.	[Rahman, M. Mahbubur] Bangladesh Agr Res Inst, Barisal, Bangladesh; [Lim, Un Taek] Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea; [Lim, Un Taek] Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea	Bangladesh Agricultural Research Institute (BARI); Andong National University; Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea.; Lim, UT (corresponding author), Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea.	utlim@andong.ac.kr		Lim, Un Taek/0000-0002-6704-0627	Cooperative Research Program for Agricultural & Technology Development, Rural Development Administration, Republic of Korea [PJ010841092015]	Cooperative Research Program for Agricultural & Technology Development, Rural Development Administration, Republic of Korea	This work was supported by the Cooperative Research Program for Agricultural & Technology Development (Project no. PJ010841092015), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes-Doria AL, 2016, ENVIRON ENTOMOL, V45, P663, DOI 10.1093/ee/nvw018; Bae SD, 2012, J ASIA-PAC ENTOMOL, V15, P148, DOI 10.1016/j.aspen.2011.09.001; Baur ME, 2000, ENVIRON ENTOMOL, V29, P312, DOI 10.1603/0046-225X(2000)029[0312:APIESP]2.0.CO;2; Bundy CS, 2000, J ECON ENTOMOL, V93, P697, DOI 10.1603/0022-0493-93.3.697; Capeleti I, 2005, SEED SCI TECHNOL, V33, P511, DOI 10.15258/sst.2005.33.2.25; Chung B. K., 1995, J AGR SCI, V37, P376; DAUGHERTY DM, 1964, J ECON ENTOMOL, V57, P719, DOI 10.1093/jee/57.5.719; Do Bae S, 2014, J ASIA-PAC ENTOMOL, V17, P477, DOI 10.1016/j.aspen.2014.04.006; Esquivel JF, 2015, ENVIRON ENTOMOL, V44, P619, DOI 10.1093/ee/nvv027; Esquivel JF, 2011, ENTOMOL EXP APPL, V140, P163, DOI 10.1111/j.1570-7458.2011.01148.x; FEHR W. R., 1977, STAGES SOYBEAN DEV; Hedstrom CS, 2014, J ECON ENTOMOL, V107, P1858, DOI 10.1603/EC14263; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Kang Chang Hoon, 2003, Korean Journal of Applied Entomology, V42, P269; Kim E, 2014, J ASIA-PAC ENTOMOL, V17, P521, DOI 10.1016/j.aspen.2014.04.013; Kim S, 2010, APPL ENTOMOL ZOOL, V45, P457, DOI 10.1303/aez.2010.457; Kim Su Bin, 2015, Korean Journal of Applied Entomology, V54, P121, DOI 10.5656/KSAE.2015.04.0.010; Kimura S, 2008, JPN J APPL ENTOMOL Z, V52, P13, DOI 10.1303/jjaez.2008.13; KOGAN M, 1987, ANNU REV ENTOMOL, V32, P507, DOI 10.1146/annurev.en.32.010187.002451; KONO S, 1989, JPN J APPL ENTOMOL Z, V33, P128, DOI 10.1303/jjaez.33.128; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; MCPHERSON RM, 1979, J ECON ENTOMOL, V72, P188, DOI 10.1093/jee/72.2.188; McPherson RM, 1996, J ENTOMOL SCI, V31, P199, DOI 10.18474/0749-8004-31.2.199; MCPHERSON RM, 1993, J ENTOMOL SCI, V28, P61, DOI 10.18474/0749-8004-28.1.61; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MINER FLOYD D., 1966, ARKANSAS EXP STABULL, V708, P1; MORRIS R. F., 1954, CANADIAN JOUR ZOOL, V32, P283, DOI 10.1139/z54-027; Oliveira EDM, 2003, BRAZ ARCH BIOL TECHN, V46, P187, DOI 10.1590/S1516-89132003000200008; PANIZZI AR, 1993, J ECON ENTOMOL, V86, P1088, DOI 10.1093/jee/86.4.1088; Zobiole LHS, 2010, PESTIC BIOCHEM PHYS, V97, P182, DOI 10.1016/j.pestbp.2010.01.004; Santos CH, 1998, ANN ENTOMOL SOC AM, V91, P445, DOI 10.1093/aesa/91.4.445; SAS Institute, 2000, SAS US GUID STAT; SCHUMANN FW, 1982, J ECON ENTOMOL, V75, P748, DOI 10.1093/jee/75.4.748; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SIMPSON SJ, 1982, PHYSIOL ENTOMOL, V7, P325, DOI 10.1111/j.1365-3032.1982.tb00305.x; Son ChangKi, 2000, Korean Journal of Crop Science, V45, P405; TALEKAR NS, 1995, ZOOL STUD, V34, P111; TODD JW, 1974, J ECON ENTOMOL, V67, P421, DOI 10.1093/jee/67.3.421; Todd JW, 1981, P S SOYB SEED QUAL S, P46; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	43	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176187	10.1371/journal.pone.0176187	http://dx.doi.org/10.1371/journal.pone.0176187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430798	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100031
J	Cuerda-Galindo, E; Lopez-Munoz, F; Krischel, M; Ley, A				Cuerda-Galindo, Esther; Lopez-Munoz, Francisco; Krischel, Matthis; Ley, Astrid			Study of deaths by suicide of homosexual prisoners in Nazi Sachsenhausen concentration camp	PLOS ONE			English	Article							MENTAL-HEALTH; METAANALYSIS; POPULATIONS; INMATES; STRESS; ADULTS; RISK; GAY	Living conditions in Nazi concentration camps were harsh and inhumane, leading many prisoners to commit suicide. Sachsenhausen (Oranienburg, Germany) was a concentration camp that operated from 1936 to 1945. More than 200,000 people were detained there under Nazi rule. This study analyzes deaths classified as suicides by inmates in this camp, classified as homosexuals, both according to the surviving Nazi files. This collective was especially repressed by the Nazi authorities. Data was collected from the archives of Sachsenhausen Memorial and the International Tracing Service in Bad Arolsen. Original death certificates and autopsy reports were reviewed. Until the end of World War II, there are 14 death certificates which state "suicide" as cause of death of prisoners classified as homosexuals, all of them men aged between 23 and 59 years and of various religions and social strata. Based on a population of 1,200 prisoners classified as homosexuals, this allows us to calculate a suicide rate of 1,167/100,000 (over the period of eight years) for this population, a rate 10 times higher than for global inmates (111/100,000). However, our study has several limitations: not all suicides are registered; some murders were covered-up as suicides; most documents were lost during the war or destroyed by the Nazis when leaving the camps and not much data is available from other camps to compare. We conclude that committing suicides in Sachsenhausen was a common practice, although accurate data may be impossible to obtain.	[Cuerda-Galindo, Esther] Rey Juan Carlos Univ, Dept Human Anat & Embryol, Madrid, Spain; [Lopez-Munoz, Francisco] Camilo Jose Cela Univ, Fac Hlth Sci, Madrid, Spain; [Lopez-Munoz, Francisco] Hosp 12 Octubre Res Inst i 12, Neuropsychopharmacol Unit, Madrid, Spain; [Krischel, Matthis] Heinrich Heine Univ Dusseldorf, Inst Hist Philosophy & Eth Med, Dusseldorf, Germany; [Ley, Astrid] Mem & Museum Sachsenhausen, Oranienburg, Germany	Universidad Rey Juan Carlos; Camilo Jose Cela University; Heinrich Heine University Dusseldorf	Lopez-Munoz, F (corresponding author), Camilo Jose Cela Univ, Fac Hlth Sci, Madrid, Spain.; Lopez-Munoz, F (corresponding author), Hosp 12 Octubre Res Inst i 12, Neuropsychopharmacol Unit, Madrid, Spain.	flopez@ucje.edu	López-Muñoz, Francisco/AAA-6933-2019	López-Muñoz, Francisco/0000-0002-5188-6038	Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva) [UCJC2013-47]	Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva)	This project was supported by a grant (UCJC2013-47) of the Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley C, 1997, Crisis, V18, P24, DOI 10.1027/0227-5910.18.1.24; Biedron R, 2014, PROMEMORIA PERIODICA; Bock G., 2010, ZWANGSSTERILISATION, V2nd; Bronisch T, 1996, ARCH SUICIDE RES, V2, P129, DOI 10.1080/13811119608251963; BRONISCH T, 1995, FORTSCHR NEUROL PSYC, V63, P139, DOI 10.1055/s-2007-996612; Brown P., 2008, PRO MEMORIA, V28, P34; Buge E, 2010, 1470 KZ GEHEIMNISE H; CHODOFF P, 1970, ARCH GEN PSYCHIAT, V22, P78; Clarke DE, 2006, J TRAUMA STRESS, V19, P417, DOI 10.1002/jts.20127; Cuerda-Galindo E, 2016, PSYCHIAT Q; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fruhwald S, 2005, LANCET, V366, P1242, DOI 10.1016/S0140-6736(05)67327-8; GILES GJ, 1992, J CONTEMP HIST, V27, P41, DOI 10.1177/002200949202700103; Goeschel C, 2010, J CONTEMP HIST, V45, P628, DOI 10.1177/0022009410366558; Goeschel Christian., 2009, SUICIDE NAZI GERMANY; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Grau G, 2011, LEXIKON HOMOSEXUELLE; Haas AP, 2010, J HOMOSEXUAL, V58, P10, DOI 10.1080/00918369.2011.534038; Haerberle E, 1980, J HOMOSEXUAL, V6, P135; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Heger H, 2011, MANNER ROSA WINKEL B; Hess R, 2000, COMMANDANT AUSCHWITZ; Hottes TS, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2016.303088; Jellonnek Burkhard, 1990, HOMOSEXUELLE UNTER H; Jensen EN, 2002, J HIST SEXUALITY, V11, P319, DOI 10.1353/sex.2002.0008; Krischel M, 2011, UROLOGEN NATIONALSOZ, V1, P203; Krischel Matthis, 2014, UROLOGIE NATIONALSOZ; Krysinska K, 2002, POL PSYCHOL B, V33, P21; Krysinska K., 2006, DIALOGUE UNIVERSALIS, V16, P141, DOI [DOI 10.5840/DU2006165/676, 10.5840/du2006165/676]; LAUTMANN R, 1990, J HOMOSEXUAL, V19, P67, DOI 10.1300/J082v19n01_04; LAUTMANN R, 1981, J HOMOSEXUAL, V6, P141, DOI 10.1300/J082v06n01_13; Lester D., 1990, GENET SOC GEN PSYCH, V116, P21; Ley Astrid, 2004, ZWANGSSTERILISATION; Lopez-Munoz F, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00088; Lopez-Munoz F, 2008, BRAIN RES BULL, V77, P388, DOI 10.1016/j.brainresbull.2008.09.002; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Muller J., 2000, HOMOSEXUELLE MANNER; Mussmann O, 1998, GEDENKSTATTENRUNDBRI, V81, P37; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Oosterhuis H, 1997, J CONTEMP HIST, V32, P187, DOI 10.1177/002200949703200204; Oron I, 2012, INT J ENV RES PUB HE, V9, P1927, DOI 10.3390/ijerph9051927; Ploderl M, 2015, INT REV PSYCHIATR, V27, P367, DOI 10.3109/09540261.2015.1083949; Rahe T, 2010, NATIONALSOZIALISTISC; Roll W, 1996, J HOMOSEXUAL, V31, P1, DOI 10.1300/J082v31n04_01; RYN Z, 1986, SUICIDE LIFE-THREAT, V16, P419; Ryn Z, 1983, AM J SOC PSYCHIAT, V3, P32; Stall R., 2008, UNEQUAL OPPORTUNITY; Wieland Gunther, 1993, SYSTEM NS KONZENTRAT; Wienau R, 2005, ORT TERRORS GESCH NA, VI, P165	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176007	10.1371/journal.pone.0176007	http://dx.doi.org/10.1371/journal.pone.0176007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426734	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900085
J	Lind, T; Ohman, C; Calounova, G; Rasmusson, A; Andersson, G; Pejler, G; Melhus, H				Lind, Thomas; Ohman, Caroline; Calounova, Gabriela; Rasmusson, Annica; Andersson, Goran; Pejler, Gunnar; Melhus, Hakan			Excessive dietary intake of vitamin A reduces skull bone thickness in mice	PLOS ONE			English	Article							RETINOIC ACID; HYPERVITAMINOSIS-A; RECEPTOR ACTIVATOR; TNF-ALPHA; OSTEOCLASTS; RESORPTION; CELLS; OSTEOBLASTS; RANKL; RAT	Calvarial thinning and skull bone defects have been reported in infants with hypervitaminosis A. These findings have also been described in humans, mice and zebrafish with loss-of-function mutations in the enzyme CYP26B1 that degrades retinoic acid (RA), the active metabolite of vitamin A, indicating that these effects are indeed caused by too high levels of vitamin A and that evolutionary conserved mechanisms are involved. To explore these mechanisms, we have fed young mice excessive doses of vitamin A for one week and then analyzed the skull bones using micro computed tomography, histomorphometry, histology and immunohistochemistry. In addition, we have examined the effect of RA on gene expression in osteoblasts in vitro. Compared to a standard diet, a high dietary intake of vitamin A resulted in a rapid and significant reduction in calvarial bone density and suture diastasis. The bone formation rate was almost halved. There was also increased staining of tartrate resistant acid phosphatase in osteocytes and an increased perilacunar matrix area, indicating osteocytic osteolysis. Consistent with this, RA induced genes associated with bone degradation in osteoblasts in vitro. Moreover, and in contrast to other known bone resorption stimulators, vitamin A induced osteoclastic bone resorption on the endocranial surfaces.	[Lind, Thomas; Calounova, Gabriela; Rasmusson, Annica; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ohman, Caroline] Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Angstrom Lab, Uppsala, Sweden; [Andersson, Goran] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Swedish University of Agricultural Sciences	Lind, T (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	thomas.lind@medsci.ee.se		Rasmusson, Annica/0000-0002-7228-7755; Lind, Thomas/0000-0003-2791-688X; Ohman Magi, Caroline/0000-0003-2709-9541	Svenska Lakaresallskapet and Medicinska for skningsradet	Svenska Lakaresallskapet and Medicinska for skningsradet	This work was supported by the Svenska Lakaresallskapet and Medicinska for skningsradet. The funders had no role in study design,data collection andanalysis,decision to publish,or preparation of the manuscript.	ARENA JM, 1951, PEDIATRICS, V8, P788; BAIR G, 1951, JAMA-J AM MED ASSOC, V146, P1573, DOI 10.1001/jama.1951.03670170027006; Barnicot N, 1956, BIOCHEMISTRY PHYSIOL, P507; Beste LA, 2016, NEW ENGL J MED, V374, P873, DOI 10.1056/NEJMcps1405984; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; DELAISSE JM, 1988, ENDOCRINOLOGY, V123, P264, DOI 10.1210/endo-123-1-264; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DHEM A, 1984, FOOD CHEM TOXICOL, V22, P199, DOI 10.1016/0278-6915(84)90127-3; Erben RG, 2012, METHODS MOL BIOL, V816, P279, DOI 10.1007/978-1-61779-415-5_19; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; GERBER A, 1954, AM J MED, V16, P729, DOI 10.1016/0002-9343(54)90281-8; Hollberg K, 2008, BONE, V42, P1111, DOI 10.1016/j.bone.2008.01.019; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Itoh K, 2000, J BONE MINER RES, V15, P1766, DOI 10.1359/jbmr.2000.15.9.1766; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Jeradi S, 2016, DEVELOPMENT, V143, P1205, DOI 10.1242/dev.129189; Jimi E, 1996, ENDOCRINOLOGY, V137, P2187; JOWSEY J, 1968, J CLIN ENDOCR METAB, V28, P1833, DOI 10.1210/jcem-28-12-1833; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lind T, 2005, BONE, V36, P408, DOI 10.1016/j.bone.2004.11.008; Lind T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082388; Lind T, 2012, CALCIFIED TISSUE INT, V90, P219, DOI 10.1007/s00223-011-9561-6; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Melhus H, 2003, NUTR ASPECTS BONE HL, P369; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; MILLER JH, 1985, AM J ROENTGENOL, V144, P767, DOI 10.2214/ajr.144.4.767; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; PERSSON B, 1965, ACTA PAEDIATR SCAND, V54, P49, DOI 10.1111/j.1651-2227.1965.tb06345.x; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Ramkumar HL, 2016, SURV OPHTHALMOL, V61, P506, DOI 10.1016/j.survophthal.2015.11.007; REYNOLDS J J, 1970, Calcified Tissue Research, V4, P339; Solberg LB, 2015, HISTOCHEM CELL BIOL, V143, P195, DOI 10.1007/s00418-014-1272-4; TOGARI A, 1991, GEN PHARMACOL, V22, P287, DOI 10.1016/0306-3623(91)90450-K; VARGHESE S, 1994, ENDOCRINOLOGY, V134, P2438, DOI 10.1210/en.134.6.2438; WALSH CA, 1991, J BONE MINER RES, V6, P661; WOODARD WK, 1961, J PEDIATR-US, V59, P260, DOI 10.1016/S0022-3476(61)80090-5; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yamamoto Y, 2006, ENDOCRINOLOGY, V147, P3366, DOI 10.1210/en.2006-0216; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517	54	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176217	10.1371/journal.pone.0176217	http://dx.doi.org/10.1371/journal.pone.0176217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426756	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900119
J	McKay, TB; Hjortdal, J; Priyadarsini, S; Karamichos, D				McKay, Tina B.; Hjortdal, Jesper; Priyadarsini, Shrestha; Karamichos, Dimitrios			Acute hypoxia influences collagen and matrix metalloproteinase expression by human keratoconus cells in vitro	PLOS ONE			English	Article							CONTACT-LENS WEAR; FATTY-ACID OXIDATION; MALONYL-COA; CORNEAL THICKNESS; INDUCIBLE FACTOR; STRESS; RESPONSES; OXYGEN; EDEMA; GELATINASE	Keratoconus (KC) is a progressive corneal ectasia linked to thinning of the central cornea. Hard contact lenses, rigid gas permeable lenses, and scleral lenses are the primary treatment modalities for early to mid-stages of KC to correct refractive error and astigmatism that develops as a result of an irregular corneal structure. These treatments are associated with significant drawbacks, including reduced availability of the tear film and oxygen to the corneal epithelium and stroma. However, it remains unknown whether hypoxia affects corneal integrity in the KC pathobiology. A number of studies have associated elevated oxidative stress with KC both in vitro and ex vivo. We hypothesized that KC-derived corneal fibroblasts are more susceptible to hypoxia-induced oxidative stress compared to healthy controls leading to exacerbation of corneal thinning in KC. This study investigated the effects of hypoxia on ECM secretion, assembly, and matrix metalloproteinase (MMP) expression in human corneal fibroblasts from healthy controls (HCFs) and KC patients (HKCs) in vitro. HCFs and HKCs were cultured in 3D constructs for 3 weeks and maintained or transferred to normoxic (21% O-2) or hypoxic (2% O-2) conditions, respectively, for 1 additional week. At the 4 week time-point, constructs were isolated and probed for Collagen I, III, and V, keratocan and MMP-1, -2, -3, -9, and -13, as well as hypoxia markers, hypoxia inducible factor-1a and lactoferrin. Conditioned media was also collected and probed for Collagen I, III, and V by Western blot. Thickness of the ECM assembled by HCFs and HKCs was measured using immunofluorescence microscopy. Results showed that hypoxia significantly reduced Collagen I secretion in HKCs, as well as upregulated the expression of MMP-1 and -2 with no significant effects on MMP-3, -9, or -13. ECM thickness was reduced in both cell types following 1 week in a low oxygen environment. Our study shows that hypoxia influences collagen and MMP expression by HKCs, which may have consequential effects on ECM structure in the context of KC.	[McKay, Tina B.; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus, Denmark; [Priyadarsini, Shrestha; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Aarhus University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.; Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	dimitrios-karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	Research to Prevent Blindness (New York, NY USA); NEI/DMEI Cellular Imaging Core Facility at OUHSC [NIH: P30EY021725];  [P30EY021725];  [5R01EY023568]; NATIONAL EYE INSTITUTE [P30EY021725, R01EY023568] Funding Source: NIH RePORTER	Research to Prevent Blindness (New York, NY USA)(Research to Prevent Blindness (RPB)); NEI/DMEI Cellular Imaging Core Facility at OUHSC; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by P30EY021725, 5R01EY023568 (DK), and an unrestricted grant (DMEI) from Research to Prevent Blindness (New York, NY USA). We acknowledge the assistance and support of the NEI/DMEI Cellular Imaging Core Facility at OUHSC (NIH: P30EY021725-Center Core Grant for Vision Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was published as a chapter in the dissertation of T.B. McKay at the University of Oklahoma Health Sciences Center.; This work was supported by P30EY021725, 5R01EY023568 (DK), and an unrestricted grant (DMEI) from Research to Prevent Blindness (NewYork, NY USA). We acknowledge the assistance and support of the NEI/DMEI Cellular Imaging Core Facility at OUHSC (NIH:P30EY021725-Center Core Grant for Vision Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; BONANNO JA, 1987, INVEST OPHTH VIS SCI, V28, P1514; BRUCE AS, 1990, SURV OPHTHALMOL, V35, P25, DOI 10.1016/0039-6257(90)90046-X; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Coskunseven E, 2007, AM J OPHTHALMOL, V144, P387, DOI 10.1016/j.ajo.2007.05.035; Fini ME, 1998, ARCH DERMATOL RES, V290, pS12, DOI 10.1007/PL00007449; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Gaskin JCF, 2015, INVEST OPHTH VIS SCI, V56, P5831, DOI 10.1167/iovs.14-15123; GASSET AR, 1978, AM J OPHTHALMOL, V85, P339, DOI 10.1016/S0002-9394(14)77725-6; Giasson CJ, 2016, OPTOM VIS SCI; GROMACKI SJ, 1994, OPTOMETRY VISION SCI, V71, P437, DOI 10.1097/00006324-199407000-00003; HARTSTEIN J, 1968, ARCH OPHTHALMOL-CHIC, V80, P345, DOI 10.1001/archopht.1968.00980050347009; HOLDEN BA, 1984, INVEST OPHTH VIS SCI, V25, P1161; Iskeleli Guzin, 2002, CLAO Journal, V28, P174; Karamichos D, 2015, EXP EYE RES, V132, P1, DOI 10.1016/j.exer.2015.01.007; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Kenney MC, 1997, CORNEA, V16, P345; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; KOCH JM, 1991, CORNEA, V10, P123, DOI 10.1097/00003226-199103000-00006; LAHOOD D, 1991, OPTOMETRY VISION SCI, V68, P877, DOI 10.1097/00006324-199111000-00008; Lim N, 2002, EYE, V16, P54, DOI 10.1038/sj.eye.6700061; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu ZG, 2000, OPHTHALMOLOGY, V107, P105, DOI 10.1016/S0161-6420(99)00027-5; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; MACSAI MS, 1990, ARCH OPHTHALMOL-CHIC, V108, P534, DOI 10.1001/archopht.1990.01070060082054; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Mckay TB, 2015, SCI REP-UK, V5, DOI 10.1038/srep09003; McKay TB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25534; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Pflugfelder SC, 2002, OPHTHALMOLOGY, V109, P2336, DOI 10.1016/S0161-6420(02)01276-9; Pizer ES, 2000, CANCER RES, V60, P213; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Pullum KW, 2005, CORNEA, V24, P269, DOI 10.1097/01.ico.0000148311.94180.6b; Rathi VM, 2013, INDIAN J OPHTHALMOL, V61, P410, DOI 10.4103/0301-4738.116066; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Seppala HPS, 2006, CORNEA, V25, P325, DOI 10.1097/01.ico.0000183534.22522.39; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Shimmura S, 1998, INVEST OPHTH VIS SCI, V39, P1346; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Smith VA, 2000, EUR J OPHTHALMOL, V10, P215, DOI 10.1177/112067210001000305; SMITH VA, 1995, EYE, V9, P429, DOI 10.1038/eye.1995.100; Tuori AJ, 1997, CURR EYE RES, V16, P792, DOI 10.1076/ceyr.16.8.792.8989; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEISSMAN BA, 1981, INVEST OPHTH VIS SCI, V20, P123; WILSON SE, 1990, OPHTHALMOLOGY, V97, P734	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176017	10.1371/journal.pone.0176017	http://dx.doi.org/10.1371/journal.pone.0176017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426715	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900086
J	Yen, YH; Chen, JB; Cheng, BC; Chen, JF; Chang, KC; Tseng, PL; Wu, CK; Tsai, MC; Lin, MT; Hu, TH				Yen, Yi-Hao; Chen, Jin-Bor; Cheng, Ben-Chung; Chen, Jung-Fu; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui			Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RISK-FACTORS; DIAGNOSIS; SEVERITY; ASSOCIATION; MARKERS; BIOPSY	Background and aims Controlled attenuation parameter (CAP) is a non-invasive method for measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVDs). CVDs are the leading cause of morbidity and mortality in hemodialysis patients. The aim of this study was to investigate the prevalence of NAFLD in hemodialysis patients. Method We prospectively enrolled patients undergoing chronic hemodialysis, as well as patients with normal renal function who served as controls. The control group patients were referred by an endocrinologist to be tested for NAFLD; most of these patients had diabetes, hypertension, or dyslipidemia. We excluded those with excess alcohol intake, use of drugs known to induce HS, chronic viral hepatitis, or CAP failure. CAP >= 238 dB/m was used as a cutoff suggesting HS. An increased liver kidney contrast, as defined by ultrasound, was used to make the diagnosis of HS. Results Three hundred and forty-three hemodialysis patients and 252 control group patients were enrolled. Among the hemodialysis patients, 192 (56.0%) had CAP- or ultrasound-identified HS compared with 91 (26.5%) who only had ultrasound-identified HS (P < 0.001). Among the control group patients, 212 (84.1%) had CAP- or ultrasound-identified HS compared with 180 (71.4%) who only had ultrasound-identified HS (P < 0.001). Conclusions The prevalence of NAFLD in the hemodialysis patients was 56%. The number of diagnoses of NAFLD made by using CAP combined with ultrasound was more than 2 times the number made with ultrasound alone in the hemodialysis patients. Therefore, we suggest the use of CAP combined with ultrasound to screen for NAFLD in hemodialysis patients.	[Yen, Yi-Hao; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepato Gastroenterol, Kaohsiung, Taiwan; [Yen, Yi-Hao; Chen, Jin-Bor; Cheng, Ben-Chung; Chen, Jung-Fu; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Jin-Bor; Cheng, Ben-Chung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Cheng, Ben-Chung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepato Gastroenterol, Kaohsiung, Taiwan.; Chen, JB; Hu, TH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, JB (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	chenjb1019@gmail.com; dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan [CMRPG8B1171]	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan	This work was supported by Grant CMRPG8B1171 from Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brophy DF, 2007, THROMB RES, V119, P723, DOI 10.1016/j.thromres.2006.02.013; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen CH, 2015, HEMATOLOGY, V20, P304, DOI 10.1179/1607845414Y.0000000199; Cheng YF, 2014, TRANSPLANTATION, V97, pS3, DOI [10.1097/TP.0000000000000060, 10.1097/01.tp.0000446265.42019.f3]; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; Hamad Asma A, 2012, Arab J Gastroenterol, V13, P161, DOI 10.1016/j.ajg.2012.06.010; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lai Yu-Cheng, 2013, Nephron Clin Pract, V124, P218, DOI 10.1159/000357952; Lee K, 2013, METAB SYNDR RELAT D, V11, P229, DOI 10.1089/met.2012.0153; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1072; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mikolasevic I, 2014, MED HYPOTHESES, V82, P205, DOI 10.1016/j.mehy.2013.11.039; Mikolasevic I, 2015, HEMODIAL INT, V19, P472, DOI 10.1111/hdi.12280; Mikolasevic I, 2015, WIEN KLIN WOCHENSCHR, V127, P451, DOI 10.1007/s00508-015-0757-z; Mikolasevic I, 2014, BLOOD PURIFICAT, V37, P259, DOI 10.1159/000360270; Mikolasevic I, 2014, CLIN INTERV AGING, V9, P1295, DOI 10.2147/CIA.S65382; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3082, DOI 10.3748/wjg.v17.i26.3082; Petta S, 2016, HEPATOLOGY; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Shi KQ, 2014, J GASTROEN HEPATOL, V29, P1149, DOI 10.1111/jgh.12519; Sniderman AD, 2010, CLIN J AM SOC NEPHRO, V5, P335, DOI 10.2215/CJN.06300909; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Yilmaz Y, 2013, EUR J GASTROEN HEPAT, V25, P1330, DOI 10.1097/MEG.0b013e3283623a16	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176027	10.1371/journal.pone.0176027	http://dx.doi.org/10.1371/journal.pone.0176027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426815	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900088
J	Zhang, ZF; Gillespie, C; Bowman, B; Yang, QH				Zhang, Zefeng; Gillespie, Cathleen; Bowman, Barbara; Yang, Quanhe			Prediction of atherosclerotic cardiovascular disease mortality in a nationally representative cohort using a set of risk factors from pooled cohort risk equations	PLOS ONE			English	Article							STATINS; PREVENTION; GUIDELINES	The American College of Cardiology/American Heart Association developed Pooled Cohort equations to estimate atherosclerotic cardiovascular disease (ASCVD) risk. It is unclear how well the equations predict ASCVD mortality in a nationally representative cohort. We used the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and Linked Mortality through 2006 (n = 6,644). Among participants aged 40-79 years without ASCVD at baseline, we used Cox proportional hazard models to estimate the 10-year probability of ASCVD death by sex and race-ethnicity (non-Hispanic white (NHW), non-Hispanic black (NHB) and Mexican American (MA)). We estimated the discrimination and calibration for each sex-race-ethnicity model. We documented 288 ASCVD deaths during 62,335 person years. The Pooled Cohort equations demonstrated moderate to good discrimination for ASCVD mortality, with modified C-statistics of 0.716 (95% CI 0.663-0.770), 0.794 (0.734-0.854), and 0.733 (0.654-0.811) for NHW, NHB and MA men, respectively. The corresponding C-statistics for women were 0.781 (0.718-0.844), 0.702 (0.633-0.771), and 0.789 (CI 0.721-0.857). Modified Hosmer-Lemeshow chi(2) suggested adequate calibration for NHW, NHB and MA men, and MA women (p-values: 0.128, 0.295, 0.104 and 0.163 respectively). The calibration was inadequate for NHW and NHB women (p < 0.05). In this nationally representative cohort, the Pooled Cohort equations performed adequately to predict 10-year ASCVD mortality for NHW and NHB men, and MA population, but not for NHW and NHB women.	[Zhang, Zefeng; Gillespie, Cathleen; Bowman, Barbara; Yang, Quanhe] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Zhang, ZF (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	zzhang3@cdc.gov						Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; MCCARTHY M, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6858; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; National Center for Health Statistics CDC, 1998, PLAN OP 3 NAT HLTH N; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Psaty BM, 2014, JAMA-J AM MED ASSOC, V311, P461, DOI 10.1001/jama.2013.284203; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175822	10.1371/journal.pone.0175822	http://dx.doi.org/10.1371/journal.pone.0175822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426694	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900054
J	Viazzi, F; Piscitelli, P; Giorda, C; Ceriello, A; Genovese, S; Russo, G; Guida, P; Fioretto, P; De Cosmo, S; Pontremoli, R				Viazzi, Francesca; Piscitelli, Pamela; Giorda, Carlo; Ceriello, Antonio; Genovese, Stefano; Russo, Giuseppina; Guida, Pietro; Fioretto, Paola; De Cosmo, Salvatore; Pontremoli, Roberto		AMD-Annals Study Grp	Metabolic syndrome, serum uric acid and renal risk in patients with T2D	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; DYSFUNCTION; PROGRESSION; HYPERURICEMIA; HYPERTENSION; INSIGHTS; OBESITY; PREDICT; HEALTH	Background and aims Metabolic Syndrome (Mets) and increased serum uric acid (SUA), are well known renal risk predictors and often coexist in patients with type 2 diabetes (T2D). Whether they independently contribute to the onset of CKD is at present unclear. Methods and results Within the AMD Annals database we identified patients with T2D and normal renal function and urine albumin excretion at baseline and regular follow- up visits during a 4- year period. Blood pressure, BMI, HDL, triglycerides, and SUA were available in 14,267 patients. The association between Mets and/or hyperuricemia (HU, top fifth gender specific quintile) and the occurrence of renal outcomes were evaluated. Results At baseline 59% of patients (n = 8,408) showed Mets and 18% (n = 2,584) HU. Over the 4- year follow- up, 14% (n = 1,990) developed low eGFR (i.e. below 60 mL/min/1.73 m(2)), and 26% (n = 3,740) albuminuria. After adjustment for confounders, BP >= 130/85, low HDL, triglycerides >= 150 and HU were independently related to the development of low eGFR (1.57, P < 0.001; 1.13, P = 0.056; 1.18, P = 0.008; 1.26, P = 0.001) and of albuminuria (1.35, P < 0.001; 1.18, P = 0.001; 1.15, P = 0.002; 1.24, P = 0.001), respectively. The incidence of low eGFR was higher in patients with HU independent of the presence or absence of Mets (21%, OR 1.30, p = 0.009 and 20%, 1.57, p < 0.000 respectively), while albuminuria occurred more frequently in those with Mets and HU (32%, OR 1.25, p = 0.005) as compared to the reference group. Conclusions HU and Mets are independent predictors of CKD and its individual components in patients with T2D.	[Viazzi, Francesca; Pontremoli, Roberto] Univ Genoa, Genoa, Italy; [Viazzi, Francesca; Pontremoli, Roberto] IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy; [Piscitelli, Pamela; De Cosmo, Salvatore] Sci Inst Casa Sollievo della Sofferenza, Dept Med Sci, San Giovanni Rotondo, FG, Italy; [Giorda, Carlo] ASL Turin 5, Diabet & Metab Unit, Chieri, TO, Italy; [Ceriello, Antonio] Inst Invest Biomed August Pii Sunyer IDIBAPS, Barcelona, Spain; [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Ceriello, Antonio; Genovese, Stefano] IRCCS Grp Multimed, Dept Cardiovasc & Metab Dis, Milan, Italy; [Russo, Giuseppina] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Guida, Pietro] Assoc Med Diabetol, Rome, Italy; [Fioretto, Paola] Univ Padua, Dept Med, Padua, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; IRCCS Casa Sollievo Della Sofferenza; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Messina; University of Padua	Pontremoli, R (corresponding author), Univ Genoa, Genoa, Italy.; Pontremoli, R (corresponding author), IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy.	roberto.pontremoli@unige.it	Guida, Pietro/AAR-7351-2021; fioretto, paola/AHD-4415-2022; Viazzi, Francesca/AAB-2479-2019; Giorda, Carlo B/D-4485-2018; Genovese, Stefano/F-9706-2017; De Cosmo, Salvatore/J-7420-2016	Giorda, Carlo B/0000-0002-4709-8696; Viazzi, Francesca/0000-0003-4219-7043; Genovese, Stefano/0000-0002-6085-437X; FIORETTO, PAOLA/0000-0003-3445-0387; De Cosmo, Salvatore/0000-0001-8787-8286				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bardin T, 2015, JOINT BONE SPINE, V82, P141, DOI 10.1016/j.jbspin.2015.01.002; Bjornstad P, 2015, DIABETOLOGIA, V58, P1993, DOI 10.1007/s00125-015-3650-4; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Carbone F, 2013, THROMB HAEMOSTASIS, V110, P940, DOI 10.1160/TH13-06-0499; Choi HK, 2008, RHEUMATOLOGY, V47, P713, DOI 10.1093/rheumatology/ken066; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; De Cosmo S, 2006, DIABETES CARE, V29, P432, DOI 10.2337/diacare.29.02.06.dc05-1841; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315; De Cosmo S, 2014, NEPHROL DIAL TRANSPL, V29, P657, DOI 10.1093/ndt/gft506; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113520; Kovacs T, 2013, CLIN KIDNEY J, V6, P395, DOI 10.1093/ckj/sfs131; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lee CC, 2011, CLIN NEPHROL, V75, P141, DOI 10.5414/CNP75141; Leoncini G, 2012, J NEPHROL, V25, P63, DOI 10.5301/JN.2011.7752; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li YQ, 2014, NEPHROLOGY, V19, P325, DOI 10.1111/nep.12219; Lin WY, 2008, ANN RHEUM DIS, V67, P432, DOI 10.1136/ard.2007.073601; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Lytvyn Y, 2015, AM J PHYSIOL-RENAL, V308, pF77, DOI 10.1152/ajprenal.00555.2014; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Navaneethan SD, 2013, CLIN J AM SOC NEPHRO, V8, P945, DOI 10.2215/CJN.09870912; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Rashidi A, 2007, CLIN J AM SOC NEPHRO, V2, P976, DOI 10.2215/CJN.01020207; Richette P, 2014, NAT REV RHEUMATOL, V10, P654, DOI 10.1038/nrrheum.2014.124; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Viazzi F, 2014, NUTR METAB CARDIOVAS, V24, P921, DOI 10.1016/j.numecd.2014.01.018; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; Yan D, 2015, PLOS ONE, V1; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080	43	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176058	10.1371/journal.pone.0176058	http://dx.doi.org/10.1371/journal.pone.0176058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423036	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600083
J	Willoughby, JR; Ivy, JA; Lacy, RC; Doyle, JM; DeWoody, JA				Willoughby, Janna R.; Ivy, Jamie A.; Lacy, Robert C.; Doyle, Jacqueline M.; DeWoody, J. Andrew			Inbreeding and selection shape genomic diversity in captive populations: Implications for the conservation of endangered species	PLOS ONE			English	Article							GENETIC ADAPTATION; FITNESS; HETEROZYGOSITY; ANNOTATION; SOFTWARE	Captive breeding programs are often initiated to prevent species extinction until reintroduction into the wild can occur. However, the evolution of captive populations via inbreeding, drift, and selection can impair fitness, compromising reintroduction programs. To better understand the evolutionary response of species bred in captivity, we used nearly 5500 single nucleotide polymorphisms (SNPs) in populations of white-footed mice (Peromyscus leucopus) to measure the impact of breeding regimes on genomic diversity. We bred mice in captivity for 20 generations using two replicates of three protocols: random mating (RAN), selection for docile behaviors (DOC), and minimizing mean kinship (MK). The MK protocol most effectively retained genomic diversity and reduced the effects of selection. Additionally, genomic diversity was significantly related to fitness, as assessed with pedigrees and SNPs supported with genomic sequence data. Because captive-born individuals are often less fit in wild settings compared to wild-born individuals, captive-estimated fitness correlations likely underestimate the effects in wild populations. Therefore, minimizing inbreeding and selection in captive populations is critical to increasing the probability of releasing fit individuals into the wild.	[Willoughby, Janna R.; DeWoody, J. Andrew] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Willoughby, Janna R.; DeWoody, J. Andrew] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ivy, Jamie A.] San Diego Zoo, Global Collect Dept, San Diego, CA USA; [Lacy, Robert C.] Chicago Zool Soc, Brookfield, IL USA; [Doyle, Jacqueline M.] Towson Univ, Dept Biol Sci, Towson, MD USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Zoological Society of San Diego; University System of Maryland; Towson University	Willoughby, JR (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.; Willoughby, JR (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	willoughby@purdue.edu	Willoughby, Janna/L-2764-2013	Willoughby, Janna/0000-0002-0176-1878	Chicago Zoological Society; Institute for Museumand Library Services; Conservation Endowment Fund of the Association of Zoos and Aquariums; Purdue University Faculty Scholars Program; NSF Doctoral Dissertation Improvement [DEB 1407021]	Chicago Zoological Society; Institute for Museumand Library Services; Conservation Endowment Fund of the Association of Zoos and Aquariums; Purdue University Faculty Scholars Program; NSF Doctoral Dissertation Improvement(National Science Foundation (NSF))	This work was supported by the Chicago Zoological Society, the Institute for Museumand Library Services, the Conservation Endowment Fund of the Association of Zoos and Aquariums, Purdue University Faculty Scholars Program, and an NSF Doctoral Dissertation Improvement Grant (DEB 1407021).; We thank the members of the DeWoody lab for helpful conversations, comments, and feedback on the manuscript as well as two anonymous reviewers whose suggestions improved this manuscript. This work was supported by the Chicago Zoological Society, the Institute for Museum and Library Services, the Conservation Endowment Fund of the Association of Zoos and Aquariums, Purdue University Faculty Scholars Program, and an NSF Doctoral Dissertation Improvement Grant (DEB 1407021).	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Ballou Jonathan D., 1995, P76; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Clayton D, 2014, SNPSTATS SNPMATRIX A; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coster A., 2013, PACKAGE PEDIGREE; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DeWoody JA, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P74; DeWoody YD, 2005, J HERED, V96, P85, DOI 10.1093/jhered/esi017; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falconer D. S., 1996, Introduction to quantitative genetics.; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; FRANKHAM R, 1992, ZOO BIOL, V11, P333, DOI 10.1002/zoo.1430110505; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Gilpin M.E., 1986, P19; Glenn JLW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-300; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hill WG, 2001, GENET RES, V93, P47; Ivy JA, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P267; Kardos M, 2015, HEREDITY, V115, P63, DOI 10.1038/hdy.2015.17; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lacy RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072452; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2010, BIOINFO; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Meffert LM, 2005, ZOO BIOL, V24, P375, DOI 10.1002/zoo.20058; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; MITTON JB, 1997, SELECTION NATURAL PO; Montgomery ME, 1997, ZOO BIOL, V16, P377, DOI 10.1002/(SICI)1098-2361(1997)16:5<377::AID-ZOO1>3.0.CO;2-7; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rodriguez-Ramilo ST, 2006, GENETICS, V172, P1043, DOI 10.1534/genetics.105.051003; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sanchez-Molano E, 2011, CONSERV GENET, V12, P343, DOI 10.1007/s10592-010-0143-3; Schoen DJ, 1998, P NATL ACAD SCI USA, V95, P394, DOI 10.1073/pnas.95.1.394; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Speed D, 2015, NAT REV GENET, V16, P33, DOI 10.1038/nrg3821; Utter F, 2002, REV FISH BIOL FISHER, V12, P59, DOI 10.1023/A:1022644021870; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Willoughby JR, 2015, MOL ECOL, V24, P98, DOI 10.1111/mec.13020; Woodworth LM, 2002, CONSERV GENET, V3, P277, DOI 10.1023/A:1019954801089	50	24	25	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175996	10.1371/journal.pone.0175996	http://dx.doi.org/10.1371/journal.pone.0175996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423000	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600075
J	Ahn, SG; Lee, JH; Lee, HW; Jeon, TJ; Ryu, YH; Kim, KM; Sohn, J; Yun, M; Lee, SA; Jeong, J; Kim, SI				Ahn, Sung Gwe; Lee, Jae-Hoon; Lee, Hak Woo; Jeon, Tae Joo; Ryu, Young Hoon; Kim, Kun Min; Sohn, Joohyuk; Yun, Mijin; Lee, Seung Ah; Jeong, Joon; Kim, Seung Il			Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer	PLOS ONE			English	Article							AMERICAN SOCIETY; GENE-EXPRESSION; PROGESTERONE; WOMEN; ASSAY; RECOMMENDATIONS; THERAPY	Background We investigated the relationship between 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG-PET-CT) standardized uptake value (SUV) and 21-gene recurrence score (RS) in estrogen receptor (ER)-positive/HER2-negative breast cancer. Materials and methods One hundred sixty-seven patients were identified among those who underwent preoperative 18F-FDG-PET-CT and had RS. Maximum SUV was obtained from 18F-FDG-PET-CT; the cut-off point was 4. Results The continuous RS and SUV correlated positively (Pearson's R = 0.555; P < 0.001). An inverse correlation was found between progesterone receptor (PR) expression by reverse transcriptase-polymerase chain reaction, and SUV (Pearson's R = -0.408; P < 0.001). Good agreement between dichotomized RS (<26 vs. >= 26) and SUV (<4 vs. >= 4) was observed in 137 of 167 patients (82.0%; 95% confidence interval [CI], 76.2-87.9). Among patients with low SUV, 114 of 115 (99.1% [95% CI, 97.4-100.0]) had tumors with lower RS (<26). Although 23 of 52 women (44.2% [95% CI, 30.7-57.7]) with high SUV had higher RS(>= 26), all 13 women with high RS (>= 31) had high-SUV tumors. Most cases with disagreements between SUV and RS (n = 30) were classified as high SUV/ lower RS (n = 29). The discordant group had higher grade or elevated Ki67 expression (>= 20%) compared with the low SUV/ lower RS group (n = 109), but higher PR expression compared with the high SUV/higher RS group (n = 23). Multiple logistic regression analysis showed that high SUV were associated with higher RS (>= 26). Conclusions SUV, as a biologic parameter represented using a continuous variable, was found to associate with RS in ER-positive, HER2-negative breast cancer. Further studies may reveal the biology underlying the discordance between the markers.	[Ahn, Sung Gwe; Lee, Hak Woo; Jeong, Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Lee, Jae-Hoon; Jeon, Tae Joo; Ryu, Young Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea; [Kim, Kun Min; Sohn, Joohyuk] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Med Oncol, Seoul, South Korea; [Yun, Mijin] Yonsei Univ, Coll Med, Severance Hosp, Dept Nucl Med, Seoul, South Korea; [Lee, Seung Ah] CHA Univ, CHA Bundang Med Ctr, Dept Surg, Seongnam, South Korea; [Kim, Seung Il] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System	Jeong, J (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea.	gsjjoon@yuhs.ac		Kim, Gun Min/0000-0001-9167-8682; Jeong, Joon/0000-0003-0397-0005; Yun, Mijin/0000-0002-1712-163X; RYU, YOUNG HOON/0000-0002-9000-5563; Sohn, Joohyuk/0000-0002-2303-2764; Kim, Kyoung Min/0000-0001-8150-0266; Jeon, Tae Joo/0000-0002-7574-6734; Ahn, Sung Gwe/0000-0002-8778-9686	Basic Science Research Program through the National Research Foundation of Korea (NRF), - Ministry of Education, Science and Technology [2013R1A1A2007759]; Basic Science Research Program through the NRF, - Ministry of Science, ICT, & Future Planning [NRF-2015R1C1A1A02037104]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1520120]	Basic Science Research Program through the National Research Foundation of Korea (NRF), - Ministry of Education, Science and Technology(National Research Foundation of Korea); Basic Science Research Program through the NRF, - Ministry of Science, ICT, & Future Planning; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (grant 2013R1A1A2007759), the Basic Science Research Program through the NRF, funded by the Ministry of Science, ICT, & Future Planning (NRF-2015R1C1A1A02037104), and a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1520120).	Ahn SG, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0502-y; Ahn SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105905; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holt S, 2013, BRIT J CANCER, V108, P2250, DOI 10.1038/bjc.2013.207; Mavi A, 2007, J NUCL MED, V48, P1266, DOI 10.2967/jnumed.106.037440; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Ueda S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-384; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yau C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3567	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175048	10.1371/journal.pone.0175048	http://dx.doi.org/10.1371/journal.pone.0175048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419166	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200008
J	Heroux, ME; Loo, CK; Taylor, JL; Gandevia, SC				Heroux, Martin E.; Loo, Colleen K.; Taylor, Janet L.; Gandevia, Simon C.			Questionable science and reproducibility in electrical brain stimulation research	PLOS ONE			English	Article							FAILURE; BIAS; METAANALYSIS; INFERENCES; HEALTHY; TDCS	Electrical brain stimulation (EBS) is a trendy new technique used to change brain function and treat neurological, psychiatric and psychological disorders. We were curious whether the published literature, which is dominated by positive results, reflects the experience of researchers using EBS. Specifically, we wanted to know whether researchers are able to reproduce published EBS effects and whether they engage in, but fail to report, questionable research practices. We invited 976 researchers to complete an online survey. We also audited 100 randomly-selected published EBS papers. A total of 154 researchers completed the survey. Survey respondents had a median of 3 [1 to 6, IQR] published EBS papers (1180 total) and 2 [1 to 3] unpublished ones (380 total). With anodal and cathodal EBS, the two most widely used techniques, 45-50% of researchers reported being able to routinely reproduce published results. When asked about how study sample size was determined, 69% of respondents reported using the sample size of published studies, while 61% had used power calculations, and 32% had based their decision on pilot data. In contrast, our audit found only 6 papers where power calculations were used and a single paper in which pilot data was used. When asked about questionable research practices, survey respondents were aware of other researchers who selectively reported study outcomes (41%) and experimental conditions (36%), adjusted statistical analysis to optimise results (43%), and engaged in other shady practices (20%). Fewer respondents admitted to engaging in these practices themselves, although 25% admitted to adjusting statistical analysis to optimize results. There was strong agreement that such practices should be reported in research papers; however, our audit found only two such admissions. The present survey confirms that questionable research practices and poor reproducibility are present in EBS studies. The belief that EBS is effective needs to be replaced by a more rigorous approach so that reproducible brain stimulation methods can be devised and applied.	[Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Neurosci Res Australia, Randwick, NSW, Australia; [Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Univ New South Wale, Sch Med Sci, Sydney, NSW, Australia; [Loo, Colleen K.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Loo, Colleen K.] Univ New South Wales, Black Dog Inst, Sydney, NSW, Australia; [Loo, Colleen K.] St George Hosp, Dept Psychiat, Sydney, NSW, Australia; [Gandevia, Simon C.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Black Dog Institute; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wale, Sch Med Sci, Sydney, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	s.gandevia@neura.edu.au	Heroux, Martin/AAD-7694-2021; Taylor, Janet/C-9667-2011; Gandevia, Simon/D-5009-2011	Heroux, Martin/0000-0002-3354-7104; Taylor, Janet/0000-0001-8976-5162; Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council [APP1055084]; NHMRC grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (https://www.nhmrc.gov.au/),APP1055084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Dr. Andrew Cartwright for help implementing the online survey. This work was supported by an NHMRC grant (JLT, SCG).	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; [Anonymous], 2016, PLOS BIOL, V14; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chambers CD, 2016, EUR J NEUROSCI; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Cumming G, 2016, INTRO NEW STAT; Curran-Everett D, 2004, AM J PHYSIOL-REG I, V287, pR247, DOI 10.1152/ajpregu.00346.2004; Curran-Everett D, 2017, J APPL PHYSIOL, V122, P91, DOI 10.1152/japplphysiol.00937.2016; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Dubljevic V, 2014, NEURON, V82, P731, DOI 10.1016/j.neuron.2014.05.003; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Elsner B, 2016, COCHRANE DB SYST REV, V5; Elsner Bernhard, 2016, Cochrane Database Syst Rev, V7, pCD010916, DOI 10.1002/14651858.CD010916.pub2; Elsner B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009645.pub3; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fiedler K, 2016, SOC PSYCHOL PERS SCI, V7, P45, DOI 10.1177/1948550615612150; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Head ML, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002106, DOI 10.1371/JOURNAL.PBIO.1002106]; Heroux M, 2016, J NEUROPHYSIOL, V116, P1536, DOI 10.1152/jn.00550.2016; Heroux ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144151; Horvath JC, 2016, EXP BRAIN RES, V234, P2629, DOI 10.1007/s00221-016-4667-8; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Lowe CJ, 2017, PSYCHOSOM MED, V79, P2, DOI 10.1097/PSY.0000000000000368; Mancuso LE, 2016, J COGNITIVE NEUROSCI, V28, P1063, DOI 10.1162/jocn_a_00956; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Paulhus DL, 2002, ROLE OF CONSTRUCTS IN PYSCHOLOGICAL AND EDUCATIONAL MEASUREMENT, P49; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Shirahige L, 2016, HEADACHE, V56, P1565, DOI 10.1111/head.12981; Sills SJ, 2002, SOC SCI COMPUT REV, V20, P22, DOI 10.1177/089443930202000103; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; The Academy of Medical Sciences, REPR REL BIOM RES IM; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Zhu CE, 2017, J REHABIL MED, V49, P2, DOI 10.2340/16501977-2179	60	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175635	10.1371/journal.pone.0175635	http://dx.doi.org/10.1371/journal.pone.0175635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445482	Green Submitted, Green Published, gold			2022-12-27	WOS:000400309200025
J	Schneider, R; Bellenberg, B; Hoepner, R; Kolb, EM; Ellrichmann, G; Haghikia, A; Gold, R; Lukas, C				Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf; Lukas, Carsten			Metabolic profiles by H-1-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)	PLOS ONE			English	Article							APPEARING WHITE-MATTER	Purpose Early diagnosis and treatment of multiple sclerosis-related progressive multifocal leukoencephalopathy (PML) significantly improve clinical outcomes. However, there is a lack of information regarding the restart of immunomodulatory therapy in the post-PML setting, when multiple sclerosis activity reappears. We aimed at the examination of metabolic differences using H-1-magnetic resonance spectroscopy (H-1-MRS) in multiple sclerosis patients at various post-PML stages and at the exploration of differences according to their disease and JC virus (JCV) status. Methods H-1-MRS of PML lesions was carried out on 15 relapsing-remitting multiple sclerosis patients with natalizumab-associated PML. Patients were grouped according to their stage after PML infection as early post-PML, less than 19 months after PML onset (n = 5), or late postPML group, more than 23 months after PML onset (n = 10). The latter group was further categorized according to persisting JCV load in the cerebrospinal fluid. Results Early post-PML patients showed significantly higher Lipid/Creatine ratios within PML lesions than late post-PML (p = 0.036). Furthermore, N-Acetyl-Aspartate/Creatine and N-AcetylAspartate/ Choline were significantly reduced in early post-PML and late post-PML lesions relative to normal-appearing white matter. In late post-PML, virus-positive patients showed significantly higher ratios of Choline/Creatine (p = 0.019) and consequently a reduced NAcetyl- Aspartate/Choline ratio (p = 0.010) in contrast to virus-negative patients. In late post-PML patients with persisting viral load, an elevated Choline/Creatine ratio correlated significantly with higher disability. Conclusions H-1-MRS may provide additional information related to underlying PML disease activity in various post-PML stages. In particular, Choline/Creatine levels, Lipid levels, and N-AcetylAspartate/Choline are relevant markers in the post-PML setting, taking also the JCV status into account.	[Schneider, Ruth; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf] Ruhr Univ Bochum, St Josef Hospital, Dept Neurol, Bochum, Germany; [Bellenberg, Barbara; Lukas, Carsten] Ruhr Univ Bochum, St Josef Hospital, Dept Diagnost & Intervent Radiol & Nucl Med, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Schneider, R (corresponding author), Ruhr Univ Bochum, St Josef Hospital, Dept Neurol, Bochum, Germany.	ruth.schneider@rub.de	Bellenberg, Barbara/ABI-6463-2020; Lukas, Carsten/A-9767-2015	Lukas, Carsten/0000-0002-8562-9697; Bellenberg, Barbara/0000-0001-7484-6787; Schneider, Ruth/0000-0002-0997-2725; Hoepner, Robert/0000-0002-0115-7021	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum.	Berger JR, 2013, NEUROLOGY, V80, P1430, DOI 10.1212/WNL.0b013e31828c2fa1; Berghoff M, 2014, CLIN NEURORADIOL, V24, P173, DOI 10.1007/s00062-013-0216-z; Brickelmaier M, 2009, ANTIMICROB AGENTS CH, V53, P1840, DOI 10.1128/AAC.01614-08; Cinque P, 2009, LANCET INFECT DIS, V9, P625, DOI 10.1016/S1473-3099(09)70226-9; Dahlhaus S, 2013, J NEUROL NEUROSUR PS, V84, P1068, DOI 10.1136/jnnp-2013-304897; De Stefano N, 2005, J NEUROL SCI, V233, P203, DOI 10.1016/j.jns.2005.03.018; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Dingley A J, 1994, Immunomethods, V4, P127, DOI 10.1006/immu.1994.1014; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; Filippi C G, 2011, AJNR Am J Neuroradiol, V32, pE156, DOI 10.3174/ajnr.A2305; Fleischer V, 2016, RADIOLOGY, V281, P536, DOI 10.1148/radiol.2016151654; Gheuens S, 2012, NEUROLOGY, V78, P1390, DOI [10.1212/WNL.0b013e318253d61e, 10.1212/01.wnl.0000423208.11698.16]; Gheuens S, 2012, NEUROLOGY, V79, P1041, DOI 10.1212/WNL.0b013e318268465b; He J, 2005, RADIOLOGY, V234, P211, DOI 10.1148/radiol.2341031895; Hoepner R, 2016, J NEUROL NEUROSUR PS, V87, P224, DOI 10.1136/jnnp-2014-310287; Hoepner R, 2016, MULTIPLE SCLEROSIS; Hoepner R, 2014, THER ADV NEUROL DISO, V7, P289, DOI 10.1177/1756285614556287; Iranzo A, 1999, J NEUROL NEUROSUR PS, V66, P520, DOI 10.1136/jnnp.66.4.520; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Koopmans RA, 1993, LANCET, P341; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin Alexander, 2005, NeuroRx, V2, P197, DOI 10.1602/neurorx.2.2.197; Linker RA, 2016, THER ADV CHRONIC DIS, V7, P198, DOI 10.1177/2040622316653307; Manenti G, 2013, CASE REP RADIOL, V2013; Mazzoni LN, 2010, RADIOL MED, V115, P125, DOI 10.1007/s11547-009-0408-4; Mohan S, 2010, NEURORADIOL J, V23, P269, DOI 10.1177/197140091002300302; Pavlovic D, 2015, THER ADV NEUROL DISO, V8, P255, DOI 10.1177/1756285615602832; Rudick R, 2013, JAMA NEUROL, V70, P172, DOI 10.1001/jamaneurol.2013.598; Sinnecker T, 2016, CASE REP NEUROL MED, V2016, DOI 10.1155/2016/5876798; Sinnecker T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000171; Tuan DS, 2015, J NEUROVIROL, V21, P637, DOI [10.1007/s13365-015-0316-4, 10.1007/s13365-015]; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Wenning W, 2009, NEW ENGL J MED, V361, P1075, DOI 10.1056/NEJMoa0810257; Wolinsky JS, 2002, CURR OPIN NEUROL, V15, P247, DOI 10.1097/00019052-200206000-00004	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176415	10.1371/journal.pone.0176415	http://dx.doi.org/10.1371/journal.pone.0176415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445498	Green Submitted, Green Published, gold			2022-12-27	WOS:000400309200058
J	Zyla, D; Homan, A; Wegierek, P				zyla, Dagmara; Homan, Agnieszka; Wegierek, Piotr			h Polyphyly of the extinct family Oviparosiphidae and its implications for inferring aphid evolution (Hemiptera, Sternorrhyncha)	PLOS ONE			English	Article							FOSSIL; APHIDOMORPHA; INSECTA; DIVERSIFICATION; ELLINAPHIDIDAE; PHYLOGENY; FRANCE; RECORD; SCALE; TREE	Aphidoidea, the so-called "true aphids" are one of the most challenging groups in terms of solving the phylogenetic relationships. Morphology-based analyses were strongly affected by widespread homoplasy, while the molecular-based attempts struggled with the lack of sufficient phylogenetic signal. Despite significant improvements, the higher classification still remains unresolved and rather controversial. However, the use of the fossil record, one of the most valuable sources of information, was mainly limited to calibration of a phylogenetic tree, without a direct inclusion into the analysis. The extinct family Oviparosiphidae has long been considered as the common ancestor of all recent Aphidoidea and it was used as a calibration point in several analyses, but it has been never analyzed in a phylogenetic context. The family has been treated as a monophyletic group purely based on the simultaneous presence of two abdominal structures, ovipositor and siphunculi. However, it has been shown recently that at least one more extinct lineage, present at the same time, was characterized by the same features. For these reasons, we performed a maximum parsimony analysis using morphological data for extinct aphid taxa to prove the monophyly of Oviparosiphidae. Our analysis shows that the presumed ancestor lineage of recent aphids is a polyphyletic group. Our results support the hypothesis of an early Mesozoic rapid radiation of aphids, which led to several different lineages characterized by both ovipositor and siphunculi. The results indicate the necessity of examining the other extinct families, and shows that the diversity of aphids before the Cretaceous Terrestrial Revolution (KTR) was higher than expected. Even though there is not enough data to perform a formal analysis, fossils seem to suggest a significant impact of the KTR on aphid diversification. Additionally, we have made a redescription of two genera and description of a new species, Vitimaphis subridens sp. nov.	[zyla, Dagmara] Nat Hist Museum Denmark, Biosystemat Sect, Zool Museum, Copenhagen, Denmark; [Homan, Agnieszka; Wegierek, Piotr] Univ Silesia, Dept Zool, Katowice, Poland	University of Silesia in Katowice	Zyla, D (corresponding author), Nat Hist Museum Denmark, Biosystemat Sect, Zool Museum, Copenhagen, Denmark.; Wegierek, P (corresponding author), Univ Silesia, Dept Zool, Katowice, Poland.	zyladagmara@gmail.com; potr.wegierek@us.edu.pl	Żyła, Dagmara/ABE-9335-2021; Węgierek, Piotr/S-1379-2019	Węgierek, Piotr/0000-0001-9960-0433	Polish National Science Centre [N N303 811140]	Polish National Science Centre	This work was supported by Polish National Science Centre (grant no. N N303 811140), recipient - PW for PhD project of DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INSECT SYST EVOL, V44, P149; Ansorge J, 1996, NEUE PALAONTOLOGISCH, V2, P132; Blackman RL., 2008, APHIDS WORLDS HERBAC; Brauckmann Carsten, 1993, Geologica et Palaeontologica, V27, P181; Brault V, 2010, J GEN VIROL, V91, P802, DOI 10.1099/vir.0.012856-0; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Dobruskina IA., 1995, NEW MEXICO MUSEUM NA, V5, P1; Favret C., 2016, APHID SPECIES FILE V; Gall JC, 2005, CR PALEVOL, V4, P637, DOI 10.1016/j.crpv.2005.04.007; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Hardy NB, 2015, EVOLUTION, V69, P1423, DOI 10.1111/evo.12643; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie O. E., 2011, MONOGRAPHS UPPER SIL, V6, P1; HEIE OE, 1994, EUR J ENTOMOL, V91, P127; Heie Ole E., 2009, Redia, V92, P69; Heie Ole E., 2009, Redia, V92, P261; Herman AB, 2011, STRATIGR GEO CORREL+, V19, P71, DOI 10.1134/S0869593811010023; Homan A, 2015, CRETACEOUS RES, V52, P357, DOI 10.1016/j.cretres.2014.03.017; Hong YC, 2009, J PALEONTOL, V83, P826, DOI 10.1666/07-135.1; Hopson PM, 2007, SHEET EXPLANATION BR; Huang DY, 2015, EUR J ENTOMOL, V112, P187, DOI 10.14411/eje.2015.013; Kania I, 2013, CRETACEOUS RES, V44, P166, DOI 10.1016/j.cretres.2013.04.006; Kopylov DS, 2015, CRETACEOUS RES, V52, P591, DOI 10.1016/j.cretres.2014.03.012; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Lu L, 2014, INSECT SCI, V21, P301, DOI 10.1111/1744-7917.12113; Maddison WP., 2021, MESQUITE MODULAR SYS; Maksoud S, NEW DATA AGE LOWER C; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; Mondor EB, 2002, ECOL ENTOMOL, V27, P758, DOI 10.1046/j.1365-2311.2002.00470.x; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nixon K.C., 2002, WINCLADA VER 1 00 08; Novakova E, 2013, MOL PHYLOGENET EVOL, V68, P42, DOI 10.1016/j.ympev.2013.03.016; Ponomarenko AG, 2014, PALEONTOL J+, V48, P1573, DOI 10.1134/S0031030114140160; Ponomarenko A. G., 2013, REV LOCATIONS FOSSIL; Ponomarenko AG, 2016, PALEONTOL J, V50, P1; Purdy DJ., 2013, GEOLOGY QUEENSLAND, P391; Rasnitsyn AP, 2016, CRETACEOUS RES, V61, P234, DOI 10.1016/j.cretres.2015.12.025; Rasnitsyn A.P., 2002, P437; Rasnitsyn AP, 2002, HIST INSECTS, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; Ross A.J., 1993, P363; Shaposhnikov G.Ch., 1987, World Crop Pests, V2A, P409; Shaposhnikov G.Kh., 1989, Paleontologicheskii Zhurnal, V1989, P42; Shaposhnikov G.Kh., 1979, Paleontologicheskii Zhurnal, V1979, P66; Shaposhnikov G.Kh., 1980, Entomologicheskoe Obozrenie, V59, P39; Shcherbakov D. E., 2010, Russian Entomological Journal, V19, P179; Shcherbakov D. Y., 2007, Russian Entomological Journal, V16, P47; Slater GJ, 2013, METHODS ECOL EVOL, V4, P699, DOI 10.1111/2041-210X.12091; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; Szwedo J, 2015, SYST ENTOMOL, V40, P207, DOI 10.1111/syen.12099; Van Doornum S, 2012, INTERN MED J, V42, P3; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wegierek P., 1991, Paleontologicheskii Zhurnal, V1991, P114; Wojciechowski W., 1992, STUDIES SYSTEMATIC S, V1269, P1; Wolfe JM, 2016, EARTH-SCI REV, V160, P43, DOI 10.1016/j.earscirev.2016.06.008; Zhang HC, 2010, SCI CHINA EARTH SCI, V53, P1908, DOI 10.1007/s11430-010-4098-5; Zhang WT, 2015, J PALEONTOL, V89, P617, DOI 10.1017/jpa.2015.39; Zyla D, 2015, ZOOKEYS, P9, DOI 10.3897/zookeys.483.8902; Zyla D, 2015, CRETACEOUS RES, V52, P348, DOI 10.1016/j.cretres.2014.02.017; Zyla D, 2014, SYST ENTOMOL, V39, P506, DOI 10.1111/syen.12073; Zyla D, 2013, INSECT SYST EVOL, V44, P149, DOI 10.1163/1876312X-04402004	64	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174791	10.1371/journal.pone.0174791	http://dx.doi.org/10.1371/journal.pone.0174791			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445493	Green Published, gold, Green Submitted			2022-12-27	WOS:000400309200009
J	Choi, EY; Kang, HG; Lee, CH; Yeo, A; Noh, HM; Gu, N; Kim, MJ; Song, JS; Kim, HC; Lee, HK				Choi, Eun Young; Kang, Hyun Goo; Lee, Chul Hee; Yeo, Areum; Noh, Hye Mi; Gu, Nayeong; Kim, Myoung Joon; Song, Jong Suk; Kim, Hyeon Chang; Lee, Hyung Keun			Langerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease	PLOS ONE			English	Article							CONFOCAL MICROSCOPIC EVALUATION; DENDRITIC CELL; CORNEAL; DENSITY; CYTOKINES; RECEPTOR; STRESS; TEARS; REGENERATION; INFLAMMATION	The functional role of Langerhans cells (LCs) in ocular surface inflammation and nerve damage in dry eye (DE) disease has yet to be determined. This study was performed to investigate this relationship through both clinical study on DE patients and in vivo mouse models with induced DE disease. In a cross-sectional case-control study (54 eyes of DE patients; 34 eyes of control patients), average cell density, area, and process length of LCs were measured using confocal microscopy. Data were analyzed to determine whether changes in LCs are correlated with subbasal nerve plexus (SNP) parameters (nerve density, beading, and tortuosity). In DE patients, SNP density marginally decreased and nerve beading and tortuosity were significantly increased compared to the control group. The total number of LCs significantly increased in DE patients, and some LCs with elongated processes were found to be attached to nerve fibers. Interestingly, nerve loss and deformation were correlated with inactivation of LCs. In an in vivo experiment to elucidate the role of LCs in ocular surface inflammation and corneal nerve loss, we used a genetically modified mouse model (CD207-DTR) that reduced the population of CD207 (Langerin) expressing cells by injection of diphtheria toxin. In CD207-depleted mice with DE disease (CD207-dDTR+DE), corneal nerves in the central region were significantly decreased, an effect that was not observed in wild-type (WT)+ DE mice. In CD207-dDTR+DE mice, infiltration of CD4+, CD19+, CD45+, and CD11b+ cells into the ocular surface was increased, as confirmed by flow cytometry. Increased IL-17 and IFN-gamma mRNA levels, and decreased expression of neurotrophic factors and neurotransmitters, were also found in the CD207-dDTR+DE mice. These data support a functional role for LCs in negatively regulating ocular surface inflammation and exhibiting a neuroprotective function in DE disease.	[Choi, Eun Young; Kang, Hyun Goo; Lee, Chul Hee; Yeo, Areum; Noh, Hye Mi; Gu, Nayeong; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Myoung Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Song, Jong Suk] Korea Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System	Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	shadik@yuhs.ac	, James/ABG-8160-2020; Kang, Hyun Goo/C-5569-2018; Kim, Hyeon Chang/F-8796-2019; Choi, Eun Young/Y-5204-2018	Kang, Hyun Goo/0000-0001-8359-9618; Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Chul Hee/0000-0002-4107-4677; Choi, Eun Young/0000-0002-1668-6452	faculty research grant, Yonsei University College of Medicine [6-2011-0111]; Korean Health Technology Research and Development Project; Ministry of Health and Welfare [HI13C0055-010016]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Science, Information and Communication Technology and Future Planning [NRF-2015R1A2A2A04002684]	faculty research grant, Yonsei University College of Medicine; Korean Health Technology Research and Development Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, Information and Communication Technology and Future Planning	This study was supported by a faculty research grant, Yonsei University College of Medicine for 2011 (6-2011-0111), a grant from the Korean Health Technology Research and Development Project, the Ministry of Health and Welfare (HI13C0055-010016), and the Basic Science Research Program through the National Research Foundation of Korea, the Ministry of Science, Information and Communication Technology and Future Planning (NRF-2015R1A2A2A04002684).	Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Choi EY, 2015, CORNEAL MICROSTRUCTU, V56, P680; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Coursey TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078508; Dastjerdi Mohammad H, 2009, Int Ophthalmol Clin, V49, P11, DOI 10.1097/IIO.0b013e31819242c9; de Brouwer SJM, 2014, RHEUMATOLOGY, V53, P1844, DOI 10.1093/rheumatology/keu221; Doss ALN, 2014, NEUROSCI LETT, V578, P55, DOI 10.1016/j.neulet.2014.06.036; Eichenfield LF, 2015, J DRUGS DERMATOL, V14, P263; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; He JC, 2015, INVEST OPHTH VIS SCI, V56, P3505, DOI 10.1167/iovs.15-16755; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Ji YW, 2014, INVESTIGATIVE OPHTHA, V55; Joachim RA, 2008, AM J PATHOL, V173, P1379, DOI 10.2353/ajpath.2008.080105; Kheirkhah A, 2015, INVEST OPHTH VIS SCI, V56, P7179, DOI 10.1167/iovs.15-17433; Kheirkhah A, 2015, OPHTHALMOLOGY, V122, P662, DOI 10.1016/j.ophtha.2014.11.006; King JK, 2015, J IMMUNOL, V195, P464, DOI 10.4049/jimmunol.1402735; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Lee HK, 2006, OPHTHALMOLOGY, V113, P198, DOI 10.1016/j.ophtha.2005.09.033; Liang CM, 2014, CYTOTHERAPY, V16, P1371, DOI 10.1016/j.jcyt.2014.05.015; Machetta F, 2014, OPEN OPHTHALMOL J, V8, P51, DOI 10.2174/1874364101408010051; Madva EN, 2013, BRAIN BEHAV IMMUN, V34, P1, DOI 10.1016/j.bbi.2013.03.006; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Marsovszky L, 2013, INNATE IMMUN-LONDON, V19, P348, DOI 10.1177/1753425912461677; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Meng ID, 2013, EXP EYE RES, V117, P79, DOI 10.1016/j.exer.2013.08.011; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Peters EMJ, 2012, ANN NY ACAD SCI, V1262, P118, DOI 10.1111/j.1749-6632.2012.06647.x; Pflugfelder SC, 2013, EXP EYE RES, V117, P118, DOI 10.1016/j.exer.2013.08.013; Renn CN, 2006, J IMMUNOL, V177, P298, DOI 10.4049/jimmunol.177.1.298; Saban DR, 2014, OCUL SURF, V12, P87, DOI 10.1016/j.jtos.2013.10.007; Seiffert K, 2006, ANN NY ACAD SCI, V1088, P195, DOI 10.1196/annals.1366.011; Shim J, 2012, OPHTHALMOLOGY, V119, P2211, DOI 10.1016/j.ophtha.2012.05.038; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; Steinhoff M, 2013, J AM ACAD DERMATOL, V69, pS15, DOI 10.1016/j.jaad.2013.04.045; Tan X, 2014, EYE, V28, P608, DOI 10.1038/eye.2014.38; Tuisku IS, 2008, EXP EYE RES, V86, P879, DOI 10.1016/j.exer.2008.03.002; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2010, IMMUNOL CELL BIOL, V88, P410, DOI 10.1038/icb.2010.32; Zhivov A, 2007, CORNEA, V26, P47, DOI 10.1097/ICO.0b013e31802e3b55	52	27	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176153	10.1371/journal.pone.0176153	http://dx.doi.org/10.1371/journal.pone.0176153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441413	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800029
J	Gunalan, K; Chaturvedi, A; Howell, B; Duchin, Y; Lempka, SF; Patriat, R; Sapiro, G; Harel, N; McIntyre, CC				Gunalan, Kabilar; Chaturvedi, Ashutosh; Howell, Bryan; Duchin, Yuval; Lempka, Scott F.; Patriat, Remi; Sapiro, Guillermo; Harel, Noam; McIntyre, Cameron C.			Creating and parameterizing patient-specific deep brain stimulation pathway-activation models using the hyperdirect pathway as an example	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; BASAL GANGLIA; FUNCTIONAL-ANATOMY; TRACTOGRAPHY; AXONS; TISSUE; DBS; LOCALIZATION	Background Deep brain stimulation (DBS) is an established clinical therapy and computational models have played an important role in advancing the technology. Patient-specific DBS models are now common tools in both academic and industrial research, as well as clinical software systems. However, the exact methodology for creating patient-specific DBS models can vary substantially and important technical details are often missing from published reports. Objective Provide a detailed description of the assembly workflow and parameterization of a patient-specific DBS pathway-activation model (PAM) and predict the response of the hyperdirect pathway to clinical stimulation. Methods Integration of multiple software tools (e.g. COMSOL, MATLAB, FSL, NEURON, Python) enables the creation and visualization of a DBS PAM. An example DBS PAM was developed using 7T magnetic resonance imaging data from a single unilaterally implanted patient with Parkinson's disease (PD). This detailed description implements our best computational practices and most elaborate parameterization steps, as defined from over a decade of technical evolution. Results Pathway recruitment curves and strength-duration relationships highlight the non-linear response of axons to changes in the DBS parameter settings. Conclusion Parameterization of patient-specific DBS models can be highly detailed and constrained, thereby providing confidence in the simulation predictions, but at the expense of time demanding technical implementation steps. DBS PAMs represent new tools for investigating possible correlations between brain pathway activation patterns and clinical symptom modulation.	[Gunalan, Kabilar; Chaturvedi, Ashutosh; Howell, Bryan; McIntyre, Cameron C.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Duchin, Yuval; Patriat, Remi; Harel, Noam] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Lempka, Scott F.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Lempka, Scott F.; McIntyre, Cameron C.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Sapiro, Guillermo] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Sapiro, Guillermo] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Sapiro, Guillermo] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA	Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Duke University; Duke University; Duke University	McIntyre, CC (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; McIntyre, CC (corresponding author), Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.	ccm4@case.edu	Harel, Noam/R-7391-2018	Harel, Noam/0000-0002-6034-3801; Patriat, Remi/0000-0003-2928-3772	National Institutes of Health (NIH) [R01 NS085188, P41 EB015894, P30 NS076408, U54 MH091657]; NIH [T32 GM007250, TL1 TR000441, T32 EB004314]; U.S. Department of Education [GAANN P200A100112]; Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549, TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085188] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Education(US Department of Education); Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) (R01 NS085188, P41 EB015894, P30 NS076408, U54 MH091657). KG was supported by training grants from the NIH (T32 GM007250, TL1 TR000441, T32 EB004314) and the U.S. Department of Education (GAANN P200A100112). SFL was supported by the Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Angela M. Noecker for assistance with electrode localization and fitting of the thalamus in Cicerone, as well as Eric Maurer and Jerrold Vitek for assistance with the patient data. This work was supported by the National Institutes of Health (NIH) (R01 NS085188, P41 EB015894, P30 NS076408, U54 MH091657). KG was supported by training grants from the NIH (T32 GM007250, TL1 TR000441, T32 EB004314) and the U.S. Department of Education (GAANN P200A100112). SFL was supported by the Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work made use of the High Performance Computing Resource in the Core Facility for Advanced Research Computing at Case Western Reserve University. The authors thank the community for making freely available software programs, such as NEURON, Python, FSL, Freesurfer, Seg3D, MeshLab, and 3DSlicer.	Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Brunenberg EJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039061; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Chaturvedi A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056023; Chaturvedi A, 2010, BRAIN STIMUL, V3, P65, DOI 10.1016/j.brs.2010.01.003; Coenen VA, 2011, NEUROSURGERY, V68, P1069, DOI 10.1227/NEU.0b013e31820a1a20; Coenen VA, 2012, INT REV NEUROBIOL, V107, P207, DOI 10.1016/B978-0-12-404706-8.00011-5; Duchin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037328; Eisenstein SA, 2014, ANN NEUROL, V76, P279, DOI 10.1002/ana.24204; Firmin L, 2014, J NEUROPHYSIOL, V112, P1229, DOI 10.1152/jn.00720.2013; Fox MD, 2014, P NATL ACAD SCI USA, V111, pE4367, DOI 10.1073/pnas.1405003111; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; GRILL WM, 1994, ANN BIOMED ENG, V22, P23, DOI 10.1007/BF02368219; Groppa S, 2014, BRAIN, V137, P109, DOI 10.1093/brain/awt304; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hahn PJ, 2010, J COMPUT NEUROSCI, V28, P425, DOI 10.1007/s10827-010-0225-8; Haynes WIA, 2013, J NEUROSCI, V33, P4804, DOI 10.1523/JNEUROSCI.4674-12.2013; Hemm S, 2009, ACTA NEUROCHIR, V151, P823, DOI 10.1007/s00701-009-0393-3; Henderson JM, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00015; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Horn A, 2015, NEUROIMAGE, V107, P127, DOI 10.1016/j.neuroimage.2014.12.002; Howell B, 2017, BRAIN STIMUL, V10, P46, DOI 10.1016/j.brs.2016.09.001; Howell B, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036023; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kahan J, 2014, BRAIN, V137, P1130, DOI 10.1093/brain/awu027; Kang GY, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00032; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Klein JC, 2012, NEUROLOGY, V78, P787, DOI 10.1212/WNL.0b013e318249f702; Lauro PM, 2016, HUM BRAIN MAPP, V37, P422, DOI 10.1002/hbm.23039; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Lujan JL, 2013, BRAIN STIMUL, V6, P737, DOI 10.1016/j.brs.2013.03.008; Lujan JL, 2012, HUM BRAIN MAPP, V33, P958, DOI 10.1002/hbm.21262; Mathai A, 2013, MOVEMENT DISORD, V28, P1811, DOI 10.1002/mds.25603; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; McNeal DR, 1976, IEEE T BIOMED ENG, V23, P329; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; Miocinovic S, 2009, EXP NEUROL, V216, P166, DOI 10.1016/j.expneurol.2008.11.024; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Petersen MV, 2017, J NEUROSURG, V126, P1657, DOI 10.3171/2016.4.JNS1624; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Reich MM, 2015, ANN CLIN TRANSL NEUR, V2, P427, DOI 10.1002/acn3.168; Riva-Posse P, 2014, BIOL PSYCHIAT, V76, P963, DOI 10.1016/j.biopsych.2014.03.029; Rizzone M, 2001, J NEUROL NEUROSUR PS, V71, P215, DOI 10.1136/jnnp.71.2.215; Rossi MA, 2010, EPILEPSY RES, V91, P176, DOI 10.1016/j.eplepsyres.2010.07.010; Sanders TH, 2016, NEUROBIOL DIS, V95, P225, DOI 10.1016/j.nbd.2016.07.021; Schlaepfer TE, 2013, BIOL PSYCHIAT, V73, P1204, DOI 10.1016/j.biopsych.2013.01.034; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Sweet JA, 2014, J NEUROSURG, V120, P988, DOI 10.3171/2013.12.JNS131537; Tommasi G, 2008, J NEUROL NEUROSUR PS, V79, P813, DOI 10.1136/jnnp.2007.117507; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; VONKEYSERLINGK DG, 1984, ANAT ANZEIGER, V157, P97; Walckiers G, 2010, J NEUROSCI METH, V186, P90, DOI 10.1016/j.jneumeth.2009.10.012; Walker HC, 2012, MOVEMENT DISORD, V27, P864, DOI 10.1002/mds.25025; Wei XF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046008; Welter ML, 2014, NEUROLOGY, V82, P1352, DOI 10.1212/WNL.0000000000000315; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155	68	59	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176132	10.1371/journal.pone.0176132	http://dx.doi.org/10.1371/journal.pone.0176132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441410	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800027
J	Park, HYL; Ha, MJ; Shin, SY				Park, Hae-Young Lopilly; Ha, Min Ji; Shin, Sun Young			The effect of parental factors in children with large cup-to-disc ratios	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; CLINICAL CHARACTERISTICS; POPULATION; MEGALOPAPILLA; HERITABILITY; APPEARANCE; GLAUCOMA; TWIN; EYE	Background To investigate large cup-to-disc ratios (CDR) in children and to determine the relationship between parental CDR and clinical characteristics associated with glaucoma. Methods Two hundred thirty six children aged 6 to 12 years with CDR >= 0.6 were enrolled in this study. Subjects were classified into two groups based on parental CDR: disc suspect children with disc suspect (CDR >= 0.6) parents and disc suspect children without disc suspect parents. Ocular variables were compared between the two groups. Results Of the 236 disc suspect children, 100 (42.4%) had at least one disc suspect parent. Intraocular pressure (IOP) was higher in disc suspect children with disc suspect parents (16.52 +/- 2.66 mmHg) than in disc suspect children without disc suspect parents (14.38 +/- 2.30 mmHg, p = 0.023). In the group with disc suspect parents, vertical CDR significantly correlated with IOP (R = -0.325, p = 0.001), average retinal nerve fiber layer (RNFL) thickness (R = -0.319, p = 0.001), rim area (R = -0.740, p = 0.001), and cup volume (R = 0.499, p = 0.001). However, spherical equivalent (R = 0.333, p = 0.001), AL (R = -0.223, p = 0.009), and disc area (R = 0.325, p = 0.001) significantly correlated with vertical CDR in disc suspect children without disc suspect parents, in contrast to those with disc suspect parents. Larger vertical CDR was associated with the presence of disc suspect parents (p = 0.001), larger disc area (p = 0.001), thinner rim area (p = 0.001), larger average CDR (p = 0.001), and larger cup volume (p = 0.021). Conclusions and relevance Family history of large CDR was a significant factor associated with large vertical CDR in children. In children with disc suspect parents, there were significant correlations between IOP and average RNFL thickness and vertical CDR.	[Park, Hae-Young Lopilly; Ha, Min Ji; Shin, Sun Young] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	eyeshin@catholic.ac.kr						ALEXANDER KL, 1978, J AM OPTOM ASSOC, V49, P1056; Aponte EP, 2010, ARCH OPHTHALMOL-CHIC, V128, P478, DOI 10.1001/archophthalmol.2010.41; Costa AMC, 2014, J GLAUCOMA, V23, P368, DOI 10.1097/IJG.0b013e318279b3af; Creavin AL, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0247-z; Fleiss J.L., 2013, STAT METHODS RATES P; Flores-Rodriguez P, 2012, OPHTHALMOLOGICA, V228, P59, DOI 10.1159/000337842; FRANCESCHETTI A, 1950, AM J OPHTHALMOL, V33, P227, DOI 10.1016/0002-9394(50)90841-5; He MG, 2008, INVEST OPHTH VIS SCI, V49, P1350, DOI 10.1167/iovs.07-1146; Healey P, 2008, INVEST OPHTH VIS SCI, V49, P77, DOI 10.1167/iovs.07-0962; Huynh SC, 2006, OPHTHALMOLOGY, V113, P1583, DOI 10.1016/j.ophtha.2006.02.067; Inuzuka H, 2015, J GLAUCOMA; Jacobson L, 1997, ARCH OPHTHALMOL-CHIC, V115, P1263, DOI 10.1001/archopht.1997.01100160433007; Kang MT, 2016, CLIN EXPT OPHTHALMOL; Lasseck J, 2008, GRAEF ARCH CLIN EXP, V246, P1463, DOI 10.1007/s00417-008-0863-y; Lee HS, 2015, ACTA OPHTHALMOL, V93, pE301, DOI 10.1111/aos.12545; MARRAFFA M, 1995, DOC OPHTHALMOL, V89, P383, DOI 10.1007/BF01203713; McMonnies CW., 2016, J OPTOMETRY; Mwanza JC, 2011, OPHTHALMOLOGY, V118, P241, DOI 10.1016/j.ophtha.2010.06.036; O'Gallagher MK, 2012, EUR J OPHTHALMOL, V22, P840, DOI 10.5301/ejo.5000142; Pakravan M, 2017, ACTA OPHTHALMOL, V95, pE144, DOI 10.1111/aos.13231; Piette SD, 2006, CURR OPIN OPHTHALMOL, V17, P1, DOI 10.1097/01.icu.0000193072.17122.f3; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Randhawa S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1134, DOI 10.1001/archopht.125.8.1134; Salchow DJ, 2006, OPHTHALMOLOGY, V113, P786, DOI 10.1016/j.ophtha.2006.01.036; Samarawickrama C, 2012, BRIT J OPHTHALMOL, V96, P68, DOI 10.1136/bjo.2010.197426; Sampaolesi Roberto, 2001, International Ophthalmology, V23, P251, DOI 10.1023/A:1014409404579; Siatkowski RM, 2013, J AAPOS, V17, P129, DOI 10.1016/j.jaapos.2012.10.022; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175900	10.1371/journal.pone.0175900	http://dx.doi.org/10.1371/journal.pone.0175900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441443	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800011
J	de Souza, GR; Hounkpe, BW; Fiusa, MML; Colella, MP; Annichino-Bizzacchi, JM; Traina, F; Costa, FF; De Paula, EV				de Souza, Gleice Regina; Hounkpe, Bidossessi Wilfried; Luz Fiusa, Maiara Marx; Colella, Marina Pereira; Annichino-Bizzacchi, Joyce M.; Traina, Fabiola; Costa, Fernando Ferreira; De Paula, Erich Vinicius			Tissue factor-dependent coagulation activation by heme: A thromboelastometry study	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; SEVERE HEMOPHILIA-A; VENOUS THROMBOEMBOLISM; THROMBIN GENERATION; INNATE IMMUNITY; WHOLE-BLOOD; FACTOR-VIIA; HEMATIN; MICE; HYPERCOAGULABILITY	Heme has been characterized as potent trigger of inflammation. In hemostasis, although heme has been shown to both induce and inhibit different compartments of hemostasis, its net effect on the hemostatic balance, and the biological relevance of these effects remain to be determined. Herein we evaluated the effect of heme on hemostasis using a global assay able to generate clinically relevant data in several other complex hemostatic diseases. Citrated whole blood samples from healthy participants were stimulated by heme or vehicle and incubated for 4h at 37 degrees C. Rotational thromboelastometry was immediately performed. The participation of tissue factor in coagulation activation was evaluated using inhibitory antibody. Heme was able of inducing ex vivo coagulation activation in whole blood, affecting predominantly parameters associated with the initial phases of clot formation. This activation effect was at least partially dependent on hematopoietic tissue factor, since the effects of heme were partially abrogated by the inhibition of human tissue factor. In conclusion, using a global hemostasis assay, our study confirmed that heme is able to activate coagulation in whole blood, in a tissue factor-dependent way. These findings could explain the disturbance in hemostatic balance observed in conditions associated with the release of heme such as sickle cell disease.	[de Souza, Gleice Regina; Hounkpe, Bidossessi Wilfried; Luz Fiusa, Maiara Marx; Annichino-Bizzacchi, Joyce M.; Costa, Fernando Ferreira; De Paula, Erich Vinicius] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Colella, Marina Pereira; Annichino-Bizzacchi, Joyce M.; Costa, Fernando Ferreira; De Paula, Erich Vinicius] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Traina, Fabiola] Univ Sao Paulo, Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Hounkpe, BW (corresponding author), Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil.	bidossessi1@live.fr	Costa, Fernando F/D-1566-2012; De Paula, Erich Vinicius/C-5943-2012; Traina, Fabiola/U-1451-2019; Hounkpe, Bidossessi/ABD-9587-2021; Traina, Fabiola/L-3809-2014; CTC USP, CEPID 13 18/J-8951-2014	Costa, Fernando F/0000-0002-4632-572X; De Paula, Erich Vinicius/0000-0003-1539-7912; Traina, Fabiola/0000-0003-4258-289X; Hounkpe, Bidossessi/0000-0002-9992-1939; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	Fapesp [2013/09319-0, 2014/00984-3, 2015/24666-3]; CNPq-Brazil [2014/457780]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by Fapesp grants 2013/09319-0, 2014/00984-3 and 2015/24666-3; and CNPq-Brazil grant 2014/457780. The Hematology and Hemotherapy Center-Hemocentro UNICAMP, forms part of the National Institute of Science and Technology of Blood, Brazil (INCT do SangueCNPq / MCT / FAPESP). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa OA, 2013, BRIT J HAEMATOL, V162, P702, DOI 10.1111/bjh.12445; Arumugam PI, 2015, BLOOD, V126, P1844, DOI 10.1182/blood-2015-01-625707; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Chantrathammachart P, 2012, BLOOD, V120, P636, DOI 10.1182/blood-2012-04-424143; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Colella MP, 2015, HAEMATOLOGICA, V100, P469, DOI 10.3324/haematol.2014.114587; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; GLUECK R, 1983, BLOOD, V61, P243; Gorlinger K, 2016, TRAUMA INDUCED COAGU, P267; GREEN D, 1983, J LAB CLIN MED, V102, P361; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hounkpe BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17822; Kaplan D, 2015, CHEST, V148, P1224, DOI 10.1378/chest.15-0287; Lim MY, 2013, CURR OPIN HEMATOL, V20, P472, DOI 10.1097/MOH.0b013e328363442f; MCCOLL KEL, 1981, Q J MED, V50, P161; Meszaros K, MONOCYTE TISSUE FACT; MORRIS DL, 1981, ANN INTERN MED, V95, P700, DOI 10.7326/0003-4819-95-6-700; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Naik RP, 2014, J THROMB HAEMOST, V12, P2010, DOI 10.1111/jth.12744; NEELY SM, 1984, BRIT J HAEMATOL, V58, P305, DOI 10.1111/j.1365-2141.1984.tb06089.x; Nielsen VG, 2011, BLOOD COAGUL FIBRIN, V22, P443, DOI 10.1097/MBC.0b013e328345c069; Nogami K, 2016, BRIT J HAEMATOL, V174, P503, DOI 10.1111/bjh.14148; Noubouossie D, 2015, BLOOD REV; Oh JY, 2016, REDOX BIOL, V9, P167, DOI 10.1016/j.redox.2016.08.003; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Rea CJ, 2014, J THROMB HAEMOST, V12, P159, DOI 10.1111/jth.12478; Rea CJ, 2011, J THROMB HAEMOST, V9, P510, DOI 10.1111/j.1538-7836.2010.04171.x; Rehani T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2215.2215; Repesse Y, 2012, J THROMB HAEMOST, V10, P1062, DOI 10.1111/j.1538-7836.2012.04724.x; Roumenina LT, 2016, TRENDS MOL MED, V22, P200, DOI 10.1016/j.molmed.2016.01.004; Schneider T, 2015, HAMOSTASEOLOGIE, V35, P181, DOI 10.5482/HAMO-14-08-0033; Schoergenhofer C, 2017, CLIN EXP MED, P1; Setty BNY, 2008, J THROMB HAEMOST, V6, P2202, DOI 10.1111/j.1538-7836.2008.03177.x; Skaf E, 2005, AM J CARDIOL, V96, P1731, DOI 10.1016/j.amjcard.2005.07.097; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Sorensen B, 2007, BRIT J HAEMATOL, V137, P158, DOI 10.1111/j.1365-2141.2007.06534.x; Sparkenbaugh E, 2013, BRIT J HAEMATOL, V162, P3, DOI 10.1111/bjh.12336; Sparkenbaugh EM, 2015, HAEMATOLOGICA, V100, P308, DOI 10.3324/haematol.2014.114728; Tarzia Vincenzo, 2015, World J Cardiol, V7, P571, DOI 10.4330/wjc.v7.i9.571; Tjonnfjord GE, 2015, HAEMOPHILIA, V21, P275; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Van Geffen M, 2012, THROMB RES, P681; Vasconcellos LRC, 2016, P NATL ACAD SCI USA; Whelihan MF, 2016, J THROMB HAEMOST, V14, P1941, DOI 10.1111/jth.13416; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Yee DL, 2005, ARCH PATHOL LAB MED, V129, P760	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176505	10.1371/journal.pone.0176505	http://dx.doi.org/10.1371/journal.pone.0176505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437457	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600051
J	McNairy, ML; Joseph, P; Unterbrink, M; Galbaud, S; Mathon, JE; Rivera, V; Jannat-Khah, D; Reif, L; Koenig, SP; Domercant, JW; Johnson, W; Fitzgerald, DW; Pape, JW				McNairy, Margaret L.; Joseph, Patrice; Unterbrink, Michelle; Galbaud, Stanislas; Mathon, Jean-Edouard; Rivera, Vanessa; Jannat-Khah, Deanna; Reif, Lindsey; Koenig, Serena P.; Domercant, Jean Wysler; Johnson, Warren; Fitzgerald, Daniel W.; Pape, Jean W.			Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; TREATMENT PROGRAMS; FOLLOW-UP; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; ADULT PATIENTS; LATIN-AMERICA; 1ST YEAR; CARE; MORTALITY	Background We report patient outcomes after antiretroviral therapy (ART) initiation in a network of HIV facilities in Haiti, including temporal trends and differences across clinics, during the expansion of HIV services in the country. Methods We assessed outcomes at 12 months after ART initiation (baseline) using routinely collected data on adults (>= 15 years) in 11 HIV facilities from July 2007-December 2013. Outcomes include death (ascertained from medical records), lost to follow-up (LTF) defined as no visit > 365 days from ART initiation, and retention defined as being alive and attending care >= 365 days from ART initiation. Outcomes were compared across calendar year of ART initiation and across facilities. Risk factors for death and LTF were assessed using Cox proportional hazards and competing risk regression models. Results Cumulatively, 9,718 adults initiated ART with median age 37 years (IQR 3-46). Median CD4 count was 254 cells/ uL (IQR 139-350). Twelve months after ART initiation, 4.4% (95% CI 4.0-4.8) of patients died, 21.7% (95% CI 20.9-22.6) were LTF, and 73.9% (95% CI 73.0-74.8) were retained in care. Twelve-month mortality decreased from 13.8% among adults who started ART in 2007 to 4.4% in 2013 (p< 0.001). Twelve-month LTF after ART start was 29.2% in 2007, 18.7% in 2008, and increased to 30.1% in 2013 (p< 0.001). Overall, twelve-month retention after ART start did not change over time but varied widely across facilities from 61.1% to 86.5%. Conclusion Expansion of HIV services across Haiti has been successful with increasing numbers of patients initiating ART and decreasing twelve-month mortality rates. However, overall retention has not improved, despite differences across facilities, suggesting additional strategies to improve engagement in care are needed.	[McNairy, Margaret L.; Reif, Lindsey; Johnson, Warren; Fitzgerald, Daniel W.; Pape, Jean W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10065 USA; [McNairy, Margaret L.; Unterbrink, Michelle; Jannat-Khah, Deanna] Weill Cornell Med Coll, Div Gen Med, New York, NY 10065 USA; [Joseph, Patrice; Galbaud, Stanislas; Mathon, Jean-Edouard; Rivera, Vanessa; Pape, Jean W.] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Domercant, Jean Wysler] Ctr Dis Control & Prevent, Port Au Prince, Haiti	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	McNairy, ML (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10065 USA.; McNairy, ML (corresponding author), Weill Cornell Med Coll, Div Gen Med, New York, NY 10065 USA.	Mam9365@med.cornell.edu	Jannat-Khah, Deanna/L-9701-2019	Jannat-Khah, Deanna/0000-0002-1091-379X	Centers for Disease Control Grants [U2GGH000545, U2GGH000541]; National Institutes of Allergy and Infectious Diseases [R01A1104344]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements [U2GGH000545, U2GGH000541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, K24AI098627, R01AI104344] Funding Source: NIH RePORTER	Centers for Disease Control Grants; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this analysis is supported by Centers for Disease Control Grants U2GGH000545 and U2GGH000541 and the National Institutes of Allergy and Infectious Diseases grant number R01A1104344. CDC Disclaimer: The findings and conclusion of this report or (research, article, publication, poster etc.) are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. PEPFAR Attribution: This report or (research, article, publication, poster etc.) has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements: U2GGH000545 and U2GGH000541.	Aliyu MH, 2015, PATHOG GLOB HEALTH, V109, P75, DOI 10.1179/2047773215Y.0000000007; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Auld AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098183; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carriquiry G, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20016; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Farahani M, 2016, TROP MED INT HEALTH, V21, P18, DOI 10.1111/tmi.12623; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Johnson LF, 2014, AM J EPIDEMIOL, V180, P1208, DOI 10.1093/aje/kwu295; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Koenig SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146903; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; Moise C BC, 2016, C RETR OPP INF BOST; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Pape JW, 2014, JAIDS-J ACQ IMM DEF, V65, pS5, DOI 10.1097/QAI.0000000000000031; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; Puttkammer N, 2016, INT J MED INFORM, V86, P104, DOI 10.1016/j.ijmedinf.2015.11.003; Puttkammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112261; Reif LK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20859; Rouzier V, 2014, ANTIVIR THER, V19, P91, DOI 10.3851/IMP2904; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2014, DECL ENG VIH SIDA RA; UNAIDS, 2014, HAIT EP FACT SHEET; WHO, 2016, WHO BMI CLASS; *WHO, SUMM COUNTR PROF HIV; WHO, 2006, AN THER HIV INF AD A; World Health Organization, 2009, RAP ADV ANT THER HIV	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175521	10.1371/journal.pone.0175521	http://dx.doi.org/10.1371/journal.pone.0175521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437477	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600008
J	Pileggi, SM; Jordan, H; Clennon, JA; Whitney, E; Benbow, ME; Merritt, R; McIntosh, M; Kimbirauskas, R; Small, P; Boakye, D; Quaye, C; Qi, JG; Campbell, L; Gronseth, J; Ampadu, E; Opare, W; Waller, LA				Pileggi, Shannon M.; Jordan, Heather; Clennon, Julie A.; Whitney, Ellen; Benbow, M. Eric; Merritt, Richard; McIntosh, Mollie; Kimbirauskas, Ryan; Small, Pamela; Boakye, Daniel; Quaye, Charles; Qi, Jiaguo; Campbell, Lindsay; Gronseth, Jenni; Ampadu, Edwin; Opare, William; Waller, Lance A.			Landscape and environmental influences on Mycobacterium ulcerans distribution among aquatic sites in Ghana	PLOS ONE			English	Article							BURULI ULCER; RISK-FACTORS; DISEASE; INFECTION; TRANSMISSION; DYNAMICS; INSECTS; OUTBREAK; ECOLOGY; GROWTH	Buruli ulcer, caused by Mycobacterium ulcerans, is highly endemic in West Africa. While the mode of transmission is unknown, many studies associate Buruli ulcer with different types of water exposure. We present results from the largest study to date to test for M. ulcerans in aquatic sites and identify environmental attributes associated with its presence. Environmental samples from 98 aquatic sites in the Greater Accra, Ashanti, and Volta regions of Ghana were tested for the presence of M. ulcerans DNA by polymerase chain reaction. The proportion of aquatic sites positive for M. ulcerans varied by region: Ashanti 66% (N = 39), Greater Accra 34% (N = 29), and Volta 0% (N = 30). We explored the spatial distribution of M. ulcerans positive and negative water bodies and found no significant clusters. We also determined both highly localized water attributes and broad scale remotely sensed land cover and terrain environmental characteristics associated with M. ulcerans presence through logistic regression. Our results concur with published results regarding conditions suitable for M. ulcerans growth and associations with Buruli ulcer disease burden with regards to water characteristics and disturbed environments, but differ from others with regards to spatial associations and topographic effects such as elevation and wetness. While our results suggest M. ulcerans is an environmental organism existing in a specific ecological niche, they also reveal variation in the elements defining this niche across the sites considered. In addition, despite the causal association between Buruli ulcer and M.ulcerans, we observed no significant statistical association between case reports of Buruli ulcer and presence of M. ulcerans in nearby waterbodies.	[Pileggi, Shannon M.] Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA; [Jordan, Heather] Mississippi State Univ, Dept Biol Sci, Starkville, MS USA; [Clennon, Julie A.; Waller, Lance A.] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Whitney, Ellen] Emory Univ, Int Assoc Natl Publ Hlth Inst Off, Atlanta, GA 30322 USA; [Benbow, M. Eric; Merritt, Richard; Kimbirauskas, Ryan] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Benbow, M. Eric] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [McIntosh, Mollie] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Small, Pamela] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Boakye, Daniel; Quaye, Charles] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Qi, Jiaguo; Gronseth, Jenni] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Campbell, Lindsay] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Ampadu, Edwin; Opare, William] Natl Buruli Ulcer Control Programme, Accra, Ghana	California State University System; California Polytechnic State University San Luis Obispo; Mississippi State University; Emory University; Rollins School Public Health; Emory University; Michigan State University; Michigan State University; Xavier University; University of Tennessee System; University of Tennessee Knoxville; University of Ghana; Michigan State University; University of Kansas	Pileggi, SM (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA.	spileggi@calpoly.edu	Qi, Jiaguo/AAC-4106-2020; Waller, Lance A./AAA-1012-2021; Benbow, Mark/V-5895-2019; aubertin, rebeckah/O-9624-2015	aubertin, rebeckah/0000-0002-0558-7571	World Health Organization; Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program [R01TW007550]; National Institute of Environmental Health Sciences [R01ES015525];  [R03A1062719]	World Health Organization(World Health Organization); Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); 	This work was supported by the World Health Organization and the project described was funded by Grant Number R01TW007550 from the Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program, and grant number R03A1062719 to RWM, MEB, JQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the National Institute of Environmental Health Sciences R01ES015525 to Lance Waller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2004, QUAL ASS QUAL CONTR; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; Benbow ME, 2008, EMERG INFECT DIS, V14, P1247, DOI 10.3201/eid1408.071503; Benbow ME, 2014, ECOHEALTH, V11, P168, DOI 10.1007/s10393-013-0886-7; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; BOISVERT H, 1977, B SOC PATHOL EXOT, V70, P125; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell LP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004123; Collett D., 2003, MODELING BINARY DATA; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Duker AA, 2006, INT J APPL EARTH OBS, V8, P126, DOI 10.1016/j.jag.2005.06.013; Eddyani M, 2004, APPL ENVIRON MICROB, V70, P5679, DOI 10.1128/AEM.70.9.5679-5681.2004; Garchitorena A, 2014, PLOS NEG TROP DIS, V8; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hagarty J, 2015, J HYDROL-REG STUD, V3, P457, DOI 10.1016/j.ejrh.2015.03.006; Hausermann H, 2012, ECOHEALTH, V9, P251, DOI 10.1007/s10393-012-0780-8; HAYMAN JA, 1991, MED J AUSTRALIA, V155, P130, DOI 10.5694/j.1326-5377.1991.tb142151.x; Horsburgh C. Robert Jr., 1997, P119; Jenkin GA, 2003, J BACTERIOL, V185, P6870, DOI 10.1128/JB.185.23.6870-6882.2003; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Kenu E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003279; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2009, SATSCAN 8 0 SOFTWARE; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Landier J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003123; Landsat ETM, 2000, USGS SIOUX FALLS; Mantey S, 2014, INT J SCI RES, V3, P1714; Marion E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000731; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; McIntosh M, 2014, ECOHEALTH, V11, P184, DOI 10.1007/s10393-013-0898-3; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; MITCHELL PJ, 1984, PATHOLOGY, V16, P256, DOI 10.3109/00313028409068533; Mosi L, 2008, APPL ENVIRON MICROB, V74, P7036, DOI 10.1128/AEM.01234-08; Palomino JC, 1998, J CLIN MICROBIOL, V36, P3420, DOI 10.1128/JCM.36.11.3420-3422.1998; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pileggi S, DRYAD DIGITAL REPOSI; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RADFORD AJ, 1975, AUST NZ J MED, V5, P162, DOI 10.1111/j.1445-5994.1975.tb03649.x; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; REVILL WDL, 1972, BRIT J PREV SOC MED, V26, P23; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Thangaraj HS, 1999, T ROY SOC TROP MED H, V93, P337, DOI 10.1016/S0035-9203(99)90104-9; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; Wagner T, 2008, ECOHEALTH, V5, P69, DOI 10.1007/s10393-007-0148-7; Wagner T, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-25; Waller L.A., 2004, APPL SPATIAL STAT PU; WHO, 2021, BURULI ULCER MYCOBAC; Williamson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088007; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506; Wu JY, 2016, AM J TROP MED HYG, V95, P63, DOI 10.4269/ajtmh.15-0647; Yeboah-Manu D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001460	65	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176375	10.1371/journal.pone.0176375	http://dx.doi.org/10.1371/journal.pone.0176375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437439	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600045
J	Droop, J; Szarvas, T; Schulz, WA; Niedworok, C; Niegisch, G; Scheckenbach, K; Hoffmann, MJ				Droop, Johanna; Szarvas, Tibor; Schulz, Wolfgang A.; Niedworok, Christian; Niegisch, Guenter; Scheckenbach, Kathrin; Hoffmann, Michele J.			Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; BLADDER-CANCER; GENE-EXPRESSION; UP-REGULATION; IDENTIFICATION; METASTASIS; ANRIL; TUG1; CONTRIBUTES; SIGNATURE	Many long noncoding RNAs (lncRNAs) are deregulated in cancer and contribute to oncogenesis. In urothelial carcinoma (UC), several lncRNAs have been reported to be overexpressed and proposed as biomarkers. As most reports have not been confirmed independently in large tissue sets, we aimed to validate the diagnostic and prognostic value of lncRNA upregulation in independent cohorts of UC patients. Thus, expression of seven lncRNA candidates (GAS5, H19, linc-UBC1, MALAT1, ncRAN, TUG1, UCA1) was measured by RT-qPCR in cell lines and tissues and correlated to clinicopathological parameters including follow-up data (set 1: N n = 10; T n = 106). Additionally, publicly available TCGA data was investigated for differential expression in UC tissues (set 2: N n = 19; T n = 252,) and correlation to overall survival (OS). All proposed candidates tended to be upregulated in tumour tissues, with the exception of MALAT1, which was rather diminished in cancer tissues of both data sets. However, strong overexpression was generally limited to individual tumour tissues and statistically significant overexpression was only observed for UCA1, TUG1, ncRAN and linc-UBC1 in tissue set 2, but for no candidate in set 1. Altered expression of individual lncRNAs was associated with overall survival, but not consistently between both patient cohorts. Interestingly, lower expression of TUG1 in a subset of UC patients with muscle-invasive tumours was significantly correlated with worse OS in both cohorts. Further analysis revealed that tumours with low TUG1 expression are characterized by a basal-squamous-like subtype signature accounting for the association with poor outcome. In conclusion, our study demonstrates that overexpression of the candidate lncRNAs is found in many UC cases, but does not occur consistently and strongly enough to provide reliable diagnostic or prognostic value as an individual biomarker. Subtype-dependent expression patterns of lncRNAs like TUG1 could become useful to stratify patients by molecular subtype, thus aiding personalized treatments.	[Droop, Johanna; Schulz, Wolfgang A.; Niegisch, Guenter; Hoffmann, Michele J.] Heinrich Heine Univ Duesseldorf, Med Fac, Dept Urol, Dusseldorf, Germany; [Szarvas, Tibor; Niedworok, Christian] Univ Duisburg Essen, Med Fac, Dept Urol, Essen, Germany; [Szarvas, Tibor] Semmelweis Univ Budapest, Dept Urol, Budapest, Hungary; [Scheckenbach, Kathrin] Heinrich Heine Univ Duesseldorf, Med Fac, Dept Otolaryngol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; Semmelweis University; Heinrich Heine University Dusseldorf	Hoffmann, MJ (corresponding author), Heinrich Heine Univ Duesseldorf, Med Fac, Dept Urol, Dusseldorf, Germany.	michele.hoffmann@hhu.de	Schulz, Wolfgang/N-3402-2019; Niegisch, Günter/AAX-3069-2021; SZARVAS, t./L-4422-2017; Hoffmann, Michele J./AAL-1028-2020; Niegisch, Günter/GSD-3569-2022	Schulz, Wolfgang/0000-0002-2196-463X; Niegisch, Günter/0000-0001-6929-8691; SZARVAS, t./0000-0002-6321-0799; 	Duesseldorf School of Oncology (Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe); Duesseldorf School of Oncology (Medical Faculty Heinrich-Heine-University Duesseldorf)	Duesseldorf School of Oncology (Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe); Duesseldorf School of Oncology (Medical Faculty Heinrich-Heine-University Duesseldorf)	Johanna Droop is supported by a fellowship of the Duesseldorf School of Oncology (funded by the Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe and the Medical Faculty Heinrich-Heine-University Duesseldorf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Buttigliero C, 2017, CANCER TREAT REV, V54, P1, DOI 10.1016/j.ctrv.2017.01.002; Cao Q, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/796786; Chapman EJ, 2009, GENE CHROMOSOME CANC, V48, P694, DOI 10.1002/gcc.20672; Chen JJ, 2016, J CANCER, V7, P1842, DOI 10.7150/jca.15876; Dadhania V, 2016, EBIOMEDICINE, V12, P105, DOI 10.1016/j.ebiom.2016.08.036; Earl J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1450-3; Eissa S, 2015, TUMOR BIOL, V36, P9545, DOI 10.1007/s13277-015-3722-6; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Greife A, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-29; Haemmerle M, 2015, INT J MOL SCI, V16, P1395, DOI 10.3390/ijms16011395; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; He W, 2013, BBA-MOL BASIS DIS, V1832, P1528, DOI 10.1016/j.bbadis.2013.05.010; Hedegaard J, 2016, CANCER CELL, V30, P1; Heubach J, 2015, MOL CANCER, V14, P361; Hoffmann Michele J., 2015, Non-Coding RNA, V1, P266, DOI 10.3390/ncrna1030266; Iliev R, 2016, TUMOUR BIOL; Lerner SP, 2016, BLADDER CANCER, V2, P37, DOI 10.3233/BLC-150037; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li SS, 2015, 2015 11TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P1, DOI 10.1109/CIS.2015.9; Liu Z, 2013, PLOS ONE, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0083549; Luo M, 2013, FEBS J, V280, P1709, DOI 10.1111/febs.12185; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Martinez-Fernandez M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0141-x; Mengual L, 2010, CLIN CANCER RES, V16, P2624, DOI 10.1158/1078-0432.CCR-09-3373; Milowich D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1092-6; Ohl F, 2006, J UROLOGY, V175, P1915, DOI 10.1016/S0022-5347(05)00919-5; Qi P, 2015, MOL CARCINOGEN, V54, P742, DOI 10.1002/mc.22137; Ronnau CGH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591703; Srivastava AK, 2014, TUMOR BIOL, V35, P11435, DOI 10.1007/s13277-014-2474-z; Tan JM, 2015, FEBS LETT, V589, P3175, DOI 10.1016/j.febslet.2015.08.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XS, 2006, CLIN CANCER RES, V12, P4851, DOI 10.1158/1078-0432.CCR-06-0134; Wu Y, 2015, TUMOR BIOL, P1; Yan J, 2016, MOL CLIN ONCOL, V4, P100, DOI 10.3892/mco.2015.657; Yan TH, 2014, TUMOR BIOL, V35, P10249, DOI 10.1007/s13277-014-2344-8; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Yu M, 2009, INT J ONCOL, V34, P931, DOI 10.3892/ijo_00000219; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhu HX, 2015, BIOCHEM BIOPH RES CO, V467, P223, DOI 10.1016/j.bbrc.2015.10.002; Zhu YY, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.09.022	45	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176287	10.1371/journal.pone.0176287	http://dx.doi.org/10.1371/journal.pone.0176287			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430799	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100039
J	Doyle, JR; Bottomley, PA; Angell, R				Doyle, John R.; Bottomley, Paul A.; Angell, Rob			Tails of the Travelling Gaussian model and the relative age effect: Tales of age discrimination and wasted talent	PLOS ONE			English	Article							ASSOCIATION FOOTBALL; BIRTH; SEASON; ACHIEVEMENT; EDUCATION; GENETICS; SUCCESS	The Relative Age Effect (RAE) documents the inherent disadvantages of being younger rather than older in an age-banded cohort, typically a school-or competition-year, to the detriment of career-progression, earnings and wellbeing into adulthood. We develop the Tails of the Travelling Gaussian (TTG) to model the mechanisms behind RAE. TTG has notable advantages over existing approaches, which have been largely descriptive, potentially confounded, and non-comparable across contexts. In Study 1, using data from the UK's Millennium Cohort Study, we investigate the different levels of RAE bias across school-level academic subjects and "personality" traits. Study 2 concerns biased admissions to elite English Premier League soccer academies, and shows the model can still be used with minimal data. We also develop two practical metrics: the discrimination index (ID), to quantify the disadvantages facing cohort-younger children; and the wastage metric (W), to quantify the loss through untapped potential. TTG is sufficiently well-specified to simulate the consequences of ID and W for policy change.	[Doyle, John R.; Bottomley, Paul A.; Angell, Rob] Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales	Cardiff University	Doyle, JR (corresponding author), Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales.	Doylejr@cardiff.ac.uk		Bottomley, Paul/0000-0001-8131-6768; Angell, Rob/0000-0001-8554-2092				Alton A, 1998, EDUC RES, V40, P105, DOI 10.1080/0013188980400111; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; BELL JF, 1990, OXFORD REV EDUC, V16, P67, DOI 10.1080/0305498900160106; Breznik K, 2016, PERCEPT MOTOR SKILL, V122, P583, DOI 10.1177/0031512516640957; Bryson A, 2016, BREAKING ICE EC HOCK; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Cobley S, 2009, J EDUC PSYCHOL, V101, P520, DOI 10.1037/a0013845; Crawford C., 2011, DOES YOU ARE BORN MA; Crawford C., 2007, YOU ARE BORN MATTERS; Delorme N, 2015, INT REV SOCIOL SPORT, V50, P740, DOI 10.1177/1012690213493104; Deprez D, 2012, INT J SPORTS MED, V33, P987, DOI 10.1055/s-0032-1311654; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Du QQ, 2012, ECON LETT, V117, P660, DOI 10.1016/j.econlet.2012.08.017; Elder TE, 2009, J HUM RESOUR, V44, P641; Fukunaga H, 2012, J ROYAL SOC MED SHOR, V4, P1; Gatenby R, 2010, TECHNICAL REPORT; Gobet F, 2008, J BIOSOC SCI, V40, P313, DOI 10.1017/S0021932007002222; Goodman R, 2003, BMJ-BRIT MED J, V327, P472, DOI 10.1136/bmj.327.7413.472; Gutierrez Diaz del Campo D, 2010, J SPORT SCI MED, V9, P190; Hancock DJ, 2013, EUR J SPORT SCI, V13, P630, DOI 10.1080/17461391.2013.775352; Jackson J, OBSERVER; Jimenez IP, 2008, J SPORT SCI, V26, P995, DOI 10.1080/02640410801910285; Joyner PW, 2013, DUKE ORTHOPAEDIC J, V3, P74; Larsen ER, 2016, LABOUR EC IN PRESS; Lewin K., 1952, FIELD THEORY SOCIAL; Lovell R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137238; Muller D, 2016, J R STAT SOC A STAT, V179, P809, DOI 10.1111/rssa.12154; Parsons S., 2011, MILLENNIUM COHORT ST; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; RUSSELL RJH, 1986, PERS INDIV DIFFER, V7, P839, DOI 10.1016/0191-8869(86)90082-6; Simmons C, 2001, J SPORT SCI, V19, P677, DOI 10.1080/02640410152475801; Tanaka Hisako, 2007, J Med Invest, V54, P133, DOI 10.2152/jmi.54.133; Thompson AH, 2004, EDUC RES-UK, V46, P313, DOI 10.1080/0013188042000277368; Thompson AH, 1999, CAN J PSYCHIAT, V44, P82, DOI 10.1177/070674379904400111; University of London.Institute of Education. Centre for Longitudinal Studies, 2015, MILL COH STUD 4 SURV; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896	37	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176206	10.1371/journal.pone.0176206	http://dx.doi.org/10.1371/journal.pone.0176206			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426748	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000399875900117
J	Francois, L; Wijnrocx, K; Colinet, FG; Gengler, N; Hulsegge, B; Windig, JJ; Buys, N; Janssens, S				Francois, Liesbeth; Wijnrocx, Katrien; Colinet, Frederic G.; Gengler, Nicolas; Hulsegge, Bettine; Windig, Jack J.; Buys, Nadine; Janssens, Steven			Genomics of a revived breed: Case study of the Belgian campine cattle	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION; INTROGRESSION; HOMOZYGOSITY; VORDERWALD; HINTERWALD; AUROCHS; ORIGIN; RUNS	Through centuries of both natural and artificial selection, a variety of local cattle populations arose with highly specific phenotypes. However, the intensification and expansion of scale in animal production systems led to the predominance of a few highly productive cattle breeds. The loss of local populations is often considered irreversible and with them specific qualities and rare variants could be lost as well. Over these last years, the interest in these local breeds has increased again leading to increasing efforts to conserve these breeds or even revive lost populations, e.g. through the use of crosses with similar breeds. However, the remaining populations are expected to contain crossbred individuals resulting from introgressions. They are likely to carry exogenous genes that affect the breed's authenticity on a genomic level. Using the revived Campine breed as a case study, 289 individuals registered as purebreds were genotyped on the Illumina BovineSNP50. In addition, genomic information on the Illumina BovineHD and Illumina BovineSNP50 of ten breeds was available to assess the current population structure, genetic diversity, and introgression with phenotypically similar and/or historically related breeds. Introgression with Holstein and beef cattle genotypes was limited to only a few farms. While the current population shows a substantial amount of within-breed variation, the majority of genotypes can be separated from other breeds in the study, supporting the re-establishment of the Campine breed. The majority of the population is genetically close to the Deep Red (NL), Improved Red (NL) and Eastern Belgium Red and White (BE) cattle, breeds known for their historical ties to the Campine breed. This would support an open herdbook policy, thereby increasing the population size and consequently providing a more secure future for the breed.	[Francois, Liesbeth; Wijnrocx, Katrien; Buys, Nadine; Janssens, Steven] Katholieke Univ Leuven, Res Grp Livestock Genet, Dept Biosyst, Leuven, Belgium; [Colinet, Frederic G.; Gengler, Nicolas] Univ Liege, Gembloux Agrobio Tech Agr, Agr Bioengn & Chem Dept, Gembloux, Belgium; [Hulsegge, Bettine; Windig, Jack J.] Wageningen Univ & Res, Ctr Genet Resources, Netherlands CGN, Wageningen, Netherlands; [Hulsegge, Bettine; Windig, Jack J.] Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands	KU Leuven; University of Liege; Wageningen University & Research; Wageningen University & Research	Janssens, S (corresponding author), Katholieke Univ Leuven, Res Grp Livestock Genet, Dept Biosyst, Leuven, Belgium.	steven.janssens@kuleuven.be	Gengler, Nicolas/B-9002-2011; Janssens, Steven/ABE-6370-2020	Gengler, Nicolas/0000-0002-5981-5509; Janssens, Steven/0000-0002-5588-3889; Buys, Nadine/0000-0002-7313-3088	Department of Agricultural and Fisheries, Government of Flanders	Department of Agricultural and Fisheries, Government of Flanders	This work was financially supported by the Department of Agricultural and Fisheries, Government of Flanders. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2012, LEVEND ERFGOED BOERD, P48; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Amador C, 2011, CONSERV GENET, V12, P1565, DOI 10.1007/s10592-011-0255-4; Bay E, 2009, 87004 EU GENRES EURE; Bennewitz J, 2008, J DAIRY SCI, V91, P2512, DOI 10.3168/jds.2007-0924; Bowling A, 2000, GENETICS OF THE HORSE, pVII; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P317; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FAO, 2013, VIV C3NS AN GEN RES; Felius M., 2014, J AGR SCI, V153, P152; Felius M., 2016, THESIS; Frateur L., 1915, APERC SITUATION LEVA; Gautier M, 2010, PLOS ONE, V5; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Hartwig S, 2015, J DAIRY SCI, V98, P2033, DOI 10.3168/jds.2014-8571; Hartwig S, 2013, ZUCHTUNGSKUNDE, V85, P270; Hiemstra SJ, 2010, LOCAL CATTLE BREEDS IN EUROPE: DEVELOPMENT OF POLICIES AND STRATEGIES FOR SELF-SUSTAINING BREEDS, P1, DOI 10.3921/978-90-8686-697-7; Hoving-Bolink R, 2009, 87004 EU GENRES EURE; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Hulsegge B, 2017, J ANIM BREED GENET, V134, P69, DOI 10.1111/jbg.12233; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lambert-Derkimba A, 2006, PROD ANIM, V19, P357; Lauvie A, 2008, LIVEST SCI, V118, P113, DOI 10.1016/j.livsci.2008.01.004; Leroy G, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0131-7; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Oldenbroek K, 2007, UTILISATION AND CONSERVATION OF FARM ANIMAL GENETIC RESOURCES, P1; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Pariset L, 2010, J ANIM BREED GENET, V127, P481, DOI 10.1111/j.1439-0388.2010.00868.x; Park SDE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0790-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; R Development Core Team, 2016, R LANG ENV STAT COMP; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rischkowsky B., 2007, STATE WORLDS ANIMAL; Van Nieuwenhuyze D, 1959, LANDBOUWTIJDSCHRIFT, V4-5, P1; Vaughan TA, 2010, MAMMALIAN DOMESTICAT, P611; Waples R.S., 1991, Reports of the International Whaling Commission Special Issue, P279; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WEIR BS, 1980, GENETICS, V95, P477; Wojcik JM, 2009, J ZOOL, V277, P81, DOI 10.1111/j.1469-7998.2008.00515.x	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175916	10.1371/journal.pone.0175916	http://dx.doi.org/10.1371/journal.pone.0175916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426822	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900070
J	Katsura, T; Kawamori, D; Aida, E; Matsuoka, T; Shimomura, I				Katsura, Takashi; Kawamori, Dan; Aida, Eri; Matsuoka, Taka-aki; Shimomura, Iichiro			Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells	PLOS ONE			English	Article							PANCREATIC ALPHA-CELLS; HIGH GLUCOSE-CONCENTRATIONS; BETA-CELL; GENE-TRANSCRIPTION; DIABETES-MELLITUS; MAP KINASES; IN-VIVO; RECEPTOR; RELEASE; INHIBITION	The significance of glucagon in the pathophysiology of diabetes mellitus is widely recognized, but the mechanisms underlying dysregulated glucagon secretion are still unclear. Here, we explored the molecular mechanisms of glucagon dysregulation, using an in vitro model. Hamster-derived glucagon-secreting InR1G cells were exposed to high glucose (25 mM) levels for 12 h before analyzing glucagon secretion and the activity of components involved in insulin signaling. High-glucose treatment induced increased glucagon secretion in InR1G cells, which represents a hallmark of diabetes mellitus. This treatment reduced the phosphorylation of Akt, indicating the deterioration of insulin signaling. Simultaneously, oxidative stress and JNK activity were shown to be increased. The inhibition of JNK signaling resulted in the amelioration of high-glucose level-induced glucagon secretion. Abnormally elevated glucagon secretion in diabetes can be reproduced by high-glucose treatment of InR1G cells, and the involvement of high glucose-oxidative stress-JNK-insulin signaling pathway axis has been demonstrated. These data elucidate, at least partly, the previously unclear mechanism of abnormal glucagon secretion, providing insights into a potential novel approach to diabetes treatment, targeting glucagon.	[Katsura, Takashi; Kawamori, Dan; Aida, Eri; Matsuoka, Taka-aki; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan	Osaka University	Kawamori, D (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan.	kawamorid@endmet.med.osaka-u.ac.jp			JSPS KAKENHI of the Ministry of Education, Culture, Sports, Science & Technology of Japan [26461336]; Kowa Life Science Foundation; Banyu Life Science Foundation Internationa; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Diabetes Foundation	JSPS KAKENHI of the Ministry of Education, Culture, Sports, Science & Technology of Japan; Kowa Life Science Foundation; Banyu Life Science Foundation Internationa; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Diabetes Foundation	The research is partially supported by JSPS KAKENHI (grant number 26461336) of the Ministry of Education, Culture, Sports, Science & Technology of Japan, and research grants from Kowa Life Science Foundation, Banyu Life Science Foundation International, Suzuken Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Japan Diabetes Foundation (to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Akiyama M, 2013, DIABETES, V62, P2439, DOI 10.2337/db12-1747; Albrechtsen NJW, 2014, DIABETOLOGIA, V57, P1919, DOI 10.1007/s00125-014-3283-z; ASPLIN CM, 1981, J CLIN INVEST, V68, P314, DOI 10.1172/JCI110251; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; BLOOM SR, 1978, J PHYSIOL-LONDON, V280, P9, DOI 10.1113/jphysiol.1978.sp012369; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; Dumonteil E, 1999, ENDOCRINOLOGY, V140, P4644, DOI 10.1210/en.140.10.4644; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; GERICH JE, 1975, J CLIN ENDOCR METAB, V41, P1178, DOI 10.1210/jcem-41-6-1178; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; GERICH JE, 1974, DIABETES, V23, P876, DOI 10.2337/diab.23.11.876; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hare KJ, 2010, DIABETES, V59, P1765, DOI 10.2337/db09-1414; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; KATSURA M, 1993, DIABETES RES CLIN PR, V20, P93, DOI 10.1016/0168-8227(93)90002-M; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawamori D, 2011, DIABETES OBES METAB, V13, P21, DOI 10.1111/j.1463-1326.2011.01442.x; Kawamori D, 2010, ADV EXP MED BIOL, V654, P421, DOI 10.1007/978-90-481-3271-3_18; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; McGirr R, 2005, ENDOCRINOLOGY, V146, P4514, DOI 10.1210/en.2005-0402; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; PATEL YC, 1982, SCIENCE, V217, P1155, DOI 10.1126/science.6126003; PHILIPPE J, 1989, J CLIN INVEST, V84, P672, DOI 10.1172/JCI114214; Raeymaekers L, 2000, MOL BIOTECHNOL, V15, P115, DOI 10.1385/MB:15:2:115; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SHICHIRI M, 1979, DIABETES, V28, P272, DOI 10.2337/diabetes.28.4.272; UNGER RH, 1977, ANNU REV MED, V28, P119, DOI 10.1146/annurev.me.28.020177.001003; Vasu S, 2015, EXP CELL RES, V336, P100, DOI 10.1016/j.yexcr.2015.05.022; WEIR GC, 1976, DIABETES, V25, P275, DOI 10.2337/diabetes.25.4.275; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176271	10.1371/journal.pone.0176271	http://dx.doi.org/10.1371/journal.pone.0176271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426798	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900125
J	Lau, HK; Wu, ER; Chen, MK; Hsieh, MJ; Yang, SF; Wang, LY; Chou, YE				Lau, Hon-Kit; Wu, Edie-Rosmin; Chen, Mu-Kuan; Hsieh, Ming-Ju; Yang, Shun-Fa; Wang, Lyu-Yao; Chou, Ying-Erh			Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility	PLOS ONE			English	Article							CCN FAMILY; LUNG-CANCER; POLYMORPHISMS; WISP1; EXPRESSION; ASSOCIATION; CONSUMPTION; TAIWAN; OSTEOARTHRITIS; METASTASIS	Background Oral squamous cell carcinoma (OSCC), which is the most common head and neck cancer, accounts for 1%-2% of all human malignancies and is characterized by poor prognosis and reduced survival rates. WNT1-inducible signaling pathway protein 1 (WISP1), a cysteine-rich protein belonging to the Cyr61, CTGF, Nov (CCN) family of matricellular proteins, has many developmental functions and may be involved in carcinogenesis. This study investigated WISP1 single-nucleotide polymorphisms (SNPs) to elucidate OSCC susceptibility and clinicopathologic characteristics. Methodology/Principal findings Real-time polymerase chain reaction was used to analyze 6 SNPs of WISP1 in 900 OSCC patients and 1200 cancer-free controls. The results showed that WISP1 rs2929970 polymorphism carriers with at least one G allele were susceptible to OSCC. Moreover, compared with smokers, non-smoker patients with higher frequencies of WISP1 rs2929970 (AG + GG) variants had a late stage (stages III and IV) and a large tumor size. In addition, OSCC patients who were betel quid chewers and carried WISP1 rs16893344 (CT + TT) variants had a low risk of lymph node metastasis. Conclusion Our results demonstrate that a joint effect of WISP1 rs2929970 with smoking as well as WISP1 rs16893344 with betel nut chewing causally contributes to the occurrence of OSCC. WISP1 polymorphism may serve as a marker or a therapeutic target in OSCC.	[Lau, Hon-Kit; Chen, Mu-Kuan; Hsieh, Ming-Ju; Yang, Shun-Fa; Wang, Lyu-Yao] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lau, Hon-Kit] Asia Univ Hosp, Dept Anaesthesiol, Taichung, Taiwan; [Wu, Edie-Rosmin] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Gen Surg, Taichung, Taiwan; [Chen, Mu-Kuan; Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Hsieh, Ming-Ju] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Yang, Shun-Fa; Chou, Ying-Erh] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Chung Shan Medical University; Tungs' Taichung MetroHarbor Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chou, YE (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Chou, YE (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	intointo814@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital Taiwan [CSH-2017E -001-Y2]	Chung Shan Medical University Hospital Taiwan	This study was supported by CSH-2017E -001-Y2 from Chung Shan Medical University Hospital Taiwan, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti S, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0483-4; Chen JJ, 2015, J COASTAL RES, P1, DOI 10.2112/SI73-001.1; Chen J, 2014, INT J MOL SCI, V15, P21011, DOI 10.3390/ijms151121011; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cheng HL, 2016, ONCOTARGET, V7, P69384, DOI 10.18632/oncotarget.12082; Chou CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171583; Chuang JY, 2015, ONCOTARGET, V6, P4239, DOI 10.18632/oncotarget.2978; Chuang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078022; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Clausen MJAM, 2016, GENE CHROMOSOME CANC, V55, P45, DOI 10.1002/gcc.22310; Fernandez-Torres J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0678-z; Frank B, 2010, CARCINOGENESIS, V31, P1381, DOI 10.1093/carcin/bgq082; Gurbuz I, 2015, INT J BIOCHEM CELL B, V62, P142, DOI 10.1016/j.biocel.2015.03.007; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Ho HY, 2016, J PINEAL RES, V61, P479, DOI 10.1111/jpi.12365; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kim SY, 2011, ANN SURG ONCOL, V18, P2310, DOI 10.1245/s10434-011-1614-6; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Mercer KE, 2014, CANCER PREV RES, V7, P675, DOI 10.1158/1940-6207.CAPR-13-0444-T; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nagai Y, 2011, ANTICANCER RES, V31, P991; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Rogers SN, 2009, ORAL ONCOL, V45, P201, DOI 10.1016/j.oraloncology.2008.05.008; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Su CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002092; Su SC, 2017, THERANOSTICS, V7, P1088, DOI 10.7150/thno.18551; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Tao J, 2016, ONCOTARGET; Urano T, 2007, J BONE MINER METAB, V25, P253, DOI 10.1007/s00774-007-0757-9; Wang SH, 2013, GENET MOL RES, V12, P1829, DOI 10.4238/2013.January.4.1; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu J., 2016, ONCOTARGET; Yamada Y, 2009, HYPERTENS RES, V32, P325, DOI 10.1038/hr.2009.23; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z; Zhang HF, 2015, ONCOTARGET, V6, P6218, DOI 10.18632/oncotarget.3358	40	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176246	10.1371/journal.pone.0176246	http://dx.doi.org/10.1371/journal.pone.0176246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426731	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900121
J	Masuda, T; Song, W; Nakanishi, H; Lei, W; Noor, AM; Arai, F				Masuda, Taisuke; Song, Woneui; Nakanishi, Hayao; Lei, Wu; Noor, Anas Mohd; Arai, Fumihito			Rare cell isolation and recovery on open-channel microfluidic chip	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; CANCER-PATIENTS; BREAST-CANCER; GENOMIC ANALYSIS; FLOW-CYTOMETRY; CAPTURE; BLOOD; DEVICE	The ability to accurately detect and analyze rare cells in a cell population is critical not only for the study of disease progression but also for next flow cytometry systems in clinical application. Here, we report the development of a prototype device, the 'Rare cell sorter', for isolating and recovering single rare cells from whole blood samples. On this device, we utilized an open-channel microfluidic chip for rare cell isolation. And the advantage of open-channel allows us to recover the isolated rare cell directly from the chip. We set the circulating tumor cell (CTC) as a target cell. For the clinical experiment, CTCs were isolated from blood samples collected from patients with metastatic breast cancer and healthy volunteers. There was a significant difference in the number of CTCs between the patients with metastatic breast cancer and healthy volunteers. To evaluate the damage to cells during isolation and recovery, we performed an RNA integrity assay using RNA extracted from CTCs recovered from the chip and found that our process for single CTC isolation and recovery is mild enough for gene analysis of CTCs.	[Masuda, Taisuke; Song, Woneui; Lei, Wu; Noor, Anas Mohd; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi, Japan; [Nakanishi, Hayao] Aichi Hosp, Aichi Canc Ctr, Lab Pathol & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Aichi Cancer Center	Masuda, T (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi, Japan.	masuda@mech.nagoya-u.ac.jp		Masuda, Taisuke/0000-0002-7853-9511	Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan	Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan	This work was supported in part by the Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan (http://www.astf-khajp/project/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TM, 2014, INT J CANCER, V134, P2523, DOI 10.1002/ijc.28516; Born P, 2011, LANGMUIR, V27, P8621, DOI 10.1021/la2006138; Cantor CR, 2000, TRENDS BIOTECHNOL, V18, P6, DOI 10.1016/S0167-7799(99)01394-3; Cheng IF, 2007, BIOMICROFLUIDICS, V1, DOI 10.1063/1.2723669; COHEN J, 2001, J HUMAN DEV, V2, P239; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Glinskii AB, 2003, CANCER RES, V63, P4239; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; Gratama JW, 2000, J IMMUNOL METHODS, V239, P13, DOI 10.1016/S0022-1759(00)00154-X; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Huang T, 2014, BIOSENS BIOELECTRON, V51, P213, DOI 10.1016/j.bios.2013.07.044; Inglis DW, 2004, APPL PHYS LETT, V85, P5093, DOI 10.1063/1.1823015; Ji HM, 2008, BIOMED MICRODEVICES, V10, P251, DOI 10.1007/s10544-007-9131-x; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mocellin S, 2006, TRENDS MOL MED, V12, P130, DOI 10.1016/j.molmed.2006.01.006; Mocellin S, 2004, INT J CANCER, V111, P741, DOI 10.1002/ijc.20347; Mohamed H, 2007, J CHROMATOGR A, V1162, P187, DOI 10.1016/j.chroma.2007.06.025; Mueller O., 2004, AGIL APPL NOTE, V2011, P1, DOI DOI 10.1186/1471-2199-7-3; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nakanishi H, 2003, CANCER SCI, V94, P112, DOI 10.1111/j.1349-7006.2003.tb01361.x; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Pinedo Rivera T, 2008, J VAC SCI TECHNOL B, V26, P2513, DOI 10.1116/1.3021396; Pratt ED, 2011, CHEM ENG SCI, V66, P1508, DOI 10.1016/j.ces.2010.09.012; Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/NMETH.3404, 10.1038/nmeth.3404]; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Tarhan MO, 2013, ASIAN PAC J CANCER P, V14, P1725, DOI 10.7314/APJCP.2013.14.3.1725; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Witzig TE, 2002, CLIN CANCER RES, V8, P1085; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064	37	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174937	10.1371/journal.pone.0174937	http://dx.doi.org/10.1371/journal.pone.0174937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426707	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900015
J	Steppeler, C; Sodring, M; Egelandsdal, B; Kirkhus, B; Oostindjer, M; Alvseike, O; Gangsei, LE; Hovland, EM; Pierre, F; Paulsen, JE				Steppeler, Christina; Sodring, Marianne; Egelandsdal, Bjorg; Kirkhus, Bente; Oostindjer, Marije; Alvseike, Ole; Gangsei, Lars Erik; Hovland, Ellen-Margrethe; Pierre, Fabrice; Paulsen, Jan Erik			Effects of dietary beef, pork, chicken and salmon on intestinal carcinogenesis in A/J Min/ plus mice	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLORECTAL-CANCER RISK; MUCIN-DEPLETED FOCI; RED MEAT INTAKE; ARACHIDONIC-ACID; FISH CONSUMPTION; FATTY-ACIDS; SIALIC-ACID; HEME IRON; RAT COLON	The International Agency for Research on Cancer has classified red meat as "probably carcinogenic to humans" (Group 2A). In mechanistic studies exploring the link between intake of red meat and CRC, heme iron, the pigment of red meat, is proposed to play a central role as a catalyzer of luminal lipid peroxidation and cytotoxicity. In the present work, the novel A/J Min/+ mouse was used to investigate the effects of dietary beef, pork, chicken, or salmon (40% muscle food (dry weight) and 60% powder diet) on Apc-driven intestinal carcinogenesis, from week 3-13 of age. Muscle food diets did not differentially affect carcinogenesis in the colon (flat ACF and tumors). In the small intestine, salmon intake resulted in a lower tumor size and load than did meat from terrestrial animals (beef, pork or chicken), while no differences were observed between the effects of white meat (chicken) and red meat (pork and beef). Additional results indicated that intestinal carcinogenesis was not related to dietary n-6 polyunsaturated fatty acids, intestinal formation of lipid peroxidation products (thiobarbituric acid reactive substances, TBARS), or cytotoxic effects of fecal water on Apc(-/+) cells. Notably, the amount of heme reaching the colon appeared to be relatively low in this study. The greatest tumor load was induced by the reference diet RM1, underlining the importance of the basic diets in experimental CRC. The present study in A/J Min/+ mice does not support the hypothesis of a role of red meat in intestinal carcinogenesis.	[Steppeler, Christina; Sodring, Marianne; Paulsen, Jan Erik] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Egelandsdal, Bjorg; Oostindjer, Marije] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Kirkhus, Bente] Norwegian Inst Food Fisheries & Aquaculture Res, Nofima, As, Norway; [Alvseike, Ole; Gangsei, Lars Erik; Hovland, Ellen-Margrethe] Animalia Norwegian Meat & Poultry Res Ctr, Oslo, Norway; [Pierre, Fabrice] Univ Toulouse, INRA UMR Toxalim 1331, Res Ctr Food Toxicol, Toulouse, France	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Nofima; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Steppeler, C (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	christina.steppeler@nmbu.no		Sodring, Marianne/0000-0003-0236-8549	Norwegian Agriculture Agency; Animalia-Norwegian Meat and Poultry Research Center; National Levy on Meat and Egg; French National Institute for Agricultural Research (INRA); Ministry of Education and Research	Norwegian Agriculture Agency; Animalia-Norwegian Meat and Poultry Research Center; National Levy on Meat and Egg; French National Institute for Agricultural Research (INRA); Ministry of Education and Research	CS was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). MS was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/4 is jointly reimbursed by the Norwegian Meat Industry). BG was financed by the Ministry of Education and Research (100%). BK was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). MO was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). OA, LEG and EMH were financed by Animalia-Norwegian Meat and Poultry Research Center (100%), mainly financed by the National Levy on Meat and Egg. FP was financed by the French National Institute for Agricultural Research (INRA) (100%). JEP were financed by the Ministry of Education and Research (100%). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajioka RS, 2007, BLOOD CELL MOL DIS, V39, P199, DOI 10.1016/j.bcmd.2007.03.007; Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Anderson GJ, 2005, BIOMETALS, V18, P339, DOI 10.1007/s10534-005-3708-8; Bastide NM, 2015, CANCER RES, V75, P870, DOI 10.1158/0008-5472.CAN-14-2554; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Cao C, 2014, J NUTR, V144, P1710, DOI 10.3945/jn.114.197939; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen GC, 2015, CANCER CAUSE CONTROL, V26, P133, DOI 10.1007/s10552-014-0492-1; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Forest V, 2003, CELL IMMUNOL, V223, P70, DOI 10.1016/S0008-8749(03)00149-7; Geelen A, 2007, AM J EPIDEMIOL, V166, P1116, DOI 10.1093/aje/kwm197; Gueraud F, 2015, FREE RADICAL BIO MED, V83, P192, DOI 10.1016/j.freeradbiomed.2015.02.023; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; Irigaray P, 2010, CARCINOGENESIS, V31, P135, DOI 10.1093/carcin/bgp252; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Mollersen L, 2004, ANTICANCER RES, V24, P2595; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Myhre JB, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29555; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paulsen JE, 1997, CARCINOGENESIS, V18, P1905, DOI 10.1093/carcin/18.10.1905; Petrik MBH, 2000, J NUTR, V130, P1153, DOI 10.1093/jn/130.5.1153; Pierre F, 2004, J NUTR, V134, P2711, DOI 10.1093/jn/134.10.2711; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pierre F, 2008, BRIT J NUTR, V99, P1000, DOI 10.1017/S0007114507843558; Pierre FHF, 2010, NUTR CANCER, V62, P567, DOI 10.1080/01635580903532408; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Santarelli RL, 2013, INT J CANCER, V133, P2533, DOI 10.1002/ijc.28286; Sesink ALA, 2001, CARCINOGENESIS, V22, P1653, DOI 10.1093/carcin/22.10.1653; Sodring M, 2016, ANTICANCER RES, V36, P2745; Sodring M, 2016, INT J CANCER, V138, P1936, DOI 10.1002/ijc.29928; Sodring M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122880; Song MY, 2014, INT J CANCER, V135, P2413, DOI 10.1002/ijc.28878; Sorland GH, 2004, MEAT SCI, V66, P543, DOI 10.1016/S0309-1740(03)00157-8; Steppeler C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2874-0; Steppeler C, 2016, J AGR FOOD CHEM, V64, P487, DOI 10.1021/acs.jafc.5b04201; Svendsen C, 2012, LAB ANIM-UK, V46, P207, DOI 10.1258/la.2012.011055; VANDENBERG JWO, 1988, CLIN CHEM, V34, P2125; WCRF/ AICR, 2007, FOOD NUTR PHYS ACT P; WCRF/AICR, 2011, CONT UPD PROJ REP FO; Whelan J, 2004, J NUTR, V134, p3421S, DOI 10.1093/jn/134.12.3421S; Winter J, 2014, MOL NUTR FOOD RES, V58, P550, DOI 10.1002/mnfr.201300430; Wu SJ, 2012, AM J MED, V125, P551, DOI 10.1016/j.amjmed.2012.01.022	53	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176001	10.1371/journal.pone.0176001	http://dx.doi.org/10.1371/journal.pone.0176001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426718	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900083
J	Zhao, WQ; Zhao, X; Zhou, T; Wu, DH; Tang, BJ; Wei, H				Zhao, Wenqian; Zhao, Xiang; Zhou, Tao; Wu, Donghai; Tang, Bijian; Wei, Hong			Climatic factors driving vegetation declines in the 2005 and 2010 Amazon droughts	PLOS ONE			English	Article							CANOPY STRUCTURE; FOREST; VARIABILITY; DYNAMICS; MODIS; WATER; NDVI; SOIL; SEASONALITY; PHENOLOGY	Along with global climate change, the occurrence of extreme droughts in recent years has had a serious impact on the Amazon region. Current studies on the driving factors of the 2005 and 2010 Amazon droughts has focused on the influence of precipitation, whereas the impacts of temperature and radiation have received less attention. This study aims to explore the climate-driven factors of Amazonian vegetation decline during the extreme droughts using vegetation index, precipitation, temperature and radiation datasets. First, time-lag effects of Amazonian vegetation responses to precipitation, radiation and temperature were analyzed. Then, a multiple linear regression model was established to estimate the contributions of climatic factors to vegetation greenness, from which the dominant climate- driving factors were determined. Finally, the climate-driven factors of Amazonian vegetation greenness decline during the 2005 and 2010 extreme droughts were explored. The results showed that (i) in the Amazon vegetation greenness responded to precipitation, radiation and temperature, with apparent time lags for most averaging interval periods associated with vegetation index responses of 0-4, 0-9 and 0-6 months, respectively; (ii) on average, the three climatic factors without time lags explained 27.28 +/- 21.73% (mean +/- 1 SD) of vegetation index variation in the Amazon basin, and this value increased by 12.22% and reached 39.50 +/- 27.85% when time lags were considered; (iii) vegetation greenness in this region in non-drought years was primarily affected by precipitation and shortwave radiation, and these two factors altogether accounted for 93.47% of the total explanation; and (iv) in the common epicenter of the two droughts, pixels with a significant variation in precipitation, radiation and temperature accounted for 36.68%, 40.07% and 10.40%, respectively, of all pixels showing a significant decrease in vegetation index in 2005, and 15.69%, 2.01% and 45.25% in 2010, respectively. Overall, vegetation greenness declines during the 2005 and 2010 extreme droughts were adversely influenced by precipitation, radiation and temperature; this study provides evidence of the influence of multiple climatic factors on vegetation during the 2005 and 2010 Amazon droughts.	[Zhao, Wenqian; Zhao, Xiang; Zhou, Tao] Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China; [Zhao, Wenqian; Zhao, Xiang; Tang, Bijian; Wei, Hong] Beijing Normal Univ, Fac Geog Sci, Coll Remote Sensing Sci & Engn, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Zhao, Wenqian; Zhao, Xiang] JCGCS, Beijing, Peoples R China; [Zhao, Wenqian] Shaanxi Jinkong Compass Informat Serv CO LTD, Xian, Peoples R China; [Zhao, Xiang] Beijing Engn Res Ctr Global Land Remote Sensing, Beijing, Peoples R China; [Zhou, Tao] Beijing Normal Univ, Minist Educ, Environm Change & Nat Disaster, Beijing, Peoples R China; [Wu, Donghai] Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Peking University	Zhao, X (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Normal Univ, Fac Geog Sci, Coll Remote Sensing Sci & Engn, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Zhao, X (corresponding author), JCGCS, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Engn Res Ctr Global Land Remote Sensing, Beijing, Peoples R China.	zhaoxiang@bnu.edu.cn	Wu, Donghai/L-9819-2019; Wu, Donghai/ADP-9152-2022	Wu, Donghai/0000-0002-4638-3743; Wu, Donghai/0000-0002-4638-3743	National Key Research and Development Program of China [2016YFA0600103]; State Key Laboratory of Earth Surface Processes and Resource Ecology	National Key Research and Development Program of China; State Key Laboratory of Earth Surface Processes and Resource Ecology	This study was supported by the National Key Research and Development Program of China (NO. 2016YFA0600103) and Project Supported by State Key Laboratory of Earth Surface Processes and Resource Ecology.; This study was supported by the National Key Research and Development Program of China (NO. 2016YFA0600103) and the Project Supported by State Key Laboratory of Earth Surface Processes and Resource Ecology. All authors want to thank the anonymous referees for their valuable suggestions and comments.	Anderson LO, 2010, NEW PHYTOL, V187, P733, DOI 10.1111/j.1469-8137.2010.03355.x; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Chen T, 2014, REMOTE SENS ENVIRON, V140, P330, DOI 10.1016/j.rse.2013.08.022; Cook KH, 2008, J CLIMATE, V21, P542, DOI 10.1175/2007JCLI1838.1; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; da Rocha HR, 2004, ECOL APPL, V14, pS22; de Jong R, 2013, GLOBAL CHANGE BIOL, V19, P1953, DOI 10.1111/gcb.12193; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fensholt R, 2009, REMOTE SENS ENVIRON, V113, P1886, DOI 10.1016/j.rse.2009.04.004; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gloor M, 2015, GLOBAL BIOGEOCHEM CY, V29, P1384, DOI 10.1002/2014GB005080; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Kitoh A, 2011, J GEOPHYS RES ATMOSP, V116; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lyapustin A, 2014, ATMOS MEAS TECH, V7, P4353, DOI 10.5194/amt-7-4353-2014; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Melaas EK, 2013, REMOTE SENS ENVIRON, V132, P176, DOI 10.1016/j.rse.2013.01.011; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Oliveira RS, 2005, OECOLOGIA, V145, P354, DOI 10.1007/s00442-005-0108-2; Oliveira RS, 2005, FUNCT ECOL, V19, P574, DOI 10.1111/j.1365-2435.2005.01003.x; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Rammig A., 2014, BIOGEOSCIENCES DISCU, V11, P2537, DOI [10.5194/bgd-11-2537-2014, DOI 10.5194/BGD-11-2537-2014]; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001818; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Soudani K, 2012, REMOTE SENS ENVIRON, V123, P234, DOI 10.1016/j.rse.2012.03.012; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; Wu DH, 2015, GLOBAL CHANGE BIOL, V21, P3520, DOI 10.1111/gcb.12945; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Xu L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048049	47	26	27	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175379	10.1371/journal.pone.0175379	http://dx.doi.org/10.1371/journal.pone.0175379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426691	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900028
J	Roy, A; Bernier, RA; Wang, JL; Benson, M; French, JJ; Good, DC; Hillary, FG				Roy, Arnab; Bernier, Rachel A.; Wang, Jianli; Benson, Monica; French, Jerry J., Jr.; Good, David C.; Hillary, Frank G.			The evolution of cost-efficiency in neural networks during recovery from traumatic brain injury	PLOS ONE			English	Article							DEFAULT MODE NETWORK; AMYLOID-BETA; FUNCTIONAL CONNECTIVITY; COMPONENT ANALYSIS; HIPPOCAMPAL; MEMORY; FMRI; SIGNAL; AXONS; ACCUMULATION	A somewhat perplexing finding in the systems neuroscience has been the observation that physical injury to neural systems may result in enhanced functional connectivity (i.e., hyperconnectivity) relative to the typical network response. The consequences of local or global enhancement of functional connectivity remain uncertain and this is particularly true for the overall metabolic cost of the network. We examine the hyperconnectivity hypothesis in a sample of 14 individuals with TBI with data collected at approximately 3, 6, and 12 months following moderate and severe TBI. As anticipated, individuals with TBI showed increased network strength and cost early after injury, but by one-year post injury hyperconnectivity was more circumscribed to frontal DMN and temporal-parietal attentional control regions. Cost in these subregions was a significant predictor of cognitive performance. Cost-efficiency analysis in the Power 264 data parcellation suggested that at 6 months post injury the network requires higher cost connections to achieve high efficiency as compared to the network 12 months post injury. These results demonstrate that networks self-organize to re-establish connectivity while balancing cost-efficiency trade-offs.	[Roy, Arnab; Bernier, Rachel A.; Benson, Monica; French, Jerry J., Jr.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Wang, Jianli] Hershey Med Ctr, Dept Radiol, Hershey, PA USA; [Good, David C.; Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Hillary, Frank G.] Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.; Hillary, FG (corresponding author), Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA.	fhillary@psu.edu	wang, jian/GVS-0711-2022; Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186	New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania; National Center for Advancing Translational Sciences; NIHUL through Penn State University's Clinical Translational Science Institute [Tr000127]; Social Life and Engineering Sciences Imaging Center; Hershey Medical Center and the Social Sciences Research Institute at the Pennsylvania State University, University Park [PA -16801]; NIHUL through the Clinical Translational Science Institute [Tr000127]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127, UL1TR002014] Funding Source: NIH RePORTER	New Jersey Commission for Brain Injury Research; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIHUL through Penn State University's Clinical Translational Science Institute; Social Life and Engineering Sciences Imaging Center; Hershey Medical Center and the Social Sciences Research Institute at the Pennsylvania State University, University Park; NIHUL through the Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The research was also supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127, through Penn State University's Clinical Translational Science Institute. Work was supported by the Social Life and Engineering Sciences Imaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Center for Advancing Translational Sciences, NIHUL Tr000127 through the Clinical Translational Science Institute, Hershey Medical Center and the Social Sciences Research Institute at the Pennsylvania State University, University Park, PA -16801.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aerts H, 2016, BRAIN; Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Alexander-Bloch A. F., 2012, CEREB CORTEX; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bernal-Casas D, 2013, NEUROIMAGE, V82, P555, DOI 10.1016/j.neuroimage.2013.05.120; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Hahn A, 2014, BRAIN CONNECT, V20, P1; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Horvat S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002512; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Marchitelli R, 2016, HUM BRAIN MAPP, V37, P2114, DOI 10.1002/hbm.23157; Mazaika P.K., 2009, HUM BRAIN MAPP, V47, P77309; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Myers N, 2014, BRAIN, V137, P2052, DOI 10.1093/brain/awu103; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Venkatesan UM, 2014, J NEUROTRAUM, V13, P1; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379	71	39	39	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0170541	10.1371/journal.pone.0170541	http://dx.doi.org/10.1371/journal.pone.0170541			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422992	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600003
J	Srisutham, S; Saralamba, N; Malleret, B; Renia, L; Dondorp, AM; Imwong, M				Srisutham, Suttipat; Saralamba, Naowarat; Malleret, Benoit; Renia, Laurent; Dondorp, Arjen M.; Imwong, Mallika			Four human Plasmodium species quantification using droplet digital PCR	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; HUMAN MALARIA PARASITES; DNA COPY NUMBER; QUANTITATIVE PCR; ACCURATE QUANTIFICATION; FALCIPARUM-MALARIA; REACTION ASSAY; IN-VIVO; INFECTIONS	Droplet digital polymerase chain reaction (ddPCR) is a partial PCR based on water-oil emulsion droplet technology. It is a highly sensitive method for detecting and delineating minor alleles from complex backgrounds and provides absolute quantification of DNA targets. The ddPCR technology has been applied for detection of many pathogens. Here the sensitive assay utilizing ddPCR for detection and quantification of Plasmodium species was investigated. The assay was developed for two levels of detection, genus specific for all Plasmodium species and for specific Plasmodium species detection. The ddPCR assay was developed based on primers and probes specific to the Plasmodium genus 18S rRNA gene. Using ddPCR for ultra-sensitive P. falciparum assessment, the lower level of detection from concentrated DNA obtained from a high volume (1 mL) blood sample was 11 parasites/mL. For species identification, in particular for samples with mixed infections, a duplex reaction was developed for detection and quantification P. falciparum/ P. vivax and P. malariae/ P. ovale. Amplification of each Plasmodium species in the duplex reaction showed equal sensitivity to singleplex single species detection. The duplex ddPCR assay had higher sensitivity to identify minor species in 32 subpatent parasitaemia samples from Cambodia, and performed better than real-time PCR. The ddPCR assay shows high sensitivity to assess very low parasitaemia of all human Plasmodium species. This provides a useful research tool for studying the role of the asymptomatic parasite reservoir for transmission in regions aiming for malaria elimination.	[Srisutham, Suttipat; Saralamba, Naowarat; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Saralamba, Naowarat; Dondorp, Arjen M.; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Malleret, Benoit; Renia, Laurent] ASTAR, Lab Pathogen Immunobiol, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore; [Malleret, Benoit] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Dondorp, Arjen M.] Univ Oxford, Churchill Hosp, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Oxford	Imwong, M (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.; Imwong, M (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	noi@tropmedres.ac; mallika.imw@mahidol.ac.th	Malleret, Benoit/E-9159-2011; Imwong, Mallika/ABE-6493-2020; Renia, Laurent/E-2117-2011	Malleret, Benoit/0000-0001-9658-7528; Renia, Laurent/0000-0003-0349-1557	Mahidol University, Thailand; Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme - Wellcome Trust of Great Britain; Royal Golden Jubilee Ph.D. Programme; Thailand Research Fund [PHD/0232/2553]	Mahidol University, Thailand; Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme - Wellcome Trust of Great Britain; Royal Golden Jubilee Ph.D. Programme; Thailand Research Fund(Thailand Research Fund (TRF))	This study was financed in part by Mahidol University, Thailand, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. SS is supported by the Royal Golden Jubilee Ph.D. Programme, the Thailand Research Fund (PHD/0232/2553).; We would like to thank Dr. Kemavit Bhangananda for his help. This study was financed in part by Mahidol University, Thailand, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. SS is supported by the Royal Golden Jubilee Ph.D. Programme, the Thailand Research Fund (PHD/0232/2553).	Berry A, 2008, PARASITE, V15, P484, DOI 10.1051/parasite/2008153484; Beshir KB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-312; Bossuyt PM, 2015, CLIN CHEM, V61, P1446, DOI 10.1373/clinchem.2015.246280; Campino S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020251; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang JT, 2015, CLIN CHEM, V61, P290, DOI 10.1373/clinchem.2014.230227; Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339; Imoukhuede EB, 2007, AM J TROP MED HYG, V76, P486, DOI 10.4269/ajtmh.2007.76.486; Imwong M, 2016, J INFECT DIS, V213, P1322, DOI 10.1093/infdis/jiv596; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Koepfli C, 2016, SCI REP-UK, V6, DOI 10.1038/srep39183; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Mangolini A, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0037-0; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; Mu D, 2015, BIOTECHNOL LETT, V37, P2063, DOI 10.1007/s10529-015-1890-5; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Peto TJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1284-8; Phommasone K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1336-0; Phuong M, 2014, J CLIN MICROBIOL, V52, P1068, DOI 10.1128/JCM.03477-13; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Program for Appropriate Technology in Health (PATH), 2005, RBP EIA COLL PROC HA; Roberts CH, 2013, J CLIN MICROBIOL, V51, P2195, DOI 10.1128/JCM.00622-13; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Schachter J, 2013, EXPERT REV MOL DIAGN, V13, P789, DOI 10.1586/14737159.2013.847792; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Sedlak RH, 2014, J CLIN MICROBIOL, V52, P2844, DOI 10.1128/JCM.00803-14; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Sillence KA, 2015, CLIN CHEM, V61, P1399, DOI 10.1373/clinchem.2015.239137; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Takeshita T, 2015, TRANSL RES, V166, P540, DOI 10.1016/j.trsl.2015.09.003; Te SH, 2015, APPL ENVIRON MICROB, V81, P5203, DOI 10.1128/AEM.00931-15; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang P, 2015, CLIN CANC RES; Wang P, 2015, BIOSENS BIOELECTRON, V74, P836, DOI 10.1016/j.bios.2015.07.048; Wilson M, 2015, EXP PARASITOL, V149, P24, DOI 10.1016/j.exppara.2014.12.003; Zhao S, 2015, J VET DIAGN INVEST	43	36	39	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175771	10.1371/journal.pone.0175771	http://dx.doi.org/10.1371/journal.pone.0175771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423028	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600051
J	Hola, D; Benesova, M; Fischer, L; Haisel, D; Hnilicka, F; Hnilickova, H; Jedelsky, PL; Kocova, M; Prochazkova, D; Rothova, O; Tumova, L; Wilhelmova, N				Hola, Dana; Benesova, Monika; Fischer, Lukas; Haisel, Daniel; Hnilicka, Frantisek; Hnilickova, Helena; Jedelsky, Petr L.; Kocova, Marie; Prochazkova, Dagmar; Rothova, Olga; Tumova, Lenka; Wilhelmova, Nada			The disadvantages of being a hybrid during drought: A combined analysis of plant morphology, physiology and leaf proteome in maize	PLOS ONE			English	Article							ZEA-MAYS L.; ANTIOXIDATIVE DEFENSE SYSTEM; WATER-USE EFFICIENCY; PHOTOSYSTEM-II; STRESS TOLERANCE; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; WHEAT CULTIVARS; DIFFERENTIAL RESPONSES; ASCORBATE PEROXIDASE	A comparative analysis of various parameters that characterize plant morphology, growth, water status, photosynthesis, cell damage, and antioxidative and osmoprotective systems together with an iTRAQ analysis of the leaf proteome was performed in two inbred lines of maize (Zea mays L.) differing in drought susceptibility and their reciprocal F1 hybrids. The aim of this study was to dissect the parent-hybrid relationships to better understand the mechanisms of the heterotic effect and its potential association with the stress response. The results clearly showed that the four examined genotypes have completely different strategies for coping with limited water availability and that the inherent properties of the F1 hybrids, i.e. positive heterosis in morphological parameters (or, more generally, a larger plant body) becomes a distinct disadvantage when the water supply is limited. However, although a greater loss of photosynthetic efficiency was an inherent disadvantage, the precise causes and consequences of the original predisposition towards faster growth and biomass accumulation differed even between reciprocal hybrids. Both maternal and paternal parents could be imitated by their progeny in some aspects of the drought response (e.g., the absence of general protein down-regulation, changes in the levels of some carbon fixation or other photosynthetic proteins). Nevertheless, other features (e.g., dehydrin or light-harvesting protein contents, reduced chloroplast proteosynthesis) were quite unique to a particular hybrid. Our study also confirmed that the strategy for leaving stomata open even when the water supply is limited (coupled to a smaller body size and some other physiological properties), observed in one of our inbred lines, is associated with drought-resistance not only during mild drought (as we showed previously) but also during more severe drought conditions.	[Hola, Dana; Benesova, Monika; Kocova, Marie; Rothova, Olga; Tumova, Lenka] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Fischer, Lukas] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Haisel, Daniel; Prochazkova, Dagmar; Wilhelmova, Nada] Acad Sci Czech Republ, Inst Expt Bot, Prague, Czech Republic; [Hnilicka, Frantisek; Hnilickova, Helena] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Bot & Plant Physiol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague; Charles University Prague	Hola, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	danahola@natur.cuni.cz	Fischer, Lukáš/M-6516-2017; Hnilička, František/E-3932-2018; Haisel, Daniel/H-2406-2014; Holá, Dana/H-9344-2016; Hniličková, Helena/E-2314-2018; Kočová, Marie/S-7733-2017; Rothova, Olga/S-7688-2017	Fischer, Lukáš/0000-0003-1852-0461; Hnilička, František/0000-0002-3223-9062; Haisel, Daniel/0000-0002-4170-5790; Holá, Dana/0000-0002-2080-8774; Hniličková, Helena/0000-0003-0057-8139; Kočová, Marie/0000-0001-7354-7937; Rothova, Olga/0000-0002-2811-6967; Jedelsky, Petr/0000-0003-3813-2343	Ministry of Education, Youth and Sports, Czech Republic [NPUI - L01417]; Czech Science Foundation [521/07/0470]; Charles University [SVV-2016-260314, SVV-2017-260426]	Ministry of Education, Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University	The study was financially supported by Ministry of Education, Youth and Sports, Czech Republic, http://www.msmt.cz/ (project no. NPUI - L01417; LF), Czech Science Foundation, https://gacr.cz (project no. 521/07/0470; DHo) and Charles University, http://www.cuni.cz (project no. SVV-2016-260314 and project no. SVV-2017-260426; LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar O, 2001, ACTA PHYSIOL PLANT, V23, P351, DOI 10.1007/s11738-001-0043-8; Adalatzadeh-Aghdam S., 2014, International Journal of Biosciences (IJB), V4, P70; Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; [Anonymous], 2012, DROUGHTS NEW RES; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; Baranwal VK, 2012, J EXP BOT, V63, P6309, DOI 10.1093/jxb/ers291; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; BARTOS J, 1975, PHOTOSYNTHETICA, V9, P395; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bedon F, 2012, PLANT CELL ENVIRON, V35, P790, DOI 10.1111/j.1365-3040.2011.02452.x; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; BLUM A, 1990, ANN BOT-LONDON, V65, P149, DOI 10.1093/oxfordjournals.aob.a087919; Blum A, 2013, J EXP BOT, V64, P4829, DOI 10.1093/jxb/ert289; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillejo M. A., 2008, OPEN PROTEOMICS J, V1, P59, DOI DOI 10.2174/1875039700801010059; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Chen XJ, 2012, FIELD CROP RES, V137, P195, DOI 10.1016/j.fcr.2012.09.008; Chen XY, 2011, J PLANT PHYSIOL, V168, P1828, DOI 10.1016/j.jplph.2011.05.019; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cheng LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0871-8; Cheng ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125302; Chmielewska K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01108; Chugh V, 2011, INDIAN J BIOCHEM BIO, V48, P47; D'Arcy-Lameta A, 2006, ANN BOT-LONDON, V97, P133, DOI 10.1093/aob/mcj010; Dahal D, 2016, J PROTEOME RES, V15, P2445, DOI 10.1021/acs.jproteome.5b01120; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Ereful NC, 2016, RICE, V9, DOI 10.1186/s12284-016-0123-4; Faghani E, 2015, J PROTEOMICS, V114, P1, DOI 10.1016/j.jprot.2014.10.018; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Ford KL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00044; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fu DH, 2015, J APPL GENET, V56, P1, DOI 10.1007/s13353-014-0231-z; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Fujimoto R, 2012, P NATL ACAD SCI USA, V109, P7109, DOI 10.1073/pnas.1204464109; Gallie D.R., 2013, SCIENTIFICA, DOI DOI 10.1155/2013/795964; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; Gontero B, 2012, BIOCHEM SOC T, V40, P995, DOI 10.1042/BST20120097; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Groszmann M, 2015, P NATL ACAD SCI USA, V112, pE6397, DOI 10.1073/pnas.1519926112; Guo BJ, 2014, PROTEOMICS, V14, P1071, DOI 10.1002/pmic.201300147; Guo BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065867; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Han PA, 2016, ACTA BIOCH BIOPH SIN, V48, P161, DOI 10.1093/abbs/gmv126; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hao PC, 2015, PROTEOMICS, V15, P1544, DOI 10.1002/pmic.201400179; Haussmann BIG, 1998, PLANT BREEDING, V117, P223, DOI 10.1111/j.1439-0523.1998.tb01930.x; He GM, 2013, J GENET GENOMICS, V40, P205, DOI 10.1016/j.jgg.2013.03.011; Hoecker N, 2008, PROTEOMICS, V8, P3882, DOI 10.1002/pmic.200800023; Hola D, 2003, PHOTOSYNTHETICA, V41, P429, DOI 10.1023/B:PHOT.0000015468.67892.9c; Hola D, 2007, J PLANT PHYSIOL, V164, P868, DOI 10.1016/j.jplph.2006.04.016; Huseynova IM, 2012, BBA-BIOENERGETICS, V1817, P1516, DOI 10.1016/j.bbabio.2012.02.037; Hyskova V, 2016, BIOCH ANAL BIOCH, V5, P1; Hyskova VD, 2014, J PLANT PHYSIOL, V171, P19, DOI 10.1016/j.jplph.2013.10.017; Jamaux I, 1997, NEW PHYTOL, V137, P117, DOI 10.1046/j.1469-8137.1997.00817.x; Jangpromma Nisachon, 2010, American Journal of Biochemistry and Biotechnology, V6, P89, DOI 10.3844/ajbbsp.2010.89.102; Jeanneau M, 2002, BIOCHIMIE, V84, P1127, DOI 10.1016/S0300-9084(02)00024-X; Jedmowski Christoph, 2014, Int J Proteomics, V2014, P395905, DOI 10.1155/2014/395905; Ji KX, 2012, J PLANT PHYSIOL, V169, P336, DOI 10.1016/j.jplph.2011.10.010; Jin XN, 2014, ACTA PHYSIOL PLANT, V36, P355, DOI 10.1007/s11738-013-1417-4; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Katam R, 2016, J PROTEOMICS, V143, P209, DOI 10.1016/j.jprot.2016.05.031; Khueychai S, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1826-7; Ko DK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006197; Kocova M, 2009, BIOL PLANTARUM, V53, P475, DOI 10.1007/s10535-009-0088-x; Kolarovic L, 2009, PLANT GROWTH REGUL, V59, P21, DOI 10.1007/s10725-009-9384-x; Kolenc Z, 2016, PLANT PHYSIOL BIOCH, V105, P67, DOI 10.1016/j.plaphy.2016.03.026; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kranner I., 2012, MYCORRHIZA MANUAL, V1st ed., P227; Kutik J, 2004, PHOTOSYNTHETICA, V42, P447, DOI 10.1023/B:PHOT.0000046165.15048.a4; Li Xiong, 2016, Plant Diversity, V38, P101, DOI 10.1016/j.pld.2016.03.002; Liu Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01011; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Araus JL, 2010, NEW PHYTOL, V187, P392, DOI 10.1111/j.1469-8137.2010.03276.x; Makumbi D, 2011, EUPHYTICA, V180, P143, DOI 10.1007/s10681-010-0334-5; Marcon C, 2013, J PROTEOMICS, V93, P295, DOI 10.1016/j.jprot.2013.04.015; Marcon C, 2010, J PROTEOME RES, V9, P6511, DOI 10.1021/pr100718d; Marri L, 2014, BIOCHIMIE, V97, P228, DOI 10.1016/j.biochi.2013.10.018; Masuda R, 1988, REP NATL FOOD RES I, V52, P30; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Mohammadi PP, 2012, AMINO ACIDS, V43, P2137, DOI 10.1007/s00726-012-1299-6; Mohayeji M, 2014, J PROTEOMICS, V99, P101, DOI 10.1016/j.jprot.2014.01.028; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Ort DR, 2015, P NATL ACAD SCI USA, V112, P8529, DOI 10.1073/pnas.1424031112; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; PREMACHANDRA GS, 1990, SOIL SCI PLANT NUTR, V36, P653, DOI 10.1080/00380768.1990.10416802; Prochazkova D, 2008, CELL BIOCHEM FUNCT, V26, P582, DOI 10.1002/cbf.1481; Qin J, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-12; Riccardi F, 2004, PLANT PHYSIOL BIOCH, V42, P1003, DOI 10.1016/j.plaphy.2004.09.009; RIED JL, 1993, PLANT PHYSIOL, V102, P125, DOI 10.1104/pp.102.1.125; Rohde P, 2004, PLANT J, V38, P790, DOI 10.1111/j.1365-313X.2004.02080.x; Roose JL, 2016, PLANTA, V243, P889, DOI 10.1007/s00425-015-2462-6; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Ryan AC, 2016, PLANT SCI, V251, P101, DOI 10.1016/j.plantsci.2016.05.018; Sairam RK, 2000, J AGRON CROP SCI, V184, P55, DOI 10.1046/j.1439-037x.2000.00358.x; Secenji M, 2010, PLANT CELL REP, V29, P37, DOI 10.1007/s00299-009-0796-x; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Shi HT, 2014, PLANT PHYSIOL BIOCH, V82, P218, DOI 10.1016/j.plaphy.2014.06.006; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; Singh S, 2012, J AGRON CROP SCI, V198, P185, DOI 10.1111/j.1439-037X.2011.00497.x; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Song S, 2012, PLANT BREEDING, V131, P276; Song X, 2009, THEOR APPL GENET, V118, P213, DOI 10.1007/s00122-008-0890-4; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Thomas DJ, 1998, PLANT PHYSIOL, V116, P1593, DOI 10.1104/pp.116.4.1593; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vikram P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14799; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; von Korff M, 2009, PLANT J, V59, P14, DOI 10.1111/j.1365-313X.2009.03848.x; Wang NB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1657-3; Wang ZZ, 2014, J PROTEOME RES, V13, P3987, DOI 10.1021/pr500337j; WHITE CN, 1995, PLANT PHYSIOL, V108, P1337, DOI 10.1104/pp.108.3.1337; Xing JW, 2016, BBA-PROTEINS PROTEOM, V1864, P908, DOI 10.1016/j.bbapap.2015.12.007; Xu CP, 2010, CROP SCI, V50, P2543, DOI 10.2135/cropsci2010.03.0152; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Yadav OP, 2000, EUPHYTICA, V112, P285, DOI 10.1023/A:1003965025727; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zadraznik T, 2013, J PROTEOMICS, V78, P254, DOI 10.1016/j.jprot.2012.09.021; Zhang CY, 2012, J PLANT PHYSIOL, V169, P387, DOI 10.1016/j.jplph.2011.11.016; Zhao PS, 2011, ACTA PHYSIOL PLANT, V33, P1063, DOI 10.1007/s11738-010-0678-4; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zhou SS, 2015, PLANT SCI, V236, P44, DOI 10.1016/j.plantsci.2015.03.017	141	20	20	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176121	10.1371/journal.pone.0176121	http://dx.doi.org/10.1371/journal.pone.0176121			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419152	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875200078
J	Cara-Fuentes, G; Segarra, A; Silva-Sanchez, C; Wang, HM; Lanaspa, MA; Johnson, RJ; Garin, EH				Cara-Fuentes, Gabriel; Segarra, Alfons; Silva-Sanchez, Cecilia; Wang, Heiman; Lanaspa, Miguel A.; Johnson, Richard J.; Garin, Eduardo H.			Angiopoietin-like-4 and minimal change disease	PLOS ONE			English	Article							PODOCYTE-SECRETED ANGIOPOIETIN-LIKE-4; NEPHROTIC SYNDROME	Background Minimal Change Disease (MCD) is the most common type of nephrotic syndrome in children. Angiopoietin-like-4 (Angplt4) has been proposed as mediator of proteinuria in MCD. The aim of this study was to evaluate the role of Angptl4 as a biomarker in MCD. Methods Patients with biopsy-proven primary MCD, focal segmental glomerulosclerosis, membranous nephropathy (60, 52 and 52 respectively) and 18 control subjects had urinary and serum Angptl4 measured by Elisa. Frozen kidney tissue sections were stained for Angptl4. Results Angptl4 was not identified in glomeruli of MCD patients in relapse. Urinary Angptl4 levels were elevated in MCD in relapse as well as in patients with massive proteinuria due to other glomerular diseases. Conclusion Neither serum nor urine Angptl4 appear to be good biomarkers in MCD. Elevated urinary Angptl4 n glomerular disease appears to reflect the degree of proteinuria rather than any specific disease.	[Cara-Fuentes, Gabriel; Wang, Heiman; Garin, Eduardo H.] Univ Florida, Dept Pediat, Div Pediat Nephrol, Gainesville, FL 32610 USA; [Segarra, Alfons] Hosp Valle De Hebron, Div Nephrol, Barcelona, Spain; [Silva-Sanchez, Cecilia] Univ Florida, Prote & Mass Spectrometry, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Lanaspa, Miguel A.; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO USA	State University System of Florida; University of Florida; Hospital Universitari Vall d'Hebron; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Garin, EH (corresponding author), Univ Florida, Dept Pediat, Div Pediat Nephrol, Gainesville, FL 32610 USA.	garineh@peds.ufl.edu	Lanaspa, Miguel/AAO-4971-2020; Segarra, Alfons/R-9077-2019	Segarra, Alfons/0000-0002-4349-2856; Cara-Fuentes, Gabriel/0000-0002-4164-3251	NIH [R01DK080764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH R01DK080764 to E.H.G. and R.J.J.	[Anonymous], 1981, KIDNEY INT, V20, P765; Araya CE, 2006, PEDIATR NEPHROL, V21, P603, DOI 10.1007/s00467-006-0026-5; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; D'Agati VD, 2016, AM J PHYSIOL-RENAL, V310, pF810, DOI 10.1152/ajprenal.00037.2016; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Li J., 2015, J CHEMOTHER, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131820; Ma J, 2015, ENDOCRINE, V49, P373, DOI 10.1007/s12020-014-0486-5; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; SHALHOUB RJ, 1974, LANCET, V2, P556; Tjeerdema N, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000034; van der Kolk BW, 2016, J CLIN ENDOCR METAB; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; 1981, J PEDIAT, V98, P561	20	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176198	10.1371/journal.pone.0176198	http://dx.doi.org/10.1371/journal.pone.0176198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441404	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800033
J	He, T; Mortensen, X; Wang, P; Tian, N				He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning			The effects of immune protein CD3 zeta development and degeneration of retinal neurons after optic nerve injury	PLOS ONE			English	Article							CHOLINERGIC AMACRINE CELLS; CLASS-I MOLECULES; DEVELOPING RAT RETINA; RABBIT RETINA; SYNAPTIC PLASTICITY; GANGLION-CELLS; ZETA-CHAIN; EXPRESSION; GLAUCOMA; MOUSE	Major histocompatibility complex (MHC) class I molecules and their receptors play fundamental roles in neuronal death during diseases. T-cell receptors (TCR) function as MHCI receptor on T-cells and both MHCI and a key component of TCR, CD3 zeta, are expressed by mouse retinal ganglion cells (RGCs) and displaced amacrine cells. Mutation of these molecules compromises the development of RGCs. We investigated whether CD3 zeta regulates the development and degeneration of amacrine cells after RGC death. Surprisingly, mutation of CD3 zeta not only impairs the proper development of amacrine cells expressing CD3 zeta but also those not expressing CD3 zeta. In contrast to effects of MHCI and its receptor, PirB, on other neurons, mutation of CD3 zeta has no effect on RGC death and starburst amacrine cells degeneration after optic nerve crush. Thus, unlike MHCI and PirB, CD3 zeta regulates the development of RGCs and amacrine cells but not their degeneration after optic nerve crush.	[He, Tao] Wuhan Univ, Eye Ctr Remin Hosp, Wuhan, Hubei, Peoples R China; [He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Dept Ophthalmol, Salt Lake City, UT USA; [He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Visual Sci John Moran Eye Ctr, Salt Lake City, UT USA; [Tian, Ning] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA	Wuhan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Tian, N (corresponding author), Univ Utah, Sch Med, Dept Ophthalmol, Salt Lake City, UT USA.; Tian, N (corresponding author), Univ Utah, Sch Med, Visual Sci John Moran Eye Ctr, Salt Lake City, UT USA.; Tian, N (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA.	ning.tian@hsc.utah.edu		Mortensen, Xavier/0000-0001-6253-2051	NIH [R01 EY012345, P30 EY014800]; VA [1 I01 BX002412]; Research to Prevent Blindness (RPB); Funds from the John Moran Eye Center; China Scholarship Council (CSC) [201406275047]; NATIONAL EYE INSTITUTE [R01EY012345, P30EY014800] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002412] Funding Source: NIH RePORTER; VA [5I01BX002412-02] Funding Source: Federal RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Funds from the John Moran Eye Center; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs)	This work was supported by NIH grants R01 EY012345 and P30 EY014800, VA grant 1 I01 BX002412, Research to Prevent Blindness (RPB), Funds from the John Moran Eye Center and China Scholarship Council (CSC) 201406275047.	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bach M, 2013, CELL TISSUE RES, V353, P287, DOI 10.1007/s00441-013-1598-6; Baldridge WH, 1996, J NEUROSCI, V16, P5060; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Bosco A, 1999, J NEUROSCI RES, V57, P759, DOI 10.1002/(SICI)1097-4547(19990915)57:6<759::AID-JNR1>3.3.CO;2-P; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; BRANDON C, 1987, BRAIN RES, V401, P385, DOI 10.1016/0006-8993(87)91426-0; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cellerino A, 1997, J COMP NEUROL, V386, P149; CohenCory S, 1996, DEV BIOL, V179, P102, DOI 10.1006/dbio.1996.0244; Dijk F, 2004, BRAIN RES, V1026, P205, DOI 10.1016/j.brainres.2004.08.014; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1987, BRAIN RES, V413, P398, DOI 10.1016/0006-8993(87)91037-7; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; HAYDEN SA, 1980, SCIENCE, V210, P435, DOI 10.1126/science.7433984; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Huang Z, 2005, J CELL BIOL, V170, P527, DOI 10.1083/jcb.200505075; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joseph MS, 2011, J NEUROSCI RES, V89, P365, DOI 10.1002/jnr.22557; Kao YH, 2006, VISUAL NEUROSCI, V23, P931, DOI 10.1017/S0952523806230293; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Levai O, 2003, HISTOCHEM CELL BIOL, V120, P483, DOI 10.1007/s00418-003-0594-4; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lowell B. B., 2006, DEV PHENOTYPE CHAT I; May CA, 2004, J GLAUCOMA, V13, P496, DOI 10.1097/01.ijg.0000137435.83307.fd; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ortin-Martinez A, 2015, EXP EYE RES, V132, P17, DOI 10.1016/j.exer.2015.01.006; OSBORNE NN, 1985, BRAIN RES, V343, P230, DOI 10.1016/0006-8993(85)90739-5; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Rickman DW, 1996, P NATL ACAD SCI USA, V93, P12564, DOI 10.1073/pnas.93.22.12564; RICKMAN DW, 1995, VISUAL NEUROSCI, V12, P215, DOI 10.1017/S0952523800007896; Sabha M, 2008, SYNAPSE, V62, P137, DOI 10.1002/syn.20475; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; TANAKA T, 1989, J IMMUNOL, V142, P2791; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VICKERS JC, 1995, BRAIN RES, V680, P23, DOI 10.1016/0006-8993(95)00211-8; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Washburn LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018439; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; WU DK, 1993, DEV BRAIN RES, V74, P253, DOI 10.1016/0165-3806(93)90011-X; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379; Xu HP, 2014, J COMP NEUROL, V522, P3403, DOI 10.1002/cne.23609; Xu HP, 2010, NEURON, V65, P503, DOI 10.1016/j.neuron.2010.01.035; Yamasaki EN, 1997, EUR J NEUROSCI, V9, P1885, DOI 10.1111/j.1460-9568.1997.tb00755.x; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	68	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175522	10.1371/journal.pone.0175522	http://dx.doi.org/10.1371/journal.pone.0175522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441398	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800005
J	Knipe, DW; Chang, SS; Dawson, A; Eddleston, M; Konradsen, F; Metcalfe, C; Gunnell, D				Knipe, Duleeka W.; Chang, Shu-Sen; Dawson, Andrew; Eddleston, Michael; Konradsen, Flemming; Metcalfe, Chris; Gunnell, David			Suicide prevention through means restriction: Impact of the 2008-2011 pesticide restrictions on suicide in Sri Lanka (vol 12, e0172893, 2017)	PLOS ONE			English	Correction													Chang, Shu-Sen/B-3518-2012; Gunnell, David/ABE-6653-2020; Chang, Shu-Sen/AAH-6733-2021	Chang, Shu-Sen/0000-0001-5012-1132; Gunnell, David/0000-0002-0829-6470; Chang, Shu-Sen/0000-0001-5012-1132; Knipe, Duleeka/0000-0002-1040-7635	Economic and Social Research Council (UK) postdoctoral fellow [ES/P009735/1]	Economic and Social Research Council (UK) postdoctoral fellow	DK is an Economic and Social Research Council (UK) postdoctoral fellow (ES/P009735/1).	Knipe DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172893	1	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176750	10.1371/journal.pone.0176750	http://dx.doi.org/10.1371/journal.pone.0176750			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441424	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800070
J	Lilja, KC; Zhang, N; Magli, A; Gunduz, V; Bowman, CJ; Arpke, RW; Darabi, R; Kyba, M; Perlingeiro, R; Dynlacht, BD				Lilja, Karin C.; Zhang, Nan; Magli, Alessandro; Gunduz, Volkan; Bowman, Christopher J.; Arpke, Robert W.; Darabi, Radbod; Kyba, Michael; Perlingeiro, Rita; Dynlacht, Brian D.			Pax7 remodels the chromatin landscape in skeletal muscle stem cells	PLOS ONE			English	Article							H3K4 MONOMETHYLATION; SATELLITE CELLS; PROGENITORS; MYOGENESIS; CULTURE; GENES; REGENERATION; RECRUITMENT; DERIVATION; MLL3/MLL4	Pluripotent stem cells (PSC) hold great promise for the treatment of human skeletal muscle diseases. However, it remains challenging to convert PSC to skeletal muscle cells, and the mechanisms by which the master regulatory transcription factor, Pax7, promotes muscle stem (satellite) cell identity are not yet understood. We have taken advantage of PSC-derived skeletal muscle precursor cells (iPax7), wherein the induced expression of Pax7 robustly initiates the muscle program and enables the in vitro generation of precursors that seed the satellite cell compartment upon transplantation. Remarkably, we found that chromatin accessibility in myogenic precursors pre-figures subsequent activation of myogenic differentiation genes. We also found that Pax7 binding is generally restricted to euchromatic regions and excluded from H3K27 tri-methylated regions in muscle cells, suggesting that recruitment of this factor is circumscribed by chromatin state. Further, we show that Pax7 binding induces dramatic, localized remodeling of chromatin characterized by the acquisition of histone marks associated with enhancer activity and induction of chromatin accessibility in both muscle precursors and lineage-committed myoblasts. Conversely, removal of Pax7 leads to rapid reversal of these features on a subset of enhancers. Interestingly, another cluster of Pax7 binding sites is associated with a durably accessible and remodeled chromatin state after removal of Pax7, and persistent enhancer accessibility is associated with subsequent, proximal binding by the muscle regulatory factors, MyoD1 and myogenin. Our studies provide new insights into the epigenetic landscape of skeletal muscle stem cells and precursors and the role of Pax7 in satellite cell specification.	[Lilja, Karin C.; Zhang, Nan; Gunduz, Volkan; Bowman, Christopher J.; Dynlacht, Brian D.] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10003 USA; [Magli, Alessandro; Perlingeiro, Rita] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Arpke, Robert W.; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Darabi, Radbod] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	New York University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10003 USA.	Brian.Dynlacht@nyumc.org	Magli, Alessandro/K-5961-2019	Magli, Alessandro/0000-0003-3874-2838; Lilja, Karin/0000-0001-5925-1240; Kyba, Michael/0000-0002-5579-7534; Arpke, Robert W/0000-0002-0876-078X; Zhang, Nan/0000-0002-4134-7911	NIH [5R01GM067132, 1R21AR068786-01A1, R01AR055299, P30CA016087]; Regenerative Medicine Minnesota [MRM 2015 PDSCH 003]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068786, R01AR055299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067132, T32GM007308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Medicine Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (Grants: 5R01GM067132 and 1R21AR068786-01A1 to BDD, R01AR055299 to RP, and P30CA016087 [https://www.nih.gov] to New York University School of Medicine's Genome Technology Center). AM was supported by a Regenerative Medicine Minnesota grant (MRM 2015 PDSCH 003; [http://www.regenmedmn.org]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Dynlacht laboratory for helpful advice and encouragement. We thank R. Raviram, members of the Skok laboratory, I. Dolgalev, B. Aranda-Orgilles, Eric Wang, and members of the Aifantis laboratory for advice on ATAC-seq library preparation and RNA-seq analysis. We thank A. Heguy, P. Zappile, P. Meyn, and the NYU GTC (supported by NIH grant P30CA016087) for assistance with high-throughput sequencing. We thank the Developmental Studies Hybridoma Bank for supplying key antibodies. This work was supported by grants from the NIH to B.D.D. (5R01GM067132 and 1R21AR068786-01A1) and R. P. (R01AR055299) A.M. was supported by a Regenerative Medicine Minnesota grant (MRM 2015 PDSCH 003).	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Himeda CL, 2013, DEV BIOL, V383, P7, DOI 10.1016/j.ydbio.2013.09.006; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Magli A, 2013, STEM CELLS, V31, P59, DOI 10.1002/stem.1254; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Micsinai M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks048; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000897; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023	39	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176190	10.1371/journal.pone.0176190	http://dx.doi.org/10.1371/journal.pone.0176190			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441415	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800030
J	Zhou, WH; Song, FF; Wu, QJ; Liu, R; Wang, LL; Liu, CC; Peng, Y; Mao, SQ; Feng, J; Chen, CS				Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Wang, Lulu; Liu, Cuicui; Peng, You; Mao, Shuqin; Feng, Jing; Chen, Ceshi			miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR; PROTEASOME DEGRADATION; PROLIFERATION; SURVIVAL; MICRORNA-217; CARCINOMA; EXPRESSION; KINASE	Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 and KLF5's downstream target gene FGF-BP and Cyclin D1 in TNBC cell lines HCC1806 and HCC1937. Consequently, miR-217 suppresses TNBC cell growth, migration, and invasion. MiR-217 suppresses TNBC, at least partially, through down-regulating the KLF5 expression. These results suggest that the miR-217-KLF5 axis might serve as a potential target for treatment of TNBC.	[Zhou, Wenhui; Feng, Jing] Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China; [Zhou, Wenhui; Wang, Lulu; Liu, Cuicui; Peng, You; Feng, Jing] Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China; [Zhou, Wenhui; Wang, Lulu; Liu, Cuicui; Peng, You; Feng, Jing] Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China; [Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China; [Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China; [Song, Fangfang; Wu, Qiuju] Jinzhou Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China; [Song, Fangfang; Wu, Qiuju] Jinzhou Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China; [Mao, Shuqin] Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Hubei Province, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Jinzhou Medical University; Jinzhou Medical University; Hubei University of Medicine	Feng, J (corresponding author), Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China.; Chen, CS (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China.; Chen, CS (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China.	fengjing8801530@163.com; chenc@mail.kiz.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010303]; National Key Basic Research Program of China [2013CB910900]; National Nature Science Foundation of China [81325016, U1602221, 81672624]; Shanghai health system outstanding academic leader training program [XBR2013114]; Yunnan Applied Basic Research Key Projects [2015FA027]; Shanghai Municipal Commission of Health and Family Planning [20164Y0274]; Shanghai Fengxian District Health and Family Planning Commission Project [20131414]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai health system outstanding academic leader training program; Yunnan Applied Basic Research Key Projects; Shanghai Municipal Commission of Health and Family Planning; Shanghai Fengxian District Health and Family Planning Commission Project	This study was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010303 to Chen, C), the National Key Basic Research Program of China (2013CB910900 to Chen, C), National Nature Science Foundation of China (81325016 and U1602221 to Chen, C and 81672624 to Feng, J), Shanghai health system outstanding academic leader training program (XBR2013114 to Feng, J), Yunnan Applied Basic Research Key Projects (2015FA027 to Liu, R), Shanghai Municipal Commission of Health and Family Planning (20164Y0274 to Liu, C) and Shanghai Fengxian District Health and Family Planning Commission Project (20131414 to Peng, Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bialkowska A, 2010, PROBE REPORTS NIH MO; Bialkowska A, 2010, CELL BIOL INT; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen DL, 2015, ONCOTARGET, V6, P10868, DOI 10.18632/oncotarget.3451; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; de Sabando AR, 2016, MOL CANCER THER, V15, P72, DOI 10.1158/1535-7163.MCT-15-0600; de Yebenes VG, 2014, BLOOD, V124, P229, DOI 10.1182/blood-2013-12-543611; Deng SC, 2014, CANCER LETT, V355, P184, DOI 10.1016/j.canlet.2014.08.007; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Gao Y, 2014, INT J MOL SCI, V15, P15173, DOI 10.3390/ijms150915173; Gao Y, 2015, CURR TOP MED CHEM, V15, P699, DOI 10.2174/1568026615666150302105052; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Li J., 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1038/0NC.2016.90; Liu R, 2016, THERANOSTICS, V6, P533, DOI 10.7150/thno.14315; Liu R, 2013, VITAM HORM, V93, P213, DOI 10.1016/B978-0-12-416673-8.00002-2; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nishioka C, 2014, CANCER SCI, V105, P297, DOI 10.1111/cas.12339; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Su J, 2014, MOL CELL BIOCHEM, V392, P289, DOI 10.1007/s11010-014-2039-x; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wang CY, 2015, ONCOTARGET, V6, P17685, DOI 10.18632/oncotarget.3779; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wei RX, 2015, BIOMED PHARMACOTHER, V72, P158, DOI 10.1016/j.biopha.2015.04.012; Xi S, 2015, ONCOGENE, V34, P5548, DOI 10.1038/onc.2015.10; Xia HJ, 2013, J BIOL CHEM, V288, P26731, DOI 10.1074/jbc.M113.483958; Xue Y, 2013, CANCER GENET-NY, V206, P217, DOI 10.1016/j.cancergen.2013.05.020; Zhang Q, 2015, J CANCER, V6, P184, DOI 10.7150/jca.10822; Zhang SH, 2017, BIOMED PHARMACOTHER, V85, P541, DOI 10.1016/j.biopha.2016.11.062; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhu YG, 2016, AM J TRANSL RES, V8, P1482	45	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176395	10.1371/journal.pone.0176395	http://dx.doi.org/10.1371/journal.pone.0176395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437471	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600046
J	Lombardi, G; Di Gregori, V; Girometti, N; Tadolini, M; Bisognin, F; Dal Monte, P				Lombardi, Giulia; Di Gregori, Valentina; Girometti, Nicolo; Tadolini, Marina; Bisognin, Francesco; Dal Monte, Paola			Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; GENEXPERT MTB/RIF; ACCURACY; ASSAY; EXTRAPULMONARY	Background Diagnosis of pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB) in smear-negative patients can be difficult. We assessed retrospectively the performance of Xpert MTB/RIF system (Xpert, Cepheid) in diagnosing smear-negative tuberculosis (TB), which represents the most common form of TB in a low incidence setting. Methods Performance of Xpert was compared to acid-fast microscopic examination using Ziehl-Neelsen (ZN) stain in patients with culture-confirmed TB. Results 386 Mycobacterium tuberculosis (MTB) culture-positive samples were detected out of 5170 specimens tested with smear microscopy, Xpert and culture: 323 were both culture- and Xpert-positive, and 63 culture-positive only. Of these, 234 (60.6%) were smear-negative. In addition Xpert detected 40 probable TB cases, based on clinical findings, which were culture-negative. Compared to culture, Xpert showed an overall sensitivity of 83.7% and a specificity of 99.1%; sensitivity was higher for respiratory samples (86.5%) than for non-respiratory samples (76.8%). Xpert sensitivity for smear-negative culture-confirmed TB was 73.1% and was not influenced by TB localization. As sensitivity of microscopy alone was poor (39.4%), Xpert improved both diagnosis of pulmonary TB (Delta = 36.5%) and extra-pulmonary TB (Delta = 63.4%). Conclusions Xpert MTB/RIF is a sensitive method for rapid diagnosis of TB compared to the conventional ZN staining. Xpert can serve as a sensitive and time-saving diagnostic method for microbiological diagnosis of smear-negative TB in countries with a low TB prevalence.	[Lombardi, Giulia; Bisognin, Francesco; Dal Monte, Paola] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Microbiol, S Orsola Malpighi Univ Hosp, Bologna, Italy; [Di Gregori, Valentina] Alma Mater Studiorum Univ Bologna, Sect Hyg & Publ Hlth, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Girometti, Nicolo; Tadolini, Marina] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Unit Infect Dis, S Orsola Malpighi Univ Hosp, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Lombardi, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Microbiol, S Orsola Malpighi Univ Hosp, Bologna, Italy.	g.lombardi@unibo.it	LOMBARDI, GIULIA/HGC-4356-2022	LOMBARDI, GIULIA/0000-0001-6423-8358; Tadolini, Marina/0000-0002-1005-7532; BISOGNIN, FRANCESCO/0000-0002-3254-9239; Girometti, Nicolo'/0000-0002-2960-2748; DAL MONTE, PAOLA/0000-0003-2326-7464				[Anonymous], 2012, FUTURE MICROBIOL, V7, P1024; [Anonymous], 2011, FUTURE MICROBIOL, V6, P1067; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Borrini BM, 2013, EPIDEMIOLOGIA TUBERC; Ramirez HLB, 2014, INT J TUBERC LUNG D, V18, P435, DOI 10.5588/ijtld.13.0747; Cepheid, 2016, XPERT MTB RIF PACK I; Clinical and Laboratory Standards Institute (CLSI), 2008, LAB DET ID MYC APPR; European Centre for Disease Prevention and Control, TUB SURV MON EUR 201; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kaur R, 2016, J GLOB INFECT DIS, V8, P32, DOI 10.4103/0974-777X.176143; Le Palud P, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-137; Li Q, 2016, BIOMED ENVIRON SCI, V29, P248, DOI 10.3967/bes2016.032; Lombardi G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-340; Luetkemeyer AF, 2016, CLIN INFECT DIS, V62, P1081, DOI 10.1093/cid/ciw035; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Munoz L, 2013, DIAGN MICR INFEC DIS, V75, P325, DOI 10.1016/j.diagmicrobio.2012.11.011; Opota O, 2016, CLIN MICROBIOL INFEC, V22, P613, DOI 10.1016/j.cmi.2016.04.010; Reechaipichitkul W, 2016, SE ASIAN J TROP MED, V47, P457; Sharma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141011; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tadesse M, 2016, INT J MYCOBACT, V5, P211, DOI 10.1016/j.ijmyco.2016.03.005; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Walusimbi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-507; Wei GM, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.19; Weitzman I, 2010, CLIN MICROBIOLOGY PR, P721; World Health Organization, ANT RES GLOB REP SUR; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	34	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176186	10.1371/journal.pone.0176186	http://dx.doi.org/10.1371/journal.pone.0176186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430807	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100030
J	Ng, CH; Lee, SL; Tnah, LH; Ng, KKS; Lee, CT; Diway, B; Khoo, E				Ng, Chin Hong; Lee, Soon Leong; Tnah, Lee Hong; Ng, Kevin Kit Siong; Lee, Chai Ting; Diway, Bibian; Khoo, Eyen			Geographic origin and individual assignment of Shorea platyclados (Dipterocarpaceae) for forensic identification	PLOS ONE			English	Article							TIMBER IDENTIFICATION; GENETIC-STRUCTURE; DNA VARIATION; CHLOROPLAST; WOOD; DISPERSAL; FRAMEWORK; MARKERS; AREA; OAKS	The development of timber tracking methods based on genetic markers can provide scientific evidence to verify the origin of timber products and fulfill the growing requirement for sustainable forestry practices. In this study, the origin of an important Dark Red Meranti wood, Shorea platyclados, was studied by using the combination of seven chloroplast DNA and 15 short tandem repeats (STRs) markers. A total of 27 natural populations of S. platyclados were sampled throughout Malaysia to establish population level and individual level identification databases. A haplotype map was generated from chloroplast DNA sequencing for population identification, resulting in 29 multilocus haplotypes, based on 39 informative intraspecific variable sites. Subsequently, a DNA profiling database was developed from 15 STRs allowing for individual identification in Malaysia. Cluster analysis divided the 27 populations into two genetic clusters, corresponding to the region of Eastern and Western Malaysia. The conservativeness tests showed that the Malaysia database is conservative after removal of bias from population subdivision and sampling effects. Independent self-assignment tests correctly assigned individuals to the database in an overall 60.60-94.95% of cases for identified populations, and in 98.99-99.23% of cases for identified regions. Both the chloroplast DNA database and the STRs appear to be useful for tracking timber originating in Malaysia. Hence, this DNA-based method could serve as an effective addition tool to the existing forensic timber identification system for ensuring the sustainably management of this species into the future.	[Ng, Chin Hong; Lee, Soon Leong; Tnah, Lee Hong; Ng, Kevin Kit Siong; Lee, Chai Ting] Forest Res Inst Malaysia, Div Forestry Biotechnol, Kepong, Selangor, Malaysia; [Diway, Bibian] Sarawak Forestry Corp, Kuching, Sarawak, Malaysia; [Khoo, Eyen] Forest Res Ctr, Sandakan, Sabah, Malaysia	Institute Penyelidikan Perhutanan Malaysia; Pusat Penyelidikan Hutan	Ng, CH (corresponding author), Forest Res Inst Malaysia, Div Forestry Biotechnol, Kepong, Selangor, Malaysia.	chinhong@frim.gov.my	Hong, Ng Chin/AAL-2377-2021; LEE, Soon Leong/AGZ-1887-2022	Ng, Chin Hong/0000-0001-5860-5553; Lee, Chai Ting/0000-0002-1736-7226	Ministry of Agriculture and Agro-Based Industry Malaysia [050310SF1035]	Ministry of Agriculture and Agro-Based Industry Malaysia	This study was made possible by financial support from the Ministry of Agriculture and Agro-Based Industry Malaysia (project number 050310SF1035).	AUGSPURGER CK, 1987, ECOLOGY, V68, P27, DOI 10.2307/1938802; Ayres KL, 1999, FORENSIC SCI INT, V103, P207, DOI 10.1016/S0379-0738(99)00087-0; BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; Butler JM, 2005, FORENSIC DNA TYPING; Cabral EC, 2012, J MASS SPECTROM, V47, P1, DOI 10.1002/jms.2016; Carlquist S., 2001, COMP WOOD ANATOMY SY; Chan H. T., 1980, Malaysian Forester, V43, P132; Chua LSL, 2010, MALAYSIA PLANT RED L; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Dawnay N, 2008, FORENSIC SCI INT-GEN, V2, P47, DOI 10.1016/j.fsigen.2007.08.006; Cunha FAFD, 2016, ECOL ECON, V130, P209, DOI 10.1016/j.ecolecon.2016.07.007; Deguilloux MF, 2003, MOL ECOL, V12, P1629, DOI 10.1046/j.1365-294X.2003.01836.x; Dormontt EE, 2015, BIOL CONSERV, V191, P790, DOI 10.1016/j.biocon.2015.06.038; Dumolin-Lapegue S, 1999, EVOLUTION, V53, P1406, DOI 10.1111/j.1558-5646.1999.tb05405.x; Dutech C, 2003, EVOLUTION, V57, P2753, DOI 10.1111/j.0014-3820.2003.tb01517.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elliott C, 2001, J EUR PUBLIC POLICY, V8, P642, DOI 10.1080/13501760110064438; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferris C, 1998, HEREDITY, V80, P584, DOI 10.1046/j.1365-2540.1998.00342.x; Foreman LA, 1998, FORENSIC SCI INT, V95, P27, DOI 10.1016/S0379-0738(98)00079-6; Fry B, 2007, STABLE ISOTOPE ECOLO; FSC, 2014, OV REC TRENDS CURR S; Gan KS, 2004, COMMON COMMERCIAL TI; Gill P, 2003, FORENSIC SCI INT, V131, P184, DOI 10.1016/S0379-0738(02)00423-1; Goncalves MP, 2012, JUSTICE FORESTS IMPR; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; ITTO, 2012, TRACK SUST REV EL SE; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kissinger G, 2012, DRIVERS DEFORESTATIO; Kozak RA, 2004, FOREST PROD J, V54, P21; Lewis PO, 2001, GENETIC DATA ANAL GD; Linacre A, 2011, FORENSIC SCI INT-GEN, V5, P501, DOI 10.1016/j.fsigen.2010.10.017; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2010, SILVAE GENET, V59, P263, DOI 10.1515/sg-2010-0037; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ng CFS, 2013, INT J BIOMETEOROL, V2013, P1, DOI DOI 10.3732/APPS.1200538; Ng CH, 2009, CONSERV GENET RESOUR, V1, P317, DOI 10.1007/s12686-009-9073-0; Ng CH, 2012, J FOREST RES-JPN, V17, P479, DOI 10.1007/s10310-011-0318-x; Ng KKS, 2016, FORENSIC SCI INT-GEN, V23, P197, DOI 10.1016/j.fsigen.2016.05.002; NRC, 1996, EV FOR DNA EV COMM D; Ogden R, 2015, FORENSIC SCI INT-GEN, V18, P152, DOI 10.1016/j.fsigen.2015.02.008; Park SDE, EXCEL MICROSATELLITE; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Ramsey CB, 2008, ARCHAEOMETRY, V50, P249, DOI [10.1111/J.1475-4754.2008.00394.X, 10.1111/j.1475-4754.2008.00394.x]; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sjerps M, 2003, STAT NEERL, V57, P368, DOI 10.1111/1467-9574.00236; Speer J.H., 2010, FUNDAMENTALS TREE RI; Symington CF, 2004, FORESTERS MANUAL DIP; Tereba A, 1999, PROFILES DNA, P14; Tnah LH, 2013, J HERED, V104, P115, DOI 10.1093/jhered/ess076; Tnah LH, 2010, FOREST ECOL MANAG, V259, P1436, DOI 10.1016/j.foreco.2010.01.017; Tnah LH, 2009, FOREST ECOL MANAG, V258, P1918, DOI 10.1016/j.foreco.2009.07.029; Triggs CM, 2002, FORENSIC SCI INT, V128, P108, DOI 10.1016/S0379-0738(02)00168-8; Tsuchikawa S, 2013, APPL SPECTROSC REV, V48, P560, DOI 10.1080/05704928.2011.621079; UNODC, 2016, BEST PRACT GUID FOR; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	63	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176158	10.1371/journal.pone.0176158	http://dx.doi.org/10.1371/journal.pone.0176158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430826	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100029
J	Gnavi, G; Garzoli, L; Polil, A; Prigione, V; Burgaud, G; Varese, GC				Gnavi, Giorgio; Garzoli, Laura; Polil, Anna; Prigione, Valeria; Burgaud, Gaetan; Varese, Giovanna Cristina			The culturable mycobiota of Flabellia petiolata: First survey of marine fungi associated to a Mediterranean green alga	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MYCOSPHAERELLA-SPP.; PRIMER SETS; PENICILLIUM; SYSTEMATICS; GENERA; PEZIZOMYCOTINA; ANTIBACTERIAL; HYPOCREALES; ASCOMYCOTA	Algae-inhabiting marine fungi represent a taxonomically and ecologically interesting group of microorganisms still largely neglected, especially in temperate regions. The aim of this study was to isolate and to identify the culturable mycobiota associated with Flabellia petiolata, a green alga frequently retrieved in the Mediterranean basin. Twenty algal thalli were collected from two different sampling sites in the Mediterranean Sea (Elba Island, Italy). A polyphasic approach showed the presence of a relevant alga-associated mycobiota with 64 taxa identified. The fungal isolates belonged mainly to Ascomycota (61 taxa), while only three Basidiomycota were detected. The phylogenetic position of sterile mycelia and cryptic taxa, inferred on the basis of LSU partial region, highlighted the presence of putative new phylogenetic lineages within Dothideomycetes and Sordariomycetes. This work represents the first quali-quantitative analysis of the culturable mycobiota associated to a green alga in the Mediterranean Sea.	[Gnavi, Giorgio; Garzoli, Laura; Polil, Anna; Prigione, Valeria; Varese, Giovanna Cristina] Univ Turin, MUT, Dept Life Sci & Syst Biol, Turin, Italy; [Burgaud, Gaetan] Univ Brest, EA 3882, Lab Univ Biodiversite & Ecol Microbienne, Technopole Brest Iroise, Plouzane, France	University of Turin; Universite de Bretagne Occidentale	Varese, GC (corresponding author), Univ Turin, MUT, Dept Life Sci & Syst Biol, Turin, Italy.	cristina.varese@unito.it	Prigione, Valeria/K-6145-2019; Garzoli, Laura/AAX-8010-2020; Gnavi, Giorgio/B-8624-2014	Garzoli, Laura/0000-0003-1353-9120; Poli, Anna/0000-0002-4027-1476; Burgaud, Gaetan/0000-0001-7741-4429; Gnavi, Giorgio/0000-0003-4725-5337				Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BALLESTEROS E, 1992, BOT MAR, V35, P481, DOI 10.1515/botm.1992.35.6.481; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bovio E, 2017, SCI TOTAL ENVIRON, V576, P310, DOI 10.1016/j.scitotenv.2016.10.064; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Cannon PF, 2007, FUNGAL FAMILIES OF T; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Cicatiello P, 2016, INT J BIOL MACROMOL, V92, P1229, DOI 10.1016/j.ijbiomac.2016.08.037; Clarke K.R., 2014, CHANGE MARINE COMMUN; Crous PW, 2007, STUD MYCOL, P33, DOI 10.3114/sim.2007.58.02; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Crous PW, 2009, PERSOONIA, V23, P99, DOI 10.3767/003158509X479487; Crous PW, 2007, FUNGAL DIVERS, V26, P143; Crous PW, 2006, STUD MYCOL, P99, DOI 10.3114/sim.55.1.99; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Flewelling AJ, 2015, CURR SCI INDIA, V109, P88; GALLARDO T, 1993, BOT MAR, V36, P399, DOI 10.1515/botm.1993.36.5.399; Garzoli L, 2015, MAR ECOL-EVOL PERSP, V36, P959, DOI 10.1111/maec.12189; Genovese G, 2009, MAR DRUGS, V7, P361, DOI 10.3390/md7030361; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gnavi G, 2016, RES MICROBIOL, V167, P492, DOI 10.1016/j.resmic.2016.04.009; Gnavi G, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-508; Goncalves VN, 2013, POLAR BIOL, V36, P1823, DOI 10.1007/s00300-013-1403-8; Gouba N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106994; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; Greiner K, 2014, IMA FUNGUS, V5, P161, DOI 10.5598/imafungus.2014.05.02.01; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey JBJ, 2010, FUNGAL BIOL-UK, V114, P82, DOI 10.1016/j.mycres.2009.10.009; Holler U, 2000, MYCOL RES, V104, P1354, DOI 10.1017/S0953756200003117; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Isola D, 2016, FUNGAL DIVERS, V76, P75, DOI 10.1007/s13225-015-0342-9; Jones EBG, 2015, FUNGAL DIVERS, V73, P1, DOI 10.1007/s13225-015-0339-4; Jones EBG, 2012, MAR FRESHW BOTANY, P329; Jones EBG, 2012, MAR FRESHW BOTANY; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; LaBarre S, 2014, OUTSTANDING MARINE MOLECULES: CHEMISTRY, BIOLOGY, ANALYSIS, P1, DOI 10.1002/9783527681501; LAPEYRE B, 1993, NUCLEIC ACIDS RES, V21, P3322, DOI 10.1093/nar/21.14.3322; Liu JK, 2014, PHYTOTAXA, V181, P1; Mahapatra S, 2016, SPR SER ADV MICROELE, V52, P1, DOI 10.1007/978-81-322-2508-9_1; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Nai C, 2013, FUNGAL GENET BIOL, V56, P54, DOI 10.1016/j.fgb.2013.04.001; Nekoduka S, 2010, MYCOSCIENCE, V51, P123, DOI 10.1007/s10267-009-0021-3; NIZAMUDDIN M, 1987, NOVA HEDWIGIA, V44, P175; Nurra N, 2009, THESIS; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Overy David P, 2014, Mycology, V5, P145; Pang KL, 2010, BOT MAR, V53, P493, DOI 10.1515/BOT.2010.061; Panno L, 2014, THESIS; Panno L, 2013, NEW BIOTECHNOL, V30, P685, DOI 10.1016/j.nbt.2013.01.010; Park MS, 2014, MYCOBIOLOGY, V42, P109, DOI 10.5941/MYCO.2014.42.2.109; Park MS, 2014, ANTON LEEUW INT J G, V106, P331, DOI 10.1007/s10482-014-0205-5; Perez CA, 2009, FOREST PATHOL, V39, P349, DOI 10.1111/j.1439-0329.2009.00598.x; Perez MJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14030052; Personnic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098994; Qin XY, 2015, MAR BIOTECHNOL, V17, P99, DOI 10.1007/s10126-014-9598-4; Redou V, 2015, APPL ENVIRON MICROB, V81, P3571, DOI 10.1128/AEM.04064-14; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Rossman AY, 1999, STUD MYCOL, P1; Sakayaroj J, 2012, MAR FRESHW BOTANY, P291; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2011, PERSOONIA, V27, P119, DOI 10.3767/003158511X617435; Sonjak S, 2006, MICROB ECOL, V52, P207, DOI 10.1007/s00248-006-9086-0; Suetrong S, 2009, STUD MYCOL, P155, DOI 10.3114/sim.2009.64.09; Suryanarayanan T S, 2012, Prog Mol Subcell Biol, V53, P53, DOI 10.1007/978-3-642-23342-5_3; Suryanarayanan T.S, 2014, OCEANOGRAPHY, V2, P2; Suryanarayanan TS, 2010, BOT MAR, V53, P457, DOI 10.1515/BOT.2010.045; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang AMC, 2007, ANTON LEEUW INT J G, V91, P327, DOI 10.1007/s10482-006-9120-8; Videira SIR, 2015, PERSOONIA, V34, P50, DOI 10.3767/003158515X685670; Wang JF, 2015, PLANTA MED, V81, P160, DOI 10.1055/s-0034-1383403; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Watanabe T, 2012, MYCOSCIENCE, V53, P45, DOI 10.1007/s10267-011-0132-5; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xu LJ, 2015, MAR DRUGS, V13, P3479, DOI 10.3390/md13063479; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zuccaro A., 2005, FUNGAL COMMUNITY ITS, P533; Zuccaro A, 2008, APPL ENVIRON MICROB, V74, P931, DOI 10.1128/AEM.01158-07	81	45	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175941	10.1371/journal.pone.0175941	http://dx.doi.org/10.1371/journal.pone.0175941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426712	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900072
J	Gupta, S; Seydel, K; Miranda-Roman, MA; Feintuch, CM; Saidi, A; Kim, RS; Birbeck, GL; Taylor, T; Daily, JP				Gupta, Sanchit; Seydel, Karl; Miranda-Roman, Miguel A.; Feintuch, Catherine M.; Saidi, Alex; Kim, Ryung S.; Birbeck, Gretchen L.; Taylor, Terrie; Daily, Johanna P.			Extensive alterations of blood metabolites in pediatric cerebral malaria	PLOS ONE			English	Article							BILE-ACID; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; PARASITE; PHENYLALANINE; GLUTAMINE; EPILEPSY; OUTCOMES; ALPHA	Cerebral malaria (CM) presents as an encephalopathy and is due to infection with Plasmodium falciparum. Patients are comatose, often with fever, recurrent seizures and this condition is associated with a high mortality rate. The etiology of the coma and seizures are poorly understood. Circulating small molecules and lipids have bioactive functions and alterations in their concentrations have been implicated in seizure disorders and other forms of encephalopathy. We carried out a comprehensive analysis of blood metabolites during CM to explore a biochemical basis of this encephalopathy. A paired metabolomics analysis was performed on the plasma samples of Malawian children (n = 11) during CM and at convalescence thirty days later, to identify differentially abundant molecules associated with CM. We also report plasma molecules associated with CM mortality (n = 4) compared to survival (n = 19). Plasma metabolites were identified through ultra high performance liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry to maximize compound detection and accuracy and then compared to a library for identification. We detected a total of 432 small molecules in the plasma and 247 metabolites were significantly differentially abundant between CM and convalescence (p < 0.05, FDR < 0.10). These represented global changes across many classes of molecules including lipids, amino acids and hemoglobin metabolites. We observed significant changes in molecules that could impact neurologic function during CM; these include increased levels of kynurenate and decreased indolepropionate, glutamate, arginine and glutamine. Moreover, 1-methylimidazoleacetate, kyurenate, arachidonic acid and dimethylarginine were associated with mortality (p < 0.05, fold change > 1.2). These results highlight the broad changes in blood chemistry during CM. We have identified metabolites that may impact central nervous system physiology and disease outcomes and can be further explored for their mechanistic roles into the pathophysiology of CM.	[Gupta, Sanchit; Miranda-Roman, Miguel A.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA; [Seydel, Karl; Saidi, Alex; Taylor, Terrie] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Seydel, Karl; Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Feintuch, Catherine M.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Birbeck, Gretchen L.] Univ Rochester, Dept Neurol, Epilepsy Div, Rochester, NY USA	Yeshiva University; Albert Einstein College of Medicine; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Rochester	Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA.; Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jdaily@einstein.yu.edu		Miranda-Roman, Miguel/0000-0003-4914-848X	NIH-NIAID [1R011AI077623, 1RC1AI086224]; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA [UL1TR001073]; Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant [P60DK020541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, R01AI034969] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors received support from NIH-NIAID grants 1R011AI077623 and 1RC1AI086224 to JPD; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA Grant Number UL1TR001073 (supported SG); and Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant P60DK020541 for lipid analysis.	Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Enwonwu CO, 2000, J NEURAL TRANSM, V107, P1273, DOI 10.1007/s007020070017; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ghosh S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1256-z; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; GREENWOOD J, 1991, J CEREBR BLOOD F MET, V11, P644, DOI 10.1038/jcbfm.1991.116; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Itoe MA, 2014, CELL HOST MICROBE, V16, P778, DOI 10.1016/j.chom.2014.11.006; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Lakshmanan V, 2012, J INFECT DIS, V206, P238, DOI 10.1093/infdis/jis339; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; MAGGIORE G, 1991, J PEDIATR GASTR NUTR, V12, P21, DOI 10.1097/00005176-199101000-00005; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; MORITA T, 1978, Gastroenterologia Japonica, V13, P491; Palmela I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00080; Papetti L, 2013, BRAIN DEV-JPN, V35, P827, DOI 10.1016/j.braindev.2012.11.010; Pappa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1036-1; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Rogers AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087538; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P265; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; SPITTLER A, 1995, BLOOD, V86, P1564, DOI 10.1182/blood.V86.4.1564.bloodjournal8641564; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Waisbren SE, 2007, MOL GENET METAB, V92, P63, DOI 10.1016/j.ymgme.2007.05.006; Whitten R, 2011, HUM PATHOL, V42, P1230, DOI 10.1016/j.humpath.2010.11.019; World Health Organization, 2015, WORLD MAL REP 2015; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868	42	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175686	10.1371/journal.pone.0175686	http://dx.doi.org/10.1371/journal.pone.0175686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426698	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900039
J	Liu, CB; Liu, ZJ; Wang, J				Liu, Chuanbo; Liu, Zuojia; Wang, Jin			Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy	PLOS ONE			English	Article							PROTEIN-BINDING; INTERMEDIATE; ACCUMULATION; CONFORMATION; RESONANCE; AFFINITY; HSA	Human serum albumin (HSA) has its ability to bind drug molecules and influence their efficacies. Although anticancer leads NSC48693 and NSC290956 functioned at the same mechanism, the drug efficacies were obviously distinct. To gain insight into the distinct drug efficacy, the molecular and physiological processes of anticancer leads binding HSA have been investigated via a combined experimental and theoretical approach. The binding site, as characterized by fluorescence quenching and molecular modeling, is found to be located at site II in subdomain III A for NSC48693 with tight binding and at site FA1 in subdomain I B for NSC290956 with negatively cooperative binding, respectively. As indicated by the thermodynamic analysis, NSC48693 binds to HSA with an enthalpy driven mechanism, while NSC290956 binding with HSA is entropically driven. The further kinetic analysis indicates that the association rates appear to be similar to these two anticancer leads, however, the dissociation rate of NSC48693 is approximately 5-fold slower than that of NSC290956. For NSC48693, the pharmacodynamic efficacy is less than that of NSC290956, while its pharmacokinetic behavior is better than that of NSC290956. These parameters influence the pharmacodynamic efficacy and pharmacokinetic behavior, which will give further impacts on drug efficacy in vivo.	[Liu, Chuanbo; Liu, Zuojia; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Liu, Chuanbo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Chuanbo; Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ; Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	zjliu@ciac.ac.cn; jin.wang.1@stonybrook.edu		Liu, Zuojia/0000-0002-1770-3998	National Natural Science Foundation of China [81573448, 91430217]; Ministry of Science and Technology of China [2016YFA0203200, 2013YQ170585]; Natural Science Foundation of Jilin Province [20150101009JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Jilin Province	This study was supported by the National Natural Science Foundation of China (grant No. 81573448 and 91430217) and Ministry of Science and Technology of China (grant No. 2016YFA0203200 and 2013YQ170585). This study was partly supported by the Natural Science Foundation of Jilin Province (grant No. 20150101009JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zied OK, 2011, CHEMPHYSCHEM, V12, P270, DOI 10.1002/cphc.201000742; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Aime S, 2002, J BIOL INORG CHEM, V7, P58, DOI 10.1007/s007750100265; Ascenzi P, 2014, J MOL STRUCT, V1077, P4, DOI 10.1016/j.molstruc.2013.09.053; Berezhkovskiy LM, 2010, J PHARM SCI-US, V99, P2153, DOI 10.1002/jps.21958; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Connelly Patrick R., 1994, Current Opinion in Biotechnology, V5, P381, DOI 10.1016/0958-1669(94)90046-9; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Fabini E, 2016, J PHARMACEUT BIOMED, V122, P166, DOI 10.1016/j.jpba.2016.01.051; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fortugno C, 2014, J PHARMACEUT BIOMED, V95, P151, DOI 10.1016/j.jpba.2014.03.002; Fu L, 2014, J LUMIN, V149, P208, DOI 10.1016/j.jlumin.2014.01.023; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Li HM, 2007, SPECTROCHIM ACTA A, V68, P1263, DOI 10.1016/j.saa.2007.02.002; Liu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050367; Liu ZJ, 2012, CHEM RES CHINESE U, V28, P287; Liu ZJ, 2009, BIOPHYS J, V96, P3917, DOI 10.1016/j.bpj.2008.12.3965; Marouzi S, 2017, INT J BIOL MACROMOL, V97, P688, DOI 10.1016/j.ijbiomac.2017.01.047; Martini JWR, 2016, J MATH BIOL, V72, P1747, DOI 10.1007/s00285-015-0922-z; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Moosavi-Movahedi AA, 2005, COLLOID SURFACE B, V43, P150, DOI 10.1016/j.colsurfb.2005.04.008; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ross NT, 2007, BIOCHEM BIOPH RES CO, V362, P1073, DOI 10.1016/j.bbrc.2007.08.123; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; Schmidt S, 2010, J PHARM SCI-US, V99, P1107, DOI 10.1002/jps.21916; SEYMOUR LW, 1995, EUR J CANCER, V31A, P766, DOI 10.1016/0959-8049(94)00514-6; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Williams MA, 2013, PROTEIN LIGAND INTER, P6; Zhang HX, 2016, SPECTROCHIM ACTA A, V161, P88, DOI 10.1016/j.saa.2016.02.014; Zhao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066362; Zheng XL, 2013, CURR PHARM DESIGN, V19, P2246, DOI 10.2174/1381612811319120012	48	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176208	10.1371/journal.pone.0176208	http://dx.doi.org/10.1371/journal.pone.0176208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426740	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900118
J	Variar, G; Pant, T; Singh, A; Ravichandran, A; Swami, S; Kalyanaraman, B; Dhanasekaranl, A				Variar, Gokul; Pant, Tarun; Singh, Apoorva; Ravichandran, Abinaya; Swami, Sushant; Kalyanaraman, Balaraman; Dhanasekaranl, Anuradha			Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action	PLOS ONE			English	Article							OXIDATIVE STRESS; MULTIDRUG-RESISTANCE; CANCER; PHOSPHORYLATION; METABOLISM; APOPTOSIS; HYPOXIA; ANTIOXIDANTS; INHIBITION; MECHANISM	Vicious cycles of mutations and reactive oxygen species (ROS) generation contribute to cancer progression. The use of antioxidants to inhibit ROS generation promotes cytostasis by affecting the mutation cycle and ROS-dependent survival signaling. However, cancer cells select mutations to elevate ROS albeit maintaining mitochondrial hyperpolarization (Delta psi m), even under hypoxia. From this perspective, the use of drugs that disrupt both ROS generation and Delta psi m is a viable anticancer strategy. Hence, we studied the effects of mitochondrially targeted carboxy proxyl nitroxide (Mito-CP) and a control ten carbon TPP moiety (Dec-TPP+) in the human Burkitt lymphoma cell line (Daudi) and normal peripheral blood mononuclear cells under hypoxia and normoxia. We found preferential localization,Delta psi m and adenosine triphosphate loss, and significant cytotoxicity by Mito-CP in Daudi cells alone. Interestingly, ROS levels were decreased and maintained in hypoxic and normoxic cancer cells, respectively, by Mito-CP but not Dec-TPP+, therefore preventing any adaptive signaling. Moreover, dual effects on mitochondrial bioenergetics and ROS by Mito-CP curtailed the cancer survival via Akt inhibition, AMPK-HIF-1 alpha activation and promoted apoptosis via increased BCL2-associated X protein and poly (ADP-ribose) polymerase expression. This dual mode of action by Mito-CP provides a better explanation of the application of antioxidants with specific relevance to cancerous transformation and adaptations in the Daudi cell line.	[Variar, Gokul; Pant, Tarun; Singh, Apoorva; Ravichandran, Abinaya; Swami, Sushant; Dhanasekaranl, Anuradha] Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA	Anna University; Anna University Chennai; Medical College of Wisconsin; Medical College of Wisconsin	Dhanasekaranl, A (corresponding author), Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India.	anu.annauniversity@gmail.com	Pant, Tarun/AAJ-4261-2020	Pant, Tarun/0000-0003-2862-3923; Singh, Apoorva/0000-0003-1060-2235; Dhanasekaran, Anuradha/0000-0002-0195-9681	MHRD-CEMA [F.NO-5-3/2015-TS VII]; BUILDER program [BT/PR12153/INF/22/200/2014]	MHRD-CEMA; BUILDER program	The Research was supported by two grants to Anuradha Dhanasekaran from MHRD-CEMA F.NO-5-3/2015-TS VII and BUILDER program BT/PR12153/INF/22/200/2014.; We thank Indian Institute of Technology, Chennai (Sophisticated Analytical Instrument facility centre) for providing EPR facility. Financial support: The research was supported by two grants to Anuradha Dhanasekaran from MHRD-CEMA F.NO-5-3/2015-TS VII and BUILDER program BT/PR12153/INF/22/200/2014.	Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; Autore G, 2010, MOLECULES, V15, P2028, DOI 10.3390/molecules15032028; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen X, 2016, ONCOGENE, V35, P3807, DOI 10.1038/onc.2015.450; Cheng G, 2015, CANCER LETT, V365, P96, DOI 10.1016/j.canlet.2015.05.016; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Darekar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042072; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dogan AL, 2004, TURK J MED SCI, V34, P227; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hideki M., 2015, J BIOL CHEM; HOFSLI E, 1990, CANCER RES, V50, P3997; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Huang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084919; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; Kreck B, 2013, LEUKEMIA, V27, P1751, DOI 10.1038/leu.2013.4; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lassoued S, 2008, MOL CELL BIOCHEM, V313, P179, DOI 10.1007/s11010-008-9755-z; Lewis JA, 1996, J BIOL CHEM, V271, P13184, DOI 10.1074/jbc.271.22.13184; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Piovan E, 2007, CANCER RES, V67, P8605, DOI 10.1158/0008-5472.CAN-06-4722; Reddy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089351; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Starenki D, 2013, J CLIN ENDOCR METAB, V98, P1529, DOI 10.1210/jc.2012-3671; Tan PL, 2015, INT J BIOCHEM CELL B, V62, P72, DOI 10.1016/j.biocel.2015.02.015; Trnka J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121837; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	42	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174546	10.1371/journal.pone.0174546	http://dx.doi.org/10.1371/journal.pone.0174546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426671	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900009
J	Jo, EJ; Li, SP; Liang, QN; Zhang, XM; Wang, H; Herbert, TP; Jenkins, TA; Xu, AM; Ye, JM				Jo, Eunjung; Li, Songpei; Liang, Qingning; Zhang, Xinmei; Wang, Hao; Herbert, Terence P.; Jenkins, Trisha A.; Xu, Aimin; Ye, Ji-Ming			Chronic activation of PPAR alpha with fenofibrate reduces autophagic proteins in the liver of mice independent of FGF21	PLOS ONE			English	Article							INSULIN SIGNALING TRANSDUCTION; GLUCOSE-HOMEOSTASIS; PATHWAY; FOXO1; FIBROBLAST-GROWTH-FACTOR-21; DEACETYLATION; METABOLISM; RESISTANCE; STEATOSIS; RECEPTORS	Autophagy is a catabolic mechanism to degrade cellular components to maintain cellular energy levels during starvation, a condition where PPAR alpha may be activated. Here we report a reduced autophagic capacity in the liver following chronic activation of PPAR alpha with fenofibrate (FB) in mice. Chronic administration of the PPARa agonist FB substantially reduced the levels of multiple autophagy proteins in the liver (Atg3, Agt4B, Atg5, Atg7 and beclin 1) which were associated with a decrease in the light chain LC3II/LC3I ratio and the accumulation of p62. This was concomitant with an increase in the expression of lipogenic proteins mSREBP1c, ACC, FAS and SCD1. These effects of FB were completely abolished in PPAR alpha(-/-) mice but remained intact in mice with global deletion of FGF21, a key downstream mediator for PPAR alpha-induced effects. Further studies showed that decreased the content of autophagy proteins by FB was associated with a significant reduction in the level of FoxO1, a transcriptional regulator of autophagic proteins, which occurred independently of both mTOR and Akt. These findings suggest that chronic stimulation of PPARa may suppress the autophagy capacity in the liver as a result of reduced content of a number of autophagy-associated proteins independent of FGF21.	[Jo, Eunjung; Li, Songpei; Zhang, Xinmei; Wang, Hao; Herbert, Terence P.; Jenkins, Trisha A.; Ye, Ji-Ming] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Liang, Qingning; Xu, Aimin] Univ Hong Kong, Dept Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	Royal Melbourne Institute of Technology (RMIT); University of Hong Kong	Ye, JM (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au		Jenkins, Trisha/0000-0003-0137-6643; Herbert, Terence/0000-0001-5402-0814; Wang, Hao/0000-0002-0901-5183	National Health and Medical Research Council of Australia Program [535921]; Diabetes Australia Research Program [GG12314]; Block Grant Earmarked for Research [(104) (201109176145)]	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Block Grant Earmarked for Research	This work was funded by a National Health and Medical Research Council of Australia Program Grant 535921 (allocation to JM Ye), Diabetes Australia Research Program GG12314 (allocation to JM Ye), and Block Grant Earmarked for Research (104) (201109176145) (allocation to A Xu).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chan SMH, 2015, BBA-MOL BASIS DIS, V1852, P1511, DOI 10.1016/j.bbadis.2015.04.005; Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jiao M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.361; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05538; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Qu S, 2007, AM J PHYSIOL-ENDOC M, V292, pE421, DOI 10.1152/ajpendo.00157.2006; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Sharara-Chami RI, 2012, INT J BIOCHEM CELL B, V44, P905, DOI 10.1016/j.biocel.2012.02.016; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang H, 2015, ENDOCRINOLOGY, V156, P169, DOI 10.1210/en.2014-1454; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173676	10.1371/journal.pone.0173676	http://dx.doi.org/10.1371/journal.pone.0173676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422956	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000399875600011
J	Pedroso, J; Toral, N; Gubert, MB				Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann			Maternal perception of children's nutritional status in the Federal District, Brazil	PLOS ONE			English	Article							SELF-REPORTED WEIGHT; MOTHERS PERCEPTIONS; FEEDING PRACTICES; DETERMINANTS; ASSOCIATION; OVERWEIGHT; CHILDHOOD; VALIDITY; OBESITY; HEIGHT	Maternal perception of child's nutritional status has a potential impact on the identification, prevention, and treatment of childhood overweight. Thus, the aim of this study was to evaluate the prevalence of misperception and factors associated with maternal perception of the nutritional status of first-to third-grade elementary school students from private schools in the Federal District, Brazil. This cross- sectional study was conducted with 554 mother-child pairs. Children's nutritional status was assessed by measuring their weight and height. The mothers completed an online questionnaire about sociodemographic data, maternal nutritional status, maternal perception of her own nutritional status (silhouette scale for female adults), and maternal perception of child's nutritional status (silhouette scale for children). Only 30.0% of the mothers were successful in choosing the most appropriate silhouette to represent child's nutritional status. Highly educated mothers (Adjusted OR = 1.51) and mothers of male children (Adjusted OR = 2.53) or of non-overweight children (Adjusted OR = 1.65) were more likely to underestimate child's nutritional status. Conversely, mothers below 35 years of age (Adjusted OR = 1.85) and mothers of female children (Adjusted OR = 2.24) or of overweight children (Adjusted OR = 1.94) were more likely to overestimate child's nutritional status. There was a high prevalence of misperception, which shows the need for interventions for children that take into account the relevance of mother's role and the adequate recognition of child's nutritional status.	[Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann] Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil	Universidade de Brasilia	Pedroso, J (corresponding author), Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil.	jessicapedroso1211@gmail.com		Pedroso, Jessica/0000-0001-5446-4319; Gubert, Muriel/0000-0002-0103-4187				Alm S, 2015, APPETITE, V89, P112, DOI 10.1016/j.appet.2015.02.002; Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; Aparicio G, 2013, ATENCION PRIMARIA S2, V45; Arpini LdSB, 2014, REV BRASILEIRA PESQU, V16, P140; Bernardo Carla de O., 2012, Rev. bras. epidemiol., V15, P651, DOI 10.1590/S1415-790X2012000300018; Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Molina MDB, 2009, CAD SAUDE PUBLICA, V25, P2285, DOI 10.1590/S0102-311X2009001000018; Camara Interministerial de Seguranca Alimentar e Nutricional (CAISAN), 2014, ESTR INT PREV CONTR; Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764; da Fonseca MDJM, 2004, REV SAUDE PUBL, V38, P392; Francescatto C, 2014, J PEDIAT-BRAZIL, V90, P332, DOI 10.1016/j.jped.2014.01.009; Giacomossi MC, REV NUTR; Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015; Guevara-Cruz M, 2012, NUTR HOSP, V27, P209, DOI [10.3305/nh.2012.27.1.5411, 10.1590/S0212-16112012000100026]; Hochdorn A, 2016, J HLTH PSYCHOL  1106; Hochdorn A, 2014, INDIAN J PEDIATR, V81, pS39, DOI 10.1007/s12098-014-1464-x; Instituto Brasileiro de Geografia e Estat A o stica, 2010, CENS DEM 2010 ED; Instituto Brasileiro de Geografia e Estat o A stica, 2010, PESQ ORC FAM 2008 20; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR GE; Kakeshita Idalina Shiraishi, 2009, Psic.: Teor. e Pesq., V25, P263, DOI 10.1590/S0102-37722009000200015; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larsen PS, 2015, HARVARD REV PSYCHIAT, V23, P395, DOI 10.1097/HRP.0000000000000073; Lazzeri G, 2006, J Prev Med Hyg, V47, P16; LdSB Arpini, 2015, DEMETRA, V10, P891; Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019; Manios Y, 2010, J AM DIET ASSOC, V110, P1527, DOI 10.1016/j.jada.2010.07.004; McCabe MP, 2005, J APPL DEV PSYCHOL, V26, P559, DOI 10.1016/j.appdev.2005.06.007; Ministerio da Educac, 2015, CART NAC AL ESC; Ministerio da Saude Ministerio da Educac, 2015, CAD GEST PROGR SAUD; Ministerio da Saude Nacional de Saude Supplementar, 2015, VIG FAT RISC PROT DO; Moraes André Guerra Esteves de, 2014, Nova econ., V24, P409, DOI 10.1590/0103-6351/1564; Parkinson KN, 2013, CHILD CARE HLTH DEV, V39, P722, DOI 10.1111/cch.12000; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; Trude ACB, PRATICA ATIVIDADE FI; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; WHO, 2009, ANTHROPLUS PERS COMP; WHO, 1997, WHO TECHN REP SER; World Health Organization, 2018, OB OV FACT SHEET 311; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR	43	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176344	10.1371/journal.pone.0176344	http://dx.doi.org/10.1371/journal.pone.0176344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445494	Green Published, gold, Green Submitted			2022-12-27	WOS:000400309200047
J	Gunnala, V; Melnick, A; Irani, M; Reichman, D; Schattman, G; Davis, O; Rosenwaks, Z				Gunnala, Vinay; Melnick, Alexis; Irani, Mohamad; Reichman, David; Schattman, Glenn; Davis, Owen; Rosenwaks, Zev			Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; IN-VITRO FERTILIZATION; FINAL OOCYTE MATURATION; GNRH AGONIST; PREVENTION; HORMONE; PROGRAM	Objective To evaluate pregnancy outcomes and the incidence of ovarian hyperstimulation syndrome (OHSS) using a sliding scale hCG protocol to trigger oocyte maturity and establish a threshold level of serum b-hCG associated with optimal oocyte maturity. Design Retrospective cohort. Setting Academic medical center. Patients Fresh IVF cycles from 9/2004-12/2011. Intervention 10,427 fresh IVF-ICSI cycles met inclusion criteria. hCG was administered according to E2 level at trigger: 10,000IU vs. 5,000IU vs. 4,000IU vs. 3,300IU vs. dual trigger (2mg leuprolide acetate + 1,500IU hCG). Serum absorption of hCG was assessed according to dose and BMI. Main outcome measures Oocyte maturity was analyzed according to post-trigger serum b-hCG. Fertilization, clinical pregnancy, live birth and OHSS rates were examined by hCG trigger dose. Results Post-trigger serum b-hCG 20-30, 30-40, and 40-50 mIU/mL was associated with reduced oocyte maturity as compared b-hCG >50 (67.8% vs. 71.4% vs. 73.3% vs. 78.9%, respectively, P<0.05). b-hCG 20-50 mIU/mL was associated with a 40.1% reduction in live birth (OR 0.59, 95% CI 0.41-0.87). No differences in IVF outcomes per retrieval were seen for varying doses of hCG or dual trigger when controlling for patient age. The incidence of moderate to severe OHSS was 0.13% (n = 14) and severe OHSS was 0.03% (n = 4) of cycles. Conclusions Moderate stimulation with sliding scale hCG at trigger and fresh transfer is associated with low rates of OHSS and favorable pregnancy rates. Doses as low as 3,300IU alone or dual trigger with 1,500IU are sufficient to facilitate oocyte maturity.	[Gunnala, Vinay; Melnick, Alexis; Irani, Mohamad; Reichman, David; Schattman, Glenn; Davis, Owen; Rosenwaks, Zev] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Rosenwaks, Zev] Weill Cornell Med, Dept Reprod Med, New York, NY USA	Cornell University; Cornell University	Gunnala, V (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	vig9035@med.cornell.edu		Gunnala, Vinay/0000-0003-4231-6989				ABDALLA HI, 1987, FERTIL STERIL, V48, P958; Aboulghar MA, 2003, HUM REPROD UPDATE, V9, P275, DOI 10.1093/humupd/dmg018; Al-Hassan S, 1998, J ASSIST REPROD GEN, V15, P583, DOI 10.1023/A:1020325125881; Chen Dehan, 2003, Reprod Biomed Online, V7, P43; Dhont M, 1998, FERTIL STERIL, V70, P847, DOI 10.1016/S0015-0282(98)00280-5; Griesinger G, 2006, HUM REPROD UPDATE, V12, P159, DOI 10.1093/humupd/dmi045; Haas J, 2014, REPROD BIOMED ONLINE, V29, P216, DOI 10.1016/j.rbmo.2014.04.015; Huang JYJ, 2014, METHODS MOL BIOL, V1154, P171, DOI 10.1007/978-1-4939-0659-8_8; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Isik AZ, 2001, EUR J OBSTET GYN R B, V97, P208, DOI 10.1016/S0301-2115(00)00539-X; Kashyap S, 2010, SEMIN REPROD MED, V28, P475, DOI 10.1055/s-0030-1265674; Kolibianakis EM, 2007, FERTIL STERIL, V88, P1382, DOI 10.1016/j.fertnstert.2006.12.058; Lin HY, 2011, EUR J OBSTET GYN R B, V159, P143, DOI 10.1016/j.ejogrb.2011.07.009; Mathur RS, 2000, BRIT J OBSTET GYNAEC, V107, P943, DOI 10.1111/j.1471-0528.2000.tb10393.x; Meyer L, 2015, FERTIL STERIL, V104, P637, DOI 10.1016/j.fertnstert.2015.06.011; Nastri CO, 2015, ULTRASOUND OBST GYN, V45, P377, DOI 10.1002/uog.14684; Olivennes F, 2010, SEMIN REPROD MED, V28, P463, DOI 10.1055/s-0030-1265672; Orvieto R, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-77; Reichman D, 2014, METHODS MOL BIOL, V1154, P289, DOI 10.1007/978-1-4939-0659-8_13; Schmidt DW, 2004, FERTIL STERIL, V82, P841, DOI 10.1016/j.fertnstert.2004.03.055; Smith V, 2015, REV ARTICLE PREVENTI, P1; WIKLAND M, 1995, HUM REPROD, V10, P1667, DOI 10.1093/oxfordjournals.humrep.a136152	22	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176019	10.1371/journal.pone.0176019	http://dx.doi.org/10.1371/journal.pone.0176019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441461	gold, Green Submitted, Green Published			2022-12-27	WOS:000400308800019
J	Rhodin, M; Egenvall, A; Andersen, PH; Pfau, T				Rhodin, Marie; Egenvall, Agneta; Andersen, Pia Haubro; Pfau, Thilo			Head and pelvic movement asymmetries at trot in riding horses in training and perceived as free from lameness by the owner	PLOS ONE			English	Article							HIND-LIMB LAMENESS; SWEDISH HORSES; REPEATABILITY; SYMMETRY; MOTION; SYSTEM	Recent studies evaluating horses in training and considered free from lameness by their owners have identified a large proportion of horses with motion asymmetries. However the prevalence, type and magnitude of asymmetries when trotting in a straight line or on the lunge have not been investigated. The aim of this study was to objectively investigate the presence of motion asymmetries in riding horses in training by identifying the side and quantifying the degree and type (impact, pushoff) of forelimb and hind limb asymmetries found during straight line trot and on the lunge. In a cross-sectional study, vertical head and pelvic movement symmetry was measured in 222 Warmblood type riding horses, all without perceived performance issues and considered free from lameness by their owners. Body-mounted uni-axial accelerometers were used and differences between maximum and minimum head (HDmax, HDmin) and pelvic (PDmax, PDmin) vertical displacement between left and right forelimb and hind limb stances were calculated during straight line trot and on the lunge. Previously reported symmetry thresholds were used. The thresholds for symmetry were exceeded in 161 horses for at least one variable while trotting in a straight line, HDmin (n = 58, mean 14.3 mm, SD 7.1), HDmax (n = 41, mean 12.7 mm, SD 5.5), PDmax (n = 87, mean 6.5 mm, SD 3.10), PDmin (n = 79, mean 5.7 mm, SD 2.1). Contralateral and ipsilateral concurrent forelimb and hind limb asymmetries were detected in 41 and 49 horses, respectively. There was a linear association between the straight line PDmin values and the values on the lunge with the lame limb to the inside of the circle. A large proportion (72.5%) of horses in training which were perceived as free from lameness by their owner showed movement asymmetries above previously reported asymmetry thresholds during straight line trot. It is not known to what extent these asymmetries are related to pain or to mechanical abnormalities. Therefore, one of the most important questions that must be addressed is how objective asymmetry scores can be translated into pain, orthopedic abnormality, or any type of unsoundness.	[Rhodin, Marie; Egenvall, Agneta; Andersen, Pia Haubro] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Pfau, Thilo] Univ London, Dept Clin Sci & Serv, Royal Vet Coll, Hawkshead Lane, Hatfield, Herts, England	Swedish University of Agricultural Sciences; University of London; University of London Royal Veterinary College	Rhodin, M (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	marie.rhodin@slu.se	Andersen, Pia Haubro/B-7077-2015; Rhodin, Marie/AAD-7266-2020	Andersen, Pia Haubro/0000-0002-6039-7439; Rhodin, Marie/0000-0003-0575-2765	Swedish Norwegian Foundation for Equine Research [H1347029]; Swedish Research Council Formas [2014-12003-28225-26]	Swedish Norwegian Foundation for Equine Research; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Funded by H1347029, Swedish Norwegian Foundation for Equine Research, http://hastforskning.se/. Marie Rhodin received the funding. 2014-12003-28225-26, The Swedish Research Council Formas, http://www.forms.se/. Marie Rhodin received the funding.	Arkell M, 2006, VET REC, V159, P346, DOI 10.1136/vr.159.11.346; Bell RP, 2016, AM J VET RES, V77, P337, DOI 10.2460/ajvr.77.4.337; Buchner HHF, 1996, EQUINE VET J, V28, P71, DOI 10.1111/j.2042-3306.1996.tb01592.x; Dyson S, 2011, EQUINE VET J, V43, P379, DOI 10.1111/j.2042-3306.2011.00391.x; Dyson S, 2016, J EQUINE VET SCI, V38, P1, DOI 10.1016/j.jevs.2015.12.012; Egenvall A, 2006, VET REC, V158, P397, DOI 10.1136/vr.158.12.397; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Hammarberg M, 2016, EQUINE VET J, V48, P78, DOI 10.1111/evj.12385; Hewetson M, 2006, VET REC, V158, P852, DOI 10.1136/vr.158.25.852; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2011, AM J VET RES, V72, P1156, DOI 10.2460/ajvr.72.9.1156; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 2004, EQUINE VET J, V36, P734, DOI 10.2746/0425164044848028; Maliye S, 2016, JAVMA-J AM VET MED A, V249, P940, DOI 10.2460/javma.249.8.940; Maliye S, 2015, VET J, V204, P208, DOI 10.1016/j.tvjl.2015.03.005; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; Murray R C, 2006, Equine Vet J Suppl, P411; Parkes RSV, 2009, EQUINE VET J, V41, P112, DOI 10.2746/042516408X343000; Peham C, 2001, VET J, V162, P153, DOI 10.1053/tvjl.2001.0593; Penell JC, 2005, VET REC, V157, P470, DOI 10.1136/vr.157.16.470; Pfau T, 2005, J EXP BIOL, V208, P2503, DOI 10.1242/jeb.01658; Pfau T, 2016, EQUINE VET J, V48, P517, DOI 10.1111/evj.12467; Pfau T, 2016, EQUINE VET J, V48, P83, DOI 10.1111/evj.12374; Pfau T, 2015, EQUINE VET J; Pfau T, 2012, AM J VET RES, V73, P1890, DOI 10.2460/ajvr.73.12.1890; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; Robartes H, 2013, VET J, V198, pE52, DOI 10.1016/j.tvjl.2013.09.033; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; ST Baxter GM, 2011, LAMENESS IN HORSES, p[115, 479]; Wallin L., 2012, LIVSLANGD UTSLAGSORS; Warner SM, 2010, EQUINE VET J, V42, P417, DOI 10.1111/j.2042-3306.2010.00200.x	32	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176253	10.1371/journal.pone.0176253	http://dx.doi.org/10.1371/journal.pone.0176253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441406	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000400308800038
J	Schmucker, CM; Blumle, A; Schell, LK; Schwarzer, G; Oeller, P; Cabrera, L; von Elm, E; Briel, M; Meerpohl, JJ				Schmucker, Christine M.; Bluemle, Anette; Schell, Lisa K.; Schwarzer, Guido; Oeller, Patrick; Cabrera, Laura; von Elm, Erik; Briel, Matthias; Meerpohl, Joerg J.		OPEN Consortium	Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research	PLOS ONE			English	Article							PUBLICATION BIAS; UNPUBLISHED DATA; CLINICAL-TRIALS; PROTOCOL	Background A meta-analysis as part of a systematic review aims to provide a thorough, comprehensive and unbiased statistical summary of data from the literature. However, relevant study results could be missing from a meta-analysis because of selective publication and inadequate dissemination. If missing outcome data differ systematically from published ones, a meta-analysis will be biased with an inaccurate assessment of the intervention effect. As part of the EU-funded OPEN project (www.open-project.eu) we conducted a systematic review that assessed whether the inclusion of data that were not published at all and/or published only in the grey literature influences pooled effect estimates in meta-analyses and leads to different interpretation. Methods and findings Systematic review of published literature (methodological research projects). Four bibliographic databases were searched up to February 2016 without restriction of publication year or language. Methodological research projects were considered eligible for inclusion if they reviewed a cohort of meta-analyses which (i) compared pooled effect estimates of meta-analyses of health care interventions according to publication status of data or (ii) examined whether the inclusion of unpublished or grey literature data impacts the result of a meta-analysis. Seven methodological research projects including 187 meta-analyses comparing pooled treatment effect estimates according to different publication status were identified. Two research projects showed that published data showed larger pooled treatment effects in favour of the intervention than unpublished or grey literature data (Ratio of ORs 1.15, 95% CI 1.04-1.28 and 1.34, 95% CI 1.09-1.66). In the remaining research projects pooled effect estimates and/or overall findings were not significantly changed by the inclusion of unpublished and/or grey literature data. The precision of the pooled estimate was increased with narrower 95% confidence interval. Conclusions Although we may anticipate that systematic reviews and meta-analyses not including unpublished or grey literature study results are likely to overestimate the treatment effects, current empirical research shows that this is only the case in a minority of reviews. Therefore, currently, a meta-analyst should particularly consider time, effort and costs when adding such data to their analysis. Future research is needed to identify which reviews may benefit most from including unpublished or grey data.	[Schmucker, Christine M.; Bluemle, Anette; Oeller, Patrick; Cabrera, Laura; Meerpohl, Joerg J.] Univ Freiburg, Cochrane Germany, Med Ctr, Fac Med, Freiburg, Germany; [Schell, Lisa K.] Inst Qual & Efficiency Hlth Care, Cologne, Germany; [Schwarzer, Guido] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany; [Schwarzer, Guido] Univ Freiburg, Med Ctr, Freiburg, Germany; [von Elm, Erik] Univ Hosp Lausanne, Cochrane Switzerland, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Briel, Matthias] Univ Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland; [Briel, Matthias] Univ Hosp Basel, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel	Schmucker, CM (corresponding author), Univ Freiburg, Cochrane Germany, Med Ctr, Fac Med, Freiburg, Germany.	schmucker@cochrane.de	Schwarzer, Guido/A-8168-2009; Meerpohl, Joerg J/J-4224-2013; Briel, Matthias/AAT-9284-2021	Schwarzer, Guido/0000-0001-6214-9087; Meerpohl, Joerg J/0000-0002-1333-5403; Schmucker, Christine/0000-0002-1188-3158; von Elm, Erik/0000-0002-7412-0406; Briel, Matthias/0000-0002-2070-5230; Blumle, Anette/0000-0003-2877-1029	European Union [285453]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 285453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutron I, 2016, JAMA-J AM MED ASSOC, V315, P2729, DOI 10.1001/jama.2016.6310; Burdett S, 2003, INT J TECHNOL ASSESS, V19, P129, DOI 10.1017/S0266462303000126; Burdett S, 2000, 8 ANN COCHR C 2000 O, P12; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; David SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070104; Driessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137864; Egger M, 2003, Health Technol Assess, V7, P1; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Fergusson D, 2000, INT J TECHNOL ASSESS, V16, P1109, DOI 10.1017/S0266462300103150; Golder S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002127; Golder S, 2010, J CLIN EPIDEMIOL, V63, P1071, DOI 10.1016/j.jclinepi.2010.02.009; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Hopewell S., 2004, THESIS, P61045; Kepes S, 2012, ORGAN RES METHODS, V15, P624, DOI 10.1177/1094428112452760; Langhorne P, 1998, BMJ-BRIT MED J, V316, P471; Loder E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2630; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Martin JLR, 2005, EUR PSYCHIAT, V20, P550, DOI 10.1016/j.eurpsy.2005.03.011; Maund E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3510; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McAuley LM, 1997, 3 INT C BIOM PEER RE; Meerpohl JJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006666; Miller JE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009758; Mueller KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116016; Mueller KF, 2016, J CLIN EPIDEMIOL, V80, P25, DOI 10.1016/j.jclinepi.2016.04.015; Mueller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-60; Portalupi S, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-2; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Scherer RW, 2015, J CLIN EPIDEMIOL, V68, P803, DOI 10.1016/j.jclinepi.2015.01.027; Schmucker C., 2013, COCHRANE DB SYST REV, V2, P24, DOI [10.1186/2046-4053-2-24, DOI 10.1186/2046-4053-2-24]; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	43	111	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176210	10.1371/journal.pone.0176210	http://dx.doi.org/10.1371/journal.pone.0176210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441452	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800034
J	Teparrukkul, P; Hantrakun, V; Day, NPJ; West, TE; Limmathurotsakul, D				Teparrukkul, Prapit; Hantrakun, Viriya; Day, Nicholas P. J.; West, T. Eoin; Limmathurotsakul, Direk			Management and outcomes of severe dengue patients presenting with sepsis in a tropical country	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; FEBRILE ILLNESSES; ADULT PATIENTS; SEPTIC SHOCK; GUIDELINES; CAMPAIGN	Background Dengue is a common cause of infection in adults in tropical countries. Sepsis is a syndrome of systemic manifestations induced by infection of any organisms; including bacterial, fungal and viral agents. Here, we investigated the diagnosis, management and outcomes of dengue patients presenting with sepsis in a prospective study of community-acquired sepsis in Thailand. Methods From June to December 2015, 874 adult patients ( age >= 18 years) with suspected or documented community-acquired infection, with >= 3 diagnostic criteria for sepsis according to the Surviving Sepsis Campaign 2012, and within 24 hours of admission were evaluated. Serum was stored and later tested for dengue PCR assays. Results A total of 126 patients had dengue PCR assays positive ( 2 DENV-1, 12 DENV-2, 24 DENV-3 and 88 DENV-4), and 5 of them ( 4%) died. We found that attending physicians suspected dengue infection on admission in 84 patients ( 67%), and recorded dengue infection as the final diagnosis in 96 patients ( 76%). Four of five fatal cases were diagnosed and treated as septic shock not due to dengue. In multivariable analysis, there was a trend showing that age >= 60 years, hypoxemia and misdiagnosis of dengue by attending physicians were associated with 28-day mortality. Conclusions A number of adult patients who died of dengue are misdiagnosed as severe sepsis and septic shock. Diagnosis of dengue based on clinical features alone is difficult. Rapid diagnostic tests for dengue may need to be routinely used in adult patients presenting with sepsis and septic shock in tropical countries. This approach could improve diagnosis and management of those patients.	[Teparrukkul, Prapit] Sunpasithiprasong Hosp, Med Dept, Ubon Ratchathani, Thailand; [Hantrakun, Viriya; Day, Nicholas P. J.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Day, Nicholas P. J.; Limmathurotsakul, Direk] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [West, T. Eoin] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [West, T. Eoin] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [West, T. Eoin] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Limmathurotsakul, D (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.; Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac		Limmathurotsakul, Direk/0000-0001-7240-5320; West, T Eoin/0000-0001-5503-7204; Hantrakun, Viriya/0000-0002-6727-3404; /0000-0002-1075-4135	Wellcome Trust [106698/B/14/Z, 101103/Z/13/Z]; National Heart, Lung and Blood Institute, National Institutes of Health [R01HL113382]; Defense Threat Reduction Agency, USA [W911QY-16-C-0017]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113382] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Defense Threat Reduction Agency, USA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The prospective sepsis study was funded by the Wellcome Trust (106698/B/14/Z) and National Heart, Lung and Blood Institute, National Institutes of Health (R01HL113382). The dengue PCR assays were funded by Defense Threat Reduction Agency, USA (W911QY-16-C-0017). DL is supported by an intermediate fellowship from the Wellcome Trust (101103/Z/13/Z).	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bureau of Epidemiology Ministry of Public Health Thailand, 2015, ANN EP SURV REP; Chan CYY, 2015, FUTURE MICROBIOL, V10, P2017, DOI 10.2217/fmb.15.105; Chareonsook O, 1999, EPIDEMIOL INFECT, V122, P161, DOI 10.1017/S0950268898001617; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Hosmer D.W., 2005, APPL LOGISTIC REGRES; Jayashree K, 2011, INDIAN J HEMATOL BLO, V27, P127, DOI 10.1007/s12288-011-0075-1; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Navarrete-Espinosa J, 2005, SALUD PUBLICA MEXICO, V47, P193, DOI 10.1590/S0036-36342005000300002; Pang JX, 2016, CURR OPIN CRIT CARE, V22, P485, DOI 10.1097/MCC.0000000000000339; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Thein TL, 2017, J MICROBIOL IMMUNOL, V50, P314, DOI 10.1016/j.jmii.2015.06.008; Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337; Thisyakorn Usa, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P118; Trunfio M, 2016, INFECTION; van Crevel R, 2016, LANCET DIABETES ENDO; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 2009, WHO TECH REP SER, V958, P1; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575; World Health Organization, 2020, IMAI DISTR CLIN MAN	36	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176233	10.1371/journal.pone.0176233	http://dx.doi.org/10.1371/journal.pone.0176233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437459	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600038
J	Nilsson, K; Jager, G; Bjork, GR				Nilsson, Kristina; Jager, Gunilla; Bjork, Glenn R.			An unmodified wobble uridine in tRNAs specific for Glutamine, Lysine, and Glutamic acid from Salmonella enterica Serovar Typhimurium results in nonviability-Due to increased missense errors?	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; URIDINE-5-OXYACETIC ACID; TRANSLATIONAL ACCURACY; ELONGATOR COMPLEX; GENETIC-CODE; 5-METHYLAMINOMETHYL-2-THIOURIDINE; BIOSYNTHESIS; POSITION; CODONS; NUCLEOSIDES	In the wobble position of tRNAs specific for Gln, Lys, and Glu a universally conserved 5-methylene- 2-thiouridine derivative (xm(5) s(2) U34, x denotes any of several chemical substituents and 34 denotes the wobble position) is present, which is 5-(carboxy) methylaminomethyl- 2-thiouridine ((c) mnm(5) s(2) U34) in Bacteria and 5-methylcarboxymethyl-2-thiouridine (mcm(5) s(2) U34) in Eukarya. Here we show that mutants of the bacterium Salmonella enterica Serovar Typhimurium LT2 lacking either the s(2) - or the (c) mnm(5) -group of (c) mnm(5) s(2) U34 grow poorly especially at low temperature and do not grow at all at 15 degrees C in both rich and glucose minimal media. A double mutant of S. enterica lacking both the s(2)- and the (c) mnm(5)-groups, and that thus has an unmodified uridine as wobble nucleoside, is nonviable at different temperatures. Overexpression of tRN(cmnm5s2UUG)(AGln) lacking either the s(2) - or the (c) mnm(5)-group and of tRNA(mnm5s2UUU)(Lys) lacking the s(2) -group exaggerated the reduced growth induced by the modification deficiency, whereas overexpression of tRNA(mnm5s2UUU)(Lys) lacking the mnm(5)-group did not. From these results we suggest that the primary function of cmnm(5) s(2) U34 in bacterial tRNA(cmnm5s2UUG)(Gln) and mnm(5) s(2) U34 in tRNA(Lys) (mnm5s2UUU) is to prevent missense errors, but the mnm(5) -group of tRNA(Lys) (mnm5s2UUU) does not. However, other translational errors causing the growth defect cannot be excluded. These results are in contrast to what is found in yeast, since overexpression of the corresponding hypomodified yeast tRNAs instead counteracts the modification deficient induced phenotypes. Accordingly, it was suggested that the primary function of mcm(5) s(2) U34 in these yeast tRNAs is to improve cognate codon reading rather than prevents missense errors. Thus, although the xm(5) s(2) U34 derivatives are universally conserved, their major functional impact on bacterial and eukaryotic tRNAs may be different.	[Nilsson, Kristina; Jager, Gunilla; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University	Bjork, GR (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	glenn.bjork@umu.se	Björk, Glenn/AAE-8219-2022		Swedish Science Research Council [BU-2930]; Carl Trygger Foundation	Swedish Science Research Council; Carl Trygger Foundation	This work was supported by grants from the Swedish Science Research Council (BU-2930) and from the Carl Trygger Foundation. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 2014, ECOSAL PLUS IN PRESS; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS W, 1980, MANUAL GENETIC ENG A; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gehrke CW, 1990, J CHROMATOGRAPHY LIB, pA3; Grosjean H, 2016, NUCLEIC ACIDS RES, V44, P8020, DOI 10.1093/nar/gkw608; Grosjean H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004363; Hagervall TG, 1998, J MOL BIOL, V284, P33, DOI 10.1006/jmbi.1998.2162; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jager G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153488; Jager G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060246; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Machnicka MA, 2014, RNA BIOL, V11, P1619, DOI 10.4161/15476286.2014.992273; Manickam N, 2016, NUCLEIC ACIDS RES, V44, P1871, DOI 10.1093/nar/gkv1506; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; PANDE S, 1995, MOL CELL BIOL, V15, P298, DOI 10.1128/MCB.15.1.298; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Rodriguez-Hernandez A, 2013, J MOL BIOL, V425, P3888, DOI 10.1016/j.jmb.2013.05.018; Rozov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10457; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; SULLIVAN MA, 1985, J BACTERIOL, V161, P368, DOI 10.1128/JB.161.1.368-376.1985; Turner DH., 1993, RNA WORLD, P447; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Yokoyama Shigeyuki, 1995, P207	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175092	10.1371/journal.pone.0175092	http://dx.doi.org/10.1371/journal.pone.0175092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430781	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100013
J	Ye, XB; Torabi, M; Lix, LM; Mahmud, SM				Ye, Xibiao; Torabi, Mahmoud; Lix, Lisa M.; Mahmud, Salaheddin M.			Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; CHILDHOOD-CANCER INCIDENCE; NON-HODGKINS-LYMPHOMA; SOCIOECONOMIC-STATUS; GEOGRAPHICAL VARIATION; EUROPEAN CHILDREN; PERIOD ANALYSIS; YOUNG-ADULTS; DISEASE	Objectives To test for time and spatial trends in lymphoid malignancies, including lymphoid leukemia (LL), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL), in children and adolescents in the province of Manitoba, Canada. Methods Incident cases diagnosed between 1984 and 2013 were identified from the Manitoba Cancer Registry. We assessed time trends in age-standardized incidence rates using joinpoint regression and in 5-year relative survival using Poisson regression model. Kulldorff's scan method was used to assess spatial variation and clustering. Results Age-standardized incidence rates (per million person-years) in males and females were 34.0 (95% confidence interval [CI] 28.9-39.1) and 26.2 (95% CI 21.5-30.7) for LL, 10.5 (95% CI 7.7-13.3) and 12.5 (95% CI 9.4-15.7) for HL, 12.5 (95% CI 9.3-15.4) and 7.7 (95% CI 5.2-10.2) for NHL (except for Burkitt lymphomas), and 3.2 (95% CI 1.6-4.7) and 1.5 (95% CI 0.4-2.5) for Burkitt lymphomas. Age-and sex-standardized LL incidence rate increased 1.4% (95% CI 0.3%-2.5%) per year, while the changes for HL and NHL incidence rates were not statistically significant. There were geographic differences in age-standardized incidence rates for LL, HL, and NHL and spatial clusters were detected in southern part of the province. Five-year relative survival has improved over time and there was no difference between rural and urban areas. Conclusions Lymphoid leukemia incidence rate increased over time and varied by geographic area. Further research should examine the factors contributing to these trends.	[Ye, Xibiao; Torabi, Mahmoud; Lix, Lisa M.; Mahmud, Salaheddin M.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Ye, Xibiao; Lix, Lisa M.; Mahmud, Salaheddin M.] Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Ye, XB (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Ye, XB (corresponding author), Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada.	xibiao.ye@gmail.com		Torabi, Mahmoud/0000-0001-7448-7729	Manitoba Medical Service Foundation [317309]; Manitoba Centre for Health Policy [2015-028 (HIPC 2015/2016-04)]	Manitoba Medical Service Foundation; Manitoba Centre for Health Policy	This research was funded by the Manitoba Medical Service Foundation (# 317309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project 2015-028 (HIPC 2015/2016-04). The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Healthy Living, and Seniors, or other data providers is intended or should be inferred.	Adam M, 2008, RADIAT PROT DOSIM, V132, P246, DOI 10.1093/rpd/ncn261; Adam M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00139; [Anonymous], 2016, JOINP REGR PROGR VER; Bao PP, 2010, PEDIATR BLOOD CANCER, V54, P1009, DOI 10.1002/pbc.22383; Borugian MJ, 2005, EPIDEMIOLOGY, V16, P526, DOI 10.1097/01.ede.0000164813.46859.63; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brown LM, 2015, INT J CANC; Brownell M, 2001, ASSESSING HLTH CHILD; CancerCare Manitoba, 2012, MAN CANC STRAT 2012; Chen AC, 2015, PACKAGE SPATIALEPI; Children's Oncology Group, 2014, LONG TERM FOLL UP GU; Clavel J, 2006, EUR J CANCER, V42, P2037, DOI 10.1016/j.ejca.2006.05.012; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Clegg LX, 2002, J NATL CANCER I, V94, P1537; Coebergh JWW, 2006, EUR J CANCER, V42, P2019, DOI 10.1016/j.ejca.2006.06.005; Copeland G, 2013, CANC N AM 2006 2010, V1; Cox D. R., 1984, ANAL SURVIVAL DATA; Ederer F., 1959, INSTRUCTIONS IBM 650; Ellison L., 2015, HLTH GLANCE CHILDHOO; Feltbower RG, 2009, EUR J CANCER, V45, P420, DOI 10.1016/j.ejca.2008.09.020; Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233; HARVEY EB, 1985, NEW ENGL J MED, V312, P541, DOI 10.1056/NEJM198502283120903; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Holleczek B, 2009, METHOD INFORM MED, V48, P123, DOI 10.3414/ME0563; Holleczek B, 2013, COMPUT METH PROG BIO, V110, P192, DOI 10.1016/j.cmpb.2012.10.004; Hung GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133051; Izarzugaza MI, 2006, EUR J CANCER, V42, P2050, DOI 10.1016/j.ejca.2006.05.005; Jarrett RF, 2003, J CLIN PATHOL, V56, P811, DOI 10.1136/jcp.56.11.811; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Katz AJ, 2015, CANCER CAUSE CONTROL, V26, P1627, DOI 10.1007/s10552-015-0657-6; Kent EE, 2015, CANCER CAUSE CONTROL, V26, P1153, DOI 10.1007/s10552-015-0609-1; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kroll ME, 2011, BRIT J CANCER, V105, P1783, DOI 10.1038/bjc.2011.415; Kulkarni K, 2011, PEDIAT HEMATOL ONCOL; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Linet MS, 2015, INT J CANCER, V138, P1862; Liu SL, 2003, HEMATOL ONCOL, V21, P57, DOI 10.1002/hon.703; Mbulaiteye Sam M., 2014, Journal of the National Cancer Institute Monographs, P106, DOI 10.1093/jncimonographs/lgu003; Mbulaiteye SM, 2012, AM J HEMATOL, V87, P573, DOI 10.1002/ajh.23187; Mezei G, 2006, AM J EPIDEMIOL, V164, P170, DOI 10.1093/aje/kwj118; Michelozzi P, 2002, AM J EPIDEMIOL, V155, P1096, DOI 10.1093/aje/155.12.1096; Milne E, 2008, INT J CANCER, V122, P1130, DOI 10.1002/ijc.23226; Mitra D, 2012, TRENDS INCIDENCE CHI, P131; Njoku K, 2013, BRIT J CANCER, V108, P2339, DOI 10.1038/bjc.2013.222; Parkin DM, 1998, IAR C SCI PUBL, V2, P1; Paulo Brazil, 2008, INT J CANCER, V123, P1907; Poole C, 2006, INT J EPIDEMIOL, V35, P370, DOI 10.1093/ije/dyi248; Ribeiro KB, 2008, INT J CANCER, V123, P1907, DOI 10.1002/ijc.23738; Schillinger JA, 1999, ARCH DIS CHILD, V80, P311, DOI 10.1136/adc.80.4.311; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Spector LG, 2015, PEDIATR CLIN N AM, V62, P11, DOI 10.1016/j.pcl.2014.09.013; Stammers DM, 2014, PEDIATR BLOOD CANCER, V61, P2164, DOI 10.1002/pbc.25005; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stolley PD, 1995, ENVIRON HEALTH PERSP, V103, P191, DOI 10.2307/3432309; Swaminathan R, 2011, IARC Sci Publ, P7; Torabi M, 2015, J PAEDIATR CHILD H, V51, P1121, DOI 10.1111/jpc.12930; Walters S, 2011, J EPIDEMIOL COMMUN H, V65, P1044, DOI 10.1136/jech.2010.126656; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; World Health Organization, 2000, INT CLASSIFICATION D; Xavier AC, 2010, HAEMATOL-HEMATOL J, V95, P1043, DOI 10.3324/haematol.2010.024968; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P476, DOI 10.1016/j.canep.2012.06.001; Youlden DR, 2012, PEDIATR BLOOD CANCER, V58, P390, DOI 10.1002/pbc.23115; Youlden DR, 2011, CANCER EPIDEM BIOMAR, V20, P1649, DOI 10.1158/1055-9965.EPI-11-0432; Zhang ZK, 2010, J PROBAB STAT, V2010, DOI 10.1155/2010/642379	65	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175701	10.1371/journal.pone.0175701	http://dx.doi.org/10.1371/journal.pone.0175701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430788	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100014
J	Cuecas, A; Kanoksilapatham, W; Gonzalez, JM				Cuecas, Alba; Kanoksilapatham, Wirojne; Gonzalez, Juan M.			Evidence of horizontal gene transfer by transposase gene analyses in Fervidobacterium species	PLOS ONE			English	Article							BACTERIAL; DIVERSITY; ALIGNMENT; EXCHANGE; SEQUENCE; ELEMENTS; GENOME; LIVES; NOV	Horizontal Gene Transfer (HGT) plays an important role in the physiology and evolution of microorganisms above all thermophilic prokaryotes. Some members of the Phylum Thermotogae (i.e., Thermotoga spp.) have been reported to present genomes constituted by a mosaic of genes from a variety of origins. This study presents a novel approach to search on the potential plasticity of Fervidobacterium genomes using putative transposase-encoding genes as the target of analysis. Transposases are key proteins involved in genomic DNA rearrangements. A comprehensive comparative analysis, including phylogeny, non-metric multidimensional scaling analysis of tetranucleotide frequencies, repetitive flanking sequences and divergence estimates, was performed on the transposase genes detected in four Fervidobacterium genomes: F. nodosum, F. pennivorans, F. islandicum and a new isolate (Fervidobacterium sp. FC2004). Transposase sequences were classified in different groups by their degree of similarity. The different methods used in this study pointed that over half of the transposase genes represented putative HGT events with closest relative sequences within the phylum Firmicutes, being Caldicellulosiruptor the genus showing highest gene sequence proximity. These results confirmed a direct evolutionary relationship through HGT between specific Fervidobacterium species and thermophilic Firmicutes leading to potential gene sequence and functionality sharing to thrive under similar environmental conditions. Transposase-encoding genes represent suitable targets to approach the plasticity and potential mosaicism of bacterial genomes.	[Cuecas, Alba; Gonzalez, Juan M.] CSIC, IRNAS, Spanish Council Res, Inst Nat Resources & Agrobiol, Avda Rena Mercedes 10, Seville, Spain; [Kanoksilapatham, Wirojne] Silpakorn Univ, Fac Sci, Dept Microbiol, Nakhon Pathom, Thailand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Silpakorn University	Gonzalez, JM (corresponding author), CSIC, IRNAS, Spanish Council Res, Inst Nat Resources & Agrobiol, Avda Rena Mercedes 10, Seville, Spain.	jmgrau@irnase.csic.es	Cuecas, Alba/HHS-5405-2022	Cuecas, Alba/0000-0001-7567-4964; Gonzalez, Juan Miguel/0000-0003-4746-6775	Spanish Ministry of Economy and Competitiveness [CSD2009-00006, CGL2014-58762-P]; Regional Government of Andalusia [RNM2529, BIO288]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Regional Government of Andalusia(Junta de Andalucia)	This study was supported by funding through projects from the Spanish Ministry of Economy and Competitiveness (CSD2009-00006 and CGL2014-58762-P) and the Regional Government of Andalusia (RNM2529 and BIO288). The participation of FEDER funds is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding through projects from the Spanish Ministry of Economy and Competitiveness (CSD2009-00006 and CGL2014-58762-P) and the Regional Government of Andalusia (RNM2529 and BIO288). The participation of FEDER funds is acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875, DOI 10.1128/AEM.62.8.2875-2882.1996; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Hooper SD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r45; HUBER R, 1990, ARCH MICROBIOL, V154, P105, DOI 10.1007/BF00423318; Kanoksilapatham W, 2016, INT J SYST EVOL MICR, V66, P5023, DOI 10.1099/ijsem.0.001463; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee YJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0063-4; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2009, J BACTERIOL, V191, P1974, DOI 10.1128/JB.01448-08; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oksanen J., 2022, VEGAN COMMUNITY ECOL; PATEL BKC, 1985, ARCH MICROBIOL, V141, P63, DOI 10.1007/BF00446741; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Snyder L., 2007, MOL GENETICS BACTERI, VThird; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techtmann SM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00132; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Wolferen M, 2013, EXTREMOPHILES, V17, P545, DOI 10.1007/s00792-013-0552-6; Wagner A, 2006, MOL BIOL EVOL, V23, P723, DOI 10.1093/molbev/msj085; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	31	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0173961	10.1371/journal.pone.0173961	http://dx.doi.org/10.1371/journal.pone.0173961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426805	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900006
J	Jordan, T; Alves, OCP; De Wilde, P; de Lima-Neto, FB				Jordan, Tobias; Pinho Alves, Oto Costa; De Wilde, Philippe; de Lima-Neto, Fernando Buarque			Link-prediction to tackle the boundary specification problem in social network surveys	PLOS ONE			English	Article							MISSING DATA	Diffusion processes in social networks often cause the emergence of global phenomena from individual behavior within a society. The study of those global phenomena and the simulation of those diffusion processes frequently require a good model of the global network. However, survey data and data from online sources are often restricted to single social groups or features, such as age groups, single schools, companies, or interest groups. Hence, a modeling approach is required that extrapolates the locally restricted data to a global network model. We tackle this Missing Data Problem using Link-Prediction techniques from social network research, network generation techniques from the area of Social Simulation, as well as a combination of both. We found that techniques employing less information may be more adequate to solve this problem, especially when data granularity is an issue. We validated the network models created with our techniques on a number of real-world networks, investigating degree distributions as well as the likelihood of links given the geographical distance between two nodes.	[Jordan, Tobias; De Wilde, Philippe] Univ Kent, Sch Comp, Canterbury, Kent, England; [Pinho Alves, Oto Costa; de Lima-Neto, Fernando Buarque] Univ Pernambuco, Computat Intelligence Res Grp, Recife, PE, Brazil; [Pinho Alves, Oto Costa; de Lima-Neto, Fernando Buarque] Rua Benfica 455, BR-50720001 Recife, PE, Brazil; [Jordan, Tobias; De Wilde, Philippe] Univ Kent, Off Vice Chancellor, Canterbury CT2 7NZ, Kent, England	University of Kent; Universidade de Pernambuco (UPE); University of Kent	Jordan, T (corresponding author), Univ Kent, Sch Comp, Canterbury, Kent, England.; Jordan, T (corresponding author), Univ Kent, Off Vice Chancellor, Canterbury CT2 7NZ, Kent, England.	tj202@kent.ac.uk	De Wilde, Philippe/C-2256-2009; de Lima Neto, Fernando Buarque/G-4592-2011	De Wilde, Philippe/0000-0002-4332-1715; de Lima Neto, Fernando Buarque/0000-0003-1200-225X	Andreav on Braun Stiftung; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Andreav on Braun Stiftung; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Andreav on Braun Stiftung (TJ), http://www.avbstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 1998, MODERN GRAPH THEORY; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Coordenacao de Estudos Econornicos e Populacionais Fundacao Joaquim Nabuco-Fundaj, 2013, COORDENACAO ESTUDO S; De Caux R, 2014, COMPLEXITY, V19, P44, DOI 10.1002/cplx.21528; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Guimarães Maria José Bezerra, 2003, Cad. Saúde Pública, V19, P1413, DOI 10.1590/S0102-311X2003000500020; Hamill L., 2010, EMERGENCE-COMPLEX OR, V12, P78; Harris K.M., 2008, NATL LONGITUDINAL ST; HOLLAND PW, 1973, J MATH SOCIOL, V3, P85, DOI 10.1080/0022250X.1973.9989825; Huerta-Quintanilla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055371; Huisman M., 2009, J SOC STRUCT, V10, P1, DOI DOI 10.21307/joss-2019-051; Huisman M, 2008, SOC NETWORKS, V30, P297, DOI 10.1016/j.socnet.2008.04.004; Jordan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066199; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Laumann E.O., 1989, RES METHODS SOCIAL N, P61, DOI DOI 10.1504/IJTM.2016.075162; Leroy V., 2010, P 16 ACM SIGKDD INT, P393; Leskovec J., 2014, SNAP DATASETS STANFO; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; LINDERT Kathy, 2007, 0709 WORLD BANK CONS, V0709, P1; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mok D, 2010, URBAN STUD, V47, P2747, DOI 10.1177/0042098010377363; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Norval EA, 2012, PLOS ONE, V7; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Pinheiro F, 2011, PLOS ONE, V7; Scellato S, 2011, ICWSM, V11, P329; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; STORK D, 1992, GROUP ORGAN MANAGE, V17, P193, DOI 10.1177/1059601192172006; Tan F, 2013, PLOS ONE, V9; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; Zhang ZK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095785; zu Erbach-Schoenberg E., 2013, SOCIAL SCI COMPUTER, V32, P373	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176094	10.1371/journal.pone.0176094	http://dx.doi.org/10.1371/journal.pone.0176094			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426826	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900102
J	Lee, MY; Ha, SE; Park, C; Park, PJ; Fuchs, R; Wei, L; Jorgensen, BG; Redelman, D; Ward, SM; Sanders, KM; Ro, S				Lee, Moon Young; Ha, Se Eun; Park, Chanjae; Park, Paul J.; Fuchs, Robert; Wei, Lai; Jorgensen, Brian G.; Redelman, Doug; Ward, Sean M.; Sanders, Kenton M.; Ro, Seungil			Transcriptome of interstitial cells of Cajal reveals unique and selective gene signatures	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; MOUSE SMALL-INTESTINE; SMOOTH-MUSCLE-CELLS; C-KIT; GASTROINTESTINAL-TRACT; GROWTH-FACTOR; ELECTRICAL-ACTIVITY; PACEMAKER ACTIVITY; MURINE INTESTINE; SLOW WAVES	Transcriptome-scale data can reveal essential clues into understanding the underlying molecular mechanisms behind specific cellular functions and biological processes. Transcriptomics is a continually growing field of research utilized in biomarker discovery. The transcriptomic profile of interstitial cells of Cajal (ICC), which serve as slow-wave electrical pacemakers for gastrointestinal (GI) smooth muscle, has yet to be uncovered. Using copGFP-labeled ICC mice and flow cytometry, we isolated ICC populations from the murine small intestine and colon and obtained their transcriptomes. In analyzing the transcriptome, we identified a unique set of ICC-restricted markers including transcription factors, epigenetic enzymes/regulators, growth factors, receptors, protein kinases/phosphatases, and ion channels/transporters. This analysis provides new and unique insights into the cellular and biological functions of ICC in GI physiology. Additionally, we constructed an interactive ICC genome browser (http://med.unr.edu/physio/transcriptome) based on the UCSC genome database. To our knowledge, this is the first online resource that provides a comprehensive library of all known genetic transcripts expressed in primary ICC. Our genome browser offers a new perspective into the alternative expression of genes in ICC and provides a valuable reference for future functional studies.	[Lee, Moon Young; Ha, Se Eun; Park, Chanjae; Park, Paul J.; Fuchs, Robert; Wei, Lai; Jorgensen, Brian G.; Redelman, Doug; Ward, Sean M.; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV USA; [Lee, Moon Young] Wonkwang Univ, Wonkwang Digest Dis Res Inst, Dept Physiol, Iksan, South Korea; [Lee, Moon Young] Wonkwang Univ, Sch Med, Wonkwang Digest Dis Res Inst, Iksan, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University; Wonkwang University	Ro, S (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV USA.	sro@med.unr.edu	Wei, Lai/GQH-9760-2022	Ro, Seungil/0000-0003-0861-8334	National Institutes of Health (NIH) [DK091752, DK094886, DK041315]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103055, R01DK094886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) [DK091752 and DK094886 to S. Ro, DK041315 to K.M. Sanders and S.Ro]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Congote LF, 2004, BIOCHEM BIOPH RES CO, V324, P673, DOI 10.1016/j.bbrc.2004.09.107; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; DiFrancesco D, 2010, HEART RHYTHM, V7, P276, DOI 10.1016/j.hrthm.2009.10.030; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirst GDS, 2002, J PHYSIOL-LONDON, V540, P1003, DOI 10.1113/jphysiol.2001.013672; Hudson NPH, 1999, RES VET SCI, V66, P265, DOI 10.1053/rvsc.1998.0297; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huizinga JD, 2002, GASTROENTEROLOGY, V123, P1627, DOI 10.1053/gast.2002.36549; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2009, ARCH HISTOL CYTOL, V72, P107, DOI 10.1679/aohc.72.107; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; Kunzelmann K, 2011, BIOL CHEM, V392, P125, DOI 10.1515/BC.2011.010; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Lammers WJEP, 2008, EXP PHYSIOL, V93, P334, DOI 10.1113/expphysiol.2007.039180; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; MAEDA H, 1992, DEVELOPMENT, V116, P369; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Nanba D, 2004, CYTOKINE GROWTH F R, V15, P13, DOI 10.1016/j.cytogfr.2003.10.002; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Park C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.353; Park C, 2015, J NEUROGASTROENTEROL, V21, P589, DOI 10.5056/jnm15063; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Quattrone A, 2012, J PATHOL, V228, P565, DOI 10.1002/path.4071; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Romert P, 1998, HISTOCHEM CELL BIOL, V109, P195, DOI 10.1007/s004180050218; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Shahi PK, 2014, J GASTROENTEROL, V49, P1001, DOI 10.1007/s00535-013-0849-3; Si XM, 2012, DIGESTION, V85, P266, DOI 10.1159/000337077; Southwell BR, 2003, NEUROGASTROENT MOTIL, V15, P139, DOI 10.1046/j.1365-2982.2003.00394.x; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Studniarczyk D, 2013, NAT NEUROSCI, V16, P1266, DOI 10.1038/nn.3473; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TORIHASHI S, 1995, CELL TISSUE RES, V280, P97, DOI 10.1007/s004410050334; Torihashi S, 1999, GASTROENTEROLOGY, V117, P140, DOI 10.1016/S0016-5085(99)70560-3; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; Vanderwinden JM, 1999, MICROSC RES TECHNIQ, V47, P344, DOI 10.1002/(SICI)1097-0029(19991201)47:5<344::AID-JEMT6>3.0.CO;2-1; Ward SM, 2006, J PHYSIOL-LONDON, V573, P147, DOI 10.1113/jphysiol.2006.105189; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 2002, AM J PHYSIOL-GASTR L, V283, pG445, DOI 10.1152/ajpgi.00475.2001; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Zhu MH, 2011, J PHYSIOL-LONDON, V589, P4565, DOI 10.1113/jphysiol.2011.211094; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	68	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176031	10.1371/journal.pone.0176031	http://dx.doi.org/10.1371/journal.pone.0176031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426719	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900090
J	Rudigier, LJ; Dame, C; Scholz, H; Kirschner, KM				Rudigier, Lucas J.; Dame, Christof; Scholz, Holger; Kirschner, Karin M.			Ex vivo cultures combined with vivo-morpholino induced gene knockdown provide a system to assess the role of WT1 and GATA4 during gonad differentiation	PLOS ONE			English	Article							WILMS-TUMOR SUPPRESSOR; TRANSCRIPTION FACTOR GATA4; FETAL LEYDIG-CELLS; SEX DETERMINATION; MOUSE TESTIS; KIDNEY DEVELOPMENT; SIGNALING PATHWAY; PROGENITOR CELLS; CANDIDATE GENES; SF1 EXPRESSION	Gonad morphogenesis relies on the correct spatiotemporal expression of a number of genes that together fulfill the differentiation of the bipotential gonad into testes or ovaries. As such, the transcription factors WT1 and GATA4 are pivotal for proper gonadal development. Here we address the contributions of GATA4 and WT1 to the sex differentiation phase in testes and ovaries. We applied an ex vivo technique for cultivating gonads in hanging droplets of media that were supplemented with vivo-morpholinos to knockdown WT1 and GATA4 either alone or in combination at the same developmental stage. We show that WT1 is equally important for both, the initial establishment and the maintenance of the sex-specific gene expression signature in testes and ovaries. We further identified Foxl2 as a novel putative downstream target gene of WT1. Moreover, knockdown of WT1 reduced mRNA levels of several molecular components of the hedgehog signaling pathway in XY gonads, whereas Gata4 vivo-morpholino treatment increased transcripts of Dhh and Ptch1 in embryonic testes. The data suggest that for its proper function, WT1 relies on the correct expression of the GATA4 protein. Furthermore, GATA4 down-regulates several ovarian promoting genes in testes, such as Ctnnb1, Fst, and Bmp2, suggesting that this repression is required for maintaining the male phenotype. In conclusion, this study provides novel insights into the role of WT1 and GATA4 during the sex differentiation phase and represents an approach that can be applied to assess other proteins with as yet unknown functions during gonadal development.	[Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.] Charite, Inst Vegetat Physiol, Campus Charite Mitte, Berlin, Germany; [Dame, Christof] Charite, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany; [Rudigier, Lucas J.] Humboldt Univ, Inst Biol, IRI Life Sci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Campus Charite Mitte, Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636	Deutsche Forschungsgemeinschaft [SCHO 634/8-1, DA 484/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants by the Deutsche Forschungsgemeinschaft (SCHO 634/8-1 to HS and DA 484/3-1 to CD), http://www.dfg.de/.	Barsoum I, 2011, BIOL REPROD, V84, P894, DOI 10.1095/biolreprod.110.088997; Barsoum IB, 2009, DEV BIOL, V329, P96, DOI 10.1016/j.ydbio.2009.02.025; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Bunce C, 2016, CURR TOP DEV BIOL, V116, P153, DOI 10.1016/bs.ctdb.2015.10.001; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Chen MX, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/954253; Chen M, 2017, DEVELOPMENT, V144, P44, DOI 10.1242/dev.144105; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Cool J, 2009, SEMIN REPROD MED, V27, P5, DOI 10.1055/s-0028-1108005; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Efimenko E, 2013, DEV BIOL, V381, P144, DOI 10.1016/j.ydbio.2013.06.004; Eggers S, 2015, EUR J HUM GENET, V23, P486, DOI 10.1038/ejhg.2014.130; Franco HL, 2012, CHROMOSOME RES, V20, P247, DOI 10.1007/s10577-011-9254-z; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao YK, 2014, DEVELOPMENT, V141, P2271, DOI 10.1242/dev.105676; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hu YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003629; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, SEX DEV, V1, P238, DOI 10.1159/000104774; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Liu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010382; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Manuylov NL, 2011, DEV BIOL, V353, P229, DOI 10.1016/j.ydbio.2011.02.032; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Mazaud-Guittot S, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113290; McClelland KS, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128918; McClelland KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114932; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; Munger SC, 2012, WIRES SYST BIOL MED, V4, P401, DOI 10.1002/wsbm.1172; Pierucci-Alves F, 2001, BIOL REPROD, V65, P1392, DOI 10.1095/biolreprod65.5.1392; R Core Team, 2013, R LANG ENV STAT COMP; Ryan J, 2011, SEX DEV, V5, P7, DOI 10.1159/000322162; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Svingen T, 2009, DEV DYNAM, V238, P956, DOI 10.1002/dvdy.21919; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takasawa K, 2014, FASEB J, V28, P2020, DOI 10.1096/fj.13-246108; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Thurisch B, 2009, J MOL ENDOCRINOL, V43, P157, DOI 10.1677/JME-09-0030; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Viger RS, 1998, DEVELOPMENT, V125, P2665; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wen Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167920; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202	65	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176296	10.1371/journal.pone.0176296	http://dx.doi.org/10.1371/journal.pone.0176296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426816	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900127
J	Shi, Y; Zhang, Y; Lou, JZ				Shi, Yi; Zhang, Yong; Lou, Jizhong			The influence of cell membrane and SNAP25 linker loop on the dynamics and unzipping of SNARE complex	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ALL-ATOM; FUSION; SYNAPTOTAGMIN; SNAP-25; PROTEIN; SIMULATIONS; EXOCYTOSIS	The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex is composed of three neuronal proteins VAMP2, Syntaxin and SNAP25, which plays a core role during the process of membrane fusion. The zipping assembly of the SNARE complex releases energies and drives the vesicle and cell membrane into close proximity. In this study, we use all-atom molecular dynamics simulations to probe the dynamics of SNARE and its unzipping process in the context of membrane at the atomistic details. Our results indicated that the NTD of SNARE core domain is relatively more stable than CTD, which is in agreement with previous experiments. More importantly, possible interactions between the linker loop (LL) region of SNAP25 and VAMP2 are observed, suggests that the LL region may facilitate VAMP2 binding and SNARE initiation. The forced unzipping of SNARE in the presence of membrane and LL of SNAP25 reveals the possible pathway for energy generation of SNARE zipping, provides information to understand how force may regulate the cooperativity between the membrane and the SNARE complex.	[Shi, Yi] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Shi, Yi; Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, JZ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China.	jlou@ibp.ac.cn		Shi, Yi/0000-0002-6281-8911	National Basic Research Program of China [2014C6910202]; National Natural Science Foundation of China [31222022, 11302240]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2014C6910202 (to JL) (program.most.gov.cn) and National Natural Science Foundation of China grants 31222022 (to JL) and 11302240 (to YZ) (isisn. nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajohrs M, 2005, BIOCHEM J, V392, P283, DOI 10.1042/BJ20050583; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bock LV, 2010, BIOPHYS J, V99, P1221, DOI 10.1016/j.bpj.2010.06.019; Bykhovskaia M, 2013, BIOPHYS J, V105, P679, DOI 10.1016/j.bpj.2013.06.018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durrieu MP, 2008, BIOPHYS J, V94, P3436, DOI 10.1529/biophysj.107.123117; Durrieu MP, 2009, CHEMPHYSCHEM, V10, P1548, DOI 10.1002/cphc.200900216; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Li F, 2014, J AM CHEM SOC, V136, P3456, DOI 10.1021/ja410690m; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma L, 2015, ELIFE, V4, P4; Malinin VS, 2004, BRACHYTHERAPY, V86, P334; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tekpinar M, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2381-7; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Wang L, 2008, MOL BIOL CELL, V19, P3944, DOI 10.1091/mbc.E08-04-0344; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zheng WJ, 2014, PROTEINS, V82, P1376, DOI 10.1002/prot.24505; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975	42	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176235	10.1371/journal.pone.0176235	http://dx.doi.org/10.1371/journal.pone.0176235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426820	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900120
J	Zhou, K; Chen, DD; Li, B; Zhang, BY; Miao, F; Zhou, L				Zhou, Kun; Chen, Dongdong; Li, Bin; Zhang, Bingyu; Miao, Fang; Zhou, Le			Bioactivity and structure-activity relationship of cinnamic acid esters and their derivatives as potential antifungal agents for plant protection	PLOS ONE			English	Article							WITTIG-TYPE; ALDEHYDES; ESTERIFICATION; OLEFINATION; ANTAGONISTS; INHIBITORS; GROWTH; QSAR	A series of cinnamic acid esters and their derivatives were synthesized and evaluated for antifungal activities in vitro against four plant pathogenic fungi by using the mycelium growth rate method. Structure-activity relationship was derived also. Almost all of the compounds showed some inhibition activity on each of the fungi at 0.5 mM. Eight compounds showed the higher average activity with average EC50 values of 17.4-28.6 mu g/mL for the fungi than kresoxim-methyl, a commercial fungicide standard, and ten compounds were much more active than commercial fungicide standards carbendazim against P. grisea or kresoxim-methyl against both P. grisea and Valsa mali. Compounds C1 and C2 showed the higher activity with average EC50 values of 17.4 and 18.5 mu g/mL and great potential for development of new plant antifungal agents. The structure-activity relationship analysis showed that both the substitution pattern of the phenyl ring and the alkyl group in the alcohol moiety significantly influences the activity. There exists complexly comprehensive effect between the substituents on the phenyl ring and the alkyl group in the alcohol moiety on the activity. Thus, cinnamic acid esters showed great potential the development of new antifungal agents for plant protection due to high activity, natural compounds or natural compound framework, simple structure, easy preparation, low-cost and environmentally friendly.	[Zhou, Kun; Chen, Dongdong; Zhang, Bingyu; Zhou, Le] Northwest A&F Univ, Coll Chem & Pharm, Yangling, Shaanxi, Peoples R China; [Li, Bin; Miao, Fang] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhou, L (corresponding author), Northwest A&F Univ, Coll Chem & Pharm, Yangling, Shaanxi, Peoples R China.; Miao, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	miaofangmf@163.com; zhoulechem@nwsuaf.edu.cn		Zhou, Kun/0000-0003-0782-3491	National Natural Science Foundation of China [31172365, 31572038]; Agricultural Science and Technology Innovation Project of Shaanxi Province [2016NY-171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Project of Shaanxi Province	This work was financially supported by the National Natural Science Foundation of China (31172365, 31572038), http://www.nsfc.gov.cn/, Zhou, Geng. This study was also supported by the Agricultural Science and Technology Innovation Project of Shaanxi Province (2016NY-171). The funders had no role in study design,data collection and analysis,decision to publish, or preparation of the manuscript.	Bisogno F, 2007, J AGR FOOD CHEM, V55, P10635, DOI 10.1021/jf0729098; Bock CH, 2014, J PEST SCI, V87, P155, DOI 10.1007/s10340-013-0519-5; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; Cao P, 2007, J ORG CHEM, V72, P6628, DOI 10.1021/jo0709899; Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Davies SG, 2007, TETRAHEDRON-ASYMMETR, V18, P1554, DOI 10.1016/j.tetasy.2007.06.008; De P, 2011, CURR MED CHEM, V18, P1672, DOI 10.2174/092986711795471347; De Vita D, 2014, BIOORG MED CHEM LETT, V24, P1502, DOI 10.1016/j.bmcl.2014.02.005; Debnath B, 2003, BIOORGAN MED CHEM, V11, P1615, DOI 10.1016/S0968-0896(03)00085-3; Delp C. J., 1980, Plant Disease, V64, P652, DOI 10.1094/PD-64-652; El-Batta A, 2007, J ORG CHEM, V72, P5244, DOI 10.1021/jo070665k; Fan X, 2010, EUR J MED CHEM, V45, P2827, DOI 10.1016/j.ejmech.2010.03.003; Fontan N, 2013, BIOORGAN MED CHEM, V21, P2056, DOI 10.1016/j.bmc.2013.01.017; FRIMER AA, 1986, ISR J CHEM, V27, P39; Fu J, 2010, EUR J MED CHEM, V45, P2638, DOI 10.1016/j.ejmech.2010.01.066; Gagey N, 2007, J AM CHEM SOC, V129, P9986, DOI 10.1021/ja0722022; Guzman JD, 2014, MEDCHEMCOMM, V5, P47, DOI 10.1039/c3md00251a; Hazir S, 2016, EUR J PLANT PATHOL, V146, P369, DOI 10.1007/s10658-016-0923-9; HOSKINS JA, 1984, J APPL TOXICOL, V4, P283, DOI 10.1002/jat.2550040602; Hou Z, 2016, J AGR FOOD CHEM, V64, P2847, DOI 10.1021/acs.jafc.6b00505; Huang ZZ, 2002, J ORG CHEM, V67, P5320, DOI 10.1021/jo025693b; Lafay Sophie, 2008, Phytochemistry Reviews, V7, P301, DOI 10.1007/s11101-007-9077-x; Lee SU, 2007, EUR J MED CHEM, V42, P1309, DOI 10.1016/j.ejmech.2007.02.016; Liu J, 2014, ORG BIOMOL CHEM, V12, P2637, DOI 10.1039/c4ob00193a; Lu M, 2013, J APPL MICROBIOL, V115, P187, DOI 10.1111/jam.12208; Otero E, 2014, MED CHEM RES, V23, P1378, DOI 10.1007/s00044-013-0741-y; Ouimet MA, 2013, MACROMOL RAPID COMM, V34, P1231, DOI 10.1002/marc.201300323; Penafiel I, 2012, EUR J ORG CHEM, V2012, P3151, DOI 10.1002/ejoc.201200181; Savary S, 2006, ANNU REV PHYTOPATHOL, V44, P89, DOI 10.1146/annurev.phyto.44.070505.143342; Sinha AK, 2008, U.S. Pat. Appl. Publ, Patent No. [US 20080045742 A1 20080221, 20080045742]; Sova M, 2012, MINI-REV MED CHEM, V12, P749, DOI 10.2174/138955712801264792; Sova M, 2006, BIOORGAN MED CHEM, V14, P7404, DOI 10.1016/j.bmc.2006.07.027; Tyagi V, 2016, ANGEW CHEM INT EDIT, V55, P2512, DOI 10.1002/anie.201508817; Wedge DE, 2000, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, P1; Wong CTT, 2013, ANGEW CHEM INT EDIT, V52, P10212, DOI 10.1002/anie.201304773; Xin YC, 2011, EUR J ORG CHEM, V2011, P6527, DOI 10.1002/ejoc.201100937; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Yang WF, 2015, CHEM COMMUN, V51, P9575, DOI 10.1039/c5cc02277k; Zhan SQ, 2014, GREEN CHEM, V16, P4649, DOI 10.1039/c4gc01395f; Zhang BY, 2015, CHEM PHARM BULL, V63, P255, DOI 10.1248/cpb.c14-00765; Zhu MK, 2011, ORG LETT, V13, P6308, DOI 10.1021/ol202862t	42	27	27	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176189	10.1371/journal.pone.0176189	http://dx.doi.org/10.1371/journal.pone.0176189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423022	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600097
J	Ali, A; Abd Rezak, S; Othman, SH; Mohammed, A; Saeed, F				Ali, Abdulalem; Abd Rezak, Shukor; Othman, Siti Hajar; Mohammed, Arafat; Saeed, Faisal			A metamodel for mobile forensics investigation domain	PLOS ONE			English	Article							VALIDATION	With the rapid development of technology, mobile phones have become an essential tool in terms of crime fighting and criminal investigation. However, many mobile forensics investigators face difficulties with the investigation process in their domain. These difficulties are due to the heavy reliance of the forensics field on knowledge which, although a valuable resource, is scattered and widely dispersed. The wide dispersion of mobile forensics knowledge not only makes investigation difficult for new investigators, resulting in substantial waste of time, but also leads to ambiguity in the concepts and terminologies of the mobile forensics domain. This paper developed an approach for mobile forensics domain based on metamodeling. The developed approach contributes to identify common concepts of mobile forensics through a development of the Mobile Forensics Metamodel (MFM). In addion, it contributes to simplifying the investigation process and enables investigation teams to capture and reuse specialized forensic knowledge, thereby supporting the training and knowledge management activities. Furthermore, it reduces the difficulty and ambiguity in the mobile forensics domain. A validation process was performed to ensure the completeness and correctness of the MFM. The validation was conducted using two techniques for improvements and adjustments to the metamodel. The last version of the adjusted metamodel was named MFM 1.2.	[Ali, Abdulalem; Abd Rezak, Shukor; Othman, Siti Hajar; Mohammed, Arafat; Saeed, Faisal] Univ Teknol Malaysia, Fac Comp, Skudai, Johor, Malaysia; [Ali, Abdulalem] Taiz Univ, Fac Engn & Informat Technol, Taizi, Yemen	Universiti Teknologi Malaysia	Ali, A (corresponding author), Univ Teknol Malaysia, Fac Comp, Skudai, Johor, Malaysia.; Ali, A (corresponding author), Taiz Univ, Fac Engn & Informat Technol, Taizi, Yemen.	almaldolah2012@gmail.com	razak, shukor abd/AAN-1035-2020; razak, shukor abd/F-5651-2011; Othman, Siti Hajar/K-5692-2012; Saeed, Faisal/ABB-6958-2020	razak, shukor abd/0000-0002-8824-6069; razak, shukor abd/0000-0002-8824-6069; Othman, Siti Hajar/0000-0002-0205-4948; Saeed, Faisal/0000-0002-2822-1708; Ali, Abdulalem/0000-0001-5542-5952				Ab Rahman NH, 2016, CONCURRENCY COMPUTAT; Ab Rahman NH, 2016, IEEE CLOUD COMPUT, V3, P50, DOI 10.1109/MCC.2016.5; Agarwal A, 2012, INT J COMPUT SCI SEC, V6, P322; Agarwal A., 2011, INT J COMPUT SCI SEC, V5, P118, DOI DOI 10.9790/3021-0203392398; Ahmed R, 2013, IJARCCE, V2, P1019; Ahmed R, 2009, COMM COM INF SC, V31, P173; Akarawita IU, 2015, ADV ICT EM REG ICTER; Alghafli KA, 2011, GUIDELINES DIGITAL F; Alhir SS, 2003, UNDERSTANDING MODEL; Ali A., 2015, 1 INT C INN SCI TECH; Alzaabi Mohammed, 2013, EL CIRC SYST ICECS 2; Ayers R., 2013, NIST SPEC PUBL, V800, P101; Azfar A, 2016, 2016 49 HAW INT C SY; Azfar A, 2016, J FORENSIC SCI, V61, P1337, DOI 10.1111/1556-4029.13164; Barmpatsalou K, 2013, DIGIT INVEST, V10, P323, DOI 10.1016/j.diin.2013.10.003; Bermell-Garcia P., 2007, METAMODEL ANNOTATE K; Beydoun G, 2009, INFORM SOFTWARE TECH, V51, P832, DOI 10.1016/j.infsof.2008.05.003; Beydoun G, 2009, IEEE T SOFTWARE ENG, V35, P841, DOI 10.1109/TSE.2009.34; Brodkin J., MOBILE PHONES BE PRI; Cahyani NDW, 2016, CONCURRENCY COMPUTAT; Caro MF, 2014, BIOL INSPIR COGN ARC, V9, P82, DOI 10.1016/j.bica.2014.07.002; Casey E., 2011, DIGITAL EVIDENCE COM; Casey E, 2010, DIGIT INVEST, V6, P136, DOI 10.1016/j.diin.2010.01.004; Cerwall P., 2015, ERICSSON MOBILITY RE; Chanajitt R, 2018, AUST J FORENSIC SCI, V50, P3, DOI 10.1080/00450618.2016.1182589; Chang C-P, 2013, SYST SCI ENG ICSSE 2; Dancer FC, 2013, ADV INTELL SYST, V178, P279; Daryabar F, 2017, AUST J FORENSIC SCI, V49, P344, DOI 10.1080/00450618.2016.1153714; Dasari Manendra Sai NRGKP, 2015, INT J COMPUTER SCI I, V6, P4847; De Kok D, 2010, P 6 INT NAT LANG GEN; Di Leom M, 2015, TRUSTCOM BIGDATASE I; Do Q, 2016, SOFTWARE PRACTICE EX; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Farjamfar A., 2014, RES J APPL SCI ENG T, V8, P358; Formica A, 2002, COMPUT J, V45, P583, DOI 10.1093/comjnl/45.6.583; Frantzi KT, 1997, P 3 DELOS WORKSH; Gartner, APPL SAMS SET CONT T; Gary Kessler RA, 2014, NIST MOB FOR WORKSH; Higginbotham S., 2010, ERICSSON CEO PREDICT; Hoog A., 2011, ANDROID FORENSICS IN; Husain M. I., 2011, DIGITAL FORENSICS CY, P27; Immanuel F, 2015, TRUSTCOM BIGDATASE I; Jane MM, 2014, ENHANCED MOBILE FORE; Jansen W., 2007, NIST SPEC PUBL, V800, P101; Jansen W., 2009, MOBILE FORENSIC REFE; Kaur R., APPROACH MOBILE FORE; Khelalfa HM, 2011, FORENSICS CHALLENGES, P72; Kristina Rose LOR, 2009, ELECT CRIME SCENE IN; Lee JH, 2012, COMM COM INF SC, V310, P268; Lessard Jeff, 2010, ANDROID FORENSICS SI; Lin I-L, 2011, BROADB WIR COMP COMM; Lutui PR, 2015, DIGITAL FORENSIC PRO; Martini B, 2014, TRUST SEC PRIV COMP; Martini B., 2015, ARXIV150605527; Martini B, 2014, DIGIT INVEST, V11, P295, DOI 10.1016/j.diin.2014.08.002; Marturana F., 2011, 2011 IEEE 10 INT C T; McMillan JER, 2013, SYST SCI HICSS 2013; Menard PA, 2015, AUTOMAT SOFTW ENG, P1; Mohtasebi S. H., 2013, International Journal of Computer Theory and Engineering, V5, P351, DOI 10.7763/IJCTE.2013.V5.708; Mumba ER, 2014, INFO SECUR S AFR; Murphy CA, 2009, DEV PROCESS MOBILE D; Mylonas A, 2012, IFIP ADV INF COMM TE, V376, P249; Omeleze S, 2013, INFORM SECURITY S AF, V2013; Othman SH, 2010, METAMODELLING APPROA; Othman SH, 2014, INFORM PROCESS MANAG, V50, P235, DOI 10.1016/j.ipm.2013.11.001; Parvez S, 2011, EL COMP TECHN ICECT; PAUL K, 2014, GENERIC PROCESS MODE; Quick D., 2013, CLOUD STORAGE FORENS; Quick D, 2016, CLUSTER COMPUT, V19, P723, DOI 10.1007/s10586-016-0553-1; Quick D, 2014, DIGIT INVEST, V11, P273, DOI 10.1016/j.diin.2014.09.002; Quick D, 2013, DIGIT INVEST, V10, P3, DOI 10.1016/j.diin.2013.02.003; Rajendran S., 2016, P INT C SOFT COMP SY; Ramabhadran A., 2007, FORENSIC INVESTIGATI, P1; Ruuhwan R., 2016, J EDUKASI DAN PENELI, DOI [10.26418/jp.v2i1.14369, DOI 10.26418/JP.V2I1.14369]; Sadiq M, 2016, ISJ THEORETICAL APPL, V1, P164; Sargent RG, 2013, J SIMUL, V7, P12, DOI [10.1057/jos.2012.20, 10.1109/WSC.1998.744907]; Sargent RG, 2005, P 37 C WINT SIM 2005; Shah V., 2012, INT J COMPUTER SCI I, V2, P739; Sophos, 2014, SEC THREAT REP; Srivastava H, 2015, INF COMPUT SECUR, V23, P450, DOI 10.1108/ICS-02-2014-0013; Summers C., 2003, BBC NEWS, V18; Teing Y-Y, 2016, COMPUTERS ELECT ENG; Turnbull B, 2009, AV REL SEC 2009 ARES; Velardi P, 2001, P WORKSH HUM LANG TE, V2001; Votipka D, 2013, PASSE PARTOUT GEN CO; Weiping Chang, 2014, Intelligence and Security Informatics. Pacific Asia Workshop, PAISI 2014. Proceedings: LNCS 8440, P8, DOI 10.1007/978-3-319-06677-6_2; Yang TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150300; Yitao YANG GS, 2014, J COMPUTATIONAL INFO, P4375; Yu X, 2009, COMM COM INF SC, V59, P86; Yusoff M.N., 2014, INT J CYBER SECUR DI, V3, P183, DOI DOI 10.17781/P001338	90	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176223	10.1371/journal.pone.0176223	http://dx.doi.org/10.1371/journal.pone.0176223			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445486	gold, Green Submitted, Green Published			2022-12-27	WOS:000400309200039
J	Ali, BH; Karaca, T; Al Suleimani, Y; Al Za'abi, M; Al Kalbani, J; Ashique, M; Nemmar, A				Ali, Badreldin H.; Karaca, Turan; Al Suleimani, Yousuf; Al Za'abi, Mohammed; Al Kalbani, Jamila; Ashique, Mohammed; Nemmar, Abderrahim			The effect of swimming exercise on adenineinduced kidney disease in rats, and the influence of curcumin or lisinopril thereon	PLOS ONE			English	Article							5/6 NEPHRECTOMIZED RATS; CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; CARDIOVASCULAR PROTECTION; SEDENTARY BEHAVIORS; PHYSICAL-ACTIVITY; HYPERTENSION; INFLAMMATION; FIBROSIS; INJURY	Patients with chronic kidney disease (CKD) have been reported to benefit from different types of exercises. It has also been shown that the ACE inhibitor lisinopril, and the natural product curcumin are also beneficial in different models of CKD in rats. We assessed the influence of moderate swimming exercise (SE) on rats with adenine- induced CKD, and tested the possible effects of lisinopril and/or curcumin thereon using several physiological, biochemical, histopathological and immunohistochemical parameters. Rats (either sedentary or subjected to SE) were randomly divided into several groups, and given for five weeks either normal food or food mixed with adenine (0.25% w/w) to induce CKD. Some of these groups were also concomitantly treated orally with curcumin (75 mg/kg), or lisinopril (10 mg/kg) and were subjected to moderate SE (45 min/day three days each week). Rats fed adenine showed the typical biochemical, histopathological signs of CKD such as elevations in blood pressure, urinary albumin / creatinine ratio, and plasma urea, creatinine, indoxyl sulfate and phosphorus. SE, curcumin or lisinopril, given singly, significantly ameliorated all the adenine-induced actions. Administering curcumin or lisinopril with SE improved the histopathology of the kidneys, a salutary effect not seen with SE alone. Combining SE to the nephroprotective agents' curcumin or lisinopril might offer additional nephroprotection.	[Ali, Badreldin H.; Al Suleimani, Yousuf; Al Za'abi, Mohammed; Al Kalbani, Jamila; Ashique, Mohammed] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman; [Karaca, Turan] Trakya Univ, Dept Histol Embryol, Fac Med, Balkan Campus, Edirne, Turkey; [Nemmar, Abderrahim] United Arab Emirates Univ, Dept Physiol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	Sultan Qaboos University; Trakya University; United Arab Emirates University	Ali, BH (corresponding author), Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman.	akthmali@squ.edu.om	KARACA, Turan/ABD-6669-2020; Za'abi, Mohammed Al/C-6591-2013	KARACA, Turan/0000-0002-2500-7781; Za'abi, Mohammed Al/0000-0002-2019-1022; Ali, Badreldin/0000-0001-6491-6278; Ashique, Mohammed/0000-0002-3132-1478	Research Council of Oman [REC/MED/PHARM/13/01]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This study was financially supported by the Research Council of Oman (REC/MED/PHARM/13/01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suleimani YM, 2017, ENVIRON TOXICOL, V32, P541, DOI 10.1002/tox.22258; Al Za'abi M, 2017, PHYSIOL RES, V66, P263, DOI 10.33549/physiolres.933374; Al Za'abi M, 2015, AM J TRANSL RES, V7, P28; Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ali BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102528; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Ali BH, 2011, PHYTOMEDICINE, V18, P1176, DOI 10.1016/j.phymed.2011.03.005; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali BH, 2005, FUND CLIN PHARMACOL, V19, P473, DOI 10.1111/j.1472-8206.2005.00343.x; Ali BH, 2016, FASEB J S, V30, p771 8; Banday AA, 2011, HYPERTENSION, V57, P452, DOI 10.1161/HYPERTENSIONAHA.110.162339; Barcellos FC, 2015, CLIN KIDNEY J, V8, P753, DOI 10.1093/ckj/sfv099; Barhoumi T, 2014, J HYPERTENS, V32, P784, DOI 10.1097/HJH.0000000000000101; Beetham KS, 2016, J SPORTS ME IN PRESS; Bugyei-Twum A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39551; Cechella JL, 2014, AMINO ACIDS, V46, P1187, DOI 10.1007/s00726-014-1679-1; Chen KC, 2014, EUR J PREV CARDIOL, V21, P507, DOI 10.1177/2047487312462827; Despres JP, 2016, CAN J CARDIOL, V32, P505, DOI 10.1016/j.cjca.2015.12.006; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Feere DA, 2015, BRIT J PHARMACOL, V172, P201, DOI 10.1111/bph.12932; Ferrari GO, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-69; Gencer B, 2014, CUTAN OCUL TOXICOL, V33, P283, DOI 10.3109/15569527.2013.857677; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Howden EJ, 2016, AUTON NEUROSCI-BASIC; Howden EJ, 2015, CURR OPIN NEPHROL HY, V24, P480, DOI 10.1097/MNH.0000000000000165; Izumi A, 2016, REV RECENT CLIN TRIA, V11, P333, DOI 10.2174/1574887111666160724182015; Kaltsatou A, 2016, CURR PHARM DESIGN, V22, P3700, DOI 10.2174/1381612822666160322144936; Kim EJ, 2013, J GINSENG RES, V37, P87, DOI 10.5142/jgr.2013.37.87; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Kumral ZNO, 2016, J PHYSIOL PHARMACOL, V67, P45; Lau WL, 2015, NEPHRON, V130, P92, DOI 10.1159/000381990; Lazar JM, 2013, INT J CARDIOL, V168, P19, DOI 10.1016/j.ijcard.2013.03.063; Lu Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0263-y; Nelson A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000370; Pechter U, 2003, INT J REHABIL RES, V26, P153, DOI 10.1097/01.mrr.0000070755.63544.5a; Pena-Polanco JE, 2016, SEMIN NEPHROL, V36, P331, DOI 10.1016/j.semnephrol.2016.05.009; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Perico N, 2016, INTERN EMERG MED, V11, P385, DOI 10.1007/s11739-016-1425-7; Raag M, INT J REHABLI RES; Sakr HF, 2013, J PHYSIOL PHARMACOL, V64, P231; Soni RK, 2010, CURR OPIN NEPHROL HY, V19, P153, DOI 10.1097/MNH.0b013e328335f939; Sutariya B, 2017, J ETHNOPHARMACOL, V198, P432, DOI 10.1016/j.jep.2016.12.048; Tokoroyama T, 2016, NEPHROL DIAL TRANSPL; Topcu-Tarladacalisir Y, 2016, REN FAIL, V19, P1; Ulu N, 2013, J PHARMACOL EXP THER, V345, P393, DOI 10.1124/jpet.113.203497; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vettoretti S, 2016, AM J PHYSIOL-RENAL, V310, pF1047, DOI 10.1152/ajprenal.00325.2015; Waly MI, 2013, TOXICOL IN VITRO, V27, P2299, DOI 10.1016/j.tiv.2013.09.023; Wouters OJ, 2015, NAT REV NEPHROL, V11, P491, DOI 10.1038/nrneph.2015.85; Xia J, 2016, J INTEGR MED-JIM, V14, P165, DOI 10.1016/S2095-4964(16)60256-X; Ziada AM, 2009, J HYPERTENS, V27, P1309, DOI 10.1097/HJH.0b013e328329fb55; Zoccali C, 2014, NEPHROL DIAL TRANSPL, V29, P483, DOI 10.1093/ndt/gfu029	53	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176316	10.1371/journal.pone.0176316	http://dx.doi.org/10.1371/journal.pone.0176316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445490	gold, Green Published, Green Submitted			2022-12-27	WOS:000400309200045
J	Lee, KB; Kelbauskas, L; Brunner, A; Meldrum, DR				Lee, Kristen B.; Kelbauskas, Laimonas; Brunner, Alan; Meldrum, Deirdre R.			A versatile method for dynamically controlled patterning of small populations of epithelial cells on substrates via non-contact piezoelectric inkjet printing	PLOS ONE			English	Article							MAMMALIAN-CELLS; CANCER; MICROARRAYS; METASTASIS; EVOLUTION	Intercellular interactions play a central role at the tissue and whole organism level modulating key cellular functions in normal and disease states. Studies of cell-cell communications are challenging due to ensemble averaging effects brought about by intrinsic heterogeneity in cellular function which requires such studies to be conducted with small populations of cells. Most of the current methods for producing and studying such small cell populations are complex to implement and require skilled personnel limiting their widespread utility in biomedical research labs. We present a simple and rapid method to produce small populations with varying size of epithelial cells (10-50 cells/population) with high-throughput (similar to 1 population/second) on flat surfaces via patterning of extracellular matrix (ECM) proteins and random seeding of cells. We demonstrate that despite inherent limitations of non-contact, drop-on-demand piezoelectric inkjet printing for protein patterning, varying mixtures of ECM proteins can be deposited with high reproducibility and level of control on glass substrates using a set of dynamically adjustable optimized deposition parameters. We demonstrate high consistency for the number of cells per population (similar to 1 cell standard error of mean), the population's size (similar to 0.2 coefficient of variation) and shape, as well as accurate spatial placement of and distance between colonies of a panel of metaplastic and dysplastic esophageal epithelial cells with differing adhesion and motility characteristics. The number of cells per colony, colony size and shape can be varied by dynamically varying the amount of ECM proteins deposited per spatial location and the number of spatial locations on the substrate. The method is applicable to a broad range of biological and biomedical studies including cell-cell communications, cellular microenvironment, migration, and stimulus response.	[Lee, Kristen B.; Kelbauskas, Laimonas; Brunner, Alan; Meldrum, Deirdre R.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Kelbauskas, L; Meldrum, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	lkelbaus@asu.edu; deirdre.meldrum@asu.edu			NIH Center of Excellence in Genomic Science (CEGS) [5P50 HG002360]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH Center of Excellence in Genomic Science (CEGS); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an NIH Center of Excellence in Genomic Science (CEGS) grant 5P50 HG002360 awarded to D.R.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sandhya Gangaraju for all cell culture needs. This work was supported by an NIH Center of Excellence in Genomic Science (CEGS) grant 5P50 HG002360 awarded to D.R.M.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Fujita S, 2013, LAB CHIP, V13, P77, DOI 10.1039/c2lc40709d; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guldner IH, 2015, INTEGR BIOL-UK, V7, P153, DOI 10.1039/c4ib00192c; Kang J, 2014, METHOD CELL BIOL, V119, P55, DOI 10.1016/B978-0-12-416742-1.00004-4; Kelbauskas L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037008; Kshitiz, 2015, INTEGR BIOL-UK, V7, P364, DOI 10.1039/c4ib00209a; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Matsusaki M, 2013, ADV HEALTHC MATER, V2, P534, DOI 10.1002/adhm.201200299; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Romanov V, 2014, ANALYST, V139, P1303, DOI 10.1039/c3an01577g; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Shimizu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091875; Tse C, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/015017; Turcu F, 2003, J NEUROSCI METH, V131, P141, DOI 10.1016/j.jneumeth.2003.08.001; Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Zhang K, 2014, P NATL ACAD SCI USA, V111, P2948, DOI 10.1073/pnas.1313661111	23	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176079	10.1371/journal.pone.0176079	http://dx.doi.org/10.1371/journal.pone.0176079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445488	Green Published, gold, Green Submitted			2022-12-27	WOS:000400309200033
J	Becker, MH; Gratwicke, B				Becker, Matthew H.; Gratwicke, Brian			Minimum lethal concentration of sodium hypochlorite for the amphibian pathogen Batrachochytrium dendrobatidis	PLOS ONE			English	Article							DISINFECTANTS	Sodium hypochlorite (NaOCl) is the active ingredient in household bleach and is commonly used as a disinfectant to clean equipment contaminated by the amphibian pathogen Batra-chochytrium dendrobatidis (Bd) in lab husbandry and field studies. We conducted a series of replicated exposure trials using a single Global Pandemic Lineage Bd isolate from Panama (JEL 310) and concentrations of NaOCl ranging from 0.006% to 0.6% for exposure times ranging from 30 seconds to 15 minutes to determine the minimum lethal concentration of NaOCl for this isolate of Bd. Sodium hypochlorite completely killed Bd at a concentration of 0.03% during a 15-minute exposure time, while 0.12% NaOCl was effective at all exposure times (30s-15min).	[Becker, Matthew H.; Gratwicke, Brian] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA; [Becker, Matthew H.] Liberty Univ, Dept Biol & Chem, Lynchburg, VA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Liberty University	Gratwicke, B (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA.	gratwickeb@si.edu		Gratwicke, Brian/0000-0002-7332-4060	U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund [FY2014, F14AP00750]; Smithsonian Institution Fellowship; Smithsonian Institution Fellowship Program; United States Fish and Wildlife Service CEACF Award [F14AP00750]	U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund; Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History); Smithsonian Institution Fellowship Program(Smithsonian InstitutionSmithsonian National Museum of Natural History); United States Fish and Wildlife Service CEACF Award	We are grateful for funding from the U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund FY2014, F14AP00750. https://www.fws.gov/international (to BG and MHB) and the Smithsonian Institution Fellowship (MHB) http://www.smithsonianofi.com/fellowship-opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the Smithsonian Institution Fellowship Program and the United States Fish and Wildlife Service CEACF Award F14AP00750. We thank J. Becker and J. Walke for valuable comments and review of the manuscript.	Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2015, MOL ECOLOGY; Brem F., 2007, FIELD SAMPLING PROTO; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Cashins SD, 2008, DIS AQUAT ORGAN, V80, P63, DOI 10.3354/dao01919; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Gold KK, 2013, DIS AQUAT ORGAN, V107, P77, DOI 10.3354/dao02670; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Pessier AP, 2009, P IUCN SSC CONS BREE; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110	10	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176439	10.1371/journal.pone.0176439	http://dx.doi.org/10.1371/journal.pone.0176439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441417	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800055
J	Boestfleisch, C; Papenbrock, J				Boestfleisch, Christian; Papenbrock, Jutta			Changes in secondary metabolites in the halophytic putative crop species Crithmum maritimum L., Triglochin maritima L. and Halimione portulacoides (L.) Aellen as reaction to mild salinity	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; SALT-MARSH PLANTS; VITAMIN-C; ABIOTIC STRESS; ORAC ASSAYS; RESPONSES; FRAP; ACCUMULATION; CAROTENOIDS; VEGETABLES	It is assumed that salinity enhances the concentration of valuable metabolites in halophytes. The objective was to find a salt concentration and a point in time at which the yield for the valuable metabolites was maximal. Therefore, three different halophyte species were grown under different salinities and harvested over a period from shortly after stress induction up to three weeks. Various reaction patterns were found in the metabolite composition of the analyzed plant material. Halimione portulacoides showed a "short term response", indicated by an increase in all metabolites analyzed after a few hours, whereas Crithmum maritimum showed a "long term response" through accumulation of proline starting after days. Triglochin maritima did not change in metabolite concentration, but like the other plant species the biomass was reduced by salinity. Generally, a higher production in secondary metabolites by higher salinity was outbalanced by a reduction in biomass production. Concentrations of analyzed antioxidants showed a similar reaction and correlated with each other.	[Boestfleisch, Christian; Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, Hannover, Germany	Leibniz University Hannover	Papenbrock, J (corresponding author), Leibniz Univ Hannover, Inst Bot, Hannover, Germany.	Jutta.Papenbrock@botanik.uni-hannover.de			Open Access Fund of the Leibniz Universitat Hannover	Open Access Fund of the Leibniz Universitat Hannover	We thank PD Dr. Frank Schaarschmidt, Institute for Biostatistics, Leibniz Universitat Hannover, for help with the statistics and Annekathrin Rumlow and Jana Theilmann, Institute of Botany, Leibniz Universitat Hannover, for contributing ICP-OES data. The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover.	ADAM P, 1977, NEW PHYTOL, V78, P237, DOI 10.1111/j.1469-8137.1977.tb01561.x; [Anonymous], 1972, MINERAL NUTR PLANTS; Athar H. R., 2009, V44, P1; Atia A, 2011, J MED PLANTS RES, V5, P3564; Ben Amor N, 2005, PLANT SCI, V168, P889, DOI 10.1016/j.plantsci.2004.11.002; Ben Hamed Karim, 2004, Tropical Ecology, V45, P151; Boestfleisch C, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu046; Breckle SW, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P53; Carillo P., 2011, PROMETHEUSWIKI CONTR; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; de la Rosa L.A., 2010, FRUIT VEGETABLE PHYT; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Diggelen J, 2006, NEW PHYTOL, V103, P573; Duarte B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00746; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Eren H, 2015, ANN APPL BIOL, V167, P208, DOI 10.1111/aab.12219; FAO, 2011, STAT WORLDS LAND WAT, P54; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; FRANKE W, 1982, ECON BOT, V36, P163, DOI 10.1007/BF02858711; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; GOAS G, 1982, PHYSIOL PLANTARUM, V55, P383, DOI 10.1111/j.1399-3054.1982.tb00309.x; GORHAM J, 1980, PLANT CELL ENVIRON, V3, P309, DOI 10.1111/1365-3040.ep11581858; Guil JL, 1997, PLANT FOOD HUM NUTR, V51, P99, DOI 10.1023/A:1007988815888; Gurkok T, 2015, PLANT MOL BIOL REP, V33, P673, DOI 10.1007/s11105-014-0772-7; Hameed A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv004; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Jacobo-Velazquez DA, J FOOD SCI, V74, pR107; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kevers C, 2007, J AGR FOOD CHEM, V55, P8596, DOI 10.1021/jf071736j; Koyro H.-W., 2010, HDB PLANT CROP STRES, P1051; Liebezeit G, 1999, J BIOTECHNOL, V70, P77, DOI 10.1016/S0168-1656(99)00061-9; Liu ZJ, 1998, TREE PHYSIOL, V18, P265; Mabey R., 2012, FOOD FOR FREE; Menezes-Benavente L, 2004, PLANT SCI, V166, P323, DOI 10.1016/j.plantsci.2003.10.001; Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606; Panta S, 2014, ENVIRON EXP BOT, V107, P71, DOI 10.1016/j.envexpbot.2014.05.006; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Redondo-Gomez S, 2007, ANN BOT-LONDON, V100, P555, DOI 10.1093/aob/mcm119; Rodrigues MJ, 2014, MAR DRUGS, V12, P2228, DOI 10.3390/md12042228; Rodriguez-Mateos A, 2014, J AGR FOOD CHEM, V62, P3842, DOI 10.1021/jf403757g; Seal CE, 2010, SEED SCI RES, V20, P47, DOI 10.1017/S0960258509990250; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Shannon MC, 1999, SCI HORTIC-AMSTERDAM, V78, P5, DOI 10.1016/S0304-4238(98)00189-7; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Stevens R, 2006, J AGR FOOD CHEM, V54, P6159, DOI 10.1021/jf061241e; STEWART GR, 1974, PLANTA, V120, P279, DOI 10.1007/BF00390296; STOREY R, 1977, OECOLOGIA, V27, P319, DOI 10.1007/BF00345565; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Ventura Y, 2015, ANN BOT-LONDON, V115, P529, DOI 10.1093/aob/mcu173; Weese A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00009; Wenzel A, 2015, METABOLOMICS, V11, P454, DOI 10.1007/s11306-014-0708-0; Wu XL, 2004, J FOOD COMPOS ANAL, V17, P407, DOI 10.1016/j.jfca.2004.03.001; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	62	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176303	10.1371/journal.pone.0176303	http://dx.doi.org/10.1371/journal.pone.0176303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441407	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800041
J	Ichikawa, HT; Cooper, JC; Lo, L; Potter, J; Terns, RM; Terns, MP				Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Potter, Jason; Terns, Rebecca M.; Terns, Michael P.			Programmable type III-A CRISPR-Cas DNA targeting modules	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RNA CLEAVAGE; CSM COMPLEX; IMMUNITY; DEGRADATION; BIOLOGY; SYSTEMS; DEFENSE	The CRISPR-Cas systems provide invader defense in a wide variety of prokaryotes, as well as technologies for many powerful applications. The Type III-A or Csm CRISPR-Cas system is one of the most widely distributed across prokaryotic phyla, and cleaves targeted DNA and RNA molecules. In this work, we have constructed modules of Csm systems from 3 bacterial species and heterologously expressed the functional modules in E. coli. The modules include a Cas6 protein and a CRISPR locus for crRNA production, and Csm effector complex proteins. The expressed modules from L. lactis, S. epidermidis and S. thermophilus specifically eliminate invading plasmids recognized by the crRNAs of the systems. Characteristically, activation of plasmid targeting activity depends on transcription of the plasmid sequence recognized by the crRNA. Activity was not observed when transcription of the crRNA target sequence was blocked, or when the opposite strand or a non-target sequence was transcribed. Moreover, the Csm module can be programmed to recognize plasmids with novel target sequences by addition of appropriate crRNA coding sequences to the module. These systems provide a platform for investigation of Type III-A CRISPR-Cas systems in E. coli, and for introduction of programmable transcription-activated DNA targeting into novel organisms.	[Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Potter, Jason] Thermo Fisher Sci, Carlsbad, CA USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Thermo Fisher Scientific; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Terns, RM; Terns, MP (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Terns, MP (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.; Terns, MP (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	rterns@bmb.uga.edu; mterns@uga.edu		Terns, Michael/0000-0001-8330-1789	Life Technologies/Thermo Fisher Scientific; National Institutes of Health [R01 GM099876, R35 GM118160]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118160] Funding Source: NIH RePORTER	Life Technologies/Thermo Fisher Scientific; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously funded by a Sponsored Research Agreement from Life Technologies/Thermo Fisher Scientific, and the National Institutes of Health R01 GM099876 to MPT and RMT, and R35 GM118160 to MPT. (tittps /Avww nig rT1S nih goy/Pages/default aspx). Life Technologies/Thermo Fisher Scientific. The funder provided support in the form of salaries for authors [HTI, JCC and LJ]. The specific roles of these authors are articulated in the 'author contributions' section. Life Technologies/Thermo Fisher Scientific played a role in study design, data analysis, decision to publish and preparation of the manuscript.	Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Goldberg GW, 2014, NATURE; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jung TY, 2015, STRUCTURE, V23, P782, DOI 10.1016/j.str.2015.01.021; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Numata T, 2015, J MOL BIOL, V427, P259, DOI 10.1016/j.jmb.2014.09.029; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	29	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176221	10.1371/journal.pone.0176221	http://dx.doi.org/10.1371/journal.pone.0176221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441427	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800035
J	Boo, S; Oh, H; Froelicher, ES; Suh, CH				Boo, Sunjoo; Oh, Hyunjin; Froelicher, Erika S.; Suh, Chang-Hee			Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; CORONARY-HEART-DISEASE; WOMENS AWARENESS; PREVENTION; EXERCISE; HYPERTENSION; POPULATION; VALIDATION; GUIDELINES; EDUCATION	Patients with rheumatoid arthritis are at increased risk for cardiovascular disease. The prerequisites for reducing the risk of cardiovascular disease are adequate levels of knowledge and being aware of the risk. In this study, the levels of knowledge about cardiovascular disease among patients with rheumatoid arthritis and the perception were evaluated in relation to their actual 10-year risk of cardiovascular disease. This cross-sectional study of 200 patients with rheumatoid arthritis was conducted in a university-affiliated hospital in South Korea. The patients' actual risk of cardiovascular disease was estimated using the Framingham Risk Score. The most common risk factor was physical inactivity, with 77% of the patients not engaging in regular exercise. The patients lacked knowledge about the effects of physical inactivity and anti-inflammatory medication on the development of cardiovascular disease. Misperceptions about the risk of cardiovascular disease were common, i.e., 19.5% of the patients underestimated their risk and 41% overestimated. Hypertension, diabetes, obesity, and smoking were the most prevalent among the patients who underestimated their risk, and these same patients had the lowest level of knowledge about cardiovascular disease. This study demonstrated the rheumatoid arthritis patients' lack of knowledge about the effects of physical inactivity and anti-inflammatory medications on the development of cardiovascular disease, and their misperception of cardiovascular risk was common. As a preventive measure, educational programs about cardiovascular disease should be tailored specifically for patients with rheumatoid arthritis, and behavioral interventions, including routine exercise, should be made available at the time of diagnosis.	[Boo, Sunjoo] Ajou Univ, Coll Nursing, Inst Nursing Sci, Suwon, Gyeonggi Do, South Korea; [Oh, Hyunjin] Gachon Univ, Coll Nursing, Incheon, South Korea; [Froelicher, Erika S.] Univ Calif San Francisco, Sch Nursing & Med, San Francisco, CA 94143 USA; [Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, Suwon, Gyeonggi Do, South Korea	Ajou University; Gachon University; University of California System; University of California San Francisco; Ajou University	Suh, CH (corresponding author), Ajou Univ, Sch Med, Dept Rheumatol, Suwon, Gyeonggi Do, South Korea.	chsuh@ajou.ac.kr	Suh, Chang-Hee/H-9723-2019	Suh, Chang-Hee/0000-0001-6156-393X	new faculty research fund of Ajou University School of Medicine [M2015C046000080]	new faculty research fund of Ajou University School of Medicine	This work was supported by the new faculty research fund of Ajou University School of Medicine (M2015C046000080) (SB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Aubry MC, 2007, J RHEUMATOL, V34, P937; Balanescu Serban, 2010, Maedica (Bucur), V5, P292; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Boo S, 2012, ASIAN NURS RES, V6, P49, DOI 10.1016/j.anr.2012.05.002; Choi EJ, 2010, INT J NURS STUD, V47, P452, DOI 10.1016/j.ijnurstu.2009.09.002; Dessein PH, 2004, J RHEUMATOL, V31, P867; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Frijling BD, 2004, PATIENT EDUC COUNS, V52, P47, DOI 10.1016/S0738-3991(02)00248-3; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Homko J, 2008, J CARDIOVASC NURS, V23, P332, DOI 10.1097/01.JCN.0000317432.44586.aa; Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166; John H, 2007, RHEUMATOLOGY, V46, P1513, DOI 10.1093/rheumatology/kem176; John H, 2009, PATIENT EDUC COUNS, V77, P136, DOI 10.1016/j.pec.2009.03.014; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Kievit W, ARTHRITIS C IN PRESS; Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618; Kim EM, 2011, KOREAN CIRC J, V41, P259, DOI 10.4070/kcj.2011.41.5.259; Ko Y, 2016, JPN J NURS SCI, V13, P65, DOI 10.1111/jjns.12087; Lee JH, 2014, KOREAN J INTERN MED, V29, P76, DOI 10.3904/kjim.2014.29.1.76; Lee SS, 2006, CLIN RHEUMATOL, V25, P353, DOI 10.1007/s10067-005-0049-5; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lynch EB, 2006, AM J EPIDEMIOL, V164, P1171, DOI 10.1093/aje/kwj334; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Metsios GS, 2014, ANN RHEUM DIS, V73, P748, DOI 10.1136/annrheumdis-2013-203291; Michos ED, 2006, ATHEROSCLEROSIS, V184, P201, DOI 10.1016/j.atherosclerosis.2005.04.004; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Niedermann K, 2004, ARTHRIT RHEUM-ARTHR, V51, P388, DOI 10.1002/art.20399; Panoulas VF, 2008, RHEUMATOLOGY, V47, P72, DOI 10.1093/rheumatology/kem311; Park SH, 2008, J KOREAN ACAD NURS, V38, P403, DOI 10.4040/jkan.2008.38.3.403; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pincus T, 1999, ARTHRITIS RHEUM-US, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5; Riemsma RP, 2004, ARTHRIT RHEUM-ARTHR, V51, P1045, DOI 10.1002/art.20823; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; Segan CJ, 2004, HEALTH PSYCHOL, V23, P86, DOI 10.1037/0278-6133.23.1.86; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sibley C, 2006, J WOMENS HEALTH, V15, P54, DOI 10.1089/jwh.2006.15.54; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stavropoulos-Kalinoglou A, 2013, ANN RHEUM DIS, V72, P1819, DOI 10.1136/annrheumdis-2012-202075; Sung YK, 2012, SEMIN ARTHRITIS RHEU, V41, P745, DOI 10.1016/j.semarthrit.2011.09.007; 허남욱, 2008, [Journal of Rheumatic Diseases, 대한류마티스학회지], V15, P11; World Health Organization, AS PAC PERSP RED OB	45	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176291	10.1371/journal.pone.0176291	http://dx.doi.org/10.1371/journal.pone.0176291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437445	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600041
J	Wang, ZK; Liu, H; Dou, MM; Du, X; Hu, JJ; Su, N; Wang, Y; Zhang, R; Li, CQ				Wang, Zongkui; Liu, Hua; Dou, Miaomiao; Du, Xi; Hu, Jijun; Su, Na; Wang, Ya; Zhang, Rong; Li, Chongqing			The quality changes in fresh frozen plasma of the blood donors at high altitude	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-VIII; AGE; PARAMETERS; FIBRINOGEN; INCREASES; PLATELET; RISK; SEX	Objective According to the international guidelines, fresh frozen plasma (FFP) is unanimously used to treat coagulation disorders. The quality of FFP is critical for the clinical transfusion. Till now, few studies have integratedly evaluated the differences of FFP from blood donors at between high altitude (HA) and low altitude (LA). Besides, there were no special quality standards for HA FFP in China. Materials and methods Up to 41 HA (Lhasa, 3700 m) and 46 LA (Chengdu, 500 m) blood donors were included in our study to estimate the differences of FFP from HA and LA blood donors. The concentration of total plasma proteins, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen (Fbg), factor (F) II, FV, FVII, FVIII, FIX, FX, FXI, FXII, D-dimer, protein C (PC), protein S (PS), antithrombin III (ATIII) and von Willebrand factor antigen (vWF:Ag) were determined, respectively. Result As compared with FFP of LA blood donors, the total protein content of HA blood donors showed a significant decrease (65.2 +/- 8.9 vs.57.2 +/- 6.3 g/L; p < 0.001); PT, aPTT, TT were significantly increased (p < 0.001); the levels of FII, FV, FVII, FVIII, FIX, FX, FXI, FXII and vWF: Ag were notably decreased (all p < 0.05), whereas Fbg and D-dimer were dramaticly increased (p = 0.038). Additionly, in HA blood donors, vWF: Ag and FVIII: C of O-group was significantly lower (p < 0.05) than that of non-O-group. It should be noted that FVIII: C of HA blood donors (0.64 +/- 0.10 IU/mL) was lower than the current Chinese quality requirements for FFP (>= 0.7 IU/ml). No significant differences were observed in PC, PS and ATIII. Conclusion In general, our findings showed that the quality of FFP was significantly different between HA and LA blood donors, and the current Chinese quality requirements of FFP are not suitable for HA FFP. Therefore, setting up a special quality requirement for HA is quite necessary and meaningful.	[Wang, Zongkui; Dou, Miaomiao; Du, Xi; Su, Na; Wang, Ya; Zhang, Rong; Li, Chongqing] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Liu, Hua] Tibet Autonomous Reg Blood Ctr, Lhasa, Tibet, Peoples R China; [Hu, Jijun] Guizhou Taibang Biol Prod Co Ltd, Guiyang, Guizhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	Zhang, R; Li, CQ (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.	kylie2009@foxmail.com; lichangqing268@163.com	Wang, Zongkui/K-6815-2019; Wang, Zongkui/F-8131-2017	Wang, Zongkui/0000-0002-5764-7660; Wang, Zongkui/0000-0002-5764-7660; Zhang, Rong/0000-0003-4480-7191	Provincial Science and Technology [2014SZ0123]; Guizhou Taibang Biological Products Co., Ltd	Provincial Science and Technology; Guizhou Taibang Biological Products Co., Ltd	Provincial Science and Technology, the funder of 2014SZ0123, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Guizhou Taibang Biological Products Co., Ltd provided support in the form of salaries for JJ Hu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Favaloro EJ, 2005, AM J CLIN PATHOL, V124, P910, DOI 10.1309/W76QF806CE80CL2T; Frisancho AR, 2013, AM J HUM BIOL, V25, P151, DOI 10.1002/ajhb.22367; Gambhir RPS., 2014, IND J VASC ENDOVASC, V1, P20, DOI [10.4103/0972-0820.142362, DOI 10.4103/0972-0820.142362]; Hefti JP, 2010, SWISS MED WKLY, V140, P111, DOI smw-12910; Iorio A, 2008, BLOOD TRANSFUS-ITALY, V6, P211, DOI 10.2450/2008.0042-07; Jha SK, 2002, HIGH ALT MED BIOL, V3, P21, DOI 10.1089/152702902753639513; Kohler HP, 2013, BLOOD, V121, P1931, DOI 10.1182/blood-2013-01-479055; Kokame K, 2011, J THROMB HAEMOST, V9, P1426, DOI 10.1111/j.1538-7836.2011.04333.x; Kotwal J, 2007, THROMB RES, V120, P391, DOI 10.1016/j.thromres.2006.09.013; Liu Y, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-19; MAHER JT, 1976, J APPL PHYSIOL, V41, P702, DOI 10.1152/jappl.1976.41.5.702; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; National Health and Family Planning Commission of the People's Republic of China, 2011, WHOL BLOOD COMP DON; National Health and Family Planning Commission of the People's Republic of China, 2000, TECHN CRIT CLIN BLOO; National Health and Family Planning Commission of the People's Republic of China, 2012, QUAL REQ WHOL BLOOD; Schofield WN, 2003, MED J AUSTRALIA, V178, P117, DOI 10.5694/j.1326-5377.2003.tb05101.x; SINGH I, 1972, BRIT HEART J, V34, P611; Stanworth SJ, 2011, TRANSFUSION, V51, P62, DOI 10.1111/j.1537-2995.2010.02798.x; Theusinger OM, 2010, THROMB HAEMOSTASIS, V104, P385, DOI 10.1160/TH09-12-0858; Vij AG, 2009, PLATELETS, V20, P421, DOI 10.1080/09537100903116516; Wang ZK, 2017, PEERJ, V5, DOI 10.7717/peerj.3156; Weitz CA, 2004, AM J HUM BIOL, V16, P405, DOI 10.1002/ajhb.20042	23	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176390	10.1371/journal.pone.0176390	http://dx.doi.org/10.1371/journal.pone.0176390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430802	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100044
J	Boreiko, D; Kaniovski, S; Kaniovski, Y; Pflug, G				Boreiko, Dmitri; Kaniovski, Serguei; Kaniovski, Yuri; Pflug, Georg			Traces of business cycles in credit-rating migrations	PLOS ONE			English	Article							MARKOV MODEL; RISK	Using migration data of a rating agency, this paper attempts to quantify the impact of macroeconomic conditions on credit-rating migrations. The migrations are modeled as a coupled Markov chain, where the macroeconomic factors are represented by unobserved tendency variables. In the simplest case, these binary random variables are static and credit-class-specific. A generalization treats tendency variables evolving as a time-homogeneous Markov chain. A more detailed analysis assumes a tendency variable for every combination of a credit class and an industry. The models are tested on a Standard and Poor's (S&P's) dataset. Parameters are estimated by the maximum likelihood method. According to the estimates, the investment-grade financial institutions evolve independently of the rest of the economy represented by the data. This might be an evidence of implicit too-big-to-fail bailout guarantee policies of the regulatory authorities.	[Boreiko, Dmitri; Kaniovski, Yuri] Free Univ Bozen Bolzano, Fac Econ & Management, Bolzano, Italy; [Kaniovski, Serguei] Austrian Inst Econ Res WIFO, Macroecon & European Econ Policy Res Grp, Vienna, Austria; [Pflug, Georg] Univ Vienna, Dept Stat & Decis Support Syst, Vienna, Austria	Free University of Bozen-Bolzano; University of Vienna	Kaniovski, Y (corresponding author), Free Univ Bozen Bolzano, Fac Econ & Management, Bolzano, Italy.	YKaniovskyi@unibz.it	Boreiko, Dmitri/AAE-9820-2019; Kaniovski, Yuri/CAF-8842-2022	Kaniovski (Kaniovskyi), Yuri (Yuriy)/0000-0003-2227-4873	Free University of Bozen-Bolzano; Free University of Bozen-Bolzano [WW2025]	Free University of Bozen-Bolzano; Free University of Bozen-Bolzano	This work was supported by Free University of Bozen-Bolzano, Coupled Markov chains models for evaluating credit and systemic risk, https://www.unibz.it/(Yuri Kaniovski, Dmitri Boreiko, Georg Pflug).; The authors acknowledge financial support from the Free University of Bozen-Bolzano (Research project WW2025: Coupled Markov chains models for evaluating credit and systemic risk).	Altman EI, 1998, J BANK FINANC, V22, P1231, DOI 10.1016/S0378-4266(98)00066-1; Bangia A, 2002, J BANK FINANC, V26, P445, DOI 10.1016/S0378-4266(01)00229-1; Boreiko DV, 2016, COMPUTATIONAL EC, V49, P499; Boreiko DV, 2015, CENTRAL EUROPEAN J O, V24, P989; Fei F, 2012, J BUS FINAN ACCOUNT, V39, P229, DOI 10.1111/j.1468-5957.2011.02272.x; Figlewski S, 2012, INT REV ECON FINANC, V21, P87, DOI 10.1016/j.iref.2011.05.004; Frydman H, 2008, J BANK FINANC, V32, P1062, DOI 10.1016/j.jbankfin.2007.09.013; Gavalas D, 2014, INT J FINANC STUD, V2, P122, DOI 10.3390/ijfs2010122; Gupton G.M., 1997, CREDITMETRICS TECHNI; Hull J., 2004, J DERIV, V12, P8, DOI DOI 10.3905/JOD.2004.450964; Jarrow RA, 1997, REV FINANC STUD, V10, P481, DOI 10.1093/rfs/10.2.481; Kaniovski YM, 2007, J BANK FINANC, V31, P2303, DOI 10.1016/j.jbankfin.2007.02.005; Korolkiewicz MW, 2008, J ECON DYN CONTROL, V32, P3807, DOI 10.1016/j.jedc.2008.03.006; McNeil A., 2007, J EMPIR FINANC, V14, P131, DOI DOI 10.1016/J.JEMPFIN.2006.05.002; Nagpal K., 2001, RISK, V14, P129; Wozabal D, 2012, J ECON DYN CONTROL, V36, P403, DOI 10.1016/j.jedc.2011.09.011; Xing HP, 2012, J BANK FINANC, V36, P78, DOI 10.1016/j.jbankfin.2011.06.005	17	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175911	10.1371/journal.pone.0175911	http://dx.doi.org/10.1371/journal.pone.0175911			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426758	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900068
J	Gafos, M; Brodnicki, E; Desai, M; McCormack, S; Nutland, W; Wayal, S; White, E; Wood, G; Barber, T; Bell, G; Clarke, A; Dolling, D; Dunn, D; Fox, J; Haddow, L; Lacey, C; Nardone, A; Quinn, K; Rae, C; Reeves, L; Rayment, M; White, D; Apea, V; Ayap, W; Dewsnap, C; Collaco-Moraes, Y; Schembri, G; Sowunmi, Y; Horne, R				Gafos, Mitzy; Brodnicki, Elizabeth; Desai, Monica; McCormack, Sheena; Nutland, Will; Wayal, Sonali; White, Ellen; Wood, Gemma; Barber, Tristan; Bell, Gill; Clarke, Amanda; Dolling, David; Dunn, David; Fox, Julie; Haddow, Lewis; Lacey, Charles; Nardone, Anthony; Quinn, Killian; Rae, Caroline; Reeves, Lain; Rayment, Michael; White, David; Apea, Vanessa; Ayap, Wilbert; Dewsnap, Claire; Collaco-Moraes, Yolanda; Schembri, Gabriel; Sowunmi, Yinka; Horne, Rob		PROUD Study Team	Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; AFRICAN WOMEN; PREVENTION; MEN; MICROBICIDE; TENOFOVIR; SEX	Background PROUD participants were randomly assigned to receive pre-exposure prophylaxis (PrEP) immediately or after a deferred period of one-year. We report on the acceptability of this open-label wait-listed trial design. Methods Participants completed an acceptability questionnaire, which included categorical study acceptability data and free-text data on most and least liked aspects of the study. We also conducted in-depth interviews (IDI) with a purposely selected sub-sample of participants. Results Acceptability questionnaires were completed by 76% (415/544) of participants. After controlling for age, immediate-group participants were almost twice as likely as deferred-group participants to complete the questionnaire (AOR:1.86;95%CI:1.24,2.81). In quantitative data, the majority of participants in both groups found the wait-listed design acceptable when measured by satisfaction of joining the study, intention to remain in the study, and interest in joining a subsequent study. However, three-quarters thought that the chance of being in the deferred-group might put other volunteers off joining the study. In free-text responses, data collection tools were the most frequently reported least liked aspect of the study. A fifth of deferred participants reported 'being deferred' as the thing they least liked about the study. However, more deferred participants disliked the data collection tools than the fact that they had to wait a year to access PrEP. Participants in the IDIs had a good understanding of the rationale for the open-label wait-listed study design. Most accepted the design but acknowledged they were, or would have been, disappointed to be randomised to the deferred group. Five of the 25 participants interviewed reported some objection to the wait-listed design. Conclusion The quantitative and qualitative findings suggest that in an environment where PrEP was not available, the rationale for the wait-listed trial design was well understood and generally acceptable to most participants in this study.	[Gafos, Mitzy; Brodnicki, Elizabeth; McCormack, Sheena; White, Ellen; Wood, Gemma; Dolling, David; Dunn, David; Collaco-Moraes, Yolanda; Sowunmi, Yinka] UCL, MRC, Clin Trials Unit, Inst Clin Trials & Methodol, London, England; [Desai, Monica; Nardone, Anthony] Publ Hlth England, HIV STI Dept, London, England; [McCormack, Sheena; Barber, Tristan; Rae, Caroline; Rayment, Michael] Chelsea & Westminster Hosp NHS Fdn Trust, Directorate HIV & GU Med, London, England; [Nutland, Will] London Sch Hyg & Trop Med, Sigma Res, London, England; [Wayal, Sonali; Haddow, Lewis] Mortimer Market Ctr, Ctr Sexual Hlth & HIV Res, London, England; [Bell, Gill; Dewsnap, Claire] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Hlth, Sheffield, S Yorkshire, England; [Clarke, Amanda] Royal Sussex Cty Hosp, Claude Nichol Ctr, Brighton, E Sussex, England; [Fox, Julie] Guys & St Thomas NHS Fdn Trust, London, England; [Haddow, Lewis] UCL, Res Dept Infect & Populat Hlth, London, England; [Lacey, Charles] York Hosp NHS Fdn Trust, York, N Yorkshire, England; [Quinn, Killian] Kings Coll Hosp NHS Fdn Trust, London, England; [Reeves, Lain] Homerton Univ Hosp NHS Fdn Trust, Dept Sexual Hlth, London, England; [White, David] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Apea, Vanessa] Barts Hlth NHS Trust, Ambrose King Ctr, London, England; [Ayap, Wilbert] Imperial Coll NHS Fdn Trust, St Marys Hosp, London, England; [Schembri, Gabriel] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Sexual Hlth, Manchester, Lancs, England; [Horne, Rob] UCL, Sch Pharm, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; Public Health England; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; University of Brighton; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; King's College Hospital NHS Foundation Trust; Heart of England NHS Foundation Trust; Barts Health NHS Trust; Imperial College London; University of Manchester; University of London; University College London; University of London School of Pharmacy	Gafos, M (corresponding author), UCL, MRC, Clin Trials Unit, Inst Clin Trials & Methodol, London, England.	m.gafos@ucl.ac.uk	White, Ellen/AAQ-6703-2020	Dunn, David/0000-0003-1836-4446; Nardone, Anthony/0000-0003-1138-0937; fox, Julie/0000-0002-0583-8019; Gafos, Mitzy/0000-0002-7894-1498; Wayal, Sonali/0000-0002-5878-7665	MRC Clinical Trials Unit at University College London; Public Health England; UK National Institute of Health Research Clinical Research Network; MRC [MC_UU_12023/1] Funding Source: UKRI; Medical Research Council [MC_UU_12023/23, MC_UU_12023/1] Funding Source: researchfish; National Institute for Health Research [ACF-2008-20-002] Funding Source: researchfish	MRC Clinical Trials Unit at University College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; UK National Institute of Health Research Clinical Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by ad hoc funding from the MRC Clinical Trials Unit at University College London and an innovations grant from Public Health England, and most clinics received support through the UK National Institute of Health Research Clinical Research Network. Gilead Sciences provided Truvada, distributed drug to clinics, and awarded a grant for the additional diagnostic tests including drug concentrations in plasma.	Auerbach, 2014, WOMEN AND PREP A Q A; Baeten J, 2015, PRESENTATION DELIVER; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2016, THE NEW ENGLAND JOUR; Batra P, 2016, J NUTR, V146, P124, DOI 10.3945/jn.115.218917; Brown CH, 2006, CLIN TRIALS, V3, P259, DOI 10.1191/1740774506cn152oa; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Desai M, 2016, PUBLIC HEALTH ENGLAN; Dolling DI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1286-4; Earley J, 2016, TWO TREATMENT OPTION; Fidler S, 2011, BHIVA BASHH POSITION; Gafos M, 2014, AIDS RES HUM RETROV, V30, pA22, DOI 10.1089/aid.2014.5030.abstract; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Holt M, 2016, LANCET HIV, V3, pE400, DOI 10.1016/S2352-3018(16)30049-2; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Jamil MS, 2017, THE LANCET HIV; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kuhn L, 2015, LANCET HIV, V2, pE460, DOI 10.1016/S2352-3018(15)00212-X; Lam K, 2016, J CHILD FAM STUD, P1; Mansergh G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001286; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, LANCET; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mensch BS, 2012, CURR OPIN HIV AIDS, V7, P534, DOI 10.1097/COH.0b013e3283590632; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Nel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147743; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; Rees H, 2015, CONFERENCE ON RETROV; Ritchie J., 2013, QUALITATIVE RES PRAC; Skingsley A YZ, 2015, HIV IN THE UK SITUAT; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tolley E, 2014, DRUG DELIVERY AND DE; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; World Health Organization, 2015, GUIDELINE ON WHEN TO	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175596	10.1371/journal.pone.0175596	http://dx.doi.org/10.1371/journal.pone.0175596			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426834	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900034
J	Raballah, E; Kempaiah, P; Karim, Z; Orinda, GO; Otieno, MF; Perkins, DJ; Ong'echa, JM				Raballah, Evans; Kempaiah, Prakasha; Karim, Zachary; Orinda, George O.; Otieno, Michael F.; Perkins, Douglas J.; Ong'echa, John Michael			CD4 T-cell expression of IFN-gamma and IL-17 in pediatric malarial anemia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; KENYAN CHILDREN; REGULATORY CYTOKINES; CEREBRAL MALARIA; CENTRAL MEMORY; AGE PATTERNS; IN-VIVO; TRANSMISSION	In Plasmodium falciparum holoendemic transmission regions of western Kenya, life-threatening pediatric malaria manifests primarily as severe malarial anemia (SMA, Hb <= 6.0 g/dL with any density parasitemia). To determine the role that CD4+ T-cell-driven inflammatory responses have in the pathogenesis of SMA, peripheral CD4+ T-cell populations and their intracellular production of pro-inflammatory cytokines (IFN-gamma and IL-17) were characterized in children aged 12-36 months of age stratified into two groups: non-severe malarial anemia (non-SMA, Hb <= 6.0 g/dL, n = 50) and SMA (n = 39). In addition, circulating IFN-gamma and IL-17 were measured as part of a Cytokine 25-plex Antibody Bead Kit, Human (BioSource (TM) International). Children with SMA had higher overall proportions of circulating lymphocytes (P = 0.003) and elevated proportions of lymphocytes expressing IFN-gamma (P = 0.014) and comparable IL-17 (P = 0.101). In addition, SMA was characterized by decreased memory-like T-cells (CD4+ CD45RA-) expressing IL-17 (P = 0.009) and lower mean fluorescence intensity in memory-like CD4+ T-cells for both IFN-gamma (P = 0.063) and IL-17 (P = 0.006). Circulating concentrations of IFN-gamma were higher in children with SMA (P = 0.009), while IL-17 levels were comparable between the groups (P = 0.164). Furthermore, circulating levels of IFN-gamma were negatively correlated with IL-17 levels in both groups of children (SMA: r = -0.610, P = 0.007; and non-SMA: r = -0.516, P = 0.001), while production of both cytokines by lymphocytes were positively correlated (SMA: r = 0.349, P = 0.037; and non-SMA: r = 0.475, P = 0.001). In addition, this correlation was only maintained by the memory-like CD4+ T cells (r = 0.365, P = 0.002) but not the naive-like CD4+ T cells. However, circulating levels of IFN-gamma were only associated with naive-like CD4+ T cells producing IFN-gamma. (r = 0.547, P = 0.028), while circulating levels of IL-17 were not associated with any of the cell populations. Taken together, these results suggest that enhanced severity of malarial anemia is associated with higher overall levels of circulating lymphocytes, enhanced intracellular production of IFN-gamma by peripheral lymphocytes and high circulating IFN-gamma levels. In addition, the observed inverse relationship between the circulating levels of IFN-gamma and IL-17 together with the reduction in the levels of memory-like CD4+ T cells expressing IL-17 in children with SMA may suggest possible relocation of these cells in the deeper tissues for their pathological effect.	[Raballah, Evans; Perkins, Douglas J.; Ong'echa, John Michael] Univ New Mexico, Labs Parasit & Viral Dis, Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [Raballah, Evans] Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, Kakamega, Kenya; [Raballah, Evans; Orinda, George O.] Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Kempaiah, Prakasha; Karim, Zachary; Perkins, Douglas J.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Otieno, Michael F.] Kenyatta Univ, Dept Med Lab Sci, Nairobi, Kenya	Kenya Medical Research Institute; Kenyatta University; University of New Mexico; University of New Mexico's Health Sciences Center; Kenyatta University	Ong'echa, JM (corresponding author), Univ New Mexico, Labs Parasit & Viral Dis, Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya.	michaelongecha@yahoo.com	Kempaiah, Prakasha/ABC-6485-2020; Raballah, Evans/AAJ-6604-2021	Kempaiah, Prakasha/0000-0002-2901-0339; Raballah, Evans/0000-0002-3304-6836; Ong'echa, John/0000-0003-3928-6774	National Institutes of Health [R01 AI51305-07, TW05884-07]; Fogarty International Center grant [R01 TW007631-03]; FOGARTY INTERNATIONAL CENTER [D43TW005884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Fogarty International Center grant R01 TW007631-03 (JMO) and National Institutes of Health grants R01 AI51305-07 (DJP) and TW05884-07 (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; [Anonymous], 2008, WORLD MAL REP 2008; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Ayimba E, 2011, CLIN EXP IMMUNOL, V166, P218, DOI 10.1111/j.1365-2249.2011.04474.x; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Biemba G, 1998, TROP MED INT HEALTH, V3, P60, DOI 10.1046/j.1365-3156.1998.00168.x; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Camacho LH, 1998, ANN TROP MED PARASIT, V92, P525, DOI 10.1080/00034989859221; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; CLARK IA, 1988, BRIT J HAEMATOL, V70, P99, DOI 10.1111/j.1365-2141.1988.tb02440.x; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Ekvall Hakan, 2001, American Journal of Tropical Medicine and Hygiene, V64, P58; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Gitau EN, 2014, J IMMUNOL, V192, P1753, DOI 10.4049/jimmunol.1200547; Helleberg M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-56; Helmby H, 2009, J IMMUNOL, V182, P5663, DOI 10.4049/jimmunol.0803790; Hillman R., 1996, RED CELL MANUAL; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ishida H, 2010, BIOCHEM BIOPH RES CO, V402, P790, DOI 10.1016/j.bbrc.2010.10.114; Jagannathan P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003864; Jason J, 2001, CLIN EXP IMMUNOL, V126, P466, DOI 10.1046/j.1365-2249.2001.01707.x; Keller CC, 2006, INFECT IMMUN, V74, P5249, DOI 10.1128/IAI.00843-06; Keswani T, 2014, EXP PARASITOL, V141, P82, DOI 10.1016/j.exppara.2014.03.003; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; LANGHORNE J, 1989, IMMUNOL REV, V112, P71, DOI 10.1111/j.1600-065X.1989.tb00553.x; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leavy O, 2011, NAT REV IMMUNOL, V11, P160, DOI 10.1038/nri2942; Liu TP, 2013, J IMMUNOL, V191, P178, DOI 10.4049/jimmunol.1201190; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; MAMUS SW, 1985, J CLIN INVEST, V75, P1496, DOI 10.1172/JCI111853; Mandala WL, 2016, CLIN VACCINE IMMUNOL, V23, P95, DOI 10.1128/CVI.00564-15; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; MEANS RT, 1992, BLOOD, V80, P1639; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Megnekou R, 2015, SCAND J IMMUNOL, V81, P508, DOI 10.1111/sji.12286; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Mullarky IK, 2007, INFECT IMMUN, V75, P2630, DOI 10.1128/IAI.01836-06; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; Obonyo CO, 2007, ANN TROP MED PARASIT, V101, P281, DOI 10.1179/136485907X176337; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Ong'echa JMO, 2003, AM J TROP MED HYG, V68, P590, DOI 10.4269/ajtmh.2003.68.590; Ong'echa JM, 2008, CLIN IMMUNOL, V126, P211, DOI 10.1016/j.clim.2007.08.007; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otieno RO, 2006, AIDS, V20, P275, DOI 10.1097/01.aids.0000200533.56490.b7; Ouma C, 2012, HUM GENET, V131, P289, DOI 10.1007/s00439-011-1076-8; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Perkmann T, 2005, CYTOKINE, V29, P153, DOI 10.1016/j.cyto.2004.10.008; Phawong C, 2010, IMMUNOGENETICS, V62, P345, DOI 10.1007/s00251-010-0439-y; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Roca-Feltrer A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-282; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Silva ALT, 2013, MICROBES INFECT, V15, P837, DOI 10.1016/j.micinf.2013.07.009; Thawani N, 2006, EXP HEMATOL, V34, P1451, DOI 10.1016/j.exphem.2006.06.014; TROYEBLOMBERG M, 1989, J IMMUNOL, V143, P3043; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; Were T, 2006, HAEMATOLOGICA, V91, P1396; WHO, 2015, WORLD MAL REP 2015; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072	80	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175864	10.1371/journal.pone.0175864	http://dx.doi.org/10.1371/journal.pone.0175864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426727	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900059
J	Schumacher, SE; Shim, BY; Corso, G; Ryu, MH; Kang, YK; Roviello, F; Saksena, G; Peng, SY; Shivdasani, RA; Bass, AJ; Beroukhim, R				Schumacher, Steven E.; Shim, Byoung Yong; Corso, Giovanni; Ryu, Min-Hee; Kang, Yoon-Koo; Roviello, Franco; Saksena, Gordon; Peng, Shouyong; Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen			Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; UNITED-STATES; HELICOBACTER-PYLORI; D2 LYMPHADENECTOMY; SURVIVAL BENEFIT; CANCER; CARCINOMA; PATTERNS; CARDIA; MUTATIONS	Gastric cancer, a leading worldwide cause of cancer mortality, shows high geographic and ethnic variation in incidence rates, which are highest in East Asia. The anatomic locations and clinical behavior also differ by geography, leading to the controversial idea that Eastern and Western forms of the disease are distinct. In view of these differences, we investigated whether gastric cancers from Eastern and Western patients show distinct genomic profiles. We used high-density profiling of somatic copy-number aberrations to analyze the largest collection to date of gastric adenocarcinomas and utilized genotyping data to rigorously annotate ethnic status. The size of this collection allowed us to accurately identify regions of significant copy-number alteration and separately to evaluate tumors arising in Eastern and Western patients. Among molecular subtypes classified by The Cancer Genome Atlas, the frequency of gastric cancers showing chromosomal instability was modestly higher in Western patients. After accounting for this difference, however, gastric cancers arising in Easterners and Westerners have highly similar somatic copy-number patterns. Only one genomic event, focal deletion of the phosphatase gene PTPRD, was significantly enriched in Western cases, though also detected in Eastern cases. Thus, despite the different risk factors and clinical features, gastric cancer appears to be a fundamentally similar disease in both populations and the divergent clinical outcomes cannot be ascribed to different underlying structural somatic genetic aberrations.	[Schumacher, Steven E.; Shim, Byoung Yong; Peng, Shouyong; Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Schumacher, Steven E.; Saksena, Gordon; Bass, Adam J.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Corso, Giovanni; Roviello, Franco] Univ Hosp, Dept Human Pathol, Siena, Italy; [Ryu, Min-Hee; Kang, Yoon-Koo] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; [Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Harvard Med Sch, Boston, MA 02115 USA; [Shim, Byoung Yong] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Siena; University Hospital of Siena; University of Ulsan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Catholic University of Korea	Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Bass, AJ; Beroukhim, R (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; adam_bass@dfci.harvard.edu; rameen_beroukhim@dfci.harvard.edu	Roviello, Franco/K-5707-2016; Corso, Giovanni/AAN-5976-2020		National Institutes of Health Specialized Programs of Research Excellence [P50CA127003]; American Cancer Society Research Scholar Grant; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	National Institutes of Health Specialized Programs of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Dana-Farber Cancer Institute/Novartis Drug Discovery Program	AJB received funding from National Institutes of Health Specialized Programs of Research Excellence grant P50CA127003 (https://grants.nih.gov) and an American Cancer Society Research Scholar Grant (http://www.cancer.org). RAS and RB received funding from the Dana-Farber Cancer Institute/Novartis Drug Discovery Program (http://www.dana-farber.org/,https://www.nibr.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bickenbach K, 2012, J GASTRIC CANCER, V12, P55, DOI 10.5230/jgc.2012.12.2.55; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Carter S. L., 2011, PREPRINT; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Falchetti M, 2008, HUM PATHOL, V39, P925, DOI 10.1016/j.humpath.2007.10.024; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gill S, 2003, J CLIN ONCOL, V21, P2070, DOI 10.1200/JCO.2003.11.054; Gong YX, 2014, NAT GENET, V46, P588, DOI 10.1038/ng.2981; Grogg KL, 2003, MODERN PATHOL, V16, P641, DOI 10.1097/01.MP.0000076980.73826.C0; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lin SJ, 2014, GUT; Macdonald JS, 2011, J CLIN ONCOL, V29, P4348, DOI 10.1200/JCO.2011.37.5691; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miyagi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055155; Noguchi Y, 2000, CANCER-AM CANCER SOC, V89, P2237, DOI 10.1002/1097-0142(20001201)89:11<2237::AID-CNCR12>3.3.CO;2-0; Onate-Ocana LF, 2000, ANN SURG ONCOL, V7, P210, DOI 10.1007/BF02523656; Otsuji E, 2000, AM J SURG, V180, P127, DOI 10.1016/S0002-9610(00)00436-0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Roviello F, 2002, ANN SURG ONCOL, V9, P894, DOI 10.1007/BF02557527; Russo A, 2001, CANCER, V92, P294, DOI 10.1002/1097-0142(20010715)92:2<294::AID-CNCR1322>3.0.CO;2-9; Saito H, 2006, WORLD J SURG, V30, P1864, DOI 10.1007/s00268-005-0582-z; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Shim JH, 2014, ANN SURG ONCOL, V21, P2332, DOI 10.1245/s10434-014-3608-7; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Song HR, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.22063; Theuer CP, 2000, CANCER, V89, P1883, DOI 10.1002/1097-0142(20001101)89:9<1883::AID-CNCR3>3.3.CO;2-8; Theuer CP, 2002, ARCH SURG-CHICAGO, V137, P960, DOI 10.1001/archsurg.137.8.960; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Beek J, 2004, J CLIN ONCOL, V22, P664, DOI 10.1200/JCO.2004.08.061; Veeriah S, 2010, CELL CYCLE, V9, P1451, DOI 10.4161/cc.9.8.11583; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176045	10.1371/journal.pone.0176045	http://dx.doi.org/10.1371/journal.pone.0176045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426752	Green Published, gold			2022-12-27	WOS:000399875900091
J	Taieb, F; Madec, Y; Cournil, A; Delaporte, E				Taieb, Fabien; Madec, Yoann; Cournil, Amandine; Delaporte, Eric			Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis	PLOS ONE			English	Article							HIV DRUG-RESISTANCE; PUBLIC-HEALTH APPROACH; RANDOMIZED CONTROLLED-TRIAL; DRIED BLOOD SPOTS; TREATMENT PROGRAM; TREATMENT OUTCOMES; SOUTH-AFRICA; VIRAL LOAD; CLINICAL-OUTCOMES; INFECTED ADULTS	Background UNAIDS recently defined the 90-90-90 target as a way to end the HIV epidemic. However, the proportion of virological success following antiretroviral therapy (ART) may not be as high as the anticipated 90%, and may in fact be highly heterogeneous. We aimed to describe the proportion of virological success in sub-Saharan Africa and to identify factors associated with the proportion of virological success. Methods We performed a systematic review and meta-analysis focusing on the proportion of patients in sub-Saharan Africa who demonstrate virological success at 12 and 24 months since ART initiation, as well as at 6 and 36 months, where possible. Programme factors associated with the proportion of virological success were identified using meta-regression. Analyses were conducted using both on-treatment (OT) and intention-to-treat (ITT) approaches. Results Eighty-five articles were included in the meta-analysis, corresponding to 125 independent study populations. Using an on-treatment approach, the proportions (95% confidence interval (CI)) of virological success at 12 (n = 64) and at 24 (n = 32) months since ART initiation were 87.7% (81.3-91.0) and 83.7% (79.8-87.6), respectively. Univariate analysis indicated that the proportion of virological success was not different by study design. Multivariate analysis at 24 months showed that the proportion of virological success was significantly larger in studies conducted in public sector sites than in other sites (p = 0.045). Using an ITT approach, the proportions (95% CI) of virological success at 12 (n = 50) and at 24 (n = 20) months were 65.4% (61.8-69.1) and 56.8% (51.3-62.4), respectively. At 12 months, multivariate analysis showed that the proportion of success was significantly lower in cohort studies than in trials (63.0% vs. 71.1%; p = 0.017). At 24 months, univariate analysis demonstrated that the proportion of success was also lower in cohorts. Discussion Regardless of the time following ART initiation, and of the threshold, proportions of virological success were highly variable. Evidence from this review suggests that the new international target of 90% of patients controlled is not yet being achieved, and that in order to improve the virological outcome, efforts should be made to improve retention in care.	[Taieb, Fabien; Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Taieb, Fabien; Cournil, Amandine; Delaporte, Eric] Univ Montpellier, Unite TransVIHMI, IRD UMI INSERM U1175 233, Montpellier, France; [Taieb, Fabien] Hop St Louis, AP HP, Direct Rech Clin & Dev, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Taieb, F (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.; Taieb, F (corresponding author), Univ Montpellier, Unite TransVIHMI, IRD UMI INSERM U1175 233, Montpellier, France.; Taieb, F (corresponding author), Hop St Louis, AP HP, Direct Rech Clin & Dev, Paris, France.	fabien.faieb@pasteur.fr	Delaporte, Eric/J-5397-2018	Delaporte, Eric/0000-0002-1822-9853; Madec, Yoann/0000-0002-6201-1261				Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Aghokeng AF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18004; Ahonkhai AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032993; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Alibhai A, 2010, CURR HIV RES, V8, P370, DOI 10.2174/157016210791330400; Almeida JM, 2011, AIDS RES HUM RETROV, V27, P705, DOI [10.1089/aid.2010.0200, 10.1089/AID.2010.0200]; [Anonymous], 2014, GLOB UPD HLTH SECT R; Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Aoudjane S, 2014, CLIN INFECT DISEASES; Aoudjane S, 2014, CLIN INFECT DIS; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Billong SC AA, 2012, IAC C; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Blacher RJ, 2010, AIDS CARE, V22, P1323, DOI 10.1080/09540121003692235; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Bolhaar MG, 2011, INT J STD AIDS, V22, P38, DOI 10.1258/ijsa.2010.010229; Bonnet M, 2013, LANCET INFECT DIS, V13, P303, DOI 10.1016/S1473-3099(13)70007-0; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan AT, 2014, TROP MED INT HEALTH, V19, P490, DOI 10.1111/tmi.12285; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Chabikuli NO, 2010, S AFR FAM PRACT, V52, P350, DOI 10.1080/20786204.2010.10874005; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Clumeck N, 2014, AIDS, V28, P1143, DOI 10.1097/QAD.0000000000000214; Cohen GM, 2013, J INT ASS PROVIDERS; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; Davies NECG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033309; De Beaudrap P, 2013, JAIDS-J ACQ IMM DEF, V62, P381, DOI 10.1097/QAI.0b013e31827a2a7a; De Luca A, 2012, JAIDS-J ACQ IMM DEF, V59, P236, DOI 10.1097/QAI.0b013e31824276e9; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dube NM, 2014, CLIN INFECT DIS, V58, P1607, DOI 10.1093/cid/ciu109; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goodall RL, 2014, J ANTIMICROBIAL CHEM; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Grant AD, 2014, AIDS BEHAV; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hoffmann CJ, 2009, AIDS, V23, P1784, DOI 10.1097/QAD.0b013e32832e0585; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Igumbor JO, 2011, AIDS CARE, V23, P231, DOI 10.1080/09540121.2010.498909; Innes C, 2012, SEX TRANSM INFECT, V88, P136, DOI 10.1136/sextrans-2011-050194; Jain V, 2014, AIDS LONDON ENGLAND; Johannessen A, 2010, BIOANALYSIS, V2, P1893, DOI 10.4155/BIO.10.120; Johannessen A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-108; Jong E, 2010, THROMB HAEMOSTASIS, V104, P1228, DOI 10.1160/TH10-04-0233; Karasi JC, 2012, J INT AIDS SOC, V15, P55; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Landman R, 2014, ANTIVIR THER, V19, P51, DOI 10.3851/IMP2675; Landman Roland, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P379, DOI 10.1177/1545109709344352; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lee FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097482; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Madec Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082724; Maskew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064392; Maskew M, 2013, JAIDS-J ACQ IMM DEF, V63, P442, DOI 10.1097/QAI.0b013e3182969cc1; Mbougua JBT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-105; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; Messou E, 2013, JAIDS-J ACQ IMM DEF, V64, P211, DOI 10.1097/QAI.0b013e3182a009e4; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Moore E, 2010, J INFECTION, V61, P155, DOI 10.1016/j.jinf.2010.04.009; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nachega JB, 2010, AIDS, V24, P1273, DOI 10.1097/QAD.0b013e328339e20e; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb; Polis CB, 2012, CONTRACEPTION, V86, P725, DOI 10.1016/j.contraception.2012.05.001; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rositch AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055383; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064345; Semvua HH, 2013, ANTIVIR THER, V18, P105, DOI 10.3851/IMP2413; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Sivapalasingam S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006828; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Sunpath H, 2012, INT J TUBERC LUNG D, V16, P917, DOI 10.5588/ijtld.11.0651; Taieb F, 2014, AIDS RES HUM RETROV, V30, P623, DOI [10.1089/aid.2014.0035, 10.1089/AID.2014.0035]; Taiwo BO, 2010, JAIDS-J ACQ IMM DEF, V54, P85, DOI 10.1097/01.qai.0000371678.25873.1c; Tiba Fabrice, 2012, Open AIDS J, V6, P16, DOI 10.2174/1874613601206010016; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; UNAIDS, 2015, AIDS NUMB 2015; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS362, DOI 10.1093/cid/cir987; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS355, DOI 10.1093/cid/cis004; WHO, 2013, CONSL GUID US ANT DR; WHO, 2010, RECOMMENDATIONS FOR; WHO, 2013, REC PUBL HLTH APPR; WHO, 2015, CONS GUID US ANT THE; WHO, 2016, GLOB REP EARL WARN I; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2014, SURV HIV DRUG RES AD; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034	119	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174767	10.1371/journal.pone.0174767	http://dx.doi.org/10.1371/journal.pone.0174767			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426819	Green Published, gold			2022-12-27	WOS:000399875900011
J	Tyutyaev, P; Grissmer, S				Tyutyaev, Pavel; Grissmer, Stephan			Observation of sigma-pore currents in mutant hKv1.2_V370C potassium channels	PLOS ONE			English	Article							K+ CHANNEL; VOLTAGE; SELECTIVITY; MUTATIONS; STATE; CELLS; N629D	Current through the sigma-pore was first detected in hKv1.3_V388C channels, where the V388C mutation in hKv1.3 channels opened a new pathway (sigma-pore) behind the central alpha-pore. Typical for this mutant channel was inward current at potentials more negative than -100 mV when the central alpha-pore was closed. The alpha-pore blockers such as TEA(+) and peptide toxins (CTX, MTX) could not reduce current through the sigma-pore of hKv1.3_V388C channels. This new pathway would proceed in parallel to the alpha-pore in the S6-S6 interface gap. To see whether this phenomenon is restricted to hKv1.3 channels we mutated hKv1.2 at the homologue position (hKv1.2_V370C). By overexpression of hKv1.2_V370C mutant channels in COS-7 cells we could show typical sigma-currents. The electrophysiological properties of the sigma-pore in hKv1.3_V388C and hKv1.2_V370C mutant channels were similar. The sigma-pore of hKv1.2_V370C channels was most permeable to Na+ and Li+ whereas Cl- and protons did not influence current through the sigma-pore. Tetraethylammonium (TEA(+)), charybdotoxin (CTX) and maurotoxin (MTX), known alpha-pore blockers, could not reduce current through the sigma-pore of hKv1.2_V370C channels. Taken together we conclude that the observation of sigma-pore currents is not restricted to Kv1.3 potassium channels but can also be observed in a closely related potassium channel. This finding could have implications in the treatment of different ion channel diseases linked to mutations of the respective channels in regions close to homologue position investigated by us.	[Tyutyaev, Pavel; Grissmer, Stephan] Ulm Univ, Inst Appl Physiol, Ulm, Germany	Ulm University	Grissmer, S (corresponding author), Ulm Univ, Inst Appl Physiol, Ulm, Germany.	stephan.grissmer@uni-ulm.de			Deutsche Forschungsgemeinschaft [Gr848/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by funds from the Deutsche Forschungsgemeinschaft (Gr848/17-1; www.dfg.de) to SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., ION CHANNELS EXCITAB, P131; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Prutting S, 2011, J BIOL CHEM, V286, P20031, DOI 10.1074/jbc.M110.185405; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Teng GQ, 2004, CARDIOVASC RES, V61, P268, DOI 10.1016/j.cardiores.2003.11.016; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837	16	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176078	10.1371/journal.pone.0176078	http://dx.doi.org/10.1371/journal.pone.0176078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426823	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900099
J	Craigon, PJ; Hobson-West, P; England, GCW; Whelan, C; Lethbridge, E; Asher, L				Craigon, Peter J.; Hobson-West, Pru; England, Gary C. W.; Whelan, Chantelle; Lethbridge, Emma; Asher, Lucy			"She's a dog at the end of the day": Guide dog owners' perspectives on the behaviour of their guide dog	PLOS ONE			English	Article							CANIS-FAMILIARIS; ASSISTANCE DOGS; TEMPERAMENT; ASSOCIATION; CANDIDATES; BENEFITS; SUCCESS; TRAITS	A guide dog is a domestic dog (Canis familiaris) that is specifically educated to provide mobility support to a blind or visually impaired owner. Current dog suitability assessments focus on behavioural traits, including: trainability, reactivity or attention to environmental stimuli, low aggressiveness, fearfulness and stress behaviour, energy levels, and attachment behaviour. The aim of this study was to find out which aspects of guide dog behaviour are of key importance to guide dog owners themselves. Sixty-three semi-structured interview surveys were carried out with guide dog owners. Topics included the behaviour of their guide dog both within and outside their working role, and also focused on examples of behaviour which might be considered outside a guide dog owner's typical expectations. Both positive and negative examples and situations were covered. This allowed for the discovery of new perspectives and emerging themes on living and working with a guide dog. Thematic analysis of the results reveals that a dog's safe behaviour in the face of traffic was the most important positive aspect of a guide dog's behaviour and pulling or high tension on the lead and/or harness was the most discussed negative aspect. Other aspects of guide dog behaviour were highlighted as particularly pleasing or disappointing by owners including attentiveness to the task, work, environment and owner; confidence in work and decision making (with confident dogs resulting in confident owners) obedience and control; calmness and locating objectives. The results reveal important areas of behaviour that are not currently considered priorities in guide dog assessments; these key areas were consistency of behaviour, the dog's maturity and the dog's behaviour in relation to children. The survey revealed a large range in what owners considered problematic or pleasing behaviours and this highlights the heterogeneity in guide dog owners and the potential multifarious roles of the guide dog. This study contributes to the literature on which behaviour is considered appropriate or inappropriate in dogs and on the nature of human-animal interactions.	[Craigon, Peter J.; Hobson-West, Pru; England, Gary C. W.; Whelan, Chantelle; Asher, Lucy] Univ Nottingham, Sch Vet Sci & Med, Loughborough, Leics, England; [Craigon, Peter J.; Lethbridge, Emma] Guide Dogs Blind Assoc, Reading, Berks, England; [Asher, Lucy] Newcastle Univ, Ctr Behav & Evolut, Henry Wellcome Bldg, Newcastle, England	University of Nottingham; Newcastle University - UK	Craigon, PJ (corresponding author), Univ Nottingham, Sch Vet Sci & Med, Loughborough, Leics, England.; Craigon, PJ (corresponding author), Guide Dogs Blind Assoc, Reading, Berks, England.	peter.craigon1@nottingham.ac.uk	England, Gary C.W./G-5432-2011	Asher, Lucy/0000-0001-9729-7856; England, Gary/0000-0001-5800-3106; Hobson-West, Pru/0000-0001-6105-0747; Whelan, Chantelle/0000-0002-5299-3177	BBSRC [RS3813]; Guide Dogs	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Guide Dogs	Lucy Asher and Gary C.W. England are in receipt of competitive research grant funding from Guide Dogs for two projects; (1) The Epidemiology of Guide Dog Behaviour and (2) Premature Retirement of Guide Dogs. This study was conducted with support from the former, but the study was conducted independently from Guide Dogs. Peter J. Craigon was employed by Guide Dogs and the project (1). Chantelle Whelan's PhD studentship is funded by BBSRC (Grantnumber: RS3813) and Guide Dogs; Sarah Freeman, Lucy Asher, Kathy Almack and Gary C.W England are supervisors of Chantelle Whelan's PhD. Gary C.W. England is a veterinary surgeon who provides clinical service work to Guide Dogs. Emma Leth bridge is employed by Guide Dogs.; We are grateful to David Grice, Simon Blythe and Naomi Harvey who helped to inform our study design, analysis and interpretation. Thanks to all the Guide Dogs staff who assisted in supporting this research through contact with GDOs, but specifically, Nottingham District Team who assisted us in producing materials in accessible formats and recruiting pilot participants. Finally and most sincerely we are grateful to all GDOs who we spoke to as part of this study and especially the five GDOs who provided invaluable feedback in piloting the study.	Arata S, 2010, J VET MED SCI, V72, P539, DOI 10.1292/jvms.09-0512; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Audrestch HM, 2015, DISABIL HEALTH J, V8, P469, DOI 10.1016/j.dhjo.2015.07.001; Baft LS, 2009, ANTHROZOOS, V22, P71, DOI 10.2752/175303708X390482; Batt LS, 2008, J VET BEHAV, V3, P143, DOI 10.1016/j.jveb.2008.04.003; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Bryman A., 1994, ANAL QUALITATIVE DAT; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Caron-Lormier G., SCI REPORTS IN PRESS; Curb LA, 2013, ANTHROZOOS, V26, P395, DOI 10.2752/175303713X13697429463673; Diesel G, 2008, PREV VET MED, V84, P228, DOI 10.1016/j.prevetmed.2007.12.004; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Fallani G, 2006, APPL ANIM BEHAV SCI, V100, P241, DOI 10.1016/j.applanim.2005.12.005; Gitlin LN, 1997, J VISUAL IMPAIR BLIN, V91, P347; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Kobayashi N, 2013, J VET MED SCI, V75, P63, DOI 10.1292/jvms.12-0148; Lloyd JK, THESIS; Michalko R., 1999, 2 IN ONE WALKING SMO; Miner R. J.-T., 2001, RE VIEW, V32, P183; Mizukoshi M, 2008, J VET BEHAV, V3, P193, DOI 10.1016/j.jveb.2008.05.002; OFarrell V, 1997, APPL ANIM BEHAV SCI, V52, P205, DOI 10.1016/S0168-1591(96)01123-9; Payne C, 2005, J ETHOL, V23, P15, DOI 10.1007/s10164-004-0122-6; Sachs-Ericsson N, 2002, REHABIL PSYCHOL, V47, P251, DOI 10.1037//0090-5550.47.3.251; Sanders CR, 2000, ANTHROZOOS, V13, P131, DOI 10.2752/089279300786999815; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Serpell J.A., 1983, NEW PERSPECTIVES OUR, P57; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Steffens M., 1998, COMPANION ANIMALS HU, P149; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; Whitmarsh L, 2001, UNPUB; Wong ML, 2006, PERCEPTIONS IN PRESS; Wright JC, 2007, J APPL ANIM WELF SCI, V10, P255, DOI 10.1080/10888700701353956; Yamamoto M, 2011, J VET BEHAV, V6, P4, DOI 10.1016/j.jveb.2010.10.002	37	18	18	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176018	10.1371/journal.pone.0176018	http://dx.doi.org/10.1371/journal.pone.0176018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423053	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600078
J	Linedale, R; Schmidt, C; King, BT; Ganko, AG; Simpson, F; Panizza, BJ; Leggatt, GR				Linedale, Richard; Schmidt, Campbell; King, Brigid T.; Ganko, Annabelle G.; Simpson, Fiona; Panizza, Benedict J.; Leggatt, Graham R.			Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients	PLOS ONE			English	Article							NKT CELLS; ANTITUMOR IMMUNITY; HEAD; NECK; SPREAD; CANCER; MALIGNANCY; INVASION; IMMUNOTHERAPY; INFILTRATION	Perineural spread of tumour cells along cranial nerves is a severe complication of primary cutaneous squamous cell carcinomas of the head and neck region. While surgical excision of the tumour is the treatment of choice, removal of all the tumour is often complicated by the neural location and recurrence is frequent. Non-invasive immune treatments such as checkpoint inhibitor blockade may be useful in this set of tumours although little is understood about the immune response to perineural spread of squamous cell carcinomas. Immunohistochemistry studies suggest that perineural tumour contains a lymphocyte infiltrate but it is difficult to quantitate the different proportions of immune cell subsets and expression of checkpoint molecules such as PD-1, Tim-3 and CTLA-4. Using flow cytometry of excised perineural tumour tissue, we show that a T cell infiltrate is prominent in addition to less frequent B cell, NK cell and NKT cell infiltrates. CD8 T cells are more frequent than other T cells in the tumour tissue. Amongst CD8 T cells, the frequency of Tim-3, CTLA-4 and PD-1 expressing cells was significantly greater in the tumour relative to the blood, a pattern that was repeated for Tim-3, CTLA-4 and PD-1 amongst non-CD8 T cells. Using immunohistochemistry, PD-1 and PD-L1-expression could be detected in close proximity amongst perineural tumour tissue. The data suggest that perineural SCC contains a mixture of immune cells with a predominant T cell infiltrate containing CD8 T cells. Elevated frequencies of tumour-associated Tim-3(+), CTLA-4(+) and PD-1(+) CD8 T cells suggests that a subset of patients may benefit from local antibody blockade of these checkpoint inhibitors.	[Linedale, Richard; Schmidt, Campbell; King, Brigid T.; Ganko, Annabelle G.; Simpson, Fiona; Leggatt, Graham R.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Schmidt, Campbell; Panizza, Benedict J.] Princess Alexandra Hosp, Dept Otolaryngol Head & Neck Surg, Brisbane, Qld, Australia; [Schmidt, Campbell; King, Brigid T.; Ganko, Annabelle G.; Panizza, Benedict J.] Univ Queensland, Fac Med, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Leggatt, GR (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	g.leggatt@uq.edu.au	Leggatt, Graham/G-1924-2010; Simpson, Fiona/ABE-1276-2020; Simpson, Fiona/J-2721-2012; Panizza, Benedict/G-6590-2012	Leggatt, Graham/0000-0002-4078-5653; Simpson, Fiona/0000-0002-0271-781X; Simpson, Fiona/0000-0002-0271-781X; Panizza, Benedict/0000-0002-3724-3773; Schmidt, Campbell/0000-0001-5593-7333	Princess Alexandra Hospital Research Foundation [2013003030]; Queensland Head and Neck Cancer Centre	Princess Alexandra Hospital Research Foundation; Queensland Head and Neck Cancer Centre	This study was funded by the Princess Alexandra Hospital Research Foundation (Grant No.2013003030). FS is supported by a Fellowship from the Queensland Head and Neck Cancer Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Chawla S, 2016, CANCER IMMUNOL IMMUN, V65, P213, DOI 10.1007/s00262-015-1788-z; Economopoulou P, 2016, ANN ONCOL, V27, P1675, DOI 10.1093/annonc/mdw226; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gandhi MR, 2011, HEAD NECK-J SCI SPEC, V33, P469, DOI 10.1002/hed.21470; Gandhi M, 2016, J NEUROL SURG PART B, V77, P113, DOI 10.1055/s-0036-1571836; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godwin JL, 2014, DISCOV MED, V18, P341; Gupta A, 2016, AUSTRALAS J DERMATOL, V57, P3, DOI 10.1111/ajd.12314; Kim JU, 2016, J NANOMATER, V2016, DOI 10.1155/2016/7602395; Lai Stephen Y, 2005, Curr Oncol Rep, V7, P154, DOI 10.1007/s11912-005-0042-9; Liu HL, 2016, FEBS OPEN BIO, V6, P807, DOI 10.1002/2211-5463.12079; Maine CJ, 2014, CANCER IMMUNOL IMMUN, V63, P215, DOI 10.1007/s00262-013-1503-x; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; McKee SJ, 2014, J LEUKOCYTE BIOL, V96, P49, DOI 10.1189/jlb.4RU0114-001R; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Panizza B, 2012, HEAD NECK-J SCI SPEC, V34, P1622, DOI 10.1002/hed.21986; Panizza BJ, 2016, J NEUROL SURG PART B, V77, P81, DOI 10.1055/s-0036-1579778; Partlova S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/21624011.2014.965570; Roh J, 2015, ORAL ONCOL, V51, P16, DOI 10.1016/j.oraloncology.2014.10.004; Schlosser HA, 2014, IMMUNOTHERAPY-UK, V6, P973, DOI 10.2217/imt.14.58; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Slater NA, 2016, J CUTAN PATHOL; Sun SY, 2014, CANCER IMMUNOL IMMUN, V63, P395, DOI 10.1007/s00262-014-1519-x; Tallon B, 2010, J CUTAN PATHOL, V37, P1184, DOI 10.1111/j.1600-0560.2009.01482.x; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Thommen DS, 2015, CANCER IMMUNOL RES, V3, P1344, DOI 10.1158/2326-6066.CIR-15-0097; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Warren TA, 2016, HEAD NECK-J SCI SPEC, V38, P824, DOI 10.1002/hed.23982; Wolf GT, 2015, ORAL ONCOL, V51, P90, DOI 10.1016/j.oraloncology.2014.09.006; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620	36	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175755	10.1371/journal.pone.0175755	http://dx.doi.org/10.1371/journal.pone.0175755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423034	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600049
J	Murray-Stewart, T; Ferrari, E; Xie, Y; Yu, F; Marton, LJ; Oupicky, D; Casero, RA				Murray-Stewart, Tracy; Ferrari, Elena; Xie, Ying; Yu, Fei; Marton, Laurence J.; Oupicky, David; Casero, Robert A., Jr.			Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047	PLOS ONE			English	Article							SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; ANTIZYME INHIBITOR; CANCER-CELLS; DELIVERY; METABOLISM; SPERMINE; ANALOGS; OXIDASE; BIOSYNTHESIS; POLYCATIONS	Synthesizing polycationic polymers directly from existing drugs overcomes the drug-loading limitations often associated with pharmacologically inert nanocarriers. We recently described nanocarriers formed from a first-generation polyamine analogue, bis(ethyl) norspermine (BENSpm), that could simultaneously target polyamine metabolism while delivering therapeutic nucleic acids. In the current study, we describe the synthesis and evaluation of self-immolative nanocarriers derived from the second-generation polyamine analogue PG-11047. Polyamines are absolutely essential for proliferation and their metabolism is frequently dysregulated in cancer. Through its effects on polyamine metabolism, PG-11047 effectively inhibits tumor growth in cancer cell lines of multiple origins as well as in human tumor mouse xenografts. Promising clinical trials have been completed verifying the safety and tolerance of this rotationally restricted polyamine analogue. We therefore used PG-11047 as the basis for Nano11047, a biodegradable, prodrug nanocarrier capable of targeting polyamine metabolism. Following exposure of lung cancer cell lines to Nano11047, uptake and intracellular degradation into the parent compound PG-11047 was observed. The release of PG-11047 highly induced the polyamine catabolic enzyme activities of spermidine/spermine N-1-acetyltransferase (SSAT) and spermine oxidase (SMOX). By contrast, the activity of ornithine decarboxylase (ODC), a rate-limiting enzyme in polyamine biosynthesis and a putative oncogene, was decreased. Consequently, intracellular levels of the natural polyamines were depleted concurrent with tumor cell growth inhibition. This availability of Nano11047 as a novel drug form and potential nucleic acid delivery vector will potentially benefit and encourage future clinical studies.	[Murray-Stewart, Tracy; Casero, Robert A., Jr.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Ferrari, Elena; Xie, Ying; Yu, Fei; Oupicky, David] Univ Nebraska Med Ctr, Ctr Drug Delivery & Nanomed, Dept Pharmaceut Sci, Omaha, NE USA; [Marton, Laurence J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Francisco	Casero, RA (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	rcasero@jhmi.edu	Stewart, Tracy Murray/B-6137-2017; Oupicky, David/AAR-1655-2021	Stewart, Tracy Murray/0000-0001-8679-6414; Casero, Robert/0000-0001-5653-3306; Yu, Fei/0000-0003-4367-2707; Oupicky, David/0000-0003-4710-861X	National Institutes of Health [EB015216, EB014570, R01-CA204345, S30-CA006973]; Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by the National Institutes of Health (www.nih.gov) grants EB015216 (DO), EB014570 (DO), R01-CA204345 (RAC), S30-CA006973 (RAC), the Maryland Cigarette Restitution Fund (http://crf.maryland.gov/) (RAC), and the Samuel Waxman Cancer Research Foundation (http://www.waxmancancer.gov/) (RAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; BALASUNDARAM D, 1991, MOL CELL BIOCHEM, V100, P129; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casero RA, 2003, BIOCHEM SOC T, V31, P361, DOI 10.1042/BST0310361; CASERO RA, 1989, CANCER RES, V49, P3829; CASERO RA, 1994, CANCER RES, V54, P3955; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cirenajwis H, 2010, ANTI-CANCER DRUG, V21, P897, DOI 10.1097/CAD.0b013e32833f2f77; COLEMAN CS, 1995, BIOCHEMISTRY-US, V34, P13423, DOI 10.1021/bi00041a020; Devereux W, 2003, CANCER CHEMOTH PHARM, V52, P383, DOI 10.1007/s00280-003-0662-4; Dong YM, 2012, MOL PHARMACEUT, V9, P1654, DOI 10.1021/mp300001m; Dredge K, 2009, CANCER CHEMOTH PHARM, V65, P191, DOI 10.1007/s00280-009-1105-7; Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hacker A, 2008, CANCER CHEMOTH PHARM, V63, P45, DOI 10.1007/s00280-008-0706-x; Hahm HA, 2002, CLIN CANCER RES, V8, P684; Holst CM, 2006, TOXICOLOGY, V223, P71, DOI 10.1016/j.tox.2006.03.009; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Ignatenko Natalia A., 2009, Cancer Genomics & Proteomics, V6, P161; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Li J, 2013, J CONTROL RELEASE, V172, P589, DOI 10.1016/j.jconrel.2013.04.010; Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847; Mitchell JLA, 2007, AMINO ACIDS, V33, P291, DOI 10.1007/s00726-007-0523-2; Murray-Stewart T, 2015, POLYAMINES, P61; Murray-Stewart T, 2008, FEBS J, V275, P2795, DOI 10.1111/j.1742-4658.2008.06419.x; Murray-Stewart T, 2013, MOL CANCER THER, V12, P2088, DOI 10.1158/1535-7163.MCT-13-0418; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Oupicky D, 2014, MACROMOL BIOSCI, V14, P908, DOI 10.1002/mabi.201400061; PORTER CW, 1988, ADV ENZYME REGUL, V27, P57; PORTER CW, 1986, ANTICANCER RES, V6, P525; PORTER CW, 1987, CANCER RES, V47, P2821; Reddy VK, 1998, J MED CHEM, V41, P4723, DOI 10.1021/jm980172v; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; Smith MA, 2011, PEDIATR BLOOD CANCER, V57, P268, DOI 10.1002/pbc.22797; Stebbins ND, 2014, ADV DRUG DELIVER REV, V78, P77, DOI 10.1016/j.addr.2014.04.006; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomas TJ, 2016, AMINO ACIDS, V48, P2423, DOI 10.1007/s00726-016-2246-8; Wang YL, 2003, BIOCHEM BIOPH RES CO, V304, P605, DOI 10.1016/S0006-291X(03)00636-3; Wattamwar PP, 2012, ACTA BIOMATER, V8, P2529, DOI 10.1016/j.actbio.2012.03.022; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Xie Y, 2017, J CONTROL RELEASE, V246, P110, DOI 10.1016/j.jconrel.2016.12.017; Zhu Y, 2015, MOL PHARMACEUT, V12, P332, DOI 10.1021/mp500469n	49	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175917	10.1371/journal.pone.0175917	http://dx.doi.org/10.1371/journal.pone.0175917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423064	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600063
J	Verma, S; Soto, J; Vasudevan, A; Schmeisser, F; Alvarado-Facundo, E; Wang, W; Weiss, CD; Weir, JP				Verma, Swati; Soto, Jackeline; Vasudevan, Anupama; Schmeisser, Falko; Alvarado-Facundo, Esmeralda; Wang, Wei; Weiss, Carol D.; Weir, Jerry P.			Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies	PLOS ONE			English	Article							SINGLE-RADIAL-IMMUNODIFFUSION; SEASONAL INFLUENZA; VIRUS VACCINES; UNITED-STATES; GROUP STRAINS; HEMAGGLUTININ; ASSAY; ADULTS; IMMUNOGENICITY; QUANTIFICATION	Co-circulation of two antigenically and genetically distinct lineages of influenza B virus, represented by prototype viruses B/Victoria/2/1987 and B/Yamagata/16/1988, has led to the development of quadrivalent influenza vaccines that contain two influenza B antigens. The inclusion of two influenza B antigens presents challenges for the production and regulation of inactivated quadrivalent vaccines, including the potential for cross-reactivity of the reagents used in identity and potency assays because of the relative close relatedness of the hemagglutinin (HA) from the two virus lineages. Monoclonal antibodies (mAbs) specific for the two lineages of influenza B HA were generated and characterized and used to set-up simple identity tests that distinguish the influenza B antigens in inactivated trivalent and quadrivalent vaccines. The lineage-specific mAbs bound well to the HA of influenza B strains included in influenza vaccines over a period of more than 10 years, suggesting that identity tests using such lineage-specific mAbs would not necessarily have to be updated with every influenza B vaccine strain change. These lineage-specific mAbs were also used in an antibody capture ELISA format to quantify HA in vaccine samples, including monovalent, trivalent, and quadrivalent vaccine samples from various manufacturers. The results demonstrated correlation with HA values determined by the traditional single radial immunodiffusion (SRID) assay. Further, the antibody-capture ELISA was able to distinguish heat-stressed vaccine from unstressed vaccine, and was similar to the SRID in quantifying the resultant loss of potency. These mAb reagents should be useful for further development of antibody-based alternative influenza B identity and potency assays.	[Verma, Swati; Soto, Jackeline; Vasudevan, Anupama; Schmeisser, Falko; Weir, Jerry P.] US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Alvarado-Facundo, Esmeralda; Wang, Wei; Weiss, Carol D.] US FDA, Lab Immunoregulat, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Weir, JP (corresponding author), US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	jerry.weir@fda.hns.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289; Ayestaran Soto, Juan/0000-0001-8027-8659; Weir, Jerry/0000-0002-0260-0996	US Food and Drug Administration; Biomedical Advanced Research and Development Authority (BARDA); inter-agency agreement	US Food and Drug Administration; Biomedical Advanced Research and Development Authority (BARDA); inter-agency agreement	This work was supported by the US Food and Drug Administration and an inter-agency agreement with the Biomedical Advanced Research and Development Authority (BARDA) to JPW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Bodle J., 2012, INFLUENZA OTHER RESP; Brogan AJ, 2017, HUM VACC IMMUNOTHER, V13, P533, DOI 10.1080/21645515.2016.1242541; CATE TR, 1983, REV INFECT DIS, V5, P737; Earl P, 1998, CURRENT PROTOCOLS MO; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hashem AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055428; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Khurana S, 2014, VACCINE, V32, P2188, DOI 10.1016/j.vaccine.2014.02.049; Kuck LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109616; LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723; Lugovtsev VY, 2007, VIROLOGY, V365, P315, DOI 10.1016/j.virol.2007.04.006; Minor PD, 2015, VACCINES-BASEL, V3, P90, DOI 10.3390/vaccines3010090; Moa AM, 2016, VACCINE, V34, P4092, DOI 10.1016/j.vaccine.2016.06.064; Nakagawa N, 2003, J GEN VIROL, V84, P769, DOI 10.1099/vir.0.18756-0; Nakagawa N, 2001, J GEN VIROL, V82, P2169, DOI 10.1099/0022-1317-82-9-2169; Nilsson CE, 2010, VACCINE, V28, P759, DOI 10.1016/j.vaccine.2009.10.070; Pierce CL, 2011, ANAL CHEM, V83, P4729, DOI 10.1021/ac2006526; QUINNAN GV, 1983, REV INFECT DIS, V5, P748; ROBERTSON JS, 1985, VIROLOGY, V143, P166, DOI 10.1016/0042-6822(85)90105-9; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Rowlen K, 2015, VACCINE, V33, P6025, DOI 10.1016/j.vaccine.2015.07.060; Schmeisser F, 2016, INFLUENZA OTHER RESP, V10, P134, DOI 10.1111/irv.12365; Schmeisser F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117108; Schmeisser F, 2014, INFLUENZA OTHER RESP, V8, P587, DOI 10.1111/irv.12272; Schmeisser F, 2013, INFLUENZA OTHER RESP, V7, P480, DOI 10.1111/irv.12029; Schmeisser F, 2012, VACCINE, V30, P3413, DOI 10.1016/j.vaccine.2012.03.033; Schmeisser F, 2010, VACCINE, V28, P2442, DOI 10.1016/j.vaccine.2009.12.079; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2010, J VIROL METHODS, V165, P305, DOI 10.1016/j.jviromet.2010.02.009; Weir JP, 2016, INFLUENZA OTHER RESP, V10, P354, DOI 10.1111/irv.12383; Wen YX, 2015, VACCINE, V33, P5342, DOI 10.1016/j.vaccine.2015.08.077; WILLIAMS MS, 1980, J BIOL STAND, V8, P289, DOI 10.1016/S0092-1157(80)80006-0; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WRIGHT PF, 1983, REV INFECT DIS, V5, P758	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175733	10.1371/journal.pone.0175733	http://dx.doi.org/10.1371/journal.pone.0175733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423025	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600047
J	Poulos, S; Agah, S; Jallah, N; Faham, S				Poulos, Sandra; Agah, Sayeh; Jallah, Nikardi; Faham, Salem			Symmetry based assembly of a 2 dimensional protein lattice	PLOS ONE			English	Article							DRIVEN CRYSTALLIZATION; NANOMATERIAL SYNTHESIS; CONSTRAINED SYNTHESIS; FUSION PROTEINS; NANOPARTICLES; LAYER; NANOWIRES; DESIGN; DOMAIN; CAGES	The design of proteins that self-assemble into higher order architectures is of great interest due to their potential application in nanotechnology. Specifically, the self-assembly of proteins into ordered lattices is of special interest to the field of structural biology. Here we designed a 2 dimensional (2D) protein lattice using a fusion of a tandem repeat of three Tel-SAM domains (TTT) to the Ferric uptake regulator (FUR) domain. We determined the structure of the designed (TTT-FUR) fusion protein to 2.3 angstrom by X-ray crystallographic methods. In agreement with the design, a 2D lattice composed of TelSAM fibers interdigitated by the FUR domain was observed. As expected, the fusion of a tandem repeat of three TelSAM domains formed 21 screw axis, and the self-assembly of the ordered oligomer was under pH control. We demonstrated that the fusion of TTT to a domain having a 2-fold symmetry, such as the FUR domain, can produce an ordered 2D lattice. The TTT-FUR system combines features from the rotational symmetry matching approach with the oligomer driven crystallization method. This TTT-FUR fusion was amenable to X-ray crystallographic methods, and is a promising crystallization chaperone.	[Poulos, Sandra; Agah, Sayeh; Jallah, Nikardi; Faham, Salem] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Faham, S (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	sf3bb@virginia.edu						Bai HY, 2009, SOFT MATTER, V5, P966, DOI 10.1039/b816449e; Behrens S, 2009, ADV MATER, V21, P3515, DOI 10.1002/adma.200900487; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DONAHUE JP, 1994, P NATL ACAD SCI USA, V91, P12178, DOI 10.1073/pnas.91.25.12178; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Hernandez-Garcia A, 2014, NAT NANOTECHNOL, V9, P698, DOI [10.1038/NNANO.2014.169, 10.1038/nnano.2014.169]; Huggins KNL, 2014, ADV FUNCT MATER, V24, P7737, DOI 10.1002/adfm.201402049; Ilk N, 2002, APPL ENVIRON MICROB, V68, P3251, DOI 10.1128/AEM.68.7.3251-3260.2002; Ilk N, 2004, BIOCHEM J, V379, P441, DOI 10.1042/BJ20031900; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim JW, 2005, CHEM COMMUN, P4101, DOI 10.1039/b505097a; Kramer RM, 2004, J AM CHEM SOC, V126, P13282, DOI 10.1021/ja046735b; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]; Leng Y, 2010, ANGEW CHEM INT EDIT, V49, P7243, DOI 10.1002/anie.201002452; Marinica DC, 2012, NANO LETT, V12, P1333, DOI 10.1021/nl300269c; McMillan RA, 2005, J AM CHEM SOC, V127, P2800, DOI 10.1021/ja043827s; Men D, 2009, NANO LETT, V9, P2246, DOI 10.1021/nl9003464; Mesnage S, 1999, INFECT IMMUN, V67, P4847, DOI 10.1128/IAI.67.9.4847-4850.1999; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nauli S, 2007, PROTEIN SCI, V16, P2542, DOI 10.1110/ps.073074207; Nudelman H, 2016, J STRUCT BIOL, V194, P244, DOI 10.1016/j.jsb.2016.03.001; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Pleschberger M, 2004, BIOCONJUGATE CHEM, V15, P664, DOI 10.1021/bc049964w; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Sadasivan S, 2008, SOFT MATTER, V4, P2054, DOI 10.1039/b803437k; Schoen AP, 2011, J AM CHEM SOC, V133, P18202, DOI 10.1021/ja204732n; Scholl JA, 2013, NANO LETT, V13, P564, DOI 10.1021/nl304078v; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Tan SF, 2014, SCIENCE, V343, P1496, DOI 10.1126/science.1248797; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Tschiggerl H, 2008, BIOCONJUGATE CHEM, V19, P860, DOI 10.1021/bc7003523; Uchida M, 2015, METHODS MOL BIOL, V1252, P17, DOI 10.1007/978-1-4939-2131-7_2; Zhan Y, 2001, GENE, V281, P1, DOI 10.1016/S0378-1119(01)00797-1	45	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0174485	10.1371/journal.pone.0174485	http://dx.doi.org/10.1371/journal.pone.0174485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419162	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200003
J	Ma, YM; Shukla, V; Merewitz, EB				Ma, Yingmei; Shukla, Vijaya; Merewitz, Emily B.			Transcriptome analysis of creeping bentgrass exposed to drought stress and polyamine treatment	PLOS ONE			English	Article							RNA-SEQ DATA; PHOSPHOENOLPYRUVATE CARBOXYLASE; GENE-EXPRESSION; KYOTO ENCYCLOPEDIA; POTASSIUM CHANNEL; STOMATAL CLOSURE; PLANT-RESPONSES; TALL FESCUE; GUARD-CELLS; IPT GENE	Creeping bentgrass is an important cool-season turfgrass species sensitive to drought. Treatment with polyamines (PAs) has been shown to improve drought tolerance; however, the mechanism is not yet fully understood. Therefore, this study aimed to evaluate transcriptome changes of creeping bentgrass in response to drought and exogenous spermidine (Spd) application using RNA sequencing (RNA-Seq). The high-quality sequences were assembled and 18,682 out of 49,190 (38%) were detected as coding sequences. A total of 22% and 19% of genes were found to be either up-or down-regulated due to drought while 20% and 34% genes were either up-or down-regulated in response to Spd application under drought conditions, respectively. Gene ontology (GO) and enrichment analysis were used to interpret the biological processes of transcripts and relative transcript abundance. Enriched or differentially expressed transcripts due to drought stress and/or Spd application were primarily associated with energy metabolism, transport, antioxidants, photosynthesis, signaling, stress defense, and cellular response to water deprivation. This research is the first to provide transcriptome data for creeping bentgrass under an abiotic stress using RNA-Seq analysis. Differentially expressed transcripts identified here could be further investigated for use as molecular markers or for functional analysis in responses to drought and Spd.	[Ma, Yingmei; Shukla, Vijaya; Merewitz, Emily B.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University	Merewitz, EB (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	merewitz@msu.edu	Ma, Yingmei/J-7409-2019					Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Alcazar R, 2005, PLANT J, V43, P425, DOI 10.1111/j.1365-313X.2005.02465.x; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; [Anonymous], 2014, FRONT PLANT SCI, V5, P687; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Araneda L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079425; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bluthgen Nils, 2005, Genome Inform, V16, P106; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Bourque S, 2002, PLANT PHYSIOL, V130, P2177, DOI 10.1104/pp.009449; Brinia F, 2007, PLANT SCI; Britto DT, 2005, PLANT CELL ENVIRON, V28, P1396, DOI 10.1111/j.1365-3040.2005.01372.x; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Bushman BS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2379-x; Campalans A, 1999, PLANT PHYSIOL BIOCH, V37, P327, DOI 10.1016/S0981-9428(99)80039-4; Chakraborty N, 2006, THEOR APPL GENET, V113, P1421, DOI 10.1007/s00122-006-0387-y; Chakraborty N, 2005, THEOR APPL GENET, V111, P795, DOI 10.1007/s00122-005-2065-x; Chan ZL, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.991577; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; Cousins AB, 2007, PLANT PHYSIOL, V145, P1006, DOI 10.1104/pp.107.103390; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dicko MH, 2006, FEBS J, V273, P2293, DOI 10.1111/j.1742-4658.2006.05243.x; Douce R, 1999, CURR OPIN PLANT BIOL, V2, P214, DOI 10.1016/S1369-5266(99)80038-7; Du HY, 2015, PLANT GROWTH REGUL, V75, P1, DOI 10.1007/s10725-014-9925-9; Eini O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058713; FEIRER RP, 1984, SCIENCE, V223, P1433, DOI 10.1126/science.223.4643.1433; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fry J., 2004, APPL TURFGRASS SCI P; Fu DL, 2007, PLANT CELL REP, V26, P467, DOI 10.1007/s00299-006-0258-7; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; Gan L, 2016, PLOS ONE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Golembiewski RC, 1997, CROP SCI, V37, P212, DOI 10.2135/cropsci1997.0011183X003700010036x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grondin A, 2015, PLANT CELL, V27, P1945, DOI 10.1105/tpc.15.00421; Groppa MD, 2001, PLANT SCI, V161, P481, DOI 10.1016/S0168-9452(01)00432-0; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; GUTTERIDGE S, 1991, J BIOL CHEM, V266, P7359; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hare PD, 1999, J EXP BOT, V50, P413, DOI 10.1093/jexbot/50.333.413; Harpel MR, 1995, BIOCHEM; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatmi S, 2015, J EXP BOT, V66, P775, DOI 10.1093/jxb/eru436; Hesse H, 2004, J EXP BOT, V55, P1283, DOI 10.1093/jxb/erh136; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Ioannidis NE, 2007, BBA-BIOENERGETICS, V1767, P1372, DOI 10.1016/j.bbabio.2007.10.002; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jiang YW, 2002, CROP SCI, V42, P202, DOI 10.2135/cropsci2002.0202; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KANG J, 2011, PLANT ABC TRANSPORTE; KING SW, 1992, PLANT MOL BIOL, V18, P119, DOI 10.1007/BF00018462; KLAPHECK S, 1992, BOT ACTA, V105, P174, DOI 10.1111/j.1438-8677.1992.tb00284.x; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; LARSON RA, 1988, PHYTOCHEMISTRY, V27, P969, DOI 10.1016/0031-9422(88)80254-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X.N., 2016, DROUGHT STRESS TOLER, V1, P17, DOI 10.1007/978-3-319-28899-4; Li Xiong, 2016, Plant Diversity, V38, P101, DOI 10.1016/j.pld.2016.03.002; Li Z, 2015, PLOS ONE; Li Z, 2015, PLANT GROWTH REGUL, V76, P71, DOI 10.1007/s10725-014-9978-9; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; Lu YB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00585; Ma Y, 2016, J AM SOC HORTIC SCI, V141, P94; Marco F, 2011, OMICS, V15, P775, DOI 10.1089/omi.2011.0084; Martinelli T, 2007, J EXP BOT, V58, P3037, DOI 10.1093/jxb/erm161; Merewitz E., 2013, INT TURFGRASS SOC, V12, P375; Merewitz EB, 2016, CAB REV, V11, P3; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Merewitz EB, 2011, J EXP BOT, V62, P5311, DOI 10.1093/jxb/err166; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; MIYAZAKI JH, 1987, PLANT PHYSIOL, V84, P277, DOI 10.1104/pp.84.2.277; Arraes FBM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0597-z; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Munemasa S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00472; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Nogues S, 1998, PLANT PHYSIOL, V117, P173, DOI 10.1104/pp.117.1.173; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Pal M, 2015, PLANT SCI, V237, P16, DOI 10.1016/j.plantsci.2015.05.003; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pottosin I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00154; Qian BY, 2015, J PLANT PHYSIOL, V175, P9, DOI 10.1016/j.jplph.2014.09.019; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Reguera M, 2013, PLANT PHYSIOL, V163, P1609, DOI 10.1104/pp.113.227702; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Savoi S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0760-1; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shen WJ, 2015, PHOTOSYNTHETICA, V53, P436, DOI 10.1007/s11099-015-0111-8; Shi H, 2012, PLOS ONE; Shukla V, 2015, J AM SOC HORTIC SCI, V140, P94, DOI 10.21273/JASHS.140.1.94; Stael S, 2011, FEBS LETT, V585, P3935, DOI 10.1016/j.febslet.2011.10.039; Stevens JR, 2008, THESIS; Stevens R, 2000, Brief Bioinform, V1, P398; Szalai G, 2009, J PLANT GROWTH REGUL, V28, P66, DOI 10.1007/s00344-008-9075-2; Tombesi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12449; Tran L.S., 2016, DROUGHT STRESS TOLER, V1, P77, DOI DOI 10.1007/978-3-319-28899-4_4; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Veljovic-Jovanovic S, 2006, J EXP BOT, V57, P1759, DOI 10.1093/jxb/erl007; VERBRUGGEN N, 1993, PLANT PHYSIOL, V103, P771, DOI 10.1104/pp.103.3.771; Vergara GV, 2004, CROP SCI, V44, P884, DOI 10.2135/cropsci2004.0884; Vergara GV, 2003, CROP SCI, V43, P2162, DOI 10.2135/cropsci2003.2162; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues PE, 2010, ARABIDOPSIS BOOK; Wan Ping, 2011, Genomics Proteomics & Bioinformatics, V9, P37, DOI 10.1016/S1672-0229(11)60006-5; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wingler A, 1999, PLANT CELL ENVIRON, V22, P361, DOI 10.1046/j.1365-3040.1999.00410.x; Xing JP, 2009, J AM SOC HORTIC SCI, V134, P602, DOI 10.21273/JASHS.134.6.602; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HM, 2010, MOL PLANT MICROBE IN, V23, P1097, DOI 10.1094/MPMI-23-8-1097; Zhang R, 2013, J GINSENG RES, V37, P361, DOI 10.5142/jgr.2013.37.361; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521	137	18	20	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175848	10.1371/journal.pone.0175848	http://dx.doi.org/10.1371/journal.pone.0175848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445484	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200030
J	Nishimori, A; Konnai, S; Okagawa, T; Maekawa, N; Ikebuchi, R; Goto, S; Sajiki, Y; Suzuki, Y; Kohara, J; Ogasawara, S; Kato, Y; Murata, S; Ohashi, K				Nishimori, Asami; Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Ikebuchi, Ryoyo; Goto, Shinya; Sajiki, Yamato; Suzuki, Yasuhiko; Kohara, Junko; Ogasawara, Satoshi; Kato, Yukinari; Murata, Shiro; Ohashi, Kazuhiko			In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) ratbovine chimeric antibody against bovine leukemia virus infection	PLOS ONE			English	Article							T-CELL EXHAUSTION; CHRONIC VIRAL-INFECTION; LYMPHOCYTE SUBPOPULATIONS; CLINICAL-SIGNIFICANCE; ANTI-PD-L1 ANTIBODY; THERAPEUTIC TARGET; IMMUNE-RESPONSES; MILK-PRODUCTION; DAIRY-CATTLE; B7-H1 PD-L1	Programmed death-1 (PD-1), an immunoinhibitory receptor on T cells, is known to be involved in immune evasion through its binding to PD-ligand 1 (PD-L1) in many chronic diseases. We previously found that PD-L1 expression was upregulated in cattle infected with bovine leukemia virus (BLV) and that an antibody that blocked the PD-1/PD-L1 interaction reactivated T-cell function in vitro. Therefore, this study assessed its antivirus activities in vivo. First, we inoculated the anti-bovine PD-L1 rat monoclonal antibody 4G12 into a BLV-infected cow. However, this did not induce T-cell proliferation or reduction of BLV provirus loads during the test period, and only bound to circulating IgM(+) B cells until one week post-inoculation. We hypothesized that this lack of in vivo effects was due to its lower stability in cattle and so established an anti-PD-L1 rat-bovine chimeric antibody (Boch4G12). Boch4G12 was able to bind specifically with bovine PD-L1, interrupt the PD-1/PD-L1 interaction, and activate the immune response in both healthy and BLV-infected cattle in vitro. Therefore, we experimentally infected a healthy calf with BLV and inoculated it intravenously with 1 mg/kg of Boch4G12 once it reached the aleukemic (AL) stage. Cultivation of peripheral blood mononuclear cells (PBMCs) isolated from the tested calf indicated that the proliferation of CD4(+) T cells was increased by Boch4G12 inoculation, while BLV provirus loads were significantly reduced, clearly demonstrating that this treatment induced antivirus activities. Therefore, further studies using a large number of animals are required to support its efficacy for clinical application.	[Nishimori, Asami; Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Ikebuchi, Ryoyo; Goto, Shinya; Sajiki, Yamato; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Div Bioresources, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Kohara, Junko] Hokkaido Res Org, Agr Res Dept, Anim Res Ctr, Shintoku, Hokkaido, Japan; [Ogasawara, Satoshi; Kato, Yukinari] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Tohoku University	Konnai, S (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan.	konnai@vetmed.hokudai.ac.jp	Okagawa, Tomohiro/AAX-1284-2021; Suzuki, Yasuhiko/F-6890-2012; Ikebuchi, Ryoyo/AAG-1138-2019	Ikebuchi, Ryoyo/0000-0003-0231-7733; Kato, Yukinari/0000-0001-5385-8201; Satoru, Konnai/0000-0002-3230-7109	SPS KAKENHI grant [25257415]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan [26058B]; Grants-in-Aid for Scientific Research [15J01886, 16K18798] Funding Source: KAKEN	SPS KAKENHI grant; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	SPS KAKENHI grant, 25257415, https://www.jsps.go.jp/english/e-grants/ (to S.K.). The grants from the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan, 26058B (to S.K.). The Promotion of Basic Research Activities for Innovative Biosciences from the National Agriculture and Food Research Organization, Bio-oriented Technology Research Advancement Institution, 16817557 (to S.K.). The Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED (to Y.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Benavides Benavides Bibiana, 2013, Rev. Lasallista Investig., V10, P18; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bradbury A, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P15, DOI 10.1007/978-3-642-01144-3_2; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Das S, 2006, J IMMUNOL, V176, P3000, DOI 10.4049/jimmunol.176.5.3000; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillet NA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003687; Giuliani M., 2017, ONCOTARGET; Hasenkrug KJ, 2000, VIROLOGY, V272, P244, DOI 10.1006/viro.2000.0387; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Ikebuchi R, 2014, IMMUNOLOGY, V142, P551, DOI 10.1111/imm.12243; Ikebuchi R, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-59; Ikebuchi R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-103; Ikebuchi R, 2010, MICROBIOL IMMUNOL, V54, P291, DOI 10.1111/j.1348-0421.2010.00208.x; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kampen AH, 2006, VET IMMUNOL IMMUNOP, V113, P53, DOI 10.1016/j.vetimm.2006.04.001; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konnai S, 2013, COMP IMMUNOL MICROB, V36, P63, DOI 10.1016/j.cimid.2012.09.005; Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272; Kozako T, 2011, HUM IMMUNOL, V72, P1001, DOI 10.1016/j.humimm.2011.07.308; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176; Maekawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098415; Mekata H, 2015, VET REC, V176, P254, DOI 10.1136/vr.102464; Morovati H, 2012, TROP ANIM HEALTH PRO, V44, P1127, DOI 10.1007/s11250-011-0062-4; Murakami K, 2013, J VET MED SCI, V75, P1123, DOI 10.1292/jvms.12-0374; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Norby B, 2016, J DAIRY SCI, V99, P2043, DOI 10.3168/jds.2015-10089; Ohira K, 2016, IMMUN INFLAMM DIS, V4, P52, DOI 10.1002/iid3.93; Okagawa T, 2016, INFECT IMMUN, V84, P2779, DOI 10.1128/IAI.00278-16; Okagawa T, 2016, INFECT IMMUN, V84, P77, DOI 10.1128/IAI.01014-15; Okagawa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-45; Paris RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144767; Rajao DS, 2014, SEMIN-CIENC AGRAR, V35, P891, DOI 10.5433/1679-0359.2014v35n2p891; Ruzina M N, 2013, Genetika, V49, P975; Sheridan C, 2014, NAT BIOTECHNOL, V32, P847, DOI 10.1038/nbt0914-847; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Strome SE, 2003, CANCER RES, V63, P6501; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011; Suzuki S, 2015, VET IMMUNOL IMMUNOP, V163, P115, DOI 10.1016/j.vetimm.2014.10.006; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; VanLeeuwen JA, 2005, CAN VET J, V46, P56; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Yang Y, 2016, J DAIRY SCI, V99, P3688, DOI 10.3168/jds.2015-10580	63	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174916	10.1371/journal.pone.0174916	http://dx.doi.org/10.1371/journal.pone.0174916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445479	gold, Green Published, Green Submitted			2022-12-27	WOS:000400309200014
J	Bauer, D; Redmon, N; Mazzio, E; Soliman, KF				Bauer, David; Redmon, Natalie; Mazzio, Elizabeth; Soliman, Karam F.			Apigenin inhibits TNF alpha/IL-1 alpha-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; GROWTH-INHIBITION; CARCINOMA-CELLS; TNF-ALPHA; EXPRESSION; APOPTOSIS; NEUTROPHILS; SUPPRESSES; INDUCTION; PROSTATE	Mortality associated with breast cancer is attributable to aggressive metastasis, to which TNF alpha plays a central orchestrating role. TNF alpha acts on breast tumor TNF receptors evoking the release of chemotactic proteins (e.g. MCP-1/CCL2). These proteins direct inward infiltration/migration of tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), myeloid-derived suppressor cells (MDSCs), T-regulatory cells (Tregs), T helper IL-17-producing cells (Th17s), metastasis-associated macrophages (MAMs) and cancer-associated fibroblasts (CAFs). Tumor embedded infiltrates collectively enable immune evasion, tumor growth, angiogenesis, and metastasis. In the current study, we investigate the potential of apigenin, a known anti-inflammatory constituent of parsley, to downregulate TNF alpha mediated release of chemokines from human triple-negative cells (MDA-MB-231 cells). The results show that TNF alpha stimulation leads to large rise of CCL2, granulocyte macrophage colony-stimulating factor (GMCSF), IL-1 alpha and IL-6, all suppressed by apigenin. While many aspects of the transcriptome for NFkB signaling were evaluated, the data show signaling patterns associated with CCL2 were blocked by apigenin and mediated through suppressed mRNA and protein synthesis of IKBKe. Moreover, the data show that the attenuation of CCL2 by apigenin in the presence TNF alpha paralleled the suppression of phosphorylated extracellular signal-regulated kinase 1 (ERK 1/2). In summary, the obtained findings suggest that there exists a TNF alpha evoked release of CCL2 and other LSP recruiting cytokines from human breast cancer cells, which can be attenuated by apigenin.	[Bauer, David; Redmon, Natalie; Mazzio, Elizabeth; Soliman, Karam F.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32301 USA	State University System of Florida; Florida A&M University	Soliman, KF (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32301 USA.	karam.soliman@famu.edu			National Institute of Minority Health and Health Disparities of the National Institutes of Health [G12 MD007582, P20 MD006738]	National Institute of Minority Health and Health Disparities of the National Institutes of Health	This research was supported by the National Institute of Minority Health and Health Disparities of the National Institutes of Health through Grant Number G12 MD007582 and Grant Number P20 MD006738.	Angelini A, 2010, J BIOL REG HOMEOS AG, V24, P197; [Anonymous], 2005, Health News, V11, P2; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Chen D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1797; Chen SS, 2012, DISCOV MED, V14, P327; Choi EJ, 2009, J CLIN BIOCHEM NUTR, V44, P260, DOI 10.3164/jcbn.08-230; Choi EJ, 2009, J NUTR BIOCHEM, V20, P285, DOI 10.1016/j.jnutbio.2008.03.005; Choi HJ, 2016, BIOCHEM BIOPH RES CO, V470, P101, DOI 10.1016/j.bbrc.2016.01.002; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Devaud C, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.975572; Ferrucci V, 2016, N-S ARCH PHARMACOL, V389, P131, DOI 10.1007/s00210-015-1191-5; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; Ibrahim SA, 2015, ONCOTARGET, V6, P33033, DOI 10.18632/oncotarget.5439; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Jehs T, 2014, INVEST OPHTH VIS SCI, V55, P5169, DOI 10.1167/iovs.14-14394; Jiang Zhe, 2014, Oncoscience, V1, P180; Katanov C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0080-7; Kimura Y, 2015, EUR J PHARMACOL, V746, P115, DOI 10.1016/j.ejphar.2014.10.048; Kindlund B, 2016, GASTRIC CANC; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Li CH, 2013, J NUTR BIOCHEM, V24, P1766, DOI 10.1016/j.jnutbio.2013.03.006; Lin CH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1965-7; Liu DW, 2016, CURR PHARM BIOTECHNO, V17, P486, DOI 10.2174/1389201017666160301102713; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Mafuvadze B, 2010, MENOPAUSE, V17, P1055, DOI 10.1097/gme.0b013e3181dd052f; Malek E, 2016, BLOOD REV; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; Mirzoeva S, 2014, MOL CARCINOGEN, V53, P598, DOI 10.1002/mc.22005; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Moses K, 2016, SEMIN IMMUNOL; Nabavi SM, 2015, ANTI-CANCER AGENT ME, V15, P728, DOI 10.2174/1871520615666150304120643; Noolu B, 2016, ANTICANCER AGENTS ME; Papi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054968; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rego SL, 2014, ANGIOGENESIS, V17, P573, DOI 10.1007/s10456-013-9405-2; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Seo HS, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150165; Seo HS, 2015, MOL MED REP, V12, P2977, DOI 10.3892/mmr.2015.3698; Seo HS, 2012, MOL CELL BIOCHEM, V366, P319, DOI 10.1007/s11010-012-1310-2; Seo HS, 2011, NUTR RES, V31, P139, DOI 10.1016/j.nutres.2011.01.011; Shen RR, 2012, MOL CELL BIOL, V32, P4756, DOI 10.1128/MCB.00468-12; Shukla S, 2015, ONCOTARGET, V6, P31216, DOI 10.18632/oncotarget.5157; Shukla S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138710; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Steiner JL, 2012, INT J BIOL MARKER, V27, P179, DOI 10.5301/JBM.2012.9345; Sun L, 2016, ONCOTARGET; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Trivanovic D, 2016, IUBMB LIFE, V68, P190, DOI 10.1002/iub.1473; Tseng TH, 2016, ENV TOXICOL; Ueno T, 2000, CLIN CANCER RES, V6, P3282; van Meeuwen JA, 2007, TOXICOL APPL PHARM, V221, P372, DOI 10.1016/j.taap.2007.03.016; Vrakas CN, 2015, IMMUNOL INVEST, V44, P174, DOI 10.3109/08820139.2014.952818; Wang QR, 2011, ONCOL LETT, V2, P43, DOI 10.3892/ol.2010.215; Wang Y, 2016, CELL PHYSIOL BIOCHEM, V38, P306, DOI 10.1159/000438631; Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169; Yan C, 2015, J HEPATOL, V63, P420, DOI 10.1016/j.jhep.2015.03.024; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782; Zhou AY, 2013, CELL REP, V3, P724, DOI 10.1016/j.celrep.2013.01.031; Zhou SL, 2016, GASTROENTEROLOGY; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5	67	50	51	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175558	10.1371/journal.pone.0175558	http://dx.doi.org/10.1371/journal.pone.0175558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441391	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800006
J	Leclere, B; Buckeridge, DL; Boelle, PY; Astagneau, P; Lepelletier, D				Leclere, Brice; Buckeridge, David L.; Boelle, Pierre-Yves; Astagneau, Pascal; Lepelletier, Didier			Automated detection of hospital outbreaks: A systematic review of methods	PLOS ONE			English	Review							INFECTION-CONTROL; NOSOCOMIAL INFECTIONS; SURVEILLANCE SYSTEMS; CONTROL CHARTS; ACCURACY	Objectives Several automated algorithms for epidemiological surveillance in hospitals have been proposed. However, the usefulness of these methods to detect nosocomial outbreaks remains unclear. The goal of this review was to describe outbreak detection algorithms that have been tested within hospitals, consider how they were evaluated, and synthesize their results. Methods We developed a search query using keywords associated with hospital outbreak detection and searched the MEDLINE database. To ensure the highest sensitivity, no limitations were initially imposed on publication languages and dates, although we subsequently excluded studies published before 2000. Every study that described a method to detect outbreaks within hospitals was included, without any exclusion based on study design. Additional studies were identified through citations in retrieved studies. Results Twenty-nine studies were included. The detection algorithms were grouped into 5 categories: simple thresholds (n = 6), statistical process control (n = 12), scan statistics (n = 6), traditional statistical models (n = 6), and data mining methods (n = 4). The evaluation of the algorithms was often solely descriptive (n = 15), but more complex epidemiological criteria were also investigated (n = 10). The performance measures varied widely between studies: e.g., the sensitivity of an algorithm in a real world setting could vary between 17 and 100%. Conclusion Even if outbreak detection algorithms are useful complementary tools for traditional surveillance, the heterogeneity in results among published studies does not support quantitative synthesis of their performance. A standardized framework should be followed when evaluating outbreak detection methods to allow comparison of algorithms across studies and synthesis of results.	[Leclere, Brice] Nantes Univ Hosp, Dept Med Evaluat & Epidemiol, Nantes, France; [Leclere, Brice; Lepelletier, Didier] Univ Nantes, MiHAR Lab, Nantes, France; [Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Boelle, Pierre-Yves] Pierre & Marie Curie Univ, UMR S 1136, Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France; [Astagneau, Pascal] Pierre & Marie Curie Univ, Dept Publ Hlth, Paris, France; [Astagneau, Pascal] Hop Broussais, Ctr Coordinat Lutte Infect Nosocomi Paris Nord, Paris, France; [Lepelletier, Didier] Nantes Univ Hosp, Dept Microbiol & Infect Control, Nantes, France	Nantes Universite; CHU de Nantes; Nantes Universite; McGill University; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes	Leclere, B (corresponding author), Nantes Univ Hosp, Dept Med Evaluat & Epidemiol, Nantes, France.; Leclere, B (corresponding author), Univ Nantes, MiHAR Lab, Nantes, France.	brice.leclere@univ-nantes.fr	Astagneau, Pascal/AAF-3473-2020					Arantes A, 2003, REV SAUDE PUBL, V37, P768, DOI 10.1590/S0034-89102003000600012; Brossette SE, 1998, J AM MED INFORM ASSN, V5, P373, DOI 10.1136/jamia.1998.0050373; Brossette SE, 2000, METHOD INFORM MED, V39, P303; Brown SM, 2002, EMERG INFECT DIS, V8, P1426, DOI 10.3201/eid0812.010514; Buckeridge D, 2007, PERSP MED V, V16, P325, DOI 10.1016/S0168-7069(06)16013-9; Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Carnevale RJ, 2011, J AM MED INFORM ASSN; Cellarosi G, 2002, COMP MED SY, P159, DOI 10.1109/CBMS.2002.1011371; Charvat H, 2010, J HOSP INFECT, V74, P250, DOI 10.1016/j.jhin.2009.08.012; Childress J A, 1981, Infect Control, V2, P247; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DESSAU RB, 1993, J CLIN MICROBIOL, V31, P857, DOI 10.1128/JCM.31.4.857-860.1993; Du MM, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-9; Faires MC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-375; Faires MC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-254; Forster AJ, 2012, J AM MED INFORM ASSN, V19, P31, DOI 10.1136/amiajnl-2011-000454; Freeman R, 2013, EUR C CLIN MICR INF; Gomes IC, 2011, CLINICS, V66, P1681, DOI 10.1590/S1807-59322011001000004; Hacek DM, 2004, J CLIN MICROBIOL, V42, P1170, DOI 10.1128/JCM.42.3.1170-1175.2004; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Kashiouris M, 2013, APPL CLIN INFORM, V4, P212, DOI 10.4338/ACI-2012-12-RA-0053; Kikuchi K., 2007, Intelligence and Security Informatics: Biosurveillance. Second NSF Workshop, Biosurveillance 2007. Proceedings (Lecture Notes in Computer Science Vol.4506), P202; Kulldorf M, 2009, SATSCANTM V8 0 SOFTW; Lamma E, 2006, IEEE T INF TECHNOL B, V10, P143, DOI 10.1109/TITB.2005.855537; Leal J, 2008, J HOSP INFECT, V69, P220, DOI 10.1016/j.jhin.2008.04.030; Leclere B, 2014, INFECT CONT HOSP EP, V35, P1330, DOI 10.1086/678422; Lefebvre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139920; Ma Lili, 2003, AMIA Annu Symp Proc, P410; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Menotti J, 2010, CLIN MICROBIOL INFEC, V16, P1368, DOI [10.1111/j.1469-0691.2010.03150.x, 10.1111/j.1469-0691.2009.03150.x]; Mitchell C, 2016, BMJ QUAL SAF, V25, P466, DOI 10.1136/bmjqs-2015-004134; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Mylotte JM, 1996, INFECT CONT HOSP EP, V17, P101; Nishiura Hiroshi, 2012, Osong Public Health Res Perspect, V3, P121, DOI 10.1016/j.phrp.2012.07.010; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Pentland A, 2006, DETECTING CLUSTERS M; Rutjes AWS., 2007, HEALTH TECHNOL ASSES, V11, P1; Sagel U, 2004, METHODS INF MED, V43; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; SCHIFMAN RB, 1985, J CLIN MICROBIOL, V21, P493, DOI 10.1128/JCM.21.4.493-495.1985; Siegrist David, 2004, MMWR Suppl, V53, P152; Skipper L., 2009, J INF TECHNOL HEALTH, V7, P13; Spearing NM, 2000, AM J INFECT CONTROL, V28, P54, DOI 10.1016/S0196-6553(00)90012-9; Tseng YJ, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2056; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Wong WK, 2003, J URBAN HEALTH, V80, pI66; Wright MO, 2004, INFECT CONT HOSP EP, V25, P325, DOI 10.1086/502400	50	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176438	10.1371/journal.pone.0176438	http://dx.doi.org/10.1371/journal.pone.0176438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441422	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800054
J	Vali, P; Chandrasekharan, P; Rawat, M; Gugino, S; Koenigsknecht, C; Helman, J; Mathew, B; Berkelhamer, S; Nair, J; Wyckoff, M; Lakshminrusimha, S				Vali, Payam; Chandrasekharan, Praveen; Rawat, Munmun; Gugino, Sylvia; Koenigsknecht, Carmon; Helman, Justin; Mathew, Bobby; Berkelhamer, Sara; Nair, Jayasree; Wyckoff, Myra; Lakshminrusimha, Satyan			Hemodynamics and gas exchange during chest compressions in neonatal resuscitation	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; PERINATAL ASPHYXIA; SWINE MODEL; LAMBS; EPINEPHRINE; VENTILATION; HYPOXIA; CPR	Purpose Current knowledge about pulmonary/systemic hemodynamics and gas exchange during neonatal resuscitation in a model of transitioning fetal circulation with fetal shunts and fluid-filled alveoli is limited. Using a fetal lamb asphyxia model, we sought to determine whether hemodynamic or gas-exchange parameters predicted successful return of spontaneous circulation (ROSC). Methods The umbilical cord was occluded in 22 lambs to induce asphyxial cardiac arrest. Following five minutes of asystole, resuscitation as per AHA-Neonatal Resuscitation Program guidelines was initiated. Hemodynamic parameters and serial arterial blood gases were assessed during resuscitation. Results ROSC occurred in 18 lambs (82%) at a median (IQR) time of 120 (105-180) seconds. There were no differences in hemodynamic parameters at baseline and at any given time point during resuscitation between the lambs that achieved ROSC and those that did not. Blood gases at arrest prior to resuscitation were comparable between groups. However, lambs that achieved ROSC had lower PaO2, higher PaCO2, and lower lactate during resuscitation. Increase in diastolic blood pressures induced by epinephrine in lambs that achieved ROSC (11 +/- 4 mmHg) did not differ from those that were not resuscitated (10 +/- 6 mmHg). Low diastolic blood pressures were adequate to achieve ROSC. Conclusions Hemodynamic parameters in a neonatal lamb asphyxia model with transitioning circulation did not predict success of ROSC. Lactic acidosis, higher PaO2 and lower PaCO2 observed in the lambs that did not achieve ROSC may represent a state of inadequate tissue perfusion and/or mitochondrial dysfunction.	[Vali, Payam] Univ Calif Davis, Pediat, Sacramento, CA 95817 USA; [Chandrasekharan, Praveen; Rawat, Munmun; Gugino, Sylvia; Koenigsknecht, Carmon; Helman, Justin; Mathew, Bobby; Berkelhamer, Sara; Nair, Jayasree; Lakshminrusimha, Satyan] SUNY Buffalo, Pediat, Buffalo, NY USA; [Wyckoff, Myra] UT Southwestern, Pediat, Dallas, TX USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vali, P (corresponding author), Univ Calif Davis, Pediat, Sacramento, CA 95817 USA.	pvali@ucdavis.edu	Chandrasekharan, Praveen/X-1729-2019	Chandrasekharan, Praveen/0000-0001-8727-3017; Rawat, Munmun/0000-0001-9703-9857; Nair, Jayasree/0000-0003-3846-2027; Lakshminrusimha, Satyan/0000-0001-6098-2155	Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant; American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award; NICHD [HD072929]	Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant; American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant (SL), American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award (PV) and NICHD HD072929 (SL). The funders had no role study design, data collection ana analysis, decision to publish, or preparation of the manuscript.	Berg RA, 1999, CRIT CARE MED, V27, P1893, DOI 10.1097/00003246-199909000-00030; Chandrasekharan P, 2017, PEDIAT RES; Crile G, 1906, J EXP MED, V8, P713, DOI 10.1084/jem.8.6.713; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Houri P K, 1997, Prehosp Emerg Care, V1, P65, DOI 10.1080/10903129708958789; Kapadia VS, 2013, J PEDIATR-US, V163, P949, DOI 10.1016/j.jpeds.2013.04.043; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Kuligowskia J, 2017, REDOX BIOL, V12, P1, DOI 10.1016/j.redox.2017.02.002; Perlman JM, 2015, PEDIATRICS; PREZIOSI MP, 1993, CRIT CARE MED, V21, P1901, DOI 10.1097/00003246-199312000-00018; Ramanathan T, 2005, BJA EDUC, V5, P61, DOI 10.1093/bjaceaccp/mki012; REDDING JS, 1963, ANESTHESIOLOGY, V24, P203, DOI 10.1097/00000542-196303000-00008; ROSENBERG AA, 1986, PEDIATR RES, V20, P778, DOI 10.1203/00006450-198608000-00016; ROSENBERG AA, 1989, STROKE, V20, P674, DOI 10.1161/01.STR.20.5.674; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Sobotka KS, 2015, PEDIAT RES; Solberg R, 2016, PEDIATR RES, V80, P284, DOI 10.1038/pr.2016.66; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Sutton RM, 2014, RESUSCITATION, V85, P983, DOI 10.1016/j.resuscitation.2014.04.015; Sutton RM, 2013, RESUSCITATION, V84, P696, DOI 10.1016/j.resuscitation.2012.10.023; TRAUB E, 1983, J PERINAT MED, V11, P103, DOI 10.1515/jpme.1983.11.2.103; Weiner GM, 2012, CLIN PERINATOL, V39, P843, DOI 10.1016/j.clp.2012.09.005; Wyckoff MH, 2008, SEMIN FETAL NEONAT M, V13, P410, DOI 10.1016/j.siny.2008.04.012; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176478	10.1371/journal.pone.0176478	http://dx.doi.org/10.1371/journal.pone.0176478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441439	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800063
J	Zhang, HF; Wei, CH; Yang, XZ; Chen, HJ; Yang, YC; Mo, YL; Li, H; Zhang, Y; Ma, JX; Yang, JQ; Zhang, X				Zhang, Haifei; Wei, Chunhua; Yang, Xiaozhen; Chen, Hejie; Yang, Yongchao; Mo, Yanling; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian			Genome-wide identification and expression analysis of calcium-dependent protein kinase and its related kinase gene families in melon (Cucumis melo L.)	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; ABSCISIC-ACID; FUNCTIONAL-CHARACTERIZATION; SIGNAL-TRANSDUCTION; CONFERS SALT; RICE; CDPK; REGULATOR; EVOLUTION; COLD	The calcium-dependent protein kinase (CDPK) is a ser/thr protein kinase that plays vital roles in plant growth, development, and responses to multiple stresses. Despite an important member of the stress responsive gene family, little is known about the evolutionary history and expression patterns of CDPK genes in melon. Herein, a total of 18 CDPK genes and 7 CDPK-related protein kinases (CRK) genes were identified in the melon genome via bioinformatic analysis, which were unevenly distributed across eleven chromosomes with an apparent exception for chromosome 3. Comparative syntenic analysis between Cucumis melo L. and Arabidopsis thaliana revealed that 13 CmCDPKs and 19 AtCPKs existed in 20 corresponding syntenic blocks. In addition, based on gene structure and phylogenetic analyses, all CmCDPKs were divided into four groups (CDPK I-IV) and CmCRKs clustered into one group (CRK I). Interestingly, group CDPK IV was clearly distinct from the other three CDPK groups, but clustered with CRK I on the phylogenetic tree, implying their origination from a common ancestor. Furthermore, CmCDPKand CmCRK genes were differentially expressed in response to various stimuli, such as biotic stress (Podosphaera xanthii), abiotic stress (salt and cold), and hormone (abscisic acid) treatment. To our knowledge, this is the first report on CDPK and CRK gene families in melon, which provides a basic foundation for functional characterizations of CmCDPK and CmCRK genes in the future.	[Zhang, Haifei; Wei, Chunhua; Yang, Xiaozhen; Chen, Hejie; Yang, Yongchao; Mo, Yanling; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian] Northwest A&F Univ, Dept Hort, Yangling, Peoples R China; [Yang, Yongchao] Wenshan Acad Agr Sci, Wenshan, Peoples R China	Northwest A&F University - China	Zhang, X (corresponding author), Northwest A&F Univ, Dept Hort, Yangling, Peoples R China.	zhangxian098@126.com			Scientific Startup Foundation for Doctors of Northwest AF University [Z109021604]; Basal Research Foundation of Northwest AF University [Z109021612]; Shaanxi Provincial Science and Technology Research and Development Project Fund, China [2015NY091]; Modern Agro-industry Technology Research System of China [CARS-26-18]	Scientific Startup Foundation for Doctors of Northwest AF University; Basal Research Foundation of Northwest AF University; Shaanxi Provincial Science and Technology Research and Development Project Fund, China; Modern Agro-industry Technology Research System of China	This work was supported by Scientific Startup Foundation for Doctors of Northwest A&F University (Z109021604), Basal Research Foundation of Northwest A&F University (Z109021612), the Shaanxi Provincial Science and Technology Research and Development Project Fund, China (No. 2015NY091), and the Modern Agro-industry Technology Research System of China (No. CARS-26-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Alex B, 2004, NUCLEIC ACIDS RES, V38, P211; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Asano T, 2011, PLANT MOL BIOL, V75, P179, DOI 10.1007/s11103-010-9717-1; Ben-Ari G, 2012, PLANT CELL REP, V31, P1357, DOI 10.1007/s00299-012-1292-2; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Cai HY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00737; Campo S, 2014, PLANT PHYSIOL, V165, P688, DOI 10.1104/pp.113.230268; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Cheng H, 2013, MOL BIOL REP, V40, P2609, DOI 10.1007/s11033-012-2347-8; Cheng H, 2012, MOL BIOL REP, V39, P1903, DOI 10.1007/s11033-011-0936-6; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ding YF, 2013, J EXP BOT, V64, P871, DOI 10.1093/jxb/ers366; Emanuel Epstein, 1972, PLANT PHYSL MINERAL; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Hamel LP, 2014, TRENDS PLANT SCI, V19, P79, DOI 10.1016/j.tplants.2013.10.009; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li AL, 2008, PLANT MOL BIOL, V66, P429, DOI 10.1007/s11103-007-9281-5; Liese A, 2013, BBA-MOL CELL RES, V1833, P1582, DOI 10.1016/j.bbamcr.2012.10.024; Liu CY, 2014, MOL BIOL REP, V41, P6769, DOI 10.1007/s11033-014-3563-1; Liu HL, 2016, FUNCT INTEGR GENOMIC, V16, P481, DOI 10.1007/s10142-016-0498-8; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098189; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SX, 2013, PLANT MOL BIOL, V82, P267, DOI 10.1007/s11103-013-0061-0; Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; MCCURDY DW, 1992, PLANTA, V188, P54, DOI 10.1007/BF00198939; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shi W, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-103, 10.1186/1471-2164-14-433]; Sirhindi G, 2016, J PLANT BIOCHEM BIOT, V25, P301, DOI 10.1007/s13562-015-0342-6; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valmonte GR, 2014, PLANT CELL PHYSIOL, V55, P551, DOI 10.1093/pcp/pct200; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang JP, 2016, MOL GENET GENOMICS, V291, P661, DOI 10.1007/s00438-015-1137-0; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Weckwerth P, 2015, PLANT CELL ENVIRON, V38, P544, DOI 10.1111/pce.12414; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Xu XW, 2015, MOL GENET GENOMICS, V290, P1403, DOI 10.1007/s00438-015-1002-1; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Zhang HF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-211; Zhang K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0552-z; Zhang M, 2005, BBA-GENE STRUCT EXPR, V1729, P174, DOI 10.1016/j.bbaexp.2005.04.006; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	79	26	30	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176352	10.1371/journal.pone.0176352	http://dx.doi.org/10.1371/journal.pone.0176352			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437432	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600044
J	Butcher, NJ; Merico, D; Zarrei, M; Ogura, L; Marshall, CR; Chow, EWC; Lang, AE; Scherer, SW; Bassett, AS				Butcher, Nancy J.; Merico, Daniele; Zarrei, Mehdi; Ogura, Lucas; Marshall, Christian R.; Chow, Eva W. C.; Lang, Anthony E.; Scherer, Stephen W.; Bassett, Anne S.			Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease	PLOS ONE			English	Article							LOW-COPY REPEATS; GENE PRIORITIZATION; FUNCTIONAL IMPACT; VITAMIN-D; SCHIZOPHRENIA; RISK; ADULTS; COOCCURRENCE; PHENOTYPE; LOCUS	Objectives To investigate disease risk mechanisms of early-onset Parkinson's disease (PD) associated with the recurrent 22q11.2 deletion, a genetic risk factor for early-onset PD. Methods In a proof-of-principle study, we used whole-genome sequencing (WGS) to investigate sequence variants in nine adults with 22q11.2DS, three with neuropathologically confirmed early-onset PD and six without PD. Adopting an approach used recently to study schizophrenia in 22q11.2DS, here we tested candidate gene-sets relevant to PD. Results No mutations common to the cases with PD were found in the intact 22q11.2 region. While all were negative for rare mutations in a gene-set comprising PD disease-causing and risk genes, another candidate gene-set of 1000 genes functionally relevant to PD presented a nominally significant (P = 0.03) enrichment of rare putatively damaging missense variants in the PD cases. Polygenic score results, based on common variants associated with PD risk, were non-significantly greater in those with PD. Conclusions The results of this first-ever pilot study of WGS in PD suggest that the cumulative burden of genome-wide sequence variants may contribute to expression of early-onset PD in the presence of threshold-lowering dosage effects of a 22q11.2 deletion. We found no evidence that expression of PD in 22q11.2DS is mediated by a recessive locus on the intact 22q11.2 chromosome or mutations in known PD genes. These findings offer initial evidence of the potential effects of multiple within-individual rare variants on the expression of PD and the utility of next generation sequencing for studying the etiology of PD.	[Butcher, Nancy J.; Ogura, Lucas; Chow, Eva W. C.; Bassett, Anne S.] Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada; [Butcher, Nancy J.; Chow, Eva W. C.; Bassett, Anne S.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Butcher, Nancy J.; Lang, Anthony E.; Scherer, Stephen W.; Bassett, Anne S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Merico, Daniele; Zarrei, Mehdi; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Merico, Daniele; Zarrei, Mehdi; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Chow, Eva W. C.; Bassett, Anne S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Lang, Anthony E.] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [Lang, Anthony E.] Univ Toronto, Dept Med, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Lang, Anthony E.] Univ Hlth Network, Toronto Western Hosp, Res Inst, Toronto, ON, Canada; [Lang, Anthony E.] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Dalglish Clin Adults Delet Syndrome 22q 22q11 2, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Div Cardiol, Dept Med, Toronto, ON, Canada; [Butcher, Nancy J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bassett, AS (corresponding author), Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada.; Bassett, AS (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Dalglish Clin Adults Delet Syndrome 22q 22q11 2, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Div Cardiol, Dept Med, Toronto, ON, Canada.	anne.bassett@utoronto.ca	Scherer, Stephen W./B-3785-2013; Lang, Anthony/ABF-8114-2021	Scherer, Stephen W./0000-0002-8326-1999; Merico, Daniele/0000-0002-3728-4401; Butcher, Nancy/0000-0002-5152-0108; Lang, Anthony/0000-0003-1229-3667	Canadian Institutes of Health Research [97800, 111238]; Genome Canada/Ontario Genomics Institute; Canada Research Chairs program; Brain Canada Mental Health Training Award; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Ontario Genomics Institute(Genome Canada); Canada Research Chairs program(Canada Research Chairs); Brain Canada Mental Health Training Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (A.S.B, MOP #97800, MOP #111238), Canada Research Chairs program (A.S.B), a Brain Canada Mental Health Training Award (N.J.B), a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship (N.J.B), and Science and Technology Innovation Centre funding from Genome Canada/Ontario Genomics Institute (D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Booij J, 2010, AM J MED GENET A, V152A, P2937, DOI 10.1002/ajmg.a.33665; Butcher N, 2015, MOVEMENT DISORD, V30, pS1035; Butcher N, 2017, NEUROIMAGIN IN PRESS; Butcher NJ, 2013, JAMA NEUROL, V70, P1359, DOI 10.1001/jamaneurol.2013.3646; Butcher NJ, 2012, GENET MED, V14, P836, DOI 10.1038/gim.2012.66; Chauveau C, 2014, HUM MUTAT, V35, P1046, DOI 10.1002/humu.22611; D'Andrea MR, 2001, NEUROSCI LETT, V306, P137, DOI 10.1016/S0304-3940(01)01811-0; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Foo JN, 2016, MOVEMENT DISORD, V31, P1924, DOI 10.1002/mds.26822; Fung WLA, 2015, GENET MED, V17, P599, DOI 10.1038/gim.2014.175; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Guna A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9113-x; Hicks David G, 2010, BMC Cancer, V10, P108, DOI 10.1186/1471-2407-10-108; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V222, P144, DOI 10.1006/bbrc.1996.0712; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kelley L, 2016, J DEV ORIG HLTH DIS, V7, P616, DOI 10.1017/S2040174416000428; Kiehl TR, 2009, CEREB CORTEX, V19, P153, DOI 10.1093/cercor/bhn066; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lubbe SJ, 2016, HUM MOL GENET; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Merico D, 2015, G3-GENES GENOM GENET, V5, P2453, DOI 10.1534/g3.115.021345; Merico D, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00238; Mok KY, 2016, LANCET NEUROL, V15, P585, DOI 10.1016/S1474-4422(16)00071-5; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ogaki K, 2014, PARKINSONISM RELAT D, V20, P945, DOI 10.1016/j.parkreldis.2014.06.020; Oki M, 2016, INTERNAL MED, V55, P303, DOI 10.2169/internalmedicine.55.5485; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pollard R, 2016, PARKINSONISM RELAT D, V25, P110, DOI 10.1016/j.parkreldis.2016.01.027; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rehman AF, 2015, MOVEMENT DISORD, V30, P1289, DOI 10.1002/mds.26305; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Spataro N, 2015, HUM MOL GENET, V24, P2023, DOI 10.1093/hmg/ddu616; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tranchevent LC, 2016, NUCLEIC ACIDS RES, V44, pW117, DOI 10.1093/nar/gkw365; Van L, 2016, GENET MED, V18, P350, DOI 10.1038/gim.2015.84; Verhoeven WM, 2015, PHARMACOPSYCHIATRY; Vogels A, 2002, ANN GENET-PARIS, V45, P89, DOI 10.1016/S0003-3995(02)01114-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LY, 2015, MOVEMENT DISORD, V30, P560, DOI 10.1002/mds.26117; Weksberg R, 2007, HUM GENET, V120, P837, DOI 10.1007/s00439-006-0242-x; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zaleski C, 2009, AM J MED GENET A, V149A, P525, DOI 10.1002/ajmg.a.32650	59	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0173944	10.1371/journal.pone.0173944	http://dx.doi.org/10.1371/journal.pone.0173944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430790	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100003
J	Mangoni, O; Saggiomo, V; Bolinesi, F; Margiotta, F; Budillon, G; Cotroneo, Y; Misic, C; Rivaro, P; Saggiomo, M				Mangoni, Olga; Saggiomo, Vincenzo; Bolinesi, Francesco; Margiotta, Francesca; Budillon, Giorgio; Cotroneo, Yuri; Misic, Cristina; Rivaro, Paola; Saggiomo, Maria			Phytoplankton blooms during austral summer in the Ross Sea, Antarctica: Driving factors and trophic implications	PLOS ONE			English	Article							FRAGILARIOPSIS-CYLINDRUS BACILLARIOPHYCEAE; NET COMMUNITY PRODUCTION; SOUTHERN-OCEAN; PHAEOCYSTIS-ANTARCTICA; QUANTUM YIELD; MESOSCALE VARIABILITY; TAXA PHOTOSYNTHESIS; IRON LIMITATION; CLIMATE-CHANGE; CARBON EXPORT	During the austral summer of 2014, an oceanographic cruise was conducted in the Ross Sea in the framework of the RoME (Ross Sea Mesoscale Experiment) Project. Forty-three hydrological stations were sampled within three different areas: the northern Ross Sea (RoME 1), Terra Nova Bay (RoME 2), and the southern Ross Sea (RoME 3). The ecological and photophysiological characteristics of the phytoplankton were investigated (i.e., size structure, functional groups, PSII maximum quantum efficiency, photoprotective pigments), as related to hydrographic and chemical features. The aim was to identify the mechanisms that modulate phytoplankton blooms, and consequently, the fate of organic materials produced by the blooms. The observed biomass standing stocks were very high (e.g., integrated chlorophyll-a up to 371 mg m(-2) in the top 100 m). Large differences in phytoplankton community composition, relative contribution of functional groups and photosynthetic parameters were observed among the three subsystems. The diatoms (in different physiological status) were the dominant taxa in RoME 1 and RoME 3; in RoME 1, a post-bloom phase was identified, whereas in RoME 3, an active phytoplankton bloom occurred. In RoME 2, diatoms co-occurred with Phaeocystis antarctica, but were vertically segregated by the upper mixed layer, with senescent diatoms dominating in the upper layer, and P. antarctica blooming in the deeper layer. The dominance of the phytoplankton micro-fraction over the whole area and the high Chl-a suggested the prevalence of non-grazed large cells, independent of the distribution of the two functional groups. These data emphasise the occurrence of significant temporal changes in the phytoplankton biomass in the Ross Sea during austral summer. The mechanisms that drive such changes and the fate of the carbon production are probably related to the variations in the limiting factors induced by the concurrent hydrological modifications to the Ross Sea, and they remain to be fully clarified. The comparison of conditions observed during summer 2014 and those reported for previous years reveal considerably different ecological assets that might be the result of current climate change. This suggests that further changes can be expected in the future, even at larger oceanic scales.	[Mangoni, Olga; Bolinesi, Francesco] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Saggiomo, Vincenzo; Margiotta, Francesca; Saggiomo, Maria] Stn Zool Anton Dohrn, Naples, Italy; [Budillon, Giorgio; Cotroneo, Yuri] Univ Parthenope, Dipartimento Sci & Tecnol, Naples, Italy; [Misic, Cristina] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Rivaro, Paola] Univ Genoa, Dipartimento Chim & Chim Ind, Genoa, Italy	University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli; Parthenope University Naples; University of Genoa; University of Genoa	Mangoni, O (corresponding author), Univ Napoli Federico II, Dipartimento Biol, Naples, Italy.	olga.mangoni@unina.it	Cotroneo, Yuri/M-4010-2019	Cotroneo, Yuri/0000-0002-0099-0142; Margiotta, Francesca/0000-0003-0757-5934; MANGONI, Olga/0000-0001-7789-0820; Saggiomo, Maria/0000-0001-5794-0050	Italian National Program for Antarctic Research (PNRA) [2013/AN2.04]; Italian National Programme for Antarctic Research	Italian National Program for Antarctic Research (PNRA); Italian National Programme for Antarctic Research	This work was carried in the framework of the Project Ross Sea Mesoscale Experiments (RoME) funded by the Italian National Program for Antarctic Research (PNRA, 2013/AN2.04).; This study was carried out in the framework of the activities of the Italian National Programme for Antarctic Research, which provided financial and logistic support. We thank the officers, crew, and technical personnel on board the R/V Italica for their support during the seagoing operations. The authors are grateful to Federico Angelini and Giuseppe Arena for their help during the cruise, and Augusto Passarelli for logistic support in Italy. We are grateful to Antonio Pusceddu for valuable and constructive comments on the manuscript, and to anonymous referees for their suggestions. The authors thanks Fred Davey for according the use of Ross Sea bathymetry data [doi:10.1594/IEDA/100405].	Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Arrigo K. R., 2003, J GEOPHYS RES, V108; Arrigo KR, 2015, J GEOPHYS RES-OCEANS, V120, P5545, DOI 10.1002/2015JC010888; Arrigo KR, 2010, INTEGR COMP BIOL, V50, P950, DOI 10.1093/icb/icq021; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035624; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Aulicino G, 2014, IEEE T GEOSCI REMOTE, V52, P4122, DOI 10.1109/TGRS.2013.2279799; Bertrand EM, 2007, LIMNOL OCEANOGR, V52, P1079, DOI 10.4319/lo.2007.52.3.1079; Boyd PW, 2008, BIOGEOSCIENCES, V5, P847, DOI 10.5194/bg-5-847-2008; Boyd PW, 2015, NATURE CLIMATE CHANG, V6, P202; Budillon G., 2000, ANTARCTIC SCI, V12, P501; Caron DA, 2000, DEEP-SEA RES, V47, P15; Carrada G. C, 2000, ROSS SEA ECOLOGY ITA, P205; Catalano G, 2010, CARBON NUTR FLUXES C, P303; Cerrone D, 2017, J CLIMATE; Cheah W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072165; Collos Y, 2005, HYDROBIOLOGIA, V550, P83, DOI 10.1007/s10750-005-4365-1; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Cotroneo Y, 2013, J GEOPHYS RES-OCEANS, V118, P2653, DOI 10.1002/jgrc.20193; Danovaro R, 2005, SCI TOTAL ENVIRON, V353, P189, DOI 10.1016/j.scitotenv.2005.09.029; de Baar HJW, 1999, MAR CHEM, V66, P1, DOI 10.1016/S0304-4203(99)00022-5; de Poll WHV, 2011, MAR ECOL PROG SER, V426, P119, DOI 10.3354/meps09000; Del Negro P, 2005, SCI TOTAL ENVIRON, V353, P258, DOI 10.1016/j.scitotenv.2005.09.018; Demmig-Adams B, 2006, PHYSIOL PLANTARUM, V127, P670, DOI 10.1111/j.1399-3054.2006.00698.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DiTullio Giacomo R., 2003, Antarctic Research Series, V78, P279; DiTullio GR, 1996, J GEOPHYS RES-OCEANS, V101, P18467, DOI 10.1029/96JC00034; DiTullio GR, 2000, NATURE, V404, P595, DOI 10.1038/35007061; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Fragoso GM, 2012, J MARINE SYST, V89, P19, DOI 10.1016/j.jmarsys.2011.07.008; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Fusco G, 2009, CONT SHELF RES, V29, P1887, DOI 10.1016/j.csr.2009.07.006; Garrison David L., 2003, Antarctic Research Series, V78, P53; Guglielmo L, 2011, POLAR BIOL, V34, P1301, DOI 10.1007/s00300-011-1031-0; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hatta M, 2017, J MARINE SYST, V166, P61, DOI 10.1016/j.jmarsys.2016.07.009; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Hiscock MR, 2008, P NATL ACAD SCI USA, V105, P4775, DOI 10.1073/pnas.0705006105; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Kennicutt MC, 2015, ANTARCT SCI, V27, P3, DOI 10.1017/S0954102014000674; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Kohut JT, 2017, J MARINE SYST, V166, P50, DOI 10.1016/j.jmarsys.2016.06.009; Lancelot C, 2000, DEEP-SEA RES PT I, V47, P1621, DOI 10.1016/S0967-0637(00)00005-4; Liu X, 2012, J MARINE SYST, V94, P135, DOI 10.1016/j.jmarsys.2011.11.013; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Mangoni O, 2004, DEEP-SEA RES PT I, V51, P1601, DOI 10.1016/j.dsr.2004.07.006; Mangoni O, 2009, POLAR BIOL, V32, P311, DOI 10.1007/s00300-008-0507-z; Mastrandrea M.D., 2014, IPCC CLIMATE CHANGE, P1132; Mathot S, 2000, J PHYCOL, V36, P1049, DOI 10.1046/j.1529-8817.2000.99078.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Mills MM, 2010, J PHYCOL, V46, P1114, DOI 10.1111/j.1529-8817.2010.00923.x; Misic C, 2017, J MARINE SYST, V166, P132, DOI 10.1016/j.jmarsys.2016.06.012; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Nitsche F, 2013, INTEGRATED EARTH DAT; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pasqual C, 2015, J MARINE SYST, V148, P142, DOI 10.1016/j.jmarsys.2015.02.006; Peloquin JA, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003816; Rivaro P, 2015, 22 C ASS IT OC LIMN; Rivaro P, 2017, J MARINE SYST, V166, P144, DOI 10.1016/j.jmarsys.2015.11.002; Rivaro P, 2012, DEEP-SEA RES PT I, V62, P97, DOI 10.1016/j.dsr.2011.12.008; Rusciano E, 2013, CONT SHELF RES, V61-62, P112, DOI 10.1016/j.csr.2013.04.002; Saggiomo V, 2002, DEEP-SEA RES PT II, V49, P1787, DOI 10.1016/S0967-0645(02)00012-7; Saggiomo V, 1998, J MARINE SYST, V17, P115, DOI 10.1016/S0924-7963(98)00033-5; Saggiomo V., 2000, ROSS SEA ECOLOGY, P247; Saggiomo V, 2011, POLAR BIOL, V34, P1255, DOI 10.1007/s00300-011-1038-6; Schine CMS, 2015, J GEOPHYS RES; Schlitzer R., 2020, OCEAN DATA VIEW; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sedwick PN, 2007, BIOGEOCHEMISTRY, V83, P83, DOI 10.1007/s10533-007-9081-7; Sedwick PN, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006553; Shields AR, 2009, J PLANKTON RES, V31, P701, DOI 10.1093/plankt/fbp022; SHUMAN FR, 1975, LIMNOL OCEANOGR, V20, P580, DOI 10.4319/lo.1975.20.4.0580; Smith WO, 2006, DEEP-SEA RES PT II, V53, P815, DOI 10.1016/j.dsr2.2006.02.014; Smith WO, 2014, ANNU REV MAR SCI, V6, P469, DOI 10.1146/annurev-marine-010213-135114; Smith WO, 2010, J MARINE SYST, V82, P177, DOI 10.1016/j.jmarsys.2010.04.014; Smith WO, 2003, DEEP-SEA RES PT II, V50, P605, DOI 10.1016/S0967-0645(02)00586-6; Smith WO, 2001, DEEP-SEA RES PT I, V48, P137, DOI 10.1016/S0967-0637(00)00045-5; Staehr PA, 2002, MAR ECOL PROG SER, V238, P47, DOI 10.3354/meps238047; Strutton PG, 2000, DEEP-SEA RES PT II, V47, P2327, DOI 10.1016/S0967-0645(00)00028-X; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Sweeney C, 2000, DEEP-SEA RES PT II, V47, P3369, DOI 10.1016/S0967-0645(00)00072-2; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; van de Poll WHV, 2009, J PHOTOCH PHOTOBIO B, V94, P32, DOI 10.1016/j.jphotobiol.2008.09.003; van Leeuwe MA, 2007, BIOGEOCHEMISTRY, V83, P61, DOI 10.1007/s10533-007-9083-5; Vidussi F, 1996, J PLANKTON RES, V18, P2377, DOI 10.1093/plankt/18.12.2377; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; Xavier JC, 2016, FRONTIERS MAR SCI; Xu K, 2014, LIMNOL OCEANOGR, V59, P1919, DOI 10.4319/lo.2014.59.6.1919	97	49	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176033	10.1371/journal.pone.0176033	http://dx.doi.org/10.1371/journal.pone.0176033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430813	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100026
J	Emberson, LL; Zinszer, BD; Raizada, RDS; Aslin, RN				Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.			Decoding the infant mind: Multivariate pattern analysis (MVPA) using fNIRS	PLOS ONE			English	Article							INFORMATION; CORTEX	The MRI environment restricts the types of populations and tasks that can be studied by cognitive neuroscientists (e.g., young infants, face-to-face communication). FNIRS is a neuroimaging modality that records the same physiological signal as fMRI but without the constraints of MRI, and with better spatial localization than EEG. However, research in the fNIRS community largely lacks the analytic sophistication of analogous fMRI work, restricting the application of this imaging technology. The current paper presents a method of multivariate pattern analysis for fNIRS that allows the authors to decode the infant mind (a key fNIRS population). Specifically, multivariate pattern analysis (MVPA) employs a correlationbased decoding method where a group model is constructed for all infants except one; both average patterns (i.e., infant-level) and single trial patterns (i.e., trial-level) of activation are decoded. Between subjects decoding is a particularly difficult task, because each infant has their own somewhat idiosyncratic patterns of neural activation. The fact that our method succeeds at across-subject decoding demonstrates the presence of group-level multi-channel regularities across infants. The code for implementing these analyses has been made readily available online to facilitate the quick adoption of this method to advance the methodological tools available to the fNIRS researcher.	[Emberson, Lauren L.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.] Univ Rochester, Brain & Cognit Sci Dept, Rochester, NY 14627 USA; [Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.] Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY 14620 USA	Princeton University; University of Rochester; University of Rochester	Emberson, LL (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Emberson, LL (corresponding author), Univ Rochester, Brain & Cognit Sci Dept, Rochester, NY 14627 USA.; Emberson, LL (corresponding author), Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY 14620 USA.	lauren.emberson@princeton.edu		Raizada, Rajeev/0000-0002-2784-1964	NICHD Grant [K99 HD076166-01A1, 4R00HD076166-02]; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship [201210MFE-290131-231192]; NSF [1228261, EAGER BCS-1514351]; National Institutes of Health, Child Health and Development (NICHD) [K99 HD076166-01A1, 4R00HD076166-02]; Canadian Institute of Health Research (CIHR postdoctoral fellowship) [201210MFE-290131-231192]; National Science Foundation (NSF US Award) [1228261, EAGER BCS-1514351]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD088731, K99HD076166, R01HD037082, R00HD076166] Funding Source: NIH RePORTER	NICHD Grant; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); National Institutes of Health, Child Health and Development (NICHD); Canadian Institute of Health Research (CIHR postdoctoral fellowship)(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF US Award)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors wish to thank all the caregivers and infants who volunteered their time to make this research possible as well as Holly Palmeri, Ashley Rizzieri, Eric Partridge, Kelsey Spear and the rest of the research assistants in the Rochester Baby Lab. This work was supported by an NICHD Grant K99 HD076166-01A1, 4R00HD076166-02, and a Canadian Institutes of Health Research (CIHR) postdoctoral fellowship, 201210MFE-290131-231192, to (to L.L.E.), NSF Award 1228261 (to R.R) and NSF EAGER BCS-1514351 (to R.N.A.).; This work was funded by the National Institutes of Health, Child Health and Development (NICHD, Grant K99 HD076166-01A1, 4R00HD076166-02), the Canadian Institute of Health Research (CIHR postdoctoral fellowship 201210MFE-290131-231192 to L.L.E.) and the National Science Foundation (NSF US Award, 1228261 to R.R. and EAGER BCS-1514351 to R.N. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2016, NEUROIMAGE, V128, P44, DOI 10.1016/j.neuroimage.2015.12.035; Aslin RN, 2015, ANNU REV PSYCHOL, V66, P349, DOI 10.1146/annurev-psych-010213-115108; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bogler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101729; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Emberson LL, 2015, P NATL ACAD SCI USA, V112, P9585, DOI 10.1073/pnas.1510343112; Emberson LL, 2017, DEV COGN NEUROS-NETH, V23, P26, DOI 10.1016/j.dcn.2016.11.002; Emberson LL, 2015, P NATL ACAD SCI USA, P1; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Heger D, 2013, INT CONF AFFECT, P832, DOI 10.1109/ACII.2013.156; Hosseini SMH, 2011, NEUROREPORT, V22, P269, DOI 10.1097/WNR.0b013e3283451f8f; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ichikawa H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00480; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kok P, 2014, J COGNITIVE NEUROSCI, V26, P1546, DOI 10.1162/jocn_a_00562; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lloyd-Fox S, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025006; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Misawa T, 2014, P INT C ADMETA PLUS, P4; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nichols T., 2004, HUM BRAIN MAPP, V15, P887, DOI [10.1016/B978-012264841-0/50048-2, DOI 10.1016/B978-012264841-0/50048-2]; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Raizada RDS, 2010, CEREB CORTEX, V20, P1, DOI 10.1093/cercor/bhp076; Serences JT, 2012, NEUROPSYCHOLOGIA, V50, P435, DOI 10.1016/j.neuropsychologia.2011.07.013; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Zinszer BD, 2014, J NEUROLINGUIST, P1	34	23	23	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0172500	10.1371/journal.pone.0172500	http://dx.doi.org/10.1371/journal.pone.0172500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426802	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900003
J	Parsons, L; Cordier, R; Munro, N; Joosten, A; Speyer, R				Parsons, Lauren; Cordier, Reinie; Munro, Natalie; Joosten, Annette; Speyer, Renee			A systematic review of pragmatic language interventions for children with autism spectrum disorder	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; HIGH-FUNCTIONING AUTISM; MANAGEMENT EDUCATION-PROGRAMS; SOCIAL-SKILLS INTERVENTIONS; JOINT ATTENTION; YOUNG-CHILDREN; MUSIC-THERAPY; COMMUNICATION; SCHOOL; ADOLESCENTS	There is a need for evidence based interventions for children with autism spectrum disorder (ASD) to limit the life-long, psychosocial impact of pragmatic language impairments. This systematic review identified 22 studies reporting on 20 pragmatic language interventions for children with ASD aged 0-18 years. The characteristics of each study, components of the interventions, and the methodological quality of each study were reviewed. Meta-analysis was conducted to assess the effectiveness of 15 interventions. Results revealed some promising approaches, indicating that active inclusion of the child and parent in the intervention was a significant mediator of intervention effect. Participant age, therapy setting or modality were not significant mediators between the interventions and measures of pragmatic language. The long-term effects of these interventions and the generalisation of learning to new contexts is largely unknown. Implications for clinical practice and directions for future research are discussed.	[Parsons, Lauren; Cordier, Reinie; Munro, Natalie; Joosten, Annette] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Munro, Natalie] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Speyer, Renee] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia	Curtin University; University of Sydney; James Cook University	Parsons, L (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia.	lauren.parsons@curtin.edu.au	Cordier, Reinie/AAH-6290-2019; Munro, Natalie/J-6163-2017; Parsons, Lauren/W-9384-2019	Cordier, Reinie/0000-0002-9906-5300; Munro, Natalie/0000-0002-5870-6378; Parsons, Lauren/0000-0002-4209-7168; Joosten, Annette/0000-0003-4722-1081				Adams C., 2005, CHILD LANG TEACH THE, V21, P227, DOI DOI 10.1191/0265659005CT2900A; Adams C, 2012, INT J LANG COMM DIS, V47, P233, DOI 10.1111/j.1460-6984.2011.00146.x; [Anonymous], 2002, ADV SPEECH LANGUAGE, DOI DOI 10.1080/14417040210001669181; Baron-Cohen Simon, 2003, MIND READING INTERAC; Bauminger N, 2000, CHILD DEV, V71, P447, DOI 10.1111/1467-8624.00156; Beaumont R, 2008, J CHILD PSYCHOL PSYC, V49, P743, DOI 10.1111/j.1469-7610.2008.01920.x; Bono MA, 2004, J AUTISM DEV DISORD, V34, P495, DOI 10.1007/s10803-004-2545-x; Casenhiser DM, 2015, J AUTISM DEV DISORD, V45, P846, DOI 10.1007/s10803-014-2242-3; Casenhiser DM, 2013, AUTISM, V17, P220, DOI 10.1177/1362361311422052; Chan JM, 2009, RES AUTISM SPECT DIS, V3, P876, DOI 10.1016/j.rasd.2009.04.003; Chiang CH, 2008, J AUTISM DEV DISORD, V38, P1898, DOI 10.1007/s10803-008-0586-2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett BA, 2015, J AUTISM DEV DISORD, P1; Cordier R, 2014, RES DEV DISABIL, V35, P1588, DOI 10.1016/j.ridd.2014.03.050; DeRosier ME, 2011, J AUTISM DEV DISORD, V41, P1033, DOI 10.1007/s10803-010-1128-2; Donaldson AL., 2015, PERSPECTIVES LANGUAG, V22, P31, DOI [10.1044/lle22.1.31, DOI 10.1044/LLE22.1.31]; Fletcher-Watson S, 2015, TRIAL IPAD INTERVENT; Gabriels RL, 2015, J AM ACAD CHILD PSY, V54, P541, DOI 10.1016/j.jaac.2015.04.007; Gattino GS, 2011, NORD J MUSIC THER, V20, P142, DOI 10.1080/08098131.2011.566933; Gerenberg M, 2006, NEW YORK ACAD SCI, V1094, P139; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Hampton LH, 2016, J INTELL DISABIL RES, V60, P444, DOI 10.1111/jir.12283; Hauck M, 1995, J AUTISM DEV DISORD, V25, P579, DOI 10.1007/BF02178189; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hopkins IM, 2011, J AUTISM DEV DISORD, V41, P1543, DOI 10.1007/s10803-011-1179-z; Houghton K, 2013, J COMMUN DISORD, V46, P495, DOI 10.1016/j.jcomdis.2013.09.004; Ichikawa K, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-14; Kaale A, 2014, J AM ACAD CHILD PSY, V53, P188, DOI 10.1016/j.jaac.2013.09.019; Kaale A, 2012, J CHILD PSYCHOL PSYC, V53, P97, DOI 10.1111/j.1469-7610.2011.02450.x; Kamps D, 2015, J AUTISM DEV DISORD, V45, P1809, DOI 10.1007/s10803-014-2340-2; Kasari C, 2006, J CHILD PSYCHOL PSYC, V47, P611, DOI 10.1111/j.1469-7610.2005.01567.x; Kasari C, 2014, PEDIATRICS, V134, pE72, DOI 10.1542/peds.2013-3229; Kasari C, 2012, J CHILD PSYCHOL PSYC, V53, P431, DOI 10.1111/j.1469-7610.2011.02493.x; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Kim J, 2008, J AUTISM DEV DISORD, V38, P1758, DOI 10.1007/s10803-008-0566-6; Kmet LM., 2004, STANDARD QUALITY ASS, DOI DOI 10.7939/R37M04F16; Kransy L, 2002, CHILD ADOLESCENT PSY, V12, P107; Lawton K, 2012, J AUTISM DEV DISORD, V42, P307, DOI 10.1007/s10803-011-1231-z; Lee L, 2008, AUSTRALAS J AGEING, V27, P170, DOI 10.1111/j.1741-6612.2008.00298.x; Lerner MD, 2012, FOCUS AUTISM DEV DIS, V27, P147, DOI 10.1177/1088357612450613; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Locke J, 2010, J RES SPEC EDUC NEED, V10, P74, DOI 10.1111/j.1471-3802.2010.01148.x; Lopata C, 2016, RES AUTISM SPECT DIS, V21, P25, DOI 10.1016/j.rasd.2015.09.003; Lopata C, 2010, J AUTISM DEV DISORD, V40, P1297, DOI 10.1007/s10803-010-0989-8; McFadden B, 2014, RES AUTISM SPECT DIS, V8, P1699, DOI 10.1016/j.rasd.2014.08.015; McMahon CM, 2013, J AUTISM DEV DISORD, V43, P1843, DOI 10.1007/s10803-012-1733-3; Millard T, 2013, AIDS PATIENT CARE ST, V27, P103, DOI 10.1089/apc.2012.0294; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Oono IP., 2013, EVIDENCE BASED CHILD, V8, P2380, DOI [10.1002/ebch.1952, DOI 10.1002/EBCH.1952]; Oosterling I, 2010, J AUTISM DEV DISORD, V40, P689, DOI 10.1007/s10803-009-0915-0; Paul R., 2012, LANGUAGE DISORDERS I; Paul R, 2009, J AUTISM DEV DISORD, V39, P115, DOI 10.1007/s10803-008-0607-1; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Radley KC, 2014, FOCUS AUTISM DEV DIS, V29, P216, DOI 10.1177/1088357614525660; Rao PA, 2008, J AUTISM DEV DISORD, V38, P353, DOI 10.1007/s10803-007-0402-4; Roberts J, 2011, RES AUTISM SPECT DIS, V5, P1553, DOI 10.1016/j.rasd.2011.03.001; Ryan C, 2010, J AUTISM DEV DISORD, V40, P1505, DOI 10.1007/s10803-010-1009-8; Shire SY, 2015, J AUTISM DEV DISORD, V45, P1712, DOI 10.1007/s10803-014-2329-x; Snow CE, 1996, SOC DEV, V5, P56, DOI 10.1111/j.1467-9507.1996.tb00072.x; Soorya LV, 2015, J AM ACAD CHILD PSY, V54, P208, DOI 10.1016/j.jaac.2014.12.005; Spence Susan H, 2003, Child Adolesc Ment Health, V8, P84, DOI 10.1111/1475-3588.00051; Tager-Flusberg H, 2013, AUTISM RES, V6, P468, DOI 10.1002/aur.1329; Thomeer ML, 2015, J AUTISM DEV DISORD, V45, P2115, DOI 10.1007/s10803-015-2374-0; Watkins L, 2015, J AUTISM DEV DISORD, V45, P1070, DOI 10.1007/s10803-014-2264-x; Wetherby AM, 2014, PEDIATRICS, V134, P1084, DOI 10.1542/peds.2014-0757; White SW, 2007, J AUTISM DEV DISORD, V37, P1858, DOI 10.1007/s10803-006-0320-x; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; Wong VCN, 2010, J AUTISM DEV DISORD, V40, P677, DOI 10.1007/s10803-009-0916-z	70	54	54	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0172242	10.1371/journal.pone.0172242	http://dx.doi.org/10.1371/journal.pone.0172242			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426832	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000399875900002
J	Vieira, GDT; Lossie, AC; Lay, DC; Radcliffe, JS; Garner, JP				Vieira, Giovana de L. T.; Lossie, Amy C.; Lay, Donald C., Jr.; Radcliffe, John S.; Garner, Joseph P.			Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of Trichotillomania	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; N-ACETYL-CYSTEINE; DNA-DAMAGE; GLUTATHIONE PRECURSOR; REACTIVE OXYGEN; DOUBLE-BLIND; ACETYLCYSTEINE; SCHIZOPHRENIA; BRAIN; 8-HYDROXY-2'-DEOXYGUANOSINE	Barbering, where a "barber" mouse plucks hair from its cagemates or itself, is both a spontaneously occurring abnormal behavior in mice and a well validated model of Trichotillomania (TTM). N-Acetylcysteine, (NAC) a cysteine derived food additive, is remarkably effective in treating TTM patients, but its mechanism of action is unknown. Reactive Oxygen Species (ROS), also known as free radicals, form as a natural byproduct of the normal metabolism of oxygen. Under normal circumstances, cells are able to defend themselves against ROS damage with antioxidant pathways. NAC is the precursor to the main antioxidant produced to defend the brain. Therefore, we hypothesized that barbering is a disease of oxidative stress, whereby ROS and/or a failure of antioxidant defenses leads to neuronal damage that induces barbering in susceptible animals. We tested this hypothesis in 32 female C57BL/6J mice by treating half with 1g/kg BW/day of NAC in their diet, and testing for protection against developing barbering behavior and curing of barbering behavior, and simultaneously testing for a panel of biomarkers of oxidative stress. NAC reduced the chance that mice would be barbers, and this effect did not differ between healthy (i.e. prevention) and affected animals (i.e. cure). Barbering animals had elevated urinary antioxidant capacity, indicative of oxidative stress, at all timepoints. Additionally, after treatment the risk of barbering increased with decreasing hydroxy-20'-deoxyguanosine (8-OHdG) levels, and with increasing glutathione (GSH) and oxidized glutathione (GSSG) levels, further indicating that barbering mice were under oxidative stress regardless of treatment with NAC. We did not find compelling evidence that urinary total antioxidant capacity, or urinary 8-OHdG, could predict response to NAC treatment. We conclude that NAC is effective in preventing and/or curing barbering at least in part by promoting GSH synthesis, thereby preventing oxidative damage.	[Vieira, Giovana de L. T.; Lossie, Amy C.; Lay, Donald C., Jr.; Radcliffe, John S.] Purdue Univ, Dept Anim Sci, W Lafayette, IN USA; [Lay, Donald C., Jr.] USDA ARS, Livestock Behav Res Unit, W Lafayette, IN USA; [Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); Stanford University; Stanford University	Garner, JP (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA USA.; Garner, JP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA USA.	jgarner@stanford.edu			Trichotillomania Learning Center; Timothy Foundation; CAPES/Fulbright Ph.D. Fellowship	Trichotillomania Learning Center; Timothy Foundation; CAPES/Fulbright Ph.D. Fellowship	This work was supported in part by a grant from the Trichotillomania Learning Center (www.trich.org) to ACL and GLTV. JPG was supported in part by the Timothy Foundation, a private nonprofit fund, whose strategic funding of Trichotillomania research is inspired by the prior head and founder of TLC, Christina Pearson, in recognition of her continuing dedication to reducing the suffering of those with Trichotillomania. GLTV was partially supported by a CAPES/Fulbright Ph.D. Fellowship (fulbright.org.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144871; Al-Shebly MM, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/329743; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Behr GA, 2012, OXID MED CELL LONGEV; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Berk M, 2008, TRENDS PHARMACOL SCI, V29, P346, DOI 10.1016/j.tips.2008.05.001; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P568, DOI 10.1176/appi.ajp.164.4.568; Choi J, 1997, BIOCHEM PHARMACOL, V53, P987, DOI 10.1016/S0006-2952(96)00867-2; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Dean O, 2004, INT J NEUROPSYCHOPH, V7, pS262; Dean O, 2011, J PSYCHIATR NEUROSCI, V36, P78, DOI 10.1503/jpn.100057; Dean O, 2010, PHARMACOL BIOCHEM BE, V97, P293, DOI 10.1016/j.pbb.2010.08.013; Dean OM, 2011, NEUROSCI LETT, V499, P149, DOI 10.1016/j.neulet.2011.05.027; Dufour BD, 2009, NEUROBIOLOGY GROOMIN, P184; Dufour BD, 2010, NUTR NEUROSCI, V13, P256, DOI 10.1179/147683010X12611460764688; Flessner CA, 2012, PSYCHIAT RES, V199, P151, DOI 10.1016/j.psychres.2012.03.039; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2004, APPL ANIM BEHAV SCI, V89, P263, DOI 10.1016/j.applanim.2004.07.004; George NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132092; Grant JE, 2009, ARCH GEN PSYCHIAT, V66, P756, DOI 10.1001/archgenpsychiatry.2009.60; Hakim IA, 2008, J NUTR, V138, P1567; Halliwell B, 2000, AM J CLIN NUTR, V72, P1082; Holmay MJ, 2013, CLIN NEUROPHARMACOL, V36, P103, DOI 10.1097/WNF.0b013e31829ae713; Kestenbaum T, 2013, SEMIN CUTAN MED SURG, V32, P83, DOI 10.12788/j.sder.0006; Khadem-Ansari M. H., 2011, J CARCINOG, V10; Kim JY, 2009, J OCCUP ENVIRON MED, V51, P1158, DOI 10.1097/JOM.0b013e3181b967aa; Kirschbaum B, 2001, CLIN CHIM ACTA, V305, P167, DOI 10.1016/S0009-8981(01)00381-3; Kumar S. V., 2010, Annals of Biological Research, V1, P158; Kusano C, 2008, J CELL MOL BIOL, V7, P1; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Leelarungrayub D, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/329643; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Mukherjee S, 2009, ACTA KINESIOL, V3, P26; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Pandya CD, 2013, PROG NEURO-PSYCHOPH, V46, P214, DOI 10.1016/j.pnpbp.2012.10.017; Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7; Poljsak B, 2011, OXID MED CELL LONGEV; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Rothbart R, 2013, COCHRANE DATABASE SY, V11; Salim S, 2014, CURR NEUROPHARMACOL, V12, P140, DOI 10.2174/1570159X11666131120230309; Sansone Randy A, 2011, Innov Clin Neurosci, V8, P10; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Sauvain JJ, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-18; Savu O, 2012, J INT MED RES, V40, P709, DOI 10.1177/147323001204000235; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Sonnen JA, 2008, FREE RADICAL BIO MED, V45, P219, DOI 10.1016/j.freeradbiomed.2008.04.022; Subash P, 2010, INDIAN J CLIN BIOCHE, V25, P127, DOI 10.1007/s12291-010-0024-z; Toraason M, 2001, INT ARCH OCC ENV HEA, V74, P396, DOI 10.1007/s004200100238; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; WITSCHI A, 1992, EUR J CLIN PHARMACOL, V43, P667, DOI 10.1007/BF02284971; Yuki K, 2010, ACTA OPHTHALMOL, V88, pe259, DOI 10.1111/j.1755-3768.2010.01997.x	70	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175222	10.1371/journal.pone.0175222	http://dx.doi.org/10.1371/journal.pone.0175222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426681	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900023
J	Jeong, H; Baek, SY; Kim, SW; Eun, YH; Kim, IY; Kim, H; Lee, J; Koh, EM; Cha, HS				Jeong, Hyemin; Baek, Sun Young; Kim, Seon Woo; Eun, Yeong Hee; Kim, In Young; Kim, Hyungjin; Lee, Jaejoon; Koh, Eun-Mi; Cha, Hoon-Suk			Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							HLA-DRB1 SHARED EPITOPE; SINGLE-NUCLEOTIDE POLYMORPHISM; CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; ADULT PATIENTS; HEPATITIS-B; DISEASE; PREVALENCE	This study aimed to evaluate the prevalence of comorbidities in patients with rheumatoid arthritis (RA) compared with the non-RA population. The 2010-2012 Korea National Health and Nutrition Examination Survey (KNHANES), which assesses the general health status of populations in South Korea using interviews and basic health assessment, was analyzed retrospectively. Weighted prevalence and odds ratio (OR) of comorbidities were analyzed in patients with RA compared with the non-RA population. The overall weighted (n = 37,453,158) prevalence of RA was 1.5%. Patients with RA were older and more female predominant than subjects without RA. The prevalence of living in an urban area, college graduation, alcohol consumption and smoking was lower in patients with RA than non-RA. Patients with RA had more comorbidities including hypertension, dyslipidemia, myocardial infarction (MI) or angina, stoke, osteoarthritis, lung cancer, colon cancer, pulmonary tuberculosis, asthma, diabetes, depression, thyroid disease and chronic kidney disease. After adjusting socioeconomic and lifestyle characteristics, RA was associated with an increased prevalence of MI or angina (OR 1.86, 95% CI 1.17-2.96, p = 0.009), pulmonary TB (OR 1.95, 95% CI 1.24-3.09, p = 0.004), asthma (OR 1.97, 95% CI 1.05-3.71, p = 0.036), thyroid disease (OR 1.71, 95% CI 1.05-2.77), depression (OR 2.38, 95% CI 1.47-3.85, p < 0.001) and hepatitis B (OR 2.34, 95% CI 1.15-4.80, p = 0.020) compared with the non-RA population. Prevalence of solid cancer was not significantly associated with RA after adjustment.	[Jeong, Hyemin; Eun, Yeong Hee; Kim, In Young; Kim, Hyungjin; Lee, Jaejoon; Koh, Eun-Mi; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Baek, Sun Young; Kim, Seon Woo] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	hoonsuk.cha@samsung.com						Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Baillet A, 2016, ANN RHEUM DIS, V75, P965, DOI 10.1136/annrheumdis-2016-209233; Bang SY, 2010, ARTHRITIS RHEUM-US, V62, P369, DOI 10.1002/art.27272; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boyer JF, 2011, JOINT BONE SPINE, V78, P179, DOI 10.1016/j.jbspin.2010.07.016; Brady SRE, 2009, J RHEUMATOL, V36, P34, DOI 10.3899/jrheum.080404; Chan ATY, 2001, RHEUMATOLOGY, V40, P353, DOI 10.1093/rheumatology/40.3.353; CHAN SH, 1994, BRIT J RHEUMATOL, V33, P713; Choi IA, 2015, ARTHRITIS RHEUMA S10, V67; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Chung CP, 2005, ARTHRITIS RHEUM-US, V52, P3045, DOI 10.1002/art.21288; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; da Cunha VR, 2012, SCAND J RHEUMATOL, V41, P186, DOI 10.3109/03009742.2011.626443; Dessein PH, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar428; Dougados M, 2015, ANN RHEUM DIS, V74, P1725, DOI 10.1136/annrheumdis-2013-204733; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Fekjaer HO, 2013, ADDICTION, V108, P2051, DOI 10.1111/add.12104; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Furuya T, 2007, CLIN EXP RHEUMATOL, V25, P219; Gabriel SE, 2008, ANN RHEUM DIS, V67, P30, DOI 10.1136/ard.2008.098038; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Gullick NJ, 2011, BEST PRACT RES CL RH, V25, P469, DOI 10.1016/j.berh.2011.10.009; Hajdarbegovic E, 2014, RHEUMATOL INT, V34, P847, DOI 10.1007/s00296-013-2785-1; Hartung AD, 2003, CLIN EXP RHEUMATOL, V21, P481; HELIOVAARA M, 1993, J RHEUMATOL, V20, P1830; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hsu CS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003551; Hu XL, 2006, ARTHRITIS RHEUM, V54, P1022, DOI 10.1002/art.21636; Jin ZC, 2014, ANN RHEUM DIS, V73, P1962, DOI 10.1136/annrheumdis-2013-203323; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kaptanoglu E, 2004, RHEUMATOL INT, V24, P267, DOI 10.1007/s00296-003-0369-1; Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Lee Choon Taek, 2002, Cancer Res Treat, V34, P3, DOI 10.4143/crt.2002.34.1.3; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Lee SH, 2016, KOREAN J FAM MED, V37, P44, DOI 10.4082/kjfm.2016.37.1.44; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Lu MC, 2015, INT J TUBERC LUNG D, V19, P1500, DOI 10.5588/ijtld.15.0087; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; Mahrholdt H, 2007, HEART, V93, P122, DOI 10.1136/hrt.2005.071290; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Margaretten Mary, 2011, Int J Clin Rheumtol, V6, P617; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Miossec P, 1997, ARTHRITIS RHEUM-US, V40, P2105, DOI 10.1002/art.1780401203; Morgan AW, 2008, ARTHRITIS RHEUM, V58, P1275, DOI 10.1002/art.23432; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Nakajima Ayako, 2006, Mod Rheumatol, V16, P151; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Pincus T, 1996, BRIT J RHEUMATOL, V35, P879; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; REAH TG, 1963, P ROY SOC MED, V56, P813, DOI 10.1177/003591576305600924; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; Scott IC, 2013, RHEUMATOLOGY, V52, P856, DOI 10.1093/rheumatology/kes376; Siebert S, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000267; Simon TA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0728-9; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Staykova Nedyalka D, 2007, Folia Med (Plovdiv), V49, P5; Sung YK, 2012, SEMIN ARTHRITIS RHEU, V41, P745, DOI 10.1016/j.semarthrit.2011.09.007; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM, V56, P425, DOI 10.1002/art.22373; van Onna M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1038-3; Vassilopoulos D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2480; VERCELLI D, 1990, J IMMUNOL, V144, P570; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; World Health Organization, WHO REP INC RAT ACT; Yoshinaga Yasuhiko, 2004, Mod Rheumatol, V14, P143, DOI 10.1007/s10165-004-0281-x	80	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176260	10.1371/journal.pone.0176260	http://dx.doi.org/10.1371/journal.pone.0176260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423031	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600099
J	Kim, CW; Chang, Y; Sung, E; Yun, KE; Jung, HS; Ko, BJ; Kwon, MJ; Hyun, YY; Lee, KB; Kim, H; Shin, H; Ryu, S				Kim, Chan-Won; Chang, Yoosoo; Sung, Eunju; Yun, Kyung Eun; Jung, Hyun-Suk; Ko, Byung-Joon; Kwon, Min-Jung; Hyun, Young Youl; Lee, Kyu-Beck; Kim, Hyang; Shin, Hocheol; Ryu, Seungho			Sleep duration and quality in relation to chronic kidney disease and glomerular hyperfiltration in healthy men and women	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; FILTRATION-RATE; CARDIOVASCULAR-DISEASE; KOREAN VERSION; RISK; ASSOCIATION; METAANALYSIS; OUTCOMES; ALBUMINURIA; VALIDATION	Background It is unclear whether sleep duration and quality are associated with chronic kidney disease (CKD) and glomerular hyperfiltration. The aim of this study was to examine the association of sleep duration and quality with CKD and glomerular hyperfiltration in young and middle-aged adults. Methods We conducted a cross-sectional study of men and women who underwent a health checkup examination, including assessment of sleep duration and quality (n = 241,607). Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 m(2), and glomerular hyperfiltration was defined as eGFR above the age-/sex-specific 95(th) percentile. Results In a multinomial logistic regression analysis adjusting for relevant confounders, the adjusted prevalence ratios for CKD (95% confidence interval) comparing sleep durations of <= 5, 6, 8, and 9 hours with 7 hours were 1.22 (0.95-1.55), 0.93 (0.75-1.14), 0.97 (0.75-1.26), and 1.56 (1.06-2.30) in men and 0.98 (0.68-1.43), 1.03 (0.72-1.46), 1.39 (0.97-2.00), and 1.31 (0.78-2.22) in women, respectively. The corresponding prevalence ratios (95% confidence interval) for glomerular hyperfiltration were 1.00 (0.93-1.08), 0.97 (0.91-1.03), 1.03 (0.94 - 1.13), and 1.39 (1.13-1.72) in men and 1.04 (0.95-1.14), 0.96 (0.90-1.04), 1.11 (1.02-1.20), and 1.28 (1.14-1.45) in women, respectively. Poor subjective sleep quality was associated with glomerular hyperfiltration in men and women. Conclusion In this large study of young and middle-aged adults, we found that long sleep duration was associated with CKD and glomerular hyperfiltration. Additionally, poor subjective sleep quality was associated with increased prevalence of glomerular hyperfiltration, suggesting the importance of adequate quantity and quality of sleep for kidney function.	[Kim, Chan-Won; Chang, Yoosoo; Yun, Kyung Eun; Jung, Hyun-Suk; Ko, Byung-Joon; Kwon, Min-Jung; Shin, Hocheol; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Sung, Eunju; Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Family Med, Seoul, South Korea; [Kwon, Min-Jung] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Lab Med, Seoul, South Korea; [Hyun, Young Youl; Lee, Kyu-Beck; Kim, Hyang] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Nephrol,Dept Internal Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea.; Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea.; Ryu, S (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea.	sh703.yoo@gmail.com		SUNG, EUNJU/0000-0002-6045-3154; Chang, Yoosoo/0000-0002-6945-9050; Kim, Chan-Won/0000-0001-5836-1974				Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Balbo M, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/759234; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; Buysse D J, 1989, Psychiatry Res, V28, P193; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chang Y, 2014, J AM COLL CARDIOL, V63, P2679, DOI 10.1016/j.jacc.2014.03.042; Cheungpasitporn W, 2016, NEPHROL DIAL TRANSPL; Cho M, 1993, J KOREAN NEUROPSYCHI, V32, P381, DOI DOI 10.1590/S0080-62342012000400002; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eriksen BO, 2014, KIDNEY INT, V86, P146, DOI 10.1038/ki.2013.470; Fujibayashi K, 2012, J ATHEROSCLER THROMB, V19, P932, DOI 10.5551/jat.12781; Grandner MA, 2007, SLEEP MED REV, V11, P341, DOI 10.1016/j.smrv.2007.03.010; Guo XF, 2015, J SLEEP RES, V24, P351, DOI 10.1111/jsr.12274; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; Hawkins MS, 2011, MED SCI SPORT EXER, V43, P1457, DOI 10.1249/MSS.0b013e31820c0130; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Jeong TD, 2016, CLIN BIOCHEM, V49, P713, DOI 10.1016/j.clinbiochem.2016.01.023; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kim CW, 2015, ARTERIOSCL THROM VAS, V35, P2238, DOI 10.1161/ATVBAHA.115.306110; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lee YC, 2015, SLEEP, V38, P213, DOI 10.5665/sleep.4400; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McMullan CJ, 2016, KIDNEY INT, V89, P1324, DOI 10.1016/j.kint.2015.12.048; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Ogna A, 2016, SLEEP, V39, P945, DOI 10.5665/sleep.5660; Ohayon MM, 2005, SLEEP, V28, P981; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Petrov ME, 2016, SLEEP HEALTH, V2, P75, DOI 10.1016/j.sleh.2015.12.003; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ryu S, 2015, J HEPATOL, V63, P1229, DOI 10.1016/j.jhep.2015.07.010; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sasaki S, 2014, J OCCUP ENVIRON MED, V56, P1243, DOI 10.1097/JOM.0000000000000322; Sedaghat S, 2015, CLIN J AM SOC NEPHRO, V10, P2190, DOI 10.2215/CJN.03000315; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tonelli M, 2011, KIDNEY INT, V80, P1306, DOI 10.1038/ki.2011.280; Turek NF, 2012, AM J KIDNEY DIS, V60, P823, DOI 10.1053/j.ajkd.2012.04.027; Wong PM, 2015, SLEEP, V38, P223, DOI 10.5665/sleep.4402	49	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175298	10.1371/journal.pone.0175298	http://dx.doi.org/10.1371/journal.pone.0175298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423054	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600029
J	Robinson, JR; Kennedy, VE; Doss, Y; Bastarache, L; Denny, J; Warner, JL				Robinson, Jamie R.; Kennedy, Vanessa E.; Doss, Youssef; Bastarache, Lisa; Denny, Joshua; Warner, Jeremy L.			Defining the complex phenotype of severe systemic loxoscelism using a large electronic health record cohort	PLOS ONE			English	Article							POSITIVE HEMOLYTIC-ANEMIA; PHENOME-WIDE ASSOCIATION; ENVENOMATION; HAPTOGLOBIN; MECHANISMS; DISEASE; SPIDERS; LAETA; CHILD; BITE	Objective Systemic loxoscelism is a rare illness resulting from the bite of the recluse spider and, in its most severe form, can lead to widespread hemolysis, coagulopathy, and death. We aim to describe the clinical features and outcomes of the largest known cohort of individuals with moderate to severe loxoscelism. Methods We performed a retrospective, cross sectional study from January 1, 1995, to December 31, 2015, at a tertiary-care academic medical center, to determine individuals with clinical records consistent with moderate to severe loxoscelism. Age-, sex-, and race-matched controls were compared. Demographics, clinical characteristics, laboratory measures, and outcomes of individuals with loxoscelism are described. Case and control groups were compared with descriptive statistics and phenome-wide association study (PheWAS). Results During the time period, 57 individuals were identified as having moderate to severe loxoscelism. Of these, only 33% had an antecedent spider bite documented. Median age of individuals diagnosed with moderate to severe loxoscelism was 14 years old (IQR 9.0-24.0 years). PheWAS confirmed associations of systemic loxoscelism with 29 other phenotypes, e.g., rash, hemolytic anemia, and sepsis. Hemoglobin level dropped an average of 3.1 g/dL over an average of 2.0 days (IQR 2.0-6.0). Lactate dehydrogenase and total bilirubin levels were on average over two times their upper limit of normal values. Eighteen individuals of 32 tested had a positive direct antiglobulin (Coombs') test. Mortality was 3.5% (2/57 individuals). Conclusion Systemic loxoscelism is a rare but devastating process with only a minority of patients recalling the toxic exposure; hemolysis reaches a peak at 2 days after admission, with some cases taking more than a week before recovery. In endemic areas, suspicion for systemic loxoscelism should be high in individuals, especially children and younger adults, presenting with a cutaneous ulcer and hemolysis or coagulopathy, even in the absence of a bite exposure history.	[Robinson, Jamie R.; Bastarache, Lisa; Denny, Joshua; Warner, Jeremy L.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA; [Robinson, Jamie R.] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN 37235 USA; [Kennedy, Vanessa E.] Stanford Univ, Dept Internal Med, Stanford, CA 94305 USA; [Doss, Youssef] Yale Univ, New Haven, CT USA; [Denny, Joshua; Warner, Jeremy L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Stanford University; Yale University; Vanderbilt University	Robinson, JR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA.; Robinson, JR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN 37235 USA.	jame.r.robinson@vanderbilt.edu	Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332; Robinson, Jamie/0000-0003-0888-0156	National Library of Medicine [5T15LM007450, R01 LM 010685]; NATIONAL LIBRARY OF MEDICINE [R01LM010685, T15LM007450] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JRR was supported by the 5T15LM007450 training grant from the National Library of Medicine. JD and JLW were supported by the R01 LM 010685 grant from the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL for the National Library of Medicine is https://www.nlm.nih.gov/grants.html.	Andersen Rebecca J, 2011, J Emerg Med, V41, pe31, DOI 10.1016/j.jemermed.2009.08.055; Barcellini W, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/635670; Barretto OCD, 2003, BRAZ J MED BIOL RES, V36, P309, DOI 10.1590/S0100-879X2003000300004; Bastarache L, 2015, COMPLEX DIS ARE ASS; BERLIN NI, 1981, BLOOD, V57, P983; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; de Oliveira KC, 2005, TOXICON, V45, P421, DOI 10.1016/j.toxicon.2004.08.022; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Forks T P, 2000, J Am Board Fam Pract, V13, P415; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Gehrie EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076558; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023; Lane DR, 2004, CUTIS, V74, P341; Lane L, 2011, PEDIATR DERMATOL, V28, P685, DOI 10.1111/j.1525-1470.2010.01302.x; Levin C, 2014, PEDIATR BLOOD CANCER, V61, P1466, DOI 10.1002/pbc.24959; McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021; Mowry JB, 2015, CLIN TOXICOL, V53, P962, DOI 10.3109/15563650.2015.1102927; MURRAY LM, 1994, J TOXICOL-CLIN TOXIC, V32, P451, DOI 10.3109/15563659409011048; NANCE WE, 1961, AM J MED, V31, P801, DOI 10.1016/0002-9343(61)90164-4; Pauli I, 2006, TOXICON, V48, P123, DOI 10.1016/j.toxicon.2006.05.005; Rios JC, 2007, REV MED CHILE, V135, P1160; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rosen JL, 2012, ANN EMERG MED, V60, P439, DOI 10.1016/j.annemergmed.2011.12.011; Said A, 2014, PEDIATRICS, V134, pE1464, DOI 10.1542/peds.2013-3338; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; SCHENONE H, 1961, ARCH DERMATOL, V83, P139, DOI 10.1001/archderm.1961.01580070145016; SCHENONE H, 1989, REV INST MED TROP SP, V31, P403, DOI 10.1590/S0036-46651989000600007; Shih AWY, 2014, AM J HEMATOL, V89, P443, DOI 10.1002/ajh.23623; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Team RC, 2015, R LANG ENV STAT COMP; Veerreddy P, 2013, CLIN MED INSIGHTS-BL, V6, P7, DOI 10.4137/CMBD.S11517; Vetter RS, 2009, SOUTH MED J, V102, P518, DOI 10.1097/SMJ.0b013e3181a0abb3; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; WangRodriguez J, 1996, TRANSFUSION, V36, P979, DOI 10.1046/j.1537-2995.1996.36111297091742.x; WILLIAMS ST, 1995, AM J CLIN PATHOL, V104, P463; Wright SW, 1997, ANN EMERG MED, V30, P28, DOI 10.1016/S0196-0644(97)70106-9; Zambrano A, 2005, REV MED CHILE, V133, P219	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174941	10.1371/journal.pone.0174941	http://dx.doi.org/10.1371/journal.pone.0174941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422977	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600024
J	Haudenshield, JS; Song, JY; Hartman, GL				Haudenshield, James S.; Song, Jeong Y.; Hartman, Glen L.			A novel, multiplexed, probe-based quantitative PCR assay for the soybean root-and stem-rot pathogen, Phytophthora sojae, utilizes its transposable element	PLOS ONE			English	Article							DNA; AMPLIFICATION; RESISTANCE; SEQUENCE; DISEASE	Phytophthora root rot of soybean [Glycine max (L.) Merr.] is caused by the oomycete Phytophthora sojae (Kaufm. & Gerd.). P. sojae has a narrow host range, consisting primarily of soybean, and it is a serious pathogen worldwide. It exists in root and stem tissues as mycelium, wherein it can form oospores which subsequently germinate to release motile, infectious zoospores. Molecular assays detecting DNA of P. sojae are useful in disease diagnostics, and for determining the presence of the organism in host tissues, soils, and runoff or ponded water from potentially infested fields. Such assays as published have utilized ITS sequences from the nuclear ribosomal RNA genes in conventional PCR or dye-binding quantitative PCR (Q-PCR) but are not amenable to multiplexing, and some of these assays did not utilize control strategies for type I or type II errors. In this study, we describe primers and a bifunctional probe with specificity to a gypsy-like retroelement in the P. sojae genome to create a fluorogenic 5'-exonuclease linear hydrolysis assay, with a multiplexed internal control reaction detecting an exogenous target to validate negative calls, and with uracildeglycosylase- mediated protection against carryover contamination. The assay specifically detected 13 different P. sojae isolates, and excluded 17 other Phytophthora species along with 20 non-Phytophthora fungal and oomycete species pathogenic on soybean. A diagnostic limit of detection of 34 fg total P. sojae DNA was observed in serial dilutions, equivalent to 0.3 genome, and a practical detection sensitivity of four zoospores per sample was achieved, despite losses during DNA extraction.	[Haudenshield, James S.; Hartman, Glen L.] Univ Illinois, USDA, ARS, Urbana, IL 61801 USA; [Haudenshield, James S.; Song, Jeong Y.; Hartman, Glen L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Song, Jeong Y.] Chungnam Natl Univ, Dept Appl Biol, Daejeon, South Korea	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chungnam National University	Hartman, GL (corresponding author), Univ Illinois, USDA, ARS, Urbana, IL 61801 USA.; Hartman, GL (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	ghartman@illinois.edu			United States Department of Agriculture, Agricultural Research Service, Project [5012-22000-021-00D]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [KRF-2005-214-000157]	United States Department of Agriculture, Agricultural Research Service, Project; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Funding for salaries for JYS and GLH came from the United States Department of Agriculture, Agricultural Research Service, Project Number 5012-22000-021-00D. Funding for JYS came from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (KRF-2005-214-000157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athow KL, 1987, SOYBEANS IMPROVEMENT, V687, P727; Bienapfl JC, 2011, FUNGAL BIOL-UK, V115, P733, DOI 10.1016/j.funbio.2011.05.007; Catal M, 2013, EUR J PLANT PATHOL, V137, P859, DOI 10.1007/s10658-013-0297-1; CHEN DW, 1970, MYCOLOGIA, V62, P397, DOI 10.2307/3757597; Dai TT, 2013, PLANT PATHOL, V62, P719, DOI 10.1111/j.1365-3059.2012.02672.x; Dorrance A.E., 2015, COMPENDIUM SOYBEAN D, P73; Haudenshield JS, 2010, PHYTOPATHOLOGY, V100, pS48; Haudenshield JS, 2011, PLANT DIS, V95, P343, DOI 10.1094/PDIS-01-10-0023; Haudenshield JS, 2015, COMPENDIUM SOYBEAN D, P131; HILDEBRAND A. A., 1959, CANADIAN JOUR BOT, V37, P927, DOI 10.1139/b59-079; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P1135, DOI 10.1128/AEM.71.3.1135-1141.2005; JONES JP, 1969, PHYTOPATHOLOGY, V59, P504; Judelson HS, 2002, MOL BIOL EVOL, V19, P1313, DOI 10.1093/oxfordjournals.molbev.a004192; Kandel YR, 2015, PHYTOPATHOLOGY, V105, P1601, DOI 10.1094/PHYTO-04-15-0096-R; KLEIN HH, 1959, PHYTOPATHOLOGY, V49, P380; Moa Y, 1991, EXP MYCOL, V15, P283; Sinclair JB., 1985, BASIC PLANT PATHOLOG; Slaminko TL, 2010, PLANT DIS, V94, P368, DOI 10.1094/PDIS-94-3-0368; SLUSHER RL, 1973, PHYTOPATHOLOGY, V63, P1168, DOI 10.1094/Phyto-63-1168; Song J, 2007, PHYTOPATHOLOGY, V97, pS110; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wang YC, 2006, PHYTOPATHOLOGY, V96, P1315, DOI 10.1094/PHYTO-96-1315; Wen JZ, 2014, J GEN PLANT PATHOL, V80, P415, DOI 10.1007/s10327-014-0530-6; Zhao W, 2015, J PLANT DIS PROTECT, V122, P66, DOI 10.1007/BF03356533	24	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176567	10.1371/journal.pone.0176567	http://dx.doi.org/10.1371/journal.pone.0176567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441441	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800067
J	Nikolakopoulou, AM; Zhao, Z; Montagne, A; Zlokovic, BV				Nikolakopoulou, Angellki Maria; Zhao, Zhen; Montagne, Axel; Zlokovic, Berislav V.			Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-beta signaling	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PDGF-B; CAPILLARY PERICYTES; BARRIER BREAKDOWN; MOUSE MODELS; DYSFUNCTION; REDUCTIONS; ASTROCYTES; PROTEIN; HEALTH	Pericytes regulate key neurovascular functions of the brain. Studies in pericyte-deficient transgenic mice with aberrant signaling between endothelial-derived platelet-derived growth factor BB (PDGF-BB) and platelet-derived growth factor receptor beta (PDGFR beta) in pericytes have contributed to better understanding of the role of pericytes in the brain. Here, we studied Pdgfr beta(F7/F7) mice, which carry seven point mutations that disrupt PDGFR beta signaling causing loss of pericytes and vascular smooth muscle cells (VSMCs) in the developing brain. We asked whether these mice have a stable or progressive vascular phenotype after birth, and whether both pericyte and VSMCs populations are affected in the adult brain. We found an early and progressive region-dependent loss of brain pericytes, microvascular reductions and blood-brain barrier (BBB) breakdown, which were more pronounced in the cortex, hippocampus and striatum than in the thalamus, whereas VSMCs population remained unaffected at the time when pericyte loss was already established. For example, compared to age-matched controls, Pdgfr beta(F7/F7) mice between 4-6 and 36-48 weeks of age developed a region-dependent loss in pericyte coverage (22-46, 24-44 and 4-31%) and cell numbers (36-49, 34-64 and 11-36%), reduction in capillary length (20-39, 13-46 and 1-30%), and an increase in extravascular fibrinogen-derived deposits (3.4-5.2, 2.8-4.1 and 0-3.6-fold) demonstrating BBB breakdown in the cortex, hippocampus and thalamus, respectively. Capillary reductions and BBB breakdown correlated with loss of pericyte coverage. Our data suggest that Pdgfr beta(F7/F7) mice develop an aggressive and rapid vascular phenotype without appreciable early involvement of VSMCs, therefore providing a valuable model to study regional effects of pericyte loss on brain vascular and neuronal functions. This model could be a useful tool for future studies directed at understanding the role of pericytes in the pathogenesis of neurological disorders associated with pericyte loss such as vascular dementia, Alzheimer's disease, amyotrophic lateral sclerosis, stroke and human immunodeficiency virus-associated neurocognitive disorder.	[Zlokovic, Berislav V.] Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90007 USA; Univ Southern Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA USA	University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90007 USA.	zlokovic@usc.edu	Montagne, Axel/AAV-4343-2020; zhao, zhen/A-2080-2012; Zlokovic, Berislav/ABE-7362-2020	Montagne, Axel/0000-0001-5564-985X; zhao, zhen/0000-0001-8967-5570; Zlokovic, Berislav/0000-0002-6802-8232	National Institutes of Health [AG039452, AG023084, NS034467, NS100459]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034467, R01NS100459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, R01AG039452, RF1AG039452, P01AG052350, P50AG005142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (https://www.nih.gov/)grants AG039452, AG023084, NS034467 and NS100459 to B.V.Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Iadecola C, 1998, NAT NEUROSCI, V1, P263, DOI 10.1038/1074; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kisler K, 2017, NAT NEUROSC IN PRESS; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Vanlandewijck M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143407; Wennstrom M, 2014, INT J TRYPTOPHAN RES, V7, P1, DOI [10.4137/IJTRTR.S13958, 10.4137/IJTR.S13958]; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	43	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176225	10.1371/journal.pone.0176225	http://dx.doi.org/10.1371/journal.pone.0176225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441414	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800036
J	Hasler, BS; Spanlang, B; Slater, M				Hasler, Beatrice S.; Spanlang, Bernhard; Slater, Mel			Virtual race transformation reverses racial ingroup bias	PLOS ONE			English	Article							PERSPECTIVE-TAKING; BEHAVIORAL MIMICRY; SELF; OWNERSHIP; EMPATHY; NEUROSCIENCE; AFFILIATION; IMPACT; BRAIN; FACES	People generally show greater preference for members of their own racial group compared to racial out-group members. This type of 'in-group bias' is evident in mimicry behaviors. We tend to automatically mimic the behaviors of in-group members, and this behavior is associated with interpersonal sensitivity and empathy. However, mimicry is reduced when interacting with out-group members. Although race is considered an unchangeable trait, it is possible using embodiment in immersive virtual reality to engender the illusion in people of having a body of a different race. Previous research has used this technique to show that after a short period of embodiment of White people in a Black virtual body their implicit racial bias against Black people diminishes. Here we show that this technique powerfully enhances mimicry. We carried out an experiment with 32 White (Caucasian) female participants. Half were embodied in a White virtual body and the remainder in a Black virtual body. Each interacted in two different sessions with a White and a Black virtual character, in counterbalanced order. The results show that dyads with the same virtual body skin color expressed greater mimicry than those of different color. Importantly, this effect occurred depending on the virtual body's race, not participants' actual racial group. When embodied in a Black virtual body, White participants treat Black as their novel in-group and Whites become their novel out-group. This reversed in-group bias effect was obtained regardless of participants' level of implicit racial bias. We discuss the theoretical and practical implications of this surprising psychological phenomenon.	[Hasler, Beatrice S.] Interdisciplinary Ctr IDC, Sammy Ofer Sch Commun, Herzliyya, Israel; [Spanlang, Bernhard; Slater, Mel] Univ Barcelona, Dept Clin Psychol & Psychobiol, Expt Virtual Environm EVENT Lab Neurosci & Techno, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England	Reichman University; University of Barcelona; ICREA; University of London; University College London	Slater, M (corresponding author), Univ Barcelona, Dept Clin Psychol & Psychobiol, Expt Virtual Environm EVENT Lab Neurosci & Techno, Barcelona, Spain.; Slater, M (corresponding author), ICREA, Barcelona, Spain.; Slater, M (corresponding author), UCL, Dept Comp Sci, London, England.	melsiater@ub.edu	Slater, Mel/M-5210-2014	Slater, Mel/0000-0002-6223-0050	Swiss National Science Foundation [142092]; European Union FP7 Future and Emerging Technologies Integrated Project Virtual Embodiment and Robotic Re-Embodiment (VERE) [257695]; Ser Einstein: La Influencia de Internalizar un Cuerpo Virtual en la Inteligencia, Ministerio de Economia, lndustria y Competitividad of Spain [PSI2014-56301-R]; EU FP7 FET Project VERE [257695]; ICREA Funding Source: Custom	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union FP7 Future and Emerging Technologies Integrated Project Virtual Embodiment and Robotic Re-Embodiment (VERE); Ser Einstein: La Influencia de Internalizar un Cuerpo Virtual en la Inteligencia, Ministerio de Economia, lndustria y Competitividad of Spain; EU FP7 FET Project VERE; ICREA(ICREA)	The first author's work was supported by a fellowship from the Swiss National Science Foundation (Grant No. 142092). The project was carried out under the European Union FP7 Future and Emerging Technologies Integrated Project Virtual Embodiment and Robotic Re-Embodiment (VERE) (#257695). This work was also supported by PSI2014-56301-R Ser Einstein: La Influencia de Internalizar un Cuerpo Virtual en la Inteligencia, Ministerio de Economia, lndustria y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author's work was supported by a fellowship from the Swiss National Science Foundation (Grant No. 142092). The project was carried out under the EU FP7 FET Project VERE (#257695). Thanks to Domna Banakou for help with the Implicit Association Test, and Sameer Kishore, Rodrigo Pizarro and Birgit Nierula for help with the video, and Prof. Salvatore Aglioti for commenting on an earlier version of the paper. This work was also supported by PSI2014-56301-R Ser Einstein: La Influencia de Internalizar un Cuerpo Virtual en la Inteligencia, Ministerio de Economia, Industria y Competitividad of Spain.	Allport G. W., 1954, NATURE PREJUDICE; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Banakou D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00601; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Blair IV, 2002, PERS SOC PSYCHOL REV, V6, P242, DOI 10.1207/S15327957PSPR0603_8; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Cadinu MR, 1996, J PERS SOC PSYCHOL, V70, P661, DOI 10.1037/0022-3514.70.4.661; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Chiao JY, 2010, CURR BIOL, V20, pR478, DOI 10.1016/j.cub.2010.04.001; Cho JC, 2013, J PERS SOC PSYCHOL, V104, P444, DOI 10.1037/a0031017; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Dasgupta N., 2004, SOCIAL JUSTICE RES, V17, P143, DOI DOI 10.1023/B:SORE.0000027407.70241.15; Davis MH, 1996, J PERS SOC PSYCHOL, V70, P713, DOI 10.1037/0022-3514.70.4.713; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Farmer H, 2012, CONSCIOUS COGN, V21, P1242, DOI 10.1016/j.concog.2012.04.011; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Gramzow RH, 2005, J PERS SOC PSYCHOL, V88, P801, DOI 10.1037/0022-3514.88.5.801; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Groom V, 2009, SOC INFLUENCE, V4, P231, DOI 10.1080/15534510802643750; Gutsell JN, 2012, SOC COGN AFFECT NEUR, V7, P596, DOI 10.1093/scan/nsr035; Gutsell JN, 2010, J EXP SOC PSYCHOL, V46, P841, DOI 10.1016/j.jesp.2010.03.011; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Johnston L, 2002, SOC COGNITION, V20, P18, DOI 10.1521/soco.20.1.18.20944; Jost JT, 2009, RES ORGAN BEHAV, V29, P39, DOI 10.1016/j.riob.2009.10.001; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Kolenikov S., 2004, USE DISCRETE DATA PC; Kubota JT, 2012, NAT NEUROSCI, V15, P940, DOI 10.1038/nn.3136; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Llobera J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0300; Maister L, 2013, COGNITION, V128, P170, DOI 10.1016/j.cognition.2013.04.002; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; Molenberghs P, 2013, NEUROSCI BIOBEHAV R, V37, P1530, DOI 10.1016/j.neubiorev.2013.06.002; Montepare JM, 2002, J NONVERBAL BEHAV, V26, P43, DOI 10.1023/A:1014470520593; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Otten S, 2003, EUROPEAN REV SOCIAL, V13, P1, DOI [DOI 10.1080/10463280240000028, 10.1080/10463280240000028]; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schnabel K., 2008, SAGE HDB PERSONALITY, V2, P508; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Spanlang B, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00009; Staudt A., 2014, CIBAR STATA MODULE P; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; Stel M, 2010, EUR J SOC PSYCHOL, V40, P867, DOI 10.1002/ejsp.655; Tajfel H., 2004, POLITICAL PSYCHOL KE; Todd AR, 2012, J EXP SOC PSYCHOL, V48, P738, DOI 10.1016/j.jesp.2011.12.011; Turner J. C, 1987, SELF CATEGORIZATION; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Vorauer JD, 2009, J PERS SOC PSYCHOL, V96, P811, DOI 10.1037/a0013411; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6	64	73	73	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174965	10.1371/journal.pone.0174965	http://dx.doi.org/10.1371/journal.pone.0174965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437469	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600005
J	Witman, JD; Smith, F; Novak, M				Witman, Jon D.; Smith, Franz; Novak, Mark			Experimental demonstration of a trophic cascade in the Galapagos rocky subtidal: Effects of consumer identity and behavior	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; INCREASES PREDATION; INTERFERENCE; PREY; BIODIVERSITY; COMMUNITIES; ECOSYSTEMS; COMPLEXITY; PATTERNS; STRENGTH	In diverse tropical webs, trophic cascades are presumed to be rare, as species interactions may dampen top-down control and reduce their prevalence. To test this hypothesis, we used an open experimental design in the Galapagos rocky subtidal that enabled a diverse guild of fish species, in the presence of each other and top predators (sea lions and sharks), to attack two species of sea urchins grazing on benthic algae. Time-lapse photography of experiments on natural and experimental substrates revealed strong species identity effects: only two predator species-blunthead triggerfish (Pseudobalistes naufragium) and finescale triggerfish (Balistes polylepis)-drove a diurnal trophic cascade extending to algae, and they preferred large pencil urchins (Eucidaris galapagensis) over green urchins (Lytechinus semituberculatus). Triggerfish predation effects were strong, causing a 24-fold reduction of pencil urchin densities during the initial 21 hours of a trophic cascade experiment. A trophic cascade was demonstrated for pencil urchins, but not for green urchins, by significantly higher percent cover of urchin-grazed algae in cages that excluded predatory fish than in predator access (fence) treatments. Pencil urchins were more abundant at night when triggerfish were absent, suggesting that this species persists by exploiting a nocturnal predation refuge. Time-series of pencil urchin survivorship further demonstrated per capita interference effects of hogfish and top predators. These interference effects respectively weakened and extended the trophic cascade to a fourth trophic level through behavioral modifications of the triggerfish-urchin interaction. We conclude that interference behaviors capable of modifying interaction strength warrant greater attention as mechanisms for altering top-down control, particularly in speciose food webs.	[Witman, Jon D.; Smith, Franz] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Novak, Mark] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Brown University; Oregon State University	Witman, JD (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Jon_Witman@brown.edu		Novak, Mark/0000-0002-7881-4253	United States National Science Foundation [OCE 1061475, OCE-1041454]	United States National Science Foundation(National Science Foundation (NSF))	This work was funded by United States National Science Foundation Award Number OCE 1061475 to J. Witman and United States National Science Foundation Award Number OCE-1041454 to M. Novak. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi R., 2012, SPECIES INTERACT; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BEDDINGTON JR, 1975, J ANIM ECOL, V44, P331, DOI 10.2307/3866; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bolker B, 2008, ECOLOGICAL MODELS DA; Brandt L., 2011, THESIS; Brandt M., 2002, RESERVA MARINA GAL P, P396; Brandt M, 2012, ECOLOGY, V93, P868, DOI 10.1890/10-1785.1; Burkepile DE, 2007, OECOLOGIA, V154, P167, DOI 10.1007/s00442-007-0801-4; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Byrnes JE, 2009, ECOLOGY, V90, P2879, DOI 10.1890/08-1073.1; CARPENTER RC, 1984, MAR BIOL, V82, P101, DOI 10.1007/BF00392768; Carr L., 2016, THESIS; Carr LA, 2013, PEERJ, V1, DOI 10.7717/peerj.109; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Casey JM, 2016, OECOLOGIA; Connell SD, 2002, J FISH BIOL, V60, P1551, DOI 10.1006/jfbi.2002.2001; Dayton P. K., 1979, ECOLOGICAL PROCESSES, P3; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; Dee LE, 2012, J EXP MAR BIOL ECOL, V416, P135, DOI 10.1016/j.jembe.2012.02.016; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dyer LA, 1999, P NATL ACAD SCI USA, V96, P5072, DOI 10.1073/pnas.96.9.5072; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Englund G, 1997, ECOLOGY, V78, P2316; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; Irving AD, 2009, J ECOL, V97, P337, DOI 10.1111/j.1365-2745.2008.01467.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; McClanahan TR, 2016, ECOLOGY, V97, P1862, DOI 10.1890/15-1492.1; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; NELSON BV, 1979, MAR BIOL, V51, P251, DOI 10.1007/BF00386805; Novak M, 2010, OIKOS, V119, P1057, DOI 10.1111/j.1600-0706.2009.18147.x; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PECKARSKY BL, 1991, OECOLOGIA, V85, P521, DOI 10.1007/BF00323764; Pimm SL, 2002, FOOD WEBS; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Sandin Stuart A., 2010, P71; Schmitz OJ., 2010, RESOLVING ECOSYSTEM; Shurin Jonathan B., 2010, P319; Siddon CE, 2004, ECOLOGY, V85, P2938, DOI 10.1890/03-0519; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sinclair A.R.E., 2010, P255; Sonnenholzner JI, 2009, MAR ECOL PROG SER, V375, P209, DOI 10.3354/meps07890; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Triplet P, 1999, J ANIM ECOL, V68, P254, DOI 10.1046/j.1365-2656.1999.00280.x; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; Tuya F, 2004, HELGOLAND MAR RES, V58, P26, DOI 10.1007/s10152-003-0164-0; Vinueza LR, 2014, ECOL MONOGR, V84, P411, DOI 10.1890/13-0169.1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WITMAN JD, 1992, OECOLOGIA, V90, P305, DOI 10.1007/BF00317686; Witman JD, 2015, ECOL MONOGR, V85, P475, DOI 10.1890/14-2265.1; Witman JD, 2010, ECOL MONOGR, V80, P153, DOI 10.1890/08-1922.1	69	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175705	10.1371/journal.pone.0175705	http://dx.doi.org/10.1371/journal.pone.0175705			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430794	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100015
J	Agrawal, N; Maatta, JAE; Kulomaa, MS; Hytonen, VP; Johnson, MS; Airenne, TT				Agrawal, Nitin; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.; Johnson, Mark S.; Airenne, Tomi T.			Structural characterization of core-bradavidin in complex with biotin	PLOS ONE			English	Article							BRADYRHIZOBIUM-JAPONICUM; CHICKEN AVIDIN; AFFINITY PEPTIDE; BINDING PROTEINS; STREPTAVIDIN; CONSTRUCTION; REFINEMENT; BACTERIUM; SEQUENCE; ARP/WARP	Bradavidin is a tetrameric biotin-binding protein similar to chicken avidin and bacterial streptavidin, and was originally cloned from the nitrogen-fixing bacteria Bradyrhizobium diazoefficiens. We have previously reported the crystal structure of the full-length, wild-type (wt) bradavidin with 138 amino acids, where the C-terminal residues Gly129-Lys138 ("Brad-tag") act as an intrinsic ligand (i.e. Gly129-Lys138 bind into the biotin-binding site of an adjacent subunit within the same tetramer) and has potential as an affinity tag for biotechnological purposes. Here, the X-ray structure of core-bradavidin lacking the C-terminal residues Gly114-Lys138, and hence missing the Brad-tag, was crystallized in complex with biotin at 1.60 angstrom resolution [PDB:4BBO]. We also report a homology model of rhodavidin, an avidin-like protein from Rhodopseudomonas palustris, and of an avidin-like protein from Bradyrhizobium sp. Ai1a-2, both of which have the Brad-tag sequence at their C-terminus. Moreover, core-bradavidin V1, an engineered variant of the original core-bradavidin, was also expressed at high levels in E. coli, as well as a double mutant (Cys39Ala and Cys69Ala) of core-bradavidin (CC mutant). Our data help us to further engineer the core-bradavidin- Brad-tag pair for biotechnological assays and chemical biology applications, and provide deeper insight into the biotin-binding mode of bradavidin.	[Agrawal, Nitin; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, Turku, Finland; [Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, BioMediTech, Tampere, Finland; [Maatta, Juha A. E.; Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	Abo Akademi University; Tampere University; Tampere University	Airenne, TT (corresponding author), Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, Turku, Finland.	tomi.airenne@abo.fi	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Agrawal, Nitin/0000-0002-9482-3440	Academy of Finland [257814, 272283, 290506, 261285, 272288]; Sigrid Juselius Foundation; Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program [141398]; Fimlab Laboratories (Tampere, Finland)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program; Fimlab Laboratories (Tampere, Finland)	This work was supported by grant funding from the Academy of Finland (257814 (MSJ), 272283 (MSJ), 290506 (VPH), 261285 (MSK), and 272288 (MSK)); Sigrid Juselius Foundation; Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program (141398) and Abo Akademi Center of Excellence in Cell Stress and Aging. The funders had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fimlab Laboratories (Tampere, Finland) provided support in the form of salaries for author VPH and in the form of research materials for the group lead by VPH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avraham O, 2015, J STRUCT BIOL, V191, P139, DOI 10.1016/j.jsb.2015.06.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BARNARD G, 1986, METHOD ENZYMOL, V133, P284; BAYER EA, 1989, BIOCHEM J, V259, P369, DOI 10.1042/bj2590369; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DAKSHINAMURTI K, 1985, ANN NY ACAD SCI, V447, P38, DOI 10.1111/j.1749-6632.1985.tb18424.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeMonte D, 2013, PROTEINS, V81, P1621, DOI 10.1002/prot.24320; DETITTA GT, 1976, J AM CHEM SOC, V98, P1920, DOI 10.1021/ja00423a045; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOPE ML, 1987, NUCLEIC ACIDS RES, V15, P3595, DOI 10.1093/nar/15.8.3595; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lehtonen SI, 2016, ACS CHEM BIOL, V11, P211, DOI 10.1021/acschembio.5b00906; Leppiniemi J, 2013, PROTEIN SCI, V22, P980, DOI 10.1002/pro.2281; Leppiniemi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035962; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2012, J BIOL CHEM, V287, P17951, DOI 10.1074/jbc.M112.357186; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; PAHLER A, 1987, J BIOL CHEM, V262, P13933; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Repo S, 2006, CHEM BIOL, V13, P1029, DOI 10.1016/j.chembiol.2006.08.006; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Rosebrough SF, 1996, J NUCL MED, V37, P1380; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, J BIOL CHEM, V270, P28204; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Schrodinger L., 2020, PYMOL; Siqueira AF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-420; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Taskinen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077207; TUOHIMAA P, 1989, International Journal of Developmental Biology, V33, P125; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	69	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176086	10.1371/journal.pone.0176086	http://dx.doi.org/10.1371/journal.pone.0176086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426764	Green Published, gold			2022-12-27	WOS:000399875900101
J	Gohring, AR; Reuter, S; Clemente, JH; Cheng, XL; Theobald, J; Wolfi, S; Mrowka, R				Goehring, Axel R.; Reuter, Stefanie; Clemente, Joachim H.; Cheng, Xinlai; Theobald, Jannick; Wolfi, Stefan; Mrowka, Ralf			Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; MICRO RNAS; PLURIPOTENCY; GENES; LINES; RESISTANCE; CARCINOMA; MIGRATION; MOUSE	Purpose Oct4 was reported to be one of the most important pluripotency transcription factors in the biology of stem cells including cancer stem cells, and progressed malignant cells. Here we report the investigation of gene expression control of Oct4 by selected human microRNAs and the physiological effect of Oct4 silencing in invasive cancer cells. Methods and results High throughput luciferase activity assay revealed the microRNA-299-3p to be the most effective in reducing gene expression of Oct4, which was confirmed by Western blot analysis and Oct4 promoter activity in a target luciferase assay. Furthermore, it could be demonstrated that downregulation of Oct4 by microRNAs-299-3p in breast cancer and fibrosarcoma cells lead to a decreased invasiveness in a microfluidic chip assay. Additionally, microRNA-299-3p causes apoptosis in cancer cells. Comparison with Oct4 specific siRNA transfection confirmed that this effect is primary due to the blockade of Oct4 expression. Conclusion The results suggest that microRNA-299-3p is an interesting target for potential clinical use. It may be able to decrease invasive behaviour of carcinoma cells; or even kill these cells by causing apoptosis.	[Goehring, Axel R.; Reuter, Stefanie; Mrowka, Ralf] Univ Klinikum Jena, Klin Innere Med 3, Expt Nephrol, Jena, Germany; [Clemente, Joachim H.] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Jena, Germany; [Cheng, Xinlai; Theobald, Jannick; Wolfi, Stefan] Heidelberg Univ, Abt Pharmazeut Biol, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Gohring, AR (corresponding author), Univ Klinikum Jena, Klin Innere Med 3, Expt Nephrol, Jena, Germany.	goehring-axel@gmx.de	Cheng, Xinlai/L-6134-2015; Mrowka, Ralf/AAW-1480-2021	Cheng, Xinlai/0000-0001-6441-3742; Mrowka, Ralf/0000-0002-0991-3418; Gohring, Axel Robert/0000-0002-7176-8506; Clement, Joachim H./0000-0002-6601-2456; Reuter nee Strobel, Stefanie/0000-0002-3805-4632	Federal German Ministry of Education and Research (BMBF) within the Medical Systems Biology Project: Drug-iPS [FKZ 0315389A]; SysToxChip BMBF [FKZ: 031A303A]; German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS [FKZ 0315389A]	Federal German Ministry of Education and Research (BMBF) within the Medical Systems Biology Project: Drug-iPS; SysToxChip BMBF; German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS	This work was supported by the Federal German Ministry of Education and Research (BMBF; http://www.bmbf.de/), within the Medical Systems Biology Project: Drug-iPS, FKZ 0315389A and B, and SysToxChip BMBF FKZ: 031A303A and E to RM and SW.; We would like to thank Christine Reinhold and Silke Nossmann for their excellent technical assistance. This work was supported by the German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS, FKZ 0315389A and B, and SysToxChip BMBF FKZ: 031A303A and E to RM and SW. We would like to thank Holger Becker from Microfluidic ChipShop GmbH for providing the microfluidic templates for the Chip assay. Furthermore, we want to thank Dr. Anita Voigt from the University Children's hospital, Jena, for providing KG-1 cells.	Adammek M, 2013, FERTIL STERIL, V99, P1346, DOI 10.1016/j.fertnstert.2012.11.055; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Dai XZ, 2013, ONCOL REP, V29, P155, DOI 10.3892/or.2012.2086; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Fernandez M, 2004, J MOL ENDOCRINOL, V33, P155, DOI 10.1677/jme.0.0330155; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; FURLEY AJ, 1986, BLOOD, V68, P1101; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu R, 2015, CANC RES; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; MANZ A, 1993, HRC-J HIGH RES CHROM, V16, P433; Pawell RS, 2015, MICROFLUID NANOFLUID, V18, P657, DOI 10.1007/s10404-014-1464-1; Peng X., 2012, ONCOL REP; Razak SRA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073532; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TESHIMA S, 1988, LAB INVEST, V59, P328; Wu G, 2015, DISCOV MED, V20, P219; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu B.-L., 2015, APF HARD MASK DISTOR, P1; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Ziolkowska K, 2011, NEW J CHEM, V35, P979, DOI 10.1039/c0nj00709a	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174912	10.1371/journal.pone.0174912	http://dx.doi.org/10.1371/journal.pone.0174912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426762	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900014
J	Palmgren, M; Engstrom, K; Hallstrom, BM; Wahlberg, K; Sondergaard, DA; Sall, T; Vahter, M; Broberg, K				Palmgren, Michael; Engstrom, Karin; Hallstrom, Bjorn M.; Wahlberg, Karin; Sondergaard, Dan Ariel; Sall, Torbjorn; Vahter, Marie; Broberg, Karin			AS3MT-mediated tolerance to arsenic evolved by multiple independent horizontal gene transfers from bacteria to eukaryotes	PLOS ONE			English	Article							ENZYMATIC METHYLATION; TRIMETHYLARSINE GAS; GENOME REVEALS; BASAL METAZOAN; IN-VITRO; METHYLTRANSFERASE; EVOLUTION; ACID; SEQUENCE; PATHWAY	Organisms have evolved the ability to tolerate toxic substances in their environments, often by producing metabolic enzymes that efficiently detoxify the toxicant. Inorganic arsenic is one of the most toxic and carcinogenic substances in the environment, but many organisms, including humans, metabolise inorganic arsenic to less toxic metabolites. This multistep process produces mono-, di-, and trimethylated arsenic metabolites, which the organism excretes. In humans, arsenite methyltransferase (AS3MT) appears to be the main metabolic enzyme that methylates arsenic. In this study, we examined the evolutionary origin of AS3MT and assessed the ability of different genotypes to produce methylated arsenic metabolites. Phylogenetic analysis suggests that multiple, independent horizontal gene transfers between different bacteria, and from bacteria to eukaryotes, increased tolerance to environmental arsenic during evolution. These findings are supported by the observation that genetic variation in AS3MT correlates with the capacity to methylate arsenic. Adaptation to arsenic thus serves as a model for how organisms evolve to survive under toxic conditions.	[Palmgren, Michael; Engstrom, Karin; Vahter, Marie; Broberg, Karin] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden; [Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark; [Engstrom, Karin; Wahlberg, Karin] Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden; [Hallstrom, Bjorn M.] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Sondergaard, Dan Ariel] Aarhus Univ, Ctr Bioinformat BiRC, Aarhus, Denmark; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden	Karolinska Institutet; University of Copenhagen; Lund University; Royal Institute of Technology; Aarhus University; Lund University	Broberg, K (corresponding author), Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden.	karin.broberg@ki.se	Vahter, Marie/HGB-1674-2022; Palmgren, Michael/A-9808-2013	Palmgren, Michael/0000-0002-9982-6114; Broberg, Karin/0000-0002-5862-468X	Swedish Council for Working Life and Social Research; Karolinska Institutet; Eric Philip So Erensen's Foundation; Danish National Research Foundation; Kungliga Fysiografiska Sallskapetto	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Eric Philip So Erensen's Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Kungliga Fysiografiska Sallskapetto	This work was supported by grants from the Swedish Council for Working Life and Social Research to K.B., the Karolinska Institutet to M.V. and K.B, Eric Philip So Erensen's Foundation to K.B., the Danish National Research Foundation to M.P., and Kungliga Fysiografiska Sallskapetto K.B.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ajees AA, 2015, GEOMICROBIOL J, V32, P570, DOI 10.1080/01490451.2014.908983; Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonelli R, 2014, ENVIRON RES, V132, P156, DOI 10.1016/j.envres.2014.03.012; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CAVALIERSMITH T, 1995, P ROY SOC B-BIOL SCI, V261, P1, DOI 10.1098/rspb.1995.0108; CHALLENGER F, 1955, Q REV CHEM SOC, V9, P255, DOI 10.1039/qr9550900255; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen J, 2013, APPL ENVIRON MICROB, V79, P4493, DOI 10.1128/AEM.01133-13; Conaco C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151092; COX DP, 1973, B ENVIRON CONTAM TOX, V9, P84, DOI 10.1007/BF01684760; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; Dheeman DS, 2014, CHEM RES TOXICOL, V27, P1979, DOI 10.1021/tx500313k; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Drobna Z, 2004, TOXICOL APPL PHARM, V201, P166, DOI 10.1016/j.taap.2004.05.004; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forterre P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00717; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Friedman R, 2012, CURR MICROBIOL, V65, P639, DOI 10.1007/s00284-012-0205-5; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Healy SM, 1997, MUTAT RES-REV MUTAT, V386, P229, DOI 10.1016/S1383-5742(97)00014-8; Hirano S, 2004, TOXICOL APPL PHARM, V198, P458, DOI 10.1016/j.taap.2003.10.023; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IARC, 2012, REV HUM CARC ARS M C, V100C; Jia Y, 2013, ENVIRON SCI TECHNOL, V47, P3141, DOI 10.1021/es303649v; Koch I, 2015, METALLOMICS, V7, P1274, DOI 10.1039/c5mt00078e; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Ku C, 2015, P NATL ACAD SCI USA, V112, P10139, DOI 10.1073/pnas.1421385112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084231; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; MARAFANTE E, 1984, CHEM-BIOL INTERACT, V50, P49, DOI 10.1016/0009-2797(84)90131-5; MARGULIS L, 1978, CURR MICROBIOL, V1, P227, DOI 10.1007/BF02602848; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Melnick JG, 2007, SCIENCE, V317, P225, DOI 10.1126/science.1144314; Miller M.A., 2010, P GAT COMP ENV WORKS; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; Moreau H, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r74; Myashita S, 2011, BIOSCI BIOTECH BIOCH, V75, P522, DOI 10.1271/bbb.100751; Najarro MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005663; Naranmandura H, 2012, TOXICOL SCI, V128, P137, DOI 10.1093/toxsci/kfs154; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Schlebusch CM, 2015, MOL BIOL EVOL, V32, P1544, DOI 10.1093/molbev/msv046; Schlebusch CM, 2013, ENVIRON HEALTH PERSP, V121, P53, DOI 10.1289/ehp.1205504; Schonknecht G, 2014, BIOESSAYS, V36, P9, DOI 10.1002/bies.201300095; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Suzuki K, 2015, RES MICROBIOL, V166, P753, DOI 10.1016/j.resmic.2015.08.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ., 2013, ENCY METALLOPROTEINS, P138, DOI [10.1007/978-1-4614-1533-6_449, DOI 10.1007/978-1-4614-1533-6]; VAHTER M, 1984, ARCH ENVIRON CON TOX, V13, P259, DOI 10.1007/BF01055275; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; VAHTER M, 1995, TOXICOL APPL PHARM, V133, P262, DOI 10.1006/taap.1995.1150; VAHTER M, 1985, ARCH TOXICOL, V57, P119, DOI 10.1007/BF00343121; Vahter Marie, 1999, Science Progress, V82, P69; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wang QQ, 2015, CHEM RES TOXICOL, V28, P351, DOI 10.1021/tx500286t; Wisecaver JH, 2016, MOL BIOL EVOL, V33, P1979, DOI 10.1093/molbev/msw073; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Ye J, 2012, TRENDS PLANT SCI, V17, P155, DOI 10.1016/j.tplants.2011.12.003; Zakharyan RA, 1996, TOXICOL APPL PHARM, V140, P77, DOI 10.1006/taap.1996.0199; Zhang SY, 2013, CHEMOSPHERE, V93, P47, DOI 10.1016/j.chemosphere.2013.04.063; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n	91	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175422	10.1371/journal.pone.0175422	http://dx.doi.org/10.1371/journal.pone.0175422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426741	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900029
J	Schwenke, D; Dshemuchadse, M; Vesper, C; Bleichner, MG; Scherbaum, S				Schwenke, Diana; Dshemuchadse, Maja; Vesper, Cordula; Bleichner, Martin Georg; Scherbaum, Stefan			Let's decide together: Differences between individual and joint delay discounting	PLOS ONE			English	Article							SELF-CONTROL; HYPOTHETICAL REWARDS; INTERTEMPORAL CHOICE; PREFRONTAL CORTEX; IMPULSIVITY; DECISIONS; RISK; INFORMATION; TIME; PERFORMANCE	This study addressed the question whether or not social collaboration has an effect on delay discounting, the tendency to prefer sooner but smaller over later but larger delivered rewards. We applied a novel paradigm in which participants executed choices between two gains in an individual and in a dyadic decision-making condition. We observed how participants reached mutual consent via joystick movement coordination and found lower discounting and a higher decisions' efficiency. In order to establish the underlying mechanism for dyadic variation, we further tested whether these differences emerge from social facilitation or inner group interchange.	[Schwenke, Diana; Scherbaum, Stefan] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Dshemuchadse, Maja] Hsch Zittau Gorlitz, Fak Sozialwissensch, Gorlitz, Germany; [Vesper, Cordula] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Bleichner, Martin Georg] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Central European University; Carl von Ossietzky Universitat Oldenburg	Schwenke, D (corresponding author), Tech Univ Dresden, Dept Psychol, Dresden, Germany.	diana.schwenke@tu-dresden.de	Bleichner, Martin G/AAA-1383-2021; Bleichner, Martin G/AAV-2585-2021	Bleichner, Martin G/0000-0001-6933-9238; Bleichner, Martin G/0000-0001-6933-9238; Schwenke, Diana/0000-0003-4994-3627; Vesper, Cordula/0000-0002-3434-4843	Volkswagen Foundation [89426]	Volkswagen Foundation(Volkswagen)	This project was supported by Volkswagen Foundation (https://www. volkswagenstiftung.de/) grant 89426 to SS and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Albrecht K, 2011, SOC COGN AFFECT NEUR, V6, P218, DOI 10.1093/scan/nsq046; Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Barlow P, 2016, INT J EPIDEMIOL, P1; Bateman I, 2005, ECON J, V115, pC176, DOI 10.1111/j.0013-0133.2005.00986.x; Baumann MR, 2004, ORGAN BEHAV HUM DEC, V93, P89, DOI 10.1016/j.obhdp.2003.12.004; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Cooper DJ, 2005, AM ECON REV, V95, P477, DOI 10.1257/0002828054201431; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Daly M, 2005, Q REV BIOL, V80, P55, DOI 10.1086/431025; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Dshemuchadse M, 2013, J EXP PSYCHOL GEN, V142, P93, DOI 10.1037/a0028499; Dzhogleva H, 2014, J CONSUM RES, V41, P361, DOI 10.1086/676599; Espin AM, 2015, PATIENCE PREDICTS GR; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garvert MM, 2015, NEURON, V85, P418, DOI 10.1016/j.neuron.2014.12.033; Gattig A, 2007, J SOC ISSUES, V63, P21, DOI 10.1111/j.1540-4560.2007.00494.x; Gigone D, 1997, J PERS SOC PSYCHOL, V72, P132, DOI 10.1037/0022-3514.72.1.132; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; HENCHY T, 1968, J PERS SOC PSYCHOL, V10, P446, DOI 10.1037/h0026814; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; HINSZ VB, 1990, J PERS SOC PSYCHOL, V59, P705, DOI 10.1037/0022-3514.59.4.705; Hinsz VB, 1997, PSYCHOL BULL, V121, P43, DOI 10.1037/0033-2909.121.1.43; Holt DD, 2016, BEHAV PROCESS, V131, P47, DOI 10.1016/j.beproc.2016.08.006; Janicik GA, 2003, GROUP DYN-THEOR RES, V7, P122, DOI 10.1037/1089-2699.7.2.122; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kim S, 2011, BIOL PSYCHIAT, V69, P1140, DOI 10.1016/j.biopsych.2010.07.005; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Lane SD, 2003, BEHAV PROCESS, V64, P287, DOI 10.1016/S0376-6357(03)00143-8; Laughlin PR, 2003, GROUP DYN-THEOR RES, V7, P55, DOI 10.1037/1089-2699.7.1.55; Maciejovsky B, 2013, MANAGE SCI, V59, P1255, DOI 10.1287/mnsc.1120.1668; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Masclet D, 2009, J ECON BEHAV ORGAN, V70, P470, DOI 10.1016/j.jebo.2007.11.002; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; O'Connell G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00174; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Ponti G, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00146; Pronin E, 2008, PERS SOC PSYCHOL B, V34, P224, DOI 10.1177/0146167207310023; Read D, 2005, MANAGE SCI, V51, P1326, DOI 10.1287/mnsc.1050.0412; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Samuelson PA, 1936, REV ECON STUD, V4, P155; Scherbaum S, J CLIN EXPT NEUROPSY; Scherbaum S, 2016, JUDGM DECIS MAK, V11, P472; Scherbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079310; Schultze T, 2012, ORGAN BEHAV HUM DEC, V118, P24, DOI 10.1016/j.obhdp.2011.12.006; Shaw ME, 1932, AM J PSYCHOL, V44, P491, DOI 10.2307/1415351; Stasser G, 2000, ORGAN BEHAV HUM DEC, V82, P102, DOI 10.1006/obhd.2000.2890; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Sullivan N, 2015, PSYCHOL SCI, V26, P122, DOI 10.1177/0956797614559543; van der Wel RPRD, 2015, COGNITION, V140, P49, DOI 10.1016/j.cognition.2015.03.011; VanDellen MR, 2010, PERS SOC PSYCHOL B, V36, P251, DOI 10.1177/0146167209356302; Vesper C, 2014, EXP BRAIN RES, V232, P2945, DOI 10.1007/s00221-014-3982-1; VOLLRATH DA, 1989, ORGAN BEHAV HUM DEC, V43, P289, DOI 10.1016/0749-5978(89)90040-X; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Ziegler FV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049479	67	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176003	10.1371/journal.pone.0176003	http://dx.doi.org/10.1371/journal.pone.0176003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426708	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900084
J	Wang, K; Li, YL; Han, R; Cai, GF; He, C; Wang, GL; Jia, D				Wang, Kun; Li, Yanlin; Han, Rui; Cai, Guofeng; He, Chuan; Wang, Guoliang; Jia, Di			T140 blocks the SDF-1/CXCR4 signaling pathway and prevents cartilage degeneration in an osteoarthritis disease model	PLOS ONE			English	Article							FACTOR-I; MATRIX METALLOPROTEINASES; KNEE OSTEOARTHRITIS; HUMAN CHONDROCYTES; CXCR4; ATTENUATION; ARTHRITIS; SDF-1; OA; PATHOGENESIS	Osteoarthritis (OA) is one of the most common diseases affecting older people; however, there remains no effective targeted drug to combat OA. The aims of this study were (1) to explore the effect of T140 in regulating degeneration of articular cartilage in vivo by targeted blocking of the SDF-1/CXCR4 signaling pathway, and (2) to provide experimental evidence for the development of a novel OA-targeted pharmacotherapy. Thirty-six healthy Hartley guinea pigs were randomly divided into three groups: a T140-treated group (n = 12), a phosphate buffer saline control group (n = 12) and an untreated control group (n = 12). At 2, 4, 6, 8, 10 and 12 weeks of treatment, SDF-1 in serum was quantified by enzyme-linked immunosorbent assay. At 12 weeks of treatment, the cartilage from knee tibial plateau in the knee joint was collected for H&E, Safranin-O staining and Mankin grading; measurement for mRNA levels of matrix metalloproteinases (MMP-3, MMP-9 and MMP-13), aggrecan (ACAN) and collagen II (Col II) using RT-PCR; and measurement for Col II protein levels by western blot. Results showed that SDF-1 in serum increased in the T140 group and increased in the control groups. H&E and Safranin-O staining revealed less cartilage loss in T140-treated animals compared to controls. The mRNA levels of MMP-3, MMP-9 and MMP-13 in cartilage were much lower in the T140 group than other groups, but mRNA levels of ACAN and Col II in cartilage were higher in the T140-treated group. Col II protein levels in the T140 group and control groups were different. T140 can downregulate the expression of matrix-degrading enzyme and lessen the degeneration of cartilage by blocking the SDF-1/CRCR4 signaling pathway in vivo. This mechanism may present a pharmacological target for the treatment of OA.	[Wang, Kun; Li, Yanlin; Cai, Guofeng; He, Chuan; Wang, Guoliang; Jia, Di] Kunming Med Univ, Dept Sports Med, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Han, Rui] Kunming Med Univ, Dept Diabetol, Affiliated Hosp 1, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University	Li, YL (corresponding author), Kunming Med Univ, Dept Sports Med, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	852387873@qq.com			National Natural Science Foundation of China [81460340]; innovative team project in Yunnan province [2014HC018]; Program for Outstanding Medical Academic Leader in Yunnan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); innovative team project in Yunnan province; Program for Outstanding Medical Academic Leader in Yunnan province	This study was supported by the National Natural Science Foundation of China (No: 81460340) and innovative team project in Yunnan province (No: 2014HC018). This study was also supported by Program for Outstanding Medical Academic Leader in Yunnan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No: 81460340) and innovative team project in Yunnan province (No: 2014HC018). This study was also supported by Program for Outstanding Medical Academic Leader in Yunnan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulais PE, 2009, BIOCHEM PHARMACOL, V78, P1382, DOI 10.1016/j.bcp.2009.07.007; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Chen HT, 2011, J CELL BIOCHEM, V112, P1219, DOI 10.1002/jcb.23043; Chiu YC, 2007, MOL PHARMACOL, V72, P695, DOI 10.1124/mol.107.036541; Cho HJ, 2016, KNEE, V23, P29, DOI 10.1016/j.knee.2015.09.003; Filardo G, 2016, KNEE SURG SPORT TR A, V24, P1775, DOI 10.1007/s00167-016-4089-y; He W, 2016, J ARTHROPLASTY, V31, P373, DOI 10.1016/j.arth.2015.08.018; Hemshekhar M, 2013, EUR J NUTR, V52, P1787, DOI 10.1007/s00394-012-0482-6; Hummel S, 2014, CURR OPIN HEMATOL, V21, P29, DOI 10.1097/MOH.0000000000000002; Kanbe K, 2004, J BONE JOINT SURG BR, V86B, P296, DOI 10.1302/0301-620X.86B2.14474; Kanbe K, 2002, ARTHRITIS RHEUM-US, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Le Clanche S, 2016, BIOCHIMIE, V121, P238, DOI 10.1016/j.biochi.2015.12.008; Li PC, 2016, MOL MED REP, V14, P1475, DOI 10.3892/mmr.2016.5419; Lu L, 2015, J DENT RES, V94, P1601, DOI 10.1177/0022034515604621; Masuda R, 2012, BIOCONJUGATE CHEM, V23, P1259, DOI 10.1021/bc300084h; Nanki Toshihiro, 2016, Nihon Rinsho Meneki Gakkai Kaishi, V39, P172, DOI 10.2177/jsci.39.172; Narumi T, 2013, CHEMMEDCHEM, V8, P118, DOI 10.1002/cmdc.201200390; Narumi T, 2012, BIOORG MED CHEM LETT, V22, P4169, DOI 10.1016/j.bmcl.2012.04.032; Nummenmaa E, 2015, SCAND J RHEUMATOL, V44, P321, DOI 10.3109/03009742.2014.1000372; Pearson RG, 2011, OSTEOARTHR CARTILAGE, V19, P324, DOI 10.1016/j.joca.2010.12.005; Poulet B, 2016, CURR OPIN PHARMACOL, V28, P8, DOI 10.1016/j.coph.2016.02.009; Santoro A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135979; Sharma L, 2016, OSTEOARTHR CARTILAGE, V24, P36, DOI 10.1016/j.joca.2015.07.026; Stone AV, 2014, OSTEOARTHR CARTILAGE, V22, P264, DOI 10.1016/j.joca.2013.11.002; Tamamura H, 2000, BIOORG MED CHEM LETT, V10, P2633, DOI 10.1016/S0960-894X(00)00535-7; Thomas NP, 2015, J ORTHOP RES, V33, P1071, DOI 10.1002/jor.22862; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Villalvilla A, 2014, EXPERT OPIN THER TAR, V18, P1077, DOI 10.1517/14728222.2014.930440; Wang XY, 2016, NEURAL NETWORKS, V74, P1, DOI 10.1016/j.neunet.2015.10.012; Wei FY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3930; Wilkinson RA, 2011, ANTIMICROB AGENTS CH, V55, P255, DOI 10.1128/AAC.00709-10; Zwickl H, 2016, CARTILAGE, V7, P185, DOI 10.1177/1947603515615388	32	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176048	10.1371/journal.pone.0176048	http://dx.doi.org/10.1371/journal.pone.0176048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426786	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900093
J	Zand, MS; Trayhan, M; Farooq, SA; Fucile, C; Ghoshal, G; White, RJ; Quill, CM; Rosenberg, A; Barbosa, HS; Bush, K; Chafi, H; Boudreau, T				Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; Fucile, Christopher; Ghoshal, Gourab; White, Robert J.; Quill, Caroline M.; Rosenberg, Alexander; Barbosa, Hugo Serrano; Bush, Kristen; Chafi, Hassan; Boudreau, Timothy			Properties of healthcare teaming networks as a function of network construction algorithms	PLOS ONE			English	Article							SOCIAL NETWORKS; PATTERNS; PROFESSIONALS; EMERGENCE	Network models of healthcare systems can be used to examine how providers collaborate, communicate, refer patients to each other, and to map how patients traverse the network of providers. Most healthcare service network models have been constructed from patient claims data, using billing claims to link a patient with a specific provider in time. The data sets can be quite large (10(6)-10(8) individual claims per year), making standard methods for network construction computationally challenging and thus requiring the use of alternate construction algorithms. While these alternate methods have seen increasing use in generating healthcare networks, there is little to no literature comparing the differences in the structural properties of the generated networks, which as we demonstrate, can be dramatically different. To address this issue, we compared the properties of healthcare networks constructed using different algorithms from 2013 Medicare Part B outpatient claims data. Three different algorithms were compared: binning, sliding frame, and trace-route. Unipartite networks linking either providers or healthcare organizations by shared patients were built using each method. We find that each algorithm produced networks with substantially different topological properties, as reflected by numbers of edges, network density, assortativity, clustering coefficients and other structural measures. Provider networks adhered to a power law, while organization networks were best fit by a power law with exponential cutoff. Censoring networks to exclude edges with less than 11 shared patients, a common de-identification practice for healthcare network data, markedly reduced edge numbers and network density, and greatly altered measures of vertex prominence such as the betweenness centrality. Data analysis identified patterns in the distance patients travel between network providers, and a striking set of teaming relationships between providers in the Northeast United States and Florida, likely due to seasonal residence patterns of Medicare beneficiaries. We conclude that the choice of network construction algorithm is critical for healthcare network analysis, and discuss the implications of our findings for selecting the algorithm best suited to the type of analysis to be performed.	[Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; Fucile, Christopher; White, Robert J.; Quill, Caroline M.; Rosenberg, Alexander; Bush, Kristen] Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA; [Zand, Martin S.; Bush, Kristen] Univ Rochester, Med Ctr, Clin Translat Sci Inst, Rochester, NY 14642 USA; [Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; White, Robert J.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [Fucile, Christopher; Rosenberg, Alexander] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Ghoshal, Gourab; Barbosa, Hugo Serrano] Univ Rochester, Dept Phys, Rochester, NY USA; [Quill, Caroline M.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Chafi, Hassan; Boudreau, Timothy] Oracle Labs, Belmont, CA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Oracle	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Clin Translat Sci Inst, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA.	martin_zand@urmc.rochester.edu		Ghoshal, Gourab/0000-0001-7593-5626; Zand, Martin/0000-0002-7095-8682; Barbosa, Hugo/0000-0002-3927-969X; WHITE, ROBERT J/0000-0002-4289-1046	National Institute of Health [UL1 TR000042, U54 TR001625, KL2 TR001999, TL1 TR002000, R01AI098112, R01AI069351]; Philip Templeton Foundation; University of Rochester Center for Health Informatics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001, TL1TR000096, KL2TR001999, TL1TR002000] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Templeton Foundation; University of Rochester Center for Health Informatics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by research grants from National Institute of Health: UL1 TR000042 and U54 TR001625 (MZ, CQ, MT, RW, and KB), KL2 TR001999 (CQ), TL1 TR002000 (KB), R01AI098112 and R01AI069351 (MZ), from the Philip Templeton Foundation (MZ, RW, MT, SF), and from the University of Rochester Center for Health Informatics (MZ, RW, AR, CF, SF, MT). The University of Rochester Center for Health Informatics worked collaboratively with Oracle Labs, who provided no additional funding for this research and whose contributions were equalin this work. Oracle Labs provided support in the form of salaries for authors [TB,HC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fred Trotter, Orna Intrator, Ann Dozier and Katia Noyes for spirited discussions on healthcare networks that greatly enhanced this manuscript. This work was supported in part by research grants from National Institute of Health: UL1 TR000042 and U54 TR001625 (MZ, CQ, MT, RW, and KB), KL2 TR001999 (CQ), TL1 TR002000 ( KB), R01AI098112 and R01AI069351 (MZ), from the Philip Templeton Foundation (MZ, RW, MT, SF), and from the University of Rochester Center for Health Informatics (MZ, RW, AR, CF, SF, MT). The University of Rochester Center for Health Informatics worked collaboratively with Oracle Labs, who provided no additional funding for this research and whose contributions were equal in this work. The affiliation did not influence, nor does it alter, adherence to PLOS ONE policies on sharing data and materials.	Almansoori W, 2012, NETW MODEL ANAL HLTH, V1, P27, DOI 10.1007/s13721-012-0005-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Begley C. G., 2014, CIRC RES, V116, P116, DOI DOI 10.1161/CIRCRESAHA.114.303819; Blanchet K, 2012, HEALTH POLICY PLANN, V27, P438, DOI 10.1093/heapol/czr055; Bourgeois FT, 2015, PEDIATR DRUGS, V17, P401, DOI 10.1007/s40272-015-0139-z; Buluc A, 2012, SIAM J SCI COMPUT, V34, pC170, DOI 10.1137/110848244; Burch H, 1999, COMPUTER, V32, P97, DOI 10.1109/2.755008; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Calvert KL, 1997, IEEE COMMUN MAG, V35, P160, DOI 10.1109/35.587723; Center for Medicare Services, 2016, PHYS SHAR PAT PATT T; Center for Medicare Services, 2016, SYNTH PUBL US FIL; Center for Medicare Services, 2016, NAT PROV ID NPI FIL; Center for Medicare Services Research Assistance Data Center, 2016, MEDICARE LTD DAT SET; Centers for Medicare and Medicaid Services, 2012, CHRON COND MED BEN C; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cunningham FC, 2012, BMJ QUAL SAF, V21, P239, DOI 10.1136/bmjqs-2011-000187; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; ERDOS P, 1960, B INT STATIST INST, V38, P343; Eubank S., 2004, P 15 ANN ACM SIAM S, P718; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fattore G, 2009, HEALTH POLICY, V92, P141, DOI 10.1016/j.healthpol.2009.03.005; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Gilbert JR, 2010, ARXIV10062183; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Govindan R., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), P1371, DOI 10.1109/INFCOM.2000.832534; Gray JE, 2010, PEDIATRICS, V125, pE1460, DOI 10.1542/peds.2009-2621; Grayson J, 2015, J AM COLL RADIOL, V12, P1413, DOI 10.1016/j.jacr.2015.09.017; Gundlapalli Adi, 2009, AMIA Annu Symp Proc, V2009, P213; Ho K., 2005, INSURER PROVIDER NET; Holder LB, 2016, ACM SIGKDD EXPLORATI, V18, P39, DOI DOI 10.1145/2980765.2980770; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Jang HL, 2012, HEALTHC INFORM RES, V18, P44, DOI 10.4258/hir.2012.18.1.44; Karimi F, 2013, PHYSICA A, V392, P3476, DOI 10.1016/j.physa.2013.03.050; Klibi W, 2013, OR SPECTRUM, V35, P867, DOI 10.1007/s00291-013-0327-6; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Lebacque JP, 2002, FIRST ORDER MACROSCO, P119; Luhn HP, 1960, US patent, Patent No. [2,950,048, 2950048]; Mandl Kenneth D, 2015, BMJ Outcomes, V2015, P6; Mandl KD, 2014, J GEN INTERN MED, V29, P1499, DOI 10.1007/s11606-014-2964-0; MARSDEN PV, 1993, SOC NETWORKS, V15, P399, DOI 10.1016/0378-8733(93)90014-C; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Mensah E, 2014, HEALTH INFORM SER, P107, DOI 10.1007/978-1-4471-4237-9_7; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; North American Association of Central Cancer Registries, 2016, GEOSP LOC US PROV; Olson RS, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.4; Ong MS, 2015, J GEN INTERN MED, P1; Padmanabhan VN, 2001, ACM SIGCOMM COMP COM, V31, P173, DOI 10.1145/964723.383073; Pollack CE, 2014, VALUE HEALTH, V17, P611, DOI 10.1016/j.jval.2014.04.011; Pujol J. M., 2002, Proceedings of the First International Joint Conference on Autonomous Agents and Multiagent Systems, P467; Scholz M., 2015, J DATA MINING DIGITA, V2015; Schumaker Alice M, 2002, J Health Hum Serv Adm, V25, P371; Scott J, 2005, ANN FAM MED, V3, P443, DOI 10.1370/afm.344; Seidel R., 1992, Proceedings of the Twenty-Fourth Annual ACM Symposium on the Theory of Computing, P745, DOI 10.1145/129712.129784; Stewart SA, 2012, J MED INTERNET RES, V14, P245, DOI 10.2196/jmir.1982; Trotter F., 2012, DOCGRAPH OPEN SOCIAL; Uddin S, 2012, AUSTR WORKSH HLTH IN, V129, P67; Uddin S, 2013, STAT MED, V32, P3539, DOI 10.1002/sim.5770; Uddin S, 2012, EUR J PUBLIC HEALTH, V22, P629, DOI 10.1093/eurpub/ckr153; Um J, 2009, P NATL ACAD SCI USA, V106, P14236, DOI 10.1073/pnas.0901898106; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-67; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X; West E, 2005, CAN J NURS RES, V37, P132; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; ZipInfo, 2016, ZIP COD MAPP FIL	72	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175876	10.1371/journal.pone.0175876	http://dx.doi.org/10.1371/journal.pone.0175876			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426795	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900062
J	Chen, CCM; Keith, JM; Mengersen, KL				Chen, Carla Chia-Ming; Keith, Jonathan Macgregor; Mengersen, Kerrie Lee			Accurate phenotyping: Reconciling approaches through Bayesian model averaging	PLOS ONE			English	Article							LINKAGE ANALYSIS; GENETIC-ANALYSIS; ASSOCIATION; SELECTION; MIGRAINE; INFORMATION; MAPS	Genetic research into complex diseases is frequently hindered by a lack of clear biomarkers for phenotype ascertainment. Phenotypes for such diseases are often identified on the basis of clinically defined criteria; however such criteria may not be suitable for understanding the genetic composition of the diseases. Various statistical approaches have been proposed for phenotype definition; however our previous studies have shown that differences in phenotypes estimated using different approaches have substantial impact on subsequent analyses. Instead of obtaining results based upon a single model, we propose a new method, using Bayesian model averaging to overcome problems associated with phenotype definition. Although Bayesian model averaging has been used in other fields of research, this is the first study that uses Bayesian model averaging to reconcile phenotypes obtained using multiple models. We illustrate the new method by applying it to simulated genetic and phenotypic data for Kofendred personality disorder-an imaginary disease with several sub-types. Two separate statistical methods were used to identify clusters of individuals with distinct phenotypes: latent class analysis and grade of membership. Bayesian model averaging was then used to combine the two clusterings for the purpose of subsequent linkage analyses. We found that causative genetic loci for the disease produced higher LOD scores using model averaging than under either individual model separately. We attribute this improvement to consolidation of the cores of phenotype clusters identified using each individual method.	[Chen, Carla Chia-Ming] Australian Inst Marine Sci, Cape Cleveland, Qld, Australia; [Chen, Carla Chia-Ming; Mengersen, Kerrie Lee] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [Keith, Jonathan Macgregor] Monash Univ, Sch Math Sci, Clayton, Vic, Australia	Australian Institute of Marine Science; Queensland University of Technology (QUT); Monash University	Chen, CCM (corresponding author), Australian Inst Marine Sci, Cape Cleveland, Qld, Australia.; Chen, CCM (corresponding author), Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia.	c.ewels@aims.gov.au	Chen, Carla/F-5958-2019; Mengersen, Kerrie/AHC-4096-2022	Chen, Carla/0000-0001-9718-4464; Mengersen, Kerrie/0000-0001-8625-9168; Keith, Jonathan/0000-0002-9675-3976	National Health and Medical Research Council capacity building grant [389892]; Australian Research Council Discovery Programme [DP0879308, DP1095849]; GAW grant [R01 GM031575];  [DK31775];  [NS27941]	National Health and Medical Research Council capacity building grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Programme(Australian Research Council); GAW grant; ; 	This study was funded by a National Health and Medical Research Council (https:// www.nhmrc.gov.au/) capacity building grant (grant number 389892). Author Keith acknowledges the support of Australian Research Council Discovery Programme (http://www.arc.gov.au/discoveryp rogramme) grants DP0879308 and DP1095849.; The authors would like to thank Dr David Greenberg for providing the Kofendred Personality Disorder data simulated for the Genetic Analysis Workshop 14 and acknowledge the grants that supported that work: DK31775 and NS27941. We would also like to thank Drs Jean MacCluer and Vanessa Olmo for obtaining the Kofendred Personality Disorder data and acknowledge their GAW grant: R01 GM031575. The authors also want to express our gratitude to Dr Jennifer Hoeting for discussions on Bayesian model averaging and Dr Timothy Moroney for his help with the MKL library.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Annest A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-72; Bernado J. M., 1994, BAYESIAN THEORY; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Chen CCM, 2009, HUM GENET, V125, P591, DOI 10.1007/s00439-009-0652-7; Cho MH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-30; CORDER EH, 1993, GENET EPIDEMIOL, V10, P495, DOI 10.1002/gepi.1370100628; Dijkstra TK, 1988, MODEL UNCERTAINTY IT, P466; DRAPER D, 1995, J R STAT SOC B, V57, P45, DOI 10.1111/j.2517-6161.1995.tb02015.x; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P506, DOI 10.1093/ajcn/62.3.506; Eaves L, 2004, TWIN RES, V7, P471, DOI 10.1375/1369052042335278; Erosheva E. A., 2002, THESIS; Evans M, 1995, STAT SCI, V10, P254, DOI 10.1214/ss/1177009938; Fern XZ, 2003, P INT C MACH LEARN, V20, P186; Fridley BL, 2009, GENET EPIDEMIOL, V33, P27, DOI 10.1002/gepi.20353; Gelfand A, 1997, ENCYCLOPEDIA OF THE, V1; Gelman A, 1998, STAT SCI, V13, P163; Gilks WR, 1996, MARKOV CHAIN MONTE C; Godsill SJ, 2001, J COMPUT GRAPH STAT, V10, P230, DOI 10.1198/10618600152627924; Greenberg DA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S3; Hallmayer JF, 2003, MOL PSYCHIATR, V8, P511, DOI 10.1038/sj.mp.4001273; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lewis SM, 1997, J AM STAT ASSOC, V92, P648, DOI 10.2307/2965712; Lord F.M., 1980, APPL ITEM RESPONSE T; MADIGAN D, 1995, COMMUN STAT-THEOR M, V24, P2271, DOI 10.1080/03610929508831616; Manton K.G., 1994, STAT APPL USING FUZZ; Marin J. M., 2007, BAYESIAN CORE PRACTI; McCutcheon A.L., 1987, LATENT CLASS ANAL QU; McLachlan GJ, 2004, STAT METHODS MED RES, V13, P347, DOI 10.1191/0962280204sm372ra; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Raftery A.E., 1995, PRACTICAL MARKOV CHA; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Raftery AE, 2003, 433 U WASH DEP STAT; Raftery AE, 1995, BAYESIAN STAT, V5, P323; Roy K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-41; Russell N, BAYESIAN MO IN PRESS; Schouwenberg E, 2000, 001 ALT GREEN WORLD; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Wei YH, 2015, ADV DATA ANAL CLASSI, V9, P197, DOI 10.1007/s11634-014-0182-6; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Zinn AR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-24	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176136	10.1371/journal.pone.0176136	http://dx.doi.org/10.1371/journal.pone.0176136			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423058	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600093
J	Cui, D; Tang, CF; Li, JM; A, XX; Yu, TQ; Ma, XD; Zhang, EL; Wang, YJ; Cao, GL; Xu, F; Dai, L; Han, L; Koh, HJ				Cui, Di; Tang, Cuifeng; Li, Jinmei; A, Xinxiang; Yu, Tengqiong; Ma, Xiaoding; Zhang, Enlai; Wang, Yanjie; Cao, Guilan; Xu, Furong; Dai, Luyuan; Han, Longzhi; Koh, Hee-Jong			Genetic structure and isolation by altitude in rice landraces of Yunnan, China revealed by nucleotide and microsatellite marker polymorphisms	PLOS ONE			English	Article							ORYZA-SATIVA L.; MULTILOCUS ANALYSIS; NATURAL VARIATION; CULTIVATED RICE; GRAIN-SIZE; DIVERSITY; CONSERVATION; ORIGIN; NUMBER; DIFFERENTIATION	Rice landraces, a genetic reservoir for varietal improvement, are developed by farmers through artificial selection during the long-term domestication process. To efficiently conserve, manage, and use such germplasm resources, an understanding of the genetic structure and differentiation of local rice landraces is required. In this study, we analyzed 188 accessions of rice landraces collected from localities across an altitudinal gradient from 425 to 2, 274 m above sea level in Yunnan Province, China using ten target genes and 48 SSR markers. We detected clear differentiation of the rice landraces into indica and japonica groups and further separation of the accessions in each group into two subgroups according to altitude, including a lower altitude subgroup and higher altitude subgroup. The AMOVA results showed significant genetic differentiation among altitude zones at SSRs and most genes, except Os1977 and STS22. We further determined that differentiation among land-race populations followed a model of isolation by altitude, in which gene flow was higher among populations at similar altitude levels than across different altitude levels. Our findings demonstrated that both adaptation to altitude and altitude-dependent gene flow played key roles in the genetic differentiation of rice landraces in Yunnan, China.	[Cui, Di; Li, Jinmei; Ma, Xiaoding; Wang, Yanjie; Cao, Guilan; Han, Longzhi] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat,Minis, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Cui, Di; Koh, Hee-Jong] Seoul Natl Univ, Dept Plant Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Tang, Cuifeng; A, Xinxiang; Yu, Tengqiong; Zhang, Enlai; Xu, Furong; Dai, Luyuan] Yunnan Acad Agr Sci, Inst Biotech & Germplasm Resources, Kunming, Yunnan, Peoples R China; [Koh, Hee-Jong] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Seoul National University (SNU); Yunnan Academy of Agricultural Sciences; Seoul National University (SNU)	Han, L (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat,Minis, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.; Koh, HJ (corresponding author), Seoul Natl Univ, Dept Plant Sci, Res Inst Agr & Life Sci, Seoul, South Korea.; Koh, HJ (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea.	hanlongzhi@caas.cn; heejkoh@snu.ac.kr			National Natural Science Foundation of China [31671664]; National Key Research and Development Program of China [2016YFD0100101, 2016YFD0100301]; National Key Technology Research and Development Program of China [2013BADO1B02-2, 2013BADO1B0101-02, 2015BADO1B01-1]; CAAS Science and Technology Innovation Program; National infrastructure for Crop Germplasm Resources; Protective Program of Crop Germplasm of China [2016NWB036-01, 2016NWB036-12-2]; Next-Generation BioGreen21 Program, RDA, Republic of Korea [PJ01102401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); CAAS Science and Technology Innovation Program; National infrastructure for Crop Germplasm Resources; Protective Program of Crop Germplasm of China; Next-Generation BioGreen21 Program, RDA, Republic of Korea	LZH was supported by the National Natural Science Foundation of China (31671664), the National Key Research and Development Program of China (2016YFD0100101 and 2016YFD0100301), the National Key Technology Research and Development Program of China (2013BADO1B02-2, 2013BADO1B0101-02 and 2015BADO1B01-1), CAAS Science and Technology Innovation Program, the National infrastructure for Crop Germplasm Resources, the Protective Program of Crop Germplasm of China (2016NWB036-01 and 2016NWB036-12-2). HJK was supported by the Next-Generation BioGreen21 Program (PJ01102401), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chang T T, 1976, P S CLIM RIC, P87; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Cui D, 2016, THEOR APPL GENET, V129, P155, DOI 10.1007/s00122-015-2617-7; Deb D, 2005, SEEDS TRADITION SEED; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Frei ER, 2014, GLOBAL CHANGE BIOL, V20, P441, DOI 10.1111/gcb.12403; Gao LZ, 2003, GENET RESOUR CROP EV, V50, P17, DOI 10.1023/A:1022933230689; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heal G, 2004, RESOUR ENERGY ECON, V26, P175, DOI 10.1016/j.reseneeco.2003.11.006; Hirao AS, 2004, HEREDITY, V93, P290, DOI 10.1038/sj.hdy.6800503; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; HUDSON RR, 1985, GENETICS, V111, P147; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Oka H. I., 1988, Origin of cultivated rice.; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; ROHLF FJ, 2000, APPL BIOSTATISTICS; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Shang JJ, 2009, GENETICS, V182, P1303, DOI 10.1534/genetics.109.102871; Shi MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021302; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Sun JC, 2012, GENET RESOUR CROP EV, V59, P1611, DOI 10.1007/s10722-011-9786-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei X, 2012, MOL ECOL, V21, P5073, DOI 10.1111/j.1365-294X.2012.05748.x; Xiong ZY, 2011, CROP SCI, V51, P1050, DOI 10.2135/cropsci2010.07.0431; Xiong ZY, 2010, GENET RESOUR CROP EV, V57, P891, DOI 10.1007/s10722-009-9528-x; Xu Fu-rong, 2011, Zhongguo Shuidao Kexue, V25, P381, DOI 10.3969/j.issn.1001-7216.2011.04.006; Xu FuRong, 2010, Biodiversity Science, V18, P365, DOI 10.3724/SP.J.1003.2010.365; [徐建欣 Xu Jianxin], 2012, [科学通报, Chinese Science Bulletin], V57, P2705; Yan Hong-Mei, 2012, Yichuan, V34, P87, DOI 10.3724/SP.J.1005.2012.00087; Zeng YW, 2007, BREEDING SCI, V57, P91, DOI 10.1270/jsbbs.57.91; Zeng YW, 2001, GENET RESOUR CROP EV, V48, P297, DOI 10.1023/A:1011257700607; Zeng YW, 2001, ACTA AGRONOMICA SINI, V1, P16; Zhang HL, 2007, GENOME, V50, P72, DOI 10.1139/G06-130; Zheng XM, 2010, MOL ECOL, V19, P2439, DOI 10.1111/j.1365-294X.2010.04674.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	54	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175731	10.1371/journal.pone.0175731	http://dx.doi.org/10.1371/journal.pone.0175731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423046	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600046
J	Frederick, A; Goldsmith, J; de Zavalia, N; Amir, S				Frederick, Ariana; Goldsmith, Jory; de Zavalia, Nuria; Amir, Shimon			Mapping the co-localization of the circadian proteins PER2 and BMAL1 with enkephalin and substance P throughout the rodent forebrain	PLOS ONE			English	Article							SIZED SPINY NEURONS; SUPRACHIASMATIC NUCLEUS; CLOCK PROTEIN; BED NUCLEUS; STRIA TERMINALIS; OVAL NUCLEUS; PARAVENTRICULAR NUCLEUS; GENE-EXPRESSION; MESSENGER-RNAS; PINEAL-BODY	Despite rhythmic expression of clock genes being found throughout the central nervous system, very little is known about their function outside of the suprachiasmatic nucleus. Determining the pattern of clock gene expression across neuronal subpopulations is a key step in understanding their regulation and how they may influence the functions of various brain structures. Using immunofluorescence and confocal microscopy, we quantified the c-oexpression of the clock proteins BMAL1 and PER2 with two neuropeptides, Substance P (SubP) and Enkephalin (Enk), expressed in distinct neuronal populations throughout the forebrain. Regions examined included the limbic forebrain (dorsal striatum, nucleus accumbens, amygdala, stria terminalis), thalamus medial habenula of the thalamus, paraventricular nucleus and arcuate nucleus of the hypothalamus and the olfactory bulb. In most regions examined, BMAL1 was homogeneously expressed in nearly all neurons (similar to 90%), and PER2 was expressed in a slightly lower proportion of cells. There was no specific correlation to SubP- or Enk- expressing subpopulations. The olfactory bulb was unique in that PER2 and BMAL1 were expressed in a much smaller percentage of cells, and Enk was rarely found in the same cells that expressed the clock proteins (SubP was undetectable). These results indicate that clock genes are not unique to specific cell types, and further studies will be required to determine the factors that contribute to the regulation of clock gene expression throughout the brain.	[Frederick, Ariana; Goldsmith, Jory; de Zavalia, Nuria; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada; [Frederick, Ariana; Goldsmith, Jory] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [de Zavalia, Nuria; Amir, Shimon] Concordia Univ, Dept Psychol, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada.; Amir, S (corresponding author), Concordia Univ, Dept Psychol, Montreal, PQ, Canada.	shimon.amir@concordia.ca	Amir, Shimon/AAE-4635-2022		Fonds de Recherche du Quebec-Sante [5833]; Concordia University, Montreal, Canada; Canada Foundation for Innovation	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Concordia University, Montreal, Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Ariana Frederick was supported by a scholarship from Fonds de Recherche du Quebec-Sante, Award Number 5833.The funder had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; All images presented here were captured on an Olympus FV10i automated confocal laser scanning microscope at the Centre for Microscopy and Cell Imaging funded by Concordia University, Montreal, Canada and the Canada Foundation for Innovation. We thank Dr. Andrew Chapman for helpful suggestions on the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; ALBANESE A, 1986, J NEURAL TRANSM, P3; Alheid GF, 2003, ANN NY ACAD SCI, V985, P185; Amir S, 1999, NEUROSCI LETT, V272, P175, DOI 10.1016/S0304-3940(99)00609-6; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Asai M, 2001, J NEUROSCI RES, V66, P1133, DOI 10.1002/jnr.10010; BIN L, 1991, LIFE SCI, V49, P345, DOI 10.1016/0024-3205(91)90441-D; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Choi S, 1998, J NEUROSCI, V18; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Coronas V, 1997, J CHEM NEUROANAT, V12, P243, DOI 10.1016/S0891-0618(97)00215-9; Davidson AJ, 2001, PHYSIOL BEHAV, V72, P231, DOI 10.1016/S0031-9384(00)00417-0; Day HEW, 1999, J COMP NEUROL, V413, P113; Delezie J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29386; Dibner C, 2009, CELL CYCLE, V8, P681; EVERITT BJ, 1986, BRAIN RES REV, V11, P97, DOI 10.1016/S0006-8993(86)80192-5; Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI [10.1517/14728222.12.6.717, 10.1517/14728222.12.6.717 ]; Foo KS, 2014, J CHEM NEUROANAT, V61-62, P20, DOI 10.1016/j.jchemneu.2014.06.008; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Gravotta L, 2011, J MOL NEUROSCI, V45, P162, DOI 10.1007/s12031-011-9520-8; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Harbour V, 2011, COMPREHENSIVE MAPPIN; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Joly-Amado A, 2014, BEST PRACT RES CL EN, V28, P725, DOI 10.1016/j.beem.2014.03.003; KAFKA M S, 1986, Chronobiology International, V3, P91, DOI 10.3109/07420528609066353; KAFKA M S, 1986, Chronobiology International, V3, P101, DOI 10.3109/07420528609066354; KHACHATURIAN H, 1983, J NEUROSCI, V3, P844; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lu XY, 1998, NEUROSCIENCE, V82, P767; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Namihira M, 1999, NEUROSCI LETT, V267, P69, DOI 10.1016/S0304-3940(99)00324-9; OLSTER DH, 1990, J NEUROBIOL, V21, P768, DOI 10.1002/neu.480210510; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Riddle M, 2016, EUR J NEUROSCI; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Silver R, 2014, EUR J NEUROSCI, V39, P1866, DOI 10.1111/ejn.12593; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Smarr BL, 2014, BEHAV NEUROSCI, V128, P283, DOI 10.1037/a0035963; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Uchida H, 2016, NEUROSCI LETT, V610, P123, DOI 10.1016/j.neulet.2015.10.071; VANDERHAEGHEN JJ, 1983, P NATL ACAD SCI-BIOL, V80, P5139, DOI 10.1073/pnas.80.16.5139; Viswanath H, 2013, STILL NEGLECTED FRON, V7, P931, DOI DOI 10.3389/FNHUM.2013.00931; WARDEN MK, 1988, J COMP NEUROL, V272, P90, DOI 10.1002/cne.902720107; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamada K, 1996, J CHEM NEUROANAT, V10, P295, DOI 10.1016/0891-0618(96)00133-0; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037	71	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176279	10.1371/journal.pone.0176279	http://dx.doi.org/10.1371/journal.pone.0176279			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423013	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875600100
J	Hashimoto, Y; Macri, D; Srivastava, I; McPherson, C; Felberbaum, R; Post, P; Cox, M				Hashimoto, Yoshifumi; Macri, Daniel; Srivastava, Indresh; McPherson, Clifton; Felberbaum, Rachael; Post, Penny; Cox, Manon			Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; SPODOPTERA-FRUGIPERDA; RNA VIRUSES; EVOLUTION; MICROVESICLES; INFECTION; PROTEIN; IDENTIFICATION; HEPATITIS; EXOSOMES	A putative novel rhabdovirus (SfRV) was previously identified in a Spodoptera frugiperda cell line (Sf9 cells [ATCC CRL-1711 lot 58078522]) by next generation sequencing and extensive bioinformatic analysis. We performed an extensive analysis of our Sf9 cell bank (ATCC CRL-1711 lot 5814 [Sf9(L5814)]) to determine whether this virus was already present in cells obtained from ATCC in 1987. Inverse PCR of DNA isolated from Sf9(L5814) cellular DNA revealed integration of SfRV sequences in the cellular genome. RT-PCR of total RNA showed a deletion of 320 nucleotides in the SfRV RNA that includes the transcriptional motifs for genes X and L. Concentrated cell culture supernatant was analyzed by sucrose density gradient centrifugation and revealed a single band at a density of 1.14 g/ml. This fraction was further analysed by electron microscopy and showed amorphous and particulate debris that did not resemble a rhabdovirus in morphology or size. SDS-PAGE analysis confirmed that the protein composition did not contain the typical five rhabdovirus structural proteins and LC-MS/MS analysis revealed primarily of exosomal marker proteins, the SfRV N protein, and truncated forms of SfRV N, P, and G proteins. The SfRV L gene fragment RNA sequence was recovered from the supernatant after ultracentrifugation of the 1.14 g/ml fraction treated with diethyl ether suggesting that the SfRV L gene fragment sequence is not associated with a diethyl ether resistant nucleocapsid. Interestingly, the 1.14 g/ml fraction was able to transfer baculovirus DNA into Sf9(L5814) cells, consistent with the presence of functional exosomes. Our results demonstrate the absence of viral particles in ATCC CRL-1711 lot 5814 Sf9 cells in contrast to a previous study that suggested the presence of infectious rhabdoviral particles in Sf9 cells from a different lot. This study highlights how cell lines with different lineages may present different virosomes and therefore no general conclusions can be drawn across Sf9 cells from different laboratories.	[Hashimoto, Yoshifumi; Macri, Daniel; Srivastava, Indresh; McPherson, Clifton; Felberbaum, Rachael; Post, Penny; Cox, Manon] Prot Sci Corp, Meriden, CT 06450 USA		Hashimoto, Y (corresponding author), Prot Sci Corp, Meriden, CT 06450 USA.	yoshihashimoto@gmail.com			Protein Sciences Corporation (PSC)	Protein Sciences Corporation (PSC)	All authors are (or were at the time the research was conducted) employees of Protein Sciences Corporation (PSC). PSC is the manufacturer of Flublok - an FDA recombinant influenza vaccine manufactured in insect cells. The safety of Flublok is extremely important to not only PSC, but also healthcare authorities. PSC has conducted and continuous to perform extensive research into the cell substrate used to manufacture Flublok and its parent cell line described in this paper. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011; Assenberg R, 2010, J VIROL, V84, P1089, DOI 10.1128/JVI.01520-09; BLUMBERG BM, 1983, CELL, V32, P559, DOI 10.1016/0092-8674(83)90475-0; Bock JO, 2004, VIROLOGY, V319, P49, DOI 10.1016/j.virol.2003.10.017; BROWN F., 1967, J VIROL, V1, P368; CAMPBELL MJ, 1995, BIOTECHNIQUES, V18, P1027; Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Cox Manon M J, 2015, Ther Adv Vaccines, V3, P97, DOI 10.1177/2051013615595595; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cui J, 2012, VIROLOGY, V427, P77, DOI 10.1016/j.virol.2012.02.014; DEZELEE S, 1987, J VIROL, V61, P1391; Dilcher M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0410-5; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Feng ZD, 2014, ANNU REV VIROL, V1, P539, DOI 10.1146/annurev-virology-031413-085359; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Johnson JB, 2012, J VIROL, V86, P9929, DOI 10.1128/JVI.01154-12; Joubert DA, 2014, J VIROL, V88, P1591, DOI 10.1128/JVI.01812-13; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; Kato T., 2009, BMC BIOTECHNOL, V9; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; Koppen T, 2011, PROTEOMICS, V11, P4397, DOI 10.1002/pmic.201000774; Layrat C, 1995, PLOS PATHOG, V7; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Li TC, 2007, J VIROL, V81, P10890, DOI 10.1128/JVI.00807-07; Liu SJ, 2014, J GEN VIROL, V95, P2809, DOI 10.1099/vir.0.069765-0; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14; Lovatt A, 1999, J VIROL METHODS, V82, P185, DOI 10.1016/S0166-0934(99)00111-1; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Lynn Dwight E, 2002, J Insect Sci, V2, P9; Ma HL, 2014, J VIROL, V88, P6576, DOI 10.1128/JVI.00780-14; Maghodia AB, 2016, PROTEIN EXPRES PURIF, V122, P45, DOI 10.1016/j.pep.2016.02.014; McPherson CE, 2008, BIOLOGICALS, V36, P350, DOI 10.1016/j.biologicals.2008.08.001; Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Murakami R, 2013, VIRUS RES, V176, P179, DOI 10.1016/j.virusres.2013.06.005; Nadala ECB, 1997, DIS AQUAT ORGAN, V31, P141, DOI 10.3354/dao031141; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Said T, 1998, J GEN VIROL, V79, P47, DOI 10.1099/0022-1317-79-1-47; Sarkar A, 2010, VIROLOGY, V401, P61, DOI 10.1016/j.virol.2010.02.014; Shimizu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05074; Smith G, 1987, TEXAS AGR EXP STN B, P1555; SUNAGA H, 1960, AM J TROP MED HYG, V9, P419, DOI 10.4269/ajtmh.1960.9.419; van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15; Vasilakis N, 2014, J GEN VIROL, V95, P787, DOI 10.1099/vir.0.058685-0; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Walker PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004664; Wilde M, 2013, TNAO38 HIGH 5 SF9 EV	51	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175633	10.1371/journal.pone.0175633	http://dx.doi.org/10.1371/journal.pone.0175633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423032	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600038
J	Sun, ZZ; Yin, XL; Ding, J; Yu, D; Hu, M; Sun, XW; Tan, YN; Sheng, XB; Liu, L; Mo, Y; Ouyang, N; Jiang, BB; Yuan, GL; Duan, MJ; Yuan, DY; Fang, J				Sun, Zhizhong; Yin, Xiaoling; Ding, Jia; Yu, Dong; Hu, Miao; Sun, Xuewu; Tan, Yanning; Sheng, Xiabing; Liu, Ling; Mo, Yi; Ouyang, Ning; Jiang, Beibei; Yuan, Guilong; Duan, Meijuan; Yuan, Dingyang; Fang, Jun			QTL analysis and dissection of panicle components in rice using advanced backcross populations derived from Oryza Sativa cultivars HR1128 and 'Nipponbare'	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC DISSECTION; SUBSTITUTION LINES; PLANT ARCHITECTURE; INBRED POPULATION; YIELD COMPONENTS; GRAIN PRODUCTION; HEADING DATE; IDENTIFICATION; JAPONICA	Panicle traits are among the most important agronomic characters which directly relate to yield in rice. Grain number (GN), panicle length (PL), primary branch number (PBN), and secondary branch number (SBN) are the major components of rice panicle structure, and are all controlled by quantitative trait loci (QTLs). In our research, four advanced backcross overlapping populations (BIL152, BIL196a, BIL196b, and BIL196b-156) carrying introgressed segments from chromosome 6 were derived from an indica/japonica cross that used the super-hybrid rice restorer line HR1128 and the international sequenced japonica cultivar 'Nipponbare' as the donor and recurrent parents, respectively. The four panicle traits, GN, PL, PBN, and SBN, were evaluated for QTL effects using the inclusive composite interval mapping (ICIM) method in populations over two years at two sites. Results showed that a total of twelve QTLs for GN, PL, PBN, and SBN were detected on chromosome 6. Based on marker loci physical positions, the QTLs were found to be tightly linked to three important chromosomal intervals described as RM7213 to RM19962, RM20000 to RM20210, and RM412 to RM20595. Three QTLs identified in this study, PL6-5, PBN6-1, and PBN6-2, were found to be novel compared with previous studies. A major QTL (PL6-5) for panicle length was detected in all four populations at two locations, and its position was narrowed down to a 1.3Mb region on chromosome 6. Near isogenic lines (NILs) carrying PL6-5 will be developed for fine mapping of the QTL, and our results will provide referable information for gene excavation of panicle components in rice.	[Sun, Zhizhong; Yu, Dong; Mo, Yi; Duan, Meijuan; Yuan, Dingyang; Fang, Jun] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Sun, Zhizhong; Ding, Jia; Yu, Dong; Hu, Miao; Sun, Xuewu; Tan, Yanning; Sheng, Xiabing; Yuan, Guilong; Duan, Meijuan; Yuan, Dingyang] Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Sun, Zhizhong; Ding, Jia; Yu, Dong; Sun, Xuewu; Tan, Yanning; Sheng, Xiabing; Yuan, Guilong; Duan, Meijuan; Yuan, Dingyang] Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China; [Yin, Xiaoling; Liu, Ling; Ouyang, Ning; Jiang, Beibei; Duan, Meijuan] Hunan Univ, Grad Sch, Long Ping Branch, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Academy of Agricultural Sciences; Hunan Academy of Agricultural Sciences; Hunan University	Duan, MJ; Yuan, DY; Fang, J (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.; Duan, MJ; Yuan, DY (corresponding author), Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China.; Duan, MJ; Yuan, DY (corresponding author), Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China.; Duan, MJ (corresponding author), Hunan Univ, Grad Sch, Long Ping Branch, Changsha, Hunan, Peoples R China.	duanmeijuan@163.com; yuandingyang@hhrrc.ac.cn; fangjun1973@hunau.edu.cn		ning, ouyang/0000-0001-6459-4686				Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bai XF, 2012, J INTEGR PLANT BIOL, V54, P300, DOI 10.1111/j.1744-7909.2012.01117.x; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Cheng FM, 2007, J CEREAL SCI, V46, P49, DOI 10.1016/j.jcs.2006.11.005; Du JH, 2008, SCI CHINA, V7, P513; Duan MJ, 2013, RICE, V6, P1, DOI 10.1186/1939-8433-6-21; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; He P, 2001, CROP SCI, V41, P1240, DOI 10.2135/cropsci2001.4141240x; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Hua JP, 2002, GENETICS, V162, P1885; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kim DH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-79; Kobayasi K, 2002, PLANT PROD SCI, V5, P3, DOI 10.1626/pps.5.3; Li JZ, 1999, ACTA BOT SIN, V41, P1199; Li SB, 2009, PLANT J, V58, P592, DOI 10.1111/j.1365-313X.2009.03799.x; Li SY, 2013, P NATL ACAD SCI USA, V110, P3167, DOI 10.1073/pnas.1300359110; Li SJ, 2013, PLANT CELL REP, V32, P103, DOI 10.1007/s00299-012-1345-6; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Liu E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00596; Liu Hai, 2012, Hybrid Rice, V27, P17; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Mai K, 2001, DEV BIOL, V231, P364; McCouch SR, 1997, PLANT MOL BIOL, V35, P89, DOI 10.1023/A:1005711431474; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Peng YL, 2014, PLANT CELL REP, V33, P1843, DOI 10.1007/s00299-014-1661-0; Redona ED, 1998, THEOR APPL GENET, V96, P957, DOI 10.1007/s001220050826; Robin S, 2003, THEOR APPL GENET, V107, P1288, DOI 10.1007/s00122-003-1360-7; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Tabuchi H, 2011, PLANT CELL, V23, P3276, DOI 10.1105/tpc.111.088765; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian YH, 2015, EUPHYTICA, V202, P1, DOI 10.1007/s10681-014-1263-5; Wang J., 2013, INT PLANT AN GEN C; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; WU KS, 1993, PLANT MOL BIOL, V23, P243, DOI 10.1007/BF00029001; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamagishi J, 2004, THEOR APPL GENET, V109, P1555, DOI 10.1007/s00122-004-1795-5; Yamamoto E, 2012, RICE, V5, DOI 10.1186/1939-8433-5-26; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Zhang H, 2011, J GENET GENOMICS, V38, P603, DOI 10.1016/j.jgg.2011.11.004; Zhang H, 2011, THEOR APPL GENET, V123, P1247, DOI 10.1007/s00122-011-1663-z; Zhang L, 2015, THEOR APPL GENET, V128, P1151, DOI 10.1007/s00122-015-2496-y; Zhang YS, 2006, THEOR APPL GENET, V113, P361, DOI 10.1007/s00122-006-0305-3	49	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175692	10.1371/journal.pone.0175692	http://dx.doi.org/10.1371/journal.pone.0175692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422981	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600043
J	Maharajan, MK; Rajiah, K; Tam, AM; Chaw, SL; Ang, MJ; Yong, MW				Maharajan, Mari Kannan; Rajiah, Kingston; Tam, Ai May; Chaw, Siew Ling; Ang, May Jing; Yong, Mei Wan			Pharmacy students' anxiety towards research during their undergraduate degree; How to reduce it?	PLOS ONE			English	Article							ACHIEVEMENT; PERSPECTIVE; MOTIVATION; ATTITUDES; PROGRAMS	Objective To measure pharmacy students' anxiety towards research and how academic support, academic effort, attitude and self-efficacy influence their research anxiety. Methods A cross-sectional study was conducted with undergraduate final year students of pharmacy using a convenient sampling method. A validated self-administered questionnaire was used. Results Response rate for this study was 85.9% ( 128 students from a population of 149). The participants agreed that they read literature to understand research, but did not attend research-related coursework. Most participants (91.4%) felt that they were under stress while doing research. Almost all participants (97.6%) felt that they were doing very badly during their data analysis or they may fail their research projects. The majority of participants agreed that help from the lecturers' and friends in research give emotional support for their research activities. Conclusion Academic support for pharmacy students, along with their additional academic effort will improve the students' self-efficacy and reduce research anxiety.	[Maharajan, Mari Kannan; Rajiah, Kingston] Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur, Malaysia; [Tam, Ai May; Chaw, Siew Ling; Ang, May Jing; Yong, Mei Wan] Int Med Univ, Sch Pharm, Kuala Lumpur, Malaysia	International Medical University Malaysia; International Medical University Malaysia	Maharajan, MK (corresponding author), Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur, Malaysia.	marikannan@imu.edu.my	Rajiah, Kingston/G-6681-2014; Maharajan, MariKannan/F-6660-2017	Rajiah, Kingston/0000-0002-7875-2902; Maharajan, MariKannan/0000-0001-6812-0533	Institute For Research, Development and Innovation [BP I-01-12 (49) 2015]; Institute for Research, Development & Innovation, International Medical University, Malaysia	Institute For Research, Development and Innovation; Institute for Research, Development & Innovation, International Medical University, Malaysia	This study was supported by the Institute For Research, Development and Innovation BP I-01-12 (49) 2015.; This research was supported by Institute for Research, Development & Innovation, International Medical University, Malaysia. All the authors acknowledge Professor Brian Furman, University of Strathclyde, for his help in improving the use of English in the manuscript.	ABRAMS HG, 1984, AM EDUC RES J, V21, P261, DOI 10.2307/1162443; Abu Bakar K, 2010, PROCD SOC BEHV, V2, P4906, DOI 10.1016/j.sbspro.2010.03.793; Akpinar O., PSYCEXTRA DATASET; Al-Kuwaiti AA, 2014, J FAM COMMUNITY MED, V21, P134, DOI 10.4103/2230-8229.134775; Alfaro EC, 2006, FAM RELAT, V55, P279, DOI 10.1111/j.1741-3729.2006.00402.x; Aslam F, 2005, PLOS MED, V2; Bard CC, 2000, REHABIL COUNS BULL, V44, P48, DOI 10.1177/003435520004400107; Barrows J., 2013, UNIVERSAL J ED RES, V1, P204, DOI [10.13189/ujer. 2013.010310, DOI 10.13189/UJER.2013.010310, 10.13189/UJER.2013.010310]; Bensoussan M, 2012, RELC J, V43, P203, DOI 10.1177/0033688212449511; Bishop RM, 1998, J COUNS PSYCHOL, V45, P182, DOI 10.1037/0022-0167.45.2.182; Bitbol M, 2014, NEW DIR PHILOS COGN, P61; Bond C., 2015, PHARM PRACTICE RES M, P1; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; Carbonaro W, 2005, SOCIOL EDUC, V78, P27, DOI 10.1177/003804070507800102; Cuseo J., 2003, ASS STUDENT ACAD SER, P271; Darbishire PL, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe76342; Deb S., 2015, INT J PSYCHOL BEHAV, V5, P26, DOI DOI 10.5923/J.IJPBS.20150501.04; Devi V, 2012, KATHMANDU U MED J, V8; Dobson C., 2012, THESIS; Duguet A, 2016, INT J HIGHER ED, V5; Dunn D. S., 2015, OXFORD HDB UNDERGRAD; Forester M, 2004, J CAREER ASSESSMENT, V12, P3, DOI 10.1177/1069072703257719; Frishman W H, 2001, Heart Dis, V3, P140, DOI 10.1097/00132580-200105000-00002; Gold J, 2005, J PSYCHOTHER INTEGR, V15, P374, DOI 10.1037/1053-0479.15.4.374; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Hasan SS, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7409166; Hassali MA, 2015, INDIAN J PHARM EDUC, V49, P93, DOI 10.5530/ijper.49.2.3; Houlden RL, 2004, MED TEACH, V26, P659, DOI 10.1080/01421590400019542; Hren D, 2004, MED EDUC, V38, P81, DOI 10.1111/j.1365-2923.2004.01735.x; Hu SP, 2007, INNOV HIGH EDUC, V32, P167, DOI 10.1007/s10755-007-9043-y; Kaur G, PSYCEXTRA DATASET; Khan MU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149623; Kritikos Vicky S., 2015, Pharmacy Pract (Granada), V13, DOI 10.18549/PharmPract.2015.03.587; Li LKY, 2012, DISCOVERY SS STUDENT, V1, P154; Maharajan MK, 2017, PHARM ED, V17; Mallow J, 2010, J SCI EDUC TECHNOL, V19, P356, DOI 10.1007/s10956-010-9205-z; Mason KK, 2006, MULTICULT PERSPECT, V8, P57, DOI 10.1207/s15327892mcp0801_10; Murray MD, 2010, PHARM WORLD SCI, V32, P546, DOI 10.1007/s11096-010-9424-7; Naing C, 2015, SYSTEMATIC REV METAA, V94; Nolen SB, 2003, J RES SCI TEACH, V40, P347, DOI 10.1002/tea.10080; OCONNOR EJ, 1980, TEACH PSYCHOL, V7, P231, DOI 10.1207/s15328023top0704_10; PENG SS, 1994, J EDUC RES, V87, P346, DOI 10.1080/00220671.1994.9941265; Perepiczka M., 2011, PROFESSIONAL COUNSEL, V1, P99, DOI [10.15241/mpa.1.2.99, DOI 10.15241/MPA.1.2.99]; Peterson GM, 2009, J CLIN PHARM THER, V34, P397, DOI 10.1111/j.1365-2710.2008.01020.x; Pintrich PR, 2003, J EDUC PSYCHOL, V95, P667, DOI 10.1037/0022-0663.95.4.667; Rajiah K, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe789163; Remes V, 2000, MED TEACH, V22, P164, DOI 10.1080/01421590078599; Rickards Gretchen, 2012, J Grad Med Educ, V4, P407, DOI 10.4300/JGME-D-12-00239.1; Robotham D, 2008, HIGH EDUC, V56, P735, DOI 10.1007/s10734-008-9137-1; Rosenbloom K, 2000, INT J PHARM PRACT, V8, P103, DOI DOI 10.1111/J.2042-7174.2000.TB00994.X; Salgueira A, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-95; Scaria V, 2004, CALICUT MED J, V2, pe1; Smith J. B., 1992, J FRESHMAN YEAR EXPE, V4, P41; Somers CL, 2016, J APPL SCH PSYCHOL, V32, P199, DOI 10.1080/15377903.2015.1136719; Stewart Derek C, 2011, Int J Pharm Pract, V19, P328, DOI 10.1111/j.2042-7174.2011.00130.x; Stewart EB, 2008, EDUC URBAN SOC, V40, P179, DOI 10.1177/0013124507304167; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Sun G, 2013, ADV PSYCHOL SCI, V21, P1864; TOBIAS S, 1979, J EDUC PSYCHOL, V71, P573, DOI 10.1037/0022-0663.71.5.573; Tsai H-M, PSYCTESTS DATASET; Vitasari P, 2010, PROCD SOC BEHV, V8, P490, DOI 10.1016/j.sbspro.2010.12.067; Yesilyurt E, 2014, ACAD LOCUS CONTROL T	62	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176095	10.1371/journal.pone.0176095	http://dx.doi.org/10.1371/journal.pone.0176095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419167	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875200071
J	Karapinar-Carkit, F; van der Kneep, R; Bouhannouch, F; Borgsteede, SD; Janssen, MJA; Siegert, CEH; Egberts, TCG; van den Bemt, PMLA; van Wier, MF; Bosmans, JE				Karapinar-Carkit, Fatma; van der Kneep, Ronald; Bouhannouch, Fatiha; Borgsteede, Sander D.; Janssen, Marjo J. A.; Siegert, Carl E. H.; Egberts, Toine C. G.; van den Bemt, Patricia M. L. A.; van Wier, Marieke F.; Bosmans, Judith E.			Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; EFFECTIVENESS ACCEPTABILITY CURVES; ADVERSE DRUG EVENTS; MEDICATION RECONCILIATION; MULTIPLE IMPUTATION; DISCREPANCIES; INTERVENTIONS; PHARMACIST; ADMISSION; MANAGEMENT	Background To improve continuity of care at hospital admission and discharge and to decrease medication errors pharmaceutical care programs are developed. This study aims to determine the cost-effectiveness of the COACH program in comparison with usual care from a societal perspective. Methods A controlled clinical trial was performed at the Internal Medicine department of a general teaching hospital. All admitted patients using at least one prescription drug were included. The COACH program consisted of medication reconciliation, patient counselling at discharge, and communication to healthcare providers in primary care. The primary outcome was the proportion of patients with an unplanned rehospitalisation within three months after discharge. Also, the number of quality-adjusted life-years (QALYs) was assessed. Cost data were collected using cost diaries. Uncertainty surrounding cost differences and incremental cost-effectiveness ratios between the groups was estimated by bootstrapping. Results In the COACH program, 168 patients were included and in usual care 151 patients. There was no significant difference in the proportion of patients with unplanned rehospitalisations (mean difference 0.17%, 95% CI-8.85; 8.51), and in QALYs (mean difference -0.0085, 95% CI-0.0170; 0.0001). Total costs for the COACH program were non-significantly lower than usual care (-(sic) 1160, 95% CI-3168; 847). Cost-effectiveness planes showed that the program was not cost-effective compared with usual care for unplanned rehospitalisations and QALYs gained. Conclusion The COACH program was not cost-effective in comparison with usual care. Future studies should focus on high risk patients and include other outcomes (e.g. adverse drug events) as this may increase the chances of a cost-effective intervention.	[Karapinar-Carkit, Fatma; van der Kneep, Ronald; Bouhannouch, Fatiha; Janssen, Marjo J. A.] OLVG, Dept Hosp Pharm, Amsterdam, Netherlands; [Borgsteede, Sander D.] Hlth Base, Dept Medicat Surveillance, Houten, Netherlands; [Siegert, Carl E. H.] OLVG, Dept Internal Med, Amsterdam, Netherlands; [Egberts, Toine C. G.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Egberts, Toine C. G.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Fac Sci, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [van den Bemt, Patricia M. L. A.] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands; [van Wier, Marieke F.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Wier, Marieke F.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Dept Hlth Sci, Fac Earth & Life Sci, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Fac Earth & Life Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Karapinar-Carkit, F (corresponding author), OLVG, Dept Hosp Pharm, Amsterdam, Netherlands.	f.karapinar@olvg.nl	Egberts, Toine/K-4579-2019; Borgsteede, Sander Diederik/AAA-6553-2022; Egberts, Toine/A-6625-2012	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779; Bosmans, Judith/0000-0002-1443-1026; Van den Bemt, Patricia/0000-0003-1418-5520; van Wier, Marieke F./0000-0002-6464-1291	Dutch insurance company Achmea	Dutch insurance company Achmea	The Dutch health care insurance company Achmea provided financial support to this study as they finance quality improvement projects in our hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to the patients and the department of Internal Medicine for the cooperation in this study. Further, we acknowledge the pharmaceutical consultants for performing the COACH program and Marlies Mak for her help in the collection of data. We would also like to thank the Dutch insurance company Achmea for their financial support to this study.	Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; American Medical Association, 2007, PHYS ROL MED REC ISS; [Anonymous], 2009, ANN REP CORD GROUP; [Anonymous], 2008, DUTCH POLICY DOCUMEN; Australian Pharmaceutical Advisory Council, 2005, GUID PRINC ACH CONT; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Bladh L, 2011, BMJ QUAL SAF, V20, P738, DOI 10.1136/bmjqs.2009.039693; Bolas H, 2004, PHARM WORLD SCI, V26, P114, DOI 10.1023/B:PHAR.0000018601.11248.89; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Boockvar KS, 2009, QUAL SAF HEALTH CARE, V18, P32, DOI 10.1136/qshc.2007.025957; Boockvar Kenneth S, 2006, Am J Geriatr Pharmacother, V4, P236, DOI 10.1016/j.amjopharm.2006.09.003; Bosmans J, 2006, J GEN INTERN MED, V21, P1020, DOI 10.1111/j.1525-1497.2006.00555.x; Bosmans JE, 2007, PHARMACOECONOMICS, V25, P25, DOI 10.2165/00019053-200725010-00004; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Brookes K, 2000, PHARM WORLD SCI, V22, P33, DOI 10.1023/A:1008713304892; Burton A, 2007, CLIN TRIALS, V4, P154, DOI 10.1177/1740774507076914; Chinthammit Chanadda, 2012, J Pharm Pract, V25, P201, DOI 10.1177/0897190011418512; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Elliott RA, 2014, PHARMACOECONOMICS, V32, P1185, DOI 10.1007/s40273-014-0197-z; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Ghatnekar O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001563; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Hakkaart-van Roijen L, 2010, MANUAL COST STUDIES; Hakkaart-van Roijen L, 1999, HANDLEIDING VRAGENLI; Karapinar-Carkit F, 2012, ANN PHARMACOTHER, V46, P329, DOI 10.1345/aph.1Q520; Karapinar-Carkit F, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-39; Karapinar-Carkit F, 2009, ANN PHARMACOTHER, V43, P1001, DOI 10.1345/aph.1L597; Karnon J, 2009, J EVAL CLIN PRACT, V15, P299, DOI 10.1111/j.1365-2753.2008.01000.x; Korthals-de Bos IBC, 2004, J RHEUMATOL, V31, P1709; Korthals-de Bos IBC, 2004, PHARMACOECONOMICS, V22, P185, DOI 10.2165/00019053-200422030-00004; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; Kramer JS, 2007, AM J HEALTH-SYST PH, V64, P404, DOI 10.2146/ajhp060506; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Makowsky Mark J, 2009, Med Care, V47, P642, DOI 10.1097/MLR.0b013e3181926032; Oostenbrink JB, 2005, HEALTH ECON, V14, P763, DOI 10.1002/hed.966; Parry Carla, 2003, Home Health Care Serv Q, V22, P1, DOI 10.1300/J027v22n03_01; Rubin DB, 2004, MULTIPLE IMPUTATION; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scullin C, 2007, J EVAL CLIN PRACT, V13, P781, DOI 10.1111/j.1365-2753.2006.00753.x; Simoens S, 2011, INT J CLIN PHARM; Spinewine A, 2010, 131AD20101027337 KCE; Stowasser DA., 2002, J PHARM PRACT RES, V32, P133, DOI DOI 10.1002/JPPR2002322133; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; The institute for healthcare improvement, 2007, PROT 5 MILL LIV HARM; The Royal Pharmaceutical Society of Great Britain, 2006, MOV PAT MOV MED MOV; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347; Wallerstedt SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000329; White TJ, 1999, PHARMACOECONOMICS, V15, P445, DOI 10.2165/00019053-199915050-00003; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong JD, 2008, ANN PHARMACOTHER, V42, P1373, DOI 10.1345/aph.1L190	58	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174513	10.1371/journal.pone.0174513	http://dx.doi.org/10.1371/journal.pone.0174513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445474	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200007
J	Gonzalez-Maya, JF; Martinez-Meyer, E; Medellin, R; Ceballos, G				Gonzalez-Maya, Jose F.; Martinez-Meyer, Enrique; Medellin, Rodrigo; Ceballos, Gerardo			Distribution of mammal functional diversity in the Neotropical realm: Influence of land-use and extinction risk	PLOS ONE			English	Article							SPECIES RICHNESS; CONSERVATION PRIORITIES; PHYLOGENETIC DIVERSITY; MEGADIVERSE MEXICO; BODY-SIZE; WORLDS; PATTERNS; TRAITS; BIODIVERSITY; REDUNDANCY	Functional diversity represents a measure of diversity that incorporates the role of species in an ecosystem, and therefore its dynamics and resilience. Assessing its drivers and spatial variation represents an important step forward in our understanding of functional ecosystem dynamics and it is also necessary to achieve a comprehensive conservation planning. In this paper, we assessed mammal functional diversity for the 218 ecoregions within the Neotropical realm. We evaluated the overall influence and spatial variation of species richness, ecoregion extent, intervention and species at risk on functional diversity. Using ordinary least squares and geographically weighted regression modeling approaches, we found that intervened areas and threatened and non-threatened species are the most influential overall drivers of functional diversity. However, we also detected that these variables do not operate equally across scales. Our local analyses indicated both that the variation explained and local coefficients vary spatially depending on the ecoregion and major habitat type. As estimates of functional diversity are based on current distribution of all mammals, negative influence of intervened areas and positive influence of non-threatened species may reflect a potential degradation of functional processes for some ecosystems. Most generally, the negative influence of intervention together with the influence of threatened species indicates that some areas are currently more susceptible to functional diversity loss. Our results help to pinpoint key areas requiring urgent conservation action to reduce natural land-cover loss and areas where threatened species play influential roles on ecosystem functioning.	[Gonzalez-Maya, Jose F.; Medellin, Rodrigo; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Gonzalez-Maya, Jose F.] ProCAT Colombia, Proyecto Conservac Aguas & Tierras, Carrera 13 96-82,Of 205, Bogota, Colombia; [Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gonzalez-Maya, JF (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico.; Gonzalez-Maya, JF (corresponding author), ProCAT Colombia, Proyecto Conservac Aguas & Tierras, Carrera 13 96-82,Of 205, Bogota, Colombia.	jfgonzalezmaya@gmail.com	González-Maya, José F./B-6913-2011	González-Maya, José F./0000-0002-8942-5157; Martinez-Meyer, Enrique/0000-0003-1184-9264	National Council of Science and Technology (CONACyT) [255983]; UNAM [255983]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico)	JFG-M acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACyT), and UNAM (scholarship 255983); This paper is a partial fulfillment of the Graduate Doctoral Degree Program in Biomedical Sciences (Programa de Doctorado en Ciencias Biomedicas) of the National Autonomous University of Mexico (UNAM) of the first author. JFG-M acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACyT; scholarship 255983), and UNAM. Thanks to J. Belant for continued support throughout the research and to the Jesus E. Maldonado and reviewers for insightful comments that significantly improved the manuscript. All data analyzed in this paper are available in the Supporting Information file.	Albuquerque F, 2015, J BIOGEOGRAPHY; Armsworth PR, 2007, CONSERV BIOL, V21, P1383, DOI 10.1111/j.1523-1739.2007.00821.x; Barragan F, 2011, PLOS ONE, V6; Belmaker J, 2013, AM NAT, V181, P464, DOI 10.1086/669906; Biswas SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00206.1; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Bonnot TW, 2011, BIOL CONSERV, V144, P2041, DOI 10.1016/j.biocon.2011.04.026; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Calba S, 2014, GLOBAL ECOL BIOGEOGR, V23, P669, DOI 10.1111/geb.12148; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Casanoves F., 2011, CATIE, P119; Cattarino L, 2014, GLOBAL ECOL BIOGEOGR; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Dias ATC, 2013, J ECOL, V101, P29, DOI 10.1111/1365-2745.12024; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Environmental Systems Research Institute, 2013, ARCGIS 10 2 1; ESA, 2009, GLOBCOVER 2009; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; Farias AA, 2014, J MAMMALIAN EVOLUTIO; Fitzpatrick U, 2007, CONSERV BIOL, V21, P1324, DOI 10.1111/j.1523-1739.2007.00782.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Freudenberger L, 2012, ECOL COMPLEX, V12, P13, DOI 10.1016/j.ecocom.2012.08.002; Gauthier P, 2010, BIOL CONSERV, V143, P1501, DOI 10.1016/j.biocon.2010.03.032; Gonzalez-Maya JF, 2016, ANIM BIODIV CONSERV, V39, P77, DOI 10.32800/abc.2016.39.0077; Gonzalez-Maya J F, 2015, CONSERVACION DIVESID; Gonzalez-Maya JF, 2016, DIVERS DISTRIB, V22, P43, DOI 10.1111/ddi.12373; Gonzalez-Maya Jose F., 2012, Revista Biodiversidad Neotropical, V2, P5; Gonzalez-Maya JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124480; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hutcheson G. D., 2011, SAGE DICT QUANTITATI, P224; IUCN, 2012, IUCN RED LIST THREAT; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kaufman L., 2005, FINDING GROUPS DATA; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Menon S, 2001, CONSERV BIOL, V15, P501, DOI 10.1046/j.1523-1739.2001.015002501.x; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Monnet AC, 2014, GLOBAL ECOL BIOGEOGR, V23, P780, DOI 10.1111/geb.12179; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Newbold T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1073, DOI 10.1111/geb.12186; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; R team development core, 2008, R LANG ENV STAT COMP; Rondinini C, 2011, PHILOS T R SOC B, V366, P2591, DOI 10.1098/rstb.2011.0111; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Sanchez-Cuervo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043943; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmera D, 2009, OIKOS, V118, P961, DOI 10.1111/j.1600-0706.2009.17076.x; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Spasojevic MJ, 2014, ECOGRAPHY; Stein A, 2014, ECOL LETT; Sundstrom SM, 2012, CONSERV BIOL, V26, P305, DOI 10.1111/j.1523-1739.2011.01822.x; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Visconti P, 2011, PHILOS T R SOC B, V366, P2693, DOI 10.1098/rstb.2011.0105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Zar JH, 1974, BIOSTATISTICAL ANAL	84	24	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175931	10.1371/journal.pone.0175931	http://dx.doi.org/10.1371/journal.pone.0175931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441467	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800014
J	Lu, TT; Gu, M; Zhao, Y; Zheng, XY; Xing, CZ				Lu, Tingting; Gu, Ming; Zhao, Yan; Zheng, Xinyu; Xing, Chengzhong			Autophagy contributes to falcarindiol-induced cell death in breast cancer cells with enhanced endoplasmic reticulum stress	PLOS ONE			English	Article							POLYACETYLENES; IDENTIFICATION; CONSTITUENTS; PROTEINS; THERAPY; PATHWAY; ATG3	Falcarindiol (FAD) is a natural polyyne have been found in many food and dietary plants. It has been found to have various beneficial biological activities. In this study, we demonstrated its anticancer function and mechanism in breast cancer cells. We found that FAD preferentially induces cell death in breast cancer cells. FAD-induced cell death is caspase-dependent. However, FAD induces autophagy to contribute to the cell death. Blocking autophagy by either chemical inhibitors or genetic knockout of autophagy signaling component inhibits FAD-induced cell death. We further found that FAD-induced cell death is mediated by the induction of endoplasmic reticulum stress. We also identified that FAD has synergistic effect with approved cancer drugs 5-FU and Bortezomib in killing breast cancer cells. Summarily, these data demonstrate that FAD has strong and specific anticancer effect in breast cancer cells, and provide some insights about the roles of autophagy in FAD-induced cell death.	[Lu, Tingting; Xing, Chengzhong] China Med Univ, Hosp 1, Dept Anorectal Surg, Shenyang, Peoples R China; [Gu, Ming; Zhao, Yan; Zheng, Xinyu] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Peoples R China	China Medical University; China Medical University	Xing, CZ (corresponding author), China Med Univ, Hosp 1, Dept Anorectal Surg, Shenyang, Peoples R China.; Zheng, XY (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Peoples R China.	xyzheng001@gmail.com; xcz1966@126.com	Zheng, Xinyu/O-9847-2018	Zheng, Xinyu/0000-0001-8425-3379				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jin HR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.122; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Metzger BT, 2008, J AGR FOOD CHEM, V56, P3554, DOI 10.1021/jf073494t; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Ohnuma T, 2011, BIOL PHARM BULL, V34, P371, DOI 10.1248/bpb.34.371; Orlowski RZ, 2003, BREAST CANCER RES, V5, P1, DOI 10.1186/bcr460; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shun ALKS, 2006, ANGEW CHEM INT EDIT, V45, P1034, DOI 10.1002/anie.200502071; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stavri M, 2005, PHYTOTHER RES, V19, P938, DOI 10.1002/ptr.1758; Sun S, 2010, J ETHNOPHARMACOL, V132, P280, DOI 10.1016/j.jep.2010.08.026; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CZ, 2013, PHYTOMEDICINE, V20, P999, DOI 10.1016/j.phymed.2013.04.013; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176348	10.1371/journal.pone.0176348	http://dx.doi.org/10.1371/journal.pone.0176348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441457	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800050
J	Tenenbaum, A; Nordeman, L; Sunnerhagen, KS; Gunnarsson, R				Tenenbaum, Artur; Nordeman, Lena; Sunnerhagen, Katharina S.; Gunnarsson, Ronny			Gender differences in care-seeking behavior and healthcare consumption immediately after whiplash trauma	PLOS ONE			English	Article							QUEBEC CLASSIFICATION; DISORDERS; ACCIDENTS; WOMEN; SYMPTOMS; DRIVERS; PROGRAM; RISK; PAIN	Objective The aim was to study gender differences in care-seeking behavior and treatment provided immediately after whiplash trauma. Methods Participants were residents from a defined geographical area, Skaraborg County in the southwestern part of Sweden. A cohort of 3,368 persons exposed to whiplash trauma and attending a healthcare facility immediately after the trauma between 1999 and 2008 were identified in a database. Information about gender, age, time elapsed prior to seeking care, type of healthcare contact, initial treatment provided and eventual hospitalization time was retrieved. Results Women sought care later than men (p = 0.00074). Women consulted primary healthcare first more often than men, who more often first sought hospital care (p = 0.0060). There were no gender differences regarding the type of treatment after trauma. Women had longer hospital admission than men (p = 0.022), indicating their injuries were at least similar to or worse than men's. Conclusion Women sought healthcare later than men after whiplash trauma. Although not directly investigated in this study, it raises the question if this may reduce their probability of getting financial compensation compared to men.	[Tenenbaum, Artur] Halsan & Arbetslivet, Occupat Hlth Care Unit, Gothenburg, Sweden; [Tenenbaum, Artur; Gunnarsson, Ronny] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden; [Nordeman, Lena; Gunnarsson, Ronny] Res & Dev Ctr Sodra Alvsborg Narhalsan, Primary Hlth Care, Gothenburg, Sweden; [Nordeman, Lena] Univ Gothenburg, Unit Physiotherapy, Dept Hlth & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Clin Neurosci Rehabil Med, Gothenburg, Sweden; [Gunnarsson, Ronny] James Cook Univ, Coll Med & Dent, Cairns Clin Sch, Cairns, Qld, Australia	University of Gothenburg; University of Gothenburg; University of Gothenburg; James Cook University	Tenenbaum, A (corresponding author), Halsan & Arbetslivet, Occupat Hlth Care Unit, Gothenburg, Sweden.; Tenenbaum, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden.	artur.tenenbaum@vgregion.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Gunnarsson, Ronny/AAH-4811-2019	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Gunnarsson, Ronny/0000-0001-9183-3072; Tenenbaum, Artur/0000-0003-0907-8536				BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Bittner Vera, 2003, J Am Med Womens Assoc (1972), V58, P227; Blom G., 1958, STAT ESTIMATES TRANS; Borenstein P, 2010, ACTA NEUROL SCAND, V122, P278, DOI 10.1111/j.1600-0404.2009.01305.x; Burgess JA, 1996, J AM DENT ASSOC, V127, P1767, DOI 10.14219/jada.archive.1996.0138; Caulin-Glaser T, 2001, J Cardiopulm Rehabil, V21, P24, DOI 10.1097/00008483-200101000-00006; Connell R., 2002, GENDER SHORT INTRO P; Dobson A, 1999, ACCIDENT ANAL PREV, V31, P525, DOI 10.1016/S0001-4575(99)00009-3; Eck JC, 2001, AM J MED, V110, P651, DOI 10.1016/S0002-9343(01)00680-5; Falk B, 2007, TRANSPORT RES F-TRAF, V10, P414, DOI 10.1016/j.trf.2007.04.001; Friberg IO, 2016, SCAND J PUBLIC HEALT, V44, P264, DOI 10.1177/1403494815618843; Frontiereconomic, MOT INS COMP SYST FO; GALASKO CSB, 1993, INJURY, V24, P155, DOI 10.1016/0020-1383(93)90279-F; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Hartling L, 2001, SPINE, V26, P36, DOI 10.1097/00007632-200101010-00008; Herrstrom P, 2000, SCAND J PRIM HEALTH, V18, P154; Holm LW, 2009, J MANIP PHYSIOL THER, V32, pS61, DOI 10.1016/j.jmpt.2008.11.011; Jansen GB, 2008, EUR SPINE J, V17; Jensen Troels Staehelin, 2010, Ugeskr Laeger, V172, P1812; Martin JL, 2008, INJURY PREV, V14, P185, DOI 10.1136/ip.2007.016600; Mellner C, 2006, INT J BEHAV MED, V13, P1, DOI 10.1207/s15327558ijbm1301_1; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Parkosewich JA, 2008, CARDIOL REV, V16, P36, DOI 10.1097/CRD.0b013e31815aff8b; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Raine R, 2000, J Health Serv Res Policy, V5, P237; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Rosenfeld M, 2003, SPINE, V28, P2491, DOI 10.1097/01.BRS.0000090822.96814.13; SchenckGustafsson K, 2012, HANDBOOK OF CLINICAL GENDER MEDICINE, P1; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; Sterner Y, 2003, J SPINAL DISORD TECH, V16, P195, DOI 10.1097/00024720-200304000-00013; Sterner Y, 2001, DISABIL REHABIL, V23, P422; Tenenbaum A, 2002, J REHABIL MED, V34, P114, DOI 10.1080/165019702753714138; Tenenbaum A, 2015, ANN COMMUNITY MED PR, V1, P1003; The Australasian Faculty of Occupational Medicine, ROYAL AUSTR COLL PHY; Tjell C., 2002, J WHIPLASH RELAT DIS, V1, P9, DOI DOI 10.3109/J180V01N02_02; Vendrig AA, 2000, SPINE, V25, P238, DOI 10.1097/00007632-200001150-00016; Verhagen AP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003338.pub3	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176328	10.1371/journal.pone.0176328	http://dx.doi.org/10.1371/journal.pone.0176328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441465	Green Published, Green Accepted, gold			2022-12-27	WOS:000400308800047
J	Huang, HH; Chen, WC; Lin, CW; Lin, YT; Ning, HC; Chang, YC; Yang, TC				Huang, Hsin-Hui; Chen, Wei-Ching; Lin, Cheng-Wen; Lin, Yi-Tsung; Ning, Hsiao-Chen; Chang, Yi-Chih; Yang, Tsuey-Ching			Relationship of the CreBC two-component regulatory system and inner membrane protein CreD with swimming motility in Stenotrophomonas maltophilia	PLOS ONE			English	Article							BETA-LACTAMASE EXPRESSION; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; GENE-EXPRESSION; INDUCTION; PATHOGEN; GROWTH; MOTOR; L1	The CreBC two-component system (TCS) is a conserved regulatory system found in Escherichia coli, Aeromonas spp., Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. In this study, we determined how CreBC TCS regulates secreted protease activities and swimming motility using creB, creC, and creBC in-frame deletion mutants (KJ triangle CreB, KJ triangle CreC, and KJ triangle BC) of S. maltophilia KJ. Compared to wild-type KJ, KJ triangle CreB had a comparable secreted protease activity; however, the secreted protease activities were obviously reduced in KJ triangle CreC and KJ triangle BC, suggesting that CreC works together with another unidentified response regulator (not CreB) to regulate secreted protease activity. Single gene inactivation of creB or creC resulted in mutants with an enhanced swimming motility, and this phenotype was exacerbated in a double mutant KJ triangle BC. To elucidate the underlying mechanism responsible for the triangle creBC-mediated swimming enhancement, flagella morphology observation, RNA-seq based transcriptome assay, qRT-PCR, and membrane integrity and potential assessment were performed. Flagella morphological observation ruled out the possibility that swimming enhancement was due to altered flagella morphology. CreBC inactivation upregulated the expression of creD and flagella-associated genes encoding the basal body-and motor-associated proteins. Furthermore, KJ triangle BC had an increased membrane susceptibility to Triton X-100 and CreD upregulation in KJ triangle BC partially alleviated the compromise of membrane integrity. The impact of creBC TCS on bacterial membrane potential was assessed by carbonyl cyanide m-chlorophenyl hydrazine (CCCP50) concentration at which 50% of bacterial swimming is inhibited. CCCP50 of wildtype KJ increased when creBC was deleted, indicating an association between the higher membrane potential of KJ triangle BC cells and enhanced motility. Upregulation of the basal body- and motor-associated genes of flagella in KJ triangle BC cells may explain the increased	[Huang, Hsin-Hui; Chen, Wei-Ching; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Chen, Wei-Ching] Super Lab Co Ltd, New Taipei, Taiwan; [Lin, Cheng-Wen; Chang, Yi-Chih] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Ning, Hsiao-Chen] Chang Gung Mem Hosp, Dept Lab Med, Linkou Branch, Taoyuan, Taiwan; [Ning, Hsiao-Chen] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan.; Chang, YC (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.	yichih@mail.cmw.edu.tw; tcyang@ym.edu.tw			Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-023-MY3]; Professor Tsuei-Chu Mong Merit Scholarship [40419001]; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan [MOST 104-2319-B-010-001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Professor Tsuei-Chu Mong Merit Scholarship; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan	This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship. The authors acknowledge the High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (MOST 104-2319-B-010-001), for sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alksne LE, 1997, J BACTERIOL, V179, P2006, DOI 10.1128/jb.179.6.2006-2013.1997; Avison MB, 2001, J BIOL CHEM, V276, P26955, DOI 10.1074/jbc.M011186200; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chaban B, 2015, SEMIN CELL DEV BIOL, V46, P91, DOI 10.1016/j.semcdb.2015.10.032; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Huang HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145009; Huang YW, 2015, ANTIMICROB AGENTS CH, V59, P6866, DOI 10.1128/AAC.05179-14; Kanda E, 2011, MOL GENET GENOMICS, V285, P163, DOI 10.1007/s00438-010-0594-8; Khajanchi BK, 2012, MICROBIOL-SGM, V158, P259, DOI 10.1099/mic.0.051805-0; Kim JS, 2014, PLANT PATHOLOGY J, V30, P215, DOI 10.5423/PPJ.NT.11.2013.0109; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Granero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031765; Merry CR, 2015, CURR MICROBIOL, V70, P556, DOI 10.1007/s00284-014-0744-z; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; Niumsup P, 2003, J ANTIMICROB CHEMOTH, V51, P1351, DOI 10.1093/jac/dkg247; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Rott P, 2013, MICROBIOL-SGM, V159, P1149, DOI 10.1099/mic.0.065748-0; Tayler AE, 2010, MICROBIOL-SGM, V156, P2327, DOI 10.1099/mic.0.035220-0; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; Wu CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160943; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zamorano L, 2014, ANTIMICROB AGENTS CH, V58, P5084, DOI 10.1128/AAC.02556-14; Zheng L, 2016, APPL ENVIRON MICROB, V82, P2444, DOI 10.1128/AEM.03951-15	31	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174704	10.1371/journal.pone.0174704	http://dx.doi.org/10.1371/journal.pone.0174704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437463	Green Submitted, Green Published, gold			2022-12-27	WOS:000400287600003
J	Inglese, M; Petracca, M; Mormina, E; Achiron, A; Straus-Farber, R; Miron, S; Fabian, M; Krieger, S; Miller, A; Lublin, F; Sormani, MP				Inglese, Matilde; Petracca, Maria; Mormina, Enricomaria; Achiron, Anat; Straus-Farber, Rebecca; Miron, Shmuel; Fabian, Michelle; Krieger, Stephen; Miller, Aaron; Lublin, Fred; Sormani, Maria Pia			Cerebellar volume as imaging outcome in progressive multiple sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER ATROPHY; CORTICAL PATHOLOGY; CEREBRAL-CORTEX; DEMYELINATION; INFLAMMATION; EXTENT; DAMAGE	Background and purpose To assess whether cerebellar volumes changes could represent a sensitive outcome measure in primary-progressive MS. Material and methods Changes in cerebellar volumes over one-year follow-up, estimated in 26 primary-progressive MS patients and 20 controls with Freesurfer longitudinal pipeline, were assessed using Wilcoxon test and tested for their correlation with disability worsening by a logistic regression. Clinical worsening was defined as EDSS score increase or change of >20% for 25-foot walk test or 9-hole peg test scores at follow-up. Sample sizes for given treatment effects and power were calculated. The findings were validated in an independent cohort of 20 primary-progressive MS patients. Results Significant changes were detected in brain T1 lesion volume (p<0.01), cerebellar T2 and T1 lesion volume (p<0.01 and p<0.05), cerebellar volume, cerebellar cortex volume, and cerebellar WM volume (p<0.001). Only cerebellar volume and cerebellar cortex volume percentage change were significantly reduced in clinically progressed patients when compared to patients who did not progress (p<0.01; respectively AUC of 0.91 and 0.96). Cerebellar volume percentage changes were consistent in the exploration and validation cohorts (cerebellar volume -1.90 +/- 1.11% vs -1.47 +/- 2.30%; cerebellar cortex volume -1.68 +/- 1.41% vs -1.56 +/- 2.23%). Based on our results the numbers of patients required to detect a 30% effect are 81 per arm for cerebellar volume and 162 per arm for cerebellar cortex volume (90% power, type 1 error alpha = 0.05). Conclusions Our results suggest a role for cerebellar cortex volume and cerebellar volume as potential short-term imaging metrics to monitor treatment effect in primary-progressive MS clinical trials.	[Inglese, Matilde; Petracca, Maria; Mormina, Enricomaria; Fabian, Michelle; Krieger, Stephen; Miller, Aaron; Lublin, Fred] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Inglese, Matilde] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy; [Inglese, Matilde] IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy; [Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy; [Achiron, Anat; Miron, Shmuel] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel; [Achiron, Anat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Straus-Farber, Rebecca] Columbia Univ, Dept Neurol, New York, NY USA; [Sormani, Maria Pia] Univ Genoa, Biostat Unit, Genoa, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Messina; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Columbia University; University of Genoa	Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Inglese, M (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.; Inglese, M (corresponding author), IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy.	matilde.inglese@mssm.edu	Mormina, Enricomaria/K-4664-2016; Sormani, Maria Pia/ABH-8756-2020; Inglese, Matilde/AAH-3189-2020; Petracca, Maria/AAB-8562-2019; Lublin, Fred/L-8405-2017	Mormina, Enricomaria/0000-0003-2716-5772; Inglese, Matilde/0000-0002-9610-0297; Petracca, Maria/0000-0001-9429-2769; SORMANI, MARIA PIA/0000-0001-6892-104X	Novartis Pharmaceuticals [CFTY2ODUSNC15T]; National Multiple Sclerosis Society [NMSS RG 5120A3/1]; Noto Foundation; research fellowship from Fondazione Italiana Sclerosi Multipla [2013/13/7]	Novartis Pharmaceuticals(Novartis); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Noto Foundation; research fellowship from Fondazione Italiana Sclerosi Multipla	This study was supported in part by Novartis Pharmaceuticals (CFTY2ODUSNC15T), National Multiple Sclerosis Society (NMSS RG 5120A3/1), and the Noto Foundation to MI and by a research fellowship from Fondazione Italiana Sclerosi Multipla (2013/13/7) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VM, 2011, MULT SCLER J, V17, P1079, DOI 10.1177/1352458511403528; Anderson VM, 2009, MULT SCLER, V15, P811, DOI 10.1177/1352458508101934; Bogovic JA, 2013, NEUROIMAGE, V64, P616, DOI 10.1016/j.neuroimage.2012.08.075; Calabrese M, 2015, PLOS ONE, V10, P1; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Ceccarelli A, 2009, HUM BRAIN MAPP, V30, P3009, DOI 10.1002/hbm.20725; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Eshaghi A, 2014, NEUROIMAGE, V86, P257, DOI 10.1016/j.neuroimage.2013.09.059; Favata A, 2016, MULT SCLER J, P1; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ghassemi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085741; Gilmore CP, 2009, J NEUROL NEUROSUR PS, V80, P182, DOI 10.1136/jnnp.2008.148767; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mainero C, 2015, BRAIN, V138, P932, DOI 10.1093/brain/awv011; Mesaros S, 2008, ARCH NEUROL-CHICAGO, V65, P1223, DOI 10.1001/archneur.65.9.1223; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Ontaneda D, 2015, LANCET NEUROL, V14, P208, DOI 10.1016/S1474-4422(14)70264-9; Park MTM, 2014, NEUROIMAGE, V95, P217, DOI 10.1016/j.neuroimage.2014.03.037; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Redondo J, 2015, BRAIN PATHOL, V25, P692, DOI 10.1111/bpa.12230; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rodrigues KD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00021; Sepulcre J, 2006, ARCH NEUROL-CHICAGO, V63, P1175, DOI 10.1001/archneur.63.8.1175; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Weier K, 2014, PLOS ONE, P9; Weier K, 2014, HUM BRAIN MAPP, V35, P5026, DOI 10.1002/hbm.22529	30	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176519	10.1371/journal.pone.0176519	http://dx.doi.org/10.1371/journal.pone.0176519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437430	Green Published, gold			2022-12-27	WOS:000400287600052
J	Lv, PF; Zhuang, Y; Deng, J; Su, W				Lv, Pengfei; Zhuang, Yuan; Deng, Jian; Su, Wei			Study on lockage safety of LNG-fueled ships based on FSA	PLOS ONE			English	Article							GAS	In the present study, formal safety assessment (FSA) is introduced to investigate lockage safety of LNG-fueled ships. Risk sources during lockage of LNG-fueled ships in four typical scenarios, namely, navigation between two dams, lockage, anchorage, and fueling, are identified, and studied in combination with fundamental leakage probabilities of various components of LNG storage tanks, and simulation results of accident consequences. Some suggestions for lockage safety management of LNG-fueled ships are then proposed. The present research results have certain practical significance for promoting applications of LNG-fueled ships along Chuanjiang River and in Three Gorges Reservoir Region.	[Lv, Pengfei; Zhuang, Yuan; Deng, Jian; Su, Wei] Wuhan Univ Technol, Sch Nav, Wuhan, Hubei, Peoples R China	Wuhan University of Technology	Su, W (corresponding author), Wuhan Univ Technol, Sch Nav, Wuhan, Hubei, Peoples R China.	suweihyxy@whut.edu.cn			National Science and Technology Support Program [2015BAG20B01]	National Science and Technology Support Program	This study was supported by the National Science and Technology Support Program (2015BAG20B01), received by JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2014, J MAR SCI TECH-JAPAN, V19, P470, DOI 10.1007/s00773-014-0262-5; American Bureau of Shipping (ABS), 2011, GUID PROP AUX SYST G; Andersen M.-L., 2011, COSTS BENEFITS LNG S; [Anonymous], 2012, RISK ASSESSMENT CONS; Busini V, 2012, IND ENG CHEM RES, V51, P7643, DOI 10.1021/ie201591b; Casal J., 2013, J HAZARD MATER, P181; Casal J., 2013, J HAZARD MATER, P246; Fang QG, 2004, FSA ITS APPL SAFETY; Gavelli F, 2010, J HAZARD MATER, V180, P332, DOI 10.1016/j.jhazmat.2010.04.035; IMO, 2006, IGC COD INT COD CONS; Komal, 2015, J NAT GAS SCI ENG, V23, P148, DOI 10.1016/j.jngse.2015.01.030; Lee S, 2015, J NAT GAS SCI ENG, V27, P1788, DOI 10.1016/j.jngse.2015.11.003; National Development and Reform Commission of PRC, 2008, RISK BAS INSP BAS RE; Nwaoha TC, 2011, P I MECH ENG E-J PRO, V225, P40, DOI 10.1243/09544089JPME336; Qi RF, 2010, J HAZARD MATER, V183, P51, DOI 10.1016/j.jhazmat.2010.06.090; Qiu L., 2014, TRAFFIC INFORM SECUR, V32, P110, DOI [10.3963/j.issn.1674-4861.2014.03.022, DOI 10.3963/J.ISSN.1674-4861.2014.03.022.]; SINTEF, 2002, HDB PREP SINTEF TECH; Skjong R., 2005, D452 SAFEFOR; Song S., 2011, FSA METHODOLOGY ITS; State Administration of Work Safety, 2015, PROV RUL SUP MAN MAJ; Tarek Elsayed, 2013, SHIPS OFFSHORE STRUC, V1, P1; [王大庆 Wang Daqing], 2014, [中国安全科学学报, China Safety Science Journal（CSSJ）], V24, P96; Wang J, 2001, SAFETY SCI, V38, P19, DOI 10.1016/S0925-7535(00)00052-7; Wang SY, 2014, TRANSPORT REV, V34, P749, DOI 10.1080/01441647.2014.981884; Yu W., 2013, RES APPL RISK ASSESS; Zhang Q., 2014, QUANTITATIVE EVALUAT	26	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174448	10.1371/journal.pone.0174448	http://dx.doi.org/10.1371/journal.pone.0174448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437482	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600002
J	Oh, J; Lee, S; Lee, H; Cho, JY; Yoon, SH; Jang, IJ; Yu, KS; Lim, KS				Oh, Jaeseong; Lee, SeungHwan; Lee, Howard; Cho, Joo-Youn; Yoon, Seo Hyun; Jang, In-Jin; Yu, Kyung-Sang; Lim, Kyoung Soo			The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans	PLOS ONE			English	Article							SINGLE NUCLEOTIDE VARIATION; CATALYTIC-PROPERTIES; PRODRUG OSELTAMIVIR; PHARMACOKINETICS; METABOLISM; CARBOXYLATE; CLOPIDOGREL; ACTIVATION; INFLUENZA; ISOZYMES	Background Human carboxylesterase 1 (CES1) is a serine esterase that hydrolyses various exogenous and endogenous compounds including oseltamivir, a prodrug used to treat influenza. A novel CES1 c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an in silico analysis. This study evaluated the effect of the c.662A>G SNP on the pharmacokinetics (PK) of oseltamivir in humans. Methods A single oral dose of oseltamivir at 75 mg was administered to 20 healthy subjects, 8 heterozygous c.662A>G carriers (c.662AG) and 12 non-carriers (c.662AA). The concentrations of oseltamivir and its active metabolite, oseltamivir carboxylate, were measured in plasma and urine using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The PK parameters were calculated using a noncompartmental method. The geometric mean ratios (GMR, c.662AG to c.662AA) of the PK parameters and their 90% confidence intervals (CI) were calculated. Results The systemic exposure to oseltamivir, as assessed by the AUC(0-48h) of oseltamivir, was increased by 10% in c.662AG subjects, whereas the AUC(0-48h) of oseltamivir carboxylate was 5% lower in c.662AG subjects. The GMR and 90% CI of the metabolic ratio (AUC(0-48h),(Oseltamivir carboxylate)/AUC(0-48h,Oseltamivir)) was 0.87 (0.66-1.14). The amount of unchanged oseltamivir excreted in the urine was increased by 15% in subjects with the c.662AG genotype. Conclusions This result suggests that CES1 enzymatic activity may be decreased in these heterozygous allele carriers, although further studies are warranted to investigate the clinical implications of this genetic variation on CES1 substrate drugs.	[Oh, Jaeseong; Lee, SeungHwan; Lee, Howard; Cho, Joo-Youn; Yoon, Seo Hyun; Jang, In-Jin; Yu, Kyung-Sang] Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Lee, Howard] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Seoul, South Korea; [Lim, Kyoung Soo] CHA Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Seongnam, South Korea; [Lim, Kyoung Soo] CHA Bundang Med Ctr, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University	Lim, KS (corresponding author), CHA Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Seongnam, South Korea.; Lim, KS (corresponding author), CHA Bundang Med Ctr, Seongnam, South Korea.	dr.kyoungsoo.lim@gmail.com	Cho, Joo-Youn/J-5672-2012; Cho, Joo-Youn/ABC-2044-2021	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Oh, Jaeseong/0000-0001-6275-8587	Basic Science Research Program through the National Research Foundation, Republic of Korea [NRF-2012R1A1A2000823]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2750]	Basic Science Research Program through the National Research Foundation, Republic of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a research grant from the Basic Science Research Program through the National Research Foundation [Grant NRF-2012R1A1A2000823], Republic of Korea (www.nrf.re.kr/). This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) [Grant HI14C2750], funded by the Ministry of Health & Welfare, Republic of Korea (http://www.khidi.or.kr/eps).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alam M, 2002, BIOCHEMISTRY-US, V41, P6679, DOI 10.1021/bi0255625; Beaumont K, 2003, CURR DRUG METAB, V4, P461, DOI 10.2174/1389200033489253; Bencharit S, 2003, NAT STRUCT BIOL, V10, P349, DOI 10.1038/nsb919; Cha Yu-Jung, 2014, Translational and Clinical Pharmacology, V22, P30; Davies BE, 2010, J ANTIMICROB CHEMOTH, V65, pII5, DOI 10.1093/jac/dkq015; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jhee SS, 2008, ANTIMICROB AGENTS CH, V52, P3687, DOI 10.1128/AAC.00327-08; Laizure SC, 2003, DRUG METAB DISPOS, V31, P16, DOI 10.1124/dmd.31.1.16; Lewis JP, 2013, PHARMACOGENET GENOM, V23, P1, DOI 10.1097/FPC.0b013e32835aa8a2; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nemoda Z, 2009, NEUROPHARMACOLOGY, V57, P731, DOI 10.1016/j.neuropharm.2009.08.014; Ohura K, 2014, DRUG METAB DISPOS, V42, P264, DOI 10.1124/dmd.113.054551; Redinbo MR, 2003, BIOCHEM SOC T, V31, P620, DOI 10.1042/BST0310620; Rowland M, 2011, CLIN PHARMACOKINETIC; Sai K, 2010, BRIT J CLIN PHARMACO, V70, P222, DOI 10.1111/j.1365-2125.2010.03695.x; SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112; Standing JF, 2012, ANTIMICROB AGENTS CH, V56, P3833, DOI 10.1128/AAC.00290-12; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Suzaki Y, 2013, EUR J CLIN PHARMACOL, V69, P21, DOI 10.1007/s00228-012-1315-5; Tarkiainen EK, 2015, CLIN PHARMACOL THER, V97, P650, DOI 10.1002/cpt.101; Tarkiainen EK, 2012, CLIN PHARMACOL THER, V92, P68, DOI 10.1038/clpt.2012.13; Tarkiainen EK, 2015, BRIT J CLIN PHARMACO, V80, P1131, DOI 10.1111/bcp.12667; Vistoli G, 2010, BIOORGAN MED CHEM, V18, P320, DOI 10.1016/j.bmc.2009.10.052; Zhu HJ, 2008, AM J HUM GENET, V82, P1241, DOI 10.1016/j.ajhg.2008.04.015; Zhu HJ, 2013, J PHARMACOL EXP THER, V344, P665, DOI 10.1124/jpet.112.201640; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P1819, DOI 10.1124/dmd.109.028209; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P264, DOI 10.1124/dmd.108.024943	34	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176320	10.1371/journal.pone.0176320	http://dx.doi.org/10.1371/journal.pone.0176320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437488	gold, Green Submitted, Green Published			2022-12-27	WOS:000400287600042
J	Frostegard, J; Su, J; Sing, S; Hua, X; Vikstrom, M; Leander, K; Gigante, B; de Faire, U; Frostegard, AG				Frostegard, Johan; Su, Jun; Sing, Sudhir; Hua, Xiang; Vikstrom, Max; Leander, Karin; Gigante, Bruna; de Faire, Ulf; Frostegard, Anna G.			IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ATHEROSCLEROTIC PLAQUES; RISK-FACTORS; CELLS; EXTERNALIZATION; CLEARANCE; APOPTOSIS; PHOSPHORYLCHOLINE; CARDIOLIPIN; PREVALENCE	Objective Phosphatidylserine is exposed on apoptotic cells and is prone to oxidation (OxPS). Here we analyze the association of IgM antibodies against OxPS (anti-OxPS) with the risk of cardiovascular disease (CVD). Methods Among sixty-year olds from Stockholm County in Sweden, previously screened for cardiovascular risk factors (2039 men, 2193 women), there were 210 incident CVD-cases identified during a 5-year follow-up. Using a nested case-control design, 622 age-and sex-matched controls were selected. Odds ratios (OR) with 95% intervals (CI) were calculated by conditional logistic regression. IgM anti-OxPS was measured by ELISA. Phagocytosis of apoptotic Jurkat-cells by macrophages was studied by flow cytometry. Results Anti-OxPS levels were lower among cases (median (interquartile range): 80.7 (60.9-101.0 vs. 84.6 (65.8-109.6); p = 0.047); among men (76.6 (55.8-99.2) vs. 82.0 (63.1-105.1); p = 0.022) and among women 89.6 (72.3-110.1) vs. 89.8 (69.9-114.4); p = 0.79). After adjustment for smoking, BMI, diabetes mellitus type II, hypercholesterolaemia and hypertension, and dividing into quartiles, using the highest quartile (quartile 4) as reference, quartile 3 was associated with a OR of 1.74 (CI 1.08-2.81). Quartiles 2 and 1 had similar associations, the later reaching statistical significance. Among men associations were stronger whereas no significant associations were observed in women. The OR of MI/angina comparing quartile 3 with quartile 4 was 2.31 (CI 1.30-4.11). The OR for quartile 2 and 1, respectively, were similar as for quartile 3. Total IgM increased uptake of apoptotic cells, which was reversed if incubated with OxPS. Conclusions IgM anti-OxPS is a novel potential protection marker for CVD, in particular in men. Increased phagocytosis of dying/dead cells could be one potential underlying mechanism.	[Frostegard, Johan; Su, Jun; Sing, Sudhir; Hua, Xiang; Frostegard, Anna G.] Karolinska Inst, Unit Immunol & Chron Dis, Inst Environm Med, Stockholm, Sweden; [Frostegard, Johan] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden; [Vikstrom, Max; Leander, Karin; Gigante, Bruna; de Faire, Ulf] Karolinska Inst, Unit Cardiovasc Epidemiol, Inst Environm Med, Stockholm, Sweden; [Gigante, Bruna] Danderyd Hosp, Dept Cardiovasc Clin Sci, Stockholm, Sweden; [de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital	Frostegard, J (corresponding author), Karolinska Inst, Unit Immunol & Chron Dis, Inst Environm Med, Stockholm, Sweden.; Frostegard, J (corresponding author), Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden.	johan.frostegard@ki.se	Gigante, Bruna/I-9252-2012; Leander, Karin/C-7261-2017	Leander, Karin/0000-0002-1404-9222; Gigante, Bruna/0000-0003-4508-7990	HjaErt-Lungfonden [20150622]; Reumatikerforbundet [66081]; Swedish Heart Lung Foundation [20150622]; Swedish Association against Rheumatism [66081]	HjaErt-Lungfonden; Reumatikerforbundet; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association against Rheumatism	This study was funded by grant number 20150622 from Hjart-Lungfonden and grant number 66081 from Reumatikerforbundet to Prof. Johan Frostegard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by by grants to JF: the Swedish Heart Lung Foundation grant number 20150622; https://www.hjart-lungfonden.se), Swedish Association against Rheumatism grant number 66081; https://www.reumatikerforbundet.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anania C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3193; Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; Fabisiak J. P., 2005, METHOD MOL BIOL, V291; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Frostegard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111764; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Frostegard J, 2010, CLIN IMMUNOL, V134, P47, DOI 10.1016/j.clim.2009.08.013; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Halldin M, 2007, NUTR METAB CARDIOVAS, V17, P349, DOI 10.1016/j.numecd.2006.01.002; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Sjoberg BG, 2009, ATHEROSCLEROSIS, V203, P528, DOI 10.1016/j.atherosclerosis.2008.07.009; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Su J, 2013, J RHEUMATOL; Su J, 2013, J RHEUMATOL, V40, P1856, DOI 10.3899/jrheum.121173; Su J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-1; Tyurin VA, 2012, BIOCHEMISTRY-US, V51, P9736, DOI 10.1021/bi301024e; Zalewski A, 2006, CLIN CHEM, V52, P1645, DOI 10.1373/clinchem.2006.070672	27	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0171195	10.1371/journal.pone.0171195	http://dx.doi.org/10.1371/journal.pone.0171195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430795	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100002
J	Hsu, YH; Yang, YY; Huwang, MH; Weng, YH; Jou, IM; Wu, PT; Lin, TY; Wu, LW; Chang, MS				Hsu, Yu-Hsiang; Yang, Ya-Yu; Huwang, Man-Hsiang; Weng, Yun-Han; Jou, I-Ming; Wu, Po-Tin; Lin, Tain-Yu; Wu, Li-Wha; Chang, Ming-Shi			Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; EXPERIMENTAL ARTHRITIS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; II COLLAGEN; IL-20; INTERLEUKIN-20; CHONDROCYTES; DISEASE	Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction of articular cartilage. Interleukin (IL)-20 is a proinflammatory cytokine involved in the pathogenesis of rheumatoid arthritis. We investigated the role of IL-20 in OA and evaluated whether anti-IL-20 antibody (7E) treatment attenuates disease severity in murine models of surgery-induced OA. Immunohistochemical staining was used to detect IL-20 and its receptors expression in synovial tissue and cartilage from OA patients, and in OA synovial fibroblasts (OASFs) and chondrocytes (OACCs) from rodents with surgery-induced OA. RTQ-PCR and western blotting were used to determine IL-20-regulated OA-associated gene expression in OASFs and OACCs. OA rats and OA mice were treated with 7E. Arthritis severity was determined based on the degree of cartilage damage and the arthritis severity score. We found that IL-20 and its receptors were expressed in OASFs and OACCs. IL-20 induced TNF-alpha, IL-1 beta, MMP-1, and MMP-13 expression by activating ERK-1/2 and JNK signals in OASFs. IL-20 not only upregulated MCP-1, IL-6, MMP-1, and MMP-13 expression, but also downregulated aggrecan, type 2 collagen, TGF-beta, and BMP-2 expression in OACCs. Arthritis severity was significantly lower in 7E-treated OA rats, and 7E- or MSC-treated OA mice. Therefore, we concluded that IL-20 was involved in the progression and development of OA through inducing proinflammatory cytokines and OA-associated gene expression in OASFs and OACCs. 7E reduced the severity of arthritis in murine models of surgery-induced OA. Our findings provide evidence that IL-20 is a novel target and that 7E is a potential therapeutic agent for OA.	[Hsu, Yu-Hsiang; Lin, Tain-Yu] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Hsu, Yu-Hsiang] Natl Cheng Kung Univ Hosp, Res Ctr Clin Med, Tainan, Taiwan; [Hsu, Yu-Hsiang; Weng, Yun-Han; Chang, Ming-Shi] Natl Cheng Kung Univ, Res Ctr New Antibody Drug, Tainan, Taiwan; [Yang, Ya-Yu; Huwang, Man-Hsiang; Weng, Yun-Han; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Jou, I-Ming; Wu, Po-Tin] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Wu, Li-Wha] Natl Cheng Kung Univ, Inst Mol Med, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, MS (corresponding author), Natl Cheng Kung Univ, Res Ctr New Antibody Drug, Tainan, Taiwan.; Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.	mschang@mail.ncku.edu.tw	Wu, Li-Wha/AAH-7768-2021	Wu, Li-Wha/0000-0001-7010-6220	Ministry of Science and Technology of Taiwan [104-2311-B-006-007-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (104-2311-B-006-007-MY2) (https://www.most.gov.tw). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Castaneda S, 2014, RHEUMATOLOGY, V53, P1, DOI 10.1093/rheumatology/ket247; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; Chimal-Monroy J, 1999, INT J DEV BIOL, V43, P59; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Leite ACRD, 2014, OSTEOARTHR CARTILAGE, V22, P1878, DOI 10.1016/j.joca.2014.07.019; Djouad F, 2006, REGEN MED, V1, P529, DOI 10.2217/17460751.1.4.529; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Frazer A, 1994, Osteoarthritis Cartilage, V2, P235; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; Hsu YH, 2014, CELL TRANSPLANT, V23, P631, DOI 10.3727/096368914X678319; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Hsu YH, 2010, ARTHRITIS RHEUM-US, V62, P3311, DOI 10.1002/art.27689; Huang KY, 2008, SPINE, V33, P2034, DOI 10.1097/BRS.0b013e31817eb872; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kayakabe M, 2006, CYTOTHERAPY, V8, P343, DOI 10.1080/14653240600845070; Kondo M, 2014, INT J MOL SCI, V15, P21270, DOI 10.3390/ijms151121270; Kragstrup TW, 2008, CYTOKINE, V41, P16, DOI 10.1016/j.cyto.2007.10.004; Lampropoulou-Adamidou Kalliopi, 2014, Eur J Orthop Surg Traumatol, V24, P263, DOI 10.1007/s00590-013-1205-2; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1052, P366, DOI 10.1016/0167-4889(90)90145-4; Li HH, 2008, GENES IMMUN, V9, P395, DOI 10.1038/gene.2008.28; Little CBS, 2008, CURRENT RHEUMATOLOGY, V4; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Punzi L, 2010, SWISS MED WKLY, V140, P16, DOI 10.4414/smw.2010.13098; Rengel Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2304; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; Senolt L, 2015, ARTHRITIS RHEUMATOL, V67, P1438, DOI 10.1002/art.39083; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Wei CC, 2008, BIOCHEM BIOPH RES CO, V374, P448, DOI 10.1016/j.bbrc.2008.07.039; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Zhao YP, 2014, JOVE-J VIS EXP, DOI 10.3791/50924	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175802	10.1371/journal.pone.0175802	http://dx.doi.org/10.1371/journal.pone.0175802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426699	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900050
J	Peng, Y; Yan, S; Chen, DQ; Cui, XQ; Jiao, K				Peng, Yin; Yan, Shun; Chen, Dongquan; Cui, Xiangqin; Jiao, Kai			Pdgfrb is a direct regulatory target of TGF beta signaling in atrioventricular cushion mesenchymal cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC DEVELOPMENT; VALVE DEVELOPMENT; HEART DEVELOPMENT; EMBRYONIC HEART; CANCER-CELLS; MICE; TRANSCRIPTION; RECEPTOR; TRANSFORMATION	Cushion formation is the initial step for the development of valvuloseptal structures in mammalian hearts. TGF beta signaling plays critical roles in multiple steps of cushion morphogenesis. We used a newly developed conditional immortal atrioventricular cushion mesenchymal cell line, tsA58-AVM, to identify the TGF beta regulatory target genes through microarray analysis. Expression of similar to 1350 genes was significantly altered by TGF beta 1 treatment. Subsequent bioinformatic analysis of TGF beta activated genes revealed that PDGF-BB signaling is the top hit as the potential upstream regulator. Among the 37 target molecules, 10 genes known to be involved in valve development and hemostasis were selected for quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis. Our results confirmed that they are all upregulated by TGF beta 1 stimulation in tsA58-AVM cells and in primary atrioventricular cushion cells. We focused on examining regulation of Pdgfrb by TGF beta 1, which encodes a tyrosine kinase receptor for PDGF-BB. We found that the similar to 150bp Pdgfrb promoter can respond to TGF beta stimulation and that this response relies on the two SP1 binding sites within the promoter. Co-immunoprecipitation analysis confirmed SP1 interacts with SMAD2 in a TGF beta-dependent fashion. Furthermore, SMAD2 is associated with the Pdgfrb promoter and this association is diminished by knocking down expression of Sp1. Our data therefore collectively suggest that upon TGF beta stimulation, SP1 recruits SMAD2 to the promoter of Pdgfrb to up-regulate its expression and thus Pdgfrb is a direct downstream target of the TGF beta/SMAD2 signaling.	[Peng, Yin; Yan, Shun; Jiao, Kai] Univ Alabama Birmingham, Div Res, Dept Genet, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Cui, Xiangqin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jiao, K (corresponding author), Univ Alabama Birmingham, Div Res, Dept Genet, Birmingham, AL 35294 USA.	kjiao@uab.edu		yan, Shun/0000-0001-8994-5542; Jiao, Kai/0000-0002-5415-9020	NIH [1R01HL095783, 1R03HD082634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by NIH 1R01HL095783 and NIH 1R03HD082634 [https://www.nih.gov/grants-funding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Azhar M, 2011, DEV DYNAM, V240, P2127, DOI 10.1002/dvdy.22702; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Bartram U, 2001, CIRCULATION, V103, P2745; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Calkoen EE, 2016, INT J CARDIOL, V202, P784, DOI 10.1016/j.ijcard.2015.09.081; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; de la Cruz MV, 2001, CARDIOL YOUNG, V11, P588, DOI 10.1017/S1047951101000932; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; El Mai M, 2014, CELL REP, V9, P1047, DOI 10.1016/j.celrep.2014.09.038; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Hata A, 2016, COLD SPRING HARBOR P, V8; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Jiao K, 2006, DEVELOPMENT, V133, P4585, DOI 10.1242/dev.02597; Jungert K, 2006, CARCINOGENESIS, V27, P2392, DOI 10.1093/carcin/bgl078; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee J, 2016, AM J PHYSIOL-CELL PH, V310, pC436, DOI 10.1152/ajpcell.00423.2014; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Liu YL, 2014, HUM MOL GENET, V23, P2145, DOI 10.1093/hmg/ddt610; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Markwald RR, 2010, ANN NY ACAD SCI, V1188, P177, DOI 10.1111/j.1749-6632.2009.05098.x; Martin-Garrido A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079657; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Molander C, 2001, MOL BIOL REP, V28, P223, DOI 10.1023/A:1015701232589; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Moskowitz IP, 2011, P NATL ACAD SCI USA, V108, P4006, DOI 10.1073/pnas.1019025108; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; Peng Y, 2016, CARDIOVASC RES; Peng Y, 2016, CARDIOVASC RES, V112, P532, DOI 10.1093/cvr/cvw200; Peng Y, 2014, CARDIOVASC RES, V103, P258, DOI 10.1093/cvr/cvu126; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Ramsdell AF, 1997, DEV BIOL, V188, P64, DOI 10.1006/dbio.1997.8637; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song LY, 2011, DEV DYNAM, V240, P211, DOI 10.1002/dvdy.22493; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Wagner M, 2007, EXP BIOL MED, V232, P866; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035	57	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175791	10.1371/journal.pone.0175791	http://dx.doi.org/10.1371/journal.pone.0175791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426709	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900047
J	Song, SH; Lee, C; Jung, J; Kim, SJ; Park, S; Park, H; Kim, KS				Song, Sang Hoon; Lee, Chanwoo; Jung, Jaeyoon; Kim, Sung Jin; Park, Sungchan; Park, Hyungkeun; Kim, Kun Suk			A comparative study of pediatric open pyeloplasty, laparoscopy-assisted extracorporeal pyeloplasty, and robot-assisted laparoscopic pyeloplasty	PLOS ONE			English	Article							URETEROPELVIC JUNCTION OBSTRUCTION; DISMEMBERED PYELOPLASTY; OPEN SURGERY; CHILDREN; OUTCOMES; METAANALYSIS; REPAIR	Purpose To compare the outcomes of open pyeloplasty (OP), laparoscopy-assisted extracorporeal (LEXP), and robotic-assisted laparoscopic pyeloplasty (RALP) for ureteropelvic junction obstruction in pediatric patients. Methods We retrospectively reviewed the age-matched cohort of 30 children who underwent OP, 30 who underwent LEXP, and 10 who underwent RALP at a single institution, from 1996 to 2014. Pre-and post-operative variables including success rate were compared among surgical groups. Results The mean age of the patients was 120.2 months, the Society for Fetal Urology grade was 3.6, the anteroposterior diameter was 3.1 cm, and the renal relative function was 44.0%. The distribution of laterality, mean body mass index, and preoperative anteroposterior pelvic diameter on ultrasound did not differ among groups. The mean length of hospital stay was significantly shorter in the RALP group (3.2 days) than in the OP (6.6 days) and LEXP (5.8 days) groups (p<0.001). The duration of analgesics use was shorter in the RALP group (1.1 days) than in the other groups (p<0.001). During the mean follow-up period of 49.0, 20.1, and 16.6 months, the success rate was 96.7%, 89.7%, and 100% in the OP, LEXP, and RALP groups, respectively, although this difference was not statistically different (p = 0.499). In multivariate regression analysis, the presence of crossing vessels was the only factor that decreased the success rate (hazard ratio: 46.09, 95% confidence interval: 2.41-879.6, p = 0.011). Conclusions Patients who undergo RALP have a reduced hospital stay and lower use of pain medication; however, there is no difference in the success rates for OP, LP, and RALP surgeries. The presence of crossing vessels is a negative prognostic indicator for surgical outcome regardless of the surgical method.	[Song, Sang Hoon; Lee, Chanwoo; Jung, Jaeyoon; Kim, Sung Jin; Park, Hyungkeun; Kim, Kun Suk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea; [Park, Sungchan] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Urol, Ulsan, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital	Kim, KS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea.	kskim2@amc.seoul.kr		Song, Sang Hoon/0000-0003-4888-483X; Kim, Sung Jin/0000-0002-5609-0485				ANDERSON J C, 1949, Br J Urol, V21, P209, DOI 10.1111/j.1464-410X.1949.tb10773.x; Autorino R, 2014, EUR UROL, V65, P430, DOI 10.1016/j.eururo.2013.06.053; Barbosa JA, 2013, J PEDIATR UROL, V9, P199, DOI 10.1016/j.jpurol.2012.02.002; Behan JW, 2011, J UROLOGY, V186, P1663, DOI 10.1016/j.juro.2011.04.019; Boylu U, 2009, J UROLOGY, V181, P1751, DOI 10.1016/j.juro.2008.11.114; Canes D, 2009, J ENDOUROL, V23, P469, DOI 10.1089/end.2008.0249; Cundy TP, 2013, J PEDIATR SURG, V48, P858, DOI 10.1016/j.jpedsurg.2013.01.031; Dangle PP, 2013, J UROLOGY, V190, P2221, DOI 10.1016/j.juro.2013.07.063; Franco I, 2007, J UROLOGY, V178, P1483, DOI 10.1016/j.juro.2007.06.012; Freilich DA, 2010, J UROLOGY, V183, P704, DOI 10.1016/j.juro.2009.10.040; Lee RS, 2006, J UROLOGY, V175, P683, DOI 10.1016/S0022-5347(05)00183-7; Lucas SM, 2012, J UROLOGY, V187, P522, DOI 10.1016/j.juro.2011.09.158; Lucas SM, 2011, J ENDOUROL, V25, P167, DOI 10.1089/end.2010.0621; Mei H, 2011, J ENDOUROL, V25, P727, DOI 10.1089/end.2010.0544; O'Reilly PH, 2001, BJU INT, V87, P287, DOI 10.1046/j.1464-410x.2001.00108.x; PETERS CA, 1995, J UROLOGY, V153, P1962, DOI 10.1016/S0022-5347(01)67378-6; Peters CA, 2011, J ENDOUROL, V25, P179, DOI 10.1089/end.2010.0597; Riachy E, 2013, J UROLOGY, V189, P283, DOI 10.1016/j.juro.2012.09.008; Sorensen MD, 2011, J UROLOGY, V185, P2517, DOI 10.1016/j.juro.2011.01.021; Valla JS, 2009, J PEDIATR UROL, V5, P368, DOI 10.1016/j.jpurol.2009.02.202; van der Toorn F, 2013, J PEDIATR UROL, V9, P161, DOI 10.1016/j.jpurol.2012.01.007; Yee DS, 2006, UROLOGY, V67, P599, DOI 10.1016/j.urology.2005.09.021	22	37	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175026	10.1371/journal.pone.0175026	http://dx.doi.org/10.1371/journal.pone.0175026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426695	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900016
J	Wang, SY; Xu, XT; Shrestha, N; Zimmermann, NE; Tang, ZY; Wang, ZH				Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Zimmermann, Niklaus E.; Tang, Zhiyao; Wang, Zhiheng			Response of spatial vegetation distribution in China to climate changes since the Last Glacial Maximum (LGM)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; QUATERNARY CLIMATE; DIVERSITY; PALAEOVEGETATION; PREDICTION; FORESTS; POLLEN; MIDHOLOCENE; GEOGRAPHY; RICHNESS	Analyzing how climate change affects vegetation distribution is one of the central issues of global change ecology as this has important implications for the carbon budget of terrestrial vegetation. Mapping vegetation distribution under historical climate scenarios is essential for understanding the response of vegetation distribution to future climatic changes. The reconstructions of palaeovegetation based on pollen data provide a useful method to understand the relationship between climate and vegetation distribution. However, this method is limited in time and space. Here, using species distribution model (SDM) approaches, we explored the climatic determinants of contemporary vegetation distribution and reconstructed the distribution of Chinese vegetation during the Last Glacial Maximum (LGM, 18,000 C-14 yr BP) and Middle-Holocene (MH, 6000 C-14 yr BP). The dynamics of vegetation distribution since the LGM reconstructed by SDMs were largely consistent with those based on pollen data, suggesting that the SDM approach is a useful tool for studying historical vegetation dynamics and its response to climate change across time and space. Comparison between the modeled contemporary potential natural vegetation distribution and the observed contemporary distribution suggests that temperate deciduous forests, subtropical evergreen broadleaf forests, temperate deciduous shrublands and temperate steppe have low range fillings and are strongly influenced by human activities. In general, the Tibetan Plateau, North and Northeast China, and the areas near the 30 degrees N in Central and Southeast China appeared to have experienced the highest turnover in vegetation due to climate change from the LGM to the present.	[Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Tang, Zhiyao; Wang, Zhiheng] Peking Univ, Dept Ecol, Beijing, Peoples R China; [Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Tang, Zhiyao; Wang, Zhiheng] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Coll Urban & Environm Sci, Beijing, Peoples R China; [Zimmermann, Niklaus E.] Swiss Fed Res Inst WSL, Dynam Macroecol, Birmensdorf, Switzerland	Peking University; Peking University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wang, ZH (corresponding author), Peking Univ, Dept Ecol, Beijing, Peoples R China.; Wang, ZH (corresponding author), Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Coll Urban & Environm Sci, Beijing, Peoples R China.	zhiheng.wang@pku.edu.en	Zimmermann, Niklaus E./A-4276-2008; Tang, Zhiyao/B-8795-2008; Wang, Zhiheng/G-1750-2010; Shrestha, Nawal/ABA-3021-2020	Zimmermann, Niklaus E./0000-0003-3099-9604; Wang, Zhiheng/0000-0003-0808-7780; Shrestha, Nawal/0000-0002-6866-5100	National Natural Science Foundation of China [31522012, 31470564, 3132106, 31400467]; Recruitment Program of Global Youth Experts	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruitment Program of Global Youth Experts	This work was supported by the National Natural Science Foundation of China (31522012, 31470564, 3132106, 31400467) and the Recruitment Program of Global Youth Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jian Ni for his help with pollen data. This work was supported by the National Natural Science Foundation of China (31522012, 31470564, 31321061, 31400467) and the Recruitment Program of Global Youth Experts.	Adams J, 1998, REV ATLAS PALAEOVEGE; Anadon JD, 2014, J ECOL, V102, P1363, DOI 10.1111/1365-2745.12325; [Anonymous], [No title captured]; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Barros V., 2015, CLIMATE CHANGE 201 A; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Blois JL, 2013, ECOGRAPHY, V36, P460, DOI 10.1111/j.1600-0587.2012.07852.x; Box EO, 1996, J VEG SCI, V7, P309, DOI 10.2307/3236274; BRZEZIECKI B, 1993, J VEG SCI, V4, P499, DOI 10.2307/3236077; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Claussen M, 2009, CLIM PAST, V5, P203, DOI 10.5194/cp-5-203-2009; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CROWLEY TJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P377, DOI 10.1029/95GB01107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Enquist CAF, 2002, J BIOGEOGR, V29, P519, DOI 10.1046/j.1365-2699.2002.00695.x; FANG J-Y, 1989, Ecological Research, V4, P71, DOI 10.1007/BF02346944; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; GARCIAMONTIEL DC, 1994, FOREST ECOL MANAG, V63, P57, DOI 10.1016/0378-1127(94)90246-1; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; GOOD R. D'O., 1931, NEW PHYTOL, V30, P149, DOI 10.1111/j.1469-8137.1931.tb07414.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Ichii K, 2002, INT J REMOTE SENS, V23, P3873, DOI 10.1080/01431160110119416; Jiang DB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002167; Kimura MK, 2014, ANN BOT-LONDON, V114, P1687, DOI 10.1093/aob/mcu197; Kira T., 1945, NEW CLASSIFICATION C; Li S, 1991, SCI GEOGRAPHICA SINI, V4, P306; Li Y, 2015, NATURE COMMUNICATION, P6; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu HY, 2013, J PALAEOGEOG-ENGLISH, V2, P297, DOI 10.3724/SP.J.1261.2013.00032; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loehle C, 2007, CLIM PAST, V3, P109, DOI 10.5194/cp-3-109-2007; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Marchant R, 2009, POLLEN BASED BIOME R; Ni J, 2010, PALAEOGEOGR PALAEOCL, V289, P44, DOI 10.1016/j.palaeo.2010.02.008; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; OVERPECK JT, 1990, CLIMATE INDUCED CHAN; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Perkins SR, 2003, PLANT ECOL, V168, P107, DOI 10.1023/A:1024447305422; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; RCore Team, 2020, R LANG ENV STAT COMP; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Shabanov NV, 2002, IEEE T GEOSCI REMOTE, V40, P115, DOI 10.1109/36.981354; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Speier M., 1994, VEGETATIONSKUNDLICHE; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Sun XJ, 1997, QUATERN INT, V37, P25, DOI 10.1016/1040-6182(96)00008-0; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Tsuyama I, 2014, J FOREST RES-JPN, V19, P154, DOI 10.1007/s10310-013-0399-9; Viera AJ, 2005, FAM MED, V37, P360; von Humboldt A, ESSAI GEOGRAPHIE PLA; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Williams JW, 2000, J BIOGEOGR, V27, P585, DOI 10.1046/j.1365-2699.2000.00428.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Worth JRP, 2013, BIOL J LINN SOC, V108, P263, DOI 10.1111/j.1095-8312.2012.02017.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang X, 1994, ACTA PALAEONTOLOGICA, V34, P647; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhao Y, 2009, EARTH-SCI REV, V97, P242, DOI 10.1016/j.earscirev.2009.10.007; Zimmermann NE, 1999, J VEG SCI, V10, P469, DOI 10.2307/3237182	89	31	34	9	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175742	10.1371/journal.pone.0175742	http://dx.doi.org/10.1371/journal.pone.0175742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426780	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900042
J	Gil, E; Na, SJ; Ryu, JA; Lee, DS; Chung, CR; Cho, YH; Jeon, K; Sung, K; Suh, GY; Yang, JH				Gil, Eunmi; Na, Soo Jin; Ryu, Jeong-Am; Lee, Dae-Sang; Chung, Chi Ryang; Cho, Yang Hyun; Jeon, Kyeongman; Sung, Kiick; Suh, Gee Young; Yang, Jeong Hoon			Association of body mass index with clinical outcomes for in-hospital cardiac arrest adult patients following extracorporeal cardiopulmonary resuscitation	PLOS ONE			English	Article							TOTAL MORTALITY; SUDDEN-DEATH; DISEASE; SURVIVAL; OBESITY; RISK; WEIGHT	Background Obesity might be associated with disturbance of cannulation in situation of extracorporeal cardiopulmonary resuscitation (ECPR). However, limited data are available on obesity in the setting of ECPR. Therefore, we investigated the association between body mass index (BMI) and clinical outcome in patients underwent ECPR. Methods From January 2004 to December 2013, in-hospital cardiac arrest patients who had ECPR were enrolled from a single-center registry. We divided patients into four group according to BMI defined with the WHO classification (underweight, BMI < 18.5, n = 14; normal weight, BMI = 18.5-24.9, n = 118; overweight, BMI = 25.0-29.9, n = 53; obese, BMI >= 30, n = 15). The primary outcome was survival to hospital discharge. Results Analysis was carried out for a total of 200 adult patients (39.5% females). Their median BMI was 23.20 (interquartile range, 20.93-25.80). The rate of survival to hospital discharge was 31.0%. There was no significant difference in survival to hospital discharge among the four groups (underweight, 35.7%; normal, 31.4%; overweight, 30.2%; obese, 26.7%, p = 0.958). Neurologic outcomes (p = 0.85) and procedural complications (p = 0.40) were not significantly different among the four groups either. SOFA score, initial arrest rhythm, and CPR to extracorporeal membrane oxygenation (ECMO) pump on time were significant predictors for survival to discharge, but not BMI. Conclusion BMI was not associated with in-hospital mortality who underwent ECPR. Neurologic outcomes at discharge or procedural complications following ECPR were not related with BMI either.	[Gil, Eunmi; Na, Soo Jin; Ryu, Jeong-Am; Lee, Dae-Sang; Chung, Chi Ryang; Jeon, Kyeongman; Suh, Gee Young; Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Cho, Yang Hyun; Sung, Kiick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Jeon, Kyeongman; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.; Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Samsung Med Ctr, Seoul, South Korea.	jhysmc@gmail.com	Jeon, Kyeongman/F-5963-2019; Suh, Gee Young/O-3676-2019	Jeon, Kyeongman/0000-0002-4822-1772; Suh, Gee Young/0000-0001-5473-1712				Bunch TJ, 2008, RESUSCITATION, V77, P351, DOI 10.1016/j.resuscitation.2007.12.014; Bunch TJ, 2004, CRIT CARE MED, V32, P963, DOI 10.1097/01.CCM.0000139460.25406.78; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X; DUFLOU J, 1995, AM HEART J, V130, P306, DOI 10.1016/0002-8703(95)90445-X; Geri G, 2016, RESUSCITATION, V109, P49, DOI 10.1016/j.resuscitation.2016.09.011; Gupta T, 2016, AM J CARDIOL, V118, P662, DOI 10.1016/j.amjcard.2016.06.019; Jain R, 2010, CIRC-CARDIOVASC QUAL, V3, P490, DOI 10.1161/CIRCOUTCOMES.109.912501; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lim SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090039; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nagao K, 2007, LANCET, V369, P920; Park SB, 2014, INT J CARDIOL, V177, P1031, DOI 10.1016/j.ijcard.2014.09.124; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; SAFAR P, 1993, ANN EMERG MED, V22, P324, DOI 10.1016/S0196-0644(05)80463-9; Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339; Testori C, 2011, RESUSCITATION, V82, P869, DOI 10.1016/j.resuscitation.2011.02.027; 2000, ARCH INTERN MED, V160, P898	22	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176143	10.1371/journal.pone.0176143	http://dx.doi.org/10.1371/journal.pone.0176143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423065	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600095
J	Haering, D; Huchez, A; Barbieri, F; Holvoet, P; Begone, M				Haering, Diane; Huchez, Aurore; Barbieri, Franck; Holvoet, Patrice; Begone, Mickael			Identification of the contribution of contact and aerial biomechanical parameters in acrobatic performance	PLOS ONE			English	Article							HUMAN JOINT MOTION; DETERMINISTIC MODEL; ISB RECOMMENDATION; HECHT VAULT; GYMNASTICS; RELEASE; BAR; DEFINITIONS; STRATEGIES; MOVEMENT	Introduction Teaching acrobatic skills with a minimal amount of repetition is a major challenge for coaches. Biomechanical, statistical or computer simulation tools can help them identify the most determinant factors of performance. Release parameters, change in moment of inertia and segmental momentum transfers were identified in the prediction of acrobatics success. The purpose of the present study was to evaluate the relative contribution of these parameters in performance throughout expertise or optimisation based improvements. The counter movement forward in flight (CMFIF) was chosen for its intrinsic dichotomy between the accessibility of its attempt and complexity of its mastery. Methods Three repetitions of the CMFIF performed by eight novice and eight advanced female gymnasts were recorded using a motion capture system. Optimal aerial techniques that maximise rotation potential at regrasp were also computed. A 14-segment-multibody-model defined through the Rigid Body Dynamics Library was used to compute recorded and optimal kinematics, and biomechanical parameters. A stepwise multiple linear regression was used to determine the relative contribution of these parameters in novice recorded, novice optimised, advanced recorded and advanced optimised trials. Finally, fixed effects of expertise and optimisation were tested through a mixed-effects analysis. Results and discussion Variation in release state only contributed to performances in novice recorded trials. Moment of inertia contribution to performance increased from novice recorded, to novice optimised, advanced recorded, and advanced optimised trials. Contribution to performance of momentum transfer to the trunk during the flight prevailed in all recorded trials. Although optimisation decreased transfer contribution, momentum transfer to the arms appeared. Conclusion Findings suggest that novices should be coached on both contact and aerial technique. Inversely, mainly improved aerial technique helped advanced gymnasts increase their performance. For both, reduction of the moment of inertia should be focused on. The method proposed in this article could be generalized to any aerial skill learning investigation.	[Haering, Diane] Inst Natl Rech Informat & Automat Rennes Bretagne, Rennes, France; [Haering, Diane; Begone, Mickael] Univ Montreal, Dept Kinesiol, Lab Simulat & Movement Modeling Laval, Laval, PQ, Canada; [Huchez, Aurore; Barbieri, Franck] Univ Valenciennes & Hainaut Cambresis, Lab Automat & Mecan Ind & Humaines, Valenciennes, France; [Holvoet, Patrice] Univ Lille 2, Fac Sci Sport & Educ Phys, Lille, France	Universite de Montreal; Universite de Lille - ISITE; Universite de Lille	Haering, D (corresponding author), Inst Natl Rech Informat & Automat Rennes Bretagne, Rennes, France.; Haering, D (corresponding author), Univ Montreal, Dept Kinesiol, Lab Simulat & Movement Modeling Laval, Laval, PQ, Canada.	diane.haering@gmail.com		HUCHEZ, Aurore/0000-0002-6283-2844	CNRS (Centre National de Recherche Scientifique)	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	All the fundings for the present study and publication in PLOS ONE are provided by the CNRS (Centre National de Recherche Scientifique) through the UMR-CNRS 8201 lab (Laboratoire d'Automatique et de Mecanique Inductrielles et Humaines).	[Anonymous], 2013, WOMEN ARTISTICS GYMN; Arampatzis A, 2001, J BIOMECH, V34, P505, DOI 10.1016/S0021-9290(00)00212-8; Bardy BG, 1998, J EXP PSYCHOL HUMAN, V24, P963, DOI 10.1037/0096-1523.24.3.963; Begon M, 2009, COMPUT METHOD BIOMEC, V12, P575, DOI 10.1080/10255840902788595; Bessonnet G, 2005, INT J ROBOT RES, V24, P523, DOI 10.1177/0278364905055377; Bobrow JE, 2001, J ROBOTIC SYST, V18, P785, DOI 10.1002/rob.8116; Bruggeman G, 1987, MED SPORT SCI, V25, P142; BRUGGEMANN GP, 1994, J APPL BIOMECH, V10, P291, DOI 10.1123/jab.10.3.291; Bruggemann GP, 1983, BIOMECHANICS B, P793; Burgess R, 2001, ISBS C P ARCH; Busquets A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067491; Caine D, 2005, MED SPORT SCI, V48, P18, DOI 10.1159/000084282; Canal M, 1987, INFORM VISUELLES GYM, P118; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Delignieres D, 1998, HUM MOVEMENT SCI, V17, P221, DOI 10.1016/S0167-9457(97)00031-6; Felis Martin L., 2012, Motion in Games. 5th International Conference (MIG 2012). Proceedings, P197, DOI 10.1007/978-3-642-34710-8_19; GERVAIS P, 1993, J APPL BIOMECH, V9, P66, DOI 10.1123/jab.9.1.66; Haering D, 2014, INT SHOULD GROUP C; Hiley MJ, 2007, SPORT BIOMECH, V6, P121, DOI 10.1080/14763140701324511; Hiley MJ, 2003, J BIOMECH, V36, P313, DOI 10.1016/S0021-9290(02)00431-1; Hiley MJ, 2013, HUMAN MOVEMENT SCI; Huchez A, 2015, COMPUTER METHODS BIO, P1; Huchez A, 2016, SCI GYMNAST J, V8, P31; Jarodzka H, 2010, LEARN INSTR, V20, P146, DOI 10.1016/j.learninstruc.2009.02.019; Karpathy Andrej, 2012, Advances in Artificial Intelligence. Proceedings 25th Canadian Conference on Artificial Intelligence, Canadian AI 2012, P325, DOI 10.1007/978-3-642-30353-1_31; Kim K-n, 1996, ADV MOTOR LEARNING C, P1; King MA, 2005, J BIOMECH, V38, P145, DOI 10.1016/j.jbiomech.2004.02.039; Koh M, 2007, J BIOMECH, V40, P1256, DOI 10.1016/j.jbiomech.2006.05.027; Koschorreck J, 2009, COMPUTER METHODS S1, V12, P157; Lee MD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096431, 10.1371/journal.pone.0104744]; Manning ML, 2011, SPORT BIOMECH, V10, P161, DOI 10.1080/14763141.2011.592208; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Mejovsek M, 2004, IASTED INT C BIOM HO; Moreno FJ, 2002, PERCEPT MOTOR SKILL, V95, P901, DOI 10.2466/PMS.95.7.901-902; Mosscrop E, 2013, BRIT J SPORT MED, V47, pe4; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Prassas SG, 1995, 23 INT S BIOM SPORTS; Prassas S, 2006, SPORT BIOMECH, V5, P261, DOI 10.1080/14763140608522878; Reinkensmeyer DJ, 2009, EXERC SPORT SCI REV, V37, P43, DOI 10.1097/JES.0b013e3181912108; Sekulic D, 2014, PERCEPT MOTOR SKILL, V118, P447, DOI 10.2466/25.10.PMS.118k16w4; Sheets AL, 2008, J BIOMECH, V41, P3139, DOI 10.1016/j.jbiomech.2008.08.027; Takei Y, 2000, J SPORT SCI, V18, P849, DOI 10.1080/026404100750017788; Takei Y, 2010, JAB, V8; Takei Y, 2007, J APPL BIOMECH, V23, P1; Tordi N., 2006, GYMTECHNIC, V55; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yeadon MR, 1997, AM J SPORT MED, V25, P575, DOI 10.1177/036354659702500423	49	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0172083	10.1371/journal.pone.0172083	http://dx.doi.org/10.1371/journal.pone.0172083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422954	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600005
J	Passamani, LZ; Barbosa, RR; Reis, RS; Heringer, AS; Rangel, PL; Santa-Catarina, C; Grativol, A; Veiga, CFM; Souza, GA; Silveira, V				Passamani, Lucas Z.; Barbosa, Roberta R.; Reis, Ricardo S.; Heringer, Angelo S.; Rangel, Patricia L.; Santa-Catarina, Claudete; Grativol, Aide; Veiga, Carlos F. M.; Souza-Filho, Goncalo A.; Silveira, Vanildo			Salt stress induces changes in the proteomic profile of micropropagated sugarcane shoots	PLOS ONE			English	Article							PROTEIN-KINASE CONFERS; PHOSPHOLIPASE-D; ABIOTIC STRESS; ANTIOXIDANT MACHINERY; ARABIDOPSIS-THALIANA; BIOCHEMICAL-CHANGES; ENHANCED TOLERANCE; PHOSPHATIDIC-ACID; PLANT DEVELOPMENT; GENETIC-VARIATION	Salt stress is one of the most common stresses in agricultural regions worldwide. In particular, sugarcane is affected by salt stress conditions, and no sugarcane cultivar presently show high productivity accompanied by a tolerance to salt stress. Proteomic analysis allows elucidation of the important pathways involved in responses to various abiotic stresses at the biochemical and molecular levels. Thus, this study aimed to analyse the proteomic effects of salt stress in micropropagated shoots of two sugarcane cultivars (CB38-22 and RB855536) using a label-free proteomic approach. The mass spectrometry proteomics data are available via ProteomeXchange with identifier PXD006075. The RB855536 cultivar is more tolerant to salt stress than CB38-22. A quantitative label-free shotgun proteomic analysis identified 1172 non-redundant proteins, and 1160 of these were observed in both cultivars in the presence or absence of NaCl. Compared with CB38-22, the RB855536 cultivar showed a greater abundance of proteins involved in non-enzymatic antioxidant mechanisms, ion transport, and photosynthesis. Some proteins, such as calcium-dependent protein kinase, photosystem I, phospholipase D, and glyceraldehyde-3-phosphate dehydrogenase, were more abundant in the RB855536 cultivar under salt stress. Our results provide new insights into the response of sugarcane to salt stress, and the changes in the abundance of these proteins might be important for the acquisition of ionic and osmotic homeostasis during exposure to salt stress.	[Passamani, Lucas Z.; Barbosa, Roberta R.; Reis, Ricardo S.; Heringer, Angelo S.; Rangel, Patricia L.; Souza-Filho, Goncalo A.; Silveira, Vanildo] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Passamani, Lucas Z.; Barbosa, Roberta R.; Reis, Ricardo S.; Heringer, Angelo S.; Rangel, Patricia L.; Souza-Filho, Goncalo A.; Silveira, Vanildo] Univ Estadual N Fluminen, Setor Genom & Prote, Unidade Biol Integrat, Campos dos Goytacazes, RJ, Brazil; [Santa-Catarina, Claudete] Univ Estadual N Fluminen, CBB, Labo Biol Celular & Tecidual, Campos dos Goytacazes, RJ, Brazil; [Grativol, Aide] Univ Estadual N Fluminen, CBB, Lab Quim & Funcao Prot & Peptideos, Campos dos Goytacazes, RJ, Brazil; [Veiga, Carlos F. M.] Univ Fed Rural Rio de Janeiro Campus Campos dos G, Lab Culture Tecidos Vegetais Biofabr, Campos Dos Goytacazes, RJ, Brazil	Universidade Estadual do Norte Fluminense	Silveira, V (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.; Silveira, V (corresponding author), Univ Estadual N Fluminen, Setor Genom & Prote, Unidade Biol Integrat, Campos dos Goytacazes, RJ, Brazil.	vanilcio@uenf.br	Passamani, Lucas/N-7213-2019; Heringer, Angelo S/M-8275-2014; Santa-Catarina, Claudete/L-5531-2014; Heringer, Angelo/S-3033-2019; Silveira, Vanildo/E-8887-2011; de Souza Filho, Goncalo/S-7251-2017	Heringer, Angelo S/0000-0002-2723-7353; Santa-Catarina, Claudete/0000-0002-1669-660X; Heringer, Angelo/0000-0002-2723-7353; Silveira, Vanildo/0000-0001-5697-6932; Reis, Ricardo/0000-0002-9683-8195; de Souza Filho, Goncalo/0000-0003-1028-4425; Grativol, Clicia/0000-0002-8873-701X	Carlos Chagas Filho Foundation [E26/201.574/2014, E26/110.058/2014, E26/010.001752/2015]; National Council for Scientific and Technological Development-CNPq [454451/2014-8, 304997/20137]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Carlos Chagas Filho Foundation; National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grant numbers: E26/201.574/2014, E26/110.058/2014 and E26/010.001752/2015 - Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro FAPERJ - www.faperj.br; grant numbers: 454451/2014-8 and 304997/20137 National Council for Scientific and Technological Development-CNPq - www.mpg.br. Scholarships were provided by the Coordination for the Improvement of Higher Education Personnel (CAPES) to LZP, RSR, and AHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2012, J PROTEOMICS, V75, P4588, DOI 10.1016/j.jprot.2012.03.055; Amara I, 2013, J PLANT PHYSIOL, V170, P864, DOI 10.1016/j.jplph.2013.01.004; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; Azevedo R. A., 2011, Tropical Plant Biology, V4, P42, DOI 10.1007/s12042-011-9067-4; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Barkla BJ, 2013, PROTEOMICS, V13, P1801, DOI 10.1002/pmic.201200401; Basnayake J, 2012, J EXP BOT, V63, P6023, DOI 10.1093/jxb/ers251; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P75, DOI 10.1007/978-90-481-3112-9_4; Brasil Ridesa, 2010, CAT NAC VAR RB CANA, P136; Bressan RA, 1998, TRENDS PLANT SCI, V3, P411, DOI 10.1016/S1360-1385(98)01331-4; Campo S, 2014, PLANT PHYSIOL, V165, P688, DOI 10.1104/pp.113.230268; Capriotti AL, 2014, ANAL BIOANAL CHEM, V406, P1423, DOI 10.1007/s00216-013-7549-y; Chang LL, 2015, PLANT SCI, V236, P223, DOI 10.1016/j.plantsci.2015.04.010; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Abreu Carlos E.B. de, 2008, Braz. J. Plant Physiol., V20, P105, DOI 10.1590/S1677-04202008000200003; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Distefano AM, 2012, PLANTA, V236, P1899, DOI 10.1007/s00425-012-1745-4; Errabii T, 2007, ACTA PHYSIOL PLANT, V29, P95, DOI 10.1007/s11738-006-0006-1; FAO, 2013, FAOSTAT CROP PROD; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Ford KL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00044; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Halperin SJ, 2003, J EXP BOT, V54, P2035, DOI 10.1093/jxb/erg219; Hanafy MS, 2013, PLANT CELL REP, V32, P663, DOI 10.1007/s00299-013-1401-x; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Heringer AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127803; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Jain S, 2012, PLANT CELL TISS ORG, V109, P19, DOI 10.1007/s11240-011-0069-6; Kamal AHM, 2015, J PROTEOMICS, V112, P1, DOI 10.1016/j.jprot.2014.08.014; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Lizana C, 2006, J EXP BOT, V57, P685, DOI 10.1093/jxb/erj062; Martin V, 2009, FEBS LETT, V583, P3425, DOI 10.1016/j.febslet.2009.09.055; Medeiros CD, 2014, ACTA PHYSIOL PLANT, V36, P447, DOI 10.1007/s11738-013-1425-4; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Mostek A, 2015, J PLANT PHYSIOL, V174, P166, DOI 10.1016/j.jplph.2014.08.020; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murad AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098463; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nogueira FTS, 2003, PLANT PHYSIOL, V132, P1811, DOI 10.1104/pp.102.017483; Pacheco CM, 2013, J PROTEOME RES, V12, P5681, DOI 10.1021/pr400654a; Patade VY, 2012, MOL BIOL REP, V39, P3311, DOI 10.1007/s11033-011-1100-z; Perales M, 2004, PLANT MOL BIOL, V56, P947, DOI 10.1007/s11103-004-6324-z; Poonsawat W, 2015, PROTOPLASMA, V252, P231, DOI 10.1007/s00709-014-0676-2; Probst AV, 2015, CURR OPIN PLANT BIOL, V27, P8, DOI 10.1016/j.pbi.2015.05.011; Rausell A, 2003, PLANT J, V34, P257, DOI 10.1046/j.1365-313X.2003.01719.x; Reis RS, 2016, J PROTEOMICS, V130, P170, DOI 10.1016/j.jprot.2015.09.029; Rius SP, 2008, PLANT PHYSIOL, V148, P1655, DOI 10.1104/pp.108.128769; Rodziewicz P, 2014, ACTA PHYSIOL PLANT, V36, P1, DOI 10.1007/s11738-013-1402-y; Rustagi A, 2015, MOL BIOTECHNOL, V57, P27, DOI 10.1007/s12033-014-9798-1; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Shomeili M, 2011, AFR J BIOTECHNOL, V10, P9337; Sousa JAGC., 1956, BRASIL ACUACAREIRO R, V67, P109; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; The International Organization for Standardization (ISO), 2012, Q MARK OUTL; Vitamvas P, 2012, PROTEOMICS, V12, P68, DOI 10.1002/pmic.201000779; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Wakeel A, 2011, J PLANT PHYSIOL, V168, P519, DOI 10.1016/j.jplph.2010.08.016; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yu HQ, 2015, PLANTA, V242, P1495, DOI 10.1007/s00425-015-2390-5; Yu XC, 2007, PLANT MOL BIOL, V64, P531, DOI 10.1007/s11103-007-9172-9; Zabaleta E, 2012, PLANT SCI, V187, P97, DOI 10.1016/j.plantsci.2012.02.001; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	84	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176076	10.1371/journal.pone.0176076	http://dx.doi.org/10.1371/journal.pone.0176076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419154	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200069
J	Doodnaught, GM; Monteiro, BP; Benito, J; Edge, D; Beaudry, F; Pelligand, L; Steagall, P				Doodnaught, Graeme M.; Monteiro, Beatriz P.; Benito, Javier; Edge, Daniel; Beaudry, Francis; Pelligand, Ludovic; Steagall, Paulo			Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats	PLOS ONE			English	Article							THERMAL THRESHOLD; SAMPLING SITE; MORPHINE; ANTINOCICEPTION; DEXMEDETOMIDINE; BUTORPHANOL; COMBINATION; ABSORPTION; PROFILES	Background The aim of this study was to describe the joint pharmacokinetic-pharmacodynamic model and evaluate thermal antinociception of a high-concentration formulation of buprenorphine (Simbadol (TM)) in cats. Methods Six healthy cats (4.9 +/- 0.7 kg) were included in a prospective, randomized, blinded, crossover study. Simbadol (TM) (1.8 mg mL(-1)) was administered by the subcutaneous (SC; 0.24 mg kg(-1)), intravenous (IV; 0.12 mg kg(-1)) or buccal (OTM; 0.12 mg kg(-1)) route of administration and thermal thresholds (TT) were compared with a saline group (SAL). Thermal threshold testing and blood sampling were performed at predetermined time points up to 72 hours including a placebo group. Plasma buprenorphine and norbuprenorphine concentrations were measured using liquid chromatography mass spectrometry. A bespoke bicompartmental pharmacokinetic model simultaneously fitted data from two analytes/ three routes of administration. Temporal changes in TT were analyzed using one-way ANOVA followed by Dunnett's test and treatment comparisons using two-way ANOVA with Bonferroni's correction (P < 0.05). Results Thermal thresholds were significantly increased after SC, IV and OTM from 1-24 hours (except 2 hours), 0.5-8 hours (except 6 hours), and 1-8 hours (except 6 hours), respectively, when compared with baseline. Thermal thresholds were significantly increased after SC (1- 30 hours), IV (1-8 hours) and OTM (1-12 hours) when compared with SAL, but not different among buprenorphine- treated cats. The absolute buprenorphine clearance was 0.98 L Kg(-1) hour(-1), volume of distribution at steady state was 7.9 L kg(-1) and the elimination-half-life was 12.3 hours. Bioavailability for SC and OTM was 94% and 24%, respectively. Subcutaneous absorption was biphasic. An initial peak (0.08 hours) was followed by a slow (half-life 11.2 hours) and progressive (peak acceleration at 2.8 hours) uptake. Conclusion The SC administration of Simbadol T was characterized by prolonged absorption half-life and sustained plasma concentrations yielding long-lasting antinociception (>= 24 hours) when compared with the IV and OTM routes.	[Doodnaught, Graeme M.; Benito, Javier; Steagall, Paulo] Univ Montreal, Fac Med Vet, Dept Sci Clin, St Hyacinthe, PQ, Canada; [Monteiro, Beatriz P.; Beaudry, Francis; Steagall, Paulo] Univ Montreal, Fac Med Vet, Dept Biomed Vet, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada; [Edge, Daniel] Zoetis Inc, Florham Pk, NJ USA; [Pelligand, Ludovic] Royal Vet Coll, Dept Clin Sci & Serv, N Mymms, Herts, England	Universite de Montreal; Universite de Montreal; Zoetis; University of London; University of London Royal Veterinary College	Steagall, P (corresponding author), Univ Montreal, Fac Med Vet, Dept Sci Clin, St Hyacinthe, PQ, Canada.; Steagall, P (corresponding author), Univ Montreal, Fac Med Vet, Dept Biomed Vet, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada.	psteagall@gmail.com	Steagall, Paulo/W-6043-2019; Beaudry, Francis/A-9462-2012; Monteiro, Beatriz/W-7596-2019	Steagall, Paulo/0000-0003-4150-6043; Beaudry, Francis/0000-0001-5403-7333; Monteiro, Beatriz/0000-0002-5722-5687; Pelligand, Ludovic/0000-0001-6005-1975	Zoetis; Vanier Canada Graduate Scholarship	Zoetis; Vanier Canada Graduate Scholarship	This study was funded by Zoetis; principal investigator Dr. Paulo Steagall. Zoetis reviewed the proposal, approved the study design, authorized data and manuscript publication. Dr. Daniel Edge is an employee of Zoetis who has participated in the conceptualization, funding acquisition, development of methodology and preparation of manuscript. Dr. Beatriz Monteiro is a recipient of the Vanier Canada Graduate Scholarship.	Center for Drug Evaluation and Research (CDER) Center of Veterinary Medicine (CVM), 2013, GUID IND BIOAN METH; Dixon MJ, 2002, RES VET SCI, V72, P205, DOI 10.1053/rvsc.2001.0543; Ellis SLH, 2013, J FELINE MED SURG, V15, P219, DOI 10.1177/1098612X13477537; Gabrielsson J, 2006, PHARMACOKINETIC PHAR, P11; Gaudreault F, 2012, J PHARMACOKINET PHAR, V39, P635, DOI 10.1007/s10928-012-9275-z; Hedges AR, 2014, J VET PHARMACOL THER, V37, P252, DOI 10.1111/jvp.12084; Hedges AR, 2014, J VET PHARMACOL THER, V37, P145, DOI 10.1111/jvp.12075; Johnson JA, 2007, AM J VET RES, V68, P699, DOI 10.2460/ajvr.68.7.699; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Messenger KM, 2011, VET ANAESTH ANALG, V38, P374, DOI 10.1111/j.1467-2995.2011.00613.x; Niedfeldt RL, 2006, VET ANAESTH ANALG, V33, P381, DOI 10.1111/j.1467-2995.2005.00275.x; Pelligand L, 2016, CPT-PHARMACOMET SYST, V5, P625, DOI 10.1002/psp4.12141; Robertson SA, 2005, J VET PHARMACOL THER, V28, P453, DOI 10.1111/j.1365-2885.2005.00677.x; Robertson SA, 2003, VET REC, V153, P462, DOI 10.1136/vr.153.15.462; Sadiq MW, 2013, J PHARM SCI-US, V102, P3320, DOI 10.1002/jps.23492; SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358; Slingsby LS, 2008, J VET PHARMACOL THER, V31, P135, DOI 10.1111/j.1365-2885.2007.00931.x; Slingsby LS, 2012, VET J, V192, P523, DOI 10.1016/j.tvjl.2011.09.008; Slingsby LS, 2010, VET ANAESTH ANALG, V37, P162, DOI 10.1111/j.1467-2995.2009.00519.x; Steagall PVM, 2006, J VET PHARMACOL THER, V29, P531, DOI 10.1111/j.1365-2885.2006.00800.x; Steagall PVM, 2014, J VET INTERN MED, V28, P762, DOI 10.1111/jvim.12346; Steagall PVM, 2013, VET ANAESTH ANALG, V40, P83, DOI 10.1111/j.1467-2995.2012.00779.x; Taylor PM, 2001, J VET PHARMACOL THER, V24, P391, DOI 10.1046/j.1365-2885.2001.368goblin.x; Taylor PM, 2016, J FELINE MED SURG, V18, P290, DOI 10.1177/1098612X15581206; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Yassen A, 2007, J PHARMACOL EXP THER, V321, P598, DOI 10.1124/jpet.106.115972; Zhou HH, 2003, J CLIN PHARMACOL, V43, P211, DOI 10.1177/0091270002250613	27	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176443	10.1371/journal.pone.0176443	http://dx.doi.org/10.1371/journal.pone.0176443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445495	Green Submitted, gold, Green Published			2022-12-27	WOS:000400309200062
J	Liu, YL; Wu, S; Liu, ZZ; Chao, H				Liu, Yongli; Wu, Shuai; Liu, Zhizhong; Chao, Hao			A fuzzy co-clustering algorithm for biomedical data	PLOS ONE			English	Article							INFORMATION BOTTLENECK; DOCUMENTS	Fuzzy co-clustering extends co-clustering by assigning membership functions to both the objects and the features, and is helpful to improve clustering accurarcy of biomedical data. In this paper, we introduce a new fuzzy co-clustering algorithm based on information bottleneck named ibFCC. The ibFCC formulates an objective function which includes a distance function that employs information bottleneck theory to measure the distance between feature data point and the feature cluster centroid. Many experiments were conducted on five biomedical datasets, and the ibFCC was compared with such prominent fuzzy (co-)clustering algorithms as FCM, FCCM, RFCC and FCCI. Experimental results showed that ibFCC could yield high quality clusters and was better than all these methods in terms of accuracy.	[Liu, Yongli; Wu, Shuai; Liu, Zhizhong; Chao, Hao] Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Liu, YL (corresponding author), Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China.	yongli.buaa@gmail.com			Natural Science Foundation of China [61202286]; Foundation for University Key Teacher by Henan Province [015GGJS-068]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for University Key Teacher by Henan Province	The authors gratefully acknowledge that this research work was supported by fundings from Natural Science Foundation of China under Frant no. 61202286 (http://www.nsfc.gov.cn/) and Foundation for University Key Teacher by Henan Province under Grant no. 2015GGJS-068(http:// www.haedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache Kevin, 2013, UCI MACHINE LEARNING; Bezdek J. C., 1981, PATTERN RECOGN, V22, P203; Chen XJ, 2013, IEEE T KNOWL DATA EN, V25, P932, DOI 10.1109/TKDE.2011.262; de Carvalho FD, 2015, NEUROCOMPUTING, V163, P115, DOI 10.1016/j.neucom.2014.11.083; Deng ZH, 2016, INFORM SCIENCES, V348, P84, DOI 10.1016/j.ins.2016.01.101; Gupta N, 2010, PATTERN RECOGN, V43, P2692, DOI 10.1016/j.patcog.2010.03.002; Hammouda KM, 2004, IEEE T KNOWL DATA EN, V16, P1279, DOI 10.1109/TKDE.2004.58; Hanmandlu M, 2013, NEUROCOMPUTING, V120, P235, DOI 10.1016/j.neucom.2012.09.043; Hersh W, 1994, OHSUMED INTERACTIVE, P192; Honda K, 2012, INT J COMPUTER SCI N; HONG ZQ, 1991, PATTERN RECOGN, V24, P317, DOI 10.1016/0031-3203(91)90074-F; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Liu Y, 2012, RES INCREMENTAL CLUS, P2803; Liu YL, 2016, J BEIJING U POSTS TE; Liu YL, 2016, J BIOMED INFORM, V62, P48, DOI 10.1016/j.jbi.2016.05.009; Liu YF, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/795101; Mei JP, 2014, IEEE INT FUZZY SYST, P1518, DOI 10.1109/FUZZ-IEEE.2014.6891554; Oh CH, 2001, FUZZY CLUSTERING CAT, V2154, P2154; Rashedi E, 2015, NEUROCOMPUTING, V148, P487, DOI 10.1016/j.neucom.2014.07.014; Saha A, 2015, NEUROCOMPUTING, V166, P422, DOI 10.1016/j.neucom.2015.03.037; Slonim N, 2000, DOCUMENT CLUSTERING, P208; Slonim N, 2002, UNSUPERVISED DOCUMEN, P129; Tjhi WC, 2006, PATTERN RECOGN LETT, V27, P151, DOI 10.1016/j.patrec.2005.07.012; Tjhi WC, 2007, ROBUST FUZZY COCLUST, P1; Tjhi WC, 2007, PATTERN RECOGN, V40, P3452, DOI 10.1016/j.patcog.2007.04.017; Ucar D, 2006, LECT NOTES COMPUTER, V363, P371; Wan XJ, 2007, INFORM SCIENCES, V177, P3718, DOI 10.1016/j.ins.2007.02.045; Wikaisuksakul S, 2014, APPL SOFT COMPUT, V24, P679, DOI 10.1016/j.asoc.2014.08.036; Yan Y, 2013, FUZZY SET SYST, V215, P74, DOI 10.1016/j.fss.2012.10.016; Ye YD, 2015, PATTERN RECOGN LETT, V51, P70, DOI 10.1016/j.patrec.2014.08.007	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176536	10.1371/journal.pone.0176536	http://dx.doi.org/10.1371/journal.pone.0176536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445496	Green Published, gold, Green Submitted			2022-12-27	WOS:000400309200071
J	Dharmarajan, K; Foster, J; Coylewright, M; Green, P; Vavalle, JP; Faheem, O; Huang, PH; Krishnaswamy, A; Thourani, VH; McCoy, LA; Wang, TY				Dharmarajan, Kumar; Foster, Jill; Coylewright, Megan; Green, Philip; Vavalle, John P.; Faheem, Osman; Huang, Pei-Hsiu; Krishnaswamy, Amar; Thourani, Vinod H.; McCoy, Lisa A.; Wang, Tracy Y.			The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers	PLOS ONE			English	Article							OF-LIFE CARE; INTERMEDIATE-RISK; ELDERLY-PATIENTS; PALLIATIVE CARE; NATURAL-HISTORY; BAD-NEWS; TRANSCATHETER; REPLACEMENT; OUTCOMES; COMMUNICATION	Background Little is known about patients with severe symptomatic aortic stenosis (AS) who receive medical management despite evaluation at a heart valve treatment center. Objective We identified patient characteristics associated with medical management, physicianreported reasons for selecting medical management, and patients' perceptions of their involvement and satisfaction with treatment selection. Methods and results Of 454 patients evaluated for AS at 9 established heart valve treatment centers from December 12, 2013 to August 19, 2014, we included 407 with severe symptomatic AS. Information was collected using medical record review and survey of patients and treating physicians. Of 407 patients, 212 received transcatheter aortic valve replacement (TAVR), 124 received surgical aortic valve replacement (SAVR), and 71 received medical management (no SAVR/TAVR). Thirty-day predicted mortality was higher in patients receiving TAVR (8.7%) or medical management (9.8%) compared with SAVR (3.4%) (P< 0.001). Physician- reported reasons for medical management included patient preference (31.0%), medical futility (19.7%), inoperability/anatomic infeasibility (11.3%), and inadequate vascular access (8.5%). Compared with patients receiving AVR, medically managed patients were less likely to report that they received enough information about the pros and cons of treatment options (P = 0.03), that their physicians involved them in treatment decisions (P< 0.001), and that final decisions were the right ones (P< 0.001). Conclusions Patient preference was the most common physician-reported reason for selecting non-invasive AS management, yet patients not undergoing AVR after valve center evaluation reported being less likely to receive sufficient education about treatment options and more likely to feel uncertain about final treatment decisions. Greater attention to shared decision making may improve the experience of care for this vulnerable group of patients.	[Dharmarajan, Kumar] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Dharmarajan, Kumar] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Foster, Jill] Amer Coll Cardiol, Washington, DC USA; [Coylewright, Megan] Dartmouth Hitchcock Med Ctr, Sect Cardiovasc Med, Lebanon, NH 03766 USA; [Green, Philip] Columbia Univ, Div Cardiol, Ctr Intervent Vasc Therapy, Med Ctr, New York, NY USA; [Vavalle, John P.] Univ North Carolina Chapel Hill, Div Cardiol, Dept Med, Chapel Hill, NC USA; [Faheem, Osman] Prima Care Cardiol, Fall River, MA USA; [Huang, Pei-Hsiu] Sutter Heart & Vasc Inst, Sacramento, CA USA; [Krishnaswamy, Amar] Cleveland Clin, Dept Cardiovasc Med, Div Intervent Cardiol, Inst Heart & Vasc, Cleveland, OH 44106 USA; [Thourani, Vinod H.] Emory Univ, Sch Med, Div Cardiothorac Surg, Atlanta, GA 30322 USA; [McCoy, Lisa A.; Wang, Tracy Y.] Duke Clin Res Inst, Durham, NC USA	Yale University; American College of Cardiology; Dartmouth College; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cleveland Clinic Foundation; Emory University; Duke University	Dharmarajan, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Dharmarajan, K (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	kumar.dharmarajan@yale.edu	thourani, vinod/AAP-5968-2020	Douglas, Pamela/0000-0001-9876-4049	Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific; Medtronic; St. Jude Medical; National Institute on Aging [K23AG048331]; American Federation for Aging Research; National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; National Heart, Lung, and Blood Institute [K23HL12114]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL121142] Funding Source: NIH RePORTER	Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific(Boston Scientific); Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by unrestricted educational grants to the ACC from the Edwards Lifesciences Fund, Edwards Lifesciences, Boston Scientific (to KD), Medtronic (to KD), and St. Jude Medical (to KD). Dr. Dharmarajan is supported by grant K23AG048331 from the National Institute on Aging and the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. He is also supported by grant P30AG021342 from the National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center. Dr. Green is supported by grant K23HL12114 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific; Medtronic; St. Jude Medical; the National Institute on Aging; the National Heart, Lung, and Blood Institute; or the American Federation for Aging Research.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Adams K, 2012, J AM GERIATR SOC, V60, P2333, DOI 10.1111/j.1532-5415.2012.04240.x; Adler ED, 2009, CIRCULATION, V120, P2597, DOI 10.1161/CIRCULATIONAHA.109.869123; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Bach DS, 2007, J AM COLL CARDIOL, V50, P2018, DOI 10.1016/j.jacc.2007.08.011; Back A, 2010, MASTERING COMMUNICAT; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Charlson E, 2006, J HEART VALVE DIS, V15, P312; CHEITLIN MD, 1979, AM HEART J, V98, P689, DOI 10.1016/0002-8703(79)90465-4; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Coylewright M, 2016, HEALTH EXPECT, V19, P1036, DOI 10.1111/hex.12393; Coylewright M, 2015, J AM COLL CARDIOL, V65, P1472, DOI 10.1016/j.jacc.2015.02.033; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; Fang JC, 2015, J CARD FAIL, V21, P519, DOI 10.1016/j.cardfail.2015.04.013; Fujimori M, 2014, J CLIN ONCOL, V32, P2166, DOI 10.1200/JCO.2013.51.2756; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Goodlin SJ, 2009, J AM COLL CARDIOL, V54, P386, DOI 10.1016/j.jacc.2009.02.078; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holmes DR, 2015, JAMA-J AM MED ASSOC, V313, P1019, DOI 10.1001/jama.2015.1474; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kelley AS, 2012, J AM GERIATR SOC, V60, P332, DOI 10.1111/j.1532-5415.2011.03787.x; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Lauck S, 2014, EUR J CARDIOVASC NUR, V13, P177, DOI 10.1177/1474515114520770; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; OTTO CM, 1989, J AM COLL CARDIOL, V13, P545, DOI 10.1016/0735-1097(89)90590-1; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Tulsky JA, 2015, JAMA INTERN MED, V175, P840, DOI 10.1001/jamainternmed.2014.8425; van Geldorp MWA, 2009, EUR J CARDIO-THORAC, V35, P953, DOI 10.1016/j.ejcts.2009.01.043; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wachterman MW, 2016, JAMA INTERN MED, V176, P1095, DOI 10.1001/jamainternmed.2016.1200; Whellan DJ, 2014, J CARD FAIL, V20, P121, DOI 10.1016/j.cardfail.2013.12.003	44	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175926	10.1371/journal.pone.0175926	http://dx.doi.org/10.1371/journal.pone.0175926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430791	gold, Green Published			2022-12-27	WOS:000399876100022
J	Gopal, A; Chidambaram, IS; Devaraj, N; Devaraj, H				Gopal, Ashidha; Chidambaram, Iyer Soumya; Devaraj, Niranjali; Devaraj, Halagowder			Shigella dysenteriae infection activates proinflammatory response through beta-catenin/NF-kappa B signaling pathway	PLOS ONE			English	Article							INTESTINAL STEM-CELLS; EPITHELIAL-CELLS; MESSENGER-RNA; INTERLEUKIN-8; INFLAMMATION; MACROPHAGES; EXPRESSION; DIFFERENTIATION; CROSSTALK; CANCER	Shigella dysenteriae (S.dysenteriae) the causative agent of bacillary dysentery invades the human colonic epithelium resulting in severe intestinal inflammatory response and epithelial destruction. However, the mechanism by which S.dysenteriae infection regulates proinflammatory cytokines during intestinal inflammation is still obscure. In this study, we evaluated whether the interaction of beta-catenin and NF-kappa B regulates proinflammatory cytokines TNF-alpha and IL-8 by modulating GSK-3 beta activity during S.dysenteriae infection in rat ileal loop model. Here we demonstrated that S.dysenteriae infection stimulate beta-catenin degradation which in turn decreased the association between NF-kappa B and beta-catenin. Also, we showed that S.dysenteriae infection increased GSK-3 beta kinase activity which in turn phosphorylates beta-catenin for its degradation by ubiquitination and upregulates IL-8 through NF-kappa B activation thereby leading to inflammation. Thus these findings revealed the role of beta-catenin/NF-kappa B and GSK-3 beta in modulating the inflammatory response during bacterial infection and also showed that beta-catenin acts as a critical regulator of inflammation.	[Gopal, Ashidha; Chidambaram, Iyer Soumya; Devaraj, Halagowder] Univ Madras, Dept Zool, Unit Biochem, Madras, Tamil Nadu, India; [Devaraj, Niranjali] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India; [Chidambaram, Iyer Soumya] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA	University of Madras; University of Madras; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Devaraj, H (corresponding author), Univ Madras, Dept Zool, Unit Biochem, Madras, Tamil Nadu, India.	hdrajum@yahoo.com						BARKER JNWN, 1991, AM J PATHOL, V139, P869; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; GILLITZER R, 1991, J INVEST DERMATOL, V97, P73, DOI 10.1111/1523-1747.ep12478128; Gomez HF, 2002, INFECT IMMUN, V70, P7050, DOI 10.1128/IAI.70.12.7050-7053.2002; Gopal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111408; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Prakash R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027046; Raja SB, 2012, J CELL SCI, V125, P703, DOI 10.1242/jcs.092148; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shaikh N, 2003, MICROB PATHOGENESIS, V35, P107, DOI 10.1016/S0882-4010(03)00093-7; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Udhayakumar G, 2011, MOL CELL BIOCHEM, V357, P283, DOI 10.1007/s11010-011-0899-x; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; Wang H, 2009, J OPTOELECTRON BIOME, V1, P1; Wang XH, 2004, ARTERIOSCL THROM VAS, V24, P85, DOI 10.1161/01.ATV.0000104012.40720.c4; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3	37	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174943	10.1371/journal.pone.0174943	http://dx.doi.org/10.1371/journal.pone.0174943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430783	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100008
J	Vicente, A; Ruiz, AJO; Paz, BMG; Lopez, JG; Bravo-Gonzalez, LA				Vicente, Ascension; Ortiz Ruiz, Antonio Jose; Gonzalez Paz, Belen Manuela; Garcia Lopez, Jose; Bravo-Gonzalez, Luis-Alberto			Efficacy of fluoride varnishes for preventing enamel demineralization after interproximal enamel reduction. Qualitative and quantitative evaluation	PLOS ONE			English	Article							HYDROXYAPATITE; RELEASE	Objectives To evaluate quantitatively and qualitatively the changes produced to enamel after interproximal reduction and subjected to demineralization cycles, after applying a fluoride varnish (Profluorid) and a fluoride varnish containing tricalcium phosphate modified by fumaric acid (Clinpro White). Materials and methods 138 interproximal dental surfaces were divided into six groups: 1) Intact enamel; 2) Intact enamel + demineralization cycles (DC); 3) Interproximal Reduction (IR); 4) IR + DC; 5) IR + Profluorid + DC; 6) IR + Clinpro White + DC. IR was performed with a 0.5 mm cylindrical diamond bur. The weight percentage of calcium (Ca), phosphorous (P) and fluoride (F) were quantified by energy-dispersive X-ray spectrometry (EDX). Samples were examined under scanning electron microscopy (SEM). Results The weight percentage of Ca was significantly higher (p < 0.05) in Groups 1, 2 and 5 than Groups 4 and 6. No significant differences were detected in the weight percentage of Ca between Group 3 and the other groups (p > 0.05). The weight percentage of P was similar among all six groups (p > 0.05). F was detected on 65% of Group 6 surfaces. SEM images of Groups 4 and 6 showed signs of demineralization, while Group 5 did not. Conclusions Profluorid application acts as a barrier against the demineralization of interproximally reduced enamel.	[Vicente, Ascension; Gonzalez Paz, Belen Manuela; Garcia Lopez, Jose; Bravo-Gonzalez, Luis-Alberto] Univ Murcia, Hosp Morales Meseguer, Dept Orthodont, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain; [Ortiz Ruiz, Antonio Jose] Univ Murcia, Hosp Morales Meseguer, Dept Integral Pediat Dent, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain	University of Murcia; University of Murcia	Vicente, A (corresponding author), Univ Murcia, Hosp Morales Meseguer, Dept Orthodont, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain.	ascenvi@um.es	BRAVO-GONZÁLEZ, LUIS-ALBERTO/S-5963-2016; Ortiz-Ruiz, Antonio J/M-2458-2018; Vicente, Ascensión/ABG-2404-2020	BRAVO-GONZÁLEZ, LUIS-ALBERTO/0000-0002-5141-4145; Ortiz-Ruiz, Antonio J/0000-0001-9113-8416; Vicente, Ascensión/0000-0002-7257-5124				Arman A, 2006, AM J ORTHOD DENTOFAC, V130, DOI 10.1016/j.ajodo.2006.01.021; Baumgartner S, 2015, PROG ORTHOD, V16, DOI 10.1186/s40510-014-0071-8; Bolis C, 2015, ORAL HLTH PREV DENT, V13, P545, DOI 10.3290/j.ohpd.a34373; Bonetti GA, 2014, SCANNING, V36, P356, DOI 10.1002/sca.21125; Cochrane N, 2014, AUST DENT J, V59, P100, DOI 10.1111/adj.12144; Cosio DJ, 2011, ORAL, V35, P642; Elkassas D, 2014, J DENT, V42, P466, DOI 10.1016/j.jdent.2013.12.017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giulio AB, 2009, J DENT, V37, P228, DOI 10.1016/j.jdent.2008.11.015; He B, 2011, ARCH ORAL BIOL, V56, P997, DOI 10.1016/j.archoralbio.2011.02.015; He B, 2010, ARCH ORAL BIOL, V55, P134, DOI 10.1016/j.archoralbio.2009.12.005; He T, 2016, AM J ORTHOD DENTOFAC, V149, P810, DOI 10.1016/j.ajodo.2015.12.010; Hellak AF, 2015, CLIN ORAL INVEST, V19, P1965, DOI 10.1007/s00784-015-1429-0; Jarjoura K, 2006, AM J ORTHOD DENTOFAC, V130, P26, DOI 10.1016/j.ajodo.2004.08.024; Kirschneck C, 2016, CLIN ORAL INVESTIG; Klockars A, 1986, SAGE U PAPER SERIES, P07; Lapenaite Egle, 2014, Stomatologija, V16, P19; Livas C, 2013, OPEN DENT J, V7, P146, DOI 10.2174/1874210601307010146; Llena-Puy Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE449; Medieiros MI Dantasde, 2016, BRAZ ORAL RES, V30, pe75; Mehta A, 2015, AM J ORTHOD DENTOFAC, V148, P814, DOI 10.1016/j.ajodo.2015.05.022; Oncag G, 2005, ANGLE ORTHOD, V75, P247; Paganelli C, 2015, SCANNING, V37, P73, DOI 10.1002/sca.21181; Patil Namrata, 2013, J Conserv Dent, V16, P116, DOI 10.4103/0972-0707.108185; Peng Y, 2016, DENT MATER J, V35, P756, DOI 10.4012/dmj.2015-398; Perrini F, 2016, AM J ORTHOD DENTOFAC, V149, P238, DOI 10.1016/j.ajodo.2015.07.039; Rossouw P Emile, 2003, J Can Dent Assoc, V69, P378; Shen P, 2015, AUST DENT J; Sheridan J J, 1985, J Clin Orthod, V19, P43; Wei J, 2011, J MATER SCI-MATER M, V22, P1607, DOI 10.1007/s10856-011-4327-2; Yoda A, 2006, DENT MATER J, V25, P261, DOI 10.4012/dmj.25.261; Zingler S, 2016, CLIN ORAL INVEST, V20, P933, DOI 10.1007/s00784-015-1585-2	32	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176389	10.1371/journal.pone.0176389	http://dx.doi.org/10.1371/journal.pone.0176389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430810	gold, Green Submitted, Green Published			2022-12-27	WOS:000399876100043
J	Allum, N; Allansdottir, A; Gaskell, G; Hampel, J; Jackson, J; Moldovan, A; Priests, S; Stares, S; Stoneman, P				Allum, Nick; Allansdottir, Agnes; Gaskell, George; Hampel, Jurgen; Jackson, Jonathan; Moldovan, Andreea; Priests, Susanna; Stares, Sally; Stoneman, Paul			Religion and the public ethics of stem-cell research: Attitudes in Europe, Canada and the United States	PLOS ONE			English	Article								We examine international public opinion towards stem-cell research during the period when the issue was at its most contentious. We draw upon representative sample surveys in Europe and North America, fielded in 2005 and find that the majority of people in Europe, Canada and the United States supported stem-cell research, providing it was tightly regulated, but that there were key differences between the geographical regions in the relative importance of different types of ethical position. In the U.S., moral acceptability was more influential as a driver of support for stem-cell research; in Europe the perceived benefit to society carried more weight; and in Canada the two were almost equally important. We also find that public opinion on stem-cell research was more strongly associated with religious convictions in the U.S. than in Canada and Europe, although many strongly religious citizens in all regions approved of stem-cell research. We conclude that if anything public opinion or 'public ethics' are likely to play an increasingly important role in framing policy and regulatory regimes for sensitive technologies in the future.	[Allum, Nick; Moldovan, Andreea] Univ Essex, Dept Sociol, Colchester, Essex, England; [Allansdottir, Agnes] Fdn Toscana Life Sci, Siena, Italy; [Gaskell, George; Jackson, Jonathan] London Sch Econ, Dept Methodol, London, England; [Hampel, Jurgen] Univ Stuttgart, Dept Sociol Technol & Environm, Stuttgart, Germany; [Stares, Sally] City Univ London, Dept Sociol, London, England; [Stoneman, Paul] Goldsmiths Coll, Dept Sociol, London, England	University of Essex; University of London; London School Economics & Political Science; University of Stuttgart; City University London; University of London; Goldsmiths University London	Allum, N (corresponding author), Univ Essex, Dept Sociol, Colchester, Essex, England.	nallum@essex.ac.uk	Jackson, Jonathan/C-5156-2008	Jackson, Jonathan/0000-0003-2426-2219; Allum, Nick/0000-0002-1746-2514; Allansdottir, Agnes/0000-0003-0961-2380	project 'Sensitive Technologies and European Public Ethics' (STEPE) - European Commission Seventh Framework Programme [217815]; Economic and Social Research Council PhD Bursary	project 'Sensitive Technologies and European Public Ethics' (STEPE) - European Commission Seventh Framework Programme; Economic and Social Research Council PhD Bursary	Authors AA, GG, NA, JH, JJ, PS and SS were partially supported by the project 'Sensitive Technologies and European Public Ethics' (STEPE), funded by the European Commission Seventh Framework Programme, grant number 217815. AM was partially funded by an Economic and Social Research Council PhD Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allum N, 2013, RELIG BELIEFS KNOWLE; Angus Reid Public Opinion, 2013, AM MOR MOR CONS CAN; [Anonymous], 2011, SACRED SECULAR RELIG; Beckmann J, 2004, J MED PHILOS, V29, P603, DOI 10.1080/03605310490518113; Beltrame L., 2016, DEV WORLD BIOETHICS; Canadian Biotechnology Secretariat, 2005, INT PUBL OP RES EM T; Center N. O. R, 2015, GEN SOC SURV 1972 20; Committee on Genetically Engineered Crops, 2016, EXP FUT PROSP; Cookson C, 2012, FINANCIAL TIMES; EINSIEDEL Edna, 2002, BIOTECHNOLOGY MAKING; European Commission, 2005, SPEC EUR 225 SOC VAL; Funk C., 2016, POLITICS CLIMATE; Gaskell G, 2005, SCIENCE, V310, P1908, DOI 10.1126/science.1119444; Gaskell G., 2006, EUROPEANS BIOTECHNOL, V64; Gaskell G, 2011, NAT BIOTECHNOL, V29, P113, DOI 10.1038/nbt.1771; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hauskeller C, 2004, J MED PHILOS, V29, P509, DOI 10.1080/03605310490518104; HUDSON K, 2005, VALUES CONFLICT PUBL; Keyes R., 2004, POSTTRUTH ERA DISHON; Link HJ, 2013, SCI ENG ETHICS, V19, P435, DOI 10.1007/s11948-012-9353-z; Miller J.D., 1983, AM PEOPLE SCI POLICY; National Research Council, 2001, STEM CELLS FUT REG M; Nielsen TH, 2008, J MED ETHICS, V34, P852, DOI 10.1136/jme.2007.022236; Nisbet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088473; Obama Barack, 2009, REMOVING BARRIERS RE; President's Council on stem-cell Research, 2004, MON STEM CELL RES; Reardon S, 2015, NATURE, V528, P173, DOI 10.1038/528173a; Shepherd R, 2007, SOC SCI MED, V65, P377, DOI 10.1016/j.socscimed.2007.03.018; Smith Gregory A., 2015, AM CHANGING RELIG LA; SUDMAN S., 1996, THINKING ANSWERS APP; Thompson C, 2013, INSIDE TECHNOL, P1; Voas D, 2009, EUR SOCIOL REV, V25, P155, DOI 10.1093/esr/jcn044; Wadman M, 2006, NATURE, V442, P335, DOI 10.1038/442335a; Wald KennethD., 2014, RELIG POLITICS US	35	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176274	10.1371/journal.pone.0176274	http://dx.doi.org/10.1371/journal.pone.0176274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426812	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399875900126
J	Volpini, LPB; Boldrini, NAT; de Freitas, LB; Miranda, AE; Spano, LC				Bondi Volpini, Lays Paula; Tosato Boldrini, Neide Aparecida; de Freitas, Luciana Bueno; Miranda, Angelica Espinosa; Spano, Liliana Cruz			The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; ONCOGENIC HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; NUCLEOTIDE-SEQUENCE; CANCER; RISK; AMPLIFICATION; TYPE-16; LESIONS	Human Immunodeficiency Virus (HIV)-seropositive women are more likely to have anogenital cancer, and high risk-HPV (HR-HPV) infection is the main associated factor. Between August 2013 and December 2015, we conducted a descriptive study to determine the HPV genotypes and HPV16 variants in cervical and anal samples of HIV-seropositive women with a normal Pap test. The viral DNA was amplified by PCR using the PGMY09/11 set of primers. Reverse line blot (RLB), restriction fragment length polymorphism (RFLP) and sequencing assays were used to determine the HPV genotypes. HPV16 variants were identified by gene sequencing. We found a high frequency of HR-HPV (60.3%; 76/126) at the anogenital site among HIV-seropositive women and without association with anal intercourse. HPV16 and European variant predominated among the HR-HPV. Mixed infections with at least three different HPV types were common, particularly at the anal site. CD4+ T-cell counts below 500 cells/mm(3), a HIV viral load above 50 copies/mL and an age of 18 to 35 years old were all related to HPV anal infection. Our study showed a high frequency of HR-HPV in both cervical and anal sites of women with negative cytology belonging to a risk group for the development of anogenital cancer.	[Bondi Volpini, Lays Paula; Tosato Boldrini, Neide Aparecida; de Freitas, Luciana Bueno; Miranda, Angelica Espinosa; Spano, Liliana Cruz] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil; [Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Social Med, Vitoria, Brazil; [Spano, Liliana Cruz] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Pathol, Vitoria, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Volpini, LPB (corresponding author), Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil.	layspaula90@gmail.com	Miranda, Angelica/AAE-5571-2021	Miranda, Angelica/0000-0002-5556-8379	Research Foundation of Espirito Santo State - FAPES [54677300/2011]; CAPES Foundation; Ministry of Education of Brazil	Research Foundation of Espirito Santo State - FAPES; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil	This work was supported by the Research Foundation of Espirito Santo State - FAPES 54677300/2011 (https://fapes.es.gov.br/). The first author had a scholarship from CAPES Foundation, Ministry of Education of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Brasil Ministerio da Saude, 2015, PROTOCOLO CLINICO E; Brasil Ministerio da Saude/INCa, 2006, J BRAS PATOL MED LAB, V42, P351, DOI DOI 10.1590/S1676-24442006000500008; Bruni L., 2016, SUMMARY REPORT; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Cambou MC, 2015, AIDS PATIENT CARE ST, V29, P4, DOI 10.1089/apc.2014.0166; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen ZG, 2015, METHODS MOL BIOL, V1249, P3, DOI 10.1007/978-1-4939-2013-6_1; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cox T, 2006, GYNECOL ONCOL, V103, P8, DOI 10.1016/j.ygyno.2006.07.030; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Denny LA, 2005, BEST PRACT RES CL OB, V19, P501, DOI 10.1016/j.bpobgyn.2005.02.004; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Goncalves Maria Alice G, 2008, Infect Agent Cancer, V3, P5, DOI 10.1186/1750-9378-3-5; Goodman MT, 2011, J INFECT DIS, V203, P335, DOI 10.1093/infdis/jiq058; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hessol NA, 2013, AIDS, V27, P1743, DOI 10.1097/QAD.0b013e3283601b09; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Huang S Z, 1989, Yi Chuan Xue Bao, V16, P475; Keller MJ, 2015, CLIN INFECT DIS, V61, P1573, DOI 10.1093/cid/civ569; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Kojic EM, 2011, SEX TRANSM DIS, V38, P253, DOI 10.1097/OLQ.0b013e3181f70253; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Palefsky JM, 2003, JNCI MONOGRAPHS, V2003, P41, DOI DOI 10.1093/0XF0RDJ0URNALS.JNCIM0N0GRAPHS.A003481; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres M, 2015, J CLIN VIROL, V67, P47, DOI 10.1016/j.jcv.2015.04.005; Vanni T, 2012, INT J CANCER, V131, pE96, DOI 10.1002/ijc.26472; Wells JS, 2014, AIDS PATIENT CARE ST, V28, P350, DOI 10.1089/apc.2013.0358; World Health Organization, 2013, WHO GUIDELINES FOR S; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995	44	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176422	10.1371/journal.pone.0176422	http://dx.doi.org/10.1371/journal.pone.0176422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426837	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900130
J	Choo, CC; Harris, KM; Chew, PKH; Ho, RC				Choo, Carol C.; Harris, Keith M.; Chew, Peter K. H.; Ho, Roger C.			Does ethnicity matter in risk and protective factors for suicide attempts and suicide lethality?	PLOS ONE			English	Article							SELF-HARM; PARASUICIDE; BEHAVIORS; ADOLESCENTS; IDEATION; MODEL	This study explored ethnic differences in risk and protective factors for suicide attempts, for the major ethnic groups in Singapore, and ethnic differences in prediction of lethality. Three years of medical records related to suicide attempters (N = 666) who were admitted to the emergency department of a large teaching hospital in Singapore were subjected to analysis. Of the sample, 69.2% were female, 30.8% male; 63.8% Chinese, 15.8% Indian, and 15.0% Malay. Indians were over-represented in this sample, as compared with the ethnic distribution in the general population. Ages ranged from 10 to 85 years old (M = 29.7, SD = 16.1). Ethnic differences were found in risk and protective factors, and perceived lethality of suicide attempts. All available variables were subjected to regression analyses for Chinese, Indian and Malay attempters to arrive at parsimonious models for prediction of perceived lethality. The findings were discussed in regards to implications in assessment of suicide risk and primary prevention for the multiethnic society in Singapore.	[Choo, Carol C.; Chew, Peter K. H.] James Cook Univ, Coll Healthcare Sci, Singapore, Singapore; [Harris, Keith M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Harris, Keith M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Ho, Roger C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	University of Tasmania; University of Queensland; National University of Singapore	Choo, CC (corresponding author), James Cook Univ, Coll Healthcare Sci, Singapore, Singapore.	carol.choo@jcu.edu.au	Ho, Roger C./ABD-9061-2021; Harris, Keith M/K-9957-2013; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Harris, Keith M/0000-0002-1199-2856; Chew, Peter/0000-0002-5243-1481	James Cook University [CRT/2016/30]	James Cook University	Publication cost will be paid by internal research grant from James Cook University provided to CC, Research Grant Code: CRT/2016/30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, INT HDB SUICIDE ATTE; APPLEBY L, 1995, PSYCHOL MED, V25, P1087, DOI 10.1017/S0033291700037570; Beautrais A., 2007, AUSTR NZ J PSYCHIAT, V37, P395; BECK AT, 1989, J AFFECT DISORDERS, V17, P203, DOI 10.1016/0165-0327(89)90001-3; BECK AT, 1976, ARCH GEN PSYCHIAT, V33, P835; Bhugra Dinesh, 2002, Crisis, V23, P108, DOI 10.1027//0227-5910.23.3.108; Cervantes RC, 2014, J ADOLESCENT HEALTH, V55, P633, DOI 10.1016/j.jadohealth.2014.05.017; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Cheng A., 2000, INT HDB SUICIDE ATTE, P29, DOI DOI 10.1002/9780470698976.CH2; Chia B, 1999, TOO YOUNG ASIAN PERS; Chia B., 1981, SUICIDAL BEHAV SINGA; Chia B., 2001, AGE DESPAIR STUDY EL; Chia B-H, 2008, SUICIDE ASIA CAUSES, P101; Chong M., 1992, SUICIDAL BEHAV ASIA, P69; Choo C, 2014, STUD COMPUT INTELL, V491, P217, DOI 10.1007/978-3-642-38550-6_12; Choo C, 2014, ASIAN J PSYCHIATR, V8, P38, DOI 10.1016/j.ajp.2013.10.001; Chu J, 2014, J CLIN PSYCHOL, V70, P1211, DOI 10.1002/jclp.22082; Chu JP, 2010, APPL PREV PSYCHOL, V14, P25, DOI 10.1016/j.appsy.2011.11.001; de Moore GM, 1998, SUICIDE PREVENTION, P79; Dear GE, 1998, SUICIDE PREVENTION, P189; Dhossche DM, 2000, SOUTHERN MED J, V93, P310; Evans E, 2005, J ADOLESCENCE, V28, P573, DOI 10.1016/j.adolescence.2004.11.001; Fones C. S. L., 1998, SMJ, V39, P251; Foo XY, 2014, J RELIG HEALTH, V53, P731, DOI 10.1007/s10943-012-9667-9; GOLDNEY RD, 1987, AUST NZ J PSYCHIAT, V21, P3, DOI 10.1080/00048678709160893; Harris KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127442; Harris KM, 2014, DEATH STUD, V38, P387, DOI 10.1080/07481187.2013.768313; Immigration Checkpoint of Singapore ICA, 2015, ETHNICITY HLTH; Immigration Checkpoint of Singapore ICA, 2015, REP REG BIRTHS DEATH; Judd F, 2012, SOC PSYCH PSYCH EPID, V47, P1, DOI 10.1007/s00127-010-0306-z; Kok L., 1993, THE WISH TO DIE; Kua E., 1998, ETHNICITY HLTH, V3, P1; Lai D. W. L., 2016, J IMMIGRANT MINORITY; Langlois Stephanie, 2002, Health Rep, V13, P9; Lasrado RA, 2016, CRISIS, V37, P205, DOI 10.1027/0227-5910/a000379; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Leung CLK, 2016, COMMUNITY MENT HLT J, V52, P574, DOI 10.1007/s10597-015-9920-2; Loh M, 2007, CRISIS, V28, P148, DOI 10.1027/0227-5910.28.3.148; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; Mehta Kalyani, 1990, GIVING HOPE STUDY AT; Ministry of Health, 2013, SUIC SING; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; PENG KL, 1990, MED SCI LAW, V30, P225, DOI 10.1177/002580249003000311; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Pritchard C., 1995, SUICIDE ULTIMATE REJ; Schneidman E., 1985, DEFINITION SUICIDE; Schneidman E., 2001, UNDERSTANDING SUICID; Singapore Department of Statistics, 2010, SING STAT; Stack S, 2016, SOCIOL QUART, V57, P282, DOI 10.1111/tsq.12109; Stoor JPA, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.27669; Takahashi Y, 1998, SUICIDE PREVENTION, P121; Tiller J, 1998, STRESS MEDICINE, V14, P249, DOI 10.1002/(SICI)1099-1700(1998100)14:4<249::AID-SMI805>3.0.CO;2-#; Tseng W., 1992, SUICIDAL BEHAV ASIA, P1; Tsoi & Kok W. F., 1982, SINGAP MED J, V23, P299; TSOI WF, 1987, BRIT J PSYCHIAT, V151, P543, DOI 10.1192/bjp.151.4.543; WHO, 2016, GLOB HLTH OBS DAT; Wu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131715; Zhang J, 2007, OMEGA-J DEATH DYING, V55, P185, DOI 10.2190/OM.55.3.b	58	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175752	10.1371/journal.pone.0175752	http://dx.doi.org/10.1371/journal.pone.0175752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426687	gold, Green Accepted, Green Published			2022-12-27	WOS:000399875900044
J	Andrade, MC; Machado, VN; Jegu, M; Farias, IP; Giarrizzo, T				Andrade, Marcelo C.; Machado, Valeria N.; Jegu, Michel; Farias, Izeni P.; Giarrizzo, Tommaso			A new species of Tometes Valenciennes 1850 (Characiformes: Serrasalmidae) from Tocantins-Araguaia River Basin based on integrative analysis of molecular and morphological data	PLOS ONE			English	Article							FRESH-WATER FISHES; HISTORICAL BIOGEOGRAPHY; GUIANA SHIELD; CHARACIDAE; TELEOSTEI; GENUS; DIVERSIFICATION; PHYLOGENY; UTILITY	A new large serrasalmid species of Tometes is described from the Tocantins-Araguaia River Basin. Tometes siderocarajensis sp. nov. is currently found in the rapids of the Ita-caiunas River Basin, and formerly inhabited the lower Tocantins River. The new species can be distinguished from all congeners, except from T. ancylorhynchus, by the presence of lateral space between 1st and 2nd premaxillary teeth, and by the absence of lateral cusps in these two teeth. However, T. siderocarajensis sp. nov. can be differentiated from syntopic congener T. ancylorhynchus by an entirely black with mottled red body in live specimens, densely pigmented pelvic fins with a high concentration of dark chromatophores, and the presence of 39 to 41 rows of circumpeduncular scales (vs. silvery body coloration with slightly reddish overtones on middle flank during breeding period in live specimens, hyaline to slightly pale coloration on distalmost region of pelvic fins, and 30 to 36 rows of circumpeduncular scales). Additionally, molecular sequence shows that T. siderocarajensis sp. nov. is reciprocally monophyletic, and diagnosable from all congeners by having two autapomorphic molecular characters in the mitochondrial gene COI. The phylogenetic reconstruction still show that T. siderocarajensis sp. nov. is closely related to T. trilobatus. This is the first molecular study using an integrative taxonomic approach based on morphological and molecular sequence data for all described species of Tometes. These findings increase the number of formally described species of Tometes to seven. A key to the Tometes species is provided.	[Andrade, Marcelo C.; Giarrizzo, Tommaso] Univ Fed Pare, Cidade Univ, Inst Ciencias Biol, Programa Pos Grad Ecol Aquat & Pesca,Lab Biol Pes, Belem, Para, Brazil; [Machado, Valeria N.; Farias, Izeni P.] Univ Fed Amazonas, Inst Ciencias Biol, Programa PosGrad Biodiversidade & Biotecnol Amazo, Lab Evolucao & Genet Anim, Manaus, Amazonas, Brazil; [Jegu, Michel] MNHN, Inst Rech Dev Biol Organismes & Ecosyst Aquat, UMR BOREA, Lab Dlcthyol, 43 rue Cuvier, Paris, France	Universidade Federal de Amazonas; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Andrade, MC (corresponding author), Univ Fed Pare, Cidade Univ, Inst Ciencias Biol, Programa Pos Grad Ecol Aquat & Pesca,Lab Biol Pes, Belem, Para, Brazil.	andrademarcosta@gmail.com	Andrade, Marcelo/P-1781-2017; Farias, Izeni Pires/J-3069-2014; Giarrizzo, Tommaso/G-8482-2016	Andrade, Marcelo/0000-0002-3573-5774; Farias, Izeni Pires/0000-0002-1416-4351; Giarrizzo, Tommaso/0000-0002-5116-5206	Coordenacao de Aproveitamento de Pessoal de Nivel Superior [6666/2015-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308278/2012-7, CNPq/PRONEX/FAPEAM]; Coordenacao de Aproveitamento de Pessoal de Nivel Superior; Programa Nacional de Pos Doutorado; Fundacao Amazonia de Amparo a Estudos e Pesquisa do Para [011/2015]; PROPESP-UFPA [23073.004649/2017-06]	Coordenacao de Aproveitamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aproveitamento de Pessoal de Nivel Superior; Programa Nacional de Pos Doutorado; Fundacao Amazonia de Amparo a Estudos e Pesquisa do Para; PROPESP-UFPA	MCA: Coordenacao de Aproveitamento de Pessoal de Nivel Superior # grant 6666/2015-9. TG: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico # grant 308278/2012-7, Coordenacao de Aproveitamento de Pessoal de Nivel Superior, Programa Nacional de Pos Doutorado, Fundacao Amazonia de Amparo a Estudos e Pesquisa do Para # grant 011/2015. IPF: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico # CNPq/PRONEX/FAPEAM. This research was supported by PROPESP-UFPA (# grant 23073.004649/2017-06).	Andrade MC, 2016, J FISH BIOL, V89, P467, DOI 10.1111/jfb.12868; Andrade MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161398; Andrade MC, 2013, NEOTROP ICHTHYOL, V11, P297, DOI 10.1590/S1679-62252013000200008; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Biomatters Ltd, 2014, GENEIOUS 7 0 6; Birstein VJ, 2009, MITOCHONDR DNA, V20, P110, DOI 10.3109/19401730903168182; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Paz FPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098603; Claro-Garcia A, 2015, B SOC BRAS ICTIOL, V116, P48; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; CRACRAFT J, 1987, Biology and Philosophy, V2, P329, DOI 10.1007/BF00128837; de Carvalho Daniel C, 2011, Mitochondrial DNA, V22 Suppl 1, P80, DOI 10.3109/19401736.2011.588214; Gery J., 1979, Amazoniana, V6, P467; Gery J., 1977, CHARACOIDS WORLD; GOSLINE WILLIAM A., 1951, PROC CALIFORNIA ACAD SCI, V27, P17; Goulding M., 1980, P1; Goulding M, 2003, SMITHSONIAN ATLAS AM; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jegu M, 2003, REV SUISSE ZOOL, V110, P833, DOI 10.5962/bhl.part.80216; Jegu M, 2002, CYBIUM, V26, P253; Jegu M, 2002, CYBIUM, V26, P99; Jegu M, 2002, CYBIUM, V26, P33; Jegu M, 2004, TAXINOMIE SERRASALMI, P421; Jegu M, 2002, B FRANCAIS PECHE PIS, V2002, P23; Jegu M, 1992, CYBIUM, V16, P105; Jegu M., 2003, CHECK LIST FRESHWATE, P182, DOI DOI 10.5962/BHL.PART.80216; Cione AL, 2009, J VERTEBR PALEONTOL, V29, P350, DOI 10.1671/039.029.0221; MACHADO-ALLISON A, 1983, Acta Biologica Venezuelica, V11, P145; Machado-Allison A., 1982, STUDIES SYSTEMATICS, P267; Mattox GMT, 2014, ICHTHYOL EXPLOR FRES, V25, P103; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Nelson JS, 2006, FISHES WORLD; Orti G, 2008, GENET MOL BIOL, V31, P343, DOI 10.1590/S1415-47572008000200030; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Thompson AW, 2014, MOL PHYLOGENET EVOL, V81, P242, DOI 10.1016/j.ympev.2014.06.018; Toffoli D, 2008, GENET MOL BIOL, V31, P324, DOI 10.1590/S1415-47572008000200028; Weitzman SH, 1962, STANFORD ICHTHYOLOGI, V8, P3; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	46	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0170053	10.1371/journal.pone.0170053	http://dx.doi.org/10.1371/journal.pone.0170053			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422969	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600002
J	Carricondo-Sanchez, D; Odden, M; Linnell, JDC; Odden, J				Carricondo-Sanchez, David; Odden, Morten; Linnell, John D. C.; Odden, John			The range of the mange: Spatiotemporal patterns of sarcoptic mange in red foxes (Vulpes vulpes) as revealed by camera trapping	PLOS ONE			English	Article							BEHAVIORAL-CHANGES; SCABIEI; POPULATION; LYNX; INFECTION; DISEASES; WILDLIFE; NORWAY; IMPACT; CARNIVORES	Sarcoptic mange is a widely distributed disease that affects numerous mammalian species. We used camera traps to investigate the apparent prevalence and spatiotemporal dynamics of sarcoptic mange in a red fox population in southeastern Norway. We monitored red foxes for five years using 305 camera traps distributed across an 18000 km(2) area. A total of 6581 fox events were examined to visually identify mange compatible lesions. We investigated factors associated with the occurrence of mange by using logistic models within a Bayesian framework, whereas the spatiotemporal dynamics of the disease were analysed with spacetime scan statistics. The apparent prevalence of the disease fluctuated over the study period with a mean of 3.15% and credible interval [1.25, 6.37], and our best logistic model explaining the presence of red foxes with mange-compatible lesions included time since the beginning of the study and the interaction between distance to settlement and season as explanatory variables. The scan analyses detected several potential clusters of the disease that varied in persistence and size, and the locations in the cluster with the highest probability were closer to human settlements than the other survey locations. Our results indicate that red foxes in an advanced stage of the disease are most likely found closer to human settlements during periods of low wild prey availability (winter). We discuss different potential causes. Furthermore, the disease appears to follow a pattern of small localized outbreaks rather than sporadic isolated events.	[Carricondo-Sanchez, David; Odden, Morten] Hedmark Univ Appl Sci, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Linnell, John D. C.; Odden, John] Norwegian Inst Nat Res, Trondheim, Norway	Norwegian Institute Nature Research	Carricondo-Sanchez, D (corresponding author), Hedmark Univ Appl Sci, Fac Appl Ecol & Agr Sci, Koppang, Norway.	david.carricondo.sanchez@gmail.com	Linnell, John/V-4177-2019; Odden, John/F-6088-2019	Linnell, John/0000-0002-8370-5633; Odden, John/0000-0002-6275-8648; Carricondo Sanchez, David/0000-0001-6564-9108	Norwegian Environment Agency;  [16S0D29E];  [16SEE579];  [16S5E030];  [15S8648C];  [15S8929D];  [15SFD167];  [15S16550];  [15SE02F8];  [14S45EDF];  [14SC0029];  [14SB22EC];  [14SD5FF3];  [14SCB72C];  [13S80C87];  [1377EF0];  [13FD9B6];  [1311C1E];  [2012/397];  [2012/395];  [2011/404];  [2011/506];  [14SBF770]	Norwegian Environment Agency; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	The study was funded by the Norwegian Environment Agency, The County administrations in Oslo & Akershus, Ostfold, Oppland, Vestfold, Buskerud and Telemark, and the County Councils in Ostfold, Akershus, Oslo, Buskerud and Vestfold (16S0D29E, 16SEE579, 16S5E030, 15S8648C, 15S8929D, 15SFD167, 15S16550, 15SE02F8, 14S45EDF, 14SC0029, 14SB22EC, 14SD5FF3, 14SCB72C, 13S80C87, 1377EF0, 13FD9B6, 1311C1E, 2012/397, 2012/395, 2011/404, 2011/506, 14SBF770).; We thank all landowners that let us work on their land. We are also very grateful to all personnel from the State Nature Inspectorate, Kjartan Sjulstad, Neri H Thorsen, Andrea Lorenzato, Andrea Mosini, Annette Stephani, Are Endal Rognes, Arnkjell Johansen, Arve Rustad, Asmund Herland, Birger Ormestoyl, Bjorn Ekre, Bjorn Halvorsen, Bjorn Lybekk, Bjorn Rustestuen, Brunella Visaggi, Carl Randin Klokkerengen, Daniel Emberland, Daniel Storengen, Deniz Mengulluoglu, Egil Berger, Erik Framstad, Ernst Harald Helgerud, Erling Bergsaker, Espen Asakskogen, Espen Marker, Evert Van Akelyen, Fridolin Zimmermann, Friedrike Stelter, Hans P. Klokkerengen, Harald Askilsrud, Hjalmar Eide, Ida Glemminge, Ingar Nettum, Irene Negre, Isham Tathgar, Ivar Jonny Sondrol, Ivar Knai, Jan Gunnar Grodtvet, Jan Petter Hoistad, Jan Wilberg, Janek Schmidt, Jens Golden, John Egil Filtvedt, Jon Petter Bergsrud, Jonas Pettersen, Jon S. Moen, Jordi Janssen, Jorid Fagerbakk, Jorgen Ronneberg, Jorn Hogne Andresen, Kim Jacobsen, Kirsten Weingarth, Kjell Arne Neverdalen, Kjell Enger, Kjelle videregaende skole, Kjetil Storbraten, Knut Gastjonn, Lasse Hertel, Leif Egil Loe, Losby Bruk, Louise McNutt, Marit Aaslie Brenden, Marius Angvik, Mats Finne, Max Kampen, Nils Oskar Naess, Nils Solberg, Odd E Skjellerud, Olav Brauti, Ole Bjorn Skoe, Ole Thorvald Riiser, Ottar Slagtern, Per Steinar Slang, Reidar Haugen, Richard Bischof, Ronny Steen, Roger Meas, Rolf Svartangen, Roy Stenersen, Rune Pedersen, Sabrina Dietz, Samantha Lyon, Sigbjorn Dropping, Silje Hals, Silje Vang, Skjatvet Gard, Stabekk videregaende skole, Stangeskovene, Stefan van der Werff, Stian Philip Andersen, Stig Andre Aasgard, Stig Helge Basnes, Svein Martinsen, Svein Sloreid, Tarjei Berg, Tea Turtumoygard, Tom G. Bengtson, Tommy Andersen, Tor Jakob Nordbo, Torbjorn Kjellman, Torbjorn Sandsengen, Torbjorn Tveter, Tore Jakob Nordbo, Tormod Pedersen, Ulsrud Videregaende skole, Vegard Aarnes, Vegard Sjoblom, Vidar Holthe, Walter Loesberg, Oistein Hogseth, Oivind Fosse and Asmund Fjellbakk. Finally, we wish to thank Roco Cano Martinez for helping in the visualization of the photographic material. This study was funded by the Norwegian Environment Agency, The County administrations in Oslo & Akershus, Ostfold, Oppland, Vestfold, Buskerud and Telemark, and the County Councils in Ostfold, Akershus, Oslo, Buskerud and Vestfold.	Alasaad S, 2012, VET PARASITOL, V185, P359, DOI 10.1016/j.vetpar.2011.10.039; Alasaad S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-16; Alasaad S, 2013, INFECT GENET EVOL, V17, P253, DOI 10.1016/j.meegid.2013.04.018; [Anonymous], ARXIV150704544V5STAT; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Balestrieri A, 2006, EUR J WILDLIFE RES, V52, P196, DOI 10.1007/s10344-006-0036-4; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Borchard P, 2012, MAMM BIOL, V77, P244, DOI 10.1016/j.mambio.2012.04.004; BORG K, 1987, J WILDLIFE DIS, V23, P527, DOI 10.7589/0090-3558-23.4.527; Bornstein S., 1991, Veterinary Dermatology, V2, P151, DOI 10.1111/j.1365-3164.1991.tb00126.x; Bornstein S, 1995, ACTA VET SCAND, V36, P509; Bornstein S, 2006, VET DERMATOL, V17, P411, DOI 10.1111/j.1365-3164.2006.00548.x; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; Bouyer Y, 2015, BIOL CONSERV, V191, P291, DOI 10.1016/j.biocon.2015.07.007; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; Buerkner P.-C., 2016, BRMS BAYESIAN REGRES; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; Chesney CJ, 1999, J SMALL ANIM PRACT, V40, P58, DOI 10.1111/j.1748-5827.1999.tb03037.x; Cross PC, 2016, ECOLOGY, V97, P1938, DOI 10.1890/15-1346.1; DANELL K, 1987, OECOLOGIA, V73, P533, DOI 10.1007/BF00379412; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson RK, 2008, VET PARASITOL, V156, P277, DOI 10.1016/j.vetpar.2008.05.019; Devenish-Nelson ES, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0524; Dorai-Raj S., 2014, BINOMIAL CONFIDENCE; ESRI, 2009, ARCGIS DESKTOP; Fernandez-Moran J, 1997, VET PARASITOL, V73, P163, DOI 10.1016/S0304-4017(97)00061-7; Fuchs B, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0780-y; Galaverni M, 2012, EUR J WILDLIFE RES, V58, P47, DOI 10.1007/s10344-011-0539-5; Garrote G, 2012, EUR J WILDLIFE RES, V58, P881, DOI 10.1007/s10344-012-0658-7; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gortazar C, 1998, Z JAGDWISS, V44, P251, DOI 10.1007/BF02242030; Hyser-Degiorgis M P, 2013, BMC VET RES, V9; Johansen B., 2009, 4200986S NOR; Kalema-Zikusoka G, 2002, VET REC, V150, P12, DOI 10.1136/vr.150.1.12; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; KNUDTSON WU, 1980, J WILDLIFE DIS, V16, P465, DOI 10.7589/0090-3558-16.4.465; Kolodziej-Sobocinska M, 2014, ECOL RES, V29, P237, DOI 10.1007/s11284-013-1118-x; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LINDSTROM E, 1989, HOLARCTIC ECOL, V12, P70; Lindstrom E., 1991, PATTERN SPREAD EFFEC, P591; Lindstrom E., 1982, THESIS; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; Linnell JDC, 2007, WILDLIFE BIOL, V13, P447, DOI 10.2981/0909-6396(2007)13[447:DRFMCO]2.0.CO;2; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Little SE, 1998, J WILDLIFE DIS, V34, P620, DOI 10.7589/0090-3558-34.3.620; Malmasi A, 2009, IRAN J VET RES, V10, P189; McCarthy P, 1960, AUSTR VET J, V34, P600; Millan J, 2010, EUR J WILDLIFE RES, V56, P455, DOI 10.1007/s10344-009-0347-3; MORNER T, 1984, VET PARASITOL, V15, P159, DOI 10.1016/0304-4017(84)90031-1; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1115; Newman TJ, 2003, ACTA THERIOL, V48, P79, DOI 10.1007/BF03194268; Newman TJ, 2002, CAN J ZOOL, V80, P154, DOI [10.1139/z01-216, 10.1139/Z01-216]; Oleaga A, 2011, VET PARASITOL, V181, P255, DOI 10.1016/j.vetpar.2011.04.036; OVERSKAUG K, 1994, ACTA VET SCAND, V35, P457; Panek M, 2002, ACTA THERIOL, V47, P433, DOI 10.1007/BF03192468; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; PENCE DB, 1994, J WILDLIFE MANAGE, V58, P624, DOI 10.2307/3809675; Perez JC I, 2016, INT J ACAROLOGY; Plumer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115124; Potts JR, 2013, AM NAT, V182, pE73, DOI 10.1086/671260; Rosalino LM, 2010, VIE MILIEU, V60, P39; Ryser-Degiorgis MP, 2002, J WILDLIFE DIS, V38, P228, DOI 10.7589/0090-3558-38.1.228; Selas V, 2006, J ZOOL, V269, P299, DOI 10.1111/j.1469-7998.2006.00048.x; Selas V, 2010, WILDLIFE BIOL, V16, P107, DOI 10.2981/09-023; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Simpson K, 2016, PLOS ONE, V11; Skerratt LF, 1999, J WILDLIFE DIS, V35, P633, DOI 10.7589/0090-3558-35.4.633; Smedshaug CA, 1999, WILDLIFE BIOL, V5, P157, DOI 10.2981/wlb.1999.020; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2011, J MAMMAL, V92, P190, DOI 10.1644/09-MAMM-A-187.1; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Todd A.W., 1981, P WORLDW FURB C FROS, P706; Turchetto S, 2014, HYSTRIX, V25, P25, DOI 10.4404/hystrix-25.1-9460; Uraguchi K, 2014, J WILDLIFE MANAGE, V78, P1356, DOI 10.1002/jwmg.794; WOOLLARD T, 1990, J ANIM ECOL, V59, P709, DOI 10.2307/4890	79	22	22	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176200	10.1371/journal.pone.0176200	http://dx.doi.org/10.1371/journal.pone.0176200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423011	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875600098
J	Landrian, I; McFarland, KN; Liu, JL; Mulligan, CJ; Rasmussen, A; Ashizawa, T				Landrian, Ivette; McFarland, Karen N.; Liu, Jilin; Mulligan, Connie J.; Rasmussen, Astrid; Ashizawa, Tetsuo			Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; AGG INTERRUPTIONS; CAG REPEAT; TRINUCLEOTIDE REPEATS; CTG REPEAT; INSTABILITY; LOCUS; ORIGIN; REDUCE; GENE	Spinocerebellar ataxia type 10 (SCA10), an autosomal dominant cerebellar ataxia disorder, is caused by a non-coding ATTCT microsatellite repeat expansion in the ataxin 10 gene. In a subset of SCA10 families, the 5'-end of the repeat expansion contains a complex sequence of penta- and heptanucleotide interruption motifs which is followed by a pure tract of tandem ATCCT repeats of unknown length at its 3'-end. Intriguingly, expansions that carry these interruption motifs correlate with an epileptic seizure phenotype and are unstable despite the theory that interruptions are expected to stabilize expanded repeats. To examine the apparent contradiction of unstable, interruption-positive SCA10 expansion alleles and to determine whether the instability originates outside of the interrupted region, we sequenced approximately 1 kb of the 5'-end of SCA10 expansions using the ATCCT-PCR product in individuals across multiple generations from four SCA10 families. We found that the greatest instability within this region occurred in paternal transmissions of the allele in stretches of pure ATTCT motifs while the intervening interrupted sequences were stable. Overall, the ATCCT interruption changes by only one to three repeat units and therefore cannot account for the instability across the length of the disease allele. We conclude that the AT-rich interruptions locally stabilize the SCA10 expansion at the 5'-end but do not completely abolish instability across the entire span of the expansion. In addition, analysis of the interruption alleles across these families support a parsimonious single origin of the mutation with a shared distant ancestor.	[Landrian, Ivette; McFarland, Karen N.; Liu, Jilin; Ashizawa, Tetsuo] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Landrian, Ivette; McFarland, Karen N.; Liu, Jilin; Ashizawa, Tetsuo] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [McFarland, Karen N.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Mulligan, Connie J.] Univ Florida, Dept Anthropol, Coll Liberal Arts & Sci, Gainesville, FL 32611 USA; [Mulligan, Connie J.] Univ Florida, Genet Inst, Gainesville, FL USA; [Rasmussen, Astrid] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Ashizawa, Tetsuo] Houston Methodist Res Inst, Neurosci Res Program, Houston, TX USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Oklahoma Medical Research Foundation; The Methodist Hospital System; The Methodist Hospital - Houston	McFarland, KN (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.; McFarland, KN (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.; McFarland, KN (corresponding author), Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.	karen.mcfarland@neurology.ufl.edu	Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948	NIH grant [NS083564]	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by an NIH grant NS083564 to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T., 2006, GENETIC INSTABILITIE, VSecond Edition, P433; Braida C, 2010, HUM MOL GENET, V19, P1399, DOI 10.1093/hmg/ddq015; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Edwards SF, 2009, MOL CARCINOGEN, V48, P336, DOI 10.1002/mc.20534; Handa V, 2005, J BIOL CHEM, V280, P29340, DOI 10.1074/jbc.M503495200; JODICE C, 1994, AM J HUM GENET, V54, P959; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; McFarland KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135906; McFarland KN, 2013, EUR J HUM GENET, V21, P1272, DOI 10.1038/ejhg.2013.32; McFarland KN, 2013, NEUROGENETICS; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Musova Z, 2009, AM J MED GENET A, V149A, P1365, DOI 10.1002/ajmg.a.32987; Nolin SL, 2015, GENET MED, V17, P358, DOI 10.1038/gim.2014.106; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1998, BIOCHEMISTRY-US, V37, P2701, DOI 10.1021/bi972546c; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Potaman VN, 2003, J MOL BIOL, V326, P1095, DOI 10.1016/S0022-2836(03)00037-8; Ramos EM, 2010, AM J MED GENET B, V153B, P524, DOI 10.1002/ajmg.b.31013; Rolfsmeier ML, 2000, MOL CELL BIOL, V20, P173, DOI 10.1128/MCB.20.1.173-180.2000; Rolfsmeier ML, 2000, MOL CELL, V6, P1501, DOI 10.1016/S1097-2765(00)00146-5; Teive HAG, 2011, PARKINSONISM RELAT D, V17, P655, DOI 10.1016/j.parkreldis.2011.04.001; Wang Jun-ling, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P501, DOI 10.3760/cma.j.issn.1003-9406.2010.05.006; Wang K, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000026; Yrigollen CM, 2013, J HUM GENET, V58, P553, DOI 10.1038/jhg.2013.50; Yrigollen CM, 2012, GENET MED, V14, P729, DOI 10.1038/gim.2012.34	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175958	10.1371/journal.pone.0175958	http://dx.doi.org/10.1371/journal.pone.0175958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423040	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600070
J	Moeller, M; Pink, C; Endlich, N; Endlich, K; Grabe, HJ; Volzke, H; Dorr, M; Nauck, M; Lerch, MM; Kohling, R; Holtfreter, B; Kocher, T; Fuellen, G				Moeller, Mark; Pink, Christiane; Endlich, Nicole; Endlich, Karlhans; Grabe, Hans-Joergen; Voelzke, Henry; Doerr, Marcus; Nauck, Matthias; Lerch, Markus M.; Koehling, Ruediger; Holtfreter, Birte; Kocher, Thomas; Fuellen, Georg			Mortality is associated with inflammation, anemia, specific diseases and treatments, and molecular markers	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CHRONIC KIDNEY-DISEASE; PERIODONTAL-DISEASE; CALCIUM INTAKE; OLDER-PEOPLE; HEALTH; RISK; BIOMARKERS; POMERANIA; SURVIVAL	Lifespan is a complex trait, and longitudinal data for humans are naturally scarce. We report the results of Cox regression and Pearson correlation analyses using data of the Study of Health in Pomerania (SHIP), with mortality data of 1518 participants (113 of which died), over a time span of more than 10 years. We found that in the Cox regression model based on the Bayesian information criterion, apart from chronological age of the participant, six baseline variables were considerably associated with higher mortality rates: smoking, mean attachment loss (i.e. loss of tooth supporting tissue), fibrinogen concentration, albumin/creatinine ratio, treated gastritis, and medication during the last 7 days. Except for smoking, the causative contribution of these variables to mortality was deemed inconclusive. In turn, four variables were found to be associated with decreased mortality rates: treatment of benign prostatic hypertrophy, treatment of dyslipidemia, IGF-1 and being female. Here, being female was an undisputed causative variable, the causal role of IFG-1 was deemed inconclusive, and the treatment effects were deemed protective to the degree that treated subjects feature better survival than respective controls. Using Cox modeling based on the Akaike information criterion, diabetes, mean corpuscular hemoglobin concentration, red blood cell count and serum calcium were also associated with mortality. The latter two, together with albumin and fibrinogen, aligned with an "integrated albunemia" model of aging proposed recently.	[Moeller, Mark; Fuellen, Georg] Rostock Univ, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Pink, Christiane; Holtfreter, Birte; Kocher, Thomas] Univ Med Greifswald, Dept Restorat Dent Periodontol Endodontol & Preve, Greifswald, Germany; [Endlich, Nicole; Endlich, Karlhans] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Grabe, Hans-Joergen] Ernst Moritz Arndt Univ, Psychiat Clin, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Dept Study Hlth Pomerania Clin Epidemiol Res, Greifswald, Germany; [Voelzke, Henry] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Voelzke, Henry] German Ctr Diabet Res DZD, Partner Site Greifswald, Greifswald, Germany; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Nauck, Matthias] Ernst Moritz Arndt Univ, Inst Clin Chem & Lab Med, Greifswald, Germany; [Lerch, Markus M.] Univ Med Greifswald, Dept Internal Med A, Greifswald, Germany; [Koehling, Ruediger] Rostock Univ, Med Ctr, Inst Physiol, Rostock, Germany	University of Rostock; Greifswald Medical School; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; German Centre for Cardiovascular Research; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Rostock	Fuellen, G (corresponding author), Rostock Univ, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany.; Kocher, T (corresponding author), Univ Med Greifswald, Dept Restorat Dent Periodontol Endodontol & Preve, Greifswald, Germany.	kocher@uni-greifswald.de; fuellen@uni-rostock.de	Lerch, Markus M./E-2206-2016; Dörr, Marcus/F-1919-2010; Köhling, Rüdiger/K-8647-2013	Lerch, Markus M./0000-0002-9643-8263; Dörr, Marcus/0000-0001-7471-475X; Köhling, Rüdiger/0000-0003-3330-4898; Endlich, Karlhans/0000-0001-6052-6061	Federal Ministry of Education and Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; European Union's Horizon 2020 research and innovation programme [633589]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; European Union's Horizon 2020 research and innovation programme	SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (BMBF, grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403, HV), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. G.F. was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 633589; this publication reflects only the authors' views and the Commission is not responsible for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CL, 2014, J AM GERIATR SOC, V62, P880, DOI 10.1111/jgs.12796; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cappellini MD, 2015, SEMIN HEMATOL, V52, P261, DOI 10.1053/j.seminhematol.2015.07.006; Castro MR, 2016, J OF GENERAL I; Chen CB, 2016, CLINICAL THERAPEUTIC; Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116489; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; COX DR, 1972, J R STAT SOC B, V34, P187; Cozzolino M, 2012, NUTR METAB CARDIOVAS, V22, P547, DOI 10.1016/j.numecd.2012.03.010; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; de Magalhaes JP, 2005, AGEING RES REV, V4, P1, DOI 10.1016/j.arr.2004.05.003; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Doblhammer G, 2009, DEMOGR RES, V20, P37, DOI 10.4054/DemRes.2009.20.5; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eurich DT, 2010, AM J MED, V123, P47, DOI 10.1016/j.amjmed.2009.05.032; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Friedrich N, 2009, J CLIN ENDOCR METAB, V94, P1732, DOI 10.1210/jc.2008-2138; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397; Gocke C, 2014, ATHEROSCLEROSIS, V235, P351, DOI 10.1016/j.atherosclerosis.2014.05.926; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; HAGER K, 1994, AGING-CLIN EXP RES, V6, P133, DOI 10.1007/BF03324226; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Harb AN, 2012, J CLIN PERIODONTOL, V39, P931, DOI 10.1111/j.1600-051X.2012.01935.x; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102; Hirani V, 2014, AGE, V36, DOI 10.1007/s11357-014-9732-2; Howick J, 2009, J ROY SOC MED, V102, P186, DOI 10.1258/jrsm.2009.090020; Huang S, 2014, BIOESSAYS, V36, P1, DOI 10.1002/bies.201370003; Inker LA, 2011, J AM SOC NEPHROL, V22, P2322, DOI 10.1681/ASN.2010111181; Ito MK, 2012, ANN PHARMACOTHER, V46, P1368, DOI 10.1345/aph.1R127; Jarcho JA, 2015, NEW ENGL J MED, V372, P2448, DOI 10.1056/NEJMe1507041; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Jylhava J, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-54; Kalben BB, 2000, N AM ACTUAR J, V4, P83; Kebede TG, 2016, J DENT RES; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; Leibrock CB, 2016, AM J PHYSIOL-RENAL, V310, pF102, DOI 10.1152/ajprenal.00037.2015; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Loffler C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0151-7; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maggio M, 2013, NUTRIENTS, V5, P4184, DOI 10.3390/nu5104184; Maletkovic J, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/893134; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Moeller M, 2014, AGING CELL, V13, P729, DOI 10.1111/acel.12226; Muhlestein JB, 2006, J AM COLL CARDIOL, V48, P396, DOI 10.1016/j.jacc.2006.05.009; Nilsson G, 2014, HEALTHY AGING RES, V3, DOI 10.12715/har.2014.3.5; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Parkar Sujal M, 2013, Heart Views, V14, P5, DOI 10.4103/1995-705X.107113; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perez-Fontan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148806; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pink C, 2015, J CLIN PERIODONTOL, V42, P988, DOI 10.1111/jcpe.12473; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ran L, 2011, ACTA NEUROCHIR SUPPL, V111, P435, DOI 10.1007/978-3-7091-0693-8_75; RCoreTeam, LANG ENV STAT COMP; Reid IR, 2016, JOURNAL OF INTERNAL; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Santoro A, 2014, MECH AGEING DEV, V136, P3, DOI 10.1016/j.mad.2013.12.001; Schnabel RB, 2013, ARTERIOSCL THROM VAS, V33, P1728, DOI 10.1161/ATVBAHA.112.301174; Schonberg MA, 2011, J CLIN ONCOL, V29, P1570, DOI 10.1200/JCO.2010.33.0472; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Sfyroeras GS, 2012, J VASC SURG, V55, P1178, DOI 10.1016/j.jvs.2011.10.008; Sharples AP, 2015, AGING CELL, V14, P511, DOI 10.1111/acel.12342; Shores MM, 2014, CURR OPIN ENDOCRINOL, V21, P209, DOI 10.1097/MED.0000000000000057; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Therneau T, PACKAGE SURVIVAL ANA; Thompson IM, 2013, NEW ENGL J MED, V369, P603, DOI 10.1056/NEJMoa1215932; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Walter Stefan, 2012, Am J Public Health, V102, pe3, DOI 10.2105/AJPH.2011.300596; Warren GW, 2014, CANCER-AM CANCER SOC, V120, P1914, DOI 10.1002/cncr.28695; Wu CK, 2011, ATHEROSCLEROSIS, V216, P226, DOI 10.1016/j.atherosclerosis.2011.01.046; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yu T, 2016, DIGEST LIVER DIS, V48, P353, DOI 10.1016/j.dld.2015.12.009	86	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175909	10.1371/journal.pone.0175909	http://dx.doi.org/10.1371/journal.pone.0175909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422991	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600062
J	Peters, EMJ; Muller, Y; Snaga, W; Fliege, H; Reisshauer, A; Schmidt-Rose, T; Max, H; Schweiger, D; Rose, M; Kruse, J				Peters, Eva M. J.; Mueller, Yvonne; Snaga, Wenke; Fliege, Herbert; Reisshauer, Anett; Schmidt-Rose, Thomas; Max, Heiner; Schweiger, Dorothea; Rose, Matthias; Kruse, Johannes			Hair and stress: A pilot study of hair and cytokine balance alteration in healthy young women under major exam stress	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBSTANCE-P; CORTISOL CONCENTRATIONS; PSYCHOLOGICAL STRESS; DEPRESSION SCALE; MEDICAL-STUDENTS; HOSPITAL ANXIETY; MESSENGER-RNA; EVENT SCALE; MOUSE MODEL	Mouse models show that experimental stress mimicking prolonged life-stress exposure enhances neurogenic inflammation, induces adaptive immunity cytokine-imbalance characterized by a shift to Type 1 T-helper cell cytokines and increases apoptosis of epithelial cells. This affects hair growth in otherwise healthy animals. In this study, we investigate whether a prolonged naturalistic life-stress exposure affects cytokine balance and hair parameters in healthy humans. 33 (18 exam, 15 comparison) female medical students with comparable sociobiological status were analyzed during a stressful final examination period, at three points in time (T) 12 weeks apart. T1 was before start of the learning period, T2 between the three-day written exam and an oral examination, and T3 after a 12 week rest and recovery from the stress of the examination period. Assessments included: self-reported distress and coping strategies (Perceived Stress Questionnaire [PSQ], Trier Inventory for the Assessment of Chronic Stress [TICS]), COPE), cytokines in supernatants of stimulated peripheral blood mononucleocytes (PBMCs), and trichogram (hair cycle and pigmentation analysis). Comparison between students participating in the final medical exam at T2 and non-exam students, revealed significantly higher stress perception in exam students. Time-wise comparison revealed that stress level, TH1/TH2 cytokine balance and hair parameters changed significantly from T1 to T2 in the exam group, but not the control. However, no group differences were found for cytokine balance or hair parameters at T2. The study concludes that in humans, naturalistic stress, as perceived during participation in a major medical exam, has the potential to shift the immune response to TH1 and transiently hamper hair growth, but these changes stay within a physiological range. Findings are instructive for patients suffering from hair loss in times of high stress. Replication in larger and more diverse sample populations is required, to assess suitability of trichogram analysis as biological outcome for stress studies.	[Peters, Eva M. J.; Snaga, Wenke; Rose, Matthias] Univ Med Charite, Ctr Internal Med & Dermatol 12, Div Gen Internal Med, Psychosomat & Psychotherapy Psychoneuroimmunol Sk, Berlin, Germany; [Peters, Eva M. J.; Mueller, Yvonne; Kruse, Johannes] Justus Liebig Univ, Dept Psychosomat & Psychotherapy, Psychoneuroimmunol Lab, Giessen, Germany; [Fliege, Herbert] Auswartiges Amt, Foreign Off, Hlth Serv, Psychosocial Counseling, Berlin, Germany; [Reisshauer, Anett] Univ Med Charite, Ctr Internal Med & Dermatol 12, Div Phys Med & Rehabil, Berlin, Germany; [Schmidt-Rose, Thomas; Max, Heiner; Schweiger, Dorothea] Beiersdorf AG, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Beiersdorf AG	Peters, EMJ (corresponding author), Univ Med Charite, Ctr Internal Med & Dermatol 12, Div Gen Internal Med, Psychosomat & Psychotherapy Psychoneuroimmunol Sk, Berlin, Germany.; Peters, EMJ (corresponding author), Justus Liebig Univ, Dept Psychosomat & Psychotherapy, Psychoneuroimmunol Lab, Giessen, Germany.	eva.peters@eva-peters.com		Fliege, Herbert/0000-0002-7962-2683; Peters, Eva Milena Johanne/0000-0003-2423-527X	Universitatsmedizin-Charite	Universitatsmedizin-Charite	The study was in financed through University Research Funding of the Universitatsmedizin-Charite to EMJP. Note also, that the Beiersdorf AG entertains basic research units for the study of skin and hair biology unrelated to the study or promotion of their cosmetic products. The researches employed by Beiersdorf who participated in our study, did so as basic science researchers. The Beiersdorf AG provided support in the form of salaries for authors DS TSR HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albar WF, 2013, CLIN INVEST MED, V36, pE312; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Asadi S, 2012, J INVEST DERMATOL, V132, P324, DOI 10.1038/jid.2011.334; Belli AA, 2016, PEDIATR DERMATOL, V33, P438, DOI 10.1111/pde.12881; Bilbo SD, 2002, P NATL ACAD SCI USA, V99, P4067, DOI 10.1073/pnas.062001899; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; BRAUNFALCO O, 1977, HAUTARZT, V28, P136; Bruenahl CA, 2013, NORD J PSYCHIAT, V67, P191, DOI 10.3109/08039488.2012.700947; Brunet A, 2014, CAN J PSYCHIAT, V59, P228, DOI 10.1177/070674371405900408; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Deinzer R, 2000, INT J PSYCHOPHYSIOL, V37, P219, DOI 10.1016/S0167-8760(99)00112-9; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Dhabhar FS, 2013, CLIN DERMATOL, V31, P18, DOI 10.1016/j.clindermatol.2011.11.003; Dhurat Rachita, 2009, Int J Trichology, V1, P108, DOI 10.4103/0974-7753.58553; Dur M, 2014, J CROHNS COLITIS, V8, P45, DOI 10.1016/j.crohns.2012.12.014; Eyre H, 2012, PSYCHONEUROENDOCRINO, V37, P1397, DOI 10.1016/j.psyneuen.2012.03.019; Filipp SH, 1980, 11 U FACHB PSYCH; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Fritzsche K, 2005, PSYCHOSOC MED, V2, pDoc11; Gidlow CJ, 2016, PSYCHONEUROENDOCRINO, V63, P163, DOI 10.1016/j.psyneuen.2015.09.022; GLASER R, 1993, HEALTH PSYCHOL, V12, P435, DOI 10.1037/0278-6133.12.6.435; Gouin JP, 2012, ANN BEHAV MED, V44, P287, DOI 10.1007/s12160-012-9386-1; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Grass J, 2015, PSYCHONEUROENDOCRINO, V53, P108, DOI 10.1016/j.psyneuen.2014.12.023; Grover C, 2013, INDIAN J DERMATOL VE, V79, P591, DOI 10.4103/0378-6323.116731; Hadshiew IM, 2004, J INVEST DERMATOL, V123, P455, DOI 10.1111/j.0022-202X.2004.23237.x; Hartman Jill M, 2006, Health Qual Life Outcomes, V4, P2, DOI 10.1186/1477-7525-4-2; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hewig J, 2008, PSYCHONEUROENDOCRINO, V33, P83, DOI 10.1016/j.psyneuen.2007.10.004; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; House SL, 2015, J WOUND OSTOMY CONT, V42, P38, DOI 10.1097/WON.0000000000000080; Huang WY, 2017, J DERMATOLOGICAL SCI; Hunter HJA, 2015, CLIN EXP DERMATOL, V40, P540, DOI 10.1111/ced.12582; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Kahn M, 2009, REV MED CHILE, V137, P1437, DOI /S0034-98872009001100004; Kamezaki Y, 2012, PSYCHOPHYSIOLOGY, V49, P991, DOI 10.1111/j.1469-8986.2012.01371.x; Kang DH, 2001, RES NURS HEALTH, V24, P245, DOI 10.1002/nur.1027; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Katayama M, 2007, EXP DERMATOL, V16, P553, DOI 10.1111/j.1600-0625.2007.00558.x; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Kiecolt-Glaser JK, 2001, J CONSULT CLIN PSYCH, V69, P674, DOI 10.1037//0022-006X.69.4.674; Klaassens ER, 2010, PSYCHONEUROENDOCRINO, V35, P878, DOI 10.1016/j.psyneuen.2009.11.012; Koh KB, 2008, BRAIN BEHAV IMMUN, V22, P1130, DOI 10.1016/j.bbi.2008.06.009; Krohn M, 2011, SUPPORT CARE CANCER, V19, P1303, DOI 10.1007/s00520-010-0946-2; Kwack MH, 2017, EXPT DERMATOLOGY; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Liu ZQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04649; Loft P, 2007, PSYCHONEUROENDOCRINO, V32, P367, DOI 10.1016/j.psyneuen.2007.02.004; Madva EN, 2013, BRAIN BEHAV IMMUN, V34, P1, DOI 10.1016/j.bbi.2013.03.006; Maes M, 2015, MOL NEUROBIOL; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Matalka KZ, 2003, NEUROENDOCRINOL LETT, V24, P283; Mavros MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020306; Merz CJ, 2015, STRESS, V18, P138, DOI 10.3109/10253890.2014.989206; Meyer J, 2014, JOVE-J VIS EXP, DOI 10.3791/50882; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nahm Michael, 2013, Int J Trichology, V5, P63, DOI 10.4103/0974-7753.122959; Nordin S, 2013, NOISE HEALTH, V15, P173, DOI 10.4103/1463-1741.112366; Novak MA, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22547; Oh JW, 2016, J INVEST DERMATOL, V136, P34, DOI 10.1038/JID.2015.354; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Paine NJ, 2013, BRAIN BEHAV IMMUNITY; Paus R, 2014, TRENDS MOL MED, V20, P559, DOI 10.1016/j.molmed.2014.06.002; Paus R, 2011, PIGM CELL MELANOMA R, V24, P89, DOI 10.1111/j.1755-148X.2010.00808.x; Paus R, 2009, J INVEST DERMATOL, V129, P1324, DOI 10.1038/jid.2009.111; Peters EMJ, 2006, EXP DERMATOL, V15, P1, DOI 10.1111/j.0906-6705.2005.00372.x; Peters EMJ, 2005, BRAIN BEHAV IMMUN, V19, P252, DOI 10.1016/j.bbi.2004.08.005; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Peters EMJ, 2013, J INVEST DERMATOL, V133, P1150, DOI 10.1038/jid.2012.462; Peters EMJ, 2012, ANN NY ACAD SCI, V1262, P118, DOI 10.1111/j.1749-6632.2012.06647.x; Plikus M.V., 2015, J BIOL RHYTHMS; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Roy S, 2005, GENE EXPRESSION, V12, P273, DOI 10.3727/000000005783992025; Schulz P, 1999, DIAGNOSTICA, V45, P8, DOI 10.1026//0012-1924.45.1.8; Schut C, 2015, EXP DERMATOL, V24, P148, DOI 10.1111/exd.12578; Segerstrom SC, 2010, ANN BEHAV MED, V40, P114, DOI 10.1007/s12160-010-9195-3; Sharpley CF, 2011, REV NEUROSCIENCES; Short SJ, 2016, PSYCHONEUROENDOCRINO, V71, P12, DOI 10.1016/j.psyneuen.2016.05.007; Siebenhaar F, 2007, J INVEST DERMATOL, V127, P1489, DOI 10.1038/sj.jid.5700704; Siedentopf F, 2008, AM J REPROD IMMUNOL, V60, P449, DOI 10.1111/j.1600-0897.2008.00644.x; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Steinisch M, 2014, PSYCHONEUROENDOCRINO, V50, P20, DOI 10.1016/j.psyneuen.2014.08.001; Steudte S, 2011, PSYCHIAT RES, V186, P310, DOI 10.1016/j.psychres.2010.09.002; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Theoharides TC, 2017, EXPT DERMATOLOGY; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; Tomiyama AJ, 2011, PSYCHONEUROENDOCRINO, V36, P1513, DOI 10.1016/j.psyneuen.2011.04.005; Trueba AF, 2013, PSYCHOPHYSIOLOGY, V50, P5, DOI 10.1111/j.1469-8986.2012.01487.x; van Leeuwen N, 2011, PSYCHONEUROENDOCRINO, V36, P699, DOI 10.1016/j.psyneuen.2010.10.003; Wang L, 2014, ARCH DERMATOL RES; Wolfram M, 2013, STRESS HEALTH, V29, P143, DOI 10.1002/smi.2439; Xiang L, 2017, NEUROIMMUNOMODULATIO; Xiang LB, 2011, NEUROIMMUNOMODULAT, V18, P1, DOI 10.1159/000311450; Zunhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084911	100	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175904	10.1371/journal.pone.0175904	http://dx.doi.org/10.1371/journal.pone.0175904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28423056	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600061
J	Michalski, D; Pitsch, R; Pillai, DR; Mages, B; Aleithe, S; Grosche, J; Martens, H; Schlachetzki, F; Hartig, W				Michalski, Dominik; Pitsch, Roman; Pillai, Deepu R.; Mages, Bianca; Aleithe, Susanne; Grosche, Jens; Martens, Henrik; Schlachetzki, Felix; Haertig, Wolfgang			Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EPITHELIUM-DERIVED FACTOR; ENDOTHELIAL GROWTH-FACTOR; REACTIVE ASTROCYTES; ARTERY OCCLUSION; STROKE; INJURY; DISRUPTION; NEUROPROTECTION; MECHANISMS	Current stroke therapy is focused on recanalizing strategies, but neuroprotective co-treatments are still lacking. Modern concepts of the ischemia-affected neurovascular unit (NVU) and surrounding penumbra emphasize the complexity during the transition from initial damaging to regenerative processes. While early treatment with neurotrophic factors was shown to result in lesion size reduction and blood-brain barrier (BBB) stabilization, cellular consequences from these treatments are poorly understood. This study explored delayed cellular responses not only to ischemic stroke, but also to an early treatment with neurotrophic factors. Rats underwent 60 minutes of focal cerebral ischemia. Fluorescence labeling was applied to sections from brains perfused 7 days after ischemia. Analyses focused on NVU constituents including the vasculature, astrocytes and microglia in the ischemic striatum, the border zone and the contralateral hemisphere. In addition to histochemical signs of BBB breakdown, a strong up-regulation of collagen IV and microglia activation occurred within the ischemic core with simultaneous degradation of astrocytes and their endfeet. Activated astroglia were mainly depicted at the border zone in terms of a glial scar formation. Early treatment with pigment epithelium-derived factor (PEDF) resulted in an attenuation of the usually up-regulated collagen IV-immunoreactivity. However, glial activation was not influenced by treatment with PEDF or the epidermal growth factor (EGF). In conclusion, these data on ischemia-induced cellular reactions within the NVU might help to develop treatments addressing the transition from injury towards regeneration. Thereby, the integrity of the vasculature in close relation to neighboring structures like astrocytes appears as a promising target.	[Michalski, Dominik; Mages, Bianca; Aleithe, Susanne] Univ Leipzig, Dept Neurol, Liebigstr 20, Leipzig, Germany; [Pitsch, Roman; Mages, Bianca; Aleithe, Susanne; Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Liebigstr 19, Leipzig, Germany; [Pillai, Deepu R.; Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Univ Str 84, Regensburg, Germany; [Pillai, Deepu R.; Schlachetzki, Felix] Clin Neurol Rehabil II, Univ Str 84, Regensburg, Germany; [Pillai, Deepu R.] Forschungszentrum Julich, Inst Neurosci & Med INM 4, Julich, Germany; [Grosche, Jens] Effigos GmbH, Deutsch Pl 4, Leipzig, Germany; [Martens, Henrik] Synapt Syst, Gottingen, Germany	Leipzig University; Leipzig University; University of Regensburg; Helmholtz Association; Research Center Julich	Michalski, D (corresponding author), Univ Leipzig, Dept Neurol, Liebigstr 20, Leipzig, Germany.	dominik.michalski@medizin.uni-leipzig.de		Mages, Bianca/0000-0002-4761-2608	Europaischer Sozialfonds (ESF) [100270131]; University of Leipzig	Europaischer Sozialfonds (ESF)(European Commission); University of Leipzig	The study was mainly performed without external funding. During the revision process, some parts were supported by the Europaischer Sozialfonds (ESF, grant 100270131 to Dominik Michalski). Dr. Carsten Hobohm (University of Leipzig) is acknowledged for financial support during the early phase of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sarah Hoffmann (University of Leipzig) for assistance in imaging acquisition. Dr. Carsten Hobohm (University of Leipzig) is acknowledged for financial support during the early phase of the study.	Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chi OZ, 2007, EXP NEUROL, V204, P283, DOI 10.1016/j.expneurol.2006.11.001; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; del Zoppo Gregory J, 2008, Rev Neurol Dis, V5 Suppl 1, pS12; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2012, ANN NY ACAD SCI, V1268, P21, DOI 10.1111/j.1749-6632.2012.06691.x; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162; Friedrich B, 2015, STROKE, V46, P692, DOI 10.1161/STROKEAHA.114.008454; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hefti F, 1997, ANNU REV PHARMACOL, V37, P239, DOI 10.1146/annurev.pharmtox.37.1.239; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Inagaki Y, 2003, DIABETOLOGIA, V46, P284, DOI 10.1007/s00125-002-1013-4; Ito U, 2011, J CEREBR BLOOD F MET, V31, P328, DOI 10.1038/jcbfm.2010.97; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lo EH, 2016, J INVEST MED, V64, P827, DOI 10.1136/jim-2016-000104; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; Morris DC, 2003, BRAIN RES, V972, P31, DOI 10.1016/S0006-8993(03)02433-8; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Pillai DR, 2013, J CEREBR BLOOD F MET, V33, P557, DOI 10.1038/jcbfm.2012.201; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Salhia B, 2000, BRAIN RES, V883, P87, DOI 10.1016/S0006-8993(00)02825-0; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Taguchi Y, 2004, ARCH HISTOL CYTOL, V67, P253, DOI 10.1679/aohc.67.253; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; YING Z, 1993, J CEREBR BLOOD F MET, V13, P378, DOI 10.1038/jcbfm.1993.51; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174996	10.1371/journal.pone.0174996	http://dx.doi.org/10.1371/journal.pone.0174996			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445478	gold, Green Submitted, Green Published			2022-12-27	WOS:000400309200015
J	Bas-Hoogendam, JM; van Steenbergen, H; Kreuk, T; van der Wee, NJA; Westenberg, PM				Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; Kreuk, Tanja; van der Wee, Nic J. A.; Westenberg, P. Michiel			How embarrassing! The behavioral and neural correlates of processing social norm violations	PLOS ONE			English	Article							MORAL EMOTIONS; DECISION-MAKING; BRAIN IMAGES; FMRI; ROBUST; GUILT; SELF; METAANALYSIS; JUDGMENTS; ANXIETY	Social norms are important for human social interactions, and violations of these norms are evaluated partly on the intention of the actor. Here, we describe the revised Social Norm Processing Task (SNPT-R), a paradigm enabling the study of behavioral and neural responses to intended and unintended social norm violations among both adults and adolescents. We investigated how participants (adolescents and adults, n = 87) rate intentional and unintentional social norm violations with respect to inappropriateness and embarrassment, and we examined the brain activation patterns underlying the processing of these transgressions in an independent sample of 21 adults using functional Magnetic Resonance Imaging (fMRI). We hypothesized to find activation within the medial prefrontal cortex, temporo-parietal cortex and orbitofrontal cortex in response to both intentional and unintentional social norm violations, with more pronounced activation for the intentional social norm violations in these regions and in the amygdala. Participants' ratings confirmed the hypothesis that the three types of stories are evaluated differently with respect to intentionality: intentional social norm violations were rated as the most inappropriate and most embarrassing. Furthermore, fMRI results showed that reading stories on intentional and unintentional social norm violations evoked activation within the frontal pole, the paracingulate gyrus and the superior frontal gyrus. In addition, processing unintentional social norm violations was associated with activation in, among others, the orbitofrontal cortex, middle frontal gyrus and superior parietal lobule, while reading intentional social norm violations was related to activation in the left amygdala. These regions have been previously implicated in thinking about one's self, thinking about others and moral reasoning. Together, these findings indicate that the SNPT-R could serve as a useful paradigm for examining social norm processing, both at the behavioral and the neural level.	[Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; Kreuk, Tanja; Westenberg, P. Michiel] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Bas-Hoogendam, Janna Marie; van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; van der Wee, Nic J. A.; Westenberg, P. Michiel] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Bas-Hoogendam, JM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; Bas-Hoogendam, JM (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands.; Bas-Hoogendam, JM (corresponding author), Leiden Inst Brain & Cognit, Leiden, Netherlands.	j.m.hoogendam@fsw.leidenuniv.nl	Bas-Hoogendam, Janna Marie/M-9927-2014; van Steenbergen, Henk/B-4512-2008; Westenberg, P. Michiel/AAA-6390-2021	Bas-Hoogendam, Janna Marie/0000-0001-8982-1670; van Steenbergen, Henk/0000-0003-1917-6412; 	Leiden University Research Profile 'Health, Prevention and the Human Life Cycle'	Leiden University Research Profile 'Health, Prevention and the Human Life Cycle'	JMBH is funded by the Leiden University Research Profile Health, Prevention and the Human Life Cycle. The funding source had no involvement in study design, data collection, data analysis, writing this paper nor in the decision to submit this work for publication.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Bas-Hoogendam JM, 2017, DATABASE OPEN SCI FR; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bicchieri C., 2006, GRAMMAR SOC; Blair KS, 2010, AM J PSYCHIAT, V167, P1526, DOI 10.1176/appi.ajp.2010.09121797; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Brennan G., 2013, EXPLAINING NORMS; Carleton RN, 2006, DEPRESS ANXIETY, V23, P297, DOI 10.1002/da.20142; Chakroff A, 2016, SOC COGN AFFECT NEUR, V11, P476, DOI 10.1093/scan/nsv131; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Colombo M, 2014, BIOL PHILOS, V29, P71, DOI 10.1007/s10539-013-9385-z; Cova F, 2012, MIND LANG, V27, P378, DOI 10.1111/j.1468-0017.2012.01449.x; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P81, DOI 10.1037/a0025403; Finger EC, 2006, NEUROIMAGE, V33, P414, DOI 10.1016/j.neuroimage.2006.06.011; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haller SPW, 2015, DEV COGN NEUROS-NETH, V13, P11, DOI 10.1016/j.dcn.2015.02.002; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Jankowski KF, 2014, PSYCHIAT CLIN NEUROS, V68, P319, DOI 10.1111/pcn.12182; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jennings PL, 2015, J ORGAN BEHAV, V36, pS104, DOI 10.1002/job.1919; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Knutson KM, 2010, SOC COGN AFFECT NEUR, V5, P378, DOI 10.1093/scan/nsq005; Krettenauer T, 2014, J YOUTH ADOLESCENCE, V43, P583, DOI 10.1007/s10964-013-9994-5; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lahat A, 2012, COGNITIVE DEV, V27, P181, DOI 10.1016/j.cogdev.2012.02.002; Lisciandra C, 2013, REV PHILOS PSYCHOL, V4, P751, DOI 10.1007/s13164-013-0161-4; Malle BF, 1997, J EXP SOC PSYCHOL, V33, P101, DOI 10.1006/jesp.1996.1314; Mclatchie N, 2016, SOC COGN AFFECT NEUR, V11, P703, DOI 10.1093/scan/nsw001; Miller R.S., 2007, SELF CONSCIOUS EMOTI, P245; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2009, NEUROSCI BIOBEHAV R, V33, P456, DOI 10.1016/j.neubiorev.2008.12.001; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Callaghan C, 2016, BRAIN, P139; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Robins RW, 2009, SOC PERSONAL PSYCHOL, V3, P887, DOI 10.1111/j.1751-9004.2009.00217.x; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Sanfey AG, 2014, TRENDS COGN SCI, V18, P172, DOI 10.1016/j.tics.2014.01.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; van Kleef GA, 2015, CURR OPIN PSYCHOL, V6, P25, DOI 10.1016/j.copsyc.2015.03.013; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; You D, 2011, ETHICS BEHAV, V21, P263, DOI 10.1080/10508422.2011.585591; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zhang Y, 2016, J NEUROSCI, V36, P9217, DOI 10.1523/JNEUROSCI.0595-16.2016	63	20	20	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176326	10.1371/journal.pone.0176326	http://dx.doi.org/10.1371/journal.pone.0176326			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441460	Green Published, gold			2022-12-27	WOS:000400308800045
J	Konstantinidis, I; Patel, S; Camargo, M; Patel, A; Poojary, P; Coca, SG; Nadkarni, GN				Konstantinidis, Ioannis; Patel, Shanti; Camargo, Marianne; Patel, Achint; Poojary, Priti; Coca, Steven G.; Nadkarni, Girish N.			Representation and reporting of kidney disease in cerebrovascular disease: A systematic review of randomized controlled trials	PLOS ONE			English	Review							GLOMERULAR-FILTRATION-RATE; HEALTH-CARE PROFESSIONALS; NIH-REVITALIZATION-ACT; CLINICAL-TRIALS; STROKE; PARTICIPATION; PREDICTION; GUIDELINES; MANAGEMENT; CREATININE	Patients with kidney disease (KD) are at increased risk for cerebrovascular disease (CVD) and CVD patients with KD have worse outcomes. We aimed to determine the representation of KD patients in major randomized controlled trials (RCTs) of CVD interventions. We searched MEDLINE for reports of major CVD trials published through February 9, 2017. We excluded trials that did not report mortality outcomes, enrolled fewer than 100 participants, or were subgroup, follow-up, or post-hoc analyses. Two independent reviewers performed study selection and data extraction. We included 135 RCTs randomizing 194,977 participants. KD patients were excluded in 48 (35.6%) trials, but were less likely to be excluded from trials of class I/II recommended interventions (n = 7; 15.9%; p = 0.001) and more likely to be excluded in trials with registered protocols (45.5% vs. 22.4%; p = 0.007). Exclusion was lower in trials supported by academic or governmental grants compared to industry or combined funding (21.2% vs. 42.0% and 47.8%; p = 0.033 and 0.028, respectively). Among trials excluding KD patients, 24 (50.0%) used serum creatinine, 7 (14.6%) used estimated glomerular filtration rate or creatinine clearance, 7 (14.6%) used renal replacement therapy, and 19 (39.6%) used non-specific kidney-related criteria. Only 4 (3.0%) trials reported baseline renal function. No trials prespecified or reported subgroup analyses by baseline renal function. Although 19 (14.1%) trials reported the incidence of acute kidney injury, no trial examined adverse event rates according to renal function. In summary, more than one third of major CVD trials excluded patients with KD, primarily based on serum creatinine or nonspecific criteria, and outcomes were not stratified by renal parameters. Therefore, purposeful efforts to increase inclusion of KD patients in CVD trials and evaluate the impact of renal function on efficacy and safety are needed to improve the quality of evidence for interventions in this vulnerable population.	[Konstantinidis, Ioannis] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Patel, Shanti; Camargo, Marianne; Patel, Achint; Coca, Steven G.; Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Poojary, Priti] Icahn Sch Med Mt Sinai, Dept Publ Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Konstantinidis, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	ikonstan@gmail.com	Coca, Steven/L-7801-2019; Patel, Achint/AAM-5379-2020	Coca, Steven/0000-0002-0928-9168; Patel, Achint/0000-0003-4270-0825; Poojary, Priti/0000-0002-8686-7945; Konstantinidis, Ioannis/0000-0001-6785-1318				Chen MS, 2014, CANCER-AM CANCER SOC, V120, P1091, DOI 10.1002/cncr.28575; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; FREEDMAN LS, 1995, CONTROL CLIN TRIALS, V16, P277, DOI 10.1016/0197-2456(95)00048-8; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Konstantinidis I, 2016, JAMA INTERN MED, V176, P121, DOI 10.1001/jamainternmed.2015.6102; Lee M, 2011, EXPERT REV NEUROTHER, V11, P241, DOI 10.1586/ERN.10.204; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Masson P, 2015, NEPHROL DIAL TRANSPL, V30, P1162, DOI 10.1093/ndt/gfv009; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nadkarni GN, 2015, STROKE, V46, P3226, DOI 10.1161/STROKEAHA.115.010985; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; United States Renal Data System, 2015, 2015 USRDS ANN DAT R	19	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176145	10.1371/journal.pone.0176145	http://dx.doi.org/10.1371/journal.pone.0176145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426831	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900107
J	Berhe, M; Medhaniye, AA; Kahsay, G; Birhane, E; Abay, M				Berhe, Megbey; Medhaniye, Araya Abraha; Kahsay, Gizienesh; Birhane, Ermyas; Abay, Mebrahtu			Essential neonatal care utilization and associated factors among mothers in public health facilities of Aksum Town, North Ethiopia, 2016	PLOS ONE			English	Article								Background Globally, neonatal death accounts about 44% of child death in 2013. Ethiopia is one of the ten countries with the highest number of neonatal death. Worldwide, more than 43% of deaths among under five year children is contributed by neonates. Half of the neonatal death occur in the first day of life. Recommendations about newborn care practices may conflict with local beliefs and practices. So, it is important to understand the existing newborn care practice and factors affecting it in order to take interventions so as to decrease neonatal death. Objective To assess magnitude of essential neonatal care utilization and associated factors among women visiting public health facilities in Aksum Town, Tigray, Northern Ethiopia, 2015. Methods Facility based cross sectional study was conducted from December 30, 2015 to January 31, 2016. The sampled population are 423 women who gave live births within the last 6 months prior to data collection. Systematic random sampling technique was employed. Data were entered, coded and cleaned using Epi info version 7, and SPSS Version 21 software was used for analysis. Both bivariable and multivariable logistic regression models were used to determine factors associated with essential neonatal care utilization. Variables with P-value <0.2 in the bivariable logistic regression model were included in to multivariable logistic regression model, and finally variables with P-value <0.05 were considered as independent factors. Odds ratio was used to measure strength of association at 95% confidence level. Result A total of 423 mothers included in the study. Prevalence of safe cord care, optimal breast feeding, thermal care and baby received Tetracycline eye ointment and vaccine at birth were 42.8%, 63.1%, 32.6% and 44.7% among the respondents respectively. Only 113 (26.7%) of the participants fulfilled essential new born care practice. Occupation, parity and counseling on essential new born care during delivery were significantly associated with utilization of essential new born care. Employed women (AOR = 7.08; 95% CI (2.21, 12.72), 2-3 number of deliveries (AOR = 1.84; 95% CI (1.04, 3.26) and received counseling about essential new born car during delivery (AOR = 3.36; 95% CI (1.86, 6.08) were more likely to practice essential neonatal care practice than their counterparts. Conclusion and recommendation Around three-fourth of mothers were not practicing Essential Newborn Care (ENC). Occupation, parity and essential new born care counseling during delivery were significantly associated with utilization of ENC. Promotion of information at community level, women empowerment and staff training is recommended.	[Berhe, Megbey; Kahsay, Gizienesh; Birhane, Ermyas; Abay, Mebrahtu] Aksum Univ, Dept Publ Hlth, Aksum, Ethiopia; [Medhaniye, Araya Abraha] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia	Mekelle University	Abay, M (corresponding author), Aksum Univ, Dept Publ Hlth, Aksum, Ethiopia.	gmebrahtuabay@gmail.com		Abay, Mebrahtu/0000-0002-3307-0588				[Anonymous], 2014, EXECUTIVE SUMMARY LA; [Anonymous], 2014, OPPORTUNITIES AFRICA; [Anonymous], 2012, ETHIOPIAN DEMOGRAPHI; [Anonymous], 2014, HLTH SECT DEV PLAN 4; [Anonymous], 2004, COMPONENTS ESSENTIAL; Callaghan-koru JA, 2013, NEWBORN CARE PRACTIC; Daba W., 2015, ASSESSMENT MAGNITUDE; Dickson KE, 2014, EVERY NEWBORN 4 HLTH, V6736, P1; Lawn JE, 2012, NEWBORN SURVIVAL MUL, P6; Maternal Newborn, 2013, MATERNAL NEWBORN CHI; Mohammadi Y, 2014, PROTOCOL NASBOD STUD, V17, P3; Patel A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S10; Saaka M, 2014, PATTERNS DETERMINANT, P2014; Tegene T., 2015, CLINICS MOTHER CHILD, V12, P1, DOI [10.4172/2090-7214.1000172, DOI 10.4172/2090-7214.1000172]; Tura G, 2015, NEONATAL CARE PRACTI, P1; Wardlaw T, 2014, UNICEF REPORT ENORMO, P1; World Health Organization (WHO), 1996, MAT NEWB HLTH SAF MO; Zone G, 2015, COMMUNITY BASED ESSE, V01, P17	18	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175902	10.1371/journal.pone.0175902	http://dx.doi.org/10.1371/journal.pone.0175902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423043	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600060
J	Gupta, H; Chaudhari, S; Rai, A; Bhat, S; Sahu, PK; Hande, MH; D'Souza, SC; Shashikiran, U; Satyamoorthy, K				Gupta, Himanshu; Chaudhari, Sima; Rai, Ayushi; Bhat, Smitha; Sahu, Pratima K.; Hande, Manjunath H.; D'Souza, Sydney C.; Shashikiran, Umakanth; Satyamoorthy, Kapaettu			Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN EXPRESSION; DNA METHYLATION ANALYSIS; MDR1 UPSTREAM PROMOTER; BRAIN BILIRUBIN; BLOOD-CELLS; POLYMORPHISMS; ASSOCIATION; HYPERMETHYLATION; CYTOKINES	Multiple mechanisms such as genetic and epigenetic variations within a key gene may play a role in malarial susceptibility and response to anti-malarial drugs in the population. ABCB1 is one of the well-studied membrane transporter genes that code for the P-glycoprotein (an efflux protein) and whose effect on malaria disease predisposition and susceptibility to drugs remains to be understood. We studied the association of single nucleotide variations in human ABCB1 that influences its function in subjects with uncomplicated and complicated malaria caused by Plasmodium falciparum (Pf). Global DNA methylation and ABCB1 DNA promoter methylation levels were performed along with transcriptional response and protein expression in subjects with malaria and healthy controls. The rs2032582 locus was significantly associated with complicated and combined malaria groups when compared to controls (p < 0.05). Significant DNA methylation difference was noticed between case and control (p < 0.05). In addition, global DNA methylation levels of the host DNA were inversely proportional to parasitemia in individuals with Pf infection. Our study also revealed the correlation between ABCB1 DNA promoter methylation with rs1128503 and rs2032582 polymorphisms in malaria and was related to increased expression of ABCB1 protein levels in complicated malaria group (p < 0.05) when compared to uncomplicated malaria and control groups. The study provides evidence for multiple mechanisms that may regulate the role of host ABCB1 function to mediate aetiology of malaria susceptibility, prognosis and drug response. These may have clinical implications and therapeutic application for various malarial conditions.	[Gupta, Himanshu; Chaudhari, Sima; Rai, Ayushi; Bhat, Smitha; Satyamoorthy, Kapaettu] Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal, Karnataka, India; [Sahu, Pratima K.] VIMSAR, Dept Biochem & Mol Biol, Sambalpur, Odisha, India; [Hande, Manjunath H.] Manipal Univ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India; [D'Souza, Sydney C.] Manipal Univ, Kasturba Med Coll, Dept Med, Mangalore, Karnataka, India; [Shashikiran, Umakanth] Dr TMA Pai Hosp, Dept Med, Udupi, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Satyamoorthy, K (corresponding author), Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal, Karnataka, India.	ksatyamoorthy@manipal.edu	Gupta, Himanshu/G-8834-2015; Umakanth, Shashikiran/K-5036-2015	Gupta, Himanshu/0000-0003-1391-8358; Satyamoorthy, Kapaettu/0000-0002-2368-5490; Umakanth, Shashikiran/0000-0001-5210-7457; Hande, Manjunatha/0000-0001-9040-5252	Dr T. M. A. Pai Endowed Chair; TIFAC-CORE in Pharmacogenomics, Government of India	Dr T. M. A. Pai Endowed Chair; TIFAC-CORE in Pharmacogenomics, Government of India(Department of Science & Technology (India))	We gratefully acknowledge the support of Dr T. M. A. Pai Endowed Chair to KS and TIFAC-CORE in Pharmacogenomics, Government of India for financial assistance.	Ali IM, 2014, PATHOG GLOB HEALTH, V108, P323, DOI 10.1179/2047773214Y.0000000159; Apinjoh TO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-236; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Bjanesoy TE, 2014, MOL IMMUNOL, V59, P208, DOI 10.1016/j.molimm.2014.02.018; Brito MA, 2000, EUR J CLIN INVEST, V30, P239; Burk O, 2012, BRIT J PHARMACOL, V167, P666, DOI 10.1111/j.1476-5381.2012.02033.x; Cacabelos R., 2016, J ALZHEIMERS DIS PAR, V6, DOI [10.4172/2161-0460.1000229, DOI 10.4172/2161-0460.1000229]; Chinn LW, 2007, CLIN PHARMACOL THER, V81, P265, DOI 10.1038/sj.clpt.6100052; Chong CR, 2003, BIOCHEM PHARMACOL, V66, P2201, DOI 10.1016/j.bcp.2003.08.009; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Correa S, 2014, EPIGENETICS-US, V9, P1172, DOI 10.4161/epi.29675; Correa S, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-23; Cox AG, 2010, CONCEPTS PHARMACOGEN, P129; Dalko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054744; Das J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1010; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; Ding SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042104; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; El-Nashar Thanaa M., 2002, Journal of the Egyptian Society of Parasitology, V32, P525; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Englund G, 2007, INFLAMM BOWEL DIS, V13, P291, DOI 10.1002/ibd.20030; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Fernandes RC, 2015, MOL GENET GENOMICS, V290, P1155, DOI 10.1007/s00438-014-0984-4; Ferreira PE, 2008, THER DRUG MONIT, V30, P10, DOI 10.1097/FTD.0b013e31815e93c6; Fyrberg A, 2011, CANCER CHEMOTH PHARM, V68, P583, DOI 10.1007/s00280-010-1524-5; Garcia-Manero G, 2002, CLIN CANCER RES, V8, P2217; Gatidis S, 2009, ANN HEMATOL, V88, P721, DOI 10.1007/s00277-009-0697-7; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; GHISO NS, 1994, IN VITRO CELL DEV-AN, V30A, P744, DOI 10.1007/BF02631295; Goncalves RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044394; Green H, 2012, PHARMACOGENOMICS J, V12, P111, DOI 10.1038/tpj.2010.79; Gupta H, 2015, INFECT GENET EVOL, V34, P188, DOI 10.1016/j.meegid.2015.06.010; Gupta H, 2013, ACTA TROP, V128, P571, DOI 10.1016/j.actatropica.2013.08.005; Gurney H, 2007, CLIN PHARMACOL THER, V82, P33, DOI 10.1038/sj.clpt.6100201; Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004; Hanko E, 2003, PEDIATR RES, V54, P441, DOI 10.1203/01.PDR.0000085169.87948.B6; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Jason J, 2001, CLIN IMMUNOL, V100, P208, DOI 10.1006/clim.2001.5057; Kanchan K, 2015, EUR J CLIN MICROBIOL, V34, P2029, DOI 10.1007/s10096-015-2448-0; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; KAUFMANN NA, 1967, CLIN SCI, V33, P201; Kerb R, 2009, LANCET INFECT DIS, V9, P760, DOI 10.1016/S1473-3099(09)70320-2; Khan NM, 2011, J LEUKOCYTE BIOL, V90, P997, DOI 10.1189/jlb.0211070; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kiyotani K, 2012, DRUG METAB PHARMACOK, V27, P122, DOI 10.2133/dmpk.DMPK-11-RV-084; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Kuerbitz SJ, 2002, CARCINOGENESIS, V23, P559, DOI 10.1093/carcin/23.4.559; Kumar A, 2011, INT J RADIAT BIOL, V87, P1086, DOI 10.3109/09553002.2011.605417; Kumar S, 2008, FREE RADICAL BIO MED, V44, P602, DOI 10.1016/j.freeradbiomed.2007.10.057; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Brambila-Tapia AJL, 2013, REV INVEST CLIN, V65, P445; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Maiga B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075675; Manjurano A, 2015, J INFECT DIS, V212, P1129, DOI 10.1093/infdis/jiv192; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Milojkovic M, 2015, BIOMED PAP, V159, P341, DOI 10.5507/bp.2014.032; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Mombo LE, 2003, AM J TROP MED HYG, V68, P186, DOI 10.4269/ajtmh.2003.68.186; Moore LR, 2006, FASEB J, V20, P747, DOI 10.1096/fj.05-5122fje; Mukonzo JK, 2010, THER DRUG MONIT, V32, P346, DOI 10.1097/FTD.0b013e3181da79d6; Ostrow JD, 2003, PEDIATR RES, V54, P98, DOI 10.1203/01.PDR.0000067486.79854.D5; Piyathilake CJ, 2001, HUM PATHOL, V32, P856, DOI 10.1053/hupa.2001.26471; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Raguz S, 2004, CLIN CANCER RES, V10, P2776, DOI 10.1158/1078-0432.CCR-03-0517; Raguz S, 2008, INT J CANCER, V122, P1058, DOI 10.1002/ijc.23149; Reed K, 2010, PHARMACOGENOMICS J, V10, P489, DOI 10.1038/tpj.2010.1; Reed K, 2008, EPIGENETICS-US, V3, P270, DOI 10.4161/epi.3.5.6868; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Rotti H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0506-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shi CJ, 2011, LEUKEMIA RES, V35, P73, DOI 10.1016/j.leukres.2010.04.019; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Silva RFM, 2001, J HEPATOL, V34, P402, DOI 10.1016/S0168-8278(01)00015-0; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sudha Jha, 2014, International Journal of Biomedical and Advance Research, V5, P160; Teeranaipong P, 2008, J INFECT DIS, V198, P1880, DOI 10.1086/593338; Torre D, 2002, LANCET INFECT DIS, V2, P719, DOI 10.1016/S1473-3099(02)00449-8; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; UEDA K, 1987, J BIOL CHEM, V262, P17432; UEDA K, 1987, J BIOL CHEM, V262, P505; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; Watchko JF, 1998, PEDIATR RES, V44, P763, DOI 10.1203/00006450-199811000-00020; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WHO, 2015, WORLD MAL REP 2015	96	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175702	10.1371/journal.pone.0175702	http://dx.doi.org/10.1371/journal.pone.0175702			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422980	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600044
J	Korse, NS; Veldman, AB; Peul, WC; Vleggeert-Lankamp, CLA				Korse, Nina S.; Veldman, Anna B.; Peul, Wilco C.; Vleggeert-Lankamp, Carmen L. A.			The long term outcome of micturition, defecation and sexual function after spinal surgery for cauda equina syndrome	PLOS ONE			English	Article							LUMBAR INTERVERTEBRAL-DISK; IMPROVING RESPONSE RATES; SYNDROME SECONDARY; FOLLOW-UP; PROLAPSE; METAANALYSIS; COMPRESSION; PREDICTORS; HERNIATION	Background Cauda equina syndrome (CES) is a rare neurologic complication of lumbar herniated disc for which emergency surgical decompression should be undertaken. Despite the common belief that the restoration of functions that are affected by CES can take several years post-operatively, follow up seldom exceeds the first year after surgery. Long term outcome of especially micturition, defecation and sexual function-which are by definition affected in CES-are unknown. The aim of this study is to evaluate 1) postoperative long term outcome of micturition, defecation and sexual function in CES patients 2) attitude of patients towards received hospital care with regard to (recovery of) these functions. Methods CES patients were selected by screening the records of all patients operated on lumbar herniated disc in our university hospital between 1995-2010. A questionnaire was sent to the selected CES patients evaluating current complaints of micturition, defecation and sexual function and attitude towards delivered care with focus on micturition, defecation and sexual function. Results Thirty-seven of 66 eligible CES patients were included (response rate 71%, inclusion rate 56%). Median time after surgery was 13.8 years (range 5.8-21.8 years). Dysfunction at follow up was highly prevalent: 38% micturition dysfunction, 43% defecation dysfunction and 54% sexual dysfunction. Younger age at presentation was associated with sexual dysfunction at follow up: for every year younger at presentation, odds ratio for sexual dysfunction at follow up was 1.11 (p = 0.035). Other associations with outcome were not identified. Two-third of the CES patients wished their neurosurgeon had given them more prognostic information about micturition, defecation and sexual function. Conclusion The presented data demonstrate that dysfunction of micturition, defecation and sexual function are still highly prevalent in a large number of CES patients even years postoperatively. These alarming follow up data probably have a devastating effect on personal perceived quality of life, which should be studied in more detail. CES patients communicate a clear demand for more prognostic information. The presented figures enable clinicians to inform their CES patients more realistically about long term postoperative outcome of micturition, defecation and sexual function after surgical intervention.	[Korse, Nina S.; Veldman, Anna B.; Peul, Wilco C.; Vleggeert-Lankamp, Carmen L. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Peul, Wilco C.] Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center	Korse, NS (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	rls.korse@lumc.nl	Vleggeert-Lankamp, Carmen/AGX-9660-2022	Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; , Anna Baukje/0000-0001-5385-4729				Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010; AHO AJ, 1969, ACTA CHIR SCAND, V135, P413; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Beculic Hakija, 2016, Med Glas (Zenica), V13, P136, DOI 10.17392/861-16; Buchner M, 2000, NEURO-ORTHOPEDICS, V27, P55; Busse J W, 2001, CJEM, V3, P285; Chang HS, 2000, SURG NEUROL, V53, P100, DOI 10.1016/S0090-3019(99)00180-9; Consortium for Spinal Cord Medicine, 2010, J SPINAL CORD MED, V33, P281; Cook JV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-160; Delong WB, 2008, J NEUROSURG-SPINE, V8, P305, DOI 10.3171/SPI/2008/8/4/305; Dhatt S, 2011, EUR SPINE J, V20, P2235, DOI 10.1007/s00586-011-1840-4; DINNING TAR, 1993, AUST NZ J SURG, V63, P927, DOI 10.1111/j.1445-2197.1993.tb01721.x; Domen PM, 2009, EUR J NEUROL, V16, P416, DOI 10.1111/j.1468-1331.2008.02510.x; Fraser S, 2009, ARCH PHYS MED REHAB, V90, P1964, DOI 10.1016/j.apmr.2009.03.021; Gardner A, 2011, EUR SPINE J, V20, P690, DOI 10.1007/s00586-010-1668-3; GLEAVE J R W, 1990, British Journal of Neurosurgery, V4, P205, DOI 10.3109/02688699008992725; Hayes RD, 2007, FERTIL STERIL, V87, P107, DOI 10.1016/j.fertnstert.2006.05.071; Hayes RD, 2007, J SEX MED, V4, P286, DOI 10.1111/j.1743-6109.2007.00433.x; HELLSTROM P, 1986, J UROLOGY, V135, P308, DOI 10.1016/S0022-5347(17)45621-7; Hussain SA, 2003, BRIT J NEUROSURG, V17, P164, DOI 10.1080/0268869031000109098; JENNETT WB, 1956, J NEUROL NEUROSUR PS, V19, P109, DOI 10.1136/jnnp.19.2.109; Kennedy JG, 1999, EUR SPINE J, V8, P317, DOI 10.1007/s005860050180; Korse NS, 2017, EUR SPINE J, V26, P894, DOI 10.1007/s00586-017-4943-8; Korse NS, 2016, EUR SPINE J, V25, P766, DOI 10.1007/s00586-015-3991-1; Korse NS, 2013, EUR SPINE J, V22, P1019, DOI 10.1007/s00586-012-2601-8; KOSTUIK JP, 1986, J BONE JOINT SURG AM, V68A, P386, DOI 10.2106/00004623-198668030-00011; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.3.e30; Ma B, 2009, CHINESE MED J-PEKING, V122, P1214, DOI 10.3760/cma.j.issn.0366-6999.2009.10.019; McCarthy MJH, 2007, SPINE, V32, P207, DOI 10.1097/01.brs.0000251750.20508.84; Phillips AW, 2016, MED TEACH, V38, P217, DOI 10.3109/0142159X.2015.1105945; Qureshi A, 2007, EUR SPINE J, V16, P2143, DOI 10.1007/s00586-007-0491-y; Raj D, 2008, ACTA ORTHOP BELG, V74, P522; SCOTT P J, 1965, J Bone Joint Surg Br, V47, P224; SHEPHARD RH, 1959, BRIT MED J, V2, P1434, DOI 10.1136/bmj.2.5164.1434; SPANNARE BJ, 1978, ACTA NEUROCHIR, V42, P189, DOI 10.1007/BF01405333; Tamburrelli FC, 2014, EUR REV MED PHARMACO, V18, P1098; TAY ECK, 1979, J BONE JOINT SURG BR, V61, P43, DOI 10.1302/0301-620X.61B1.154521; Todd NV, 2011, BRIT J NEUROSURG, V25, P503, DOI 10.3109/02688697.2010.550344; Todd NV, 2005, BRIT J NEUROSURG, V19, P301, DOI 10.1080/02688690500305324; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899	40	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175987	10.1371/journal.pone.0175987	http://dx.doi.org/10.1371/journal.pone.0175987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423044	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600072
J	Robb, KP; Cotechini, T; Allaire, C; Sperou, A; Graham, CH				Robb, Kevin P.; Cotechini, Tiziana; Allaire, Camille; Sperou, Arissa; Graham, Charles H.			Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1 alpha accumulation	PLOS ONE			English	Article							OXIDE SYNTHASE INHIBITION; TUMOR-NECROSIS-FACTOR; PREECLAMPTIC PLACENTAE; TYROSINE KINASE-1; CYTOKINE PROFILE; PREGNANT MICE; SERUM-LEVELS; BLOOD-FLOW; HYPOXIA; WOMEN	Introduction Hypoxia-inducible factor 1-alpha (HIF-1 alpha) is the oxygen-sensitive subunit of the transcription factor HIF-1, and its expression is increased in placentas from pregnancies complicated by pre-eclampsia (PE). Fetal growth restriction (FGR) and PE often share a common pathophysiology; however, it is unknown whether increased placental HIF-1 alpha occurs in FGR. We previously demonstrated that aberrant maternal inflammation in rats resulted in altered utero-placental perfusion and FGR, both of which were prevented by administration of the nitric oxide mimetic glyceryl trinitrate (GTN). Our aim here was to determine whether abnormal maternal inflammation causing FGR is linked to placental HIF-1 alpha accumulation and whether GTN administration could prevent increases in placental HIF-1 alpha. Methods Levels of inflammatory factors in maternal plasma were measured using a multiplex assay after an injection of low-dose lipopolysaccharide (LPS) to rats on gestational day (GD) 13.5. Following three additional daily LPS injections from GD14.5-16.5, GD17.5 placentas were harvested for HIF-1 alpha immunolocalisation; serial sections were also stained for the hypoxia marker pimonidazole. A subset of rats received LPS injections along with GTN delivered continuously (25 mu g/h via a transdermal patch) on GD12.5-GD17.5. Results Within two hours of LPS administration, levels of maternal pro-inflammatory cytokines were increased compared with saline-treated controls. GD17.5 placentas of growth-restricted fetuses exhibited increased HIF-1 alpha accumulation; however, this did not correlate with pimonidazole staining for which no differences were observed between groups. Furthermore, the LPS-mediated increases in maternal inflammatory cytokine levels and placental HIF-1 alpha accumulation did not occur in rats treated with GTN. Discussion Our results demonstrate that inflammation-induced FGR is associated with increased placental HIF-1 alpha accumulation; however, expression of this transcription factor may not correlate with regions of hypoxia in late-gestation placentas. The GTN-mediated attenuation of placental HIF-1 alpha accumulation in LPS-treated rats provides insight into the mechanism by which GTN improves inflammation-induced complications of pregnancy.	[Robb, Kevin P.; Cotechini, Tiziana; Allaire, Camille; Sperou, Arissa; Graham, Charles H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Graham, CH (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	grahame@queensu.ca	Cotechini, Tiziana/AAH-2161-2021	Cotechini, Tiziana/0000-0001-6762-3649	Canadian Institutes of Health Research [MOP 119496]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (grant number MOP 119496) awarded to CHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barsoum IB, 2011, AM J PATHOL, V178, P2888, DOI 10.1016/j.ajpath.2011.02.013; Bartha JL, 2003, ACTA OBSTET GYN SCAN, V82, P1099, DOI 10.1046/j.1600-0412.2003.00259.x; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Cotechini T, 2014, PLACENTA, V35, P575, DOI 10.1016/j.placenta.2014.05.002; Cotechini T, 2015, PLACENTA; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Cotechini T, 2012, THROMB HAEMOSTASIS, V107, P864, DOI 10.1160/TH11-10-0730; Damodaram M, 2011, AUST NZ J OBSTET GYN, V51, P204, DOI 10.1111/j.1479-828X.2011.01299.x; DIKET AL, 1994, AM J OBSTET GYNECOL, V171, P1243, DOI 10.1016/0002-9378(94)90141-4; Elfayomy AK, 2013, J OBSTET GYNAECOL, V33, P135, DOI 10.3109/01443615.2012.721821; Hayashi M, 2007, AM J REPROD IMMUNOL, V57, P488, DOI 10.1111/j.1600-0897.2007.00480.x; Helmbrecht GD, 1996, AM J OBSTET GYNECOL, V175, P800, DOI 10.1016/S0002-9378(96)80002-0; Huang SJ, 2010, AM J PATHOL, V177, P2472, DOI 10.2353/ajpath.2010.091247; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kulandavelu S, 2013, HYPERTENSION, V61, P259, DOI 10.1161/HYPERTENSIONAHA.112.201996; Kulandavelu S, 2012, HYPERTENSION, V60, P231, DOI 10.1161/HYPERTENSIONAHA.111.187559; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; Lausten-Thomsen U, 2014, FETAL PEDIATR PATHOL, V33, P114, DOI 10.3109/15513815.2013.879239; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MALLMANN P, 1991, ARCH GYNECOL OBSTET, V249, P73, DOI 10.1007/BF02390365; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moffett A, 2004, PLACENTA, V25, P1, DOI 10.1016/S0143-4004(03)00167-X; Movafagh S, 2015, J CELL BIOCHEM, V116, P696, DOI 10.1002/jcb.25074; Mullins E, 2013, AM J REPROD IMMUNOL, V69, P441, DOI 10.1111/aji.12052; Mullins E, 2012, AM J REPROD IMMUNOL, V68, P1, DOI 10.1111/j.1600-0897.2012.01132.x; Neerhof MG, 2011, HYPERTENS PREGNANCY, V30, P28, DOI 10.3109/10641950903322915; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Peleg D, 1998, AM FAM PHYSICIAN, V58, P453; Rajakumar A, 2008, PLACENTA, V29, P290, DOI 10.1016/j.placenta.2007.11.015; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Rajakumar A, 2003, PLACENTA, V24, P199, DOI 10.1053/plac.2002.0893; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Rennie MY, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123968; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Vassiliadis S, 1998, MEDIAT INFLAMM, V7, P69, DOI 10.1080/09629359891199; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429	53	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175805	10.1371/journal.pone.0175805	http://dx.doi.org/10.1371/journal.pone.0175805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423052	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600054
J	Wei, HS; Li, KB; Zhang, S; Cao, YZ; Yin, J				Wei, Hong-Shuang; Li, Ke-Bin; Zhang, Shuai; Cao, Ya-Zhong; Yin, Jiao			Identification of candidate chemosensory genes by transcriptome analysis in Loxostege sticticalis Linnaeus	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; IONOTROPIC GLUTAMATE RECEPTORS; PHEROMONE BINDING; SOLUBLE-PROTEINS; MOLECULAR-BASIS; BOMBYX-MORI; MOTH; EXPRESSION; FAMILY; SILKWORM	Loxostege sticticalis Linnaeus is an economically important agricultural pest, and the larvae cause great damage to crops, especially in Northern China. However, effective and environmentally friendly chemical methods for controlling this pest have not been discovered to date. In the present study, we performed HiSeq2500 sequencing of transcriptomes of the male and female adult antennae, adult legs and third instar larvae, and we identified 54 candidate odorant receptors (ORs), including 1 odorant receptor coreceptor (Orco) and 5 pheromone receptors (PRs), 18 ionotropic receptors (IRs), 13 gustatory receptors (GRs), 34 odorant binding proteins (OBPs), including 1 general odorant binding protein (GOBP1) and 3 pheromone binding proteins (PBPs), 10 chemosensory proteins (CSPs) and 2 sensory neuron membrane proteins (SNMPs). The results of RNA-Seq and RT-qPCR analyses showed the expression levels of most genes in the antennae were higher than that in the legs and larvae. Furthermore, PR4, OR1-4, 7-11, 13-15, 23, 29-32, 34, 41, 43, 47/IR7d.2/GR5b, 45, 7/PBP2-3, GOBP1, OBP3, 8 showed female antennae-biased expression, while PR1/OBP2, 7/IR75d/CSP2 showed male antennae-biased expression. However, IR1, 7d.3, 68a/OBP11, 20-22, 28/CSP9 had larvae enriched expression, and OBP15, 17, 25, 29/CSP5 were mainly expressed in the legs. The results shown above indicated that these genes might play a key role in foraging, seeking mates and host recognition in the L. sticticalis. Our findings will provide the basic knowledge for further studies on the molecular mechanisms of the olfactory system of L. sticticalis and potential novel targets for pest control strategies.	[Wei, Hong-Shuang; Li, Ke-Bin; Zhang, Shuai; Cao, Ya-Zhong; Yin, Jiao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yin, J (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	jyin@ippcaas.cn		Zhang, Shuai/0000-0003-3646-1522	National Natural Science Foundation of China [31572007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This present work was supported by the National Natural Science Foundation of China (No. 31572007).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Allen JE, 2011, INSECT BIOCHEM MOLEC, V41, P141, DOI 10.1016/j.ibmb.2010.10.005; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Blomquist GJ, 2003, INSECT BIOCH MOL BIO; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Freeman EG, 2014, P NATL ACAD SCI USA, V111, P1598, DOI 10.1073/pnas.1311724111; Ge X, 2016, SCI REP-UK, V6, DOI 10.1038/srep32636; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Jia XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29067; Jia Xiao-Jian, 2015, Acta Entomologica Sinica, V58, P1167; Jiang XJ, 2015, INSECT BIOCHEM MOLEC, V60, P39, DOI 10.1016/j.ibmb.2015.03.002; Jin R, 2015, J INTEGR AGR, V14, P1356, DOI 10.1016/S2095-3119(14)60849-2; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li Liang, 2009, Acta Entomologica Sinica, V52, P1199; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149591; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Ning C, 2016, INSECT BIOCHEM MOLEC, V73, P12, DOI 10.1016/j.ibmb.2016.04.002; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Poudel S, 2015, INSECT BIOCHEM MOLEC, V66, P110, DOI 10.1016/j.ibmb.2015.10.010; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Qu Xi-Feng, 1999, Entomological Knowledge, V36, P11; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Struble DL, 1997, CAN ENTOMOL, V109, P261; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu W, 2015, INSECT MOL BIOL, V24, P253, DOI 10.1111/imb.12153; Xu W, 2012, J CHEM ECOL, V38, P1513, DOI 10.1007/s10886-012-0221-8; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121261; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Yin Jiao, 2004, Entomological Knowledge, V41, P56; Yin Jiao, 2004, Acta Phytophylacica Sinica, V31, P173; [尹姣 Yin Xiao], 2005, [生态学报, Acta Ecologica Sinica], V25, P1844; Zeng FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144267; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang LX, 2010, CHIN AGR SCI B, V26, P215; Zhang TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128550; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	74	17	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174036	10.1371/journal.pone.0174036	http://dx.doi.org/10.1371/journal.pone.0174036			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423037	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600013
J	Deng, YM; Sun, XB; Gu, CS; Jia, XP; Liang, LJ; Su, JL				Deng, Yanming; Sun, Xiaobo; Gu, Chunsun; Jia, Xinping; Liang, Lijian; Su, Jiale			Identification of pre-fertilization reproductive barriers and the underlying cytological mechanism in crosses among three petal-types of Jasminum sambac and their relevance to phylogenetic relationships	PLOS ONE			English	Article							DIFFERENTIAL RESPONSES; STIGMA RECEPTIVITY; POLLEN VIABILITY; MORPHOLOGY; ANATOMY; PISTIL	Crosses among single-, double- and multi-petal jasmine cultivars (Jasminum sambac Aiton) are unable to easily generate hybrids. To identify the reproductive barriers restricting hybrid set, dynamic changes in jasmine pollen viability and pistil receptivity were compared at different flowering stages. Pollen-pistil interactions in six reciprocal crosses were also investigated to characterize pollen-stigma compatibility. Additionally, paraffin sections of pollinated embryo sacs were prepared for subsequent analyses of developmental status. Furthermore, pistil cell ultrastructural characteristics were observed to reveal cytological mechanism regulating pistil receptivity and the pollen-pistil interactions. We observed that pollen viability and stigma receptivity varied depending on petal phenotype and flowering stage and were easily lost during flowering. Different reciprocal crosses exhibited varied pollen-stigma compatibilities according to the pollen germination rates. Although some pollen grains germinated normally on maternal stigmas, the pollen tubes were arrested in the pistils and were unable to reach the ovaries. Additionally, the embryo sacs remained unfertilized until degenerating. Therefore, jasmine crosses are affected by pre-fertilization reproductive barriers. Low pollen fertility and poor stigma receptivity are detrimental to pollen germination and pollen-pistil compatibility, indicating they are two factors affecting hybrid set. Ultrastructural observation of the pistil cells revealed that cell death occurred during flowering. Thus, the early and rapid senescence of pistils is likely responsible for the decreased pistil receptivity and inhibited pollen tube growth. These findings may be relevant for future jasmine hybridizations. They provide new insights for the development of methods to overcome reproductive barriers and may also be useful for clarifying the phylogenetic relationships among jasmine cultivars with differing petal phenotypes.	[Deng, Yanming; Sun, Xiaobo; Jia, Xinping; Su, Jiale] Jiangsu Acad Agr Sci, Inst Leisure Agr, Prov Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China; [Gu, Chunsun; Liang, Lijian] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Su, JL (corresponding author), Jiangsu Acad Agr Sci, Inst Leisure Agr, Prov Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	potted_flowers@163.com		Li, Chang/0000-0001-5722-0336; Sun, Xiaobo/0000-0002-3532-7287; Deng, Yanming/0000-0001-7978-1417	Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX(14)5053]; National Natural Science Foundation of China [31101569]; Science and Technology Support Program of Jiangsu Province [BE2014408]; Jiangsu Government Scholarship Overseas Studies [JS-2014-118]	Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangsu Province; Jiangsu Government Scholarship Overseas Studies	This study was funded by the Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX(14)5053), National Natural Science Foundation of China (31101569), Science and Technology Support Program of Jiangsu Province (BE2014408), and Jiangsu Government Scholarship Overseas Studies (JS-2014-118). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Twab Magdy Hussein, 1999, Chromosome Science, V3, P21; Aleemullah M, 2000, AUST J EXP AGR, V40, P755, DOI 10.1071/EA99038; Aliyu OM, 2007, EUPHYTICA, V158, P249, DOI 10.1007/s10681-007-9447-x; BOYLE TH, 1982, EUPHYTICA, V31, P857, DOI 10.1007/BF00039226; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Chatelet P, 2007, J EXP BOT, V58, P4107, DOI 10.1093/jxb/erm269; Cisneros-Lopez ME, 2012, PLANT BREEDING, V131, P88, DOI 10.1111/j.1439-0523.2011.01922.x; Dadpour MR, 2011, SCI HORTIC-AMSTERDAM, V127, P535, DOI 10.1016/j.scienta.2010.12.004; Deng Y.M., 2014, ACTA AGR BOR SIN, V29, P172; Deng YM, 2016, SCI HORTIC-AMSTERDAM, V198, P257, DOI 10.1016/j.scienta.2015.11.036; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V144, P19, DOI 10.1016/j.scienta.2012.06.031; Deng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044337; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Deng YM, 2010, EUPHYTICA, V174, P41, DOI 10.1007/s10681-009-0113-3; Deng YM, 2010, PLANTA, V231, P693, DOI 10.1007/s00425-009-1081-5; Douglas AC, 2010, EUPHYTICA, V174, P105, DOI 10.1007/s10681-010-0145-8; Guo SuZhi, 2013, Journal of Tropical and Subtropical Botany, V21, P123; [郭素枝 GUO SuZhi], 2006, [中国生态农业学报, Chinese journal of eco-agriculture], V14, P42; [郭素枝 Guo Suzhi], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P40; Knox RB, 1986, PLANT BREEDING REV, V4; Lai MingZhi, 1995, Journal of Fujian Agricultural University, V24, P291; Lai MingZhi, 1996, Journal of Fujian Agricultural University, V25, P442; Li J, 2009, SCI HORTIC-AMSTERDAM, V121, P474, DOI 10.1016/j.scienta.2009.02.025; Raghavan V, 2007, DOUBLE FERTILIZATION; Ram SG, 2008, EUPHYTICA, V159, P241, DOI 10.1007/s10681-007-9483-6; Serrano I, 2008, SEX PLANT REPROD, V21, P99, DOI 10.1007/s00497-008-0075-y; Shen DX, 1995, BREEDING FRUIT TREES; STONE JL, 1995, AM J BOT, V82, P1186, DOI 10.2307/2446073; Suarez C, 2012, SEX PLANT REPROD, V25, P133, DOI 10.1007/s00497-012-0186-3; Sun CQ, 2010, EUPHYTICA, V171, P181, DOI 10.1007/s10681-009-0005-6; Teng NJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-82; Vervaeke I, 2001, EUPHYTICA, V118, P91, DOI 10.1023/A:1004016709231; Wang QC, 2005, CHINESE LOTUS; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Xie LL, 2007, MOD AGRIC SCI TECH, V3, P26; Zhao HE, 2009, GENET RESOUR CROP EV, V56, P937, DOI 10.1007/s10722-009-9412-8; Zhao L.M., 2004, SOYBEAN SCI, V23, P250; Zrao HB, 2007, ACTA PHYTOTAXON SIN, V45, P661, DOI 10.1360/aps06112	38	14	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176026	10.1371/journal.pone.0176026	http://dx.doi.org/10.1371/journal.pone.0176026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419158	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200062
J	Ehrmann, FR; Stojko, J; Metz, A; Debaene, F; Barandun, LJ; Heine, A; Diederich, F; Cianferani, S; Reuter, K; Klebe, G				Ehrmann, Frederik Rainer; Stojko, Johann; Metz, Alexander; Debaene, Francois; Barandun, Luzi Jakob; Heine, Andreas; Diederich, Francois; Cianferani, Sarah; Reuter, Klaus; Klebe, Gerhard			Soaking suggests " alternative facts " : Only cocrystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; GUANINE TRANSGLYCOSYLASE TGT; SHIGELLA-FLEXNERI; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; AFFINITY BINDING; HOT-SPOT; REPLACEMENT; VIRULENCE; MECHANISM	For the efficient pathogenesis of Shigella, the causative agent of bacillary dysentery, full functionality of tRNA-guanine transglycosylase (TGT) is mandatory. TGT performs posttranscriptional modifications of tRNAs in the anticodon loop taking impact on virulence development. This suggests TGT as a putative target for selective anti-shigellosis drug therapy. Since bacterial TGT is only functional as homodimer, its activity can be inhibited either by blocking its active site or by preventing dimerization. Recently, we discovered that in some crystal structures obtained by soaking the full conformational adaptation most likely induced in solution upon ligand binding is not displayed. Thus, soaked structures may be misleading and suggest irrelevant binding modes. Accordingly, we re-investigated these complexes by co-crystallization. The obtained structures revealed large conformational rearrangements not visible in the soaked complexes. They result from spatial perturbations in the ribose-34/phosphate-35 recognition pocket and, consequently, an extended loophelix motif required to prevent access of water molecules into the dimer interface loses its geometric integrity. Thermodynamic profiles of ligand binding in solution indicate favorable entropic contributions to complex formation when large conformational adaptations in the dimer interface are involved. Native MS titration experiments reveal the extent to which the homodimer is destabilized in the presence of each inhibitor. Unexpectedly, one ligand causes a complete rearrangement of subunit packing within the homodimer, never observed in any other TGT crystal structure before. Likely, this novel twisted dimer is catalytically inactive and, therefore, suggests that stabilizing this non-productive subunit arrangement may be used as a further strategy for TGT inhibition.	[Ehrmann, Frederik Rainer; Metz, Alexander; Heine, Andreas; Reuter, Klaus; Klebe, Gerhard] Philipps Univ Marburg, Inst Pharmazeut Chem, Marburg, Germany; [Stojko, Johann; Debaene, Francois; Cianferani, Sarah] Univ Strasbourg, CNRS, IPHC UMR 7178, Lab Spectrometrie Masse Bio Organ, Strasbourg, France; [Barandun, Luzi Jakob; Diederich, Francois] Swiss Fed Inst Technol, Lab Organ Chem, Zurich, Switzerland	Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Klebe, G (corresponding author), Philipps Univ Marburg, Inst Pharmazeut Chem, Marburg, Germany.	klebe@mailer.uni-marburg.de		Reuter, Klaus/0000-0003-3673-7971; Cianferani, Sarah/0000-0003-4013-4129	BESSY II (Berlin); DESY (Hamburg); Elettra (Trieste); BioStruct-X [283570]; Centre National de la Recherche Scientifique; Universite de Strasbourg; Region Alsace; Institute de Recherches Servier; ETH research council [ETH-01 13-2]; Institut de Recherches Servier	BESSY II (Berlin); DESY (Hamburg); Elettra (Trieste); BioStruct-X; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Institute de Recherches Servier; ETH research council; Institut de Recherches Servier	The authors acknowledge funding from BioStruct-X (Grant agreement number 283570) and Institut de Recherches Servier for supporting doctoral fellowship of JS. Synthesis work at ETH was supported by the ETH research council (ETH-01 13-2). JS and SC acknowledge the Centre National de la Recherche Scientifique, the Universite de Strasbourg and the Region Alsace for financial support. FRE, AM, AH, KR and GK acknowledge the beamline support staff at BESSY II (Berlin), DESY (Hamburg) and Elettra (Trieste) for providing support during data collection and for financial support as well as travel grants.; FRE, AM, AH, KR and GK acknowledge the beamline support staff at BESSY II (Berlin), DESY (Hamburg) and Elettra (Trieste) for providing support during data collection and for financial support as well as travel grants. Part of the research leading to these results has received funding from BioStruct-X (Grant agreement number 283570). Engi Hassaan and Phong Nguyen are acknowledged for reviewing the manuscript. JS and SC acknowledge the Centre National de la Recherche Scientifique, the Universite de Strasbourg and the Region Alsace for financial support. J.S acknowledges the Institute de Recherches Servier for financially supporting his doctoral fellowship. The synthesis work at ETH was supported by the ETH research council (ETH-01 13-2) and contributions by Drs. Emmanuel Meyer, Philip Kohler, Christoph Hohn and Maude Giroud are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Barandun LJ, 2015, CHEM-EUR J, V21, P126, DOI 10.1002/chem.201405764; Barandun LJ, 2012, CHEM-EUR J, V18, P9246, DOI 10.1002/chem.201200809; Bowen A, 2015, MMWR-MORBID MORTAL W, V64, P318; Brautigam C, 2014, GUSSI 1 0 8E; Brenk R, 2003, CHEMBIOCHEM, V4, P1066, DOI 10.1002/cbic.200300644; CURNOW AW, 1993, BIOCHEMISTRY-US, V32, P5239, DOI 10.1021/bi00070a036; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; Durand JMB, 1997, J BACTERIOL, V179, P5777, DOI 10.1128/jb.179.18.5777-5782.1997; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; FREY B, 1988, J BACTERIOL, V170, P2078, DOI 10.1128/jb.170.5.2078-2082.1988; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Hortner SR, 2007, ANGEW CHEM INT EDIT, V46, P8266, DOI 10.1002/anie.200702961; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Immekus F, 2013, ACS CHEM BIOL, V8, P1163, DOI 10.1021/cb400020b; Jakobi S, 2015, ACS CHEM BIOL, V10, P1897, DOI 10.1021/acschembio.5b00028; Jakobi S, 2014, PROTEINS, V82, P2713, DOI 10.1002/prot.24637; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kleywegt GJ, 2006, INT TABLES CRYSTALLO, P353; Kohler PC, 2009, CHEM-EUR J, V15, P10809, DOI 10.1002/chem.200901270; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Meyer EA, 2006, HELV CHIM ACTA, V89, P573, DOI 10.1002/hlca.200690062; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Neeb M, 2014, J MED CHEM, V57, P5554, DOI 10.1021/jm500401x; Niyogi SK, 2005, J MICROBIOL, V43, P133; Nuesch-Inderbinen M, 2016, EMERG INFECT DIS, V22, P1083, DOI 10.3201/eid2206.152088; OKADA N, 1979, J BIOL CHEM, V254, P3067; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ritschel T, 2009, CHEMMEDCHEM, V4, P2012, DOI 10.1002/cmdc.200900343; Ritschel T, 2009, J MOL BIOL, V393, P833, DOI 10.1016/j.jmb.2009.07.040; Ritschel T, 2009, CHEMBIOCHEM, V10, P716, DOI 10.1002/cbic.200800782; Ruhmann E, 2015, BBA-GEN SUBJECTS, V1850, P647, DOI 10.1016/j.bbagen.2014.12.007; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SHERIFF S, 1993, IMMUNOMETHODS, V3, P191; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Smart OS, 2015, GRADE, V2015; Stengl B, 2005, CHEMBIOCHEM, V6, P1926, DOI 10.1002/cbic.200500063; Stengl B, 2007, J MOL BIOL, V370, P492, DOI 10.1016/j.jmb.2007.04.008; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Van Lanen SG, 2003, J BIOL CHEM, V278, P10491, DOI 10.1074/jbc.M207727200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976; Yang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29124; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738	61	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175723	10.1371/journal.pone.0175723	http://dx.doi.org/10.1371/journal.pone.0175723			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419165	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200039
J	Wang, J; Wei, Y; Zhao, SS; Zhou, Y; He, W; Zhang, Y; Deng, WS				Wang, Juan; Wei, Yun; Zhao, Shasha; Zhou, Ying; He, Wei; Zhang, Yang; Deng, Wensheng			The analysis of viability for mammalian cells treated at different temperatures and its application in cell shipment	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITORS; WHOLE-BLOOD; IN-VITRO; STORAGE; STRESS; PRESERVATION; HYPERTHERMIA; OXYGEN	Mammalian cells are very important experimental materials and widely used in biological and medical research fields. It is often required that mammalian cells are transported from one laboratory to another to meet with various researches. Conventional methods for cell shipment are laborious and costive despite of maintaining high viability. In this study we aimed to develop a simple and low-cost method for cell shipment by investigating the viabilities of different cell lines treated at different temperatures. We show that the viability of mammalian cells incubated at 1 degrees C or 5 degrees C significantly reduced when compared with that at 16 degrees C or 22 degrees C. Colony formation assays revealed that preservation of mammalian cells at 1 degrees C or 5 degrees C led to a poorer recovery than that at 16 degrees C or 22 degrees C. The data from proliferation and apoptotic assays confirmed that M2 cells could continue to proliferate at 16 degrees C or 22 degrees C but massive death was caused by apoptosis at 1 degrees C or 5 degrees C. The morphology of mammalian cells treated under hypothermia showed little difference from that of the untreated cells. Quantitative RT-PCR and alkaline phosphatase staining confirmed that hypothermic treatment did not change the identity of mouse embryonic stem cells. A case study showed that mammalian cells directly suspended in culture medium were able to be shipped for long distance and maintained a high level of viability and recovery. Our findings not only broaden the understanding to the effect of hypothermia on the viability of mammalian cells but also provide an alternative approach for cell shipment.	[Wang, Juan; Wei, Yun; Zhao, Shasha; Zhou, Ying; He, Wei; Zhang, Yang; Deng, Wensheng] Wuhan Univ Sci & Technol, Inst Biol & Med, Huangjiahu Campus, Wuhan, Hubei Province, Peoples R China; [Wang, Juan] Wuhan Univ Sci & Technol, Sch Chem & Chem Engn, Qingshan Campus, Wuhan, Hubei Province, Peoples R China	Wuhan University of Science & Technology; Wuhan University of Science & Technology	Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Huangjiahu Campus, Wuhan, Hubei Province, Peoples R China.	dengwensheng@wust.edu.cn			National Natural Science Foundation of China [31671357, 31271395]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), the project numbers are 31671357 and 31271395; W.D. is the project holder. The funder has no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azambuja RM, 1998, THERIOGENOLOGY, V49, P1155, DOI 10.1016/S0093-691X(98)00063-6; Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; Broomfield A, 1998, J LARYNGOL OTOL, V112, P230, DOI 10.1017/S0022215100158256; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; Chevaleyre J, 2014, STEM CELLS DEV, V23, P1820, DOI 10.1089/scd.2014.0046; Choudhery MS, 2015, CYTOTHERAPY, V17, P359, DOI 10.1016/j.jcyt.2014.11.003; Coriell L L, 1979, Methods Enzymol, V58, P29; de Kreuk AM, 2001, BONE MARROW TRANSPL, V28, P145, DOI 10.1038/sj.bmt.1703127; Ivanovic Z, 2010, TRANSFUSION, V50, P120, DOI 10.1111/j.1537-2995.2009.02436.x; Jeanne M, 2009, TRANSFUSION, V49, P1738, DOI 10.1111/j.1537-2995.2009.02191.x; Jin B, 2008, CRYOBIOLOGY, V56, P233, DOI 10.1016/j.cryobiol.2008.03.004; Kaushik S, 2005, STRESS, V8, P191, DOI 10.1080/10253890500245953; Louis I, 2012, TRANSFUSION, V52, P2401, DOI 10.1111/j.1537-2995.2012.03650.x; Moussa M, 2008, BIOTECHNOL BIOENG, V101, P1245, DOI 10.1002/bit.21981; Olson WC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-26; PETTENGELL R, 1994, BONE MARROW TRANSPL, V14, P703; Prento P, 1997, HISTOCHEM CELL BIOL, V108, P543, DOI 10.1007/s004180050195; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Tounkara FK, 2012, STEM CELLS DEV, V21, P3197, DOI 10.1089/scd.2012.0112; Vergara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093865; Wang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128229; Wille JJ, 2014, METHODS MOL BIOL, V1195, P203, DOI 10.1007/7651_2014_72; Yang Lingzhi, 2009, Curr Chem Genomics, V3, P50, DOI 10.2174/1875397300903010050; Zieger MAJ, 2006, CELL TRANSPLANT, V15, P499, DOI 10.3727/000000006783981756	24	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176120	10.1371/journal.pone.0176120	http://dx.doi.org/10.1371/journal.pone.0176120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419157	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200077
J	Adejumo, AC; Alliu, S; Ajayi, TO; Adejumo, KL; Adegbale, OM; Onyeakusi, NE; Akinjero, AM; Durojaiye, M; Bukong, TN				Adejumo, Adeyinka Charles; Alliu, Samson; Ajayi, Tokunbo Opeyemi; Adejumo, Kelechi Lauretta; Adegbale, Oluwole Muyiwa; Onyeakusi, Nnaemeka Egbuna; Akinjero, Akintunde Micheal; Durojaiye, Modupeoluwa; Bukong, Terence Ndonyi			Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; MARIJUANA USE; EPIDEMIOLOGY; RISK; EXERCISE; OBESITY; NAFLD; ATHEROSCLEROSIS; STEATOHEPATITIS	Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally. The effects of cannabis use on NAFLD prevalence in humans remains ill-defined. Our objective is to determine the relationship between cannabis use and the prevalence of NAFLD in humans. We conducted a population-based case-control study of 5,950,391 patients using the 2014 Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Survey (NIS) discharge records of patients 18 years and older. After identifying patients with NAFLD (1% of all patients), we next identified three exposure groups: non-cannabis users (98.04%), non-dependent cannabis users (1.74%), and dependent cannabis users (0.22%). We adjusted for potential demographics and patient related confounders and used multivariate logistic regression (SAS 9.4) to determine the odds of developing NAFLD with respects to cannabis use. Our findings revealed that cannabis users (dependent and non-dependent) showed significantly lower NAFLD prevalence compared to non-users (AOR: 0.82[0.76-0.88]; p<0.0001). The prevalence of NAFLD was 15% lower in non-dependent users (AOR: 0.85[0.79-0.92]; p<0.0001) and 52% lower in dependent users (AOR: 0.49 [0.36-0.65]; p<0.0001). Among cannabis users, dependent patients had 43% significantly lower prevalence of NAFLD compared to non-dependent patients (AOR: 0.57[0.42-0.77]; p<0.0001). Our observations suggest that cannabis use is associated with lower prevalence of NAFLD in patients. These novel findings suggest additional molecular mechanistic studies to explore the potential role of cannabis use in NAFLD development.	[Adejumo, Adeyinka Charles; Bukong, Terence Ndonyi] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01655 USA; [Adejumo, Adeyinka Charles] Univ Massachusetts Lowell, Biomed Engn & Biotechnol Program, Lowell, MA USA; [Alliu, Samson] Maimonides Hosp, Dept Med, Brooklyn, NY 11219 USA; [Ajayi, Tokunbo Opeyemi] Howard Cty Gen Hosp, Johns Hopkins Med, Columbia, MD USA; [Adejumo, Kelechi Lauretta] Univ Massachusetts Lowell, Publ Hlth Program, Lowell, MA USA; [Adegbale, Oluwole Muyiwa; Akinjero, Akintunde Micheal] Englewood Hosp & Med Ctr, Dept Med, Englewood, NJ USA; [Onyeakusi, Nnaemeka Egbuna] Bronx Lebanon Hosp Ctr, Dept Pediat, Bronx, NY 10456 USA; [Durojaiye, Modupeoluwa] Univ Alabama Birmingham, Dept Maternal & Child Hlth, Birmingham, AL USA; [Bukong, Terence Ndonyi] Inst Natl Res Sci, INRS Inst Armand Frappier, Laval, PQ, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Lowell; Maimonides Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Massachusetts System; University of Massachusetts Lowell; Englewood Hospital & Medical Center; BronxCare Health System; University of Alabama System; University of Alabama Birmingham; University of Quebec; Institut national de la recherche scientifique (INRS)	Bukong, TN (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01655 USA.; Bukong, TN (corresponding author), Inst Natl Res Sci, INRS Inst Armand Frappier, Laval, PQ, Canada.	terencendonyi.bukong@iaf.inrs.ca	Adejumo, Adeyinka/AAQ-1547-2020; Alliu, Samson/AAA-3051-2020	Onyeakusi, Nnaemeka/0000-0003-1660-5621	INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada	INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada	This work was funded by a start-up grant to BTN by INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, 531 Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada. The funder had no role in the project design, execution, data interpretation or decision to publish.	Allen JH, 2004, GUT, V53, P1566, DOI 10.1136/gut.2003.036350; [Anonymous], 2012, J GASTROEN HEPATOL, V1, P315; Azzam H, 2015, WORLD J HEPATOL, V7, P1369, DOI 10.4254/wjh.v7.i10.1369; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185; Bird Y, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0237-0; Burstein S, 2015, BIOORGAN MED CHEM, V23, P1377, DOI 10.1016/j.bmc.2015.01.059; Charlton M, 2008, HEPATOLOGY, V47, P1431, DOI 10.1002/hep.22246; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Chen K, 1997, DRUG ALCOHOL DEPEN, V46, P53, DOI 10.1016/S0376-8716(97)00047-1; Cohen D, 2016, J PEDIATR NURS, V31, P152, DOI 10.1016/j.pedn.2015.10.009; Dagogo-Jack S., 2016, DIABETES RISKS PRESC; Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Foster T, 2013, DIGEST DIS SCI, V58, P2392, DOI 10.1007/s10620-013-2652-7; Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7; Giroud C, 2002, CHIMIA, V56, P80, DOI 10.2533/000942902777680702; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Houchen R, 2014, HCUP METHODS SERIES; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Hunter Gary R, 2010, Int J Body Compos Res, V8, P103; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Katz K, 2010, J OBES, V2010, DOI 10.1155/2010/496829; Kawaguchi T, 2011, J GASTROENTEROL, V46, P746, DOI 10.1007/s00535-011-0378-x; Keating SE, 2015, J HEPATOL, V63, P174, DOI 10.1016/j.jhep.2015.02.022; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Levine JA, 2011, DIABETES, V60, P2667, DOI 10.2337/db11-1118; Lonardo A, 2006, WORLD J GASTROENTERO, V12, P5826, DOI 10.3748/wjg.v12.i36.5826; Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177, DOI 10.2174/1381612811319290003; Loomba R, 2015, J HEPATOL, V63, P10, DOI 10.1016/j.jhep.2015.03.009; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Loomis AK, 2016, J CLIN ENDOCR METAB, V101, P945, DOI 10.1210/jc.2015-3444; Martinasek MP, 2016, RESP CARE, V61, P1543, DOI 10.4187/respcare.04846; McPartland J. M., 2001, Journal of Cannabis Therapeutics, V1, P103, DOI 10.1300/J175v01n03_08; Muller-Vahl Kirsten R, 2008, Expert Rev Neurother, V8, P1037, DOI 10.1586/14737175.8.7.1037; NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142; Oh S, 2014, THER CLIN RISK MANAG, V10, P925, DOI 10.2147/TCRM.S68322; Okafor PN, 2016, J HEPATOL, V64, P946, DOI 10.1016/j.jhep.2015.12.019; Olsen MA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1501-7; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Patsenker Eleonora, 2016, Clin Liver Dis (Hoboken), V7, P21, DOI 10.1002/cld.527; Penner EA, 2013, AM J MED, V126, P583, DOI 10.1016/j.amjmed.2013.03.002; Pertwee R.G., 1998, ADV CANNABINOID RECE, P148; Piomelli D, 2016, CANNABIS CANNABINOID, V1, P1, DOI [10.1089/can.2015.29003.ebr, 10.1089/can.2015.29002.edi]; Rajavashisth TB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000494; Rossi F, 2016, J CLIN ENDOCR METAB, V101, P3469, DOI 10.1210/jc.2015-4381; Schoenman JA, 2007, MED CARE RES REV, V64, P449, DOI 10.1177/1077558707301963; Shaw FE, 2014, LANCET, V384, P75, DOI 10.1016/S0140-6736(14)60259-2; Shen L, 2003, WORLD J GASTROENTERO, V9, P1106; Sidney S, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0795-6; Substance Abuse and Mental Health Services Administration, HHS PUBL; Swift W, 2009, ADDICTION, V104, P806, DOI 10.1111/j.1360-0443.2009.02534.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trebicka J, 2011, LIVER INT, V31, P862, DOI 10.1111/j.1478-3231.2011.02496.x; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Whitsett M, 2015, WORLD J HEPATOL, V7, P2041, DOI 10.4254/wjh.v7.i16.2041; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49	66	48	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176416	10.1371/journal.pone.0176416	http://dx.doi.org/10.1371/journal.pone.0176416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441459	gold, Green Published, Green Accepted			2022-12-27	WOS:000400308800053
J	Bailey, G; Healy, A; Young, BD; Sharma, E; Meadows, J; Chung, HJ; Wu, WC; Choudhary, G; Morrison, AR				Bailey, Grant; Healy, Abigail; Young, Bryan D.; Sharma, Esseim; Meadows, Judith; Chung, Hyung J.; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.			Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium	PLOS ONE			English	Article							ARTERY CALCIUM; IONIZING-RADIATION; HEART-DISEASE; CALCIFICATION; RISK; TOMOGRAPHY; MORTALITY; PLAQUE; QUANTIFICATION; SPECT/CT	Coronary artery calcium scores (CACS) from lung cancer screening computed tomography (LCSCT) or myocardial perfusion attenuation correction computed tomography (ACCT) are not routinely performed or reported. CACS from LCSCT and ACCT have not been directly compared in the same patient population. We identified 66 patients who underwent both LCSCT (non-gated) and ECG-gated cardiac CT (CCT) within a 2-year span. Of this population, 40 subjects had also undergone ACCT. Using the Agatston method, CACS for 264 individual vessels from the LCSCT population and for 160 vessels from ACCT population were calculated and evaluated for agreement with ECG-gated CCT as the gold standard. Secondary analysis included a comparison of individual vessel contribution to variations in agreement and a comparison of total CACS from CCT, LCSCT, and ACCT for respective MACE prediction. CACS from LCSCT demonstrated a strong Pearson correlation, r = 0.9017 (0.876-0.9223), with good agreement when compared to CACS from CCT. CACS from ACCT demonstrated a significantly (P < 0.00001) weaker correlation, r = 0.5593 (0.4401-0.6592). On an individual vessel basis, CACS from all major vessels (LM, LAD, LCX, and RCA) contributed to the weaker correlation. For total vessel CACS, LCSCT demonstrated comparable area under the curve (AUC) for the receiver operating characteristic (ROC) curve (LCSCT AUC = 0.8133 and CCT AUC = 0.8302, P = 0.691) for prediction of MACE. Although ACCT demonstrated a similar AUC (ACCT AUC = 0.7969, P = 0.662) for MACE prediction the cutoff value for elevated risk was extremely low. In conclusion, LCSCT outperformed ACCT at calcium scoring by providing better agreement and comparable risk assessment to CCT despite the absence of ECG-gating. It is therefore reasonable to use LCSCT images to derive and report Agatston-based CACS for cardiovascular risk assessment, whereas the use of ACCT images to report Agatston-based CACS is not currently practical.	[Bailey, Grant; Healy, Abigail; Young, Bryan D.; Meadows, Judith; Morrison, Alan R.] VA Connecticut Healthcare Syst, Dept Internal Med, Sect Cardiovasc Med, West Haven, CT 06111 USA; [Bailey, Grant; Young, Bryan D.; Meadows, Judith; Chung, Hyung J.; Morrison, Alan R.] Yale Univ, Yale Cardiovasc Res Ctr, Sch Med, Dept Internal Med,Sect Cardiovasc Med, New Haven, CT 06520 USA; [Healy, Abigail; Sharma, Esseim; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.] Providence VA Med Ctr, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02908 USA; [Healy, Abigail; Sharma, Esseim; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.] Brown Univ, Alpert Med Sch, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Morrison, AR (corresponding author), VA Connecticut Healthcare Syst, Dept Internal Med, Sect Cardiovasc Med, West Haven, CT 06111 USA.; Morrison, AR (corresponding author), Yale Univ, Yale Cardiovasc Res Ctr, Sch Med, Dept Internal Med,Sect Cardiovasc Med, New Haven, CT 06520 USA.; Morrison, AR (corresponding author), Providence VA Med Ctr, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02908 USA.; Morrison, AR (corresponding author), Brown Univ, Alpert Med Sch, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02912 USA.	judith.meadows@yale.edu; alan_morrison@.brown.edu	Morrison, Alan R./ABH-3831-2020; Choudhary, Gaurav/M-1643-2019	Morrison, Alan R./0000-0002-2412-7669; Choudhary, Gaurav/0000-0001-9343-5481; Chun, Hyung/0000-0003-3508-2678; Sharma, Esseim/0000-0003-4091-5208	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [71K2BX002527]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103652]; Actelion ENTELLIGENCE Young Investigator Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Actelion ENTELLIGENCE Young Investigator Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Career Development Award Number 71K2BX002527 from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program (A.R.M.). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103652. This work was also supported in part by the Actelion ENTELLIGENCE Young Investigator Award (A.R. M.).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bateman TM, 2006, J NUCL CARDIOL, V13, P24, DOI 10.1016/j.nuclcard.2005.12.004; Bengel FM, 2009, J AM COLL CARDIOL, V54, P1, DOI 10.1016/j.jacc.2009.02.065; Buck AK, 2008, J NUCL MED, V49, P1305, DOI 10.2967/jnumed.107.050195; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Budoff MJ, 2001, INT J CARDIOL, V77, P181, DOI 10.1016/S0167-5273(00)00449-6; Cancer Facts & Figures 2015, 2015, 09202015 AM CANC SOC; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chen J, 2010, J AM COLL CARDIOL, V56, P702, DOI 10.1016/j.jacc.2010.05.014; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Di Carli MF, 2009, CARDIOL CLIN, V27, P257, DOI 10.1016/j.ccl.2008.12.001; Dorbala S, 2013, J NUCL MED, V54, P1485, DOI 10.2967/jnumed.112.105155; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Einstein AJ, 2010, J AM COLL CARDIOL, V56, P1914, DOI 10.1016/j.jacc.2010.05.057; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Hughes-Austin JM, 2016, JACC-CARDIOVASC IMAG, V9, P152, DOI 10.1016/j.jcmg.2015.06.030; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Husmann L, 2007, RADIOLOGY, V245, P567, DOI 10.1148/radiol.2451061791; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Kaster TS, 2015, J NUCL CARDIOL, V22, P419, DOI 10.1007/s12350-014-0026-y; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Mylonas I, 2012, EUR HEART J-CARD IMG, V13, P786, DOI 10.1093/ehjci/jes079; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Sharma D, 2015, ARCH MED SCI, V11, P1033, DOI 10.5114/aoms.2015.54859; Sung JH, 2016, BR J MED MED RES, V11; Takx RAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091239; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; WHO, 2012, 10 LEAD CAUS DEATH W; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie XQ, 2013, CIRC-CARDIOVASC IMAG, V6, P514, DOI 10.1161/CIRCIMAGING.113.000092	42	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175678	10.1371/journal.pone.0175678	http://dx.doi.org/10.1371/journal.pone.0175678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437443	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600009
J	Holloway, DM; Spirov, AV				Holloway, David M.; Spirov, Alexander V.			Transcriptional bursting in Drosophila development: Stochastic dynamics of eve stripe 2 expression	PLOS ONE			English	Article							GENE-EXPRESSION; REACTION-DIFFUSION; EMBRYO; KINETICS; ELEMENTS; NOISE	Anterior-posterior (AP) body segmentation of the fruit fly (Drosophila) is first seen in the 7stripe spatial expression patterns of the pair-rule genes, which regulate downstream genes determining specific segment identities. Regulation of pair-rule expression has been extensively studied for the even-skipped (eve) gene. Recent live imaging, of a reporter for the 2nd eve stripe, has demonstrated the stochastic nature of this process, with `bursts' in the number of RNA transcripts being made over time. We developed a stochastic model of the spatial and temporal expression of eve stripe 2 (binding by transcriptional activators (Bicoid and Hunchback proteins) and repressors (Giant and Kruppel proteins), transcriptional initiation and termination; with all rate parameters constrained by features of the experimental data) in order to analyze the noisy experimental time series and test hypotheses for how eve transcription is regulated. These include whether eve transcription is simply OFF or ON, with a single ON rate, or whether it proceeds by a more complex mechanism, with multiple ON rates. We find that both mechanisms can produce long (multi-minute) RNA bursts, but that the short-time (minute-to-minute) statistics of the data is indicative of eve being transcribed with at least two distinct ON rates, consistent with data on the joint activation of eve by Bicoid and Hunchback. We also predict distinct statistical signatures for cases in which eve is repressed (e.g. along the edges of the stripe) vs. cases in which activation is reduced (e.g. by mutagenesis of transcription factor binding sites). Fundamental developmental processes such as gene transcription are intrinsically noisy; our approach presents a new way to quantify and analyze time series data during developmental patterning in order to understand regulatory mechanisms and how they propagate noise and impact embryonic robustness.	[Holloway, David M.] British Columbia Inst Technol, Math Dept, Burnaby, BC, Canada; [Holloway, David M.] Univ Victoria, Biol Dept, Victoria, BC, Canada; [Spirov, Alexander V.] SUNY Stony Brook, Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] SUNY Stony Brook, Ctr Excellence Wireless & Informat Technol, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	British Columbia Institute of Technology; University of Victoria; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Holloway, DM (corresponding author), British Columbia Inst Technol, Math Dept, Burnaby, BC, Canada.; Holloway, DM (corresponding author), Univ Victoria, Biol Dept, Victoria, BC, Canada.	David_Holloway@bcit.ca	Spirov, Alexander V/G-4806-2010; Holloway, David/B-1075-2015	Spirov, Alexander V/0000-0002-0509-6203; Holloway, Courtney Jean/0000-0003-3661-1957; Holloway, David/0000-0002-3865-0725	U.S. National Institutes of Health [GM072022]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This worked was supported by the U.S. National Institutes of Health, GM072022, www.nih.gov.	Arnosti DN, 1996, DEVELOPMENT, V122, P205; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Choubey S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004345; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; ELF J, 2004, SYST BIOL, V2, P230, DOI DOI 10.1049/SB:20045021; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Gilbert S.F., 2016, DEV BIOL, V11th ed.; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Holloway DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118450; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Munsky B, 2015, METHODS, V85, P12, DOI 10.1016/j.ymeth.2015.06.009; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Prata GN, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022403; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176228	10.1371/journal.pone.0176228	http://dx.doi.org/10.1371/journal.pone.0176228			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437444	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600036
J	Miyata, H; Koseki, H; Takizawa, K; Kasuya, H; Nozaki, K; Narumiya, S; Aoki, T				Miyata, Haruka; Koseki, Hirokazu; Takizawa, Katsumi; Kasuya, Hidetoshi; Nozaki, Kazuhiko; Narumiya, Shuh; Aoki, Tomohiro			T cell function is dispensable for intracranial aneurysm formation and progression	PLOS ONE			English	Article							INDUCED CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; RUPTURE; ATHEROSCLEROSIS; RATS; INFLAMMATION; PREVALENCE; MECHANISMS; ALPHA; JAPAN	Given the social importance of intracranial aneurysm as a major cause of a lethal subarachnoid hemorrhage, clarification of mechanisms underlying the pathogenesis of this disease is essential for improving poor prognosis once after rupture. Previous histopathological analyses of human aneurysm walls have revealed the presence of T cells in lesions suggesting involvement of this type of cell in the pathogenesis. However, it remains unclear whether T cell actively participates in intracranial aneurysm progression. To examine whether T cell is involved in aneurysm progression, intracranial aneurysm model of rat was used. In this model, aneurysm is induced by increase in hemodynamic force loaded on bifurcation site of intracranial arteries where aneurysms are developed. Deficiency in T cells and pharmacological inhibition of T cell function were applied to this model. CD3-positive T cells were present in human aneurysm walls, whose number was significantly larger compared with that in control arterial walls. Deficiency in T cells in rats and pharmacological inhibition of T cell function by oral administration of Cyclosporine A both failed to affect intracranial aneurysm progression, degenerative changes of arterial walls and macrophage infiltration in lesions. Although T cells are detectable in intracranial aneurysm walls, their function is dispensable for macrophage-mediated inflammation and degenerative changes in arterial walls, which presumably leads to intracranial aneurysm progression.	[Miyata, Haruka; Koseki, Hirokazu; Narumiya, Shuh; Aoki, Tomohiro] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat Technol & Therapeut AK, Kyoto, Japan; [Miyata, Haruka; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Shiga, Japan; [Miyata, Haruka; Koseki, Hirokazu; Aoki, Tomohiro] Kyoto Univ, Grad Sch Med, Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Kyoto, Japan; [Koseki, Hirokazu; Kasuya, Hidetoshi] Tokyo Womens Med Univ, Med Ctr East, Dept Neurosurg, Tokyo, Japan; [Takizawa, Katsumi] Japan Red Cross Asahikawa Hosp, Dept Neurosurg, Asahikawa, Hokkaido, Japan	Kyoto University; Shiga University of Medical Science; Japan Science & Technology Agency (JST); Kyoto University; Tokyo Women's Medical University	Aoki, T (corresponding author), Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat Technol & Therapeut AK, Kyoto, Japan.; Aoki, T (corresponding author), Kyoto Univ, Grad Sch Med, Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Kyoto, Japan.	tomoaoki@kuhp.kyoto-u.ac.jp		Aoki, Tomohiro/0000-0002-1578-1394	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K10719]; Grants-in-Aid for Scientific Research [17H01531] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#16K10719, T.A.).; This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#16K10719, T.A.). We thank T. Kurita and Y. Imai for their technical and K. Shiota, H. Kaimori, A. Washimi and T.Arai for their secretarial assistance. We also thank the invaluable help from the Center for Anatomical, Pathological and Forensic Medical Research at Kyoto University Graduate School of Medicine for immunostaining of human samples and from Japan Red Cross Asahikawa Hospital for preparing human specimen.	Aoki T, 2011, BRIT J PHARMACOL, V163, P1237, DOI 10.1111/j.1476-5381.2011.01358.x; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-34; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Chyatte D, 1999, NEUROSURGERY, V45, P1137, DOI 10.1097/00006123-199911000-00024; Foks AC, 2015, ARTERIOSCL THROM VAS, V35, P280, DOI 10.1161/ATVBAHA.114.303568; Frosen J, 2006, NEUROSURGERY, V58, P534, DOI 10.1227/01.NEU.0000197332.55054.C8; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Fukuda Miyuki, 2015, Acta Neurochir Suppl, V120, P13, DOI 10.1007/978-3-319-04981-6_2; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; Hedrick CC, 2015, ARTERIOSCL THROM VAS, V35, P253, DOI 10.1161/ATVBAHA.114.305144; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Meng X, 2016, NAT REV CARDIOL, V13, P167, DOI 10.1038/nrcardio.2015.169; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; NAGATA I, 1980, SURG NEUROL, V14, P477; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Piantino JA, 2013, PEDIATR NEUROL, V48, P130, DOI 10.1016/j.pediatrneurol.2012.10.004; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Sawyer DM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0654-z; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Starke RM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-77; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Yokoi T, 2014, J NEUROSURG, V120, P1193, DOI 10.3171/2014.1.JNS13818; Yoshimura Y, 2014, J STROKE CEREBROVASC, V23, P343, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.022	32	21	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175421	10.1371/journal.pone.0175421	http://dx.doi.org/10.1371/journal.pone.0175421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437485	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600007
J	Rodrigues, RFN; Almeida, LR; dos Santos, FG; Carvalho, PS; de Souza, WC; Moreira, KS; de Aquino, GLB; Valverde, C; Napolitano, HB; Baseia, B				Rodrigues, Rosemberg F. N.; Almeida, Leonardo R.; dos Santos, Florisberto G.; Carvalho, Paulo S., Jr.; de Souza, Wanderson C.; Moreira, Kleber S.; de Aquino, Gilberto L. B.; Valverde, Clodoaldo; Napolitano, Hamilton B.; Baseia, Basilio			Solid state characterization and theoretical study of non-linear optical properties of a Fluoro-N-Acylhydrazide derivative	PLOS ONE			English	Article							F HYDROGEN-BONDS; DIPOLE-MOMENT ENHANCEMENT; MOLECULAR-CRYSTALS; HYPERPOLARIZABILITY; ASSEMBLIES; GEOMETRY; DESIGN; GROWTH; WATER; FIELD	In this work we determine the linear and non-linear optical properties of a Fluoro-N-Acylhydrazide derivative (FBHZ), using a combined supermolecule approach and an iterative scheme of electrostatic polarization, where the atoms of neighbouring molecules are represented by point charges. Our results for non-linear optics (NLO) are comparable to those found experimentally, suggesting that FBHZ constitutes an attractive object for future studies and for use as an interesting material for third-order NLO applications. The dynamic electrical properties of FBHZ in different solvent media are reported. Its molecular properties are closely related to supramolecular features; accordingly, we analysed all its crystal structure properties via intermolecular interactions in the solid state, using X-ray crystallography data and Hirshfeld surface (HS), including thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and hot-stage microscopy (HSM), where the results reveal crystal stability in respect to temperature variation.	[Rodrigues, Rosemberg F. N.; Almeida, Leonardo R.; de Souza, Wanderson C.; Moreira, Kleber S.; de Aquino, Gilberto L. B.; Valverde, Clodoaldo; Napolitano, Hamilton B.] Univ Estadual Goias, Campus Ciencias Exatas & Tecnol, Anapolis, Go, Brazil; [Rodrigues, Rosemberg F. N.; dos Santos, Florisberto G.; Valverde, Clodoaldo] Univ Paulista UNIP, Goiania, Go, Brazil; [Almeida, Leonardo R.; Carvalho, Paulo S., Jr.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Baseia, Basilio] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Baseia, Basilio] Univ Fed Paraiba, Dept Fis, Joao Pessoa, Paraiba, Brazil	Universidade Estadual de Goias; Universidade Paulista; Universidade de Sao Paulo; Universidade Federal de Goias; Universidade Federal da Paraiba	Valverde, C (corresponding author), Univ Estadual Goias, Campus Ciencias Exatas & Tecnol, Anapolis, Go, Brazil.; Valverde, C (corresponding author), Univ Paulista UNIP, Goiania, Go, Brazil.	valverde@ueg.br	de Souza, Wanderson/AAR-8593-2021; Carvalho Jr, Paulo S./G-8049-2016; Baseia, Basilio/AAM-4614-2020; Baseia, Basilio/AAJ-8355-2020; Aquino, Gilberto L B/O-5203-2014; Aquino, Gilberto Lucio Benedito/I-3780-2015; , Gilberto/W-8821-2019; Valverde, Clodoaldo/O-3547-2019; Napolitano, Hamilton Barbosa/ABC-1986-2020; Valverde, Clodoaldo/L-8548-2015	Carvalho Jr, Paulo S./0000-0002-5551-9155; Baseia, Basilio/0000-0002-2464-9889; Aquino, Gilberto L B/0000-0001-9397-7803; Aquino, Gilberto Lucio Benedito/0000-0001-9397-7803; , Gilberto/0000-0001-9397-7803; Valverde, Clodoaldo/0000-0002-1656-4981; Almeida, Leonardo/0000-0002-6737-0642	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), and the Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the following Brazilian agencies for financial support: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2006, CHEM PHYS LETT, V429, P119; [Anonymous], 2007, BRUK APEX2; [Anonymous], 2006, J PHYS CHEM A, V110, P8970; Arshad MN, 2015, MOLECULES, V20, P5851, DOI 10.3390/molecules20045851; Bamba M, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.021802; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Boyd RW, 2014, OPT COMMUN, V326, P74, DOI 10.1016/j.optcom.2014.03.005; Calhorda MJ, 2000, CHEM COMMUN, P801, DOI 10.1039/a900221i; Carcelli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31500; Castro AN, 2016, CHEM PHYS LETT, V653, P122, DOI 10.1016/j.cplett.2016.04.070; Champagne B, 2003, ADV CHEM PHYS, V126, P41, DOI 10.1002/0471428019.ch2; De Proft F, 2007, FARADAY DISCUSS, V135, P151, DOI 10.1039/b605302p; Desiraju G.R., 2001, WEAK HYDROGEN BOND S, Vvol. 9; Desiraju GR, 2013, J AM CHEM SOC, V135, P9952, DOI 10.1021/ja403264c; Desiraju GR, 2011, ANGEW CHEM INT EDIT, V50, P52, DOI 10.1002/anie.201002960; Desiraju GR, 2011, CRYSTAL ENG TXB, P1; do Amaral DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085380; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Espinosa E, 1996, ACTA CRYSTALLOGR B, V52, P519, DOI 10.1107/S0108768195015205; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Feng Q, 2016, J MATER CHEM C, V4, P8552, DOI 10.1039/c6tc01549b; Ferretti S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025012; Fonseca TL, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3501237; GAVEZZOTTI A, 1994, J PHYS CHEM-US, V98, P4831, DOI 10.1021/j100069a010; GAVEZZOTTI A, 1994, ACCOUNTS CHEM RES, V27, P309, DOI 10.1021/ar00046a004; Gavezzotti A., 1998, CRYSTALLOGR REV, V7, P5, DOI DOI 10.1080/08893119808035402; Georg HC, 2006, CHEM PHYS LETT, V429, P119, DOI 10.1016/j.cplett.2006.08.047; Gerace D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.031803; Guillaume M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3104629; Hagberg DP, 2007, J ORG CHEM, V72, P9550, DOI 10.1021/jo701592x; Irvine WTM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057405; Jayatilaka D, 2003, LECT NOTES COMPUT SC, V2660, P142; Jayatilaka D, 2005, TONTO SYSTEM COMPU; Jayatilaka D, 2006, ACTA CRYSTALLOGR A, V62, pS90, DOI 10.1107/S0108767306098199; Johnson JC, 2016, J MATER CHEM C, V4, P4847, DOI 10.1039/c6tc01436d; KANIS DR, 1994, CHEM REV, V94, P195, DOI 10.1021/cr00025a007; Kanoun MB, 2010, CHEM PHYS LETT, V487, P256, DOI 10.1016/j.cplett.2010.01.021; Karakas A, 2012, PHOTONICS LETT POL, V4, P17, DOI 10.4302/plp.2012.1.07; Karthigha S, 2016, RSC ADV, V6, P33159, DOI 10.1039/c6ra05055g; Kongsted J, 2004, J CHEM PHYS, V120, P3787, DOI 10.1063/1.1642593; Kryachko E, 2004, J PHYS CHEM A, V108, P2527, DOI 10.1021/jp0365108; Lee KM, 2004, J CHEM PHYS, V120, P8645, DOI 10.1063/1.1697380; Lian ZX, 2015, RSC ADV, V5, P82781, DOI 10.1039/c5ra14734d; Licandro E, 2004, EUR J ORG CHEM, V2004, P665, DOI 10.1002/ejoc.200300416; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Macrae CF, 2020, J APPL CRYSTALLOGR, V53, P226, DOI 10.1107/S1600576719014092; MEC P, 2012, J THEOR COMPUT CHEM, V11, P209; Mukhopadhyay S, 2012, CHEM SCI, V3, P3103, DOI 10.1039/c2sc20861j; Narayanan S, 2015, NEW J CHEM, V39, P2795, DOI 10.1039/c4nj01899k; Nardelli M., 1995, J APPL CRYSTALLOGR, V28, P659, DOI [10.1107/s0021889895007138, 10.1107/S0021889895007138, DOI 10.1107/S0021889895007138]; Nishio M, 2009, CRYSTENGCOMM, V11, P1757, DOI 10.1039/b902318f; Picon-Ferrer I, 2009, J INORG BIOCHEM, V103, P94, DOI 10.1016/j.jinorgbio.2008.09.014; Prasad AA, 2015, SPECTROCHIM ACTA A, V140, P311, DOI 10.1016/j.saa.2014.12.011; Rao G.R., 2015, OPT PHOTONICS J, V05, P91, DOI [DOI 10.4236/OPJ.2015.53008, DOI 10.4236/0PJ.2015.53008]; Rodrigues DA, 2016, J MED CHEM, V59, P655, DOI 10.1021/acs.jmedchem.5b01525; Rohde D, 2006, LANGMUIR, V22, P4750, DOI 10.1021/la053138+; Samson ZL, 2011, OPT LETT, V36, P250, DOI 10.1364/OL.36.000250; Santos OL, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4937481; Schonleber A, 2014, ACTA CRYSTALLOGR B, V70, P652, DOI 10.1107/S2052520614007707; Seidler T, 2015, PHYS CHEM CHEM PHYS, V17, P19546, DOI 10.1039/c5cp03248b; Seidler T, 2014, ADV OPT MATER, V2, P1000, DOI 10.1002/adom.201400245; Seidler T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894483; Seidler T, 2014, J CHEM THEORY COMPUT, V10, P2114, DOI 10.1021/ct5001654; Seidler T, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4819769; Seo JT, 2006, J PHYS CONF SER, V38, P91, DOI 10.1088/1742-6596/38/1/023; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shen HZ, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.063808; Shen HZ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.023849; Silva AG, 2005, BIOORGAN MED CHEM, V13, P3431, DOI 10.1016/j.bmc.2005.03.003; Spackman MA, 2007, CHEMPHYSCHEM, V8, P2051, DOI 10.1002/cphc.200700339; Spackman MA, 2007, CHEM PHYS LETT, V443, P87, DOI 10.1016/j.cplett.2007.06.058; Spada L, 2014, PHYS CHEM CHEM PHYS, V16, P2149, DOI 10.1039/c3cp54430c; Sugiura M, 2005, ANGEW CHEM INT EDIT, V44, P5176, DOI 10.1002/anie.200500691; Sun ZH, 2011, NEW J CHEM, V35, P2804, DOI 10.1039/c1nj20420c; Takahashi O, 2010, CHEM REV, V110, P6049, DOI 10.1021/cr100072x; Tiekink E.R.T., 2012, IMPORTANCE PI INTERA; Wang D, 2016, ROYAL SOC CHEM, V7, P3714, DOI DOI 10.1039/C6PY00106H; Wolff S.K, 2012, CRYSTALEXPLORER VER; Wolstenholme DJ, 2006, J PHYS CHEM A, V110, P8970, DOI 10.1021/jp061205i; Xu XW, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043822; Xu XW, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033809; Xu XW, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/3/035502; Zhang B, 2012, CHEM PHARM BULL, V60, P1046, DOI 10.1248/cpb.c12-00234; Zhang G, 2007, J PHYS CHEM A, V111, P1554, DOI 10.1021/jp061633o; Zhang W, 2014, PHYS REV A, V89, DOI [10.1103/physRevA.89.043832, 10.1103/PhysRevA.89.043832]; Zhang X, 2014, J MATER CHEM C, V2, P6966, DOI 10.1039/c4tc00856a; Zhao X, 2003, J AM CHEM SOC, V125, P15128, DOI 10.1021/ja037312x; Zhou YH, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.023838; Zyss J, 1987, QUANT ELE	91	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175859	10.1371/journal.pone.0175859	http://dx.doi.org/10.1371/journal.pone.0175859			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437446	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600017
J	Chang, WH; Niu, DM; Lu, CY; Lin, SY; Liu, TC; Chang, JG				Chang, Wen-Hsin; Niu, Dau-Ming; Lu, Chi-Yu; Lin, Shyr-Yi; Liu, Ta-Chih; Chang, Jan-Gowth			Modulation the alternative splicing of GLA (IVS4+919G > A) in Fabry disease	PLOS ONE			English	Article							RNA-POLYMERASE-II; GALACTOSIDASE-A GENE; HISTONE MODIFICATIONS; CHROMATIN; HSP70; HYPERACETYLATION; RECOGNITION; MECHANISMS; PREDICTION; INCLUSION	While a base substitution in intron 4 of GLA (IVS4+919G>A) that causes aberrant alternative splicing resulting in Fabry disease has been reported, its molecular mechanism remains unclear. Here we reported that upon IVS4+919G>A transversion, H3K36me3 was enriched across the alternatively spliced region. PSIP1, an adapter of H3K36me3, together with Hsp70 and NONO were recruited and formed a complex with SF2/ASF and SRp20, which further promoted GLA splicing. Amiloride, a splicing regulator in cancer cells, could reverse aberrant histone modification patterns and disrupt the association of splicing complex with GLA. It could also reverse aberrant GLA splicing in a PP1-dependant manner. Our findings revealed the alternative splicing mechanism of GLA (IVS4+919G>A), and a potential treatment for this specific genetic type of Fabry disease by amiloride in the future.	[Chang, Wen-Hsin; Lin, Shyr-Yi] Taipei Med Univ Hosp, Dept Primary Care Med, Taipei, Taiwan; [Niu, Dau-Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Niu, Dau-Ming] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Lin, Shyr-Yi] Taipei Med Univ, Sch Med, Dept Gen Med, Coll Med, Taipei, Taiwan; [Liu, Ta-Chih] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Liu, Ta-Chih] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ, Sch Med, Taichung, Taiwan; [Chang, Jan-Gowth] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Lin, SY (corresponding author), Taipei Med Univ Hosp, Dept Primary Care Med, Taipei, Taiwan.; Lin, SY (corresponding author), Taipei Med Univ, Sch Med, Dept Gen Med, Coll Med, Taipei, Taiwan.; Liu, TC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Liu, TC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Kaohsiung, Taiwan.; Chang, JG (corresponding author), China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan.; Chang, JG (corresponding author), China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan.; Chang, JG (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Chang, JG (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	sylin@tmu.edu.tw; d730093@kmu.edu.tw; d6781@mail.cmuh.org.tw			Ministry of Science and Technology, Taiwan [103-2320-B-039-050-MY3]; Jin-lung-yuan Foundation; China Medical University Hospital [DM R-106-104]; Taipei Veterans General Hospital [VGHUST102-G7-4-1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Jin-lung-yuan Foundation; China Medical University Hospital; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from the Ministry of Science and Technology, Taiwan (103-2320-B-039-050-MY3), Jin-lung-yuan Foundation, 2015 to 2016 (SYL), China Medical University Hospital (DM R-106-104), and Taipei Veterans General Hospital (VGHUST102-G7-4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2014, METABOLIC MOL BASES; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brown SJ, 2012, HUM MOL GENET, V21, pR90, DOI 10.1093/hmg/dds353; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018643; Chang WH, 2011, CANCER RES, V71, P383, DOI 10.1158/0008-5472.CAN-10-1037; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Ishii S, 2002, AM J HUM GENET, V70, P994, DOI 10.1086/339431; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lai LW, 2003, CLIN GENET, V63, P476, DOI 10.1034/j.1399-0004.2003.00077.x; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Liu LL, 2011, MOL ENDOCRINOL, V25, P1197, DOI 10.1210/me.2010-0517; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Manzoor R, 2014, J BIOL CHEM, V289, P7599, DOI 10.1074/jbc.M113.507798; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Moreno NN, 2015, FEBS LETT, V589, P3370, DOI 10.1016/j.febslet.2015.08.002; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schor Ignacio E, 2013, Cancer Treat Res, V158, P1, DOI 10.1007/978-3-642-31659-3_1; Schor IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048084; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Seydelmann N, 2015, BEST PRACT RES CL EN, V29, P195, DOI 10.1016/j.beem.2014.10.003; Sharma A, 2015, NUCLEUS-PHILA, V6, P273, DOI 10.1080/19491034.2015.1081324; Shindo Y, 2013, FEBS LETT, V587, P516, DOI 10.1016/j.febslet.2013.01.032; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Teves SS, 2011, GENE DEV, V25, P2387, DOI [10.1101/gad.177675.111, 10.1101/gad.178079.111]; VOGEL JL, 1995, CURR BIOL, V5, P306, DOI 10.1016/S0960-9822(95)00061-3; Wang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037764; Zhang SR, 2006, MOL MICROBIOL, V62, P1090, DOI 10.1111/j.1365-2958.2006.05422.x; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175929	10.1371/journal.pone.0175929	http://dx.doi.org/10.1371/journal.pone.0175929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430823	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100023
J	Stribos, EGD; Nielsen, SH; Brix, S; Karsdal, MA; Seelen, MA; van Goor, H; Bakker, SJL; Olinga, P; Mutsaers, HAM; Genovese, F				Stribos, Elisabeth G. D.; Nielsen, Signe Holm; Brix, Susanne; Karsdal, Morten Asser; Seelen, Marc A.; van Goor, Harry; Bakker, Stephan J. L.; Olinga, Peter; Mutsaers, Henricus A. M.; Genovese, Federica			Non-invasive quantification of collagen turnover in renal transplant recipients	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; IV COLLAGEN; EXTRACELLULAR-MATRIX; KIDNEY-DISEASES; URINARY; VI; MARKERS; MUSCLE; NEPHROPATHY; ASSOCIATION	Kidney allograft failure due to chronic injury/rejection remains the main cause of graft loss in renal transplant recipients (RTR). Here, we investigated whether specific biomarkers of extracellular matrix (ECM) turnover are associated with allograft function and chronic kidney disease (CKD) stage in RTR. Seventy-eight patients who attended the University Medical Center Groningen for a routine check-up after kidney transplantation were enrolled in the study. Plasma and/or 24h-urine samples were collected and specific matrix-metalloproteinase- generated neo-epitope fragments of collagens were measured by enzyme-linked immunosorbent assay. Our results demonstrated that urinary levels of C3M, a marker for collagen type III degradation, correlated with estimated glomerular filtration rate (eGFR; r = 0.58, p< 0.0001), with lower levels detected in the urine of patients with advanced CKD. In addition, plasma levels of Pro-C6, a marker for collagen type VI formation, significantly increased with disease progression and correlated with eGFR (r = -0.72, p< 0.0001). Conversely, plasma C3M and urinary Pro-C6 levels showed no correlation with renal function. We identified two neo-epitope biomarkers of tissue turnover associated with ECM remodeling and fibrosis that can stratify patients by CKD stage. This is as promising first step towards non-invasive monitoring of ECM turnover in the kidneys.	[Stribos, Elisabeth G. D.; Olinga, Peter; Mutsaers, Henricus A. M.] Univ Groningen, Groningen Res Inst Pharm, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Stribos, Elisabeth G. D.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Nielsen, Signe Holm; Karsdal, Morten Asser; Genovese, Federica] Nord Biosci AS, Herlev, Denmark; [Nielsen, Signe Holm; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; Nordic Bioscience; Technical University of Denmark; University of Groningen	Olinga, P (corresponding author), Univ Groningen, Groningen Res Inst Pharm, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.; Nielsen, SH (corresponding author), Nord Biosci AS, Herlev, Denmark.; Nielsen, SH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	shn@nordicbio.com; p.olinga@rug.nl	Pedersen, Susanne Brix/B-3484-2009; Holm, Signe/GLT-8793-2022; Mutsaers, Henricus/AAK-6321-2020	Pedersen, Susanne Brix/0000-0001-8951-6705; Holm, Signe/0000-0002-4612-1014; Mutsaers, Henricus/0000-0002-9553-8860; van Goor, Harry/0000-0002-6670-1577; Genovese, Federica/0000-0003-1984-1881; Karsdal, Morten/0000-0001-5026-8740; Olinga, Peter/0000-0003-4855-8452	Danish Research Fund (Den Danske Forsknings fond); Netherlands Organization for Health Research and Development (ZonMw) [114021010]	Danish Research Fund (Den Danske Forsknings fond); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Danish Research Fund (Den Danske Forsknings fond) and the Netherlands Organization for Health Research and Development (ZonMw; grant number 114021010, PO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Racca MA, 2015, TRANSPL INT, V28, P71, DOI 10.1111/tri.12445; Araki S, 2010, DIABETES CARE, V33, P1805, DOI 10.2337/dc10-0199; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Boor P, 2015, AM J TRANSPLANT, V15, P863, DOI 10.1111/ajt.13180; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; de Jong S, 2011, J CARDIOVASC PHARM, V57, P522, DOI 10.1097/FJC.0b013e31821823d9; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; El Ghoul B, 2010, CLIN J AM SOC NEPHRO, V5, P205, DOI 10.2215/CJN.06610909; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fitzgerald J, 2013, CONNECT TISSUE RES, V54, P345, DOI 10.3109/03008207.2013.822865; Furumatsu Y, 2011, NEPHRON CLIN PRACT, V117, pC160, DOI 10.1159/000319794; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Genovese F, 2016, NEPHROL DIAL TRANSPL, V31, P472, DOI 10.1093/ndt/gfv301; Genovese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111134; Groma V, 1998, NEPHROL DIAL TRANSPL, V13, P305, DOI 10.1093/oxfordjournals.ndt.a027823; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Kawamura E, 2015, MOD RHEUMATOL, V25, P571, DOI 10.3109/14397595.2014.1001474; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; LEMLEY KV, 1991, KIDNEY INT, V39, P370, DOI 10.1038/ki.1991.49; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Mazanowska O, 2011, TRANSPL P, V43, P3000, DOI 10.1016/j.transproceed.2011.08.012; Morita M, 2011, AM J KIDNEY DIS, V58, P915, DOI 10.1053/j.ajkd.2011.04.019; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Okonogi H, 2001, CLIN NEPHROL, V55, P357; Papasotiriou M, 2015, NEPHROL DIAL TRANSPL, V30, P1112, DOI 10.1093/ndt/gfv063; Sand JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084934; Scian MJ, 2011, TRANSPLANTATION, V91, P657, DOI 10.1097/TP.0b013e3182094a5a; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Seron D, 2000, TRANSPLANTATION, V69, P1849; Soylemezoglu O, 1997, NEPHROL DIAL TRANSPL, V12, P1883, DOI 10.1093/ndt/12.9.1883; Sun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144525; Teppo AM, 2003, TRANSPLANTATION, V75, P2113, DOI 10.1097/01.TP.0000066809.60389.48; Veidal SS, 2012, CLIN BIOCHEM, V45, P541, DOI 10.1016/j.clinbiochem.2012.02.007; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Vleming LJ, 1997, CLIN NEPHROL, V47, P158; Wong W, 2010, AM J TRANSPLANT, V10, P2463, DOI 10.1111/j.1600-6143.2010.03290.x	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175898	10.1371/journal.pone.0175898	http://dx.doi.org/10.1371/journal.pone.0175898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430784	gold, Green Published, Green Submitted			2022-12-27	WOS:000399876100020
J	de Oliveira-Fonoff, AM; Mady, C; Pessoa, FG; Fonseca, KCB; Salemi, VMC; Fernandes, F; Saldiva, PHN; Ramires, FJA				de Oliveira-Fonoff, A. M.; Mady, C.; Pessoa, F. G.; Fonseca, K. C. B.; Salemi, V. M. C.; Fernandes, F.; Saldiva, P. H. N.; Ramires, F. J. A.			The role of air pollution in myocardial remodeling	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; OXIDATIVE STRESS; HEART-FAILURE; INFLAMMATION; DYSFUNCTION; MECHANISMS; INFARCTION; PARTICLES; CYTOKINES; KINASE	Background Excessive air pollution in urban environments can impact morbidity and mortality. The authors evaluated the role of particulate matter(2.5) (PM2.5) in structural, geometric, and functional remodeling in hearts, using an experimental model of myocardial infarction. Methods and findings Seventy-five rats were divided into 5 groups: control (CG), CG exposed to PM2.5 pollution (CGP), myocardial infarcted group (MI), infarcted group immediately exposed to pollution (IGP-I), and infarcted group previously exposed to pollution and kept exposed after infarction (IGP-II). Greater deposition of interstitial collagen occurred in the left ventricle in CGP, MI, IGP-I, and IGP-II groups compared with that in controls (p = 0.002 CG vs CGP and p<0.0001 CG vs MI, IGP-I, and IGP-II). In the right ventricle, greater collagen deposition existed in CGP, MI, IGP-I, and IGP-II compared with that in CG (p<0.021 CG vs CGP and p<0.0001 CG vs MI, IGP-I, and IGP-II). At the end of the study, CG had a higher mean shortening fraction than the other groups had (p <= 0.03). Left ventricular systolic diameter was lower in CG than in infarcted groups (p <= 0.003). The infarcted groups had greater expression of TGF-beta (p <= 0.04). PM2.5 increased the expression of TGF-beta in the IGP-II compared with the MI group (p = 0.004). The TNF-alpha gene was overexpressed in the IGP-II compared with the CGP group (p = 0.012). INF-gamma gene expression was greater in IGP-II (p <= 0.01). Oxidative stress analysis showed a higher glutathione concentration in CGP (p = 0.03), MI (p = 0.014), and IGP-I (p = 0.008) compared with that in CG. Conclusions PM2.5 stimulates the deposition of fibrosis in the myocardium of healthy hearts, but not in infarcted hearts. PM2.5 modulates the inflammatory response, which was greater in the IGP-II group. It also modulates oxidative stress in healthy hearts but not in infarcted hearts.	[de Oliveira-Fonoff, A. M.; Mady, C.; Pessoa, F. G.; Fonseca, K. C. B.; Salemi, V. M. C.; Fernandes, F.; Ramires, F. J. A.] Univ Sao Paulo, Heart Inst InCor, Cardiomyopathy Unit, Sao Paulo, Brazil; [de Oliveira-Fonoff, A. M.; Saldiva, P. H. N.] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ramires, FJA (corresponding author), Univ Sao Paulo, Heart Inst InCor, Cardiomyopathy Unit, Sao Paulo, Brazil.	felix.ramires@incor.usp.br	Fernandes, Fábio/D-5994-2012; Ramires, Felix JA/D-5996-2012; Fonseca, Keila Cardoso Barbosa/N-2484-2014; Pessoa, Fernanda G/N-1315-2014; Mady, Charles/C-8870-2012; Salemi, Vera/AAY-5024-2020; Saldiva, Paulo HN/D-7385-2012	Fernandes, Fábio/0000-0002-9323-8805; Ramires, Felix JA/0000-0003-2437-2485; Pessoa, Fernanda G/0000-0002-8781-495X; Mady, Charles/0000-0002-8838-199X; Saldiva, Paulo HN/0000-0003-2005-8253	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP) [2010/11541-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP). 2010/11541-4.	Ahn J, 2012, CURR HYPERTENS REP, V14, P510, DOI 10.1007/s11906-012-0309-0; Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; Deswal A, 2001, CIRCULATION, V103, P2055; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Frimm CD, 1997, J LAB CLIN MED, V129, P439, DOI 10.1016/S0022-2143(97)90077-9; Georges S, 2005, ENVIRON MANAGE, V35, P667, DOI 10.1007/s00267-004-0042-9; Hsieh YL, 2013, INHAL TOXICOL, V25, P455, DOI 10.3109/08958378.2013.804609; Kim JB, 2012, TOXICOL APPL PHARM, V259, P66, DOI 10.1016/j.taap.2011.12.007; Kodavanti UP, 2003, TOXICOL SCI, V71, P237, DOI 10.1093/toxsci/71.2.237; Koike MK, 2007, INT J EXP PATHOL, V88, P279, DOI 10.1111/j.1365-2613.2007.00540.x; Lee WH, 2014, NEUROBIOL AGING, V35, P1459, DOI 10.1016/j.neurobiolaging.2013.12.002; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nichols CE, 2015, AM J PHYSIOL-HEART C, V309, pH2017, DOI 10.1152/ajpheart.00353.2015; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Routledge HC, 2005, OCCUP MED-OXFORD, V55, P439, DOI 10.1093/occmed/kqi136; Salemi Vera M C, 2005, Eur J Echocardiogr, V6, P41, DOI 10.1016/j.euje.2004.06.001; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Todandsdal AI, 2008, TOXICOLOGY, V247, P23, DOI 10.1016/j.tox.2008.01.019; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580; Xu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071414; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008	28	16	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176084	10.1371/journal.pone.0176084	http://dx.doi.org/10.1371/journal.pone.0176084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426774	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900100
J	Liu, JH; Wang, L; Wang, YL; Zhang, WJ; Cao, YL				Liu, Jianhua; Wang, Lu; Wang, Yaoling; Zhang, Wenjie; Cao, Yilin			Phenotypic characterization and anticancer capacity of CD8+cytokine-induced killer cells after antigen-induced expansion	PLOS ONE			English	Article							CD8(+) T-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; CANCER STEM-CELLS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ANTITUMOR-ACTIVITY; POOR-PROGNOSIS; NKG2D LIGANDS; CYTOTOXICITY; EXPRESSION	Cytokine-induced killer cells (CIK) have been used in clinic for adoptive immunotherapy in a variety of malignant tumors and have improved the prognosis of cancer patients. However, there are individual differences in the CIK cell preparations including the obvious differences in the ratio of effector CIK cells among different cancer patients. Infusion of such heterogeneous immune cell preparation is an important factor that would affect the therapeutic efficacy. We report here the enrichment and expansion of CD8+ cells from CIK cells cultured for one week using magnetic activated cell sorting ( MACS). These enriched CD8+ CIK cells expressed T cell marker CD3 and antigen recognition receptor NKG2D. Phenotypic analysis showed that CD8+ CIK cells contained 32.4% of CD3+ CD56+ natural killer (NK)-like T cells, 23.6% of CD45RO+ CD28+, and 50.5% of CD45RA+ CD27+ memory T cells. In vitro cytotoxic activity assay demonstrated that the enriched CD8+ CIK cells had significant cytotoxic activity against K562 cells and five ovarian cancer cell lines. Intriguingly, CD8+ CIK cells had strong cytotoxic activity against OVCAR3 cells that has weak binding capability to NKG2D. Flow cytometry and quantitative RT-PCR analysis revealed that OVCAR3 cells expressed HLA-I and OCT4 and Sox2, suggesting that CD8+ CIK cells recognize surface antigen via specific T cell receptor and effectively kill the target cells. The results suggest that transplantation of such in vitro enriched and expanded OCT4-specific CD8+ CIK cells may improve the specific immune defense mechanism against cancer stem cells, providing a novel avenue of cancer stem cell targeted immunotherapy for clinical treatment of ovarian cancer.	[Liu, Jianhua; Wang, Lu; Wang, Yaoling; Zhang, Wenjie; Cao, Yilin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, WJ; Cao, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast Surg, Shanghai, Peoples R China.	wenjieboshi@aliyun.com; drcaoyilin@163.com						Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Di JB, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24271; Franceschetti M, 2009, EXP HEMATOL, V37, P616, DOI 10.1016/j.exphem.2009.01.010; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hoyle C, 1998, BLOOD, V92, P3318, DOI 10.1182/blood.V92.9.3318.421k39_3318_3327; Huang BC, 2011, J IMMUNOTHER, V34, P289, DOI 10.1097/CJI.0b013e31820e1b0d; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Introna M, 2006, BONE MARROW TRANSPL, V38, P621, DOI 10.1038/sj.bmt.1705503; Karimi M, 2005, J IMMUNOL, V175, P7819, DOI 10.4049/jimmunol.175.12.7819; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Li RM, 2012, CANCER IMMUNOL IMMUN, V61, P2125, DOI 10.1007/s00262-012-1260-2; Linn YC, 2002, BRIT J HAEMATOL, V116, P78, DOI 10.1046/j.1365-2141.2002.03247.x; Linn YC, 2009, IMMUNOLOGY, V126, P423, DOI 10.1111/j.1365-2567.2008.02910.x; LU PH, 1994, J IMMUNOL, V153, P1687; McGilvray RW, 2010, INT J CANCER, V127, P1412, DOI 10.1002/ijc.25156; Nishimura R, 2008, BLOOD, V112, P2563, DOI 10.1182/blood-2007-06-092817; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Rong XX, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086060; Samardzija C, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-37; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shi M, 2004, WORLD J GASTROENTERO, V10, P1146; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang FS, 2002, WORLD J GASTROENTERO, V8, P464, DOI 10.3748/wjg.v8.i3.464; Zikherman J, 2008, IMMUNITY, V29, P839, DOI 10.1016/j.immuni.2008.12.005	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175704	10.1371/journal.pone.0175704	http://dx.doi.org/10.1371/journal.pone.0175704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426690	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900041
J	Monnin, D; Kremer, N; Desouhant, E; Vavre, F				Monnin, David; Kremer, Natacha; Desouhant, Emmanuel; Vavre, Fabrice			Impact of Wolbachia on oxidative stress sensitivity in the parasitic wasp Asobara japonica	PLOS ONE			English	Article							HOST; HOMEOSTASIS; DEPENDENCE; INDUCTION; VIRUS	The oxidative homeostasis is the balance between reactive oxygen species and antioxidant molecules. In addition to be considered as a key factor underlying life-history traits evolution, the oxidative homeostasis has been shown to be involved in many host-symbiont associations. Previous studies suggest an interaction between the bacterial endosymbiont Wolbachia and the oxidative homeostasis of some insect hosts. This interaction is likely to exert a strong influence on the host evolution, as it has been proposed in the wasp Asobara tabida, whose dependence upon Wolbachia is due to the evolutionary loss of its ability to regulate the oxidative homeostasis in the absence of the symbiont. Although such cases of complete dependence are rare, cases of insects having lost only a part of their autonomy over the control of the oxidative homeostasis might be more common. If so, one can expect that insects having coevolved with Wolbachia will be more sensitive to oxidative stress when cured of their symbionts. We tested this hypothesis by studying the effects of an experimentally-induced oxidative stress on various life-history traits of Asobara japonica, a species closely related to A. tabida. For most of the life-history traits studied, the sensitivity of the wasps to oxidative stress did not correlate with their infection status. The only exception was the parasitic success. However, contrarily to our expectation, the sensitivity to oxidative stress was increased, rather than decreased, when Wolbachia was present. This result suggests that Wolbachia does not participate to mitigate oxidative stress in A. japonica, and that on the contrary its presence might still be costly in stressful environments.	[Monnin, David; Kremer, Natacha; Desouhant, Emmanuel; Vavre, Fabrice] Univ Lyon 1, CNRS, UMR 5558, Lab Biornetrie & Biol Evolut, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Monnin, D (corresponding author), Univ Lyon 1, CNRS, UMR 5558, Lab Biornetrie & Biol Evolut, Villeurbanne, France.	david.monnin@hotmail.fr	vavre, fabrice/N-2945-2017; Kremer, Natacha/AAC-2877-2019	vavre, fabrice/0000-0003-0909-2936; Kremer, Natacha/0000-0001-5678-9416; DESOUHANT, Emmanuel/0000-0003-0317-4463	Agence Nationale de la Recherche Program 'ImmunSymbArt' [ANR-2010-BLAN- 170101]; Marie Curie Actions [FP7-PEOPLE-2010-IOF/272684/SymbiOx]	Agence Nationale de la Recherche Program 'ImmunSymbArt'(French National Research Agency (ANR)); Marie Curie Actions(European Commission)	This work was supported by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) Program 'ImmunSymbArt', ANR-2010-BLAN- 170101 to FV and the Marie Curie Actions, FP7-PEOPLE-2010-IOF/272684/SymbiOx to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrews ES, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003075; BOULETREAU M, 1986, ENTOMOL EXP APPL, V41, P107, DOI 10.1007/BF00195565; Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Costantini D., 2014, OXIDATIVE STRESS HOR; DAVID JEAN, 1965, BULL BIOL FRANCE BELG, V99, P369; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P501, DOI 10.1007/s11626-013-9634-0; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Kremer N, 2009, HEREDITY, V103, P248, DOI 10.1038/hdy.2009.63; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2010, EVOLUTION, V64, P2969, DOI 10.1111/j.1558-5646.2010.01034.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Mone A Y, 2014, P R SOC A, V281; Monnin D, 2016, J EVOLUTION BIOL, V29, P1211, DOI 10.1111/jeb.12863; Murata Y, 2009, EUR J ENTOMOL, V106, P171, DOI 10.14411/eje.2009.020; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Poinsot D, 1997, EVOLUTION, V51, P180, DOI 10.1111/j.1558-5646.1997.tb02399.x; R Core Team, 2016, R LANG ENV STAT COMP; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201	31	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175974	10.1371/journal.pone.0175974	http://dx.doi.org/10.1371/journal.pone.0175974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426794	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900078
J	Rani, S; Sreenivasaiah, PK; Kim, JO; Lee, MY; Kang, WS; Kim, YS; Ahn, Y; Park, WJ; Cho, C; Kim, DH				Rani, Shilpa; Sreenivasaiah, Pradeep Kumar; Kim, Jin Ock; Lee, Mi Young; Kang, Wan Seok; Kim, Yong Sook; Ahn, Youngkeun; Park, Woo Jin; Cho, Chunghee; Kim, Do Han			Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TRANSGENIC MICE; HEART-FAILURE; DILATED CARDIOMYOPATHY; CHEMICAL CHAPERONES; THERAPEUTIC TARGET; APOPTOSIS; HYPERTROPHY; DYSFUNCTION; MYOCARDIUM	Pressure overload in the heart induces pathological hypertrophy and is associated with cardiac dysfunction. Apoptosis and fibrosis signaling initiated by the endoplasmic reticulum stress (ERS) is known to contribute to these maladaptive effects. The aim of this study was to investigate whether reduction of ERS by a known chemical chaperone, tauroursodeoxycholic acid (TUDCA) can attenuate pressure overload-induced cardiac remodeling in a mouse model of transverse aortic constriction (TAC). Oral administration of TUDCA at a dose of 300 mg/kg body weight (BW) in the TUDCA-TAC group reduced ERS markers (GRP78, p-PERK, and p-elf2 alpha), compared to the Vehicle (Veh)-TAC group. TUDCA administration, for 4 weeks after TAC significantly reduced cardiac hypertrophy as shown by the reduced heart weight (HW) to BW ratio, and expression of hypertrophic marker genes (ANF, BNP, and alpha-SKA). Masson's trichrome staining showed that myocardial fibrosis and collagen deposition were also significantly reduced in the TUDCA-TAC group. We also found that TUDCA significantly decreased expression of TGF-beta signaling proteins and collagen isoforms. TUDCA administration also reduced cardiac apoptosis and the related proteins in the TUDCA-TAC group. Microarray analysis followed by gene ontology (GO) and pathway analysis demonstrated that extracellular matrix genes responsible for hypertrophy and fibrosis, and mitochondrial genes responsible for apoptosis and fatty acid metabolism were significantly altered in the Veh-TAC group, but the alterations were normalized in the TUDCA-TAC group, suggesting potential of TUDCA in treatment of heart diseases related to pressure-overload.	[Rani, Shilpa; Sreenivasaiah, Pradeep Kumar; Kim, Jin Ock; Lee, Mi Young; Park, Woo Jin; Cho, Chunghee; Kim, Do Han] GIST, Sch Life Sci, Gwangju, South Korea; [Kang, Wan Seok; Kim, Yong Sook; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University Hospital	Kim, DH (corresponding author), GIST, Sch Life Sci, Gwangju, South Korea.	dhkim@gist.ac.kr		Kim, Jin Ock/0000-0002-5323-7808	GIST Research Institute (GRI) grant - GIST; NRF grant - Korean Ministry of Science, ICT & Future Planning [NRF-2013M3A9A7046297]	GIST Research Institute (GRI) grant - GIST; NRF grant - Korean Ministry of Science, ICT & Future Planning	This work was supported by GIST Research Institute (GRI) grant funded by GIST in 2017, and the NRF grant funded by the Korean Ministry of Science, ICT & Future Planning (NRF-2013M3A9A7046297).	Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Ding W, 2016, CELL PHYSIOL BIOCHEM, V38, P141, DOI 10.1159/000438616; Dixon IMC, 1997, J MOL CELL CARDIOL, V29, P1837, DOI 10.1006/jmcc.1997.0420; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Groenendyk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159682; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Jeong D, 2006, CIRC RES, V99, P307, DOI 10.1161/01.RES.0000234780.06115.2c; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lo AC, 2013, NEUROBIOL DIS, V50, P21, DOI 10.1016/j.nbd.2012.09.003; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Papp E, 2006, HANDB EXP PHARM, V172, P405; Park CS, 2012, BIOCHEM BIOPH RES CO, V421, P578, DOI 10.1016/j.bbrc.2012.04.048; Polyakova V, 2004, J AM COLL CARDIOL, V44, P1609, DOI 10.1016/j.jacc.2004.07.023; Rivard AL, 2007, AM J CHINESE MED, V35, P279, DOI 10.1142/S0192415X07004813; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Turdi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063615; Vettorazzi JF, 2016, METABOLISM, V65, P54, DOI 10.1016/j.metabol.2015.10.021; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhou LY, 2013, INT J CARDIOL, V167, P1118, DOI 10.1016/j.ijcard.2012.09.082	42	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176071	10.1371/journal.pone.0176071	http://dx.doi.org/10.1371/journal.pone.0176071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426781	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900097
J	Saarinen, L; Nummela, P; Thiel, A; Lehtonen, R; Jarvinen, P; Jarvinen, H; Aaltonen, LA; Lepisto, A; Hautaniemi, S; Ristimaki, A				Saarinen, Lilli; Nummela, Pirjo; Thiel, Alexandra; Lehtonen, Rainer; Jarvinen, Petrus; Jarvinen, Heikki; Aaltonen, Lauri A.; Lepisto, Anna; Hautaniemi, Sampsa; Ristimaki, Ari			Multiple components of PKA and TGF-beta pathways are mutated in pseudomyxoma peritonei	PLOS ONE			English	Article							APPENDICEAL MUCINOUS NEOPLASMS; PROTEIN-KINASE; SOMATIC MUTATIONS; CARNEY COMPLEX; HUMAN CANCER; SEQUENCE; ORIGIN; IDENTIFICATION; GENOME; GRADE	Pseudomyxoma peritonei (PMP) is a subtype of mucinous adenocarcinoma mainly restricted to the peritoneal cavity and most commonly originating from the appendix. The genetic background of PMP is poorly understood and no targeted treatments are currently available for this fatal disease. While RAS signaling pathway is affected in most if not all PMP cases and over half of them also have a mutation in the GNAS gene, other genetic alterations and affected pathways are, to a large degree, poorly known. In this study, we sequenced whole coding genome of nine PMP tumors and paired normal tissues in order to identify additional, commonly mutated genes and signaling pathways affected in PMP. These exome sequencing results were validated with an ultra-deep amplicon sequencing method, leading to 14 validated variants. The validated results contain seven genes that contribute to the protein kinase A (PKA) pathway. PKA pathway, which also contains GNAS, is a major player of overproduction of mucin, which is the characteristic feature of PMP. In addition to PKA pathway, we identified mutations in six genes that belong to the transforming growth factor beta (TGF-beta) pathway, which is a key regulator of cell proliferation. Since either GNAS mutation or an alternative mutation in the PKA pathway was identified in 8/9 patients, inhibition of the PKA pathway might reduce mucin production in most of the PMP patients and potentially suppress disease progression.	[Saarinen, Lilli; Nummela, Pirjo; Thiel, Alexandra; Lehtonen, Rainer; Aaltonen, Lauri A.; Hautaniemi, Sampsa; Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, Helsinki, Finland; [Jarvinen, Petrus; Jarvinen, Heikki; Lepisto, Anna] Helsinki Univ Hosp, Dept Surg, Helsinki, Finland; [Jarvinen, Petrus] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Hosp, HUSLAB, Dept Pathol, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Ristimaki, A (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, Helsinki, Finland.; Ristimaki, A (corresponding author), Helsinki Univ Hosp, HUSLAB, Dept Pathol, Helsinki, Finland.; Ristimaki, A (corresponding author), Univ Helsinki, Helsinki, Finland.	ari.ristimaki@helsinki.fi	Aaltonen, Lauri/A-5375-2010; Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022	Aaltonen, Lauri/0000-0001-6839-4286; Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Ristimaki, Ari/0000-0002-5373-9234; Jarvinen, Petrus/0000-0002-3751-4609; Lepisto, Anna Henriikka/0000-0002-5866-4059	University of Helsinki; Sigrid Juselius Foundation; Finnish Cancer Organizations; Helsinki University Central Hospital Research Funds; Academy of Finland (Center of Excellence in Cancer Genetics Research); Ida Montin Foundation; Cancer Society of Finland; Orion Research Foundation; K. Albin Johansson Foundation; Cancer Foundation Finland sr [150127] Funding Source: researchfish	University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Helsinki University Central Hospital Research Funds; Academy of Finland (Center of Excellence in Cancer Genetics Research); Ida Montin Foundation; Cancer Society of Finland; Orion Research Foundation; K. Albin Johansson Foundation; Cancer Foundation Finland sr	This study was supported by University of Helsinki, Sigrid Juselius Foundation, the Finnish Cancer Organizations, Helsinki University Central Hospital Research Funds, the Academy of Finland (Center of Excellence in Cancer Genetics Research), Ida Montin Foundation (LS), Cancer Society of Finland (LS), Orion Research Foundation (LS), and K. Albin Johansson Foundation (LS). The funding sources had no involvement in planning, execution, or reporting of this research.	Alakus H, 2014, GENOME MED, V6, DOI 10.1186/gm559; Amini A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradbury NA, 2000, J CELL PHYSIOL, V185, P408, DOI 10.1002/1097-4652(200012)185:3<408::AID-JCP11>3.0.CO;2-2; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Carr NJ, 2010, WHO CLASSIFICATION T, P122; Carr NJ, 2012, J CLIN PATHOL, V65, P919, DOI 10.1136/jclinpath-2012-200843; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davison JM, 2014, MODERN PATHOL, V27, P1521, DOI 10.1038/modpathol.2014.37; Fassunke J, 2015, INT J MOL MED, V36, P1233, DOI 10.3892/ijmm.2015.2339; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaujoux S, 2011, J CLIN ENDOCR METAB, V96, pE1888, DOI 10.1210/jc.2011-1433; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvinen P, 2013, SCAND J SURG, V102, P145, DOI 10.1177/1457496913490463; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2014, CLIN CHEM, V60, P1004, DOI 10.1373/clinchem.2014.225565; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Noguchi R, 2015, CANCER MED-US, V4, P1809, DOI 10.1002/cam4.542; Nummela P, 2015, INT J CANCER, V136, pE282, DOI 10.1002/ijc.29245; O'Connell JT, 2002, MODERN PATHOL, V15, P958, DOI 10.1097/01.MP.0000026617.52466.9F; ONO M, 1988, J BIOL CHEM, V263, P5884; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qiu WL, 2016, GASTROENTEROLOGY, V150, P218, DOI 10.1053/j.gastro.2015.09.013; Rhayem Y, 2015, J BIOL CHEM, V290, P27816, DOI 10.1074/jbc.M115.656553; Robinson-White A, 2003, HUM MOL GENET, V12, P1475, DOI 10.1093/hmg/ddg160; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Shetty S, 2013, J SURG RES, V180, P97, DOI 10.1016/j.jss.2012.10.053; Sio TT, 2014, J HUM GENET, V59, P124, DOI 10.1038/jhg.2013.132; Smeenk RM, 2008, EJSO-EUR J SURG ONC, V34, P196, DOI 10.1016/j.ejso.2007.04.002; SUGARBAKER PH, 1987, DIS COLON RECTUM, V30, P772, DOI 10.1007/BF02554625; Szych C, 1999, AM J PATHOL, V154, P1849, DOI 10.1016/S0002-9440(10)65442-9; Thiel A, 2015, HUM PATHOL, V46, P169, DOI 10.1016/j.humpath.2014.08.018; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yost SE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks299	54	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174898	10.1371/journal.pone.0174898	http://dx.doi.org/10.1371/journal.pone.0174898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426742	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900013
J	Talmage, GD; Coppes, OJM; Javed, A; Bernard, J				Talmage, Garrick D.; Coppes, Oscar J. M.; Javed, Adil; Bernard, Jacqueline			Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS; BRAIN ATROPHY; IMPAIRMENT; DISABILITY; DYSFUNCTION; OUTCOMES; IMPACT; RISK	Natalizumab is an effective therapy for multiple sclerosis (MS). Its effectiveness has been demonstrated in several clinical and imaging studies. The objective of this study was to further demonstrate the efficacy of natalizumab using a comprehensive battery of clinical and imaging markers in the same cohort of patients followed longitudinally, hence capturing the multi-faceted nature of the MS disease process. A prospective, open-label, pilot study of 20 MS patients treated with natalizumab was conducted. High resolution MRI, Symbol-Digit Modalities Test (SDMT), and Optical Coherence Tomography (OCT) scans were obtained at baseline, 48, and 96 weeks. 15 patients completed the study. Natalizumab treatment decreased Expanded Disability Status Scale score (EDSS) and no change in SDMT, Brain Parenchymal Fraction (BPF), or any of the OCT markers of retinal degeneration was observed. Thalamic and whole brain volume as assessed by Percentage Brain Volume Change (PBVC) showed continuous deterioration. Higher baseline T2 lesion load correlated with increased rate of PBVC at 96-weeks (r = 0.566, R-2 = 0.320, p = 0.035) and thalamic volume loss (r = -0.586, R-2 = 0.344, p = 0.027). Most patients, 93%, achieved no evidence of disease activity (NEDA) at 2 years, likely due to early disease duration and lower initial baseline lesion load. This study further demonstrates stabilization of clinical and imaging markers of disease activity during natalizumab treatment.	[Talmage, Garrick D.; Coppes, Oscar J. M.; Javed, Adil; Bernard, Jacqueline] Univ Colorado, Dept Ear Nose & Throat, Aurora, CO 80045 USA; [Bernard, Jacqueline] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University	Bernard, J (corresponding author), Univ Colorado, Dept Ear Nose & Throat, Aurora, CO 80045 USA.; Bernard, J (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	jtbernard06@comcast.net			Biogen; Idec [US-TYS-09-10019]; Calvin Fentress Senior Research Fellowship at the University of Chicago; NIH [NIH CTSA UL1 TR000430]	Biogen(Biogen); Idec; Calvin Fentress Senior Research Fellowship at the University of Chicago; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JB received funding from Biogen, Idec (http://www.biogen.com) under grant number US-TYS-09-10019. GT received funding from the Calvin Fentress Senior Research Fellowship at the University of Chicago (https://pritzker.uchicago. edu/). Data duration was performed using RED Cap at the University of Chicago, which was funded by the NIH (http://www.ncats.nih.gov/ctsa) under grant number NIH CTSA UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroughani R, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0762-5; Baroncini D, 2016, MULT SCLER J, V22, P1315, DOI 10.1177/1352458516650736; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Ciampi E, 2016, MULT SCLER IN PRESS; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coyle PK, 2009, MULT SCLER J, V15, pS26, DOI 10.1177/1352458509347131; Matta APD, 2016, EXPERT REV NEUROTHER, V16, P1279, DOI 10.1080/14737175.2016.1202763; Dupuy SL, 2015, EUR J RADIOL, V84, P1564, DOI 10.1016/j.ejrad.2015.05.004; Erlanger DM, 2014, J NEUROL SCI, V340, P123, DOI 10.1016/j.jns.2014.03.009; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Jeffery DR, 2013, THER ADV CHRONIC DIS, V4, P45, DOI 10.1177/2040622312466279; Kunkel A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00097; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, MULT SCLER RELAT DIS, V3, P705, DOI 10.1016/j.msard.2014.08.005; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Radue EW, 2010, J NEUROL SCI, V292, P28, DOI 10.1016/j.jns.2010.02.012; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Shiee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037049; Smith A, 1973, W PSYCHOL SERVICES F; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steckova T, 2014, J NEUROL SCI, V342, P62, DOI 10.1016/j.jns.2014.04.026; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Vollmer T, 2016, NEUROL SCI, V37, P165, DOI 10.1007/s10072-015-2400-1; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053; Ziemssen T, 2016, J NEUROL, V263, P1053, DOI 10.1007/s00415-015-7986-y; Zivadinov R, 2016, EUR J NEUROL, V23, P1101, DOI 10.1111/ene.12992	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0173299	10.1371/journal.pone.0173299	http://dx.doi.org/10.1371/journal.pone.0173299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426702	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900004
J	Fogel, S; Albouyi, G; King, BR; Lungu, O; Vien, C; Bore, A; Pinsard, B; Benali, H; Carrier, J; Doyon, J				Fogel, Stuart; Albouyi, Genevieve; King, Bradley R.; Lungu, Ovidiu; Vien, Catherine; Bore, Amaud; Pinsard, Basile; Benali, Habib; Carrier, Julie; Doyon, Julien			Reactivation or transformation? Motor memory consolidation associated with cerebral activation time-locked to sleep spindles	PLOS ONE			English	Article							SLOW-WAVE SLEEP; LEARNING-DEPENDENT CHANGES; HIPPOCAMPAL RIPPLES; VENTRAL STRIATUM; BRAIN PLASTICITY; SPATIAL MEMORY; NREM SLEEP; SEQUENCE; SKILL; FMRI	Motor memory consolidation is thought to depend on sleep-dependent reactivation of brain areas recruited during learning. However, up to this point, there has been no direct evidence to support this assertion in humans, and the physiological processes supporting such reactivation are unknown. Here, simultaneous electroencephalographic and functional magnetic resonance imaging (EEG-fMRI) recordings were conducted during post-learning sleep to directly investigate the spindle-related reactivation of a memory trace formed during motor sequence learning (MSL), and its relationship to overnight enhancement in performance (reflecting consolidation). We show that brain regions within the striato-cerebello-cortical network recruited during training on the MSL task, and in particular the striatum, were also activated during sleep, time-locked to spindles. Interestingly, the consolidated trace in the striatum was not simply strengthened, but was transformed/reorganized from rostrodorsal (associative) to caudoventral (sensorimotor) subregions. Moreover, the degree of the reactivation was correlated with overnight improvements in performance. Altogether, the present findings demonstrate that striatal reactivation linked to sleep spindles in the post-learning night, is related to motor memory consolidation.	[Fogel, Stuart; Albouyi, Genevieve; King, Bradley R.; Lungu, Ovidiu; Vien, Catherine; Bore, Amaud; Pinsard, Basile; Benali, Habib; Carrier, Julie; Doyon, Julien] Ctr Rech Inst Univ Geriat Montreal, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Fogel, Stuart; Albouyi, Genevieve; King, Bradley R.; Vien, Catherine; Pinsard, Basile; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Fogel, Stuart] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Fogel, Stuart] Univ Ottawa, Inst Mental Hlth Res, Ottawa, ON, Canada; [Fogel, Stuart] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Benali, Habib] INSERM, Funct Neuroimaging Lab, Paris, France; [Carrier, Julie] Hop Sacre Coeur, Ctr Etudes Avancees Med Sommeil, Montreal, PQ, Canada	Universite de Montreal; University of Ottawa; University of Ottawa; University of Ottawa; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal	Doyon, J (corresponding author), Ctr Rech Inst Univ Geriat Montreal, Funct Neuroimaging Unit, Montreal, PQ, Canada.; Doyon, J (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	julien.dcyon@umontreal.ca	King, Bradley/U-1820-2018; ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019; Fogel, Stuart/F-7179-2017	King, Bradley/0000-0002-3010-8755; ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Fogel, Stuart/0000-0002-3227-5370; Carrier, Julie/0000-0001-5311-2370; Lungu, Ovidiu/0000-0001-6608-5818	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de Recherche du Quebec - Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) to AC, HB, JC and JD. Fellowship support from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Fonds de Recherche du Quebec - Sante (FRQS) to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059490; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Andrade KC, 2011, J NEUROSCI, V31, P10331, DOI 10.1523/JNEUROSCI.5660-10.2011; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Barakat M, 2013, HUM BRAIN MAPP, V34, P2918, DOI 10.1002/hbm.22116; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1974, PSYCHOL REP, V34, P1184; Bergmann TO, 2012, NEUROIMAGE, V59, P2733, DOI 10.1016/j.neuroimage.2011.10.036; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; Buysse D J, 1989, Psychiatry Res, V28, P193; Cai DJ, 2009, BEHAV NEUROSCI, V123, P1153, DOI 10.1037/a0017672; Caporro M, 2012, CLIN NEUROPHYSIOL, V123, P303, DOI 10.1016/j.clinph.2011.06.018; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fogel S, 2017, NEUROBIOL AGING, V49, P154, DOI 10.1016/j.neurobiolaging.2016.10.009; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Fogel SM, 2014, HUM BRAIN MAPP, V35, P3625, DOI 10.1002/hbm.22426; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gais S, 2002, J NEUROSCI, V22, P6830; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Himanen SL, 2002, J SLEEP RES, V11, P35, DOI 10.1046/j.1365-2869.2002.00273.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, NATURE, V377, P155; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Lansink CS, 2008, J NEUROSCI, V28, P6372, DOI 10.1523/JNEUROSCI.1054-08.2008; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Laventure S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002429; Leclercq Y, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/598206; Leclercq Y, 2009, NEUROIMAGE, V44, P679, DOI 10.1016/j.neuroimage.2008.10.017; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Molle M, 2002, J NEUROSCI, V22, P10941; Morin A, 2008, SLEEP, V31, P1149; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nettersheim A, 2015, J NEUROSCI, V35, P6696, DOI 10.1523/JNEUROSCI.1236-14.2015; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2010, NEUROIMAGE, V49, P694, DOI 10.1016/j.neuroimage.2009.08.055; PAN SC, 2015, PSYCHOL B, V141; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Pezzulo G, 2014, TRENDS COGN SCI, V18, P647, DOI 10.1016/j.tics.2014.06.011; Ramanathan DS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002263; Ray LB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00507; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schonauer M, 2014, J COGNITIVE NEUROSCI, V26, P143, DOI 10.1162/jocn_a_00471; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Tyvaert L, 2008, CLIN NEUROPHYSIOL, V119, P2762, DOI 10.1016/j.clinph.2008.07.284; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Valdes JL, 2015, J NEUROPHYSIOL, V114, P1183, DOI 10.1152/jn.00758.2014; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Walter D. O., 1968, ELECTROEN CLIN NEURO, P53; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Zsofia C, 2011, EUR J NEUROSCI, V33, P511, DOI 10.1111/j.1460-9568.2010.07505.x	82	46	46	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174755	10.1371/journal.pone.0174755	http://dx.doi.org/10.1371/journal.pone.0174755			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422976	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600021
J	Konrath, JM; Saxby, DJ; Killen, BA; Pizzolato, C; Vertullo, CJ; Barrett, RS; Lloyd, DG				Konrath, Jason M.; Saxby, David J.; Killen, Bryce A.; Pizzolato, Claudio; Vertullo, Christopher J.; Barrett, Rod S.; Lloyd, David G.			Muscle contributions to medial tibiofemoral compartment contact loading following ACL reconstruction using semitendinosus and gracilis tendon grafts	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; TIBIAL ROTATION STRENGTH; KNEE ADDUCTION MOMENT; HIP-JOINT CENTER; HAMSTRING TENDONS; PATELLAR TENDON; OSTEOARTHRITIS; PROGRESSION; STRATEGIES; PREDICTION	Background The muscle-tendon properties of the semitendinosus (ST) and gracilis (GR) are substantially altered following tendon harvest for the purpose of anterior cruciate ligament reconstruction (ACLR). This study adopted a musculoskeletal modelling approach to determine how the changes to the ST and GR muscle-tendon properties alter their contribution to medial compartment contact loading within the tibiofemoral joint in post ACLR patients, and the extent to which other muscles compensate under the same external loading conditions during walking, running and sidestep cutting. Materials and methods Motion capture and electromyography (EMG) data from 16 lower extremity muscles were acquired during walking, running and cutting in 25 participants that had undergone an ACLR using a quadruple (ST +GR) hamstring auto-graft. An EMG-driven musculoskeletal model was used to estimate the medial compartment contact loads during the stance phase of each gait task. An adjusted model was then created by altering muscle-tendon properties for the ST and GR to reflect their reported changes following ACLR. Parameters for the other muscles in the model were calibrated to match the experimental joint moments. Results The medial compartment contact loads for the standard and adjusted models were similar. The combined contributions of ST and GR to medial compartment contact load in the adjusted model were reduced by 26%, 17% and 17% during walking, running and cutting, respectively. These deficits were balanced by increases in the contribution made by the semimembranosus muscle of 33% and 22% during running and cutting, respectively. Conclusion Alterations to the ST and GR muscle-tendon properties in ACLR patients resulted in reduced contribution to medial compartment contact loads during gait tasks, for which the semimembranosus muscle can compensate.	[Konrath, Jason M.; Saxby, David J.; Killen, Bryce A.; Pizzolato, Claudio; Vertullo, Christopher J.; Barrett, Rod S.; Lloyd, David G.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia; [Konrath, Jason M.; Saxby, David J.; Killen, Bryce A.; Pizzolato, Claudio; Vertullo, Christopher J.; Barrett, Rod S.; Lloyd, David G.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Vertullo, Christopher J.] Knee Res Australia, Gold Coast, Qld, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland	Konrath, JM (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia.; Konrath, JM (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	jason.konrath@griffithuni.edu.au	Saxby, David John/T-4036-2019; Vertullo, Christopher/Y-2560-2019; Lloyd, David Gavin/AAH-6066-2020; Pizzolato, Claudio/R-6215-2019	Vertullo, Christopher/0000-0002-8447-8399; Lloyd, David Gavin/0000-0002-0824-9682; Pizzolato, Claudio/0000-0002-0292-2776; Saxby, David John/0000-0002-0874-7518; Killen, Bryce/0000-0001-6389-2497; Barrett, Rod/0000-0002-1784-1629	National Health and Medical Research Council (NHMRC) [628850]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The following study was funded through agrant from the National Health and Medical Research Council (NHMRC). The grant number was 628850, and the URL is https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2005, ARTHRITIS RHEUM, V52, P3152, DOI 10.1002/art.21296; ANDRIACCHI T P, 1984, Journal of Orthopaedic Research, V1, P266; Armour T, 2004, AM J SPORT MED, V32, P1639, DOI 10.1177/0363546504263405; Aune AK, 2001, AM J SPORT MED, V29, P722, DOI 10.1177/03635465010290060901; Belli A, 2002, INT J SPORTS MED, V23, P136, DOI 10.1055/s-2002-20136; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; BROWN CH, 1993, CLIN SPORT MED, V12, P723; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Cicuttini FM, 2001, ANN RHEUM DIS, V60, P977, DOI 10.1136/ard.60.10.977; D'Alessandro P, 2013, J KNEE SURG, V26, P139, DOI 10.1055/s-0032-1324811; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dempsey AR, 2009, AM J SPORT MED, V37, P2194, DOI 10.1177/0363546509334373; Egloff C, 2014, OSTEOARTHR CARTILAGE, V22, P1886, DOI 10.1016/j.joca.2014.07.026; Feller JA, 2003, AM J SPORT MED, V31, P564, DOI 10.1177/03635465030310041501; Foroughi N, 2009, KNEE, V16, P303, DOI 10.1016/j.knee.2008.12.007; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Gardinier ES, 2013, J ORTHOP RES, V31, P458, DOI 10.1002/jor.22249; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Konrath JM, 2016, AM J SPORT MED, V44, P2589, DOI 10.1177/0363546516651441; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Manal K, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023457; Mantoan A, 2015, SOURCE CODE BIOL MED, V10, DOI 10.1186/s13029-015-0044-4; Modenese L, 2016, J BIOMECH, V49, P141, DOI 10.1016/j.jbiomech.2015.11.006; Pizzolato C, 2015, J BIOMECH, V48, P3929, DOI 10.1016/j.jbiomech.2015.09.021; Sartori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052618; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Saxby DJ, 2016, MEDICINE AND SCIENCE; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; Spicer DDM, 2000, KNEE SURG SPORT TR A, V8, P286, DOI 10.1007/s001670000139; Viola RW, 2000, AM J SPORT MED, V28, P552, DOI 10.1177/03635465000280041801; Wellsandt E, 2016, AM J SPORT MED, V44, P143, DOI 10.1177/0363546515608475; Williams GN, 2004, J BONE JOINT SURG AM, V86A, P1936, DOI 10.2106/00004623-200409000-00012; Winby CR, 2008, J BIOMECH, V41, P1682, DOI 10.1016/j.jbiomech.2008.03.008; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zabala ME, 2013, J BIOMECH, V46, P515, DOI 10.1016/j.jbiomech.2012.10.010; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176016	10.1371/journal.pone.0176016	http://dx.doi.org/10.1371/journal.pone.0176016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423061	Green Published, gold			2022-12-27	WOS:000399875600077
J	Rashid, R; Cazenave-Gassiot, A; Gao, IH; Nair, ZJ; Kumar, JK; Gao, L; Kline, KA; Wenk, MR				Rashid, Rafi; Cazenave-Gassiot, Amaury; Gao, Iris H.; Nair, Zeus J.; Kumar, Jaspal K.; Gao, Liang; Kline, Kimberly A.; Wenk, Markus R.			Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; DAPTOMYCIN RESISTANCE; LIPID DOMAINS; BACTERIAL; CARDIOLIPIN; ACIDS; QUANTIFICATION; BIOSYNTHESIS; LOCALIZATION	Enterococcus faecalis is a Gram-positive, opportunistic, pathogenic bacterium that causes a significant number of antibiotic-resistant infections in hospitalized patients. The development of antibiotic resistance in hospital-associated pathogens is a formidable public health threat. In E. faecalis and other Gram-positive pathogens, correlations exist between lipid composition and antibiotic resistance. Resistance to the last-resort antibiotic daptomycin is accompanied by a decrease in phosphatidylglycerol (PG) levels, whereas multiple peptide resistance factor (MprF) converts anionic PG into cationic lysyl-PG via a trans-esterification reaction, providing resistance to cationic antimicrobial peptides. Unlike previous studies that relied on thin layer chromatography and spectrophotometry, we have performed liquid chromatography- tandem mass spectrometry (LC-MS/MS) directly on lipids extracted from E. faecalis, and quantified the phospholipids through multiple reaction monitoring (MRM). In the daptomycin-sensitive E. faecalis strain OG1RF, we have identified 17 PGs, 8 lysyl-PGs (LPGs), 23 cardiolipins (CL), 3 glycerophospho-diglucosyl-diacylglycerols (GPDGDAG), 5 diglucosyl-diacylglycerols (DGDAG), 3 diacylglycerols (DAGs), and 4 triacylglycerols (TAGs). We have quantified PG and shown that PG levels vary during growth of E. faecalis in vitro. We also show that two daptomycin-resistant (DapR) strains of E. faecalis have substantially lower levels of PG and LPG levels. Since LPG levels in these strains are lower, daptomycin resistance is likely due to the reduction in PG. This lipidome map is the first comprehensive analysis of membrane phospholipids and glycolipids in the important human pathogen E. faecalis, for which antimicrobial resistance and altered lipid homeostasis have been intimately linked.	[Rashid, Rafi; Gao, Iris H.; Nair, Zeus J.; Kline, Kimberly A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Rashid, Rafi; Gao, Iris H.; Nair, Zeus J.; Kline, Kimberly A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Cazenave-Gassiot, Amaury; Kumar, Jaspal K.; Gao, Liang; Wenk, Markus R.] Natl Univ Singapore, Singapore Lipid Incubator, Singapore, Singapore; [Kumar, Jaspal K.; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Gao, Liang] Natl Univ Singapore, Inst Life Sci, Singapore, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Kline, KA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.; Kline, KA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Wenk, MR (corresponding author), Natl Univ Singapore, Singapore Lipid Incubator, Singapore, Singapore.; Wenk, MR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Wenk, MR (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.	kkline@ntu.edu.sg; markus_wenk@nuhs.edu.sg	Kline, Kimberly/H-1589-2011; Cazenave-Gassiot, Amaury/E-4536-2014; Rashid, Rafi/P-6178-2016	Kline, Kimberly/0000-0002-5472-3074; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Rashid, Rafi/0000-0003-0737-9116; Gao, Liang/0000-0003-3700-1069; Nair, Zeus/0000-0001-9662-4958	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme; National Research Foundation under its Singapore NRF Fellowship programme [NRF-NRFF2011-11]; National University of Singapore via the Life Sciences Institute (LSI); National Research Foundation [NRFI2015-05]; BMRC-SERC joint grant from the Agency for Science, Technology and Research (A*Star) [BMRC-SERC 112 148 0006]	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme(Ministry of Education, Singapore); National Research Foundation under its Singapore NRF Fellowship programme(National Research Foundation, Singapore); National University of Singapore via the Life Sciences Institute (LSI)(National University of Singapore); National Research Foundation; BMRC-SERC joint grant from the Agency for Science, Technology and Research (A*Star)(Agency for Science Technology & Research (A*STAR))	Authors RR, IHG, ZJN, and KAK were supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and by the National Research Foundation under its Singapore NRF Fellowship programme awarded to KAK (NRF-NRFF2011-11). ACG, JKK, LG, and MRW were supported by grants from the National University of Singapore via the Life Sciences Institute (LSI), the National Research Foundation (NRFI2015-05), and a BMRC-SERC joint grant (BMRC-SERC 112 148 0006) from the Agency for Science, Technology and Research (A*Star). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.R., I. H.G., Z.J.N., and K.A.K. were supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and by the National Research Foundation under its Singapore NRF Fellowship programme awarded to K.A.K. ( NRF-NRFF2011-11). A.C.G., J.K.K., L.G. and M.R.W. were supported by grants from the National University of Singapore via the Life Sciences Institute (LSI), the National Research Foundation (NRFI2015-05) and a BMRC-SERC joint grant (BMRC-SERC 112 148 0006) from the Agency for Science, Technology and Research ( A * Star).	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bach JN, 2013, MOL MICROBIOL, V88, P1205, DOI 10.1111/mmi.12252; Bao Y, 2012, PLOS ONE, V7; Bao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038458; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Barak I, 2013, INT J MOL SCI, V14, P4050, DOI 10.3390/ijms14024050; Bramkamp M, 2015, MICROBIOL MOL BIOL R, V79, P81, DOI 10.1128/MMBR.00036-14; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Diaz L, 2014, ANTIMICROB AGENTS CH, V58, P4527, DOI 10.1128/AAC.02686-14; Donovan C, 2009, MICROBIOL-SGM, V155, P1786, DOI 10.1099/mic.0.025312-0; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Dunnick JK, 1970, J BACTERIOL, V101, P892, DOI 10.1128/JB.101.3.892-900.1970; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; DUNNY GM, 1995, J BACTERIOL, V177, P871, DOI 10.1128/jb.177.4.871-876.1995; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Farnoud AM, 2015, CURR TOP MEMBR, V75, P233, DOI 10.1016/bs.ctm.2015.03.005; Foss MH, 2011, BIOCHEMISTRY-US, V50, P7719, DOI 10.1021/bi200940d; Garrett TA, 2007, METHOD ENZYMOL, V433, P213, DOI 10.1016/S0076-6879(07)33012-7; Garrett TA, 2012, RAPID COMMUN MASS SP, V26, P2267, DOI 10.1002/rcm.6350; Geiger O, 2010, HANDBOOK OF HYDROCAR; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Gidden J, 2009, INT J MASS SPECTROM, V283, P178, DOI 10.1016/j.ijms.2009.03.005; Govindarajan S, 2012, FEMS MICROBIOL REV, V36, P1005, DOI 10.1111/j.1574-6976.2012.00348.x; Harp JR, 2016, APPL ENVIRON MICROB, V82, P4410, DOI 10.1128/AEM.00933-16; Heath R, 2002, BIOCHEMISTRY OF LIPI, P59; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kandaswamy K, 2013, P NATL ACAD SCI USA, V110, P20230, DOI 10.1073/pnas.1319066110; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Martinez M, 2010, HANDBOOK OF HYDROCAR, P510; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mishra NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043958; Mitra SD, 2016, TRENDS MICROBIOL, V24, P611, DOI 10.1016/j.tim.2016.03.009; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nielsen H.D., 2012, INT J AQUAT SCI, V3, P3; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Rashid R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00055; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Saito HE, 2014, APPL ENVIRON MICROB, V80, P6527, DOI 10.1128/AEM.02044-14; Sallans L, 2013, BBA-MOL CELL BIOL L, V1831, P1239, DOI 10.1016/j.bbalip.2013.03.012; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Sohlenkamp C, 2015, FEMS MICROBIOLOGY RE; Takahashi H, 1999, BIOPHYS CHEM, V77, P37, DOI 10.1016/S0301-4622(99)00005-8; Tran TT, 2013, MBIO, V4, DOI 10.1128/mBio.00281-13; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Wenk MR, 2006, FEBS LETT, V580, P5541, DOI 10.1016/j.febslet.2006.07.007; White D, 2012, THE PHYSIOLOGY AND B; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wilson B.A., 2011, BACTERIAL PATHOGENES; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	76	34	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175886	10.1371/journal.pone.0175886	http://dx.doi.org/10.1371/journal.pone.0175886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423018	Green Published, gold			2022-12-27	WOS:000399875600059
J	Li, XF; Pei, KQ; Kery, M; Niklaus, PA; Schmid, B				Li, Xuefei; Pei, Kequan; Kery, Marc; Niklaus, Pascal A.; Schmid, Bernhard			Decomposing functional trait associations in a Chinese subtropical forest	PLOS ONE			English	Article							PLANT ECONOMICS SPECTRUM; LEAF PHOTOSYNTHETIC CAPACITY; WOOD DENSITY; LIMITING SIMILARITY; STEM; EVOLUTION; CONVERGENCE; STRATEGIES; COORDINATION; PRODUCTIVITY	Functional traits, properties of organisms correlated with ecological performance, play a central role in plant community assembly and functioning. To some extents, functional traits vary in concert, reflecting fundamental ecological strategies. While "trait syndromes" characteristic of e. g. fast-growing, early-successional vs. competitive, late-successional species are recognized in principle, less is known about the environmental and genetic factors at the source of trait variation and covariation within plant communities. We studied the three leaf traits leaf half-life (LHL), leaf mass per area (LMA) and nitrogen concentration in green leaves (Ngreen) and the wood trait wood density (WD) in 294 individuals belonging to 45 tree or shrub species in a Chinese subtropical forest from September 2006 to January 2009. Using multilevel ANOVA and decomposition of sums of products, we estimated the amount of trait variation and covariation among species (mainly genetic causes), i. e. plant functional type (deciduous vs. evergreen species), growth form (tree vs. shrub species), family/genus/species differences, and within species (mainly environmental causes), i. e. individual and season. For single traits, the variation between functional types and among species within functional types was large, but only LMA and Ngreen varied significantly among families and thus showed phylogenetic signal. Trait variation among individuals within species was small, but large temporal variation due to seasonal effects was found within individuals. We did not find any trait variation related to soil conditions underneath the measured individuals. For pairs of traits, variation between functional types and among species within functional types was large, reflecting a strong evolutionary coordination of the traits, with LMA, LHL and WD being positively correlated among each other and negatively with Ngreen. This integration of traits was consistent with a putative stem-leaf economics spectrum ranging from deciduous species with thin, highnitrogen leaves and low-density wood to evergreen species with thick, low-nitrogen leaves and dense wood and was not influenced by phylogenetic history. Trait coordination within species was weak, allowing individual trees to deviate from the interspecific trait coordination and thus respond flexibly to environmental heterogeneity. Our findings suggest that within a single woody plant community variation and covariation in functional traits allows a large number of species to co-exist and cover a broad spectrum of multivariate niche space, which in turn may increase total resource extraction by the community and community functioning.	[Li, Xuefei; Niklaus, Pascal A.; Schmid, Bernhard] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pei, Kequan] Chinese Acad Sci, Inst Bot, Lab Quantitat Vegetat Ecol, Beijing, Peoples R China; [Kery, Marc] Swiss Ornithol Inst, Sempach, Switzerland; [Li, Xuefei] Univ Helsinki, Dept Phys, Helsinki, Finland	University of Zurich; Chinese Academy of Sciences; Institute of Botany, CAS; Swiss Ornithological Institute; University of Helsinki	Li, XF; Schmid, B (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.; Li, XF (corresponding author), Univ Helsinki, Dept Phys, Helsinki, Finland.		Schmid, Bernhard/C-8625-2009; Niklaus, Pascal A/G-5786-2010; Li, Xuefei/AAC-6421-2019; Pei, Kequan/HDO-8289-2022	Schmid, Bernhard/0000-0002-8430-3214; Niklaus, Pascal A/0000-0002-2360-1357; 	German Science Foundation [DFG FOR 891/1]; Swiss National Science Foundation [31003A_166457]	German Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by the German Science Foundation (DFG FOR 891/1) and the Swiss National Science Foundation (31003A_166457).r We thank Keping Ma from the Institute of Botany, Chinese Academy of Sciences for allowing us to use their permanent sample plot area to conduct this study; staff and personnel at the West China Subalpine Botanical Garden of China for logistic support and plant identification; Fei Wang, Jianjiang Li, Anyan Hou, Sabine Both, Wenzel Krober, Wuting Du, Qiang Guo, Yann Salmon for help with the sample collection; Rene Husi for help with the leaf nitrogen concentration analysis; Yu Liang for help with soil nitrogen content analysis; Song S. Qian for the method of multilevel ANOVA, Marc Cadotte for testing phylogenetic signal and C.E. Timothy Paine for scientific input and proof-reading. This project was funded by the German Science Foundation (DFG FOR 891/1) and the Swiss National Science Foundation (31003A_166457).	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; BELL G, 1989, AM NAT, V133, P553, DOI 10.1086/284935; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; Campanello PI, 2008, TREE PHYSIOL, V28, P85, DOI 10.1093/treephys/28.1.85; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CHEN C, 2000, ACTA ECOL SINICA, V20, P28; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; de la Riva EG, 2016, J VEG SCI, V27, P187, DOI 10.1111/jvs.12341; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Eccas, 1974, FLORA CHINA; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Field C., 1986, EC PLANT FORM FUNCTI, P22; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Gelman A., 2007, DATA ANAL USING REGR; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; HARPER JL, 1967, J ECOL, V55, P247, DOI 10.2307/2257876; He JS, 2009, ECOLOGY, V90, P2779, DOI 10.1890/08-1126.1; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Kery M, 2010, INTRODUCTION TO WINB; Kong DL, 2016, BIOGEOSCIENCES, V13, P415, DOI 10.5194/bg-13-415-2016; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Qian SS, 2007, ECOLOGY, V88, P2489, DOI 10.1890/06-2041.1; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; SCHMID B, 1985, J ECOL, V73, P793, DOI 10.2307/2260147; SCHMID B, 1994, ECOL MONOGR, V64, P177, DOI 10.2307/2937040; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	58	13	13	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175727	10.1371/journal.pone.0175727	http://dx.doi.org/10.1371/journal.pone.0175727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419169	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000399875200040
J	Santamaria, E; Estevez, JA; Riba, J; Izquierdo, I; Valle, M				Santamaria, Eva; Alejandro Estevez, Javier; Riba, Jordi; Izquierdo, Inaki; Valle, Marta			Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children	PLOS ONE			English	Article							ALLERGIC RHINITIS	Aims To optimise a pharmacokinetic (PK) study design of rupatadine for 2-5 year olds by using a population PK model developed with data from a study in 6-11 year olds. The design optimisation was driven by the need to avoid children's discomfort in the study. Methods PK data from 6-11 year olds with allergic rhinitis available from a previous study were used to construct a population PK model which we used in simulations to assess the dose to administer in a study in 2-5 year olds. In addition, an optimal design approach was used to determine the most appropriate number of sampling groups, sampling days, total samples and sampling times. Results A two-compartmental model with first-order absorption and elimination, with clearance dependent on weight adequately described the PK of rupatadine for 6-11 year olds. The dose selected for a trial in 2-5 year olds was 2.5 mg, as it provided a Cmax below the 3 ng/ ml threshold. The optimal study design consisted of four groups of children (10 children each), a maximum sampling window of 2 hours in two clinic visits for drawing three samples on day 14 and one on day 28 coinciding with the final examination of the study. Conclusions A PK study design was optimised in order to prioritise avoidance of discomfort for enrolled 2-5 year olds by taking only four blood samples from each child and minimising the length of hospital stays.	[Santamaria, Eva; Izquierdo, Inaki] J Uriach & Co SA, R&D, Clin Dev, Barcelona, Spain; [Santamaria, Eva; Alejandro Estevez, Javier; Valle, Marta] Univ Autonoma Barcelona, Dept Farmacol Terapeut & Toxicol, Barcelona, Spain; [Alejandro Estevez, Javier; Valle, Marta] Inst Recerca Hosp Santa Creu & St Pau IIB St Pau, CIM St Pau, Pharmacokinet Pharmacodynam Modeling & Simulat, Barcelona, Spain; [Riba, Jordi] Inst Recerca Hosp Santa Creu & St Pau IIB St Pau, CIM St Pau, Human Neuropsychopharmacol Grp, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau	Valle, M (corresponding author), Univ Autonoma Barcelona, Dept Farmacol Terapeut & Toxicol, Barcelona, Spain.; Valle, M (corresponding author), Inst Recerca Hosp Santa Creu & St Pau IIB St Pau, CIM St Pau, Pharmacokinet Pharmacodynam Modeling & Simulat, Barcelona, Spain.	MValleC@santpau.cat		valle, marta/0000-0002-3515-251X; Riba, Jordi/0000-0002-9375-8421; Leggas, Markos/0000-0003-4314-4533	Spanish Health Ministry [FIS CP04/00121]; Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona; Institute de Salud Carlos III; Spanish Ministry of Health [TRA-076]; Alban Program; European Union Program of High Level Scholarships [E06D101499CU]; J. Uriach y Compania, S.A; ES	Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona; Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Alban Program; European Union Program of High Level Scholarships; J. Uriach y Compania, S.A; ES	This work was financed by J. Uriach y Compania, S.A. and ES and II participated in the study design, data colection and preparation of the manuscript. Marta Valle was supported by a grant (FIS CP04/00121) from the Spanish Health Ministry in collaboration with Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona; she and Jordi Riba are members of CIBERSAM (funded by the Spanish Health Ministry, Institute de Salud Carlos III). FEDER. CERCA Programme/ Generalitat de Catalunya. Javier Estevez was supported by a grant from the Spanish Ministry of Health, Project TRA-076; he was also partially supported by the Alban Program, the European Union Program of High Level Scholarships for Latin America (scholarship No. E06D101499CU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal S, 1989, NONMEM USERS GUIDES; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Centers for Disease Control and Prevention. National Center for Health Statistics, IND GROWTH CHARTS WE; Donado E, 2010, BRIT J CLIN PHARMACO, V69, P401, DOI 10.1111/j.1365-2125.2009.03599.x; Dufful S, 2008, WINPOPT VERSION 1 2; European Medicines Agency, 2006, EMEACHMPEWP147013200; Gupta S, 2007, BRIT J CLIN PHARMACO, V63, P534, DOI 10.1111/j.1365-2125.2006.02810.x; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Krishnaswami S, 2003, J CLIN PHARMACOL, V43, P1016; Mentre F, 2001, J PHARMACOKINET PHAR, V28, P299, DOI 10.1023/A:1011583210549; Mullo J, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2008.01640.x; Ogungbenro K, 2009, BRIT J CLIN PHARMACO, V68, P546, DOI 10.1111/j.1365-2125.2009.03479.x; Panetta JC, 2002, J PHARMACOKINET PHAR, V29, P171, DOI 10.1023/A:1019755608555; Pena J, 2008, EUR J DRUG METAB PH, V33, P107; Pitsiu M, 2004, BRIT J CLIN PHARMACO, V57, P402, DOI 10.1111/j.1365-2125.2003.02017.x; Post TM, 2008, J PHARMACOKINET PHAR, V35, P185, DOI 10.1007/s10928-007-9081-1; Salem F, 2014, CLIN PHARMACOKINET, V53, P625, DOI 10.1007/s40262-014-0140-7; Sarashina A, 2005, BRIT J CLIN PHARMACO, V59, P43, DOI 10.1111/j.1365-2125.2005.2250; Simons FER, 2005, J ALLERGY CLIN IMMUN, V116, P355, DOI 10.1016/j.jaci.2005.04.010; Simons FER, 2005, PEDIAT ALLERG IMM-UK, V16, P97, DOI 10.1111/j.1399-3038.2005.00240.x; Tod M, 2008, CLIN PHARMACOKINET, V47, P231, DOI 10.2165/00003088-200847040-00002; Valero A, 2009, DRUG SAFETY, V32, P33, DOI 10.2165/00002018-200932010-00003	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0176091	10.1371/journal.pone.0176091	http://dx.doi.org/10.1371/journal.pone.0176091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419164	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875200070
J	Pfannmuller, A; Leufken, J; Studt, L; Michielse, CB; Sieber, CMK; Guidener, U; Hawat, S; Hippler, M; Fufezan, C; Tudzynski, B				Pfannmueller, Andreas; Leufken, Johannes; Studt, Lena; Michielse, Caroline B.; Sieber, Christian M. K.; Gueidener, Ulrich; Hawat, Susan; Hippler, Michael; Fufezan, Christian; Tudzynski, Bettina			Comparative transcriptome and proteome analysis reveals a global impact of the nitrogen regulators AreA and AreB on secondary metabolism in Fusarium fujikuroi	PLOS ONE			English	Article							GATA FACTOR AREA; GIBBERELLIN BIOSYNTHETIC-PATHWAY; IN-VIVO BINDING; ASPERGILLUS-NIDULANS; GENE-CLUSTER; SACCHAROMYCES-CEREVISIAE; PENICILLIUM-CHRYSOGENUM; ARGININE CATABOLISM; PYTHON MODULE; NITRATE	The biosynthesis of multiple secondary metabolites in the phytopathogenic ascomycete Fusarium fujikuroi is strongly affected by nitrogen availability. Here, we present the first genome-wide transcriptome and proteome analysis that compared the wild type and deletion mutants of the two major nitrogen regulators AreA and AreB. We show that AreB acts not simply as an antagonist of AreA counteracting the expression of AreA target genes as suggested based on the yeast model. Both GATA transcription factors affect a large and diverse set of common as well as specific target genes and proteins, acting as activators and repressors. We demonstrate that AreA and AreB are not only involved in fungal nitrogen metabolism, but also in the control of several complex cellular processes like carbon metabolism, transport and secondary metabolism. We show that both GATA transcription factors can be considered as master regulators of secondary metabolism as they affect the expression of more than half of the 47 putative secondary metabolite clusters identified in the genome of F. fujikuroi. While AreA acts as a positive regulator of many clusters under nitrogen-limiting conditions, AreB is able to activate and repress gene clusters (e.g. bikaverin) under nitrogen limitation and sufficiency. In addition, ChIP analyses revealed that loss of AreA or AreB causes histone modifications at some of the regulated gene clusters.	[Pfannmueller, Andreas; Studt, Lena; Michielse, Caroline B.; Tudzynski, Bettina] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Mol Biol & Biotechnol Fungi, Munster, Germany; [Leufken, Johannes; Fufezan, Christian] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Computat Biol, Munster, Germany; [Studt, Lena] BOKU Univ Nat Resources & Life Sci, Div Microbial Genet & Pathogen Interact, Dept Appl Genet & Cell Biol, Campus Tulin, Vienna, Austria; [Sieber, Christian M. K.; Gueidener, Ulrich] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Gueidener, Ulrich] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany; [Hawat, Susan; Hippler, Michael] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Plant Biochem & Biotechnol, Munster, Germany; [Michielse, Caroline B.] DuPont Ind Biosci, Wageningen, Netherlands; [Sieber, Christian M. K.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of Natural Resources & Life Sciences, Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Tudzynski, B (corresponding author), Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Mol Biol & Biotechnol Fungi, Munster, Germany.	Bettina.Tudzynski@uni-muenster.de	Güldener, Ulrich/G-5227-2012; Studt, Lena/AAE-3991-2021	Güldener, Ulrich/0000-0001-5052-8610; Michael, Hippler/0000-0001-9670-6101; Studt-Reinhold, Lena/0000-0002-8738-2106; Leufken, Johannes/0000-0001-6343-2431; Sieber, Christian/0000-0002-9560-0281	Deutsche Forschungsgemeinschaft [TU101/12-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de), Grant Number TU101/12-2, BT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Bald T, 2012, BIOINFORMATICS, V28, P1052, DOI 10.1093/bioinformatics/bts066; Barth J, 2014, MOL CELL PROTEOMICS, V13, P969, DOI 10.1074/mcp.M113.032771; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Bergner SV, 2015, PLANT PHYSIOL, V168, P615, DOI 10.1104/pp.15.00072; Bibbins M, 2002, MOL GENET GENOMICS, V267, P498, DOI 10.1007/s00438-002-0682-5; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Caddick MX, 1998, J BACTERIOL, V180, P5762, DOI 10.1128/JB.180.21.5762-5764.1998; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conlon H, 2001, MOL MICROBIOL, V40, P361, DOI 10.1046/j.1365-2958.2001.02399.x; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Davis MA, 1996, J BACTERIOL, V178, P3406, DOI 10.1128/jb.178.11.3406-3409.1996; Desjardins AE, 1997, APPL ENVIRON MICROB, V63, P1838, DOI 10.1128/AEM.63.5.1838-1842.1997; Deutsch E, 2008, PROTEOMICS, V8, P2776, DOI 10.1002/pmic.200890049; Dzikowska A, 2003, FUNGAL GENET BIOL, V38, P175, DOI 10.1016/S1087-1845(02)00522-4; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FU YH, 1990, MOL MICROBIOL, V4, P1847, DOI 10.1111/j.1365-2958.1990.tb02033.x; Gacek-Matthews A, 2015, MOL MICROBIOL, V96, P839, DOI 10.1111/mmi.12977; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Giese H, 2013, FUNGAL BIOL-UK, V117, P814, DOI 10.1016/j.funbio.2013.10.006; Haas H, 1997, J BIOL CHEM, V272, P22576, DOI 10.1074/jbc.272.36.22576; HAAS H, 1995, CURR GENET, V28, P177, DOI 10.1007/BF00315785; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Krappmann S, 2005, MED MYCOL, V43, pS31, DOI 10.1080/13693780400024271; Kremer LPM, 2016, J PROTEOME RES, V15, P788, DOI 10.1021/acs.jproteome.5b00860; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; Kukuczka B, 2014, PLANT PHYSIOL, V165, P1604, DOI 10.1104/pp.114.240648; Kurat CF, 2014, P NATL ACAD SCI USA, V111, P14124, DOI 10.1073/pnas.1414024111; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Li JY, 2013, FUNGAL GENET BIOL, V61, P69, DOI 10.1016/j.fgb.2013.10.006; Lopez-Berges MS, 2014, FUNGAL GENET BIOL, V62, P78, DOI 10.1016/j.fgb.2013.11.002; Macios M, 2012, FUNGAL GENET BIOL, V49, P189, DOI 10.1016/j.fgb.2012.01.004; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marroquin-Guzman M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004851; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Ment D, 2015, MOL PLANT MICROBE IN, V28, P154, DOI 10.1094/MPMI-09-14-0252-R; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Michielse CB, 2014, MOL MICROBIOL, V91, P472, DOI 10.1111/mmi.12472; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Muro-Pastor MI, 2004, EUKARYOT CELL, V3, P393, DOI 10.1128/EC.3.2.393-405.2004; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Nazari F, 2015, IRAN J PHARM RES, V14, P505; Niehaus EM, 2016, ENVIRON MICROBIOL, V18, P4282, DOI 10.1111/1462-2920.13576; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Ravagnani A, 1997, EMBO J, V16, P3974, DOI 10.1093/emboj/16.13.3974; Rosler SM, 2016, APPL MICROBIOL BIOT, V100, P5869, DOI 10.1007/s00253-016-7426-7; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Small AJ, 2001, MOL GENET GENOMICS, V265, P636, DOI 10.1007/s004380100456; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Studt L, 2016, ENVIRON MICROBIOL, V18, P936, DOI 10.1111/1462-2920.13150; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Todd RB, 2005, EUKARYOT CELL, V4, P1646, DOI 10.1128/EC.4.10.1646-1653.2005; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Tudzynski B, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00656; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wisniewski JR, 2011, ANAL BIOCHEM, V410, P307, DOI 10.1016/j.ab.2010.12.004; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Wong KH, 2009, MICROBIOL-SGM, V155, P3868, DOI 10.1099/mic.0.031252-0; Yabuta T., 1935, AGR HORTIC, V10, P17; Yates F, 1934, J AM STAT ASSOC, V29, P51, DOI 10.2307/2278459	89	24	28	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176194	10.1371/journal.pone.0176194	http://dx.doi.org/10.1371/journal.pone.0176194			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441411	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800032
J	Plochocki, JH; Ruiz, S; Rodriguez-Sosa, JR; Hall, MI				Plochocki, Jeffrey H.; Ruiz, Saul; Rodriguez-Sosa, Jose R.; Hall, Margaret I.			Histological study of white rhinoceros integument	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM; FIBER ARRANGEMENT; SKIN; EPIDERMIS; PIG; HIPPOPOTAMUS; ELASTICITY; PHYSIOLOGY; ANATOMY	In this study, we report findings from a microscopic analysis of the white rhinoceros (Ceratotherium simum) integumentary ultrastructure. Skin samples from the cheek, shoulder, flank and rump were taken from a 46-year-old female southern white rhinoceros and examined using H&E and elastic histological stains. The epidermis was thickest in the flank (1.003 mm) followed by the rump, cheek and shoulder. The stratum corneum comprised more than half the epidermal thickness. Numerous melanin granules were found in the basal and spinosum layers. The epidermal-dermal junction was characterized by abundant papillary folds increasing surface contact between integument layers. Most of the dermal thickness consisted of organized collagen bundles with scattered elastic fibers. Collagen fiber bundles were thickest in the flank (210.9 mu m) followed by shoulder, rump and cheek. Simple coiled sweat glands were present in the dermis, but hair and sebaceous glands were absent. Together, these data suggest the white rhinoceros has a unique integumentary system among large terrestrial herbivores.	[Plochocki, Jeffrey H.; Ruiz, Saul; Rodriguez-Sosa, Jose R.; Hall, Margaret I.] Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA; [Plochocki, Jeffrey H.; Hall, Margaret I.] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA; [Rodriguez-Sosa, Jose R.; Hall, Margaret I.] Midwestern Univ, Coll Vet Med, Glendale, AZ USA	Midwestern University; Midwestern University; Midwestern University	Plochocki, JH (corresponding author), Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA.	jplochocki@midwestern.edu		Plochocki, Jeffrey/0000-0002-9054-2078				ALLBROOK DAVID, 1962, PROC ZOOL SOC LONDON, V139, P67; CAVE A. J. E., 1959, PROC ZOOL SOC LONDON, V132, P99; CAVE AJE, 1958, NATURE, V182, P196, DOI 10.1038/182196a0; CAVE AJE, 1969, J ZOOL, V157, P247, DOI 10.1111/j.1469-7998.1969.tb01700.x; DOWNING DT, 1992, J LIPID RES, V33, P301; Dunkin RC, 2013, J EXP BIOL, V216, P2939, DOI 10.1242/jeb.080218; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Fuller A., 2016, CLIM CHANG RESPONSES, V3, P10, DOI [10.1186/s40665-016-0024-1, DOI 10.1186/S40665-016-0024-1]; Gartner LP, 2012, COLOR ATLAS TEXT HIS; Hadley NF, 2016, ADV LIPID RES SKIN L, V24, P303; HEDBERG CL, 1988, J INVEST DERMATOL, V90, P225, DOI 10.1111/1523-1747.ep12462257; Hiley PG, 1977, AFR J ECOL, V15, P337; Hill RV, 2006, J MORPHOL, V267, P1441, DOI 10.1002/jmor.10490; HORSTMANN E, 1966, Z ZELLFORSCH MIK ANA, V75, P146, DOI 10.1007/BF00407152; Hutchins M., 2006, International Zoo Yearbook, V40, P150, DOI 10.1111/j.1748-1090.2006.00150.x; Imokawa G, 2015, INT J MOL SCI, V16, P7753, DOI 10.3390/ijms16047753; Krmpotic CM, 2009, ACTA ZOOL-STOCKHOLM, V90, P339, DOI 10.1111/j.1463-6395.2008.00359.x; LILLYWHITE HB, 1987, J ZOOL, V211, P727; LUCK CP, 1964, Q J EXP PHYSIOL CMS, V49, P1; MEYER W, 1981, ARCH DERMATOL RES, V270, P391, DOI 10.1007/BF00403783; MEYER W, 1982, J ANAT, V134, P139; Nowak R.M., 1999, WALKERS MAMMALS WORL, V1; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; OWENSMIT.N, 1971, NATURE, V231, P294, DOI 10.1038/231294a0; Pawlina W., 2016, HISTOLOGY TEXT ATLAS, V6th ed; Sarna M, 2014, EXP DERMATOL, V23, P813, DOI 10.1111/exd.12535; SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, SENSING ENV REGULATI, P1; Slotow R., 2001, Koedoe, V44, P85; Smith F, 1890, J Anat Physiol, V24, P493; SPEARMAN R I C, 1970, Zoologica Africana, V5, P327; Stommel C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157145; Watson REB, 2014, ANTIOXID REDOX SIGN, V21, P1063, DOI 10.1089/ars.2013.5653; WRIGHT PG, 1987, S AFR J ZOOL, V22, P237; WRIGHT PG, 1984, S AFR J ZOOL, V19, P270	36	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176327	10.1371/journal.pone.0176327	http://dx.doi.org/10.1371/journal.pone.0176327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441468	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800046
J	Funakoshi, M; Azami, Y; Matsumoto, H; Ikota, A; Ito, K; Okimoto, H; Shimizu, N; Tsujimura, F; Fukuda, H; Miyagi, C; Osawa, S; Osawa, R; Miura, J				Funakoshi, Mitsuhiko; Azami, Yasushi; Matsumoto, Hisashi; Ikota, Akemi; Ito, Koichi; Okimoto, Hisashi; Shimizu, Nobuaki; Tsujimura, Fumihiro; Fukuda, Hiroshi; Miyagi, Chozi; Osawa, Sayaka; Osawa, Ryo; Miura, Jiro			Socioeconomic status and type 2 diabetes complications among young adult patients in Japan	PLOS ONE			English	Article							RISK-FACTORS; SOCIAL INEQUALITIES; WHITEHALL II; HEALTH; PREVALENCE; ASSOCIATION; OUTCOMES; EPIDEMIOLOGY; DEPRIVATION; MELLITUS	Objective To assess the relationship between socioeconomic status (SES) and complications of type 2 diabetes among young adults in Japan. Design A cross-sectional study. Setting Outpatient wards of 96 member hospitals and clinics of the Japan Federation of Democratic Medical Institutions. Participants A total of 782 outpatients with type 2 diabetes (525 males, 257 females), aged 20-40 years as of March 31, 2012. After excluding 110 participants whose retinopathy diagnosis was in question, 672 participants were analyzed. Measurements We examined the relations between SES (educational level, income, type of public health-care insurance, and employment status) and diabetes complications (retinopathy and nephropathy) using a multivariate logistic regression analysis. Results The prevalence of type 2 diabetic retinopathy was 23.2%, while that of nephropathy was 8.9%. The odds of having retinopathy were higher among junior high school graduates (OR 1.91, 95% CI 1.09-3.34), patients receiving public assistance (OR 2.19, 95% CI 1.20-3.95), and patients with irregular (OR 1.72, 95% CI 1.03-2.86) or no employment (OR 2.23, 95% CI 1.36-3.68), compared to those with a higher SES, even after covariate adjustment (e.g., age, gender, body mass index). Similarly, the odds of having nephropathy were higher among patients with middle (OR 3.61, 95% CI 1.69-8.27) or low income levels (OR 2.53, 95% CI 1.11-6.07), even after covariate adjustment. Conclusions Low SES was associated with a greater likelihood of type 2 diabetes complications in young adults. These findings suggest the necessity of health policies that mitigate socioeconomic disparity and thereby reduce the prevalence of diabetic complications.	[Funakoshi, Mitsuhiko] Chidoribashi Gen Hosp, Prevent Med, Fukuoka, Japan; [Azami, Yasushi] Jouhoku Hosp, Internal Med, Kanazawa, Ishikawa, Japan; [Matsumoto, Hisashi] Kuwamizu Hosp, Internal Med, Kumamoto, Japan; [Ikota, Akemi] Kin Ikyo Chuo Hosp, Diabet Endocrine, Sapporo, Hokkaido, Japan; [Ito, Koichi] Nakano Kyoritsu Hosp, Internal Med, Tokyo, Japan; [Okimoto, Hisashi] Saka Gen Hosp, Diabet & Metab, Shiogama, Japan; [Shimizu, Nobuaki] Kamiina Co Op Hosp, Internal Med, Minowa, Japan; [Tsujimura, Fumihiro] Tanaka Clin, Internal Med, Bihoro, Japan; [Fukuda, Hiroshi] Juntendo Univ Hosp, Gen Med, Tokyo, Japan; [Miyagi, Chozi] Tachikawa Sogo Hosp, Endocrine Metab, Tachikawa, Tokyo, Japan; [Osawa, Sayaka; Osawa, Ryo] Univ Tsukuba Hosp, Gen Med & Primary Care, Tsukuba, Ibaraki, Japan; [Miura, Jiro] Kissyouin Hosp, Internal Med, Kyoto, Japan	Juntendo University; University of Tsukuba	Funakoshi, M (corresponding author), Chidoribashi Gen Hosp, Prevent Med, Fukuoka, Japan.	funakosi@wc4.so-net.ne.jp	Miura, Jiro/AAF-8083-2021	Miura, Jiro/0000-0002-0000-025X				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; [Anonymous], 2014, RAT ACC PUBL ASS AGE; Ashman J. J., 2014, NCHS DATA BRIEF, V161, P1; Bachmann MO, 2003, DIABETIC MED, V20, P921, DOI 10.1046/j.1464-5491.2003.01050.x; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Fano V, 2013, EUR J PUBLIC HEALTH, V23, P991, DOI 10.1093/eurpub/cks168; Fukuda Yoshiharu, 2012, Environmental Health and Preventive Medicine, V17, P299, DOI 10.1007/s12199-011-0254-6; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Gary-Webb TL, 2013, CURR DIABETES REP, V13, P850, DOI 10.1007/s11892-013-0427-3; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hayashino Y, 2010, ARCH ENVIRON OCCUP H, V65, P224, DOI 10.1080/19338244.2010.486423; Hideyo T., 2009, KOSHU EISEI, V73, P546; Hwang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005710; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kim SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117034; Kondo Katsunori, 2011, Nihon Koshu Eisei Zasshi, V58, P550; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Labour Force Surve, 2016, STAT BUR MIN INT AFF; Larranaga I, 2005, DIABETIC MED, V22, P1047, DOI 10.1111/j.1464-5491.2005.01598.x; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Low L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007290; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; McFarlane P, 2013, CAN J DIABETES, V37, pS129, DOI 10.1016/j.jcjd.2013.01.037; Ministry of Health Labor and Welfare, 2011, 2011 REP RED INC; Ministry of Health Labour and Welfare, 2015, ANN HLTH LAB WELF RE; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; Nagaya T, 2006, DIABETES RES CLIN PR, V74, P169, DOI 10.1016/j.diabres.2006.03.010; Nation FaAOotU, 2012, MIN HLTH LAB WELF, P7; Nishi N, 2004, SOC SCI MED, V58, P1159, DOI 10.1016/S0277-9536(03)00287-9; Parving H. H, 2011, BRENNER RECTORS KIDN, V2, P1411; Reisig V, 2007, INT J PUBLIC HEALTH, V52, P158, DOI 10.1007/s00038-007-5077-2; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Secrest AM, 2011, ANN EPIDEMIOL, V21, P374, DOI 10.1016/j.annepidem.2011.02.007; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Uchida Y, 2011, J TOKYO WOM MED U, V81, pE154; Walker RJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-82; Wilmot E, 2014, THER ADV CHRONIC DIS, V5, P234, DOI 10.1177/2040622314548679; Woodward M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006408	45	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176087	10.1371/journal.pone.0176087	http://dx.doi.org/10.1371/journal.pone.0176087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437472	gold, Green Published			2022-12-27	WOS:000400287600029
J	Guan, ZY; Feng, YT; Song, AP; Shi, XM; Mao, YC; Chen, SM; Jiang, JF; Ding, L; Chen, FD				Guan, Zhiyong; Feng, Yitong; Song, Aiping; Shi, Xiaomeng; Mao, Yachao; Chen, Sumei; Jiang, Jiafu; Ding, Lian; Chen, Fadi			Expression profiling of Chrysanthemum crassum under salinity stress and the initiation of morphological changes	PLOS ONE			English	Article							SALT-STRESS; CELL-WALL; SALICORNIA-EUROPAEA; OSMOTIC ADJUSTMENT; OXIDATIVE STRESS; GENE-EXPRESSION; PHOTOSYSTEM-I; PLANTS; TOLERANCE; MECHANISM	Chrysanthemum crassum is a decaploid species of Chrysanthemum with high stress tolerance that allows survival under salinity stress while maintaining a relatively ideal growth rate. We previously recorded morphological changes after salt treatment, such as the expansion of leaf cells. To explore the underlying salinity tolerance mechanisms, we used an Illumina platform and obtained three sequencing libraries from samples collected after 0 h, 12 h and 24 h of salt treatment. Following de novo assembly, 154,944 transcripts were generated, and 97,833 (63.14%) transcripts were annotated, including 55 Gene Ontology (GO) terms and 128 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The expression profile of C. crassum was globally altered after salt treatment. We selected functional genes and pathways that may contribute to salinity tolerance and identified some factors involved in the salinity tolerance strategies of C. crassum, such as signal transduction, transcription factors and plant hormone regulation, enhancement of energy metabolism, functional proteins and osmolyte synthesis, reactive oxygen species (ROS) scavenging, photosystem protection and recovery, and cell wall protein modifications. Forty-six genes were selected for quantitative real-time polymerase chain reaction detection, and their expression patterns were shown to be consistent with the changes in their transcript abundance determined by RNA sequencing.	[Guan, Zhiyong; Feng, Yitong; Song, Aiping; Shi, Xiaomeng; Mao, Yachao; Chen, Sumei; Jiang, Jiafu; Ding, Lian; Chen, Fadi] Inst Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China		Guan, ZY (corresponding author), Inst Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	guanzhy@nja.edu.cn			948 Project of the Ministry of Agriculture [2016-X18]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (16) 1025]; Fundamental Research Funds for the Central Universities [KYCYL201501]	948 Project of the Ministry of Agriculture; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the 948 Project of the Ministry of Agriculture (2016-X18), the Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (16) 1025], and the Fundamental Research Funds for the Central Universities (KYCYL201501).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; An J, 2014, MOL BIOL REP, V41, P4155, DOI 10.1007/s11033-014-3287-2; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; Fahad S, 2015, PLANT GROWTH REGUL, V75, P391, DOI 10.1007/s10725-014-0013-y; Fan QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150572; Fei J, 2016, J PLANT RES; Fillingame RH, 1996, CURR OPIN STRUC BIOL, V6, P491, DOI 10.1016/S0959-440X(96)80114-X; Fincher GB, 2003, INORG CHEM, V34, P47; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gao CY, 2015, INT J MOL SCI, V16, P2052, DOI 10.3390/ijms16012052; Ghuge Sandip A., 2015, Plants-Basel, V4, P489, DOI 10.3390/plants4030489; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haiminen N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S6-S18; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Li QY, 2015, J EXP BOT, V66, P5821, DOI 10.1093/jxb/erv287; Long WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116217; LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5; MELLON JE, 1982, PLANT PHYSIOL, V70, P401, DOI 10.1104/pp.70.2.401; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Porto BN, 2013, J AGRON CROP SCI, V199, P134, DOI 10.1111/j.1439-037X.2012.00535.x; Quinet M, 2010, J EXP BOT, V61, P2719, DOI 10.1093/jxb/erq118; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryser U, 1997, PLANT J, V12, P97, DOI 10.1046/j.1365-313X.1997.12010097.x; Savci S, 2012, APCBEE PROC, V1, P287, DOI 10.1016/j.apcbee.2012.03.047; Shi Y, 2013, REV ESP DERECHO CONS, V59, P681; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; SMITH RC, 1991, BIOCHEM J, V279, P529, DOI 10.1042/bj2790529; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Song AP, 2016, PLANT PHYSIOL BIOCH, V102, P10, DOI 10.1016/j.plaphy.2016.02.009; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; STITT M, 1993, PHILOS T R SOC B, V342, P225, DOI 10.1098/rstb.1993.0151; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Wang B, 1993, AM J MED GENET, V48, P40; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1373-z; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15; Wang YY, 2001, J CHEM ECOL, V27, P327, DOI 10.1023/A:1005632506230; Wei Z, 2012, PLOS ONE, V7; WHITE AJ, 1994, J EXP BOT, V45, P1885, DOI 10.1093/jxb/45.12.1885; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; [吴锡冬 Wu Xidong], 2006, [农业环境科学学报, Journal of Agro-environment science], V25, P312; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yao J, 2008, RUSS J PLANT PHYSL+, V55, P232, DOI 10.1134/S1021443708020106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zahra J, 2014, ACTA PHYSIOL PLANT, V36, P1261, DOI 10.1007/s11738-014-1506-z; Zhao Y, 2013, CELL RES, V23, P1380, DOI 10.1038/cr.2013.149; Zheng QS, 2009, J PLANT NUTR SOIL SC, V172, P875, DOI 10.1002/jpln.200900122	76	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175972	10.1371/journal.pone.0175972	http://dx.doi.org/10.1371/journal.pone.0175972			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437448	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600025
J	Wang, WD; Xin, HW; Fang, XC; Dou, HT; Liu, FY; Huang, D; Han, SM; Fei, GJ; Zhu, LM; Zha, SH; Zhang, H; Ke, MY				Wang, Weida; Xin, Haiwei; Fang, Xiucai; Dou, Hongtao; Liu, Fangyi; Huang, Dan; Han, Shaomei; Fei, Guijun; Zhu, Liming; Zha, Shenghua; Zhang, Hong; Ke, Meiyun			Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; LACTULOSE INGESTION; ABDOMINAL-PAIN; NEW-MODEL; HYPERSENSITIVITY; STRESS; PROBIOTICS; MURINE; BIFIDOBACTERIA	Background Treatment of irritable bowel syndrome (IBS) with probiotics has achieved effectiveness to a certain extent. Whether prebiotics will work is still unclear. This study aimed to investigate the therapeutic effects of the prebiotic isomalto-oligosaccharides (IMO) on visceral hypersensitivity (VHS) in rats and to explore potential mechanism. Methods Water avoidance stress (WAS) was used to induce VHS in rats. The score for the abdominal withdrawal reflex (AWR) was determined while colorectal distension and compared between VHS group and control group in order to validate VHS preparation. Rats with VHS were then divided into an IMO-treated group (intragastric 5% IMO, 2 mL/d, 14 days) and a water-control group (intragastric water). After treatment, AWR score and intestinal transit rate (ITR) were determined, stool culture was performed, the ultrastructure of the ileum epithelium was observed with scanning electron microscopy (SEM), and serum cytokines were measured. Results WAS significantly increased AWR score responding to colorectal distension, and lowered the pain threshold. IMO treatment improved VHS with a reduction in AWR score on graded colorectal distension and an increase in pain threshold. SEM showed damages on the ileal epithelial ultrastructure in VHS rats, which was attenuated by IMO treatment. ITR, fecal microbiota and serum cytokine levels were comparable among control group, water-control group, and IMO-treated rats. Conclusion In this randomized placebo-controlled study, the results showed that IMO ameliorated WAS-induced visceral hyperalgesia in rats, this effect may be attributed to the repair of damages on intestinal epithelial ultrastructure.	[Wang, Weida; Xin, Haiwei; Fang, Xiucai; Liu, Fangyi; Fei, Guijun; Zhu, Liming; Ke, Meiyun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Wang, Weida; Xin, Haiwei; Fang, Xiucai; Dou, Hongtao; Liu, Fangyi; Fei, Guijun; Zhu, Liming; Ke, Meiyun] Peking Union Med Coll, Beijing, Peoples R China; [Dou, Hongtao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Huang, Dan] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Peoples R China; [Han, Shaomei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Han, Shaomei] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Zha, Shenghua; Zhang, Hong] Beijing Tongrentang Hlth Pharmaceut Co Ltd, Beijing, Peoples R China; [Wang, Weida] Sun Yat Sen Univ, Canc Ctr, Dept Hemotol & Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State Key Lab Oncology South China; Sun Yat Sen University	Fang, XC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China.; Fang, XC (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	fangxiucai2@aliyun.com	Wang, Weida/HGV-1933-2022		National High-tech R&D Program ("863" Program) [2010AA023007]; National Key Technologies R&D Program in the 11th Five Year Plan period [2007BA104B01]	National High-tech R&D Program ("863" Program); National Key Technologies R&D Program in the 11th Five Year Plan period(National Key Technology R&D Program)	This work was funded by the National High-tech R&D Program ("863" Program, 2010AA023007) and the National Key Technologies R&D Program in the 11th Five Year Plan period (2007BA104B01) to author XF (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.	Agostini S, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01865.x; Ait-Belgnaoui A, 2006, GUT, V55, P1090, DOI 10.1136/gut.2005.084194; Ait-Belgnaoui A, 2009, NEUROGASTROENT MOTIL, V21, P585, DOI 10.1111/j.1365-2982.2009.01280.x; Akbar A, 2009, ALIMENT PHARM THER, V30, P423, DOI 10.1111/j.1365-2036.2009.04056.x; Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Aziz Q, 2013, NEUROGASTROENT MOTIL, V25, P4, DOI 10.1111/nmo.12046; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Bouhnik Y, 2004, EUR J CLIN NUTR, V58, P462, DOI 10.1038/sj.ejcn.1601829; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Charbonneau D, 2013, GUT MICROBES, V4, P201, DOI 10.4161/gmic.24196; Christodoulides S, 2016, ALIMENT PHARM THER, V44, P103, DOI 10.1111/apt.13662; Dai C, 2012, MOL CELL BIOCHEM, V362, P43, DOI 10.1007/s11010-011-1126-5; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; Ford AC, 2009, CLIN GASTROENTEROL H, V7, P1279, DOI 10.1016/j.cgh.2009.06.031; Ghoshal Uday C, 2010, J Neurogastroenterol Motil, V16, P40, DOI 10.5056/jnm.2010.16.1.40; Giannetti E, 2017, J CLIN GASTROENTEROL, V51, pE5, DOI 10.1097/MCG.0000000000000528; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Horvath A, 2011, ALIMENT PHARM THER, V33, P1302, DOI 10.1111/j.1365-2036.2011.04665.x; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Koleva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111717; Kolmeder Carolin A., 2016, PLOS ONE, V11; Lindsay B, 2013, J CLIN MICROBIOL, V51, P3263, DOI 10.1128/JCM.01342-13; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Lorenzo-Zuniga V, 2014, WORLD J GASTROENTERO, V20, P8709, DOI 10.3748/wjg.v20.i26.8709; Ludidi S, 2014, NEUROGASTROENT MOTIL, V26, P1104, DOI 10.1111/nmo.12365; Ludidi S, 2012, NEUROGASTROENT MOTIL, V24, P729, DOI 10.1111/j.1365-2982.2012.01926.x; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mezzasalma V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4740907; Mizubuchi H, 2005, J NUTR, V135, P2857, DOI 10.1093/jn/135.12.2857; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090153; Wasilewski A, 2015, INFLAMM BOWEL DIS, V21, P1674, DOI 10.1097/MIB.0000000000000364; Whelan K, 2011, CURR OPIN CLIN NUTR, V14, P581, DOI 10.1097/MCO.0b013e32834b8082; Xu DB, 2014, GASTROENTEROLOGY, V146, P484, DOI 10.1053/j.gastro.2013.10.026; Yen CH, 2011, NUTRITION, V27, P445, DOI 10.1016/j.nut.2010.05.012	42	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175276	10.1371/journal.pone.0175276	http://dx.doi.org/10.1371/journal.pone.0175276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437458	gold, Green Published, Green Submitted			2022-12-27	WOS:000400287600006
J	Fondjo, LA; Owiredu, WKBA; Sakyi, SA; Laing, EF; Adotey-Kwofie, MA; Antoh, EO; Detoh, E				Fondjo, Linda Ahenkorah; Owiredu, William K. B. A.; Sakyi, Samuel Asamoah; Laing, Edwin Ferguson; Adotey-Kwofie, Michael Acquaye; Antoh, Enoch Odame; Detoh, Eric			Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana	PLOS ONE			English	Article							BETA-CELL FUNCTION; PLASMA 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D DEFICIENCY; MARKERS; RISK; PREVALENCE; CALCIUM; SENSITIVITY; CAPACITY	Background Vitamin D plays a major role in physiological processes that modulate mineral metabolism and immune function with probable link to several chronic and infectious conditions. Emerging data suggests a possible influence of vitamin D on glucose homeostasis. This study sought to provide preliminary information on vitamin D status among Ghanaian type 2 diabetics and assessed its association with glucose homeostasis. Methods In a case control study, 118 clinically diagnosed Type 2 Diabetes Mellitus (T2DM) patients attending Diabetic Clinic at the Nkawie Government Hospital were enrolled between October and December 2015. Hundred healthy non-diabetics living in Nkawie district were selected as controls. Structured questionnaires were administered to obtain socio-demographic data. Venous blood samples were taken from both cases and controls to estimate their FBG, Lipid profile spectrophotometrically and IPTH, 25OHD by ELISA. Statistical analyses were performed using SPSS v20.0 Statistics. Results The average age of the study participants was 58.81years for cases and 57.79year for controls. There was vitamin D deficiency of 92.4% among T2DM cases and 60.2% among the non diabetic controls. Vitamin D deficiency did not significantly associate with HOMA-beta [T2DM: r(2) = 0.0209, p = 0.1338 and Control: r(2) = 0.0213, p = 0.2703] and HOMA-IR [T2DM: r(2) = 0.0233, p = 0.1132 and Control: r(2) = 0.0214, p = 0.2690] in both the controls and the cases. Conclusion Vitamin D deficiency is prevalent in both T2DM and non-diabetics. There is no association between vitamin D deficiency and insulin resistance or beta cell function in our study population. Vitamin D supplementation among type 2 diabetics is recommended.	[Fondjo, Linda Ahenkorah; Owiredu, William K. B. A.; Sakyi, Samuel Asamoah; Laing, Edwin Ferguson; Adotey-Kwofie, Michael Acquaye; Antoh, Enoch Odame] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Detoh, Eric] Nkawie Govt Hosp, Kumasi, Ghana	Kwame Nkrumah University Science & Technology	Fondjo, LA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	linda.ahenkorahfondjo@yahoo.com	Sakyi, Samuel Asamoah/AAQ-3998-2021	sakyi, samuel/0000-0001-5168-4762				Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Banini AE, 2003, NUTRITION, V19, P722, DOI 10.1016/S0899-9007(03)00108-4; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Chaudhuri K., 2003, J LIPIDS, V2013, P7; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Elkassaby S, 2014, DIABETES RES CLIN PR, V106, P576, DOI 10.1016/j.diabres.2014.08.030; Foss YJ, 2009, MED HYPOTHESES, V72, P314, DOI 10.1016/j.mehy.2008.10.005; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kampmann U, 2014, METABOLISM, V63, P1115, DOI 10.1016/j.metabol.2014.06.008; Karhapaa P, 2010, J Intern Med, V268, P604, DOI 10.1111/j.1365-2796.2010.02279.x; Kayaniyil S, 2011, DIABETES, V60, P2947, DOI 10.2337/db11-0465; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; Luo C, 2009, DIABETES VASC DIS RE, V6, P194, DOI 10.1177/1479164109337974; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Malvy DJM, 2000, PHOTOCHEM PHOTOBIOL, V71, P466, DOI 10.1562/0031-8655(2000)071&lt;0466:RBVDSA&gt;2.0.CO;2; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Marwaha R K, 2011, J Assoc Physicians India, V59, P706; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Moradzadeh K., 2008, International Journal of Osteoporosis & Metabolic Disorders, V1, P8, DOI 10.3923/ijom.2008.8.15; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; McLellan KCP, 2014, THER CLIN RISK MANAG, V10, P173, DOI 10.2147/TCRM.S39564; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Ritu G, 2014, NUTRIENTS, V6, P729, DOI 10.3390/nu6020729; Rodriguez-Rodriguez E, 2009, OBESITY, V17, P778, DOI 10.1038/oby.2008.649; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sheth JJ, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0003-8; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Taheri E, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-16; Talaei A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-8; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje	43	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175388	10.1371/journal.pone.0175388	http://dx.doi.org/10.1371/journal.pone.0175388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423063	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600031
J	Neparaczki, E; Kocsy, K; Toth, GE; Maroti, Z; Kalmar, T; Bihari, P; Nagy, I; Palfi, G; Molnar, E; Rasko, I; Torok, T				Neparaczki, Endre; Kocsy, Klaudia; Toth, Gabor Endre; Maroti, Zoltan; Kalmar, Tibor; Bihari, Peter; Nagy, Istvan; Palfi, Gyorgy; Molnar, Erika; Rasko, Istvan; Torok, Tibor			Revising mtDNA haplotypes of the ancient Hungarian conquerors with next generation sequencing	PLOS ONE			English	Article							DNA CONTAMINATION; MITOCHONDRIAL-DNA; BONES	As part of the effort to create a high resolution representative sequence database of the medieval Hungarian conquerors we have resequenced the entire mtDNA genome of 24 published ancient samples with Next Generation Sequencing, whose haplotypes had been previously determined with traditional PCR based methods. We show that PCR based methods are prone to erroneous haplotype or haplogroup determination due to ambiguous sequence reads, and many of the resequenced samples had been classified inaccurately. The SNaPshot method applied with published ancient DNA authenticity criteria is the most straightforward and cheapest PCR based approach for testing a large number of coding region SNP-s, which greatly facilitates correct haplogroup determination.	[Neparaczki, Endre; Kocsy, Klaudia; Toth, Gabor Endre; Torok, Tibor] Univ Szeged, Dept Genet, Szeged, Hungary; [Neparaczki, Endre; Palfi, Gyorgy; Molnar, Erika] Univ Szeged, Dept Biol Anthropol, Szeged, Hungary; [Maroti, Zoltan; Kalmar, Tibor] Univ Szeged, Fac Med, Dept Pediat, Szeged, Hungary; [Maroti, Zoltan; Kalmar, Tibor] Univ Szeged, Fac Med, Pediat Hlth Ctr, Szeged, Hungary; [Bihari, Peter; Nagy, Istvan] SeqOm Biotechnol Ltd, Morahalom, Hungary; [Nagy, Istvan] Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Rasko, Istvan] Biol Res Ctr, Inst Genet, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Torok, T (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.	torokt@bio.u-szeged.hu	Pálfi, György/AAL-7268-2020; Pálfi, György/M-3555-2018; Molnar, Erika/A-8780-2015; Neparáczki, Endre/L-8186-2018	Pálfi, György/0000-0003-0989-4090; Molnar, Erika/0000-0001-6660-9239; Neparáczki, Endre/0000-0003-3466-0368; Maroti, Zoltan/0000-0002-0515-117X; Kalmar, Tibor/0000-0002-0419-2009	Avicenna Foundation [GF/JSZF/814/9/2015]; OTKA [NN 78696]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	Avicenna Foundation; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The generous support of Avicenna Foundation grant no. GF/JSZF/814/9/2015 to I.R. and encouragement of professor Miklos Maroth is highly appreciated. This research was also supported in part by OTKA NN 78696. SeqOmics Biotechnology Ltd. IN was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. Hereby we certify that this company did not provide any funding for our study, they simply performed NGS sequencing services, and had consulting roles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The generous support of Avicenna Foundation grant no. GF/JSZF/814/9/2015 to I.R. and encouragement of professor Miklos Maroth is highly appreciated. This research was also supported in part by OTKA NN 78696. IN was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Andrews S, 2016, FASTQC QUALITY CONTR; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Bouakaze C, 2007, INT J LEGAL MED, V121, P493, DOI 10.1007/s00414-007-0177-3; Broad Institute, 2016, PIC TOOLS; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; Cooper A, 2000, SCIENCE, V289, P1139; Csosz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33446; Damgaard PB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11184; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Garrison E, 2012, HAPLOTYPE BASED VARI; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Heupink TH, 2016, P NATL ACAD SCI USA; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M., 2010, COLD SPRING HARB PRO, V5; Neparaczki E, 2017, MOL GENET GENOMICS, V292, P201, DOI 10.1007/s00438-016-1267-z; Pickrell JK, 2014, TRENDS GENET, V30, P377, DOI 10.1016/j.tig.2014.07.007; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; Rizzi E, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-21; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Salas Antonio, 2005, V297, P197; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Sawyer S, 2012, PLOS ONE, V7; Tomory G, 2007, AM J PHYS ANTHROPOL, V134, P354, DOI 10.1002/ajpa.20677; van Oven M, 2015, FORENSIC SCI INT G S, V5, P9; van Oven M, 2010, P NATL ACAD SCI USA, V107, pE38, DOI 10.1073/pnas.0915120107; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233	39	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174886	10.1371/journal.pone.0174886	http://dx.doi.org/10.1371/journal.pone.0174886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422985	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399875600023
J	Stringfellow, WT; Camarillo, MK; Domen, JK; Shonkoff, SBC				Stringfellow, William T.; Camarillo, Mary Kay; Domen, Jeremy K.; Shonkoff, Seth B. C.			Comparison of chemical-use between hydraulic fracturing, acidizing, and routine oil and gas development	PLOS ONE			English	Article							FLUIDS; TOXICITY; USAGE	The potential hazards and risks associated with well-stimulation in unconventional oil and gas development (hydraulic fracturing, acid fracturing, and matrix acidizing) have been investigated and evaluated and federal and state regulations requiring chemical disclosure for well-stimulation have been implemented as part of an overall risk management strategy for unconventional oil and gas development. Similar evaluations for chemicals used in other routine oil and gas development activities, such as maintenance acidizing, gravel packing, and well drilling, have not been previously conducted, in part due to a lack of reliable information concerning on-field chemical-use. In this study, we compare chemical-use between routine activities and the more closely regulated well-stimulation activities using data collected by the South Coast Air Quality Monitoring District (SCAQMD), which mandates the reporting of both unconventional and routine on-field chemical-use for parts of Southern California. Analysis of this data shows that there is significant overlap in chemical-use between so-called unconventional activities and routine activities conducted for well maintenance, well-completion, or rework. A comparison within the SCAQMD shows a significant overlap between both types and amounts of chemicals used for well-stimulation treatments included under State mandatory-disclosure regulations and routine treatments that are not included under State regulations. A comparison between SCAQMD chemical-use for routine treatments and state-wide chemical-use for hydraulic fracturing also showed close similarity in chemical-use between activities covered under chemical disclosure requirements (e.g. hydraulic fracturing) and many other oil and gas field activities. The results of this study indicate regulations and risk assessments focused exclusively on chemicals used in well-stimulation activities may underestimate potential hazard or risk from overall oil field chemicaluse.	[Stringfellow, William T.; Camarillo, Mary Kay; Domen, Jeremy K.] Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Berkeley, CA USA; [Stringfellow, William T.; Camarillo, Mary Kay; Domen, Jeremy K.] Univ Pacific, Sch Engn & Comp Sci, Ecol Engn Res Program, 3601 Pacific Ave, Stockton, CA 95211 USA; [Shonkoff, Seth B. C.] PSE Hlth Energy, 1440 Broadway,Suite 205, Oakland, CA 94612 USA; [Shonkoff, Seth B. C.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of the Pacific; University of California System; University of California Berkeley	Shonkoff, SBC (corresponding author), PSE Hlth Energy, 1440 Broadway,Suite 205, Oakland, CA 94612 USA.; Shonkoff, SBC (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	sshonkoff@psehealthyenergy.org	Stringfellow, William T/O-4389-2015	Stringfellow, William T/0000-0003-3189-5604; Domen, Jeremy/0000-0002-0481-5579	Department of Energy [DE-IA0000018]; Broad Reach Fund; Laboratory Directed Research and Development (LDRD); Berkeley Lab; Office of Science, of the U.S. Department of Energy [DE-ACO2-05CH1123]	Department of Energy(United States Department of Energy (DOE)); Broad Reach Fund; Laboratory Directed Research and Development (LDRD); Berkeley Lab; Office of Science, of the U.S. Department of Energy(United States Department of Energy (DOE))	This material is based upon work supported by the Department of Energy under Award Number DE-IA0000018. This study was supported in part by grants from The Broad Reach Fund and Laboratory Directed Research and Development (LDRD) funding from Berkeley Lab, provided by the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-ACO2-05CH1123.; This material is based upon work supported by the Department of Energy under Award Number DE-IA0000018 (CERC-WET). This study was also supported by grants from The Broad Reach Fund and Laboratory Directed Research and Development (LDRD) funding from Berkeley Lab, provided by the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-ACO2-05CH1123.	Abdullah K, 2017, TOXICOL ENVIRON CHEM, V99, P78, DOI 10.1080/02772248.2016.1160285; [Anonymous], 2012, 822S12001 US EPA; [Anonymous], 2015, HAZ SUBST DAT BANK T; [Anonymous], 2015, EXOTOXICOLOGY DAT EX; [Anonymous], 2013, SRC I PHYSPR DAT; [Anonymous], 2015, CHEM RISK INF PLATF; [Anonymous], 2014, SCIFINDER; [Anonymous], 2015, AGGR COMP TOX RES AC; [Anonymous], 2015, CHEMIDPLUS ADV TOXNE; Brantley SL, 2014, INT J COAL GEOL, V126, P140, DOI 10.1016/j.coal.2013.12.017; California Air Resources Board, 2010, TOX AIR CONT TAC ID; California Department of Conservation, 2016, WELL STIM TREATM WST; Camarillo MK, 2016, J ENVIRON MANAGE, V183, P164, DOI 10.1016/j.jenvman.2016.08.065; Doman L, 2016, US REMAINS LARGEST P; Donnelly K., 2015, OIL FOOD WATER CHALL; Economides M. J., 2012, PETROLEUM PRODUCTION, V2nd; European Chemicals Agency, 2015, CAND LIST SUBST VER; European Chemicals Agency, 2000, INT UN CHEM INF DAT; Fink J, 2015, PETROLEUM ENG GUIDE, V2nd; Guerra K, 2011, 157 S T US DEP INT B; HUDGINS CM, 1992, J PETROL TECHNOL, V44, P604, DOI 10.2118/22477-PA; HUDGINS CM, 1994, J PETROL TECHNOL, V46, P67, DOI 10.2118/24106-PA; International Agency for Research on Cancer on the Evaluation of Carcinogenic Risk to Humans, 2015, INT CHILDH CANC DAY, V87; Kahrilas GA, 2015, ENVIRON SCI TECHNOL, V49, P16, DOI 10.1021/es503724k; Kelland MA., 2014, PRODUCTION CHEM OIL, V2nd, DOI DOI 10.1201/B16648; Long J, 2015, SUMMARY REPORT EXAMI; Long J.C., 2015, INDEPENDENT SCI ASSE; Muggeridge A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0320; National Research Council, 2009, SCI DEC ADV RISK ASS; NELSON E, 2012, SCHLUMBERGER OILFIEL, V24, P59; Office of Environmental Health Hazard Assessment, 2015, CURR PROP 65 LIST; OSPAR Commission, 2013, OSPAR LIST SUBST US; OSPAR Commission, 2015, LIST SUBST POSS CONC; OSPAR Commission, 2015, OSPAR REP DISCH SPIL; Pattanayek M, 2004, USITC PUBL; Reagan M. T., 2015, IMPACTS WELL STIMULA, VII; Richardson N., 2013, STATE STATE SHALE GA; Shaffer DL, 2013, ENVIRON SCI TECHNOL, V47, P9569, DOI 10.1021/es401966e; Shonkoff S, 2015, POTENTIAL IMPACTS WE; Stringfellow WT, 2017, ENVIRON POLLUT, V220, P413, DOI 10.1016/j.envpol.2016.09.082; Stringfellow WT, 2014, J HAZARD MATER, V275, P37, DOI 10.1016/j.jhazmat.2014.04.040; U.S. Environmental Protection Agency, 2012, EPI SUIT EST PROGR V; U.S. Environmental Protection Agency, 2015, CONT CAND LIST CCL 4; United Nations, 2013, STSGAC1030REV5 UN; Veil J.A., 2015, US PRODUCED WATER VO; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y	46	15	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175344	10.1371/journal.pone.0175344	http://dx.doi.org/10.1371/journal.pone.0175344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422971	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875600030
J	Negin, B; Shemer, O; Sorek, Y; Williams, LE				Negin, Boaz; Shemer, Or; Sorek, Yonatan; Williams, Leor Eshed			Shoot stem cell specification in roots by the WUSCHEL transcription factor	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; APICAL MERISTEM; GENE ENCODES; ARABIDOPSIS; CYTOKININ; NICHE; MAINTENANCE; HOMEOSTASIS; MECHANISM; PROTEIN	The WUSCHEL homeobox transcription factor is required to specify stem-cell identity at the shoot apical meristem and its ectopic expression is sufficient to induce de novo shoot meristem formation. Yet, the manner by which WUS promotes stem-cell fate is not yet fully understood. In the present research we address this question by inducing WUS function outside of its domain. We show that activation of WUS function in the root inhibits the responses to exogenous auxin and suppresses the initiation and growth of lateral roots. Using time lapse movies to follow the cell-cycle marker CYCB1; 1:: GFP, we also show that activation of WUS function suppresses cell division and cell elongation. In addition, activation of WUS represses the auxin-induced expression of the PLETHORA1 root identity gene and promotes shoot fate. Shoot apical meristem formation requires a high cytokinin-to-auxin ratio. Our findings provide evidence for the manner by which WUS specifies stem-cell identity: by affecting auxin responses, by reducing the cell mitotic activity and by repressing other developmental pathways. At the meristem, the stem-cells which are characterized by low division rate are surrounded by the highly proliferative meristematic cells. Our results also provide a model for WUS establishing the differential mitotic rates between two cell populations at the minute structure of the meristem.	[Negin, Boaz; Shemer, Or; Sorek, Yonatan; Williams, Leor Eshed] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Williams, LE (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, Rehovot, Israel.	leor.williams@mail.huji.ac.il		Eshed Williams, Leor/0000-0002-2766-2608	Vaadia-BARD [IS-4336-10R]; MARIE CURIE IRG [249270]	Vaadia-BARD(US-Israel Binational Science Foundation); MARIE CURIE IRG(European Commission)	This work was supported by: Vaadia-BARD [IS-4336-10R to O.S.]; MARIE CURIE IRG [249270 to B.N]	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brenner WG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-112; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Forzani C, 2014, CURR BIOL, V24, P1939, DOI 10.1016/j.cub.2014.07.019; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Huang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113768; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Mandel T, 2016, DEVELOPMENT, V143, P1612, DOI 10.1242/dev.129973; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Smith ZR, 2010, NATURE, V464, P423, DOI 10.1038/nature08843; Soyars CL, 2016, CURR OPIN PLANT BIOL, V29, P163, DOI 10.1016/j.pbi.2015.12.002; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Talbot MJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-36; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Uchida N, 2013, PLANT CELL PHYSIOL, V54, P343, DOI 10.1093/pcp/pcs109; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2012, PLANT SIGNAL BEHAV, V7, P592, DOI 10.4161/psb.19793; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	49	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176093	10.1371/journal.pone.0176093	http://dx.doi.org/10.1371/journal.pone.0176093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445492	gold, Green Published, Green Submitted			2022-12-27	WOS:000400309200034
J	Dunsky, A; Abu-Rukun, M; Tsuk, S; Dwolatzky, T; Carasso, R; Netz, Y				Dunsky, Ayelet; Abu-Rukun, Mona; Tsuk, Sharon; Dwolatzky, Tzvi; Carasso, Rafi; Netz, Yael			The effects of a resistance vs. an aerobic single session on attention and executive functioning in adults	PLOS ONE			English	Article							MIDDLE-AGED ADULTS; EXERCISE-INDUCED AROUSAL; OLDER-ADULTS; COGNITIVE PERFORMANCE; PHYSICAL-ACTIVITY; SHORT-TERM; MEMORY; STRENGTH; FITNESS; ADAPTATIONS	Evidence from recent studies showed that acute aerobic exercise results in improvements in different cognitive functions. The goal of this study was to assess the influence of acute bouts of aerobic versus resistance exercise on attention and executive function in adults. Thirty-nine physically active adults (age = 52 +/- 8 yr) served as participants. Each participant visited the laboratory four times: on the first visit participants performed a cognitive test (NeuroTrax) followed by an aerobic fitness assessment, as well as maximal strength test composed of six exercises. During visits 2 - 4, participants completed the cognitive test before and after the experimental condition, which consisted of either 25 min of aerobic exercise or resistance exercise, or watching a recorded interview show in a seated position (control condition). Findings indicated significantly higher changes in scores of attention after acute aerobic exercise (mean change 3.46, 95% CI -0.32, 7.27) than following the control condition (mean change -0.64, 95% CI -2.23, 0.96). The changes following resistance exercise (mean change -0.67, 95% CI -4.47, 3.13) were not significantly different from the changes following the control condition. Executive function scores showed a marginally significant improvement following acute aerobic (mean change 4.06, 95% CI 1.68, 6.44) and resistance exercise (mean change 3.69, 95% CI 0.78, 6.60), but not after control (mean change 0.91, 95% CI -1.21, 3.02). We suggest that adults should consider augmenting both modalities into their training routines, which may improve their cognition in addition to providing other physical benefits.	[Dunsky, Ayelet; Abu-Rukun, Mona; Tsuk, Sharon; Netz, Yael] Zinman Coll Phys Educ & Sport Sci, Wingate Inst, Netanya, Israel; [Dwolatzky, Tzvi] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Carasso, Rafi] Hillel Yaffe Med Ctr, Hadera, Israel	Ben Gurion University	Dunsky, A (corresponding author), Zinman Coll Phys Educ & Sport Sci, Wingate Inst, Netanya, Israel.	ayelet@wincol.ac.il	Dwolatzky, Tzvi/P-4752-2019	Dwolatzky, Tzvi/0000-0002-3861-2278				Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; American College of Sports Medicine's (ACSM's), 2010, AM COLL SPORTS MED A; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Borg G., 1986, PERCEPTION EXERTION, P3; Brink TL., 1982, CLIN GERON, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Candow DG, 2007, J STRENGTH COND RES, V21, P204, DOI 10.1519/00124278-200702000-00037; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2009, RES Q EXERCISE SPORT, V80, P78; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hogan CL, 2013, PSYCHOL AGING, V28, P587, DOI 10.1037/a0032634; Hogervorst E, 1996, PERCEPT MOTOR SKILL, V83, P479, DOI 10.2466/pms.1996.83.2.479; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lachman ME, 2006, J AGING PHYS ACTIV, V14, P59, DOI 10.1123/japa.14.1.59; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Lin TW, 2012, NEUROBIOL LEARN MEM, V97, P140, DOI 10.1016/j.nlm.2011.10.006; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lutz W, 2008, VIENNA YB POPULATION, P221; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; McMorris T, 2015, J SPORT HEALTH SCI, V4, P4, DOI 10.1016/j.jshs.2014.08.003; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Nanda B, 2013, J CLIN DIAGN RES, V7, P1883, DOI 10.7860/JCDR/2013/5855.3341; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; Netz Y, 2016, BRAIN COGNITION, V109, P59, DOI 10.1016/j.bandc.2016.08.002; Netz Y, 2015, ISR J PSYCHIATR REL, V52, P55; Peiffer R, 2015, J SPORT SCI MED, V14, P574; Pereira M.I.R., 2003, BRAZ J SPORTS MED, V9, P336, DOI [10.1590/S1517-86922003000500007, DOI 10.1590/S1517-86922003000500007]; Pesce C, 2011, J SPORT EXERCISE PSY, V33, P609, DOI 10.1123/jsep.33.5.609; Pontifex M, 2009, SPORT EXERC, V28, P587; Ritchie SJ, 2015, J NEUROSCI, V35, P8672, DOI 10.1523/JNEUROSCI.0862-15.2015; Alves CRR, 2012, J SPORT EXERCISE PSY, V34, P539, DOI 10.1123/jsep.34.4.539; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Yuki A, 2012, MED SCI SPORT EXER, V44, P2362, DOI 10.1249/MSS.0b013e3182667d1d	50	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176092	10.1371/journal.pone.0176092	http://dx.doi.org/10.1371/journal.pone.0176092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441442	gold, Green Published			2022-12-27	WOS:000400308800025
J	Dysthe, JC; Carim, KJ; Ruggles, M; McKelvey, KS; Young, MK; Schwartz, MK				Dysthe, Joseph C.; Carim, Kellie J.; Ruggles, Michael; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			Environmental DNA assays for the sister taxa sauger (Sander canadensis) and walleye (Sander vitreus)	PLOS ONE			English	Article							PERCIDAE	Sauger (Sander canadensis) and walleye (S. vitreus) are percid fishes that naturally co-occur throughout much of the eastern United States. The native range of sauger extends into the upper Missouri River drainage where walleye did not historically occur, but have been stocked as a sport fish. Sauger populations have been declining due to habitat loss, fragmentation, and competition with non-native species, such as walleye. To effectively manage sauger populations, it is necessary to identify areas where sauger occur, and particularly where they co- occur with walleye. We developed quantitative PCR assays that can detect sauger and walleye DNA in filtered water samples. Each assay efficiently detected low quantities of target DNA and failed to detect DNA of non-target species with which they commonly co- occur.	[Dysthe, Joseph C.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA; [Ruggles, Michael] Montana Dept Fish Wildlife & Parks, Reg 5, Billings, MT USA	United States Department of Agriculture (USDA); United States Forest Service	Dysthe, JC (corresponding author), US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA.	jdysthe@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841	Walleyes Unlimited of Montana	Walleyes Unlimited of Montana	This work was completed through funding issued to MR by Walleyes Unlimited of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgraph BJ, 2008, T AM FISH SOC, V137, P790, DOI 10.1577/T07-102.1; Billington N, 1997, T AM FISH SOC, V126, P804, DOI 10.1577/1548-8659(1997)126&lt;0804:GAPCOW&gt;2.3.CO;2; Bingham DM, 2012, CONSERV GENET, V13, P509, DOI 10.1007/s10592-011-0303-0; Bozek MA, 2011, BIOLOGY, MANAGEMENT, AND CULTURE OF WALLEYE AND SAUGER, P133; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Carim KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161664; Carim KJ, 2016, TECH REP; Carufel LH, 1963, J WILDLIFE MANAGE, V27, P450; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dreves DP, 2014, NATIVE WALLEYE MANAG, P16; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Graeb BDS, 2010, N AM J FISH MANAGE, V30, P887, DOI 10.1577/M09-091.1; Haponski AE, 2013, BIOL J LINN SOC, V110, P156, DOI 10.1111/bij.12114; Johnston TA, 2012, J GREAT LAKES RES, V38, P35, DOI 10.1016/j.jglr.2010.06.009; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; McMahon Thomas E., 2001, Intermountain Journal of Sciences, V7, P1; Near TJ, 2002, COPEIA, P1; NELSON WR, 1977, J FISH RES BOARD CAN, V34, P1748, DOI 10.1139/f77-240; Page LM, 2011, FIELD GUIDE FRESHWAT; Palmer George C., 2006, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V60, P125; Pegg Mark A., 1997, North American Journal of Fisheries Management, V17, P763, DOI 10.1577/1548-8675(1997)017<0763:MOSITL>2.3.CO;2; R Core Development Team, 2013, R LANG ENV STAT COMP; Schneider JC, 2007, 41 MICH DEP NAT RES; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Sloss BL, 2004, MOL PHYLOGENET EVOL, V32, P545, DOI 10.1016/j.ympev.2004.01.011; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; White MM, 2012, AM MIDL NAT, V167, P373, DOI 10.1674/0003-0031-167.2.373; White MM, 1993, USES EFFECTS CULTURE, P52; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259	34	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176459	10.1371/journal.pone.0176459	http://dx.doi.org/10.1371/journal.pone.0176459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441436	Green Submitted, Green Published, gold			2022-12-27	WOS:000400308800059
J	Kim, KI; Suh, HS; Kwak, A; Kim, S; Han, N; Lee, E; Oh, JM				Kim, Kyung Im; Suh, Hae Sun; Kwak, Arim; Kim, Siin; Han, Nayoung; Lee, Euni; Oh, Jung Mi			Development and validation of a modified Korean version of the Pharmacy Services Questionnaire (PSQ-K) for the quality assessment of community pharmacy services	PLOS ONE			English	Article							SATISFACTION; EQ-5D-5L; GENDER; CARE	Patient-reported outcome (PRO) measures and validated instruments have become integral in assessing the quality of healthcare delivery, including pharmaceutical care services. The Pharmacy Services Questionnaire (PSQ) measures patient satisfaction with pharmaceutical care. In this study, we developed a modified Korean version of the PSQ (PSQ-K) and evaluated its validity and reliability. The PSQ-K was developed using a strict translation and cultural-adaptation procedure. A validation study was performed in six community pharmacies in Korea. A total of 300 respondents completed three questionnaires (a brief questionnaire for social demographics and clinical characteristics, the PSQ-K, and the 5-level EuroQoL Group's 5-dimension [EQ-5D-5L]). Standard validity and reliability analyses were performed. The internal consistency of the PSQ-K was high for all scales (Cronbach's alpha > 0.9). The PSQ-K indicated good discriminant and divergent validity. Known-group comparisons revealed that the PSQ-K was able to distinguish between respondents differing in socio-demographic characteristics, such as gender, level of education, and household income. In conclusion, the PSQ-K is a highly reliable and valid PRO instrument for assessing the level of satisfaction with community pharmacy services.	[Kim, Kyung Im; Kwak, Arim] Korea Univ, Coll Pharm, Sejong, South Korea; [Kim, Kyung Im] Korea Univ, Biomed Res Ctr, Guro Hosp, Seoul, South Korea; [Suh, Hae Sun; Kim, Siin] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Han, Nayoung; Lee, Euni; Oh, Jung Mi] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Lee, Euni; Oh, Jung Mi] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Pusan National University; Seoul National University (SNU); Seoul National University (SNU)	Lee, E; Oh, JM (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea.; Lee, E; Oh, JM (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	eunilee@snu.ac.kr; jmoh@snu.ac.kr	Kim, Siin/AAH-8085-2020	Kim, Siin/0000-0002-4368-7389	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI13C0731]; Drug Treatment Evaluation and Management (DrugTEAM) Group	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Drug Treatment Evaluation and Management (DrugTEAM) Group	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI; http://www.khidi.or.kr/), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI13C0731) [JMO]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support of the Drug Treatment Evaluation and Management (DrugTEAM) Group in conducting this research. And we wish to thank the priceless contributions of all participants.	Bener A, 2013, NIGER J CLIN PRACT, V16, P285, DOI 10.4103/1119-3077.113448; Centers for Medicare & Medicaid, HOSP CONS ASS HEALTH; Chow A, 2009, SURGERY, V146, P435, DOI 10.1016/j.surg.2009.03.019; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Elderkin-Thompson V, 1999, J GEN INTERN MED, V14, P112, DOI 10.1046/j.1525-1497.1999.00296.x; George D, 2003, SPSS WINDOWS STEP ST; Gourley GK, 2001, AM J MANAG CARE, V7, P461; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Kim SH, 2016, QUAL LIFE RES, V25, P1845, DOI 10.1007/s11136-015-1205-2; Kim TH, 2013, QUAL LIFE RES, V22, P2245, DOI 10.1007/s11136-012-0331-3; Kline P., 2000, HDB PSYCHOL TESTING; Larson Lon N, 2002, J Am Pharm Assoc (Wash), V42, P44, DOI 10.1331/108658002763538062; Lee Y, 2014, J KOREAN MED SCI, V29, P758, DOI 10.3346/jkms.2014.29.6.758; McLeod LD, 2011, EXPERT REV PHARM OUT, V11, P163, DOI [10.1586/erp.11.12, 10.1586/ERP.11.12]; Reay Naomi, 2010, Nurs Times, V106, P12; Sakharkar P, 2015, RES SOC ADMIN PHARM, V11, P487, DOI 10.1016/j.sapharm.2014.10.006; Spasojevic Nada, 2015, Mater Sociomed, V27, P220, DOI 10.5455/msm.2015.27.220-224; Tabachnik B. J., 1993, USING MULTIVARIATE S; Ware J. E., 1997, MAP R WINDOWS MULTIT; Woods Scott E, 2003, J Gend Specif Med, V6, P30; World Health Organization, 1993, PHARM CAR TOK DECL	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0174004	10.1371/journal.pone.0174004	http://dx.doi.org/10.1371/journal.pone.0174004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441448	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800002
J	Lu, XL; Ding, Y; Niu, QN; Xuan, SJ; Yang, Y; Jin, YL; Wang, H				Lu, Xiaolin; Ding, Yin; Niu, Qiannan; Xuan, Shijie; Yang, Yan; Jin, Yulong; Wang, Huan			ClC-3 chloride channel mediates the role of parathyroid hormone [1-34] on osteogenic differentiation of osteoblasts	PLOS ONE			English	Article							MATRIX GLA PROTEIN; ANABOLIC ACTION; MC3T3-E1 CELLS; KINASE-C; OSTEOPOROSIS; INTERMITTENT; TERIPARATIDE; RUNX2; WNT; PTH	Introduction Different concentrations of parathyroid hormone [ 1-34] ( PTH [ 1-34]) can have totally opposite effects on osteoblasts. Intermittent stimulation with PTH can significantly increase bone mineral density in vitro, mainly through the protein kinase A ( PKA) signaling pathway, which phosphorylates runt-related transcription factor 2 ( Runx2). The ClC-3 chloride channel, an important anion channel, can also promote osteogenesis via the Runx2 pathway based on recent studies. The purpose of our study, therefore, is to research whether the ClC-3 chloride channel has an effect on PTH osteodifferentiation in MC3T3-E1 cells. Methods and results A cell counting kit ( CCK-8) and real-time PCR were used to investigate the impact of different PTH stimulation modes on MC3T3-E1 cell proliferation and osteogenesis-related gene expression, respectively. We found that the minimum inhibitory concentration of PTH was 10(-9) M, and the expression of alkaline phosphatase ( Alpl) and Runx2 were at the highest levels when treated with 10-9 M PTH. Next, we used real-time PCR and immunofluorescence technique to detect changes in ClC-3 in MC3T3-E1 cells under PTH treatment. The results showed higher expression of the ClC-3 chloride channel at 10-9 M intermittent PTH administration than in the other groups. Finally, we used the ClC-3 siRNA technique to examine the role of the ClC-3 chloride channel in the effect of PTH on the osteogenesis of osteoblasts, and we found an obvious decrease in the expression of bone sialoprotein ( Ibsp), osteocalcin ( Bglap), osterix ( Sp7), Alpl and Runx2, the formation of mineralization nodules as well. Conclusions From the above data, we conclude that the expression of ClC-3 chloride channels in osteoblasts helps them respond to PTH stimulation, which mediates osteogenic differentiation.	[Lu, Xiaolin; Ding, Yin; Niu, Qiannan; Xuan, Shijie; Yang, Yan; Wang, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Jin, Yulong] Fourth Mil Med Univ, Dept Hematol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, H (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.	wanghuan8001@hotmail.com	lu, xl/HDO-8340-2022		National Nature Science Foundation of China [81200648]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (Grant No. 81200648, http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander IM, 2009, NURSE PRACT, V34, P30, DOI 10.1097/01.NPR.0000352286.81981.0e; Ardura JA, 2013, KIDNEY INT, V83, P825, DOI 10.1038/ki.2012.476; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Chen BL, 2016, EXP THER MED, V11, P2399, DOI 10.3892/etm.2016.3177; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Dempster DW, 2016, J CLIN ENDOCR METAB, V101, P1353, DOI 10.1210/jc.2015-4181; Duan D, 1999, ILLUMINATING ENG I J, P164; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Fei YR, 2012, J CELL PHYSIOL, V227, P3539, DOI 10.1002/jcp.24075; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Gordon JAR, 2009, CELLS TISSUES ORGANS, V189, P138, DOI 10.1159/000151728; Guida G, 2011, AGING CLIN EXP RES, V23, P8; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; Jhaveri S, 2015, J CLIN DIAGN RES, V9; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kates SL, 2016, INJURY, V47, pS65, DOI 10.1016/S0020-1383(16)30015-8; Komm BS, 2015, EXPERT REV CLIN PHAR, V8, P769, DOI 10.1586/17512433.2015.1099432; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Larrouture QC, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12607; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lindsay R, 2016, OSTEOPOROSIS INT, V27, P2395, DOI 10.1007/s00198-016-3534-6; Liu Q, 2012, BIOCHEM BIOPH RES CO, V424, P182, DOI 10.1016/j.bbrc.2012.06.106; Lossdorfer S, 2011, J PERIODONTAL RES, V46, P318, DOI 10.1111/j.1600-0765.2011.01345.x; Lumetti S, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5678-5; Merciris D, 2007, AM J PATHOL, V170, P1676, DOI 10.2353/ajpath.2007.061069; NEMANI R, 1991, ARCH BIOCHEM BIOPHYS, V285, P153, DOI 10.1016/0003-9861(91)90343-H; Okamoto F, 2008, AM J PHYSIOL-CELL PH, V294, pC693, DOI 10.1152/ajpcell.00251.2007; Pengjam Y, 2016, BIOMOL THER, V24, P123, DOI 10.4062/biomolther.2015.106; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; Shimizu M, 2016, BIOL PHARM BULL, V39, P625, DOI 10.1248/bpb.b15-00756; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suttamanatwong S, 2009, J CELL BIOCHEM, V107, P284, DOI 10.1002/jcb.22124; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Tian Y, 2011, MOL CELL BIOCHEM, V355, P211, DOI 10.1007/s11010-011-0856-8; Tremollieres FA, 2014, MATURITAS, V79, P343, DOI 10.1016/j.maturitas.2014.08.001; Wang D, 2016, J CELLULAR BIOCH; Wang H, 2015, BIOCHEM CELL BIOL, V93, P558, DOI 10.1139/bcb-2015-0018; Wang HA, 2010, J CELL BIOCHEM, V111, P49, DOI 10.1002/jcb.22658; Wang HA, 2010, MOL CELL BIOCHEM, V342, P191, DOI 10.1007/s11010-010-0483-9; Xu ZX, 2016, DRUG DES DEV THER, V10, P509, DOI 10.2147/DDDT.S84264; Yang CM, 2009, BIOCHEM BIOPH RES CO, V380, P791, DOI 10.1016/j.bbrc.2009.01.167	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176196	10.1371/journal.pone.0176196	http://dx.doi.org/10.1371/journal.pone.0176196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437476	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600032
J	Tung, EWY; Ahmed, S; Peshdary, V; Atlas, E				Tung, Emily W. Y.; Ahmed, Shaimaa; Peshdary, Vian; Atlas, Ella			Firemaster (R) 550 and its components isopropylated triphenyl phosphate and triphenyl phosphate enhance adipogenesis and transcriptional activity of peroxisome proliferator activated receptor (Ppar gamma) on the adipocyte protein 2 (aP2) promoter	PLOS ONE			English	Article							ORGANOPHOSPHATE FLAME RETARDANTS; ACID-BINDING PROTEINS; EXPOSURE; TOXICITY; MIXTURE; DIFFERENTIATION; IDENTIFICATION; ALPHA; DUST; TBPH	Firemaster (R) 550 (FM550) is a chemical mixture currently used as an additive flame retardant in commercial products, and is comprised of 2-ethylhexyl-2,3,4,5-tertrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), triphenyl phosphate (TPP), and isopropylated triphenyl phosphate (IPTP). Animal and in vitro studies suggest that FM550, TPP and IPTP may have adipogenic effects and may exert these effects through PPAR. activation. Using murine 3T3-L1 preadipocytes, we investigated the detailed expression of transcription factors and adipogenic markers in response to FM550 and its components. Further we investigated the mechanism of action of the peroxisome proliferator- activated receptor gamma (PPAR.) on downstream targets of the receptor by focussing on the mature adipocyte marker, adipocyte protein 2 (aP2). In addition, we set to elucidate the components responsible for the adipogenic effects seen in the FM550 mixture. We show that FM550 and its components TPP, IPTP, and TBPH, but not TBB induced lipid accumulation in a dose-dependent manner. Interestingly, despite displaying enhanced lipid accumulation, TBPH did not alter the mRNA or protein expression of terminal differentiation markers. In contrast, FM550, TPP, and IPTP treatment enhanced lipid accumulation, and mRNA and protein expression of terminal differentiation markers. To further delineate the mechanisms of action of FM550 and its components we focussed on aP2 promoter activity. For this purpose we used the enhancer region of the mouse aP2 promoter using a 584-bp reporter construct containing an active PPRE located 5.4 kb away from the transcription start site of aP2. Exposure to FM550, IPTP, and TPP significantly increased PPAR. mediated aP2 enhancer activity. Furthermore, we show that TPP-and IPTP-dependent upregulation of aP2 was significantly inhibited by the selective PPAR. antagonist GW9662. In addition, chromatin immunoprecipitation experiments showed that IPTP and TPP treatment led to the recruitment of PPAR. to the regulatory region of ap2.	[Tung, Emily W. Y.; Ahmed, Shaimaa; Peshdary, Vian; Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada	Health Canada	Atlas, E (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.	ella.atlas@canada.ca			Health Canada Chemical Management Plan	Health Canada Chemical Management Plan	This work was supported by the Health Canada Chemical Management Plan.	Bakillah A, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0061-6; Biasiotto G, 2016, TOXICOL APPL PHARM, V297, P32, DOI 10.1016/j.taap.2016.02.023; Boucher JG, 2016, ENDOCRINOLOGY, V157, P1397, DOI 10.1210/en.2015-1872; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; HAUNER H, 1990, ENDOCRINOLOGY, V127, P865, DOI 10.1210/endo-127-2-865; Hoffman K, 2015, ENVIRON HEALTH PERSP, V123, P160, DOI 10.1289/ehp.1408669; Hoffman K, 2014, ENVIRON HEALTH PERSP, V122, P963, DOI 10.1289/ehp.1308028; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Honkakoski P, 2004, BIOCHEM PHARMACOL, V67, P97, DOI 10.1016/j.bcp.2003.08.037; Ikonomov OC, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12812; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; Li X, 2011, J STEROID BIOCHEM, V127, P9, DOI 10.1016/j.jsbmb.2011.03.012; Liu LY, 2015, J CHROMATOGR A, V1406, P251, DOI 10.1016/j.chroma.2015.06.003; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Matthews J, 2007, BIOCHEM J, V406, P343, DOI 10.1042/BJ20070585; McGee SP, 2013, TOXICOL SCI, V133, P144, DOI 10.1093/toxsci/kft020; Meeker JD, 2010, ENVIRON HEALTH PERSP, V118, P318, DOI 10.1289/ehp.0901332; Mendelsohn E, 2016, ENVIRON INT, V86, P45, DOI 10.1016/j.envint.2015.10.005; Mizouchi S, 2015, CHEMOSPHERE, V123, P17, DOI 10.1016/j.chemosphere.2014.11.028; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patisaul HB, 2013, J BIOCHEM MOL TOXIC, V27, P124, DOI 10.1002/jbt.21439; Peng H, 2015, ENVIRON SCI TECHNOL, V49, P2999, DOI 10.1021/es505743d; Pillai HK, 2014, ENVIRON HEALTH PERSP, V122, P1225, DOI 10.1289/ehp.1408111; Roberts SC, 2012, CHEM RES TOXICOL, V25, P1435, DOI 10.1021/tx300086x; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Springer C, 2012, ENVIRON HEALTH PERSP, V120, P1711, DOI 10.1289/ehp.1204932; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P6910, DOI 10.1021/es801070p; Stapleton HM, 2011, ENVIRON SCI TECHNOL, V45, P5323, DOI 10.1021/es2007462; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tung EWY, 2016, BIRTH DEFECTS RES B, V107, P157, DOI 10.1002/bdrb.21180; Tung EWY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094583; Wei GL, 2015, ENVIRON POLLUT, V196, P29, DOI 10.1016/j.envpol.2014.09.012; Yang WS, 1998, J LIPID RES, V39, P2054	43	32	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175855	10.1371/journal.pone.0175855	http://dx.doi.org/10.1371/journal.pone.0175855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437481	gold, Green Submitted, Green Published			2022-12-27	WOS:000400287600016
J	Aivazidis, S; Coughlan, CM; Rauniyar, AK; Jiang, H; Liggett, LA; Maclean, KN; Roede, JR				Aivazidis, Stefanos; Coughlan, Christina M.; Rauniyar, Abhishek K.; Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.; Roede, James R.			The burden of trisomy 21 disrupts the proteostasis network in Down syndrome	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; OXIDATIVE STRESS; PROTEASOMAL INHIBITION; PROTEOTOXIC STRESS; QUALITY-CONTROL; ACTIVATION; EXPRESSION; INSIGHTS	Down syndrome (DS) is a genetic disorder caused by trisomy of chromosome 21. Abnormalities in chromosome number have the potential to lead to disruption of the proteostasis network (PN) and accumulation of misfolded proteins. DS individuals suffer from several comorbidities, and we hypothesized that disruption of proteostasis could contribute to the observed pathology and decreased cell viability in DS. Our results confirm the presence of a disrupted PN in DS, as several of its elements, including the unfolded protein response, chaperone system, and proteasomal degradation exhibited significant alterations compared to euploid controls in both cell and mouse models. Additionally, when cell models were treated with compounds that promote disrupted proteostasis, we observed diminished levels of cell viability in DS compared to controls. Collectively our findings provide a cellular-level characterization of PN dysfunction in DS and an improved understanding of the potential pathogenic mechanisms contributing to disrupted cellular physiology in DS. Lastly, this study highlights the future potential of designing therapeutic strategies that mitigate protein quality control dysfunction.	[Aivazidis, Stefanos; Rauniyar, Abhishek K.; Roede, James R.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Coughlan, Christina M.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Coughlan, Christina M.; Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.] Univ Colorado, Linda Crn Inst Down Syndrome, Aurora, CO USA; [Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Roede, JR (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	james.roede@ucdenver.edu		Aivazids, Stefanos/0000-0003-0421-1473	Linda Crnic Institute for Down Syndrome; National Institute of Environmental Health Sciences [ES027593]; NATIONAL CANCER INSTITUTE [F31CA196231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027593] Funding Source: NIH RePORTER	Linda Crnic Institute for Down Syndrome; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A Grand Challenge Grant from the Linda Crnic Institute for Down Syndrome was awarded to KNM and grant funds from the National Institute of Environmental Health Sciences (ES027593) were used to support some of this research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, funds allocated to JRR for laboratory start-up were used to support a majority of this work.	Aitken RJ, 2013, DIABETES CARE, V36, P1181, DOI 10.2337/dc12-1712; Alexander M, 2016, DEV MED CHILD NEUROL, V58, P246, DOI 10.1111/dmcn.12868; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Ansari N, 2013, CURR DRUG TARGETS, V14, P114, DOI 10.2174/138945013804806532; Anwar AJ, 1998, DIABETIC MED, V15, P160, DOI 10.1002/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445; Berthoud VM, 2016, J BIOL CHEM; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Brickell P M, 1992, Methods Mol Biol, V8, P213, DOI 10.1385/0-89603-191-8:213; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chan JY, 2015, MOL CELL ENDOCRINOL, V413, P189, DOI 10.1016/j.mce.2015.06.025; Cheng WP, 2008, CARDIOVASC RES, V77, P551, DOI 10.1093/cvr/cvm057; Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Donnelly N, 2014, EMBO J, V33, P2374, DOI 10.15252/embj.201488648; Diaz-Villanueva JF, 2015, INT J MOL SCI, V16, P17193, DOI 10.3390/ijms160817193; Garlet TR, 2013, LIFE SCI, V93, P558, DOI 10.1016/j.lfs.2013.08.017; Ghribi O, 2003, J NEUROPATH EXP NEUR, V62, P1144, DOI 10.1093/jnen/62.11.1144; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Gimeno A, 2014, BBA-MOL BASIS DIS, V1842, P116, DOI 10.1016/j.bbadis.2013.10.014; Gomez JA, 2016, ELIFE, V5, DOI 10.7554/eLife.20390; Govoni S, 1996, NEUROLOGY, V47, P1069, DOI 10.1212/WNL.47.4.1069; Graber E, 2012, ENDOCRIN METAB CLIN, V41, P735, DOI 10.1016/j.ecl.2012.08.008; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jensen KM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5596; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kim JS, 2014, J NEURAL TRANSM, V121, P1233, DOI 10.1007/s00702-014-1208-0; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirstein J, 2015, EMBO J, V34, P2334, DOI 10.15252/embj.201591711; Krinsky-McHale SJ, 2014, J APPL RES INTELLECT, V27, P247, DOI 10.1111/jar.12062; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lefter S, 2011, J CLIN NEUROPHYSIOL, V28, P469, DOI 10.1097/WNP.0b013e318230da76; Liu GL, 2011, BRAIN RES BULL, V84, P94, DOI 10.1016/j.brainresbull.2010.10.004; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lott IT, 2012, J ALZHEIMERS DIS, V29, P177, DOI 10.3233/JAD-2012-111613; Martinez G, 2016, CELL REP, V14, P1382, DOI 10.1016/j.celrep.2016.01.028; Masouleh BK, 2014, P NATL ACAD SCI USA, V111, pE2219, DOI 10.1073/pnas.1400958111; Mateos MK, 2015, TRANSL PEDIATR, V4, P76, DOI 10.3978/j.issn.2224-4336.2015.03.03; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Melville CA, 2005, J INTELL DISABIL RES, V49, P125, DOI 10.1111/j.1365-2788.2004.00616.x; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mota SI, 2015, BBA-MOL BASIS DIS, V1852, P1428, DOI 10.1016/j.bbadis.2015.03.015; Muchova J, 2014, PHYSIOL RES, V63, P535, DOI 10.33549/physiolres.932722; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Orlicky DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066837; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palsamy P, 2014, BBA-MOL BASIS DIS, V1842, P1794, DOI 10.1016/j.bbadis.2014.06.028; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Perluigi M, 2014, BBA-MOL BASIS DIS, V1842, P1144, DOI 10.1016/j.bbadis.2014.04.007; Perluigi M, 2014, PROTEOM CLIN APPL, V8, P73, DOI 10.1002/prca.201300066; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Rodriguez-Sureda V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509241; Roede JR, 2014, REDOX BIOL, V2, P651, DOI 10.1016/j.redox.2014.04.007; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Ruparelia A, 2013, DEV DISABIL RES REV, V18, P43, DOI 10.1002/ddrr.1127; Sarto C, 2000, ELECTROPHORESIS, V21, P1218, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1218::AID-ELPS1218>3.3.CO;2-8; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seth A, 1999, CELL DEATH DIFFER, V6, P902, DOI 10.1038/sj.cdd.4400567; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Spellman C, 2013, GENE, V512, P219, DOI 10.1016/j.gene.2012.10.051; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Sun YW, 2011, J PROTEOMICS, V74, P547, DOI 10.1016/j.jprot.2011.01.009; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tlili A, 2012, MOL NEUROBIOL, V46, P297, DOI 10.1007/s12035-012-8284-7; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Videla LA, 2015, FREE RADICAL BIO MED, V89, P401, DOI 10.1016/j.freeradbiomed.2015.09.004; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xiong R, 2013, CHEM-BIOL INTERACT, V204, P116, DOI 10.1016/j.cbi.2013.04.016; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130705; Yoo BC, 2001, ELECTROPHORESIS, V22, P1233, DOI 10.1002/1522-2683()22:6<1233::AID-ELPS1233>3.0.CO;2-M; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Zhou Y, 2004, NEUROSCIENCE, V128, P281, DOI 10.1016/j.neuroscience.2004.06.048	101	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176307	10.1371/journal.pone.0176307	http://dx.doi.org/10.1371/journal.pone.0176307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430800	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100040
J	Workneh, MH; Bjune, GA; Yimer, SA				Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe			Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review	PLOS ONE			English	Review							TERTIARY CARE CENTER; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; SCREENING PATIENTS; CLINICAL CHARACTERISTICS; SMEAR CONVERSION; IMPACT; POPULATION; RESISTANCE; SHANGHAI	Introduction The dual burden of tuberculosis (TB) and diabetes mellitus (DM) has become a major global public health concern. There is mounting evidence from different countries on the burden of TB and DM comorbidity. The objective of this systematic review was to summarize the existing evidence on prevalence and associated/risk factors of TBDM comorbidity at global and regional levels. Methods Ovid Medline, Embase, Global health, Cochrane library, Web of science and Scopus Elsevier databases were searched to identify eligible articles for the systematic review. Data were extracted using standardized excel form and pilot tested. Median with interquartile range (IQR) was used to estimate prevalence of TBDM comorbidity. Associated/risk factors that were identified from individual studies were thematically analyzed and described. Results The prevalence of DM among TB patients ranged from 1.9% to 45%. The overall median global prevalence was 16% (IQR 9.0%-25.3%) Similarly, the prevalence of TB among DM patients ranged from 0.38% to 14% and the overall median global prevalence was 4.1% (IQR 1.8%-6.2%). The highest prevalence of DM among TB patients is observed in the studied countries of Asia, North America and Oceania. On the contrary, the prevalence of TB among DM patients is low globally, but relatively higher in the studied countries of Asia and the African continents. Sex, older age, urban residence, tobacco smoking, sedentary lifestyle, poor glycemic control, having family history of DM and TB illness were among the variables identified as associated/risk factors for TBDM comorbidity. Conclusion Assessing the magnitude and risk/associated factors of TBDM comorbidity at country/local level is crucial before making decisions to undertake TBDM integrated services.This systematic review revealed that there is a high burden of DM among TB patients at global level. On the contrary, the global prevalence of TB among DM patients is low.	[Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Workneh, Mahteme Haile; Yimer, Solomon Abebe] Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia; [Yimer, Solomon Abebe] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Yimer, Solomon Abebe] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Workneh, MH (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway.; Workneh, MH (corresponding author), Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia.	maykm24@yahoo.com						Achanta S, 2013, PUBLIC HEALTH ACTION, V3, pS43, DOI 10.5588/pha.13.0033; Ade S, 2015, PUBLIC HEALTH ACTION, V5, P147, DOI 10.5588/pha.14.0110; Alavi SM, 2012, CASP J INTERN MED, V3, P421; Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Alladin B, 2011, INT J INFECT DIS, V15, pE818, DOI 10.1016/j.ijid.2011.07.006; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; Amin S, 2011, GOMAL J MED SCI, V9, P163; Baghaei P, 2015, INFECT DIS-NOR, V47, P472, DOI 10.3109/23744235.2015.1018317; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Balde NM, 2006, INT J TUBERC LUNG D, V10, P1036; Bridson T, 2015, AM J TROP MED HYG, V93, P547, DOI 10.4269/ajtmh.15-0264; Castellanos-Joya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106961; Chachra Vaibhav, 2014, Indian J Tuberc, V61, P65; Chaudhry LA, 2012, INT J MYCOBACT, V1, P106, DOI 10.1016/j.ijmyco.2012.03.002; Chen HG, 2014, INT J TUBERC LUNG D, V18, P267, DOI 10.5588/ijtld.13.0140; Damtew E, 2014, WORLD J MED SCI, V11, P389; Dave P, 2013, PUBLIC HEALTH ACTION, V3, pS29, DOI 10.5588/pha.13.0027; Delgado-Sanchez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129312; Deshmukh PA, 1984, IND TUB, V31, P114; Duangrithi D, 2013, INT J CLIN PRACT, V67, P1199, DOI 10.1111/ijcp.12215; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Feleke Y, 1999, E AFR MED J, V76, P361; Getachew A., 2014, British Journal of Medicine and Medical Research, V4, P862; Gounder S, 2012, PUBLIC HEALTH ACTION, V2, P145, DOI 10.5588/pha.12.0058; Haraldsdottir TL, 2015, T ROY SOC TROP MED H, V109, P400, DOI 10.1093/trstmh/trv030; International Diabetes Federation, 2015, DIABETES ATLAS, V7th; Jabbar A., 2006, Eastern Mediterranean Health Journal, V12, P522; Jain K.K., 2015, INT MED J, V2, P245; Jali MV, 2013, PUBLIC HEALTH ACTION, V3, pS51, DOI 10.5588/pha.13.0031; Jali MV, 2013, DIABETES METAB J, V37, P291, DOI 10.4093/dmj.2013.37.4.291; Jawad Fatema, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P237; Jeon CY, 2012, EXPERT REV ANTI-INFE, V10, P863, DOI [10.1586/eri.12.75, 10.1586/ERI.12.75]; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kermansaravi F, 2014, INT J INFECT, V1; Kibirige D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-122; Kirui NK, 2012, PUBLIC HEALTH ACTION, V2, P148, DOI 10.5588/pha.12.0031; Kottarath M., 2015, INT J RES MED SCI, V3, P2810, DOI 10.18203/2320-6012.ijrms20150687; Kumar A, 2013, TROP MED INT HEALTH, V18, P646, DOI 10.1111/tmi.12083; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Lin YH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/1471-2458-15-3; Magee MJ, 2015, INT J TUBERC LUNG D, V19, P685, DOI 10.5588/ijtld.14.0811; Magee MJ, 2013, INT J INFECT DIS, V17, pE404, DOI 10.1016/j.ijid.2012.12.029; Magee MJ, 2014, ANN EPIDEMIOL, V24, P369, DOI 10.1016/j.annepidem.2014.01.012; Mehta S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1204-5; Mi FL, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24022; Mi FL, 2013, TROP MED INT HEALTH, V18, P1379, DOI 10.1111/tmi.12198; Moreno-Martinez A, 2015, INT J TUBERC LUNG D, V19, P1507, DOI 10.5588/ijtld.15.0102; Mtwangambate G, 2014, DIABETIC MED, V31, P600, DOI 10.1111/dme.12348; MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F; Naeem A, 2016, PROFESSIONAL MED J, V23; Nair S, 2013, PUBLIC HEALTH ACTION, V3, pS38, DOI 10.5588/pha.13.0037; Nasa JN, 2014, PUBLIC HEALTH ACTION, V4, pS50, DOI 10.5588/pha.13.0079; Ogbera A O, 2014, J Prev Med Hyg, V55, P42; Ogbera AO, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000112; Olayinka Adeyeye Olufunke, 2013, Indian J Endocrinol Metab, V17, P486, DOI 10.4103/2230-8210.111646; Pablo-Villamor MP., 2014, PHILIPP J INTERN MED, V52, P1; Padmalatha P, 2014, INDIAN J BASIC APPL, V4, P494; PANDYA L, 1991, ANN SAUDI MED, V11, P293, DOI 10.5144/0256-4947.1991.293; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Prakash BC, 2013, PUBLIC HEALTH ACTION, V3, pS18, DOI 10.5588/pha.13.0032; Prasad P, 2014, PUBLIC HEALTH ACTION, V4, P159, DOI 10.5588/pha.14.0023; Qayyum A, 2004, BIOMEDICAL, V20, P73; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Rajapakshe W, 2015, PUBLIC HEALTH ACTION, V5, P150, DOI 10.5588/pha.15.0006; Rakotonirina J, 2014, INT J RES MED SCI, V2, P834; Rao MSS, 2015, INDIAN J MICROBIOL R, V2, P220, DOI 10.1186/2049-9957-2-6; Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Rimpi Sangral, 2012, JK Science, V14, P177; Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X; Roghieh G, 2011, PAK J MED SCI, V27, P819; Sarvamangala K, 2014, INDIAN J PUBLIC HLTH, V5, P193; Shaikh MA, 2003, SAUDI MED J, V24, P278; Shidam UG, 2015, INT J TUBERC LUNG D, V19, P1163, DOI 10.5588/ijtld.14.0971; Siddiqui AM, 2009, J TAIBAH UNIV MED SC, V4, P148; Sulaiman SAS, 2013, AM J MED SCI, V345, P321, DOI 10.1097/MAJ.0b013e318288f8f3; Suwanpimolkul G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114442; SWAI ABM, 1990, TROP DOCT, V20, P147, DOI 10.1177/004947559002000402; Syal K, 2015, INDIAN J CLIN BIOCHE, V30, P323, DOI 10.1007/s12291-014-0431-7; Tahir NB, 2014, EUR ACAD RES, V2, P9948; Thapa B., 2015, SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, V12, P20; Tiroro S, 2015, THESIS; Tripathy SR, 1984, IND J TUB, V31, P122; Usmani Rabia Arshed, 2014, J Ayub Med Coll Abbottabad, V26, P61; Viney K, 2015, TROP MED INT HEALTH, V20, P650, DOI 10.1111/tmi.12462; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Vivek Nagar, 2015, International Journal of Medical Science and Public Health, V4, P245; Wang PairDong, 2000, Journal of Infectious Diseases and Antimicrobial Agents, V17, P101; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; WARWICK MT, 1957, Q J MED, V26, P31; Webb EA, 2009, INT J TUBERC LUNG D, V13, P868; WHO, 2016, GLOB TUB REP; Workneh MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147621; World Health Organization, COLL FRAM CAR CONTR; Wu ZY, 2016, J DIABETES COMPLICAT, V30, P237, DOI 10.1016/j.jdiacomp.2015.11.014; Zhang Q, 2009, JPN J INFECT DIS, V62, P390	106	91	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175925	10.1371/journal.pone.0175925	http://dx.doi.org/10.1371/journal.pone.0175925			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430796	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100021
J	Hernandez-Martinez, S; Sanchez-Zavaleta, M; Brito, K; Herrera-Ortiz, A; Ons, S; Noriega, FG				Hernandez-Martinez, Salvador; Sanchez-Zavaleta, Minerva; Brito, Kevin; Herrera-Ortiz, Antonia; Ons, Sheila; Noriega, Fernando G.			Allatotropin: A pleiotropic neuropeptide that elicits mosquito immune responses	PLOS ONE			English	Article							ANOPHELES-ALBIMANUS DIPTERA; MANDUCA-SEXTA ALLATOTROPIN; NITRIC-OXIDE PRODUCTION; AEDES-AEGYPTI; PLASMODIUM-BERGHEI; BACTERIAL LIPOPOLYSACCHARIDE; FUNCTIONAL-CHARACTERIZATION; MACROPHAGE ACTIVATION; JUVENILE-HORMONE; NERVOUS-SYSTEM	Allatotropins (AT) are neuropeptides with pleotropic functions on a variety of insect tissues. They affect processes such as juvenile hormone biosynthesis, cardiac rhythm, oviduct and hindgut contractions, nutrient absorption and circadian cycle. The present work provides experimental evidence that AT elicits immune responses in two important mosquito disease vectors, Anopheles albimanus and Aedes aegypti. Hemocytes and an immune-competent mosquito cell line responded to AT by showing strong morphological changes and increasing bacterial phagocytic activity. Phenoloxidase activity in hemolymph was also increased in Ae. aegypti mosquitoes treated with AT but not in An. albimanus, suggesting differences in the AT-dependent immune activation in the two species. In addition, two important insect immune markers, nitric oxide levels and expression of antimicrobial peptide genes, were increased in An. albimanus guts after AT treatment. AT conjugated to quantum dot nano-crystals (QDots) specifically labeled hemocytes in vivo in both mosquito species, implying molecular interactions between AT and hemocytes. The results of our studies suggest a new role for AT in the modulation of the immune response in mosquitoes.	[Hernandez-Martinez, Salvador; Sanchez-Zavaleta, Minerva; Brito, Kevin; Herrera-Ortiz, Antonia] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Ons, Sheila] Univ Nacl La Plata, Ctr Reg Estudios Genom, Lab Neurobiol Insectos, La Plata, Buenos Aires, Argentina; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Noriega, Fernando G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	Instituto Nacional de Salud Publica; National University of La Plata; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Hernandez-Martinez, S (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	shernandez@insp.mx	Ons, Sheila/ABI-2195-2020	Hernandez-Martinez, Salvador/0000-0003-1276-9397; Herrera Ortiz, Antonia/0000-0001-6307-0370	Consejo Nacional de Ciencia y Tecnologia Mexico [258239]; National Institutes of Health USA [2R01AI045545-16]; CONACyT [12471]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Mexico, grant 258239 to SH-M, the National Institutes of Health USA, grant 2R01AI045545-16 to FGN, and CONACyT for the fellowship 12471 to MS-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Consejo Nacional de Ciencia y Tecnologia Mexico, grant 258239 to SH-M, the National Institutes of Health USA, grant 2R01AI045545-16 to FGN, and CONACyT for the fellowship 12471 to MS-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WA, 1971, J CELL BIOL, V50, P201, DOI 10.1083/jcb.50.1.201; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Bello FJ, 1997, MEM I OSWALDO CRUZ, V92, P123, DOI 10.1590/S0074-02761997000100027; Bryant WB, 2016, DEV COMP IMMUNOL, V55, P119, DOI 10.1016/j.dci.2015.10.020; Bryant WB, 2014, J EXP BIOL, V217, P1238, DOI 10.1242/jeb.094573; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goldsworthy G, 2003, J INSECT PHYSIOL, V49, P795, DOI 10.1016/S0022-1910(03)00118-5; Goldsworthy G, 2002, J INSECT PHYSIOL, V48, P601, DOI 10.1016/S0022-1910(02)00085-9; Hernandez S, 1999, J MED ENTOMOL, V36, P426, DOI 10.1093/jmedent/36.4.426; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hernandez-Martinez S, 2007, J INSECT PHYSIOL, V53, P230, DOI 10.1016/j.jinsphys.2006.08.009; Hernandez-Martinez S, 2013, ARCH INSECT BIOCHEM, V84, P1, DOI 10.1002/arch.21108; Hernandez-Martinez S, 2013, CELL TISSUE RES, V351, P127, DOI 10.1007/s00441-012-1505-6; Herrera-Ortiz A, 2004, INSECT BIOCHEM MOLEC, V34, P893, DOI 10.1016/j.ibmb.2004.05.007; Herrera-Ortiz A, 2011, DEV COMP IMMUNOL, V35, P44, DOI 10.1016/j.dci.2010.08.004; Hillyer JF, 2014, CURR OPIN INSECT SCI, V3, P14, DOI 10.1016/j.cois.2014.07.002; Horodyski FM., 2013, HDB BIOL ACTIVE PEPT, P197; Horton AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-574; HOUK EJ, 1981, ACTA TROP, V38, P163; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; LANZ H, 1993, DEV COMP IMMUNOL, V17, P399, DOI 10.1016/0145-305X(93)90031-K; League GP, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0305-y; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Lombardo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003145; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Petricevich VL, 2008, CLIN EXP IMMUNOL, V154, P415, DOI 10.1111/j.1365-2249.2008.03754.x; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Rachinsky A, 2003, ARCH INSECT BIOCHEM, V54, P121, DOI 10.1002/arch.10107; REDDY JT, 1990, J INSECT PHYSIOL, V36, P397, DOI 10.1016/0022-1910(90)90057-M; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015; Sigle LT, 2016, DEV COMP IMMUNOL, V55, P90, DOI 10.1016/j.dci.2015.10.018; Skinner JR, 1997, CELL TISSUE RES, V290, P119, DOI 10.1007/s004410050914; STEFANO GB, 1989, P NATL ACAD SCI USA, V86, P626, DOI 10.1073/pnas.86.2.626; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tafalla C, 2002, COMP BIOCHEM PHYS B, V132, P423, DOI 10.1016/S1096-4959(02)00050-7; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; Wenzel J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00071	53	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175759	10.1371/journal.pone.0175759	http://dx.doi.org/10.1371/journal.pone.0175759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426765	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900045
J	Marini, MA; Fiorentino, TV; Succurro, E; Pedace, E; Andreozzi, F; Sciacqua, A; Perticone, F; Sesti, G				Marini, Maria Adelaide; Fiorentino, Teresa Vanessa; Succurro, Elena; Pedace, Elisabetta; Andreozzi, Francesco; Sciacqua, Angela; Perticone, Francesco; Sesti, Giorgio			Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; C-REACTIVE PROTEIN; MEAN BLOOD-GLUCOSE; END-PRODUCTS; BIOLOGICAL VARIATION; RISK-FACTOR; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; MEDIA THICKNESS	Hemoglobin glycation index (HGI), defined as the difference between the observed HbA1c value and the value of HbA1c predicted from plasma glucose levels, represents a measure of the degree of non-enzymatic glycation of hemoglobin and it has been found to be positively associated with micro-and macro-vascular complications in subjects with type 2 diabetes. To investigate the pathophysiological abnormalities responsible for the increased cardiovascular risk of patients with higher HGI, we evaluated the association of HGI with cardio-metabolic characteristics in nondiabetic offspring of type 2 diabetic individuals. Insulin sensitivity, measured by a hyperinsulinemic-euglycemic clamp, cardio-metabolic risk factors including lipid profile, uric acid and inflammatory factors, and ultrasound measurement of carotid intima-media thickness (IMT) were assessed in 387 nondiabetic individuals. Participants were stratified in tertiles according to HGI (high, moderate and low). As compared with subjects with low HGI, those with high HGI displayed an unfavorable cardio-metabolic risk profile having significantly higher values of BMI, waist circumference, triglycerides, uric acid, fasting insulin, inflammatory markers, such as high sensitivity C reactive protein, erythrocytes sedimentation rate, complement C3, fibrinogen, and white blood cell count, and carotid IMT, and lower HDL and insulin-stimulated glucose disposal. In a linear regression analysis model including several atherosclerotic risk factors such as gender, age, BMI, inflammatory factors, lipid profile, insulin-stimulated glucose disposal, fasting insulin, uric acid, and blood pressure, HGI was the major predictor of IMT (beta = 0.35; P = 0.001). In a logistic regression analysis adjusted for confounders, individuals with high HGI showed a 2.7-fold increased risk of vascular atherosclerosis (OR 2.72, 95% CI 1.01-7.37) as compared with subjects with low HGI. The present findings support the notion that HGI may be a useful tool to identify a subset of nondiabetic individuals conceivably harboring a higher risk of cardiovascular disease.	[Marini, Maria Adelaide; Perticone, Francesco; Sesti, Giorgio] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Fiorentino, Teresa Vanessa; Succurro, Elena; Pedace, Elisabetta; Andreozzi, Francesco; Sciacqua, Angela] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	sesti@unicz.it	Succurro, Elena/K-4138-2016; Fiorentino, Teresa Vanessa/AAP-1855-2020; Perticone, Francesco/I-4260-2017; Andreozzi, Francesco/J-4073-2018	Succurro, Elena/0000-0003-2578-692X; Andreozzi, Francesco/0000-0001-9375-1513				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; Felipe DL, 2011, DIABETES CARE, V34, P1816, DOI 10.2337/dc11-0049; Fukudome M, 2009, INTERNAL MED, V48, P273, DOI 10.2169/internalmedicine.48.1544; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; GONEN B, 1977, LANCET, V2, P734; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Hempe JM, 2015, DIABETES CARE, V38, P1067, DOI 10.2337/dc14-1844; Hempe JM, 2010, DIABETES CARE, V33, P1449, DOI 10.2337/dc09-1498; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Kilhovd BK, 2005, ARTERIOSCL THROM VAS, V25, P815, DOI 10.1161/01.ATV.0000158380.44231.fe; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kim JI, 2005, DIABETES, V54, pA244; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Leslie RDG, 2003, DIABETES, V52, P2441, DOI 10.2337/diabetes.52.9.2441; Marini MA, 2014, NUTR METAB CARDIOVAS, V24, P27, DOI 10.1016/j.numecd.2013.01.011; Marini MA, 2012, DIABETES CARE, V35, P1144, DOI 10.2337/dc11-2032; McCarter RJ, 2004, DIABETES CARE, V27, P1259, DOI 10.2337/diacare.27.6.1259; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; PHILLIPOU G, 1993, CLIN CHEM, V39, P2305; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rodriguez-Segade S, 2012, DIABETES CARE, V35, P2447, DOI 10.2337/dc11-2450; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Rojas A, 2014, INT REV IMMUNOL, V33, P67, DOI 10.3109/08830185.2013.849702; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sesti G, 2014, NUTR METAB CARDIOVAS, V24, P1365, DOI 10.1016/j.numecd.2014.06.012; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soros AA, 2010, PEDIATR DIABETES, V11, P455, DOI 10.1111/j.1399-5448.2009.00630.x; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Wilson DM, 2008, DIABETES CARE, V31, P381, DOI 10.2337/dc07-1835; Wilson DM, 2011, DIABETES CARE, V34, P1315, DOI 10.2337/dc10-1661; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798; Zafon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066696	52	35	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175547	10.1371/journal.pone.0175547	http://dx.doi.org/10.1371/journal.pone.0175547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426788	Green Published, gold			2022-12-27	WOS:000399875900031
J	Sanchez-Azanza, VA; Lopez-Penades, R; Buil-Legaz, L; Aguilar-Mediavilla, E; Adrover-Roig, D				Sanchez-Azanza, Victor A.; Lopez-Penades, Raul; Buil-Legaz, Lucia; Aguilar-Mediavilla, Eva; Adrover-Roig, Daniel			Is bilingualism losing its advantage? A bibliometric approach	PLOS ONE			English	Article							CONFLICT-RESOLUTION; COGNITIVE CONTROL; EXECUTIVE CONTROL; PUBLICATION BIAS; REACTION-TIME; 2 LANGUAGES; DECLINE; IMPACT; FLEXIBILITY; CITATION	This study uses several bibliometric indices to explore the temporal course of publication trends regarding the bilingual advantage in executive control over a ten-year window. These indices include the number of published papers, numbers of citations, and the journal impact factor. According to the information available in their abstracts, studies were classified into one of four categories: supporting, ambiguous towards, not mentioning, or challenging the bilingual advantage. Results show that the number of papers challenging the bilingual advantage increased notably in 2014 and 2015. Both the average impact factor and the accumulated citations as of June 2016 were equivalent between categories. However, of the studies published in 2014, those that challenge the bilingual advantage accumulated more citations in June 2016 than those supporting it. Our findings offer evidence-based bibliometric information about the current state of the literature and suggest a change in publication trends regarding the literature on the bilingual advantage.	[Sanchez-Azanza, Victor A.; Lopez-Penades, Raul; Buil-Legaz, Lucia; Aguilar-Mediavilla, Eva; Adrover-Roig, Daniel] Univ Illes Balears, Dept Appl Pedag & Educ Psychol, Illes Balears, Spain	Universitat de les Illes Balears	Sanchez-Azanza, VA (corresponding author), Univ Illes Balears, Dept Appl Pedag & Educ Psychol, Illes Balears, Spain.	v.sanchez@uib.es	López-Penadés, Raúl/G-1581-2015; Adrover-Roig, Daniel/B-9645-2009; Aguilar-Mediavilla, Eva/D-9208-2011; Sanchez-Azanza, Victor A./ABH-7392-2020; Buil-Legaz, Lucía/ABG-8406-2020; Buil-Legaz, Lucía/K-4118-2017	López-Penadés, Raúl/0000-0002-1284-9955; Adrover-Roig, Daniel/0000-0002-4337-1325; Aguilar-Mediavilla, Eva/0000-0003-0286-6572; Sanchez-Azanza, Victor A./0000-0002-2650-3277; Buil-Legaz, Lucía/0000-0002-9454-8194; Buil-Legaz, Lucía/0000-0002-9454-8194	Spain's Ministry of Economy, Industry and Competitiveness [EDU2013-45174-P]; predoctoral fellowship from Spain's Ministry of Economy, Industry and Competitiveness [BES-2014-069063 AEI/FEDER,UE]	Spain's Ministry of Economy, Industry and Competitiveness; predoctoral fellowship from Spain's Ministry of Economy, Industry and Competitiveness	This study received the support of Grant EDU2013-45174-P (AEI/FEDER,UE) from Spain's Ministry of Economy, Industry and Competitiveness, and VSA received support from a predoctoral fellowship from Spain's Ministry of Economy, Industry and Competitiveness (BES-2014-069063 AEI/FEDER,UE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rabia S, 2002, J PSYCHOLINGUIST RES, V31, P661, DOI 10.1023/A:1021221206119; Aguinis H, 2011, J ORGAN BEHAV, V32, P1033, DOI 10.1002/job.719; Dunabeitia JA, 2014, EXP PSYCHOL, V61, P234, DOI 10.1027/1618-3169/a000243; Anton E, 2016, J MEM LANG, V90, P147, DOI 10.1016/j.jml.2016.04.007; Bala MM, 2013, J CLIN EPIDEMIOL, V66, P286, DOI 10.1016/j.jclinepi.2012.10.005; Barac R, 2014, EARLY CHILD RES Q, V29, P699, DOI 10.1016/j.ecresq.2014.02.003; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2016, AGEING RES REV, V27, P56, DOI 10.1016/j.arr.2016.03.003; Branzi FM, 2016, CEREB CORTEX, V26, P2367, DOI 10.1093/cercor/bhv052; Buchweitz A, 2013, PHYS LIFE REV, V10, P428, DOI 10.1016/j.plrev.2013.07.020; Burkner PC, 2014, STAT MED, V33, P3061, DOI 10.1002/sim.6177; Calabria M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00250; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Can S, 2016, PUBLICATIONS, V4, DOI 10.3390/publications4030023; Casaponsa A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00588; Colzato LS, 2008, J EXP PSYCHOL LEARN, V34, P302, DOI 10.1037/0278-7393.34.2.302; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; DARCY NT, 1963, J GENET PSYCHOL, V103, P259, DOI 10.1080/00221325.1963.10532521; DARCY NT, 1953, J GENET PSYCHOL, V82, P21; De Bellis N., 2009, BIBLIOMETRICS CITATI; de Bruin A, 2015, CORTEX, V73, P375, DOI 10.1016/j.cortex.2015.05.025; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Foy JG, 2014, INT J BILINGUAL, V18, P717, DOI 10.1177/1367006912472263; Garbin G, 2010, NEUROIMAGE, V53, P1272, DOI 10.1016/j.neuroimage.2010.05.078; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Karlsson LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125867; Koletsi D, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.02.024; Kousaie S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00250; Kousaie S, 2012, BRAIN RES, V1446, P71, DOI 10.1016/j.brainres.2012.01.052; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Ozonoff S, 2011, J CHILD PSYCHOL PSYC, V52, P729, DOI 10.1111/j.1469-7610.2011.02425.x; Paap KR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00962; Paap KR, 2015, CORTEX, V69, P265, DOI 10.1016/j.cortex.2015.04.014; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; PEAL E, 1962, PSYCHOL MONOGR, V76, P1, DOI 10.1037/h0093840; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosselli M, 2002, J INT NEUROPSYCH SOC, V8, P819, DOI 10.1017/S1355617702860106; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tse CS, 2012, BILING-LANG COGN, V15, P663, DOI 10.1017/S1366728912000077; Yow WQ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00164	47	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176151	10.1371/journal.pone.0176151	http://dx.doi.org/10.1371/journal.pone.0176151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426797	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900109
J	Wang, L; Cao, M; Wei, QL; Zhao, ZH; Xiang, Q; Wang, HJ; Zhang, HT; Lai, GQ				Wang, Lei; Cao, Min; Wei, Qing Lu; Zhao, Zhong Hua; Xiang, Qin; Wang, Hui Juan; Zhang, Hua Tang; Lai, Guo Qi			A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ROLLING CIRCLE AMPLIFICATION; CORE PROMOTER; PRECORE; REPLICATION; EXPRESSION; MANAGEMENT; MUTATIONS; CCCDNA; TRANSCRIPTION	Despite the availability of an effective vaccine, hepatitis B virus (HBV) infection remains a major health problem. HBV e antigen (HBeAg)-negative strains have become prevalent. Previously, no animal model mimicked the clinical course of HBeAg-negative HBV infection. To establish an HBeAg-negative HBV infection model, the 3.2-kb full-length genome of HBeAg-negative HBV was cloned from a clinical sample and then circularized to form covalently closed circular (cccDNA). The resulting cccDNA was introduced into the liver of C57BL/6J mice through hydrodynamic injection. Persistence of the HBeAg-negative infection was monitored at predetermined time points using HBV-specific markers including HBV surface antigen (HBsAg), HBeAg, and HBV core antigen (HBcAg) as well as DNA copies. Throughout the study, pAAV-HBV1.2 was used as a control. In mice injected with HBeAg-negative cccDNA, the HBV infection rate was 100% at the initial stage. HBsAg levels increased up to 1 week, at which point levels peaked and dropped quickly thereafter. In 60% of injected mice, HBsAg and HBcAg persisted for more than 10 weeks. High numbers of HBV DNA copies were detected in the serum and liver. Moreover, cccDNA persisted in the liver tissue of HBeAg-negative mice. In contrast to the pAAV-HBV 1.2 injected mice, no HBeAg was found in mice injected with HBeAg-negative HBV throughout the study period. These results demonstrate the first successful establishment of a model of HBeAg-negative HBV-persistent infection in immunocompetent mice. Compared to pAAV-HBV1.2-injected mice, the infection persistence and levels of serum virological and biochemical markers were approximately equal in the model mice. This model will be useful for mechanistic studies on HBeAg-negative HBV infection and will facilitate the evaluation of new antiviral drugs.	[Wang, Lei; Cao, Min; Xiang, Qin; Wang, Hui Juan; Lai, Guo Qi] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China; [Wei, Qing Lu; Zhao, Zhong Hua; Zhang, Hua Tang] Chongqing Acad Sci & Technol, Chongqing, Peoples R China	Chongqing Medical University	Lai, GQ (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.; Zhang, HT (corresponding author), Chongqing Acad Sci & Technol, Chongqing, Peoples R China.	zht@cast.gov.cn; laiguoqi@163.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [8157041877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 8157041877). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1981, LANCET, V2, P1129; BRUNETTO MR, 1990, J HEPATOL, V10, P258, DOI 10.1016/0168-8278(90)90062-V; Buckwold VE, 1996, J VIROL, V70, P5845, DOI 10.1128/JVI.70.9.5845-5851.1996; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Cheng L, 2015, ANTIVIR RES, V121, P1, DOI 10.1016/j.antiviral.2015.06.012; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GUNTHER S, 1995, J VIROL, V69, P5437; Guo XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25552; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Hadziyannis SJ, 2007, EXPERT OPIN INV DRUG, V16, P777, DOI 10.1517/13543784.16.6.777; Hibbitt OC, 2007, J GENE MED, V9, P488, DOI 10.1002/jgm.1041; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Inoue J, 2011, J INFECT DIS, V204, P1017, DOI 10.1093/infdis/jir485; Keeffe EB, 2004, CLIN GASTROENTEROL H, V2, P87, DOI 10.1016/S1542-3565(03)00312-4; Kim H, 2016, WORLD J GASTROENTERO, V22, P4287, DOI 10.3748/wjg.v22.i17.4287; Lai GQ, 2014, MOL MED REP, V10, P1245, DOI 10.3892/mmr.2014.2372; Lebosse F, 2016, J HEPATOLOGY; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36483; Li XS, 2015, INT J MOL SCI, V16, P5141, DOI 10.3390/ijms16035141; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Moriyama K, 1996, VIROLOGY, V226, P269, DOI 10.1006/viro.1996.0655; Qi ZH, 2014, J VIROL, V88, P8045, DOI 10.1128/JVI.01024-14; Qin YL, 2011, J CLIN MICROBIOL, V49, P1226, DOI 10.1128/JCM.02340-10; Saikia N, 2007, POSTGRAD MED J, V83, P32, DOI 10.1136/pgmj.2006.044826; Samal J, 2015, VIROLOGY, V484, P234, DOI 10.1016/j.virol.2015.06.011; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shen T, 2014, WORLD J GASTROENTERO, V20, P5435, DOI 10.3748/wjg.v20.i18.5435; Shintani M, 2010, ONCOL REP, V23, P1345, DOI 10.3892/or_00000770; Tohme RA, 2013, J CLIN VIROL, V58, P396, DOI 10.1016/j.jcv.2013.08.012; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179; Yeh ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122259; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhong YW, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0608-y; Zhong YW, 2011, CLIN CHIM ACTA, V412, P1905, DOI 10.1016/j.cca.2011.06.031; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175992	10.1371/journal.pone.0175992	http://dx.doi.org/10.1371/journal.pone.0175992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426720	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900082
J	de Paula, AF; Dinato, NB; Vigna, BBZ; Favero, AP				de Paula, Ailton Ferreira; Dinato, Naiana Barbosa; Zanotto Vigna, Bianca Baccili; Favero, Alessandra Pereira			Recombinants from the crosses between amphidiploid and cultivated peanut (Arachis hypogaea) for pest-resistance breeding programs	PLOS ONE			English	Article							SECTION ARACHIS; MARKERS	Peanut is a major oilseed crop worldwide. In the Brazilian peanut production, silvering thrips and red necked peanut worm are the most threatening pests. Resistant varieties are considered an alternative to pest control. Many wild diploid Arachis species have shown resistance to these pests, and these can be used in peanut breeding by obtaining hybrid of A and B genomes and subsequent polyploidization with colchicine, resulting in an AABB amphidiploid. This amphidiploid can be crossed with cultivated peanut (AABB) to provide genes of interest to the cultivar. In this study, the sterile diploid hybrids from A. magna V 13751 and A. kempff-mercadoi V 13250 were treated with colchicine for polyploidization, and the amphidiploids were crossed with A. hypogaea cv. IAC OL 4 to initiate the introgression of the wild genes into the cultivated peanut. The confirmation of the hybridity of the progenies was obtained by: (1) reproductive characterization through viability of pollen, (2) molecular characterization using microsatellite markers and (3) morphological characterization using 61 morphological traits with principal component analysis. The diploid hybrid individual was polyploidized, generating the amphidiploid An 13 (A. magna V 13751 x A. kempff-mercadoi V 13250)(4x). Four F-1 hybrid plants were obtained from IAC OL 4 x An 13, and 51 F-2 seeds were obtained from these F-1 plants. Using reproductive, molecular and morphological characterizations, it was possible to distinguish hybrid plants from selfed plants. In the cross between A. hypogaea and the amphidiploid, as the two parents are polyploid, the hybrid progeny and selves had the viability of the pollen grains as high as the parents. This fact turns the use of reproductive characteristics impossible for discriminating, in this case, the hybrid individuals from selfing. The hybrids between A. hypogaea and An 13 will be used in breeding programs seeking pest resistance, being subjected to successive backcrosses until recovering all traits of interest of A. hypogaea, keeping the pest resistance.	[de Paula, Ailton Ferreira; Dinato, Naiana Barbosa] Univ Fed Sao Carlos, Dept Morfol & Patol, Sao Carlos, SP, Brazil; [Zanotto Vigna, Bianca Baccili; Favero, Alessandra Pereira] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [de Paula, Ailton Ferreira] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Morfol & Patol, Sao Carlos, SP, Brazil; [Favero, Alessandra Pereira] Fazenda Canchim, Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Sao Carlos; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	de Paula, AF (corresponding author), Univ Fed Sao Carlos, Dept Morfol & Patol, Sao Carlos, SP, Brazil.; de Paula, AF (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Morfol & Patol, Sao Carlos, SP, Brazil.	ailtonfp_biolog@yahoo.com.br	Vigna, Bianca BZ/B-7640-2012; Fávero, Alessandra P/I-3557-2012; Vigna, Bianca BZ/H-8853-2013	Vigna, Bianca BZ/0000-0003-0192-9877; Vigna, Bianca BZ/0000-0003-0192-9877; Favero, Alessandra/0000-0001-9461-1539	Embrapa [0211080060008]; National Council for Scientific and Technological Development (CNPq) [471657/2011-5]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	APF received funds by Embrapa (no. 0211080060008) and National Council for Scientific and Technological Development (CNPq, grant number 471657/2011-5). AFP received a grant by Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borror DJ, 1969, INTRODUCAO AO ESTUDO; Bravo JP, 2006, GENET MOL BIOL, V29, P516, DOI 10.1590/S1415-47572006000300021; Calcagnolo G., 1974, Biologico, V40, P239; Silvestri MC, 2015, PLANT SYST EVOL, V301, P555, DOI 10.1007/s00606-014-1092-y; CONAB, 2015, ACOMPANHAMENTO DA SA, P1; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Faleiro FG., 2012, EMBRAPA CERRADOS, P1; Favero AP, 2015, GENET MOL RES, V14, P16694, DOI 10.4238/2015.December.11.17; Favero AP, 2015, GENET MOL BIOL, V38, P353, DOI 10.1590/S1415-475738320140376; Favero AP, 2004, THESIS; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Fernandez A., 1994, Bonplandia, V8, P187; Gallo D, 2002, ENTOMOLOGIA AGR COLA; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Janini J. C., 2011, THESIS; LARA F. M., 1991, PRINCIPIOS DE RESIST; Lavia Graciela Ines, 1998, Cytologia (Tokyo), V63, P177, DOI 10.1508/cytologia.63.177; Ludke DCW, 2015, THESIS; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; Moretzsohn Marcio de Carvalho, 2004, BMC Plant Biology, V4, P11, DOI 10.1186/1471-2229-4-11; Nigam SN., 1990, ARTIFICIAL HYBRIDIZA; Penaloza A, 2005, BONPLANDIA, V14, P65; Pereira RC, DUPLICAC CROMOSSOMIC; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Robledo G, 2009, THEOR APPL GENET, V118, P1295, DOI 10.1007/s00122-009-0981-x; Robledo G, 2008, GENET MOL BIOL, V31, P717, DOI 10.1590/S1415-47572008000400019; Robledo G, 2010, THEOR APPL GENET, V121, P1033, DOI 10.1007/s00122-010-1369-7; Simpson C. E., 1991, Peanut Science, V18, P22, DOI 10.3146/i0095-3679-18-1-8; Simpson CE, 2001, CROP SCI, V41, P918, DOI 10.2135/cropsci2001.413918x; STALKER HT, 1991, AM J BOT, V78, P630, DOI 10.2307/2445084; TALLURY SP, 1995, ANN BOT-LONDON, V76, P397, DOI 10.1006/anbo.1995.1113; USDA, 2015, TABLE 13 PEANUT AREA; USDA, 2015, TABLE 01 MAJOR OILSE; WYNNE J C, 1989, P155	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175940	10.1371/journal.pone.0175940	http://dx.doi.org/10.1371/journal.pone.0175940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423007	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600064
J	Saghazadeh, A; Mahmoudi, M; Ashkezari, AD; Rezaie, NO; Rezaei, N				Saghazadeh, Amene; Mahmoudi, Maryam; Ashkezari, Atefeh Dehghani; Rezaie, Nooshin Oliaie; Rezaei, Nima			Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium	PLOS ONE			English	Review							GLUTATHIONE-PEROXIDASE ACTIVITY; THYROID-HORMONE METABOLISM; OXIDATIVE STRESS; SYNDROME CHILDREN; VITAMIN-A; SUPEROXIDE-DISMUTASE; AMINO-ACIDS; FOLATE METABOLISM; PARATHYROID-HORMONE; ALZHEIMERS-DISEASE	Different metabolic profiles as well as comorbidities are common in people with Down Syndrome (DS). Therefore it is relevant to know whether micronutrient levels in people with DS are also different. This systematic review was designed to review the literature on micronutrient levels in people with DS compared to age and sex-matched controls without DS. We identified sixty nine studies from January 1967 to April 2016 through main electronic medical databases PubMed, Scopus, and Web of knowledge. We carried out meta-analysis of the data on four essential trace elements (Cu, Fe, Se, and Zn), six minerals (Ca, Cl, K, Mg, Na, and P), and five vitamins (vitamin A, B9, B12, D, and E). People with DS showed lower blood levels of Ca (standard mean difference (SMD) = -0.63; 95% confidence interval (CI): -1.16 to -0.09), Se (SMD = -0.99; 95% CI: -1.55 to -0.43), and Zn (SMD = -1.30; 95% CI: -1.75 to -0.84), while red cell levels of Zn (SMD = 1.88; 95% CI: 0.48 to 3.28) and Cu (SMD = 2.77; 95% CI: 1.96 to 3.57) were higher. They had also higher salivary levels of Ca (SMD = 0.85; 95% CI: 0.38 to 1.33) and Na (SMD = 1.04; 95% CI: 0.39 to 1.69). Our findings that micronutrient levels are different in people with DS raise the question whether these differences are related to the different metabolic profiles, the common comorbidities or merely reflect DS.	[Saghazadeh, Amene; Ashkezari, Atefeh Dehghani; Rezaie, Nooshin Oliaie; Rezaei, Nima] Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Tehran, Iran; [Saghazadeh, Amene] USERN, MCIG, Tehran, Iran; [Mahmoudi, Maryam] Univ Tehran Med Sci, Sch Nutr & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran; [Mahmoudi, Maryam] USERN, DiNET, Tehran, Iran; [Ashkezari, Atefeh Dehghani] USERN, NIRA, Tehran, Iran; [Rezaie, Nooshin Oliaie; Rezaei, Nima] USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Boston, MA 02215 USA; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Rezaei, N (corresponding author), Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Tehran, Iran.; Rezaei, N (corresponding author), USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Boston, MA 02215 USA.; Rezaei, N (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.	Rezaei_nima@tums.ac.ir	Rezaei, Nima/B-4245-2008	Rezaei, Nima/0000-0002-3836-1827; Saghazadeh, Amene/0000-0002-0945-8443				AGUS ZS, 1973, AM J PHYSIOL, V224, P1143, DOI 10.1152/ajplegacy.1973.224.5.1143; Allen EG, 2009, HUM GENET, V125, P41, DOI 10.1007/s00439-008-0603-8; Angelopoulou N, 2000, CALCIFIED TISSUE INT, V66, P176, DOI 10.1007/s002230010035; ANNEREN G, 1985, ACTA PAEDIATR SCAND, V74, P508, DOI 10.1111/j.1651-2227.1985.tb11019.x; ANNEREN G, 1985, ACTA PAEDIATR SCAND, V74, P259, DOI 10.1111/j.1651-2227.1985.tb10961.x; ANNEREN G, 1987, HUM NUTR-CLIN NUTR, V41C, P291; ANNEREN G, 1989, ACTA PAEDIATR SCAND, V78, P879, DOI 10.1111/j.1651-2227.1989.tb11167.x; Areias C, 2013, EUR J PAEDIATR DENT, V14, P23; ARTHUR JR, 1993, AM J CLIN NUTR, V57, P236; BAETEMAN MA, 1984, ACTA PAEDIATR SCAND, V73, P341, DOI 10.1111/j.1651-2227.1994.tb17745.x; Ballestin R, 2014, NEUROCHEM INT, V75, P48, DOI 10.1016/j.neuint.2014.05.013; BARDEN HS, 1977, J MENT DEFIC RES, V21, P63; BARDEN HS, 1978, J MENT DEFIC RES, V22, P213; BARLOW PJ, 1981, J MENT DEFIC RES, V25, P161; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Berger MM, 2001, INTENS CARE MED, V27, P91, DOI 10.1007/s001340000757; Biselli JM, 2012, MOL BIOL REP, V39, P9277, DOI 10.1007/s11033-012-1629-5; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; BJORKSTEN B, 1980, ACTA PAEDIATR SCAND, V69, P183, DOI 10.1111/j.1651-2227.1980.tb07057.x; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; BOTTINO NR, 1984, PHYTOCHEMISTRY, V23, P2445, DOI 10.1016/S0031-9422(00)84073-X; BRAS A, 1989, OPHTHALMIC PAED GEN, V10, P271, DOI 10.3109/13816818909009882; BRUHL HH, 1987, AM J MENT DEF, V92, P103; Bucci I, 1999, BIOL TRACE ELEM RES, V67, P257, DOI 10.1007/BF02784425; Burgio G R, 1983, Birth Defects Orig Artic Ser, V19, P325; Carratelli M, 2001, INT J CLIN PHARM RES, V21, P79; Cengiz M, 2000, TRACE ELEM ELECTROLY, V17, P156; Center J, 1998, AM J MENT RETARD, V103, P19, DOI 10.1352/0895-8017(1998)103<0019:PWMRHA>2.0.CO;2; CHAPMAN MJ, 1967, J MENT DEFIC RES, V11, P185; Chavez CJ, 2010, AN PEDIATR, V72, P185, DOI 10.1016/j.anpedi.2009.10.024; Ciaccio Marcello, 2003, Ital J Biochem, V52, P72; COBURN SP, 1983, AM J CLIN NUTR, V38, P352, DOI 10.1093/ajcn/38.3.352; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Colombo M L, 1989, Minerva Pediatr, V41, P71; Colombo M L, 1989, Minerva Pediatr, V41, P189; Concolino D, 2001, ITALIAN J PEDIAT, V27, P791; Coppus AW, 2007, J NEURAL TRANSM, V114, P1041, DOI 10.1007/s00702-007-0656-1; CRONK C, 1988, PEDIATRICS, V81, P102; CUTRESS TW, 1972, ARCH ORAL BIOL, V17, P1081, DOI 10.1016/0003-9969(72)90183-5; Daniels LA, 1996, BIOL TRACE ELEM RES, V54, P185, DOI 10.1007/BF02784430; David O, 1996, PEDIATR HEMAT ONCOL, V13, P271, DOI 10.3109/08880019609030827; Davidovich E, 2010, INT J PAEDIATR DENT, V20, P235, DOI 10.1111/j.1365-263X.2010.01045.x; de Asua DR, 2014, DIABETES METAB J, V38, P464, DOI 10.4093/dmj.2014.38.6.464; de Sousa MC, 2015, ARCH ORAL BIOL, V60, P600, DOI 10.1016/j.archoralbio.2014.09.013; DELARCO C, 1992, J INTELL DISABIL RES, V36, P251; DWORKIN BM, 1994, CHEM-BIOL INTERACT, V91, P181, DOI 10.1016/0009-2797(94)90038-8; El-Gendy H, 2007, J RES MED SCI, V12, P86; Englund A, 2013, AM J MED GENET A, V161A, P642, DOI 10.1002/ajmg.a.35706; Ercis M, 1996, CLIN GENET, V50, P317; FABRIS N, 1984, LANCET, V1, P983; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Farzin L., 2014, Zahedan Journal of Research in Medical Sciences, V16, P77; Fernandez DR, 2005, ATOM SPECTROSC, V26, P117; Fillon-Emery N, 2004, AM J CLIN NUTR, V80, P1551, DOI 10.1093/ajcn/80.6.1551; FORT P, 1984, J PEDIATR-US, V104, P545, DOI 10.1016/S0022-3476(84)80544-2; FRANCESCHI C, 1988, J MENT DEFIC RES, V32, P169; Frischer H, 1981, Prog Clin Biol Res, V55, P269; Garaiova I, 2004, BIOLOGIA, V59, P787; Garcez ME, 2005, MAYO CLIN PROC, V80, P1607, DOI 10.4065/80.12.1607; Garlet TR, 2013, LIFE SCI, V93, P558, DOI 10.1016/j.lfs.2013.08.017; GERICKE GS, 1977, S AFR MED J, V51, P369; GIROUX EL, 1972, BIOCHIM BIOPHYS ACTA, V273, P64, DOI 10.1016/0304-4165(72)90191-2; GROMADZINSKA J, 1988, J CLIN CHEM CLIN BIO, V26, P255; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; HALSTED JA, 1970, LANCET, V1, P322; HARRISON M, 1960, J ENDOCRINOL, V21, P197, DOI 10.1677/joe.0.0210197; Heggarty HJ, 1996, ARCH DIS CHILD, V74, P347, DOI 10.1136/adc.74.4.347; HESTNES A, 1991, J MENT DEFIC RES, V35, P179; HOWELL A, 1973, SCAND J HAEMATOL, V11, P140; HSIANG YHH, 1987, AM J MED GENET, V27, P449, DOI 10.1002/ajmg.1320270223; IBARRA B, 1990, ANN GENET-PARIS, V33, P84; JACKSON CVE, 1988, J MENT DEFIC RES, V32, P479; James SJ, 1999, AM J CLIN NUTR, V70, P495; JARA L, 1991, Archivos de Biologia y Medicina Experimentales, V24, P57; Jovanovic SV, 1998, FREE RADICAL BIO MED, V25, P1044, DOI 10.1016/S0891-5849(98)00137-3; Kadrabova J, 1996, BIOL TRACE ELEM RES, V54, P201, DOI 10.1007/BF02784431; Kaminski K, 1996, PEDIAT RELATED TOPIC, V35, P49; KANAVIN O, 1988, ACTA MED SCAND, V224, P473; Kanavin OJ, 2000, BIOL TRACE ELEM RES, V78, P35, DOI 10.1385/BTER:78:1-3:35; Karlsson B, 1998, ARCH DIS CHILD, V79, P242, DOI 10.1136/adc.79.3.242; KEDZIORA J, 1986, CLIN CHIM ACTA, V154, P191, DOI 10.1016/0009-8981(86)90030-6; Kent L, 1999, DEV MED CHILD NEUROL, V41, P153, DOI 10.1017/S001216229900033X; Kralik A, 1996, HORM METAB RES, V28, P223, DOI 10.1055/s-2007-979169; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; LEJEUNE J, 1992, ANN GENET-PARIS, V35, P8; LICASTRO F, 1994, J INTELL DISABIL RES, V38, P149; LICASTRO F, 1992, INT J NEUROSCI, V65, P259, DOI 10.3109/00207459209003299; Licastro F, 2001, BRAIN RES BULL, V55, P313, DOI 10.1016/S0361-9230(01)00476-2; LICASTRO F, 1993, J TRACE ELEM ELECT H, V7, P237; Licastro F, 2006, ARCH GERONTOL GERIAT, V43, P381, DOI 10.1016/j.archger.2006.01.003; Lima AS, 2010, BIOL TRACE ELEM RES, V133, P20, DOI 10.1007/s12011-009-8408-8; Lloret A, 2008, FREE RADICAL BIO MED, V44, P495, DOI 10.1016/j.freeradbiomed.2007.10.046; LOCKITCH G, 1987, PEDIATR RES, V22, P536, DOI 10.1203/00006450-198711000-00013; Lott Ira T., 2006, Current Alzheimer Research, V3, P521, DOI 10.2174/156720506779025305; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Siqueira WL, 2007, SPEC CARE DENT, V27, P202, DOI 10.1111/j.1754-4505.2007.tb00347.x; MALLET B, 1979, J MENT DEFIC RES, V23, P219; Marques RC, 2007, BIOL TRACE ELEM RES, V120, P11, DOI 10.1007/s12011-007-0061-5; Marreiro DD, 2009, BIOL TRACE ELEM RES, V129, P20, DOI 10.1007/s12011-008-8280-y; MATIN MA, 1981, J MENT DEFIC RES, V25, P121; MCBEAN LD, 1974, CLIN CHIM ACTA, V50, P43, DOI 10.1016/0009-8981(74)90076-X; Meguid NA, 2001, BIOL TRACE ELEM RES, V81, P21, DOI 10.1385/BTER:81:1:21; Meguid NA, 2010, CLIN BIOCHEM, V43, P963, DOI 10.1016/j.clinbiochem.2010.04.058; Mendes CC, 2013, GENET TEST MOL BIOMA, V17, P274, DOI 10.1089/gtmb.2012.0293; MILLAR AL, 1993, MED SCI SPORT EXER, V25, P270; MILUNSKY A, 1968, ARCH ENVIRON HEALTH, V17, P372, DOI 10.1080/00039896.1968.10665244; MILUNSKY A, 1970, J MENT DEFIC RES, V14, P99; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nandha Kumar S, 2014, CURRENT PEDIAT RES, V18, P11; Napolitano G, 1989, IS ZINC DEFICIENCY C; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; NEVE J, 1984, J MENT DEFIC RES, V28, P261; NEVE J, 1983, CLIN CHIM ACTA, V133, P209, DOI 10.1016/0009-8981(83)90406-0; NEVE J, 1983, BIOL TRACE ELEM RES, V5, P75, DOI 10.1007/BF02916627; NOBLE RL, 1988, J MENT DEFIC RES, V32, P193; Nordstrom M, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.25487; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Obermann-Borst SA, 2011, EUR J CLIN INVEST, V41, P143, DOI 10.1111/j.1365-2362.2010.02388.x; Ordonez FJ, 2006, BRIT J SPORT MED, V40, P717, DOI 10.1136/bjsm.2005.024315; Pallardo FV, 2006, BIOGERONTOLOGY, V7, P211, DOI 10.1007/s10522-006-9002-5; PALMER S, 1978, INT J VITAM NUTR RES, V48, P188; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Parisotto EB, 2015, RES DEV DISABIL, V45-46, P14, DOI 10.1016/j.ridd.2015.07.010; Parisotto EB, 2014, RES DEV DISABIL, V35, P1228, DOI 10.1016/j.ridd.2014.03.013; PARTINGTON MW, 1971, DEV MED CHILD NEUROL, V13, P362; Pastor MC, 1998, CLIN CHEM, V44, P924; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; PUESCHEL SM, 1990, J MENT DEFIC RES, V34, P269; PUESCHEL SM, 1985, AM J DIS CHILD, V139, P636, DOI 10.1001/archpedi.1985.02140080106045; Purice M, 1988, Endocrinologie, V26, P113; Rabiei M, 2013, INT J RHEUM DIS, V16, P198, DOI 10.1111/1756-185X.12003; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Rascon Trincado MV, 1992, AN ESP PEDIATR, V37, P391; REYNOLDS GP, 1988, NEUROSCI LETT, V94, P224, DOI 10.1016/0304-3940(88)90299-6; ROIZEN NJ, 1993, AM J MED GENET, V46, P510, DOI 10.1002/ajmg.1320460509; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; ROSNER F, 1965, LANCET, V1, P1191; Rubin SS, 1998, MENT RETARD, V36, P175, DOI 10.1352/0047-6765(1998)036<0175:OPIPWD>2.0.CO;2; Saghazadeh A, 2017, J AUTISM DEV DISORD, V47, P1018, DOI 10.1007/s10803-016-3024-x; Sakadamis A, 2002, EUR J OBSTET GYN R B, V100, P208, DOI 10.1016/S0301-2115(01)00478-X; Schmid F, 1975, Fortschr Med, V93, P1170; SCHNEIDER P, 1977, EUR J CLIN INVEST, V7, P121, DOI 10.1111/j.1365-2362.1977.tb01583.x; Schrauzer GN, 2000, J NUTR, V130, P1653, DOI 10.1093/jn/130.7.1653; Schwertner C, 2016, INT J PAEDIATR DENT, V26, P134, DOI 10.1111/ipd.12168; SHAH SN, 1990, ANN NY ACAD SCI, V587, P313, DOI 10.1111/j.1749-6632.1990.tb00169.x; SHAH SN, 1989, NUTR RES, V9, P709, DOI 10.1016/S0271-5317(89)80014-4; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; SINET PM, 1982, ANN NY ACAD SCI, V396, P83, DOI 10.1111/j.1749-6632.1982.tb26845.x; SINET PM, 1984, ACTA PAEDIATR SCAND, V73, P275, DOI 10.1111/j.1651-2227.1984.tb09945.x; Siqueira WL, 2004, ORAL SURG ORAL MED O, V98, P76, DOI 10.1016/j.tripleo.2004.04.007; Marin AS, 2011, NUTR HOSP, V26, P1059, DOI [10.3305/nh.2011.26.5.5233, 10.1590/S0212-16112011000500021]; Solomon B D, 2015, J Neonatal Perinatal Med, V8, P73, DOI 10.3233/NPM-15915031; Song C, 2015, MOL MED REP, V12, P8209, DOI 10.3892/mmr.2015.4439; Soto-Quintana Marisol, 2003, Invest. clín, V44, P51; STABILE A, 1991, CLIN IMMUNOL IMMUNOP, V58, P207, DOI 10.1016/0090-1229(91)90137-Y; Stagi S, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/896758; Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5; STORM W, 1990, J MENT DEFIC RES, V34, P283; Sukla KK, 2015, HUM REPROD, V30, P1982, DOI 10.1093/humrep/dev126; SUSTROVA M, 1994, J ENDOCRINOL INVEST, V17, P385, DOI 10.1007/BF03347724; Sustrova M, 2008, RHEUMATOLOGIA, V22, P87; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7; Teksen F, 1998, BIOL TRACE ELEM RES, V63, P123, DOI 10.1007/BF02778871; Tenenbaum A, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/813541; Toledo C, 1997, ARCH PEDIATRIE, V4, P116, DOI 10.1016/S0929-693X(97)86151-9; Torsdottir G, 2001, PHARMACOL TOXICOL, V89, P320, DOI 10.1034/j.1600-0773.2001.d01-168.x; Tu J- B, LANCET, V286, P715; TUKIAINEN E, 1980, ACTA PHARMACOL TOX, V47, P365; van Gameren-Oosterom HBM, 2012, PRENATAL DIAG, V32, P1035, DOI 10.1002/pd.3951; van Trotsenburg ASP, 2005, J CLIN ENDOCR METAB, V90, P3304, DOI 10.1210/jc.2005-0130; Varga Petra, 2008, Orvosi Hetilap, V149, P1203, DOI 10.1556/OH.2008.28327; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wachowicz B, 1974, Endokrynol Pol, V25, P9; WADA L, 1986, J NUTR, V116, P1045, DOI 10.1093/jn/116.6.1045; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P347; Wells G, 2000, NEWCASTLE OTTAWA SCA; WESTERMARCK T, 1993, J TRACE ELEM ELECT H, V7, P125; Whittle N, 2007, PEDIATRICS, V120, pE1465, DOI 10.1542/peds.2006-3448; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yamato F, 2009, PEDIATR INT, V51, P474, DOI 10.1111/j.1442-200X.2008.02761.x; Yenigun Ayse, 2004, Downs Syndr Res Pract, V9, P53, DOI 10.3104/reports.292; Zubillaga P, 2006, EUR J CLIN NUTR, V60, P605, DOI 10.1038/sj.ejcn.1602357	183	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175437	10.1371/journal.pone.0175437	http://dx.doi.org/10.1371/journal.pone.0175437			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422987	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600033
J	Larkin, P; O'Connor, D				Larkin, Paul; O'Connor, Donna			Talent identification and recruitment in youth soccer: Recruiter's perceptions of the key attributes for player recruitment	PLOS ONE			English	Article							RELATIVE AGE; SKILL DEVELOPMENT; RUGBY LEAGUE; SELECTION; FOOTBALL; ELITE; COACHES; LEVEL	Using the modified Delphi method, we aimed to understand the attributes youth coaches and recruiters perceive as important when identifying skilled youth performance at the entry level of representative soccer in Australia (i. e., Under 13 years). Furthermore, we also aimed to describe the current methods youth coaches and recruiters use to assess and identify these attributes in youth players. Australian regional youth technical directors and coaches (n = 20) completed a three stage process, including an initial interview and two subsequent questionnaires, whereby attributes and qualities associated with talent identification were rated and justified according to the importance for youth player performance and talent identification. Results indicate a hierarchy of attributes recruiters perceive as important for Under 13 soccer performance, including technical (i. e., first touch, striking the ball, one-versus- one ability, and technical ability under pressure), tactical (i. e., decision-making ability) and psychological attributes (i. e., coachability and positive attitude). In addition, the findings indicated attributes and qualities not emphasised within the talent identification process including, physiological, anthropometrical, sociological and several psychological attributes. It is suggested talent recruiters apply a holistic multidisciplinary approach to talent identification, with the current findings potentially providing initial evidence to suggest recruiters do consider numerous attributes when selecting and identifying youth players.	[Larkin, Paul; O'Connor, Donna] Univ Sydney, Sydney Sch Educ & Social Work, Sydney, NSW, Australia	University of Sydney	Larkin, P (corresponding author), Univ Sydney, Sydney Sch Educ & Social Work, Sydney, NSW, Australia.	paul.larkin@vu.edu.au	Larkin, Paul/AAV-2213-2020	O'Connor, Donna/0000-0003-1825-2727; LARKIN, PAUL/0000-0002-0493-4148	Australian Research Council [LP120100243]; Football Federation Australia	Australian Research Council(Australian Research Council); Football Federation Australia	The research project was funded by an Australian Research Council Linkage Grant, with Football Federation Australia the industry partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Australian Research Council (LP120100243) http://www.arc.gov.au/.	Abbott Angela, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P61; Araya J, 2013, U SYDNEY PAPERS HUMA, V2, P17; Cobley S, 2014, INT J SPORTS SCI COA, V9, P335, DOI 10.1260/1747-9541.9.2.335; Cobley S, 2008, J SPORT SCI, V26, P1531, DOI 10.1080/02640410802298250; Silva MJCE, 2010, INT J SPORTS MED, V31, P790, DOI 10.1055/s-0030-1263139; Creswell J. W., 2007, QUALITATIVE INQUIRY; Cupples B, 2011, INT J SPORTS SCI COA, V6, P125, DOI 10.1260/1747-9541.6.1.125; Cushion C, 2012, J SPORT SCI, V30, P1631, DOI 10.1080/02640414.2012.721930; Favor JK, 2011, INT J SPORTS SCI COA, V6, P301, DOI 10.1260/1747-9541.6.2.301; Figueiredo AJ, 2009, J SPORT SCI, V27, P883, DOI 10.1080/02640410902946469; Gucciardi DF, 2008, J APPL SPORT PSYCHOL, V20, P261, DOI 10.1080/10413200801998556; Gullich A, 2014, EUR J SPORT SCI, V14, P530, DOI 10.1080/17461391.2013.858371; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Hoare DG, 2000, J SPORT SCI, V18, P751; Huijgen BCH, 2009, INT J SPORTS MED, V30, P585, DOI 10.1055/s-0029-1202354; Lago-Penas C, 2010, J HUM KINET, V25, P93, DOI 10.2478/v10078-010-0036-z; Malina RM, 2007, BRIT J SPORT MED, V41, P290, DOI 10.1136/bjsm.2006.031294; Gil SM, 2014, J SPORT SCI, V32, P1931, DOI 10.1080/02640414.2014.964290; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; MILLER DC, 1972, INT J COMP SOCIOL, V13, P201, DOI 10.1177/002071527201300303; Mills A, 2012, J SPORT SCI, V30, P1593, DOI 10.1080/02640414.2012.710753; Morris G, 2017, J SPORT SCI, V35, P852, DOI 10.1080/02640414.2016.1194524; O'Connor D, 2016, EUR J SPORT SCI, V16, P837, DOI 10.1080/17461391.2016.1151945; Partington M, 2013, SCAND J MED SCI SPOR, V23, P374, DOI 10.1111/j.1600-0838.2011.01383.x; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Rosch D, 2000, AM J SPORT MED, V28, pS29, DOI 10.1177/28.suppl_5.s-29; Ross S, 2014, RES Q EXERCISE SPORT, V85, P316, DOI 10.1080/02701367.2014.930087; Solomon GB, 2008, INT J SPORTS SCI COA, V3, P251, DOI 10.1260/174795408785100725; Suppiah HT, 2015, BRIT J SPORT MED, V49, P878, DOI 10.1136/bjsports-2015-094648; Thomas C, 2009, MEAS PHYS EDUC EXERC, V13, P108, DOI 10.1080/10913670902812770; Toering TT, 2009, J SPORT SCI, V27, P1509, DOI 10.1080/02640410903369919; Unnithan V, 2012, J SPORT SCI, V30, P1719, DOI 10.1080/02640414.2012.731515; Vaeyens R, 2006, BRIT J SPORT MED, V40, P928, DOI 10.1136/bjsm.2006.029652; Van Yperen NW, 2009, SPORT PSYCHOL, V23, P317, DOI 10.1123/tsp.23.3.317; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Ward P, 2013, J COGN ENG DECIS MAK, V7, P231, DOI 10.1177/1555343412461254; Williams AM, 1998, SPORTS EXERC INJURY, V4, P159; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Wiseman AC, 2014, INT J SPORTS SCI COA, V9, P447, DOI 10.1260/1747-9541.9.3.447; Ziglio E., 1996, GAZING ORACLE DELPHI, pp.3	40	57	58	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175716	10.1371/journal.pone.0175716	http://dx.doi.org/10.1371/journal.pone.0175716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KH	28419175	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200036
J	Wang, ZZ; Han, Q; Zi, Q; Lv, S; Qiu, DW; Zeng, HM				Wang, Zhenzhen; Han, Qiang; Zi, Qian; Lv, Shun; Qiu, Dewen; Zeng, Hongmei			Enhanced disease resistance and drought tolerance in transgenic rice plants overexpressing protein elicitors from Magnaporthe oryzae	PLOS ONE			English	Article							RAY DIFFRACTION ANALYSIS; ANTIFUNGAL AFP PROTEIN; ABSCISIC-ACID; CONSTITUTIVE EXPRESSION; BLAST FUNGUS; STRESS TOLERANCE; GENE; ARABIDOPSIS; DEFENSE; TOBACCO	Exogenous application of the protein elicitors MoHrip1 and MoHrip2, which were isolated from the pathogenic fungus Magnaporthe oryzae (M. oryzae), was previously shown to induce a hypersensitive response in tobacco and to enhance resistance to rice blast. In this work, we successfully transformed rice with the mohrip1 and mohrip2 genes separately. The MoHrip1 and MoHrip2 transgenic rice plants displayed higher resistance to rice blast and stronger tolerance to drought stress than wild-type (WT) rice and the vector-control pCXUN rice. The expression of salicylic acid (SA)-and abscisic acid (ABA)-related genes was also increased, suggesting that these two elicitors may trigger SA signaling to protect the rice from damage during pathogen infection and regulate the ABA content to increase drought tolerance in transgenic rice. Trypan blue staining indicated that expressing MoHrip1 and MoHrip2 in rice plants inhibited hyphal growth of the rice blast fungus. Relative water content (RWC), water usage efficiency (WUE) and water loss rate (WLR) were measured to confirm the high capacity for water retention in transgenic rice. The MoHrip1 and MoHrip2 transgenic rice also exhibited enhanced agronomic traits such as increased plant height and tiller number.	[Wang, Zhenzhen; Han, Qiang; Zi, Qian; Lv, Shun; Qiu, Dewen; Zeng, Hongmei] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zeng, HM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China.	zenghongmei@caas.cn			National Hi-Tech Research and Development Program of China ("863" Projects) [2012M101504, 2012AA101504]	National Hi-Tech Research and Development Program of China ("863" Projects)	We would like to thank Professor Songbiao Chen in Fujian Academy of Agricultural Sciences for cultivating transgenic rice. This work was supported by grants from the National Hi-Tech Research and Development Program of China ("863" Projects, grant nos. 2012M101504).; We would like to thank Professor Songbiao Chen of the Fujian Academy of Agricultural Sciences for cultivating transgenic rice. This work was supported by grants from the National Hi Tech Research and Development Program of China ("863" Projects, Grant No. 2012AA101504)	Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Chen MJ, 2014, PLANT CELL REP, V33, P1865, DOI 10.1007/s00299-014-1663-y; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Coca M, 2004, PLANT MOL BIOL, V54, P245, DOI 10.1023/B:PLAN.0000028791.34706.80; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Ger MJ, 2002, MOL PLANT MICROBE IN, V15, P764, DOI 10.1094/MPMI.2002.15.8.764; Hahn MG, 1996, ANNU REV PHYTOPATHOL, V34, P387, DOI 10.1146/annurev.phyto.34.1.387; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Li XL, 2013, ELECTRON J QUAL THEO; Liang J, 1997, PHOTOSYNTH RES, V51, P149, DOI 10.1023/A:1005797410190; Liu MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01103; Liu MJ, 2013, ACTA CRYSTALLOGR F, V69, P463, DOI 10.1107/S1744309113007094; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Lopez-Carbonell M, 2005, PLANT PHYSIOL BIOCH, V43, P407, DOI 10.1016/j.plaphy.2005.02.006; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Moreno AB, 2005, MOL PLANT MICROBE IN, V18, P960, DOI 10.1094/MPMI-18-0960; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Peng XC, 2015, TRANSGENIC RES, V24, P135, DOI 10.1007/s11248-014-9824-x; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Qiu DW, 2009, PLANT CELL REP, V28, P925, DOI 10.1007/s00299-009-0698-y; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; SCHMUGGE TJ, 1980, WATER RESOUR RES, V16, P961, DOI 10.1029/WR016i006p00961; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Takakura Y, 2008, MOL PLANT PATHOL, V9, P525, DOI 10.1111/J.1364-3703.2008.00477.X; TEMPLETON MD, 1988, PLANT CELL ENVIRON, V11, P395, DOI 10.1111/j.1365-3040.1988.tb01363.x; Teng KQ, 2014, ACTA PHYSIOL PLANT, V36, P2219, DOI 10.1007/s11738-014-1599-4; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Zhang CZ, 2013, ACTA CRYSTALLOGR F, V69, P460, DOI 10.1107/S1744309113006490; Zhang LX, 2011, J NANOMATER, V2011, DOI 10.1155/2011/467170; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	48	17	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175734	10.1371/journal.pone.0175734	http://dx.doi.org/10.1371/journal.pone.0175734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	28419172	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875200041
J	Sharma, A; Vatapalli, R; Abdelfatah, E; McMahon, KW; Kerner, Z; Guzzetta, AA; Singh, J; Zahnow, C; Baylin, SB; Yerram, S; Hu, Y; Azad, N; Ahuja, N				Sharma, Anup; Vatapalli, Rajita; Abdelfatah, Eihab; McMahon, K. Wyatt; Kerner, Zachary; Guzzetta, Angela A.; Singh, Jasvinder; Zahnow, Cynthia; Baylin, Stephen B.; Yerram, Sashidhar; Hu, Yue; Azad, Nilofer; Ahuja, Nita			Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells	PLOS ONE			English	Article							EPIGENETIC THERAPY; SOLID TUMORS; MYELODYSPLASTIC SYNDROME; DIFFERENTIAL EXPRESSION; MICROARRAY DATA; COLON-CANCER; MULTICENTER; AZACITIDINE; COMBINATION; DECITABINE	Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. In the metastatic setting, the majority of patients respond to initial therapies but eventually develop resistance and progress. In this study, we test the hypothesis that priming with epigenetic therapy sensitizes CRC cell lines, which were previously resistant to subsequent chemotherapeutic agents. When multiple CRC cell lines are first exposed to 500 nM of the DNA demethylating agent, 5-aza-cytidine (AZA) in-vitro, and the cells then established as in-vivo xenografts in untreated NOD-SCID mice; there is an enhanced response to cytotoxic chemotherapy with agents commonly used in CRC treatment. For irinotecan (IRI), growth diminished by 16-62 fold as assessed, by both proliferation (IC50) and anchorage independent cell growth soft agar assays. Treatment of resistant HCT116 cell line along with in-vivo, for CRC line xenografts, AZA plus IRI again exhibits this synergistic response with significant improvement in survival and tumor regression in the mice. Genome-wide expression correlates changes in pathways for cell adhesion and DNA repair with the above responses. A Phase 1/2 clinical trial testing this concept is already underway testing the clinical efficacy of this concept in IRI resistant, metastatic CRC (NCT01896856).	[Sharma, Anup; Vatapalli, Rajita; Abdelfatah, Eihab; McMahon, K. Wyatt; Kerner, Zachary; Guzzetta, Angela A.; Singh, Jasvinder; Yerram, Sashidhar; Hu, Yue; Azad, Nilofer; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Zahnow, Cynthia; Baylin, Stephen B.; Azad, Nilofer; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hu, Yue] Third Mil Med Univ, Daping Hosp, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Army Medical University; Johns Hopkins University	Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.	nahuja1@jhmi.edu	SINGH, JASVINDER/S-8678-2019; Vatapalli, Rajita/AAN-1397-2021	Kerner, Zachary/0000-0002-5623-0089	National Cancer Institute [K23 CM 27141]; Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; T32 grant	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; T32 grant	We gratefully acknowledge T32 grant funding mechanism, to support EA for this study. A portion of this work was also funded by K23 CM 27141 from National Cancer Institute. Research funding was provided by Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team. Stand Up to Cancer is a program of the Entertainment Industry Foundation, administered by AACR.	Abdelfatah E, 2016, THER ADV GASTROENTER, V9, P560, DOI 10.1177/1756283X16644247; Ahuja N, 2016, ANNU REV MED, V67, P73, DOI 10.1146/annurev-med-111314-035900; Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Azad Nilofer Saba E-K AB, 2013, AMERICAN SOCIETY OF; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Crea F, 2009, MOL CANCER THER, V8, P1964, DOI 10.1158/1535-7163.MCT-09-0027; Flis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092305; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hong X, 2010, J SURG ONCOL, V101, P564, DOI 10.1002/jso.21538; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Issa JPJ, 2015, LANCET ONCOL, V16, P1099, DOI 10.1016/S1470-2045(15)00038-8; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Labianca R, 2010, CRIT REV ONCOL HEMAT, V74, P106, DOI 10.1016/j.critrevonc.2010.01.010; Lenz HJ, 2015, CANCER TREAT REV, V41, P777, DOI 10.1016/j.ctrv.2015.06.001; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Liu T, 2016, ONCOTARGET, DOI 10.18632/oncotarget.1346527888803; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Qin L, 2014, MOL PHARMACOL, V86, P561, DOI 10.1124/mol.114.092544; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sundermeyer Mark L, 2005, Clin Colorectal Cancer, V5, P108, DOI 10.3816/CCC.2005.n.022; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Valdespino V, 2015, CANCER MANAG RES, V7, P241, DOI 10.2147/CMAR.S70358; Valerie Lee JW, 2016, P 107 ANN M AM ASS C; Vishnubalaji R, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0355-9; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337	40	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176139	10.1371/journal.pone.0176139	http://dx.doi.org/10.1371/journal.pone.0176139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445481	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200036
J	Eguchi, K; Honig, LS; Lee, JH; Hoshide, S; Kario, K				Eguchi, Kazuo; Honig, Lawrence S.; Lee, Joseph H.; Hoshide, Satoshi; kario, Kazuomi			Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; FLOW-MEDIATED VASODILATION; AUGMENTATION INDEX; DISEASE; PRESSURE; BLOOD; HEART; ATHEROSCLEROSIS; REPRODUCIBILITY; DYSFUNCTION	Introduction Short telomere length has been suggested to be associated with atherosclerotic changes in Western populations. We examined the relationships between leukocyte telomere length and cardiovascular and renal function in a Japanese cohort. Participants and methods We enrolled 770 subjects who each had at least one cardiovascular risk factor. The mean age was 59.5 +/- 12.2 years; mean BMI was 25.1 +/- 4.6 kg/m(2). We measured leukocyte telomere length (LTL) by quantitative PCR (T/S ratio), and measured other biomarkers from blood and urine samples. In addition, we assessed surrogate markers of arterial stiffness, cardiovascular organ damage and kidney function, including flow-mediated vasodilation (FMD), pulse wave velocity (PWV), carotid artery augmentation index (CAAI), and urinary albumin creatinine ratio (UACR) and eGFR. Results Leukocyte telomere length (T/S ratio) was inversely associated with age (r = -0.194, P<0.001), and was lower in men (1.13 +/- 0.29%) than in women (1.20 +/- 0.31%, P = 0.002). T/S ratio was positively associated with BMI in women (r = 0.11, P = 0.047), but not in men. LTL did not show a significant relationship to cardiovascular surrogate markers, including arterial stiffness, FMD, and PWV, but did show some relationship to CAAI, which was inversely associated with T/S ratio only in men (r = -0.159, P = 0.015). LTL did show a significant positive association with renal function measured by eGFR (r = 0.16, P<0.001) both in men and women. Conclusions In this Japanese sample of persons with increased cardiovascular risk, telomere length showed a relationship of longer telomere length to better renal function, but did not overall show convincing association with cardiovascular measures of arterial stiffness and target organ damage.	[Eguchi, Kazuo; Hoshide, Satoshi; kario, Kazuomi] Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Honig, Lawrence S.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Lee, Joseph H.] Columbia Univ, Sergievsky Ctr, Taub Inst, New York, NY USA	Jichi Medical University; Columbia University; Columbia University	Eguchi, K (corresponding author), Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	ke112@jichi.ac.jp	Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821	JSPS KAKENHI [JP 22590793]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 22590793, Grant-in-Aid for Scientific Research (C) from 2010 to 2013.; This work was supported by JSPS KAKENHI Grant Number JP 22590793, Grant-in-Aid for Scientific Research (C) from 2010 to 2013. The authors thank the subjects for their participation in this study. The authors also thank Dr. Yukihiro Hojo, Ms. Rumiko Ochiai, Ms. Takako Takagi, and Ms. Junko Tsujimura for the DNA isolation, and Ms. Kimiyo Saito, Ms. Mayumi Yahata, Ms. Mitsuko Sato, and Ms. Yasuko Ohtsuki for the laboratory examinations and data management of this study.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bansal N, 2012, AM J NEPHROL, V36, P405, DOI 10.1159/000343495; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Butt HZ, 2010, EUR J VASC ENDOVASC, V40, P17, DOI 10.1016/j.ejvs.2010.04.012; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Eguchi K, 2016, ATHEROSCLEROSIS, V246, P338, DOI 10.1016/j.atherosclerosis.2016.01.034; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Kabutoya T, 2012, J AM SOC HYPERTENS, V6, P109, DOI 10.1016/j.jash.2011.11.005; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzawa Yuji., 2005, J JPN SOC INT MED, V94, P188, DOI [10.5551/jat.12.301, DOI 10.5551/JAT.12.301]; Morimoto Y, 2014, INT J OBESITY, V38, P1416, DOI 10.1038/ijo.2014.25; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Nakashima H, 2004, HYPERTENS RES, V27, P319, DOI 10.1291/hypres.27.319; Nezu T, 2015, EBIOMEDICINE, V2, P960, DOI 10.1016/j.ebiom.2015.05.025; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Raschenberger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11887; Raymond AR, 2015, AM J HYPERTENS, V28, P623, DOI 10.1093/ajh/hpu212; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tabara Y, 2014, HYPERTENSION, V64, P1212, DOI 10.1161/HYPERTENSIONAHA.114.04277; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Tomiyama H, 2008, HYPERTENS RES, V31, P2019, DOI 10.1291/hypres.31.2019; Wong LSM, 2009, CLIN RES CARDIOL, V98, P629, DOI 10.1007/s00392-009-0048-7; Wu AH, 2005, CARCINOGENESIS, V26, P976, DOI 10.1093/carcin/bgi028; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yang HC, 2014, KIDNEY INT SUPPL, V4, P75, DOI 10.1038/kisup.2014.14; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Zhang WG, 2014, HEART LUNG CIRC, V23, P883, DOI 10.1016/j.hlc.2013.12.016; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176138	10.1371/journal.pone.0176138	http://dx.doi.org/10.1371/journal.pone.0176138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441430	gold, Green Submitted, Green Published			2022-12-27	WOS:000400308800028
J	Minocha, S; Boll, W; Noll, M				Minocha, Shilpi; Boll, Werner; Noll, Markus			Crucial roles of Pox neuro in the developing ellipsoid body and antennal lobes of the Drosophila brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY LOCAL INTERNEURONS; MALE COURTSHIP BEHAVIOR; CENTRAL COMPLEX; POSTEMBRYONIC NEUROBLASTS; SCHISTOCERCA-GREGARIA; TRANSCRIPTION FACTORS; WIRING SPECIFICITY; ORIENTATION MEMORY; GENETIC-ANALYSIS	The paired box gene Pox neuro (Poxn) is expressed in two bilaterally symmetric neuronal clusters of the developing adult Drosophila brain, a protocerebral dorsal cluster (DC) and a deutocerebral ventral cluster (VC). We show that all cells that express Poxn in the developing brain are postmitotic neurons. During embryogenesis, the DC and VC consist of only 20 and 12 neurons that express Poxn, designated embryonic Poxn-neurons. The number of Poxn-neurons increases only during the third larval instar, when the DC and VC increase dramatically to about 242 and 109 Poxn-neurons, respectively, virtually all of which survive to the adult stage, while no new Poxn-neurons are added during metamorphosis. Although the vast majority of Poxn-neurons express Poxn only during third instar, about half of them are born by the end of embryogenesis, as demonstrated by the absence of BrdU incorporation during larval stages. At late third instar, embryonic Poxn-neurons, which begin to express Poxn during embryogenesis, can be easily distinguished from embryonic-born and larval-born Poxn-neurons, which begin to express Poxn only during third instar, (i) by the absence of Pros, (ii) their overt differentiation of axons and neurites, and (iii) the strikingly larger diameter of their cell bodies still apparent in the adult brain. The embryonic Poxn-neurons are primary neurons that lay out the pioneering tracts for the secondary Poxn-neurons, which differentiate projections and axons that follow those of the primary neurons during metamorphosis. The DC and the VC participate only in two neuropils of the adult brain. The DC forms most, if not all, of the neurons that connect the bulb (lateral triangle) with the ellipsoid body, a prominent neuropil of the central complex, while the VC forms most of the ventral projection neurons of the antennal lobe, which connect it ipsilaterally to the lateral horn, bypassing the mushroom bodies. In addition, Poxn-neurons of the VC are ventral local interneurons of the antennal lobe. In the absence of Poxn protein in the developing brain, embryonic Poxn-neurons stall their projections and cannot find their proper target neuropils, the bulb and ellipsoid body in the case of the DC, or the antennal lobe and lateral horn in the case of the VC, whereby the absence of the ellipsoid body neuropil is particularly striking. Poxn is thus crucial for pathfinding both in the DC and VC. Additional implications of our results are discussed.	[Minocha, Shilpi; Boll, Werner; Noll, Markus] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Minocha, Shilpi] Univ Lausanne, Ctr Integrat Genom, Genopode, Lausanne, Switzerland	University of Zurich; University of Lausanne	Noll, M (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	markus.noll@imis.uzh.ch		Minocha, Shilpi/0000-0001-8229-1443	Swiss National Science Foundation [3100A0-105823]; Kanton ZuErich, Switzerlad	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton ZuErich, Switzerlad	This work was funded by Swiss National Science Foundation grant 3100A0-105823 (to MN) and by the Kanton ZuErich, Switzerlad.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bearer EL, 2003, CURR PROTOC MOL BIOL, V14, P1; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; Carmona R, 2007, J MICROSC-OXFORD, V225, P96, DOI 10.1111/j.1365-2818.2007.01719.x; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Colonques J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019342; Consoulas C, 2000, BRAIN RES BULL, V53, P571, DOI 10.1016/S0361-9230(00)00391-9; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Das A, 2013, DEV BIOL, V373, P322, DOI 10.1016/j.ydbio.2012.11.003; Das Abhijit, 2011, Neural Syst Circuits, V1, P4, DOI 10.1186/2042-1001-1-4; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484; Eliceiri KW, 2005, PHOTOCHEM PHOTOBIOL, V81, P1116, DOI 10.1562/2004-11-22-IR-377; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALTER DA, 1995, DEVELOPMENT, V121, P317; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438; Hofbauer A, 1991, THESIS; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; Homberg U., 1987, P347; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Jager R.F., 1987, Drosophila Information Service, P162; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jiang YR, 2015, DEV BIOL, V397, P162, DOI 10.1016/j.ydbio.2014.10.013; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kuntz S, 2012, LEARN MEMORY, V19, P337, DOI 10.1101/lm.026369.112; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Li L, 2000, GENE DEV, V14, P147; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Lovick JK, 2013, DEV BIOL, V384, P228, DOI 10.1016/j.ydbio.2013.07.008; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Martin J-R, 2001, POWER LAW DISTRIBUTI; Martin-Pena A, 2014, EUR J NEUROSCI, V39, P1586, DOI 10.1111/ejn.12537; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, SCI STKE, P16, DOI DOI 10.1126/28822202004P16; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Nassif C, 1998, J COMP NEUROL, V402, P10; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006; Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376; Power ME, 1943, J MORPHOL, V72, P517, DOI 10.1002/jmor.1050720306; PROKOP A, 1991, DEVELOPMENT, V111, P79; Python F, 2002, J COMP NEUROL, V453, P157, DOI 10.1002/cne.10383; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Renn SCP, 1999, J NEUROBIOL, V41, P189; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Spindler SR, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-16; Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Strausfeld NJ, 1999, PROG BRAIN RES, V123, P273, DOI 10.1016/S0079-6123(08)62863-0; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thran J, 2013, CURR BIOL, V23, P1756, DOI 10.1016/j.cub.2013.07.034; Tissot M, 2000, PROG NEUROBIOL, V62, P89, DOI 10.1016/S0301-0082(99)00069-6; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Truman JW, 1996, DEV NEUROSCI-BASEL, V18, P87, DOI 10.1159/000111398; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Urbach R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-23; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WILLIAMS JLD, 1975, J ZOOL, V176, P67; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wong DC, 2013, DEV BIOL, V384, P258, DOI 10.1016/j.ydbio.2013.07.009; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yang JS, 2013, J COMP NEUROL, V521, P2645, DOI 10.1002/cne.23339; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884; YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Zhou BH, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-39; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	116	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176002	10.1371/journal.pone.0176002	http://dx.doi.org/10.1371/journal.pone.0176002			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441464	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800016
J	Gehring, KB; Heufelder, K; Depner, H; Kersting, I; Sigrist, SJ; Eisenhardt, D				Gehring, Katrin B.; Heufelder, Karin; Depner, Harald; Kersting, Isabella; Sigrist, Stephan J.; Eisenhardt, Dorothea			Age-associated increase of the active zone protein Bruchpilot within the honeybee mushroom body	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; INSECT BRAIN; IDENTIFIED SYNAPSES; JUVENILE-HORMONE; BEE BRAIN; BODIES; DROSOPHILA; PLASTICITY; EXPERIENCE	In honeybees, age-associated structural modifications can be observed in the mushroom bodies. Prominent examples are the synaptic complexes (microglomeruli, MG) in the mushroom body calyces, which were shown to alter their size and density with age. It is not known whether the amount of intracellular synaptic proteins in the MG is altered as well. The presynaptic protein Bruchpilot (BRP) is localized at active zones and is involved in regulating the probability of neurotransmitter release in the fruit fly, Drosophila melanogaster. Here, we explored the localization of the honeybee BRP (Apis mellifera BRP, AmBRP) in the bee brain and examined age-related changes in the AmBRP abundance in the central bee brain and in microglomeruli of the mushroom body calyces. We report predominant AmBRP localization near the membrane of presynaptic boutons within the mushroom body MG. The relative amount of AmBRP was increased in the central brain of two-week old bees whereas the amount of Synapsin, another presynaptic protein involved in the regulation of neurotransmitter release, shows an increase during the first two weeks followed by a decrease. In addition, we demonstrate an age-associated modulation of AmBRP located near the membrane of presynaptic boutons within MG located in mushroom body calyces where sensory input is conveyed to mushroom body intrinsic neurons. We discuss that the observed age-associated AmBRP modulation might be related to maturation processes or to homeostatic mechanisms that might help to maintain synaptic functionality in old animals.	[Gehring, Katrin B.; Heufelder, Karin; Kersting, Isabella; Eisenhardt, Dorothea] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Depner, Harald; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Takustr 6, Berlin, Germany	Free University of Berlin; Free University of Berlin	Eisenhardt, D (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	dorothea.eisenhardt@fu-berlin.de			German Federal Ministry of Education and Research (BMBF) under Grant within the Bernstein Focus Neuronal Basis of Learning [01GQ0941]; Deutsche Forschungsgemeinschaft (DFG), Biogenic amines in insects: coordination of physiological processes and behavior [El 512/1, El 512/2-1, FOR 1363]	German Federal Ministry of Education and Research (BMBF) under Grant within the Bernstein Focus Neuronal Basis of Learning; Deutsche Forschungsgemeinschaft (DFG), Biogenic amines in insects: coordination of physiological processes and behavior	This study was supported by the German Federal Ministry of Education and Research (BMBF) under Grant No. 01GQ0941 awarded to D. E. within the Bernstein Focus Neuronal Basis of Learning and by the Deutsche Forschungsgemeinschaft (DFG) under Grant No. El 512/1 awarded to D.E. and Grant No. El 512/2-1 awarded to D.E. as part of the joint project FOR 1363 Biogenic amines in insects: coordination of physiological processes and behavior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christine Quentin, Institute for Genetics, Freie Universitat Berlin, and Thorsten Mielke, Max Planck Institute of Molecular Genetics Berlin, for their support and ongoing fruitful discussion on the analysis of AmBRP localization in the honeybee brain. This study was supported by the German Federal Ministry of Education and Research (BMBF) under Grant No. 01GQ0941 awarded to DE within the Bernstein Focus Neuronal Basis of Learning and by the Deutsche Forschungsgemeinschaft (DFG) under Grant No. EI 512/1 awarded to DE and Grant No. EI 512/2-1 awarded to DE as part of the joint project FOR 1363 Biogenic amines in insects: coordination of physiological processes and behavior.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frambach I, 2004, J COMP NEUROL, V475, P303, DOI 10.1002/cne.20165; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Ganeshina O, 2006, J COMP NEUROL, V497, P876, DOI 10.1002/cne.21033; GASCUEL J, 1991, J NEUROBIOL, V22, P795, DOI 10.1002/neu.480220802; Gehring KB, 2016, J COMP NEUROL, V524, P1165, DOI 10.1002/cne.23894; Gray DT, 2015, NEUROSCIENCE, V309, P17, DOI 10.1016/j.neuroscience.2015.08.001; Grillo F. W., 2015, J CHEM NEUROANAT; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Gupta VK, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002563; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Huang JK, 2013, NEUROBIOL DIS, V51, P161, DOI 10.1016/j.nbd.2012.11.006; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Knapek S, 2011, J NEUROSCI, V31, P3453, DOI 10.1523/JNEUROSCI.2585-10.2011; Krofczik S, 2008, DEV NEUROBIOL, V68, P1007, DOI 10.1002/dneu.20640; Leitinger G, 2012, J COMP NEUROL, V520, P384, DOI 10.1002/cne.22744; MASSON C, 1984, J INSECT PHYSIOL, V30, P7, DOI 10.1016/0022-1910(84)90104-5; Matkovic T, 2013, J CELL BIOL, V202, P667, DOI 10.1083/jcb.201301072; Melom JE, 2013, J NEUROSCI, V33, P17253, DOI 10.1523/JNEUROSCI.3334-13.2013; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Mussig L, 2010, J NEUROSCI, V30, P7817, DOI 10.1523/JNEUROSCI.5543-09.2010; Pasch E, 2011, J COMP NEUROL, V519, P3700, DOI 10.1002/cne.22683; Peled ES, 2014, CURR BIOL, V24, P484, DOI 10.1016/j.cub.2014.01.022; Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Terman A, 2005, BIOGERONTOLOGY, V6, P205, DOI 10.1007/s10522-005-7956-3; TRUJILLOCENOZ O, 1962, J ULTRA MOL STRUCT R, V7, P389, DOI 10.1016/S0022-5320(62)90035-7; Ullrich A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004407; van der Zee EA, 2015, NEUROSCI BIOBEHAV R, V50, P77, DOI 10.1016/j.neubiorev.2014.06.012; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wagner N, 2015, J COMP NEUROL, V523, P2457, DOI 10.1002/cne.23798; Wang SP, 2005, J INSECT PHYSIOL, V51, P1244, DOI 10.1016/j.jinsphys.2005.07.003; Winston ML, 1987, APIS MELLIFERA; WITHERS GS, 1995, J NEUROBIOL, V26, P130, DOI 10.1002/neu.480260111; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	57	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175894	10.1371/journal.pone.0175894	http://dx.doi.org/10.1371/journal.pone.0175894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437454	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600019
J	Yamori, Y; Sagara, M; Arai, Y; Kobayashi, H; Kishimoto, K; Matsuno, I; Mori, H; Mori, M				Yamori, Yukio; Sagara, Miki; Arai, Yoshimi; Kobayashi, Hitomi; Kishimoto, Kazumi; Matsuno, Ikuko; Mori, Hideki; Mori, Mari			Soy and fish as features of the Japanese diet and cardiovascular disease risks	PLOS ONE			English	Article							MIDDLE-AGED SUBJECTS; BLOOD-PRESSURE; METABOLIC SYNDROME; PRODUCT KINAKO; UNITED-STATES; 24-H URINE; WOMEN; ATHEROSCLEROSIS; HOMOCYSTEINE; TAURINE	In the World Health Organization (WHO)-coordinated Cardiovascular Disease and Alimentary Comparison Study, isoflavones (I; biomarker for dietary soy) and taurine (T; biomarker for dietary fish) in 24-hour-urine (24U) were inversely related to coronary heart disease (CHD) mortality. High levels of these biomarkers are found in Japanese people, whose CHD mortality is lowest among developed countries. We analyzed the association of these biomarkers with cardiovascular disease risk in the Japanese to know their health effects within one ethnic population. First, to compare the Japanese intake of I and T with international intakes, the ratios of 24UI and 24UT to creatinine from the WHO Study were divided into quintiles for analysis. The ratio for the Japanese was the highest in the highest quintiles for both I and T, reaching 88.1%, far higher than the average ratio for the Japanese (26.3%) in the total study population. Second, 553 inhabitants of Hyogo Prefecture, Japan, aged 30 to 79 years underwent 24-U collection and blood analyses. The 24UT and 24UI were divided into tertiles and adjusted for age and sex. The highest T tertile, compared with the lowest tertile, showed significantly higher levels of high-density lipoprotein-cholesterol (HDL-C), total cholesterol, 24U sodium (Na) and potassium (K). The highest I tertile showed significantly higher folate, 24UNa and 24UK compared with the lowest tertile. The highest tertile of both T and I showed significantly higher HDL-C, folate, and 24UNa and 24UK compared with the lowest tertile. Thus, greater consumption of fish and soy were significantly associated with higher HDL-C and folate levels, possibly a contributor to Japan having the lowest CHD mortality and longest life expectancy among developed countries. As these intakes were also associated with a high intake of salt, a low-salt intake of fish and soy should be recommended for healthy life expectancy.	[Yamori, Yukio; Mori, Hideki; Mori, Mari] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan; [Yamori, Yukio; Sagara, Miki] Res Inst Prod & Dev, Lab Prevent Nutr Med, Kyoto, Japan; [Yamori, Yukio; Arai, Yoshimi; Kobayashi, Hitomi; Kishimoto, Kazumi; Matsuno, Ikuko] Hyogo Prefecture Hlth Promot Assoc, Kobe, Hyogo, Japan	Mukogawa Women's University	Yamori, Y (corresponding author), Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan.; Yamori, Y (corresponding author), Res Inst Prod & Dev, Lab Prevent Nutr Med, Kyoto, Japan.; Yamori, Y (corresponding author), Hyogo Prefecture Hlth Promot Assoc, Kobe, Hyogo, Japan.	yamori@cardiacstudy.com			JSPS KAKENHI [A20256001]; Hyogo Health Promotion Association; HPHPA	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hyogo Health Promotion Association; HPHPA	This work was supported by JSPS KAKENHI Grant Number A20256001 and by Hyogo Health Promotion Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our appreciation to all participants in the WHO-CARDIAC Study and the Hyogo Prefecture Health Promotion Association (HPHPA) for conducting the health examinations. This work was supported by JSPS KAKENHI Grant Number A20256001 and by HPHPA.	ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; Acharjee S, 2015, METABOLISM, V64, P236, DOI 10.1016/j.metabol.2014.09.005; Aiello A, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0071-2; [Anonymous], REP FOOD SELF SUFF R; Simao ANC, 2014, NUTRITION, V30, P112, DOI 10.1016/j.nut.2013.05.024; Simao ANC, 2012, BRIT J NUTR, V108, P1435, DOI 10.1017/S0007114511006921; Cui RZ, 2010, STROKE, V41, P1285, DOI 10.1161/STROKEAHA.110.578906; Davinelli S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-9; Emilio R, 2014, ADV NUTR, V5, p330S; Haynes WG, 2002, CARDIOVASC DRUG THER, V16, P391, DOI 10.1023/A:1022130217463; Hermansen K, 2001, DIABETES CARE, V24, P228, DOI 10.2337/diacare.24.2.228; Jacobson TA, 2008, AM J CLIN NUTR, V87, p1981S, DOI 10.1093/ajcn/87.6.1981S; Jenkins DJA, 2002, AM J CLIN NUTR, V76, P365, DOI 10.1093/ajcn/76.2.365; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; Matsumura Y, 2001, ASIA PAC J CLIN NUTR, V10, pS40, DOI 10.1046/j.1440-6047.2001.0100s1S40.x; McCully KS, 2015, EXPERT REV CLIN PHAR, V8, P211, DOI 10.1586/17512433.2015.1010516; Mori M, 2007, THER RES, V28, P1788; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; Naar AM, 2013, ARTERIOSCL THROM VAS, V33, P447, DOI 10.1161/ATVBAHA.112.301021; Nagata C, 2003, J NUTR, V133, P797, DOI 10.1093/jn/133.3.797; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Sagara M, 2015, ADV EXP MED BIOL, V803, P623, DOI 10.1007/978-3-319-15126-7_50; Sagara M, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/809198; Sharifi-Zahabi Elham, 2015, Clin Nutr Res, V4, P225, DOI 10.7762/cnr.2015.4.4.225; United Nations Development Programme, HUM DEV REP 2015 INT; Weber P, 2000, NUTR METAB CARDIOVAS, V10, P28; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, WORLD HLTH STAT 2016; YAMORI Y, 1984, CLIN EXP HYPERTENS A, V6, P1161, DOI 10.3109/10641968409039588; Yamori Y, 1996, ADV EXP MED BIOL, V403, P623; Yamori Y, 2008, P INT S FOOD CULT DE, P23; Yamori Yukio, 2006, Exp Clin Cardiol, V11, P94; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Yamori Y, 2015, HYPERTENS RES, V38, P219, DOI 10.1038/hr.2014.158; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Yamori Y, 2006, NUTR DIS PREV, P107; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846	38	18	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176039	10.1371/journal.pone.0176039	http://dx.doi.org/10.1371/journal.pone.0176039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430815	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100027
J	Yang, L; Mu, YP; Cui, HW; Liang, YB; Su, XL				Yang, Ling; Mu, Yongping; Cui, Hongwei; Liang, Yabing; Su, Xiulan			MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; CANCER CELLS; STEM-CELLS; GLIOBLASTOMA; INHIBITION; EXPRESSION; PATHWAY; PROLIFERATION	MicroRNAs are short, single-stranded non-coding RNA molecules that function as regulators of tumor progression in various cancers, including glioma. The present study sought to investigate the biological functions of miR-9-3p in glioma progression. The results of a microRNA microarray indicated that microRNA-9-3p (miR-9-3p, miR-9*) is down-regulated in high-grade (grades III and IV) gliomas compared with non-tumor tissues. These results were confirmed with real-time PCR. The miR-9-3p expression level was associated with age and tumor grade. Herpud1 was regulated by miR-9-3p in glioma cells and tissues and was identified as a miR-9-3p target with luciferase reporter assays. Glioma cells transfected with miR-9-3p mimics or HERPUD1-RNAi had more apoptotic cells than them in control after induced by H2O2. Our results indicated that low expression of miR-9-3p results in a high level of Herpud1, which may protect against apoptosis in glioma.	[Yang, Ling; Cui, Hongwei; Liang, Yabing; Su, Xiulan] Inner Mongolia Med Univ, Clin Med Res Ctr, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Mu, Yongping] Inner Mongolia Med Univ, Dept Clin Lab, Affiliated Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University	Su, XL (corresponding author), Inner Mongolia Med Univ, Clin Med Res Ctr, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China.	xlsu2015@163.com			Autonomous Tumor Innovation Team; Laboratory of Ministry Funding [X201005, X201002]	Autonomous Tumor Innovation Team; Laboratory of Ministry Funding	Our study was supported by Autonomous Tumor Innovation Team (No Funding Number) and Laboratory of Ministry Funding (X201005 and X201002) to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Higashi T, 2015, BRIT J CANCER, V113, P252, DOI 10.1038/bjc.2015.170; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li SZ, 2014, BIOCHEM BIOPH RES CO, V444, P6, DOI 10.1016/j.bbrc.2013.12.136; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XY, 2009, J CLIN NEUROSCI, V16, P1595, DOI 10.1016/j.jocn.2009.02.036; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Miller CR, 2007, ARCH PATHOL LAB MED, V131, P397; Morry J, 2017, REDOX BIOL, V11, P240, DOI 10.1016/j.redox.2016.12.011; Ohtsuka M, 2015, J CLIN MED, V4, P1651, DOI 10.3390/jcm4081651; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Peiris-Pages M, 2015, CELL METAB, V22, P956, DOI 10.1016/j.cmet.2015.11.008; Pogue AI, 2011, J INORG BIOCHEM, V105, P1434, DOI 10.1016/j.jinorgbio.2011.05.012; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Schumacker PT, 2015, CANCER CELL, V27, P156, DOI 10.1016/j.ccell.2015.01.007; Speranza MC, 2012, ONCOTARGET, V3, P724; Sun YN, 2015, MOL MED REP, V12, P7742, DOI 10.3892/mmr.2015.4373; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Ullrich Nicole J, 2006, Curr Oncol Rep, V8, P423, DOI 10.1007/s11912-006-0070-0; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Laar T, 2000, FEBS LETT, V469, P123, DOI 10.1016/S0014-5793(00)01253-9; Wang F, 2016, J RECEPT SIGNAL TRAN, V1, P1, DOI DOI 10.1016/J2TM0SENV.2016.09.014; Wang LN, 2015, GENE, V572, P252, DOI 10.1016/j.gene.2015.07.017; Yang W, 2014, EXP CELL RES, V326, P22, DOI 10.1016/j.yexcr.2014.05.022; Yang YP, 2012, BIOMATERIALS, V33, P1462, DOI 10.1016/j.biomaterials.2011.10.071; Zawistowski JS, 2013, MOL CELL BIOL, V33, P2260, DOI 10.1128/MCB.00269-13; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639	38	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174839	10.1371/journal.pone.0174839	http://dx.doi.org/10.1371/journal.pone.0174839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430789	Green Submitted, Green Published, gold			2022-12-27	WOS:000399876100006
J	Han, Q; Ren, S; Lang, H; Zhang, CL				Han, Qing; Ren, Shan; Lang, Hao; Zhang, Changliang			Bearing-based localization for leader-follower formation control	PLOS ONE			English	Article								The observability of the leader robot system and the leader-follower formation control are studied. First, the nonlinear observability is studied for when the leader robot observes landmarks. Second, the system is shown to be completely observable when the leader robot observes two different landmarks. When the leader robot system is observable, multi-robots can rapidly form and maintain a formation based on the bearing-only information that the follower robots observe from the leader robot. Finally, simulations confirm the effectiveness of the proposed formation control.	[Han, Qing; Ren, Shan] Honghe Univ, Engn Coll, Honghe, Yunnan, Peoples R China; [Han, Qing; Ren, Shan; Lang, Hao; Zhang, Changliang] Northwestern Polytech Univ, Sch Mech Engn, Xian, Peoples R China	Honghe University; Northwestern Polytechnical University	Han, Q (corresponding author), Honghe Univ, Engn Coll, Honghe, Yunnan, Peoples R China.; Han, Q (corresponding author), Northwestern Polytech Univ, Sch Mech Engn, Xian, Peoples R China.	hanqing@mail.nwpu.edu.cn			National Natural Science Foundation of China [51475383, 51075337]; applied basic research project of Yunnan [2013FD049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); applied basic research project of Yunnan	This work is sponsored by the National Natural Science Foundation of China (grant no. 51475383, 51075337) and the applied basic research project of Yunnan (grant no. 2013FD049).	Balch T, 1998, IEEE T ROBOTIC AUTOM, V14, P926, DOI 10.1109/70.736776; Barnes LE, 2009, IEEE T SYST MAN CY B, V39, P1434, DOI 10.1109/TSMCB.2009.2018139; Basiri M, 2010, SYST CONTROL LETT, V59, P147, DOI 10.1016/j.sysconle.2009.12.010; Betke M, 1997, IEEE T ROBOTIC AUTOM, V13, P251, DOI 10.1109/70.563647; Bishop A. N, 2011, IFAC P, V44, P4507; Bishop A. N., 2011, P 18 IFAC WORLD C MI, V44, P5991, DOI DOI 10.3182/20110828-6-IT-1002.00105; Chen J, 2010, INT J ROBOT RES, V29, P727, DOI 10.1177/0278364909104290; Gustavi T, 2008, IEEE T ROBOT, V24, P1457, DOI 10.1109/TRO.2008.2006244; Han Q, 2015, LECT NOTES ARTIF INT, V9086, P120, DOI 10.1007/978-3-319-18944-4_10; HERMANN R, 1977, IEEE T AUTOMAT CONTR, V22, P728, DOI 10.1109/TAC.1977.1101601; Acevedo JJ, 2013, J INTELL ROBOT SYST, V70, P329, DOI 10.1007/s10846-012-9716-3; Kwon JW, 2012, IEEE T ROBOT, V28, P1335, DOI 10.1109/TRO.2012.2206869; Lee KW, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P3569, DOI 10.1109/IROS.2006.281646; Lewis MA, 1997, AUTON ROBOT, V4, P387, DOI 10.1023/A:1008814708459; Li TC, 2015, IEEE SIGNAL PROC MAG, V32, P70, DOI 10.1109/MSP.2014.2330626; Mariottini GL, 2009, IEEE T ROBOT, V25, P1431, DOI 10.1109/TRO.2009.2032975; Martinelli A., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P1471; Morbidi F, 2010, AUTOMATICA, V46, P148, DOI 10.1016/j.automatica.2009.10.016; Peng Z, 2013, P 28 ANN ACM S APPL, P211; Pereira LM, 2009, LECT NOTES COMPUT SC, V5418, P1, DOI 10.1007/978-3-540-92995-6_1; Reif JH, 1999, ROBOT AUTON SYST, V27, P171, DOI 10.1016/S0921-8890(99)00004-4; Ren W, 2004, IEE P-CONTR THEOR AP, V151, P357, DOI 10.1049/ip-cta:20040484; Roumeliotis SI, 2002, IEEE T ROBOTIC AUTOM, V18, P781, DOI 10.1109/TRA.2002.803461; Saska M, 2013, J INTELL ROBOT SYST, V72, P239, DOI 10.1007/s10846-013-9829-3; Shao J, 2007, IET CONTROL THEORY A, V1, P545, DOI 10.1049/iet-cta:20050371; Sharma R, 2013, J INTELL ROBOT SYST, V72, P429, DOI 10.1007/s10846-012-9809-z; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Tanner HG, 2010, IEEE T AUTOMAT CONTR, V55, P2640, DOI 10.1109/TAC.2010.2063291	28	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175378	10.1371/journal.pone.0175378	http://dx.doi.org/10.1371/journal.pone.0175378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426706	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900027
J	Li, GH; Zhang, YX				Li, Gui-Hua; Zhang, Yong-Xin			Dynamic behaviors of a modified SIR model in epidemic diseases using nonlinear incidence and recovery rates	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BIFURCATIONS; OUTBREAK	The transmission of infectious diseases has been studied by mathematical methods since 1760s, among which SIR model shows its advantage in its epidemiological description of spread mechanisms. Here we established a modified SIR model with nonlinear incidence and recovery rates, to understand the influence by any government intervention and hospitalization condition variation in the spread of diseases. By analyzing the existence and stability of the equilibria, we found that the basic reproduction number R-0 is not a threshold parameter, and our model undergoes backward bifurcation when there is limited number of hospital beds. When the saturated coefficient a is set to zero, it is discovered that the model undergoes the Saddle-Node bifurcation, Hopf bifurcation, and Bogdanov-Takens bifurcation of codimension 2. The bifurcation diagram can further be drawn near the cusp type of the Bogdanov-Takens bifurcation of codimension 3 by numerical simulation. We also found a critical value of the hospital beds b(c) at R-0 < 1 and sufficiently small a, which suggests that the disease can be eliminated at the hospitals where the number of beds is larger than bc. The same dynamic behaviors exist even when a not equal 0. Therefore, it can be concluded that a sufficient number of the beds is critical to control the epidemic.	[Li, Gui-Hua; Zhang, Yong-Xin] North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China	North University of China	Li, GH (corresponding author), North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China.	liguihua@nuc.edu.cn			National Science Foundation of China [11331009]; Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province; National Sciences Foundation of Shanxi Province [2015011009]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Sciences Foundation of Shanxi Province	This work is supported by the National Science Foundation of China (11331009), Research Project Supported by Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province and the National Sciences Foundation of Shanxi Province (2015011009).	Brauer F, 2001, MATHEMATICAL MODELS; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; DUMORTIER F, 1987, ERGOD THEOR DYN SYST, V7, P375, DOI 10.1017/S0143385700004119; Dushoff F, 1998, JOURNAL OF MATHEMATI, V36, P227; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Huang JC, 2014, J DIFFER EQUATIONS, V257, P1721, DOI 10.1016/j.jde.2014.04.024; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; Shan CH, 2014, J DIFFER EQUATIONS, V257, P1662, DOI 10.1016/j.jde.2014.05.030; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Tang SY, 2012, J THEOR BIOL, V295, P47, DOI 10.1016/j.jtbi.2011.10.035; Wang WD, 2004, J MATH ANAL APPL, V291, P775, DOI 10.1016/j.jmaa.2003.11.043; Wang W, 2006, MATH BIOSCI, V201, P58, DOI 10.1016/j.mbs.2005.12.022; Wu YF, 2016, J FRANKLIN I, V353, P4772, DOI 10.1016/j.jfranklin.2016.09.012; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Xiao Y., 2015, SCI REPORTS, V5; Zhang J, 2005, APPL MATH COMPUT, V162, P909, DOI 10.1016/j.amc.2003.12.131	27	35	35	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175789	10.1371/journal.pone.0175789	http://dx.doi.org/10.1371/journal.pone.0175789			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426775	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900046
J	Li, XH; Zhang, JL; Li, BF; Yi, DH; Zhang, CS; Sun, N; Lv, W; Jiao, A				Li, Xiaohang; Zhang, Jialin; Li, Baifeng; Yi, Dehui; Zhang, Chengshuo; Sun, Ning; Lv, Wu; Jiao, Ao			Diagnosis, treatment and prognosis of small bowel volvulus in adults: A monocentric summary of a rare small intestinal obstruction	PLOS ONE			English	Article							MIDGUT VOLVULUS; MALROTATION; MANAGEMENT	Objectives Small bowel volvulus is a rare disease, which is also challenging to diagnose. The aims of this study were to characterize the clinical and radiological features associated with small bowel volvulus and treatment and to identify risk factors for associated small bowel necrosis. Methods Patients with small bowel volvulus who underwent operations from January 2001 to December 2015 at the First Affiliated Hospital of China Medical University (Shenyang, China) were reviewed. Clinical, surgical and postsurgical data were registered and analyzed. Results Thirty-one patients were included for analysis. Fifteen patients were female (48.4%), with an average age of 47.7 years (18-79 years). The clinical signs and symptoms were unspecific and resembled intestinal obstruction. Clinical examination revealed abdominal distension and/or diffuse tenderness with or without signs of peritonitis. The use of CT scans, X-rays or ultrasound did not differ significantly between patients. In 9 of 20 patients that received abdominal CT scans, "whirlpool sign" on the CT scan was present. Secondary small bowel volvulus was present in 58.1% of patients, and causes included bands (3), adhesion (7), congenital anomalies (7) and stromal tumor (1). Out of the 31 patients, 15 with gangrenous small bowel had to undergo intestinal resection. Intestinal gangrene was present with higher neutrophils count (p< 0.0001) and the presence of bloody ascites (p = 0.004). Three patients died of septic shock (9.68%), and the recurrence rate was 3.23%. Conclusions To complete an early and accurate diagnosis, a CT scan plus physical exam seems to be the best plan. After diagnosis, an urgent laparotomy must be performed to avoid intestinal necrosis and perforation. After surgery, more than 90% of the patients can expect to have a favorable prognosis.	[Li, Xiaohang; Zhang, Jialin; Li, Baifeng; Yi, Dehui; Zhang, Chengshuo; Sun, Ning; Lv, Wu; Jiao, Ao] China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Zhang, JL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Shenyang, Liaoning, Peoples R China.	jlz2200@126.com						Birnbaum DJ, 2013, J EMERG MED, V44, pE329, DOI 10.1016/j.jemermed.2012.08.023; Brinda MAA, 2015, J CLIN DIAGN RES, V9, pPD08, DOI 10.7860/JCDR/2015/16252.6799; DUKE JH, 1977, ARCH SURG-CHICAGO, V112, P685; Gamblin T Clark, 2003, Curr Surg, V60, P517, DOI 10.1016/S0149-7944(03)00030-8; Gurleyik E, 1998, EUR J SURG, V164, P51, DOI 10.1080/110241598750004959; Huang JC, 2005, J GASTROEN HEPATOL, V20, P1906, DOI 10.1111/j.1440-1746.2005.03945.x; Iwuagwu O, 1999, J ROY COLL SURG EDIN, V44, P150; Kim KH, 2007, SURG LAPARO ENDO PER, V17, P335, DOI 10.1097/SLE.0b013e31806c7d04; Papadimitriou G, 2011, J GASTROINTEST SURG, V15, P1889, DOI 10.1007/s11605-011-1534-6; ROGGO A, 1992, ANN SURG, V216, P135, DOI 10.1097/00000658-199208000-00003; ROWSOM JT, 1987, J CLIN GASTROENTEROL, V9, P212, DOI 10.1097/00004836-198704000-00021; Ruiz-Tovar J, 2009, AM SURGEON, V75, P1179; Takemura M, 2000, J GASTROENTEROL, V35, P52, DOI 10.1007/PL00009976; Tamura J, 2014, WEST J EMERG MED, V15, P359, DOI 10.5811/westjem.2014.4.20679; Zheng ZH, 2014, INT J CLIN EXP MED, V7, P1614	15	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175866	10.1371/journal.pone.0175866	http://dx.doi.org/10.1371/journal.pone.0175866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426721	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900060
J	Simoes, E; Sokolov, AN; Kronenthaler, A; Hiltner, H; Schaeffeler, N; Rall, K; Ueding, E; Rieger, MA; Wagner, A; Poesch, LS; Baur, MC; Kittel, J; Brucker, SY				Simoes, Elisabeth; Sokolov, Alexander N.; Kronenthaler, Andrea; Hiltner, Hanna; Schaeffeler, Norbert; Rall, Katharina; Ueding, Esther; Rieger, Monika A.; Wagner, Anke; Poesch, Leonie S.; Baur, Marie-Christin; Kittel, Judith; Brucker, Sara Y.			Information ranks highest: Expectations of female adolescents with a rare genital malformation towards health care services	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; TRANSITIONAL CARE; PROGRAM	Background Access to highly specialized health care services and support to meet the patient's specific needs is critical for health outcome, especially during age-related transitions within the health care system such as with adolescents entering adult medicine. Being affected by an orphan disease complicates the situation in several important respects. Long distances to dedicated institutions and scarcity of knowledge, even among medical doctors, may present major obstacles for proper access to health care services and health chances. This study is part of the BMBF funded TransCareO project examining in a mixed-method design health care provisional deficits, preferences, and barriers in health care access as perceived by female adolescents affected by the Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS), a rare (orphan) genital malformation. Methods Prior to a communicative validation workshop, critical elements of MRKHS related care and support (items) were identified in interviews with MRKHS patients. During the subsequent workshop, 87 persons involved in health care and support for MRKHS were asked to rate the items using a 7-point Likert scale (7, strongly agree; 1, strongly disagree) as to 1) the elements' potential importance (i.e., health care expected to be "best practice", or priority) and 2) the presently experienced care. A gap score between the two was computed highlighting fields of action. Items were arranged into ten separate questionnaires representing domains of care and support (e.g., online-portal, patient participation). Within each domain, several items addressed various aspects of "information" and "access". Here, we present the outcome of items' evaluation by patients (attended, N-PAT = 35; respondents, N-RESP = 19). Results Highest priority scores occurred for domains "Online-Portal", "Patient participation", and "Tailored informational offers", characterizing them as extremely important for the perception as best practice. Highest gap scores yielded domains "Tailored informational offers", reflecting perceived lack of disease-related information for affected persons, medical experts, and health insurance companies, "Online-Portal" (with limited information available on specialist clinics and specialized doctors), and regarding insufficient support offers (e.g., in school and occupational settings). Conversely, lowest gap scores were found with group offers for MRKHS patients ("Transition programs") and MRKHS self-help days ("Patient participation"), suggesting satisfaction or good solutions in place. Discussion The importance assigned to disease-related information indicates that informational deficits are perceived by patients as barriers, hindering proper access to health care, especially in an orphan disease. Access to health-related information plays a role for all persons seeking help and care. However, the overwhelmingly high scores attributed to these elements in the context of an orphan disease reveal that here improved information policies are crucial, demanding for institutionalized solutions supported by the health care system. Implications for practice The disparity between experience of care and attribution as best practice detected describes areas of action in all domains involved, highlighting information related fields. New concepts and structures for health care in orphan diseases could draw upon these patient-oriented results a) regarding orphan-disease specific elements demanding institutionalized reimbursement, b) essential elements for center care and corresponding networks, and c) elements reflecting patients A participation in the conception of centers for rare diseases.	[Simoes, Elisabeth; Sokolov, Alexander N.; Rall, Katharina; Ueding, Esther; Poesch, Leonie S.; Baur, Marie-Christin; Brucker, Sara Y.] Univ Hosp Tubingen, Dept Womens Hlth, Womens Hlth Res Inst, Tubingen, Germany; [Simoes, Elisabeth] Eberhard Karls Univ Tubingen, Sch Med, Staff Unit Social Med, Tubingen, Germany; [Simoes, Elisabeth] Univ Hosp Tubingen, Tubingen, Germany; [Kronenthaler, Andrea; Hiltner, Hanna] Eberhard Karls Univ Tubingen, Fac Econ & Social Sci, Inst Sociol, Tubingen, Germany; [Schaeffeler, Norbert; Kittel, Judith] Univ Hosp Tubingen, Psychosomat Med & Psychotherapy, Tubingen, Germany; [Rieger, Monika A.; Wagner, Anke] Univ Hosp Tubingen, Inst Occupat & Social Med, Tubingen, Germany; [Rieger, Monika A.; Wagner, Anke] Univ Hosp Tubingen, Hlth Serv Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Simoes, E; Sokolov, AN (corresponding author), Univ Hosp Tubingen, Dept Womens Hlth, Womens Hlth Res Inst, Tubingen, Germany.; Simoes, E (corresponding author), Eberhard Karls Univ Tubingen, Sch Med, Staff Unit Social Med, Tubingen, Germany.; Simoes, E (corresponding author), Univ Hosp Tubingen, Tubingen, Germany.	elisabeth.simoes@med.uni-tuebingen.de; alexander.sokolov@uni-tuebingen.de	Norbert, Schäffeler/O-3224-2019	Schaffeler, Norbert/0000-0001-6569-921X	German Federal Ministry of Education and Research (BMBF) [01GY1125]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF; Grant No. 01GY1125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Allianz Chronischer Seltener Erkrankungen (ACHSE) e.V Alliance for Chronic Rare Diseases], 2015, STELL ENT EIN GES RE; Bahrs O, 2013, GESUNDHEITSWESEN, V75, pA77, DOI [10.1055/s-0033-1354059, DOI 10.1055/S-0033-1354059]; Brucker S, 2009, GEBURTSH FRAUENHEILK, V69, P568, DOI 10.1055/s-0029-1185932; [Bundesministerium fu E r Bildung und Forschung (BMBF) Federal Ministry of Education and Research], 2005, SELT ERKR MILL PAT; DONABEDIAN A, 1972, MILBANK MEML FUND Q, V50, P103, DOI 10.2307/3349436; Flowers J, 1999, BRIT MED J, V319, P866, DOI 10.1136/bmj.319.7214.866; HM Government, 2006, OUR HLTH OUR CAR OUR; Klasen F, 2015, EUR CHILD ADOLES PSY, V24, P695, DOI 10.1007/s00787-014-0637-5; McDonagh JE, 2007, RHEUMATOLOGY, V46, P161, DOI 10.1093/rheumatology/kel198; Millman M., 1993, ACCESS HLTH CARE AM; Oppelt P, 2006, HUM REPROD, V21, P792, DOI 10.1093/humrep/dei381; Owen H., 2008, OPEN SPACE TECHNOLOG, V3rd edition; Royal College of Paediatrics and Child Health, 2003, BRIDG GAP HLTH CARE; Sachversta E ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen [Advisory Council on the Assessment of Developments in the Health Care System], 2009, SPEC REP COORD INT H; Schnabel P-E, 2001, MUNDIGE PATIENT KONZ, p[61, 169]; Shaw KL, 2007, CHILD CARE HLTH DEV, V33, P380, DOI 10.1111/j.1365-2214.2006.00699.x; Shaw KL, 2004, RHEUMATOLOGY, V43, P211, DOI 10.1093/rheumatology/keh018; Simoes E, 2012, GEBURTSH FRAUENHEILK, V72, P893; Simoes E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913842; Weinick RM, 1998, HEALTH AFFAIR, V17, P127, DOI 10.1377/hlthaff.17.2.127; While A, 2004, CHILD CARE HLTH DEV, V30, P439, DOI 10.1111/j.1365-2214.2004.00440.x; World Health Organization, 2016, ADOLESCENT HEALTH	22	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174031	10.1371/journal.pone.0174031	http://dx.doi.org/10.1371/journal.pone.0174031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426677	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900007
J	Yaguchi, S; Yaguchi, S; Yagi-Yaguchi, Y; Kozawa, T; Bissen-Miyajima, H				Yaguchi, Saori; Yaguchi, Shigeo; Yagi-Yaguchi, Yukari; Kozawa, Tadahiko; Bissen-Miyajima, Hiroko			Objective classification of zonular weakness based on lens movement at the start of capsulorhexis	PLOS ONE			English	Article							CAPSULAR TENSION RINGS; INTRAOCULAR-LENS; CRYSTALLINE LENS; ANTERIOR CAPSULE; PHACOEMULSIFICATION; PSEUDOEXFOLIATION; IMPLANTATION; DISLOCATION; MANAGEMENT; CATARACT	Purpose To quantify zonular weakness based on lens movement at the start of continuous curvilinear capsulorhexis (CCC) and establish a classification system for it. Setting Kozawa Eye Hospital and Diabetes Center, Mito, Japan. Design Retrospective interventional case series. Methods We examined 402 consecutive eyes of 316 patients who underwent CCC, phacoemulsification and aspiration (PEA), and intraocular lens (IOL) implantation. The movement of the lens capsule was measured using images from video recordings of the CCC procedure. Zonular weakness was classified based on the shifted distance: Grade I, less than 0.20 mm; Grade II, 0.20-0.39 mm; and Grade III, greater than 0.40 mm. For each of these grades, we examined the use of the capsule stabilization device during PEA, the surgical procedure for lens removal, and IOL fixation. Results We classified 276 eyes (68.6%) as Grade I, 102 eyes (25.4%) as Grade II, and 24 eyes (6.0%) as Grade III. As the grade increased, the use of the capsule stabilization device in PEA and scleral suture fixation of IOL increased. Conclusions Zonular weakness was quantified by measuring the movement of the lens capsule. An objective classification of zonular weakness based on lens movement may be useful for selecting the appropriate device and procedure during cataract surgery.	[Yaguchi, Saori; Bissen-Miyajima, Hiroko] Tokyo Dent Coll Suidobashi Hosp, Dept Ophthalmol, Tokyo, Japan; [Yaguchi, Saori; Yaguchi, Shigeo; Kozawa, Tadahiko] Kozawa Eye Hosp & Diabet Ctr, Mito, Ibaraki, Japan; [Yagi-Yaguchi, Yukari] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan	Tokyo Dental College; Tokyo Dental College	Yaguchi, S (corresponding author), Kozawa Eye Hosp & Diabet Ctr, Mito, Ibaraki, Japan.	yaguchis@hotmail.ca.jp	Negishi, Kazuno/AAG-3260-2021	Negishi, Kazuno/0000-0002-2892-9810				Ahmed IIK, 2005, OPHTHALMOLOGY, V112, P1725, DOI 10.1016/j.ophtha.2005.05.006; ASSIA EI, 1991, INVEST OPHTH VIS SCI, V32, P2835; Blecher MH, 2008, CURR OPIN OPHTHALMOL, V19, P31, DOI 10.1097/ICU.0b013e3282f2ccc8; Bron AJ, 1997, WOLFFS ANATOMY EYE O, P411; CANAVAN YM, 1982, BRIT J OPHTHALMOL, V66, P549, DOI 10.1136/bjo.66.9.549; HARA T, 1991, OPHTHALMIC SURG LAS, V22, P358; Hasanee K, 2006, CURR OPIN OPHTHALMOL, V17, P31; Hasanee Khalid, 2006, Ophthalmol Clin North Am, V19, P507; Hayashi H, 1998, BRIT J OPHTHALMOL, V82, P1429, DOI 10.1136/bjo.82.12.1429; Hoffman RS, 2013, J CATARACT REFR SURG, V39, P1904, DOI 10.1016/j.jcrs.2013.09.005; Jacob S, 2003, J CATARACT REFR SURG, V29, P315, DOI 10.1016/S0886-3350(02)01534-1; Ladewig MS, 2006, OPHTHALMOLOGE, V103, P777, DOI 10.1007/s00347-006-1386-8; Mackool RJ, 2009, J CATARACT REFR SURG, V35, P1323, DOI 10.1016/j.jcrs.2009.02.041; Najjar Dany M, 2011, J Med Case Rep, V5, P65, DOI 10.1186/1752-1947-5-65; Nishimura E, 2006, J CATARACT REFR SURG, V32, P392, DOI 10.1016/j.jcrs.2005.12.097; Peter NM, 2005, EUR J OPHTHALMOL, V15, P409, DOI 10.1177/112067210501500316; RAITTA C, 1986, ACTA OPHTHALMOL, V64, P130; ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366; Shingleton BJ, 2016, ACTA OPHTHALMOL; Shingleton BJ, 2009, J CATARACT REFR SURG, V35, P1101, DOI 10.1016/j.jcrs.2009.03.011; Soda M, 2015, J CATARACT REFR SURG, V41, P1132, DOI 10.1016/j.jcrs.2015.05.007; Yaguchi S, J CLIN EXP OPHTHALMO, V6, P407; Yaguchi S, 2011, J CATARACT REFR SURG, V37, P1386, DOI 10.1016/j.jcrs.2011.06.015; Yaguchi Y, J CLIN EXP OPHTHALMO, V7, P541; Yasuda A, 2000, AM J OPHTHALMOL, V130, P836, DOI 10.1016/S0002-9394(00)00630-9	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176169	10.1371/journal.pone.0176169	http://dx.doi.org/10.1371/journal.pone.0176169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426745	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875900114
J	Zhao, M; Klipstein-Grobusch, K; Wang, X; Reitsma, JB; Zhao, D; Grobbee, DE; Graham, I; Vaartjes, I				Zhao, Min; Klipstein-Grobusch, Kerstin; Wang, Xin; Reitsma, Johannes B.; Zhao, Dong; Grobbee, Diederick E.; Graham, Ian; Vaartjes, Ilonca			Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICIANS KNOWLEDGE; DRUG-TREATMENT; GUIDELINES	Background Myocardial Infarction (MI) has become a major cause of morbidity and mortality in China, but little is known about the prevalence of guideline-recommended cardiovascular medications after MI events over the last two decades. This systematic review and meta-analysis aims to summarize cardiovascular medication use between 1995-2015 and to assess factors in associated with the trends in cardiovascular medications. Method A systematic search was conducted in four databases (Pubmed, Embase, CENTRAL, and CNKI) to obtain observational studies published between 1995 and 2015, reporting on the use of cardiovascular medications in China. Risk of bias of individual studies was appraised and selected studies were pooled for estimated prevalence of cardiovascular medication. Prevalence of cardiovascular medication use for 1995 and 2015 was estimated by random effects meta-regression model. Results From 13,940 identified publications, 35 studies, comprising 28,000 patients, were included. The pooled prevalence for aspirin, beta-blockers, statins, ACE-Inhibitors, ACE-Inhibitor/ARBs and nitrates was 92% [95% confidence interval (CI): 0.89-0.95], 63% (95% CI: 0.57-0.69), 72% (95% CI: 0.60-0.82), 49% (95% CI: 0.41-0.57), 59% (95% CI: 0.48-0.69) and 79% (95% CI: 0.74-0.91), respectively. A significant increase in beta-blocker and statin use and a decrease of nitrate use was observed over time. The estimated prevalence of beta-blockers, statins, and nitrates was 78%, 91.1%, and 59.3% in 2015, compared to 32%, 17% and 96% in 1995, respectively. Conclusion Cardiovascular medication use after MI is far from optimal in Chinese patients, even though the prevalence of use increased over the period 1995-2015. With a rapidly increasing number of MI patients in China, a comprehensive strategy on secondary prevention is warranted.	[Zhao, Min; Klipstein-Grobusch, Kerstin; Wang, Xin; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, Gauteng, South Africa; [Reitsma, Johannes B.; Vaartjes, Ilonca] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Zhao, Dong] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Vaartjes, Ilonca] Univ Utrecht, Global Geo & Hlth Data Ctr, Utrecht, Netherlands; [Graham, Ian] Trinity Coll Dublin, Dublin, Ireland	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; Capital Medical University; Utrecht University; Trinity College Dublin	Zhao, M (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	m.zhao@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Zhao, D/AAX-5040-2021; Zhao, Min/AAG-1046-2019	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Reitsma, Johannes/0000-0003-4026-4345	Netherlands Organization for Scientific Research (NOW) [0.22.005.021]; Dutch Heart Foundation (grant 'Facts and Figures')	Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation (grant 'Facts and Figures')	MZ has been supported by a grant from Netherlands Organization for Scientific Research (NOW; grant number:0.22.005.021). IV was supported by a grant from the Dutch Heart Foundation (grant 'Facts and Figures'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Barber L, HLTH INSURANCE SYSTE; Bi YF, 2009, AM HEART J, V157, P509, DOI 10.1016/j.ahj.2008.09.026; Chai R, 2008, J TIANJIN MED U, V14, P495; Chen YP, 2014, INT J CARDIOL, V172, P88, DOI 10.1016/j.ijcard.2013.12.065; China Milltary of Health of the People Republic of China, 2011, IMPL NAT ESS MED POL; China Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of Cardiology, 2015, Zhonghua Xin Xue Guan Bing Za Zhi, V43, P380; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Fang C, 2006, CHINESE J MED GUIDE, V8, P30; Fang YK, 2003, THESIS; Gong YJ, 2012, J ZHEJIANG UNIV-SC B, V13, P231, DOI 10.1631/jzus.B1100299; Gui X, 2008, ZHONGGUO LAO NIANG X, V10, P2024; Guidelines for the diagnosis, 2010, CHIN J CARDIOVASC DI, P675; Han L, 2012, J CARDIOVASCULAR PUL, V31, P579; [韩文正 HAN Wenzheng], 2011, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V31, P302; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Jiang J, 2012, EUR J PREV CARDIOL, V19, P991, DOI 10.1177/1741826711421299; Khatib R, 2015, LANCET, V6736, P1; Koopman C, 2013, EUR HEART J, V34, P3198, DOI 10.1093/eurheartj/eht368; Kotseva K, 2015, EUR J PREV CARDIOL, V23, P59; Kramer HU, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-88; Krishnan MN, 2016, CIRC-CARDIOVASC QUAL, V6, P436; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Li W.T., 2013, THESIS; Li X., 2014, THESIS; Li X, 2014, INT J CLIN PHARM TH, V52, P587, DOI 10.5414/CP202016; Liang Yan, 2005, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V17, P142; Liu G.Q., 2011, DEGREE PAPER; Liu L, 1999, CHINESE J HYPERTENSI, V7, P301; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Mahe I, 2003, DRUG AGING, V20, P999; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Ni J. - Y., 2009, THESIS; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Peng Y., 2008, THESIS; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Simon DN, 2016, CIRC-CARDIOVASC QUAL, V8, P576; Tacconelli E., 2010, SYSTEMATIC REV CRDS, VVolume 10; Tian Q., 2014, THESIS; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang D., 2010, CHINA MODERN DOCTOR, V48, P29; Wang S, 2005, ZHONGGUO XIANG CUN Y, V12, P63; Wang W, 2013, CHINESE JOUNRAL HYPE, V21, P738; Wang WZ, 2011, CHINESE MED J-PEKING, V124, P1235, DOI 10.3760/cma.j.issn.0366-6999.2011.08.021; Wu J, 2005, ZHONGGUO LAO NIAN XI, V7, P324; Wu YF, 2016, CIRCULATION, V133, P2545, DOI 10.1161/CIRCULATIONAHA.115.008728; Xiang Z, 2006, CHINA PHARM, V17, P2; Xiao G, 2014, ZHONGGUO YE JIN GONG, V31, P348; Xu M., 2012, CHIN J CARDIOVASC ME, V17, P18, DOI [10.3969/j.issn.1006-7795.2012.01.024, DOI 10.3969/J.ISSN.1006-7795.2012.01.024]; Yan Hong-bing, 2010, Zhonghua Yi Xue Za Zhi, V90, P2103; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang H, 2006, CHINESE J CARDIOVASC, V4, P446; Yang Jin-gang, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P474; Yang Q, 2014, CHINA J PHARM EC, V5, P83; Yao D, 2011, J CLIN EXPT MED, V10, P6; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang B, 2011, J DALIAN MED U, V33, P462; Zhang H, 2016, PLOS ONE, V1-13; Zhang H, 2012, THESIS; Zhang H, 2015, CIRCULATION, V131, P2194, DOI 10.1161/CIRCULATIONAHA.114.014209; [张伟 Zhang Wei], 2014, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V34, P5; Zhao D, 2012, NAT REV CARDIOL, V9, P425, DOI 10.1038/nrcardio.2012.62; Zhao M, 2015, PROS PERO; Zhao R. G., 2010, THESIS; Zhao Y, 2004, ACTA ACAD MED, V13, P296; [周爱琴 ZHOU Aiqin], 2010, [临床心血管病杂志, Journal of Clinical Cardiology], V26, P36; Zhou L, 2011, THESIS; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	71	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175947	10.1371/journal.pone.0175947	http://dx.doi.org/10.1371/journal.pone.0175947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426793	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900074
J	Burghardt, TP; Sun, XJ; Wang, YH; Ajtai, K				Burghardt, Thomas P.; Sun, Xiaojing; Wang, Yihua; Ajtai, Katalin			Auxotonic to isometric contraction transitioning in a beating heart causes myosin step-size to down shift	PLOS ONE			English	Article							CARDIAC-MUSCLE CONTRACTION; ESSENTIAL LIGHT-CHAIN; SKELETAL-MUSCLE; WORKING STROKE; 3-DIMENSIONAL STRUCTURE; CROSS-BRIDGES; N-TERMINUS; LEVER-ARM; ACTIN; ZEBRAFISH	Myosin motors in cardiac ventriculum convert ATP free energy to the work of moving blood volume under pressure. The actin bound motor cyclically rotates its lever-arm/light-chain complex linking motor generated torque to the myosin filament backbone and translating actin against resisting force. Previous research showed that the unloaded in vitro motor is described with high precision by single molecule mechanical characteristics including unitary step-sizes of approximately 3, 5, and 8 nm and their relative step-frequencies of approximately 13, 50, and 37%. The 3 and 8 nm unitary step-sizes are dependent on myosin essential light chain (ELC) N-terminus actin binding. Step-size and step-frequency quantitation specifies in vitro motor function including duty-ratio, power, and strain sensitivity metrics. In vivo, motors integrated into the muscle sarcomere form the more complex and hierarchically functioning muscle machine. The goal of the research reported here is to measure single myosin step-size and step-frequency in vivo to assess how tissue integration impacts motor function. A photoactivatable GFP tags the ventriculum myosin lever-arm/light-chain complex in the beating heart of a live zebrafish embryo. Detected single GFP emission reports time-resolved myosin lever-arm orientation interpreted as step-size and step-frequency providing single myosin mechanical characteristics over the active cycle. Following step-frequency of cardiac ventriculum myosin transitioning from low to high force in relaxed to auxotonic to isometric contraction phases indicates that the imposition of resisting force during contraction causes the motor to down-shift to the 3 nm step-size accounting for >80% of all the steps in the near-isometric phase. At peak force, the ATP initiated actomyosin dissociation is the predominant strain inhibited transition in the native myosin contraction cycle. The proposed model for motor down-shifting and strain sensing involves ELC N-terminus actin binding. Overall, the approach is a unique bottom-up single molecule mechanical characterization of a hierarchically functional native muscle myosin.	[Burghardt, Thomas P.; Sun, Xiaojing; Wang, Yihua; Ajtai, Katalin] Mayo Clin Rochester, Dept Biochem & Mol Biol, Rochester, MN USA; [Burghardt, Thomas P.] Mayo Clin Rochester, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Burghardt, TP (corresponding author), Mayo Clin Rochester, Dept Biochem & Mol Biol, Rochester, MN USA.; Burghardt, TP (corresponding author), Mayo Clin Rochester, Dept Physiol & Biomed Engn, Rochester, MN USA.	burghardt@mayo.edu	Wang, Yihua/ABA-8649-2020	Wang, Yihua/0000-0002-7758-6738; Burghardt, Thomas/0000-0003-3119-4074	National Institutes of Health [R01AR049277]; Mayo Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation	This work was supported by National Institutes of Health grant R01AR049277 and by the Mayo Foundation.	AL-Khayat HA, 2013, P NATL ACAD SCI USA, V110, P318, DOI 10.1073/pnas.1212708110; Alamo L, 2016, J MOL BIOL, V428, P1142, DOI 10.1016/j.jmb.2016.01.027; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; BOREJDO J, 1979, P NATL ACAD SCI USA, V76, P6346, DOI 10.1073/pnas.76.12.6346; Boulter N, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0256-y; Burghardt TP, 2007, BIOPHYS J, V93, P2226, DOI 10.1529/biophysj.107.107433; Burghardt TP, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160075; Burghardt TP, 2013, BIOCHEMISTRY-US, V52, P1249, DOI 10.1021/bi301500d; Burghardt TP, 2011, BIOCHEMISTRY-US, V50, P7809, DOI 10.1021/bi2008992; Burghardt TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016772; BURGHARDT TP, 1985, BIOCHEMISTRY-US, V24, P3731, DOI 10.1021/bi00335a048; Burghardt TP, 1997, P NATL ACAD SCI USA, V94, P9631, DOI 10.1073/pnas.94.18.9631; Burghardt TP, 2016, J MUSCLE RES CELL M, P1; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Gonzalez-Sola M, 2014, BIOPHYS J, V106, P1671, DOI 10.1016/j.bpj.2014.01.050; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; Kazmierczak K, 2009, J MOL BIOL, V387, P706, DOI 10.1016/j.jmb.2009.02.006; Lossie J, 2014, BIOCHEM BIOPH RES CO, V450, P464, DOI 10.1016/j.bbrc.2014.05.142; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Moczarska A, 1995, BIOCHEM MOL BIOL INT, V37, P765; Muthu P, 2011, FASEB J, V25, P4394, DOI 10.1096/fj.11-191973; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Pant K, 2009, FASEB J, V23, P3571, DOI 10.1096/fj.08-126672; Petzhold D, 2014, BIOCHEM BIOPH RES CO, V449, P284, DOI 10.1016/j.bbrc.2014.05.040; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Sun XJ, 2014, BIOPHYS J, V107, P1403, DOI 10.1016/j.bpj.2014.07.055; Timson DJ, 1998, EUR J BIOCHEM, V255, P654, DOI 10.1046/j.1432-1327.1998.2550654.x; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Wang YH, 2016, BIOCHEMISTRY-US, V55, P186, DOI 10.1021/acs.biochem.5b00817; Wang YH, 2014, J MOL CELL CARDIOL, V72, P231, DOI 10.1016/j.yjmcc.2014.03.022; Wang YH, 2013, BIOCHEMISTRY-US, V52, P1611, DOI 10.1021/bi301702p; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174690	10.1371/journal.pone.0174690	http://dx.doi.org/10.1371/journal.pone.0174690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423017	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600019
J	Guan, XY; Li, ZJ; Zhang, ZL; Wei, XY; Xie, JH; Chen, JJ; Chen, QX				Guan, Xiayu; Li, Zhijian; Zhang, Zhiliang; Wei, Xiangying; Xie, Jiahua; Chen, Jianjun; Chen, Qingxi			Overexpression of an EaZIP gene devoid of transit peptide sequence induced leaf variegation in tobacco	PLOS ONE			English	Article							ARABIDOPSIS; MUTATIONS; FTSH; HOMOLOG; LOCUS; MAINTENANCE; ENVELOPE; MUTANTS	Leaf variegation is an ornamental trait that is not only biologically but also economically important. In our previous study, a Mg-protoporphyrin IX monomethyl ester cyclase homologue, EaZIP (Epipremnum aureum leucine zipper) was found to be associated with leaf variegation in Epipremnum aureum (Linden & Andre) G.S. Bunting. The protein product of this nuclear-encoded gene is targeted back to chloroplast involving in chlorophyll biosynthesis. Based on a web-based homology analysis, the EaZIP was found to lack a chloroplast transit peptide (cTP) sequence. In the present study, we tested if overexpression of the EaZIP cDNA with or without the cTP sequence could affect leaf variegation. Transgenic tobacco plants overexpressing EaZIP genes with (EaZIPwcTP) and without (EaZIPwocTP) cTP sequence were generated. Many plant lines harboring EaZIPwocTP showed variegated leaves, while none of the plant lines with EaZIPwcTP produced such a phenotype. Molecular analysis of T0 plants and selfed T1 progeny, as well as observations of tagged marker GFP (green fluorescent protein) did not show any other difference in patterns of gene integrity and expression. Results from this study indicate that transgenic approach for expressing EaZIPwocTP could be a novel method of generating variegated plants even through the underlying mechanisms remain to be elucidated.	[Guan, Xiayu; Wei, Xiangying; Chen, Jianjun; Chen, Qingxi] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China; [Guan, Xiayu; Li, Zhijian; Zhang, Zhiliang; Wei, Xiangying; Chen, Jianjun] Univ Florida, IFAS, Dept Environm Horticulrture, Apopka, FL 32703 USA; [Guan, Xiayu; Li, Zhijian; Zhang, Zhiliang; Wei, Xiangying; Chen, Jianjun] Univ Florida, Midflorida Res & Educ Ctr, Apopka, FL 32703 USA; [Zhang, Zhiliang] Sichuan Agr Univ, Dept Agr Water Conservancy, Coll Water Resource & Hydropower, Yaan, Sichuan Provinc, Peoples R China; [Chen, Jianjun] North Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC USA	Fujian Agriculture & Forestry University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sichuan Agricultural University; University of North Carolina; North Carolina Central University	Chen, JJ; Chen, QX (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China.; Chen, JJ (corresponding author), Univ Florida, IFAS, Dept Environm Horticulrture, Apopka, FL 32703 USA.; Chen, JJ (corresponding author), Univ Florida, Midflorida Res & Educ Ctr, Apopka, FL 32703 USA.	lichen@ufl.edu; cqx0246@163.com	Chen, Jianjun/C-3914-2016	Chen, Jianjun/0000-0002-0293-4574	Fujian Science and Technology Key Projects [2013NZ0002-4, 2015N0002-1]; Forestry University as Construction of High-level Horticulture Science Discipline [612014007]	Fujian Science and Technology Key Projects; Forestry University as Construction of High-level Horticulture Science Discipline	The authors would like to thank the Fujian Science and Technology Key Projects (2013NZ0002-4 and 2015N0002-1) for Construction of High-level University Program designated to Fujian Agriculture and Forestry University as Construction of High-level Horticulture Science Discipline (612014007).; The authors would like to thank the Fujian Science and Technology Key Projects (2013NZ0002-4 and 2015N0002-1) for Construction of High-level University Program designated to Fujian Agriculture and Forestry University as Construction of High-level Horticulture Science Discipline (612014007). The authors are grateful to all members of the Grape Genetics Laboratory at MREC/IFAS for providing technical assistance.	Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Burge GK, 2002, PLANT CELL TISS ORG, V70, P13, DOI 10.1023/A:1016088621471; BURK LG, 1964, AM J BOT, V51, P713, DOI 10.2307/2440210; Burow MD., 1990, PLANT MOL BIOL REP, V8, P124, DOI [10.1007/BF02669766, DOI 10.1007/BF02669766]; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chen J, 2006, PLANT CELL REP, V24, P743, DOI 10.1007/s00299-005-0032-2; Chen J, 2010, HORTIC REV, V31, P45; Chen J. J., 2006, Floriculture, ornamental and plant biotechnology, P244; Chen M, 1999, J HERED, V90, P207, DOI 10.1093/jhered/90.1.207; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Henny R. J, 2003, PLANT BREEDING REV, V23, P245, DOI DOI 10.1002/9780470650226.CH6; Hung CY, 2010, J EXP BOT, V61, P1483, DOI 10.1093/jxb/erq020; Kato Y, 2012, PLANT CELL PHYSIOL, V53, P391, DOI 10.1093/pcp/pcr189; Kindle KL, 1998, PLANT PHYSIOL, V116, P1179, DOI 10.1104/pp.116.3.1179; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Li QS, 2007, HORTTECHNOLOGY, V17, P285, DOI 10.21273/HORTTECH.17.3.285; Li ZT, 2011, PLANT CELL REP, V30, P1, DOI 10.1007/s00299-010-0934-5; Li ZJT, 2004, TRANSGENIC RES, V13, P143, DOI 10.1023/B:TRAG.0000026074.11859.77; Liedl B. E., 1993, Plant Breeding Reviews, V11, P11; Liu N, 2004, PLANT PHYSIOL BIOCH, V42, P321, DOI 10.1016/j.plaphy.2004.02.007; Marcotrigiano M, 1997, HORTSCIENCE, V32, P773, DOI 10.21273/HORTSCI.32.5.773; MARCOTRIGIANO M, 1990, J AM SOC HORTIC SCI, V115, P681, DOI 10.21273/JASHS.115.4.681; Peter E, 2010, PLANT CELL PHYSIOL, V51, P1229, DOI 10.1093/pcp/pcq071; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; REISS B, 1989, P NATL ACAD SCI USA, V86, P886, DOI 10.1073/pnas.86.3.886; RODERMEL S, 2002, ARABIDOPSIS BOOK; Sakamoto W, 2003, GENES GENET SYST, V78, P1, DOI 10.1266/ggs.78.1; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; Schum A, 2003, ACTA HORTIC, P47, DOI 10.17660/ActaHortic.2003.612.6; Shen XL, 2007, PLANT CELL TISS ORG, V91, P21, DOI 10.1007/s11240-007-9273-9; Sheue CR, 2012, ANN BOT-LONDON, V109, P1065, DOI 10.1093/aob/mcs025; Smith HB, 1999, PLANT CELL, V11, P1, DOI 10.1105/tpc.11.1.1; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; STEWART RN, 1965, GENETICS, V52, P925; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Yin Zhimin, 2004, Journal of Applied Genetics, V45, P127; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Zhang LG, 2012, PLANT CELL, V24, P3695, DOI 10.1105/tpc.112.103606	44	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175995	10.1371/journal.pone.0175995	http://dx.doi.org/10.1371/journal.pone.0175995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422996	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600074
J	Jia, SQ; Qu, TT; Wang, XH; Feng, MM; Yang, Y; Feng, XM; Mal, RT; Li, WM; Hui, Y; Feng, Y; Ji, K; Li, ZY; Jiang, WG; Ji, JF				Jia, Shuqin; Qu, Tingting; Wang, Xiaohong; Feng, Mengmeng; Yang, Yang; Feng, Xuemin; Mal, Ruiting; Li, Wenmei; Hui, Ying; Feng, Yi; ji, Ke; Li, Ziyu; Jiang, Wenguo; Ji, Jiafu			KIAA1199 promotes migration and invasion by Wnt/beta-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; CELLS; OVEREXPRESSION; ADENOCARCINOMA; EXPRESSION; PHENOTYPE; CARCINOMA; SURVIVAL	Background KIAA1199 was upregulated in diverse cancers, but the association of KIAA1199 with gastric cancer (GC), the biological role of KIAA1199 in GC cells and the related molecular mechanisms remain to be elucidated. Methods KIAA1199 expression was analysed by reverse transcription-polymerase chain reaction assay (RT-PCR) and immunohistochemistry (IHC) in GC patient tissue. The small hairpin RNA (shRNA) was applied for the knockdown of endogenous KIAA1199 in NCI-N87 and AGS cells. MTT, colony formation, scratch wounding migration, transwell chamber migration and invasion assays were employed respectively to investigate the role of KIAA1199 in GC cells. The potential signaling pathway of KIAA1199 induced migration and invasion was detected. Results KIAA1199 was upregulated in GC tissue and was an essential independent marker for poor prognosis. Knockdown KIAA1199 suppressed the proliferation, migration and invasion in GC cells. KIAA1199 stimulated the Wnt/beta-catenin signaling pathway and the enzymatic activity of matrix metalloproteinase (MMP) family members and thus accelerated the epithelial- to-mesenchymal transition (EMT) progression in GC cells. Conclusion These findings demonstrated that KIAA1199 was upregulated in GC tissue and associated with worse clinical outcomes in GC, and KIAA1199 acted as an oncogene by promoting migration and invasion through the enhancement of Wnt/beta-catenin signaling pathway and MMPs mediated EMT progression in GC cells.	[Jia, Shuqin; Feng, Mengmeng; Yang, Yang; Feng, Xuemin; Mal, Ruiting] Inner Mongolia Med Univ, Affiliated Hosp, Lab Surg, Hohhot, Peoples R China; [Jia, Shuqin; Qu, Tingting; Li, Wenmei; Feng, Yi] Peking Univ, Canc Hosp & Inst, Minist Educ, Ctr Mol Diag,Key Lab Carcinogenesis & Translat Re, Beijing, Peoples R China; [Wang, Xiaohong; Hui, Ying] Peking Univ, Canc Hosp & Inst, Minist Educ, Tissue Bank,Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [ji, Ke; Li, Ziyu; Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Jiang, Wenguo] Cardiff Univ, Sch Med, Cardiff China Med Res Collaborat, Cardiff, S Glam, Wales	Inner Mongolia Medical University; Peking University; Peking University; Peking University; Cardiff University	Jia, SQ (corresponding author), Inner Mongolia Med Univ, Affiliated Hosp, Lab Surg, Hohhot, Peoples R China.; Jia, SQ (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Ctr Mol Diag,Key Lab Carcinogenesis & Translat Re, Beijing, Peoples R China.; Ji, JF (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.	jiashugin2014@163.com; jijiafu@hsc.pku.edu.cn	Jiang, Wen G/B-1293-2010; Jiang, Wen G./AAF-1876-2020; jiang, wen/GYI-9662-2022	Jiang, Wen G/0000-0002-3283-1111; Jiang, Wen G./0000-0002-3283-1111; JI, JIAFU/0000-0001-6878-5543	Young Talents of Science and Technology Support Project of Colleges and Universities of Inner Mongolia Autonomous Region [NJYT-12-B21, 2012]; Great Project of the Affiliated Hospital of Inner Mongolia Medical University [NYFY ZD 2012014]; National Natural Science Foundation of China [81260363]; Beijing Municipal Administration of Hospitals' Youth Programme [QM120151003]; Shuqin Jia; the National Natural Science Foundation of China [81101879]; National Science and Technology Ministry [2014BA109B02]; Beijing Municipal Administration of Hospitals Clinical Medicine Development [ZYLX201701]	Young Talents of Science and Technology Support Project of Colleges and Universities of Inner Mongolia Autonomous Region; Great Project of the Affiliated Hospital of Inner Mongolia Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals' Youth Programme; Shuqin Jia; the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Ministry; Beijing Municipal Administration of Hospitals Clinical Medicine Development	Support by the Young Talents of Science and Technology Support Project of Colleges and Universities of Inner Mongolia Autonomous Region (NJYT-12-B21, 2012), the Great Project of the Affiliated Hospital of Inner Mongolia Medical University (No. NYFY ZD 2012014), the National Natural Science Foundation of China (No. 81260363) and Beijing Municipal Administration of Hospitals' Youth Programme (QM120151003) were obtained by Shuqin Jia; the National Natural Science Foundation of China (No. 81101879) was obtained by Xiaohong Wang; the Project supported by National Science and Technology Ministry (2014BA109B02) was obtained by Ziyu Li; and Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201701) was obtained by Jiafu Ji.	Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Chanthammachat P, 2013, ARCH ORAL BIOL, V58, P1677, DOI 10.1016/j.archoralbio.2013.08.002; Chivu-Economescu M, 2010, HEPATO-GASTROENTEROL, V57, P1453; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Elsamany S, 2016, Asian Pac J Cancer Prev, V17, P4089; Evensen NA, 2015, ONCOTARGET, V6, P20723, DOI 10.18632/oncotarget.3978; Fink SP, 2015, ONCOTARGET, V6, P30500, DOI 10.18632/oncotarget.5921; Ghosn M, 2016, WORLD J GASTROENTERO, V22, P3069, DOI 10.3748/wjg.v22.i11.3069; Jami MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-194; Kanagavel D, 2015, WORLD J GASTROENTERO, V21, P11621, DOI 10.3748/wjg.v21.i41.11621; Koga A, 2017, PANCREATOLOGY, V17, P115, DOI 10.1016/j.pan.2016.12.007; Kuscu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044661; Li C, 2016, ONCOTARGET, V7, P66989, DOI 10.18632/oncotarget.11888; Liu CC, 2016, ONCO GENE; Mao WJ, 2016, LASER MED SCI, V31, P1697, DOI 10.1007/s10103-016-2040-6; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Polimeni M, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0138-4; Qi JJ, 2016, GUT, V65, P1690, DOI 10.1136/gutjnl-2014-307900; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Tiwari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069473; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wu Q, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0411-0; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Xu J, 2015, INT J CLIN EXP PATHO, V8, P2909	24	46	51	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175058	10.1371/journal.pone.0175058	http://dx.doi.org/10.1371/journal.pone.0175058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422983	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399875600026
J	Mercurio, L; Cecchetti, S; Ricci, A; Pacella, A; Cigliana, G; Bozzuto, G; Podo, F; Iorio, E; Carpinelli, G				Mercurio, Laura; Cecchetti, Serena; Ricci, Alessandro; Pacella, Aurora; Cigliana, Giovanni; Bozzuto, Giuseppina; Podo, Franca; Iorio, Egidio; Carpinelli, Giulia			Phosphatidylcholine-specific phospholipase C inhibition down-regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells	PLOS ONE			English	Article							CANCER-CELLS; IN-VITRO; ACTIVATION; BREAST; METABOLISM; RECEPTOR; GROWTH; GLIOBLASTOMA; ANTAGONIST; MEMBRANE	Background The chemokine receptor CXCR4 plays a crucial role in tumors, including glioblastoma multiforme (GBM), the most aggressive glioma. Phosphatidylcholine-specific phospholipase C (PC-PLC), a catabolic enzyme of PC metabolism, is involved in several aspects of cancer biology and its inhibition down-modulates the expression of growth factor membrane receptors interfering with their signaling pathways. In the present work we investigated the possible interplay between CXCR4 and PC-PLC in GBM cells. Methods Confocal microscopy, immunoprecipitation, western blot analyses, and the evaluation of migration and invasion potential were performed on U87MG cells after PC-PLC inhibition with the xanthate D609. The intracellular metabolome was investigated by magnetic resonance spectroscopy; lactate levels and lactate dehydrogenase (LDH) activity were analyzed by colorimetric assay. Results Our studies demonstrated that CXCR4 and PC-PLC co-localize and are associated on U87MG cell membrane. D609 reduced CXCR4 expression, cell proliferation and invasion, interfering with AKT and EGFR activation and expression. Metabolic analyses showed a decrease in intracellular lactate concentration together with a decrement in LDH activity. Conclusions Our data suggest that inhibition of PC-PLC could represent a new molecular approach in glioma biology not only for its ability in modulating cell metabolism, glioma growth and motility, but also for its inhibitory effect on crucial molecules involved in cancer progression.	[Mercurio, Laura; Cecchetti, Serena; Ricci, Alessandro; Pacella, Aurora; Podo, Franca; Iorio, Egidio; Carpinelli, Giulia] Ist Super Sanita, Dept Cell Biol & Neurosci, Rome, Italy; [Cigliana, Giovanni] Regina Elena Inst Canc Res, Clin Pathol Labs, Dept Res Adv Diagnost & Technol Innovat, Translat Res Area, Rome, Italy; [Bozzuto, Giuseppina] Ist Super Sanita, Dept Technol & Hlth, Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS)	Cecchetti, S; Iorio, E (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Rome, Italy.	serena.cecchetti@iss.it; egidio.lorio@iss.it	Iorio, Egidio/M-7077-2017; Mercurio, Laura/K-2750-2018; Cigliana, Giovanni/AAA-6570-2019; Bozzuto, Giuseppina/E-9094-2015; Cecchetti, Serena/N-1061-2015	Iorio, Egidio/0000-0001-6673-3838; Mercurio, Laura/0000-0003-0629-1729; Bozzuto, Giuseppina/0000-0002-9761-3326; Cecchetti, Serena/0000-0002-3601-176X	Associazione Italiana per la Ricerca sul Cancro (AIRC); Special Program Alleanza Controil Cancro, Ministry of Health, Italy [ACC3-AC9]; Programma Oncotecnologico [ISS/13ONC/5]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Alleanza Controil Cancro, Ministry of Health, Italy; Programma Oncotecnologico	This work was funded by grants from: Associazione Italiana per la Ricerca sul Cancro (AIRC) 2007-2010; Special Program Alleanza Controil Cancro 2006, ACC3-AC9 Ministry of Health, Italy; Programma Oncotecnologico ISS/13ONC/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; ALBINI A, 1987, CANCER RES, V47, P3239; Ali MM, 2013, TRANSL ONCOL, V6, P660, DOI 10.1593/tlo.13559; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canese R, 2009, CURR MED IMAGING, V5, P110, DOI 10.2174/157340509788185306; Cecchetti S, 2007, EUR J IMMUNOL, V37, P2912, DOI 10.1002/eji.200737266; Cecchetti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136120; Cichocki M, 2014, MOL CELL BIOCHEM, V396, P221, DOI 10.1007/s11010-014-2157-5; Cipriano R, 2013, ONCOTARGET, V4, P729, DOI 10.18632/oncotarget.1027; CLARK MA, 1986, BIOCHEM BIOPH RES CO, V140, P114, DOI 10.1016/0006-291X(86)91065-X; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Epstein RJ, 2004, NAT REV CANCER, V4, P901, DOI 10.1038/nrc1473; Fu D, 2009, J CELL BIOCHEM, V107, P686, DOI 10.1002/jcb.22163; Gagliardi F, 2014, GLIA, V62, P1015, DOI 10.1002/glia.22669; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong X, 2006, CANCER LETT, V236, P39, DOI 10.1016/j.canlet.2005.05.011; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Iorio E, 2013, METHODS MOL BIOL, V1049, P255, DOI 10.1007/978-1-62703-547-7_19; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Mercurio L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0326-y; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Paris L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2575; Peng SB, 2005, MOL CANCER RES, V3, P227; Pisanu ME, 2014, BRIT J CANCER, V110, P625, DOI 10.1038/bjc.2013.758; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Podo F, 1996, ANTICANCER RES, V16, P1399; Podo F, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00171; Podo F, 2011, NMR BIOMED, V24, P648, DOI 10.1002/nbm.1658; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Ramoni C, 2004, EXP CELL RES, V299, P370, DOI 10.1016/j.yexcr.2004.05.037; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Rinaudo M, 2015, EAS, p[252, 85]; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Sesen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123721; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Spinello I, 2001, BLOOD CANC J, V1, pe26; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tseng D, 2011, BRIT J CANCER, V104, P1805, DOI 10.1038/bjc.2011.169; WARBURG O, 1956, SCIENCE, V124, P269; Wu WH, 2013, ACTA BIOCH BIOPH SIN, V45, P18, DOI 10.1093/abbs/gms104; Zhang J, 2005, CARCINOGENESIS, V26, P2069, DOI 10.1093/carcin/bgi183; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200	53	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176108	10.1371/journal.pone.0176108	http://dx.doi.org/10.1371/journal.pone.0176108			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423060	Green Submitted, gold, Green Published			2022-12-27	WOS:000399875600089
J	Wells, S; Rafter, N; Kenealy, T; Herd, G; Eggleton, K; Lightfoot, R; Arcus, K; Wadham, A; Jiang, YN; Bullen, C				Wells, Sue; Rafter, Natasha; Kenealy, Timothy; Herd, Geoff; Eggleton, Kyle; Lightfoot, Rose; Arcus, Kim; Wadham, Angela; Jiang, Yannan; Bullen, Chris			The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation	PLOS ONE			English	Article							DISEASE; POCT	Objectives To assess the effect of a point of care (POC) device for testing lipids and HbA(1c) in addition to testing by community laboratory facilities (usual practice) on the completion of cardiovascular disease (CVD) risk assessments in general practice. Methods We conducted a pragmatic, cluster randomised controlled trial in 20 New Zealand general practices stratified by size and rurality and randomised to POC device plus usual practice or usual practice alone (controls). Patients aged 35-79 years were eligible if they met national guideline criteria for CVD risk assessment. Data on CVD risk assessments were aggregated using a web-based decision support programme common to each practice. Data entered into the on-line CVD risk assessment form could be saved pending blood test results. The primary outcome was the proportion of completed CVD risk assessments. Qualitative data on practice processes for CVD risk assessment and feasibility of POC testing were collected at the end of the study by interviews and questionnaire. The POC testing was supported by a comprehensive quality assurance programme. Results A CVD risk assessment entry was recorded for 7421 patients in 10 POC practices and 6217 patients in 10 control practices; 99.5% of CVD risk assessments had complete data in both groups (adjusted odds ratio 1.02 [95% CI 0.61-1.69]). There were major external influences that affected the trial: including a national performance target for CVD risk assessment and changes to CVD guidelines. All practices had invested in systems and dedicated staff time to identify and follow up patients to completion. However, the POC device was viewed by most as an additional tool rather than as an opportunity to review practice work flow and leverage the immediate test results for patient education and CVD risk management discussions. Shortly after commencement, the trial was halted due to a change in the HbA(1c) test assay performance. The trial restarted after the manufacturing issue was rectified but this affected the end use of the device. Conclusions Performance incentives and external influences were more powerful modifiers of practice behaviours than the POC device in relation to CVD risk assessment completion. The promise of combining risk assessment, communication and management within one consultation was not realised. With shifts in policy focus, the utility of POC devices for patient engagement in CVD preventive care may be demonstrated if fully integrated into the clinical setting.	[Wells, Sue] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland, New Zealand; [Rafter, Natasha; Wadham, Angela; Jiang, Yannan; Bullen, Chris] Univ Auckland, Natl Inst Hlth Innovat, Sch Populat Hlth, Auckland, New Zealand; [Kenealy, Timothy; Eggleton, Kyle] Univ Auckland, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Auckland, New Zealand; [Herd, Geoff] Whangarei Hosp, Northland Dist Hlth Board, Whangarei, New Zealand; [Lightfoot, Rose] Te Tai Tokerau Primary Hlth Org, Kaitaia, New Zealand; [Arcus, Kim] Natl Heart Fdn New Zealand, Auckland, New Zealand; [Rafter, Natasha] Royal Coll Surg Dublin, Dept Epidemiol & Publ Hlth Med, Dublin, Ireland	University of Auckland; University of Auckland; University of Auckland; Royal College of Surgeons - Ireland	Wells, S (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland, New Zealand.	s.wells@auckland.ac.nz	Eggleton, Kyle/AAC-4573-2019; Bullen, Chris/E-4594-2017	Eggleton, Kyle/0000-0001-5645-8326; Bullen, Chris/0000-0001-6807-2930	Roche Diagnostics International Ltd; Roche Diagnostics NZ Ltd; National Heart Foundation of New Zealand Research Fellowship	Roche Diagnostics International Ltd; Roche Diagnostics NZ Ltd; National Heart Foundation of New Zealand Research Fellowship	This study was supported by funding from Roche Diagnostics International Ltd and Roche Diagnostics NZ Ltd. The funders contributed to discussions about the study design and all aspects are reported in the methods section. The funders provided the POC device, consumables and training for practices on the use of the tool. The funders had otherwise no role in the data collection, analysis, decision to publish or preparation of the manuscript. SW has a Stevenson Fellowship in Health Innovation and Quality Improvement. This sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Natasha Rafter was the recipient of a National Heart Foundation of New Zealand Research Fellowship. This sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ETHN DAT PROT HLTH D; [Anonymous], 2013, NZ PRIM CAR HDB 2012; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briggs C, 2012, BRIT J HAEMATOL, V158, P679, DOI 10.1111/j.1365-2141.2012.09207.x; Bubner TK, 2009, MED J AUSTRALIA, V190, P624, DOI 10.5694/j.1326-5377.2009.tb02590.x; Cals J, 2013, EUR J GEN PRACT, V19, P251, DOI 10.3109/13814788.2013.800041; Chan WC, 2008, NZ MED J, V121, P3341; Creswell JW, 2004, ANN FAM MED, V2, P7, DOI 10.1370/afm.104; Dalsgaard EM, 2009, DIABETIC MED, V26, P518, DOI 10.1111/j.1464-5491.2009.02715.x; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Elley CR, 2005, AUST NZ J PUBL HEAL, V29, P461, DOI 10.1111/j.1467-842X.2005.tb00227.x; FRANKS P, 1991, J FAM PRACTICE, V32, P614; Gialamas A, 2010, FAM PRACT, V27, P17, DOI 10.1093/fampra/cmp084; Gialamas A, 2009, MED J AUSTRALIA, V191, P487, DOI 10.5694/j.1326-5377.2009.tb02910.x; Greenhalgh T, 2011, MILBANK Q, V89, P533, DOI 10.1111/j.1468-0009.2011.00642.x; Hobbs FD, 1997, HEALTH TECHNOL ASSES, V1, p[i, 1]; Holmes JS, 2005, MED CARE, V43, P33; Kenealy TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116188; Kirschner K, 2013, AUST J PRIM HEALTH, V19, P102, DOI 10.1071/PY12032; Laurence CO, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-165; Laurence CO, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483508; Lenters-Westra E, 2014, CLIN CHEM, V60, P1062, DOI 10.1373/clinchem.2014.224311; Ministry of Health, 2015, IS MY PHO PERF 2014; Ministry of Health, 2014, MORT DEM DAT 2011; Ministry of Health, 2014, HLTH TARG MOR HEART; Ministry of Health, 2015, POP NORTHL DHB; Ministry of Health, 2014, NZ HLTH SURV ANN UPD; Ministry of Health, 2013, HLTH LOSS NZ REPORT; Musaad SMA, 2013, NEW ZEAL MED J, V126, P72; Nijhof N, 2008, J COMMUN HEALTH, V33, P313, DOI 10.1007/s10900-008-9099-3; nz, 2014, BEST PRACT J, P347; Pawson R., 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Perera ML, 2014, EMERG MED AUSTRALAS, V26, P549, DOI 10.1111/1742-6723.12300; Rothman K., 1998, MODERN EPIDEMIOLOGY; Salmond C., 2007, NZDEP2006 INDEX DEPR; Shi Q, 2014, DIABETES CARE, V37, P1321, DOI 10.2337/dc13-1038; Stange KC, 2001, FAM MED, V33, P286; Tsuyuki RT, 2002, ARCH INTERN MED, V162, P1149, DOI 10.1001/archinte.162.10.1149; Wells S, 2015, INT J EPIDEMIOLOGY; Wells S, 2008, EUR J CARDIOV PREV R, V15, P173, DOI 10.1097/HJR.0b013e3282f13af4; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; WILCOX LS, 1993, PUBLIC HEALTH REP, V108, P76	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174504	10.1371/journal.pone.0174504	http://dx.doi.org/10.1371/journal.pone.0174504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KK	28422968	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600017
J	Jones, JJ; Bond, RM; Bakshy, E; Eckles, D; Fowler, JH				Jones, Jason J.; Bond, Robert M.; Bakshy, Eytan; Eckles, Dean; Fowler, James H.			Social influence and political mobilization: Further evidence from a randomized experiment in the 2012 US presidential election	PLOS ONE			English	Article							NETWORK; SPREAD; BEHAVIOR; ADOPTION	A large-scale experiment during the 2010 U.S. Congressional Election demonstrated a positive effect of an online get-out-the-vote message on real world voting behavior. Here, we report results from a replication of the experiment conducted during the U.S. Presidential Election in 2012. In spite of the fact that get-out-the-vote messages typically yield smaller effects during high-stakes elections due to saturation of mobilization efforts from many sources, a significant increase in voting was again observed. Voting also increased significantly among the close friends of those who received the message to go to the polls, and the total effect on the friends was likely larger than the direct effect, suggesting that understanding social influence effects is potentially even more important than understanding the direct effects of messaging. These results replicate earlier work and they add to growing evidence that online social networks can be instrumental for spreading offline behaviors.	[Jones, Jason J.] SUNY Stony Brook, Dept Sociol, Stony Brook, NY 11794 USA; [Jones, Jason J.] SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA; [Bond, Robert M.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA; [Bakshy, Eytan; Eckles, Dean] Facebook, Menlo Pk, CA USA; [Fowler, James H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio State University; Facebook Inc; University of California System; University of California San Diego; University of California System; University of California San Diego	Jones, JJ (corresponding author), SUNY Stony Brook, Dept Sociol, Stony Brook, NY 11794 USA.; Jones, JJ (corresponding author), SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA.	jason.j.jones@stonybrook.edu	Bond, Robert Meade/A-1561-2014; Jones, Jason J/I-3350-2012	Jones, Jason J/0000-0002-4140-0268; Eckles, Dean/0000-0001-8439-442X				Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Aronow PM, 2012, SOCIOL METHOD RES, V41, P3, DOI 10.1177/0049124112437535; Athey S, J AM STAT A IN PRESS; Bakshy E, 2014, P WWW2014; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Federal Election Commission, 2012, FEC SUMM CAMP ACT 20; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gerber AS, ELECTORAL S IN PRESS; Green D.P., 2008, GET OUT VOTE INCREAS, V2nd ed.; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Miratrix LW, 2013, J R STAT SOC B, V75, P369, DOI 10.1111/j.1467-9868.2012.01048.x; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pew Research Center, 2010, NEWS COV SURP INT CA; Pew Research Center, GOP HOLDS EARL TURN; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066	26	68	68	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0173851	10.1371/journal.pone.0173851	http://dx.doi.org/10.1371/journal.pone.0173851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445476	Green Published, Green Submitted, gold			2022-12-27	WOS:000400309200002
J	Sanchis, MLB; Cesani, MF; Oyhenart, EE				Bergel Sanchis, Maria Laura; Florencia Cesani, Maria; Edith Oyhenart, Evelia			Contexts of occurrence of child malnutrition in the district of Villaguay, Entre Rios, Argentina. A multivariate analysis	PLOS ONE			English	Article							NUTRITION TRANSITION; BODY-COMPOSITION; SOCIOECONOMIC-STATUS; OBESITY; UNDERNUTRITION; GROWTH; SCHOOLCHILDREN; COUNTRIES; BURDEN; HEALTH	The analysis of nutritional status is anthropologically important to address the complex interaction of biological, social, political, economic and cultural factors. To deepen the knowledge about contexts of occurrence of child malnutrition, we analyzed nutritional status in relation to socio-environmental conditions of residence in children between three and six years from Villaguay, Entre RoAos, Argentina. We performed a cross-sectional study of 1,435 school children of both sexes. Body weight and height were measured and prevalence of low height/age (LH/A), low weight/age (LW/A), low BMI/age (LBMI/A), overweight (Ow) and obesity (Ob) was calculated using World Health Organization reference charts. Socio-environmental information was obtained through a semi-structured survey and processed by Categorical Principal Component Analysis (CatPCA). Anthropometric data showed 1.5% LW/A, 5.2% LH/A; 0.6% LBMI/A, 20.9% Ow and 10.9% Ob. CatPCA allowed us to define four groups (G1-G4) with better (G2), middle (G1) and worst (G4) urban socio-environmental conditions and one with rural characteristics (G3). G4 presented the highest LH/A prevalence and G2 the highest Ow and Ob prevalence (P<0.05). It is concluded that since the distribution of malnutrition was not even it may dependent on the context in which children grow up. Thus, the higher the socio-economic level, the higher the incidence of overweight and obesity. Conversely, at the other end of the social scale, undernutrition and increasing weight excess remained major health problems.	[Bergel Sanchis, Maria Laura; Florencia Cesani, Maria; Edith Oyhenart, Evelia] UNLP, Fac Ciencias Vet, UNLP CONICET La Plata, IGEVET Inst Genet Vet Ing Fernando Noel Dulout, La Plata, Buenos Aires, Argentina; [Edith Oyhenart, Evelia] UNLP, Fac Ciencias Nat & Museo, Catedra Antropol Biol 4, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Museo La Plata	Sanchis, MLB (corresponding author), UNLP, Fac Ciencias Vet, UNLP CONICET La Plata, IGEVET Inst Genet Vet Ing Fernando Noel Dulout, La Plata, Buenos Aires, Argentina.	lbergel@igevet.gob.ar	Cesani, María Florencia/AAE-8475-2021	Bergel Sanchis, Maria Laura/0000-0002-4293-9855				Adjemian D, 2007, ARCH LATINOAM NUTR, V57, P125; Aguirre P., 2005, ESTRATEGIAS CONSUMO; Álvarez-Castaño Luz Stella, 2012, Rev. Gerenc. Polit. Salud, V11, P98; [Anonymous], 2002, NUTR TRANSITION DIET; Bejarano Ignacio, 2005, Arch. argent. pediatr., V103, P101; Bergel Sanchís María L, 2016, Rev Arg Antrop Biol, V18, DOI 10.17139/ raab.2016.0018.02.09; Bolzán Andrés, 2005, Arch. argent. pediatr., V103, P545; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Carvalho A. T., 2014, J HUMAN GROWTH DEV, V24, P221; Cesani MF, 2010, ARCH ARGENT PEDIATR, V108, P294, DOI 10.1590/S0325-00752010000400002; CESNI/SAOTA, 2012, HAC MAP OB ARG; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Duran P, 2009, ARCH ARGENT PEDIATR, V107, P397, DOI 10.1590/S0325-00752009000500005; Ferreira VA, 2006, REV PORTUGUESA SAUDE, V24, P71; FERREIRA Viviane Gualberto, 2003, THESIS, P87; Gardner G, 2000, NOURISHING UNDERFED; Garraza M, 2016, AM J HUM BIOL, V28, P796, DOI 10.1002/ajhb.22869; Laurentin Alexander, 2007, An Venez Nutr, V20, P47; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lomaglio DB, 2012, NUTR CLIN DIET HOSP, V32, P30; Martorell R, 1998, J NUTR, V128, P1464, DOI 10.1093/jn/128.9.1464; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; Motta M E, 2001, J Pediatr (Rio J), V77, P288; OMS, 1995, INF SAL MUND 1995 RE; OPS, 2008, MALN INF YOUNG CHILD; Ortale S, 2002, THESIS; Oyhenart E, 2008, REV ARGENTINA ANTROP, V10, P1; Oyhenart EE, 2005, REV ARG ANTROP BIOL, V7, P35; Oyhenart EE, 2008, AM J HUM BIOL, V20, P399, DOI 10.1002/ajhb.20738; Oyhenart EE, 2007, REV PANAM SALUD PUBL, V22, P194, DOI 10.1590/S1020-49892007000800006; Paraje G., 2008, CEPAL SERIE POLITICA; Pedraza DF, 2009, SAUDE SOC-SAO PAULO, V18, P103, DOI 10.1590/S0104-12902009000100011; Pena M, 2001, Rev Panam Salud Publica, V10, P75; Pena M., 2000, Obesity and poverty: a new public health challenge., P3; Pena M, 2005, REV FUTUROS, V3; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poletti Oscar H., 2007, Arch. argent. pediatr., V105, P293; Popkin B. M., 1998, ENCY HUMAN NUTR, P1562; Popkin BM, 2009, NESTLE NUTR WORKS SE, V63, P1, DOI 10.1159/000209967; Prieto L, 1998, MED CLIN-BARCELONA, V110, P142; Caro AR, 2009, REV ESP SALUD PUBLIC, V83, P25, DOI 10.1590/s1135-57272009000100003; Sanchis M L Bergel, 2014, THESIS; Stunkard AJ, 2000, OBESIDAD POBREZA NUE, P27; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; UNICEF, 2011, EST MUND INF; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wanderley EN, 2010, CIENC SAUDE COLETIVA, V15, P185, DOI 10.1590/S1413-81232010000100024; World Health Organization, 2008, OB OV; Zonta M. L., 2011, Nutricion Clinica y Dietetica Hospitalaria, V31, P48	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176346	10.1371/journal.pone.0176346	http://dx.doi.org/10.1371/journal.pone.0176346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441444	Green Published, gold			2022-12-27	WOS:000400308800049
J	Oldrini, G; Huertas, A; Renard-Oldrini, S; Taste-George, H; Vogin, G; Laurent, V; Salleron, J; Henrot, P				Oldrini, Guillaume; Huertas, Andres; Renard-Oldrini, Sophie; Taste-George, Helene; Vogin, Guillaume; Laurent, Valerie; Salleron, Julia; Henrot, Philippe			Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma	PLOS ONE			English	Article							ABLATIVE RADIOTHERAPY; LIVER; FEASIBILITY; CYBERKNIFE; EFFICACY	Background To evaluate the MRI features of a tumor response, local control, and predictive factors of local control after stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Methods Thirty-five consecutive patients with 48 HCCs who were treated by SBRT were included in this retrospective study. All patients provided written informed consent to be treated by SBRT, and prior to inclusion they authorized use of the treatment data for further studies. The assessment was made using MRI, with determination of local and hepatic responses according to Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST (mRECIST) criteria during a two-year follow-up. Results The local response rate according to mRECIST was higher than with RECIST. A tumor diameter less than 20 mm at baseline was an independent predictive factor for RECIST and mRECIST responses, as was diffusion-weighted signal for RECIST. During follow-up, a tumor diameter of <20 mm (p = 0.034) and absence of a high intensity on T2-weighted (p = 0.006) and diffusion-weighted images (p = 0.039) were associated with a better response according to RECIST. Post-treatment changes include peritumoral ring-like enhanced changes with high intensity on T2-weighted images. Conclusions SBRT is a promising technique for the treatment of inoperable HCC. Post-treatment changes on MRI images can resemble tumor progression and as such must be adequately distinguished.The regression of tumorous enhancement is variable over time, although diffusion-weighted and T2-weighted intensities are predictive factors for tumor RECIST responses on subsequent MRIs. They hence provide a way to reliably predict treatment responses.	[Oldrini, Guillaume; Henrot, Philippe] Inst Cancerol Lorraine, Serv Imagerie, Vandoeuvre Les Nancy, France; [Huertas, Andres; Renard-Oldrini, Sophie; Taste-George, Helene; Vogin, Guillaume] Inst Cancerol Lorraine, Serv Radiotherapie, Vandoeuvre Les Nancy, France; [Laurent, Valerie] CHU Nancy, Dept Radiol Adulte, Vandoeuvre Les Nancy, France; [Salleron, Julia] Inst Cancerol Lorraine, Cellule Data Biostat, Vandoeuvre Les Nancy, France	UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU de Nancy; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Oldrini, G (corresponding author), Inst Cancerol Lorraine, Serv Imagerie, Vandoeuvre Les Nancy, France.	g.oldrini@nancy.unicancer.fr	Laurent, Valerie/AAA-9259-2022; Oldrini, Guillaume/O-5198-2017	Oldrini, Guillaume/0000-0002-5638-3560; Vogin, Guillaume/0000-0002-8114-5900				Adler JR, 2009, NEUROSURGERY, V64, pA1, DOI 10.1227/01.NEU.0000312703.46158.54; Adler JR, 1997, STEREOT FUNCT NEUROS, V69, P124, DOI 10.1159/000099863; Bae SH, 2013, J KOREAN MED SCI, V28, P213, DOI 10.3346/jkms.2013.28.2.213; Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; Bibault JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077472; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; De Bari B, 2011, CANCER RADIOTHER, V15, P43, DOI 10.1016/j.canrad.2010.11.009; Facciuto ME, 2011, J SURG ONCOL, V105, P692, DOI DOI 10.1002/JS0.22104; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lo CH, 2014, EUR J GASTROEN HEPAT, V26, P345, DOI 10.1097/MEG.0000000000000032; Maddala YK, 2004, LIVER TRANSPLANT, V10, P449, DOI 10.1002/lt.20099; Maturen KE, 2013, RADIOGRAPHICS, V33, P599, DOI 10.1148/rg.332125119; Mornex F, 2006, INT J RADIAT ONCOL, V66, P1152, DOI 10.1016/j.ijrobp.2006.06.015; Oldrini G, 2015, DIAGN INTERV IMAG, V96, P589, DOI 10.1016/j.diii.2014.01.010; Park MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090327; Price TR, 2012, CANCER-AM CANCER SOC, V118, P3191, DOI 10.1002/cncr.26404; Sanuki N, 2013, AM J ROENTGENOL, V201, pW812, DOI 10.2214/AJR.12.10169; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282; Song PP, 2012, LIVER INT, V32, P1053, DOI 10.1111/j.1478-3231.2012.02792.x; Yoon SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079854	24	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176118	10.1371/journal.pone.0176118	http://dx.doi.org/10.1371/journal.pone.0176118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441447	gold, Green Published, Green Submitted			2022-12-27	WOS:000400308800026
J	Koulisis, N; Kim, AY; Chu, ZD; Shahidzadeh, A; Burkemper, B; de Koo, LCO; Moshfeghi, AA; Ameri, H; Puliafito, CA; Isozaki, VL; Wang, RKK; Kashani, AH				Koulisis, Nicole; Kim, Alice Y.; Chu, Zhongdi; Shahidzadeh, Anoush; Burkemper, Bruce; de Koo, Lisa C. Olmos; Moshfeghi, Andrew A.; Ameri, Hossein; Puliafito, Carmen A.; Isozaki, Veronica L.; Wang, Ruikang K.; Kashani, Amir H.			Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography	PLOS ONE			English	Article							VEIN OCCLUSION; NONPERFUSION	Purpose To quantitatively evaluate the retinal microvasculature in human subjects with retinal venous occlusions (RVO) using optical coherence tomography angiography (OCTA). Design Retrospective, cross-sectional, observational case series. Participants Sixty subjects (84 eyes) were included (20 BRVO, 14 CRVO, 24 unaffected fellow eyes, and 26 controls). Methods OCTA was performed on a prototype, spectral domain-OCTA system in the 3x3mm central macular region. Custom software was used to quantify morphology and density of retinal capillaries using four quantitative parameters. The vasculature of the segmented retinal layers and nonsegmented whole retina were analyzed. Main outcome measures Fractal dimension (FD), vessel density (VD), skeletal density (SD), and vessel diameter index (VDI) within the segmented retinal layers and nonsegmented whole retina vasculature. Results Nonsegmented analysis of RVO eyes demonstrated significantly lower FD (1.64 +/- 0.01 vs 1.715 +/- 0.002; p<0.001), VD (0.32 +/- 0.01 vs 0.432 +/- 0.002; p<0.001), and SD (0.073 +/- 0.004 vs0.099 +/- 0.001; p<0.001) compared to controls. Compared to the fellow eye, FD, VD and SD were lower ( p<0.001), and VDI was higher ( p<0.001). FD, VD, and SD progressively decreased as the extent ( or type) of RVO increased ( control vs BRVO vs CRVO; p<0.001). In the unaffected fellow eye FD, VD and SD showed significant differences when compared to control eyes or affected RVO eyes ( p<0.001). Conclusions Quantitative OCTA of the central 3x3mm macular region demonstrates significant differences in capillary density and morphology among subjects with BRVO and CRVO compared to controls or unaffected fellow eyes in all vascular layers. The unaffected fellow eyes also demonstrate significant differences when compared to controls. OCTA allows for noninvasive, layer-specific, quantitative evaluation of RVO-associated microvascular changes.	[Koulisis, Nicole; Kim, Alice Y.; Shahidzadeh, Anoush; Burkemper, Bruce; Moshfeghi, Andrew A.; Ameri, Hossein; Puliafito, Carmen A.; Isozaki, Veronica L.; Kashani, Amir H.] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Koulisis, Nicole] Univ Massachusetts, Sch Med, Worcester, MA USA; [Chu, Zhongdi; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [de Koo, Lisa C. Olmos] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA	University of Southern California; University of Massachusetts System; University of Massachusetts Worcester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kashani, AH (corresponding author), Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Ophthalmol, Los Angeles, CA 90033 USA.	ahkashan@med.usc.edu	Wang, Ruikang/L-3889-2019; Chu, Zhongdi/F-9604-2019	Wang, Ruikang/0000-0001-5169-8822; Chu, Zhongdi/0000-0001-7430-5032	USC, grant from Research to Prevent Blindness, New York [NY 10022]; National Eye Institute [R01EY024158, 1K08EY027006-01]; Carl Zeiss Meditec, Inc., Dublin, CA [94568]; NATIONAL EYE INSTITUTE [K08EY027006] Funding Source: NIH RePORTER	USC, grant from Research to Prevent Blindness, New York; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Carl Zeiss Meditec, Inc., Dublin, CA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by an internal grant from USC, an unrestricted grant from Research to Prevent Blindness, New York, NY 10022, by the National Eye Institute (R01EY024158 and 1K08EY027006-01), and by Carl Zeiss Meditec, Inc., Dublin, CA, 94568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P1783, DOI 10.1016/j.ophtha.2014.03.021; Campochiaro PA, 2013, OPHTHALMOLOGY, V120, P795, DOI 10.1016/j.ophtha.2012.09.032; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Holladay JT, 1997, J REFRACT SURG, V13, P388; Kashani AH, 2015, RETINA-J RET VIT DIS, V35, P2323, DOI 10.1097/IAE.0000000000000811; Kim A. Y., 2016, INVEST OPHTH VIS SCI, V57, DOI DOI 10.1167/I0VS.15-18904; Kim AY, 2016, AM J OPHTHALMOL; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Kuehlewein L, 2015, OSLI RETINA, V46, P249, DOI 10.3928/23258160-20150213-19; Mastropasqua R, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/343515; Matsunaga D, 2014, OSLI RETINA, V45, P510, DOI 10.3928/23258160-20141118-04; Matsunaga DR, 2015, OSLI RETINA, V46, P796, DOI 10.3928/23258160-20150909-03; Nobre Cardoso J, 2015, AM J OPHTHALMOL; Pinhas A, 2015, RETINA-J RET VIT DIS, V35, P2028, DOI 10.1097/IAE.0000000000000586; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Rispoli M, 2015, RETINA-J RET VIT DIS, V35, P2332, DOI 10.1097/IAE.0000000000000845; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Samara WA, 2016, AM J OPHTHALMOL, V166, P76, DOI 10.1016/j.ajo.2016.03.033; Sellam A, 2016, QUALITATIVE QUANITAT; Shahlaee A, 2016, RETIN CASES BRIEF RE; YANNUZZI LA, 1986, OPHTHALMOLOGY, V93, P611; Zhang AQ, 2015, BIOMED OPT EXPRESS, V6, P4130, DOI 10.1364/BOE.6.004130	22	47	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176404	10.1371/journal.pone.0176404	http://dx.doi.org/10.1371/journal.pone.0176404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437483	Green Published, Green Submitted, gold			2022-12-27	WOS:000400287600048
J	Carroll, MJ; Brown, N; Goodall, C; Downs, AM; Sheenan, TH; Anderson, KE				Carroll, Mark J.; Brown, Nicholas; Goodall, Craig; Downs, Alexandra M.; Sheenan, Timothy H.; Anderson, Kirk E.			Honey bees preferentially consume freshly-stored pollen	PLOS ONE			English	Article							APIS-MELLIFERA L; FORAGING PREFERENCES; NUTRITIONAL CONTENT; WORKER HONEYBEES; PHEROMONE; COLONIES; CARBOHYDRATE; HYMENOPTERA; FORAGERS; BALANCE	Honey bees (Apis mellifera) collect and store both honey and pollen in preserved forms. Pollen storage involves the addition of honey or nectar and oral secretions to pollen granules. It is controversial whether the duration of pollen storage alters the palatability or nutritive value of the pollen storage medium. We examined how bees utilize different-aged stored pollen during an extended pollen flow. The deposition of pollen into wax cells and subsequent consumption were monitored daily on 18 brood frames from 6 colonies over an 8d observation period. Despite a greater abundance of older stored pollen cells on brood frames, bees showed a marked preference for the consumption of freshly-stored pollen. Two to four day-old pollen cell contents were significantly more likely to be consumed, while pollen cell contents more than seven days old were eaten at much lower rates. Similar experiments that controlled for cell abundance and spatial effects using cage assays yielded the same result. One day-old stored pollen was consumed approximately three times more often than 10d-old stored pollen, and two times more often than 5d-old stored pollen. These consumption preferences for freshly-stored pollen occurred despite a lack of clear developmental advantages. Young adult workers reared for 7 days on 1d-, 5d-, or 10d-old stored pollen showed no difference in body mass, stored pollen consumption, hindgut fecal material accumulation, or hypopharyngeal gland (HPG) protein titers, suggesting that different-aged pollen stores did not vary in their nutritional value to adult bees. These findings are inconsistent with the hypothesis promoting a period of microbially-mediated, "beebread maturation" that results in greater palatability or nutritive value for aged pollen stores. Rather, stored pollen that is not eaten in the first few days accumulates as excess stores preserved in a less preferred, but nutritionally-similar state.	[Carroll, Mark J.; Brown, Nicholas; Goodall, Craig; Sheenan, Timothy H.; Anderson, Kirk E.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Carroll, Mark J.; Downs, Alexandra M.; Anderson, Kirk E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Goodall, Craig] Univ Arizona, Coll Med, Tucson, AZ USA; [Downs, Alexandra M.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	United States Department of Agriculture (USDA); University of Arizona; University of Arizona; University of Arizona; University of California System; University of California Santa Barbara	Carroll, MJ (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.; Carroll, MJ (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	Mark.Carroll@ars.usda.gov		Downs, Alex/0000-0002-7220-231X	University of Arizona UBRP scholarship; USDA-ARS, an equal opportunity employer and provider	University of Arizona UBRP scholarship; USDA-ARS, an equal opportunity employer and provider	The author(s) received no specific funding for this work. AD was supported by an University of Arizona UBRP scholarship during this study.; We would like to thank Austin Brown for technical support. This work was supported by the USDA-ARS, an equal opportunity employer and provider.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alqarni A. S., 2006, Journal of Biological Sciences, V6, P734; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arenas A, 2014, J INSECT PHYSIOL, V66, P28, DOI 10.1016/j.jinsphys.2014.05.010; Arenas A, 2012, ANIM BEHAV, V83, P1023, DOI 10.1016/j.anbehav.2012.01.026; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Behrends A, 2012, J EXP BIOL, V215, P1076, DOI 10.1242/jeb.063297; BOELTER AM, 1984, AM BEE J, V124, P609; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Cook SM, 2005, PHYSIOL ENTOMOL, V30, P164, DOI 10.1111/j.1365-3032.2005.00445.x; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Corby-Harris V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-134; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, ZOOL JAHRB ALLG ZOOL, V94, P303; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; DUSTMANN JH, 1988, APIDOLOGIE, V19, P245, DOI 10.1051/apido:19880304; EISHCHEN FA, 1982, J APICULT RES, V21, P19, DOI 10.1080/00218839.1982.11100511; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Free J. B., 1987, PHEROMONES SOCIAL BE; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Harano K, 2014, NATURWISSENSCHAFTEN, V101, P595, DOI 10.1007/s00114-014-1185-z; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; Hendriksma HP, 2016, BEHAV ECOL SOCIOBIOL, V70, P509, DOI 10.1007/s00265-016-2067-5; Herbert E.W., 1992, HIVE HONEY BEE, P197; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; JAY SC, 1964, CAN J ZOOLOG, V42, P455, DOI 10.1139/z64-039; Judd Timothy M., 2011, P1; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Maes PW, 2016, MOL ECOL, V25, P5439, DOI 10.1111/mec.13862; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Mattila HR, 2007, ECOL ENTOMOL, V32, P496, DOI 10.1111/j.1365-2311.2007.00904.x; Maurizio A, 1954, POLLENERNAHRUNG LEBE, V68, P115; MCNALLY LC, 1992, INSECT SOC, V39, P167, DOI 10.1007/BF01249292; Naiem ES, 1999, J COMP PHYSIOL B, V169, P271, DOI 10.1007/s003600050221; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; O'Neal R. J., 1984, Desert Plants, V6, P81; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROSCH G. A., 1930, ZEITSCHR WISSENSCH BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V12, P1, DOI 10.1007/BF00339476; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sagili RR, 2009, J INSECT BEHAV, V22, P339, DOI 10.1007/s10905-009-9176-1; Saraiva MA, 2015, ANTON LEEUW INT J G, V107, P921, DOI 10.1007/s10482-015-0384-8; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT JO, 1984, SOUTHWEST ENTOMOL, V9, P41; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Schulz DJ, 2002, INSECT SOC, V49, P50, DOI 10.1007/s00040-002-8279-x; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shreve F., 1964, VEGETATION FLORA SON; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SPIVAK M, 1992, J APPL ECOL, V29, P150, DOI 10.2307/2404358; STANDIFER L N, 1973, American Bee Journal, V113, P94; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vaudo AD, 2016, P NATL ACAD SCI USA, V113, pE4035, DOI 10.1073/pnas.1606101113; Winston M., 1987, The biology of the honey bee.; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133; Zar J.H., 2010, BIOSTAT ANAL	79	43	43	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175933	10.1371/journal.pone.0175933	http://dx.doi.org/10.1371/journal.pone.0175933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430801	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100024
J	Fu, WW; Fu, TS; Jing, R; McFaull, SR; Cusimano, MD				Fu, Wayne W.; Fu, Terence S.; Jing, Rowan; McFaull, Steven R.; Cusimano, Michael D.			Predictors of falls and mortality among elderly adults with traumatic brain injury: A nationwide, population-based study	PLOS ONE			English	Article							OLDER-ADULTS; MULTIFACTORIAL INTERVENTION; REDUCE FALLS; RISK; AGE; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PREVENTION; SEVERITY	Background Elderly adults are at particular risk of sustaining a traumatic brain injury (TBI), and tend to suffer worse outcomes compared to other age groups. Falls are the leading cause of TBI among the elderly. Methods We examined nationwide trends in TBI hospitalizations among elderly adults (ages 65 and older) between April 2006 and March 2011 using a population-based database that is mandatory for all hospitals in Canada. Trends in admission rates were analyzed using linear regression. Predictors of falls and in-hospital mortality were identified using logistic regression. Results Between 2006 and 2011, there were 43,823 TBI hospitalizations resulting in 6,939 deaths among elderly adults in Canada. Over the five-year study period, the overall rate of TBI admissions increased by an average of 6% per year from 173.2 to 214.7 per 100,000, while the rate of fall-related TBI increased by 7% annually from 138.6 to 179.2 per 100,000. There were significant trends towards increasing age and comorbidity level (p< 0.001 and p = 0.002). Advanced age, comorbidity, and injury severity were independent predictors of both TBI-related falls and mortality on multivariate analysis. Conclusion Prevention efforts should be targeted towards vulnerable demographics including the "older old" (ages 85 and older) and those with multiple medical comorbidities. Additionally, hospitals and long-term care facilities should be prepared to manage the burgeoning population of older patients with more complex comorbidities.	[Fu, Wayne W.] Albany Med Coll, Albany, NY USA; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Univ Toronto, Toronto, ON, Canada; [McFaull, Steven R.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Injury Sect, Ottawa, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Albany Medical College; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Public Health Agency of Canada; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Bohnert N., 2014, POPULATION PROJECTIO; Campbell AJ, 2007, AGE AGEING, V36, P656, DOI 10.1093/ageing/afm122; Centers for Disease Control and Prevention, 2010, EXT CAUS INJ MORT MA; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CIoHI, 2012, CIHI DAT QUAL STUD 2; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2012, EPIDEMIOLOGY PREVENT, P45; Cryer C, 2006, INJURY PREV, V12, P67, DOI 10.1136/ip.2006.011668; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Gillespie LD, 2012, COCHRANE DATABASE SY, V9; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murphy TE, 2014, J GERONTOL GERIATR R, V3, P3; Ortman J. M., 2014, AGING NATION OLDER P, P25; Perula LA, 2012, ARCH PHYS MED REHAB, V93, P1677, DOI 10.1016/j.apmr.2012.03.035; Petridou ET, 2009, J AGING HEALTH, V21, P713, DOI 10.1177/0898264309338298; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, STANDARDS SURVEILLAN; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	46	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175868	10.1371/journal.pone.0175868	http://dx.doi.org/10.1371/journal.pone.0175868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430782	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100019
J	Grabias, B; Verma, N; Zheng, H; Tripathi, AK; Mlambo, G; Morin, MJ; Locke, E; Kumar, S				Grabias, Bryan; Verma, Nitin; Zheng, Hong; Tripathi, Abhai K.; Mlambo, Godfree; Morin, Merribeth J.; Locke, Emily; Kumar, Sanjai			A no film slot blot for the detection of developing P. falciparum oocysts in mosquitoes	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; MALARIA TRANSMISSION; PCR ASSAY; VIVAX; ANTIGEN; VACCINE; IDENTIFICATION; SPOROZOITES	Non-microscopy-based assays for sensitive and rapid detection of Plasmodium infection in mosquitoes are needed to allow rapid and high throughput measurement of transmission intensity and malaria control program effectiveness. Here, we report on a modified enhanced chemiluminescence-based slot blot assay for detection of Plasmodium falciparum (Pf) circumsporozite protein (PfCSP) expressed on parasite oocysts developing inside the mosquito midgut. This modified assay has several novel features that include eliminating the need for exposure to autoradiography (AR) film, as well as utilizing a novel high affinity anti-CSP antibody, and optimizing assay procedures resulting in significant reduction in the time required to perform the assay. The chemiluminescent signal for the detection of PfCSP in mosquito samples was captured digitally utilizing the C-Digit blot scanner that, allowed the detection of 0.01 pg of recombinant P. falciparum CSP and as few as 0.02 P. falciparum oocysts in a little over two hours. The earlier ECL-SB detected rCSP and oocysts and took approximately 5 h to perform. Whole mosquito lysates from both high and low prevalence-infected mosquito populations were prepared and evaluated for PfCSP detection on the ECL-SB by both AR film and digital data capture and analysis. There was a 100% agreement between the AR film and the C-Digit scanner methods for PfCSP detection in randomly sampled mosquitoes. This novel "No Film" Slot Blot assay obviates the need for AR film exposure and development and significantly reduces the assay time enabling widespread use in field settings.	[Grabias, Bryan; Verma, Nitin; Zheng, Hong; Kumar, Sanjai] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Morin, Merribeth J.; Locke, Emily] PATH Malaria Vaccine Initiat, Washington, DC USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, S (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Sanjay.Kumar@fda.hhs.gov		Tripathi, Abhai/0000-0001-9848-0142	PATH	PATH	Work on this study was supported through PATH. Representatives of PATH listed as coauthors on this manuscript contributed to the preparation of this manuscript.	Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; BEIER JC, 1987, AM J TROP MED HYG, V36, P459, DOI 10.4269/ajtmh.1987.36.459; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Collins KM, 2004, ANN TROP MED PARASIT, V98, P469, DOI 10.1179/000349804225003479; De Arruda ME, 2004, ANN TROP MED PARASIT, V98, P121, DOI 10.1179/000349804225003181; Eamkum P, 2014, PARASITOL INT, V63, P442, DOI 10.1016/j.parint.2013.11.001; Ferrer P, 2015, ANTIMICROB AGENTS CH, V59, P1418, DOI 10.1128/AAC.04642-14; Grabias B, 2015, J MICROBIOL METH, V108, P19, DOI 10.1016/j.mimet.2014.10.006; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Kohler G, 2005, J IMMUNOL, V174, P2453; Kumar R, 2013, VACCINE, V31, P3140, DOI 10.1016/j.vaccine.2013.05.006; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115807; Kumar S, 2013, J IMMUNOL METHODS, V390, P99, DOI 10.1016/j.jim.2013.02.001; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Sandeu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052719; Stone WJ, 2014, THE JOURNAL OF INFEC; Usui M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-118; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WIRTZ RA, 1985, AM J TROP MED HYG, V34, P1048, DOI 10.4269/ajtmh.1985.34.1048; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174229	10.1371/journal.pone.0174229	http://dx.doi.org/10.1371/journal.pone.0174229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430778	Green Published, Green Submitted, gold			2022-12-27	WOS:000399876100004
J	Aaron, CP; Hoffman, EA; Lima, JAC; Kawut, SM; Bertoni, AG; Vogel-Claussen, J; Habibi, M; Hueper, K; Jacobs, DR; Kalhan, R; Michos, ED; Post, WS; Prince, MR; Smith, BM; Ambale-Venkatesh, B; Liu, CY; Zemrak, F; Watson, KE; Budoff, M; Bluemke, DA; Barr, RG				Aaron, Carrie P.; Hoffman, Eric A.; Lima, Joao A. C.; Kawut, Steven M.; Bertoni, Alain G.; Vogel-Claussen, Jens; Habibi, Mohammadali; Hueper, Katja; Jacobs, David R., Jr.; Kalhan, Ravi; Michos, Erin D.; Post, Wendy S.; Prince, Martin R.; Smith, Benjamin M.; Ambale-Venkatesh, Bharath; Liu, Chia-Ying; Zemrak, Filip; Watson, Karol E.; Budoff, Matthew; Bluemke, David A.; Barr, R. Graham			Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study	PLOS ONE			English	Article							HEART-FAILURE; BLOOD-VOLUME; MYOCARDIAL FIBROSIS; COMPUTED-TOMOGRAPHY; CIGARETTE-SMOKING; ATHEROSCLEROSIS; EMPHYSEMA; DISEASE; ASSOCIATION; EXERCISE	Background Evaluation of impaired left ventricular (LV) filling has focused on intrinsic causes of LV dysfunction; however, pulmonary vascular changes may contribute to reduced LV filling and dyspnea. We hypothesized that lower total pulmonary vascular volume (TPVV) on computed tomography (CT) would be associated with dyspnea and decrements in LV end-diastolic volume, particularly among ever-smokers. Methods The Multi-Ethnic Study of Atherosclerosis recruited adults without clinical cardiovascular disease in 2000-02. In 2010-12, TPVV was ascertained as the volume of arteries and veins in the lungs detectable on non-contrast chest CT (vessels >= 1 mm diameter). Cardiac measures were assessed by magnetic resonance imaging (MRI). Dyspnea was selfreported. Results Of 2303 participants, 53% had ever smoked cigarettes. Among ever-smokers, a lower TPVV was associated with a lower LV end-diastolic volume (6.9 mL per SD TPVV), stroke volume, and cardiac output and with dyspnea (all P-values <0.001). Findings were similar among those without lung disease and those with 0-10 pack-years but were mostly non-significant among never-smokers. TPVV was associated smaller left atrial volume but not with LV ejection fraction or MRI measures of impaired LV relaxation. In a second sample of ever-smokers, a lower pulmonary microvascular blood volume on contrast-enhanced MRI was also associated with a lower LV end-diastolic volume (P-value = 0.008). Conclusion Reductions in pulmonary vascular volume were associated with lower LV filling and dyspnea among ever-smokers, including those without lung disease, suggesting that smoking-related pulmonary vascular changes may contribute to symptoms and impair cardiac filling and function without evidence of impaired LV relaxation.	[Aaron, Carrie P.; Smith, Benjamin M.; Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA USA; [Lima, Joao A. C.; Habibi, Mohammadali; Michos, Erin D.; Post, Wendy S.; Ambale-Venkatesh, Bharath; Liu, Chia-Ying] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Epidemiol, Philadelphia, PA USA; [Bertoni, Alain G.] Wake Forest Univ, Sch Med, Dept Med & Epidemiol & Prevent, Winston Salem, NC USA; [Vogel-Claussen, Jens; Hueper, Katja] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kalhan, Ravi] Northwestern Univ, Feinberg Sch Med, Asthma & COPD Program, Chicago, IL USA; [Michos, Erin D.; Post, Wendy S.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Prince, Martin R.] Columbia Univ, Dept Radiol, Coll Phys & Surg, New York, NY USA; [Smith, Benjamin M.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Liu, Chia-Ying; Zemrak, Filip; Bluemke, David A.] NIH, Ctr Clin, Radiol & Imaging Sci, Bethesda, MD USA; [Watson, Karol E.; Budoff, Matthew] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Iowa; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; Hannover Medical School; University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; McGill University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of California System; University of California Los Angeles; Columbia University	Aaron, CP (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA.	cp2346@columbia.edu	Watson, Karol/ABD-7425-2021; Habibi, Mohammadali/AAT-8531-2021; Vogel-Claussen, Jens/Q-3374-2019; Budoff, Matthew/ABD-5175-2021; Bluemke, David/GYU-8169-2022; Ambale Venkatesh, Bharath/F-4941-2016	Budoff, Matthew/0000-0002-9616-1946; Jacobs, David/0000-0002-7232-0543; Pistenmaa, Carrie/0000-0003-1563-1916; Hoffman, Eric/0000-0001-8456-9437; Bluemke, David/0000-0002-8323-8086; Bertoni, Alain/0000-0002-7503-6273; Zemrak, Filip/0000-0001-6730-4955; Ambale Venkatesh, Bharath/0000-0002-2330-2373; Kalhan, Ravi/0000-0003-2443-0876; Vogel-Claussen, Jens/0000-0001-5595-6948	National Institutes of Health/National Heart, Lung and Blood Institute [R01-HL077612, R01-HL093081, N01-HC95159-HC95169, UL1-TR000040]; US Environmental Protection Agency [R831697]; Quebec Health Research Fund (BMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122477, R01HL077612, R01HL093081, K24HL103844, R01HL112986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Environmental Protection Agency(United States Environmental Protection Agency); Quebec Health Research Fund (BMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health/National Heart, Lung and Blood Institute R01-HL077612 (RGB), R01-HL093081 (RGB), N01-HC95159-HC95169, UL1-TR000040; US Environmental Protection Agency R831697; Quebec Health Research Fund (BMS). The protocols of MESA and all studies described were approved by the National Heart Lung and Blood Institute. The authors, together with other MESA investigators, collected and analyzed the data, and wrote and submitted the manuscript for publication. NHLBI staff monitored study performance routinely and participated in internal manuscript review before submission.	Ambale-Venkatesh B, 2014, EUR HEART J-CARD IMG, V15, P442, DOI 10.1093/ehjci/jet189; Andersen MJ, 2014, CIRC-HEART FAIL, V7, P911, DOI 10.1161/CIRCHEARTFAILURE.114.001575; [Anonymous], 2008, MESA MAN OP; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094916; Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Cuttica MJ, 2015, AM J RESP CRIT CARE, V192, P76, DOI 10.1164/rccm.201501-0116OC; Donekal S, 2014, CIRC-CARDIOVASC IMAG, V7, P292, DOI 10.1161/CIRCIMAGING.113.001073; Estepar RSJ, 2013, AM J RESP CRIT CARE, V188, P231, DOI 10.1164/rccm.201301-0162OC; Fontana M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-88; GIUNTINI C, 1963, J CLIN INVEST, V42, P1589, DOI 10.1172/JCI104844; Grau M, 2013, CHEST, V144, P136, DOI 10.1378/chest.12-1779; Habibi M, 2014, JACC-CARDIOVASC IMAG, V7, P570, DOI 10.1016/j.jcmg.2014.01.016; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Iyer KS, 2016, AM J RESP CRIT CARE, V193, P652, DOI 10.1164/rccm.201506-1196OC; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kaess BM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002693; Kaufmann MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056826; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kawut SM, 2014, J AM COLL CARDIOL, V64, P2000, DOI 10.1016/j.jacc.2014.07.991; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Liu C.-Y., 2013, J CARDIOVASC MAGN R, V15, pO62; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Meyer T, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-1-201301010-01001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILNOR WR, 1960, CIRCULATION, V22, P130, DOI 10.1161/01.CIR.22.1.130; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; MOTLEY HL, 1947, AM J PHYSIOL, V150, P315, DOI 10.1152/ajplegacy.1947.150.2.315; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOOTENS M, 1995, AM J CARDIOL, V75, P374, DOI 10.1016/S0002-9149(99)80557-8; Oelsner EC, 2014, AM J MED; Ohyama Y, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004426; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Rommel KP, 2016, J AM COLL CARDIOL, V67, P1815, DOI 10.1016/j.jacc.2016.02.018; SAMET P, 1966, CIRCULATION, V33, P847, DOI 10.1161/01.CIR.33.6.847; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; SAXTON GA, 1956, J CLIN INVEST, V35, P611, DOI 10.1172/JCI103316; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Shikata H, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/636240; Sibley CT, 2012, RADIOLOGY, V265, P724, DOI 10.1148/radiol.12112721; Sieren JP, 2016, AM J RESP CRIT CARE, V194, P794, DOI 10.1164/rccm.201506-1208PP; Smith BM, 2013, CHEST, V144, P1143, DOI 10.1378/chest.13-0183; Smith BM, 2013, CIRCULATION, V127, P1503, DOI 10.1161/CIRCULATIONAHA.113.001653; Smith NL, 1999, J CLIN EPIDEMIOL, V52, P143, DOI 10.1016/S0895-4356(98)00141-3; Stone IS, 2016, AM J RESP CRIT CARE, V193, P717, DOI 10.1164/rccm.201508-1647OC; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Yamato H, 1996, LAB INVEST, V75, P211; Yi CJ, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0121-5; Young AA, 2000, RADIOLOGY, V216, P597, DOI 10.1148/radiology.216.2.r00au14597	65	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176180	10.1371/journal.pone.0176180	http://dx.doi.org/10.1371/journal.pone.0176180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426728	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875900116
J	de Haan, S; Rietveld, E; Stokhof, M; Denys, D				de Haan, Sanneke; Rietveld, Erik; Stokhof, Martin; Denys, Damiaan			Becoming more oneself? Changes in personality following DBS treatment for psychiatric disorders: Experiences of OCD patients and general considerations	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; PARKINSONS-DISEASE; AUTHENTICITY; NEUROSURGERY; ACCUMBENS; ENHANCEMENT; PERCEPTIONS; IMPULSIVITY; INCREASES	Does DBS change a patient's personality? This is one of the central questions in the debate on the ethics of treatment with Deep Brain Stimulation ( DBS). At the moment, however, this important debate is hampered by the fact that there is relatively little data available concerning what patients actually experience following DBS treatment. There are a few qualitative studies with patients with Parkinson's disease and Primary Dystonia and some case reports, but there has been no qualitative study yet with patients suffering from psychiatric disorders. In this paper, we present the experiences of 18 patients with Obsessive-Compulsive Disorder (OCD) who are undergoing treatment with DBS. We will also discuss the inherent difficulties of how to define and assess changes in personality, in particular for patients with psychiatric disorders. We end with a discussion of the data and how these shed new light on the conceptual debate about how to define personality.	[de Haan, Sanneke] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [de Haan, Sanneke] Radboud Univ Nijmegen, Fac Philosophy Theol & Religious Studies, Nijmegen, Netherlands; [Rietveld, Erik; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Rietveld, Erik] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Rietveld, Erik; Stokhof, Martin] Univ Amsterdam, Dept Philosophy, Inst Log Language & Computat, Amsterdam, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Humboldt University of Berlin; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	de Haan, S (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany.; de Haan, S (corresponding author), Radboud Univ Nijmegen, Fac Philosophy Theol & Religious Studies, Nijmegen, Netherlands.	Sannekedehaan@gmail.com	Stokhof, Martin/AAI-3468-2020	Rietveld, Erik/0000-0001-5197-142X; Stokhof, Martin/0000-0002-8966-8095	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	ER received a VIDI grant from the Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all participants of the study and their therapists at the AMC; Ron de Joode, Mariska Mantione, and Pieter Ooms. Thanks also to Sabine Muller, Merlin Bittlinger, Roy Dings, and Simon Raymaekers for their valuable feedback on an earlier version of this paper. Thanks to Julian Kiverstein for language corrections. Erik Rietveld gratefully acknowledges the support he obtained from the Netherlands Organisation for Scientific Research (NWO) in the form of a VIDI grant.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Agid Y, 2006, J NEURAL TRANSM-SUPP, P409; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; [Anonymous], 2011, AJOB NEUROSCIENCE, DOI DOI 10.1080/21507740.2010.537535; Baylis F, 2013, NEUROETHICS-NETH, V6, P513, DOI 10.1007/s12152-011-9137-1; Bergfeld IO, 2016, JAMA PSYCHIAT, V73, P456, DOI 10.1001/jamapsychiatry.2016.0152; Clausen J, 2010, EUR J NEUROSCI, V32, P1152, DOI 10.1111/j.1460-9568.2010.07421.x; de Haan S, 2015, FREE WILL AND THE BR; de Haan S, 2013, ANXIETY DISORDERS MO; de Haan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135524; de Haan S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00653; DEHAAN SE, 2014, AJOB NEUROSCIENCE, V5, P46; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Ding R., 2015, POWERTECH 2015 IEEE, P1; Dougherty DD, 2014, BIOLOGICAL PSYCHIATR; Erler A, 2014, PHILOS PSYCHIATR PSY, V21, P219, DOI 10.1353/ppp.2014.0032; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; FRANKFURT H, 1982, SYNTHESE, V53, P257, DOI 10.1007/BF00484902; Frankfurt HG., 1971, JOURNAL OF PHILOSOPH, V68; GALLAGHER S, 2013, FRONT HUM NEUROSCI, V7, P1; Glannon W, 2009, J MED ETHICS, V35, P289, DOI 10.1136/jme.2008.027789; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Grant RA, 2014, J CLIN NEUROSCI, V21, P1, DOI 10.1016/j.jocn.2013.04.004; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Haahr A, 2010, INT J NURS STUD, V47, P1228, DOI 10.1016/j.ijnurstu.2010.03.006; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Haq IU, 2010, STEREOT FUNCT NEUROS, V88, P322, DOI 10.1159/000319960; Hariz GM, 2016, J PARKINSON DIS, V6, P335, DOI 10.3233/JPD-160799; Hariz GM, 2014, NEUROMODULATION, V17, P272, DOI 10.1111/ner.12073; Hariz GM, 2011, MOVEMENT DISORD, V26, P2101, DOI 10.1002/mds.23796; Heyman I, 2006, BMJ-BRIT MED J, V333, P424, DOI 10.1136/bmj.333.7565.424; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Ineichen C, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030040; Johansson V, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00021; Klaming L, 2013, NEUROETHICS-NETH, V6, P527, DOI 10.1007/s12152-010-9093-1; Kraemer F, 2013, NEUROETHICS-NETH, V6, P483, DOI 10.1007/s12152-011-9115-7; Kraemer F, 2013, J MED ETHICS, V39, P757, DOI 10.1136/medethics-2011-100427; Kramer PD, 1997, LISTENING PROZAC; Krause M, 2001, J NEUROL NEUROSUR PS, V70, P464, DOI 10.1136/jnnp.70.4.464; Leentjens A F G, 2004, Ned Tijdschr Geneeskd, V148, P1394; Lewis CJ, 2015, PSYCHOL MED, V45, P73, DOI 10.1017/S0033291714001081; Lipsman N, 2009, BIOETHICS, V23, P375, DOI 10.1111/j.1467-8519.2009.01729.x; Luigjes J, 2011, INT CLIN PSYCHOPHARM, V26, P338, DOI 10.1097/YIC.0b013e32834af505; Mackenzie R., 2011, AM J BIOETHICS, V2, P18; Mackenzie R., 2011, FRONTIERS INTEGRATIV, V5, P1; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; Mantione M, 2014, PSYCHOL MED, P1; Mantione M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00152; MECACCI G, 2014, AJOB NEUROSCIENCE, V5, P30, DOI DOI 10.1080/21507740.2014.951776; Muller S, 2014, INT J LAW PSYCHIAT, V37, P295, DOI 10.1016/j.ijlp.2013.11.015; Muller S., 2011, AJOB NEUROSCI, V2, P3, DOI [10.1080/21507740.2010.533151, DOI 10.1080/21507740.2010.533151]; Okun MS, 2007, J NEUROL NEUROSUR PS, V78, P310, DOI 10.1136/jnnp.2006.095315; Pham U, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/490507; Rietveld E, 2014, ECOL PSYCHOL, V26, P325, DOI 10.1080/10407413.2014.958035; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Schechtman M., 2009, PERSONAL IDENTITY AN; Schechtman M, 2010, J CLIN ETHIC, V21, P133; Schermer M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00017; Schermer M, 2013, NEUROETHICS-NETH, V6, P435, DOI 10.1007/s12152-011-9097-5; Schupbach M, 2006, NEUROLOGY, V66, P1811, DOI 10.1212/01.wnl.0000234880.51322.16; Smeding HMM, 2007, J NEUROL NEUROSUR PS, V78, P517, DOI 10.1136/jnnp.2006.102061; Synofzik Matthis, 2008, Biotechnology Journal, V3, P1511, DOI 10.1002/biot.200800187; Synolzik M., 2012, AJOB NEUROSCIENCE, V3, P30, DOI [DOI 10.1080/21507740.2011.635633, 10.1080/21507740.2011.635633]; Tsai Hsin-Chi, 2010, Biol Psychiatry, V68, pe7, DOI 10.1016/j.biopsych.2010.04.001; Videnovic A, 2008, MOVEMENT DISORD, V23, P343, DOI 10.1002/mds.21753; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Wardrope A, 2014, J MED ETHICS, V40, P563, DOI 10.1136/medethics-2013-101419; Witt K, 2013, NEUROETHICS-NETH, V6, P499, DOI 10.1007/s12152-011-9100-1; Zahavi D., 2005, SUBJECTIVITY AND SEL	69	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175748	10.1371/journal.pone.0175748	http://dx.doi.org/10.1371/journal.pone.0175748			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426824	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900043
J	Hong, SE; Kim, TY; Yoo, JH; Kim, JK; Kim, SG; Kim, HJ; Song, YR				Hong, Seong Eun; Kim, Tae-Young; Yoo, Je-Hyun; Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim			Acute kidney injury can predict in-hospital and long-term mortality in elderly patients undergoing hip fracture surgery	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL DYSFUNCTION; EXCESS MORTALITY; RISK; POPULATION; DISEASE; ADULTS; NECK; MEN; AGE	Background Hip fracture is a common health problem in the elderly that is associated with increased mortality. Acute kidney injury (AKI) is a frequent complication in elderly patients undergoing surgery and is associated with the clinical outcome. We evaluated the incidence and risk factors of AKI in elderly patients undergoing hip fracture surgery and the impact of AKI on short-and long-term clinical outcomes. Methods We performed a retrospective cohort study of 450 elderly patients who underwent hip fracture surgery between January 2010 and December 2012. We defined AKI according to the Acute Kidney Injury Network (AKIN) criteria and investigated the effect of AKI on the duration of hospital stay and in-hospital and long-term mortality. Results Of the 450 patients, 95 (21.1%) developed AKI during hospitalization and 178 (39.6%) died, with a mean follow-up of 3.6 +/- 1.0 years. The baseline serum creatinine level, use of angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists, red blood cell transfusion volume, and history of coronary artery disease were independent risk factors for AKI. Patients with AKI during hospitalization had significantly longer hospital stays and higher in-hospital and long-term mortality than those without AKI. Multivariate analysis revealed that age, history of coronary artery disease, serum albumin level, and AKI were independent predictors of long-term mortality. Conclusions AKI is a frequent complication in elderly patients undergoing hip fracture surgery and is independently associated with increased in-hospital and long-term mortality.	[Hong, Seong Eun; Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim] Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea; [Kim, Tae-Young; Yoo, Je-Hyun] Hallym Univ, Sacred Heart Hosp, Dept Orthoped Surg, Anyang, South Korea; [Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim] Hallym Univ, Kidney Res Inst, Seoul, South Korea	Hallym University; Hallym University; Hallym University	Song, YR (corresponding author), Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea.; Song, YR (corresponding author), Hallym Univ, Kidney Res Inst, Seoul, South Korea.	yrisong@hanmail.net	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836				Abdel-Kader K, 2009, CLIN GERIATR MED, V25, P331, DOI 10.1016/j.cger.2009.04.001; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Bennet SJ, 2010, INJURY, V41, P335, DOI 10.1016/j.injury.2009.07.009; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Cameron ID, 2010, HIP FRACTURE CAUSES; Carpintero P, 2014, WORLD J ORTHOP, V5, P402, DOI 10.5312/wjo.v5.i4.402; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Eren Z, 2012, EUR GERIATR MED, V3, P345, DOI 10.1016/j.eurger.2012.07.456; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hagino T, 2013, ARCH ORTHOP TRAUM SU, V133, P507, DOI 10.1007/s00402-013-1693-x; Harty John, 2014, Ulster Med J, V83, P149; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Kayatas K, 2014, RENAL FAILURE, V36, P1273, DOI 10.3109/0886022X.2014.934693; Khan SK, 2013, AGE AGEING, V42, P76, DOI 10.1093/ageing/afs152; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Lewis JR, 2006, INJURY, V37, P698, DOI 10.1016/j.injury.2006.04.121; Maaravi Y, 2007, QJM-INT J MED, V100, P441, DOI 10.1093/qjmed/hcm043; Maaravi Y, 2006, QJM-INT J MED, V99, P97, DOI 10.1093/qjmed/hcl002; Macedo E, 2010, NEPHROL DIAL TRANSPL; Martensson J, 2014, CURR OPIN CRIT CARE, V20, P451, DOI 10.1097/MCC.0000000000000107; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Petersen MB, 2006, INJURY, V37, P705, DOI 10.1016/j.injury.2006.02.046; Pioli G, 2006, AGING CLIN EXP RES, V18, P381; Rosner MH, 2009, ACUTE KIDNEY INJURY; Sever MS, 2011, NEPHROL DIAL TRANSPL, V26, P515, DOI 10.1093/ndt/gfq426; Seyedi HR, 2015, ARCH BONE JT SURG-AB, V3, P51; Talsnes O, 2012, ARCH ORTHOP TRAUM SU, V132, P1753, DOI 10.1007/s00402-012-1611-7; Ulucay C, 2013, GERIATRIC ORTHOPAEDI; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Yun Y-S, 2013, KOREAN J MED, V84, P818	35	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176259	10.1371/journal.pone.0176259	http://dx.doi.org/10.1371/journal.pone.0176259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426743	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875900122
J	Zhang, X; Chu, Q; Guo, G; Dong, GH; Li, XZ; Zhang, Q; Zhang, SL; Zhang, ZW; Wang, YC				Zhang, Xu; Chu, Qin; Guo, Gang; Dong, Ganghui; Li, Xizhi; Zhang, Qin; Zhang, Shengli; Zhang, Zhiwu; Wang, Yachun			Genome-wide association studies identified multiple genetic loci for body size at four growth stages in Chinese Holstein cattle	PLOS ONE			English	Article							CONDITION SCORE; HEART-GIRTH; PARAMETER-ESTIMATION; CONFORMATION TRAITS; MOLECULAR-CLONING; FRIESIAN CATTLE; PROMOTER REGION; MILK-PRODUCTION; BONE-GROWTH; DAIRY	The growth and maturity of cattle body size affect not only feed efficiency, but also productivity and longevity. Dissecting the genetic architecture of body size is critical for cattle breeding to improve both efficiency and productivity. The volume and weight of body size are indicated by several measurements. Among them, Heart Girth (HG) and Hip Height (HH) are the most important traits. They are widely used as predictors of body weight (BW). Few association studies have been conducted for HG and HH in cattle focusing on single growth stage. In this study, we extended the Genome-wide association studies to a full spectrum of four growth stages (6-, 12-, 18-, and 24-months after birth) in Chinese Holstein heifers. The whole genomic single nucleotide polymorphisms (SNPs) were obtained from the Illumina BovineSNP50 v2 BeadChip genotyped on 3,325 individuals. Estimated breeding values (EBVs) were derived for both HG and HH at the four different ages and analyzed separately for GWAS by using the Fixed and random model Circuitous Probability Unification (Farm-CPU) method. In total, 27 SNPs were identified to be significantly associated with HG and HH at different growth stages. We found 66 candidate genes located nearby the associated SNPs, including nine genes that were known as highly related to development and skeletal and muscular growth. In addition, biological function analysis was performed by Ingenuity Pathway Analysis and an interaction network related to development was obtained, which contained 16 genes out of the 66 candidates. The set of putative genes provided valuable resources and can help elucidate the genomic architecture and mechanisms underlying growth traits in dairy cattle.	[Zhang, Xu; Zhang, Qin; Zhang, Shengli; Wang, Yachun] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing, Peoples R China; [Zhang, Xu; Zhang, Zhiwu] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Chu, Qin] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Guo, Gang; Dong, Ganghui; Li, Xizhi] Beijing Sunlon Livestock Dev Co Ltd, Beijing, Peoples R China	China Agricultural University; Washington State University; Beijing Academy of Agriculture & Forestry	Wang, YC (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing, Peoples R China.; Zhang, ZW (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	zhiwu.zhang@wsw.edu; wangyachun@cau.edu.cn	Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Zhang, Zhiwu/0000-0002-5784-9684; 	earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences [17A-3019-8663]; Washington Grain Commission [126593]; China Scholarship Council [201406350114]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Beijing Sunlon Livestock Development Co. Ltd.	earmarked fund for Modern Agro-industry Technology Research System; Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences; Washington Grain Commission; China Scholarship Council(China Scholarship Council); Program for Changjiang Scholar and Innovation Research Team in University; Beijing Sunlon Livestock Development Co. Ltd.	This work was financially supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-37), the Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences (17A-3019-8663), Washington Grain Commission (126593), China Scholarship Council (201406350114), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). Beijing Sunlon Livestock Development Co. Ltd. provided support in the form of salaries for authors GG, GD, and XL and assisted in measurement and data collection for this study. The funder had no additional role in study design, decision to publish, or preparation of the manuscript.	Amann R, 2014, DEV BIOL, V394, P228, DOI 10.1016/j.ydbio.2014.08.016; Bardakcioglu HE, 2011, J ANIM VET ADV, V10, P1735; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Bilal G, 2016, CAN J ANIM SCI, V96, P434, DOI 10.1139/cjas-2015-0127; Bluteau G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105210; Bolormaa S., 2009, Matching genetics and environment: a new look at an old topic. Proceedings of the 18th Conference of the Association for the Advancement of Animal Breeding and Genetics, Barossa Valley, South Australia, Australia, 28 September-1 October, 2009, P125; Buzanskas ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094802; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; Clempson AM, 2011, J DAIRY SCI, V94, P3618, DOI 10.3168/jds.2010-3626; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Copf T, 2015, EUR J NEUROSCI, V42, P2234, DOI 10.1111/ejn.13002; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; de Haas Y, 2007, J ANIM BREED GENET, V124, P12, DOI 10.1111/j.1439-0388.2007.00630.x; Dechow CD, 2003, J DAIRY SCI, V86, P2236, DOI 10.3168/jds.S0022-0302(03)73814-4; Dekkers J. C. M., 2004, J ANIM SCI, V82, pE313; Deng YJ, 2016, CELL REP, V14, P2224, DOI 10.1016/j.celrep.2016.02.021; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Farooq M, 2016, J HUM GENET, V61, P271, DOI 10.1038/jhg.2015.138; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fu WX, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0430-1; Gallo L, 2001, J DAIRY SCI, V84, P2321, DOI 10.3168/jds.S0022-0302(01)74680-2; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; HAGGER C, 1991, LIVEST PROD SCI, V28, P265, DOI 10.1016/0301-6226(91)90147-I; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Heinrichs AJ, 2007, PREV VET MED, V78, P333, DOI 10.1016/j.prevetmed.2006.11.002; Heinrichs AJ, 1998, J ANIM SCI, V76, P1254; Huang W, 2010, ANIM GENET, V41, P570, DOI 10.1111/j.1365-2052.2010.02046.x; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Jahuey-Martinez FJ, 2016, J ANIM SCI, V94, P4570, DOI 10.2527/jas.2016-0359; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kadarmideen HN, 2003, J DAIRY SCI, V86, P3685, DOI 10.3168/jds.S0022-0302(03)73974-5; Kashyap N, 2015, VET WORLD, V8, P892, DOI 10.14202/vetworld.2015.892-897; Koenen EPC, 1998, J DAIRY SCI, V81, P1709, DOI 10.3168/jds.S0022-0302(98)75738-8; Kraatz S, 2016, STRUCTURE, V24, P1358, DOI 10.1016/j.str.2016.06.011; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lesosky M, 2012, TROP ANIM HEALTH PRO, V45, P311, DOI 10.1007/s11250-012-0220-3; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Liu YF, 2011, GENET MOL RES, V10, P1777, DOI 10.4238/vol10-3gmr1466; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Liu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166146; Lu D, 2013, J ANIM SCI, V91, P3612, DOI 10.2527/jas.2012-5716; Lu Y, 2015, DEV GROWTH DIFFER, V57, P614, DOI 10.1111/dgd.12250; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079495; Luco SM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0276-4; Madsen P., 2013, USERS GUIDE DMU VERS; Marques F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006307; Matoso E, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0087-2; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Minegishi Y, 2014, BIOCHEM BIOPH RES CO, V454, P12, DOI 10.1016/j.bbrc.2014.10.001; Munim T, 2013, ANIM SCI J, V84, P206, DOI 10.1111/asj.12005; Niu TH, 2015, HUM MOL GENET, V24, P4710, DOI 10.1093/hmg/ddv144; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randhawa IAS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-34; Reijntjes S, 2007, INT J DEV BIOL, V51, P351, DOI 10.1387/ijdb.062258sr; [任小丽 Ren Xiaoli], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P5020; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Santana ML, 2013, LIVEST SCI, V154, P13, DOI 10.1016/j.livsci.2013.02.018; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Szklarczyk R, 2016, NUCLEIC ACIDS RES, V44, pD567, DOI 10.1093/nar/gkv1228; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Thomasen JR, 2008, J DAIRY SCI, V91, P2098, DOI 10.3168/jds.2007-0602; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VanRaden PM, 2004, J DAIRY SCI, V87, P3125, DOI 10.3168/jds.S0022-0302(04)73447-5; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wu XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-897; Yang X, 1899, INT J MOL MED, V38, P30; Yang YQ, 2013, GENET MOL RES, V12, P3651, DOI 10.4238/2013.September.13.9; Yu Y, 2010, CHINA ANIM HUSB VET, V37, P106; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3	78	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175971	10.1371/journal.pone.0175971	http://dx.doi.org/10.1371/journal.pone.0175971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426785	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900077
J	Borths, MR; Seiffert, ER				Borths, Matthew R.; Seiffert, Erik R.			Craniodental and humeral morphology of a new species of Masrasector (Teratodontinae, Hyaenodonta, Placentalia) from the late Eocene of Egypt and locomotor diversity in hyaenodonts	PLOS ONE			English	Article							PROTEOPITHECUS-SYLVIAE; EARLY OLIGOCENE; MIDDLE EOCENE; PHYLOGENY; MAMMALIA; CREODONTA; EVOLUTION; PROVIVERRINES; DISCOVERY; RADIATION	Hyaenodonta is a diverse clade of carnivorous mammals that were part of terrestrial faunas in the Paleogene of Eurasia and North America, but the oldest record for the group is Afro-Arabian, making the record there vital for understanding the evolution of this widespread group. Previous studies show an ancient split between two major clades of hyaenodonts that converged in hypercarnivory: Hyainailourinae and Hyaenodontinae. These clades are each supported by cranial characters. Phylogenetic analyses of hyaenodonts also support the monophyly of Teratodontinae, an Afro-Arabian clade of mesocarnivorous to hypercarnivorous hyaenodonts. Unfortunately, the cranial anatomy of teratodontines is poorly known, and aligning the clade with other lineages has been difficult. Here, a new species of the phylogenetically controversial teratodontine Masrasector is described from Locality 41 (latest Priabonian, late Eocene) from the Fayum Depression, Egypt. The hypodigm includes the most complete remains of a Paleogene teratodontine, including largely complete crania, multiple dentaries, and isolated humeri. Standard and "tip-dating" Bayesian analyses of a character-taxon matrix that samples cranial, postcranial, and dental characters support a monophyletic Masrasector within Teratodontinae, which is consistently placed as a close sister group of Hyainailouridae. The cranial morphology of Masrasector provides new support for an expanded Hyainailouroidea (Teratodontinae + Hyainailouridae), particularly characters of the nuchal crest, palate, and basicranium. A discriminant function analysis was performed using measurements of the distal humerus from a diverse sample of extant carnivorans to infer the locomotor habits of Masrasector. Masrasector was assigned to the "terrestrial" locomotor category, a result consistent with the well-defined medial trochlear ridges, and moderately developed supinator crests of the specimens. Masrasector appears to have been a fast-moving terrestrial form with a diverse diet. These specimens considerably improve our understanding of Teratodontinae, an ancient member of the Afro-Arabian mammalian fauna, and our understanding of hyaenodont diversity before the dispersal of Carnivora to the continent near the end of the Paleogene.	[Borths, Matthew R.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Seiffert, Erik R.] Univ Southern Calif, Keck Sch Med, Dept Integrat Anat Sci, Los Angeles, CA 90033 USA	University System of Ohio; Ohio University; University of Southern California	Borths, MR (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	borths.1@gmail.com			U.S. National Science Foundation [BCS-0416164, BCS-0819186, BCS-1231288]; U.S. National Science Foundation Doctoral Dissertation Improvement Grant [DEB 1311354]; National Science Foundation; Turkana Basin Institute; Stony Brook University Graduate Council; U.S. National Science Foundation Postdoctoral Fellowship in Biology [DBI-1612062]; The Explorers Club; Society for Integrative and Comparative Biology; The Leakey Foundation; Gordon and Ann Getty; Div Of Biological Infrastructure [1612062] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Turkana Basin Institute; Stony Brook University Graduate Council; U.S. National Science Foundation Postdoctoral Fellowship in Biology; The Explorers Club; Society for Integrative and Comparative Biology; The Leakey Foundation; Gordon and Ann Getty; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Field work in the Fayum Depression, Egypt, and digital curation of Fayum fossils is supported by the U.S. National Science Foundation through grants BCS-0416164 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=0416164), BCS-0819186 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=0819186), and BCS-1231288 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1231288), Gordon and Ann Getty, and The Leakey Foundation (https://leakeyfoundation.org/). MRB was supported by a U.S. National Science Foundation Doctoral Dissertation Improvement Grant (DEB-1311354; https://www.nsf.gov/awardsearch/showAward?AWD_ID=1311354&HistoricalAwards=false), a National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/), a Turkana Basin Institute Graduate Fellowship (http://www.turkanabasin.org/about/fellowships/), and a Stony Brook University Graduate Council Fellowship, and is currently supported by a U.S. National Science Foundation Postdoctoral Fellowship in Biology (DBI-1612062; https://www.nsf..gov/awardsearch/showAward?AWD_ID=1612062). Portions of the data acquisition for this study were also supported by grants from The Explorers Club (https://explorers.org/expeditions/funding/expedition_grants) and the Society for Integrative and Comparative Biology (http://www.sicb.org/grants/fgstinfo.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CW., 1906, DESCRIPTIVE CATALOGU; Archibald JK, 2003, TAXON, V52, P187, DOI 10.2307/3647388; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Barry J.C., 1988, Journal of Vertebrate Paleontology, V8, P25; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Borths MR, 2016, PEERJ, V4, DOI 10.7717/peerj.2639; Bown T.M., 1988, US GEOL SURV PROF PA, V1452, P1; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; COLBERT EDWIN H., 1933, AMER MUS NOVITATES, V603, P1; Crochet J.-Y., 2001, PETITS MAMMIFERES AF, P91; CROCHET JY, 1990, CR ACAD SCI II, V311, P1455; De Muizon C, 1997, LETHAIA, V30, P353; Egi N, 2005, J SYST PALAEONTOL, V3, P337, DOI 10.1017/S1477201905001707; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friscia Anthony R., 2010, P311; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; GINSBURG L, 1980, Annales de Paleontologie Vertebres, V66, P19; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grohe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049054; Halliday TJD, 2015, BIOL REV; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hildebrand M., 1998, ANAL VERTEBRATE STRU; Holroyd PA., 1994, THESIS; Holroyd Patricia A., 1999, Paleobios, V19, P1; Iwaniuk AN, 1999, CAN J ZOOL, V77, P1064, DOI 10.1139/cjz-77-7-1064; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; KAPPELMAN J, 1992, J GEOL, V100, P647, DOI 10.1086/629619; Lange-Badre B., 1979, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V42, P1; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewis Margaret E., 2010, P543; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison WP., 2021, MESQUITE MODULAR SYS; Matthew W.D., 1909, MEM AM MUS NAT HIST, V9, P291; Matthew WD, 1915, B AM MUS NAT HIST, V34, P1; Matthew WD, 1906, MEMOIRS AM MUSEUM NA, V9, P291, DOI DOI 10.5479/SI.00963801.30-1449.203; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Morlo M, 1999, GEOBIOS-LYON, V32, P297, DOI 10.1016/S0016-6995(99)80043-6; Morlo M., 2003, CONTRIBUTIONS MUSEUM, V31, P43; Morlo M, 2007, J VERTEBR PALEONTOL, V27, P145, DOI 10.1671/0272-4634(2007)27[145:CACFWM]2.0.CO;2; Myers P., 2001, HYSTRICIDAE ONLINE A; Nowak R. M., 2005, WALKERS CARNIVORES W; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Osborn HF, 1909, B AM MUS NAT HIST, V26, P415; Peigne S, 2007, GEODIVERSITAS, V29, P441; PICKFORD M, 1994, CR ACAD SCI II, V318, P1395; Pilgrim Guy E., 1910, Records of the Geological Survey of India Calcutta, V40; Polly P. David, 2007, P245; Polly PD, 1996, J VERTEBR PALEONTOL, V16, P303, DOI 10.1080/02724634.1996.10011318; Rana RS, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.965308; Rasmussen D.T., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V182, P187; Rasmussen DT, 2009, PALAEONTOGR ABT A, V288, P1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSE KD, 2006, BEGINNING AGE MAMMAL; Sallam HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016525; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Savage R. J. G., 1965, Bulletin of the British Museum (Natural History) Geology, V10, P239; SAVAGE R J G, 1973, Bulletin of the British Museum (Natural History) Geology, V22, P483; Schlosser M., 1911, Beitreage zur Palaeontologie u Geologie Oesterreich-Ungarns u des Orients Wien u Leipzig, V24; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiffert ER, 2006, P NATL ACAD SCI USA, V103, P5000, DOI 10.1073/pnas.0600689103; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Simons E.L., 1974, Annals of the Geological Survey of Egypt, V4, P157; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; Simons EL, 1996, AM J PHYS ANTHROPOL, V100, P261, DOI 10.1002/(SICI)1096-8644(199606)100:2<261::AID-AJPA7>3.0.CO;2-#; Simons EL, 2001, FOLIA PRIMATOL, V72, P316, DOI 10.1159/000052748; Simons EL, 1999, CR ACAD SCI II A, V329, P921, DOI 10.1016/S1251-8050(00)88506-7; Simons EL, 1997, P NATL ACAD SCI USA, V94, P14970, DOI 10.1073/pnas.94.26.14970; SIMONS EL, 1998, GEOLOGICAL SURVEY EG, V75, P785; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Sole F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141941; Sole F, 2016, PALAEONTOL ELECTRON, V19; Sole F, 2014, ZOOL J LINN SOC-LOND, V171, P878, DOI 10.1111/zoj.12155; Sole F, 2014, J SYST PALAEONTOL, V12, P303, DOI 10.1080/14772019.2013.795196; Sole F, 2013, J SYST PALAEONTOL, V11, P375, DOI 10.1080/14772019.2012.686927; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Taylor M.E., 1989, P382; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; Trapp G.R., 1975, P164; Ungar PS., 2010, MAMMAL TEETH; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1990, P181; Van Valkenburgh B, 1987, J VERT PALEONTOL, V7, P162, DOI DOI 10.1080/02724634.1987.10011651; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Wible JR, 2013, ANN CARNEGIE MUS, V82, P1; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Zack SP, 2011, J PALEONTOL, V85, P315, DOI 10.1666/10-093.1	93	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0173527	10.1371/journal.pone.0173527	http://dx.doi.org/10.1371/journal.pone.0173527			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422967	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600009
J	Chen, CY; Liao, YH; Chou, CC; Sung, YC; Tsai, SC				Chen, Chung-Yu; Liao, Yi-Hung; Chou, Chun-Chung; Sung, Yu-Chi; Tsai, Shiow-Chwen			Initial systemic inflammatory state perturbs exercise training adaptations in elite Taekwondo athletes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL-LYMPHOCYTE RATIO; SKELETAL-MUSCLE; PHYSIOLOGICAL PROFILES; RESISTANCE EXERCISE; PERCEIVED EXERTION; RESPONSES; REDUCTION; RECOVERY; MARKERS	Purpose This study examined ten-week TKD-specific training effects on aerobic capacity, body composition, hormone responses and hematological parameters in elite TKD athletes with varied initial inflammatory states. Methods Twenty-two elite college TKD athletes were divided into two groups according to their initial neutrophils-to-lymphocytes ratio (NLR) values: Low NLR (N = 11, 9M/2F, age: 21.6 +/- 1.0 yrs; NLR: 1.3 +/- 0.2) and High NLR (N = 11, 8M/3F, age: 22.0 +/- 0.7 yrs, NLR: 2.5 +/- 1.3), and participated in a 10-week TKD-specific training program. Aerobic capacity, body composition, hormonal responses and hematological parameters were measured at baseline and 10-weeks after TKD training. Results VO2max and shuttle run distance were significantly increased in both groups after training. However, the degree of improvement was greater in the Low NLR group than in the High NLR group. After 10-weeks of exercise training, the High NLR group presented markedly higher fat mass percentage and visceral fat area and significantly lowers DHEA-S to cortisol ratio (D/C ratio) than the Low NRL group. The post-training NLR was negatively correlated with the D/C ratio. Neutrophil counts and NLR were still significantly higher in the High NLR group after training. Conclusions This study provides new evidence that young elite TKD athletes with slightly high baseline systemic inflammatory state appear to perturb adaptations to exercise training.	[Chen, Chung-Yu] Univ Taipei, Dept Exercise & Hlth Sci, Taipei, Taiwan; [Liao, Yi-Hung] Natl Taipei Univ Nursing & Hlth Sci, Dept Exercise & Hlth Sci, Taipei, Taiwan; [Chou, Chun-Chung] Natl Taipei Univ Technol, Phys Educ Off, Taipei, Taiwan; [Sung, Yu-Chi] Chinese Culture Univ, Dept Chinese Martial Arts, Taipei, Taiwan; [Tsai, Shiow-Chwen] Univ Taipei, Dept Sports Sci, Taipei, Taiwan	University of Taipei; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Technology; Chinese Culture University; University of Taipei	Chen, CY (corresponding author), Univ Taipei, Dept Exercise & Hlth Sci, Taipei, Taiwan.	fish0510@gmail.com			University of Taipei;  [MOST 104-2410-H-845-006-MY2];  [MOST 105-2410-H-227-004]	University of Taipei; ; 	We deeply appreciate the participants for their participating in this study. This study was partly supported by MOST 104-2410-H-845-006-MY2, MOST 105-2410-H-227-004, and University of Taipei.; This study was partly supported by MOST 104-2410-H-845-006-MY2, MOST 105-2410-H-227-004, and University of Taipei.	Balta S, 2016, CLIN APPL THROMB-HEM, V22, P405, DOI 10.1177/1076029615569568; Booth FW, 2015, PROG MOL BIOL TRANSL, V135, P129, DOI 10.1016/bs.pmbts.2015.07.016; Bridge CA, 2014, SPORTS MED, V44, P713, DOI 10.1007/s40279-014-0159-9; Bridge CA, 2009, INT J SPORT PHYSIOL, V4, P485, DOI 10.1123/ijspp.4.4.485; Chazaud B, 2016, IMMUNOL CELL BIOL, V94, P140, DOI 10.1038/icb.2015.97; Chen ZY, 2015, BRIT J CANCER, V112, P1088, DOI 10.1038/bjc.2015.61; Campos FAD, 2012, EUR J APPL PHYSIOL, V112, P1221, DOI 10.1007/s00421-011-2071-4; Festa A, 2001, INT J OBESITY, V25, P1407, DOI 10.1038/sj.ijo.0801792; Fong SSM, 2011, PHYS THER SPORT, V12, P100, DOI 10.1016/j.ptsp.2010.07.001; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934; Haddad M, 2014, EUR J SPORT SCI, V14, pS275, DOI 10.1080/17461391.2012.691115; Heller J, 1998, J SPORT SCI, V16, P243, DOI 10.1080/026404198366768; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Ishizuka M, 2012, INT SURG, V97, P299, DOI 10.9738/CC161.1; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Kahramanca S, 2014, ULUS TRAVMA ACIL CER, V20, P19, DOI 10.5505/tjtes.2014.20688; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Liao YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160167; Liao YH, 2013, EUR J APPL PHYSIOL, V113, P99, DOI 10.1007/s00421-012-2409-6; Lou MQ, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0002-9; Mackey AL, 2007, J APPL PHYSIOL, V103, P425, DOI 10.1152/japplphysiol.00157.2007; Mattusch F, 2000, INT J SPORTS MED, V21, P21; Melhim AF, 2001, BRIT J SPORT MED, V35, P231, DOI 10.1136/bjsm.35.4.231; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; Okita K, 2004, ARTERIOSCL THROM VAS, V24, P1868, DOI 10.1161/01.ATV.0000140199.14930.32; Pieter W., 2003, J ASIAN MARTIAL ARTS, V12, P8; Rieu I, 2009, J PHYSIOL-LONDON, V587, P5483, DOI 10.1113/jphysiol.2009.178319; Shimizu Tomomi, 2011, Rinsho Byori, V59, P930; Sultan P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/727451; Thompson WR, 1991, SPORTS MED TRAINING, V3, P49; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tomita M, 2011, ANTICANCER RES, V31, P2995; Toskovic NN, 2004, J SPORT MED PHYS FIT, V44, P164; Trappe TA, 2011, AM J PHYSIOL-REG I, V300, pR655, DOI 10.1152/ajpregu.00611.2010; Tremblay M. S., 2004, J APPL PHYSIOL, V96, P531; Tsai YM, 2006, LIFE SCI, V79, P1281, DOI 10.1016/j.lfs.2006.04.001	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0176140	10.1371/journal.pone.0176140	http://dx.doi.org/10.1371/journal.pone.0176140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423014	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600094
J	Dannemiller, NG; Webb, CT; Wilson, KR; Bentler, KT; Mooers, NL; Ellis, JW; Root, JJ; Franklin, AB; Shriner, SA				Dannemiller, Nicholas G.; Webb, Colleen T.; Wilson, Kenneth R.; Bentler, Kevin T.; Mooers, Nicole L.; Ellis, Jeremy W.; Root, J. Jeffrey; Franklin, Alan B.; Shriner, Susan A.			Impact of body condition on influenza A virus infection dynamics in mallards following a secondary exposure	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; SURVEILLANCE; DUCKS; IMMUNOLOGY; ANTIBODIES; BIRDS	Migratory waterfowl are often viewed as vehicles for the global spread of influenza A viruses (IAVs), with mallards (Anas platyrhynchos) implicated as particularly important reservoir hosts. The physical demands and energetic costs of migration have been shown to influence birds' body condition; poorer body condition may suppress immune function and affect the course of IAV infection. Our study evaluated the impact of body condition on immune function and viral shedding dynamics in mallards naturally exposed to an H9 IAV, and then secondarily exposed to an H4N6 IAV. Mallards were divided into three treatment groups of 10 birds per group, with each bird's body condition manipulated as a function of body weight by restricting food availability to achieve either a -10%, -20%, or control body weight class. We found that mallards exhibit moderate heterosubtypic immunity against an H4N6 IAV infection after an infection from an H9 IAV, and that body condition did not have an impact on shedding dynamics in response to a secondary exposure. Furthermore, body condition did not affect aspects of the innate and adaptive immune system, including the acute phase protein haptoglobin, heterophil/lymphocyte ratios, and antibody production. Contrary to recently proposed hypotheses and some experimental evidence, our data do not support relationships between body condition, infection and immunocompetence following a second exposure to IAV in mallards. Consequently, while annual migration may be a driver in the maintenance and spread of IAVs, the energetic demands of migration may not affect susceptibility in mallards.	[Dannemiller, Nicholas G.; Wilson, Kenneth R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Dannemiller, Nicholas G.; Bentler, Kevin T.; Mooers, Nicole L.; Ellis, Jeremy W.; Root, J. Jeffrey; Franklin, Alan B.; Shriner, Susan A.] Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA; [Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; United States Department of Agriculture (USDA); Colorado State University	Dannemiller, NG (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.; Dannemiller, NG (corresponding author), Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA.	dannemillern@gmail.com	Wilson, Kenneth R./P-8692-2019	Franklin, Alan/0000-0001-9491-795X; Shriner, Susan/0000-0003-0349-7182	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsnoe DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022633; Avril A, 2016, J APPL ECOL, V53, P1289, DOI 10.1111/1365-2664.12699; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015; Bengtsson D, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150633; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Chaise C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105189; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Cray C, 2009, COMPARATIVE MED, V59, P517; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DEIBEL R, 1985, AVIAN DIS, V29, P970, DOI 10.2307/1590450; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Flint PL, 2009, P ROY SOC B-BIOL SCI, V276, P2345, DOI 10.1098/rspb.2008.1962; Forbes KM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0471; Freidl GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20385; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P2347, DOI 10.1098/rspb.2009.0275; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Pepin KM, 2017, ECOL LETT, V20, P275, DOI 10.1111/ele.12732; Piaggio AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050834; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Root JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14354; Root JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102964; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Short KR, 2015, ONE HEALTH-AMSTERDAM, V1, P1, DOI [10.1016/j.onehlt.2015.03.001, 10.1016/j.onehit.2015.03.001]; Shriner SA, 2016, J VIROL METHODS, V228, P130, DOI 10.1016/j.jviromet.2015.11.021; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; van Dijk JGB, 2015, ECOL EVOL, V5, P436, DOI 10.1002/ece3.1359; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; Verhagen JH, 2015, J VIROL, V89, P11507, DOI 10.1128/JVI.01765-15; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175757	10.1371/journal.pone.0175757	http://dx.doi.org/10.1371/journal.pone.0175757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423047	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600050
J	Gajowniczek, K; Zabkowski, T				Gajowniczek, Krzysztof; Zabkowski, Tomasz			Electricity forecasting on the individual household level enhanced based on activity patterns	PLOS ONE			English	Article							HOME ENERGY MANAGEMENT; SYSTEMS	Leveraging smart metering solutions to support energy efficiency on the individual household level poses novel research challenges in monitoring usage and providing accurate load forecasting. Forecasting electricity usage is an especially important component that can provide intelligence to smart meters. In this paper, we propose an enhanced approach for load forecasting at the household level. The impacts of residents' daily activities and appliance usages on the power consumption of the entire household are incorporated to improve the accuracy of the forecasting model. The contributions of this paper are threefold: (1) we addressed short-term electricity load forecasting for 24 hours ahead, not on the aggregate but on the individual household level, which fits into the Residential Power Load Forecasting (RPLF) methods; (2) for the forecasting, we utilized a household specific dataset of behaviors that influence power consumption, which was derived using segmentation and sequence mining algorithms; and (3) an extensive load forecasting study using different forecasting algorithms enhanced by the household activity patterns was undertaken.	[Gajowniczek, Krzysztof; Zabkowski, Tomasz] Warsaw Univ Life Sci, Fac Appl Informat & Math, Dept Informat, Warsaw, Poland	Warsaw University of Life Sciences	Gajowniczek, K (corresponding author), Warsaw Univ Life Sci, Fac Appl Informat & Math, Dept Informat, Warsaw, Poland.	krzysztof_gajowniczek@sggw.pl	Gajowniczek, Krzysztof/K-4792-2017; Zabkowski, Tomasz/H-8645-2018	Gajowniczek, Krzysztof/0000-0001-6953-8907; Zabkowski, Tomasz/0000-0003-1722-1179	Interdisciplinary Centre for Mathematical and Computational Modelling at the Warsaw University [G59-31]; National Science Centre, Poland [2016/21/N/ST8/02435]	Interdisciplinary Centre for Mathematical and Computational Modelling at the Warsaw University; National Science Centre, Poland(National Science Centre, Poland)	The computations were performed partially employing the computational resources of the Interdisciplinary Centre for Mathematical and Computational Modelling at the Warsaw University (Computational Grant No. G59-31). The study was cofounded by the National Science Centre, Poland Grant No. 2016/21/N/ST8/02435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari-Moghaddam A, 2015, IEEE T SMART GRID, V6, P324, DOI 10.1109/TSG.2014.2349352; Beaudin M, 2015, RENEW SUST ENERG REV, V45, P318, DOI 10.1016/j.rser.2015.01.046; Beccali M, 2004, ENERG CONVERS MANAGE, V45, P2879, DOI 10.1016/j.enconman.2004.01.006; Brockwell PJ, 2006, INTRO TIME SERIES FO; Ciok A., 1995, COLLECTED PAPERS THE, V7, P5; De Giorgi MG, 2014, ENERGIES, V7, P5251, DOI 10.3390/en7085251; Ding Y., 2015, INT J MICROW WIRELES, V8, P1; Edwards RE, 2012, ENERG BUILDINGS, V49, P591, DOI 10.1016/j.enbuild.2012.03.010; Gajowniczek K, 2016, J INTELL FUZZY SYST, V30, P223, DOI 10.3233/IFS-151748; Gajowniczek K, 2015, ENERGIES, V8, P7407, DOI 10.3390/en8077407; Ghofrani M., 2011, P 2011 N AM POW S BO, P1, DOI 10.1109/naps.2011.6025124; Giudici P., 2003, APPL DATA MINING STA; GradeStat, 2004, PROGRAM FOR GRADE DA; GROSS G, 1987, P IEEE, V75, P1558, DOI 10.1109/PROC.1987.13927; Hong T, 2014, INT J FORECASTING, V30, P357, DOI 10.1016/j.ijforecast.2013.07.001; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Huber P. H., 1981, ROBUST STAT; Javed F, 2012, APPL ENERG, V96, P150, DOI 10.1016/j.apenergy.2012.02.027; Lv GY, 2006, ADV SOFT COMP, P117, DOI 10.1007/3-540-34783-6_13; Mahonin S., 2013, IEEE EL POW EN C EPE, P1; Moreno JJM, 2013, PSICOTHEMA, V25, P500, DOI 10.7334/psicothema2013.23; Palka Piotr, 2012, Control and Cybernetics, V41, P777; Polkowski L., 1998, LECT NOTES ARTIF INT, V1424, P75; Radziszewska W, 2014, ISSUES CHALLENGES IN, P293; Radziszewska W, 2014, ACSIS-ANN COMPUT SCI, V2, P1515; Rao CR, 2005, HANDB STAT, V24, P189, DOI 10.1016/S0169-7161(04)24007-X; Singh RP, 2012, INT CONF SMART GRID, P163, DOI 10.1109/SmartGridComm.2012.6485977; Siwek K, 2005, Proceedings of the 2005 European Conference on Circuit Theory and Design, Vol 3, P61; Siwek K, 2009, INT J AP MAT COM-POL, V19, P303, DOI 10.2478/v10006-009-0026-2; Song KB, 2005, IEEE T POWER SYST, V20, P96, DOI 10.1109/TPWRS.2004.835632; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; SZCZESNY W, 1991, J CLASSIF, V8, P201, DOI 10.1007/BF02616239; Szupiluk R, 2006, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P439; Szupiluk R, 2006, LECT NOTES COMPUT SC, V4132, P133; Veit A., 2014, P 5 INT C FUT EN SYS, P233, DOI DOI 10.1145/2602044.2602082; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weron R., 2006, MODELING FORECASTING; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Zhou B, 2016, RENEW SUST ENERG REV, V61, P30, DOI 10.1016/j.rser.2016.03.047; Ziekow H., 2013, IEEE INT C SMART GRI	40	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0174098	10.1371/journal.pone.0174098	http://dx.doi.org/10.1371/journal.pone.0174098			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423039	gold, Green Published, Green Submitted			2022-12-27	WOS:000399875600014
J	Zettler, ML; Friedland, R; Gogina, M; Darr, A				Zettler, Michael Lothar; Friedland, Rene; Gogina, Mayya; Darr, Alexander			Variation in benthic long-term data of transitional waters: Is interpretation more than speculation?	PLOS ONE			English	Article							BOTTOM MACROBENTHIC COMMUNITIES; NORDERNEY EAST FRISIA; CLIMATE-CHANGE; BALTIC SEA; MACROFAUNA COMMUNITIES; NORTH-SEA; DECADAL CHANGES; MARINE; HYPOXIA; SHIFTS	Biological long-term data series in marine habitats are often used to identify anthropogenic impacts on the environment or climate induced regime shifts. However, particularly in transitional waters, environmental properties like water mass dynamics, salinity variability and the occurrence of oxygen minima not necessarily caused by either human activities or climate change can attenuate or mask apparent signals. At first glance it very often seems impossible to interpret the strong fluctuations of e.g. abundances or species richness, since abiotic variables like salinity and oxygen content vary simultaneously as well as in apparently erratic ways. The long-term development of major macrozoobenthic parameters (abundance, bio-mass, species numbers) and derivative macrozoobenthic indices (Shannon diversity, Margalef, Pilou's evenness and Hurlbert) has been successfully interpreted and related to the long-term fluctuations of salinity and oxygen, incorporation of the North Atlantic Oscillation index (NAO index), relying on the statistical analysis of modelled and measured data during 35 years of observation at three stations in the south-western Baltic Sea. Our results suggest that even at a restricted spatial scale the benthic system does not appear to be tightly controlled by any single environmental driver and highlight the complexity of spatially varying temporal response.	[Zettler, Michael Lothar; Friedland, Rene; Gogina, Mayya; Darr, Alexander] Leibniz Inst Balt Sea Res Warnemunde, Seestr 15, Rostock, Germany	Leibniz Institut fur Ostseeforschung Warnemunde	Zettler, ML (corresponding author), Leibniz Inst Balt Sea Res Warnemunde, Seestr 15, Rostock, Germany.	michael.zettler@io-warnemuende.de	Gogina, Mayya/C-4922-2014; Friedland, Rene/AFK-5229-2022; Zettler, Michael Lothar/R-3186-2019	Gogina, Mayya/0000-0003-0909-4296; Friedland, Rene/0000-0002-3690-666X; Zettler, Michael Lothar/0000-0002-5437-5495	Bundesministerium fur Bildung und Forschung [03F0738A, 03F0740B]; Bundesamt fur Naturschutz [532 02]; BONUS Programme [03F0717A]; German Federal Maritime and Hydrographic Agency (BSH)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bundesamt fur Naturschutz; BONUS Programme; German Federal Maritime and Hydrographic Agency (BSH)	On behalf of the "Bundesamt fur Seeschifffahrt und Hydrography (BSH)" the Leibniz Institute for Baltic Sea Research achieved the data according to the HELCOM requirements. For the benthic data MLZ is responsible. This work received support from Bundesministerium fur Bildung und Forschung, 03F0738A, to Dr. Mayya Gogina; Bundesamt fur Naturschutz, 532 02, to Dr. Alexander Darr; Bundesministerium fur Bildung and Forschung, 03F0740B, to Dr. Rene Friedland; and BONUS Programme, 03F0717A, Dr. Rene Friedland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the versatile logistic and administrative support by the German Federal Maritime and Hydrographic Agency (BSH). Supercomputing power was provided by HLRN (North-German Supercomputing Alliance). We thank Irina Steinberg (UK, London) for the English proof reading.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2008, STATE EVOLUTION BALT, DOI DOI 10.1002/9780470283134.CH2; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Birchenough SNR, 2015, WIRES CLIM CHANGE, V6, P203, DOI 10.1002/wcc.330; Bowler DE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0067; Carstensen J, 2014, AMBIO, V43, P26, DOI 10.1007/s13280-013-0474-7; Cloern JE, 2016, GLOBAL CHANGE BIOL, V22, P513, DOI 10.1111/gcb.13059; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Darr A, 2014, J SEA RES, V85, P315, DOI 10.1016/j.seares.2013.06.003; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dippner JW, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00057; Dippner JW, 2015, J MARINE SYST, V150, P34, DOI 10.1016/j.jmarsys.2015.05.009; Dippner JW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045696; Dippner JW, 2003, CLIMATE RES, V25, P179, DOI 10.3354/cr025179; Dippner JW, 2001, J MARINE SYST, V30, P155, DOI 10.1016/S0924-7963(01)00055-0; Feistel S., 2016, MEERESWISS BER WARNE, DOI [10.12754/msr 2016-0100., DOI 10.12754/MSR-2016-0100]; Foshtomi MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130116; Frid CLJ, 2009, J MARINE SYST, V77, P227, DOI 10.1016/j.jmarsys.2008.01.011; Frid CLJ, 2009, J MAR BIOL ASSOC UK, V89, P1, DOI 10.1017/S0025315408002956; Friedland R, BIOGEOSCIENCES; Gogina M, 2016, ICES J MAR SCI, V73, P1196, DOI 10.1093/icesjms/fsv265; Gogina M, 2010, J MARINE SYST, V79, P112, DOI 10.1016/j.jmarsys.2009.07.006; Grawe U, 2015, J GEOPHYS RES-OCEANS, V120, P7676, DOI 10.1002/2015JC011269; GRAY JS, 1983, MAR ECOL PROG SER, V13, P87, DOI 10.3354/meps013087; Haase P, 2016, ECOL INDIC, V65, P1, DOI 10.1016/j.ecolind.2016.01.040; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; HELCOM, 2015, BALT SEA ENV P, V145, P1; Hily C, 2008, ESTUAR COAST SHELF S, V78, P413, DOI 10.1016/j.ecss.2008.01.004; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jansson BO, 2002, SCOPE SER, V60, P71; Klingbeil K, 2014, OCEAN MODEL, V81, P49, DOI 10.1016/j.ocemod.2014.06.001; Kroncke I, 2013, ESTUAR COAST SHELF S, V119, P79, DOI 10.1016/j.ecss.2012.12.024; Kroncke I, 2011, ESTUAR COAST SHELF S, V94, P234, DOI 10.1016/j.ecss.2011.06.015; Kroncke I, 1998, MAR ECOL PROG SER, V167, P25, DOI 10.3354/meps167025; Kroncke I., 2001, SENCKENBERG MARITIMA, V321, P65, DOI [10.1007/BF03042837, DOI 10.1007/BF03042837]; Leunda PM, 2009, ECOL INDIC, V9, P52, DOI 10.1016/j.ecolind.2008.01.009; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Margalef R., 1958, GEN SYST, V3, P36, DOI DOI 10.1016/S0097-8485(01)00073-0; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Moberg A, 2002, CLIMATIC CHANGE, V53, P171, DOI 10.1023/A:1014966724670; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Molen J, 2013, BIOGEOCHEMISTRY, V113, P213, DOI 10.1007/s10533-012-9763-7; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Rees HL, 2006, J MAR BIOL ASSOC UK, V86, P1, DOI 10.1017/S002531540601280X; Rosenberg D.M.., 1993, FRESHWATER BIOMONITO; Rousi H, 2013, ICES J MAR SCI; Schernewski G, 2015, MAR POLICY, V51, P305, DOI 10.1016/j.marpol.2014.09.002; Segerstrale S. G., 1957, Geol Soc Amer, V67, P751; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shojaei MG, 2016, J SEA RES, V107, P25, DOI 10.1016/j.seares.2015.11.002; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Sukhotin A, 2013, HYDROBIOLOGIA, V706, P1, DOI 10.1007/s10750-013-1456-2; Tunberg BG, 1998, MAR ECOL PROG SER, V170, P85, DOI 10.3354/meps170085; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wang X, 2015, STAT SINICA, V25, P189, DOI 10.5705/ss.2013.212w; Weinert M, 2016, ESTUAR COAST SHELF S, V175, P157, DOI 10.1016/j.ecss.2016.03.024; Wieking G, 2001, SENCK MARIT, V31, P125, DOI 10.1007/BF03043023; Zeiss B, 1997, OCEANOL ACTA, V20, P311; Zettler M. L., 2008, STATE EVOLUTION BALT, P517; Zettler ML, 2014, HELGOLAND MAR RES, V68, P49, DOI 10.1007/s10152-013-0368-x; Zettler ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078219	64	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175746	10.1371/journal.pone.0175746	http://dx.doi.org/10.1371/journal.pone.0175746			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28422974	Green Published, Green Submitted, gold			2022-12-27	WOS:000399875600048
J	Brady, E; Hill, K				Brady, Eoghan; Hill, Kenneth			Testing survey-based methods for rapid monitoring of child mortality, with implications for summary birth history data	PLOS ONE			English	Article							FERTILITY	Introduction Under-five mortality estimates are increasingly used in low and middle income countries to target interventions and measure performance against global development goals. Two new methods to rapidly estimate under-5 mortality based on Summary Birth Histories (SBH) were described in a previous paper and tested with data available. This analysis tests the methods using data appropriate to each method from 5 countries that lack vital registration systems. SBH data are collected across many countries through censuses and surveys, and indirect methods often rely upon their quality to estimate mortality rates. Methods and findings The Birth History Imputation method imputes data from a recent Full Birth History (FBH) onto the birth, death and age distribution of the SBH to produce estimates based on the resulting distribution of child mortality. DHS FBHs and MICS SBHs are used for all five countries. In the implementation, 43 of 70 estimates are within 20% of validation estimates (61%). Mean Absolute Relative Error is 17.7.%. 1 of 7 countries produces acceptable estimates. The Cohort Change method considers the differences in births and deaths between repeated Summary Birth Histories at 1 or 2-year intervals to estimate the mortality rate in that period. SBHs are taken from Brazil's PNAD Surveys 2004-2011 and validated against IGME estimates. 2 of 10 estimates are within 10% of validation estimates. Mean absolute relative error is greater than 100%. Conclusions Appropriate testing of these new methods demonstrates that they do not produce sufficiently good estimates based on the data available. We conclude this is due to the poor quality of most SBH data included in the study. This has wider implications for the next round of censuses and future household surveys across many low-and middle-income countries.	[Brady, Eoghan; Hill, Kenneth] Johns Hopkins Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Brady, E (corresponding author), Johns Hopkins Sch Publ Hlth, Baltimore, MD 21205 USA.	ebrady9@jhu.edu			RMM project of the Institute of International Programs of Johns Hopkins Bloomberg School of Public Health; Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative to Save a Million Lives	RMM project of the Institute of International Programs of Johns Hopkins Bloomberg School of Public Health; Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative to Save a Million Lives	The authors received funding as part of the RMM project of the Institute of International Programs of Johns Hopkins Bloomberg School of Public Health. Support was provided by the Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative to Save a Million Lives. The funder provided support in the form of salaries for authors EB and KH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 2008, SUMM STAT REP 2007 P; Bryce Jennifer, 2016, PLoS Med, V13, pe1001912, DOI 10.1371/journal.pmed.1001912; COALE AJ, 1985, DEMOGRAPHY, V22, P611, DOI 10.2307/2061591; Hill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137713; IGME U, LEVELS TRENDS CHILD; Montana LS, 2011, ESTIMATING CHILD MOR; Moultrie TomA., 2013, TOOLS DEMOGRAPHIC ES; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Silva R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001296; Stupp PW, 1988, POPUL INDEX, P209; UNICEF, 2007, UNICEF GHAN MULT IND; United Nations, MILL DEV GOALS REP 2; United Nations, 1983, MAN 10 IND TECHN DEM; Verhulst A, 2016, DEMOGR RES, V34, P1075, DOI 10.4054/DemRes.2016.34.39; ZLOTNIK H, 1981, DEMOGRAPHY, V18, P103, DOI 10.2307/2061052	15	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176366	10.1371/journal.pone.0176366	http://dx.doi.org/10.1371/journal.pone.0176366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441434	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800052
J	Meyer, L; Leymarie, O; Chevalier, C; Esnault, E; Moroldo, M; Da Costal, B; Georgeault, S; Roingeard', P; Delmasl, B; Quere, P; Le Goffic, R				Meyer, Lea; Leymarie, Olivier; Chevalier, Christophe; Esnault, Evelyne; Moroldo, Marco; Da Costal, Bruno; Georgeault, Sonia; Roingeard', Philippe; Delmasl, Bernard; Quere, Pascale; Le Goffic, Ronan			Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection	PLOS ONE			English	Article							A VIRUS; INNATE IMMUNITY; MESSENGER-RNA; EXPRESSION; PROTEIN; REPLICATION; GLYCOLYSIS; INFLAMMATION; CASPASE-1; NLRP3	Avian Influenza virus (AIV) is a major concern for the global poultry industry. Since 2012, several countries have reported AIV outbreaks among domestic poultry. These outbreaks had tremendous impact on poultry production and socio-economic repercussion on farmers. In addition, the constant emergence of highly pathogenic AIV also poses a significant risk to human health. In this study, we used a chicken lung epithelial cell line (CLEC213) to gain a better understanding of the molecular consequences of low pathogenic AIV infection in their natural host. Using a transcriptome profiling approach based on microarrays, we identified a cluster of mitochondrial genes highly induced during the infection. Interestingly, most of the regulated genes are encoded by the mitochondrial genome and are involved in the oxidative phosphorylation metabolic pathway. The biological consequences of this transcriptomic induction result in a 2.5- to 4-fold increase of the ATP concentration within the infected cells. PB1-F2, a viral protein that targets the mitochondria was not found associated to the boost of activity of the respiratory chain. We next explored the possibility that ATP may act as a host-derived danger signal (through production of extracellular ATP) or as a boost to increase AIV replication. We observed that, despite the activation of the P2X7 purinergic receptor pathway, a 1mM ATP addition in the cell culture medium had no effect on the virus replication in our epithelial cell model. Finally, we found that oligomycin, a drug that inhibits the oxidative phosphorylation process, drastically reduced the AIV replication in CLEC213 cells, without apparent cellular toxicity. Collectively, our results suggest that AIV is able to boost the metabolic capacities of its avian host in order to provide the important energy needs required to produce progeny virus.	[Meyer, Lea; Leymarie, Olivier; Chevalier, Christophe; Da Costal, Bruno; Delmasl, Bernard; Le Goffic, Ronan] Univ Paris Saclay, VIM, INRA, Jouy En Josas, France; [Esnault, Evelyne; Quere, Pascale] Univ Francois Rabelais Tours, ISP, INRA, UMR 1282, Nouzilly, France; [Moroldo, Marco] CRB GADIE INRA, Ctr Ressources Biol Genom Anim Domest & Interet E, Domaine Vilvert, Jouy En Josas, France; [Georgeault, Sonia; Roingeard', Philippe] Univ Tours, Plateforme IBiSA Microscopie Elect, Tours, France; [Georgeault, Sonia; Roingeard', Philippe] CHRU Tours, Tours, France; [Roingeard', Philippe] Univ Tours, INSERM U966, Tours, France; [Leymarie, Olivier] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR8104, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Goffic, R (corresponding author), Univ Paris Saclay, VIM, INRA, Jouy En Josas, France.	ronan.le-goffic@inra.fr	Chevalier, Christophe/C-2575-2009; Chevalier, Christophe/AAW-5560-2020; Quéré, Pascale/G-6590-2019; LE GOFFIC, Ronan/M-3099-2019; Meyer, Léa/AAH-5321-2020; Chevalier, Christophe/AAK-4461-2020; LE GOFFIC, Ronan/B-7649-2008	Chevalier, Christophe/0000-0003-3231-9027; Quéré, Pascale/0000-0001-7763-3867; LE GOFFIC, Ronan/0000-0002-2012-0064; Meyer, Léa/0000-0002-3405-7967; LE GOFFIC, Ronan/0000-0002-2012-0064; Leymarie, Olivier/0000-0001-8670-3089	Conseil regional dIle-de-France [dim100157]; Animal Health Division of INRA; DIM Malinf doctoral fellowships - Conseil regional dIle-de-France	Conseil regional dIle-de-France(Region Ile-de-France); Animal Health Division of INRA; DIM Malinf doctoral fellowships - Conseil regional dIle-de-France	This work was partially funded by the Conseil regional dIle-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes", Grant#: dim100157). LM was supported by a grant of the Animal Health Division of INRA, OL was supported by DIM Malinf doctoral fellowships awarded by the Conseil regional dIle-de-France.	Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Burnstock G, 2016, PURINERG SIGNAL, V12, P59, DOI 10.1007/s11302-015-9493-0; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chang CW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-80; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Chmielewski R, 2011, ANNU REV FOOD SCI T, V2, P37, DOI 10.1146/annurev-food-022510-133710; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14; Huang SW, 2016, IMMUNOL CELL BIOL; Jang HJ, 2015, POULTRY SCI, V94, P1190, DOI 10.3382/ps/pev033; Johnson AL, 1998, GENE, V219, P55, DOI 10.1016/S0378-1119(98)00373-4; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lee BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035812; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Pourcelot M, 2014, FEBS J, V281, P3791, DOI 10.1111/febs.12940; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Soubies SM, 2013, J GEN VIROL, V94, P50, DOI 10.1099/vir.0.045153-0; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wu XP, 2013, J PROTEOMICS, V91, P136, DOI 10.1016/j.jprot.2013.06.037; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Ye JH, 2015, VET RES COMMUN, V39, P171, DOI 10.1007/s11259-015-9641-6; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Yogev O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004400; Zaffuto KM, 2008, AVIAN PATHOL, V37, P25, DOI 10.1080/03079450701774850; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	38	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176355	10.1371/journal.pone.0176355	http://dx.doi.org/10.1371/journal.pone.0176355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441462	gold, Green Submitted, Green Published			2022-12-27	WOS:000400308800051
J	Seifert, L; Cordier, R; Orth, D; Courtine, Y; Croft, JL				Seifert, Ludovic; Cordier, Romain; Orth, Dominic; Courtine, Yoan; Croft, James L.			Role of route previewing strategies on climbing fluency and exploratory movements	PLOS ONE			English	Article							SPORT; AFFORDANCES; BEHAVIOR; SKILL	This study examined the role of route previewing strategies on climbing fluency and on exploratory movements of the limbs, in order to understand whether previewing helps people to perceive and to realize affordances. Eight inexperienced and ten experienced climbers previewed a 10 m high route of 5b difficulty on French scale, then climbed it with a toprope as fluently as possible. Gaze behavior was collected from an eye tracking system during the preview and allowed us to determine the number of times they scanned the route, and which of four route previewing strategies (fragmentary, ascending, zigzagging, and sequence-of-blocks) they used. Five inertial measurement units (IMU) (3D accelerometer, 3D gyroscope, 3D magnetometer) were attached to the hip, both feet, and forearms to analyze the vertical acceleration and direction of each limb and hip during the ascent. We were able to detect movement and immobility phases of each IMU using segmentation and classification processes. Depending on whether the limbs and/or hip were moving, five states of behavior were detected: immobility, postural regulation, hold exploration, hold change, and hold traction. Using cluster analysis we identified four clusters of gaze behavior during route previewing depending on route preview duration, number of scan paths, fixations duration, ascending, zigzagging, and sequence-of-blocks strategies. The number of scan paths was positively correlated with relative duration of exploration and negatively correlated with relative duration of hold changes during the ascent. Additionally, a high relative duration of sequence-of-blocks strategy and zigzagging strategy were associated with a high relative duration of immobility during the ascent. Route previewing might help to pick up functional information about reachable, graspable, and usable holds, in order to chain movements together and to find the route. In other words, route previewing might contribute to perceiving and realizing nested affordances.	[Seifert, Ludovic; Cordier, Romain; Courtine, Yoan] Univ Rouen Normandy, Fac Sport Sci, EA 3832, CETAPS, Rouen, France; [Orth, Dominic] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst, Amsterdam, Netherlands; [Croft, James L.] Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sports Sci Res, Perth, WA, Australia	Vrije Universiteit Amsterdam; Edith Cowan University	Seifert, L (corresponding author), Univ Rouen Normandy, Fac Sport Sci, EA 3832, CETAPS, Rouen, France.	ludovic.seifert@univ-rouen.fr	SEIFERT, Ludovic/AAI-7486-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Orth, D.O./0000-0001-8844-3815	CPER/FEDER, GRR Logistic, Mobility and Numeric [RISC 1880 - FEDER 33172]; French National Agency of Research [ANR-13-JSH2-0004]; Edith Cowan University	CPER/FEDER, GRR Logistic, Mobility and Numeric; French National Agency of Research(French National Research Agency (ANR)); Edith Cowan University	This project received the support of the CPER/FEDER, GRR Logistic, Mobility and Numeric RISC 1880 - FEDER 33172 for (LS). This project also received the funding of the French National Agency of Research (ID: ANR-13-JSH2-0004 DynaMov) for (LS) and Edith Cowan University for (JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Boschker MSJ, 2002, Q J EXP PSYCHOL-A, V55, P775, DOI 10.1080/02724980143000622; Boschker MSJ, 2002, J MOTOR BEHAV, V34, P25, DOI 10.1080/00222890209601928; Boschker MSJ, 2002, PERCEPT MOTOR SKILL, V95, P3, DOI 10.2466/PMS.95.4.3-9; Boulanger J, 2016, IEEE SENS J, V16, P742, DOI 10.1109/JSEN.2015.2481511; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Button C, 2017, ROUT RES SPORT EXERC, P210; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; CORDIER P, 1993, INT J SPORT PSYCHOL, V24, P370; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; DELIGNIERES D, 1993, INT J SPORT PSYCHOL, V24, P404; Dicks M, 2016, SPORT MED; Draper N, 2011, J SPORT SCI, V29, P851, DOI 10.1080/02640414.2011.565362; Duda R.O., 2006, PATTERN CLASSIFICATI; Everitt B. S., 2001, CLUSTER ANAL; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Grushko AI, 2014, PROCD SOC BEHV, V146, P169, DOI 10.1016/j.sbspro.2014.08.075; Horst E., 2008, TRAINING CLIMBING DE; Johnson H.W., 1961, PERCEPT MOTOR SKILLS, V13, P163; Kaijun Wang, 2009, Data Science Journal, V8, P88, DOI 10.2481/dsj.007-020; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Nieuwenhuys A, 2008, J SPORT EXERCISE PSY, V30, P171, DOI 10.1123/jsep.30.2.171; NOUGIER V, 1993, INT J SPORT PSYCHOL, V24, P379; Orth D, 2017, ROUT RES SPORT EXERC, P196; Orth D, 2016, SPORTS MED, V46, P255, DOI 10.1007/s40279-015-0417-5; Pezzulo G, 2010, BRAIN COGNITION, V73, P68, DOI 10.1016/j.bandc.2010.03.002; Rein Robert, 2010, Motor Control, V14, P211; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sanchez X, 2012, SCAND J MED SCI SPOR, V22, P67, DOI 10.1111/j.1600-0838.2010.01151.x; Seifert L., 2014, SPORTS TECHNOL, V7, P166, DOI DOI 10.1080/19346182.2014.968250; Seifert L, 2014, J APPL BIOMECH, V30, P619, DOI [10.1123/JAB.2014-0052, 10.1123/jab.2014-0052]; Seifert L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01819; Seifert L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089865; Sibella F, 2007, HUM MOVEMENT SCI, V26, P841, DOI 10.1016/j.humov.2007.05.008; Smyth MM, 1998, APPL COGNITIVE PSYCH, V12, P145, DOI 10.1002/(SICI)1099-0720(199804)12:2<145::AID-ACP505>3.0.CO;2-Z; Wagman JB, 2010, PSYCHON B REV, V17, P905, DOI 10.3758/PBR.17.6.905; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003; Zhao Y, 2005, MOL BIOTECHNOL, V31, P55, DOI 10.1385/MB:31:1:055	42	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176306	10.1371/journal.pone.0176306	http://dx.doi.org/10.1371/journal.pone.0176306			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441425	Green Published, Green Submitted, gold			2022-12-27	WOS:000400308800042
J	Shuryak, I				Shuryak, Igor			Quantitative modeling of responses to chronic ionizing radiation exposure using targeted and non-targeted effects	PLOS ONE			English	Article							CHERNOBYL EXCLUSION ZONE; DEINOCOCCUS-RADIODURANS; CELLS; RESISTANCE; DAMAGE; RATES; IRRADIATION; CULTURE; STRESS; RISKS	The biological effects of chronic ionizing radiation exposure can be difficult to study, but important to understand in order to protect the health of occupationally-exposed persons and victims of radiological accidents or malicious events. They include targeted effects (TE) caused by ionizations within/close to nuclear DNA, and non-targeted effects (NTE) caused by damage to other cell structures and/or activation of stress-signaling pathways in distant cells. Data on radiation damage in animal populations exposed over multiple generations to wide ranges of dose rates after the Chernobyl nuclear-power-plant accident are very useful for enhancing our understanding of these processes. We used a mechanistically-motivated mathematical model which includes TE and NTE to analyze a large published data set on chromosomal aberrations in pond snail (Lymnaea stagnalis) embryos collected over 16 years from water bodies contaminated by Chernobyl fallout, and from control locations. The fraction of embryo cells with aberrations increased dramatically (> 10-fold) and non-linearly over a dose rate range of 0.03-420 mu Gy/h (0.00026-3.7 Gy/year). NTE were very important for describing the non-linearity of this radiation response: the TE-only model (without NTE) performed dramatically worse than the TE+NTE model. NTE were predicted to reach 1/2 of maximal intensity at 2.5 mu Gy/h (0.022 Gy/year) and to contribute >90% to the radiation response slope at dose rates < 11 mu Gy/h (0.1 Gy/year). Internally-incorporated Sr-90 was possibly more effective per unit dose than other radionuclides. The radiation response shape for chromosomal aberrations in snail embryos was consistent with data for a different end-point: the fraction of young amoebocytes in adult snail haemolymph. Therefore, radiation may affect different snail life stages by similar mechanisms. The importance of NTE in our model-based analysis suggests that the search for modulators of NTE-related signaling pathways could be a promising strategy for mitigating the deleterious effects of chronic irradiation.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu						Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alonzo F, 2008, J ENVIRON RADIOACTIV, V99, P1464, DOI 10.1016/j.jenvrad.2007.11.021; Brenner DJ, 2003, HEALTH PHYS, V85, P103, DOI 10.1097/00004032-200307000-00018; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; EDWARDS AA, 1979, RADIAT ENVIRON BIOPH, V16, P89, DOI 10.1007/BF01323216; Einor D, 2016, SCI TOTAL ENVIRON, V548, P463, DOI 10.1016/j.scitotenv.2016.01.027; Frantsevich L, 2007, ANIMAL RADIOECOLOGY; Friedland W, 2011, RADIAT PROT DOSIM, V143, P542, DOI 10.1093/rpd/ncq383; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Golubev A., 2005, RADIOPROTECTION, V40, pS511, DOI [10.1051/radiopro, DOI 10.1051/RADIOPRO]; Gudkov DI, 2016, J ENVIRON RADIOACTIV, V151, P438, DOI 10.1016/j.jenvrad.2015.09.004; Gudkov D, 2006, NATO SEC SCI B PHYS, V9, P69, DOI 10.1007/1-4020-4956-0_6; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Hertel-Aas T, 2007, RADIAT RES, V168, P515, DOI 10.1667/RR1012.1; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lawrence CT, 2001, SIAM J OPTIMIZ, V11, P1092, DOI 10.1137/S1052623498344562; Loucas BD, 2013, RADIAT RES, V179, P9, DOI 10.1667/RR3089.1; LUBIN JH, 1995, HEALTH PHYS, V69, P494, DOI 10.1097/00004032-199510000-00007; Miller DL, 2003, J VASC INTERV RADIOL, V14, P711, DOI 10.1097/01.RVI.0000079980.80153.4B; MITCHELL JB, 1979, RADIAT RES, V79, P537, DOI 10.2307/3575179; Moller AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08363; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Mollert AP, 2016, TRENDS ECOL EVOL, V31, P281, DOI 10.1016/j.tree.2016.01.005; Mothersill C, 2006, DOSE RESPONSE, V4; Murphy JF, 2011, J ENVIRON RADIOACTIV, V102, P688, DOI 10.1016/j.jenvrad.2011.04.007; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Pinto M, 2005, RADIAT RES, V164, P73, DOI 10.1667/RR3394; Puskin JS, 2003, HEALTH PHYS, V84, P526, DOI 10.1097/00004032-200304000-00012; Sasaki K, 2012, COMP MATH MATH PHYS, V2012; Sawant SG, 2001, RADIAT RES, V156, P177, DOI 10.1667/0033-7587(2001)156[0177:ARATBE]2.0.CO;2; Schmid E, 1996, RADIAT ENV BIOPH, V35; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Shuryak I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147696; Shuryak I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028559; STEEL GG, 1987, RADIOTHER ONCOL, V9, P299; Tugay TI, 2011, HEALTH PHYS, V101, P375, DOI 10.1097/HP.0b013e3181f56bf8; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Venzon D, 1988, APPL STAT, P87; Ward J., 2009, INT J RAD BIOL; Zaitsev AS, 2014, PEDOBIOLOGIA, V57, P5, DOI 10.1016/j.pedobi.2013.09.005	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176476	10.1371/journal.pone.0176476	http://dx.doi.org/10.1371/journal.pone.0176476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441437	Green Published, gold, Green Submitted			2022-12-27	WOS:000400308800062
J	Quang, TT; Kim, HY; Bao, FS; Papay, FA; Edwards, WB; Liu, Y				Quang, Tri T.; Kim, Hye-Yeong; Bao, Forrest Sheng; Papay, Francis A.; Edwards, W. Barry; Liu, Yang			Fluorescence Imaging Topography Scanning System for intraoperative multimodal imaging	PLOS ONE			English	Article							SENTINEL LYMPH-NODES; INDOCYANINE GREEN; GUIDED SURGERY; IN-VIVO; BREAST-CANCER; TOMOGRAPHY; SPECT	Fluorescence imaging is a powerful technique with diverse applications in intraoperative settings. Visualization of three dimensional (3D) structures and depth assessment of lesions, however, are oftentimes limited in planar fluorescence imaging systems. In this study, a novel Fluorescence Imaging Topography Scanning ( FITS) system has been developed, which offers color reflectance imaging, fluorescence imaging and surface topography scanning capabilities. The system is compact and portable, and thus suitable for deployment in the operating room without disturbing the surgical flow. For system performance, parameters including near infrared fluorescence detection limit, contrast transfer functions and topography depth resolution were characterized. The developed system was tested in chicken tissues ex vivo with simulated tumors for intraoperative imaging. We subsequently conducted in vivo multimodal imaging of sentinel lymph nodes in mice using FITS and PET/CT. The PET/CT/optical multimodal images were co-registered and conveniently presented to users to guide surgeries. Our results show that the developed system can facilitate multimodal intraoperative imaging.	[Quang, Tri T.; Liu, Yang] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Kim, Hye-Yeong; Edwards, W. Barry] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Bao, Forrest Sheng] Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA; [Papay, Francis A.] Cleveland Clin, Dermatol & Plast Surg Inst, Cleveland, OH 44106 USA	University System of Ohio; University of Akron; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Akron; Cleveland Clinic Foundation	Liu, Y (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.; Edwards, WB (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	edwardsw@upmc.edu; yliu@uakron.edu	Edwards, Wilson/AAD-8002-2021	Edwards, Wilson/0000-0002-6070-8778	Ohio Department of Development Third Frontier Grant [TVSF 15-0123]; LEAP Award [F14-10-LIU-WEB]; University of Akron Startup Funds	Ohio Department of Development Third Frontier Grant; LEAP Award; University of Akron Startup Funds	This study was supported in part by grants from the Ohio Department of Development Third Frontier Grant (TVSF 15-0123), the LEAP Award (F14-10-LIU-WEB) and the University of Akron Startup Funds.; This study was supported in part by grants from the Ohio Department of Development Third Frontier Grant (TVSF 15-0123), the LEAP Award (F14-10-LIU-WEB) and the University of Akron Startup Funds. We thank Dr. Bing Yu and Vivek Nagarajan for their assistance.	Ale A, 2012, NAT METHODS, V9, P615, DOI [10.1038/NMETH.2014, 10.1038/nmeth.2014]; Bostanci E., 2015, ARXIV151203156; Cao LJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066015; Chi C, 2014, THERANOSTICS, V4, P1072, DOI 10.7150/thno.9899; Cignoni P, 2008, EUR IT CHAPT C JUL 2; Geng J, 2011, ADV OPT PHOTONICS, V3, P128, DOI 10.1364/AOP.3.000128; Gilmore DM, 2013, J THORAC CARDIOV SUR, V146, P562, DOI 10.1016/j.jtcvs.2013.04.010; Goshtasby A., 2005, 2 D 3 D IMAGE REGIST; Guo WB, 2014, TUMOR BIOL, V35, P3073, DOI 10.1007/s13277-013-1399-2; Handgraaf H.J., 2015, MINIM INVASIV THER, P1; Handgraaf HJM, 2014, GYNECOL ONCOL, V135, P606, DOI 10.1016/j.ygyno.2014.08.005; Inokuchi S., 1984, Seventh International Conference on Pattern Recognition (Cat. No. 84CH2046-1), P806; Jewell EL, 2014, GYNECOL ONCOL, V133, P274, DOI 10.1016/j.ygyno.2014.02.028; Laios Alexandros, 2015, BMC Res Notes, V8, P608, DOI 10.1186/s13104-015-1576-z; Li CQ, 2011, J NUCL MED, V52, P1268, DOI 10.2967/jnumed.110.082859; Liu JTC, 2014, NEUROSURGERY, V75, P61, DOI 10.1227/NEU.0000000000000344; Lutje S, 2014, CANCER RES, V74, P6216, DOI 10.1158/0008-5472.CAN-14-0594; Mohajerani P, 2014, IEEE T MED IMAGING, V33, P1434, DOI 10.1109/TMI.2014.2313405; Oh Y, 2013, J THORAC CARDIOV SUR, V146, P1509, DOI 10.1016/j.jtcvs.2013.02.044; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Solomon M, 2013, J NUCL MED, V54, P639, DOI 10.2967/jnumed.112.105742; Stuker F, 2011, IEEE T MED IMAGING, V30, P1265, DOI 10.1109/TMI.2011.2112669; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; van Oosterom MN, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0056-0; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Vonwil D, 2014, MOL IMAGING BIOL, V16, P350, DOI 10.1007/s11307-013-0698-8; Yi XM, 2014, INT J NANOMED, V9, P1347, DOI 10.2147/IJN.S60206; Zhang GL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.040505	28	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174928	10.1371/journal.pone.0174928	http://dx.doi.org/10.1371/journal.pone.0174928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437441	Green Published, gold, Green Submitted			2022-12-27	WOS:000400287600004
J	Trotta, F; Spila-Alegiani, S; Da Cas, R; Rajevic, M; Conti, V; Venegoni, M; Rossi, M; Traversa, G				Trotta, Francesco; Spila-Alegiani, Stefania; Da Cas, Roberto; Rajevic, Maja; Conti, Valentino; Venegoni, Mauro; Rossi, Mariangela; Traversa, Giuseppe			Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study	PLOS ONE			English	Article							TIOSPIR TRIAL; MIST INHALER; RISK; MORTALITY; COPD; MEDICATIONS; INCREASES; DEATH; PRO	The cardiovascular safety of tiotropium Respimat formulation in the routine clinical practice is still an open issue. Our aim was to compare the risk of acute myocardial infarction and heart rhythm disorders in incident users of either tiotropium Respimat or HandiHaler. The study population comprises patients aged >= 45 years, resident in two Italian regions with a first prescription of tiotropium (HandiHaler or Respimat) between 01/07/2011-30/11/2013. The cohort was identified through the database of prescriptions reimbursed by the Italian National Health Service. Comorbidities and clinical outcomes were obtained from hospital records. The primary outcome was the first hospitalization for acute myocardial infarction and/or for heart rhythm disorders during the exposure period. Hazard ratios were estimated in the propensity score-matched groups through Cox regression. After matching, 31,334 patients with incident prescription of tiotropium were included. The two groups were balanced with regard to baseline characteristics. Similar incidence rates of the primary outcome between Respimat and HandiHaler users were identified (adjusted hazard ratio 1.02, 95% CI 0.82-1.28). No risk difference between Respimat and HandiHaler emerged when considering clinical events separately. This large cohort study showed a comparable acute cardiovascular safety profile of the two tiotropium formulations.	[Trotta, Francesco] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Spila-Alegiani, Stefania; Da Cas, Roberto; Traversa, Giuseppe] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy; [Rajevic, Maja] Univ Roma La Sapienza, Pharmaceut Sci Drug Chem & Technol Dept, Rome, Italy; [Conti, Valentino; Venegoni, Mauro] Gen Directorate Hlth, Reg Ctr Pharmacovigilance, Milan, Italy; [Rossi, Mariangela] Gen Directorate Hlth, Unit Pharmaceut Governance, Perugia, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome	Spila-Alegiani, S (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy.	stefania.spila@iss.it	Trotta, Francesco/G-8702-2013; Venegoni, Mauro/H-3416-2019	Trotta, Francesco/0000-0001-6889-8484; Venegoni, Mauro/0000-0002-5462-5327	Umbria Regional Health Authority	Umbria Regional Health Authority	Only public employees of the National or Regional health authorities were involved in conceiving, planning, and conducting the study; partial financial support was received from the Umbria Regional Health Authority. The corresponding author had full access to all study data and approved the manuscript for publication.	[Anonymous], SPIR RESP SUMM PROD; Bateman ED, 2013, EUR RESPIR J, V42, P590, DOI 10.1183/09031936.00042213; Beasley R, 2013, EUR RESPIR J, V42, P584, DOI 10.1183/09031936.00042113; Beasley R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7390; Dong YH, 2013, THORAX, V68, P48, DOI 10.1136/thoraxjnl-2012-201926; EVERITT DE, 1990, ANN INTERN MED, V112, P120, DOI 10.7326/0003-4819-112-2-120; Halpin DMG, 2015, INT J CHRONIC OBSTR, V10, P239, DOI 10.2147/COPD.S75146; Jenkins CR, 2013, NEW ENGL J MED, V369, P1555, DOI 10.1056/NEJMe1310107; Jenkins CR, 2013, THORAX, V68, P5, DOI 10.1136/thoraxjnl-2012-202482; Kruis AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090145; Loke YK, 2014, NEW ENGL J MED, V370, P480, DOI 10.1056/NEJMc1314411; Pulmonary-Allergy Drugs Advisory Committee. US Food and Drug Administration. Clinical briefing document, 2009, OVERVIEW OF THE FDA; r Summary of Product Characteristics, SUMM PROD CHAR; Schmiedl S, 2016, BRIT J CLIN PHARMACO, V81, P379, DOI 10.1111/bcp.12808; Scichilone N, 2014, RESPIRATION, V87, P11, DOI 10.1159/000355082; Singh S, 2013, THORAX, V68, P114, DOI 10.1136/thoraxjnl-2011-201275; The Medicines Utilisation Monitoring Centre, 2015, NAT REP MED US IT; Trotta F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006619; Verhamme KMC, 2013, EUR RESPIR J, V42, P606, DOI 10.1183/09031936.00005813; Wise R, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.67; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176276	10.1371/journal.pone.0176276	http://dx.doi.org/10.1371/journal.pone.0176276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430820	Green Published, gold, Green Submitted			2022-12-27	WOS:000399876100037
J	Laurent, S; Salamin, N; Robinson-Rechavi, M				Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc			No evidence for the radiation time lag model after whole genome duplications in Teleostei	PLOS ONE			English	Article							RECIPROCAL GENE LOSS; DIVERSIFICATION; FISH; EVOLUTION; EXTINCTION; SPECIATION; DIVERGENCE; POLYPLOIDY; RESOLUTION; PHYLOGENY	The short and long term effects of polyploidization on the evolutionary fate of lineages is still unclear despite much interest. First recognized in land plants, it has become clear that polyploidization is widespread in eukaryotes, notably at the origin of vertebrates and teleost fishes. Many hypotheses have been proposed to link the species richness of lineages and whole genome duplications. For instance, the radiation time lag model suggests that paleopolyploidy would favour the apparition of new phenotypic traits, although the radiation of the lineage would not occur before a later dispersion event. Some results indicate that this model may be observed during land plant evolution. In this work, we test predictions of the radiation time lag model using both fossil data and molecular phylogenies in ancient and more recent teleost whole genome duplications. We fail to find any evidence of delayed increase of the species number after any of these events and conclude that paleopolyploidization still remains to be unambiguously linked to taxonomic diversity in teleosts.	[Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics	Robinson-Rechavi, M (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.; Robinson-Rechavi, M (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	marc.robinson-rechavi@unil.ch	Robinson-Rechavi, Marc/E-9727-2011	Robinson-Rechavi, Marc/0000-0002-3437-3329; Salamin, Nicolas/0000-0002-3963-4954	ProDoc of the Swiss National Science Fondation [134931]; Etat de Vaud	ProDoc of the Swiss National Science Fondation; Etat de Vaud	This work was supported by the ProDoc grant number 134931 of the Swiss National Science Fondation; and Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ProDoc grant number 134931 of the Swiss National Science Fondation; and Etat de Vaud. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the Swiss Institute of Bioinformatics. We would like to thank Christian Parisod and Nils Arrigo for comments on an earlier version of the manuscript.	Alexandrou MA, 2013, MOL PHYLOGENET EVOL, V69, P514, DOI 10.1016/j.ympev.2013.07.026; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Beaulieu JM, 2016, SYST BIOL, V65, P583, DOI 10.1093/sysbio/syw022; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Campbell MA, 2013, GENE, V530, P57, DOI 10.1016/j.gene.2013.07.068; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Dodsworth S, 2015, BOTANICAL JOURNAL OF; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Froese R., 2021, FISHBASE; Givnish TJ, 2015, P ROY SOC B-BIOL SCI, V282, P171, DOI 10.1098/rspb.2015.1553; Guinot G, 2015, BIOL REV, V41; Havelka M, 2011, FOLIA ZOOL, V60, P93; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Laurent S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0432-z; Li Z, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501084; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Maclean CJ, 2011, EVOLUTION, V65, P932, DOI 10.1111/j.1558-5646.2010.01171.x; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; May MR, 2016, SYST BIOL; Moriyama Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10397; Morlon H, 2014, ECOL LETT, V17, P508, DOI 10.1111/ele.12251; Muir CD, 2015, AM NAT, V185, P70, DOI 10.1086/679108; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; O'Meara BC., 2011, ANNUAL REVIEW OF ECO, V43; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; Robertson FM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1241-z; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Scott AD, 2015, BIORXIV; Shi FX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0669-0; Silvestro D, 2016, PHILOSOPHICAL TRANSA, V371; Silvestro D, 2014, SYST BIOL, P1; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Smith DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0060; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vogel G, 1998, SCIENCE, V281, P1119, DOI 10.1126/science.281.5380.1119; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wagner PJ, 2014, P NATL ACAD SCI USA, V111, P16419, DOI 10.1073/pnas.1406304111; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Zhan SH, DATA FROM COMPARATIV; Zhang S, 2018, J INTELL MANUF, V29, P585, DOI 10.1007/s10845-014-1023-3	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176384	10.1371/journal.pone.0176384	http://dx.doi.org/10.1371/journal.pone.0176384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426792	gold, Green Submitted, Green Published			2022-12-27	WOS:000399875900129
J	Marcus, DJ; Henderson-Redmond, AN; Gonek, M; Zee, ML; Farnsworth, JC; Amin, RA; Andrews, MJ; Davis, BJ; Mackie, K; Morgan, DJ				Marcus, David J.; Henderson-Redmond, Angela N.; Gonek, Maciej; Zee, Michael L.; Farnsworth, Jill C.; Amin, Randa A.; Andrews, Mary-Jeanette; Davis, Brian J.; Mackie, Ken; Morgan, Daniel J.			Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; RANDOMIZED CONTROLLED-TRIAL; MORPHINE-DEPENDENT MICE; NUCLEUS-ACCUMBENS; KNOCKOUT MICE; DOPAMINE RELEASE; PRECIPITATED WITHDRAWAL; ETHANOL-CONSUMPTION; OPIOID DEPENDENCE; CROSS-TOLERANCE	We recently characterized S426A/S430A mutant mice expressing a desensitization-resistant form of the CB1 receptor. These mice display an enhanced response to endocannabinoids and Delta(9)-THC. In this study, S426A/S430A mutants were used as a novel model to test whether ethanol consumption, morphine dependence, and reward for these drugs are potentiated in mice with a "hyper-sensitive" form of CB1. Using an unlimited-access, two-bottle choice, voluntary drinking paradigm, S426A/S430A mutants exhibit modestly increased intake and preference for low (6%) but not higher concentrations of ethanol. S426A/S430A mutants and wildtype mice show similar taste preference for sucrose and quinine, exhibit normal sensitivity to the hypothermic and ataxic effects of ethanol, and have normal blood ethanol concentrations following administration of ethanol. S426A/S430A mutants develop robust conditioned place preference for ethanol (2 g/kg), morphine (10 mg/kg), and cocaine (10 mg/kg), demonstrating that drug reward is not changed in S426A/S430A mutants. Precipitated morphine withdrawal is also unchanged in opioid-dependent S426A/S430A mutant mice. Although ethanol consumption is modestly changed by enhanced CB1 signaling, reward, tolerance, and acute sensitivity to ethanol and morphine are normal in this model.	[Marcus, David J.; Gonek, Maciej; Zee, Michael L.; Farnsworth, Jill C.; Amin, Randa A.; Andrews, Mary-Jeanette; Davis, Brian J.; Mackie, Ken; Morgan, Daniel J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Marcus, David J.; Gonek, Maciej; Zee, Michael L.; Farnsworth, Jill C.; Amin, Randa A.; Andrews, Mary-Jeanette; Davis, Brian J.; Mackie, Ken; Morgan, Daniel J.] Indiana Univ, Linda & Jack Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [Marcus, David J.; Henderson-Redmond, Angela N.; Zee, Michael L.; Morgan, Daniel J.] Penn State Univ, Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Morgan, DJ (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.; Morgan, DJ (corresponding author), Indiana Univ, Linda & Jack Gill Ctr Biomol Sci, Bloomington, IN 47405 USA.; Morgan, DJ (corresponding author), Penn State Univ, Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA.	djm68@psu.edu		Morgan, Daniel/0000-0002-9467-4019	NIH [DA036385, DA037355, DA011322, DA021696]; Pennsylvania Department of Health using Tobacco CURE Funds [4100057673]; Indiana University METACyt Initiative; Lilly Foundation; Linda and Jack Gill Center for Biomolecular Science; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322, K01DA037355, R21DA036385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health using Tobacco CURE Funds; Indiana University METACyt Initiative; Lilly Foundation; Linda and Jack Gill Center for Biomolecular Science; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been supported by NIH grants DA036385 (DJM), DA037355 (DJM), DA011322 (KM), DA021696 (KM) and is funded, in part, under a grant from the Pennsylvania Department of Health using Tobacco CURE Funds (DJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by NIH grants DA036385 (DJM), DA037355 (DJM), DA011322 (KM), DA021696 (KM) and is funded, in part, by grant 4100057673 from the Pennsylvania Department of Health using Tobacco CURE Funds (DJM). Additional support was provided by the Indiana University METACyt Initiative (funded in part by a grant from the Lilly Foundation) and the Linda and Jack Gill Center for Biomolecular Science.	Administration. SAaMHS, 2013, RES 2012 NAT SURV DR, pv; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Befort K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00006; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Caille S, 2006, NEUROPSYCHOPHARMACOL, V31, P804, DOI 10.1038/sj.npp.1300848; Caille S, 2003, EUR J NEUROSCI, V18, P3145, DOI 10.1111/j.1460-9568.2003.02961.x; Chaperon F, 1998, PSYCHOPHARMACOLOGY, V135, P324, DOI 10.1007/s002130050518; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; CHEN JP, 1990, PSYCHOPHARMACOLOGY, V102, P156, DOI 10.1007/BF02245916; Cichewicz DL, 2003, J PHARMACOL EXP THER, V305, P812, DOI 10.1124/jpet.102.046870; Cossu G, 2001, BEHAV BRAIN RES, V118, P61, DOI 10.1016/S0166-4328(00)00311-9; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; De Carvalho CR, 2014, PSYCHOPHARMACOLOGY, V231, P1417, DOI 10.1007/s00213-013-3331-2; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Fischer BD, 2010, NEUROPHARMACOLOGY, V58, P544, DOI 10.1016/j.neuropharm.2009.08.005; Foa EB, 2013, JAMA-J AM MED ASSOC, V310, P488, DOI 10.1001/jama.2013.8268; Gerak LR, 2015, PSYCHOPHARMACOLOGY B; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Henderson-Redmond AN, 2015, PROG NEUROPSYCHOPHAR; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Herkenham M, 1991, ANNU REV NEUROSCI, V11, P563; HINE B, 1985, PSYCHOPHARMACOLOGY, V87, P34, DOI 10.1007/BF00431774; Houchi H, 2005, NEUROPSYCHOPHARMACOL, V30, P339, DOI 10.1038/sj.npp.1300568; Hungund BL, 2003, J NEUROCHEM, V84, P698, DOI 10.1046/j.1471-4159.2003.01576.x; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kranzler HR, 2004, ALCOHOL CLIN EXP RES, V28, P1051, DOI 10.1097/01.ALC.0000130804.08397.29; Latt NC, 2002, MED J AUSTRALIA, V176, P530, DOI 10.5694/j.1326-5377.2002.tb04550.x; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lichtman AH, 2001, J PHARMACOL EXP THER, V298, P1007; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P161; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marcus DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160462; Martin M, 2000, EUR J NEUROSCI, V12, P4038, DOI 10.1046/j.1460-9568.2000.00287.x; Mas-Nieto M, 2001, BRIT J PHARMACOL, V132, P1809, DOI 10.1038/sj.bjp.0703990; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Morgan DJ, 2014, J NEUROSCI, V34, P5152, DOI 10.1523/JNEUROSCI.3445-12.2014; Racz I, 2003, J NEUROSCI, V23, P2453; Ramesh D, 2013, NEUROPSYCHOPHARMACOL, V38, P1039, DOI 10.1038/npp.2012.269; Ramesh D, 2011, J PHARMACOL EXP THER, V339, P173, DOI 10.1124/jpet.111.181370; Rubino T, 2000, LIFE SCI, V66, P2213, DOI 10.1016/S0024-3205(00)00547-6; Scavone JL, 2013, NEUROSCIENCE, V248, P637, DOI 10.1016/j.neuroscience.2013.04.034; Singh ME, 2004, BRAIN RES, V1026, P244, DOI 10.1016/j.brainres.2004.08.027; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Thanos PK, 2005, BEHAV BRAIN RES, V164, P206, DOI 10.1016/j.bbr.2005.06.021; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; THORAT SN, 1994, EUR J PHARMACOL, V260, P5, DOI 10.1016/0014-2999(94)90003-5; Trang T, 2007, NEUROSCIENCE, V146, P1275, DOI 10.1016/j.neuroscience.2007.02.031; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Valverde O, 2000, J NEUROSCI, V20, P9284; Vigano D, 2005, PSYCHOPHARMACOLOGY, V182, P527, DOI 10.1007/s00213-005-0114-4; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; World Health Organization, 2011, GLOB STAT REP ALC HL	58	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174826	10.1371/journal.pone.0174826	http://dx.doi.org/10.1371/journal.pone.0174826			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426670	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875900012
J	Peters, M; Scharmga, A; de Jong, J; van Tubergen, A; Geusens, P; Arts, JJ; Loeffen, D; Weijers, R; van Rietbergen, B; van den Bergh, J				Peters, M.; Scharmga, A.; de Jong, J.; van Tubergen, A.; Geusens, P.; Arts, J. J.; Loeffen, D.; Weijers, R.; van Rietbergen, B.; van den Bergh, J.			An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; BONE EROSIONS; MICRO-CT; HR-PQCT; MICROARCHITECTURE; QUALITY; QUANTIFICATION; SEGMENTATION; RADIOGRAPHY; REPAIR	Objectives To introduce a fully-automated algorithm for the detection of small cortical interruptions (>= 0.246mm in diameter) on high resolution peripheral quantitative computed tomography (HR-pQCT) images, and to investigate the additional value of manual correction of the automatically obtained contours (semi-automated procedure). Methods Ten metacarpophalangeal joints from seven patients with rheumatoid arthritis (RA) and three healthy controls were imaged with HR-pQCT. The images were evaluated by an algorithm according to the fully-and semi-automated procedure for the number and surface of interruptions per joint. Reliability between the fully-and semi-automated procedure and between two independent operators was tested using intra-class correlation coefficient (ICC) and the proportion of matching interruptions. Validity of single interruptions detected was tested by comparing it to visual scoring, as gold standard. The positive predictive value (PPV) and sensitivity were calculated. Results The median number of interruptions per joint was 14 (range 2 to 59) and did not significantly differ between the fully-and semi-automated procedure (p = 0.37). The median interruption surface per joint was significantly higher with the fully-vs. semi-automated procedure (respectively, 8.6mm(2) vs. 5.8mm(2) and 6.1mm(2), p = 0.01). Reliability was almost perfect between the fully-and semi-automated procedure for both the number and surface of interruptions (ICC >= 0.95) and the proportion of matching interruptions was high (>= 76%). Also the inter-operator reliability was almost perfect (ICC >= 0.97, proportion of matching interruptions 92%). The PPV ranged from 27.6% to 29.9%, and sensitivity from 69.7% to 76.3%. Most interruptions detected with the algorithm, did show an interruption on a 2D grayscale image. However, this interruption did not meet the criteria of an interruption with visual scoring. Conclusion The algorithm for HR-pQCT images detects cortical interruptions, and its interruption surface. Reliability and validity was comparable for the fully- and semi-automated procedures. However, we advise the use of the semi-automated procedure to assure quality. The algorithm is a promising tool for a sensitive and objective assessment of cortical interruptions in finger joints assessed by HR-pQCT.	[Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.; van den Bergh, J.] Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands; [Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands; [Peters, M.; Scharmga, A.; van den Bergh, J.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [de Jong, J.; Loeffen, D.; Weijers, R.] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [Geusens, P.; van den Bergh, J.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Arts, J. J.; van Rietbergen, B.] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands; [Arts, J. J.; van Rietbergen, B.] Eindhoven Univ Technol, Fac Biomed Engn, Eindhoven, Netherlands; [van den Bergh, J.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Hasselt University; Maastricht University; Eindhoven University of Technology; VieCuri Medical Center	Peters, M (corresponding author), Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands.; Peters, M (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands.; Peters, M (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	michiel.peters@maastrichtuniversity.nl	van Tubergen, Astrid/AAY-7065-2020; Arts, Chris/ABH-5550-2020	van Tubergen, Astrid/0000-0001-8477-0683; Arts, Chris/0000-0002-2947-8564; van den Bergh, Joop/0000-0003-3984-2232	Weijerhorst Foundation (JvdB); Pfizer [WS2056904]	Weijerhorst Foundation (JvdB); Pfizer(Pfizer)	This work was supported by: Weijerhorst Foundation (JvdB), http//www.deweijerhorst.nl/ weijerhorst/home. funding that was used to purchase the HR-pQCT scanner and pay half of the PhD student salaries of MP and AS. It was also supported by Pfizer (PG), grant number: WS2056904, http//www.pfizer.nl/. This funding was used to perform our study (NL42300.068.12 / METC 12-2-037) of HR-pQCT imaging in patients with RA compared to conventional imaging techniques.	Albrecht A, 2013, ANN RHEUM DIS, V72, P1351, DOI 10.1136/annrheumdis-2012-201982; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Aschenberg S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4235; Baillet A, 2011, RHEUMATOLOGY, V50, P1137, DOI 10.1093/rheumatology/keq437; Barnabe C, 2013, CLIN EXP RHEUMATOL, V31, P243; Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; Dohn UM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2378; Ejbjerg B, 2004, ARTHRITIS RHEUM, V50, P1097, DOI 10.1002/art.20135; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Finzel S, 2011, ANN RHEUM DIS, V70, P1587, DOI 10.1136/ard.2010.148395; Finzel S, 2011, ARTHRITIS RHEUM-US, V63, P1231, DOI 10.1002/art.30285; Finzel S, 2011, ANN RHEUM DIS, V70, P122, DOI 10.1136/ard.2010.132423; Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512; Geusens P, 2014, NAT REV RHEUMATOL, V10, P304, DOI 10.1038/nrrheum.2014.23; Geusens P, 2014, RHEUMATOLOGY, V53, P4, DOI 10.1093/rheumatology/ket358; Hulsmans HMJ, 2000, ARTHRITIS RHEUM, V43, P1927, DOI 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO;2-B; Kocijan R, 2014, J BONE MINER RES, V29, P1005, DOI 10.1002/jbmr.2109; Laib A, 1998, Technol Health Care, V6, P329; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lillegraven S, 2012, NAT REV RHEUMATOL, V8, P117, DOI 10.1038/nrrheum.2011.202; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Scharmga A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1148-y; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Srikhum W, 2013, J RHEUMATOL, V40, P408, DOI 10.3899/jrheum.120780; Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252; Topfer D, 2014, RHEUMATOLOGY, V53, P65, DOI 10.1093/rheumatology/ket259; VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175829	10.1371/journal.pone.0175829	http://dx.doi.org/10.1371/journal.pone.0175829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426705	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875900055
J	Bazafkan, H; Dattenbock, C; Stappler, E; Beier, S; Schmoll, M				Bazafkan, Hoda; Dattenbock, Christoph; Stappler, Eva; Beier, Sabrina; Schmoll, Monika			Interrelationships of VEL1 and ENV1 in light response and development in Trichoderma reesei	PLOS ONE			English	Article							HYPOCREA-JECORINA; SEXUAL DEVELOPMENT; PROTEIN; GENE; NEUROSPORA; CELLULASE; BIOCHEMISTRY; REVEALS; IMPACT; FUNGI	Sexual development is regulated by a complex regulatory mechanism in fungi. For Trichoderma reesei, the light response pathway was shown to impact sexual development, particularly through the photoreceptor ENVOY. Moreover, T. reesei communicates chemically with a potential mating partner in its vicinity, a response which is mediated by the velvet family protein VEL1 and its impact on secondary metabolism. We therefore studied the regulatory interactions of ENV1 and VEL1 with a focus on sexual development. Although individual mutants in both genes are female sterile under standard crossing conditions (light -dark cycles), an altered light regime enabled sexual development, which we found to be due to conditional female sterility Delta env1, but not Delta vel1. Phenotypes of growth and asexual sporulation as well as regulation of the peptide pheromone precursors of double mutants suggested that ENV1 and VEL1 balance positive and negative regulators of these functions. Additionally, VEL1 contributed to the strong deregulation of the pheromone system observed in env1 mutants. Female sterility of Delta vel1 was rescued by deletion of env1 in darkness in MAT1-1, indicating a block of sexual development by ENV1 in darkness that is balanced by VEL1 in the wild-type. We conclude that ENV1 and VEL1 exert complementing functions in development of T. reesei. Our results further showed that the different developmental phenotypes of vel1/veA mutants in T. reesei and Aspergillus nidulans are not due to the presence or function of ENV1 in the VELVET regulatory pathway in T. reesei.	[Bazafkan, Hoda; Dattenbock, Christoph; Stappler, Eva; Beier, Sabrina; Schmoll, Monika] AIT Austrian Inst Technol GmbH, Dept Hlth & Environm, Bioresources, Tulin, Austria; [Bazafkan, Hoda] Univ Innsbruck, Inst Microbiol, Innsbruck, Austria	Austrian Institute of Technology (AIT); University of Innsbruck	Schmoll, M (corresponding author), AIT Austrian Inst Technol GmbH, Dept Hlth & Environm, Bioresources, Tulin, Austria.	monika.schmoll@ait.ac.at	Schmoll, Monika/I-6541-2016	Schmoll, Monika/0000-0003-3918-0574; Hitzenhammer, Eva/0000-0002-4764-3711	Austrian Science Fund (FWF) [V152-B20, P24350]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work of HB, CD, ES and MS was supported by grants of the Austrian Science Fund (FWF) to MS (grant IDs V152-B20 and P24350). We want to thank Stefan Bohmdorfer and Josua Oberlerchner (University of Life Sciences, Vienna) for technical assistance with secondary metabolite analysis.; This work was supported by Austrian Science Fund (FWF; www.fwf.ac.at), grants V152B 20 and P24350 (MS).	Aanen Duur K., 2007, P527; ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Atanasova L, 2013, EUKARYOT CELL, V12, P1499, DOI 10.1128/EC.00103-13; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; Bazafkan H, 2015, MOL MICROBIOL, V96, P1103, DOI 10.1111/mmi.12993; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; CARDER JH, 1986, ANAL BIOCHEM, V153, P75, DOI 10.1016/0003-2697(86)90063-1; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Champe S, 1981, FUNGAL SPORE MORPHOG, P255; Chen CH, 2010, FUNGAL GENET BIOL, V47, P922, DOI 10.1016/j.fgb.2010.07.005; Chen CH, 2009, EMBO J, V28, P1029, DOI 10.1038/emboj.2009.54; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044969; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Lokhandwala J, 2016, J BIOL CHEM, V291, P14839, DOI 10.1074/jbc.M116.731448; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Metz B, 2011, EUKARYOT CELL, V10, P1527, DOI 10.1128/EC.05014-11; Metz B, 2009, FEBS LETT, V583, P1309, DOI 10.1016/j.febslet.2009.03.027; MOORELANDECKER E, 1992, MYCOL RES, V96, P705, DOI 10.1016/S0953-7562(09)80438-3; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Sarikaya-Bayram O, 2014, DEV CELL, V29, P406, DOI 10.1016/j.devcel.2014.03.020; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schmoll M., 2014, MYCOTA 13, P233, DOI [10.1007/978-3-642-45218-5_10, DOI 10.1007/978-3-642-45218-5_10]; Schmoll M, 2016, MYCOTA, V1, P457; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Schmoll M, 2010, FUNGAL GENET BIOL, V47, P909, DOI 10.1016/j.fgb.2010.04.010; Schmoll M, 2010, MOL MICROBIOL, V77, P1483, DOI 10.1111/j.1365-2958.2010.07295.x; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; Seibel C, 2012, FUNGAL GENET BIOL, V49, P814, DOI 10.1016/j.fgb.2012.07.004; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Tisch D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-425; Tisch D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-657; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; Yager L N, 1992, Biotechnology, V23, P19	52	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175946	10.1371/journal.pone.0175946	http://dx.doi.org/10.1371/journal.pone.0175946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423024	Green Published, gold, Green Submitted			2022-12-27	WOS:000399875600067
J	Favre, G; Grangeon-Chapon, C; Raffaelli, C; Francois-Chalmin, F; Iannelli, A; Esnault, V				Favre, Guillaume; Grangeon-Chapon, Caroline; Raffaelli, Charles; Francois-Chalmin, Florence; Iannelli, Antonio; Esnault, Vincent			Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CHRONIC KIDNEY-DISEASE; LOW URINE PH; METABOLIC SYNDROME; ANGIOTENSIN-II; OBESITY; HEART; INDEX	Deposition of perirenal adipose tissue has been associated with adverse renal and cardiovascular events. We compared various methods to measure perirenal adipose tissue using computerized tomography (CT)-scan and performed correlations with anthropometric measures associated with renal and cardiovascular events. Voluntary overweight and obese subjects undergoing a CT-scan for diagnostic purposes were included in the study. Perirenal adipose tissue volume, adipose tissue area of the renal sinus and perirenal fat thickness were manually measured bilaterally. The intra-and inter-observer coefficient correlations and the correlation between the diverse measures of renal adipose tissue, subcutaneous (SC-)fat and anthropometrics measures were analyzed using Pearson's correlation tests. The forty included patients (24 men, 16 women) had a mean age of 57.6 +/- 18.1 years and a mean body mass index of 28.9 +/- 2.9 kg/m(2). Despite comparable waist circumference, women had a greater SC-fat thickness compared to men, and therefore a smaller amount of visceral fat, as well as smaller perirenal fat volumes. Perirenal fat thickness was better correlated with perirenal fat volume than adipose area of the renal sinus (p < 0.02). The adipose area of the renal sinus did not correlate with any anthropometric measures. In women, perirenal fat volume and thickness showed a negative correlation with SC-fat thickness and no correlation with waist circumference. In men, perirenal fat volume and thickness showed a positive correlation with waist circumference and no correlation with subcutaneous fat thickness. In conclusion, perirenal fat thickness measured with CT-scan at the level of the renal veins is a simple and reliable estimate of perirenal fat volume, that correlated negatively with SC-fat in women and positively with waist circumference in men. The adipose area of the renal sinus did not correlate with any anthropometric measure.	[Favre, Guillaume; Francois-Chalmin, Florence; Esnault, Vincent] Nice Univ Hosp, Nephrol Unit, Nice, France; [Favre, Guillaume; Iannelli, Antonio; Esnault, Vincent] Univ Nice Sophia Antipolis, Nice, France; [Favre, Guillaume; Esnault, Vincent] Nice IRCAN, Inst Res Canc & Aging, Aging & Diabet team, Nice, France; [Grangeon-Chapon, Caroline] Nice Univ Hosp, Nucl Med Dept, Nice, France; [Raffaelli, Charles] Nice Univ Hosp, Radiol Dept, Nice, France; [Iannelli, Antonio] Univ Hosp Nice, Archet Hosp 2, Digest Unit, Nice, France; [Iannelli, Antonio] INSERM, Team Hepat Complicat Obes 8, U1065, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Favre, G (corresponding author), Nice Univ Hosp, Nephrol Unit, Nice, France.; Favre, G (corresponding author), Univ Nice Sophia Antipolis, Nice, France.; Favre, G (corresponding author), Nice IRCAN, Inst Res Canc & Aging, Aging & Diabet team, Nice, France.	favre.g@chu-nice.fr		Iannelli, Antonio/0000-0002-1611-071X; FAVRE, GUILLAUME/0000-0003-1069-4344	Fresenius Medical Care	Fresenius Medical Care	The authors received funding from Fresenius Medical Care for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosma RJ, 2007, AM J TRANSPLANT, V7, P645, DOI 10.1111/j.1600-6143.2006.01672.x; Chughtai HL, 2010, HYPERTENSION, V56, P901, DOI 10.1161/HYPERTENSIONAHA.110.157370; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Eisner BH, 2010, SURG RADIOL ANAT, V32, P879, DOI 10.1007/s00276-010-0692-7; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; GRAUER WO, 1984, AM J CLIN NUTR, V39, P631, DOI 10.1093/ajcn/39.4.631; Guo GJ, 2001, AM J PHYSIOL-RENAL, V280, pF777, DOI 10.1152/ajprenal.2001.280.5.F777; Kaissling B, 1979, Adv Anat Embryol Cell Biol, V56, P1; Kwakernaak AJ, 2013, J AM SOC NEPHROL; Lamacchia O, 2011, NEPHROL DIAL TRANSPL, V26, P892, DOI 10.1093/ndt/gfq522; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; Maalouf NM, 2010, CLIN J AM SOC NEPHRO, V5, P1277, DOI 10.2215/CJN.08331109; Maalouf NM, 2004, KIDNEY INT, V65, P1422, DOI 10.1111/j.1523-1755.2004.00522.x; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; ROSSNER S, 1990, INT J OBESITY, V14, P893; Shoja MM, 2010, ANN ANAT, V192, P194, DOI 10.1016/j.aanat.2010.05.001; Tarzi RM, 2004, AM J PATHOL, V164, P385, DOI 10.1016/S0002-9440(10)63128-8; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	23	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2017	12	4							e0175561	10.1371/journal.pone.0175561	http://dx.doi.org/10.1371/journal.pone.0175561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KK	28423008	Green Submitted, Green Published, gold			2022-12-27	WOS:000399875600035
J	Hong, M; Jung, J; Park, HS; Lee, SM; Jeong, NJ; Kim, SH; Lee, KW; Lee, JA; Kim, MS				Hong, Moonju; Jung, Jeeyoun; Park, Hee-Sook; Lee, So Min; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Lee, Ju-A; Kim, Myung-Sunny			Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; ACTIVE FRACTION; BLOOD-STASIS; TNF-ALPHA; MEDICINE; RATS; IDENTIFICATION	Shaofu Zhuyu decoction (SFZYD, also known as Sobokchugeo-tang), a classical prescription drug in traditional East Asian medicine, has been used to treat blood stasis syndrome (BSS). Hepatic steatosis is the result of excess caloric intake, and its pathogenesis involves internal retention of phlegm and dampness, blood stasis, and liver Qi stagnation. To evaluate the effects of treatment with SFZYD on obesity-induced inflammation and hepatic steatosis, we fed male C57BL/6N mice a high fat diet (HFD) for 8 weeks and then treated them with SFZYD by oral gavage for an additional 4 weeks. The results of histological and biochemical examinations indicated that SFZYD treatment ameliorates systemic inflammation and hepatic steatosis. A partial least squares-discriminant analysis (PLS-DA) scores plot of serum metabolites showed that HFD mice began to produce metabolites similar to those of normal chow (NC) mice after SFZYD administration. We noted significant alterations in the levels of twenty-seven metabolites, alterations indicating that SFZYD regulates the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism. Increases in the levels of TCA cycle intermediate metabolites, such as 2-oxoglutaric acid, isocitric acid, and malic acid, in the serum of obese mice were significantly reversed after SFZYD treatment. In addition to inducing changes in the above metabolites, treatment with SFZYD also recovered the expression of genes related to hepatic mitochondrial dysfunction, including Ucp2, Cpt1 alpha, and Ppargc1 alpha, as well as the expression of genes involved in lipid metabolism and inflammation, without affecting glucose uptake or insulin signaling. Taken together, these findings suggest that treatment with SFZYD ameliorated obesity-induced systemic inflammation and hepatic steatosis by regulating inflammatory cytokine and adipokine levels in the circulation and various tissues. Moreover, treatment with SFZYD also reversed alterations in the levels of metabolites of the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism.	[Hong, Moonju; Park, Hee-Sook; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Kim, Myung-Sunny] Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea; [Hong, Moonju; Kim, Myung-Sunny] Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea; [Jung, Jeeyoun; Lee, So Min; Lee, Ju-A] Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea	Korea Food Research Institute (KFRI); Korea Institute of Oriental Medicine (KIOM)	Kim, MS (corresponding author), Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea.; Kim, MS (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea.	truka@kfri.re.kr	Jung, Jeeyoun/G-8438-2018	Hong, Moonju/0000-0001-7688-6803	Korea Institute of Oriental Medicine [K15113, K15114]; Korea Food Research Institute [E0150302-2]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024748] Funding Source: NIH RePORTER	Korea Institute of Oriental Medicine; Korea Food Research Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). We thank Drs. K.S. Sung and C.E. Lee for providing technical support for the animal experiments.	Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Dong H, 2012, CHIN J INTEGR MED, V18, P152, DOI 10.1007/s11655-012-0993-2; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fan M., 2011, BEIJING J TRADIT CHI, V30, P455; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Guo N, 2014, J CHROMATOGR A, V1362, P89, DOI 10.1016/j.chroma.2014.08.028; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Huang XC, 2016, J ETHNOPHARMACOL, V186, P234, DOI 10.1016/j.jep.2016.03.067; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Jia W, 2006, PHYTOTHER RES, V20, P819, DOI 10.1002/ptr.1905; Kim M, 2002, J COMMUN HEALTH, V27, P109, DOI 10.1023/A:1014509200352; Kim MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082847; Kim SH, 2016, J ETHNOPHARMACOL, V192, P201, DOI 10.1016/j.jep.2016.07.023; KUNJARA S, 1993, BIOCHEM MED METAB B, V49, P217, DOI 10.1006/bmmb.1993.1024; Lan K, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819147; Li SM, 2014, CHIN J INTEGR MED, V20, P483, DOI 10.1007/s11655-014-1803-9; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liu CG, 2013, BIOL PHARM BULL, V36, P1700; Liu L, 2010, MOLECULES, V15, P5066, DOI 10.3390/molecules15085066; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Park HS, 2016, MOL NUTR FOOD RES, V60, P1944, DOI 10.1002/mnfr.201500689; Rodriguez-Gallego E, 2015, INT J OBESITY, V39, P279, DOI 10.1038/ijo.2014.53; Su SL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/901943; Su SL, 2010, AM J CHINESE MED, V38, P777, DOI 10.1142/S0192415X10008238; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yonghe CMY, 2007, J TRADITIONAL CHINES, V27, P115; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19288; Zhao XJ, 2008, J CHROMATOGR B, V873, P151, DOI 10.1016/j.jchromb.2008.08.010	39	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178514	10.1371/journal.pone.0178514	http://dx.doi.org/10.1371/journal.pone.0178514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28441416	Green Submitted, Green Published, gold			2022-12-27	WOS:000402611800069
